covid-19 ,novel:122
covid-19 ,coronavirus:474
covid-19 ,recent:24
covid-19 ,trends:12
novel ,coronavirus:508
novel ,recent:12
novel ,trends:2
coronavirus ,recent:32
coronavirus ,trends:4
recent ,trends:4
sars ,covid-19:46
sars ,learned:8
sars ,children:6
sars ,infected:2
covid-19 ,learned:28
covid-19 ,children:132
covid-19 ,infected:12
learned ,children:2
learned ,infected:2
children ,infected:8
comprehensive ,review:54
comprehensive ,covid-19:52
comprehensive ,characteristics:2
review ,covid-19:438
review ,characteristics:8
covid-19 ,characteristics:140
covid-19 ,diagnosis:126
covid-19 ,management:236
diagnosis ,management:22
diagnosis ,comprehensive:2
diagnosis ,review:18
management ,comprehensive:2
management ,review:26
covid-19 ,virology:10
covid-19 ,geroscience:6
covid-19 ,perspective:76
virology ,geroscience:2
virology ,perspective:2
geroscience ,perspective:4
perspectives ,monoclonal:2
perspectives ,antibody:2
perspectives ,therapy:4
perspectives ,potential:4
perspectives ,therapeutic:8
perspectives ,intervention:2
monoclonal ,antibody:8
monoclonal ,therapy:4
monoclonal ,potential:4
monoclonal ,therapeutic:4
monoclonal ,intervention:2
antibody ,therapy:6
antibody ,potential:6
antibody ,therapeutic:4
antibody ,intervention:2
therapy ,potential:24
therapy ,therapeutic:4
therapy ,intervention:2
potential ,therapeutic:100
potential ,intervention:2
therapeutic ,intervention:4
understanding ,covid-19:40
understanding ,based:2
understanding ,current:8
understanding ,evidence:2
covid-19 ,based:34
covid-19 ,current:160
covid-19 ,evidence:62
based ,current:8
based ,evidence:12
current ,evidence:28
chloroquine ,covid-19:30
coronavirus ,disease:878
coronavirus ,literature:2
coronavirus ,review:122
disease ,covid-19:486
disease ,literature:2
disease ,review:80
covid-19 ,literature:44
literature ,review:56
sars-cov-2 ,covid-19:496
sars-cov-2 ,important:8
sars-cov-2 ,research:32
sars-cov-2 ,questions:8
covid-19 ,important:10
covid-19 ,research:54
covid-19 ,questions:20
important ,research:2
important ,questions:2
research ,questions:4
coronavirus ,current:40
coronavirus ,status:12
coronavirus ,future:4
coronavirus ,perspectives:14
disease ,current:22
disease ,status:10
disease ,future:2
disease ,perspectives:12
covid-19 ,status:50
covid-19 ,future:42
covid-19 ,perspectives:32
current ,status:32
current ,future:26
current ,perspectives:12
status ,future:10
status ,perspectives:4
future ,perspectives:12
covid-19 ,knowns:4
covid-19 ,unknowns:4
knowns ,unknowns:8
knowns ,questions:2
unknowns ,questions:2
sars-cov-2 ,disease:92
sars-cov-2 ,mini:2
sars-cov-2 ,review:150
sars-cov-2 ,diagnostic:58
sars-cov-2 ,methods:16
covid-19 ,mini:2
covid-19 ,diagnostic:80
covid-19 ,methods:14
disease ,mini:4
disease ,diagnostic:22
disease ,methods:4
mini ,review:4
mini ,diagnostic:2
mini ,methods:2
review ,diagnostic:8
review ,methods:8
diagnostic ,methods:14
pathogenesis ,treatment:16
pathogenesis ,cytokine:6
pathogenesis ,storm:6
pathogenesis ,covid-19:64
treatment ,cytokine:8
treatment ,storm:6
treatment ,covid-19:268
cytokine ,storm:74
cytokine ,covid-19:48
storm ,covid-19:44
current ,epidemiology:2
current ,diagnosis:16
current ,therapeutics:6
current ,vaccines:12
current ,novel:16
status ,epidemiology:2
status ,diagnosis:4
status ,therapeutics:4
status ,vaccines:6
status ,novel:4
epidemiology ,diagnosis:12
epidemiology ,therapeutics:2
epidemiology ,vaccines:4
epidemiology ,novel:4
diagnosis ,therapeutics:2
diagnosis ,vaccines:2
diagnosis ,novel:32
therapeutics ,vaccines:10
therapeutics ,novel:10
vaccines ,novel:6
neuroinvasive ,potential:10
neuroinvasive ,sars-cov2:2
neuroinvasive ,may:6
neuroinvasive ,play:6
neuroinvasive ,role:6
neuroinvasive ,respiratory:4
neuroinvasive ,failure:2
potential ,sars-cov2:6
potential ,may:10
potential ,play:6
potential ,role:60
potential ,respiratory:22
potential ,failure:2
sars-cov2 ,may:2
sars-cov2 ,play:2
sars-cov2 ,role:2
sars-cov2 ,respiratory:4
sars-cov2 ,failure:2
may ,play:8
may ,role:8
may ,respiratory:2
may ,failure:2
play ,role:16
play ,respiratory:2
play ,failure:2
role ,respiratory:8
role ,failure:4
respiratory ,failure:20
clinical ,characteristics:244
clinical ,children:52
clinical ,covid-19:416
characteristics ,children:24
laboratory ,findings:14
laboratory ,covid-19:68
laboratory ,diagnosis:28
laboratory ,prognosis:6
findings ,covid-19:76
findings ,diagnosis:2
findings ,prognosis:2
covid-19 ,prognosis:36
diagnosis ,prognosis:6
covid-19 ,outbreak:208
covid-19 ,caused:30
covid-19 ,new:96
outbreak ,caused:8
outbreak ,new:10
outbreak ,coronavirus:76
caused ,new:4
caused ,coronavirus:8
new ,coronavirus:54
review ,disease-2019:4
coronavirus ,disease-2019:24
disease-2019 ,covid-19:12
global ,treatments:4
global ,coronaviruses:6
global ,including:2
global ,covid-19:60
treatments ,coronaviruses:2
treatments ,including:2
treatments ,covid-19:18
coronaviruses ,including:6
coronaviruses ,covid-19:22
including ,covid-19:2
covid-19 ,abnormal:6
covid-19 ,liver:56
covid-19 ,function:10
covid-19 ,tests:28
abnormal ,liver:8
abnormal ,function:4
abnormal ,tests:6
liver ,function:4
liver ,tests:6
function ,tests:4
possible ,immunotherapy:2
possible ,covid-19:66
possible ,systematic:2
possible ,review:14
immunotherapy ,covid-19:14
immunotherapy ,systematic:2
immunotherapy ,review:2
covid-19 ,systematic:138
systematic ,review:180
discovering ,drugs:2
discovering ,treat:2
discovering ,coronavirus:2
discovering ,disease:2
discovering ,covid-19:2
drugs ,treat:4
drugs ,coronavirus:20
drugs ,disease:10
drugs ,covid-19:62
treat ,coronavirus:6
treat ,disease:4
treat ,covid-19:18
systematic ,children:12
systematic ,shows:2
systematic ,milder:2
systematic ,cases:6
systematic ,better:2
systematic ,prognosis:6
review ,children:22
review ,shows:2
review ,milder:2
review ,cases:10
review ,better:2
review ,prognosis:8
covid-19 ,shows:4
covid-19 ,milder:2
covid-19 ,cases:128
covid-19 ,better:6
children ,shows:2
children ,milder:2
children ,cases:12
children ,better:4
children ,prognosis:2
shows ,milder:2
shows ,cases:2
shows ,better:2
shows ,prognosis:2
milder ,cases:2
milder ,better:2
milder ,prognosis:2
cases ,better:2
cases ,prognosis:2
better ,prognosis:2
current ,epidemiological:6
current ,clinical:16
current ,features:6
current ,global:6
current ,perspective:12
epidemiological ,clinical:62
epidemiological ,features:28
epidemiological ,covid-19:64
epidemiological ,global:2
epidemiological ,perspective:4
clinical ,features:124
clinical ,global:6
clinical ,perspective:12
features ,covid-19:76
features ,global:2
features ,perspective:2
global ,perspective:4
pediatric ,covid-19:50
pediatric ,systematic:2
pediatric ,review:8
pediatric ,literature:2
systematic ,literature:6
emergency ,surgery:10
emergency ,covid-19:60
emergency ,pandemic:20
emergency ,need:2
emergency ,know:2
emergency ,practice:4
surgery ,covid-19:66
surgery ,pandemic:42
surgery ,need:4
surgery ,know:2
surgery ,practice:8
covid-19 ,pandemic:704
covid-19 ,need:44
covid-19 ,know:60
covid-19 ,practice:74
pandemic ,need:14
pandemic ,know:6
pandemic ,practice:22
need ,know:20
need ,practice:2
know ,practice:2
origin ,transmission:8
origin ,clinical:2
origin ,therapies:2
origin ,coronavirus:8
origin ,disease:4
transmission ,clinical:6
transmission ,therapies:2
transmission ,coronavirus:58
transmission ,disease:22
clinical ,therapies:6
clinical ,coronavirus:172
clinical ,disease:116
therapies ,coronavirus:2
therapies ,disease:4
novel ,disease:70
novel ,newborns:4
novel ,infants:4
novel ,know:8
novel ,far:2
coronavirus ,newborns:2
coronavirus ,infants:6
coronavirus ,know:16
coronavirus ,far:4
disease ,newborns:4
disease ,infants:2
disease ,know:8
disease ,far:4
covid-19 ,newborns:12
covid-19 ,infants:12
covid-19 ,far:24
newborns ,infants:2
newborns ,know:2
newborns ,far:2
infants ,know:2
infants ,far:2
know ,far:20
glucovigilance ,covid-19:2
current ,practice:8
current ,potential:18
current ,strategy:2
current ,diagnosing:2
practice ,potential:2
practice ,strategy:2
practice ,diagnosing:2
potential ,strategy:20
potential ,diagnosing:2
potential ,covid-19:244
strategy ,diagnosing:2
strategy ,covid-19:38
diagnosing ,covid-19:8
diagnostics ,sars-cov-2:8
diagnostics ,detection:4
diagnostics ,comprehensive:2
diagnostics ,review:2
diagnostics ,fda-eua:2
diagnostics ,covid-19:22
sars-cov-2 ,detection:306
sars-cov-2 ,comprehensive:22
sars-cov-2 ,fda-eua:2
detection ,comprehensive:4
detection ,review:10
detection ,fda-eua:2
detection ,covid-19:70
comprehensive ,fda-eua:2
review ,fda-eua:2
fda-eua ,covid-19:2
persistence ,sars-cov-2:20
persistence ,environment:2
persistence ,covid-19:6
persistence ,transmission:2
persistence ,risk:2
sars-cov-2 ,environment:16
sars-cov-2 ,transmission:264
sars-cov-2 ,risk:104
environment ,covid-19:14
environment ,transmission:4
environment ,risk:4
covid-19 ,transmission:142
covid-19 ,risk:154
transmission ,risk:34
know ,current:4
know ,clinical:2
know ,knowledge:2
know ,research:2
far ,current:2
far ,clinical:2
far ,knowledge:2
far ,research:4
covid-19 ,knowledge:38
current ,knowledge:24
current ,research:6
clinical ,knowledge:2
clinical ,research:14
knowledge ,research:4
covid-19 ,rheumatologists:4
covid-19 ,highly:14
pediatric ,rheumatologists:4
pediatric ,know:2
pediatric ,highly:2
rheumatologists ,know:2
rheumatologists ,review:2
rheumatologists ,highly:2
know ,review:16
know ,highly:2
review ,highly:2
covid-19 ,spontaneous:8
covid-19 ,pneumothorax:14
covid-19 ,pneumomediastinum:2
covid-19 ,subcutaneous:4
spontaneous ,pneumothorax:8
spontaneous ,pneumomediastinum:2
spontaneous ,subcutaneous:4
pneumothorax ,pneumomediastinum:2
pneumothorax ,subcutaneous:4
pneumomediastinum ,subcutaneous:4
covid-19 ,real-time:6
covid-19 ,dissemination:4
covid-19 ,scientific:6
covid-19 ,information:16
covid-19 ,fight:32
covid-19 ,public:48
covid-19 ,health:148
real-time ,dissemination:2
real-time ,scientific:2
real-time ,information:2
real-time ,fight:2
real-time ,public:2
real-time ,health:2
dissemination ,scientific:2
dissemination ,information:2
dissemination ,fight:2
dissemination ,public:2
dissemination ,health:2
scientific ,information:2
scientific ,fight:2
scientific ,public:2
scientific ,health:2
information ,fight:4
information ,public:2
information ,health:2
fight ,public:2
fight ,health:4
public ,health:72
emerging ,therapeutic:6
emerging ,strategies:6
emerging ,covid-19:48
emerging ,patients:4
therapeutic ,strategies:12
therapeutic ,covid-19:104
therapeutic ,patients:8
strategies ,covid-19:52
strategies ,patients:2
covid-19 ,patients:820
brief ,review:16
brief ,covid-19:22
brief ,pandemic:4
brief ,caused:2
brief ,sars-cov-2:16
review ,pandemic:44
review ,caused:4
pandemic ,caused:6
pandemic ,sars-cov-2:156
caused ,sars-cov-2:20
preliminary ,identification:2
preliminary ,potential:4
preliminary ,vaccine:2
preliminary ,targets:2
preliminary ,covid-19:22
preliminary ,coronavirus:6
identification ,potential:14
identification ,vaccine:6
identification ,targets:4
identification ,covid-19:14
identification ,coronavirus:10
potential ,vaccine:10
potential ,targets:16
potential ,coronavirus:50
vaccine ,targets:6
vaccine ,covid-19:48
vaccine ,coronavirus:24
targets ,covid-19:22
targets ,coronavirus:10
covid-19 ,australia:58
covid-19 ,epidemiology:116
covid-19 ,report:214
covid-19 ,reporting:60
covid-19 ,week:28
covid-19 ,ending:38
covid-19 ,1900:14
covid-19 ,aedt:16
covid-19 ,march:10
australia ,epidemiology:58
australia ,report:58
australia ,reporting:58
australia ,week:28
australia ,ending:38
australia ,1900:14
australia ,aedt:16
australia ,march:4
epidemiology ,report:58
epidemiology ,reporting:58
epidemiology ,week:28
epidemiology ,ending:38
epidemiology ,1900:14
epidemiology ,aedt:16
epidemiology ,march:4
report ,reporting:58
report ,week:28
report ,ending:38
report ,1900:14
report ,aedt:16
report ,march:6
reporting ,week:28
reporting ,ending:38
reporting ,1900:14
reporting ,aedt:16
reporting ,march:4
week ,ending:12
week ,1900:12
week ,aedt:14
week ,march:4
ending ,1900:12
ending ,aedt:12
ending ,march:2
1900 ,aedt:14
1900 ,march:2
aedt ,march:4
dengue ,fever:2
dengue ,covid-19:4
dengue ,sars-cov-2:6
dengue ,antibody-dependent:2
dengue ,enhancement:2
dengue ,ade:2
fever ,covid-19:8
fever ,sars-cov-2:2
fever ,antibody-dependent:2
fever ,enhancement:2
fever ,ade:2
covid-19 ,antibody-dependent:2
covid-19 ,enhancement:2
covid-19 ,ade:4
sars-cov-2 ,antibody-dependent:6
sars-cov-2 ,enhancement:8
sars-cov-2 ,ade:2
antibody-dependent ,enhancement:8
antibody-dependent ,ade:2
enhancement ,ade:2
diabetes ,mellitus:36
diabetes ,associated:6
diabetes ,mortality:4
diabetes ,severity:14
diabetes ,covid-19:62
mellitus ,associated:4
mellitus ,mortality:4
mellitus ,severity:6
mellitus ,covid-19:16
associated ,mortality:26
associated ,severity:8
associated ,covid-19:132
mortality ,severity:10
mortality ,covid-19:64
severity ,covid-19:66
potential ,influence:4
potential ,covid-19ace2:2
potential ,female:2
potential ,reproductive:2
potential ,system:10
influence ,covid-19ace2:2
influence ,female:2
influence ,reproductive:2
influence ,system:2
covid-19ace2 ,female:2
covid-19ace2 ,reproductive:2
covid-19ace2 ,system:2
female ,reproductive:2
female ,system:2
reproductive ,system:2
new ,insights:8
new ,antiviral:4
new ,effects:2
new ,chloroquine:2
insights ,antiviral:4
insights ,effects:2
insights ,chloroquine:6
insights ,coronavirus:18
antiviral ,effects:8
antiviral ,chloroquine:4
antiviral ,coronavirus:16
effects ,chloroquine:2
effects ,coronavirus:16
chloroquine ,coronavirus:6
breakthrough ,chloroquine:2
breakthrough ,phosphate:2
breakthrough ,shown:2
breakthrough ,apparent:2
breakthrough ,efficacy:2
breakthrough ,treatment:2
chloroquine ,phosphate:2
chloroquine ,shown:2
chloroquine ,apparent:2
chloroquine ,efficacy:8
chloroquine ,treatment:14
phosphate ,shown:2
phosphate ,apparent:2
phosphate ,efficacy:2
phosphate ,treatment:2
shown ,apparent:2
shown ,efficacy:2
shown ,treatment:2
apparent ,efficacy:2
apparent ,treatment:2
efficacy ,treatment:8
covid-19 ,conundrum:2
covid-19 ,decipher:2
conundrum ,decipher:2
effects ,social:6
effects ,support:2
effects ,sleep:4
effects ,quality:4
effects ,medical:2
effects ,staff:2
effects ,treating:2
effects ,patients:8
social ,support:2
social ,sleep:4
social ,quality:2
social ,medical:4
social ,staff:2
social ,treating:2
social ,patients:4
support ,sleep:2
support ,quality:2
support ,medical:2
support ,staff:2
support ,treating:2
support ,patients:8
sleep ,quality:4
sleep ,medical:2
sleep ,staff:2
sleep ,treating:2
sleep ,patients:2
quality ,medical:2
quality ,staff:2
quality ,treating:2
quality ,patients:2
medical ,staff:12
medical ,treating:2
medical ,patients:12
staff ,treating:2
staff ,patients:6
treating ,patients:14
covid-19 ,dentistry-related:2
covid-19 ,aspects:16
covid-19 ,overview:56
dentistry-related ,aspects:2
dentistry-related ,literature:2
dentistry-related ,overview:2
aspects ,literature:2
aspects ,overview:2
literature ,overview:2
immune ,response:62
immune ,immunopathology:6
immune ,covid-19:86
response ,immunopathology:4
response ,covid-19:104
immunopathology ,covid-19:4
covid-19 ,guidelines:22
covid-19 ,ophthalmology:26
covid-19 ,practices:26
preliminary ,clinical:4
preliminary ,guidelines:2
preliminary ,ophthalmology:2
preliminary ,practices:2
clinical ,guidelines:4
clinical ,ophthalmology:4
clinical ,practices:2
guidelines ,ophthalmology:2
guidelines ,practices:4
ophthalmology ,practices:2
rapid ,detection:66
rapid ,covid-19:66
rapid ,causative:2
rapid ,virus:6
rapid ,sars-cov-2:112
rapid ,human:6
rapid ,nasopharyngeal:2
detection ,causative:2
detection ,virus:18
detection ,human:16
detection ,nasopharyngeal:14
covid-19 ,causative:4
covid-19 ,virus:68
covid-19 ,human:34
covid-19 ,nasopharyngeal:14
causative ,virus:4
causative ,sars-cov-2:2
causative ,human:2
causative ,nasopharyngeal:2
virus ,sars-cov-2:122
virus ,human:14
virus ,nasopharyngeal:4
sars-cov-2 ,human:166
sars-cov-2 ,nasopharyngeal:20
human ,nasopharyngeal:2
sars ,pathogens:2
sars ,receptor:2
sars ,pathogenesis:4
sars ,principles:2
covid-19 ,pathogens:2
covid-19 ,receptor:12
covid-19 ,principles:8
pathogens ,receptor:2
pathogens ,pathogenesis:2
pathogens ,principles:2
receptor ,pathogenesis:2
receptor ,principles:2
pathogenesis ,principles:2
hepatic ,gastrointestinal:12
hepatic ,involvement:4
hepatic ,coronavirus:4
hepatic ,disease:2
hepatic ,covid-19:12
gastrointestinal ,involvement:6
gastrointestinal ,coronavirus:8
gastrointestinal ,disease:6
gastrointestinal ,covid-19:40
involvement ,coronavirus:14
involvement ,disease:10
involvement ,covid-19:40
covid-19 ,worldwide:10
covid-19 ,zoonotic:6
worldwide ,zoonotic:2
worldwide ,pandemic:6
worldwide ,outbreak:2
zoonotic ,pandemic:6
zoonotic ,outbreak:2
pandemic ,outbreak:10
covid-19 ,experiences:22
covid-19 ,china:84
covid-19 ,implications:64
covid-19 ,prevention:70
pandemic ,experiences:6
pandemic ,china:10
pandemic ,implications:10
pandemic ,prevention:8
experiences ,china:2
experiences ,implications:2
experiences ,prevention:4
china ,implications:2
china ,prevention:2
implications ,prevention:4
sars-cov-2 ,much:4
sars-cov-2 ,know:24
covid-19 ,much:4
much ,know:2
severe ,acute:606
severe ,respiratory:542
severe ,syndrome:426
severe ,coronavirus:352
severe ,sars-cov-2:116
acute ,respiratory:568
acute ,syndrome:448
acute ,coronavirus:360
acute ,sars-cov-2:118
respiratory ,syndrome:446
respiratory ,coronavirus:336
respiratory ,sars-cov-2:132
syndrome ,coronavirus:330
syndrome ,sars-cov-2:98
coronavirus ,sars-cov-2:248
trial ,chloroquines:2
trial ,treatment:2
trial ,covid-19:10
trial ,research:4
trial ,progress:2
chloroquines ,treatment:2
chloroquines ,covid-19:4
chloroquines ,research:2
chloroquines ,progress:2
treatment ,research:8
treatment ,progress:8
covid-19 ,progress:20
research ,progress:18
hydroxychloroquine ,azithromycin:16
hydroxychloroquine ,treatment:12
hydroxychloroquine ,covid-19:52
hydroxychloroquine ,results:2
azithromycin ,treatment:6
azithromycin ,covid-19:10
azithromycin ,results:2
treatment ,results:4
covid-19 ,results:34
ongoing ,clinical:14
ongoing ,trials:8
ongoing ,management:2
ongoing ,covid-19:16
ongoing ,pandemic:4
clinical ,trials:40
clinical ,management:38
clinical ,pandemic:22
trials ,management:2
trials ,covid-19:28
trials ,pandemic:8
management ,pandemic:50
clinical ,display:2
clinical ,diagnostics:6
clinical ,genetic:8
clinical ,implication:2
clinical ,novel:54
display ,diagnostics:2
display ,genetic:2
display ,implication:2
display ,novel:2
display ,coronavirus:4
diagnostics ,genetic:2
diagnostics ,implication:2
diagnostics ,novel:8
diagnostics ,coronavirus:12
genetic ,implication:2
genetic ,novel:8
genetic ,coronavirus:14
implication ,novel:2
implication ,coronavirus:2
first ,cases:14
first ,coronavirus:34
first ,disease:22
first ,covid-19:88
first ,france:2
first ,surveillance:6
cases ,coronavirus:46
cases ,disease:30
cases ,france:2
cases ,surveillance:2
coronavirus ,france:2
coronavirus ,surveillance:4
disease ,france:2
disease ,surveillance:4
covid-19 ,france:10
covid-19 ,surveillance:24
france ,surveillance:2
covid-19 ,spike:10
covid-19 ,protein:10
covid-19 ,analysis:120
covid-19 ,synthetic:2
covid-19 ,vaccines:44
covid-19 ,peptidomimetic:2
coronavirus ,spike:28
coronavirus ,protein:24
coronavirus ,analysis:56
coronavirus ,synthetic:2
coronavirus ,vaccines:10
coronavirus ,peptidomimetic:2
spike ,protein:102
spike ,analysis:16
spike ,synthetic:2
spike ,vaccines:4
spike ,peptidomimetic:2
protein ,analysis:22
protein ,synthetic:2
protein ,vaccines:4
protein ,peptidomimetic:2
analysis ,synthetic:2
analysis ,vaccines:2
analysis ,peptidomimetic:2
synthetic ,vaccines:2
synthetic ,peptidomimetic:2
vaccines ,peptidomimetic:2
neurological ,manifestations:64
neurological ,covid-19:86
manifestations ,covid-19:144
top ,concerns:2
top ,tweeters:2
top ,covid-19:4
top ,pandemic:4
top ,infoveillance:2
top ,study:2
concerns ,tweeters:2
concerns ,covid-19:8
concerns ,pandemic:4
concerns ,infoveillance:2
concerns ,study:2
tweeters ,covid-19:2
tweeters ,pandemic:2
tweeters ,infoveillance:2
tweeters ,study:2
covid-19 ,infoveillance:2
covid-19 ,study:96
pandemic ,infoveillance:2
pandemic ,study:18
infoveillance ,study:2
crosstalk ,endoplasmic:2
crosstalk ,reticulum:2
crosstalk ,stress:2
crosstalk ,anti-viral:2
crosstalk ,activities:2
crosstalk ,novel:2
endoplasmic ,reticulum:4
endoplasmic ,stress:2
endoplasmic ,anti-viral:2
endoplasmic ,activities:2
endoplasmic ,novel:2
reticulum ,stress:2
reticulum ,anti-viral:2
reticulum ,activities:2
reticulum ,novel:2
stress ,anti-viral:2
stress ,activities:2
stress ,novel:2
anti-viral ,activities:4
anti-viral ,novel:6
activities ,novel:4
novel ,pandemic:18
novel ,review:36
coronavirus ,pandemic:86
disease ,pandemic:50
pandemic ,current:28
review ,current:52
detection ,analysis:14
detection ,nucleic:22
detection ,acid:22
detection ,various:2
detection ,biological:2
detection ,samples:22
analysis ,nucleic:6
analysis ,acid:6
analysis ,various:2
analysis ,biological:4
analysis ,samples:6
nucleic ,acid:68
nucleic ,various:2
nucleic ,biological:2
nucleic ,samples:2
nucleic ,covid-19:20
acid ,various:2
acid ,biological:2
acid ,samples:2
acid ,covid-19:26
various ,biological:2
various ,samples:2
various ,covid-19:4
biological ,samples:2
biological ,covid-19:14
samples ,covid-19:6
comprehensive ,manifestations:10
comprehensive ,novel:6
comprehensive ,coronaviruses:4
comprehensive ,context:2
review ,manifestations:46
review ,coronaviruses:14
review ,context:2
manifestations ,novel:10
manifestations ,coronaviruses:6
manifestations ,context:2
novel ,coronaviruses:14
novel ,context:2
coronaviruses ,context:4
assessing ,ace2:2
assessing ,expression:2
assessing ,patterns:2
assessing ,lung:2
assessing ,tissues:2
assessing ,pathogenesis:2
assessing ,covid-19:14
ace2 ,expression:58
ace2 ,patterns:2
ace2 ,lung:2
ace2 ,tissues:4
ace2 ,pathogenesis:2
ace2 ,covid-19:34
expression ,patterns:2
expression ,lung:2
expression ,tissues:4
expression ,pathogenesis:2
expression ,covid-19:12
patterns ,lung:2
patterns ,tissues:2
patterns ,pathogenesis:2
patterns ,covid-19:8
lung ,tissues:2
lung ,pathogenesis:2
lung ,covid-19:68
tissues ,pathogenesis:2
tissues ,covid-19:2
current ,diagnostic:8
current ,techniques:2
perspective ,diagnostic:4
perspective ,techniques:2
diagnostic ,techniques:2
techniques ,covid-19:2
geographical ,tracking:2
geographical ,mapping:2
geographical ,coronavirus:2
geographical ,disease:2
geographical ,covid-19severe:2
geographical ,acute:2
tracking ,mapping:2
tracking ,coronavirus:2
tracking ,disease:2
tracking ,covid-19severe:2
tracking ,acute:2
mapping ,coronavirus:6
mapping ,disease:2
mapping ,covid-19severe:2
mapping ,acute:2
coronavirus ,covid-19severe:2
disease ,covid-19severe:2
disease ,acute:48
covid-19severe ,acute:2
covid-19 ,spotlight:2
covid-19 ,close:10
covid-19 ,look:10
covid-19 ,origin:10
spotlight ,close:2
spotlight ,look:2
spotlight ,origin:2
spotlight ,transmission:2
spotlight ,diagnosis:2
close ,look:4
close ,origin:2
close ,transmission:6
close ,diagnosis:2
look ,origin:2
look ,transmission:2
look ,diagnosis:2
origin ,diagnosis:8
transmission ,diagnosis:10
updating ,diagnostic:2
updating ,criteria:2
updating ,covid-19:4
updating ,suspected:2
updating ,case:2
updating ,confirmed:2
diagnostic ,criteria:4
diagnostic ,suspected:6
diagnostic ,case:2
diagnostic ,confirmed:2
criteria ,covid-19:6
criteria ,suspected:2
criteria ,case:2
criteria ,confirmed:2
covid-19 ,suspected:28
covid-19 ,case:286
covid-19 ,confirmed:22
suspected ,case:6
suspected ,confirmed:8
case ,confirmed:8
covid-19 ,emergence:14
covid-19 ,spread:36
covid-19 ,burden:8
emergence ,spread:2
emergence ,possible:2
emergence ,treatments:2
emergence ,global:2
emergence ,burden:2
spread ,possible:4
spread ,treatments:2
spread ,global:8
spread ,burden:2
possible ,treatments:2
possible ,global:2
possible ,burden:2
treatments ,burden:2
global ,burden:2
covid-19 ,repurposing:46
covid-19 ,cardiac:42
covid-19 ,safety:24
covid-19 ,concern:12
covid-19 ,chirality:2
covid-19 ,might:10
covid-19 ,help:22
chloroquine ,repurposing:4
chloroquine ,cardiac:2
chloroquine ,safety:4
chloroquine ,concern:2
chloroquine ,chirality:2
chloroquine ,might:2
chloroquine ,help:4
repurposing ,cardiac:2
repurposing ,safety:2
repurposing ,concern:2
repurposing ,chirality:2
repurposing ,might:2
repurposing ,help:2
cardiac ,safety:2
cardiac ,concern:2
cardiac ,chirality:2
cardiac ,might:2
cardiac ,help:2
safety ,concern:2
safety ,chirality:2
safety ,might:2
safety ,help:2
concern ,chirality:2
concern ,might:2
concern ,help:2
chirality ,might:2
chirality ,help:2
might ,help:4
analyzing ,epidemiological:2
analyzing ,outbreak:2
analyzing ,covid-19:2
analyzing ,visual:2
analyzing ,exploratory:2
analyzing ,data:2
epidemiological ,outbreak:8
epidemiological ,visual:2
epidemiological ,exploratory:2
epidemiological ,data:6
outbreak ,visual:2
outbreak ,exploratory:2
outbreak ,data:6
covid-19 ,visual:6
covid-19 ,exploratory:4
covid-19 ,data:44
visual ,exploratory:2
visual ,data:2
exploratory ,data:2
therapeutic ,options:22
therapeutic ,review:10
options ,covid-19:22
options ,review:12
chloroquine ,potential:4
chloroquine ,game:2
chloroquine ,changer:2
covid-19 ,game:2
covid-19 ,changer:2
potential ,game:2
potential ,changer:2
game ,changer:2
virological ,clinical:6
virological ,cure:2
virological ,covid-19:6
virological ,patients:4
virological ,treated:2
virological ,hydroxychloroquine:2
clinical ,cure:4
clinical ,patients:206
clinical ,treated:2
clinical ,hydroxychloroquine:12
cure ,covid-19:10
cure ,patients:2
cure ,treated:2
cure ,hydroxychloroquine:4
covid-19 ,treated:20
patients ,treated:8
patients ,hydroxychloroquine:10
treated ,hydroxychloroquine:4
anesthetic ,management:6
anesthetic ,patients:6
anesthetic ,covid:2
anesthetic ,19:2
anesthetic ,infections:2
anesthetic ,emergency:2
management ,patients:86
management ,covid:6
management ,19:4
management ,infections:8
management ,emergency:14
patients ,covid:8
patients ,19:8
patients ,infections:16
patients ,emergency:12
covid ,19:48
covid ,infections:2
covid ,emergency:4
19 ,infections:2
19 ,emergency:4
infections ,emergency:4
updates ,acs:2
updates ,reported:2
updates ,emerging:2
updates ,evidences:2
updates ,covid-19:4
updates ,nervous:2
updates ,system:2
acs ,reported:2
acs ,emerging:2
acs ,evidences:2
acs ,covid-19:2
acs ,nervous:2
acs ,system:2
reported ,emerging:2
reported ,evidences:2
reported ,covid-19:12
reported ,nervous:2
reported ,system:2
emerging ,evidences:2
emerging ,nervous:2
emerging ,system:4
evidences ,covid-19:8
evidences ,nervous:2
evidences ,system:2
covid-19 ,nervous:22
covid-19 ,system:102
nervous ,system:50
clinical ,progression:4
clinical ,patient:14
clinical ,extended:4
clinical ,incubation:2
clinical ,period:4
clinical ,delayed:2
progression ,covid-19:20
progression ,patient:2
progression ,extended:2
progression ,incubation:2
progression ,period:2
progression ,delayed:2
covid-19 ,patient:222
covid-19 ,extended:2
covid-19 ,incubation:10
covid-19 ,period:52
covid-19 ,delayed:8
patient ,extended:2
patient ,incubation:2
patient ,period:2
patient ,delayed:4
extended ,incubation:2
extended ,period:2
extended ,delayed:2
incubation ,period:18
incubation ,delayed:2
period ,delayed:2
therapeutic ,structural:2
therapeutic ,characterization:4
strategies ,structural:2
strategies ,characterization:2
covid-19 ,structural:12
covid-19 ,characterization:6
structural ,characterization:6
diagnosis ,first:6
diagnosis ,case:8
diagnosis ,canada:2
diagnosis ,lessons:2
diagnosis ,applied:2
management ,first:4
management ,case:10
management ,canada:2
management ,lessons:6
management ,applied:2
first ,case:42
first ,canada:2
first ,lessons:2
first ,applied:2
case ,canada:2
case ,lessons:2
case ,applied:2
covid-19 ,canada:8
covid-19 ,lessons:66
covid-19 ,applied:4
canada ,lessons:2
canada ,applied:2
lessons ,applied:2
respiratory ,conditions:6
respiratory ,disease:22
respiratory ,covid-19:76
respiratory ,important:2
conditions ,coronavirus:6
conditions ,disease:4
conditions ,covid-19:16
conditions ,important:2
coronavirus ,important:4
disease ,important:2
covid-19 ,15:4
australia ,15:4
epidemiology ,15:4
report ,15:4
reporting ,15:4
week ,15:4
ending ,15:2
1900 ,15:2
aedt ,15:2
covid-19 ,29:6
australia ,29:6
epidemiology ,29:6
report ,29:6
reporting ,29:6
week ,29:4
ending ,29:4
1900 ,29:2
aedt ,29:4
review ,modes:8
review ,action:6
review ,chloroquinehydroxychloroquine:2
review ,repurposing:10
possible ,modes:4
possible ,action:8
possible ,chloroquinehydroxychloroquine:2
possible ,repurposing:2
modes ,action:4
modes ,chloroquinehydroxychloroquine:2
modes ,repurposing:2
action ,chloroquinehydroxychloroquine:2
action ,repurposing:2
chloroquinehydroxychloroquine ,repurposing:2
covid-19 ,catching:2
covid-19 ,cataclysm:2
pandemic ,catching:2
pandemic ,cataclysm:2
catching ,cataclysm:2
genomic ,analysis:12
genomic ,2019-novel:2
genomic ,coronavirus:16
genomic ,2019-ncov:6
genomic ,strain:2
genomic ,first:2
analysis ,2019-novel:2
analysis ,2019-ncov:14
analysis ,strain:2
analysis ,first:6
2019-novel ,coronavirus:20
2019-novel ,2019-ncov:6
2019-novel ,strain:2
2019-novel ,first:2
coronavirus ,2019-ncov:88
coronavirus ,strain:2
2019-ncov ,strain:2
2019-ncov ,first:6
strain ,first:2
comparison ,clinical:24
comparison ,characteristics:14
comparison ,coronavirus:6
comparison ,disease:4
comparison ,covid-19:28
comparison ,severe:6
clinical ,severe:46
characteristics ,coronavirus:90
characteristics ,disease:58
characteristics ,severe:28
disease ,severe:48
covid-19 ,severe:190
epidemiological ,comorbidity:2
epidemiological ,factors:2
epidemiological ,severity:2
epidemiological ,prognosis:2
comorbidity ,factors:2
comorbidity ,severity:2
comorbidity ,prognosis:2
comorbidity ,covid-19:6
factors ,severity:10
factors ,prognosis:2
factors ,covid-19:46
severity ,prognosis:4
gastrointestinal ,presentation:2
gastrointestinal ,indonesia:2
gastrointestinal ,case:4
gastrointestinal ,report:2
presentation ,covid-19:42
presentation ,indonesia:2
presentation ,case:12
presentation ,report:4
covid-19 ,indonesia:6
indonesia ,case:2
indonesia ,report:2
case ,report:166
computers ,viral:2
computers ,diseases:2
computers ,preliminary:2
computers ,bioinformatics:2
computers ,studies:2
computers ,design:2
viral ,diseases:12
viral ,preliminary:2
viral ,bioinformatics:2
viral ,studies:6
viral ,design:2
diseases ,preliminary:2
diseases ,bioinformatics:2
diseases ,studies:2
diseases ,design:2
preliminary ,bioinformatics:2
preliminary ,studies:2
preliminary ,design:2
bioinformatics ,studies:4
bioinformatics ,design:4
studies ,design:2
rigidity ,outer:2
rigidity ,shell:2
rigidity ,predicted:2
rigidity ,protein:2
rigidity ,intrinsic:2
rigidity ,disorder:2
rigidity ,model:2
rigidity ,sheds:2
outer ,shell:2
outer ,predicted:2
outer ,protein:2
outer ,intrinsic:2
outer ,disorder:2
outer ,model:2
outer ,sheds:2
shell ,predicted:2
shell ,protein:2
shell ,intrinsic:2
shell ,disorder:6
shell ,model:2
shell ,sheds:2
predicted ,protein:2
predicted ,intrinsic:2
predicted ,disorder:2
predicted ,model:2
predicted ,sheds:2
protein ,intrinsic:2
protein ,disorder:2
protein ,model:2
protein ,sheds:2
intrinsic ,disorder:2
intrinsic ,model:2
intrinsic ,sheds:2
disorder ,model:2
disorder ,sheds:2
model ,sheds:2
analytical ,insights:2
analytical ,covid-19:4
analytical ,pandemic:4
insights ,covid-19:48
insights ,pandemic:16
initial ,success:2
initial ,identification:2
initial ,management:4
initial ,coronavirus:10
initial ,disease:6
success ,identification:2
success ,management:2
success ,coronavirus:2
success ,disease:2
identification ,management:2
identification ,disease:4
management ,coronavirus:28
management ,disease:32
cd-sace2 ,inclusion:2
cd-sace2 ,compounds:2
cd-sace2 ,effective:2
cd-sace2 ,treatment:2
cd-sace2 ,coronavirus:2
cd-sace2 ,disease:2
inclusion ,compounds:2
inclusion ,effective:2
inclusion ,treatment:2
inclusion ,coronavirus:2
inclusion ,disease:2
compounds ,effective:4
compounds ,treatment:2
compounds ,coronavirus:4
compounds ,disease:2
effective ,treatment:4
effective ,coronavirus:10
effective ,disease:2
treatment ,coronavirus:84
treatment ,disease:44
diagnosing ,miss:2
diagnosing ,anything:2
covid-19 ,miss:2
covid-19 ,anything:4
miss ,anything:2
potential ,options:16
potential ,status:4
potential ,challenges:10
potential ,future:6
therapeutic ,current:16
therapeutic ,status:4
therapeutic ,challenges:4
therapeutic ,future:2
options ,current:12
options ,status:4
options ,challenges:4
options ,future:2
covid-19 ,challenges:94
current ,challenges:10
status ,challenges:2
challenges ,future:4
dental ,schools:2
dental ,adequately:2
dental ,preparing:2
dental ,students:2
dental ,face:2
dental ,outbreaks:2
schools ,adequately:2
schools ,preparing:2
schools ,students:2
schools ,face:4
schools ,outbreaks:2
adequately ,preparing:2
adequately ,students:2
adequately ,face:2
adequately ,outbreaks:2
preparing ,students:2
preparing ,face:2
preparing ,outbreaks:2
students ,face:2
students ,outbreaks:2
face ,outbreaks:2
effective ,strategies:4
effective ,required:2
effective ,strengthen:2
effective ,public:2
effective ,awareness:2
effective ,covid-19:18
strategies ,required:2
strategies ,strengthen:2
strategies ,public:2
strategies ,awareness:2
required ,strengthen:2
required ,public:4
required ,awareness:2
required ,covid-19:2
strengthen ,public:2
strengthen ,awareness:2
strengthen ,covid-19:4
public ,awareness:4
awareness ,covid-19:8
covid-19 ,22:4
australia ,22:4
epidemiology ,22:4
report ,22:4
reporting ,22:4
week ,22:2
ending ,22:4
1900 ,22:2
aedt ,22:2
pathogenetic ,profiling:2
pathogenetic ,covid-19:2
pathogenetic ,sars-like:2
pathogenetic ,viruses:2
profiling ,covid-19:6
profiling ,sars-like:2
profiling ,viruses:2
covid-19 ,sars-like:2
covid-19 ,viruses:10
sars-like ,viruses:2
four ,point-of-care:2
four ,lateral:2
four ,flow:2
four ,immunoassays:4
four ,diagnosis:2
four ,covid-19:20
point-of-care ,lateral:2
point-of-care ,flow:2
point-of-care ,immunoassays:2
point-of-care ,diagnosis:4
point-of-care ,covid-19:6
lateral ,flow:32
lateral ,immunoassays:10
lateral ,diagnosis:2
lateral ,covid-19:4
flow ,immunoassays:10
flow ,diagnosis:2
flow ,covid-19:6
immunoassays ,diagnosis:2
immunoassays ,covid-19:2
increasing ,signal-to-noise:2
increasing ,ratio:2
increasing ,covid-19:12
increasing ,clinical:2
increasing ,synopsis:2
increasing ,outpatient:2
signal-to-noise ,ratio:2
signal-to-noise ,covid-19:2
signal-to-noise ,clinical:2
signal-to-noise ,synopsis:2
signal-to-noise ,outpatient:2
ratio ,covid-19:2
ratio ,clinical:2
ratio ,synopsis:2
ratio ,outpatient:2
covid-19 ,synopsis:2
covid-19 ,outpatient:8
clinical ,synopsis:2
clinical ,outpatient:4
synopsis ,outpatient:2
covid-19 ,healthcare:68
covid-19 ,workers:64
covid-19 ,living:10
covid-19 ,meta-analysis:22
healthcare ,workers:96
healthcare ,living:2
healthcare ,systematic:4
healthcare ,review:4
healthcare ,meta-analysis:2
workers ,living:2
workers ,systematic:2
workers ,review:2
workers ,meta-analysis:2
living ,systematic:2
living ,review:2
living ,meta-analysis:2
systematic ,meta-analysis:16
review ,meta-analysis:16
successful ,treatment:8
successful ,plasma:4
successful ,exchange:2
successful ,followed:2
successful ,intravenous:2
successful ,immunoglobulin:2
treatment ,plasma:26
treatment ,exchange:2
treatment ,followed:2
treatment ,intravenous:6
treatment ,immunoglobulin:4
plasma ,exchange:6
plasma ,followed:2
plasma ,intravenous:2
plasma ,immunoglobulin:2
exchange ,followed:2
exchange ,intravenous:2
exchange ,immunoglobulin:2
followed ,intravenous:2
followed ,immunoglobulin:2
intravenous ,immunoglobulin:10
covid-19 ,2359:16
australia ,2359:16
epidemiology ,2359:16
report ,2359:16
reporting ,2359:16
week ,2359:16
2359 ,aedt:2
2359 ,29:2
2359 ,march:2
29 ,march:2
asymptomatic ,carrier:4
asymptomatic ,state:2
asymptomatic ,acute:12
asymptomatic ,respiratory:10
asymptomatic ,disease:2
asymptomatic ,pneumonia:10
asymptomatic ,due:2
asymptomatic ,severe:14
carrier ,state:2
carrier ,acute:2
carrier ,respiratory:2
carrier ,disease:2
carrier ,pneumonia:2
carrier ,due:2
carrier ,severe:2
state ,acute:2
state ,respiratory:2
state ,disease:8
state ,pneumonia:4
state ,due:2
state ,severe:4
acute ,pneumonia:8
acute ,due:8
respiratory ,pneumonia:6
respiratory ,due:6
disease ,pneumonia:12
disease ,due:14
pneumonia ,due:6
pneumonia ,severe:22
due ,severe:6
outbreak ,china:20
evolution ,severe:6
evolution ,acute:6
evolution ,respiratory:6
evolution ,syndrome:6
evolution ,coronavirus:14
evolution ,sars-cov-2:28
sars-cov-2 ,outbreak:68
outbreak ,know:2
recent ,advancements:2
recent ,diagnosis:6
recent ,prevention:4
recent ,prospective:2
recent ,drug:6
recent ,therapy:4
advancements ,diagnosis:2
advancements ,prevention:2
advancements ,prospective:2
advancements ,drug:2
advancements ,therapy:2
diagnosis ,prevention:16
diagnosis ,prospective:2
diagnosis ,drug:2
diagnosis ,therapy:6
prevention ,prospective:2
prevention ,drug:6
prevention ,therapy:8
prospective ,drug:2
prospective ,therapy:2
drug ,therapy:6
coronavirus ,coronaviruses:12
coronavirus ,blood:10
coronavirus ,safety:4
disease ,coronaviruses:8
disease ,blood:2
disease ,safety:2
coronaviruses ,blood:2
coronaviruses ,safety:2
blood ,safety:2
management ,liver:8
management ,transplantation:2
management ,beijing:2
management ,working:2
covid-19 ,transplantation:22
covid-19 ,beijing:6
covid-19 ,working:2
patients ,liver:42
patients ,transplantation:6
patients ,beijing:2
patients ,working:2
liver ,transplantation:6
liver ,beijing:2
liver ,working:2
transplantation ,beijing:2
transplantation ,working:2
beijing ,working:2
happen ,narrowing:2
happen ,contagion:2
happen ,covid-19:2
happen ,preventing:2
narrowing ,contagion:2
narrowing ,covid-19:2
narrowing ,preventing:2
contagion ,covid-19:6
contagion ,preventing:2
covid-19 ,preventing:16
reply ,gautret:2
reply ,et:2
reply ,al:2
reply ,hydroxychloroquine:2
reply ,sulfate:2
reply ,azithromycin:2
reply ,covid-19:4
gautret ,et:2
gautret ,al:2
gautret ,hydroxychloroquine:2
gautret ,sulfate:2
gautret ,azithromycin:2
gautret ,covid-19:2
et ,al:2
et ,hydroxychloroquine:2
et ,sulfate:2
et ,azithromycin:2
et ,covid-19:2
al ,hydroxychloroquine:2
al ,sulfate:2
al ,azithromycin:2
al ,covid-19:2
hydroxychloroquine ,sulfate:4
sulfate ,azithromycin:2
sulfate ,covid-19:2
computational ,screening:2
computational ,antagonists:2
computational ,sars-cov-2:18
computational ,covid-19:6
computational ,coronavirus:2
screening ,antagonists:2
screening ,sars-cov-2:54
screening ,covid-19:54
screening ,coronavirus:8
antagonists ,sars-cov-2:2
antagonists ,covid-19:2
antagonists ,coronavirus:2
comprehensive ,overview:4
comprehensive ,clinical:4
comprehensive ,trials:2
overview ,clinical:12
overview ,trials:4
impact ,social:12
impact ,determinants:2
impact ,health:18
impact ,emerging:2
impact ,covid-19:192
impact ,pandemic:68
social ,determinants:2
social ,health:12
social ,emerging:2
social ,covid-19:22
social ,pandemic:6
determinants ,health:2
determinants ,emerging:2
determinants ,covid-19:6
determinants ,pandemic:2
health ,emerging:6
health ,pandemic:58
emerging ,pandemic:8
comparison ,throat:2
comparison ,swabs:8
comparison ,sputum:2
comparison ,specimens:2
comparison ,viral:4
comparison ,nucleic:6
comparison ,acid:4
comparison ,detection:24
throat ,swabs:8
throat ,sputum:4
throat ,specimens:4
throat ,viral:4
throat ,nucleic:4
throat ,acid:4
throat ,detection:10
swabs ,sputum:2
swabs ,specimens:2
swabs ,viral:6
swabs ,nucleic:2
swabs ,acid:2
swabs ,detection:14
sputum ,specimens:2
sputum ,viral:4
sputum ,nucleic:4
sputum ,acid:4
sputum ,detection:2
specimens ,viral:6
specimens ,nucleic:2
specimens ,acid:2
specimens ,detection:22
viral ,nucleic:12
viral ,acid:14
viral ,detection:20
emergency ,authorization:4
emergency ,chloroquine:2
emergency ,hydroxychloroquine:2
emergency ,treatment:4
authorization ,chloroquine:2
authorization ,hydroxychloroquine:2
authorization ,treatment:2
chloroquine ,hydroxychloroquine:36
harnessing ,immune:4
harnessing ,system:4
harnessing ,overcome:2
harnessing ,cytokine:2
harnessing ,storm:2
harnessing ,reduce:2
harnessing ,viral:2
harnessing ,load:2
immune ,system:36
immune ,overcome:4
immune ,cytokine:6
immune ,storm:4
immune ,reduce:2
immune ,viral:8
immune ,load:2
system ,overcome:2
system ,cytokine:2
system ,storm:2
system ,reduce:2
system ,viral:4
system ,load:2
overcome ,cytokine:2
overcome ,storm:2
overcome ,reduce:2
overcome ,viral:2
overcome ,load:2
cytokine ,reduce:2
cytokine ,viral:2
cytokine ,load:2
storm ,reduce:2
storm ,viral:2
storm ,load:2
reduce ,viral:2
reduce ,load:2
viral ,load:52
lessons ,learned:28
lessons ,date:2
lessons ,hyperinflammatory:2
lessons ,syndrome:2
lessons ,considerations:2
learned ,date:2
learned ,hyperinflammatory:2
learned ,syndrome:2
learned ,considerations:2
date ,covid-19:4
date ,hyperinflammatory:2
date ,syndrome:2
date ,considerations:2
covid-19 ,hyperinflammatory:4
covid-19 ,syndrome:70
covid-19 ,considerations:42
hyperinflammatory ,syndrome:6
hyperinflammatory ,considerations:2
syndrome ,considerations:2
covid-19 ,predictions:4
covid-19 ,viral:96
covid-19 ,success:4
structural ,predictions:2
structural ,viral:4
structural ,success:2
predictions ,viral:2
predictions ,success:2
viral ,success:2
recent ,advances:20
recent ,therapeutic:4
recent ,targets:2
recent ,potential:4
recent ,drugs:4
advances ,therapeutic:6
advances ,targets:4
advances ,potential:8
advances ,drugs:2
advances ,covid-19:16
therapeutic ,targets:12
therapeutic ,drugs:6
targets ,drugs:4
potential ,drugs:42
impact ,nephrology:2
impact ,patients:26
impact ,mechanistic:2
impact ,outlook:2
impact ,pathogenesis:4
covid-19 ,nephrology:6
covid-19 ,mechanistic:6
covid-19 ,outlook:2
nephrology ,patients:2
nephrology ,mechanistic:2
nephrology ,outlook:2
nephrology ,pathogenesis:2
patients ,mechanistic:2
patients ,outlook:2
patients ,pathogenesis:4
mechanistic ,outlook:2
mechanistic ,pathogenesis:2
outlook ,pathogenesis:2
current ,therapies:8
current ,investigation:2
current ,treatments:8
therapies ,investigation:2
therapies ,covid-19:36
therapies ,potential:4
therapies ,treatments:2
investigation ,covid-19:18
investigation ,potential:4
investigation ,treatments:2
potential ,treatments:4
review ,ongoing:2
review ,clinical:48
review ,trials:6
sars-cov-2 ,ongoing:4
sars-cov-2 ,clinical:198
sars-cov-2 ,trials:10
covid-19 ,14:8
australia ,14:6
epidemiology ,14:6
report ,14:6
reporting ,14:6
week ,14:4
ending ,14:2
1900 ,14:4
aedt ,14:4
current ,pharmacological:8
current ,modalities:2
current ,management:6
pharmacological ,modalities:2
pharmacological ,management:2
pharmacological ,novel:2
pharmacological ,coronavirus:2
pharmacological ,disease:2
modalities ,management:2
modalities ,novel:2
modalities ,coronavirus:2
modalities ,disease:2
management ,novel:10
kidney ,covid-19:58
kidney ,chemokine:2
kidney ,network:2
kidney ,intriguing:2
kidney ,trio:2
covid-19 ,chemokine:2
covid-19 ,network:12
covid-19 ,intriguing:4
covid-19 ,trio:2
chemokine ,network:2
chemokine ,intriguing:2
chemokine ,trio:2
network ,intriguing:2
network ,trio:2
intriguing ,trio:2
early ,predictors:4
early ,clinical:6
early ,deterioration:2
early ,cohort:2
early ,239:2
early ,patients:24
early ,hospitalized:2
predictors ,clinical:10
predictors ,deterioration:2
predictors ,cohort:2
predictors ,239:2
predictors ,patients:16
predictors ,hospitalized:2
clinical ,deterioration:2
clinical ,cohort:4
clinical ,239:2
clinical ,hospitalized:26
deterioration ,cohort:2
deterioration ,239:2
deterioration ,patients:4
deterioration ,hospitalized:2
cohort ,239:2
cohort ,patients:12
cohort ,hospitalized:2
239 ,patients:2
239 ,hospitalized:2
patients ,hospitalized:62
clinical ,outcomes:52
clinical ,201:2
clinical ,neonates:12
clinical ,born:8
clinical ,mothers:8
clinical ,systematic:24
outcomes ,201:2
outcomes ,neonates:2
outcomes ,born:2
outcomes ,mothers:2
outcomes ,covid-19:62
outcomes ,systematic:12
201 ,neonates:2
201 ,born:2
201 ,mothers:2
201 ,covid-19:2
201 ,systematic:2
neonates ,born:14
neonates ,mothers:16
neonates ,covid-19:16
neonates ,systematic:4
born ,mothers:22
born ,covid-19:10
born ,systematic:2
mothers ,covid-19:14
mothers ,systematic:2
covid-19 ,28:6
covid-19 ,fortnightly:26
covid-19 ,25:10
australia ,28:2
australia ,fortnightly:26
australia ,period:28
australia ,25:4
epidemiology ,28:2
epidemiology ,fortnightly:26
epidemiology ,period:30
epidemiology ,25:4
report ,28:2
report ,fortnightly:26
report ,period:28
report ,25:4
28 ,fortnightly:2
28 ,reporting:2
28 ,period:2
28 ,ending:2
28 ,25:2
fortnightly ,reporting:26
fortnightly ,period:26
fortnightly ,ending:26
fortnightly ,25:4
reporting ,period:28
reporting ,25:4
period ,ending:26
period ,25:4
ending ,25:4
analysis ,hosts:4
analysis ,transmission:8
analysis ,paths:2
analysis ,sars-cov-2:166
analysis ,outbreak:8
hosts ,transmission:2
hosts ,paths:2
hosts ,sars-cov-2:8
hosts ,covid-19:4
hosts ,outbreak:2
transmission ,paths:2
transmission ,outbreak:6
paths ,sars-cov-2:2
paths ,covid-19:2
paths ,outbreak:2
immune-epidemiological ,parameters:2
immune-epidemiological ,novel:2
immune-epidemiological ,coronavirus:2
immune-epidemiological ,perspective:2
parameters ,novel:4
parameters ,coronavirus:2
parameters ,perspective:2
novel ,perspective:10
coronavirus ,perspective:24
update ,novel:8
update ,covid-19:42
update ,pandemic:4
update ,battle:2
update ,humans:2
update ,virus:4
novel ,battle:4
novel ,humans:6
novel ,virus:30
covid-19 ,battle:6
covid-19 ,humans:4
pandemic ,battle:2
pandemic ,humans:2
pandemic ,virus:8
battle ,humans:2
battle ,virus:4
humans ,virus:2
immune ,responses:42
immune ,pathogenesis:10
immune ,sars-cov-2:78
immune ,outbreak:8
immune ,iran:2
responses ,pathogenesis:2
responses ,sars-cov-2:76
responses ,outbreak:4
responses ,iran:2
pathogenesis ,sars-cov-2:46
pathogenesis ,outbreak:2
pathogenesis ,iran:2
sars-cov-2 ,iran:6
outbreak ,iran:6
can ,stem:4
can ,cells:4
can ,beat:2
can ,covid-19:68
can ,advancing:2
can ,extracellular:2
can ,vesicles:2
can ,toward:2
stem ,cells:24
stem ,beat:2
stem ,covid-19:10
stem ,advancing:2
stem ,extracellular:2
stem ,vesicles:2
stem ,toward:2
cells ,beat:2
cells ,covid-19:30
cells ,advancing:2
cells ,extracellular:2
cells ,vesicles:2
cells ,toward:2
beat ,covid-19:4
beat ,advancing:2
beat ,extracellular:2
beat ,vesicles:2
beat ,toward:2
covid-19 ,advancing:2
covid-19 ,extracellular:8
covid-19 ,vesicles:4
covid-19 ,toward:14
advancing ,extracellular:2
advancing ,vesicles:2
advancing ,toward:2
extracellular ,vesicles:8
extracellular ,toward:2
vesicles ,toward:2
novel ,birds:2
novel ,eye:2
novel ,view:2
coronavirus ,birds:2
coronavirus ,eye:10
coronavirus ,view:4
birds ,eye:2
birds ,view:2
eye ,view:2
recovered ,case:6
recovered ,covid-19:26
recovered ,myocarditis:2
recovered ,ards:2
recovered ,treated:2
recovered ,corticosteroids:2
case ,myocarditis:2
case ,ards:4
case ,treated:6
case ,corticosteroids:2
covid-19 ,myocarditis:8
covid-19 ,ards:10
covid-19 ,corticosteroids:8
myocarditis ,ards:2
myocarditis ,treated:2
myocarditis ,corticosteroids:2
ards ,treated:2
ards ,corticosteroids:2
treated ,corticosteroids:4
covid-19 ,10:4
covid-19 ,aest:14
covid-19 ,april:12
australia ,10:4
australia ,aest:14
australia ,april:8
epidemiology ,10:4
epidemiology ,aest:14
epidemiology ,april:8
report ,10:4
report ,aest:14
report ,april:8
10 ,reporting:4
10 ,week:4
10 ,2359:4
10 ,aest:4
10 ,april:2
reporting ,aest:14
reporting ,april:8
week ,aest:14
week ,april:8
2359 ,aest:14
2359 ,april:8
aest ,april:8
covid-19 ,infection:354
covid-19 ,mobile:2
covid-19 ,technology:10
infection ,disease:40
infection ,detection:14
infection ,mobile:2
infection ,technology:2
disease ,detection:10
disease ,mobile:2
disease ,technology:4
detection ,mobile:2
detection ,technology:2
mobile ,technology:2
chinas ,local:2
chinas ,governments:2
chinas ,combating:2
chinas ,covid-19:2
chinas ,unprecedented:2
chinas ,responses:2
local ,governments:2
local ,combating:2
local ,covid-19:8
local ,unprecedented:2
local ,responses:2
governments ,combating:2
governments ,covid-19:2
governments ,unprecedented:2
governments ,responses:2
combating ,covid-19:18
combating ,unprecedented:2
combating ,responses:2
covid-19 ,unprecedented:4
covid-19 ,responses:48
unprecedented ,responses:2
period ,1900:2
period ,aedt:2
period ,14:2
multimodality ,imaging:4
multimodality ,coronavirus:2
multimodality ,disease:2
multimodality ,covid-19:4
multimodality ,pictorial:2
multimodality ,essay:2
imaging ,coronavirus:20
imaging ,disease:6
imaging ,covid-19:44
imaging ,pictorial:2
imaging ,essay:2
coronavirus ,pictorial:2
coronavirus ,essay:2
disease ,pictorial:2
disease ,essay:2
covid-19 ,pictorial:2
covid-19 ,essay:2
pictorial ,essay:2
targeting ,hub:2
targeting ,genes:2
targeting ,pathways:6
targeting ,innate:4
targeting ,immune:8
targeting ,response:4
targeting ,covid-19:30
targeting ,network:2
hub ,genes:2
hub ,pathways:2
hub ,innate:2
hub ,immune:2
hub ,response:2
hub ,covid-19:2
hub ,network:2
genes ,pathways:2
genes ,innate:2
genes ,immune:2
genes ,response:2
genes ,covid-19:6
genes ,network:2
pathways ,innate:4
pathways ,immune:4
pathways ,response:2
pathways ,covid-19:12
pathways ,network:2
innate ,immune:20
innate ,response:4
innate ,covid-19:8
innate ,network:2
immune ,network:2
response ,network:2
saliva ,reliable:4
saliva ,tool:2
saliva ,detect:2
saliva ,sars-cov-2:24
reliable ,tool:2
reliable ,detect:2
reliable ,sars-cov-2:8
tool ,detect:2
tool ,sars-cov-2:14
detect ,sars-cov-2:10
drug ,treatment:28
drug ,options:2
drug ,2019-new:2
drug ,coronavirus:32
drug ,2019-ncov:4
treatment ,options:24
treatment ,2019-new:4
treatment ,2019-ncov:8
options ,2019-new:2
options ,coronavirus:8
options ,2019-ncov:4
2019-new ,coronavirus:4
2019-new ,2019-ncov:2
recent ,understandings:2
recent ,toward:2
recent ,disease:6
recent ,bench:2
understandings ,toward:2
understandings ,coronavirus:2
understandings ,disease:2
understandings ,covid-19:2
understandings ,bench:2
toward ,coronavirus:6
toward ,disease:4
toward ,bench:2
coronavirus ,bench:2
disease ,bench:2
covid-19 ,bench:6
transmission ,routes:20
transmission ,2019-ncov:20
transmission ,controls:2
transmission ,dental:8
transmission ,practice:6
routes ,2019-ncov:4
routes ,controls:2
routes ,dental:4
routes ,practice:2
2019-ncov ,controls:2
2019-ncov ,dental:2
2019-ncov ,practice:2
controls ,dental:2
controls ,practice:2
dental ,practice:16
neutralizing ,antibodies:22
neutralizing ,sars-cov-2:30
neutralizing ,human:10
neutralizing ,coronaviruses:4
antibodies ,sars-cov-2:94
antibodies ,human:10
antibodies ,coronaviruses:6
sars-cov-2 ,coronaviruses:44
human ,coronaviruses:50
transmission ,2019-novel:2
routes ,2019-novel:2
routes ,coronavirus:2
etiology ,epidemic:2
etiology ,outbreaks:2
etiology ,covid-19:6
etiology ,wuhan:2
etiology ,hubei:2
etiology ,province:2
etiology ,chinese:2
etiology ,people:2
epidemic ,outbreaks:2
epidemic ,covid-19:70
epidemic ,wuhan:2
epidemic ,hubei:8
epidemic ,province:6
epidemic ,chinese:4
epidemic ,people:2
outbreaks ,covid-19:12
outbreaks ,wuhan:2
outbreaks ,hubei:2
outbreaks ,province:2
outbreaks ,chinese:2
outbreaks ,people:2
covid-19 ,wuhan:28
covid-19 ,hubei:8
covid-19 ,province:8
covid-19 ,chinese:18
covid-19 ,people:20
wuhan ,hubei:4
wuhan ,province:4
wuhan ,chinese:2
wuhan ,people:2
hubei ,province:8
hubei ,chinese:2
hubei ,people:2
province ,chinese:2
province ,people:2
chinese ,people:2
expression ,angiotensin-converting:6
expression ,enzyme:8
expression ,proteases:2
expression ,patients:8
angiotensin-converting ,enzyme:54
angiotensin-converting ,proteases:2
angiotensin-converting ,covid-19:4
angiotensin-converting ,patients:4
enzyme ,proteases:2
enzyme ,covid-19:6
enzyme ,patients:6
proteases ,covid-19:4
proteases ,patients:2
imaging ,clinical:14
imaging ,features:14
imaging ,patients:16
imaging ,novel:10
imaging ,sars-cov-2:10
features ,patients:42
features ,novel:26
features ,coronavirus:50
features ,sars-cov-2:48
patients ,novel:34
patients ,coronavirus:160
patients ,sars-cov-2:318
novel ,sars-cov-2:158
novel ,2019-ncov:62
novel ,outbreak:34
novel ,new:8
novel ,challenge:4
coronavirus ,challenge:10
2019-ncov ,outbreak:14
2019-ncov ,new:12
2019-ncov ,challenge:2
outbreak ,challenge:2
new ,challenge:6
saliva ,potential:6
saliva ,diagnostic:10
saliva ,value:2
saliva ,transmission:4
saliva ,2019-ncov:6
potential ,diagnostic:8
potential ,value:2
potential ,transmission:40
potential ,2019-ncov:16
diagnostic ,value:14
diagnostic ,transmission:4
diagnostic ,2019-ncov:6
value ,transmission:2
value ,2019-ncov:2
covid-19 ,16:4
covid-19 ,17:4
covid-19 ,may:40
australia ,16:4
australia ,17:4
australia ,may:6
epidemiology ,16:4
epidemiology ,17:4
epidemiology ,may:6
report ,16:4
report ,17:4
report ,may:6
16 ,reporting:4
16 ,week:2
16 ,2359:2
16 ,aest:2
16 ,17:2
16 ,may:2
reporting ,17:4
reporting ,may:6
week ,17:2
week ,may:6
2359 ,17:2
2359 ,may:6
aest ,17:2
aest ,may:6
17 ,may:2
compounds ,therapeutic:6
compounds ,potential:10
compounds ,novel:4
compounds ,respiratory:2
therapeutic ,novel:18
therapeutic ,respiratory:8
therapeutic ,coronavirus:20
potential ,novel:30
novel ,respiratory:20
covid-19 ,lacrimal:2
covid-19 ,multipronged:2
covid-19 ,resumption:2
pandemic ,lacrimal:2
pandemic ,multipronged:2
pandemic ,resumption:2
pandemic ,strategies:8
lacrimal ,practice:2
lacrimal ,multipronged:2
lacrimal ,resumption:2
lacrimal ,strategies:2
practice ,multipronged:2
practice ,resumption:2
practice ,strategies:4
multipronged ,resumption:2
multipronged ,strategies:2
resumption ,strategies:2
species ,severe:2
species ,acute:2
species ,respiratory:2
species ,syndrome-related:2
species ,coronavirus:2
species ,classifying:2
severe ,syndrome-related:6
severe ,classifying:2
acute ,syndrome-related:6
acute ,classifying:2
respiratory ,syndrome-related:6
respiratory ,classifying:2
syndrome-related ,coronavirus:4
syndrome-related ,classifying:2
coronavirus ,classifying:2
first ,75:2
first ,days:2
first ,novel:4
first ,sars-cov-2:58
first ,outbreak:14
first ,recent:2
first ,advances:2
75 ,days:2
75 ,novel:2
75 ,coronavirus:2
75 ,sars-cov-2:2
75 ,outbreak:2
75 ,recent:2
75 ,advances:2
days ,novel:2
days ,coronavirus:6
days ,sars-cov-2:14
days ,outbreak:2
days ,recent:2
days ,advances:2
novel ,advances:6
coronavirus ,advances:14
sars-cov-2 ,recent:18
sars-cov-2 ,advances:8
outbreak ,recent:2
outbreak ,advances:2
pneumonia ,outbreak:2
pneumonia ,associated:8
pneumonia ,new:6
pneumonia ,coronavirus:70
pneumonia ,probable:2
pneumonia ,bat:2
pneumonia ,origin:2
outbreak ,associated:8
outbreak ,probable:4
outbreak ,bat:2
outbreak ,origin:6
associated ,new:4
associated ,coronavirus:30
associated ,probable:4
associated ,bat:2
associated ,origin:4
new ,probable:2
new ,bat:2
new ,origin:2
coronavirus ,probable:2
coronavirus ,bat:8
probable ,bat:2
probable ,origin:4
bat ,origin:4
report ,lactating:2
report ,patient:28
lactating ,patient:2
lactating ,covid-19:2
overlapping ,discrete:2
overlapping ,aspects:2
overlapping ,pathology:2
overlapping ,pathogenesis:2
overlapping ,emerging:2
discrete ,aspects:2
discrete ,pathology:2
discrete ,pathogenesis:2
discrete ,emerging:2
aspects ,pathology:2
aspects ,pathogenesis:2
aspects ,emerging:2
pathology ,pathogenesis:4
pathology ,emerging:2
pathogenesis ,emerging:4
traditional ,chinese:32
traditional ,medicine:28
traditional ,treatment:12
traditional ,patients:2
traditional ,infected:2
traditional ,2019-new:2
chinese ,medicine:32
chinese ,treatment:14
chinese ,patients:4
chinese ,infected:4
chinese ,2019-new:2
medicine ,treatment:14
medicine ,patients:2
medicine ,infected:2
medicine ,2019-new:2
treatment ,patients:52
treatment ,infected:4
patients ,infected:50
patients ,2019-new:2
infected ,2019-new:2
antiviral ,immunomodulatory:4
antiviral ,phytochemicals:4
antiviral ,honey:2
immunomodulatory ,effects:2
immunomodulatory ,phytochemicals:2
immunomodulatory ,honey:2
effects ,phytochemicals:2
effects ,honey:2
phytochemicals ,honey:2
saliva-based ,pcr:2
saliva-based ,tests:2
saliva-based ,sars-cov-2:2
saliva-based ,detection:2
pcr ,tests:4
pcr ,sars-cov-2:44
pcr ,detection:16
tests ,sars-cov-2:34
tests ,detection:14
return ,coronavirus:2
return ,2019-ncov:2
infection ,rapid:6
infection ,transmission:36
infection ,sars-cov-2:770
infection ,ferrets:4
rapid ,transmission:6
rapid ,ferrets:2
transmission ,ferrets:2
sars-cov-2 ,ferrets:4
sars-cov-2 ,emerging:20
sars-cov-2 ,causes:10
sars-cov-2 ,global:20
sars-cov-2 ,threat:4
emerging ,coronavirus:28
emerging ,causes:2
emerging ,global:12
emerging ,threat:8
coronavirus ,causes:2
coronavirus ,global:22
coronavirus ,threat:8
causes ,global:2
causes ,threat:2
global ,threat:10
insight ,novel:8
insight ,coronavirus:6
insight ,updated:4
insight ,interim:2
insight ,review:2
insight ,lessons:2
novel ,updated:6
novel ,interim:6
novel ,lessons:4
coronavirus ,updated:10
coronavirus ,interim:4
coronavirus ,lessons:14
updated ,interim:2
updated ,review:8
updated ,lessons:2
interim ,review:4
interim ,lessons:2
review ,lessons:2
gene ,month:2
gene ,2019-ncovsars-cov-2:2
gene ,novel:4
gene ,coronavirus:4
gene ,spike:2
gene ,protein:2
month ,2019-ncovsars-cov-2:2
month ,novel:2
month ,coronavirus:2
month ,spike:2
month ,protein:2
2019-ncovsars-cov-2 ,novel:4
2019-ncovsars-cov-2 ,coronavirus:4
2019-ncovsars-cov-2 ,spike:2
2019-ncovsars-cov-2 ,protein:2
novel ,spike:14
novel ,protein:16
molecular ,serological:12
molecular ,investigation:4
molecular ,2019-ncov:6
molecular ,infected:2
molecular ,patients:4
molecular ,implication:2
serological ,investigation:4
serological ,2019-ncov:6
serological ,infected:4
serological ,patients:6
serological ,implication:2
investigation ,2019-ncov:4
investigation ,infected:2
investigation ,patients:8
investigation ,implication:2
2019-ncov ,infected:4
2019-ncov ,patients:8
2019-ncov ,implication:2
infected ,implication:2
patients ,implication:4
disease ,2019-ncov:6
2019-ncov ,covid-19:6
covid-19 ,24:6
australia ,24:4
epidemiology ,24:4
report ,24:4
17 ,fortnightly:2
17 ,period:2
17 ,ending:2
17 ,24:2
fortnightly ,24:4
reporting ,24:4
period ,24:4
ending ,24:4
small ,solitary:2
small ,ground-glass:2
small ,nodule:2
small ,ct:2
small ,initial:2
small ,manifestation:2
small ,coronavirus:4
solitary ,ground-glass:2
solitary ,nodule:2
solitary ,ct:2
solitary ,initial:2
solitary ,manifestation:2
solitary ,coronavirus:2
ground-glass ,nodule:2
ground-glass ,ct:4
ground-glass ,initial:2
ground-glass ,manifestation:2
ground-glass ,coronavirus:2
nodule ,ct:2
nodule ,initial:2
nodule ,manifestation:2
nodule ,coronavirus:2
ct ,initial:12
ct ,manifestation:2
ct ,coronavirus:42
initial ,manifestation:2
manifestation ,coronavirus:8
novel ,discovery:8
coronavirus ,discovery:8
discovery ,clinical:2
discovery ,diagnostics:4
genotyping ,coronavirus:2
genotyping ,sars-cov-2:2
genotyping ,methods:2
genotyping ,implications:2
coronavirus ,methods:12
coronavirus ,implications:16
sars-cov-2 ,implications:64
methods ,implications:2
development ,crispr:2
development ,antiviral:6
development ,strategy:4
development ,combat:2
development ,sars-cov-2:48
development ,influenza:2
crispr ,antiviral:2
crispr ,strategy:2
crispr ,combat:2
crispr ,sars-cov-2:2
crispr ,influenza:2
antiviral ,strategy:2
antiviral ,combat:2
antiviral ,sars-cov-2:62
antiviral ,influenza:2
strategy ,combat:6
strategy ,sars-cov-2:20
strategy ,influenza:2
combat ,sars-cov-2:6
combat ,influenza:2
sars-cov-2 ,influenza:36
interim ,epidemiological:2
interim ,characteristics:2
review ,epidemiological:2
epidemiological ,characteristics:46
epidemiological ,novel:16
epidemiological ,coronavirus:32
characteristics ,novel:26
coronavirus ,brief:6
coronavirus ,front:2
coronavirus ,line:2
2019-ncov ,brief:2
2019-ncov ,perspective:2
2019-ncov ,front:2
2019-ncov ,line:2
brief ,perspective:2
brief ,front:2
brief ,line:2
perspective ,front:2
perspective ,line:2
front ,line:4
evaluating ,trends:2
evaluating ,covid-19:6
evaluating ,research:2
evaluating ,activity:2
evaluating ,early:2
evaluating ,creation:2
trends ,research:4
trends ,activity:2
trends ,early:2
trends ,creation:2
covid-19 ,activity:18
covid-19 ,early:102
covid-19 ,creation:2
research ,activity:2
research ,early:2
research ,creation:2
activity ,early:2
activity ,creation:2
early ,creation:2
covid-19 ,maintenance:4
covid-19 ,hemodialysis:22
covid-19 ,scoping:16
maintenance ,hemodialysis:2
maintenance ,systematic:2
maintenance ,scoping:2
maintenance ,review:2
maintenance ,practice:2
hemodialysis ,systematic:2
hemodialysis ,scoping:2
hemodialysis ,review:2
hemodialysis ,practice:2
systematic ,scoping:2
systematic ,practice:2
scoping ,review:22
scoping ,practice:2
review ,practice:8
covid-19 ,20:4
australia ,20:2
epidemiology ,20:2
report ,20:2
20 ,fortnightly:2
20 ,reporting:2
20 ,period:2
20 ,ending:2
potent ,binding:2
potent ,novel:2
potent ,coronavirus:2
potent ,spike:4
potent ,protein:2
potent ,sars:2
binding ,novel:6
binding ,coronavirus:6
binding ,spike:24
binding ,protein:16
binding ,sars:2
novel ,sars:10
coronavirus ,sars:18
spike ,sars:6
protein ,sars:10
characterization ,receptor-binding:2
characterization ,domain:2
characterization ,rbd:2
characterization ,novel:6
characterization ,coronavirus:10
receptor-binding ,domain:20
receptor-binding ,rbd:4
receptor-binding ,novel:2
receptor-binding ,coronavirus:2
domain ,rbd:8
domain ,novel:4
domain ,coronavirus:2
rbd ,novel:2
rbd ,coronavirus:2
correlation ,travellers:2
correlation ,departing:2
correlation ,wuhan:2
correlation ,spring:2
correlation ,festival:2
travellers ,departing:2
travellers ,wuhan:2
travellers ,spring:2
travellers ,festival:2
departing ,wuhan:2
departing ,spring:2
departing ,festival:2
wuhan ,spring:2
wuhan ,festival:2
spring ,festival:2
insights ,recent:4
insights ,novel:14
insights ,sars-cov-2:34
insights ,light:2
insights ,past:2
insights ,human:2
recent ,light:2
recent ,past:2
recent ,human:4
novel ,light:2
novel ,past:2
novel ,human:24
coronavirus ,light:8
coronavirus ,past:4
coronavirus ,human:50
sars-cov-2 ,light:10
sars-cov-2 ,past:8
light ,past:2
light ,human:2
past ,human:2
genomic ,variance:4
variance ,2019-ncov:2
variance ,coronavirus:4
genomic ,characterization:6
genomic ,novel:10
genomic ,human-pathogenic:2
genomic ,isolated:2
characterization ,human-pathogenic:2
characterization ,isolated:2
novel ,human-pathogenic:2
novel ,isolated:4
human-pathogenic ,coronavirus:2
human-pathogenic ,isolated:2
coronavirus ,isolated:2
coronaviruses ,paradigm:2
coronaviruses ,new:8
coronaviruses ,emerging:12
coronaviruses ,zoonotic:4
coronaviruses ,diseases:8
paradigm ,new:6
paradigm ,emerging:2
paradigm ,zoonotic:2
paradigm ,diseases:4
new ,emerging:6
new ,zoonotic:2
new ,diseases:2
emerging ,zoonotic:2
emerging ,diseases:4
zoonotic ,diseases:2
performance ,six:2
performance ,sars-cov-2:36
performance ,immunoassays:6
performance ,comparison:8
performance ,microneutralisation:2
six ,sars-cov-2:6
six ,immunoassays:2
six ,comparison:2
six ,microneutralisation:2
sars-cov-2 ,immunoassays:8
sars-cov-2 ,comparison:48
sars-cov-2 ,microneutralisation:2
immunoassays ,comparison:8
immunoassays ,microneutralisation:2
comparison ,microneutralisation:2
potential ,antiviral:32
potential ,therapeutics:22
antiviral ,therapeutics:4
antiviral ,novel:12
therapeutics ,coronavirus:6
epidemic ,2019-novel-coronavirus:2
epidemic ,2019-ncov:10
epidemic ,pneumonia:2
epidemic ,insights:4
2019-novel-coronavirus ,2019-ncov:2
2019-novel-coronavirus ,pneumonia:2
2019-novel-coronavirus ,insights:2
2019-ncov ,pneumonia:6
2019-ncov ,insights:2
pneumonia ,insights:4
machine ,learning:16
machine ,maps:2
machine ,research:2
machine ,needs:2
machine ,covid-19:10
machine ,literature:2
learning ,maps:2
learning ,research:2
learning ,needs:2
learning ,covid-19:26
learning ,literature:2
maps ,research:2
maps ,needs:2
maps ,covid-19:2
maps ,literature:2
research ,needs:6
research ,literature:4
needs ,covid-19:8
needs ,literature:2
potential ,maternal:2
potential ,infant:2
potential ,outcomes:4
potential ,wuhan:4
potential ,infecting:2
maternal ,infant:4
maternal ,outcomes:8
maternal ,wuhan:2
maternal ,coronavirus:12
maternal ,2019-ncov:2
maternal ,infecting:2
infant ,outcomes:6
infant ,wuhan:2
infant ,coronavirus:4
infant ,2019-ncov:2
infant ,infecting:2
outcomes ,wuhan:4
outcomes ,coronavirus:14
outcomes ,2019-ncov:2
outcomes ,infecting:2
wuhan ,coronavirus:28
wuhan ,2019-ncov:6
wuhan ,infecting:2
coronavirus ,infecting:2
2019-ncov ,infecting:2
receptor ,recognition:8
receptor ,novel:4
receptor ,coronavirus:6
receptor ,wuhan:2
receptor ,analysis:18
receptor ,based:2
recognition ,novel:4
recognition ,coronavirus:4
recognition ,wuhan:2
recognition ,analysis:2
recognition ,based:2
novel ,wuhan:18
novel ,analysis:38
novel ,based:8
coronavirus ,based:18
wuhan ,analysis:6
wuhan ,based:2
analysis ,based:10
snapshot ,ongoing:2
snapshot ,clinical:2
snapshot ,research:2
snapshot ,covid-19:4
ongoing ,research:2
clinical ,radiological:16
clinical ,pneumonia:34
radiological ,features:4
radiological ,novel:2
radiological ,coronavirus:4
radiological ,pneumonia:2
features ,pneumonia:14
novel ,pneumonia:50
challenges ,experiences:4
challenges ,dental:2
challenges ,medicine:6
challenges ,combating:2
challenges ,pandemic:28
experiences ,dental:2
experiences ,medicine:2
experiences ,combating:2
dental ,medicine:2
dental ,combating:2
dental ,covid-19:40
dental ,pandemic:14
medicine ,combating:2
medicine ,covid-19:48
medicine ,pandemic:12
combating ,pandemic:4
treatment ,perspective:2
treatment ,convalescent:20
treatment ,transfusion:4
covid-19 ,convalescent:30
covid-19 ,plasma:32
covid-19 ,transfusion:10
perspective ,convalescent:2
perspective ,plasma:2
perspective ,transfusion:2
convalescent ,plasma:60
convalescent ,transfusion:6
plasma ,transfusion:6
coronavirus ,patient:52
coronavirus ,multifocal:2
coronavirus ,treated:4
disease ,patient:52
disease ,multifocal:2
disease ,treated:4
covid-19 ,multifocal:2
covid-19 ,pneumonia:156
patient ,multifocal:2
patient ,pneumonia:28
patient ,treated:10
multifocal ,pneumonia:2
multifocal ,treated:2
pneumonia ,treated:2
covid-19 ,19:20
covid-19 ,21:4
australia ,19:6
australia ,21:4
epidemiology ,19:6
epidemiology ,21:4
report ,19:8
report ,21:4
19 ,fortnightly:4
19 ,reporting:6
19 ,period:4
19 ,ending:4
19 ,21:4
fortnightly ,21:4
reporting ,21:4
period ,21:4
ending ,21:4
practical ,recommendations:10
practical ,critical:2
practical ,care:4
practical ,anesthesiology:2
practical ,teams:2
practical ,caring:2
recommendations ,critical:4
recommendations ,care:20
recommendations ,anesthesiology:2
recommendations ,teams:2
recommendations ,caring:2
critical ,care:12
critical ,anesthesiology:2
critical ,teams:2
critical ,caring:2
care ,anesthesiology:2
care ,teams:2
care ,caring:2
anesthesiology ,teams:2
anesthesiology ,caring:2
teams ,caring:2
covid-19 ,18:4
australia ,18:2
epidemiology ,18:2
report ,18:2
18 ,fortnightly:2
18 ,reporting:2
18 ,period:2
18 ,ending:2
therapeutic ,outbreak:4
therapeutic ,scenario:2
therapeutic ,treat:4
strategies ,outbreak:2
strategies ,scenario:2
strategies ,treat:2
strategies ,novel:12
strategies ,coronavirus:12
outbreak ,scenario:2
outbreak ,treat:2
scenario ,treat:2
scenario ,novel:4
scenario ,coronavirus:4
treat ,novel:2
repurposing ,clinically:2
repurposing ,approved:8
repurposing ,drugs:26
repurposing ,treatment:14
repurposing ,coronavirus:6
repurposing ,disease:4
clinically ,approved:4
clinically ,drugs:6
clinically ,treatment:2
clinically ,coronavirus:2
clinically ,disease:2
approved ,drugs:18
approved ,treatment:2
approved ,coronavirus:2
approved ,disease:2
drugs ,treatment:26
air ,disinfection:2
air ,procedures:2
air ,dental:2
air ,office:2
air ,covid-19:42
air ,pandemic:6
disinfection ,procedures:2
disinfection ,dental:2
disinfection ,office:2
disinfection ,covid-19:6
disinfection ,pandemic:2
procedures ,dental:8
procedures ,office:2
procedures ,covid-19:18
procedures ,pandemic:10
dental ,office:2
office ,covid-19:2
office ,pandemic:2
covid-19 ,27:4
covid-19 ,11:4
australia ,27:4
australia ,11:4
epidemiology ,27:4
epidemiology ,11:4
report ,27:4
report ,11:4
27 ,fortnightly:4
27 ,reporting:4
27 ,period:4
27 ,ending:4
27 ,11:2
fortnightly ,11:2
reporting ,11:4
period ,11:2
ending ,11:2
laboratory ,testing:18
laboratory ,sars-cov:2
laboratory ,mers-cov:2
laboratory ,sars-cov-2:52
laboratory ,2019-ncov:4
laboratory ,current:14
testing ,sars-cov:2
testing ,mers-cov:2
testing ,sars-cov-2:126
testing ,2019-ncov:2
testing ,current:12
sars-cov ,mers-cov:28
sars-cov ,sars-cov-2:58
sars-cov ,2019-ncov:4
sars-cov ,current:2
mers-cov ,sars-cov-2:24
mers-cov ,2019-ncov:4
mers-cov ,current:2
sars-cov-2 ,2019-ncov:8
sars-cov-2 ,current:62
2019-ncov ,current:6
drug ,targets:16
drug ,corona:2
drug ,virus:6
drug ,systematic:2
drug ,review:10
targets ,corona:2
targets ,virus:2
targets ,systematic:2
targets ,review:2
corona ,virus:54
corona ,systematic:4
corona ,review:8
virus ,systematic:6
virus ,review:18
molecular ,docking:24
molecular ,virtual:6
molecular ,screening:6
molecular ,based:6
molecular ,prediction:2
molecular ,drugs:10
molecular ,covid-19:54
docking ,virtual:2
docking ,screening:2
docking ,based:4
docking ,prediction:2
docking ,drugs:4
docking ,covid-19:4
virtual ,screening:24
virtual ,based:2
virtual ,prediction:2
virtual ,drugs:10
virtual ,covid-19:4
screening ,based:8
screening ,prediction:2
screening ,drugs:12
based ,prediction:4
based ,drugs:2
prediction ,drugs:4
prediction ,covid-19:8
29 ,fortnightly:2
29 ,period:2
covid-19 ,12:4
australia ,12:4
epidemiology ,12:4
report ,12:4
11 ,week:2
11 ,2359:2
11 ,aest:2
11 ,12:2
11 ,april:2
reporting ,12:4
week ,12:4
2359 ,12:4
aest ,12:4
12 ,april:4
analysis ,maternal:2
analysis ,infections:4
analysis ,neonates:4
analysis ,born:4
analysis ,mothers:4
maternal ,infections:4
maternal ,neonates:4
maternal ,born:4
maternal ,mothers:4
coronavirus ,infections:48
coronavirus ,neonates:12
coronavirus ,born:8
coronavirus ,mothers:6
infections ,neonates:4
infections ,born:4
infections ,mothers:4
human ,saliva:2
human ,non-invasive:2
human ,fluid:2
human ,detecting:2
human ,2019-ncov:6
saliva ,non-invasive:4
saliva ,fluid:2
saliva ,detecting:2
saliva ,novel:4
saliva ,coronavirus:6
non-invasive ,fluid:2
non-invasive ,detecting:2
non-invasive ,novel:2
non-invasive ,coronavirus:2
non-invasive ,2019-ncov:2
fluid ,detecting:2
fluid ,novel:2
fluid ,coronavirus:4
fluid ,2019-ncov:4
detecting ,novel:6
detecting ,coronavirus:4
detecting ,2019-ncov:2
isolation ,quarantine:6
isolation ,social:2
isolation ,distancing:2
isolation ,community:6
isolation ,containment:2
isolation ,pivotal:2
isolation ,role:4
quarantine ,social:2
quarantine ,distancing:2
quarantine ,community:2
quarantine ,containment:2
quarantine ,pivotal:2
quarantine ,role:2
social ,distancing:26
social ,community:2
social ,containment:2
social ,pivotal:2
social ,role:4
distancing ,community:2
distancing ,containment:2
distancing ,pivotal:2
distancing ,role:4
community ,containment:2
community ,pivotal:2
community ,role:6
containment ,pivotal:2
containment ,role:2
pivotal ,role:2
potential ,sars-cov-2:180
potential ,treatment:62
potential ,preclinical:2
potential ,findings:4
potential ,ongoing:2
antiviral ,drugs:14
antiviral ,treatment:10
antiviral ,preclinical:2
antiviral ,findings:2
antiviral ,ongoing:2
drugs ,sars-cov-2:34
drugs ,preclinical:2
drugs ,findings:2
drugs ,ongoing:2
sars-cov-2 ,treatment:84
sars-cov-2 ,preclinical:2
sars-cov-2 ,findings:28
treatment ,preclinical:2
treatment ,findings:2
treatment ,ongoing:4
preclinical ,findings:2
preclinical ,ongoing:2
findings ,ongoing:2
human ,infections:8
human ,children:4
human ,review:10
novel ,infections:8
novel ,children:12
coronavirus ,children:48
infections ,children:10
infections ,review:14
co-infection ,sars-cov-2:36
co-infection ,influenza:18
co-infection ,virus:14
co-infection ,patient:6
co-infection ,pneumonia:2
co-infection ,china:2
sars-cov-2 ,patient:90
sars-cov-2 ,pneumonia:62
sars-cov-2 ,china:34
influenza ,virus:18
influenza ,patient:4
influenza ,pneumonia:4
influenza ,china:4
virus ,patient:6
virus ,pneumonia:4
virus ,china:4
patient ,china:2
pneumonia ,china:4
transmission ,breast:2
transmission ,milk:2
transmission ,breastfeeding:2
transmission ,living:2
sars-cov-2 ,breast:4
sars-cov-2 ,milk:8
sars-cov-2 ,breastfeeding:2
sars-cov-2 ,living:4
breast ,milk:6
breast ,breastfeeding:2
breast ,living:2
milk ,breastfeeding:2
milk ,living:2
breastfeeding ,living:2
14 ,2359:2
14 ,aest:2
14 ,may:2
novel ,genome:10
novel ,structure:2
novel ,trials:2
novel ,outstanding:2
coronavirus ,genome:18
coronavirus ,structure:6
coronavirus ,trials:6
coronavirus ,outstanding:2
genome ,structure:12
genome ,clinical:8
genome ,trials:2
genome ,outstanding:2
structure ,clinical:4
structure ,trials:2
structure ,outstanding:2
clinical ,outstanding:2
trials ,outstanding:2
decoding ,evolution:4
decoding ,transmissions:2
decoding ,novel:2
decoding ,pneumonia:2
decoding ,coronavirus:4
evolution ,transmissions:2
evolution ,novel:10
evolution ,pneumonia:4
transmissions ,novel:4
transmissions ,pneumonia:2
transmissions ,coronavirus:4
covid-19 ,13:4
covid-19 ,26:6
australia ,13:4
australia ,26:4
epidemiology ,13:4
epidemiology ,26:4
report ,13:4
report ,26:4
13 ,reporting:4
13 ,week:2
13 ,2359:2
13 ,aest:2
13 ,26:2
13 ,april:2
reporting ,26:4
week ,26:2
2359 ,26:2
aest ,26:2
26 ,april:2
pathology ,sars-cov-2:6
pathology ,associated:2
pathology ,fatal:2
pathology ,coronavirus:6
pathology ,disease:2
pathogenesis ,associated:4
pathogenesis ,fatal:4
pathogenesis ,coronavirus:12
pathogenesis ,disease:10
sars-cov-2 ,associated:66
sars-cov-2 ,fatal:10
associated ,fatal:2
associated ,disease:26
fatal ,coronavirus:8
fatal ,disease:8
novel ,understanding:8
coronavirus ,understanding:10
coronavirus ,diagnosis:56
understanding ,clinical:2
understanding ,features:2
understanding ,diagnosis:4
clinical ,diagnosis:22
features ,diagnosis:4
emerging ,novel:12
emerging ,2019-ncov-current:2
emerging ,scenario:2
emerging ,evolutionary:2
emerging ,perspective:2
novel ,2019-ncov-current:2
novel ,evolutionary:4
coronavirus ,2019-ncov-current:2
coronavirus ,evolutionary:6
2019-ncov-current ,scenario:2
2019-ncov-current ,evolutionary:2
2019-ncov-current ,perspective:2
scenario ,evolutionary:2
scenario ,perspective:4
evolutionary ,perspective:2
epidemiologic ,characteristics:12
epidemiologic ,early:4
epidemiologic ,cases:6
epidemiologic ,novel:4
epidemiologic ,coronavirus:6
epidemiologic ,2019-ncov:2
characteristics ,early:2
characteristics ,cases:28
characteristics ,2019-ncov:6
early ,cases:4
early ,novel:12
early ,coronavirus:46
early ,2019-ncov:4
cases ,novel:26
cases ,2019-ncov:12
22 ,fortnightly:2
22 ,period:2
incubation ,novel:4
incubation ,coronavirus:6
incubation ,2019-ncov:2
incubation ,infections:2
incubation ,among:2
incubation ,travellers:2
period ,novel:6
period ,coronavirus:8
period ,2019-ncov:2
period ,infections:2
period ,among:2
period ,travellers:2
novel ,among:10
novel ,travellers:6
coronavirus ,among:28
coronavirus ,travellers:6
2019-ncov ,infections:2
2019-ncov ,among:4
2019-ncov ,travellers:4
infections ,among:2
infections ,travellers:2
among ,travellers:2
novel ,lesson:2
novel ,animal:2
human ,lesson:2
human ,animal:6
coronavirus ,lesson:4
coronavirus ,animal:8
sars-cov-2 ,lesson:4
sars-cov-2 ,animal:28
lesson ,animal:4
lesson ,coronaviruses:4
animal ,coronaviruses:8
coronavirus ,disinfection:6
coronavirus ,histopathology:2
disinfection ,histopathology:4
effects ,covid-19:56
effects ,prevention:10
effects ,measures:8
effects ,common:2
effects ,infections:2
effects ,taiwan:2
covid-19 ,measures:50
covid-19 ,common:16
covid-19 ,infections:62
covid-19 ,taiwan:14
prevention ,measures:18
prevention ,common:2
prevention ,infections:10
prevention ,taiwan:2
measures ,common:2
measures ,infections:4
measures ,taiwan:4
common ,infections:2
common ,taiwan:2
infections ,taiwan:2
structural ,genomics:2
structural ,sars-cov-2:56
structural ,indicates:2
structural ,evolutionary:6
structural ,conserved:2
structural ,functional:10
genomics ,sars-cov-2:4
genomics ,indicates:2
genomics ,evolutionary:2
genomics ,conserved:2
genomics ,functional:2
sars-cov-2 ,indicates:6
sars-cov-2 ,evolutionary:16
sars-cov-2 ,conserved:6
sars-cov-2 ,functional:22
indicates ,evolutionary:2
indicates ,conserved:2
indicates ,functional:2
evolutionary ,conserved:2
evolutionary ,functional:2
conserved ,functional:2
26 ,fortnightly:2
26 ,period:2
26 ,ending:2
26 ,27:2
lithium ,coronaviral:2
lithium ,infections:2
lithium ,scoping:2
lithium ,review:2
coronaviral ,infections:2
coronaviral ,scoping:2
coronaviral ,review:2
infections ,scoping:2
understanding ,epidemiology:2
understanding ,pathophysiology:4
understanding ,management:2
epidemiology ,pathophysiology:2
epidemiology ,management:6
pathophysiology ,diagnosis:4
pathophysiology ,management:2
covid-19 ,30:2
australia ,30:2
epidemiology ,30:2
report ,30:2
24 ,30:2
fortnightly ,30:2
reporting ,30:2
period ,30:2
ending ,30:2
full-genome ,evolutionary:2
full-genome ,analysis:2
full-genome ,novel:2
full-genome ,corona:2
full-genome ,virus:2
full-genome ,2019-ncov:2
full-genome ,rejects:2
evolutionary ,analysis:8
evolutionary ,corona:2
evolutionary ,virus:2
evolutionary ,2019-ncov:6
evolutionary ,rejects:2
analysis ,corona:6
analysis ,virus:12
analysis ,rejects:2
novel ,corona:16
novel ,rejects:2
corona ,2019-ncov:6
corona ,rejects:2
virus ,2019-ncov:8
virus ,rejects:2
2019-ncov ,rejects:2
biocides ,novel:2
biocides ,antimicrobial:2
biocides ,agents:2
biocides ,mitigation:2
biocides ,coronaviruses:2
novel ,antimicrobial:2
novel ,agents:2
novel ,mitigation:4
antimicrobial ,agents:2
antimicrobial ,mitigation:2
antimicrobial ,coronaviruses:2
agents ,mitigation:2
agents ,coronaviruses:6
mitigation ,coronaviruses:2
12 ,19:2
week ,19:2
2359 ,19:2
aest ,19:2
19 ,april:2
25 ,13:2
fortnightly ,13:2
period ,13:2
ending ,13:2
molecular ,diagnosis:18
molecular ,novel:6
molecular ,coronavirus:14
molecular ,causing:2
molecular ,outbreak:2
diagnosis ,2019-ncov:4
diagnosis ,causing:4
diagnosis ,outbreak:4
novel ,causing:4
coronavirus ,causing:4
2019-ncov ,causing:4
causing ,outbreak:2
covid-19 ,23:2
australia ,23:2
epidemiology ,23:2
report ,23:2
23 ,fortnightly:2
23 ,reporting:2
23 ,period:2
23 ,ending:2
23 ,16:2
fortnightly ,16:2
period ,16:2
ending ,16:2
persistent ,viral:6
persistent ,shedding:6
persistent ,sars-cov-2:18
persistent ,faeces:2
persistent ,rapid:2
persistent ,review:2
viral ,shedding:42
viral ,sars-cov-2:112
viral ,faeces:2
viral ,rapid:6
viral ,review:4
shedding ,sars-cov-2:28
shedding ,faeces:2
shedding ,rapid:2
shedding ,review:2
sars-cov-2 ,faeces:4
faeces ,rapid:2
faeces ,review:4
rapid ,review:18
development ,genetic:2
development ,diagnostic:4
development ,methods:2
development ,detection:12
development ,novel:12
development ,coronavirus:22
genetic ,diagnostic:2
genetic ,methods:2
genetic ,detection:4
diagnostic ,detection:20
diagnostic ,novel:6
diagnostic ,coronavirus:28
methods ,detection:12
methods ,novel:10
detection ,novel:42
detection ,coronavirus:68
smell ,impairment:4
smell ,covid-19:34
smell ,patients:16
smell ,mechanisms:2
smell ,clinical:2
smell ,significance:2
impairment ,covid-19:8
impairment ,patients:4
impairment ,mechanisms:2
impairment ,clinical:2
impairment ,significance:2
covid-19 ,mechanisms:44
covid-19 ,significance:4
patients ,mechanisms:8
patients ,significance:4
mechanisms ,clinical:12
mechanisms ,significance:2
clinical ,significance:12
humoral ,immune:10
humoral ,response:6
humoral ,sars-cov-2:14
response ,sars-cov-2:68
novel ,unorthodox:2
novel ,reduce:2
novel ,case:24
novel ,fatality:2
novel ,rate:2
novel ,high:2
unorthodox ,strategies:2
unorthodox ,reduce:2
unorthodox ,case:2
unorthodox ,fatality:2
unorthodox ,rate:2
unorthodox ,covid-19:2
unorthodox ,high:2
strategies ,reduce:2
strategies ,case:2
strategies ,fatality:2
strategies ,rate:2
strategies ,high:2
reduce ,case:2
reduce ,fatality:2
reduce ,rate:2
reduce ,covid-19:10
reduce ,high:2
case ,fatality:16
case ,rate:8
case ,high:4
fatality ,rate:10
fatality ,covid-19:20
fatality ,high:2
rate ,covid-19:34
rate ,high:10
covid-19 ,high:32
duration ,sars-cov-2:12
duration ,shedding:12
duration ,patients:6
duration ,recovering:2
duration ,covid-19:6
sars-cov-2 ,recovering:4
shedding ,patients:24
shedding ,recovering:2
shedding ,covid-19:18
patients ,recovering:2
recovering ,covid-19:2
global ,2019-ncov:2
global ,molecular:2
global ,evolutionary:2
global ,analysis:8
spread ,2019-ncov:10
spread ,molecular:2
spread ,evolutionary:2
spread ,analysis:6
molecular ,evolutionary:2
molecular ,analysis:20
sars-cov-2 ,infection-associated:2
sars-cov-2 ,hemophagocytic:2
sars-cov-2 ,lymphohistiocytosis:2
infection-associated ,hemophagocytic:2
infection-associated ,lymphohistiocytosis:2
hemophagocytic ,lymphohistiocytosis:4
evidence ,supporting:8
evidence ,transmission:18
evidence ,severe:8
evidence ,acute:6
evidence ,respiratory:10
evidence ,syndrome:6
evidence ,coronavirus:12
supporting ,transmission:2
supporting ,severe:4
supporting ,acute:2
supporting ,respiratory:2
supporting ,syndrome:2
supporting ,coronavirus:2
transmission ,severe:34
transmission ,acute:32
transmission ,respiratory:34
transmission ,syndrome:26
can ,sars-cov-2-infected:4
can ,women:2
can ,breastfeed:2
can ,viral:4
can ,clearance:2
sars-cov-2-infected ,women:4
sars-cov-2-infected ,breastfeed:2
sars-cov-2-infected ,viral:4
sars-cov-2-infected ,clearance:2
women ,breastfeed:2
women ,viral:4
women ,clearance:2
breastfeed ,viral:2
breastfeed ,clearance:2
viral ,clearance:6
clinical ,infection:80
characteristics ,hospitalized:14
characteristics ,patients:128
characteristics ,sars-cov-2:52
characteristics ,infection:24
hospitalized ,sars-cov-2:24
hospitalized ,infection:6
patients ,infection:104
novel ,prevalence:6
novel ,biological:2
coronavirus ,prevalence:16
coronavirus ,biological:4
2019-ncov ,prevalence:2
2019-ncov ,biological:2
2019-ncov ,clinical:8
prevalence ,biological:2
prevalence ,clinical:6
prevalence ,characteristics:6
biological ,clinical:6
biological ,characteristics:6
pathogenicity ,transmissibility:2
pathogenicity ,2019-ncov-a:2
pathogenicity ,quick:2
pathogenicity ,overview:2
pathogenicity ,comparison:2
transmissibility ,2019-ncov-a:2
transmissibility ,quick:2
transmissibility ,overview:2
transmissibility ,comparison:2
2019-ncov-a ,quick:2
2019-ncov-a ,overview:2
2019-ncov-a ,comparison:2
quick ,overview:2
quick ,comparison:2
overview ,comparison:2
immunoinformatics-aided ,identification:2
immunoinformatics-aided ,cell:2
immunoinformatics-aided ,epitopes:2
immunoinformatics-aided ,surface:2
identification ,cell:8
identification ,epitopes:10
identification ,surface:2
cell ,epitopes:14
cell ,surface:4
epitopes ,surface:4
pattern ,early:2
pattern ,human-to-human:2
pattern ,transmission:2
pattern ,wuhan:2
pattern ,novel:2
pattern ,coronavirus:2
early ,human-to-human:2
early ,transmission:10
early ,wuhan:2
human-to-human ,transmission:10
human-to-human ,wuhan:4
human-to-human ,novel:4
human-to-human ,coronavirus:4
transmission ,wuhan:4
transmission ,novel:14
mesenchymal ,stem:34
mesenchymal ,cells:24
mesenchymal ,treatment:14
mesenchymal ,strategy:4
mesenchymal ,coronavirus:6
mesenchymal ,disease:4
stem ,treatment:14
stem ,strategy:4
stem ,coronavirus:8
stem ,disease:4
cells ,treatment:12
cells ,strategy:2
cells ,coronavirus:14
cells ,disease:6
treatment ,strategy:8
strategy ,coronavirus:8
strategy ,disease:4
covid-19 ,pleural:2
covid-19 ,effusion:2
covid-19 ,initial:20
covid-19 ,symptom:16
pleural ,effusion:2
pleural ,initial:2
pleural ,symptom:2
pleural ,case:2
pleural ,study:2
pleural ,analysis:2
effusion ,initial:2
effusion ,symptom:2
effusion ,case:2
effusion ,study:2
effusion ,analysis:2
initial ,symptom:2
initial ,case:2
initial ,study:6
initial ,analysis:2
symptom ,case:6
symptom ,study:2
symptom ,analysis:2
case ,study:22
case ,analysis:8
study ,analysis:6
viral ,kinetics:12
viral ,infection:32
viral ,first:4
viral ,two:2
viral ,patients:46
viral ,korea:2
load ,kinetics:6
load ,sars-cov-2:24
load ,infection:6
load ,first:2
load ,two:2
load ,patients:16
load ,korea:2
kinetics ,sars-cov-2:12
kinetics ,infection:6
kinetics ,first:2
kinetics ,two:4
kinetics ,patients:8
kinetics ,korea:2
sars-cov-2 ,two:60
sars-cov-2 ,korea:4
infection ,first:16
infection ,two:14
infection ,korea:4
first ,two:8
first ,patients:16
first ,korea:6
two ,patients:24
two ,korea:2
patients ,korea:2
sars-cov-2 ,pathogenicity:6
comprehensive ,pathogenicity:2
comprehensive ,virus:2
review ,pathogenicity:2
pathogenicity ,virus:2
pathogenicity ,clinical:2
virus ,clinical:18
chir ,score:2
chir ,evaluating:2
chir ,hyperimmune:2
chir ,response:2
chir ,covid-19:2
chir ,preliminary:2
score ,evaluating:2
score ,hyperimmune:2
score ,response:2
score ,covid-19:10
score ,preliminary:2
evaluating ,hyperimmune:2
evaluating ,response:2
evaluating ,preliminary:2
hyperimmune ,response:2
hyperimmune ,covid-19:2
hyperimmune ,preliminary:2
response ,preliminary:2
unveiling ,origin:2
unveiling ,transmission:2
unveiling ,2019-ncov:2
origin ,2019-ncov:4
single-cell ,rna-seq:4
single-cell ,data:2
single-cell ,analysis:8
single-cell ,receptor:4
single-cell ,ace2:8
single-cell ,expression:8
single-cell ,reveals:4
rna-seq ,data:2
rna-seq ,analysis:2
rna-seq ,receptor:2
rna-seq ,ace2:2
rna-seq ,expression:2
rna-seq ,reveals:2
data ,analysis:16
data ,receptor:2
data ,ace2:6
data ,expression:2
data ,reveals:2
analysis ,ace2:18
analysis ,expression:14
analysis ,reveals:22
receptor ,ace2:64
receptor ,expression:32
receptor ,reveals:4
ace2 ,reveals:6
expression ,reveals:8
rehabilitation ,community:2
rehabilitation ,prepare:2
rehabilitation ,2019-ncov:2
community ,prepare:2
community ,2019-ncov:2
prepare ,2019-ncov:2
first ,italy:6
first ,come:2
two ,cases:26
two ,2019-ncov:6
two ,italy:4
two ,come:2
cases ,italy:6
cases ,come:2
2019-ncov ,italy:2
2019-ncov ,come:2
italy ,come:2
reactivation ,sars-cov-2:2
reactivation ,recovery:2
sars-cov-2 ,recovery:6
sars-cov ,safety:2
sars-cov ,broad-spectrum:2
sars-cov ,important:2
sars-cov ,coronavirus:14
sars-cov-2 ,safety:12
sars-cov-2 ,broad-spectrum:4
safety ,broad-spectrum:2
safety ,important:2
broad-spectrum ,important:2
broad-spectrum ,coronavirus:2
options ,controlling:2
options ,new:2
options ,corona:2
options ,virus:2
options ,infection:4
controlling ,new:2
controlling ,corona:2
controlling ,virus:2
controlling ,infection:4
controlling ,2019-ncov:2
new ,corona:4
new ,virus:12
new ,infection:26
corona ,infection:4
virus ,infection:14
infection ,2019-ncov:16
pregnancy ,new:2
pregnancy ,coronavirus:22
pregnancy ,infection:32
pregnancy ,clinical:8
pregnancy ,characteristics:4
pregnancy ,placental:4
new ,clinical:10
new ,characteristics:2
new ,placental:2
coronavirus ,infection:144
coronavirus ,placental:2
infection ,placental:2
clinical ,placental:2
characteristics ,placental:2
advances ,systematic:2
advances ,review:6
sars-cov-2 ,systematic:54
comparative ,performance:4
comparative ,sars-cov-2:36
comparative ,detection:6
comparative ,assays:8
comparative ,using:4
comparative ,seven:4
comparative ,different:6
performance ,detection:12
performance ,assays:14
performance ,using:8
performance ,seven:6
performance ,different:4
sars-cov-2 ,assays:66
sars-cov-2 ,using:102
sars-cov-2 ,seven:6
sars-cov-2 ,different:42
detection ,assays:22
detection ,using:44
detection ,seven:6
detection ,different:12
assays ,using:8
assays ,seven:4
assays ,different:8
using ,seven:4
using ,different:4
seven ,different:4
leveraging ,best:2
leveraging ,practices:2
leveraging ,protecting:2
leveraging ,sub-saharan:2
leveraging ,african:2
leveraging ,prison:2
leveraging ,detainees:2
leveraging ,amid:2
best ,practices:4
best ,protecting:2
best ,sub-saharan:2
best ,african:2
best ,prison:2
best ,detainees:2
best ,amid:2
practices ,protecting:2
practices ,sub-saharan:2
practices ,african:2
practices ,prison:2
practices ,detainees:2
practices ,amid:2
protecting ,sub-saharan:2
protecting ,african:2
protecting ,prison:2
protecting ,detainees:2
protecting ,amid:2
sub-saharan ,african:2
sub-saharan ,prison:2
sub-saharan ,detainees:2
sub-saharan ,amid:2
african ,prison:2
african ,detainees:2
african ,amid:2
prison ,detainees:2
prison ,amid:2
detainees ,amid:2
drug ,discovery:32
drug ,repurposing:44
drug ,combating:6
drug ,covid-19:90
drug ,21st:2
drug ,century:2
discovery ,repurposing:4
discovery ,combating:2
discovery ,covid-19:24
discovery ,21st:2
discovery ,century:2
repurposing ,combating:6
repurposing ,21st:2
repurposing ,century:2
combating ,21st:2
combating ,century:2
covid-19 ,21st:2
covid-19 ,century:2
21st ,century:4
vitro ,testing:2
vitro ,combined:4
vitro ,hydroxychloroquine:4
vitro ,azithromycin:2
vitro ,sars-cov-2:26
vitro ,shows:2
testing ,combined:2
testing ,hydroxychloroquine:2
testing ,azithromycin:2
testing ,shows:4
combined ,hydroxychloroquine:2
combined ,azithromycin:2
combined ,sars-cov-2:4
combined ,shows:2
hydroxychloroquine ,sars-cov-2:16
hydroxychloroquine ,shows:2
azithromycin ,sars-cov-2:6
azithromycin ,shows:2
sars-cov-2 ,shows:4
structural ,glycosylation:2
structural ,antigenic:2
structural ,variation:4
structural ,novel:4
structural ,coronavirus:10
glycosylation ,antigenic:2
glycosylation ,variation:2
glycosylation ,novel:2
glycosylation ,coronavirus:2
antigenic ,variation:2
antigenic ,novel:6
antigenic ,coronavirus:4
variation ,novel:2
variation ,coronavirus:4
introducing ,21st:2
introducing ,centurys:2
introducing ,new:2
introducing ,four:2
introducing ,horsemen:2
introducing ,coronapocalypse:2
21st ,centurys:2
21st ,new:2
21st ,four:2
21st ,horsemen:2
21st ,coronapocalypse:2
centurys ,new:2
centurys ,four:2
centurys ,horsemen:2
centurys ,coronapocalypse:2
new ,four:4
new ,horsemen:2
new ,coronapocalypse:2
four ,horsemen:4
four ,coronapocalypse:2
horsemen ,coronapocalypse:2
presence ,lung:2
presence ,injury:2
presence ,covid-19:12
presence ,independent:2
presence ,risk:2
presence ,factor:2
presence ,secondary:2
lung ,injury:18
lung ,independent:2
lung ,risk:2
lung ,factor:2
lung ,secondary:2
injury ,covid-19:50
injury ,independent:2
injury ,risk:6
injury ,factor:2
injury ,secondary:2
covid-19 ,independent:4
covid-19 ,factor:26
covid-19 ,secondary:18
independent ,risk:2
independent ,factor:2
independent ,secondary:2
risk ,factor:28
risk ,secondary:2
factor ,secondary:2
first ,caused:2
first ,highly:4
first ,transmissible:2
first ,acute:16
first ,respiratory:20
first ,syndrome:12
disease ,caused:8
disease ,highly:6
disease ,transmissible:2
disease ,syndrome:18
caused ,highly:4
caused ,transmissible:2
caused ,acute:8
caused ,respiratory:8
caused ,syndrome:2
highly ,transmissible:2
highly ,acute:4
highly ,respiratory:2
highly ,syndrome:2
transmissible ,acute:2
transmissible ,respiratory:2
transmissible ,syndrome:2
sars-cov-2 ,previous:2
sars-cov-2 ,vaccines:28
previous ,coronaviruses:2
previous ,immune:2
previous ,response:2
previous ,development:2
previous ,vaccines:2
coronaviruses ,immune:4
coronaviruses ,response:2
coronaviruses ,development:4
coronaviruses ,vaccines:4
immune ,development:4
immune ,vaccines:4
response ,development:4
response ,vaccines:4
development ,vaccines:22
youtube ,source:4
youtube ,patient:2
youtube ,information:4
youtube ,coronavirus:2
youtube ,disease:4
youtube ,covid-19:4
source ,patient:2
source ,information:4
source ,coronavirus:2
source ,disease:4
source ,covid-19:12
patient ,information:2
information ,coronavirus:4
information ,disease:6
prediction ,sars-cov-2:18
prediction ,2019-ncov:2
prediction ,3c-like:2
prediction ,protease:6
prediction ,3cl:2
prediction ,pro:2
prediction ,structure:2
sars-cov-2 ,3c-like:8
sars-cov-2 ,protease:56
sars-cov-2 ,3cl:2
sars-cov-2 ,pro:2
sars-cov-2 ,structure:38
2019-ncov ,3c-like:2
2019-ncov ,protease:6
2019-ncov ,3cl:2
2019-ncov ,pro:2
2019-ncov ,structure:8
3c-like ,protease:10
3c-like ,3cl:2
3c-like ,pro:2
3c-like ,structure:2
protease ,3cl:2
protease ,pro:2
protease ,structure:2
3cl ,pro:2
3cl ,structure:2
pro ,structure:2
rna ,based:2
rna ,mngs:2
rna ,approach:4
rna ,identifies:2
rna ,novel:8
rna ,human:12
rna ,coronavirus:26
rna ,two:6
rna ,individual:2
based ,mngs:2
based ,approach:6
based ,identifies:2
based ,human:4
based ,two:2
based ,individual:2
mngs ,approach:2
mngs ,identifies:2
mngs ,novel:2
mngs ,human:2
mngs ,coronavirus:2
mngs ,two:2
mngs ,individual:2
approach ,identifies:2
approach ,novel:8
approach ,human:2
approach ,coronavirus:14
approach ,two:2
approach ,individual:2
identifies ,novel:2
identifies ,human:4
identifies ,coronavirus:2
identifies ,two:2
identifies ,individual:2
novel ,two:8
novel ,individual:2
human ,two:4
human ,individual:2
coronavirus ,two:14
coronavirus ,individual:2
two ,individual:2
sars-cov-2 ,pregnancy:32
sars-cov-2 ,literature:16
sars-cov-2 ,possible:66
infection ,review:44
infection ,current:12
infection ,literature:8
infection ,possible:16
pregnancy ,review:22
pregnancy ,current:4
pregnancy ,literature:2
pregnancy ,possible:4
current ,literature:8
current ,possible:4
literature ,possible:2
silico ,identification:4
silico ,vaccine:4
silico ,targets:2
silico ,2019-ncov:4
identification ,2019-ncov:2
vaccine ,2019-ncov:6
targets ,2019-ncov:2
rapid ,novel:26
rapid ,coronavirussevere:2
rapid ,acute:10
rapid ,respiratory:16
rapid ,syndrome:8
rapid ,coronavirus:26
detection ,coronavirussevere:2
detection ,acute:40
detection ,respiratory:38
detection ,syndrome:26
novel ,coronavirussevere:2
novel ,acute:24
novel ,syndrome:20
coronavirussevere ,acute:2
coronavirussevere ,respiratory:2
coronavirussevere ,syndrome:2
coronavirussevere ,coronavirus:2
2019-ncov ,challenges:6
new ,challenges:6
challenges ,coronavirus:12
first ,transmitted:2
first ,food:2
first ,borne:2
respiratory ,transmitted:2
respiratory ,food:2
respiratory ,borne:2
respiratory ,outbreak:12
transmitted ,food:2
transmitted ,borne:2
transmitted ,outbreak:2
food ,borne:2
food ,outbreak:2
borne ,outbreak:2
role ,eye:2
role ,transmitting:2
role ,human:8
role ,coronavirus:28
role ,know:2
eye ,transmitting:2
eye ,human:2
eye ,know:2
transmitting ,human:2
transmitting ,coronavirus:2
transmitting ,know:2
human ,know:2
clinical ,epidemiologic:16
clinical ,evaluation:38
clinical ,inconclusive:2
clinical ,pcr:8
clinical ,results:2
clinical ,using:8
epidemiologic ,evaluation:2
epidemiologic ,inconclusive:2
epidemiologic ,covid-19:12
epidemiologic ,pcr:2
epidemiologic ,results:2
epidemiologic ,using:2
evaluation ,inconclusive:2
evaluation ,covid-19:50
evaluation ,pcr:12
evaluation ,results:4
evaluation ,using:20
inconclusive ,covid-19:2
inconclusive ,pcr:2
inconclusive ,results:2
inconclusive ,using:2
covid-19 ,pcr:12
covid-19 ,using:72
pcr ,results:10
pcr ,using:4
results ,using:2
studies ,pneumonia:2
studies ,related:2
studies ,novel:2
studies ,coronavirus:6
studies ,sars-cov-2:12
studies ,sars-cov:2
viral ,pneumonia:12
viral ,related:4
viral ,novel:8
viral ,coronavirus:26
viral ,sars-cov:2
pneumonia ,related:6
pneumonia ,sars-cov:4
related ,novel:4
related ,coronavirus:10
related ,sars-cov-2:24
related ,sars-cov:2
novel ,sars-cov:2
combination ,therapy:12
combination ,using:2
combination ,inhalable:2
combination ,gapmer:2
combination ,recombinant:2
combination ,ace2:2
combination ,covid-19:14
therapy ,using:2
therapy ,inhalable:2
therapy ,gapmer:2
therapy ,recombinant:2
therapy ,ace2:2
therapy ,covid-19:106
using ,inhalable:2
using ,gapmer:2
using ,recombinant:4
using ,ace2:2
inhalable ,gapmer:2
inhalable ,recombinant:2
inhalable ,ace2:2
inhalable ,covid-19:2
gapmer ,recombinant:2
gapmer ,ace2:2
gapmer ,covid-19:2
recombinant ,ace2:2
recombinant ,covid-19:4
comparison ,nasopharyngeal:4
comparison ,oropharyngeal:2
comparison ,353:2
nasopharyngeal ,oropharyngeal:6
nasopharyngeal ,swabs:14
nasopharyngeal ,353:2
oropharyngeal ,swabs:4
oropharyngeal ,sars-cov-2:6
oropharyngeal ,detection:4
oropharyngeal ,353:2
swabs ,sars-cov-2:30
swabs ,353:2
sars-cov-2 ,353:2
detection ,353:2
cutting ,edge:2
cutting ,thoracic:2
cutting ,anesthesia:2
cutting ,coronavirus:2
cutting ,disease:2
edge ,thoracic:2
edge ,anesthesia:2
edge ,coronavirus:2
edge ,disease:2
thoracic ,anesthesia:2
thoracic ,coronavirus:6
thoracic ,disease:6
anesthesia ,coronavirus:2
anesthesia ,disease:2
first ,reported:12
first ,unrepaired:2
first ,tetralogy:2
first ,fallot:2
first ,complicated:2
reported ,case:4
reported ,unrepaired:2
reported ,tetralogy:2
reported ,fallot:2
reported ,complicated:2
reported ,coronavirus:8
case ,unrepaired:2
case ,tetralogy:2
case ,fallot:2
case ,complicated:6
case ,coronavirus:70
unrepaired ,tetralogy:2
unrepaired ,fallot:2
unrepaired ,complicated:2
unrepaired ,coronavirus:2
tetralogy ,fallot:4
tetralogy ,complicated:2
tetralogy ,coronavirus:2
fallot ,complicated:2
fallot ,coronavirus:2
complicated ,coronavirus:4
gastrointestinal ,manifestations:20
gastrointestinal ,corona:2
gastrointestinal ,virus:2
gastrointestinal ,disease-19:2
hepatic ,manifestations:6
hepatic ,corona:2
hepatic ,virus:2
hepatic ,disease-19:2
manifestations ,corona:2
manifestations ,virus:4
manifestations ,disease-19:2
corona ,disease-19:8
virus ,disease-19:8
2019-novel ,coronavirus-related:2
2019-novel ,acute:2
2019-novel ,cardiac:2
2019-novel ,injury:2
2019-novel ,ignored:2
coronavirus-related ,acute:2
coronavirus-related ,cardiac:2
coronavirus-related ,injury:2
coronavirus-related ,ignored:2
acute ,cardiac:4
acute ,injury:34
acute ,ignored:2
cardiac ,injury:10
cardiac ,ignored:2
injury ,ignored:2
rapid ,using:28
rapid ,crispr-based:2
rapid ,detectr:2
detection ,crispr-based:2
detection ,detectr:2
novel ,using:8
novel ,crispr-based:2
novel ,detectr:2
coronavirus ,using:12
coronavirus ,crispr-based:2
coronavirus ,detectr:2
sars-cov-2 ,crispr-based:2
sars-cov-2 ,detectr:2
using ,crispr-based:2
using ,detectr:2
crispr-based ,detectr:2
two ,pandemics:8
two ,one:4
two ,challenge-leveraging:2
two ,molecular:4
two ,test:4
two ,capacity:2
two ,tuberculosis:2
pandemics ,one:2
pandemics ,challenge-leveraging:2
pandemics ,molecular:2
pandemics ,test:2
pandemics ,capacity:2
pandemics ,tuberculosis:2
one ,challenge-leveraging:2
one ,molecular:4
one ,test:2
one ,capacity:2
one ,tuberculosis:2
challenge-leveraging ,molecular:2
challenge-leveraging ,test:2
challenge-leveraging ,capacity:2
challenge-leveraging ,tuberculosis:2
molecular ,test:2
molecular ,capacity:2
molecular ,tuberculosis:2
test ,capacity:2
test ,tuberculosis:2
capacity ,tuberculosis:2
comparative ,analysis:32
comparative ,primer-probe:2
comparative ,sets:2
comparative ,rt-qpcr:2
comparative ,covid-19:24
comparative ,causative:2
comparative ,virus:2
analysis ,primer-probe:2
analysis ,sets:2
analysis ,rt-qpcr:2
analysis ,causative:2
primer-probe ,sets:4
primer-probe ,rt-qpcr:2
primer-probe ,covid-19:2
primer-probe ,causative:2
primer-probe ,virus:2
sets ,rt-qpcr:2
sets ,covid-19:2
sets ,causative:2
sets ,virus:2
rt-qpcr ,covid-19:2
rt-qpcr ,causative:2
rt-qpcr ,virus:2
comparative ,immunological:2
comparative ,characteristics:4
comparative ,sars-cov:8
comparative ,mers-cov:6
immunological ,characteristics:2
immunological ,sars-cov:4
immunological ,mers-cov:2
immunological ,sars-cov-2:12
characteristics ,sars-cov:2
characteristics ,mers-cov:2
computational ,simulation:2
computational ,platform:2
computational ,designing:2
computational ,real-time:2
computational ,monitoring:2
computational ,systems:2
simulation ,platform:2
simulation ,designing:2
simulation ,real-time:2
simulation ,monitoring:2
simulation ,systems:2
platform ,designing:2
platform ,real-time:2
platform ,monitoring:2
platform ,systems:2
designing ,real-time:2
designing ,monitoring:2
designing ,systems:2
real-time ,monitoring:6
real-time ,systems:2
monitoring ,systems:2
recent ,progress:10
recent ,understanding:2
recent ,associated:4
progress ,understanding:2
progress ,novel:10
progress ,coronavirus:22
progress ,sars-cov-2:12
progress ,associated:2
understanding ,sars-cov-2:18
understanding ,associated:2
novel ,associated:6
novel ,quiz:2
novel ,final:2
novel ,exam:2
coronavirus ,quiz:2
coronavirus ,final:2
coronavirus ,exam:2
outbreak ,quiz:2
outbreak ,final:2
outbreak ,exam:2
quiz ,final:2
quiz ,exam:2
final ,exam:2
proteasome ,activator:2
proteasome ,pa28-dependent:2
proteasome ,degradation:2
proteasome ,coronavirus:2
proteasome ,disease:2
proteasome ,covid-19:2
activator ,pa28-dependent:2
activator ,degradation:2
activator ,coronavirus:2
activator ,disease:2
activator ,covid-19:2
pa28-dependent ,degradation:2
pa28-dependent ,coronavirus:2
pa28-dependent ,disease:2
pa28-dependent ,covid-19:2
degradation ,coronavirus:2
degradation ,disease:2
degradation ,covid-19:2
respiratory ,support:12
respiratory ,2019-ncov:4
respiratory ,suffering:2
support ,severe:4
support ,2019-ncov:2
support ,pneumonia:2
support ,suffering:2
support ,acute:6
severe ,2019-ncov:2
severe ,suffering:2
2019-ncov ,suffering:2
2019-ncov ,acute:6
pneumonia ,suffering:2
suffering ,acute:2
update ,2019-ncov:4
update ,outbreak:6
d3targets-2019-ncov ,webserver:2
d3targets-2019-ncov ,predicting:2
d3targets-2019-ncov ,drug:2
d3targets-2019-ncov ,targets:2
d3targets-2019-ncov ,multi-target:2
webserver ,predicting:2
webserver ,drug:2
webserver ,targets:2
webserver ,multi-target:2
predicting ,drug:2
predicting ,targets:2
predicting ,multi-target:2
drug ,multi-target:2
targets ,multi-target:2
saliva ,specimen:10
saliva ,detection:20
saliva ,suspected:2
saliva ,patients:4
diagnostic ,specimen:6
diagnostic ,patients:8
specimen ,detection:16
specimen ,sars-cov-2:14
specimen ,suspected:2
specimen ,patients:2
detection ,suspected:2
detection ,patients:28
sars-cov-2 ,suspected:10
suspected ,patients:18
emerging ,insight:2
emerging ,biology:2
novel ,global:10
novel ,threat:4
novel ,biology:4
coronavirus ,biology:2
global ,insight:2
global ,biology:2
threat ,insight:2
threat ,biology:2
threat ,covid-19:12
insight ,biology:4
insight ,covid-19:8
biology ,covid-19:8
allplex ,2019-ncov:2
allplex ,seegene:2
allplex ,assay:2
allplex ,performances:2
allplex ,sars-cov-2:2
2019-ncov ,seegene:2
2019-ncov ,assay:2
2019-ncov ,performances:2
seegene ,assay:2
seegene ,performances:2
seegene ,sars-cov-2:2
assay ,performances:2
assay ,sars-cov-2:52
performances ,sars-cov-2:6
culture-competent ,sars-cov-2:2
culture-competent ,nasopharynx:2
culture-competent ,symptomatic:2
culture-competent ,neonates:2
culture-competent ,children:2
sars-cov-2 ,nasopharynx:4
sars-cov-2 ,symptomatic:14
sars-cov-2 ,neonates:16
sars-cov-2 ,children:76
nasopharynx ,symptomatic:2
nasopharynx ,neonates:2
nasopharynx ,children:2
symptomatic ,neonates:2
symptomatic ,children:4
neonates ,children:6
preliminary ,recommendations:2
preliminary ,surgical:2
preliminary ,practice:2
preliminary ,neurosurgery:2
preliminary ,department:2
recommendations ,surgical:4
recommendations ,practice:8
recommendations ,neurosurgery:2
recommendations ,department:2
surgical ,practice:2
surgical ,neurosurgery:2
surgical ,department:4
practice ,neurosurgery:2
practice ,department:4
neurosurgery ,department:2
community ,pharmacist:2
community ,public:2
community ,health:6
community ,emergencies:2
community ,quick:2
community ,action:2
pharmacist ,public:2
pharmacist ,health:2
pharmacist ,emergencies:2
pharmacist ,quick:2
pharmacist ,action:2
public ,emergencies:6
public ,quick:2
public ,action:2
health ,emergencies:6
health ,quick:2
health ,action:2
emergencies ,quick:2
emergencies ,action:2
quick ,action:2
spread ,china:6
spread ,primarily:2
spread ,driven:2
spread ,population:4
spread ,density:2
spread ,comment:2
2019-ncov ,china:8
2019-ncov ,primarily:2
2019-ncov ,driven:2
2019-ncov ,population:4
2019-ncov ,density:2
2019-ncov ,comment:2
china ,primarily:2
china ,driven:2
china ,population:6
china ,density:2
china ,comment:2
primarily ,driven:2
primarily ,population:2
primarily ,density:2
primarily ,comment:2
driven ,population:2
driven ,density:2
driven ,comment:2
population ,density:2
population ,comment:2
density ,comment:2
incidence ,novel:4
incidence ,coronavirus:10
incidence ,2019-ncov:2
incidence ,infection:6
incidence ,among:4
incidence ,people:2
incidence ,home:2
novel ,infection:62
novel ,people:2
novel ,home:2
coronavirus ,people:6
coronavirus ,home:2
2019-ncov ,people:2
2019-ncov ,home:2
infection ,among:36
infection ,people:8
infection ,home:2
among ,people:4
among ,home:2
people ,home:2
passengers ,destinations:2
passengers ,china:2
passengers ,low:2
passengers ,risk:2
passengers ,novel:2
passengers ,coronavirus:2
passengers ,2019-ncov:2
destinations ,china:2
destinations ,low:2
destinations ,risk:2
destinations ,novel:2
destinations ,coronavirus:2
destinations ,2019-ncov:2
china ,low:2
china ,risk:12
china ,novel:16
china ,coronavirus:38
low ,risk:6
low ,novel:2
low ,coronavirus:2
low ,2019-ncov:2
risk ,novel:6
risk ,coronavirus:36
risk ,2019-ncov:6
epidemiological ,genomic:2
epidemiological ,analysis:10
epidemiological ,sars-cov-2:24
epidemiological ,10:2
epidemiological ,patients:24
epidemiological ,mid-sized:2
genomic ,sars-cov-2:42
genomic ,10:2
genomic ,patients:6
genomic ,mid-sized:2
analysis ,10:2
analysis ,patients:40
analysis ,mid-sized:2
sars-cov-2 ,10:2
sars-cov-2 ,mid-sized:2
10 ,patients:2
10 ,mid-sized:2
patients ,mid-sized:2
saliva ,option:4
saliva ,route:2
diagnostic ,option:2
diagnostic ,route:2
option ,transmission:2
option ,route:2
option ,2019-ncov:4
transmission ,route:12
route ,2019-ncov:2
efficacy ,novel:2
efficacy ,sars-cov-2:16
efficacy ,detection:6
efficacy ,kit:2
efficacy ,without:2
efficacy ,rna:4
efficacy ,extraction:2
novel ,kit:2
novel ,without:4
novel ,extraction:2
sars-cov-2 ,kit:10
sars-cov-2 ,without:18
sars-cov-2 ,rna:180
sars-cov-2 ,extraction:18
detection ,kit:6
detection ,without:12
detection ,rna:58
detection ,extraction:10
kit ,without:2
kit ,rna:2
kit ,extraction:2
without ,rna:12
without ,extraction:10
rna ,extraction:16
direct ,comparison:6
direct ,enhanced:2
direct ,saliva:4
direct ,nasopharyngeal:4
direct ,swab:2
direct ,detection:14
comparison ,enhanced:2
comparison ,saliva:4
comparison ,swab:6
enhanced ,saliva:2
enhanced ,nasopharyngeal:2
enhanced ,swab:2
enhanced ,detection:2
saliva ,nasopharyngeal:4
saliva ,swab:6
nasopharyngeal ,swab:16
swab ,detection:10
protein ,structure:8
protein ,sequence:4
protein ,reanalysis:2
protein ,2019-ncov:2
protein ,genome:2
protein ,refutes:2
protein ,snakes:2
structure ,sequence:4
structure ,reanalysis:2
structure ,refutes:2
structure ,snakes:2
sequence ,reanalysis:2
sequence ,2019-ncov:2
sequence ,genome:4
sequence ,refutes:2
sequence ,snakes:2
reanalysis ,2019-ncov:2
reanalysis ,genome:2
reanalysis ,refutes:2
reanalysis ,snakes:2
2019-ncov ,genome:4
2019-ncov ,refutes:2
2019-ncov ,snakes:2
genome ,refutes:2
genome ,snakes:2
refutes ,snakes:2
triplex ,real-time:2
triplex ,rt-pcr:2
triplex ,severe:2
triplex ,acute:2
triplex ,respiratory:2
triplex ,syndrome:2
triplex ,coronavirus:2
real-time ,rt-pcr:16
real-time ,severe:6
real-time ,acute:6
real-time ,respiratory:4
real-time ,syndrome:2
real-time ,coronavirus:10
rt-pcr ,severe:4
rt-pcr ,acute:4
rt-pcr ,respiratory:6
rt-pcr ,syndrome:2
rt-pcr ,coronavirus:10
non-sars-cov-2 ,genome:2
non-sars-cov-2 ,sequences:2
non-sars-cov-2 ,identified:2
non-sars-cov-2 ,clinical:4
non-sars-cov-2 ,samples:2
non-sars-cov-2 ,covid-19:4
genome ,sequences:6
genome ,identified:2
genome ,samples:2
genome ,covid-19:6
sequences ,identified:2
sequences ,clinical:2
sequences ,samples:2
sequences ,covid-19:2
identified ,clinical:2
identified ,samples:2
identified ,covid-19:6
clinical ,samples:10
novel ,early-stage:2
novel ,importation:2
novel ,europe:2
novel ,january:4
coronavirus ,early-stage:2
coronavirus ,importation:2
coronavirus ,europe:4
coronavirus ,january:4
2019-ncov ,early-stage:2
2019-ncov ,importation:2
2019-ncov ,europe:2
2019-ncov ,january:2
early-stage ,importation:2
early-stage ,risk:2
early-stage ,europe:2
early-stage ,january:2
importation ,risk:2
importation ,europe:2
importation ,january:2
risk ,europe:2
risk ,january:2
europe ,january:2
rapid ,identification:14
rapid ,potential:6
rapid ,inhibitors:2
rapid ,main:2
rapid ,protease:2
rapid ,deep:2
identification ,inhibitors:10
identification ,sars-cov-2:54
identification ,main:8
identification ,protease:8
identification ,deep:2
potential ,inhibitors:46
potential ,main:16
potential ,protease:18
potential ,deep:2
inhibitors ,sars-cov-2:76
inhibitors ,main:30
inhibitors ,protease:42
inhibitors ,deep:2
sars-cov-2 ,main:48
sars-cov-2 ,deep:4
main ,protease:56
main ,deep:2
protease ,deep:2
comprehensive ,analysis:10
comprehensive ,genome:2
comprehensive ,composition:2
comprehensive ,codon:2
comprehensive ,usage:2
comprehensive ,patterns:2
comprehensive ,emerging:2
analysis ,genome:18
analysis ,composition:2
analysis ,codon:6
analysis ,usage:4
analysis ,patterns:2
analysis ,emerging:2
genome ,composition:4
genome ,codon:2
genome ,usage:2
genome ,patterns:2
genome ,emerging:4
composition ,codon:2
composition ,usage:2
composition ,patterns:2
composition ,emerging:2
codon ,usage:14
codon ,patterns:2
codon ,emerging:2
usage ,patterns:2
usage ,emerging:2
patterns ,emerging:2
vaccine ,development:60
vaccine ,therapeutic:4
vaccine ,design:18
vaccine ,2019-ncovsars-cov-2:2
vaccine ,challenges:8
development ,therapeutic:8
development ,design:2
development ,2019-ncovsars-cov-2:2
development ,challenges:10
therapeutic ,design:2
therapeutic ,2019-ncovsars-cov-2:2
design ,2019-ncovsars-cov-2:2
design ,challenges:2
2019-ncovsars-cov-2 ,challenges:2
innate ,responses:6
innate ,highly:2
innate ,pathogenic:2
innate ,coronaviruses:2
innate ,significant:2
immune ,highly:2
immune ,pathogenic:4
immune ,significant:2
responses ,highly:2
responses ,pathogenic:2
responses ,coronaviruses:2
responses ,significant:2
highly ,pathogenic:14
highly ,coronaviruses:6
highly ,significant:2
pathogenic ,coronaviruses:8
pathogenic ,significant:2
coronaviruses ,significant:2
comparison ,two:16
comparison ,commercial:18
comparison ,molecular:10
comparison ,tests:10
comparison ,laboratory-developed:10
comparison ,modification:2
two ,commercial:6
two ,tests:6
two ,laboratory-developed:2
two ,modification:2
commercial ,molecular:6
commercial ,tests:4
commercial ,laboratory-developed:2
commercial ,modification:2
molecular ,tests:8
molecular ,laboratory-developed:2
molecular ,modification:2
tests ,laboratory-developed:2
tests ,modification:2
laboratory-developed ,modification:2
environmental ,concern:2
environmental ,regarding:2
environmental ,effect:6
environmental ,humidity:2
environmental ,temperature:6
environmental ,2019-ncov:2
concern ,regarding:2
concern ,effect:2
concern ,humidity:2
concern ,temperature:2
concern ,2019-ncov:2
regarding ,effect:2
regarding ,humidity:2
regarding ,temperature:2
regarding ,2019-ncov:2
effect ,humidity:2
effect ,temperature:6
effect ,2019-ncov:2
humidity ,temperature:2
humidity ,2019-ncov:2
temperature ,2019-ncov:2
molecular ,characterization:6
molecular ,sars-cov-2:86
characterization ,sars-cov-2:22
type ,interferon:18
type ,susceptibility:2
type ,distinguishes:2
type ,sars-cov-2:28
type ,sars-cov:2
interferon ,susceptibility:2
interferon ,distinguishes:2
interferon ,sars-cov-2:18
interferon ,sars-cov:2
susceptibility ,distinguishes:2
susceptibility ,sars-cov-2:30
susceptibility ,sars-cov:2
distinguishes ,sars-cov-2:2
distinguishes ,sars-cov:2
nonstructural ,proteins:2
nonstructural ,ns7b:2
nonstructural ,ns8:2
nonstructural ,likely:2
nonstructural ,phylogenetically:2
nonstructural ,associated:2
proteins ,ns7b:2
proteins ,ns8:2
proteins ,likely:2
proteins ,phylogenetically:2
proteins ,associated:4
ns7b ,ns8:2
ns7b ,likely:2
ns7b ,phylogenetically:2
ns7b ,associated:2
ns8 ,likely:2
ns8 ,phylogenetically:2
ns8 ,associated:2
likely ,phylogenetically:2
likely ,associated:2
phylogenetically ,associated:2
immune ,bioinformatics:2
immune ,identification:2
immune ,cell:4
immune ,epitopes:2
bioinformatics ,identification:2
bioinformatics ,cell:2
bioinformatics ,epitopes:2
rapid ,random:2
rapid ,access:2
rapid ,sars-coronavirus-2:4
random ,access:2
random ,detection:2
random ,novel:2
random ,sars-coronavirus-2:2
random ,sars-cov-2:2
access ,detection:2
access ,novel:2
access ,sars-coronavirus-2:2
access ,sars-cov-2:4
detection ,sars-coronavirus-2:2
novel ,sars-coronavirus-2:2
sars-coronavirus-2 ,sars-cov-2:2
broad ,anti-coronavirus:2
broad ,activity:2
broad ,food:2
broad ,drug:2
broad ,administration-approved:2
broad ,drugs:2
anti-coronavirus ,activity:2
anti-coronavirus ,food:2
anti-coronavirus ,drug:2
anti-coronavirus ,administration-approved:2
anti-coronavirus ,drugs:2
activity ,food:2
activity ,drug:4
activity ,administration-approved:2
activity ,drugs:4
food ,drug:2
food ,administration-approved:2
food ,drugs:2
drug ,administration-approved:2
drug ,drugs:2
administration-approved ,drugs:2
coronavirus ,public:8
coronavirus ,health:36
disease ,new:12
disease ,threat:2
disease ,public:8
disease ,health:18
review ,new:4
review ,threat:2
review ,public:6
review ,health:18
new ,threat:2
new ,public:2
new ,health:4
threat ,public:2
threat ,health:2
2019-ncov ,australia:2
2019-ncov ,epidemiology:2
2019-ncov ,report:2
2019-ncov ,reporting:2
acute ,australia:2
acute ,epidemiology:14
acute ,report:20
acute ,reporting:2
respiratory ,australia:2
respiratory ,epidemiology:12
respiratory ,report:6
respiratory ,reporting:2
disease ,australia:2
disease ,epidemiology:10
disease ,report:26
disease ,reporting:2
phylogenetic ,analysis:14
phylogenetic ,structural:2
phylogenetic ,modeling:2
phylogenetic ,sars-cov-2:20
phylogenetic ,spike:2
phylogenetic ,protein:2
phylogenetic ,reveals:2
analysis ,structural:12
analysis ,modeling:2
structural ,modeling:6
structural ,spike:20
structural ,protein:18
structural ,reveals:8
modeling ,sars-cov-2:14
modeling ,spike:6
modeling ,protein:6
modeling ,reveals:6
sars-cov-2 ,spike:156
sars-cov-2 ,protein:98
sars-cov-2 ,reveals:28
spike ,reveals:12
protein ,reveals:8
2019ncovsars-cov-2 ,rapid:2
2019ncovsars-cov-2 ,classification:2
2019ncovsars-cov-2 ,betacoronaviruses:2
2019ncovsars-cov-2 ,identification:2
rapid ,classification:4
rapid ,betacoronaviruses:2
classification ,betacoronaviruses:2
classification ,identification:2
betacoronaviruses ,identification:2
emergency ,response:2
emergency ,plan:4
emergency ,neonatal:2
emergency ,intensive:4
emergency ,care:6
emergency ,unit:2
emergency ,epidemic:2
response ,plan:4
response ,neonatal:6
response ,intensive:4
response ,care:8
response ,unit:4
response ,epidemic:4
plan ,neonatal:8
plan ,intensive:4
plan ,care:4
plan ,unit:4
plan ,epidemic:4
neonatal ,intensive:4
neonatal ,care:8
neonatal ,unit:4
neonatal ,epidemic:4
intensive ,care:58
intensive ,unit:22
intensive ,epidemic:6
care ,unit:22
care ,epidemic:8
unit ,epidemic:4
prediction ,novel:4
prediction ,inhibitors:6
prediction ,main:4
prediction ,m-pro:2
novel ,inhibitors:10
novel ,main:10
novel ,protease:10
novel ,m-pro:2
inhibitors ,m-pro:2
main ,m-pro:2
protease ,m-pro:2
m-pro ,sars-cov-2:2
clinical ,outcome:16
features ,outcome:8
features ,infection:22
features ,neonates:2
features ,systematic:6
outcome ,sars-cov-2:20
outcome ,infection:6
outcome ,neonates:2
outcome ,systematic:4
infection ,neonates:10
infection ,systematic:18
increasing ,importance:4
increasing ,novel:2
increasing ,coronavirus:4
importance ,novel:4
importance ,coronavirus:4
simulating ,forecasting:2
simulating ,cumulative:2
simulating ,confirmed:2
simulating ,cases:2
simulating ,sars-cov-2:2
simulating ,china:2
forecasting ,cumulative:2
forecasting ,confirmed:4
forecasting ,cases:4
forecasting ,sars-cov-2:2
forecasting ,china:2
cumulative ,confirmed:2
cumulative ,cases:2
cumulative ,sars-cov-2:4
cumulative ,china:2
confirmed ,cases:14
confirmed ,sars-cov-2:12
confirmed ,china:4
cases ,sars-cov-2:34
cases ,china:10
aromatic ,herbs:2
aromatic ,medicinal:2
aromatic ,plant-derived:2
aromatic ,essential:2
aromatic ,oils:2
aromatic ,phytochemical:2
aromatic ,extracts:2
herbs ,medicinal:4
herbs ,plant-derived:2
herbs ,essential:2
herbs ,oils:2
herbs ,phytochemical:2
herbs ,extracts:2
medicinal ,plant-derived:2
medicinal ,essential:2
medicinal ,oils:2
medicinal ,phytochemical:2
medicinal ,extracts:2
plant-derived ,essential:2
plant-derived ,oils:2
plant-derived ,phytochemical:2
plant-derived ,extracts:2
essential ,oils:4
essential ,phytochemical:2
essential ,extracts:2
oils ,phytochemical:2
oils ,extracts:2
phytochemical ,extracts:2
discovery ,aptamers:2
discovery ,targeting:8
discovery ,receptor-binding:2
discovery ,domain:2
discovery ,sars-cov-2:20
discovery ,spike:4
aptamers ,targeting:2
aptamers ,receptor-binding:2
aptamers ,domain:2
aptamers ,sars-cov-2:2
aptamers ,spike:2
targeting ,receptor-binding:2
targeting ,domain:2
targeting ,sars-cov-2:62
targeting ,spike:14
receptor-binding ,sars-cov-2:16
receptor-binding ,spike:12
domain ,sars-cov-2:22
domain ,spike:16
profile ,peripheral:2
profile ,blood:2
profile ,lymphocyte:4
profile ,subsets:4
profile ,serum:4
profile ,cytokines:2
profile ,children:2
peripheral ,blood:14
peripheral ,lymphocyte:6
peripheral ,subsets:4
peripheral ,serum:2
peripheral ,cytokines:2
peripheral ,children:2
blood ,lymphocyte:4
blood ,subsets:4
blood ,serum:4
blood ,cytokines:2
blood ,children:2
lymphocyte ,subsets:6
lymphocyte ,serum:2
lymphocyte ,cytokines:2
lymphocyte ,children:2
subsets ,serum:2
subsets ,cytokines:2
subsets ,children:2
serum ,cytokines:4
serum ,children:2
cytokines ,children:2
effect ,early:4
effect ,application:4
effect ,social:2
effect ,distancing:2
effect ,interventions:4
effect ,covid-19:36
effect ,mortality:4
early ,application:2
early ,social:2
early ,distancing:2
early ,interventions:8
early ,mortality:4
application ,social:2
application ,distancing:2
application ,interventions:2
application ,covid-19:10
application ,mortality:2
social ,interventions:4
social ,mortality:2
distancing ,interventions:4
distancing ,covid-19:12
distancing ,mortality:2
interventions ,covid-19:20
interventions ,mortality:2
effect ,throat:2
effect ,washings:2
effect ,detection:4
effect ,novel:6
effect ,coronavirus:18
throat ,washings:2
throat ,novel:2
throat ,coronavirus:2
washings ,detection:2
washings ,novel:2
washings ,coronavirus:2
2019-ncov ,identify-isolate-inform:2
2019-ncov ,3i:2
2019-ncov ,tool:2
2019-ncov ,applied:2
2019-ncov ,emerging:4
identify-isolate-inform ,3i:2
identify-isolate-inform ,tool:2
identify-isolate-inform ,applied:2
identify-isolate-inform ,novel:2
identify-isolate-inform ,emerging:2
3i ,tool:2
3i ,applied:2
3i ,novel:2
3i ,emerging:2
tool ,applied:2
tool ,novel:2
tool ,emerging:2
applied ,novel:2
applied ,emerging:2
2019-ncov ,towards:2
2019-ncov ,4th:2
2019-ncov ,generation:4
towards ,4th:2
towards ,generation:2
towards ,vaccine:2
4th ,generation:2
4th ,vaccine:2
generation ,vaccine:2
immuno-pathogenesis ,ncovid-19:2
immuno-pathogenesis ,possible:2
immuno-pathogenesis ,host-directed:2
immuno-pathogenesis ,therapy:2
immuno-pathogenesis ,including:2
ncovid-19 ,possible:2
ncovid-19 ,host-directed:2
ncovid-19 ,therapy:2
ncovid-19 ,including:2
possible ,host-directed:2
possible ,therapy:8
possible ,including:2
host-directed ,therapy:2
host-directed ,including:2
therapy ,including:2
persistent ,severe:6
persistent ,acute:4
persistent ,respiratory:4
persistent ,syndrome:2
persistent ,coronavirus:2
persistent ,detection:4
severe ,detection:44
diagnostic ,approaches:2
diagnostic ,therapeutic:6
diagnostic ,options:2
approaches ,potential:10
approaches ,therapeutic:12
approaches ,options:2
approaches ,coronavirus:4
approaches ,disease:4
potential ,disease:12
therapeutic ,disease:8
options ,disease:6
increasing ,host:2
increasing ,cellular:2
increasing ,receptor-angiotensin-converting:2
increasing ,enzyme:2
increasing ,expression:2
host ,cellular:6
host ,receptor-angiotensin-converting:2
host ,enzyme:2
host ,expression:10
cellular ,receptor-angiotensin-converting:2
cellular ,enzyme:2
cellular ,expression:2
receptor-angiotensin-converting ,enzyme:2
receptor-angiotensin-converting ,expression:2
tocilizumab ,sars-cov-2:6
tocilizumab ,patients:4
tocilizumab ,syndrome:4
tocilizumab ,cytokine:2
tocilizumab ,storm:2
tocilizumab ,narrative:2
sars-cov-2 ,cytokine:10
sars-cov-2 ,storm:12
sars-cov-2 ,narrative:12
patients ,syndrome:16
patients ,cytokine:12
patients ,storm:8
patients ,narrative:6
syndrome ,cytokine:10
syndrome ,storm:4
syndrome ,narrative:2
cytokine ,narrative:2
storm ,narrative:2
progress ,analysis:4
progress ,development:10
progress ,2019-ncov:4
progress ,vaccine:10
analysis ,development:6
analysis ,vaccine:6
development ,2019-ncov:2
mysterious ,virus:2
mysterious ,review:2
mysterious ,behavior:2
mysterious ,treatment:2
mysterious ,approaches:2
mysterious ,novel:2
virus ,behavior:2
virus ,treatment:6
virus ,approaches:6
review ,behavior:2
review ,treatment:40
review ,approaches:2
behavior ,treatment:2
behavior ,approaches:2
behavior ,novel:6
treatment ,approaches:4
treatment ,novel:26
approaches ,novel:2
updated ,min-review:2
updated ,environmental:2
updated ,route:2
updated ,sars-cov-2:8
updated ,transmission:2
min-review ,environmental:2
min-review ,route:2
min-review ,sars-cov-2:2
min-review ,transmission:2
environmental ,route:2
environmental ,sars-cov-2:36
environmental ,transmission:10
route ,sars-cov-2:6
sars-cov-2 ,zoonotic:14
sars-cov-2 ,origin:22
zoonotic ,origin:2
zoonotic ,coronavirus:4
origin ,pandemic:4
importance ,cycle:2
importance ,threshold:2
importance ,values:2
importance ,interpreting:2
importance ,molecular:2
importance ,tests:2
cycle ,threshold:10
cycle ,values:8
cycle ,interpreting:2
cycle ,molecular:2
cycle ,tests:2
threshold ,values:8
threshold ,interpreting:2
threshold ,molecular:2
threshold ,tests:2
values ,interpreting:2
values ,molecular:2
values ,tests:2
interpreting ,molecular:2
interpreting ,tests:2
molecular ,detection:24
molecular ,infection:16
molecular ,ffpe:2
molecular ,samples:4
molecular ,histopathologic:2
detection ,ffpe:2
detection ,histopathologic:2
sars-cov-2 ,ffpe:2
sars-cov-2 ,samples:36
sars-cov-2 ,histopathologic:2
infection ,ffpe:2
infection ,samples:4
infection ,histopathologic:2
ffpe ,samples:2
ffpe ,histopathologic:2
samples ,histopathologic:2
challenges ,directions:2
challenges ,natural:2
challenges ,products:2
challenges ,leads:2
future ,directions:4
future ,natural:2
future ,products:2
future ,leads:2
directions ,potential:2
directions ,natural:2
directions ,products:2
directions ,leads:2
potential ,natural:16
potential ,products:6
potential ,leads:2
natural ,products:16
natural ,leads:2
products ,leads:2
gemcitabine ,lycorine:2
gemcitabine ,oxysophoridine:2
gemcitabine ,inhibit:2
gemcitabine ,novel:2
gemcitabine ,coronavirus:2
gemcitabine ,sars-cov-2:2
lycorine ,oxysophoridine:2
lycorine ,inhibit:2
lycorine ,novel:2
lycorine ,coronavirus:2
lycorine ,sars-cov-2:2
oxysophoridine ,inhibit:2
oxysophoridine ,novel:2
oxysophoridine ,coronavirus:2
oxysophoridine ,sars-cov-2:2
inhibit ,novel:2
inhibit ,coronavirus:2
inhibit ,sars-cov-2:20
global ,emergency:4
global ,update:4
emergency ,novel:10
emergency ,coronavirus:10
emergency ,sars-cov-2:20
emergency ,update:2
emergency ,current:4
coronavirus ,update:12
sars-cov-2 ,update:28
update ,current:16
establishing ,diagnostic:2
establishing ,algorithms:2
establishing ,sars-cov-2:2
establishing ,nucleic:2
establishing ,acid:2
establishing ,testing:2
establishing ,clinical:2
diagnostic ,algorithms:2
diagnostic ,nucleic:6
diagnostic ,acid:4
diagnostic ,testing:18
diagnostic ,clinical:16
algorithms ,sars-cov-2:2
algorithms ,nucleic:2
algorithms ,acid:2
algorithms ,testing:2
algorithms ,clinical:2
sars-cov-2 ,nucleic:32
sars-cov-2 ,acid:34
nucleic ,testing:20
nucleic ,clinical:14
acid ,testing:20
acid ,clinical:12
testing ,clinical:24
comparison ,five:2
comparison ,assays:24
comparison ,correlations:2
five ,sars-cov-2:4
five ,molecular:2
five ,assays:4
five ,clinical:6
five ,correlations:2
sars-cov-2 ,correlations:4
molecular ,assays:10
molecular ,clinical:20
molecular ,correlations:2
assays ,clinical:14
assays ,correlations:2
clinical ,correlations:4
epidemiological ,infections:2
epidemiological ,shaanxi:2
epidemiological ,china:12
characteristics ,infections:4
characteristics ,shaanxi:2
characteristics ,china:20
sars-cov-2 ,infections:70
sars-cov-2 ,shaanxi:2
infections ,shaanxi:2
infections ,china:2
shaanxi ,china:2
prevalence ,diabetes:4
prevalence ,mellitus:2
prevalence ,meta-analysis:2
diabetes ,novel:4
diabetes ,coronavirus:14
diabetes ,meta-analysis:2
mellitus ,novel:2
mellitus ,coronavirus:8
mellitus ,meta-analysis:2
novel ,meta-analysis:2
coronavirus ,meta-analysis:2
mccs ,novel:2
mccs ,recognition:2
mccs ,pattern-based:2
mccs ,method:2
mccs ,fast:2
mccs ,track:2
mccs ,discovery:2
novel ,pattern-based:2
novel ,method:6
novel ,fast:2
novel ,track:2
recognition ,pattern-based:2
recognition ,method:2
recognition ,fast:2
recognition ,track:2
recognition ,discovery:2
pattern-based ,method:2
pattern-based ,fast:2
pattern-based ,track:2
pattern-based ,discovery:2
method ,fast:2
method ,track:2
method ,discovery:4
fast ,track:2
fast ,discovery:2
track ,discovery:2
2019-novel ,survey:2
2019-novel ,knowledge:2
2019-novel ,attitudes:2
2019-novel ,hospital:2
2019-novel ,staff:2
2019-novel ,large:2
coronavirus ,survey:4
coronavirus ,knowledge:10
coronavirus ,attitudes:4
coronavirus ,hospital:14
coronavirus ,staff:2
coronavirus ,large:4
survey ,knowledge:4
survey ,attitudes:2
survey ,hospital:4
survey ,staff:4
survey ,large:2
knowledge ,attitudes:8
knowledge ,hospital:2
knowledge ,staff:2
knowledge ,large:2
attitudes ,hospital:2
attitudes ,staff:2
attitudes ,large:2
hospital ,staff:12
hospital ,large:6
staff ,large:2
replication ,severe:4
replication ,acute:4
replication ,respiratory:2
replication ,syndrome:2
replication ,coronavirus:10
replication ,human:6
severe ,human:8
acute ,human:6
respiratory ,human:10
syndrome ,human:8
silico ,design:2
silico ,antiviral:2
silico ,peptides:2
silico ,targeting:4
silico ,spike:6
silico ,protein:2
silico ,sars-cov-2:24
design ,antiviral:8
design ,peptides:2
design ,targeting:4
design ,spike:2
design ,protein:6
design ,sars-cov-2:28
antiviral ,peptides:2
antiviral ,targeting:4
antiviral ,spike:2
antiviral ,protein:4
peptides ,targeting:4
peptides ,spike:4
peptides ,protein:2
peptides ,sars-cov-2:14
targeting ,protein:8
can ,vitamins:4
can ,andor:2
can ,supplements:2
can ,provide:2
can ,hope:2
can ,coronavirus:16
vitamins ,andor:2
vitamins ,supplements:2
vitamins ,provide:2
vitamins ,hope:2
vitamins ,coronavirus:2
andor ,supplements:2
andor ,provide:2
andor ,hope:2
andor ,coronavirus:4
supplements ,provide:2
supplements ,hope:2
supplements ,coronavirus:2
provide ,hope:2
provide ,coronavirus:2
hope ,coronavirus:2
composition ,human-specific:2
composition ,slow:2
composition ,codons:2
composition ,di-codons:2
composition ,sars-cov:2
human-specific ,slow:2
human-specific ,codons:2
human-specific ,di-codons:2
human-specific ,sars-cov:2
slow ,codons:2
slow ,di-codons:2
slow ,sars-cov:2
codons ,di-codons:2
codons ,sars-cov:2
di-codons ,sars-cov:2
progress ,studies:2
progress ,structural:4
progress ,remedial:2
progress ,aspects:2
progress ,newly:2
progress ,born:2
studies ,structural:6
studies ,remedial:2
studies ,aspects:2
studies ,newly:2
studies ,born:2
structural ,remedial:2
structural ,aspects:4
structural ,newly:2
structural ,born:2
remedial ,aspects:2
remedial ,newly:2
remedial ,born:2
remedial ,coronavirus:2
aspects ,newly:2
aspects ,born:2
aspects ,coronavirus:8
newly ,born:2
newly ,coronavirus:8
nanobiosensors ,detection:2
nanobiosensors ,novel:2
nanobiosensors ,coronavirus:2
nanobiosensors ,2019-ncov:2
detection ,2019-ncov:8
chloroquine ,controlling:2
chloroquine ,biological:2
chloroquine ,infections:2
controlling ,biological:2
controlling ,infections:2
biological ,infections:2
minimum ,sizes:2
minimum ,respiratory:2
minimum ,particles:2
minimum ,carrying:2
minimum ,sars-cov-2:2
minimum ,possibility:2
sizes ,respiratory:2
sizes ,particles:2
sizes ,carrying:2
sizes ,sars-cov-2:2
sizes ,possibility:2
respiratory ,particles:4
respiratory ,carrying:2
respiratory ,possibility:2
particles ,carrying:2
particles ,sars-cov-2:6
particles ,possibility:2
carrying ,sars-cov-2:2
carrying ,possibility:2
sars-cov-2 ,possibility:4
severe ,distress:6
severe ,secondary:6
acute ,distress:26
acute ,secondary:2
respiratory ,distress:30
respiratory ,secondary:2
distress ,syndrome:16
distress ,secondary:2
distress ,coronavirus:6
distress ,sars-cov-2:6
syndrome ,secondary:2
secondary ,coronavirus:4
secondary ,sars-cov-2:10
novel ,pathogenesis:4
insight ,sars-cov-2:8
insight ,molecular:4
insight ,pathogenesis:4
insight ,therapeutic:2
sars-cov-2 ,biology:14
sars-cov-2 ,therapeutic:28
molecular ,biology:8
molecular ,pathogenesis:10
molecular ,therapeutic:2
biology ,pathogenesis:2
biology ,therapeutic:2
pathogenesis ,therapeutic:4
hunting ,severe:2
hunting ,acute:2
hunting ,respiratory:2
hunting ,syndrome:2
hunting ,coronavirus:2
hunting ,novel:2
severe ,novel:28
perspectives ,development:2
perspectives ,vaccines:4
perspectives ,severe:4
perspectives ,acute:4
perspectives ,respiratory:6
perspectives ,syndrome:2
development ,severe:8
development ,acute:8
development ,respiratory:6
development ,syndrome:4
vaccines ,severe:4
vaccines ,acute:2
vaccines ,respiratory:6
vaccines ,syndrome:2
bronchoalveolar ,lavage:10
bronchoalveolar ,fluid:6
bronchoalveolar ,used:2
bronchoalveolar ,diagnose:2
bronchoalveolar ,two:2
bronchoalveolar ,cases:2
bronchoalveolar ,2019-ncov:2
lavage ,fluid:6
lavage ,used:2
lavage ,diagnose:2
lavage ,two:2
lavage ,cases:2
lavage ,2019-ncov:2
fluid ,used:2
fluid ,diagnose:2
fluid ,two:2
fluid ,cases:2
used ,diagnose:2
used ,two:2
used ,cases:2
used ,2019-ncov:2
diagnose ,two:2
diagnose ,cases:2
diagnose ,2019-ncov:2
comprehensive ,analyses:2
comprehensive ,transmission:4
comprehensive ,public:2
comprehensive ,health:2
comprehensive ,virology:2
analyses ,sars-cov-2:8
analyses ,transmission:2
analyses ,public:2
analyses ,health:2
analyses ,virology:2
sars-cov-2 ,public:14
sars-cov-2 ,health:66
sars-cov-2 ,virology:8
transmission ,public:8
transmission ,health:10
transmission ,virology:2
public ,virology:2
health ,virology:2
recent ,discovery:2
recent ,inhibitors:2
recent ,targeting:6
recent ,developed:2
recent ,anti-ncp:2
discovery ,inhibitors:8
discovery ,developed:2
discovery ,anti-ncp:2
inhibitors ,targeting:8
inhibitors ,developed:2
inhibitors ,anti-ncp:2
targeting ,developed:2
targeting ,anti-ncp:2
sars-cov-2 ,developed:2
sars-cov-2 ,anti-ncp:2
developed ,anti-ncp:2
features ,outbreak:2
features ,china:6
structural ,basis:20
structural ,main:2
structural ,protease:2
structural ,inhibition:2
structural ,broad-spectrum:2
basis ,sars-cov-2:22
basis ,main:2
basis ,protease:2
basis ,inhibition:2
basis ,broad-spectrum:2
sars-cov-2 ,inhibition:24
main ,inhibition:2
main ,broad-spectrum:2
protease ,inhibition:2
protease ,broad-spectrum:2
inhibition ,broad-spectrum:2
detection ,2019-novel:2
detection ,rrt-pcr:10
detection ,mymensingh:2
detection ,medical:2
2019-novel ,rrt-pcr:2
2019-novel ,mymensingh:2
2019-novel ,medical:2
coronavirus ,rrt-pcr:2
coronavirus ,mymensingh:2
coronavirus ,medical:2
2019-ncov ,rrt-pcr:2
2019-ncov ,mymensingh:2
2019-ncov ,medical:2
rrt-pcr ,mymensingh:2
rrt-pcr ,medical:2
mymensingh ,medical:2
potential ,chimeric:2
potential ,peptides:2
potential ,block:4
potential ,spike:8
potential ,receptor-binding:4
potential ,domain:4
chimeric ,peptides:2
chimeric ,block:2
chimeric ,sars-cov-2:4
chimeric ,spike:2
chimeric ,receptor-binding:2
chimeric ,domain:2
peptides ,block:2
peptides ,receptor-binding:2
peptides ,domain:2
block ,sars-cov-2:6
block ,spike:2
block ,receptor-binding:2
block ,domain:2
determination ,methods:2
determination ,novel:4
determination ,coronavirus:4
determination ,sars-cov-2:6
comparison ,rapid:6
comparison ,immunochromatographic:2
comparison ,test:14
comparison ,chemiluminescence:2
rapid ,immunochromatographic:6
rapid ,test:18
rapid ,chemiluminescence:2
immunochromatographic ,test:2
immunochromatographic ,chemiluminescence:2
test ,chemiluminescence:2
potential ,small-molecule:4
potential ,available:6
potential ,weapons:2
potential ,fight:4
small-molecule ,drugs:2
small-molecule ,available:2
small-molecule ,weapons:2
small-molecule ,fight:2
small-molecule ,novel:4
small-molecule ,coronavirus:4
drugs ,available:4
drugs ,weapons:2
drugs ,fight:4
drugs ,novel:6
available ,weapons:2
available ,fight:2
available ,novel:2
available ,coronavirus:2
weapons ,fight:2
weapons ,novel:2
weapons ,coronavirus:2
fight ,novel:6
fight ,coronavirus:6
learned ,may:2
learned ,provide:2
learned ,important:2
learned ,insights:2
learned ,understanding:2
sars ,may:2
sars ,provide:2
sars ,important:2
sars ,insights:4
sars ,understanding:2
may ,provide:4
may ,important:2
may ,insights:2
may ,understanding:2
provide ,important:2
provide ,insights:4
provide ,understanding:2
important ,insights:2
important ,understanding:2
insights ,understanding:4
sars-cov ,viruses:2
sars-cov ,overview:4
sars-cov ,origin:2
sars-cov ,evolution:2
mers-cov ,viruses:2
mers-cov ,overview:4
mers-cov ,origin:2
mers-cov ,evolution:2
2019-ncov ,viruses:2
2019-ncov ,overview:2
2019-ncov ,evolution:6
viruses ,overview:2
viruses ,origin:2
viruses ,evolution:2
overview ,origin:2
overview ,evolution:2
origin ,evolution:2
therapeutic ,mirnas:2
therapeutic ,targeting:10
therapeutic ,host:2
therapeutic ,cell:4
therapeutic ,receptor:4
therapeutic ,ace2:4
potential ,mirnas:2
potential ,targeting:22
potential ,host:8
potential ,cell:12
potential ,receptor:6
potential ,ace2:18
mirnas ,targeting:2
mirnas ,sars-cov-2:4
mirnas ,host:2
mirnas ,cell:2
mirnas ,receptor:2
mirnas ,ace2:2
targeting ,host:6
targeting ,cell:2
targeting ,receptor:2
targeting ,ace2:4
sars-cov-2 ,host:70
sars-cov-2 ,cell:62
sars-cov-2 ,receptor:92
sars-cov-2 ,ace2:108
host ,cell:12
host ,receptor:8
host ,ace2:8
cell ,receptor:14
cell ,ace2:6
andrographolide ,fluorescent:2
andrographolide ,derivative:2
andrographolide ,inhibit:2
andrographolide ,main:2
andrographolide ,proteases:2
fluorescent ,derivative:2
fluorescent ,inhibit:2
fluorescent ,main:2
fluorescent ,proteases:2
derivative ,inhibit:2
derivative ,main:2
derivative ,proteases:2
inhibit ,main:2
inhibit ,proteases:2
main ,proteases:2
bcg ,vaccine:10
bcg ,ray:2
bcg ,hope:4
bcg ,treating:2
bcg ,severe:2
bcg ,acute:2
bcg ,respiratory:2
bcg ,syndrome:2
bcg ,sars:2
vaccine ,ray:2
vaccine ,hope:2
vaccine ,treating:2
vaccine ,severe:4
vaccine ,acute:4
vaccine ,respiratory:2
vaccine ,syndrome:2
vaccine ,sars:6
ray ,hope:2
ray ,treating:2
ray ,severe:2
ray ,acute:2
ray ,respiratory:2
ray ,syndrome:2
ray ,sars:2
hope ,treating:2
hope ,severe:2
hope ,acute:2
hope ,respiratory:2
hope ,syndrome:2
hope ,sars:2
treating ,severe:4
treating ,acute:2
treating ,respiratory:2
treating ,syndrome:2
treating ,sars:4
severe ,sars:10
acute ,sars:8
respiratory ,sars:6
syndrome ,sars:6
coronavirus ,microbiology:2
coronavirus ,laboratory:22
coronavirus ,ready:2
detection ,clinical:16
detection ,microbiology:4
detection ,laboratory:8
detection ,ready:2
clinical ,microbiology:2
clinical ,laboratory:26
clinical ,ready:2
microbiology ,laboratory:2
microbiology ,ready:2
laboratory ,ready:2
molecular ,modelling:4
molecular ,antiviral:6
molecular ,action:4
molecular ,resveratrol:2
molecular ,derivatives:6
modelling ,antiviral:2
modelling ,action:4
modelling ,resveratrol:2
modelling ,derivatives:2
antiviral ,action:4
antiviral ,resveratrol:2
antiviral ,derivatives:2
action ,resveratrol:2
action ,derivatives:2
resveratrol ,derivatives:2
masks ,thermometers:2
masks ,paramount:2
masks ,measures:2
masks ,stop:2
masks ,rapid:2
masks ,spread:4
masks ,sars-cov-2:12
thermometers ,paramount:2
thermometers ,measures:2
thermometers ,stop:2
thermometers ,rapid:2
thermometers ,spread:2
thermometers ,sars-cov-2:2
paramount ,measures:2
paramount ,stop:2
paramount ,rapid:2
paramount ,spread:2
paramount ,sars-cov-2:2
measures ,stop:2
measures ,rapid:2
measures ,spread:6
measures ,sars-cov-2:8
stop ,rapid:2
stop ,spread:4
stop ,sars-cov-2:4
rapid ,spread:4
spread ,sars-cov-2:28
presence ,mismatches:2
presence ,diagnostic:2
presence ,pcr:2
presence ,assays:2
presence ,coronavirus:8
presence ,sars-cov-2:20
mismatches ,diagnostic:2
mismatches ,pcr:2
mismatches ,assays:2
mismatches ,coronavirus:2
mismatches ,sars-cov-2:2
diagnostic ,pcr:8
diagnostic ,assays:12
pcr ,assays:6
pcr ,coronavirus:4
assays ,coronavirus:4
database ,resource:2
database ,online:4
database ,analysis:2
database ,tools:2
database ,coronaviruses:2
database ,historical:2
resource ,online:2
resource ,analysis:4
resource ,tools:2
resource ,coronaviruses:2
resource ,historical:2
online ,analysis:8
online ,tools:2
online ,coronaviruses:2
online ,historical:2
analysis ,tools:2
analysis ,coronaviruses:8
analysis ,historical:2
tools ,coronaviruses:2
tools ,historical:2
coronaviruses ,historical:2
cardiovascular ,disease:34
cardiovascular ,sars-cov-2:22
cardiovascular ,role:2
cardiovascular ,host:2
cardiovascular ,immune:4
cardiovascular ,response:2
cardiovascular ,versus:2
disease ,role:30
disease ,host:2
disease ,immune:6
disease ,response:6
disease ,versus:2
sars-cov-2 ,role:92
sars-cov-2 ,versus:18
role ,host:14
role ,immune:10
role ,response:12
role ,versus:2
host ,immune:8
host ,response:14
host ,versus:2
immune ,versus:6
response ,versus:2
sars-cov-2 ,evidence:48
sars-cov-2 ,unresolved:2
infection ,evidence:10
infection ,unresolved:2
infection ,questions:2
neonates ,review:6
neonates ,evidence:4
neonates ,unresolved:2
neonates ,questions:2
review ,evidence:12
review ,unresolved:2
review ,questions:2
evidence ,unresolved:2
evidence ,questions:6
unresolved ,questions:2
sars-cov-2 ,real:8
sars-cov-2 ,time:32
sars-cov-2 ,commercial:24
detection ,real:2
detection ,time:4
detection ,commercial:14
using ,real:2
using ,time:6
using ,commercial:10
using ,diagnostic:6
using ,kit:2
real ,time:10
real ,pcr:4
real ,commercial:2
real ,diagnostic:2
real ,kit:4
time ,pcr:4
time ,commercial:2
time ,diagnostic:2
time ,kit:4
pcr ,commercial:6
pcr ,kit:2
commercial ,diagnostic:6
commercial ,kit:2
diagnostic ,kit:4
confirmed ,unconfirmed:2
confirmed ,novel:6
confirmed ,coronavirus:2
confirmed ,pneumonia:2
confirmed ,italian:2
unconfirmed ,cases:2
unconfirmed ,novel:2
unconfirmed ,coronavirus:2
unconfirmed ,pneumonia:2
unconfirmed ,italian:2
cases ,pneumonia:20
cases ,italian:2
novel ,italian:2
coronavirus ,italian:4
pneumonia ,italian:2
ticking ,bomb:2
ticking ,prolonged:2
ticking ,faecal:2
ticking ,shedding:2
ticking ,novel:2
ticking ,coronavirus:2
ticking ,2019-ncov:2
bomb ,prolonged:2
bomb ,faecal:2
bomb ,shedding:2
bomb ,novel:2
bomb ,coronavirus:2
bomb ,2019-ncov:2
prolonged ,faecal:2
prolonged ,shedding:16
prolonged ,novel:2
prolonged ,coronavirus:10
prolonged ,2019-ncov:2
faecal ,shedding:2
faecal ,novel:2
faecal ,coronavirus:2
faecal ,2019-ncov:2
shedding ,novel:4
shedding ,coronavirus:16
shedding ,2019-ncov:2
applying ,fixed:2
applying ,point:2
applying ,methods:2
applying ,fractional:2
applying ,operators:2
applying ,modelling:2
applying ,novel:2
fixed ,point:2
fixed ,methods:2
fixed ,fractional:2
fixed ,operators:2
fixed ,modelling:2
fixed ,novel:2
point ,methods:2
point ,fractional:2
point ,operators:2
point ,modelling:2
point ,novel:4
methods ,fractional:2
methods ,operators:2
methods ,modelling:2
fractional ,operators:2
fractional ,modelling:2
fractional ,novel:2
operators ,modelling:2
operators ,novel:2
modelling ,novel:2
elucidation ,cellular:2
elucidation ,targets:2
elucidation ,exploitation:2
elucidation ,receptor-binding:2
elucidation ,domain:2
cellular ,targets:2
cellular ,exploitation:2
cellular ,receptor-binding:2
cellular ,domain:2
targets ,exploitation:2
targets ,receptor-binding:2
targets ,domain:2
exploitation ,receptor-binding:2
exploitation ,domain:2
severe ,coronavirus-2:36
severe ,deduction:2
severe ,effect:4
acute ,coronavirus-2:36
acute ,deduction:2
acute ,effect:8
respiratory ,coronavirus-2:36
respiratory ,deduction:2
respiratory ,effect:2
syndrome ,coronavirus-2:36
syndrome ,deduction:2
syndrome ,effect:2
coronavirus-2 ,deduction:2
coronavirus-2 ,effect:2
deduction ,effect:2
coronavr ,computational:2
coronavr ,resource:2
coronavr ,analysis:2
coronavr ,epitopes:2
coronavr ,therapeutics:2
computational ,resource:2
computational ,analysis:10
computational ,epitopes:4
computational ,therapeutics:2
resource ,epitopes:2
resource ,therapeutics:2
analysis ,epitopes:6
analysis ,therapeutics:4
epitopes ,therapeutics:2
rapid ,sensitive:14
rapid ,diagnostic:18
rapid ,procedure:2
rapid ,multiple:2
rapid ,pandemic:10
sensitive ,diagnostic:2
sensitive ,procedure:2
sensitive ,multiple:2
sensitive ,detection:16
sensitive ,pandemic:2
diagnostic ,procedure:2
diagnostic ,multiple:4
diagnostic ,pandemic:10
procedure ,multiple:2
procedure ,detection:2
procedure ,pandemic:2
multiple ,detection:8
multiple ,pandemic:8
detection ,pandemic:2
evaluation ,four:2
evaluation ,commercial:12
evaluation ,kits:4
evaluation ,sars-cov-2:92
evaluation ,real-time:2
evaluation ,reverse-transcription:2
four ,commercial:4
four ,kits:2
four ,sars-cov-2:18
four ,real-time:2
four ,reverse-transcription:2
commercial ,kits:6
commercial ,real-time:2
commercial ,reverse-transcription:2
kits ,sars-cov-2:8
kits ,real-time:4
kits ,reverse-transcription:2
sars-cov-2 ,real-time:24
sars-cov-2 ,reverse-transcription:2
real-time ,reverse-transcription:2
heated ,air:2
heated ,delivery:2
heated ,micro-sauna:2
heated ,experimental:2
heated ,treatment:2
heated ,prototype:2
heated ,concept:2
air ,delivery:2
air ,micro-sauna:2
air ,experimental:2
air ,treatment:2
air ,prototype:2
air ,concept:2
delivery ,micro-sauna:2
delivery ,experimental:2
delivery ,treatment:4
delivery ,prototype:2
delivery ,concept:2
micro-sauna ,experimental:2
micro-sauna ,treatment:2
micro-sauna ,prototype:2
micro-sauna ,concept:2
experimental ,treatment:2
experimental ,prototype:2
experimental ,concept:2
treatment ,prototype:2
treatment ,concept:2
prototype ,concept:2
possibility ,mesenchymal:2
possibility ,stem:2
possibility ,cell:2
possibility ,transplantation:2
possibility ,treatment:2
mesenchymal ,cell:12
mesenchymal ,transplantation:4
stem ,cell:12
stem ,transplantation:4
cell ,transplantation:2
cell ,treatment:8
transplantation ,treatment:4
towards ,design:4
towards ,epitope:4
towards ,candidates:2
towards ,coronavirus:8
design ,epitope:2
design ,candidates:2
design ,coronavirus:10
epitope ,candidates:2
epitope ,coronavirus:2
candidates ,coronavirus:6
coronavirus ,dental:8
coronavirus ,practice:10
coronavirus ,project:2
coronavirus ,use:14
coronavirus ,ozonized:2
coronavirus ,water:10
disease-2019 ,dental:2
disease-2019 ,practice:2
disease-2019 ,project:2
disease-2019 ,use:2
disease-2019 ,ozonized:2
disease-2019 ,water:2
dental ,project:2
dental ,use:2
dental ,ozonized:2
dental ,water:2
practice ,project:2
practice ,use:2
practice ,ozonized:2
practice ,water:2
project ,use:2
project ,ozonized:2
project ,water:2
use ,ozonized:2
use ,water:2
ozonized ,water:2
polyacylated ,anthocyanins:2
polyacylated ,constructively:2
polyacylated ,network:2
polyacylated ,catalytic:2
polyacylated ,dyad:2
polyacylated ,residues:2
anthocyanins ,constructively:2
anthocyanins ,network:2
anthocyanins ,catalytic:2
anthocyanins ,dyad:2
anthocyanins ,residues:2
constructively ,network:2
constructively ,catalytic:2
constructively ,dyad:2
constructively ,residues:2
network ,catalytic:2
network ,dyad:2
network ,residues:2
catalytic ,dyad:2
catalytic ,residues:2
dyad ,residues:2
review ,pneumonia:4
review ,ophthalmology:2
novel ,ophthalmology:4
coronavirus ,ophthalmology:4
pneumonia ,ophthalmology:2
analysis ,different:10
analysis ,settings:2
analysis ,brunei:2
sars-cov-2 ,settings:8
sars-cov-2 ,brunei:2
transmission ,different:2
transmission ,settings:4
transmission ,brunei:2
different ,settings:2
different ,brunei:2
settings ,brunei:2
analysis ,pathogenesis:2
analysis ,syndrome:6
analysis ,differentiation:2
analysis ,treatment:12
analysis ,asymptomatic:6
pathogenesis ,syndrome:6
pathogenesis ,differentiation:2
pathogenesis ,asymptomatic:2
syndrome ,differentiation:2
syndrome ,treatment:10
syndrome ,asymptomatic:6
differentiation ,treatment:2
differentiation ,asymptomatic:2
treatment ,asymptomatic:6
novel ,sos:2
novel ,alert:2
novel ,dentists:2
coronavirus ,sos:2
coronavirus ,alert:2
coronavirus ,dentists:2
outbreak ,sos:2
outbreak ,alert:2
outbreak ,dentists:4
sos ,alert:2
sos ,dentists:2
alert ,dentists:2
rhabdomyolysis ,patient:6
rhabdomyolysis ,coronavirus:4
rhabdomyolysis ,disease:4
evaluating ,potential:2
evaluating ,different:2
evaluating ,inhibitors:2
evaluating ,rna-dependent:2
evaluating ,rna:4
evaluating ,polymerase:2
potential ,different:2
potential ,rna-dependent:10
potential ,rna:10
potential ,polymerase:12
different ,inhibitors:2
different ,rna-dependent:2
different ,rna:2
different ,polymerase:2
inhibitors ,rna-dependent:6
inhibitors ,rna:6
inhibitors ,polymerase:10
rna-dependent ,rna:22
rna-dependent ,polymerase:20
rna ,polymerase:26
novel ,renin-angiotension:2
novel ,system:14
novel ,imbalance:2
coronavirus ,renin-angiotension:2
coronavirus ,system:26
coronavirus ,imbalance:2
renin-angiotension ,system:2
renin-angiotension ,imbalance:2
renin-angiotension ,disease:2
system ,imbalance:4
system ,disease:18
imbalance ,disease:2
cellular ,basis:2
cellular ,loss:2
cellular ,smell:2
cellular ,2019-ncov-infected:2
cellular ,individuals:2
basis ,loss:2
basis ,smell:2
basis ,2019-ncov-infected:2
basis ,individuals:2
loss ,smell:26
loss ,2019-ncov-infected:2
loss ,individuals:2
smell ,2019-ncov-infected:2
smell ,individuals:2
2019-ncov-infected ,individuals:2
adrenal ,insufficiency:2
adrenal ,coronavirus:2
adrenal ,disease:2
adrenal ,case:2
adrenal ,report:2
insufficiency ,coronavirus:2
insufficiency ,disease:2
insufficiency ,case:2
insufficiency ,report:2
coronavirus ,report:38
disease ,case:46
molecular ,n-substituted:2
molecular ,oseltamivir:2
docking ,analysis:6
docking ,n-substituted:2
docking ,oseltamivir:2
docking ,derivatives:4
analysis ,n-substituted:2
analysis ,oseltamivir:2
analysis ,derivatives:2
n-substituted ,oseltamivir:2
n-substituted ,derivatives:2
oseltamivir ,derivatives:2
progress ,myocardial:2
progress ,injury:2
progress ,patients:2
progress ,chinese:4
treatment ,myocardial:2
treatment ,injury:4
myocardial ,injury:28
myocardial ,patients:4
myocardial ,2019-ncov:2
myocardial ,chinese:2
injury ,patients:30
injury ,2019-ncov:2
injury ,chinese:2
2019-ncov ,chinese:4
role ,key:8
role ,point:2
role ,mutations:2
role ,receptor:6
role ,binding:2
role ,domain:4
role ,spike:6
key ,point:2
key ,mutations:2
key ,receptor:4
key ,binding:6
key ,domain:2
key ,sars-cov-2:12
key ,spike:4
point ,mutations:4
point ,receptor:2
point ,binding:2
point ,domain:2
point ,sars-cov-2:14
point ,spike:2
mutations ,receptor:2
mutations ,binding:4
mutations ,domain:2
mutations ,sars-cov-2:22
mutations ,spike:4
receptor ,binding:32
receptor ,domain:12
receptor ,spike:14
binding ,domain:14
binding ,sars-cov-2:38
homogeneous ,circle-to-circle:2
homogeneous ,amplification:2
homogeneous ,real-time:2
homogeneous ,optomagnetic:2
homogeneous ,detection:2
circle-to-circle ,amplification:2
circle-to-circle ,real-time:2
circle-to-circle ,optomagnetic:2
circle-to-circle ,detection:2
amplification ,real-time:2
amplification ,optomagnetic:2
amplification ,detection:10
real-time ,optomagnetic:2
real-time ,detection:18
optomagnetic ,detection:2
search ,potential:4
search ,epitopes:2
search ,wuhan:2
search ,seafood:2
search ,market:2
search ,pneumonia:2
search ,virus:2
search ,using:2
potential ,epitopes:6
potential ,seafood:2
potential ,market:2
potential ,pneumonia:8
potential ,virus:8
potential ,using:10
epitopes ,wuhan:2
epitopes ,seafood:2
epitopes ,market:2
epitopes ,pneumonia:2
epitopes ,virus:2
epitopes ,using:2
wuhan ,seafood:2
wuhan ,market:2
wuhan ,pneumonia:6
wuhan ,virus:6
wuhan ,using:2
seafood ,market:2
seafood ,pneumonia:2
seafood ,virus:2
seafood ,using:2
market ,pneumonia:2
market ,virus:2
market ,using:2
pneumonia ,using:2
virus ,using:8
exploring ,rdrp-remdesivir:2
exploring ,interactions:4
exploring ,screen:2
exploring ,rdrp:2
exploring ,inhibitors:2
exploring ,management:2
rdrp-remdesivir ,interactions:2
rdrp-remdesivir ,screen:2
rdrp-remdesivir ,rdrp:2
rdrp-remdesivir ,inhibitors:2
rdrp-remdesivir ,management:2
interactions ,screen:2
interactions ,rdrp:2
interactions ,inhibitors:2
interactions ,management:2
screen ,rdrp:2
screen ,inhibitors:2
screen ,management:2
rdrp ,inhibitors:2
rdrp ,management:2
inhibitors ,management:6
candidate ,targets:4
candidate ,immune:2
candidate ,responses:2
candidate ,2019-novel:2
candidate ,coronavirus:2
candidate ,ncov:2
candidate ,sequence:4
targets ,immune:4
targets ,responses:4
targets ,2019-novel:2
targets ,ncov:2
targets ,sequence:4
immune ,2019-novel:2
immune ,coronavirus:16
immune ,ncov:2
immune ,sequence:2
responses ,2019-novel:2
responses ,coronavirus:14
responses ,ncov:2
responses ,sequence:2
2019-novel ,ncov:6
2019-novel ,sequence:2
coronavirus ,ncov:6
coronavirus ,sequence:4
ncov ,sequence:2
value ,swab:2
value ,types:2
value ,collection:2
value ,time:2
value ,sars-cov-2:6
value ,detection:2
value ,using:2
value ,rt-pcr:2
value ,assay:2
swab ,types:2
swab ,collection:4
swab ,time:2
swab ,sars-cov-2:22
swab ,using:2
swab ,rt-pcr:2
swab ,assay:2
types ,collection:2
types ,time:2
types ,sars-cov-2:14
types ,detection:8
types ,using:2
types ,rt-pcr:2
types ,assay:2
collection ,time:2
collection ,sars-cov-2:6
collection ,detection:2
collection ,using:4
collection ,rt-pcr:2
collection ,assay:2
time ,rt-pcr:4
time ,assay:6
sars-cov-2 ,rt-pcr:48
detection ,rt-pcr:24
detection ,assay:24
using ,rt-pcr:6
using ,assay:6
rt-pcr ,assay:16
pandemic ,characteristics:4
pandemic ,2019-ncov:2
pandemic ,case-control:2
pandemic ,severity:4
characteristics ,case-control:2
characteristics ,study:6
characteristics ,severity:2
2019-ncov ,case-control:2
2019-ncov ,study:6
2019-ncov ,severity:2
case-control ,study:6
case-control ,severity:2
study ,severity:2
possible ,case:6
possible ,vertical:8
possible ,transmission:22
possible ,severe:14
possible ,acute:8
possible ,respiratory:6
possible ,syndrome:8
case ,vertical:8
case ,transmission:16
case ,severe:24
case ,acute:28
case ,respiratory:12
case ,syndrome:24
vertical ,transmission:46
vertical ,severe:8
vertical ,acute:6
vertical ,respiratory:6
vertical ,syndrome:6
special ,epidemic:8
special ,prevention:6
special ,control:4
special ,ophthalmologic:2
special ,research:2
epidemic ,prevention:16
epidemic ,control:12
epidemic ,ophthalmologic:2
epidemic ,research:2
prevention ,control:48
prevention ,ophthalmologic:2
prevention ,research:4
control ,ophthalmologic:2
control ,research:2
ophthalmologic ,research:2
ligand ,structure-based:2
ligand ,virtual:2
ligand ,screening:2
ligand ,lamiaceae:2
ligand ,diterpenes:2
ligand ,potential:2
structure-based ,virtual:2
structure-based ,screening:2
structure-based ,lamiaceae:2
structure-based ,diterpenes:2
structure-based ,potential:2
virtual ,lamiaceae:2
virtual ,diterpenes:2
virtual ,potential:8
screening ,lamiaceae:2
screening ,diterpenes:2
screening ,potential:14
lamiaceae ,diterpenes:2
lamiaceae ,potential:2
diterpenes ,potential:2
evaluation ,ncov-qs:2
evaluation ,mico:2
evaluation ,biomed:2
evaluation ,rt-qpcr:6
evaluation ,detection:36
ncov-qs ,mico:2
ncov-qs ,biomed:2
ncov-qs ,rt-qpcr:2
ncov-qs ,detection:2
ncov-qs ,sars-cov-2:2
mico ,biomed:2
mico ,rt-qpcr:2
mico ,detection:2
mico ,sars-cov-2:2
biomed ,rt-qpcr:2
biomed ,detection:2
biomed ,sars-cov-2:2
rt-qpcr ,detection:14
rt-qpcr ,sars-cov-2:24
fatal ,central:2
fatal ,nervous:2
fatal ,system:2
fatal ,co-infection:2
fatal ,tuberculosis:2
central ,nervous:28
central ,system:24
central ,co-infection:2
central ,sars-cov-2:12
central ,tuberculosis:2
nervous ,co-infection:2
nervous ,sars-cov-2:24
nervous ,tuberculosis:2
system ,co-infection:2
system ,sars-cov-2:58
system ,tuberculosis:2
co-infection ,tuberculosis:6
sars-cov-2 ,tuberculosis:6
use ,informational:2
use ,spectrum:2
use ,methodology:2
use ,rapid:4
use ,biological:2
use ,analysis:4
informational ,spectrum:2
informational ,methodology:2
informational ,rapid:2
informational ,biological:2
informational ,analysis:2
spectrum ,methodology:2
spectrum ,rapid:2
spectrum ,biological:2
spectrum ,analysis:2
methodology ,rapid:2
methodology ,biological:2
methodology ,analysis:2
rapid ,biological:2
rapid ,analysis:4
double-quencher ,probes:2
double-quencher ,improve:2
double-quencher ,detection:2
double-quencher ,sensitivity:2
double-quencher ,toward:2
double-quencher ,severe:2
double-quencher ,acute:2
double-quencher ,respiratory:2
probes ,improve:2
probes ,detection:2
probes ,sensitivity:2
probes ,toward:2
probes ,severe:2
probes ,acute:2
probes ,respiratory:2
improve ,detection:2
improve ,sensitivity:2
improve ,toward:2
improve ,severe:4
improve ,acute:2
improve ,respiratory:2
detection ,sensitivity:10
detection ,toward:4
sensitivity ,toward:2
sensitivity ,severe:6
sensitivity ,acute:4
sensitivity ,respiratory:6
toward ,severe:2
toward ,acute:2
toward ,respiratory:2
heavy ,exposure:2
heavy ,children:2
heavy ,aged:2
heavy ,9-12:2
heavy ,years:2
heavy ,severe:2
heavy ,acute:2
heavy ,respiratory:2
heavy ,syndrome:2
exposure ,children:2
exposure ,aged:2
exposure ,9-12:2
exposure ,years:2
exposure ,severe:4
exposure ,acute:6
exposure ,respiratory:6
exposure ,syndrome:6
children ,aged:4
children ,9-12:2
children ,years:4
children ,severe:12
children ,acute:14
children ,respiratory:10
children ,syndrome:30
aged ,9-12:2
aged ,years:4
aged ,severe:2
aged ,acute:2
aged ,respiratory:2
aged ,syndrome:2
9-12 ,years:2
9-12 ,severe:2
9-12 ,acute:2
9-12 ,respiratory:2
9-12 ,syndrome:2
years ,severe:2
years ,acute:2
years ,respiratory:2
years ,syndrome:2
large ,sars-cov-2:16
large ,outbreak:10
large ,caused:4
large ,asymptomatic:6
large ,traveler:2
large ,china:2
sars-cov-2 ,asymptomatic:88
sars-cov-2 ,traveler:2
outbreak ,asymptomatic:2
outbreak ,traveler:2
caused ,asymptomatic:2
caused ,traveler:2
caused ,china:4
asymptomatic ,traveler:2
asymptomatic ,china:4
traveler ,china:2
updated ,approaches:2
approaches ,sars-cov-2:12
covid-19 ,dermatology:8
covid-19 ,guide:14
covid-19 ,dermatologists:4
dermatology ,comprehensive:2
dermatology ,guide:2
dermatology ,dermatologists:2
comprehensive ,guide:2
comprehensive ,dermatologists:2
guide ,dermatologists:2
spike ,glycoprotein:32
spike ,new:2
spike ,2019-ncov:6
spike ,contains:2
spike ,furin-like:2
glycoprotein ,new:2
glycoprotein ,coronavirus:6
glycoprotein ,2019-ncov:2
glycoprotein ,contains:2
glycoprotein ,furin-like:2
new ,contains:2
new ,furin-like:2
coronavirus ,contains:4
coronavirus ,furin-like:2
2019-ncov ,contains:2
2019-ncov ,furin-like:2
contains ,furin-like:2
cardiovascular ,system:24
progress ,challenge:2
progress ,2019-novel:2
challenge ,vaccine:6
challenge ,development:4
challenge ,2019-novel:2
vaccine ,2019-novel:2
development ,2019-novel:2
sars-cov-2 ,disposable:2
sars-cov-2 ,wooden:2
sars-cov-2 ,chopsticks:2
sars-cov-2 ,hong:4
sars-cov-2 ,kong:4
rna ,disposable:2
rna ,wooden:2
rna ,chopsticks:2
rna ,hong:2
rna ,kong:2
detection ,disposable:2
detection ,wooden:2
detection ,chopsticks:2
detection ,hong:2
detection ,kong:2
disposable ,wooden:2
disposable ,chopsticks:2
disposable ,hong:2
disposable ,kong:2
wooden ,chopsticks:2
wooden ,hong:2
wooden ,kong:2
chopsticks ,hong:2
chopsticks ,kong:2
hong ,kong:10
detectable ,2019-ncov:2
detectable ,viral:6
detectable ,rna:4
detectable ,blood:2
detectable ,strong:2
detectable ,indicator:2
2019-ncov ,viral:4
2019-ncov ,rna:2
2019-ncov ,blood:2
2019-ncov ,strong:2
2019-ncov ,indicator:2
viral ,rna:42
viral ,blood:2
viral ,strong:2
viral ,indicator:2
rna ,blood:6
rna ,strong:2
rna ,indicator:2
blood ,strong:2
blood ,indicator:2
strong ,indicator:2
expert ,consensus:4
expert ,bronchoscopy:2
expert ,epidemic:2
expert ,novel:4
expert ,coronavirus:4
consensus ,bronchoscopy:2
consensus ,epidemic:2
consensus ,novel:2
consensus ,coronavirus:2
bronchoscopy ,epidemic:2
bronchoscopy ,novel:2
bronchoscopy ,coronavirus:2
epidemic ,novel:8
epidemic ,coronavirus:18
pangolins ,harbor:2
pangolins ,sars-cov-2-related:4
pangolins ,coronaviruses:2
harbor ,sars-cov-2-related:2
harbor ,coronaviruses:2
sars-cov-2-related ,coronaviruses:2
rediscovery ,caffeine:2
rediscovery ,excellent:2
rediscovery ,drug:2
rediscovery ,improving:2
rediscovery ,patient:2
rediscovery ,outcomes:2
caffeine ,excellent:2
caffeine ,drug:2
caffeine ,improving:2
caffeine ,patient:2
caffeine ,outcomes:2
excellent ,drug:2
excellent ,improving:2
excellent ,patient:2
excellent ,outcomes:2
drug ,improving:2
drug ,patient:2
drug ,outcomes:2
improving ,patient:4
improving ,outcomes:2
patient ,outcomes:4
isolation ,sequence:2
isolation ,infectivity:4
isolation ,replication:2
isolation ,kinetics:2
isolation ,severe:6
isolation ,acute:4
sequence ,infectivity:2
sequence ,replication:2
sequence ,kinetics:2
sequence ,severe:2
sequence ,acute:2
infectivity ,replication:2
infectivity ,kinetics:2
infectivity ,severe:6
infectivity ,acute:6
replication ,kinetics:4
kinetics ,severe:4
kinetics ,acute:2
sars-cov-2 ,trenches:2
sars-cov-2 ,perspective:20
sars-cov-2 ,new:58
sars-cov-2 ,york:14
sars-cov-2 ,city:10
trenches ,perspective:2
trenches ,new:2
trenches ,york:2
trenches ,city:2
perspective ,new:2
perspective ,york:2
perspective ,city:2
new ,york:36
new ,city:20
york ,city:20
sars-cov-2 ,pathophysiology:14
sars-cov-2 ,assessment:48
sars-cov-2 ,cns:6
sars-cov-2 ,diseases:12
pathophysiology ,assessment:2
pathophysiology ,coronaviruses:2
pathophysiology ,cns:2
pathophysiology ,diseases:2
assessment ,coronaviruses:2
assessment ,cns:2
assessment ,diseases:2
coronaviruses ,cns:2
cns ,diseases:2
ten ,challenging:2
ten ,questions:2
ten ,sars-cov-2:2
ten ,covid-19:4
challenging ,questions:2
challenging ,sars-cov-2:2
challenging ,covid-19:4
food ,safety:4
food ,issues:2
food ,related:2
food ,wildlife:2
food ,taken:2
food ,seriously:2
food ,sars:2
safety ,issues:4
safety ,related:2
safety ,wildlife:2
safety ,taken:2
safety ,seriously:2
safety ,sars:2
issues ,related:4
issues ,wildlife:2
issues ,taken:2
issues ,seriously:2
issues ,sars:2
related ,wildlife:2
related ,taken:2
related ,seriously:2
related ,sars:6
wildlife ,taken:2
wildlife ,seriously:2
wildlife ,sars:2
taken ,seriously:2
taken ,sars:2
seriously ,sars:2
progress ,challenges:4
progress ,vaccines:4
progress ,current:6
challenges ,vaccines:6
development ,covid-19:50
development ,current:16
currently ,available:6
currently ,intravenous:2
currently ,immunoglobulin:2
currently ,contains:2
currently ,antibodies:2
currently ,reacting:2
available ,intravenous:2
available ,immunoglobulin:2
available ,contains:2
available ,antibodies:4
available ,reacting:2
intravenous ,contains:2
intravenous ,antibodies:2
intravenous ,reacting:2
immunoglobulin ,contains:2
immunoglobulin ,antibodies:4
immunoglobulin ,reacting:2
contains ,antibodies:2
contains ,reacting:2
antibodies ,reacting:2
methemoglobinemia ,patient:2
methemoglobinemia ,g6pd:2
methemoglobinemia ,deficiency:2
methemoglobinemia ,sars-cov-2:2
methemoglobinemia ,infection:2
patient ,g6pd:2
patient ,deficiency:2
patient ,infection:30
g6pd ,deficiency:2
g6pd ,sars-cov-2:2
g6pd ,infection:2
deficiency ,sars-cov-2:8
deficiency ,infection:6
prolonged ,infectivity:2
prolonged ,sars-cov-2:18
prolonged ,fomites:2
infectivity ,sars-cov-2:26
infectivity ,fomites:2
sars-cov-2 ,fomites:2
heralding ,healthcare:2
heralding ,professionals:2
heralding ,recognition:2
heralding ,neurological:2
heralding ,deficits:2
healthcare ,professionals:12
healthcare ,recognition:2
healthcare ,neurological:2
healthcare ,deficits:2
professionals ,recognition:2
professionals ,neurological:2
professionals ,deficits:2
recognition ,neurological:2
recognition ,deficits:2
neurological ,deficits:2
covid-19 ,evolution:8
covid-19 ,cross-disciplinary:2
epidemiology ,evolution:4
epidemiology ,cross-disciplinary:2
epidemiology ,perspectives:4
evolution ,cross-disciplinary:2
evolution ,perspectives:2
cross-disciplinary ,perspectives:2
detection ,surfaces:12
severe ,rna:16
severe ,surfaces:2
acute ,rna:12
acute ,surfaces:2
respiratory ,rna:18
respiratory ,surfaces:2
syndrome ,rna:10
syndrome ,surfaces:2
coronavirus ,surfaces:4
rna ,surfaces:8
facts ,myths:4
facts ,efficacies:2
facts ,repurposing:2
facts ,chloroquine:4
facts ,hydroxychloroquine:4
myths ,efficacies:2
myths ,repurposing:2
myths ,chloroquine:2
myths ,hydroxychloroquine:2
efficacies ,repurposing:2
efficacies ,chloroquine:2
efficacies ,hydroxychloroquine:2
repurposing ,hydroxychloroquine:2
severe ,newly:2
severe ,emerged:2
acute ,newly:6
acute ,emerged:2
respiratory ,newly:4
respiratory ,emerged:2
syndrome ,newly:4
syndrome ,emerged:2
coronavirus-2 ,sars-cov-2:10
coronavirus-2 ,newly:2
coronavirus-2 ,emerged:2
sars-cov-2 ,newly:4
sars-cov-2 ,emerged:4
newly ,emerged:6
experience ,sars-cov-2:16
experience ,focus:2
experience ,testing:6
sars-cov-2 ,focus:4
focus ,testing:2
sars-cov-2 ,sociological:2
transmission ,sociological:2
transmission ,review:30
sociological ,review:2
comparison ,four:4
comparison ,new:2
comparison ,serologic:2
comparison ,determination:2
four ,serologic:2
four ,assays:6
four ,determination:2
new ,commercial:2
new ,serologic:2
new ,assays:2
new ,determination:2
commercial ,serologic:2
commercial ,assays:14
commercial ,determination:2
serologic ,assays:6
serologic ,determination:2
serologic ,sars-cov-2:20
assays ,determination:2
association ,clinical:6
association ,manifestations:2
association ,prognosis:4
association ,patients:20
association ,covid-19:56
clinical ,manifestations:38
clinical ,prognosis:6
manifestations ,prognosis:2
manifestations ,patients:22
prognosis ,patients:8
epidemiology ,sars-cov-2:28
epidemiology ,infection:8
importance ,corneal:2
importance ,organ:2
importance ,culture:2
importance ,donors:2
importance ,possible:2
importance ,sars-cov-2:10
importance ,infections:2
corneal ,organ:2
corneal ,culture:2
corneal ,donors:2
corneal ,possible:2
corneal ,sars-cov-2:4
corneal ,infections:2
organ ,culture:2
organ ,donors:4
organ ,possible:2
organ ,sars-cov-2:10
organ ,infections:2
culture ,donors:2
culture ,possible:2
culture ,sars-cov-2:10
culture ,infections:2
donors ,possible:2
donors ,sars-cov-2:6
donors ,infections:2
possible ,infections:2
corona ,international:2
corona ,public:2
corona ,health:2
corona ,emergencies:2
corona ,implications:2
corona ,radiology:2
virus ,international:2
virus ,public:4
virus ,health:2
virus ,emergencies:2
virus ,implications:2
virus ,radiology:2
international ,public:4
international ,health:4
international ,emergencies:2
international ,implications:2
international ,radiology:2
public ,implications:2
public ,radiology:2
health ,implications:4
health ,radiology:2
emergencies ,implications:2
emergencies ,radiology:2
implications ,radiology:2
risks ,novel:2
risks ,coronavirus:2
risks ,disease:2
risks ,covid-19:18
risks ,pregnancy:2
risks ,narrative:4
risks ,review:4
novel ,pregnancy:2
novel ,narrative:2
coronavirus ,narrative:14
disease ,pregnancy:14
disease ,narrative:6
covid-19 ,pregnancy:66
covid-19 ,narrative:32
pregnancy ,narrative:2
narrative ,review:38
infectious ,sars-cov-2:18
infectious ,feces:2
infectious ,patient:4
infectious ,severe:4
infectious ,covid-19:10
sars-cov-2 ,feces:8
feces ,patient:2
feces ,severe:2
feces ,covid-19:4
patient ,severe:28
persons ,evaluated:2
persons ,novel:2
persons ,coronavirus:8
persons ,united:6
persons ,states:4
persons ,january:2
evaluated ,novel:2
evaluated ,coronavirus:2
evaluated ,united:2
evaluated ,states:2
evaluated ,january:2
novel ,united:4
novel ,states:4
coronavirus ,united:10
coronavirus ,states:8
united ,states:20
united ,january:2
states ,january:2
dentistry ,covid-19:14
dentistry ,pandemic:2
dentistry ,operative:2
dentistry ,indications:2
dentistry ,post-lockdown:2
covid-19 ,operative:2
covid-19 ,indications:6
covid-19 ,post-lockdown:4
pandemic ,operative:4
pandemic ,indications:4
pandemic ,post-lockdown:2
operative ,indications:2
operative ,post-lockdown:2
indications ,post-lockdown:2
evaluation ,quantitative:6
evaluation ,rt-pcr:8
evaluation ,assay:26
evaluation ,emerging:2
quantitative ,rt-pcr:6
quantitative ,assay:8
quantitative ,detection:8
quantitative ,emerging:4
rt-pcr ,emerging:2
assay ,emerging:2
detection ,emerging:2
can ,drinking:2
can ,microfiltered:2
can ,raw:2
can ,immune:4
can ,milk:2
can ,cows:2
can ,immunized:2
can ,sars-cov-2:48
drinking ,microfiltered:2
drinking ,raw:2
drinking ,immune:2
drinking ,milk:2
drinking ,cows:2
drinking ,immunized:2
drinking ,sars-cov-2:2
microfiltered ,raw:2
microfiltered ,immune:2
microfiltered ,milk:2
microfiltered ,cows:2
microfiltered ,immunized:2
microfiltered ,sars-cov-2:2
raw ,immune:2
raw ,milk:2
raw ,cows:2
raw ,immunized:2
raw ,sars-cov-2:6
immune ,milk:2
immune ,cows:2
immune ,immunized:2
milk ,cows:2
milk ,immunized:2
cows ,immunized:2
cows ,sars-cov-2:2
immunized ,sars-cov-2:2
clinical ,coping:2
clinical ,strategies:2
clinical ,neoplasms:2
characteristics ,coping:2
characteristics ,strategies:2
characteristics ,neoplasms:2
coping ,strategies:2
coping ,neoplasms:2
coping ,novel:2
strategies ,neoplasms:2
neoplasms ,novel:2
genomic ,modeling:2
genomic ,approach:2
genomic ,identify:4
genomic ,surrogates:2
genomic ,use:2
genomic ,experimental:2
modeling ,approach:2
modeling ,identify:2
modeling ,surrogates:2
modeling ,use:2
modeling ,experimental:2
approach ,identify:2
approach ,surrogates:2
approach ,use:2
approach ,experimental:2
identify ,surrogates:2
identify ,use:6
identify ,experimental:2
surrogates ,use:2
surrogates ,experimental:2
use ,experimental:2
current ,efforts:2
current ,facing:2
current ,responses:2
current ,africa:4
efforts ,challenges:4
efforts ,facing:2
efforts ,responses:2
efforts ,2019-ncov:2
efforts ,africa:2
challenges ,facing:2
challenges ,responses:2
challenges ,africa:4
facing ,responses:2
facing ,2019-ncov:2
facing ,africa:2
responses ,2019-ncov:2
responses ,africa:2
2019-ncov ,africa:2
rhabdomyolysis ,potential:2
rhabdomyolysis ,late:2
rhabdomyolysis ,complication:2
rhabdomyolysis ,associated:2
rhabdomyolysis ,covid-19:10
potential ,late:4
potential ,complication:6
potential ,associated:6
late ,complication:10
late ,associated:4
late ,covid-19:12
complication ,associated:4
complication ,covid-19:10
sars-cov-2 ,igg:46
sars-cov-2 ,seroprevalence:32
sars-cov-2 ,blood:20
sars-cov-2 ,located:2
sars-cov-2 ,three:26
sars-cov-2 ,federal:2
igg ,seroprevalence:6
igg ,blood:2
igg ,donors:2
igg ,located:2
igg ,three:2
igg ,different:2
igg ,federal:2
seroprevalence ,blood:4
seroprevalence ,donors:4
seroprevalence ,located:2
seroprevalence ,three:2
seroprevalence ,different:2
seroprevalence ,federal:2
blood ,donors:8
blood ,located:2
blood ,three:4
blood ,different:2
blood ,federal:2
donors ,located:2
donors ,three:2
donors ,different:2
donors ,federal:2
located ,three:2
located ,different:2
located ,federal:2
three ,different:2
three ,federal:2
different ,federal:2
detection ,hemodialysis:4
detection ,effluent:2
detection ,patient:6
detection ,pneumonia:6
sars-cov-2 ,hemodialysis:8
sars-cov-2 ,effluent:4
hemodialysis ,effluent:2
hemodialysis ,patient:8
hemodialysis ,pneumonia:6
effluent ,patient:2
effluent ,covid-19:2
effluent ,pneumonia:2
characterization ,codon:2
characterization ,usage:2
characterization ,pattern:2
codon ,pattern:2
codon ,sars-cov-2:8
usage ,pattern:2
usage ,sars-cov-2:10
pattern ,sars-cov-2:6
coronavirus ,2019-covid-19:2
disease ,2019-covid-19:2
analytical ,performances:2
analytical ,chemiluminescence:2
analytical ,immunoassay:4
analytical ,sars-cov-2:12
analytical ,igmigg:2
performances ,chemiluminescence:2
performances ,immunoassay:2
performances ,igmigg:2
chemiluminescence ,immunoassay:8
chemiluminescence ,sars-cov-2:6
chemiluminescence ,igmigg:2
immunoassay ,sars-cov-2:12
immunoassay ,igmigg:2
sars-cov-2 ,igmigg:2
potential ,fecal:2
potential ,evidence:2
potential ,implications:14
fecal ,transmission:2
fecal ,sars-cov-2:8
fecal ,current:2
fecal ,evidence:2
fecal ,implications:2
transmission ,current:6
transmission ,implications:2
current ,implications:4
evidence ,implications:6
aerosol ,surface:8
aerosol ,persistence:4
aerosol ,novel:4
aerosol ,sars-cov-2:12
aerosol ,versus:2
aerosol ,coronaviruses:2
surface ,persistence:2
surface ,novel:4
surface ,sars-cov-2:24
surface ,versus:2
surface ,coronaviruses:4
persistence ,novel:4
persistence ,versus:2
persistence ,coronaviruses:4
novel ,versus:4
versus ,coronaviruses:2
case ,patents:2
case ,coronaviruses:2
case ,technology:2
study ,patents:2
study ,coronaviruses:2
study ,technology:2
analysis ,patents:2
analysis ,technology:2
patents ,coronaviruses:2
patents ,covid-19:2
patents ,technology:2
coronaviruses ,technology:2
medically ,unexplained:2
medically ,symptoms:2
medically ,times:2
medically ,covid-19:2
medically ,pandemic:2
medically ,case-report:2
unexplained ,symptoms:2
unexplained ,times:2
unexplained ,covid-19:2
unexplained ,pandemic:2
unexplained ,case-report:2
symptoms ,times:2
symptoms ,covid-19:42
symptoms ,pandemic:2
symptoms ,case-report:2
times ,covid-19:28
times ,pandemic:12
times ,case-report:2
covid-19 ,case-report:2
pandemic ,case-report:2
peripheral ,examination:2
peripheral ,findings:2
peripheral ,sars-cov-2:4
peripheral ,infection:2
blood ,examination:2
blood ,findings:2
blood ,infection:16
examination ,findings:2
examination ,sars-cov-2:4
examination ,infection:4
findings ,infection:16
sars-cov-2 ,overview:32
influenza ,comparative:8
influenza ,overview:2
influenza ,treatment:2
influenza ,implications:2
comparative ,overview:6
comparative ,treatment:2
comparative ,implications:2
overview ,treatment:6
overview ,implications:4
treatment ,implications:6
recognition ,natural:2
recognition ,products:2
recognition ,potential:2
recognition ,inhibitors:2
recognition ,covid-19:10
recognition ,main:2
recognition ,protease:2
natural ,inhibitors:12
natural ,covid-19:18
natural ,main:6
natural ,protease:6
products ,inhibitors:4
products ,covid-19:10
products ,main:4
products ,protease:4
inhibitors ,covid-19:22
covid-19 ,main:6
covid-19 ,protease:4
using ,sequencing:4
using ,determine:2
using ,source:2
using ,transmission:4
using ,healthcare:4
virus ,sequencing:4
virus ,determine:2
virus ,source:2
virus ,transmission:18
virus ,healthcare:2
sequencing ,determine:2
sequencing ,source:2
sequencing ,sars-cov-2:20
sequencing ,transmission:4
sequencing ,healthcare:2
determine ,source:2
determine ,sars-cov-2:2
determine ,transmission:2
determine ,healthcare:2
source ,sars-cov-2:4
source ,transmission:2
source ,healthcare:2
sars-cov-2 ,healthcare:62
transmission ,healthcare:6
sars-cov-2 ,disinfection:8
sars-cov-2 ,strategies:24
sars-cov-2 ,prevent:14
sars-cov-2 ,neuropathogens:2
sars-cov-2 ,via:16
disinfection ,strategies:2
disinfection ,prevent:2
disinfection ,transmission:4
disinfection ,neuropathogens:2
disinfection ,via:2
strategies ,prevent:6
strategies ,transmission:2
strategies ,neuropathogens:2
strategies ,via:2
prevent ,transmission:6
prevent ,neuropathogens:2
prevent ,via:2
transmission ,neuropathogens:2
transmission ,via:6
neuropathogens ,via:2
measures ,diagnosing:2
measures ,treating:2
measures ,novel:6
measures ,coronavirus:14
measures ,responsible:2
diagnosing ,treating:2
diagnosing ,infections:2
diagnosing ,novel:2
diagnosing ,coronavirus:2
diagnosing ,responsible:2
treating ,infections:2
treating ,novel:4
treating ,coronavirus:6
treating ,responsible:2
infections ,responsible:2
novel ,responsible:2
coronavirus ,responsible:2
long-term ,positive:2
long-term ,severe:4
long-term ,acute:4
long-term ,respiratory:6
long-term ,syndrome:4
long-term ,coronavirus:2
long-term ,ribonucleic:2
long-term ,acid:4
positive ,severe:4
positive ,acute:6
positive ,respiratory:6
positive ,syndrome:4
positive ,coronavirus:2
positive ,ribonucleic:2
positive ,acid:8
severe ,ribonucleic:2
severe ,acid:10
acute ,ribonucleic:2
acute ,acid:10
respiratory ,ribonucleic:2
respiratory ,acid:6
syndrome ,ribonucleic:2
syndrome ,acid:4
coronavirus ,ribonucleic:2
coronavirus ,acid:4
ribonucleic ,acid:2
sars-cov-2 ,vs:4
sars-cov-2 ,dilemma:2
viral ,vs:2
viral ,infectivity:4
viral ,dilemma:2
shedding ,vs:2
shedding ,infectivity:2
shedding ,dilemma:2
vs ,infectivity:2
vs ,dilemma:2
infectivity ,dilemma:2
comparative ,protein:4
comparative ,synthesis:2
comparative ,rate:2
comparative ,human:2
analysis ,synthesis:2
analysis ,rate:4
analysis ,human:10
protein ,synthesis:2
protein ,rate:2
protein ,human:10
synthesis ,rate:2
synthesis ,covid-19:4
synthesis ,human:2
rate ,human:2
orf3a ,mutation:2
orf3a ,associated:2
orf3a ,higher:2
orf3a ,mortality:2
orf3a ,rate:2
orf3a ,sars-cov-2:4
orf3a ,infection:2
mutation ,associated:4
mutation ,higher:4
mutation ,mortality:2
mutation ,rate:4
mutation ,sars-cov-2:20
mutation ,infection:2
associated ,higher:6
associated ,rate:6
associated ,infection:44
higher ,mortality:6
higher ,rate:4
higher ,sars-cov-2:6
higher ,infection:2
mortality ,rate:10
mortality ,sars-cov-2:34
mortality ,infection:4
rate ,sars-cov-2:20
rate ,infection:6
vaccination ,severe:2
vaccination ,acute:2
vaccination ,respiratory:2
vaccination ,syndrome:2
vaccination ,coronavirus:2
sars-cov-2 ,high-risk:4
sars-cov-2 ,non-muscle-invasive:2
sars-cov-2 ,bladder:2
sars-cov-2 ,cancer:30
infection ,high-risk:2
infection ,non-muscle-invasive:2
infection ,bladder:2
infection ,cancer:18
high-risk ,non-muscle-invasive:2
high-risk ,bladder:2
high-risk ,cancer:2
non-muscle-invasive ,bladder:2
non-muscle-invasive ,cancer:2
bladder ,cancer:4
sars-cov-2 ,piece:2
sars-cov-2 ,bad:2
sars-cov-2 ,news:2
piece ,bad:2
piece ,news:2
bad ,news:2
nppv ,treatment:2
nppv ,neuromuscular:2
nppv ,diseases:2
nppv ,covid-19:2
nppv ,pandemic:2
treatment ,neuromuscular:2
treatment ,diseases:4
treatment ,pandemic:18
neuromuscular ,diseases:4
neuromuscular ,covid-19:6
neuromuscular ,pandemic:4
diseases ,covid-19:54
diseases ,pandemic:6
cluster ,severe:8
cluster ,acute:10
cluster ,respiratory:10
cluster ,syndrome:6
cluster ,coronavirus:20
cluster ,infections:6
cluster ,linked:2
severe ,infections:14
severe ,linked:2
acute ,infections:10
acute ,linked:2
respiratory ,infections:26
respiratory ,linked:2
syndrome ,infections:6
syndrome ,linked:2
coronavirus ,linked:2
infections ,linked:4
ocular ,manifestations:14
ocular ,transmission:10
ocular ,covid-19:26
ocular ,recommendations:4
manifestations ,transmission:4
manifestations ,recommendations:4
transmission ,recommendations:2
covid-19 ,recommendations:72
potential ,presymptomatic:4
potential ,zhejiang:2
potential ,province:2
potential ,china:8
presymptomatic ,transmission:12
presymptomatic ,sars-cov-2:12
presymptomatic ,zhejiang:2
presymptomatic ,province:2
presymptomatic ,china:4
transmission ,zhejiang:2
transmission ,province:4
transmission ,china:12
sars-cov-2 ,zhejiang:2
sars-cov-2 ,province:6
zhejiang ,province:4
zhejiang ,china:2
province ,china:16
identifying ,locations:2
identifying ,possible:2
identifying ,undetected:2
identifying ,imported:2
identifying ,severe:4
identifying ,acute:4
identifying ,respiratory:4
locations ,possible:2
locations ,undetected:2
locations ,imported:2
locations ,severe:2
locations ,acute:2
locations ,respiratory:2
possible ,undetected:2
possible ,imported:2
undetected ,imported:2
undetected ,severe:2
undetected ,acute:2
undetected ,respiratory:2
imported ,severe:2
imported ,acute:2
imported ,respiratory:4
severe ,2-specific:2
severe ,antibody:12
severe ,responses:12
acute ,2-specific:2
acute ,antibody:4
acute ,responses:4
respiratory ,2-specific:2
respiratory ,antibody:4
respiratory ,responses:4
syndrome ,2-specific:2
syndrome ,antibody:4
syndrome ,responses:2
coronavirus ,2-specific:2
coronavirus ,antibody:16
2-specific ,antibody:2
2-specific ,responses:2
antibody ,responses:40
unprecedented ,disruption:2
unprecedented ,lives:2
unprecedented ,work:2
unprecedented ,health:2
unprecedented ,distress:2
unprecedented ,life:2
unprecedented ,satisfaction:2
disruption ,lives:2
disruption ,work:2
disruption ,health:2
disruption ,distress:2
disruption ,life:2
disruption ,satisfaction:2
lives ,work:2
lives ,health:2
lives ,distress:2
lives ,life:2
lives ,satisfaction:2
work ,health:6
work ,distress:2
work ,life:2
work ,satisfaction:2
health ,distress:2
health ,life:2
health ,satisfaction:2
distress ,life:2
distress ,satisfaction:2
life ,satisfaction:2
microstructure ,pathophysiology:2
microstructure ,potential:2
microstructure ,therapeutics:2
microstructure ,covid-19:2
pathophysiology ,potential:2
pathophysiology ,therapeutics:2
pathophysiology ,covid-19:24
therapeutics ,covid-19:36
covid-19-related ,web:2
covid-19-related ,search:2
covid-19-related ,behaviors:2
covid-19-related ,infodemic:2
covid-19-related ,attitudes:2
covid-19-related ,italy:2
web ,search:2
web ,behaviors:2
web ,infodemic:2
web ,attitudes:2
web ,italy:2
search ,behaviors:2
search ,infodemic:2
search ,attitudes:2
search ,italy:2
behaviors ,infodemic:2
behaviors ,attitudes:2
behaviors ,italy:2
infodemic ,attitudes:2
infodemic ,italy:2
attitudes ,italy:2
prevalence ,severe:10
prevalence ,acute:12
prevalence ,respiratory:10
prevalence ,syndrome:8
prevalence ,coronavirus-2-specific:2
prevalence ,antibodies:14
severe ,coronavirus-2-specific:2
severe ,antibodies:14
acute ,coronavirus-2-specific:2
acute ,antibodies:12
respiratory ,coronavirus-2-specific:2
respiratory ,antibodies:12
syndrome ,coronavirus-2-specific:2
syndrome ,antibodies:8
coronavirus-2-specific ,antibodies:2
implications ,sex:2
implications ,differences:2
implications ,immunity:4
implications ,pathogenesis:4
implications ,design:2
sex ,differences:6
sex ,immunity:2
sex ,sars-cov-2:2
sex ,pathogenesis:2
sex ,design:2
differences ,immunity:2
differences ,sars-cov-2:12
differences ,pathogenesis:2
differences ,design:2
immunity ,sars-cov-2:30
immunity ,pathogenesis:4
immunity ,design:2
pathogenesis ,design:2
ivermectin ,potential:8
ivermectin ,role:2
ivermectin ,repurposed:2
ivermectin ,drug:4
ivermectin ,covid-19:8
potential ,repurposed:2
potential ,drug:22
role ,repurposed:2
role ,drug:4
role ,covid-19:150
repurposed ,drug:8
repurposed ,covid-19:8
guillain-barr ,syndrome:30
guillain-barr ,associated:6
guillain-barr ,severe:4
guillain-barr ,acute:4
guillain-barr ,respiratory:2
syndrome ,associated:20
associated ,severe:24
associated ,acute:18
associated ,respiratory:4
sars-cov-2 ,antivirals:6
sars-cov-2 ,drug:64
update ,potential:2
update ,antivirals:2
update ,light:2
update ,sars-cov:2
update ,antiviral:2
update ,drug:4
potential ,antivirals:4
potential ,light:2
potential ,sars-cov:6
antivirals ,light:2
antivirals ,sars-cov:2
antivirals ,antiviral:2
antivirals ,drug:4
light ,sars-cov:2
light ,antiviral:2
light ,drug:2
sars-cov ,antiviral:2
sars-cov ,drug:4
antiviral ,drug:26
specific ,ace2:4
specific ,expression:2
specific ,small:4
specific ,intestinal:2
specific ,enterocytes:2
specific ,may:4
specific ,cause:2
specific ,gastrointestinal:2
ace2 ,small:6
ace2 ,intestinal:2
ace2 ,enterocytes:2
ace2 ,may:8
ace2 ,cause:4
ace2 ,gastrointestinal:2
expression ,small:4
expression ,intestinal:2
expression ,enterocytes:2
expression ,may:6
expression ,cause:4
expression ,gastrointestinal:2
small ,intestinal:2
small ,enterocytes:2
small ,may:2
small ,cause:2
small ,gastrointestinal:2
intestinal ,enterocytes:2
intestinal ,may:2
intestinal ,cause:2
intestinal ,gastrointestinal:2
enterocytes ,may:2
enterocytes ,cause:2
enterocytes ,gastrointestinal:2
may ,cause:6
may ,gastrointestinal:2
cause ,gastrointestinal:2
role ,ophthalmology:2
role ,pandemic:24
ophthalmology ,pandemic:2
publishing ,research:2
publishing ,pandemics:2
publishing ,vulnerable:2
publishing ,covid-19:2
research ,pandemics:2
research ,vulnerable:2
pandemics ,vulnerable:2
pandemics ,covid-19:10
vulnerable ,covid-19:4
subacute ,thyroiditis:6
subacute ,underestimated:2
subacute ,manifestation:2
subacute ,sars-cov-2:4
subacute ,infection:4
thyroiditis ,underestimated:2
thyroiditis ,manifestation:2
thyroiditis ,sars-cov-2:4
thyroiditis ,infection:4
underestimated ,manifestation:2
underestimated ,sars-cov-2:2
underestimated ,infection:2
manifestation ,sars-cov-2:14
manifestation ,infection:8
clinical ,therapeutic:10
clinical ,procedure:2
clinical ,four:6
clinical ,cases:44
characteristics ,therapeutic:6
characteristics ,procedure:2
characteristics ,four:12
therapeutic ,procedure:2
therapeutic ,four:2
therapeutic ,cases:4
procedure ,four:2
procedure ,cases:2
procedure ,novel:2
four ,cases:12
four ,novel:2
pathology ,pathogenicity:2
pathology ,severe:2
pathology ,acute:2
pathology ,respiratory:2
pathology ,syndrome:2
pathogenicity ,severe:2
pathogenicity ,acute:2
pathogenicity ,respiratory:2
pathogenicity ,syndrome:2
pathogenicity ,coronavirus:2
spheroids ,organoids:2
spheroids ,humanized:2
spheroids ,3d:2
spheroids ,scaffold-free:2
spheroids ,engineered:2
spheroids ,tissues:2
organoids ,humanized:2
organoids ,3d:2
organoids ,scaffold-free:2
organoids ,engineered:2
organoids ,tissues:2
humanized ,3d:2
humanized ,scaffold-free:2
humanized ,engineered:2
humanized ,tissues:2
3d ,scaffold-free:2
3d ,engineered:2
3d ,tissues:2
scaffold-free ,engineered:2
scaffold-free ,tissues:2
engineered ,tissues:4
coronaviruses ,brief:2
coronaviruses ,overview:6
brief ,overview:6
severe ,infection:82
severe ,febrile:4
severe ,neonates:4
acute ,infection:74
acute ,febrile:6
acute ,neonates:4
respiratory ,infection:42
respiratory ,febrile:4
respiratory ,neonates:4
syndrome ,infection:42
syndrome ,febrile:4
syndrome ,neonates:4
coronavirus ,febrile:8
infection ,febrile:4
febrile ,neonates:2
retrospective ,screening:2
retrospective ,sars-cov-2:10
retrospective ,rna:4
retrospective ,california:2
retrospective ,usa:2
retrospective ,late:2
screening ,rna:2
screening ,california:2
screening ,usa:2
screening ,late:2
sars-cov-2 ,california:2
sars-cov-2 ,usa:2
sars-cov-2 ,late:8
rna ,california:2
rna ,usa:2
rna ,late:2
california ,usa:2
california ,late:2
usa ,late:2
implication ,ocular:2
implication ,manifestation:2
implication ,covid-19:8
implication ,medical:2
implication ,staff:2
ocular ,manifestation:6
ocular ,medical:2
ocular ,staff:2
ocular ,patients:12
manifestation ,covid-19:26
manifestation ,medical:2
manifestation ,staff:2
manifestation ,patients:6
covid-19 ,medical:34
covid-19 ,staff:18
isolation ,characterization:6
isolation ,sars-cov-2:28
isolation ,first:4
isolation ,us:2
isolation ,covid-19:20
isolation ,patient:4
characterization ,first:2
characterization ,us:2
characterization ,patient:4
sars-cov-2 ,us:12
first ,us:2
first ,patient:14
us ,covid-19:22
us ,patient:2
case-control ,use:2
case-control ,personal:2
case-control ,protective:2
case-control ,measures:2
case-control ,risk:2
case-control ,sars-cov:2
study ,use:4
study ,personal:2
study ,protective:2
study ,measures:2
study ,risk:10
study ,sars-cov:2
use ,personal:10
use ,protective:8
use ,measures:2
use ,risk:8
use ,sars-cov:2
personal ,protective:32
personal ,measures:2
personal ,risk:4
personal ,sars-cov:2
protective ,measures:14
protective ,risk:10
protective ,sars-cov:2
measures ,risk:2
measures ,sars-cov:2
risk ,sars-cov:2
association ,hypertension:4
association ,diabetes:8
association ,stroke:6
association ,cancer:2
association ,kidney:2
association ,disease:20
hypertension ,diabetes:8
hypertension ,stroke:2
hypertension ,cancer:2
hypertension ,kidney:2
hypertension ,disease:14
diabetes ,stroke:2
diabetes ,cancer:2
diabetes ,kidney:2
diabetes ,disease:20
stroke ,cancer:2
stroke ,kidney:2
stroke ,disease:8
cancer ,kidney:2
cancer ,disease:12
kidney ,disease:20
novel ,can:4
novel ,learned:6
novel ,public:8
novel ,reporting:2
coronavirus ,learned:8
coronavirus ,reporting:2
outbreak ,can:8
outbreak ,learned:4
outbreak ,public:8
outbreak ,reporting:2
can ,learned:2
can ,china:2
can ,public:4
can ,reporting:2
learned ,china:2
learned ,public:2
learned ,reporting:2
china ,public:6
china ,reporting:2
public ,reporting:2
resilient ,agile:2
resilient ,engineering:2
resilient ,solutions:2
resilient ,address:2
resilient ,societal:2
resilient ,challenges:2
agile ,engineering:2
agile ,solutions:2
agile ,address:2
agile ,societal:2
agile ,challenges:2
engineering ,solutions:2
engineering ,address:2
engineering ,societal:2
engineering ,challenges:2
solutions ,address:4
solutions ,societal:2
solutions ,challenges:4
address ,societal:2
address ,challenges:2
societal ,challenges:2
disappearance ,sars-cov-2:2
disappearance ,antibodies:2
disappearance ,infants:2
disappearance ,born:2
disappearance ,women:2
disappearance ,covid-19:2
sars-cov-2 ,infants:12
sars-cov-2 ,born:6
sars-cov-2 ,women:30
antibodies ,infants:2
antibodies ,born:2
antibodies ,women:4
antibodies ,covid-19:24
infants ,born:6
infants ,women:2
born ,women:2
women ,covid-19:34
ent ,manifestation:2
ent ,covid-19:14
ent ,patients:2
narrative ,immune:2
narrative ,response:4
narrative ,overview:2
review ,immune:6
review ,response:6
review ,overview:4
immune ,overview:4
response ,coronavirus:14
response ,overview:4
coronavirus ,overview:26
recreational ,waters:2
recreational ,potential:2
recreational ,transmission:2
recreational ,route:2
recreational ,sars-cov-2:2
recreational ,humans:2
waters ,potential:2
waters ,transmission:2
waters ,route:2
waters ,sars-cov-2:2
waters ,humans:2
potential ,route:4
potential ,humans:2
transmission ,humans:6
route ,humans:2
sars-cov-2 ,humans:14
technical ,report:2
technical ,italian:2
technical ,sars-cov-2:4
technical ,outbreak:2
technical ,postmortem:2
technical ,sampling:2
report ,italian:2
report ,sars-cov-2:52
report ,outbreak:2
report ,postmortem:2
report ,sampling:2
italian ,sars-cov-2:16
italian ,outbreak:16
italian ,postmortem:2
italian ,sampling:2
sars-cov-2 ,postmortem:2
sars-cov-2 ,sampling:8
outbreak ,postmortem:2
outbreak ,sampling:2
postmortem ,sampling:2
longitudinal ,isolation:2
longitudinal ,potent:2
longitudinal ,near-germline:2
longitudinal ,sars-cov-2-neutralizing:2
longitudinal ,antibodies:4
isolation ,potent:2
isolation ,near-germline:2
isolation ,sars-cov-2-neutralizing:2
isolation ,antibodies:2
potent ,near-germline:2
potent ,sars-cov-2-neutralizing:2
potent ,antibodies:4
near-germline ,sars-cov-2-neutralizing:2
near-germline ,antibodies:2
sars-cov-2-neutralizing ,antibodies:2
air ,filtration:2
air ,sars-cov-2:28
filtration ,sars-cov-2:4
asymptomatic ,infection:46
asymptomatic ,household:2
asymptomatic ,contacts:2
asymptomatic ,healthcare:6
asymptomatic ,provider:2
sars-cov-2 ,household:12
sars-cov-2 ,contacts:8
sars-cov-2 ,provider:2
infection ,household:4
infection ,contacts:6
infection ,healthcare:26
infection ,provider:2
household ,contacts:4
household ,healthcare:2
household ,provider:2
contacts ,healthcare:2
contacts ,provider:2
healthcare ,provider:2
direct-rt-qpcr ,detection:2
direct-rt-qpcr ,sars-cov-2:2
direct-rt-qpcr ,without:2
direct-rt-qpcr ,rna:2
direct-rt-qpcr ,extraction:2
direct-rt-qpcr ,part:2
direct-rt-qpcr ,covid-19:2
detection ,part:4
sars-cov-2 ,part:6
without ,part:2
without ,covid-19:12
rna ,part:2
rna ,covid-19:48
extraction ,part:2
extraction ,covid-19:2
part ,covid-19:8
potential ,effects:14
potential ,resveratrol:4
therapeutic ,effects:2
therapeutic ,resveratrol:2
effects ,resveratrol:2
effects ,sars-cov-2:36
resveratrol ,sars-cov-2:2
microneedle ,array:2
microneedle ,delivered:2
microneedle ,recombinant:2
microneedle ,coronavirus:2
microneedle ,vaccines:2
microneedle ,immunogenicity:2
array ,delivered:2
array ,recombinant:2
array ,coronavirus:2
array ,vaccines:2
array ,immunogenicity:2
delivered ,recombinant:2
delivered ,coronavirus:2
delivered ,vaccines:2
delivered ,immunogenicity:2
recombinant ,coronavirus:2
recombinant ,vaccines:2
recombinant ,immunogenicity:2
coronavirus ,immunogenicity:2
vaccines ,immunogenicity:4
diagnostic ,today:2
diagnostic ,future:4
methods ,pandemic:2
methods ,today:2
methods ,future:2
covid-19 ,today:2
pandemic ,today:2
pandemic ,future:12
today ,future:2
hematological ,manifestations:4
hematological ,sars-cov-2:2
hematological ,children:2
manifestations ,sars-cov-2:28
manifestations ,children:10
fatal ,eosinophilic:2
fatal ,myocarditis:2
fatal ,healthy:4
fatal ,17-year-old:2
fatal ,male:2
fatal ,severe:6
fatal ,acute:2
eosinophilic ,myocarditis:2
eosinophilic ,healthy:2
eosinophilic ,17-year-old:2
eosinophilic ,male:2
eosinophilic ,severe:2
eosinophilic ,acute:2
myocarditis ,healthy:2
myocarditis ,17-year-old:2
myocarditis ,male:2
myocarditis ,severe:2
myocarditis ,acute:2
healthy ,17-year-old:2
healthy ,male:2
healthy ,severe:2
healthy ,acute:2
17-year-old ,male:2
17-year-old ,severe:2
17-year-old ,acute:2
male ,severe:2
male ,acute:2
precaution ,novel:2
precaution ,coronavirus:4
precaution ,infection:4
precaution ,department:2
precaution ,oral:2
novel ,department:2
novel ,oral:4
coronavirus ,department:4
coronavirus ,oral:8
infection ,department:4
infection ,oral:4
department ,oral:2
research ,intervention:2
research ,chinese:2
research ,herbal:2
research ,medicine:2
research ,active:2
progress ,intervention:2
progress ,herbal:2
progress ,medicine:2
progress ,active:2
intervention ,chinese:2
intervention ,herbal:2
intervention ,medicine:2
intervention ,active:2
chinese ,herbal:8
chinese ,active:2
herbal ,medicine:10
herbal ,active:2
medicine ,active:2
mutations ,recombination:2
mutations ,insertion:2
mutations ,evolution:2
mutations ,2019-ncov:2
recombination ,insertion:2
recombination ,evolution:2
recombination ,2019-ncov:2
insertion ,evolution:2
insertion ,2019-ncov:2
covid-19 ,follow:4
covid-19 ,testing:106
follow ,testing:2
effect ,conditions:2
effect ,sars-cov-2:26
effect ,stability:2
effect ,human:2
effect ,nasal:2
effect ,mucus:2
environmental ,conditions:4
environmental ,stability:2
environmental ,human:4
environmental ,nasal:2
environmental ,mucus:2
conditions ,sars-cov-2:12
conditions ,stability:2
conditions ,human:2
conditions ,nasal:2
conditions ,mucus:2
sars-cov-2 ,stability:10
sars-cov-2 ,nasal:8
sars-cov-2 ,mucus:2
stability ,human:4
stability ,nasal:2
stability ,mucus:2
human ,nasal:2
human ,mucus:2
nasal ,mucus:2
covid-19 ,nigeria:6
covid-19 ,putting:2
covid-19 ,realities:2
covid-19 ,context:18
nigeria ,putting:2
nigeria ,realities:2
nigeria ,context:2
putting ,realities:2
putting ,context:2
realities ,context:2
sudden ,sensorineural:2
sudden ,hearing:2
sudden ,loss:8
sudden ,sole:2
sudden ,manifestation:2
sudden ,covid-19:12
sensorineural ,hearing:2
sensorineural ,loss:2
sensorineural ,sole:2
sensorineural ,manifestation:2
sensorineural ,covid-19:2
hearing ,loss:2
hearing ,sole:2
hearing ,manifestation:2
hearing ,covid-19:2
loss ,sole:2
loss ,manifestation:2
loss ,covid-19:24
sole ,manifestation:4
sole ,covid-19:6
acute ,cerebral:2
acute ,stroke:8
acute ,multiple:4
acute ,infarctions:2
acute ,covid-19:138
acute ,france:2
cerebral ,stroke:2
cerebral ,multiple:4
cerebral ,infarctions:2
cerebral ,covid-19:8
cerebral ,france:2
stroke ,multiple:4
stroke ,infarctions:2
stroke ,covid-19:36
stroke ,france:2
multiple ,infarctions:2
multiple ,covid-19:36
multiple ,france:2
infarctions ,covid-19:2
infarctions ,france:2
outbreak ,severe:10
outbreak ,acute:14
outbreak ,syndrome:8
computing ,effects:2
computing ,sars-cov-2:2
computing ,respiration:2
computing ,regulatory:2
computing ,mechanisms:2
effects ,respiration:2
effects ,regulatory:2
effects ,mechanisms:2
sars-cov-2 ,respiration:2
sars-cov-2 ,regulatory:2
sars-cov-2 ,mechanisms:32
respiration ,regulatory:2
respiration ,mechanisms:2
regulatory ,mechanisms:2
approaches ,advances:4
approaches ,development:6
approaches ,targets:2
advances ,development:2
development ,potential:8
development ,targets:6
endocrine ,vigilance:2
endocrine ,covid-19:4
vigilance ,covid-19:2
roll-out ,sars-cov-2:2
roll-out ,testing:2
roll-out ,healthcare:2
roll-out ,workers:2
roll-out ,large:2
roll-out ,nhs:2
roll-out ,foundation:2
sars-cov-2 ,workers:68
sars-cov-2 ,nhs:2
sars-cov-2 ,foundation:2
testing ,healthcare:10
testing ,workers:8
testing ,large:4
testing ,nhs:4
testing ,foundation:2
healthcare ,large:8
healthcare ,nhs:2
healthcare ,foundation:2
workers ,large:8
workers ,nhs:2
workers ,foundation:2
large ,nhs:4
large ,foundation:2
nhs ,foundation:2
emergence ,deadly:2
emergence ,severe:8
emergence ,acute:8
emergence ,respiratory:8
emergence ,syndrome:8
emergence ,coronavirus-2:2
deadly ,severe:2
deadly ,acute:2
deadly ,respiratory:2
deadly ,syndrome:2
deadly ,coronavirus-2:2
ct ,imaging:14
ct ,analysis:4
ct ,33:2
ct ,cases:6
ct ,novel:16
ct ,infection:10
imaging ,analysis:2
imaging ,33:2
imaging ,cases:6
imaging ,infection:10
analysis ,33:2
analysis ,cases:30
analysis ,infection:36
33 ,cases:2
33 ,novel:2
33 ,coronavirus:2
33 ,infection:4
cases ,infection:26
therapeutic ,approach:14
therapeutic ,2019-ncov:4
therapeutic ,inhibition:6
therapeutic ,ace-2:2
approach ,2019-ncov:2
approach ,inhibition:4
approach ,ace-2:2
approach ,receptor:2
2019-ncov ,inhibition:2
2019-ncov ,ace-2:2
2019-ncov ,receptor:10
inhibition ,ace-2:2
inhibition ,receptor:4
ace-2 ,receptor:4
asymptomatic ,human-to-human:2
asymptomatic ,transmission:20
asymptomatic ,2-family:2
asymptomatic ,cluster:6
human-to-human ,sars-cov-2:2
human-to-human ,2-family:2
human-to-human ,cluster:2
transmission ,2-family:2
transmission ,cluster:14
sars-cov-2 ,2-family:2
sars-cov-2 ,cluster:16
2-family ,cluster:2
liver ,diseases:8
liver ,etiology:4
liver ,treatment:4
liver ,prognosis:2
diseases ,etiology:2
diseases ,prognosis:2
etiology ,treatment:2
etiology ,prognosis:2
treatment ,prognosis:4
global ,seasonality:4
global ,human:2
global ,seasonal:2
global ,clue:2
global ,postpandemic:2
seasonality ,human:2
seasonality ,seasonal:2
seasonality ,coronaviruses:2
seasonality ,clue:2
seasonality ,postpandemic:2
human ,seasonal:2
human ,clue:2
human ,postpandemic:2
seasonal ,coronaviruses:4
seasonal ,clue:2
seasonal ,postpandemic:2
coronaviruses ,clue:2
coronaviruses ,postpandemic:2
clue ,postpandemic:2
delayed ,laboratory:2
delayed ,response:4
delayed ,caused:2
delayed ,molecular:2
delayed ,diagnostic:2
laboratory ,response:10
laboratory ,caused:2
laboratory ,molecular:4
laboratory ,diagnostic:8
response ,caused:4
response ,molecular:2
response ,diagnostic:4
caused ,molecular:2
caused ,diagnostic:2
molecular ,diagnostic:14
preliminary ,study:8
preliminary ,contact:2
preliminary ,tracing:2
preliminary ,transmission:2
preliminary ,chain:2
preliminary ,cluster:4
preliminary ,17:2
preliminary ,cases:2
study ,contact:2
study ,tracing:2
study ,transmission:10
study ,chain:2
study ,cluster:2
study ,17:2
study ,cases:4
contact ,tracing:16
contact ,transmission:8
contact ,chain:2
contact ,cluster:4
contact ,17:2
contact ,cases:2
tracing ,transmission:2
tracing ,chain:2
tracing ,cluster:2
tracing ,17:2
tracing ,cases:2
transmission ,chain:2
transmission ,17:2
transmission ,cases:4
chain ,cluster:2
chain ,17:2
chain ,cases:2
cluster ,17:2
cluster ,cases:10
17 ,cases:4
structural ,proteins:14
structural ,severe:2
structural ,acute:2
structural ,respiratory:2
structural ,syndrome:2
structural ,coronavirus-2:2
proteins ,severe:8
proteins ,acute:6
proteins ,respiratory:8
proteins ,syndrome:6
proteins ,coronavirus-2:4
long ,road:2
long ,toward:2
long ,covid-19:2
long ,herd:2
long ,immunity:2
long ,vaccine:2
long ,platform:2
long ,technologies:2
long ,mass:2
road ,toward:4
road ,covid-19:6
road ,herd:2
road ,immunity:2
road ,vaccine:2
road ,platform:2
road ,technologies:2
road ,mass:2
toward ,herd:2
toward ,immunity:2
toward ,vaccine:4
toward ,platform:2
toward ,technologies:2
toward ,mass:2
covid-19 ,herd:8
covid-19 ,immunity:36
covid-19 ,platform:2
covid-19 ,technologies:6
covid-19 ,mass:14
herd ,immunity:14
herd ,vaccine:2
herd ,platform:2
herd ,technologies:2
herd ,mass:2
immunity ,vaccine:8
immunity ,platform:2
immunity ,technologies:2
immunity ,mass:2
vaccine ,platform:4
vaccine ,technologies:2
vaccine ,mass:2
platform ,technologies:2
platform ,mass:2
technologies ,mass:2
outbreak ,emerging:6
outbreak ,global:6
outbreak ,threat:2
global ,pandemic:22
pandemic ,threat:2
presence ,rna:10
presence ,feces:2
presence ,patients:4
rna ,feces:6
rna ,patients:30
feces ,patients:4
pandemic ,coronaviruses:8
pandemic ,diabetes:4
pandemic ,mellitus:2
coronaviruses ,diabetes:2
coronaviruses ,mellitus:2
earlier ,better:2
earlier ,convalescent:2
earlier ,plasma:2
better ,convalescent:2
better ,plasma:2
postmortem ,examination:4
postmortem ,two:2
postmortem ,cases:4
postmortem ,death:2
postmortem ,related:2
postmortem ,2019-ncov:2
postmortem ,infection:2
examination ,two:2
examination ,cases:2
examination ,death:2
examination ,related:2
examination ,2019-ncov:2
two ,death:2
two ,related:4
cases ,death:8
cases ,related:4
death ,related:4
death ,2019-ncov:2
death ,infection:10
related ,2019-ncov:2
related ,infection:6
spike ,detection:12
spike ,treatment:2
protein ,detection:6
protein ,treatment:2
detection ,treatment:4
early ,introduction:2
early ,severe:12
early ,acute:12
early ,respiratory:16
early ,syndrome:14
early ,europe:2
introduction ,severe:2
introduction ,acute:2
introduction ,respiratory:2
introduction ,syndrome:2
introduction ,coronavirus:2
introduction ,europe:2
severe ,europe:2
acute ,europe:2
respiratory ,europe:2
syndrome ,europe:2
influence ,covid-19:12
influence ,cerebrovascular:2
influence ,disease:4
influence ,possible:2
influence ,mechanism:2
covid-19 ,cerebrovascular:10
covid-19 ,mechanism:22
cerebrovascular ,disease:10
cerebrovascular ,possible:2
cerebrovascular ,mechanism:2
disease ,possible:6
disease ,mechanism:4
possible ,mechanism:8
d614g ,substitution:2
d614g ,sars-cov-2:8
d614g ,spike:10
d614g ,protein:6
d614g ,associated:2
substitution ,sars-cov-2:2
substitution ,spike:2
substitution ,protein:2
substitution ,associated:2
spike ,associated:2
protein ,associated:2
five-step ,risk:2
five-step ,management:2
five-step ,process:2
five-step ,geriatric:2
five-step ,dental:2
five-step ,practice:2
five-step ,sars-cov-2:2
risk ,management:16
risk ,process:2
risk ,geriatric:2
risk ,dental:4
risk ,practice:2
management ,process:2
management ,geriatric:2
management ,dental:2
management ,practice:6
management ,sars-cov-2:60
process ,geriatric:2
process ,dental:2
process ,practice:2
process ,sars-cov-2:6
geriatric ,dental:2
geriatric ,practice:2
geriatric ,sars-cov-2:4
dental ,sars-cov-2:6
practice ,sars-cov-2:14
sars-cov-2 ,dentistry-review:2
cross-species ,transmission:4
cross-species ,newly:4
cross-species ,identified:4
cross-species ,coronavirus:2
cross-species ,2019-ncov:2
transmission ,newly:4
transmission ,identified:4
newly ,identified:4
newly ,2019-ncov:2
identified ,coronavirus:2
identified ,2019-ncov:2
covid-19 ,conditioning:2
covid-19 ,restaurant:2
covid-19 ,guangzhou:2
outbreak ,air:6
outbreak ,conditioning:2
outbreak ,restaurant:2
outbreak ,guangzhou:2
associated ,air:6
associated ,conditioning:2
associated ,restaurant:2
associated ,guangzhou:2
associated ,china:2
air ,conditioning:2
air ,restaurant:2
air ,guangzhou:2
air ,china:2
conditioning ,restaurant:2
conditioning ,guangzhou:2
conditioning ,china:2
restaurant ,guangzhou:2
restaurant ,china:2
guangzhou ,china:4
digital ,tools:4
digital ,ameliorate:2
digital ,psychological:2
digital ,symptoms:2
digital ,associated:2
digital ,covid-19:6
digital ,scoping:2
tools ,ameliorate:2
tools ,psychological:2
tools ,symptoms:2
tools ,associated:2
tools ,covid-19:8
tools ,scoping:2
ameliorate ,psychological:2
ameliorate ,symptoms:2
ameliorate ,associated:2
ameliorate ,covid-19:6
ameliorate ,scoping:2
psychological ,symptoms:2
psychological ,associated:2
psychological ,covid-19:16
psychological ,scoping:2
symptoms ,associated:8
symptoms ,scoping:2
associated ,scoping:2
unprotected ,stroke:2
unprotected ,management:2
unprotected ,undiagnosed:2
unprotected ,case:2
unprotected ,severe:2
unprotected ,acute:2
unprotected ,respiratory:2
stroke ,management:2
stroke ,undiagnosed:2
stroke ,case:10
stroke ,severe:2
stroke ,respiratory:2
management ,undiagnosed:2
management ,severe:16
management ,acute:18
management ,respiratory:12
undiagnosed ,case:2
undiagnosed ,severe:2
undiagnosed ,acute:2
undiagnosed ,respiratory:2
deep ,vein:8
deep ,thrombosis:10
deep ,pneumonia-affected:2
deep ,patients:2
deep ,within:2
deep ,standard:2
deep ,care:2
vein ,thrombosis:8
vein ,sars-cov-2:2
vein ,pneumonia-affected:2
vein ,patients:2
vein ,within:2
vein ,standard:2
vein ,care:2
thrombosis ,sars-cov-2:8
thrombosis ,pneumonia-affected:2
thrombosis ,patients:10
thrombosis ,within:2
thrombosis ,standard:2
thrombosis ,care:2
sars-cov-2 ,pneumonia-affected:2
sars-cov-2 ,within:8
sars-cov-2 ,standard:6
sars-cov-2 ,care:84
pneumonia-affected ,patients:2
pneumonia-affected ,within:2
pneumonia-affected ,standard:2
pneumonia-affected ,care:2
patients ,within:4
patients ,standard:6
patients ,care:60
within ,standard:2
within ,care:2
standard ,care:2
network-based ,drug:2
network-based ,repurposing:2
network-based ,novel:2
network-based ,coronavirus:2
network-based ,2019-ncovsars-cov-2:2
drug ,novel:14
drug ,2019-ncovsars-cov-2:2
repurposing ,novel:6
repurposing ,2019-ncovsars-cov-2:2
viral ,mildly:2
viral ,symptomatic:4
viral ,asymptomatic:8
viral ,children:12
viral ,seoul:2
rna ,load:4
rna ,mildly:2
rna ,symptomatic:4
rna ,asymptomatic:2
rna ,children:6
rna ,seoul:2
load ,mildly:2
load ,symptomatic:2
load ,asymptomatic:2
load ,children:2
load ,covid-19:14
load ,seoul:2
mildly ,symptomatic:12
mildly ,asymptomatic:8
mildly ,children:2
mildly ,covid-19:4
mildly ,seoul:2
symptomatic ,asymptomatic:18
symptomatic ,covid-19:18
symptomatic ,seoul:2
asymptomatic ,children:6
asymptomatic ,covid-19:54
asymptomatic ,seoul:2
children ,seoul:2
covid-19 ,seoul:2
indirect ,virus:2
indirect ,transmission:4
indirect ,cluster:2
indirect ,covid-19:4
indirect ,cases:2
indirect ,wenzhou:2
indirect ,china:4
virus ,cluster:2
virus ,cases:6
virus ,wenzhou:2
transmission ,wenzhou:2
cluster ,covid-19:28
cluster ,wenzhou:2
cluster ,china:4
covid-19 ,wenzhou:2
cases ,wenzhou:2
wenzhou ,china:2
identification ,new:2
identification ,anti-ncov:2
identification ,drug:14
identification ,chemical:2
identification ,compounds:2
identification ,indian:2
identification ,spices:2
new ,anti-ncov:2
new ,drug:8
new ,chemical:2
new ,compounds:2
new ,indian:2
new ,spices:2
anti-ncov ,drug:2
anti-ncov ,chemical:2
anti-ncov ,compounds:2
anti-ncov ,indian:2
anti-ncov ,spices:2
drug ,chemical:2
drug ,compounds:4
drug ,indian:2
drug ,spices:4
chemical ,compounds:2
chemical ,indian:2
chemical ,spices:2
compounds ,indian:2
compounds ,spices:2
indian ,spices:2
parotitis-like ,symptoms:2
parotitis-like ,associated:2
parotitis-like ,covid-19:2
parotitis-like ,france:2
parotitis-like ,march-april:2
symptoms ,france:2
symptoms ,march-april:2
associated ,france:2
associated ,march-april:2
covid-19 ,march-april:4
france ,march-april:2
public ,mental:2
public ,crisis:4
public ,pandemic:16
mental ,health:40
mental ,crisis:4
mental ,covid-19:30
mental ,pandemic:14
mental ,china:4
health ,crisis:12
health ,china:8
crisis ,covid-19:24
crisis ,pandemic:12
crisis ,china:2
unpuzzling ,covid-19:2
unpuzzling ,tissue-related:2
unpuzzling ,signaling:2
unpuzzling ,pathways:2
unpuzzling ,associated:2
unpuzzling ,sars-cov-2:2
covid-19 ,tissue-related:2
covid-19 ,signaling:2
tissue-related ,signaling:2
tissue-related ,pathways:2
tissue-related ,associated:2
tissue-related ,sars-cov-2:2
signaling ,pathways:4
signaling ,associated:2
signaling ,sars-cov-2:10
pathways ,associated:2
pathways ,sars-cov-2:10
drug ,interactions:2
drug ,unseen:2
drug ,danger:2
drug ,experimental:2
drug ,therapies:2
interactions ,review:2
interactions ,unseen:2
interactions ,danger:2
interactions ,experimental:2
interactions ,covid-19:8
interactions ,therapies:2
review ,unseen:2
review ,danger:2
review ,experimental:2
review ,therapies:12
unseen ,danger:2
unseen ,experimental:2
unseen ,covid-19:6
unseen ,therapies:2
danger ,experimental:2
danger ,covid-19:4
danger ,therapies:2
experimental ,covid-19:4
experimental ,therapies:2
laboratory ,readiness:2
laboratory ,novel:10
laboratory ,expert:2
readiness ,response:2
readiness ,novel:2
readiness ,coronavirus:2
readiness ,2019-ncov:2
readiness ,expert:2
response ,novel:8
response ,2019-ncov:4
response ,expert:2
2019-ncov ,expert:2
2019-2020 ,novel:2
2019-2020 ,coronavirus:2
2019-2020 ,severe:2
2019-2020 ,acute:2
2019-2020 ,respiratory:2
2019-2020 ,syndrome:2
re-analysis ,sars-cov-2-infected:2
re-analysis ,host:2
re-analysis ,cell:4
re-analysis ,proteomics:2
re-analysis ,time-course:2
re-analysis ,data:2
re-analysis ,impact:2
sars-cov-2-infected ,host:4
sars-cov-2-infected ,cell:4
sars-cov-2-infected ,proteomics:6
sars-cov-2-infected ,time-course:2
sars-cov-2-infected ,data:2
sars-cov-2-infected ,impact:2
host ,proteomics:4
host ,time-course:2
host ,data:2
host ,impact:4
cell ,proteomics:2
cell ,time-course:2
cell ,data:2
cell ,impact:4
proteomics ,time-course:2
proteomics ,data:4
proteomics ,impact:2
time-course ,data:2
time-course ,impact:2
data ,impact:4
gastrointestinal ,potential:6
gastrointestinal ,faecal:2
gastrointestinal ,transmission:2
involvement ,potential:4
involvement ,faecal:2
involvement ,transmission:2
covid-19 ,faecal:2
potential ,faecal:2
faecal ,transmission:2
respiratory ,sampling:6
sampling ,severe:4
sampling ,acute:4
sampling ,syndrome:4
sampling ,coronavirus:4
prolonged ,detection:2
prolonged ,severe:2
prolonged ,acute:2
prolonged ,respiratory:4
prolonged ,syndrome:2
strengthening ,basic:2
strengthening ,clinical:2
strengthening ,research:2
strengthening ,ocular:2
strengthening ,infection:2
strengthening ,caused:2
basic ,clinical:4
basic ,research:2
basic ,ocular:2
basic ,infection:2
basic ,caused:2
clinical ,ocular:6
clinical ,caused:4
research ,ocular:2
research ,infection:2
research ,caused:4
ocular ,infection:6
ocular ,caused:2
infection ,caused:4
safety ,efficacy:16
safety ,different:2
safety ,therapeutic:4
safety ,interventions:2
safety ,prevention:4
efficacy ,different:4
efficacy ,therapeutic:6
efficacy ,interventions:2
efficacy ,prevention:2
different ,therapeutic:2
different ,interventions:2
different ,prevention:2
therapeutic ,interventions:6
therapeutic ,prevention:4
interventions ,prevention:6
covid-19 ,immunopathological:4
covid-19 ,view:16
immunopathological ,view:2
structures ,sars-cov-2:6
structures ,nucleocapsid:2
structures ,perspectives:2
structures ,drug:2
structures ,design:2
sars-cov-2 ,nucleocapsid:20
sars-cov-2 ,perspectives:6
nucleocapsid ,perspectives:2
nucleocapsid ,drug:2
nucleocapsid ,design:2
perspectives ,drug:2
perspectives ,design:2
drug ,design:4
sars-cov-2 ,antibody:114
igg ,antibody:14
igg ,responses:4
igg ,new:2
igg ,york:2
igg ,city:2
antibody ,new:4
antibody ,york:2
antibody ,city:2
responses ,new:2
responses ,york:2
responses ,city:2
epidemiological ,modelling:2
epidemiological ,approach:2
epidemiological ,via:2
epidemiological ,assimilation:2
modelling ,approach:2
modelling ,covid-19:18
modelling ,via:2
modelling ,data:2
modelling ,assimilation:2
approach ,covid-19:50
approach ,via:2
approach ,data:4
approach ,assimilation:2
covid-19 ,via:16
covid-19 ,assimilation:2
via ,data:2
via ,assimilation:2
data ,assimilation:2
epidemiology ,genome:4
epidemiology ,clinical:18
epidemiology ,features:6
epidemiology ,pandemic:6
epidemiology ,recent:2
genome ,features:4
genome ,pandemic:2
genome ,sars-cov-2:44
genome ,recent:2
clinical ,recent:4
features ,pandemic:2
features ,recent:2
pandemic ,recent:4
optimal ,temperature:2
optimal ,zone:2
optimal ,dispersal:2
optimal ,covid-19:10
temperature ,zone:2
temperature ,dispersal:2
temperature ,covid-19:18
zone ,dispersal:2
zone ,covid-19:2
dispersal ,covid-19:4
fractional ,diffusion:2
fractional ,human:2
fractional ,proteome:2
fractional ,alternative:2
fractional ,multi-organ:2
diffusion ,human:2
diffusion ,proteome:2
diffusion ,alternative:2
diffusion ,multi-organ:2
human ,proteome:4
human ,alternative:2
human ,multi-organ:2
proteome ,alternative:2
proteome ,multi-organ:2
alternative ,multi-organ:2
mice ,men:2
mice ,coronavirus:2
mice ,mhv:2
mice ,mouse:2
mice ,models:4
mice ,translational:2
mice ,approach:2
men ,coronavirus:4
men ,mhv:2
men ,mouse:2
men ,models:2
men ,translational:2
men ,approach:2
coronavirus ,mhv:2
coronavirus ,mouse:2
coronavirus ,models:4
coronavirus ,translational:2
mhv ,mouse:2
mhv ,models:2
mhv ,translational:2
mhv ,approach:2
mouse ,models:4
mouse ,translational:2
mouse ,approach:2
models ,translational:4
models ,approach:2
translational ,approach:2
attaching ,clinical:2
attaching ,significance:2
attaching ,covid-19-associated:2
attaching ,diarrhea:2
clinical ,covid-19-associated:2
clinical ,diarrhea:2
significance ,covid-19-associated:2
significance ,diarrhea:2
covid-19-associated ,diarrhea:2
hemostatic ,laboratory:2
hemostatic ,derangements:2
hemostatic ,covid-19:4
hemostatic ,focus:2
hemostatic ,platelet:2
hemostatic ,count:2
laboratory ,derangements:2
laboratory ,focus:2
laboratory ,platelet:2
laboratory ,count:2
derangements ,covid-19:2
derangements ,focus:2
derangements ,platelet:2
derangements ,count:2
covid-19 ,focus:24
covid-19 ,platelet:6
covid-19 ,count:2
focus ,platelet:2
focus ,count:2
platelet ,count:2
abdominal ,visceral:2
abdominal ,infarction:2
abdominal ,patients:6
abdominal ,covid-19:8
visceral ,infarction:2
visceral ,patients:2
visceral ,covid-19:2
infarction ,patients:4
infarction ,covid-19:10
evaluation ,automated:14
evaluation ,igg:18
evaluation ,iga:4
evaluation ,elisas:2
commercial ,automated:2
commercial ,igg:4
commercial ,iga:2
commercial ,elisas:2
automated ,sars-cov-2:18
automated ,igg:2
automated ,iga:2
automated ,elisas:2
automated ,using:4
sars-cov-2 ,iga:4
sars-cov-2 ,elisas:2
igg ,iga:4
igg ,elisas:2
igg ,using:8
iga ,elisas:2
iga ,using:2
elisas ,using:2
coronavirus ,arterial:2
coronavirus ,hypertension:6
coronavirus ,facts:4
coronavirus ,myths:2
sars-cov-2 ,arterial:4
sars-cov-2 ,hypertension:6
sars-cov-2 ,facts:2
sars-cov-2 ,myths:2
arterial ,hypertension:2
arterial ,facts:2
arterial ,myths:2
hypertension ,facts:2
hypertension ,myths:2
favipiravir ,need:2
favipiravir ,early:2
favipiravir ,ambulatory:2
favipiravir ,treatment:6
favipiravir ,sars-cov-2:4
favipiravir ,infection:2
need ,early:2
need ,ambulatory:2
need ,treatment:4
need ,sars-cov-2:14
need ,infection:4
early ,ambulatory:2
early ,treatment:6
early ,sars-cov-2:70
early ,infection:20
ambulatory ,treatment:2
ambulatory ,sars-cov-2:4
ambulatory ,infection:2
treatment ,infection:34
targeting ,endocytic:2
targeting ,pathway:4
targeting ,autophagy:4
targeting ,process:2
targeting ,novel:10
endocytic ,pathway:2
endocytic ,autophagy:2
endocytic ,process:2
endocytic ,novel:2
endocytic ,therapeutic:2
pathway ,autophagy:2
pathway ,process:2
pathway ,novel:2
pathway ,therapeutic:4
autophagy ,process:2
autophagy ,novel:2
autophagy ,therapeutic:2
process ,novel:2
process ,therapeutic:2
retrospective ,description:2
retrospective ,pregnant:2
retrospective ,women:2
retrospective ,infected:2
retrospective ,severe:8
retrospective ,acute:6
retrospective ,respiratory:4
description ,pregnant:2
description ,women:2
description ,infected:2
description ,severe:2
description ,acute:2
description ,respiratory:2
pregnant ,women:74
pregnant ,infected:10
pregnant ,severe:6
pregnant ,acute:10
pregnant ,respiratory:8
women ,infected:10
women ,severe:6
women ,acute:4
women ,respiratory:4
infected ,severe:6
infected ,acute:8
infected ,respiratory:6
buying ,time:2
buying ,covid-19:2
buying ,outbreak:2
buying ,response:2
buying ,israel:2
time ,covid-19:78
time ,outbreak:6
time ,response:2
time ,israel:2
covid-19 ,israel:2
outbreak ,response:12
outbreak ,israel:2
response ,israel:4
characteristics ,potential:10
characteristics ,pharmacological:2
characteristics ,treatment:12
sars-cov-2 ,pharmacological:6
potential ,pharmacological:6
pharmacological ,treatment:2
vitro ,animal:2
vitro ,models:2
vitro ,research:2
animal ,models:20
animal ,research:6
models ,sars-cov-2:26
models ,research:6
sars-cov-2 ,indias:2
laboratory ,indias:2
laboratory ,pandemic:12
laboratory ,public:6
laboratory ,health:6
testing ,indias:2
testing ,pandemic:6
testing ,response:4
testing ,public:2
testing ,health:6
indias ,pandemic:4
indias ,response:2
indias ,public:2
indias ,health:2
pandemic ,response:20
response ,public:14
response ,health:26
laboratory ,biosafety:4
laboratory ,considerations:2
laboratory ,level:2
biosafety ,considerations:2
biosafety ,sars-cov-2:2
biosafety ,level:2
considerations ,sars-cov-2:16
considerations ,level:2
sars-cov-2 ,level:8
comparison ,vitro:4
comparison ,diagnostic:10
four ,molecular:2
four ,vitro:2
four ,diagnostic:2
four ,detection:10
molecular ,vitro:4
vitro ,diagnostic:6
vitro ,assays:10
vitro ,detection:2
covid-19 ,persons:8
covid-19 ,mild:44
covid-19 ,upper:16
covid-19 ,tract:10
covid-19 ,cruise:6
covid-19 ,ship:6
persons ,mild:2
persons ,upper:2
persons ,respiratory:2
persons ,tract:2
persons ,symptoms:2
persons ,cruise:2
persons ,ship:2
mild ,upper:4
mild ,respiratory:2
mild ,tract:2
mild ,symptoms:6
mild ,cruise:2
mild ,ship:2
upper ,respiratory:18
upper ,tract:10
upper ,symptoms:2
upper ,cruise:2
upper ,ship:2
respiratory ,tract:26
respiratory ,symptoms:6
respiratory ,cruise:2
respiratory ,ship:2
tract ,symptoms:2
tract ,cruise:2
tract ,ship:2
symptoms ,cruise:2
symptoms ,ship:2
cruise ,ship:12
understanding ,complexities:2
understanding ,sars-cov2:4
understanding ,infection:6
understanding ,immunology:2
understanding ,road:2
complexities ,sars-cov2:2
complexities ,infection:2
complexities ,immunology:2
complexities ,road:2
sars-cov2 ,infection:8
sars-cov2 ,immunology:2
sars-cov2 ,road:2
infection ,immunology:2
infection ,road:2
immunology ,road:2
longitudinal ,monitoring:2
longitudinal ,sars-cov-2:2
longitudinal ,igm:2
longitudinal ,igg:2
longitudinal ,seropositivity:2
longitudinal ,detect:2
longitudinal ,covid-19:4
monitoring ,sars-cov-2:16
monitoring ,igm:2
monitoring ,igg:2
monitoring ,seropositivity:2
monitoring ,detect:2
monitoring ,covid-19:18
sars-cov-2 ,igm:18
sars-cov-2 ,seropositivity:2
igm ,igg:12
igm ,seropositivity:2
igm ,detect:2
igm ,covid-19:10
igg ,seropositivity:2
igg ,detect:2
igg ,covid-19:14
seropositivity ,detect:2
seropositivity ,covid-19:2
detect ,covid-19:2
novel ,ribavirin:2
novel ,groundwork:2
novel ,evaluation:14
novel ,concerning:2
coronavirus ,ribavirin:2
coronavirus ,groundwork:2
coronavirus ,evaluation:12
coronavirus ,concerning:2
treatment ,ribavirin:2
treatment ,groundwork:2
treatment ,evaluation:6
treatment ,concerning:4
ribavirin ,groundwork:2
ribavirin ,evaluation:2
ribavirin ,concerning:2
groundwork ,evaluation:2
groundwork ,concerning:2
evaluation ,concerning:2
arbidol ,potential:4
arbidol ,antiviral:6
arbidol ,drug:4
arbidol ,treatment:2
arbidol ,sars-cov-2:4
arbidol ,blocking:2
potential ,blocking:2
antiviral ,blocking:2
drug ,blocking:2
treatment ,blocking:4
sars-cov-2 ,blocking:12
chadox1ncov-19 ,vaccine:2
chadox1ncov-19 ,prevents:2
chadox1ncov-19 ,sars-cov-2:2
chadox1ncov-19 ,pneumonia:2
chadox1ncov-19 ,rhesus:2
chadox1ncov-19 ,macaques:2
vaccine ,prevents:2
vaccine ,sars-cov-2:76
vaccine ,pneumonia:2
vaccine ,rhesus:2
vaccine ,macaques:2
prevents ,sars-cov-2:12
prevents ,pneumonia:4
prevents ,rhesus:4
prevents ,macaques:4
sars-cov-2 ,rhesus:14
sars-cov-2 ,macaques:12
pneumonia ,rhesus:4
pneumonia ,macaques:4
rhesus ,macaques:12
inhibitors ,renin-angiotensin:8
inhibitors ,system:8
inhibitors ,role:6
inhibitors ,pathogenesis:2
renin-angiotensin ,system:56
renin-angiotensin ,potential:2
renin-angiotensin ,role:8
renin-angiotensin ,pathogenesis:4
system ,role:16
system ,pathogenesis:8
potential ,pathogenesis:18
role ,pathogenesis:12
chronicle ,sars-cov-2:2
chronicle ,part-i:2
chronicle ,epidemiology:2
chronicle ,diagnosis:2
chronicle ,prognosis:2
chronicle ,transmission:2
sars-cov-2 ,part-i:2
sars-cov-2 ,diagnosis:50
sars-cov-2 ,prognosis:2
part-i ,epidemiology:2
part-i ,diagnosis:2
part-i ,prognosis:2
part-i ,transmission:2
epidemiology ,prognosis:2
epidemiology ,transmission:4
prognosis ,transmission:2
cryo-em ,structure:2
cryo-em ,2019-ncov:2
cryo-em ,spike:2
cryo-em ,prefusion:2
cryo-em ,conformation:2
structure ,spike:10
structure ,prefusion:2
structure ,conformation:2
2019-ncov ,prefusion:4
2019-ncov ,conformation:2
spike ,prefusion:8
spike ,conformation:4
prefusion ,conformation:4
analysis ,features:16
analysis ,15:2
analysis ,children:16
ct ,features:28
ct ,15:2
ct ,children:6
features ,15:2
features ,children:22
15 ,children:2
15 ,novel:2
15 ,coronavirus:2
15 ,infection:2
children ,infection:50
covid-19 ,learn:12
covid-19 ,past:8
look ,future:2
look ,learn:2
look ,past:2
future ,learn:2
future ,past:6
learn ,past:2
sars-cov-2 ,hiv:12
sars-cov-2 ,lessons:30
sars-cov-2 ,learned:6
hiv ,epidemiology:2
hiv ,treatment:4
hiv ,lessons:4
hiv ,learned:2
epidemiology ,treatment:10
epidemiology ,lessons:2
epidemiology ,learned:2
treatment ,lessons:6
treatment ,learned:2
prepared ,africa:4
prepared ,face:2
prepared ,covid-19:6
africa ,face:2
africa ,covid-19:14
face ,covid-19:14
perspectives ,neutralizing:2
perspectives ,antibodies:2
perspectives ,novel:4
therapeutic ,neutralizing:4
therapeutic ,antibodies:6
neutralizing ,novel:2
neutralizing ,coronavirus:4
antibodies ,novel:2
antibodies ,coronavirus:8
fatal ,invasive:2
fatal ,aspergillosis:4
fatal ,immunocompetent:2
fatal ,patient:2
invasive ,aspergillosis:2
invasive ,coronavirus:2
invasive ,disease:2
invasive ,immunocompetent:2
invasive ,patient:2
aspergillosis ,coronavirus:4
aspergillosis ,disease:4
aspergillosis ,immunocompetent:2
aspergillosis ,patient:2
coronavirus ,immunocompetent:2
disease ,immunocompetent:2
immunocompetent ,patient:4
large ,disease:2
large ,among:4
large ,wedding:2
large ,attendees:2
large ,jordan:2
outbreak ,disease:34
outbreak ,among:10
outbreak ,wedding:2
outbreak ,attendees:2
outbreak ,jordan:2
coronavirus ,wedding:2
coronavirus ,attendees:2
coronavirus ,jordan:2
disease ,among:16
disease ,wedding:2
disease ,attendees:2
disease ,jordan:2
among ,wedding:4
among ,attendees:4
among ,jordan:2
wedding ,attendees:4
wedding ,jordan:2
attendees ,jordan:2
psychological ,impact:4
psychological ,novel:2
psychological ,coronavirus:4
psychological ,2019-ncov:2
psychological ,outbreak:6
psychological ,health:4
impact ,novel:12
impact ,coronavirus:20
impact ,2019-ncov:8
impact ,outbreak:16
novel ,health:10
2019-ncov ,health:2
outbreak ,health:18
potential ,scenarios:2
potential ,progression:2
potential ,epidemic:8
potential ,european:2
potential ,union:2
scenarios ,progression:2
scenarios ,covid-19:6
scenarios ,epidemic:2
scenarios ,european:2
scenarios ,union:2
progression ,epidemic:2
progression ,european:2
progression ,union:2
covid-19 ,european:10
covid-19 ,union:2
epidemic ,european:2
epidemic ,union:2
european ,union:2
origin ,structural:2
origin ,characteristics:6
origin ,prevention:2
origin ,measures:2
origin ,potential:4
structural ,characteristics:4
structural ,prevention:2
structural ,measures:2
structural ,diagnosis:2
structural ,potential:12
characteristics ,prevention:2
characteristics ,measures:2
characteristics ,diagnosis:10
prevention ,potential:6
measures ,diagnosis:2
measures ,potential:4
diagnosis ,potential:6
sars-cov-2 ,advanced:8
sars-cov-2 ,rheumatoid:4
sars-cov-2 ,arthritis:4
infection ,advanced:2
infection ,rheumatoid:4
infection ,arthritis:6
advanced ,rheumatoid:2
advanced ,arthritis:2
advanced ,patient:4
rheumatoid ,arthritis:6
rheumatoid ,patient:2
arthritis ,patient:2
nasopharyngeal ,carcinoma:2
nasopharyngeal ,patient:4
nasopharyngeal ,infection:2
nasopharyngeal ,immunotherapy:2
carcinoma ,patient:4
carcinoma ,covid-19:4
carcinoma ,infection:2
carcinoma ,immunotherapy:4
patient ,immunotherapy:4
infection ,immunotherapy:2
systematic ,screening:4
systematic ,pregnant:4
systematic ,women:4
systematic ,admitted:2
systematic ,delivery:2
screening ,pregnant:6
screening ,women:8
screening ,admitted:8
screening ,delivery:6
sars-cov-2 ,pregnant:28
sars-cov-2 ,admitted:14
sars-cov-2 ,delivery:6
pregnant ,admitted:10
pregnant ,delivery:18
women ,admitted:12
women ,delivery:16
admitted ,delivery:4
sars-cov-2 ,meeting:2
sars-cov-2 ,attendee:2
sars-cov-2 ,germany:4
transmission ,meeting:4
transmission ,attendee:2
transmission ,germany:2
presymptomatic ,meeting:2
presymptomatic ,attendee:2
presymptomatic ,germany:2
meeting ,attendee:2
meeting ,germany:2
attendee ,germany:2
silico ,screening:6
silico ,fda:2
silico ,approved:4
silico ,drugs:8
silico ,reveals:2
silico ,ergotamine:2
silico ,dihydroergotamine:2
screening ,fda:6
screening ,approved:10
screening ,reveals:8
screening ,ergotamine:2
screening ,dihydroergotamine:2
fda ,approved:8
fda ,drugs:6
fda ,reveals:4
fda ,ergotamine:2
fda ,dihydroergotamine:2
approved ,reveals:4
approved ,ergotamine:2
approved ,dihydroergotamine:2
drugs ,reveals:4
drugs ,ergotamine:2
drugs ,dihydroergotamine:2
reveals ,ergotamine:2
reveals ,dihydroergotamine:2
ergotamine ,dihydroergotamine:2
worldwide ,public:2
worldwide ,health:2
worldwide ,emergency:2
public ,emergency:10
health ,emergency:14
genetic ,landscape:2
genetic ,covid-19:20
genetic ,south:2
genetic ,asian:2
genetic ,perspective:6
landscape ,covid-19:6
landscape ,south:2
landscape ,asian:2
landscape ,perspective:2
covid-19 ,south:10
covid-19 ,asian:2
south ,asian:2
south ,perspective:2
asian ,perspective:2
otolaryngology ,providers:2
otolaryngology ,must:2
otolaryngology ,alert:2
otolaryngology ,patients:4
otolaryngology ,mild:2
otolaryngology ,asymptomatic:2
providers ,must:2
providers ,alert:2
providers ,patients:2
providers ,mild:2
providers ,asymptomatic:2
must ,alert:2
must ,patients:2
must ,mild:2
must ,asymptomatic:2
alert ,patients:2
alert ,mild:2
alert ,asymptomatic:2
patients ,mild:14
patients ,asymptomatic:48
mild ,asymptomatic:12
nitazoxanideazithromycin ,combination:2
nitazoxanideazithromycin ,covid-19:2
nitazoxanideazithromycin ,suggested:2
nitazoxanideazithromycin ,new:2
nitazoxanideazithromycin ,protocol:2
combination ,suggested:2
combination ,new:2
combination ,protocol:2
covid-19 ,suggested:6
covid-19 ,protocol:18
suggested ,new:2
suggested ,protocol:2
new ,protocol:2
seroprevalence ,infection:2
seroprevalence ,fatality:2
seroprevalence ,ratio:2
seroprevalence ,orleans:2
seroprevalence ,jefferson:2
sars-cov-2 ,fatality:6
sars-cov-2 ,ratio:4
sars-cov-2 ,orleans:2
sars-cov-2 ,jefferson:2
infection ,fatality:4
infection ,ratio:4
infection ,orleans:2
infection ,jefferson:2
fatality ,ratio:4
fatality ,orleans:2
fatality ,jefferson:2
ratio ,orleans:2
ratio ,jefferson:2
orleans ,jefferson:2
case ,newborn:4
case ,baby:2
case ,girl:2
case ,infected:4
case ,sars-cov-2:110
case ,due:2
case ,transplacental:2
case ,viral:14
newborn ,baby:2
newborn ,girl:2
newborn ,infected:4
newborn ,sars-cov-2:4
newborn ,due:2
newborn ,transplacental:2
newborn ,viral:2
baby ,girl:2
baby ,infected:2
baby ,sars-cov-2:2
baby ,due:2
baby ,transplacental:2
baby ,viral:2
girl ,infected:2
girl ,sars-cov-2:2
girl ,due:2
girl ,transplacental:2
girl ,viral:2
infected ,sars-cov-2:64
infected ,due:2
infected ,transplacental:2
infected ,viral:10
sars-cov-2 ,due:12
sars-cov-2 ,transplacental:4
due ,transplacental:2
due ,viral:2
transplacental ,viral:2
novel ,overview:10
pandemic ,overview:16
pandemic ,number:2
pandemic ,five:2
pandemic ,latest:4
number ,five:2
number ,latest:2
number ,insights:2
number ,covid-19:10
number ,crisis:2
five ,latest:2
five ,insights:2
five ,covid-19:8
five ,crisis:2
latest ,insights:2
latest ,covid-19:6
latest ,crisis:2
insights ,crisis:2
cytokine ,induced:4
storm ,induced:4
induced ,sars-cov-2:6
proposed ,mechanism:2
proposed ,possible:4
proposed ,therapeutic:2
proposed ,potential:2
proposed ,metformin:2
mechanism ,therapeutic:2
mechanism ,potential:12
mechanism ,metformin:2
possible ,therapeutic:12
possible ,potential:4
possible ,metformin:4
therapeutic ,metformin:2
potential ,metformin:4
evaluation ,viral:2
evaluation ,rna:4
evaluation ,fecal:2
evaluation ,samples:4
viral ,fecal:6
viral ,samples:8
rna ,fecal:4
rna ,samples:6
fecal ,samples:2
loss ,taste:22
loss ,symptom:2
smell ,taste:48
smell ,symptom:2
taste ,symptom:2
taste ,covid-19:30
microbiology ,coronaviruses:2
macrolide ,treatment:2
macrolide ,covid-19:2
macrolide ,will:2
macrolide ,way:2
macrolide ,forward:2
treatment ,will:2
treatment ,way:4
treatment ,forward:2
covid-19 ,will:14
covid-19 ,way:8
covid-19 ,forward:2
will ,way:2
will ,forward:2
way ,forward:2
association ,exposure:2
association ,middle:2
association ,east:2
association ,respiratory:2
association ,syndrome:4
association ,mers:2
exposure ,middle:2
exposure ,east:2
exposure ,mers:2
middle ,east:8
middle ,respiratory:6
middle ,syndrome:2
middle ,mers:2
east ,respiratory:6
east ,syndrome:2
east ,mers:2
respiratory ,mers:2
syndrome ,mers:2
severe ,detected:2
severe ,blood:4
severe ,donations:2
acute ,detected:2
acute ,blood:2
acute ,donations:2
respiratory ,detected:2
respiratory ,blood:6
respiratory ,donations:2
syndrome ,detected:2
syndrome ,blood:2
syndrome ,donations:2
coronavirus ,detected:2
coronavirus ,donations:2
rna ,detected:2
rna ,donations:2
detected ,blood:2
detected ,donations:2
blood ,donations:2
tug-of-war ,severe:2
tug-of-war ,acute:2
tug-of-war ,respiratory:2
tug-of-war ,syndrome:2
tug-of-war ,coronavirus:2
tug-of-war ,host:2
severe ,host:6
acute ,host:2
respiratory ,host:2
syndrome ,host:2
coronavirus ,host:8
correlation ,renin-angiotensin:2
correlation ,system:6
correlation ,severe:2
correlation ,acute:2
correlation ,respiratory:2
correlation ,syndrome:2
renin-angiotensin ,severe:8
renin-angiotensin ,acute:8
renin-angiotensin ,respiratory:6
renin-angiotensin ,syndrome:4
system ,severe:12
system ,acute:12
system ,respiratory:10
system ,syndrome:8
moonlighting ,protein:2
moonlighting ,able:2
moonlighting ,explain:2
moonlighting ,th1:2
moonlighting ,immune:2
moonlighting ,lockdown:2
moonlighting ,severe:2
protein ,able:2
protein ,explain:2
protein ,th1:2
protein ,immune:2
protein ,lockdown:2
protein ,severe:18
able ,explain:2
able ,th1:2
able ,immune:2
able ,lockdown:2
able ,severe:2
explain ,th1:2
explain ,immune:2
explain ,lockdown:2
explain ,severe:2
th1 ,immune:2
th1 ,lockdown:2
th1 ,severe:2
immune ,lockdown:2
immune ,severe:14
lockdown ,severe:2
geographic ,components:2
geographic ,sars-cov-2:2
geographic ,expansion:2
geographic ,hypothesis:2
components ,sars-cov-2:4
components ,expansion:2
components ,hypothesis:2
sars-cov-2 ,expansion:4
sars-cov-2 ,hypothesis:10
expansion ,hypothesis:2
review ,mental:6
review ,china:8
mental ,response:2
response ,china:4
seeding ,brain:2
seeding ,protein:2
seeding ,aggregation:2
seeding ,sars-cov-2:2
seeding ,possible:2
seeding ,long-term:2
seeding ,complication:2
brain ,protein:2
brain ,aggregation:2
brain ,sars-cov-2:14
brain ,possible:4
brain ,long-term:2
brain ,complication:2
protein ,aggregation:2
protein ,possible:2
protein ,long-term:2
protein ,complication:2
aggregation ,sars-cov-2:2
aggregation ,possible:2
aggregation ,long-term:2
aggregation ,complication:2
sars-cov-2 ,long-term:18
sars-cov-2 ,complication:2
possible ,long-term:4
possible ,complication:2
long-term ,complication:4
current ,combat:2
understanding ,potential:6
understanding ,therapeutic:2
understanding ,options:2
understanding ,combat:2
potential ,combat:8
therapeutic ,combat:6
options ,combat:2
combat ,covid-19:16
sars-cov-2 ,retina:2
sars-cov-2 ,host-virus:2
sars-cov-2 ,interaction:34
targeting ,retina:2
targeting ,host-virus:4
targeting ,interaction:4
targeting ,possible:2
targeting ,mechanisms:2
retina ,host-virus:2
retina ,interaction:2
retina ,possible:2
retina ,mechanisms:2
host-virus ,interaction:2
host-virus ,possible:2
host-virus ,mechanisms:2
interaction ,possible:2
interaction ,mechanisms:4
possible ,mechanisms:12
use ,nebulized:2
use ,pharmacotherapies:2
use ,covid-19:50
use ,pandemic:8
nebulized ,pharmacotherapies:2
nebulized ,covid-19:2
nebulized ,pandemic:2
pharmacotherapies ,covid-19:4
pharmacotherapies ,pandemic:2
antiviral ,agent:4
antiviral ,therapy:14
antiviral ,optimization:2
antiviral ,special:2
antiviral ,populations:2
antiviral ,covid-19:28
antiviral ,patients:6
agent ,therapy:2
agent ,optimization:2
agent ,special:2
agent ,populations:2
agent ,covid-19:4
agent ,patients:2
therapy ,optimization:4
therapy ,special:2
therapy ,populations:2
therapy ,patients:50
optimization ,special:2
optimization ,populations:2
optimization ,covid-19:8
optimization ,patients:2
special ,populations:2
special ,covid-19:18
special ,patients:4
populations ,covid-19:8
populations ,patients:2
pathophysiology ,treatment:4
pathophysiology ,strategies:2
treatment ,strategies:26
structural ,sars-cov:4
structural ,antibody:4
structural ,interactions:4
basis ,sars-cov:2
basis ,antibody:4
basis ,interactions:2
sars-cov-2 ,interactions:22
sars-cov ,antibody:6
sars-cov ,interactions:4
antibody ,interactions:2
assessment ,real-time:2
assessment ,rt-pcr:2
assessment ,kits:2
assessment ,detection:10
rt-pcr ,kits:6
kits ,detection:4
effectiveness ,n95:4
effectiveness ,respirator:4
effectiveness ,decontamination:2
effectiveness ,reuse:2
effectiveness ,sars-cov-2:8
effectiveness ,virus:2
n95 ,respirator:6
n95 ,decontamination:8
n95 ,reuse:4
n95 ,sars-cov-2:10
n95 ,virus:2
respirator ,decontamination:2
respirator ,reuse:2
respirator ,sars-cov-2:4
respirator ,virus:2
decontamination ,reuse:2
decontamination ,sars-cov-2:6
decontamination ,virus:2
reuse ,sars-cov-2:2
reuse ,virus:2
leaving ,stone:2
leaving ,unturned:2
leaving ,light:2
leaving ,covid-19:2
leaving ,faecal-oral:2
leaving ,hypothesis:2
leaving ,water:2
stone ,unturned:2
stone ,light:2
stone ,covid-19:2
stone ,faecal-oral:2
stone ,hypothesis:2
stone ,water:2
unturned ,light:2
unturned ,covid-19:2
unturned ,faecal-oral:2
unturned ,hypothesis:2
unturned ,water:2
light ,covid-19:6
light ,faecal-oral:2
light ,hypothesis:2
light ,water:2
covid-19 ,faecal-oral:4
covid-19 ,hypothesis:18
covid-19 ,water:4
faecal-oral ,hypothesis:2
faecal-oral ,water:2
hypothesis ,water:2
proteins ,sars:2
proteins ,cov-2:2
severe ,cov-2:6
acute ,cov-2:4
respiratory ,cov-2:4
syndrome ,cov-2:4
coronavirus-2 ,sars:8
coronavirus-2 ,cov-2:4
sars ,cov-2:32
treatment ,guided:2
treatment ,holistic:2
treatment ,view:4
covid-19 ,guided:4
covid-19 ,holistic:6
covid-19 ,traditional:10
guided ,holistic:2
guided ,view:2
guided ,traditional:2
guided ,chinese:2
holistic ,view:2
holistic ,traditional:2
holistic ,chinese:2
view ,traditional:2
view ,chinese:2
functionalized ,tio2:2
functionalized ,nanotube-based:2
functionalized ,electrochemical:2
functionalized ,biosensor:2
functionalized ,rapid:2
functionalized ,detection:2
tio2 ,nanotube-based:2
tio2 ,electrochemical:2
tio2 ,biosensor:2
tio2 ,rapid:2
tio2 ,detection:2
nanotube-based ,electrochemical:2
nanotube-based ,biosensor:2
nanotube-based ,rapid:2
nanotube-based ,detection:2
electrochemical ,biosensor:2
electrochemical ,rapid:4
electrochemical ,detection:4
biosensor ,rapid:2
biosensor ,detection:6
coronavirus ,19:16
coronavirus ,care:28
disease ,19:16
disease ,implications:8
disease ,dental:6
disease ,care:16
19 ,implications:2
19 ,clinical:4
19 ,dental:2
19 ,care:2
covid-19 ,care:132
implications ,clinical:20
implications ,dental:2
implications ,care:8
clinical ,dental:2
clinical ,care:16
dental ,care:12
sars-cov-2 ,sensitive:6
sars-cov-2 ,pretreatment:2
sensitive ,type:2
sensitive ,interferon:2
sensitive ,pretreatment:2
type ,pretreatment:2
interferon ,pretreatment:2
interactions ,coronaviruses:2
interactions ,ace2:8
interactions ,angiotensin:2
interactions ,ii:2
interactions ,ras:2
interactions ,inhibitors-lessons:2
coronaviruses ,ace2:4
coronaviruses ,angiotensin:2
coronaviruses ,ii:2
coronaviruses ,ras:2
coronaviruses ,inhibitors-lessons:2
ace2 ,angiotensin:10
ace2 ,ii:6
ace2 ,ras:4
ace2 ,inhibitors-lessons:2
angiotensin ,ii:12
angiotensin ,ras:2
angiotensin ,inhibitors-lessons:2
ii ,ras:2
ii ,inhibitors-lessons:2
ras ,inhibitors-lessons:2
covid-19 ,hopes:4
covid-19 ,proteomics:6
covid-19 ,multiomics:2
pandemic ,hopes:2
pandemic ,proteomics:2
pandemic ,multiomics:2
pandemic ,research:14
hopes ,proteomics:2
hopes ,multiomics:2
hopes ,research:2
proteomics ,multiomics:2
proteomics ,research:4
multiomics ,research:2
clinical ,zhejiang:2
clinical ,province:4
characteristics ,pneumonia:22
characteristics ,zhejiang:2
characteristics ,province:4
novel ,zhejiang:2
novel ,province:2
coronavirus ,zhejiang:2
coronavirus ,province:8
pneumonia ,zhejiang:2
pneumonia ,province:2
transmission ,protective:4
transmission ,measures:6
transmission ,clinics:2
routes ,sars-cov-2:18
routes ,protective:2
routes ,measures:2
routes ,clinics:2
sars-cov-2 ,protective:16
sars-cov-2 ,clinics:2
protective ,dental:2
protective ,clinics:2
measures ,dental:4
measures ,clinics:2
dental ,clinics:2
concentration ,infectious:2
concentration ,sars-cov-2:2
concentration ,polyethylene:2
concentration ,glycol:2
concentration ,precipitation:2
infectious ,polyethylene:2
infectious ,glycol:2
infectious ,precipitation:2
sars-cov-2 ,polyethylene:2
sars-cov-2 ,glycol:2
sars-cov-2 ,precipitation:2
polyethylene ,glycol:2
polyethylene ,precipitation:2
glycol ,precipitation:2
multicenter ,evaluation:8
multicenter ,two:2
multicenter ,chemiluminescence:2
multicenter ,three:2
multicenter ,lateral:2
multicenter ,flow:2
multicenter ,immunoassays:2
evaluation ,two:8
evaluation ,chemiluminescence:2
evaluation ,three:14
evaluation ,lateral:10
evaluation ,flow:10
evaluation ,immunoassays:4
two ,chemiluminescence:2
two ,three:4
two ,lateral:6
two ,flow:6
two ,immunoassays:6
chemiluminescence ,three:2
chemiluminescence ,lateral:2
chemiluminescence ,flow:2
chemiluminescence ,immunoassays:2
three ,lateral:4
three ,flow:4
three ,immunoassays:4
covid-19 ,lombardy:10
covid-19 ,wave:8
lombardy ,testing:2
lombardy ,impact:2
lombardy ,first:2
lombardy ,wave:2
lombardy ,pandemic:2
testing ,impact:2
testing ,first:4
testing ,wave:2
impact ,first:2
impact ,wave:2
first ,wave:8
first ,pandemic:10
wave ,pandemic:2
sociodemographic ,predictors:2
sociodemographic ,sars-cov-2:2
sociodemographic ,infection:2
sociodemographic ,obstetric:2
sociodemographic ,patients:2
sociodemographic ,georgia:2
predictors ,sars-cov-2:6
predictors ,infection:4
predictors ,obstetric:2
predictors ,georgia:2
sars-cov-2 ,obstetric:8
sars-cov-2 ,georgia:4
infection ,obstetric:2
infection ,georgia:2
obstetric ,patients:6
obstetric ,georgia:2
patients ,georgia:2
six ,cases:2
six ,acute:2
six ,pulmonary:2
six ,embolism:2
six ,associated:2
six ,covid-19:4
cases ,acute:10
cases ,pulmonary:4
cases ,embolism:4
cases ,associated:4
acute ,pulmonary:16
acute ,embolism:10
pulmonary ,embolism:22
pulmonary ,associated:10
pulmonary ,covid-19:54
embolism ,associated:2
embolism ,covid-19:16
interferon--1a ,inhibition:2
interferon--1a ,severe:2
interferon--1a ,acute:2
interferon--1a ,respiratory:2
interferon--1a ,syndrome-coronavirus:2
inhibition ,severe:2
inhibition ,acute:2
inhibition ,respiratory:2
inhibition ,syndrome-coronavirus:2
severe ,syndrome-coronavirus:6
acute ,syndrome-coronavirus:6
respiratory ,syndrome-coronavirus:6
prolonged ,persistence:6
prolonged ,rna:6
prolonged ,body:2
prolonged ,fluids:2
persistence ,rna:10
persistence ,body:2
persistence ,fluids:2
sars-cov-2 ,body:8
sars-cov-2 ,fluids:2
rna ,body:2
rna ,fluids:2
body ,fluids:4
asymptomatic ,can:2
asymptomatic ,contaminate:2
asymptomatic ,surroundings:2
asymptomatic ,environment:2
covid-19 ,contaminate:2
covid-19 ,surroundings:2
patients ,can:14
patients ,contaminate:2
patients ,surroundings:2
patients ,environment:4
can ,contaminate:2
can ,surroundings:2
can ,environment:2
contaminate ,surroundings:2
contaminate ,environment:2
surroundings ,environment:2
handling ,outbreak:2
handling ,unknown:2
handling ,pathogen:2
handling ,wuhan:2
handling ,preparedness:2
outbreak ,unknown:2
outbreak ,pathogen:2
outbreak ,wuhan:6
outbreak ,preparedness:2
unknown ,pathogen:2
unknown ,wuhan:2
unknown ,preparedness:2
pathogen ,wuhan:2
pathogen ,preparedness:2
wuhan ,preparedness:2
effect ,tuberculosis:2
effect ,notification:2
effect ,south:2
effect ,korea:2
covid-19 ,tuberculosis:20
covid-19 ,notification:2
covid-19 ,korea:8
tuberculosis ,notification:2
tuberculosis ,south:2
tuberculosis ,korea:2
notification ,south:2
notification ,korea:2
south ,korea:12
diagnostic ,tools:2
diagnostic ,comparing:4
diagnostic ,ct:2
diagnostic ,rt-pcr:6
diagnostic ,viral:4
tools ,coronavirus:2
tools ,disease:4
tools ,comparing:2
tools ,ct:2
tools ,rt-pcr:2
tools ,viral:4
coronavirus ,comparing:2
disease ,comparing:2
disease ,ct:30
disease ,rt-pcr:4
disease ,viral:16
covid-19 ,comparing:4
covid-19 ,ct:54
covid-19 ,rt-pcr:24
comparing ,ct:2
comparing ,rt-pcr:2
comparing ,viral:2
ct ,rt-pcr:2
ct ,viral:2
rt-pcr ,viral:4
main ,routes:2
main ,entry:2
main ,genomic:2
main ,diversity:2
main ,uganda:2
routes ,entry:2
routes ,genomic:4
routes ,diversity:2
routes ,uganda:2
entry ,genomic:2
entry ,diversity:2
entry ,sars-cov-2:42
entry ,uganda:2
genomic ,diversity:6
genomic ,uganda:2
diversity ,sars-cov-2:14
diversity ,uganda:2
sars-cov-2 ,uganda:2
sars-cov-2 ,detectable:10
sars-cov-2 ,vaginal:2
sars-cov-2 ,fluid:12
detectable ,vaginal:2
detectable ,fluid:2
detectable ,women:2
detectable ,severe:6
detectable ,covid-19:2
vaginal ,fluid:2
vaginal ,women:6
vaginal ,severe:2
vaginal ,covid-19:4
fluid ,women:4
fluid ,severe:4
fluid ,covid-19:4
drive-through ,testing:4
drive-through ,covid-19:4
drive-through ,experience:2
drive-through ,nhs:2
drive-through ,lothian:2
testing ,lothian:2
covid-19 ,experience:72
covid-19 ,nhs:4
covid-19 ,lothian:2
experience ,nhs:4
experience ,lothian:2
nhs ,lothian:2
potential ,jaktinib:2
potential ,hydrochloride:2
potential ,treat:8
potential ,cytokine:8
potential ,storms:2
potential ,patients:26
jaktinib ,hydrochloride:2
jaktinib ,treat:2
jaktinib ,cytokine:2
jaktinib ,storms:2
jaktinib ,patients:2
hydrochloride ,treat:2
hydrochloride ,cytokine:2
hydrochloride ,storms:2
hydrochloride ,patients:2
treat ,cytokine:2
treat ,storms:2
treat ,patients:8
cytokine ,storms:4
storms ,patients:2
liver ,injury:22
liver ,highly:2
liver ,pathogenic:2
liver ,human:2
liver ,coronavirus:20
liver ,infections:2
injury ,highly:2
injury ,pathogenic:4
injury ,human:4
injury ,coronavirus:16
injury ,infections:2
highly ,human:8
highly ,coronavirus:6
highly ,infections:2
pathogenic ,human:8
pathogenic ,coronavirus:6
pathogenic ,infections:4
neurological ,patients:14
neurological ,potential:14
neurological ,routes:4
manifestations ,potential:6
manifestations ,routes:2
patients ,routes:4
covid-19 ,routes:6
potential ,routes:4
antibody ,weeks:2
antibody ,postinfection:2
antibody ,asymptomatic:6
antibody ,patients:24
responses ,weeks:2
responses ,postinfection:2
responses ,asymptomatic:4
responses ,patients:18
sars-cov-2 ,weeks:2
sars-cov-2 ,postinfection:2
weeks ,postinfection:2
weeks ,asymptomatic:2
weeks ,patients:2
postinfection ,asymptomatic:2
postinfection ,patients:2
brainstem ,dysfunction:2
brainstem ,sars-cov-2:2
brainstem ,infection:2
brainstem ,can:2
brainstem ,potential:2
brainstem ,cause:2
dysfunction ,sars-cov-2:12
dysfunction ,infection:8
dysfunction ,can:2
dysfunction ,potential:2
dysfunction ,cause:2
sars-cov-2 ,cause:18
infection ,can:10
infection ,potential:28
infection ,cause:12
can ,potential:4
can ,cause:8
potential ,cause:2
peripheral ,neuropathy:2
peripheral ,myopathy:2
peripheral ,associated:2
peripheral ,severe:2
peripheral ,acute:2
peripheral ,respiratory:2
neuropathy ,myopathy:2
neuropathy ,associated:2
neuropathy ,severe:2
neuropathy ,acute:4
neuropathy ,respiratory:2
myopathy ,associated:2
myopathy ,severe:2
myopathy ,acute:2
myopathy ,respiratory:2
application ,convalescent:2
application ,plasma:2
application ,therapy:2
application ,novel:2
application ,coronavirus:4
application ,infection:4
convalescent ,therapy:14
convalescent ,novel:2
convalescent ,coronavirus:10
convalescent ,infection:8
plasma ,therapy:16
plasma ,novel:2
plasma ,coronavirus:16
plasma ,infection:10
therapy ,novel:12
therapy ,coronavirus:32
therapy ,infection:16
estimation ,coronavirus:8
estimation ,disease:4
estimation ,case-fatality:2
estimation ,risk:4
estimation ,real:2
estimation ,time:2
coronavirus ,case-fatality:2
coronavirus ,real:2
coronavirus ,time:14
disease ,case-fatality:2
disease ,risk:36
disease ,real:2
disease ,time:14
case-fatality ,risk:4
case-fatality ,real:2
case-fatality ,time:4
risk ,real:2
risk ,time:10
asymptomatic ,nursing:2
asymptomatic ,homes:2
asymptomatic ,barcelona:2
asymptomatic ,spain:2
asymptomatic ,april:2
sars-cov-2 ,nursing:8
sars-cov-2 ,homes:6
sars-cov-2 ,barcelona:2
sars-cov-2 ,spain:14
sars-cov-2 ,april:8
infection ,nursing:2
infection ,homes:4
infection ,barcelona:2
infection ,spain:6
infection ,april:4
nursing ,homes:10
nursing ,barcelona:2
nursing ,spain:2
nursing ,april:2
homes ,barcelona:2
homes ,spain:2
homes ,april:2
barcelona ,spain:4
barcelona ,april:2
spain ,april:2
seroprevalence ,sars-cov-2-specific:4
seroprevalence ,antibodies:14
seroprevalence ,faroe:2
seroprevalence ,islands:2
sars-cov-2-specific ,antibodies:6
sars-cov-2-specific ,faroe:2
sars-cov-2-specific ,islands:2
antibodies ,faroe:2
antibodies ,islands:2
faroe ,islands:2
ace2 ,polymorphism:2
ace2 ,susceptibility:8
ace2 ,hypertension:2
ace2 ,multi-organ:2
receptor ,polymorphism:2
receptor ,susceptibility:2
receptor ,hypertension:2
receptor ,multi-organ:2
polymorphism ,susceptibility:2
polymorphism ,sars-cov-2:2
polymorphism ,hypertension:2
polymorphism ,multi-organ:2
susceptibility ,hypertension:2
susceptibility ,multi-organ:2
sars-cov-2 ,multi-organ:2
hypertension ,multi-organ:2
lung ,lesions:2
lung ,severe:4
lung ,anatomoclinical:2
lung ,confrontation:2
lesions ,severe:2
lesions ,covid-19:16
lesions ,anatomoclinical:2
lesions ,confrontation:2
severe ,anatomoclinical:2
severe ,confrontation:2
covid-19 ,anatomoclinical:2
covid-19 ,confrontation:2
anatomoclinical ,confrontation:2
zoonotic ,origins:8
zoonotic ,human:6
zoonotic ,hcov-19:2
zoonotic ,work:2
origins ,human:6
origins ,coronavirus:4
origins ,hcov-19:2
origins ,sars-cov-2:10
origins ,work:2
human ,hcov-19:2
human ,work:2
coronavirus ,hcov-19:2
coronavirus ,work:4
hcov-19 ,sars-cov-2:2
hcov-19 ,work:2
sars-cov-2 ,work:8
co-infections ,among:2
co-infections ,patients:6
co-infections ,covid-19:4
co-infections ,need:2
co-infections ,combination:2
co-infections ,therapy:2
among ,patients:36
among ,covid-19:84
among ,need:2
among ,combination:2
among ,therapy:2
patients ,need:8
patients ,combination:2
need ,combination:2
need ,therapy:4
sars-cov-2 ,recurrent:6
sars-cov-2 ,positivity:18
recurrent ,rna:2
recurrent ,positivity:2
recurrent ,recovering:2
recurrent ,coronavirus:4
recurrent ,disease:2
rna ,positivity:4
rna ,recovering:2
rna ,disease:6
positivity ,recovering:2
positivity ,coronavirus:2
positivity ,disease:4
recovering ,coronavirus:2
recovering ,disease:2
covid-19-related ,cerebrovascular:2
covid-19-related ,disease:4
covid-19-related ,vasculitis:2
cerebrovascular ,vasculitis:2
disease ,vasculitis:2
covid-19-associated ,neurological:4
covid-19-associated ,disorders:2
covid-19-associated ,potential:2
covid-19-associated ,route:2
covid-19-associated ,cns:2
covid-19-associated ,invasion:2
neurological ,disorders:6
neurological ,route:2
neurological ,cns:4
neurological ,invasion:6
disorders ,potential:6
disorders ,route:2
disorders ,cns:2
disorders ,invasion:2
potential ,cns:2
potential ,invasion:2
route ,cns:2
route ,invasion:2
cns ,invasion:2
review ,remdesivir:16
review ,promising:4
review ,agent:2
remdesivir ,possible:2
remdesivir ,promising:2
remdesivir ,agent:2
remdesivir ,treatment:14
remdesivir ,covid-19:28
possible ,promising:2
possible ,agent:2
possible ,treatment:16
promising ,agent:4
promising ,treatment:14
promising ,covid-19:20
agent ,treatment:2
use ,remdesivir:4
use ,patients:14
use ,review:10
use ,article:2
remdesivir ,patients:6
remdesivir ,article:2
patients ,review:38
patients ,article:2
covid-19 ,article:14
review ,article:12
role ,quercetin:2
quercetin ,coronavirus:2
quercetin ,disease:2
quercetin ,covid-19:2
testing ,wastewater:2
testing ,detect:2
testing ,severe:18
testing ,acute:18
testing ,respiratory:18
testing ,syndrome:8
testing ,coronavirus:24
wastewater ,detect:2
wastewater ,severe:2
wastewater ,acute:2
wastewater ,respiratory:2
wastewater ,syndrome:2
wastewater ,coronavirus:4
detect ,severe:4
detect ,acute:2
detect ,respiratory:4
detect ,syndrome:2
detect ,coronavirus:2
deadly ,coronaviruses:2
deadly ,2003:2
deadly ,sars:2
deadly ,pandemic:2
deadly ,novel:2
deadly ,coronavirus:2
coronaviruses ,2003:2
coronaviruses ,sars:6
2003 ,sars:2
2003 ,pandemic:2
2003 ,novel:2
2003 ,coronavirus:4
sars ,pandemic:2
zoonotic ,ensure:2
zoonotic ,survival:2
zoonotic ,disease:4
origins ,ensure:2
origins ,survival:2
origins ,disease:2
sars-cov-2 ,ensure:2
sars-cov-2 ,survival:8
ensure ,survival:2
ensure ,human:2
ensure ,disease:2
survival ,human:2
survival ,disease:2
human ,disease:6
can ,dentistry:2
can ,get:2
can ,back:2
can ,work:2
can ,safely:2
dentistry ,get:2
dentistry ,back:2
dentistry ,work:2
dentistry ,safely:2
get ,back:2
get ,work:2
get ,safely:2
back ,work:2
back ,safely:2
work ,safely:2
response ,commentary:2
response ,neuroinvasive:2
response ,potential:6
response ,may:2
response ,play:2
commentary ,neuroinvasive:2
commentary ,potential:2
commentary ,sars-cov-2:2
commentary ,may:2
commentary ,play:2
commentary ,role:2
neuroinvasive ,sars-cov-2:8
sars-cov-2 ,may:26
sars-cov-2 ,play:6
relative ,bradycardia:2
relative ,patients:2
relative ,mild-to-moderate:2
relative ,coronavirus:2
relative ,disease:2
relative ,japan:2
bradycardia ,patients:2
bradycardia ,mild-to-moderate:2
bradycardia ,coronavirus:2
bradycardia ,disease:2
bradycardia ,japan:2
patients ,mild-to-moderate:2
patients ,disease:156
patients ,japan:6
mild-to-moderate ,coronavirus:2
mild-to-moderate ,disease:2
mild-to-moderate ,japan:2
coronavirus ,japan:8
disease ,japan:6
covert ,pathways:2
covert ,cranial:2
covert ,cavity:2
covert ,potential:2
covert ,routes:2
covert ,sars-cov-2:2
pathways ,cranial:2
pathways ,cavity:2
pathways ,potential:8
pathways ,routes:2
cranial ,cavity:2
cranial ,potential:2
cranial ,routes:2
cranial ,sars-cov-2:2
cavity ,potential:2
cavity ,routes:2
cavity ,sars-cov-2:4
prevalence ,rate:2
prevalence ,anti-sars-cov-2-igg:2
prevalence ,12:2
prevalence ,screening:2
prevalence ,asymptomatic:16
rate ,anti-sars-cov-2-igg:2
rate ,12:2
rate ,screening:2
rate ,asymptomatic:4
anti-sars-cov-2-igg ,12:2
anti-sars-cov-2-igg ,screening:2
anti-sars-cov-2-igg ,asymptomatic:2
12 ,screening:2
12 ,asymptomatic:2
screening ,asymptomatic:2
genome ,isolates:4
genome ,occurring:2
genome ,india:2
genome ,present:2
genome ,scenario:2
analysis ,isolates:4
analysis ,occurring:2
analysis ,india:6
analysis ,present:2
analysis ,scenario:2
sars-cov-2 ,isolates:10
sars-cov-2 ,occurring:2
sars-cov-2 ,india:24
sars-cov-2 ,present:10
sars-cov-2 ,scenario:2
isolates ,occurring:2
isolates ,india:2
isolates ,present:2
isolates ,scenario:2
occurring ,india:2
occurring ,present:2
occurring ,scenario:2
india ,present:2
india ,scenario:2
present ,scenario:2
probable ,pangolin:2
probable ,sars-cov-2:4
probable ,covid-19:6
pangolin ,origin:2
pangolin ,sars-cov-2:4
pangolin ,associated:2
pangolin ,covid-19:4
pangolin ,outbreak:2
revealing ,targets:2
revealing ,mechanisms:2
revealing ,vitamin:2
revealing ,treatment:2
revealing ,covid-19:4
targets ,mechanisms:2
targets ,vitamin:2
targets ,treatment:6
mechanisms ,vitamin:2
mechanisms ,treatment:6
vitamin ,treatment:4
vitamin ,covid-19:24
sars-cov-2 ,subgenomic:2
sars-cov-2 ,specimens:36
virus ,culture:2
virus ,subgenomic:2
virus ,rna:8
virus ,respiratory:18
virus ,specimens:2
virus ,patients:18
culture ,subgenomic:2
culture ,rna:4
culture ,respiratory:2
culture ,specimens:2
culture ,patients:2
subgenomic ,rna:2
subgenomic ,respiratory:2
subgenomic ,specimens:2
subgenomic ,patients:2
rna ,specimens:14
respiratory ,specimens:8
respiratory ,patients:28
specimens ,patients:10
leon ,fredericq:2
leon ,foundation:2
leon ,covid-19:2
leon ,liege:2
fredericq ,foundation:2
fredericq ,covid-19:2
fredericq ,liege:2
foundation ,covid-19:2
foundation ,liege:2
covid-19 ,liege:2
covid-19 ,deep:14
covid-19 ,models:24
covid-19 ,exploit:2
covid-19 ,mimic:2
detection ,deep:6
detection ,learning:6
detection ,models:2
detection ,exploit:2
detection ,social:2
detection ,mimic:2
detection ,optimization:6
using ,deep:6
using ,learning:8
using ,models:4
using ,exploit:2
using ,social:2
using ,mimic:2
using ,optimization:2
deep ,learning:12
deep ,models:6
deep ,exploit:2
deep ,social:2
deep ,mimic:2
deep ,optimization:2
learning ,models:6
learning ,exploit:2
learning ,social:2
learning ,mimic:2
learning ,optimization:2
models ,exploit:2
models ,social:2
models ,mimic:2
models ,optimization:2
exploit ,social:2
exploit ,mimic:2
exploit ,optimization:2
social ,mimic:2
social ,optimization:2
mimic ,optimization:2
case-fatality ,estimates:2
case-fatality ,covid-19:4
case-fatality ,calculated:2
case-fatality ,using:2
case-fatality ,lag:2
risk ,estimates:6
risk ,calculated:2
risk ,using:6
risk ,lag:2
estimates ,covid-19:4
estimates ,calculated:2
estimates ,using:2
estimates ,lag:2
estimates ,time:2
covid-19 ,calculated:2
covid-19 ,lag:2
calculated ,using:2
calculated ,lag:2
calculated ,time:2
using ,lag:2
lag ,time:2
covid-19 ,vaccination:22
progress ,diagnostics:2
progress ,therapy:2
progress ,vaccination:2
diagnostics ,therapy:2
diagnostics ,vaccination:2
therapy ,vaccination:2
neurological ,aspects:4
neurological ,pandemic:8
neurological ,caused:2
neurological ,sars-cov-2:32
aspects ,pandemic:6
aspects ,caused:2
aspects ,sars-cov-2:12
overview ,first:2
overview ,months:4
overview ,pharmacotherapy:2
first ,months:8
first ,clinical:6
first ,trials:4
first ,pharmacotherapy:2
months ,clinical:2
months ,trials:2
months ,covid-19:12
months ,pharmacotherapy:2
clinical ,pharmacotherapy:2
trials ,pharmacotherapy:2
covid-19 ,pharmacotherapy:10
sars-cov-2 ,remarks:2
remarks ,covid-19:2
remarks ,pandemic:2
in-flight ,transmission:4
in-flight ,sars-cov-2:2
molecular ,current:6
molecular ,situation:2
molecular ,trend:2
molecular ,china:2
molecular ,review:4
diagnosis ,situation:2
diagnosis ,trend:2
diagnosis ,china:2
covid-19 ,situation:14
covid-19 ,trend:10
current ,situation:12
current ,trend:2
current ,china:2
situation ,trend:2
situation ,china:2
situation ,review:2
trend ,china:2
trend ,review:2
covid-19 ,38-day:2
covid-19 ,old:16
covid-19 ,infant:16
cardiac ,involvement:12
cardiac ,38-day:2
cardiac ,old:2
cardiac ,infant:2
involvement ,38-day:2
involvement ,old:2
involvement ,infant:2
38-day ,old:2
38-day ,infant:2
old ,infant:2
recommendation ,diagnosis:4
recommendation ,treatment:2
recommendation ,novel:2
recommendation ,coronavirus:2
recommendation ,infection:2
diagnosis ,treatment:34
diagnosis ,infection:20
unfolding ,covid-19:6
unfolding ,lessons-in-learning:2
unfolding ,ophthalmology:2
covid-19 ,lessons-in-learning:2
lessons-in-learning ,ophthalmology:2
interaction ,raas:2
interaction ,inhibitors:4
interaction ,covid-19:6
interaction ,current:2
interaction ,progress:2
interaction ,perspective:2
raas ,inhibitors:6
raas ,covid-19:8
raas ,current:2
raas ,progress:2
raas ,perspective:2
inhibitors ,current:4
inhibitors ,progress:4
inhibitors ,perspective:2
progress ,perspective:2
asymptomatic ,evacuation:2
asymptomatic ,flight:2
transmission ,evacuation:2
transmission ,flight:6
sars-cov-2 ,evacuation:2
sars-cov-2 ,flight:4
evacuation ,flight:2
coinfection ,sars-cov-2:10
coinfection ,respiratory:2
coinfection ,pathogens:2
coinfection ,patients:4
sars-cov-2 ,pathogens:8
respiratory ,pathogens:10
pathogens ,patients:2
four ,patients:12
four ,tuberculosis:2
four ,singapore:2
four ,april-may:2
patients ,tuberculosis:4
patients ,singapore:2
patients ,april-may:2
covid-19 ,singapore:16
covid-19 ,april-may:2
tuberculosis ,singapore:2
tuberculosis ,april-may:2
singapore ,april-may:2
identification ,antiviral:2
identification ,candidates:2
identification ,fda-approved:2
antiviral ,candidates:4
antiviral ,fda-approved:4
drug ,candidates:12
drug ,fda-approved:6
candidates ,sars-cov-2:14
candidates ,fda-approved:2
sars-cov-2 ,fda-approved:8
seroepidemiologic ,study:2
seroepidemiologic ,designs:2
seroepidemiologic ,determining:2
seroepidemiologic ,sars-cov-2:2
seroepidemiologic ,transmission:2
study ,designs:2
study ,determining:2
study ,sars-cov-2:74
designs ,determining:2
designs ,sars-cov-2:2
designs ,transmission:2
determining ,sars-cov-2:4
determining ,transmission:2
facing ,sars-cov-2:8
facing ,outbreak:4
facing ,immunotherapy:2
facing ,era:2
sars-cov-2 ,immunotherapy:2
sars-cov-2 ,era:12
outbreak ,immunotherapy:2
outbreak ,era:4
immunotherapy ,era:4
severe ,global:4
severe ,pandemic:4
acute ,global:4
acute ,pandemic:8
respiratory ,global:4
respiratory ,pandemic:4
syndrome ,global:4
syndrome ,pandemic:10
coronavirus-2 ,global:2
coronavirus-2 ,pandemic:2
laboratory ,disease-2019:2
diagnosis ,disease-2019:2
three ,patients:8
three ,covid-19:38
three ,pulmonary:2
three ,tuberculosis:2
three ,wuhan:2
three ,china:2
patients ,pulmonary:14
patients ,wuhan:18
patients ,china:26
pulmonary ,tuberculosis:4
pulmonary ,wuhan:2
pulmonary ,china:2
tuberculosis ,wuhan:2
tuberculosis ,china:2
wuhan ,china:28
pooling ,upper:2
pooling ,respiratory:2
pooling ,specimens:2
pooling ,rapid:2
pooling ,mass:2
pooling ,screening:6
pooling ,covid-19:4
upper ,specimens:2
upper ,rapid:2
upper ,mass:2
upper ,screening:2
respiratory ,mass:6
respiratory ,screening:4
specimens ,rapid:4
specimens ,mass:2
specimens ,screening:2
specimens ,covid-19:12
rapid ,mass:2
rapid ,screening:14
mass ,screening:6
investigation ,serologic:2
investigation ,follow-up:2
investigation ,contacts:2
investigation ,early:2
investigation ,confirmed:2
investigation ,case-patient:2
serologic ,follow-up:2
serologic ,contacts:2
serologic ,early:2
serologic ,confirmed:2
serologic ,case-patient:2
follow-up ,contacts:2
follow-up ,early:2
follow-up ,confirmed:2
follow-up ,case-patient:2
contacts ,early:2
contacts ,confirmed:4
contacts ,case-patient:2
early ,confirmed:2
early ,case-patient:2
confirmed ,case-patient:2
comparison ,seven:6
comparison ,rt-pcr:8
comparison ,kits:4
seven ,commercial:6
seven ,rt-pcr:4
seven ,diagnostic:4
seven ,kits:4
seven ,covid-19:6
commercial ,rt-pcr:4
commercial ,covid-19:12
diagnostic ,kits:6
kits ,covid-19:4
neurological ,systematic:14
neurological ,review:30
neurological ,current:4
neurological ,update:4
manifestations ,systematic:20
manifestations ,current:4
manifestations ,update:10
systematic ,current:10
systematic ,update:6
review ,update:8
biochemical ,dynamics:2
biochemical ,clinical:10
biochemical ,features:2
biochemical ,novel:4
biochemical ,corona:2
biochemical ,virus:2
biochemical ,2019-ncov:4
dynamics ,clinical:4
dynamics ,features:4
dynamics ,novel:4
dynamics ,corona:2
dynamics ,virus:4
dynamics ,2019-ncov:6
clinical ,corona:6
features ,corona:2
features ,virus:2
features ,2019-ncov:4
atrial ,arrhythmias:2
atrial ,patient:4
atrial ,presenting:2
atrial ,coronavirus:4
atrial ,disease-2019:2
atrial ,covid-19:4
arrhythmias ,patient:2
arrhythmias ,presenting:2
arrhythmias ,coronavirus:4
arrhythmias ,disease-2019:2
arrhythmias ,covid-19:4
patient ,presenting:8
patient ,disease-2019:2
presenting ,coronavirus:10
presenting ,disease-2019:2
presenting ,covid-19:42
severe ,among:10
severe ,workers:4
severe ,screened:2
acute ,among:8
acute ,workers:2
acute ,screened:2
respiratory ,among:8
respiratory ,workers:2
respiratory ,screened:2
syndrome ,among:6
syndrome ,workers:2
syndrome ,screened:2
coronavirus ,asymptomatic:16
coronavirus ,workers:14
coronavirus ,screened:2
among ,asymptomatic:8
among ,workers:42
among ,screened:2
asymptomatic ,workers:8
asymptomatic ,screened:2
workers ,screened:2
h1n1 ,2019-ncov:2
h1n1 ,learn:2
2019-ncov ,learn:2
ingavirin ,might:2
ingavirin ,promising:2
ingavirin ,agent:2
ingavirin ,combat:2
ingavirin ,severe:2
ingavirin ,acute:2
ingavirin ,respiratory:2
ingavirin ,coronavirus:2
might ,promising:2
might ,agent:2
might ,combat:2
might ,severe:4
might ,acute:2
might ,respiratory:2
might ,coronavirus:2
promising ,combat:2
promising ,severe:2
promising ,acute:2
promising ,respiratory:2
promising ,coronavirus:4
agent ,combat:2
agent ,severe:2
agent ,acute:2
agent ,respiratory:2
agent ,coronavirus:2
combat ,severe:6
combat ,acute:6
combat ,respiratory:6
combat ,coronavirus:4
transmission ,dynamics:18
transmission ,evolutionary:2
transmission ,history:4
dynamics ,evolutionary:2
dynamics ,history:4
evolutionary ,history:4
history ,2019-ncov:2
lack ,vertical:2
lack ,transmission:2
lack ,severe:4
lack ,acute:2
lack ,respiratory:2
lack ,syndrome:2
lack ,coronavirus:2
vertical ,coronavirus:6
evolutionary ,relationships:2
evolutionary ,sequence-structure:2
evolutionary ,determinants:2
evolutionary ,human:2
evolutionary ,sars:2
relationships ,sequence-structure:2
relationships ,determinants:2
relationships ,human:2
relationships ,sars:2
sequence-structure ,determinants:2
sequence-structure ,human:2
sequence-structure ,sars:2
determinants ,human:4
determinants ,sars:2
human ,sars:4
covid-19 ,autopsies:8
covid-19 ,oklahoma:2
covid-19 ,usa:10
autopsies ,oklahoma:2
autopsies ,usa:2
oklahoma ,usa:2
urgent ,recommendation:2
urgent ,protective:2
urgent ,measures:2
urgent ,west:2
urgent ,china:2
urgent ,hospital:2
urgent ,medical:2
recommendation ,protective:2
recommendation ,measures:2
recommendation ,west:2
recommendation ,china:2
recommendation ,hospital:2
recommendation ,medical:2
protective ,west:2
protective ,china:2
protective ,hospital:2
protective ,medical:2
measures ,west:2
measures ,china:2
measures ,hospital:4
measures ,medical:2
west ,china:2
west ,hospital:2
west ,medical:2
china ,hospital:2
china ,medical:4
hospital ,medical:4
sars-cov-2 ,neglect:2
sars-cov-2 ,symptoms:26
infection ,neglect:2
infection ,neurological:20
infection ,symptoms:8
neglect ,neurological:2
neglect ,symptoms:2
neurological ,symptoms:10
overview ,potential:2
overview ,therapeutic:4
overview ,agents:2
overview ,treat:2
potential ,agents:12
therapeutic ,agents:12
agents ,treat:4
agents ,covid-19:20
gastrointestinal ,comprehensive:2
gastrointestinal ,review:2
hepatic ,comprehensive:2
hepatic ,review:2
extra-respiratory ,manifestations:2
extra-respiratory ,covid-19:2
can ,levamisole:2
can ,used:4
can ,treatment:2
can ,presenting:2
levamisole ,used:2
levamisole ,treatment:2
levamisole ,covid-19:2
levamisole ,patients:2
levamisole ,presenting:2
used ,treatment:6
used ,covid-19:12
used ,patients:2
used ,presenting:2
treatment ,presenting:2
patients ,presenting:8
testicular ,pain:2
testicular ,unusual:2
testicular ,presentation:2
testicular ,covid-19:2
testicular ,brief:2
testicular ,review:2
testicular ,sars-cov-2:2
pain ,unusual:2
pain ,presentation:2
pain ,covid-19:8
pain ,brief:2
pain ,review:2
pain ,sars-cov-2:2
unusual ,presentation:2
unusual ,covid-19:10
unusual ,brief:2
unusual ,review:2
unusual ,sars-cov-2:2
presentation ,brief:2
presentation ,review:6
presentation ,sars-cov-2:6
placental ,barrier:2
placental ,covid-19:8
barrier ,covid-19:4
suitability ,two:2
suitability ,rapid:2
suitability ,lateral:2
suitability ,flow:2
suitability ,immunochromatographic:2
suitability ,assays:2
suitability ,predicting:2
two ,rapid:8
two ,immunochromatographic:2
two ,assays:12
two ,predicting:2
rapid ,lateral:14
rapid ,flow:14
rapid ,assays:14
rapid ,predicting:2
lateral ,immunochromatographic:2
lateral ,assays:4
lateral ,predicting:2
flow ,immunochromatographic:2
flow ,assays:4
flow ,predicting:2
immunochromatographic ,assays:2
immunochromatographic ,predicting:2
assays ,predicting:2
covid-19-associated ,coagulopathy:6
animal ,comprehensive:4
animal ,literature:2
animal ,review:8
models ,comprehensive:4
models ,literature:2
models ,review:8
research ,comprehensive:2
research ,review:4
comprehensive ,literature:6
clostridioides ,difficile:2
clostridioides ,covid-19:2
clostridioides ,patients:2
clostridioides ,detroit:2
clostridioides ,michigan:2
clostridioides ,usa:2
clostridioides ,march-april:2
difficile ,covid-19:2
difficile ,patients:2
difficile ,detroit:2
difficile ,michigan:2
difficile ,usa:2
difficile ,march-april:2
covid-19 ,detroit:2
covid-19 ,michigan:2
patients ,detroit:2
patients ,michigan:2
patients ,usa:2
patients ,march-april:2
detroit ,michigan:2
detroit ,usa:2
detroit ,march-april:2
michigan ,usa:2
michigan ,march-april:2
usa ,march-april:2
clinical ,validation:8
clinical ,performance:12
clinical ,automated:10
clinical ,vitros:2
clinical ,total:2
validation ,performance:4
validation ,evaluation:4
validation ,automated:2
validation ,vitros:2
validation ,total:2
performance ,evaluation:12
performance ,automated:8
performance ,vitros:2
performance ,total:2
evaluation ,vitros:2
evaluation ,total:2
automated ,vitros:2
automated ,total:2
vitros ,total:2
vasculopathy ,coagulopathy:2
vasculopathy ,associated:2
vasculopathy ,sars-cov-2:4
vasculopathy ,infection:2
coagulopathy ,associated:2
coagulopathy ,sars-cov-2:4
coagulopathy ,infection:4
guillain-barr ,leptomeningeal:2
guillain-barr ,enhancement:2
guillain-barr ,following:2
syndrome ,leptomeningeal:2
syndrome ,enhancement:2
syndrome ,following:2
associated ,leptomeningeal:2
associated ,enhancement:2
associated ,following:2
leptomeningeal ,enhancement:2
leptomeningeal ,following:2
enhancement ,following:2
face ,masks:14
face ,worn:2
face ,contain:2
face ,spread:2
face ,postlockdown:2
masks ,worn:2
masks ,contain:2
masks ,covid-19:6
masks ,postlockdown:2
worn ,contain:2
worn ,spread:2
worn ,covid-19:2
worn ,postlockdown:2
contain ,spread:2
contain ,covid-19:2
contain ,postlockdown:2
spread ,postlockdown:2
covid-19 ,postlockdown:2
characteristics ,asymptomatic:10
characteristics ,jinan:2
asymptomatic ,jinan:2
patients ,jinan:2
sars-cov-2 ,jinan:2
infection ,jinan:2
infection ,china:10
jinan ,china:2
ocular ,involvement:4
ocular ,coronavirus:12
ocular ,disease:10
ocular ,molecular:2
involvement ,clinical:4
involvement ,molecular:2
disease ,molecular:8
preliminary ,prediction:2
preliminary ,basic:4
preliminary ,reproduction:4
preliminary ,number:4
preliminary ,wuhan:2
preliminary ,novel:6
prediction ,basic:2
prediction ,reproduction:2
prediction ,number:2
prediction ,wuhan:2
basic ,reproduction:6
basic ,number:8
basic ,wuhan:4
basic ,novel:6
reproduction ,number:10
reproduction ,wuhan:4
reproduction ,novel:4
number ,wuhan:4
number ,novel:6
pandemic ,liver:8
pandemic ,transplantation:8
impact ,liver:6
impact ,disease:22
impact ,transplantation:2
liver ,disease:28
disease ,transplantation:6
risk ,transportation:2
risk ,wuhan:2
risk ,cities:2
transportation ,coronavirus:2
transportation ,disease:2
transportation ,wuhan:2
transportation ,cities:2
transportation ,china:2
coronavirus ,cities:2
disease ,wuhan:6
disease ,cities:2
disease ,china:20
wuhan ,cities:2
cities ,china:4
positive ,effects:4
positive ,covid-19:44
positive ,control:4
positive ,measures:4
positive ,influenza:2
positive ,prevention:4
effects ,control:4
effects ,influenza:2
covid-19 ,control:56
covid-19 ,influenza:24
control ,measures:24
control ,influenza:6
measures ,influenza:6
influenza ,prevention:2
effortful ,speech:2
effortful ,distortion:2
effortful ,prosody:2
effortful ,following:2
effortful ,sars-cov-2:2
effortful ,infection:2
speech ,distortion:2
speech ,prosody:2
speech ,following:2
speech ,sars-cov-2:2
speech ,infection:2
distortion ,prosody:2
distortion ,following:2
distortion ,sars-cov-2:2
distortion ,infection:2
prosody ,following:2
prosody ,sars-cov-2:2
prosody ,infection:2
following ,sars-cov-2:24
following ,infection:14
pre-existing ,cerebrovascular:2
pre-existing ,disease:2
pre-existing ,poor:2
pre-existing ,outcomes:4
pre-existing ,covid-19:8
pre-existing ,hospitalized:2
cerebrovascular ,poor:2
cerebrovascular ,outcomes:2
cerebrovascular ,hospitalized:2
disease ,poor:2
disease ,outcomes:16
disease ,hospitalized:12
poor ,outcomes:8
poor ,covid-19:10
poor ,hospitalized:2
outcomes ,hospitalized:20
covid-19 ,hospitalized:30
special ,controlscreening:2
special ,novel:4
special ,coronavirus:4
epidemic ,controlscreening:2
prevention ,controlscreening:2
prevention ,novel:4
prevention ,coronavirus:30
controlscreening ,novel:2
controlscreening ,coronavirus:2
immune ,privilege:2
immune ,result:2
immune ,recovered:2
immune ,patients:20
immune ,testing:2
immune ,positive:4
privilege ,result:2
privilege ,recovered:2
privilege ,patients:2
privilege ,testing:2
privilege ,positive:2
privilege ,covid-19:2
result ,recovered:2
result ,patients:2
result ,testing:2
result ,positive:2
result ,covid-19:2
recovered ,patients:20
recovered ,testing:2
recovered ,positive:8
patients ,testing:18
patients ,positive:32
testing ,positive:10
covid-19 ,urban:4
covid-19 ,unit:10
outbreak ,urban:2
outbreak ,hemodialysis:2
outbreak ,unit:4
urban ,hemodialysis:2
urban ,unit:2
hemodialysis ,unit:2
lower ,levels:4
lower ,vitamin:2
lower ,associated:4
lower ,sars-cov-2:10
lower ,infection:2
lower ,mortality:2
levels ,vitamin:4
levels ,associated:8
levels ,sars-cov-2:12
levels ,infection:6
levels ,mortality:6
vitamin ,associated:4
vitamin ,sars-cov-2:4
vitamin ,infection:10
vitamin ,mortality:2
value ,viral:2
value ,nucleic:2
value ,acid:2
value ,sputum:2
value ,feces:2
value ,specific:2
value ,igmigg:2
value ,serum:4
viral ,feces:6
viral ,specific:2
viral ,igmigg:2
viral ,serum:10
nucleic ,feces:2
nucleic ,specific:2
nucleic ,igmigg:2
nucleic ,serum:2
acid ,feces:2
acid ,specific:2
acid ,igmigg:2
acid ,serum:2
sputum ,feces:2
sputum ,specific:2
sputum ,igmigg:2
sputum ,serum:2
feces ,specific:2
feces ,igmigg:2
feces ,serum:2
specific ,igmigg:2
specific ,serum:4
igmigg ,serum:4
strategy ,pharmaceutical:2
strategy ,care:2
strategy ,services:2
strategy ,clinical:2
strategy ,chinese:4
strategy ,pharmacists:2
pharmaceutical ,care:2
pharmaceutical ,services:2
pharmaceutical ,clinical:2
pharmaceutical ,chinese:2
pharmaceutical ,pharmacists:2
care ,services:6
care ,chinese:2
care ,pharmacists:2
services ,clinical:2
services ,chinese:2
services ,pharmacists:2
clinical ,chinese:8
clinical ,pharmacists:2
chinese ,pharmacists:2
molecular ,targets:8
molecular ,testing:12
targets ,testing:2
covid-19 ,isothermal:2
covid-19 ,amplification:4
infection ,impact:16
infection ,isothermal:2
infection ,amplification:2
diagnosis ,impact:2
diagnosis ,isothermal:2
diagnosis ,amplification:2
potential ,impact:18
potential ,isothermal:2
potential ,amplification:2
impact ,isothermal:2
impact ,amplification:2
isothermal ,amplification:20
hallmarks ,covid-19:4
hallmarks ,disease:2
sars-cov-2 ,neuropathogenesis:4
respiratory ,neuropathogenesis:2
virus ,role:12
virus ,neuropathogenesis:2
potential ,neuropathogenesis:2
role ,neuropathogenesis:2
sars-cov-2 ,involve:2
can ,involve:2
can ,central:2
can ,nervous:2
can ,system:2
can ,systematic:2
can ,analysis:4
involve ,central:2
involve ,nervous:2
involve ,system:2
involve ,systematic:2
involve ,analysis:2
central ,systematic:4
central ,analysis:4
nervous ,systematic:4
nervous ,analysis:2
system ,systematic:8
system ,analysis:8
systematic ,analysis:4
research ,advances:8
research ,cardiovascular:2
research ,system:2
research ,damage:2
advances ,cardiovascular:2
advances ,system:2
advances ,damage:2
advances ,caused:2
cardiovascular ,damage:2
cardiovascular ,caused:2
system ,damage:2
system ,caused:2
damage ,caused:2
damage ,sars-cov-2:10
respiratory ,ventilator:2
ventilator ,management:2
ventilator ,covid-19:4
infection ,nervous:16
infection ,system:24
nervous ,review:4
nervous ,literature:2
system ,review:18
system ,literature:2
assays ,detect:4
assays ,functional:2
assays ,antibody:10
assays ,responses:2
assays ,block:2
assays ,ace2:2
detect ,functional:2
detect ,antibody:2
detect ,responses:2
detect ,block:2
detect ,ace2:2
functional ,antibody:2
functional ,responses:2
functional ,block:2
functional ,ace2:4
antibody ,block:2
antibody ,ace2:4
responses ,block:2
responses ,ace2:2
block ,ace2:2
kindergartens ,reopening:2
kindergartens ,period:2
kindergartens ,regular:2
kindergartens ,epidemic:2
kindergartens ,prevention:2
kindergartens ,control:2
reopening ,period:2
reopening ,regular:2
reopening ,epidemic:4
reopening ,prevention:2
reopening ,control:2
period ,regular:2
period ,epidemic:4
period ,prevention:2
period ,control:2
regular ,epidemic:2
regular ,prevention:2
regular ,control:2
sensitivity ,antibodies:4
sensitivity ,nucleocapsid:4
sensitivity ,spike:2
sensitivity ,proteins:2
detection ,antibodies:26
detection ,nucleocapsid:6
detection ,proteins:2
antibodies ,nucleocapsid:8
antibodies ,spike:16
antibodies ,proteins:2
nucleocapsid ,spike:8
nucleocapsid ,proteins:4
nucleocapsid ,severe:6
spike ,proteins:14
spike ,severe:12
potential ,africa:2
potential ,going:2
implications ,epidemic:4
implications ,africa:2
implications ,going:2
sars-cov-2 ,epidemic:42
sars-cov-2 ,africa:10
sars-cov-2 ,going:4
epidemic ,africa:2
epidemic ,going:2
africa ,going:2
sars-cov ,covid-19:10
sars-cov ,differences:4
sars-cov ,dermatological:2
sars-cov ,viewpoint:2
mers-cov ,covid-19:4
mers-cov ,differences:2
mers-cov ,dermatological:2
mers-cov ,viewpoint:2
covid-19 ,differences:10
covid-19 ,dermatological:8
covid-19 ,viewpoint:8
differences ,dermatological:2
differences ,viewpoint:2
dermatological ,viewpoint:2
comprehensive ,sars-cov:2
review ,sars-cov:8
animal ,sars-cov:2
models ,coronaviruses:4
models ,sars-cov:2
coronaviruses ,sars-cov:4
combating ,devastating:2
devastating ,covid-19:4
devastating ,drug:2
devastating ,repurposing:2
differences ,antibody:2
differences ,kinetics:2
differences ,functionality:2
differences ,severe:6
differences ,mild:2
antibody ,kinetics:8
antibody ,functionality:2
antibody ,mild:8
kinetics ,functionality:2
kinetics ,mild:4
functionality ,severe:4
functionality ,mild:2
severe ,mild:12
hiv ,points:2
hiv ,consider:2
hiv ,face:2
hiv ,new:6
hiv ,pandemic:6
sars-cov-2 ,points:2
sars-cov-2 ,consider:6
sars-cov-2 ,face:8
points ,consider:2
points ,face:2
points ,new:2
points ,pandemic:2
consider ,face:2
consider ,new:2
consider ,pandemic:4
face ,new:2
face ,pandemic:6
new ,pandemic:18
rapid ,full-genome:2
rapid ,sequencing:4
rapid ,severe:8
sensitive ,full-genome:2
sensitive ,sequencing:2
sensitive ,severe:2
sensitive ,acute:2
sensitive ,respiratory:2
sensitive ,syndrome:2
full-genome ,sequencing:2
full-genome ,severe:2
full-genome ,acute:2
full-genome ,respiratory:2
full-genome ,syndrome:2
sequencing ,severe:2
sequencing ,acute:2
sequencing ,respiratory:4
sequencing ,syndrome:2
visual ,analysis:2
visual ,coronavirus:6
visual ,disease:2
visual ,studies:2
visual ,based:2
analysis ,disease:18
analysis ,studies:4
disease ,studies:4
disease ,based:8
covid-19 ,studies:12
studies ,based:2
potential ,zinc:2
potential ,supplementation:4
impact ,zinc:2
impact ,supplementation:2
zinc ,supplementation:4
zinc ,covid-19:6
zinc ,pathogenesis:2
supplementation ,covid-19:6
supplementation ,pathogenesis:2
recommendations ,normalizing:2
recommendations ,medical:2
recommendations ,practices:2
recommendations ,burn:2
recommendations ,treatment:18
normalizing ,medical:2
normalizing ,practices:2
normalizing ,burn:2
normalizing ,treatment:2
medical ,practices:2
medical ,burn:2
medical ,treatment:6
practices ,burn:2
practices ,treatment:4
burn ,treatment:2
reissuing ,sigma:2
reissuing ,receptors:2
reissuing ,sars-cov-2:2
sigma ,receptors:2
sigma ,sars-cov-2:2
receptors ,sars-cov-2:16
comparison ,commercially:2
comparison ,available:2
commercially ,available:8
commercially ,laboratory-developed:2
commercially ,assays:2
commercially ,vitro:2
available ,laboratory-developed:2
available ,assays:2
available ,vitro:2
laboratory-developed ,assays:2
laboratory-developed ,vitro:2
co-infection ,human:4
co-infection ,metapneumovirus:4
sars-cov-2 ,metapneumovirus:4
human ,metapneumovirus:4
genomic ,characterisation:4
genomic ,epidemiology:8
genomic ,implications:4
characterisation ,epidemiology:2
characterisation ,novel:2
characterisation ,coronavirus:2
characterisation ,implications:2
epidemiology ,coronavirus:16
epidemiology ,implications:2
novel ,implications:6
clinical ,infected:16
characteristics ,radiological:6
characteristics ,features:6
characteristics ,infected:14
radiological ,children:2
radiological ,infected:2
features ,infected:6
endocrine ,aspects:2
endocrine ,ace2:4
endocrine ,regulation:2
endocrine ,raas:2
endocrine ,steroid:2
endocrine ,hormones:2
endocrine ,sars-cov-2:2
aspects ,ace2:2
aspects ,regulation:2
aspects ,raas:2
aspects ,steroid:2
aspects ,hormones:2
ace2 ,regulation:8
ace2 ,raas:2
ace2 ,steroid:2
ace2 ,hormones:2
regulation ,raas:2
regulation ,steroid:2
regulation ,hormones:2
regulation ,sars-cov-2:8
raas ,steroid:2
raas ,hormones:2
raas ,sars-cov-2:4
steroid ,hormones:2
steroid ,sars-cov-2:6
hormones ,sars-cov-2:2
nationwide ,external:2
nationwide ,quality:2
nationwide ,assessment:2
nationwide ,sars-cov-2:8
nationwide ,molecular:2
nationwide ,testing:2
nationwide ,south:2
nationwide ,korea:2
external ,quality:8
external ,assessment:8
external ,sars-cov-2:4
external ,molecular:4
external ,testing:2
external ,south:2
external ,korea:2
quality ,assessment:8
quality ,sars-cov-2:10
quality ,molecular:4
quality ,testing:2
quality ,south:2
quality ,korea:2
assessment ,molecular:6
assessment ,testing:6
assessment ,south:2
assessment ,korea:2
sars-cov-2 ,south:12
molecular ,south:2
molecular ,korea:2
testing ,south:2
testing ,korea:2
molecular ,mechanisms:16
molecular ,epidemiology:6
molecular ,allergists:2
molecular ,perspective:2
mechanisms ,epidemiology:2
mechanisms ,allergists:2
mechanisms ,perspective:4
epidemiology ,allergists:2
epidemiology ,perspective:2
covid-19 ,allergists:2
allergists ,perspective:2
expected ,immune:2
expected ,recognition:2
expected ,covid-19:4
expected ,virus:2
expected ,memory:2
expected ,earlier:2
expected ,infections:2
immune ,recognition:2
immune ,virus:2
immune ,memory:2
immune ,earlier:2
immune ,infections:4
recognition ,virus:2
recognition ,memory:2
recognition ,earlier:2
recognition ,infections:2
covid-19 ,memory:4
covid-19 ,earlier:2
virus ,memory:2
virus ,earlier:2
virus ,infections:10
memory ,earlier:2
memory ,infections:2
earlier ,infections:2
sars-cov-2 ,affect:6
sars-cov-2 ,male:14
sars-cov-2 ,fertility:6
affect ,male:2
affect ,fertility:2
male ,fertility:12
high-dose ,prednisone:2
high-dose ,treatment:4
high-dose ,autoimmune:2
high-dose ,pancreatitis:2
high-dose ,patient:4
prednisone ,treatment:2
prednisone ,autoimmune:2
prednisone ,pancreatitis:2
prednisone ,patient:2
treatment ,autoimmune:4
treatment ,pancreatitis:2
treatment ,patient:18
autoimmune ,pancreatitis:2
autoimmune ,patient:2
pancreatitis ,patient:6
neuroradiologic ,manifestations:2
neuroradiologic ,covid-19:2
neuroradiologic ,emergency:2
neuroradiologic ,radiologist:2
neuroradiologic ,needs:2
manifestations ,emergency:2
manifestations ,radiologist:2
manifestations ,needs:2
covid-19 ,radiologist:4
emergency ,radiologist:2
emergency ,needs:2
radiologist ,needs:2
antibody-dependent ,coronavirus:2
enhancement ,coronavirus:2
dynamics ,humoral:2
dynamics ,immune:6
dynamics ,responses:2
dynamics ,following:2
dynamics ,sars-cov-2:24
dynamics ,infection:8
humoral ,responses:8
humoral ,following:2
humoral ,infection:4
immune ,following:6
immune ,infection:30
responses ,following:4
responses ,infection:18
secondary ,transmission:2
secondary ,disease:4
secondary ,presymptomatic:2
secondary ,persons:2
secondary ,china:2
transmission ,persons:2
coronavirus ,presymptomatic:2
disease ,presymptomatic:2
disease ,persons:6
presymptomatic ,persons:2
persons ,china:2
persistence ,intestinal:2
persistence ,infection:2
persistence ,patients:4
persistence ,leads:2
intestinal ,sars-cov-2:10
intestinal ,infection:10
intestinal ,patients:2
intestinal ,covid-19:2
intestinal ,leads:2
sars-cov-2 ,leads:6
infection ,leads:6
patients ,leads:2
covid-19 ,leads:4
sex-biased ,immune:2
sex-biased ,responses:2
sex-biased ,following:2
sex-biased ,sars-cov-2:2
sex-biased ,infection:2
preparedness ,lessons:2
preparedness ,learned:2
preparedness ,novel:2
preparedness ,coronavirus:4
preparedness ,disease:2
lessons ,disease:2
learned ,disease:2
detection ,retinal:2
detection ,biopsies:2
detection ,deceased:2
sars-cov-2 ,retinal:2
sars-cov-2 ,biopsies:2
sars-cov-2 ,deceased:2
human ,retinal:2
human ,biopsies:2
human ,deceased:2
human ,patients:2
retinal ,biopsies:2
retinal ,deceased:2
retinal ,covid-19:6
retinal ,patients:4
biopsies ,deceased:2
biopsies ,covid-19:4
biopsies ,patients:2
deceased ,covid-19:8
deceased ,patients:2
infant ,mild:2
infant ,sars-cov-2:8
infant ,infection:8
infant ,detected:2
infant ,anal:4
infant ,swabs:2
infant ,case:8
mild ,sars-cov-2:34
mild ,infection:22
mild ,detected:2
mild ,anal:2
mild ,swabs:2
mild ,case:14
sars-cov-2 ,detected:8
sars-cov-2 ,anal:10
infection ,detected:8
infection ,anal:2
infection ,swabs:2
infection ,case:48
detected ,anal:2
detected ,swabs:2
detected ,case:2
anal ,swabs:4
anal ,case:2
swabs ,case:2
evidence ,speculations:2
evidence ,vaccines:2
evidence ,therapeutic:4
evidence ,options:2
evidence ,pandemic:12
speculations ,vaccines:2
speculations ,therapeutic:2
speculations ,options:2
speculations ,covid-19:4
speculations ,pandemic:2
vaccines ,therapeutic:6
vaccines ,options:4
vaccines ,pandemic:4
therapeutic ,pandemic:6
options ,pandemic:2
importance ,anosmia:2
importance ,phenomenology:2
importance ,neurobiology:2
sars-cov-2 ,anosmia:8
sars-cov-2 ,phenomenology:2
sars-cov-2 ,neurobiology:2
anosmia ,phenomenology:2
anosmia ,neurobiology:2
phenomenology ,neurobiology:2
molecular ,proteins:4
molecular ,interactions:2
investigation ,sars-cov-2:12
investigation ,proteins:2
investigation ,interactions:2
investigation ,antiviral:2
sars-cov-2 ,proteins:34
proteins ,interactions:2
proteins ,antiviral:2
interactions ,antiviral:2
covid-19 ,lens:6
covid-19 ,science:20
covid-19 ,painstaking:2
pandemic ,lens:6
pandemic ,science:6
pandemic ,painstaking:2
lens ,science:4
lens ,painstaking:2
lens ,review:2
science ,painstaking:2
science ,review:2
painstaking ,review:2
emotional ,impact:2
emotional ,coronavirus:2
emotional ,2019-ncov:2
emotional ,new:2
emotional ,disease:2
impact ,new:4
covid-19 ,hyperinflammation:6
covid-19 ,neutrophils:4
hyperinflammation ,neutrophils:2
covid-19 ,challenge:16
covid-19 ,modern:2
challenge ,modern:2
challenge ,medicine:4
modern ,medicine:2
sars-cov-2 ,ambiguous:2
sars-cov-2 ,childrenand:2
transmission ,ambiguous:2
transmission ,role:12
transmission ,childrenand:2
transmission ,considerations:2
ambiguous ,role:2
ambiguous ,childrenand:2
ambiguous ,considerations:2
role ,childrenand:2
role ,considerations:2
childrenand ,considerations:2
cluster ,disease:10
cluster ,associated:6
cluster ,fitness:2
cluster ,dance:2
cluster ,classes:2
cluster ,south:2
cluster ,korea:2
coronavirus ,fitness:2
coronavirus ,dance:2
coronavirus ,classes:2
coronavirus ,south:8
coronavirus ,korea:12
disease ,fitness:2
disease ,dance:2
disease ,classes:2
disease ,south:8
disease ,korea:12
associated ,fitness:2
associated ,dance:2
associated ,classes:2
associated ,south:2
associated ,korea:2
fitness ,dance:2
fitness ,classes:2
fitness ,south:2
fitness ,korea:2
dance ,classes:2
dance ,south:2
dance ,korea:2
classes ,south:2
classes ,korea:2
sars-cov-2 ,sepsis:6
sars-cov-2 ,meningoencephalitis:2
viral ,sepsis:4
viral ,meningoencephalitis:2
sepsis ,meningoencephalitis:2
diabetic ,patient:4
diabetic ,2019-ncov:2
diabetic ,covid-19:12
diabetic ,infection:4
diabetic ,recovered:2
patient ,2019-ncov:2
patient ,recovered:4
2019-ncov ,recovered:2
infection ,recovered:2
covid-19 ,fears:2
covid-19 ,italian:34
covid-19 ,senior:2
covid-19 ,citizens:6
fears ,italian:2
fears ,senior:2
fears ,citizens:2
italian ,senior:2
italian ,citizens:4
senior ,citizens:2
subacute ,aspergillosis:2
subacute ,fungal:2
subacute ,balls:2
subacute ,complicating:2
subacute ,covid-19:4
aspergillosis ,fungal:2
aspergillosis ,balls:2
aspergillosis ,complicating:6
aspergillosis ,covid-19:4
fungal ,balls:2
fungal ,complicating:2
fungal ,covid-19:8
balls ,complicating:2
balls ,covid-19:2
complicating ,covid-19:2
seropositivity ,rate:2
seropositivity ,diagnostic:2
seropositivity ,accuracy:2
seropositivity ,serological:2
seropositivity ,tests:2
seropositivity ,2019-ncov:2
seropositivity ,cases:2
rate ,diagnostic:2
rate ,accuracy:2
rate ,serological:2
rate ,tests:2
rate ,2019-ncov:2
rate ,cases:4
diagnostic ,accuracy:12
diagnostic ,serological:12
diagnostic ,tests:22
diagnostic ,cases:4
accuracy ,serological:2
accuracy ,tests:4
accuracy ,2019-ncov:2
accuracy ,cases:2
serological ,tests:18
serological ,cases:2
tests ,2019-ncov:2
tests ,cases:2
hospitalized ,coronavirus:8
insights ,underlying:2
insights ,genomic:2
insights ,data:2
sars-cov-2 ,underlying:8
sars-cov-2 ,data:24
coronavirus ,underlying:2
coronavirus ,data:8
underlying ,covid-19:10
underlying ,recent:2
underlying ,genomic:2
underlying ,data:2
covid-19 ,genomic:8
recent ,genomic:2
recent ,data:2
genomic ,data:2
serum ,cytokine:2
serum ,chemokine:2
serum ,relation:2
serum ,severity:6
serum ,coronavirus:6
cytokine ,chemokine:2
cytokine ,profile:4
cytokine ,relation:2
cytokine ,severity:4
cytokine ,coronavirus:8
chemokine ,profile:2
chemokine ,relation:2
chemokine ,severity:2
chemokine ,coronavirus:2
profile ,relation:2
profile ,severity:4
profile ,coronavirus:4
relation ,severity:4
relation ,coronavirus:4
severity ,coronavirus:10
physiological ,pathological:2
physiological ,regulation:2
physiological ,ace2:2
physiological ,sars-cov-2:2
physiological ,receptor:2
pathological ,regulation:2
pathological ,ace2:2
pathological ,sars-cov-2:4
pathological ,receptor:2
regulation ,receptor:6
familial ,cluster:10
familial ,infection:6
familial ,associated:4
familial ,novel:4
familial ,coronavirus:2
cluster ,infection:12
cluster ,novel:4
prognostic ,value:8
prognostic ,leukocytosis:2
prognostic ,lymphopenia:2
prognostic ,coronavirus:2
prognostic ,disease:2
prognostic ,severity:2
value ,leukocytosis:2
value ,lymphopenia:2
value ,coronavirus:14
value ,disease:8
value ,severity:6
leukocytosis ,lymphopenia:2
leukocytosis ,coronavirus:2
leukocytosis ,disease:2
leukocytosis ,severity:2
lymphopenia ,coronavirus:2
lymphopenia ,disease:2
lymphopenia ,severity:2
disease ,severity:32
molecular ,formalin-fixed:2
molecular ,paraffin-embedded:2
molecular ,specimens:6
detection ,formalin-fixed:6
detection ,paraffin-embedded:6
sars-cov-2 ,formalin-fixed:6
sars-cov-2 ,paraffin-embedded:6
formalin-fixed ,paraffin-embedded:6
formalin-fixed ,specimens:4
paraffin-embedded ,specimens:4
coronavirus ,show:2
pandemic ,show:2
evidence ,show:2
new ,developing:2
new ,diagnostic:4
new ,platforms:2
new ,systematic:2
developing ,diagnostic:2
developing ,platforms:2
developing ,covid-19:2
developing ,systematic:2
developing ,review:2
diagnostic ,platforms:2
diagnostic ,systematic:4
platforms ,covid-19:2
platforms ,systematic:2
platforms ,review:2
potential ,functional:6
potential ,food:4
potential ,components:4
potential ,nutritional:2
inhibitors ,functional:2
inhibitors ,food:2
inhibitors ,components:2
inhibitors ,nutritional:2
sars-cov-2 ,food:4
sars-cov-2 ,nutritional:2
functional ,food:2
functional ,components:2
functional ,nutritional:2
food ,components:2
food ,nutritional:2
components ,nutritional:2
pharmacological ,therapeutics:2
pharmacological ,targeting:4
pharmacological ,rna-dependent:2
pharmacological ,rna:2
pharmacological ,polymerase:2
pharmacological ,proteinase:2
therapeutics ,targeting:2
therapeutics ,rna-dependent:4
therapeutics ,rna:4
therapeutics ,polymerase:4
therapeutics ,proteinase:2
targeting ,rna-dependent:4
targeting ,rna:6
targeting ,polymerase:4
targeting ,proteinase:2
rna-dependent ,proteinase:2
rna ,proteinase:2
polymerase ,proteinase:2
covid-19 ,column:2
covid-19 ,behind:4
covid-19 ,detecting:10
special ,column:2
special ,principles:2
special ,behind:2
special ,technology:2
special ,detecting:2
special ,sars-cov-2:8
column ,principles:2
column ,behind:2
column ,technology:2
column ,detecting:2
column ,sars-cov-2:2
principles ,behind:2
principles ,technology:2
principles ,detecting:2
principles ,sars-cov-2:6
behind ,technology:2
behind ,detecting:2
behind ,sars-cov-2:2
technology ,detecting:2
technology ,sars-cov-2:2
detecting ,sars-cov-2:4
case ,covid:4
case ,19:4
case ,staphylococcus:2
case ,coinfection:12
covid ,staphylococcus:2
covid ,coinfection:2
19 ,staphylococcus:2
19 ,coinfection:2
staphylococcus ,coinfection:2
air ,pollution:30
air ,connect:2
air ,worth:2
air ,weight:2
pollution ,covid-19:26
pollution ,connect:2
pollution ,worth:2
pollution ,weight:2
covid-19 ,connect:2
covid-19 ,worth:2
covid-19 ,weight:4
connect ,worth:2
connect ,weight:2
worth ,weight:2
trends ,mers-cov:2
trends ,sars-cov:2
trends ,sars-cov-2:4
trends ,diagnosis:2
trends ,strategies:2
mers-cov ,diagnosis:2
mers-cov ,strategies:2
sars-cov ,diagnosis:2
sars-cov ,strategies:2
diagnosis ,strategies:4
community ,transmission:6
community ,severe:2
community ,acute:2
community ,respiratory:2
community ,syndrome:2
community ,coronavirus:2
community ,shenzhen:2
transmission ,shenzhen:2
severe ,shenzhen:2
acute ,shenzhen:2
respiratory ,shenzhen:2
syndrome ,shenzhen:2
coronavirus ,shenzhen:4
generation ,recombinant:2
generation ,sars-cov-2:4
generation ,using:2
generation ,bacterial:2
generation ,artificial:2
generation ,chromosome:2
recombinant ,sars-cov-2:2
recombinant ,bacterial:2
recombinant ,artificial:2
recombinant ,chromosome:2
sars-cov-2 ,bacterial:6
sars-cov-2 ,artificial:10
sars-cov-2 ,chromosome:6
using ,bacterial:2
using ,artificial:4
using ,chromosome:2
bacterial ,artificial:4
bacterial ,chromosome:4
artificial ,chromosome:4
possible ,intrauterine:2
possible ,positive:2
possible ,nucleic:2
possible ,acid:2
possible ,testing:2
possible ,results:2
intrauterine ,sars-cov-2:6
intrauterine ,infection:4
intrauterine ,positive:2
intrauterine ,nucleic:2
intrauterine ,acid:2
intrauterine ,testing:2
intrauterine ,results:2
sars-cov-2 ,positive:54
sars-cov-2 ,results:36
infection ,positive:6
infection ,nucleic:2
infection ,acid:6
infection ,testing:8
infection ,results:8
positive ,nucleic:6
positive ,results:6
nucleic ,results:6
acid ,results:6
testing ,results:10
deciphering ,tcr:2
deciphering ,repertoire:2
deciphering ,solve:2
deciphering ,covid-19:6
deciphering ,mystery:2
tcr ,repertoire:2
tcr ,solve:2
tcr ,covid-19:2
tcr ,mystery:2
repertoire ,solve:2
repertoire ,covid-19:2
repertoire ,mystery:2
solve ,covid-19:4
solve ,mystery:2
covid-19 ,mystery:6
approach ,chilblains:2
approach ,pandemic:10
approach ,formula:2
approach ,see:2
approach ,text:2
chilblains ,covid-19:12
chilblains ,pandemic:4
chilblains ,formula:2
chilblains ,see:2
chilblains ,text:2
covid-19 ,formula:2
covid-19 ,see:2
covid-19 ,text:2
pandemic ,formula:2
pandemic ,see:4
pandemic ,text:2
formula ,see:2
formula ,text:2
see ,text:2
comparing ,contrasting:2
comparing ,mers:2
comparing ,sars-cov:4
comparing ,sars-cov-2:10
comparing ,prevention:2
comparing ,transmission:2
contrasting ,mers:2
contrasting ,sars-cov:2
contrasting ,sars-cov-2:2
contrasting ,prevention:2
contrasting ,transmission:2
mers ,sars-cov:2
mers ,sars-cov-2:12
mers ,prevention:2
mers ,transmission:2
sars-cov ,prevention:4
sars-cov ,transmission:4
sars-cov-2 ,prevention:44
prevention ,transmission:12
comprehensive ,coronavirus:12
comprehensive ,disease:10
clinical ,similar:2
clinical ,sars:4
characteristics ,similar:2
characteristics ,sars:2
covid-19 ,similar:6
children ,similar:2
similar ,sars:2
conserved ,high:2
conserved ,free:2
conserved ,energy:2
conserved ,sites:2
conserved ,human:2
conserved ,coronavirus:2
conserved ,spike:2
conserved ,glycoprotein:2
conserved ,backbones:2
high ,free:2
high ,energy:2
high ,sites:2
high ,human:4
high ,coronavirus:6
high ,spike:4
high ,glycoprotein:2
high ,backbones:2
free ,energy:4
free ,sites:2
free ,human:2
free ,coronavirus:2
free ,spike:4
free ,glycoprotein:2
free ,backbones:2
energy ,sites:2
energy ,human:2
energy ,coronavirus:2
energy ,spike:2
energy ,glycoprotein:2
energy ,backbones:2
sites ,human:2
sites ,coronavirus:2
sites ,spike:4
sites ,glycoprotein:2
sites ,backbones:2
human ,spike:16
human ,glycoprotein:2
human ,backbones:2
coronavirus ,backbones:2
spike ,backbones:2
glycoprotein ,backbones:2
aerosol ,environmental:2
aerosol ,monitoring:2
aerosol ,rna:2
aerosol ,designated:2
environmental ,surface:8
environmental ,monitoring:2
environmental ,rna:4
environmental ,designated:4
surface ,monitoring:2
surface ,rna:2
surface ,designated:2
monitoring ,rna:4
monitoring ,designated:2
sars-cov-2 ,designated:6
rna ,designated:2
update ,use:2
update ,chloroquinehydroxychloroquine:2
update ,treat:2
update ,disease:10
use ,chloroquinehydroxychloroquine:2
use ,treat:8
use ,disease:14
chloroquinehydroxychloroquine ,treat:2
chloroquinehydroxychloroquine ,coronavirus:2
chloroquinehydroxychloroquine ,disease:2
sars-cov-2 ,predict:6
sars-cov-2 ,severity:14
antibody ,predict:4
antibody ,covid-19:42
antibody ,disease:14
antibody ,severity:8
responses ,predict:2
responses ,disease:10
responses ,severity:4
predict ,covid-19:8
predict ,disease:2
predict ,severity:4
laboratory ,review:6
laboratory ,methods:6
diagnosis ,methods:4
current ,methods:4
can ,test:2
can ,way:2
can ,pandemic:12
test ,way:2
test ,covid-19:38
test ,pandemic:2
way ,pandemic:6
cross-neutralization ,activity:2
cross-neutralization ,sars-cov-2:6
cross-neutralization ,present:2
cross-neutralization ,currently:2
cross-neutralization ,available:2
activity ,sars-cov-2:20
activity ,present:2
activity ,currently:2
activity ,available:2
sars-cov-2 ,currently:4
sars-cov-2 ,available:10
present ,currently:2
present ,available:2
covid-19 ,craniofacial:2
pandemic ,craniofacial:2
impact ,craniofacial:2
impact ,surgery:12
craniofacial ,surgery:2
central ,targets:2
central ,routes:4
central ,current:2
central ,views:2
central ,new:4
nervous ,targets:2
nervous ,routes:4
nervous ,current:2
nervous ,views:2
nervous ,new:2
system ,targets:2
system ,routes:4
system ,current:2
system ,views:2
system ,new:2
targets ,routes:2
targets ,sars-cov-2:14
targets ,current:4
targets ,views:2
targets ,new:4
routes ,current:2
routes ,views:2
routes ,new:2
sars-cov-2 ,views:2
current ,views:2
current ,new:4
views ,new:2
transmission ,children:12
transmission ,aged:2
transmission ,19:4
transmission ,years:2
transmission ,childcare:2
transmission ,facilities:4
sars-cov-2 ,aged:2
sars-cov-2 ,19:6
sars-cov-2 ,years:2
sars-cov-2 ,childcare:2
sars-cov-2 ,facilities:2
children ,19:4
children ,childcare:2
children ,facilities:2
aged ,19:2
aged ,childcare:2
aged ,facilities:2
19 ,years:2
19 ,childcare:2
19 ,facilities:2
years ,childcare:2
years ,facilities:2
childcare ,facilities:2
selecting ,sars-cov-2covid:2
selecting ,molecular:2
selecting ,testing:2
selecting ,method:2
selecting ,laboratory:2
sars-cov-2covid ,molecular:2
sars-cov-2covid ,testing:2
sars-cov-2covid ,method:2
sars-cov-2covid ,laboratory:2
molecular ,method:2
testing ,method:4
method ,laboratory:2
old ,drugs:6
old ,new:12
old ,virus:2
old ,repurposed:2
old ,approaches:2
old ,combating:2
drugs ,new:4
drugs ,virus:2
drugs ,repurposed:8
drugs ,approaches:2
drugs ,combating:2
new ,repurposed:2
new ,approaches:2
new ,combating:2
virus ,repurposed:2
virus ,combating:2
repurposed ,approaches:2
repurposed ,combating:2
approaches ,combating:2
approaches ,covid-19:22
findings ,probability-based:2
findings ,survey:2
findings ,united:2
findings ,states:2
findings ,households:2
probability-based ,survey:2
probability-based ,united:2
probability-based ,states:2
probability-based ,households:2
survey ,united:2
survey ,states:2
survey ,households:2
united ,households:2
states ,households:2
sars-cov-2 ,restricted:2
sars-cov-2 ,zinc:6
sars-cov-2 ,finger:2
sars-cov-2 ,despite:4
sars-cov-2 ,preadaptation:2
restricted ,zinc:2
restricted ,finger:2
restricted ,antiviral:2
restricted ,protein:2
restricted ,despite:2
restricted ,preadaptation:2
zinc ,finger:2
zinc ,antiviral:2
zinc ,protein:2
zinc ,despite:2
zinc ,preadaptation:2
finger ,antiviral:2
finger ,protein:2
finger ,despite:2
finger ,preadaptation:2
antiviral ,despite:2
antiviral ,preadaptation:2
protein ,despite:2
protein ,preadaptation:2
despite ,preadaptation:2
frontline ,workers:6
frontline ,backrooms:2
frontline ,covid-19:14
workers ,backrooms:2
backrooms ,covid-19:2
role ,comorbidities:4
role ,like:2
role ,diabetes:4
role ,severe:10
role ,acute:6
role ,syndrome:2
comorbidities ,like:2
comorbidities ,diabetes:4
comorbidities ,severe:4
comorbidities ,acute:4
comorbidities ,respiratory:4
comorbidities ,syndrome:2
like ,diabetes:2
like ,severe:2
like ,acute:2
like ,respiratory:2
like ,syndrome:2
diabetes ,severe:2
diabetes ,acute:4
diabetes ,respiratory:2
diabetes ,syndrome:2
novel ,co-infection:2
severe ,co-infection:4
acute ,co-infection:8
respiratory ,co-infection:10
syndrome ,co-infection:6
coronavirus ,co-infection:6
understanding ,impact:2
understanding ,organ:2
understanding ,failure:2
understanding ,risk:4
understanding ,assessment:2
novel ,organ:4
novel ,failure:4
novel ,assessment:4
covid-19 ,organ:10
covid-19 ,failure:26
covid-19 ,assessment:18
impact ,organ:2
impact ,failure:2
impact ,risk:6
impact ,assessment:2
organ ,failure:6
organ ,risk:2
organ ,assessment:2
failure ,risk:2
failure ,assessment:2
risk ,assessment:28
covid-19 ,elusive:2
covid-19 ,enemy:10
outbreak ,elusive:2
outbreak ,enemy:2
elusive ,enemy:2
pandemic ,vaccine:2
pandemic ,development:6
current ,vaccine:8
considerations ,use:2
considerations ,antihypertensive:2
considerations ,blockers:2
considerations ,renin-angiotensin:2
use ,antihypertensive:2
use ,blockers:4
use ,renin-angiotensin:2
antihypertensive ,blockers:2
antihypertensive ,renin-angiotensin:2
blockers ,renin-angiotensin:6
chloroquine ,practice:2
chloroquine ,implications:4
chloroquine ,healthcare:2
hydroxychloroquine ,practice:2
hydroxychloroquine ,implications:4
hydroxychloroquine ,healthcare:4
practice ,implications:4
practice ,healthcare:4
implications ,healthcare:2
severe ,seroprevalence:4
acute ,seroprevalence:6
respiratory ,seroprevalence:4
syndrome ,seroprevalence:4
coronavirus ,seroprevalence:4
prevalence ,seroprevalence:2
pathologic ,features:2
pathologic ,covid-19:4
pathologic ,concise:2
pathologic ,review:2
features ,concise:2
features ,review:4
covid-19 ,concise:2
concise ,review:2
unexpected ,findings:2
unexpected ,coronavirus:6
unexpected ,disease:6
unexpected ,covid-19:6
unexpected ,lung:2
unexpected ,bases:2
findings ,coronavirus:40
findings ,disease:28
findings ,lung:16
findings ,bases:2
coronavirus ,lung:20
coronavirus ,bases:2
disease ,lung:12
disease ,bases:2
covid-19 ,bases:2
lung ,bases:2
child ,infected:4
child ,severe:2
child ,acute:2
child ,respiratory:2
child ,syndrome:4
child ,coronavirus:6
child ,presenting:2
infected ,syndrome:4
infected ,coronavirus:4
infected ,presenting:2
severe ,presenting:6
acute ,presenting:18
respiratory ,presenting:2
syndrome ,presenting:6
diagnosis ,disease:24
covid-19 ,overcomes:2
covid-19 ,structure:6
overcomes ,battle:2
overcomes ,approach:2
overcomes ,virus:2
overcomes ,structure:2
battle ,approach:2
battle ,structure:2
approach ,virus:4
approach ,structure:2
virus ,structure:2
metabolic ,syndrome:4
metabolic ,covid:2
metabolic ,19:2
metabolic ,endocrine-immune-vascular:2
metabolic ,interactions:2
metabolic ,shapes:2
syndrome ,covid:4
syndrome ,19:4
syndrome ,endocrine-immune-vascular:2
syndrome ,interactions:2
syndrome ,shapes:2
covid ,endocrine-immune-vascular:2
covid ,interactions:2
covid ,shapes:2
19 ,endocrine-immune-vascular:2
19 ,interactions:2
19 ,shapes:2
endocrine-immune-vascular ,interactions:2
endocrine-immune-vascular ,shapes:2
interactions ,shapes:2
serial ,computed:4
serial ,tomographic:2
serial ,findings:4
serial ,specific:2
serial ,clinical:2
serial ,features:2
serial ,pediatric:2
computed ,tomographic:8
computed ,findings:8
computed ,specific:2
computed ,clinical:6
computed ,features:10
computed ,pediatric:2
tomographic ,findings:4
tomographic ,specific:2
tomographic ,clinical:4
tomographic ,features:4
tomographic ,pediatric:2
findings ,specific:2
findings ,clinical:18
findings ,features:8
findings ,pediatric:4
specific ,clinical:4
specific ,features:2
specific ,pediatric:2
clinical ,pediatric:16
features ,pediatric:6
us ,cdc:2
us ,real-time:2
us ,reverse:2
us ,transcription:2
us ,pcr:2
us ,panel:2
us ,detection:2
us ,severe:2
us ,acute:2
cdc ,real-time:2
cdc ,reverse:2
cdc ,transcription:2
cdc ,pcr:2
cdc ,panel:2
cdc ,detection:2
cdc ,severe:2
cdc ,acute:2
real-time ,reverse:12
real-time ,transcription:6
real-time ,pcr:14
real-time ,panel:4
reverse ,transcription:20
reverse ,pcr:8
reverse ,panel:2
reverse ,detection:12
reverse ,severe:6
reverse ,acute:6
transcription ,pcr:6
transcription ,panel:2
transcription ,detection:6
transcription ,severe:4
transcription ,acute:4
pcr ,panel:2
pcr ,severe:2
pcr ,acute:2
panel ,detection:4
panel ,severe:2
panel ,acute:2
severe ,point:2
acute ,point:2
respiratory ,point:2
syndrome ,point:2
coronavirus ,point:4
point ,prevalence:4
point ,among:2
point ,asymptomatic:2
prevalence ,among:22
coronavirus ,exposure:10
coronavirus ,spread:14
coronavirus ,nightclubs:2
disease ,exposure:8
disease ,spread:8
disease ,nightclubs:2
exposure ,spread:2
exposure ,nightclubs:2
exposure ,south:2
exposure ,korea:2
spread ,nightclubs:2
spread ,south:2
spread ,korea:2
nightclubs ,south:2
nightclubs ,korea:2
retrospective ,detection:4
retrospective ,hospitalized:2
retrospective ,patients:16
retrospective ,influenza-like:2
detection ,hospitalized:2
detection ,influenza-like:4
sars-cov-2 ,influenza-like:4
hospitalized ,influenza-like:2
patients ,influenza-like:4
potential ,adjuvants:2
potential ,based:10
adjuvants ,development:2
adjuvants ,sars-cov-2:2
adjuvants ,vaccine:2
adjuvants ,based:2
development ,based:6
sars-cov-2 ,based:20
vaccine ,based:6
clinicopathologic ,immunohistochemical:2
clinicopathologic ,findings:2
clinicopathologic ,autopsy:2
clinicopathologic ,patient:2
immunohistochemical ,findings:2
immunohistochemical ,autopsy:2
immunohistochemical ,patient:2
findings ,autopsy:6
findings ,patient:6
autopsy ,patient:2
severe ,impact:4
severe ,central:10
severe ,nervous:6
acute ,impact:6
acute ,central:6
acute ,nervous:6
respiratory ,impact:4
respiratory ,central:8
respiratory ,nervous:6
syndrome ,impact:4
syndrome ,central:8
syndrome ,nervous:8
coronavirus ,central:10
coronavirus ,nervous:8
impact ,central:4
impact ,nervous:2
genetic ,evolution:6
genetic ,analysis:14
evolution ,analysis:6
presence ,viral:4
presence ,conjunctival:2
presence ,swab:2
presence ,specimens:2
viral ,conjunctival:2
viral ,swab:4
rna ,conjunctival:4
rna ,swab:6
sars-cov-2 ,conjunctival:10
conjunctival ,swab:6
conjunctival ,specimens:2
conjunctival ,covid-19:4
swab ,specimens:4
swab ,covid-19:12
neurological ,brief:2
manifestations ,brief:2
unbiased ,screens:2
unbiased ,show:2
unbiased ,cd8:2
unbiased ,cells:2
unbiased ,covid-19:2
unbiased ,patients:2
unbiased ,recognize:2
unbiased ,shared:2
unbiased ,epitopes:2
screens ,show:2
screens ,cd8:2
screens ,cells:2
screens ,covid-19:2
screens ,patients:2
screens ,recognize:2
screens ,shared:2
screens ,epitopes:2
show ,cd8:2
show ,cells:2
show ,covid-19:4
show ,patients:4
show ,recognize:2
show ,shared:2
show ,epitopes:2
cd8 ,cells:4
cd8 ,covid-19:6
cd8 ,patients:8
cd8 ,recognize:2
cd8 ,shared:2
cd8 ,epitopes:2
cells ,patients:14
cells ,recognize:2
cells ,shared:2
cells ,epitopes:2
covid-19 ,recognize:2
covid-19 ,shared:6
covid-19 ,epitopes:6
patients ,recognize:2
patients ,shared:2
patients ,epitopes:2
recognize ,shared:2
recognize ,epitopes:2
shared ,epitopes:2
dynamic ,surveillance:4
dynamic ,sars-cov-2:16
dynamic ,shedding:4
dynamic ,neutralizing:2
dynamic ,antibody:6
dynamic ,children:2
surveillance ,sars-cov-2:26
surveillance ,shedding:2
surveillance ,neutralizing:2
surveillance ,antibody:2
surveillance ,children:2
shedding ,neutralizing:2
shedding ,antibody:2
shedding ,children:4
neutralizing ,antibody:24
neutralizing ,children:2
antibody ,children:2
covid-19 ,exonerate:2
time ,exonerate:2
time ,pangolin:2
time ,transmission:4
exonerate ,pangolin:2
exonerate ,transmission:2
exonerate ,sars-cov-2:2
pangolin ,transmission:2
effectiveness ,cloth:2
effectiveness ,masks:6
effectiveness ,protection:2
effectiveness ,severe:6
effectiveness ,acute:4
effectiveness ,respiratory:4
cloth ,masks:2
cloth ,protection:2
cloth ,severe:2
cloth ,acute:2
cloth ,respiratory:2
masks ,protection:6
masks ,severe:2
masks ,acute:2
masks ,respiratory:4
protection ,severe:2
protection ,acute:2
protection ,respiratory:4
alcohol-based ,hand:2
alcohol-based ,sanitisers:2
alcohol-based ,first:2
alcohol-based ,line:2
alcohol-based ,defence:2
alcohol-based ,sars-cov-2:2
alcohol-based ,review:2
hand ,sanitisers:2
hand ,first:2
hand ,line:2
hand ,defence:2
hand ,sars-cov-2:4
hand ,review:4
sanitisers ,first:2
sanitisers ,line:2
sanitisers ,defence:2
sanitisers ,sars-cov-2:2
sanitisers ,review:2
first ,line:4
first ,defence:2
first ,review:2
line ,defence:2
line ,sars-cov-2:2
line ,review:2
defence ,sars-cov-2:2
defence ,review:2
cell-mediated ,immune:2
cell-mediated ,responses:2
cell-mediated ,covid-19:2
cell-mediated ,infection:4
spiking ,pandemic:2
spiking ,potential:2
spiking ,structural:2
spiking ,immunological:2
spiking ,aspects:2
spiking ,sars-cov-2:2
pandemic ,potential:18
pandemic ,structural:2
pandemic ,immunological:2
potential ,immunological:2
potential ,aspects:2
structural ,immunological:2
immunological ,aspects:4
covid-19 ,bed:2
covid-19 ,side:8
bench ,bed:2
bench ,side:2
bed ,side:2
mechanisms ,involved:4
mechanisms ,development:2
mechanisms ,thrombocytopenia:2
involved ,development:2
involved ,thrombocytopenia:2
involved ,patients:2
development ,thrombocytopenia:2
development ,patients:2
thrombocytopenia ,patients:10
mild ,encephalopathy:2
mild ,reversible:2
mild ,splenium:2
mild ,lesion:2
mild ,mers:2
mild ,patient:12
encephalopathy ,reversible:6
encephalopathy ,splenium:2
encephalopathy ,lesion:2
encephalopathy ,mers:2
encephalopathy ,patient:4
reversible ,splenium:2
reversible ,lesion:2
reversible ,mers:2
reversible ,patient:4
splenium ,lesion:2
splenium ,mers:2
splenium ,patient:2
lesion ,mers:2
lesion ,patient:2
mers ,patient:2
sars-cov-2 ,lazio:4
sars-cov-2 ,region:10
sars-cov-2 ,italy:38
sars-cov-2 ,february-march:2
phylogenetic ,lazio:2
phylogenetic ,region:2
phylogenetic ,italy:4
phylogenetic ,february-march:2
analysis ,lazio:2
analysis ,region:2
analysis ,italy:6
analysis ,february-march:2
lazio ,region:2
lazio ,italy:2
lazio ,february-march:2
region ,italy:2
region ,february-march:2
italy ,february-march:2
immune ,inflammation:4
immune ,clinical:10
immune ,spectrum:2
response ,inflammation:2
response ,clinical:6
response ,spectrum:2
inflammation ,clinical:6
inflammation ,spectrum:2
inflammation ,covid-19:32
clinical ,spectrum:6
spectrum ,covid-19:16
analysis ,pregnancy:6
analysis ,outcomes:6
analysis ,pregnant:4
analysis ,women:4
analysis ,hubei:2
pregnancy ,outcomes:10
pregnancy ,pregnant:2
pregnancy ,women:2
pregnancy ,hubei:2
outcomes ,pregnant:16
outcomes ,women:18
outcomes ,hubei:2
pregnant ,covid-19:36
pregnant ,hubei:2
women ,hubei:2
sars-cov-2 ,modes:8
environment ,modes:2
environment ,early:4
environment ,detection:2
environment ,potential:4
modes ,transmission:6
modes ,early:2
modes ,detection:2
modes ,potential:2
transmission ,detection:2
early ,detection:10
early ,potential:6
detection ,potential:6
virtual ,repurposing:4
virtual ,fda:2
virtual ,approved:6
virtual ,main:6
screening ,repurposing:4
screening ,main:6
repurposing ,fda:2
repurposing ,main:12
fda ,covid-19:4
fda ,main:4
approved ,covid-19:4
approved ,main:6
drugs ,main:10
structural ,biophysical:2
structural ,biochemical:4
structural ,elucidation:2
structural ,nonstructural:2
biophysical ,biochemical:2
biophysical ,elucidation:2
biophysical ,sars-cov-2:2
biophysical ,nonstructural:2
biochemical ,elucidation:2
biochemical ,sars-cov-2:4
biochemical ,nonstructural:2
elucidation ,sars-cov-2:2
elucidation ,nonstructural:2
sars-cov-2 ,nonstructural:2
positive ,chest:4
positive ,ct:2
positive ,features:2
positive ,pneumonia:6
positive ,negative:10
chest ,ct:46
chest ,features:16
chest ,patients:22
chest ,covid-19:54
chest ,pneumonia:14
chest ,negative:2
ct ,patients:22
ct ,pneumonia:18
ct ,negative:4
features ,negative:2
patients ,pneumonia:46
patients ,negative:8
covid-19 ,negative:28
pneumonia ,negative:8
sars-cov-2 ,increasing:4
sars-cov-2 ,water:14
sars-cov-2 ,highly:10
sars-cov-2 ,pathogenic:8
increasing ,water:2
increasing ,filtration:2
increasing ,highly:2
increasing ,pathogenic:2
importance ,water:2
importance ,filtration:2
importance ,highly:2
importance ,pathogenic:2
water ,filtration:2
water ,highly:2
water ,pathogenic:2
filtration ,highly:2
filtration ,pathogenic:2
severe ,aging:2
severe ,monocytes:2
severe ,key:6
covid-19 ,aging:6
covid-19 ,monocytes:4
covid-19 ,key:22
aging ,monocytes:2
aging ,key:2
monocytes ,key:4
pituitary ,tumor:2
pituitary ,resection:4
pituitary ,patient:4
pituitary ,sars-cov-2:2
pituitary ,covid-19:8
pituitary ,infection:4
pituitary ,case:2
tumor ,resection:2
tumor ,patient:2
tumor ,sars-cov-2:4
tumor ,covid-19:2
tumor ,infection:4
tumor ,case:2
resection ,patient:4
resection ,sars-cov-2:2
resection ,covid-19:4
resection ,infection:2
resection ,case:2
patient ,case:56
shedding ,light:2
shedding ,effect:4
shedding ,natural:2
shedding ,anti-herpesvirus:2
shedding ,alkaloids:2
light ,effect:2
light ,natural:2
light ,anti-herpesvirus:2
light ,alkaloids:2
effect ,natural:2
effect ,anti-herpesvirus:2
effect ,alkaloids:2
natural ,anti-herpesvirus:2
natural ,alkaloids:2
natural ,sars-cov-2:34
anti-herpesvirus ,alkaloids:2
anti-herpesvirus ,sars-cov-2:2
alkaloids ,sars-cov-2:2
emergency ,cesarean:6
emergency ,section:6
emergency ,performed:4
emergency ,patient:2
emergency ,confirmed:2
emergency ,severe:2
emergency ,acute:2
cesarean ,section:8
cesarean ,performed:2
cesarean ,patient:2
cesarean ,confirmed:2
cesarean ,severe:2
cesarean ,acute:2
section ,performed:2
section ,patient:2
section ,confirmed:2
section ,severe:2
section ,acute:2
performed ,patient:2
performed ,confirmed:2
performed ,severe:2
performed ,acute:2
patient ,confirmed:4
patient ,acute:34
confirmed ,severe:2
confirmed ,acute:4
minimizing ,cross:2
minimizing ,transmission:2
minimizing ,sars-cov-2:2
minimizing ,obstetric:2
minimizing ,ultrasound:2
minimizing ,covid-19:2
cross ,transmission:2
cross ,sars-cov-2:2
cross ,obstetric:2
cross ,ultrasound:2
cross ,covid-19:4
transmission ,obstetric:2
transmission ,ultrasound:2
sars-cov-2 ,ultrasound:4
obstetric ,ultrasound:2
obstetric ,covid-19:10
ultrasound ,covid-19:26
evaluation ,high-speed:2
evaluation ,low-throughput:2
evaluation ,system:4
high-speed ,low-throughput:2
high-speed ,rt-qpcr:2
high-speed ,system:2
high-speed ,detection:2
low-throughput ,rt-qpcr:2
low-throughput ,system:2
low-throughput ,detection:2
rt-qpcr ,system:2
system ,detection:8
sars-cov-2 ,obesity:10
sars-cov-2 ,common:14
sars-cov-2 ,inflammatory:18
sars-cov-2 ,metabolic:2
infection ,obesity:4
infection ,common:4
infection ,inflammatory:2
infection ,metabolic:2
infection ,aspects:6
obesity ,common:4
obesity ,inflammatory:2
obesity ,metabolic:6
obesity ,aspects:2
common ,inflammatory:2
common ,metabolic:2
common ,aspects:2
inflammatory ,metabolic:2
inflammatory ,aspects:2
metabolic ,aspects:2
update ,cerebrovascular:2
cerebrovascular ,manifestations:2
prevalence ,sars-cov-2:62
prevalence ,infection:22
prevalence ,narrative:2
prevalence ,review:6
asymptomatic ,narrative:2
asymptomatic ,review:4
infection ,narrative:2
gut ,microbiota:4
gut ,covid-19-:2
gut ,possible:2
gut ,link:2
gut ,implications:2
microbiota ,covid-19-:2
microbiota ,possible:2
microbiota ,link:2
microbiota ,implications:2
covid-19- ,possible:2
covid-19- ,link:2
covid-19- ,implications:2
possible ,link:8
possible ,implications:12
link ,implications:2
two ,detailed:2
two ,plaque:2
two ,assay:4
two ,protocols:2
two ,quantification:2
two ,infectious:2
detailed ,plaque:2
detailed ,assay:4
detailed ,protocols:2
detailed ,quantification:2
detailed ,infectious:2
detailed ,sars-cov-2:4
plaque ,assay:4
plaque ,protocols:2
plaque ,quantification:2
plaque ,infectious:2
plaque ,sars-cov-2:4
assay ,protocols:2
assay ,quantification:4
assay ,infectious:2
protocols ,quantification:2
protocols ,infectious:4
protocols ,sars-cov-2:10
quantification ,infectious:2
quantification ,sars-cov-2:14
pathological ,report:2
pathological ,three:2
pathological ,covid-19:12
pathological ,cases:2
pathological ,minimal:2
pathological ,invasive:2
pathological ,autopsies:2
report ,three:6
report ,cases:22
report ,minimal:2
report ,invasive:2
report ,autopsies:4
three ,cases:16
three ,minimal:2
three ,invasive:2
three ,autopsies:2
covid-19 ,minimal:4
covid-19 ,invasive:2
cases ,minimal:2
cases ,invasive:2
cases ,autopsies:2
minimal ,invasive:2
minimal ,autopsies:2
invasive ,autopsies:2
environmental ,factors:10
environmental ,involved:2
environmental ,role:6
environmental ,indoor:2
factors ,involved:2
factors ,sars-cov-2:36
factors ,transmission:10
factors ,effect:2
factors ,role:8
factors ,indoor:2
involved ,sars-cov-2:2
involved ,transmission:2
involved ,effect:2
involved ,role:2
involved ,indoor:2
sars-cov-2 ,indoor:10
transmission ,effect:8
transmission ,indoor:6
effect ,role:2
effect ,indoor:2
role ,indoor:2
15 ,2359:2
15 ,aest:2
15 ,10:2
15 ,may:2
10 ,may:2
preliminary ,information:2
preliminary ,prevention:2
preliminary ,infections:2
preliminary ,caused:2
preliminary ,sars-cov-2:20
preliminary ,virus:2
information ,prevention:2
information ,infections:2
information ,caused:2
information ,sars-cov-2:6
information ,virus:2
prevention ,caused:4
prevention ,virus:4
infections ,caused:2
caused ,virus:2
data-driven ,hypothesis:2
data-driven ,epigenetic:2
data-driven ,dysregulation:2
data-driven ,host:2
data-driven ,metabolism:2
data-driven ,sars:2
hypothesis ,epigenetic:2
hypothesis ,dysregulation:2
hypothesis ,host:2
hypothesis ,metabolism:2
hypothesis ,sars:2
epigenetic ,dysregulation:4
epigenetic ,host:2
epigenetic ,metabolism:2
epigenetic ,sars:2
dysregulation ,host:2
dysregulation ,metabolism:2
dysregulation ,sars:2
host ,metabolism:2
host ,sars:2
metabolism ,sars:2
neuroinvasion ,neurotropic:2
neuroinvasion ,neuroinflammatory:2
neuroinvasion ,events:2
neuroinvasion ,sars-cov-2:4
neurotropic ,neuroinflammatory:2
neurotropic ,events:2
neurotropic ,sars-cov-2:6
neuroinflammatory ,events:2
neuroinflammatory ,sars-cov-2:2
events ,sars-cov-2:12
potential ,severe:22
neurological ,effects:2
neurological ,severe:6
effects ,severe:6
effects ,infection:16
remdesivir ,pharmacology:4
remdesivir ,pre-clinical:4
remdesivir ,data:4
remdesivir ,emerging:2
remdesivir ,clinical:10
review ,pharmacology:8
review ,pre-clinical:4
review ,data:6
review ,emerging:6
pharmacology ,pre-clinical:4
pharmacology ,data:2
pharmacology ,emerging:4
pharmacology ,clinical:8
pre-clinical ,data:2
pre-clinical ,emerging:2
pre-clinical ,clinical:4
data ,emerging:2
data ,clinical:6
emerging ,clinical:8
first ,results:8
first ,investigations:4
first ,sars-cov2:2
first ,rna:8
first ,human:4
first ,corneal:4
first ,tissue:4
results ,investigations:4
results ,sars-cov2:2
results ,rna:8
results ,human:4
results ,corneal:4
results ,tissue:4
investigations ,sars-cov2:2
investigations ,rna:4
investigations ,human:4
investigations ,corneal:4
investigations ,tissue:4
sars-cov2 ,rna:2
sars-cov2 ,human:2
sars-cov2 ,corneal:2
sars-cov2 ,tissue:2
rna ,corneal:4
rna ,tissue:4
human ,corneal:4
human ,tissue:4
corneal ,tissue:4
neurological ,available:2
neurological ,evidences:2
neurological ,new:2
neurological ,paradigm:2
manifestations ,available:2
manifestations ,evidences:2
manifestations ,new:4
manifestations ,paradigm:2
covid-19 ,available:14
covid-19 ,paradigm:8
available ,evidences:2
available ,new:2
available ,paradigm:2
evidences ,new:2
evidences ,paradigm:2
pandemic ,pregnancy:8
clinical ,technology:2
diagnostics ,testing:2
diagnostics ,technology:2
testing ,technology:2
sars-cov-2 ,causing:6
sars-cov-2 ,pneumonia-associated:2
sars-cov-2 ,disorder:6
causing ,pneumonia-associated:2
causing ,respiratory:4
causing ,disorder:2
causing ,covid-19:8
causing ,diagnostic:2
pneumonia-associated ,respiratory:2
pneumonia-associated ,disorder:2
pneumonia-associated ,covid-19:2
pneumonia-associated ,diagnostic:2
respiratory ,disorder:6
respiratory ,diagnostic:4
disorder ,covid-19:12
disorder ,diagnostic:4
exacerbation ,chronic:2
exacerbation ,inflammatory:2
exacerbation ,demyelinating:2
exacerbation ,polyneuropathy:2
exacerbation ,concomitance:2
chronic ,inflammatory:2
chronic ,demyelinating:2
chronic ,polyneuropathy:2
chronic ,concomitance:2
inflammatory ,demyelinating:2
inflammatory ,polyneuropathy:2
inflammatory ,concomitance:2
demyelinating ,polyneuropathy:2
demyelinating ,concomitance:2
polyneuropathy ,concomitance:2
anesthesia ,covid-19:6
anesthesia ,know:2
smell ,dysfunction:8
smell ,systematic:2
smell ,review:4
taste ,dysfunction:6
taste ,patients:14
taste ,systematic:4
taste ,review:6
dysfunction ,patients:10
dysfunction ,covid-19:48
dysfunction ,systematic:2
dysfunction ,review:4
patients ,systematic:24
saliva ,alternative:4
saliva ,upper:2
saliva ,respiratory:6
saliva ,swabs:2
saliva ,diagnosis:4
alternative ,upper:2
alternative ,respiratory:2
alternative ,swabs:4
alternative ,sars-cov-2:18
alternative ,diagnosis:2
upper ,swabs:2
upper ,sars-cov-2:16
upper ,diagnosis:2
respiratory ,swabs:6
respiratory ,diagnosis:6
swabs ,diagnosis:6
sweat ,possible:2
sweat ,route:2
sweat ,transmission:2
sweat ,sars-cov-2:2
possible ,route:2
rampant ,cu:2
rampant ,hypermutation:2
rampant ,genomes:2
rampant ,sars-cov-2:2
rampant ,coronaviruses:2
cu ,hypermutation:2
cu ,genomes:2
cu ,sars-cov-2:2
cu ,coronaviruses:2
hypermutation ,genomes:2
hypermutation ,sars-cov-2:2
hypermutation ,coronaviruses:2
genomes ,sars-cov-2:20
genomes ,coronaviruses:2
clinical ,pathological:6
clinical ,outbreaks:4
clinical ,farmed:2
clinical ,mink:2
pathological ,findings:6
pathological ,disease:6
pathological ,outbreaks:2
pathological ,farmed:2
pathological ,mink:2
findings ,outbreaks:2
findings ,farmed:2
findings ,mink:2
sars-cov-2 ,outbreaks:6
sars-cov-2 ,farmed:4
sars-cov-2 ,mink:4
disease ,outbreaks:4
disease ,farmed:2
disease ,mink:2
outbreaks ,farmed:2
outbreaks ,mink:2
farmed ,mink:2
covid-19 ,cardiovascular:80
concern ,cardiovascular:2
concern ,disease:4
concern ,patients:4
cardiovascular ,patients:20
disease ,children:44
children ,current:6
children ,status:4
environmental ,contamination:20
environmental ,covid-19:22
environmental ,outbreak:4
environmental ,south:2
contamination ,sars-cov-2:32
contamination ,covid-19:10
contamination ,outbreak:2
contamination ,south:2
outbreak ,south:6
covid-19 ,microvascular:8
microvascular ,disease:4
microvascular ,pathophysiology:2
microvascular ,sars-cov-2:2
microvascular ,infection:2
disease ,pathophysiology:8
pathophysiology ,infection:6
severe ,returnees:2
severe ,japan:2
acute ,returnees:2
acute ,japan:2
respiratory ,returnees:2
respiratory ,japan:2
syndrome ,returnees:2
syndrome ,japan:2
coronavirus ,returnees:2
infection ,returnees:2
infection ,japan:2
among ,returnees:2
among ,japan:2
returnees ,japan:2
single ,centre:4
single ,study:2
single ,viral:2
single ,community-acquired:2
single ,pneumonia:2
single ,children:2
single ,evidence:2
centre ,study:2
centre ,viral:2
centre ,community-acquired:2
centre ,pneumonia:2
centre ,children:2
centre ,evidence:2
study ,viral:4
study ,community-acquired:2
study ,pneumonia:6
study ,children:6
study ,evidence:2
viral ,community-acquired:4
viral ,evidence:4
community-acquired ,pneumonia:4
community-acquired ,children:2
community-acquired ,evidence:2
pneumonia ,children:6
pneumonia ,evidence:2
children ,evidence:8
alternative ,workflow:2
alternative ,molecular:2
alternative ,detection:10
alternative ,escape:2
alternative ,na:2
workflow ,molecular:2
workflow ,detection:2
workflow ,sars-cov-2:2
workflow ,escape:2
workflow ,na:2
molecular ,escape:2
molecular ,na:2
detection ,escape:4
detection ,na:2
sars-cov-2 ,escape:6
sars-cov-2 ,na:2
escape ,na:2
clinical ,utility:6
clinical ,buccal:2
clinical ,swabs:2
clinical ,acute:24
clinical ,respiratory:26
clinical ,syndrome:28
utility ,buccal:2
utility ,swabs:2
utility ,severe:2
utility ,acute:2
utility ,respiratory:2
utility ,syndrome:2
utility ,coronavirus:4
buccal ,swabs:2
buccal ,severe:2
buccal ,acute:2
buccal ,respiratory:2
buccal ,syndrome:2
buccal ,coronavirus:2
swabs ,severe:6
swabs ,acute:4
swabs ,syndrome:4
swabs ,coronavirus:6
mechanisms ,underlying:8
mechanisms ,potential:14
mechanisms ,therapeutic:2
mechanisms ,approaches:4
underlying ,potential:2
underlying ,therapeutic:2
underlying ,approaches:2
covid-19 ,recommendation:4
covid-19 ,examine:2
covid-19 ,mouthrinses:2
covid-19 ,-cyclodextrin:2
recommendation ,examine:2
recommendation ,effect:2
recommendation ,mouthrinses:2
recommendation ,-cyclodextrin:2
examine ,effect:2
examine ,mouthrinses:2
examine ,-cyclodextrin:2
effect ,mouthrinses:2
effect ,-cyclodextrin:2
mouthrinses ,-cyclodextrin:2
sars-cov-2 ,cells-multiple:2
entry ,host:10
entry ,cells-multiple:2
entry ,targets:2
entry ,treatment:2
entry ,prevention:2
host ,cells-multiple:2
host ,targets:4
host ,treatment:4
host ,prevention:2
cells-multiple ,targets:2
cells-multiple ,treatment:2
cells-multiple ,prevention:2
targets ,prevention:4
treatment ,prevention:34
pregnancy ,postpartum:4
pregnancy ,universally:2
pregnancy ,tested:2
pregnancy ,population:2
postpartum ,outcomes:2
postpartum ,universally:2
postpartum ,tested:2
postpartum ,population:2
postpartum ,sars-cov-2:2
outcomes ,universally:2
outcomes ,tested:2
outcomes ,population:2
outcomes ,sars-cov-2:22
universally ,tested:2
universally ,population:2
universally ,sars-cov-2:2
tested ,population:2
tested ,sars-cov-2:4
population ,sars-cov-2:14
study ,potential:12
study ,antiviral:4
study ,drugs:4
study ,research:2
potential ,research:2
antiviral ,preliminary:2
antiviral ,research:6
drugs ,preliminary:2
drugs ,research:4
preliminary ,research:2
screening ,testing:12
screening ,upon:2
screening ,admission:4
screening ,rehabilitation:2
screening ,hospitals:2
testing ,upon:2
testing ,admission:2
testing ,rehabilitation:2
testing ,hospitals:2
sars-cov-2 ,upon:2
sars-cov-2 ,admission:4
sars-cov-2 ,rehabilitation:6
sars-cov-2 ,hospitals:10
upon ,admission:2
upon ,rehabilitation:2
upon ,hospitals:2
admission ,rehabilitation:2
admission ,hospitals:2
rehabilitation ,hospitals:2
antibody ,detection:22
antibody ,characteristics:4
detection ,dynamic:4
detection ,characteristics:4
dynamic ,characteristics:4
dynamic ,patients:8
dynamic ,coronavirus:8
dynamic ,disease:6
structural ,rna:4
structural ,replication:2
structural ,polymerase:4
basis ,rna:2
basis ,replication:2
basis ,polymerase:2
rna ,replication:4
replication ,sars-cov-2:20
replication ,polymerase:2
sars-cov-2 ,polymerase:22
multiple ,sclerosis:28
multiple ,following:2
multiple ,sars-cov-2:26
multiple ,infection:2
sclerosis ,following:2
sclerosis ,sars-cov-2:4
sclerosis ,infection:2
targeting ,source:2
targeting ,compounds:2
sars-cov-2 ,compounds:6
novel ,source:2
source ,antiviral:4
source ,compounds:2
antiviral ,compounds:4
compounds ,covid-19:6
covid-19 ,formidable:2
covid-19 ,foe:8
covid-19 ,ahead:8
comprehensive ,formidable:2
comprehensive ,foe:2
comprehensive ,road:2
comprehensive ,ahead:2
review ,formidable:2
review ,foe:2
review ,road:2
review ,ahead:2
formidable ,foe:2
formidable ,road:2
formidable ,ahead:2
foe ,road:2
foe ,ahead:2
road ,ahead:2
pathological ,changes:4
pathological ,fatal:2
pathological ,coronavirus:4
pathological ,lungs:2
changes ,fatal:2
changes ,coronavirus:8
changes ,disease:6
changes ,covid-19:36
changes ,lungs:2
fatal ,covid-19:14
fatal ,lungs:2
coronavirus ,lungs:4
disease ,lungs:6
covid-19 ,lungs:8
covid-19 ,complications:32
epidemic ,focus:2
epidemic ,diagnosis:2
epidemic ,complications:2
epidemic ,management:6
special ,focus:6
special ,diagnosis:2
special ,complications:2
special ,management:2
focus ,diagnosis:4
focus ,complications:2
focus ,management:2
diagnosis ,complications:4
complications ,management:2
rapid ,point-of-care:10
rapid ,serology:4
rapid ,testing:16
point-of-care ,serology:2
point-of-care ,testing:4
point-of-care ,sars-cov-2:16
serology ,testing:8
serology ,sars-cov-2:26
covid-19 ,preventive:12
update ,epidemiological:4
update ,clinical:12
update ,preventive:2
update ,therapeutic:4
epidemiological ,preventive:2
epidemiological ,therapeutic:4
clinical ,preventive:2
preventive ,therapeutic:2
covid-19 ,italy:42
covid-19 ,x-ray:12
covid-19 ,scoring:2
covid-19 ,quantifying:4
outbreak ,italy:14
outbreak ,experimental:2
outbreak ,chest:4
outbreak ,x-ray:2
outbreak ,scoring:2
outbreak ,system:2
outbreak ,quantifying:2
italy ,experimental:2
italy ,chest:2
italy ,x-ray:2
italy ,scoring:2
italy ,system:2
italy ,quantifying:2
experimental ,chest:2
experimental ,x-ray:2
experimental ,scoring:2
experimental ,system:4
experimental ,quantifying:2
chest ,x-ray:14
chest ,scoring:2
chest ,system:2
chest ,quantifying:2
x-ray ,scoring:2
x-ray ,system:2
x-ray ,quantifying:2
scoring ,system:2
scoring ,quantifying:2
system ,quantifying:2
analysis ,adjunctive:2
analysis ,serological:8
analysis ,test:2
analysis ,severe:8
analysis ,acute:8
adjunctive ,serological:2
adjunctive ,detection:2
adjunctive ,nucleic:2
adjunctive ,acid:2
adjunctive ,test:2
adjunctive ,severe:2
adjunctive ,acute:4
serological ,detection:12
serological ,nucleic:2
serological ,acid:2
serological ,test:8
serological ,severe:8
serological ,acute:6
detection ,test:16
nucleic ,test:10
nucleic ,severe:8
nucleic ,acute:8
acid ,test:10
test ,severe:4
test ,acute:4
precaution ,prevention:2
precaution ,disease:2
precaution ,eye:2
prevention ,disease:16
prevention ,infection:34
prevention ,eye:2
disease ,eye:6
infection ,eye:2
performance ,characteristics:8
performance ,abbott:6
performance ,architect:4
performance ,igg:6
performance ,assay:6
characteristics ,abbott:2
characteristics ,architect:2
characteristics ,igg:2
characteristics ,assay:2
abbott ,architect:4
abbott ,sars-cov-2:6
abbott ,igg:6
abbott ,assay:4
architect ,sars-cov-2:4
architect ,igg:4
architect ,assay:2
igg ,assay:8
perspectives ,repurposing:2
perspectives ,drugs:2
effect ,related:2
effect ,lockdown:4
effect ,ophthalmic:2
effect ,practice:2
effect ,patient:2
effect ,care:2
covid-19 ,related:40
covid-19 ,lockdown:44
covid-19 ,ophthalmic:2
related ,lockdown:8
related ,ophthalmic:2
related ,practice:6
related ,patient:2
related ,care:6
lockdown ,ophthalmic:2
lockdown ,practice:4
lockdown ,patient:2
lockdown ,care:4
ophthalmic ,practice:2
ophthalmic ,patient:2
ophthalmic ,care:2
practice ,patient:2
practice ,care:2
patient ,care:10
treatment ,lines:2
research ,lines:2
research ,patient:2
lines ,patient:2
lines ,covid-19:2
overwhelming ,mutations:2
overwhelming ,snps:2
overwhelming ,sars-cov-2:2
overwhelming ,point:2
overwhelming ,caution:2
mutations ,snps:2
mutations ,caution:2
snps ,sars-cov-2:2
snps ,point:2
snps ,caution:2
sars-cov-2 ,caution:4
point ,caution:2
opportunistic ,physiology:2
opportunistic ,inserting:2
opportunistic ,pathophysiology:2
opportunistic ,content:2
physiology ,inserting:2
physiology ,pathophysiology:2
physiology ,content:2
inserting ,pathophysiology:2
inserting ,content:2
pathophysiology ,content:2
impact ,population:6
impact ,movement:2
impact ,spread:8
impact ,china:6
population ,movement:4
movement ,spread:2
movement ,2019-ncov:2
movement ,china:2
quadruple ,negative:2
quadruple ,sars-cov-2-pcr:2
quadruple ,still:2
quadruple ,covid-19:2
quadruple ,pneumonia:2
negative ,sars-cov-2-pcr:2
negative ,still:2
sars-cov-2-pcr ,still:2
sars-cov-2-pcr ,covid-19:2
sars-cov-2-pcr ,pneumonia:2
still ,covid-19:6
still ,pneumonia:2
clinical ,course:40
course ,characteristics:2
course ,patients:16
course ,coronavirus:10
course ,disease:10
coronavirus ,diseases:10
coronavirus ,covid-19sars:2
coronavirus ,mers:6
diseases ,pregnancy:2
diseases ,covid-19sars:2
diseases ,mers:2
pregnancy ,covid-19sars:2
pregnancy ,mers:2
covid-19sars ,mers:2
convalescent ,promising:2
convalescent ,disease:4
plasma ,promising:2
plasma ,disease:6
therapy ,promising:4
therapy ,disease:26
therapy ,treatment:10
promising ,disease:4
longer ,duration:2
longer ,sars-cov-2:10
longer ,infection:4
longer ,case:2
longer ,mild:2
longer ,covid-19:2
longer ,weak:2
duration ,infection:2
duration ,case:2
duration ,mild:4
duration ,weak:2
sars-cov-2 ,weak:2
infection ,weak:2
case ,weak:2
mild ,weak:2
covid-19 ,weak:2
can ,environmental:4
can ,phagocyte:2
can ,acanthamoeba:2
can ,useful:4
can ,model:6
can ,study:4
environmental ,phagocyte:2
environmental ,acanthamoeba:2
environmental ,useful:2
environmental ,model:2
environmental ,study:2
phagocyte ,acanthamoeba:2
phagocyte ,useful:2
phagocyte ,model:2
phagocyte ,study:2
phagocyte ,sars-cov-2:2
acanthamoeba ,useful:2
acanthamoeba ,model:2
acanthamoeba ,study:2
acanthamoeba ,sars-cov-2:2
useful ,model:2
useful ,study:2
useful ,sars-cov-2:2
model ,study:6
model ,sars-cov-2:36
homeless ,shelter:4
homeless ,characteristics:2
homeless ,prevalence:6
homeless ,sars-cov-2:6
shelter ,characteristics:2
shelter ,prevalence:4
shelter ,sars-cov-2:4
high ,levels:4
high ,sars-cov-2-specific:2
high ,cells:6
high ,restricted:2
high ,functionality:2
high ,severe:20
levels ,sars-cov-2-specific:2
levels ,cells:4
levels ,restricted:2
levels ,functionality:2
levels ,severe:6
sars-cov-2-specific ,cells:6
sars-cov-2-specific ,restricted:2
sars-cov-2-specific ,functionality:2
sars-cov-2-specific ,severe:2
cells ,restricted:2
cells ,functionality:2
cells ,severe:12
restricted ,functionality:2
restricted ,severe:2
epidemiology ,gansu:4
epidemiology ,province:6
epidemiology ,china:6
coronavirus ,gansu:4
disease ,gansu:4
disease ,province:4
gansu ,province:6
gansu ,china:6
potential ,spreading:4
potential ,risks:4
potential ,disinfection:4
potential ,medical:2
potential ,wastewater:2
spreading ,risks:2
spreading ,disinfection:2
spreading ,challenges:2
spreading ,medical:2
spreading ,wastewater:2
risks ,disinfection:2
risks ,challenges:2
risks ,medical:2
risks ,wastewater:2
disinfection ,challenges:2
disinfection ,medical:2
disinfection ,wastewater:2
challenges ,medical:6
challenges ,wastewater:2
medical ,wastewater:2
facial ,diplegia:2
facial ,possible:2
facial ,atypical:2
facial ,variant:2
facial ,guillain-barr:2
facial ,syndrome:2
facial ,rare:2
diplegia ,possible:2
diplegia ,atypical:2
diplegia ,variant:2
diplegia ,guillain-barr:2
diplegia ,syndrome:2
diplegia ,rare:2
possible ,atypical:2
possible ,variant:2
possible ,guillain-barr:2
possible ,rare:4
atypical ,variant:2
atypical ,guillain-barr:2
atypical ,syndrome:4
atypical ,rare:2
variant ,guillain-barr:2
variant ,syndrome:2
variant ,rare:2
guillain-barr ,rare:2
syndrome ,rare:2
point-of-care ,lung:8
point-of-care ,ultrasound:12
point-of-care ,three:2
point-of-care ,neonates:2
lung ,ultrasound:38
lung ,three:2
lung ,neonates:2
ultrasound ,three:2
ultrasound ,neonates:2
three ,neonates:2
dangers ,scientific:2
dangers ,bias:2
dangers ,herbal:2
dangers ,drugs:2
dangers ,coronavirus:2
dangers ,disease:2
scientific ,bias:2
scientific ,herbal:2
scientific ,drugs:2
scientific ,coronavirus:6
scientific ,disease:4
bias ,herbal:2
bias ,drugs:2
bias ,coronavirus:2
bias ,disease:2
herbal ,drugs:2
herbal ,coronavirus:2
herbal ,disease:2
2019-ncov ,human-to-human:4
virus ,coronavirus:8
virus ,human-to-human:2
old ,re-purposed:2
old ,treatment:2
re-purposed ,drugs:4
re-purposed ,treatment:4
re-purposed ,covid-19:4
human ,sars-cov:8
human ,mers-cov:4
coronaviruses ,mers-cov:2
coronaviruses ,children:2
sars-cov ,children:2
mers-cov ,children:2
coronavirus ,stop:2
disease ,stop:2
pandemic ,spread:8
pandemic ,stop:2
neuropathogenic ,human:2
neuropathogenic ,coronaviruses:2
neuropathogenic ,review:2
molecular ,faisalabad:2
molecular ,pakistan:2
molecular ,real-world:2
epidemiology ,faisalabad:2
epidemiology ,pakistan:2
epidemiology ,real-world:2
sars-cov-2 ,faisalabad:2
sars-cov-2 ,pakistan:2
sars-cov-2 ,real-world:2
faisalabad ,pakistan:2
faisalabad ,real-world:2
faisalabad ,clinical:2
pakistan ,real-world:2
pakistan ,clinical:2
real-world ,clinical:2
dentists ,need:2
dentists ,know:2
dentists ,covid-19:10
cholera ,epidemics:2
cholera ,hamburg:2
cholera ,learn:2
cholera ,covid-19:2
cholera ,sars-cov-2:2
epidemics ,hamburg:2
epidemics ,learn:4
epidemics ,covid-19:2
epidemics ,sars-cov-2:6
hamburg ,learn:2
hamburg ,covid-19:2
hamburg ,sars-cov-2:2
learn ,sars-cov-2:2
covid-19 ,evasion:2
perspectives ,innate:2
perspectives ,immune:4
perspectives ,evasion:2
innate ,evasion:6
immune ,evasion:4
comparative ,mers:4
comparative ,sars:4
comparative ,review:10
comparative ,article:2
overview ,mers:2
overview ,sars:2
overview ,article:2
covid-19 ,mers:28
mers ,sars:34
mers ,review:4
mers ,article:2
sars ,review:4
sars ,article:2
fight ,perspective:4
fight ,medicinal:2
fight ,chemists:2
novel ,medicinal:2
novel ,chemists:2
coronavirus ,medicinal:2
coronavirus ,chemists:2
perspective ,medicinal:4
perspective ,chemists:2
medicinal ,chemists:2
recent ,outbreaks:2
recent ,coronaviruses:2
recent ,medicinal:2
recent ,chemistry:2
recent ,perspective:2
outbreaks ,human:2
outbreaks ,coronaviruses:2
outbreaks ,medicinal:2
outbreaks ,chemistry:2
outbreaks ,perspective:2
human ,medicinal:4
human ,chemistry:2
human ,perspective:8
coronaviruses ,medicinal:2
coronaviruses ,chemistry:2
coronaviruses ,perspective:4
medicinal ,chemistry:2
chemistry ,perspective:2
asymptomatic ,novel:10
asymptomatic ,patient:10
asymptomatic ,outside:2
asymptomatic ,wuhan:2
asymptomatic ,value:4
asymptomatic ,ct:4
novel ,patient:4
novel ,outside:4
novel ,value:4
coronavirus ,outside:6
pneumonia ,outside:2
pneumonia ,value:2
patient ,outside:4
patient ,wuhan:6
patient ,value:2
patient ,ct:6
outside ,wuhan:6
outside ,value:2
outside ,ct:2
wuhan ,value:2
wuhan ,ct:2
value ,ct:2
methylation ,pathways:2
methylation ,sars-cov-2:2
methylation ,lung:2
methylation ,infiltration:2
methylation ,cell:2
methylation ,membrane-virus:2
methylation ,fusion:2
pathways ,lung:2
pathways ,infiltration:2
pathways ,cell:2
pathways ,membrane-virus:2
pathways ,fusion:2
sars-cov-2 ,lung:22
sars-cov-2 ,infiltration:2
sars-cov-2 ,membrane-virus:2
sars-cov-2 ,fusion:10
lung ,infiltration:2
lung ,cell:6
lung ,membrane-virus:2
lung ,fusion:2
infiltration ,cell:6
infiltration ,membrane-virus:2
infiltration ,fusion:2
cell ,membrane-virus:2
cell ,fusion:4
membrane-virus ,fusion:2
combination ,western:2
combination ,medicine:4
combination ,chinese:2
combination ,traditional:2
combination ,patent:2
combination ,treating:2
western ,medicine:4
western ,chinese:4
western ,traditional:4
western ,patent:2
western ,treating:2
medicine ,patent:4
medicine ,treating:2
chinese ,patent:6
chinese ,treating:4
traditional ,patent:4
traditional ,treating:2
patent ,treating:2
mutations ,strengthened:2
mutations ,infectivity:2
strengthened ,sars-cov-2:4
strengthened ,infectivity:2
evidence ,vertical:6
evidence ,two:2
evidence ,mothers:2
vertical ,sars-cov-2:26
vertical ,two:2
vertical ,neonates:2
vertical ,mothers:2
transmission ,two:6
transmission ,neonates:2
transmission ,mothers:2
sars-cov-2 ,mothers:6
two ,neonates:4
two ,mothers:6
mechanism ,treatment:8
mechanism ,gastrointestinal:2
mechanism ,symptoms:2
mechanism ,patients:4
treatment ,gastrointestinal:2
treatment ,symptoms:2
gastrointestinal ,symptoms:20
gastrointestinal ,patients:14
symptoms ,patients:16
bcg ,may:2
bcg ,generate:2
bcg ,cross-reactive:2
bcg ,cells:2
bcg ,sars-cov-2:10
bcg ,silico:2
vaccine ,may:2
vaccine ,generate:2
vaccine ,cross-reactive:2
vaccine ,cells:2
may ,generate:2
may ,cross-reactive:2
may ,cells:4
may ,silico:2
generate ,cross-reactive:2
generate ,cells:2
generate ,sars-cov-2:2
generate ,silico:2
cross-reactive ,cells:4
cross-reactive ,sars-cov-2:8
cross-reactive ,silico:2
cells ,sars-cov-2:52
cells ,silico:2
management ,hemodialysis:2
management ,units:4
sars-cov-2 ,units:8
covid-19 ,units:6
coronavirus ,hemodialysis:6
coronavirus ,units:2
epidemic ,hemodialysis:2
epidemic ,units:2
hemodialysis ,units:2
containing ,2019-ncov:2
containing ,wuhan:2
containing ,coronavirus:4
anti-viral ,facet:2
anti-viral ,anti-rheumatic:2
anti-viral ,drugs:2
anti-viral ,lessons:2
anti-viral ,covid-19:2
facet ,anti-rheumatic:2
facet ,drugs:2
facet ,lessons:2
facet ,covid-19:2
anti-rheumatic ,drugs:2
anti-rheumatic ,lessons:2
anti-rheumatic ,covid-19:2
drugs ,lessons:2
longitudinal ,change:2
longitudinal ,severe:2
longitudinal ,acute:2
longitudinal ,respiratory:2
longitudinal ,syndrome:2
longitudinal ,coronavirus:2
change ,severe:2
change ,acute:2
change ,respiratory:2
change ,syndrome:2
change ,coronavirus:2
change ,antibodies:2
covid-19 ,decontamination:2
covid-19 ,photographic:2
covid-19 ,equipment:6
decontamination ,procedures:2
decontamination ,photographic:2
decontamination ,equipment:2
decontamination ,secondary:2
decontamination ,care:2
procedures ,photographic:2
procedures ,equipment:2
procedures ,secondary:2
procedures ,care:4
photographic ,equipment:2
photographic ,secondary:2
photographic ,care:2
equipment ,secondary:2
equipment ,care:2
secondary ,care:2
clusters ,coronavirus:2
clusters ,disease:2
clusters ,communities:2
clusters ,japan:2
clusters ,january-april:2
coronavirus ,communities:2
coronavirus ,january-april:2
disease ,communities:2
disease ,january-april:2
communities ,japan:2
communities ,january-april:2
japan ,january-april:2
sars-cov-2 ,glycoprotein:26
sars-cov-2 ,target:32
spike ,drug:8
spike ,vaccine:6
spike ,target:4
spike ,insights:2
glycoprotein ,drug:2
glycoprotein ,vaccine:2
glycoprotein ,target:2
glycoprotein ,structural:2
glycoprotein ,insights:2
drug ,vaccine:4
drug ,target:12
drug ,structural:4
drug ,insights:4
vaccine ,target:2
vaccine ,structural:4
vaccine ,insights:4
target ,structural:4
target ,insights:2
structural ,insights:6
sudden ,persistent:2
sudden ,dysphonia:2
sudden ,within:2
sudden ,framework:2
sudden ,case:2
sudden ,report:2
persistent ,dysphonia:2
persistent ,within:2
persistent ,framework:2
persistent ,covid-19:10
persistent ,case:6
persistent ,report:2
dysphonia ,within:2
dysphonia ,framework:2
dysphonia ,covid-19:2
dysphonia ,case:2
dysphonia ,report:2
within ,framework:2
within ,covid-19:12
within ,case:2
within ,report:2
framework ,covid-19:12
framework ,case:2
framework ,report:2
transmission ,long-haul:2
sars-cov ,long-haul:2
sars-cov ,flight:2
long-haul ,flight:2
correlation ,arterial:2
correlation ,blood:2
correlation ,gas:2
correlation ,ct:6
correlation ,volumetry:2
correlation ,patients:12
correlation ,sars-cov-2:6
arterial ,blood:2
arterial ,gas:2
arterial ,ct:2
arterial ,volumetry:2
arterial ,patients:4
blood ,gas:2
blood ,ct:2
blood ,volumetry:2
blood ,patients:14
gas ,ct:2
gas ,volumetry:2
gas ,patients:2
gas ,sars-cov-2:2
ct ,volumetry:2
ct ,sars-cov-2:10
volumetry ,patients:2
volumetry ,sars-cov-2:2
impact ,circulating:2
impact ,sars-cov-2:48
impact ,mutant:2
impact ,g614:2
circulating ,sars-cov-2:10
circulating ,mutant:2
circulating ,g614:2
circulating ,covid-19:2
circulating ,pandemic:2
sars-cov-2 ,mutant:4
sars-cov-2 ,g614:4
mutant ,g614:2
mutant ,covid-19:2
mutant ,pandemic:2
g614 ,covid-19:2
g614 ,pandemic:2
burden ,illness:2
burden ,households:2
burden ,severe:2
burden ,acute:4
burden ,respiratory:2
burden ,syndrome:2
burden ,coronavirus:2
illness ,households:2
illness ,severe:6
illness ,acute:2
illness ,respiratory:4
illness ,syndrome:2
illness ,coronavirus:4
households ,severe:2
households ,acute:2
households ,respiratory:2
households ,syndrome:2
households ,coronavirus:2
family ,cluster:22
family ,coronavirus:8
family ,disease:4
family ,covid-19:22
family ,infection:2
family ,different:4
family ,clinical:12
cluster ,different:2
cluster ,clinical:14
coronavirus ,different:4
disease ,different:6
covid-19 ,different:20
infection ,different:6
different ,clinical:10
prolonged ,viral:16
prolonged ,feces:2
prolonged ,pediatric:4
prolonged ,patients:12
prolonged ,disease:4
viral ,pediatric:2
shedding ,feces:2
shedding ,pediatric:4
shedding ,disease:4
feces ,pediatric:2
feces ,coronavirus:2
feces ,disease:2
pediatric ,patients:30
pediatric ,coronavirus:20
pediatric ,disease:16
group ,testing:4
group ,severe:2
group ,acute:2
group ,respiratory:2
group ,syndrome-:2
group ,coronavirus:2
group ,enable:2
group ,rapid:2
testing ,syndrome-:2
testing ,enable:2
severe ,syndrome-:2
severe ,enable:2
acute ,syndrome-:2
acute ,enable:2
respiratory ,syndrome-:2
respiratory ,enable:2
syndrome- ,coronavirus:2
syndrome- ,enable:2
syndrome- ,rapid:2
coronavirus ,enable:2
enable ,rapid:2
review ,severe:10
review ,acute:16
review ,respiratory:16
review ,syndrome:18
collapse ,respiratory:2
collapse ,center:2
collapse ,brain:2
collapse ,responsible:2
respiratory ,center:2
respiratory ,brain:2
respiratory ,responsible:2
center ,brain:2
center ,responsible:2
brain ,responsible:2
severe ,risk:26
severe ,elective:2
acute ,risk:14
acute ,elective:2
respiratory ,risk:16
respiratory ,elective:2
syndrome ,risk:8
syndrome ,elective:2
coronavirus ,elective:2
infection ,risk:60
infection ,elective:4
risk ,elective:2
ace2 ,evidence:2
ace2 ,role:6
ace2 ,entry:10
ace2 ,implications:6
evidence ,role:2
evidence ,entry:2
evidence ,receptor:2
role ,entry:4
role ,implications:4
entry ,receptor:8
entry ,implications:2
receptor ,implications:6
decreased ,influenza:2
decreased ,incidence:2
decreased ,covid-19:2
decreased ,control:2
decreased ,measures:2
decreased ,singapore:2
influenza ,incidence:4
influenza ,singapore:2
incidence ,covid-19:32
incidence ,control:2
incidence ,measures:4
incidence ,singapore:2
control ,singapore:2
measures ,singapore:2
transient ,lymphopenia:2
transient ,interstitial:2
transient ,pneumonia:2
transient ,endotheliitis:2
lymphopenia ,interstitial:2
lymphopenia ,pneumonia:2
lymphopenia ,endotheliitis:2
interstitial ,pneumonia:6
interstitial ,endotheliitis:2
pneumonia ,endotheliitis:2
coronavirus ,colonization:2
coronavirus ,tissues:2
disease ,colonization:2
disease ,tissues:2
sars-cov-2 ,colonization:2
sars-cov-2 ,ocular:22
sars-cov-2 ,tissues:8
colonization ,ocular:2
colonization ,tissues:2
ocular ,tissues:4
silico ,known:2
silico ,small:2
silico ,molecules:2
silico ,bind:2
silico ,ace2:2
silico ,specific:2
silico ,rbd:2
screening ,known:2
screening ,small:2
screening ,molecules:2
screening ,bind:2
screening ,ace2:2
screening ,specific:2
screening ,rbd:2
screening ,spike:4
known ,small:2
known ,molecules:2
known ,bind:2
known ,ace2:2
known ,specific:2
known ,rbd:2
known ,spike:2
small ,molecules:4
small ,bind:2
small ,rbd:2
small ,spike:2
molecules ,bind:2
molecules ,ace2:2
molecules ,specific:2
molecules ,rbd:2
molecules ,spike:2
bind ,ace2:4
bind ,specific:2
bind ,rbd:2
bind ,spike:2
ace2 ,rbd:10
ace2 ,spike:22
specific ,rbd:4
specific ,spike:4
rbd ,spike:8
pathogenesis ,strategies:2
pathogenesis ,covid-19-related:2
pathogenesis ,hypercoagulant:2
treatment ,covid-19-related:4
treatment ,hypercoagulant:2
strategies ,covid-19-related:2
strategies ,hypercoagulant:2
covid-19-related ,hypercoagulant:2
taiwan ,government-guided:2
taiwan ,strategies:2
taiwan ,contributed:2
taiwan ,combating:2
taiwan ,controlling:2
government-guided ,strategies:2
government-guided ,contributed:2
government-guided ,combating:2
government-guided ,controlling:2
strategies ,contributed:2
strategies ,combating:2
strategies ,controlling:2
contributed ,combating:2
contributed ,controlling:2
combating ,controlling:2
characteristics ,roles:2
characteristics ,acute:20
characteristics ,respiratory:18
characteristics ,syndrome:14
roles ,severe:2
roles ,acute:2
roles ,respiratory:2
roles ,syndrome:2
roles ,coronavirus:4
evaluation ,aptima:2
evaluation ,transcription-mediated:2
evaluation ,amplification:2
evaluation ,hologic:2
aptima ,transcription-mediated:2
aptima ,amplification:2
aptima ,assay:2
aptima ,hologic:2
transcription-mediated ,amplification:4
transcription-mediated ,assay:2
transcription-mediated ,hologic:4
amplification ,assay:6
amplification ,hologic:4
assay ,hologic:2
low ,prevalence:8
low ,active:2
low ,covid-19:20
low ,slovenia:2
low ,nationwide:2
low ,population:2
low ,study:2
prevalence ,active:4
prevalence ,covid-19:44
prevalence ,slovenia:2
prevalence ,nationwide:4
prevalence ,population:4
prevalence ,study:6
active ,covid-19:14
active ,slovenia:2
active ,nationwide:2
active ,population:2
active ,study:2
covid-19 ,slovenia:2
covid-19 ,nationwide:4
covid-19 ,population:20
slovenia ,nationwide:2
slovenia ,population:2
slovenia ,study:2
nationwide ,population:4
nationwide ,study:2
population ,study:2
paediatric ,inflammatory:2
paediatric ,multisystem:2
paediatric ,syndrome:2
paediatric ,temporally:2
paediatric ,associated:2
paediatric ,sars-cov-2:2
inflammatory ,multisystem:32
inflammatory ,syndrome:38
inflammatory ,temporally:4
inflammatory ,associated:10
multisystem ,syndrome:32
multisystem ,temporally:4
multisystem ,associated:8
multisystem ,sars-cov-2:2
syndrome ,temporally:4
temporally ,associated:4
temporally ,sars-cov-2:2
protective ,immunity:8
protective ,covid-19:16
protective ,questioned:2
protective ,can:2
protective ,without:2
immunity ,questioned:2
immunity ,can:4
immunity ,without:2
covid-19 ,questioned:2
questioned ,can:2
questioned ,without:2
can ,without:4
diagnostic ,consideration:4
diagnostic ,bedside:2
diagnostic ,estimation:6
diagnostic ,prognosis:2
consideration ,bedside:2
consideration ,estimation:2
consideration ,prognosis:2
consideration ,covid-19:8
bedside ,estimation:2
bedside ,prognosis:2
bedside ,covid-19:6
estimation ,prognosis:2
estimation ,covid-19:8
sars-cov-2 ,cross-sectional:4
infection ,health:26
infection ,care:40
infection ,workers:36
infection ,cross-sectional:2
health ,care:72
health ,workers:56
health ,cross-sectional:4
health ,analysis:4
care ,workers:40
care ,cross-sectional:2
care ,analysis:4
workers ,cross-sectional:2
workers ,analysis:6
cross-sectional ,analysis:4
perspectives ,surgical:2
perspectives ,anaesthetic:2
perspectives ,management:4
perspectives ,lung:2
perspectives ,cancer:2
perspectives ,era:2
surgical ,anaesthetic:2
surgical ,management:12
surgical ,lung:2
surgical ,cancer:4
surgical ,era:2
anaesthetic ,management:2
anaesthetic ,lung:2
anaesthetic ,cancer:2
anaesthetic ,era:2
management ,lung:6
management ,cancer:22
management ,era:8
lung ,cancer:18
lung ,era:4
cancer ,era:6
estimating ,risk:2
estimating ,death:2
estimating ,coronavirus:4
estimating ,disease:2
estimating ,china:4
estimating ,january-february:2
risk ,death:16
risk ,january-february:2
death ,coronavirus:2
death ,disease:4
death ,china:2
death ,january-february:2
coronavirus ,january-february:2
disease ,january-february:2
china ,january-february:4
molecular ,study:10
molecular ,revealed:2
molecular ,synthetic:2
molecular ,peptides:2
molecular ,induced:4
molecular ,conformational:2
docking ,study:4
docking ,revealed:2
docking ,synthetic:2
docking ,peptides:2
docking ,induced:2
docking ,conformational:2
study ,revealed:2
study ,synthetic:2
study ,peptides:2
study ,induced:2
study ,conformational:2
revealed ,synthetic:2
revealed ,peptides:2
revealed ,induced:2
revealed ,conformational:2
synthetic ,peptides:2
synthetic ,induced:2
synthetic ,conformational:2
peptides ,induced:2
peptides ,conformational:2
induced ,conformational:2
report ,positive:6
report ,placental:2
report ,swabs:2
report ,asymptomatic:2
report ,pregnant:6
report ,woman:4
positive ,placental:2
positive ,swabs:2
positive ,asymptomatic:8
positive ,pregnant:2
positive ,woman:4
placental ,swabs:2
placental ,sars-cov-2:4
placental ,asymptomatic:2
placental ,pregnant:4
placental ,woman:4
swabs ,asymptomatic:2
swabs ,pregnant:2
swabs ,woman:2
sars-cov-2 ,woman:12
asymptomatic ,pregnant:6
asymptomatic ,woman:4
pregnant ,woman:18
interleukin-6 ,receptor:2
interleukin-6 ,antagonist:2
interleukin-6 ,therapy:2
interleukin-6 ,treat:2
interleukin-6 ,sars-cov-2:6
interleukin-6 ,driven:2
interleukin-6 ,inflammatory:2
receptor ,antagonist:4
receptor ,therapy:2
receptor ,treat:2
receptor ,driven:2
receptor ,inflammatory:2
antagonist ,therapy:2
antagonist ,treat:4
antagonist ,sars-cov-2:4
antagonist ,driven:2
antagonist ,inflammatory:2
therapy ,treat:4
therapy ,sars-cov-2:24
therapy ,driven:2
therapy ,inflammatory:6
treat ,sars-cov-2:10
treat ,driven:2
treat ,inflammatory:2
sars-cov-2 ,driven:2
driven ,inflammatory:2
disease ,social:8
management ,treatment:2
management ,social:2
management ,impact:10
treatment ,social:2
treatment ,impact:8
cardiac ,arrhythmic:2
cardiac ,complications:10
cardiac ,patients:6
arrhythmic ,complications:2
arrhythmic ,patients:2
arrhythmic ,covid-19:2
complications ,patients:10
rapid ,evaluation:28
rapid ,igg:14
rapid ,z-scores:2
rapid ,standardize:2
screening ,evaluation:2
screening ,igg:2
screening ,assays:4
screening ,using:14
screening ,z-scores:2
screening ,standardize:2
evaluation ,assays:24
evaluation ,z-scores:2
evaluation ,standardize:2
sars-cov-2 ,z-scores:2
sars-cov-2 ,standardize:2
igg ,assays:8
igg ,z-scores:2
igg ,standardize:2
assays ,z-scores:2
assays ,standardize:2
using ,z-scores:2
using ,standardize:2
z-scores ,standardize:2
echocardiographic ,examinations:2
echocardiographic ,times:2
echocardiographic ,covid-19:2
echocardiographic ,pandemic:2
echocardiographic ,international:2
examinations ,times:2
examinations ,covid-19:2
examinations ,pandemic:2
examinations ,international:2
times ,international:2
covid-19 ,international:6
pandemic ,international:2
sars-cov-2 ,utilize:2
sars-cov-2 ,orthologs:2
three ,related:2
three ,coronaviruses:2
three ,utilize:2
three ,multiple:2
three ,ace2:2
three ,orthologs:2
related ,coronaviruses:2
related ,utilize:2
related ,multiple:4
related ,ace2:4
related ,orthologs:2
coronaviruses ,utilize:2
coronaviruses ,multiple:2
coronaviruses ,orthologs:2
utilize ,multiple:2
utilize ,ace2:2
utilize ,orthologs:2
multiple ,ace2:6
multiple ,orthologs:2
ace2 ,orthologs:2
sars-cov-2 ,controlled:4
sars-cov-2 ,ethics:2
sars-cov-2 ,challenge:14
sars-cov-2 ,agent:4
sars-cov-2 ,production:10
controlled ,human:4
controlled ,infection:4
controlled ,models:2
controlled ,ethics:2
controlled ,challenge:2
controlled ,agent:2
controlled ,production:2
human ,infection:40
human ,models:6
human ,ethics:2
human ,challenge:6
human ,agent:2
human ,production:4
infection ,models:8
infection ,ethics:2
infection ,challenge:2
infection ,agent:2
infection ,production:4
models ,ethics:2
models ,challenge:2
models ,agent:2
models ,production:2
ethics ,challenge:2
ethics ,agent:2
ethics ,production:2
challenge ,agent:2
challenge ,production:2
agent ,production:2
clinical ,421:2
characteristics ,outcomes:30
characteristics ,421:2
outcomes ,421:2
outcomes ,patients:50
421 ,patients:2
421 ,coronavirus:2
421 ,disease:2
strong ,associations:2
strong ,moderate:2
strong ,predictive:2
strong ,value:2
strong ,early:2
strong ,symptoms:2
strong ,sars-cov-2:6
associations ,moderate:2
associations ,predictive:2
associations ,value:2
associations ,early:2
associations ,symptoms:2
associations ,sars-cov-2:6
moderate ,predictive:2
moderate ,value:2
moderate ,early:2
moderate ,symptoms:2
moderate ,sars-cov-2:4
predictive ,value:8
predictive ,early:6
predictive ,symptoms:4
predictive ,sars-cov-2:6
value ,early:4
value ,symptoms:2
early ,symptoms:2
immunological ,co-ordination:2
immunological ,gut:2
immunological ,lungs:2
immunological ,infection:2
co-ordination ,gut:2
co-ordination ,lungs:2
co-ordination ,sars-cov-2:2
co-ordination ,infection:2
gut ,lungs:2
gut ,sars-cov-2:6
gut ,infection:4
lungs ,sars-cov-2:8
lungs ,infection:4
differential ,diagnosis:12
differential ,pulmonary:2
differential ,infiltrates:2
differential ,cancer:2
differential ,patients:8
diagnosis ,pulmonary:6
diagnosis ,infiltrates:2
diagnosis ,cancer:2
diagnosis ,patients:12
pulmonary ,infiltrates:2
pulmonary ,cancer:2
infiltrates ,cancer:2
infiltrates ,patients:2
cancer ,patients:88
pulmonary ,fibrosis:2
pulmonary ,potential:2
pulmonary ,role:2
pulmonary ,antifibrotic:2
pulmonary ,therapy:2
fibrosis ,covid-19:6
fibrosis ,potential:2
fibrosis ,role:2
fibrosis ,antifibrotic:2
fibrosis ,therapy:2
covid-19 ,antifibrotic:2
potential ,antifibrotic:2
role ,antifibrotic:2
role ,therapy:4
antifibrotic ,therapy:2
online ,dashboard:2
online ,data:4
online ,approach:2
online ,assessing:4
online ,covid-19:8
online ,case:2
online ,death:2
dashboard ,data:2
dashboard ,analysis:2
dashboard ,approach:2
dashboard ,assessing:2
dashboard ,covid-19:2
dashboard ,case:2
dashboard ,death:2
data ,assessing:2
data ,case:8
data ,death:2
analysis ,approach:2
analysis ,assessing:2
analysis ,death:6
approach ,assessing:2
approach ,case:4
approach ,death:2
assessing ,case:4
assessing ,death:2
covid-19 ,death:24
case ,death:2
evaluation ,high-throughput:4
evaluation ,serological:8
evaluation ,tests:10
high-throughput ,serological:2
high-throughput ,tests:2
high-throughput ,sars-cov-2:10
serological ,sars-cov-2:58
myocardial ,covid-19:12
myocardial ,possible:2
myocardial ,mechanisms:2
injury ,possible:4
injury ,mechanisms:10
therapeutic ,opportunities:6
therapeutic ,manage:2
therapeutic ,covid-19sars-cov-2:2
therapeutic ,infection:8
therapeutic ,present:2
opportunities ,manage:2
opportunities ,covid-19sars-cov-2:2
opportunities ,infection:2
opportunities ,present:2
manage ,covid-19sars-cov-2:2
manage ,infection:2
manage ,present:2
covid-19sars-cov-2 ,infection:4
covid-19sars-cov-2 ,present:2
infection ,present:2
topical ,preparations:2
topical ,reduce:2
topical ,sars-cov-2:4
topical ,aerosolization:2
topical ,head:2
topical ,neck:2
topical ,mucosal:4
preparations ,reduce:2
preparations ,sars-cov-2:2
preparations ,aerosolization:2
preparations ,head:2
preparations ,neck:2
preparations ,mucosal:2
reduce ,sars-cov-2:16
reduce ,aerosolization:2
reduce ,head:2
reduce ,neck:2
reduce ,mucosal:2
sars-cov-2 ,aerosolization:2
sars-cov-2 ,head:8
sars-cov-2 ,neck:8
sars-cov-2 ,mucosal:8
aerosolization ,head:2
aerosolization ,neck:2
aerosolization ,mucosal:2
head ,neck:32
head ,mucosal:4
neck ,mucosal:4
computational ,design:2
computational ,ace2-based:2
computational ,peptide:2
computational ,inhibitors:4
design ,ace2-based:2
design ,peptide:4
design ,inhibitors:6
ace2-based ,peptide:2
ace2-based ,inhibitors:2
ace2-based ,sars-cov-2:2
peptide ,inhibitors:4
peptide ,sars-cov-2:6
sars-cov-2 ,newest:2
sars-cov-2 ,spark:2
sars-cov-2 ,torch:2
newest ,spark:2
newest ,torch:2
spark ,torch:2
covid-19 ,renin-angiotensin:26
covid-19 ,imbalance:4
renin-angiotensin ,imbalance:2
renin-angiotensin ,hypothesis:2
system ,hypothesis:4
imbalance ,hypothesis:2
inactivation ,severe:8
inactivation ,acute:8
inactivation ,respiratory:8
inactivation ,syndrome:8
inactivation ,coronavirus:6
inactivation ,who-recommended:2
severe ,who-recommended:2
acute ,who-recommended:2
respiratory ,who-recommended:2
syndrome ,who-recommended:2
coronavirus ,who-recommended:2
kidney ,injury:30
pandemic ,tale:2
pandemic ,viremia:2
pandemic ,cellular:2
pandemic ,oxidation:2
pandemic ,immune:2
pandemic ,dysfunction:2
covid-19 ,tale:6
covid-19 ,viremia:2
covid-19 ,cellular:12
covid-19 ,oxidation:2
tale ,viremia:2
tale ,cellular:2
tale ,oxidation:2
tale ,immune:2
tale ,dysfunction:2
viremia ,cellular:2
viremia ,oxidation:2
viremia ,immune:2
viremia ,dysfunction:2
cellular ,oxidation:2
cellular ,immune:4
cellular ,dysfunction:2
oxidation ,immune:2
oxidation ,dysfunction:2
immune ,dysfunction:2
making ,case:2
making ,using:2
making ,cells:2
making ,sars-cov-2:2
case ,using:4
case ,cells:4
using ,cells:2
sars-cov-2 ,kidney:14
sars-cov-2 ,injury:16
sars-cov-2 ,pre-existing:4
infection ,kidney:12
infection ,injury:10
infection ,pre-existing:2
associated ,kidney:2
associated ,injury:10
associated ,patients:18
associated ,pre-existing:2
acute ,kidney:22
acute ,patients:50
acute ,pre-existing:2
kidney ,patients:20
kidney ,pre-existing:2
injury ,pre-existing:2
patients ,pre-existing:6
covid-19 ,learnt:2
covid-19 ,plan:4
learnt ,plan:2
learnt ,future:2
plan ,future:2
sars-cov-2 ,come:2
combating ,mva:2
combating ,vector:2
combating ,vaccines:2
combating ,applied:2
combating ,respiratory:2
combating ,tract:2
covid-19 ,mva:2
covid-19 ,vector:2
mva ,vector:2
mva ,vaccines:2
mva ,applied:2
mva ,respiratory:2
mva ,tract:2
vector ,vaccines:2
vector ,applied:2
vector ,respiratory:2
vector ,tract:2
vaccines ,applied:2
vaccines ,tract:2
applied ,respiratory:2
applied ,tract:2
decoy ,ace2-expressing:2
decoy ,extracellular:2
decoy ,vesicles:2
decoy ,competitively:2
decoy ,bind:2
decoy ,sars-cov-2:2
ace2-expressing ,extracellular:2
ace2-expressing ,vesicles:2
ace2-expressing ,competitively:2
ace2-expressing ,bind:2
ace2-expressing ,sars-cov-2:2
extracellular ,competitively:2
extracellular ,bind:2
extracellular ,sars-cov-2:2
vesicles ,competitively:2
vesicles ,bind:2
vesicles ,sars-cov-2:2
competitively ,bind:2
competitively ,sars-cov-2:2
bind ,sars-cov-2:4
neurological ,comorbidity:2
neurological ,associated:2
neurological ,overview:2
manifestations ,comorbidity:2
manifestations ,associated:6
manifestations ,overview:6
comorbidity ,associated:4
comorbidity ,overview:2
associated ,overview:2
hospital ,indoor:2
hospital ,air:6
hospital ,quality:2
hospital ,monitoring:4
hospital ,detection:6
hospital ,sars-cov-2:28
hospital ,covid-19:60
indoor ,air:6
indoor ,quality:2
indoor ,monitoring:2
indoor ,detection:2
indoor ,covid-19:4
air ,quality:14
air ,monitoring:2
air ,detection:6
quality ,monitoring:2
quality ,detection:6
quality ,covid-19:8
monitoring ,detection:4
azithromycin ,infection:4
azithromycin ,now:2
azithromycin ,going:2
sars-cov-2 ,now:4
infection ,now:2
infection ,going:2
now ,going:2
possible ,unregistered:2
possible ,young:2
possible ,man:2
possible ,anosmia:2
unregistered ,sars-cov-2:2
unregistered ,infection:2
unregistered ,young:2
unregistered ,man:2
unregistered ,anosmia:2
sars-cov-2 ,young:12
sars-cov-2 ,man:4
infection ,young:4
infection ,man:2
infection ,anosmia:10
young ,man:2
young ,anosmia:2
man ,anosmia:2
co-expression ,mitochondrial:2
co-expression ,genes:2
co-expression ,ace2:2
co-expression ,cornea:2
co-expression ,involved:2
co-expression ,covid-19:2
mitochondrial ,genes:2
mitochondrial ,ace2:2
mitochondrial ,cornea:2
mitochondrial ,involved:2
mitochondrial ,covid-19:2
genes ,ace2:6
genes ,cornea:2
genes ,involved:2
ace2 ,cornea:2
ace2 ,involved:2
cornea ,involved:2
cornea ,covid-19:2
involved ,covid-19:2
serial ,interval:4
serial ,covid-19:6
serial ,among:2
serial ,publicly:2
serial ,reported:2
serial ,confirmed:2
serial ,cases:4
interval ,covid-19:4
interval ,among:2
interval ,publicly:2
interval ,reported:2
interval ,confirmed:2
interval ,cases:2
covid-19 ,publicly:6
among ,publicly:2
among ,reported:2
among ,confirmed:2
among ,cases:6
publicly ,reported:6
publicly ,confirmed:2
publicly ,cases:2
reported ,confirmed:2
reported ,cases:6
effect ,convalescent:4
effect ,plasma:4
effect ,therapy:2
effect ,viral:2
effect ,survival:2
effect ,patients:8
convalescent ,viral:4
convalescent ,shedding:2
convalescent ,survival:2
convalescent ,patients:16
plasma ,viral:4
plasma ,shedding:2
plasma ,survival:2
plasma ,patients:16
therapy ,viral:6
therapy ,shedding:2
therapy ,survival:2
viral ,survival:2
shedding ,survival:2
survival ,patients:6
neuropsychological ,functioning:2
neuropsychological ,severe:2
neuropsychological ,acute:2
neuropsychological ,respiratory:2
neuropsychological ,disorders:2
neuropsychological ,caused:2
functioning ,severe:2
functioning ,acute:2
functioning ,respiratory:2
functioning ,disorders:2
functioning ,caused:2
severe ,disorders:2
severe ,caused:10
acute ,disorders:4
respiratory ,disorders:2
disorders ,caused:2
update ,status:4
update ,comprehensive:4
status ,comprehensive:4
status ,review:8
first ,cancer:2
first ,slovakia:2
cancer ,patient:12
cancer ,covid-19:90
cancer ,slovakia:2
patient ,slovakia:2
covid-19 ,slovakia:2
clinical ,repurposed:2
clinical ,antivirals:2
trials ,repurposed:2
trials ,antivirals:2
repurposed ,antivirals:2
repurposed ,sars-cov-2:4
coronavirus ,systematic:30
coronavirus ,919:2
disease ,systematic:28
disease ,919:2
covid-19 ,919:2
systematic ,imaging:4
systematic ,findings:6
systematic ,919:2
review ,imaging:6
review ,findings:8
review ,919:2
imaging ,findings:18
imaging ,919:2
findings ,919:2
dying ,sars-cov-2:2
dying ,infection-an:2
dying ,autopsy:2
dying ,study:2
dying ,first:2
dying ,consecutive:2
dying ,80:2
dying ,cases:2
sars-cov-2 ,infection-an:2
sars-cov-2 ,autopsy:6
sars-cov-2 ,consecutive:2
sars-cov-2 ,80:2
infection-an ,autopsy:2
infection-an ,study:2
infection-an ,first:2
infection-an ,consecutive:2
infection-an ,80:2
infection-an ,cases:2
autopsy ,study:2
autopsy ,first:4
autopsy ,consecutive:2
autopsy ,80:2
autopsy ,cases:6
study ,first:10
study ,consecutive:2
study ,80:2
first ,consecutive:2
first ,80:2
consecutive ,80:2
consecutive ,cases:2
80 ,cases:2
positive ,rna:18
positive ,recurs:2
positive ,repeatedly:2
positive ,case:14
positive ,dynamic:2
sars-cov-2 ,recurs:2
sars-cov-2 ,repeatedly:2
sars-cov-2 ,recovered:12
rna ,recurs:2
rna ,repeatedly:2
rna ,case:10
rna ,recovered:10
rna ,dynamic:6
recurs ,repeatedly:2
recurs ,case:2
recurs ,recovered:2
recurs ,covid-19:2
recurs ,dynamic:2
repeatedly ,case:2
repeatedly ,recovered:2
repeatedly ,covid-19:4
repeatedly ,dynamic:2
case ,dynamic:2
recovered ,dynamic:2
covid-19 ,dynamic:12
significance ,serology:2
significance ,testing:2
significance ,assist:2
significance ,timely:2
significance ,diagnosis:2
significance ,sars-cov-2:4
serology ,assist:2
serology ,timely:2
serology ,diagnosis:2
testing ,assist:2
testing ,timely:2
testing ,diagnosis:4
assist ,timely:2
assist ,diagnosis:2
assist ,sars-cov-2:2
timely ,diagnosis:4
timely ,sars-cov-2:2
haemophilia ,impacts:2
haemophilia ,severe:2
haemophilia ,acute:2
haemophilia ,respiratory:2
haemophilia ,syndrome:2
haemophilia ,coronavirus:2
impacts ,severe:2
impacts ,acute:2
impacts ,respiratory:2
impacts ,syndrome:2
impacts ,coronavirus:4
virology ,epidemiology:8
virology ,pathogenesis:6
virology ,control:2
epidemiology ,pathogenesis:6
epidemiology ,control:10
pathogenesis ,control:4
diffuse ,alveolar:4
diffuse ,damage:4
diffuse ,dad:2
diffuse ,resulting:2
diffuse ,coronavirus:2
diffuse ,disease:2
diffuse ,infection:2
alveolar ,damage:4
alveolar ,dad:2
alveolar ,resulting:2
alveolar ,coronavirus:2
alveolar ,disease:2
alveolar ,infection:2
damage ,dad:2
damage ,resulting:2
damage ,coronavirus:2
damage ,disease:2
damage ,infection:10
dad ,resulting:2
dad ,coronavirus:2
dad ,disease:2
dad ,infection:2
resulting ,coronavirus:2
resulting ,disease:2
resulting ,infection:2
anosmia ,covid-19:28
anosmia ,bumpy:2
anosmia ,road:2
anosmia ,establishing:2
anosmia ,cellular:2
anosmia ,mechanism:2
covid-19 ,bumpy:2
covid-19 ,establishing:4
bumpy ,road:2
bumpy ,establishing:2
bumpy ,cellular:2
bumpy ,mechanism:2
road ,establishing:2
road ,cellular:2
road ,mechanism:2
establishing ,cellular:2
establishing ,mechanism:2
cellular ,mechanism:2
novel ,antigens:2
novel ,angiotensin:2
rapid ,spike:6
rapid ,antigens:2
rapid ,angiotensin:2
detection ,antigens:2
detection ,angiotensin:2
sars-cov-2 ,antigens:6
sars-cov-2 ,angiotensin:4
spike ,antigens:2
spike ,using:6
spike ,angiotensin:2
antigens ,using:2
antigens ,human:2
antigens ,angiotensin:2
using ,human:8
using ,angiotensin:2
human ,angiotensin:2
acute ,manic:4
acute ,episode:4
acute ,quarantine:2
manic ,episode:4
manic ,2019-ncov:2
manic ,quarantine:2
episode ,2019-ncov:2
episode ,quarantine:2
2019-ncov ,quarantine:2
covid-19 ,radiological:16
covid-19 ,adults:34
clinical ,adults:6
clinical ,infants:2
biological ,radiological:2
biological ,adults:2
biological ,infants:2
radiological ,adults:2
radiological ,infants:2
characteristics ,adults:2
characteristics ,infants:2
adults ,infants:2
hydroxychloroquine ,used:2
hydroxychloroquine ,standard:2
chloroquine ,used:2
chloroquine ,standard:2
covid-19 ,standard:6
used ,standard:2
similarities ,effect:2
similarities ,sars-cov-2:4
similarities ,hcv:2
similarities ,cellular:2
similarities ,level:2
effect ,hcv:2
effect ,cellular:2
effect ,level:2
sars-cov-2 ,hcv:2
sars-cov-2 ,cellular:12
hcv ,cellular:2
hcv ,level:2
cellular ,level:2
neurological ,coronavirus:20
neurological ,infections:6
manifestations ,coronavirus:34
manifestations ,infections:6
virolactia ,asymptomatic:2
virolactia ,mother:2
virolactia ,covid-19:2
asymptomatic ,mother:2
mother ,covid-19:4
hazards ,cytokine:2
hazards ,storm:2
hazards ,cytokine-targeted:2
hazards ,therapy:2
hazards ,patients:2
cytokine ,cytokine-targeted:2
cytokine ,therapy:4
storm ,cytokine-targeted:2
storm ,therapy:4
cytokine-targeted ,therapy:2
cytokine-targeted ,patients:2
clinical ,immunity:2
clinical ,discharged:6
clinical ,medical:4
immunity ,discharged:2
immunity ,medical:2
immunity ,patients:6
discharged ,medical:2
discharged ,patients:14
discharged ,covid-19:8
advances ,ace2:2
advances ,receptor:2
advances ,2019-ncov:2
research ,ace2:2
research ,receptor:2
research ,2019-ncov:2
ace2 ,2019-ncov:8
epidemiology ,severe:14
epidemiology ,syndrome:10
epidemiology ,emergence:4
epidemiology ,amidst:2
severe ,amidst:2
acute ,amidst:2
respiratory ,amidst:2
syndrome ,amidst:2
coronavirus ,emergence:18
coronavirus ,amidst:4
emergence ,amidst:2
identifying ,interrupting:2
identifying ,superspreading:2
identifying ,events-implications:2
identifying ,control:2
interrupting ,superspreading:2
interrupting ,events-implications:2
interrupting ,control:2
superspreading ,events-implications:2
superspreading ,control:2
events-implications ,control:2
assessment ,human:2
assessment ,semen-a:2
assessment ,cohort:4
assessment ,study:2
sars-cov-2 ,semen-a:2
sars-cov-2 ,cohort:14
human ,semen-a:2
human ,cohort:2
human ,study:4
semen-a ,cohort:2
semen-a ,study:2
cohort ,study:6
clinical ,luminex:2
clinical ,nxtag:2
clinical ,cov:2
clinical ,panel:4
performance ,luminex:2
performance ,nxtag:2
performance ,cov:2
performance ,extended:4
performance ,panel:2
luminex ,nxtag:2
luminex ,cov:2
luminex ,extended:2
luminex ,panel:2
luminex ,sars-cov-2:2
nxtag ,cov:2
nxtag ,extended:2
nxtag ,panel:2
nxtag ,sars-cov-2:2
cov ,extended:2
cov ,panel:2
cov ,sars-cov-2:2
extended ,panel:2
extended ,sars-cov-2:2
panel ,sars-cov-2:10
coronaviruses ,cats:2
coronaviruses ,companion:2
coronaviruses ,animals:2
coronaviruses ,sars-cov-2covid-19:2
cats ,companion:2
cats ,animals:4
cats ,sars-cov-2covid-19:2
companion ,animals:10
companion ,sars-cov-2covid-19:2
animals ,sars-cov-2covid-19:2
sars-cov-2 ,soils:2
angiotensin ,receptor:14
angiotensin ,blockers:10
angiotensin ,tentative:2
angiotensin ,therapeutics:2
receptor ,blockers:10
receptor ,tentative:2
receptor ,therapeutics:2
blockers ,tentative:2
blockers ,sars-cov-2:2
blockers ,therapeutics:2
tentative ,sars-cov-2:2
tentative ,therapeutics:2
sars-cov-2 ,therapeutics:6
review ,based:8
novel ,evidence:4
infection ,special:4
infection ,considerations:6
children ,special:2
children ,considerations:4
special ,considerations:12
comparison ,high-throughput:4
comparison ,platform:2
sars-cov-2 ,platform:6
rt-pcr ,high-throughput:2
rt-pcr ,molecular:2
rt-pcr ,platform:2
high-throughput ,molecular:2
high-throughput ,diagnostic:2
high-throughput ,platform:2
molecular ,platform:2
diagnostic ,platform:4
serological ,survey:4
serological ,cat:2
serological ,wuhan:2
survey ,sars-cov-2:8
survey ,cat:2
survey ,wuhan:2
sars-cov-2 ,cat:6
sars-cov-2 ,wuhan:18
cat ,wuhan:2
hypothesis ,affects:2
hypothesis ,male:2
hypothesis ,reproductive:2
hypothesis ,ability:2
hypothesis ,regulating:2
sars-cov-2 ,affects:2
sars-cov-2 ,reproductive:8
sars-cov-2 ,ability:6
sars-cov-2 ,regulating:2
affects ,male:2
affects ,reproductive:2
affects ,ability:2
affects ,regulating:2
male ,reproductive:2
male ,ability:2
male ,regulating:2
reproductive ,ability:2
reproductive ,regulating:2
ability ,regulating:2
evaluation ,diagnosis:4
evaluation ,disease:4
rapid ,diagnosis:16
rapid ,disease:4
diagnosis ,using:4
disease ,using:4
role ,gtngtkr:2
role ,motif:2
role ,n-terminal:2
role ,receptor-binding:2
gtngtkr ,motif:2
gtngtkr ,n-terminal:2
gtngtkr ,receptor-binding:2
gtngtkr ,domain:2
motif ,n-terminal:2
motif ,receptor-binding:4
motif ,domain:2
n-terminal ,receptor-binding:2
n-terminal ,domain:2
covid-19 ,work:14
covid-19 ,legislative:2
covid-19 ,developments:2
work ,environment:2
work ,legislative:2
work ,developments:2
work ,role:2
environment ,legislative:2
environment ,developments:2
environment ,role:2
legislative ,developments:2
legislative ,role:2
developments ,role:2
coronavirus ,kidney:10
disease ,injury:16
coronaviruses ,kidney:2
coronaviruses ,injury:2
aerosol ,distribution:2
aerosol ,severe:6
aerosol ,acute:4
aerosol ,respiratory:6
aerosol ,syndrome:4
aerosol ,coronavirus:6
surface ,distribution:2
surface ,severe:4
surface ,acute:4
surface ,respiratory:4
surface ,syndrome:4
surface ,coronavirus:6
distribution ,severe:2
distribution ,acute:2
distribution ,respiratory:2
distribution ,syndrome:2
distribution ,coronavirus:2
actual ,threat:2
actual ,covid-19:2
sars-cov-2 ,mortalities:2
sars-cov-2 ,strongly:4
sars-cov-2 ,correlate:4
sars-cov-2 ,ace1:2
sars-cov-2 ,id:2
infections ,mortalities:2
infections ,strongly:2
infections ,correlate:2
infections ,ace1:2
infections ,id:2
covid-19 ,mortalities:2
covid-19 ,strongly:4
covid-19 ,correlate:2
covid-19 ,ace1:2
covid-19 ,id:6
mortalities ,strongly:2
mortalities ,correlate:2
mortalities ,ace1:2
mortalities ,id:2
strongly ,correlate:2
strongly ,ace1:2
strongly ,id:2
correlate ,ace1:2
correlate ,id:2
ace1 ,id:2
clinical ,28:4
clinical ,diabetes:2
clinical ,wuhan:12
clinical ,china:18
characteristics ,28:2
characteristics ,diabetes:4
characteristics ,wuhan:8
28 ,patients:4
28 ,diabetes:2
28 ,wuhan:2
28 ,china:2
patients ,diabetes:22
diabetes ,wuhan:2
diabetes ,china:2
uhms ,position:2
uhms ,statement:2
uhms ,hyperbaric:2
uhms ,oxygen:2
uhms ,hbo2:2
uhms ,covid-19:2
uhms ,patients:2
position ,statement:6
position ,hyperbaric:2
position ,oxygen:2
position ,hbo2:2
position ,covid-19:16
position ,patients:8
statement ,hyperbaric:2
statement ,oxygen:2
statement ,hbo2:2
statement ,covid-19:2
statement ,patients:2
hyperbaric ,oxygen:6
hyperbaric ,hbo2:2
hyperbaric ,covid-19:6
hyperbaric ,patients:4
oxygen ,hbo2:2
oxygen ,covid-19:14
oxygen ,patients:10
hbo2 ,covid-19:2
hbo2 ,patients:2
endothelial ,dysfunction:12
endothelial ,covid-19:14
endothelial ,lessons:2
endothelial ,learned:2
endothelial ,coronaviruses:2
dysfunction ,lessons:2
dysfunction ,learned:2
dysfunction ,coronaviruses:2
lessons ,coronaviruses:2
learned ,coronaviruses:2
gastrointestinal ,bleeding:2
gastrointestinal ,severe:4
gastrointestinal ,sars-cov-2:18
bleeding ,patients:4
bleeding ,severe:2
bleeding ,sars-cov-2:2
patients ,severe:68
severe ,dentistry:2
acute ,dentistry:2
respiratory ,dentistry:2
syndrome ,dentistry:2
coronavirus-2 ,dentistry:2
sars ,dentistry:2
cov-2 ,dentistry:2
covid-19 ,mumbai:2
lockdown ,insights:2
lockdown ,mumbai:2
insights ,mumbai:2
covid-19 ,dealing:2
covid-19 ,multisystem:18
covid-19 ,vasculopathy:2
covid-19 ,disguise:2
dealing ,multisystem:2
dealing ,vasculopathy:2
dealing ,disguise:2
dealing ,viral:2
multisystem ,vasculopathy:2
multisystem ,disguise:2
multisystem ,viral:2
vasculopathy ,disguise:2
vasculopathy ,viral:2
disguise ,viral:2
lessons ,lumbar:2
lessons ,burst:2
lessons ,fracture:2
lessons ,patient:2
lessons ,infected:2
lumbar ,burst:2
lumbar ,fracture:2
lumbar ,patient:2
lumbar ,infected:2
lumbar ,sars-cov-2:2
burst ,fracture:2
burst ,patient:2
burst ,infected:2
burst ,sars-cov-2:2
fracture ,patient:2
fracture ,infected:2
fracture ,sars-cov-2:2
patient ,infected:8
sars-cov-2 ,test:44
sars-cov-2 ,interpret:2
serology ,test:4
serology ,interpret:2
serology ,caution:2
test ,interpret:2
test ,caution:2
interpret ,caution:4
inactivation ,plasma:2
severe ,plasma:10
acute ,plasma:4
respiratory ,plasma:2
syndrome ,plasma:2
acute ,smell:4
acute ,taste:4
acute ,loss:10
acute ,outpatients:2
smell ,outpatients:4
smell ,infected:2
smell ,sars-cov-2:10
taste ,outpatients:4
taste ,infected:2
taste ,sars-cov-2:8
loss ,outpatients:2
loss ,infected:2
loss ,sars-cov-2:8
outpatients ,infected:2
outpatients ,sars-cov-2:6
genome ,epidemiological:2
genome ,study:2
genome ,introduction:2
genome ,japan:2
epidemiological ,study:8
epidemiological ,introduction:2
epidemiological ,japan:2
study ,introduction:2
study ,japan:2
sars-cov-2 ,introduction:2
sars-cov-2 ,japan:8
introduction ,japan:2
estimating ,covid-19:8
estimating ,prevalence:2
estimating ,infection:2
estimating ,control:2
estimating ,practices:2
estimating ,among:2
estimating ,us:2
estimating ,dentists:2
prevalence ,control:2
prevalence ,practices:2
prevalence ,us:4
prevalence ,dentists:2
infection ,control:44
infection ,practices:4
infection ,us:6
infection ,dentists:2
control ,practices:4
control ,among:2
control ,us:4
control ,dentists:2
practices ,among:4
practices ,us:2
practices ,dentists:2
among ,us:8
among ,dentists:2
us ,dentists:2
targeting ,drug:8
targeting ,repurposing:4
sars-cov-2 ,rna-dependent:8
sars-cov-2 ,repurposing:26
rna-dependent ,silico:2
rna-dependent ,drug:6
rna-dependent ,repurposing:2
rna ,silico:2
rna ,drug:8
rna ,repurposing:4
polymerase ,silico:2
polymerase ,drug:8
polymerase ,repurposing:2
silico ,drug:12
silico ,repurposing:14
molecular ,human:8
molecular ,north:2
molecular ,central:2
molecular ,part:2
molecular ,bangladesh:2
detection ,north:4
detection ,central:2
detection ,bangladesh:2
human ,north:2
human ,central:2
human ,part:2
human ,bangladesh:2
coronavirus ,north:4
coronavirus ,part:2
coronavirus ,bangladesh:2
north ,central:2
north ,part:2
north ,bangladesh:2
central ,part:2
central ,bangladesh:2
part ,bangladesh:2
response ,non-covid-19:2
response ,designated:2
response ,latin-american:2
sars-cov-2 ,non-covid-19:2
sars-cov-2 ,latin-american:2
pandemic ,non-covid-19:2
pandemic ,designated:2
pandemic ,latin-american:2
non-covid-19 ,designated:2
non-covid-19 ,latin-american:2
designated ,latin-american:2
covid-19 ,paucisymptomatic:4
covid-19 ,raising:4
covid-19 ,index:6
covid-19 ,suspicion:6
infection ,paucisymptomatic:2
infection ,raising:2
infection ,index:6
infection ,suspicion:2
paucisymptomatic ,infant:2
paucisymptomatic ,raising:2
paucisymptomatic ,index:2
paucisymptomatic ,suspicion:2
infant ,raising:2
infant ,index:2
infant ,suspicion:2
raising ,index:2
raising ,suspicion:2
index ,suspicion:2
challenges ,prevent:2
challenges ,control:4
challenges ,outbreak:10
prevent ,control:6
prevent ,outbreak:4
prevent ,covid-19:10
control ,outbreak:6
molecular ,basis:14
molecular ,coronaviruses:4
molecular ,comparative:8
molecular ,genomics:2
molecular ,approach:2
basis ,pathogenesis:2
basis ,coronaviruses:2
basis ,comparative:2
basis ,genomics:2
basis ,approach:2
pathogenesis ,coronaviruses:10
pathogenesis ,comparative:6
pathogenesis ,genomics:2
pathogenesis ,approach:2
coronaviruses ,comparative:6
coronaviruses ,genomics:2
coronaviruses ,approach:6
comparative ,genomics:2
comparative ,approach:2
genomics ,approach:2
laboratory ,issues:2
laboratory ,challenges:6
diagnosis ,issues:2
diagnosis ,challenges:8
covid-19 ,issues:16
current ,issues:2
issues ,challenges:4
importance ,cellular:2
importance ,immunity:2
importance ,development:2
importance ,vaccines:2
importance ,therapeutics:2
cellular ,immunity:6
cellular ,development:2
cellular ,vaccines:2
cellular ,therapeutics:2
immunity ,development:2
immunity ,vaccines:4
immunity ,therapeutics:2
development ,therapeutics:6
understanding ,prevention:2
understanding ,d-dimer:2
understanding ,elevation:2
understanding ,disease:4
prevention ,d-dimer:2
prevention ,elevation:2
d-dimer ,elevation:2
d-dimer ,coronavirus:6
d-dimer ,disease:2
elevation ,coronavirus:4
elevation ,disease:4
intranasal ,exposure:2
intranasal ,african:2
intranasal ,green:2
intranasal ,monkeys:2
intranasal ,sars-cov-2:2
intranasal ,results:2
intranasal ,acute:2
intranasal ,phase:2
exposure ,african:4
exposure ,green:4
exposure ,monkeys:4
exposure ,sars-cov-2:22
exposure ,results:2
exposure ,phase:2
african ,green:4
african ,monkeys:4
african ,sars-cov-2:6
african ,results:2
african ,acute:2
african ,phase:2
green ,monkeys:4
green ,sars-cov-2:2
green ,results:2
green ,acute:2
green ,phase:2
monkeys ,sars-cov-2:2
monkeys ,results:2
monkeys ,acute:2
monkeys ,phase:2
sars-cov-2 ,phase:4
results ,acute:6
results ,phase:2
acute ,phase:2
emergency ,medicine:2
emergency ,aspects:2
intensive ,medicine:6
intensive ,aspects:2
intensive ,covid-19:26
intensive ,infections:2
care ,medicine:6
care ,aspects:2
care ,infections:4
medicine ,aspects:2
medicine ,infections:2
aspects ,infections:2
machine ,intelligence:4
machine ,design:4
machine ,2019-ncov:2
machine ,drugs:2
intelligence ,design:2
intelligence ,2019-ncov:2
intelligence ,drugs:4
design ,2019-ncov:2
design ,drugs:2
2019-ncov ,drugs:2
vaccination ,sars-cov-2:14
vaccination ,disease:2
vaccination ,enhancement:2
vaccination ,knowns:2
vaccination ,unknowns:2
sars-cov-2 ,knowns:8
sars-cov-2 ,unknowns:6
disease ,enhancement:2
disease ,knowns:2
disease ,unknowns:4
enhancement ,knowns:2
enhancement ,unknowns:2
pediatric ,impact:6
sars-cov-2 ,virulence:4
sars-cov-2 ,interplay:4
sars-cov-2 ,floating:2
sars-cov-2 ,virus-laden:2
sars-cov-2 ,climate:6
virulence ,interplay:2
virulence ,floating:2
virulence ,virus-laden:2
virulence ,particles:2
virulence ,climate:2
interplay ,floating:2
interplay ,virus-laden:2
interplay ,particles:2
interplay ,climate:2
floating ,virus-laden:2
floating ,particles:2
floating ,climate:2
virus-laden ,particles:2
virus-laden ,climate:2
particles ,climate:2
covid-19 ,immunothrombosis:4
immunothrombosis ,gastrointestinal:2
immunothrombosis ,tract:2
gastrointestinal ,tract:2
retinal ,vein:6
retinal ,occlusion:6
retinal ,novel:2
retinal ,entity:2
vein ,occlusion:6
vein ,covid-19:4
vein ,novel:2
vein ,entity:2
occlusion ,covid-19:4
occlusion ,novel:2
occlusion ,entity:2
covid-19 ,entity:2
novel ,entity:2
sampling ,detection:4
sampling ,corona:2
sampling ,viruses:2
sampling ,air:4
sampling ,mini:2
sampling ,review:2
detection ,corona:4
detection ,viruses:4
detection ,mini:2
corona ,viruses:2
corona ,air:4
corona ,mini:2
viruses ,air:2
viruses ,mini:2
viruses ,review:2
air ,mini:2
air ,review:2
novel ,hypothesis:2
novel ,original:2
novel ,sin:2
hypothesis ,original:2
hypothesis ,antigenic:2
hypothesis ,sin:2
hypothesis ,severe:2
hypothesis ,disease:4
original ,antigenic:6
original ,sin:6
original ,severe:4
original ,disease:4
original ,sars-cov-2:2
antigenic ,sin:6
antigenic ,severe:4
antigenic ,disease:2
antigenic ,sars-cov-2:4
sin ,severe:4
sin ,disease:2
sin ,sars-cov-2:2
effect ,nonpharmaceutical:2
nonpharmaceutical ,interventions:6
nonpharmaceutical ,transmission:2
nonpharmaceutical ,severe:2
nonpharmaceutical ,acute:2
interventions ,transmission:2
interventions ,severe:2
interventions ,acute:2
understanding ,neurotropic:2
understanding ,characteristics:4
understanding ,neurological:2
neurotropic ,characteristics:2
neurotropic ,neurological:2
characteristics ,neurological:2
neutrophil-to-lymphocyte ,ratio:6
neutrophil-to-lymphocyte ,predicts:2
neutrophil-to-lymphocyte ,critical:4
neutrophil-to-lymphocyte ,illness:4
neutrophil-to-lymphocyte ,patients:2
ratio ,predicts:2
ratio ,critical:4
ratio ,illness:4
ratio ,patients:2
predicts ,critical:2
predicts ,illness:2
predicts ,patients:4
critical ,illness:10
critical ,patients:16
illness ,patients:6
covid-19 ,fortuitous:2
covid-19 ,chronic:14
covid-19 ,lymphocytic:4
covid-19 ,leukemia:2
fortuitous ,discovery:2
fortuitous ,chronic:2
fortuitous ,lymphocytic:2
fortuitous ,leukemia:2
fortuitous ,biological:2
discovery ,chronic:2
discovery ,lymphocytic:2
discovery ,leukemia:2
discovery ,biological:2
chronic ,lymphocytic:4
chronic ,leukemia:4
chronic ,biological:2
lymphocytic ,leukemia:4
lymphocytic ,biological:2
leukemia ,biological:2
immunotherapeutic ,approaches:2
immunotherapeutic ,curtail:2
immunotherapeutic ,covid-19:2
approaches ,curtail:2
curtail ,covid-19:2
covid-19 ,magic:2
covid-19 ,bullets:2
treatment ,much:2
treatment ,testing:2
treatment ,far:6
treatment ,magic:2
treatment ,bullets:2
much ,research:2
much ,testing:2
much ,far:2
much ,magic:2
much ,bullets:2
research ,testing:4
research ,magic:2
research ,bullets:2
testing ,far:2
testing ,magic:2
testing ,bullets:2
far ,magic:2
far ,bullets:2
magic ,bullets:2
sars-cov-2 ,rhode:2
sars-cov-2 ,island:2
sars-cov-2 ,united:8
hiv ,coinfection:4
hiv ,clinical:2
hiv ,experience:2
hiv ,rhode:2
hiv ,island:2
hiv ,united:2
coinfection ,clinical:4
coinfection ,experience:2
coinfection ,rhode:2
coinfection ,island:2
coinfection ,united:2
clinical ,experience:6
clinical ,rhode:2
clinical ,island:2
clinical ,united:4
experience ,rhode:2
experience ,island:2
experience ,united:2
rhode ,island:2
rhode ,united:2
island ,united:2
overview ,common:2
overview ,laboratory:2
overview ,parameter:2
overview ,alterations:2
overview ,related:2
common ,laboratory:2
common ,parameter:2
common ,alterations:2
common ,related:2
laboratory ,parameter:2
laboratory ,alterations:4
laboratory ,related:2
parameter ,alterations:2
parameter ,related:2
alterations ,related:2
analytical ,clinical:8
analytical ,evaluation:2
analytical ,automated:4
analytical ,elecsys:2
analytical ,anti-sars-cov-2:2
analytical ,antibody:2
clinical ,elecsys:2
clinical ,anti-sars-cov-2:2
clinical ,antibody:8
evaluation ,elecsys:2
evaluation ,anti-sars-cov-2:6
evaluation ,antibody:18
automated ,elecsys:2
automated ,anti-sars-cov-2:4
automated ,antibody:4
elecsys ,anti-sars-cov-2:6
elecsys ,antibody:2
anti-sars-cov-2 ,antibody:10
ace ,model:2
ace ,sars-cov-2:4
ace ,infection:2
model ,infection:16
comparison ,reverse:4
comparison ,transcription-pcr:2
comparison ,systems:2
two ,high-throughput:2
two ,reverse:4
two ,transcription-pcr:4
two ,systems:2
high-throughput ,reverse:2
high-throughput ,transcription-pcr:2
high-throughput ,systems:2
reverse ,transcription-pcr:4
reverse ,systems:2
transcription-pcr ,systems:2
role ,antibody:4
role ,testing:10
role ,one:2
antibody ,testing:10
antibody ,one:2
testing ,one:2
sars-cov-2 ,one:10
shortlisting ,sars-cov-2:2
shortlisting ,peptides:2
shortlisting ,targeted:2
shortlisting ,studies:2
shortlisting ,experimental:2
sars-cov-2 ,targeted:8
sars-cov-2 ,experimental:18
peptides ,targeted:2
peptides ,studies:2
peptides ,experimental:2
targeted ,studies:2
targeted ,experimental:2
studies ,experimental:2
role ,retinoids:2
role ,treatment:12
retinoids ,treatment:2
retinoids ,covid-19:2
plan ,sars-cov-2:6
neonatal ,sars-cov-2:14
intensive ,sars-cov-2:12
unit ,sars-cov-2:10
commercial ,severe:2
commercial ,acute:2
commercial ,respiratory:2
commercial ,syndrome:2
commercial ,coronavirus:2
severe ,molecular:6
acute ,molecular:6
respiratory ,molecular:6
syndrome ,molecular:8
new ,framework:2
new ,identify:2
new ,dental:4
new ,emergencies:2
new ,era:4
framework ,identify:2
framework ,dental:2
framework ,emergencies:2
framework ,era:2
identify ,dental:2
identify ,emergencies:2
identify ,covid-19:6
identify ,era:2
dental ,emergencies:2
dental ,era:2
emergencies ,covid-19:4
emergencies ,era:2
covid-19 ,era:60
abrupt ,subsidence:2
abrupt ,seasonal:2
abrupt ,influenza:2
abrupt ,covid-19:2
abrupt ,outbreak:2
abrupt ,hong:2
abrupt ,kong:2
abrupt ,china:2
subsidence ,seasonal:2
subsidence ,influenza:2
subsidence ,covid-19:2
subsidence ,outbreak:2
subsidence ,hong:2
subsidence ,kong:2
subsidence ,china:2
seasonal ,influenza:6
seasonal ,covid-19:6
seasonal ,outbreak:4
seasonal ,hong:2
seasonal ,kong:2
seasonal ,china:2
influenza ,outbreak:4
influenza ,hong:2
influenza ,kong:2
covid-19 ,hong:8
covid-19 ,kong:6
outbreak ,hong:2
outbreak ,kong:2
hong ,china:2
kong ,china:2
clinical ,cancer:14
characteristics ,cancer:8
four ,cancer:4
four ,infection:12
four ,wuhan:2
cancer ,wuhan:2
infection ,wuhan:6
clinical ,utilization:2
clinical ,multiple:6
clinical ,vitro:2
evaluation ,utilization:2
evaluation ,multiple:2
evaluation ,molecular:10
evaluation ,vitro:6
evaluation ,diagnostic:12
utilization ,multiple:2
utilization ,molecular:2
utilization ,vitro:2
utilization ,diagnostic:2
utilization ,assays:2
multiple ,molecular:4
multiple ,vitro:2
multiple ,assays:6
pathogenic ,clinical:6
pathogenic ,diagnostic:2
pathogenic ,characteristics:2
pathogenic ,pandemic:2
diagnostic ,characteristics:6
pervasive ,rna:2
pervasive ,secondary:2
pervasive ,structure:2
pervasive ,genomes:2
pervasive ,sars-cov-2:2
rna ,secondary:4
rna ,structure:10
rna ,genomes:2
secondary ,structure:4
secondary ,genomes:2
structure ,genomes:2
rapid ,antibodies:10
rapid ,impedance-based:2
detection ,impedance-based:2
sars-cov-2 ,electrochemical:2
sars-cov-2 ,impedance-based:2
antibodies ,using:10
antibodies ,electrochemical:2
antibodies ,impedance-based:2
using ,electrochemical:2
using ,impedance-based:2
electrochemical ,impedance-based:2
learning ,past:6
learning ,possible:4
learning ,urgent:4
learning ,prevention:6
learning ,treatment:6
learning ,options:4
learning ,severe:4
past ,possible:6
past ,urgent:4
past ,prevention:4
past ,treatment:6
past ,options:4
past ,severe:6
possible ,urgent:4
possible ,prevention:6
possible ,options:6
urgent ,prevention:4
urgent ,treatment:4
urgent ,options:4
urgent ,severe:4
prevention ,options:4
prevention ,severe:4
treatment ,severe:30
options ,severe:6
ocular ,symptoms:2
ocular ,indication:2
ocular ,possible:2
ocular ,viral:4
symptoms ,indication:2
symptoms ,possible:4
symptoms ,transmission:2
symptoms ,viral:6
sars-cov-2 ,indication:2
indication ,possible:2
indication ,transmission:2
indication ,viral:2
possible ,viral:8
transmission ,viral:14
online ,learning:4
online ,meta-synthesis:2
learning ,meta-synthesis:2
learning ,analysis:4
covid-19 ,meta-synthesis:2
meta-synthesis ,analysis:2
covid-19 ,geriatric:6
covid-19 ,point-of-view:6
geriatric ,point-of-view:2
community ,sars-cov-2:24
community ,two:4
community ,family:2
community ,gatherings:2
community ,chicago:2
community ,illinois:2
transmission ,family:4
transmission ,gatherings:2
transmission ,chicago:2
transmission ,illinois:2
sars-cov-2 ,family:2
sars-cov-2 ,gatherings:2
sars-cov-2 ,chicago:2
sars-cov-2 ,illinois:2
two ,family:2
two ,gatherings:2
two ,chicago:2
two ,illinois:2
family ,gatherings:2
family ,chicago:2
family ,illinois:2
gatherings ,chicago:2
gatherings ,illinois:2
chicago ,illinois:2
covid-19 ,intravascular:4
covid-19 ,coagulation:16
covid-19 ,present:8
progression ,disease:12
progression ,intravascular:2
progression ,coagulation:2
progression ,present:2
progression ,status:2
disease ,intravascular:2
disease ,coagulation:2
disease ,present:2
intravascular ,coagulation:2
intravascular ,present:2
intravascular ,status:2
coagulation ,present:2
coagulation ,status:6
present ,status:2
qualitative ,rt-pcr:2
qualitative ,used:2
qualitative ,determine:2
qualitative ,release:2
qualitative ,isolation:2
qualitative ,covid-19:6
rt-pcr ,used:2
rt-pcr ,determine:2
rt-pcr ,release:2
rt-pcr ,isolation:2
used ,determine:2
used ,release:2
used ,isolation:2
determine ,release:2
determine ,isolation:2
determine ,covid-19:2
release ,isolation:2
release ,covid-19:8
pathophysiology ,patients:2
pathophysiology ,intracerebral:2
pathophysiology ,hemorrhage:2
sars-cov-2 ,intracerebral:2
sars-cov-2 ,hemorrhage:2
infection ,intracerebral:4
infection ,hemorrhage:4
patients ,intracerebral:2
patients ,hemorrhage:4
intracerebral ,hemorrhage:4
presymptomatic ,singapore:2
presymptomatic ,january:2
presymptomatic ,23-march:2
presymptomatic ,16:2
transmission ,singapore:4
transmission ,january:2
transmission ,23-march:2
transmission ,16:2
sars-cov-2 ,singapore:4
sars-cov-2 ,january:4
sars-cov-2 ,23-march:2
sars-cov-2 ,16:2
singapore ,january:2
singapore ,23-march:2
singapore ,16:2
january ,23-march:2
january ,16:2
23-march ,16:2
protecting ,healthcare:8
protecting ,workers:6
protecting ,sars-cov-2:4
protecting ,infections:2
healthcare ,infections:2
workers ,infections:2
antiviral ,anti-inflammatory:6
antiviral ,natural:4
antiviral ,medicinal:2
antiviral ,herbs:2
antiviral ,mushrooms:2
anti-inflammatory ,effects:2
anti-inflammatory ,natural:2
anti-inflammatory ,medicinal:2
anti-inflammatory ,herbs:2
anti-inflammatory ,mushrooms:2
effects ,natural:2
effects ,medicinal:2
effects ,herbs:2
effects ,mushrooms:2
natural ,medicinal:2
natural ,herbs:2
natural ,mushrooms:2
medicinal ,mushrooms:2
herbs ,mushrooms:2
updated ,molecular:2
updated ,pathogenesis:4
updated ,secondary:2
updated ,complications:4
insight ,secondary:2
insight ,complications:2
molecular ,secondary:4
molecular ,complications:4
pathogenesis ,secondary:4
pathogenesis ,complications:4
secondary ,complications:2
abdominal ,imaging:2
abdominal ,findings:4
abdominal ,sars-cov-2:4
abdominal ,infection:2
abdominal ,scoping:2
abdominal ,review:2
imaging ,scoping:2
findings ,patients:48
findings ,scoping:2
patients ,scoping:2
sars-cov-2 ,scoping:4
infection ,scoping:2
covid-19 ,blood:34
covid-19 ,clotting:2
covid-19 ,masquerading:4
covid-19 ,illness:6
blood ,clotting:2
blood ,disorder:2
blood ,masquerading:2
blood ,illness:2
clotting ,disorder:4
clotting ,masquerading:2
clotting ,respiratory:4
clotting ,illness:2
disorder ,masquerading:2
disorder ,illness:2
masquerading ,respiratory:2
masquerading ,illness:2
fruitful ,neutralizing:2
fruitful ,antibody:2
fruitful ,pipeline:2
fruitful ,brings:2
fruitful ,hope:2
fruitful ,defeat:2
fruitful ,sars-cov-2:2
neutralizing ,pipeline:2
neutralizing ,brings:2
neutralizing ,hope:2
neutralizing ,defeat:2
antibody ,pipeline:2
antibody ,brings:2
antibody ,hope:2
antibody ,defeat:2
pipeline ,brings:2
pipeline ,hope:2
pipeline ,defeat:2
pipeline ,sars-cov-2:4
brings ,hope:2
brings ,defeat:2
brings ,sars-cov-2:2
hope ,defeat:2
hope ,sars-cov-2:6
defeat ,sars-cov-2:2
covid-19 ,postpartum:8
acute ,postpartum:2
pulmonary ,postpartum:2
pulmonary ,patient:6
embolism ,postpartum:2
embolism ,patient:2
postpartum ,patient:2
aprotinin ,inhibits:2
aprotinin ,sars-cov-2:2
aprotinin ,replication:2
inhibits ,sars-cov-2:20
inhibits ,replication:8
dynamics ,ace2-sars-cov-2sars-cov:2
dynamics ,spike:2
dynamics ,protein:2
dynamics ,interface:2
dynamics ,reveal:4
dynamics ,unique:2
ace2-sars-cov-2sars-cov ,spike:2
ace2-sars-cov-2sars-cov ,protein:2
ace2-sars-cov-2sars-cov ,interface:2
ace2-sars-cov-2sars-cov ,reveal:2
ace2-sars-cov-2sars-cov ,unique:2
spike ,interface:2
spike ,reveal:4
spike ,unique:4
protein ,interface:6
protein ,reveal:2
protein ,unique:2
interface ,reveal:2
interface ,unique:2
reveal ,unique:2
il-15 ,immunotherapy:2
il-15 ,viable:2
il-15 ,strategy:2
il-15 ,covid-19:2
immunotherapy ,viable:2
immunotherapy ,strategy:2
viable ,strategy:2
viable ,covid-19:6
covid-19 ,multi-faceted:2
pathogenesis ,multi-faceted:2
multi-faceted ,disease:2
new ,molecular:6
new ,technologies:2
new ,detection:2
molecular ,technologies:2
diagnostic ,technologies:8
technologies ,clinical:2
technologies ,detection:2
technologies ,sars-cov-2:4
potential ,memantine:2
role ,memantine:2
role ,prevention:8
memantine ,prevention:2
memantine ,treatment:2
memantine ,covid-19:2
covid-19 ,candidates:4
immune ,therapy:8
immune ,candidates:2
responses ,clinical:2
responses ,therapy:2
responses ,candidates:2
clinical ,therapy:8
clinical ,candidates:2
therapy ,candidates:2
considerations ,treating:4
considerations ,patients:18
considerations ,advance:2
considerations ,lung:4
considerations ,cancer:4
considerations ,epidemic:2
treating ,advance:2
treating ,lung:4
treating ,cancer:4
treating ,epidemic:2
patients ,advance:2
patients ,lung:28
patients ,epidemic:4
advance ,lung:2
advance ,cancer:2
advance ,epidemic:2
lung ,epidemic:2
cancer ,epidemic:2
vitro ,data:2
vitro ,current:2
vitro ,therapies:2
data ,current:4
data ,therapies:2
therapies ,sars-cov-2:14
era ,molecular:2
era ,diagnosis:6
era ,pathogen:2
era ,identification:2
era ,unexplained:2
era ,pneumonia:2
molecular ,pathogen:2
molecular ,identification:2
molecular ,unexplained:2
molecular ,pneumonia:2
diagnosis ,pathogen:2
diagnosis ,identification:2
diagnosis ,unexplained:2
diagnosis ,pneumonia:8
pathogen ,identification:2
pathogen ,unexplained:2
pathogen ,pneumonia:2
identification ,unexplained:2
identification ,pneumonia:2
unexplained ,pneumonia:2
current ,northern:2
current ,cyprus:2
situation ,northern:2
situation ,cyprus:2
covid-19 ,northern:4
covid-19 ,cyprus:2
northern ,cyprus:2
multidrug-resistant ,candida:2
multidrug-resistant ,auris:2
multidrug-resistant ,infections:2
multidrug-resistant ,critically:2
multidrug-resistant ,ill:2
multidrug-resistant ,coronavirus:2
multidrug-resistant ,disease:2
candida ,auris:2
candida ,infections:2
candida ,critically:2
candida ,ill:2
candida ,coronavirus:2
candida ,disease:2
auris ,infections:2
auris ,critically:2
auris ,ill:2
auris ,coronavirus:2
auris ,disease:2
infections ,critically:4
infections ,ill:6
infections ,disease:6
critically ,ill:52
critically ,coronavirus:4
critically ,disease:4
ill ,coronavirus:6
ill ,disease:8
covid-19 ,comes:6
covid-19 ,40:2
covid-19 ,years:2
covid-19 ,aids:2
covid-19 ,lesson:8
comes ,40:2
comes ,years:2
comes ,aids:2
comes ,lesson:2
40 ,years:2
40 ,aids:2
40 ,lesson:2
years ,aids:2
years ,lesson:2
aids ,lesson:2
sars-cov-2 ,bench:2
sars-cov-2 ,bedside:4
bench ,bedside:4
ultrastructural ,evidence:2
ultrastructural ,direct:2
ultrastructural ,renal:2
ultrastructural ,infection:2
ultrastructural ,sars-cov-2:2
evidence ,direct:2
evidence ,renal:2
direct ,renal:2
direct ,infection:4
direct ,sars-cov-2:22
renal ,infection:10
renal ,sars-cov-2:8
flavonoids ,inhibitory:2
flavonoids ,activity:2
flavonoids ,sars-cov-2:2
flavonoids ,3clpro:2
inhibitory ,activity:2
inhibitory ,sars-cov-2:4
inhibitory ,3clpro:2
activity ,3clpro:2
sars-cov-2 ,3clpro:6
biochemical ,biomarkers:2
biochemical ,alterations:2
biochemical ,coronavirus:4
biochemical ,disease:6
biochemical ,covid-19:6
biomarkers ,alterations:2
biomarkers ,coronavirus:2
biomarkers ,disease:4
biomarkers ,covid-19:12
alterations ,coronavirus:2
alterations ,disease:2
alterations ,covid-19:10
olfactory ,dysfunction:14
olfactory ,covid-19:28
olfactory ,outbreak:2
dysfunction ,outbreak:2
possible ,bat:2
possible ,origin:2
possible ,coronavirus:8
bat ,severe:2
bat ,acute:2
bat ,respiratory:2
bat ,syndrome:2
origin ,severe:2
origin ,acute:2
origin ,respiratory:2
origin ,syndrome:2
unheralded ,lower:2
unheralded ,limb:2
unheralded ,threatening:2
unheralded ,ischemia:2
unheralded ,covid-19:2
unheralded ,patient:2
lower ,limb:2
lower ,threatening:2
lower ,ischemia:4
lower ,covid-19:14
lower ,patient:4
limb ,threatening:2
limb ,ischemia:8
limb ,covid-19:8
limb ,patient:6
threatening ,ischemia:2
threatening ,covid-19:2
threatening ,patient:2
ischemia ,covid-19:14
ischemia ,patient:12
drugs ,targeting:10
drugs ,various:2
drugs ,stages:2
drugs ,life:2
drugs ,cycle:2
drugs ,exploring:2
drugs ,promising:4
targeting ,various:2
targeting ,stages:2
targeting ,life:2
targeting ,cycle:2
targeting ,exploring:2
targeting ,promising:2
various ,stages:2
various ,sars-cov-2:6
various ,life:2
various ,cycle:2
various ,exploring:2
various ,promising:2
stages ,sars-cov-2:6
stages ,life:2
stages ,cycle:2
stages ,exploring:2
stages ,promising:4
sars-cov-2 ,life:8
sars-cov-2 ,cycle:6
sars-cov-2 ,exploring:16
sars-cov-2 ,promising:10
life ,cycle:4
life ,exploring:2
life ,promising:2
cycle ,exploring:2
cycle ,promising:2
exploring ,promising:2
lack ,sensitivity:2
lack ,ivdce-labelled:2
lack ,kit:2
lack ,targeting:2
lack ,gene:2
lack ,detection:2
sensitivity ,ivdce-labelled:2
sensitivity ,kit:4
sensitivity ,targeting:2
sensitivity ,gene:2
ivdce-labelled ,kit:2
ivdce-labelled ,targeting:2
ivdce-labelled ,gene:2
ivdce-labelled ,detection:2
kit ,targeting:2
kit ,gene:2
targeting ,gene:4
targeting ,detection:4
gene ,detection:6
tracking ,sars-cov-2:10
tracking ,sewage:4
tracking ,evidence:4
tracking ,changes:4
tracking ,virus:2
tracking ,variant:2
tracking ,predominance:2
sars-cov-2 ,sewage:2
sars-cov-2 ,changes:18
sars-cov-2 ,variant:10
sars-cov-2 ,predominance:2
sewage ,evidence:2
sewage ,changes:2
sewage ,virus:2
sewage ,variant:2
sewage ,predominance:2
evidence ,changes:4
evidence ,virus:6
evidence ,variant:2
evidence ,predominance:2
changes ,virus:2
changes ,variant:2
changes ,predominance:2
virus ,variant:2
virus ,predominance:2
variant ,predominance:2
antiviral ,mechanisms:4
antiviral ,candidate:4
antiviral ,chemical:2
antiviral ,medicines:2
antiviral ,traditional:4
antiviral ,chinese:4
mechanisms ,candidate:2
mechanisms ,chemical:2
mechanisms ,medicines:4
mechanisms ,traditional:2
mechanisms ,chinese:4
candidate ,chemical:2
candidate ,medicines:2
candidate ,traditional:2
candidate ,chinese:2
chemical ,medicines:2
chemical ,traditional:2
chemical ,chinese:2
medicines ,traditional:4
medicines ,chinese:10
treatment ,reality:2
treatment ,challenges:6
options ,reality:2
covid-19 ,reality:8
reality ,challenges:2
linking ,statistics:2
linking ,testing:2
linking ,policy:2
linking ,manage:2
linking ,covid-19:2
linking ,community:2
statistics ,testing:2
statistics ,policy:2
statistics ,manage:2
statistics ,covid-19:2
statistics ,community:2
testing ,policy:2
testing ,manage:4
testing ,community:6
policy ,manage:2
policy ,covid-19:14
policy ,community:2
manage ,covid-19:8
manage ,community:2
covid-19 ,community:16
lack ,clinical:2
lack ,evidence:2
lack ,use:2
lack ,hydroxychloroquine:2
lack ,treat:2
lack ,sars-cov-2:10
clinical ,evidence:8
clinical ,use:6
clinical ,treat:2
evidence ,use:6
evidence ,hydroxychloroquine:4
evidence ,treat:2
use ,hydroxychloroquine:14
use ,sars-cov-2:24
hydroxychloroquine ,treat:4
might ,sars-cov-2:8
might ,arisen:2
might ,via:2
might ,serial:2
might ,passage:2
might ,animal:2
might ,host:2
might ,cell:2
sars-cov-2 ,arisen:2
sars-cov-2 ,serial:12
sars-cov-2 ,passage:2
arisen ,via:2
arisen ,serial:2
arisen ,passage:2
arisen ,animal:2
arisen ,host:2
arisen ,cell:2
via ,serial:2
via ,passage:2
via ,animal:2
via ,host:4
via ,cell:4
serial ,passage:2
serial ,animal:2
serial ,host:2
serial ,cell:2
passage ,animal:2
passage ,host:2
passage ,cell:2
animal ,host:8
animal ,cell:4
high ,sars-cov-2:36
high ,antibody:6
high ,prevalence:12
high ,among:6
high ,healthcare:2
high ,workers:4
high ,exposed:2
sars-cov-2 ,among:74
sars-cov-2 ,exposed:6
antibody ,prevalence:6
antibody ,among:6
antibody ,healthcare:6
antibody ,workers:6
antibody ,exposed:2
prevalence ,healthcare:4
prevalence ,workers:8
prevalence ,exposed:2
among ,healthcare:26
among ,exposed:4
healthcare ,exposed:6
workers ,exposed:6
exposed ,covid-19:4
free ,dna:2
free ,reason:2
free ,severe:2
free ,covid-19:4
free ,infection:2
dna ,reason:2
dna ,severe:2
dna ,covid-19:4
dna ,infection:2
reason ,severe:2
reason ,covid-19:2
reason ,infection:2
evaluation ,antigen:2
evaluation ,test:14
evaluation ,virus:8
rapid ,antigen:8
antigen ,test:6
antigen ,detection:6
antigen ,sars-cov-2:12
antigen ,virus:2
test ,virus:2
one ,case:4
one ,coronavirus:6
one ,disease:8
one ,covid-19:12
one ,patient:4
one ,co-infected:2
one ,hiv:2
case ,co-infected:2
case ,hiv:8
coronavirus ,co-infected:2
coronavirus ,hiv:6
disease ,co-infected:2
disease ,hiv:2
covid-19 ,co-infected:2
covid-19 ,hiv:16
patient ,co-infected:2
patient ,hiv:6
co-infected ,hiv:2
gastrointestinal ,hepatobiliary:2
gastrointestinal ,pancreatic:2
hepatobiliary ,pancreatic:2
hepatobiliary ,manifestations:2
hepatobiliary ,covid-19:2
pancreatic ,manifestations:2
pancreatic ,covid-19:4
deal ,learn:2
deal ,threat:2
deal ,covid-19:4
deal ,paediatric:2
deal ,dentistry:2
learn ,threat:2
learn ,paediatric:2
learn ,dentistry:4
threat ,paediatric:2
threat ,dentistry:2
covid-19 ,paediatric:14
paediatric ,dentistry:2
acute ,mesenteric:6
acute ,ischemia:12
mesenteric ,ischemia:4
mesenteric ,patient:2
mesenteric ,covid-19:6
mesenteric ,case:2
mesenteric ,report:4
ischemia ,case:4
ischemia ,report:2
first ,detection:12
first ,wastewater:8
first ,north:2
first ,america:2
detection ,wastewater:8
detection ,america:2
detection ,study:2
sars-cov-2 ,wastewater:30
sars-cov-2 ,north:6
sars-cov-2 ,america:6
rna ,wastewater:10
rna ,north:2
rna ,america:2
rna ,study:2
wastewater ,north:2
wastewater ,america:2
wastewater ,study:4
north ,america:4
north ,study:2
america ,study:2
overview ,genetic:2
overview ,variations:2
overview ,genomes:2
overview ,isolated:2
genetic ,variations:6
genetic ,sars-cov-2:30
genetic ,genomes:2
genetic ,isolated:2
variations ,sars-cov-2:12
variations ,genomes:2
variations ,isolated:2
sars-cov-2 ,isolated:4
genomes ,isolated:2
sars-cov-2-igg ,response:2
sars-cov-2-igg ,different:2
sars-cov-2-igg ,covid-19:2
sars-cov-2-igg ,outpatients:2
sars-cov-2-igg ,asymptomatic:2
response ,different:2
response ,outpatients:2
response ,asymptomatic:2
different ,outpatients:2
different ,asymptomatic:2
covid-19 ,outpatients:2
outpatients ,asymptomatic:2
molecular ,profiling:2
molecular ,immune:8
molecular ,cell-enriched:2
profiling ,immune:2
profiling ,cell-enriched:2
profiling ,severe:2
profiling ,acute:2
profiling ,respiratory:2
profiling ,syndrome:2
immune ,cell-enriched:2
immune ,acute:2
immune ,respiratory:4
immune ,syndrome:2
cell-enriched ,severe:2
cell-enriched ,acute:2
cell-enriched ,respiratory:2
cell-enriched ,syndrome:2
citation ,network:2
citation ,analysis:2
citation ,novel:2
citation ,coronavirus:2
citation ,disease:2
citation ,covid-19:2
network ,analysis:10
network ,novel:2
network ,coronavirus:6
network ,disease:2
first ,companion:2
first ,animals:2
first ,new:2
first ,york:2
reported ,sars-cov-2:10
reported ,infection:2
reported ,companion:2
reported ,animals:2
reported ,new:2
reported ,york:2
cases ,companion:2
cases ,animals:2
cases ,new:4
cases ,york:2
sars-cov-2 ,companion:4
sars-cov-2 ,animals:4
infection ,companion:2
infection ,animals:2
infection ,york:2
companion ,new:2
companion ,york:2
animals ,new:2
animals ,york:2
can ,combination:2
can ,at1r:2
can ,antagonist:2
can ,vitamin:2
can ,treat:2
can ,lung:2
can ,complication:2
combination ,at1r:2
combination ,antagonist:2
combination ,vitamin:2
combination ,treat:2
combination ,lung:2
combination ,complication:2
at1r ,antagonist:2
at1r ,vitamin:2
at1r ,treat:2
at1r ,lung:2
at1r ,complication:2
antagonist ,vitamin:2
antagonist ,lung:2
antagonist ,complication:2
vitamin ,treat:2
vitamin ,lung:2
vitamin ,complication:2
treat ,lung:2
treat ,complication:2
lung ,complication:2
glecaprevir ,maraviroc:2
glecaprevir ,high-affinity:2
glecaprevir ,inhibitors:2
glecaprevir ,sars-cov-2:2
glecaprevir ,main:2
glecaprevir ,protease:2
maraviroc ,high-affinity:2
maraviroc ,inhibitors:2
maraviroc ,sars-cov-2:2
maraviroc ,main:2
maraviroc ,protease:2
high-affinity ,inhibitors:4
high-affinity ,sars-cov-2:6
high-affinity ,main:4
high-affinity ,protease:4
postoperative ,fever:2
postoperative ,time:2
postoperative ,covid-19:6
fever ,time:2
mathematical ,model:8
mathematical ,simulating:2
mathematical ,phase-based:2
mathematical ,transmissibility:2
mathematical ,novel:2
model ,simulating:2
model ,phase-based:2
model ,transmissibility:4
model ,novel:6
simulating ,phase-based:2
simulating ,transmissibility:2
simulating ,novel:2
phase-based ,transmissibility:2
phase-based ,novel:2
transmissibility ,novel:2
third-trimester ,placentas:2
third-trimester ,severe:2
third-trimester ,acute:2
third-trimester ,respiratory:2
third-trimester ,syndrome:2
third-trimester ,coronavirus:2
placentas ,severe:2
placentas ,acute:2
placentas ,respiratory:2
placentas ,syndrome:2
placentas ,coronavirus:2
analysis ,131:4
analysis ,treated:2
analysis ,ganlu:2
analysis ,xiaodu:2
analysis ,decoction:2
131 ,cases:2
131 ,covid-19:2
131 ,treated:2
131 ,ganlu:2
131 ,xiaodu:2
131 ,decoction:2
cases ,treated:4
cases ,ganlu:2
cases ,xiaodu:2
cases ,decoction:2
covid-19 ,ganlu:2
covid-19 ,xiaodu:2
covid-19 ,decoction:2
treated ,ganlu:2
treated ,xiaodu:2
treated ,decoction:2
ganlu ,xiaodu:2
ganlu ,decoction:2
xiaodu ,decoction:2
late ,bowel:2
late ,iischemia:2
late ,colovaginal:2
late ,fistula:2
late ,low:2
late ,anterior:2
late ,resection:2
bowel ,iischemia:2
bowel ,colovaginal:2
bowel ,fistula:2
bowel ,low:2
bowel ,anterior:2
bowel ,resection:2
iischemia ,colovaginal:2
iischemia ,fistula:2
iischemia ,low:2
iischemia ,anterior:2
iischemia ,resection:2
colovaginal ,fistula:2
colovaginal ,low:2
colovaginal ,anterior:2
colovaginal ,resection:2
fistula ,low:2
fistula ,anterior:2
fistula ,resection:2
low ,anterior:2
low ,resection:2
anterior ,resection:2
procedures ,flow:2
procedures ,cytometry-based:2
procedures ,sorting:2
procedures ,unfixed:2
procedures ,severe:6
procedures ,acute:6
procedures ,respiratory:6
flow ,cytometry-based:2
flow ,sorting:2
flow ,unfixed:2
flow ,severe:4
flow ,acute:2
flow ,respiratory:4
cytometry-based ,sorting:2
cytometry-based ,unfixed:2
cytometry-based ,severe:2
cytometry-based ,acute:2
cytometry-based ,respiratory:2
sorting ,unfixed:2
sorting ,severe:2
sorting ,acute:2
sorting ,respiratory:2
unfixed ,severe:2
unfixed ,acute:2
unfixed ,respiratory:2
potential ,acute:16
potential ,syndrome:6
pathogenesis ,severe:6
pathogenesis ,acute:4
pathogenesis ,respiratory:4
pediatric ,emergency:4
pediatric ,department:4
pediatric ,protocol:2
pediatric ,avoid:2
pediatric ,intrahospital:2
pediatric ,spread:2
emergency ,department:30
emergency ,protocol:2
emergency ,avoid:2
emergency ,intrahospital:2
emergency ,spread:2
department ,protocol:2
department ,avoid:2
department ,intrahospital:2
department ,spread:2
protocol ,avoid:2
protocol ,intrahospital:2
protocol ,spread:2
avoid ,intrahospital:2
avoid ,spread:4
intrahospital ,spread:2
can ,ace2:2
can ,expression:2
can ,explain:4
can ,respiratory:2
can ,epithelia:2
ace2 ,explain:2
ace2 ,infection:16
ace2 ,respiratory:6
ace2 ,epithelia:2
expression ,explain:2
expression ,sars-cov-2:48
expression ,infection:10
expression ,respiratory:4
expression ,epithelia:2
explain ,sars-cov-2:2
explain ,infection:2
explain ,respiratory:2
explain ,epithelia:2
sars-cov-2 ,epithelia:2
infection ,epithelia:2
respiratory ,epithelia:2
tiotropium ,predicted:2
tiotropium ,promising:2
tiotropium ,drug:2
tiotropium ,covid-19:2
predicted ,promising:2
predicted ,drug:4
predicted ,covid-19:2
promising ,drug:4
testing ,support:2
testing ,persons:2
testing ,disease:8
patients ,persons:4
support ,persons:2
support ,coronavirus:6
support ,disease:6
support ,covid-19:18
increasing ,nucleic:2
increasing ,acid:2
increasing ,testing:2
increasing ,capacity:2
increasing ,epidemic:2
sars-cov-2 ,capacity:4
nucleic ,capacity:2
nucleic ,epidemic:2
acid ,capacity:2
acid ,epidemic:2
testing ,capacity:4
testing ,epidemic:4
capacity ,covid-19:10
capacity ,epidemic:2
need ,consider:2
comparative ,phylogenomic:4
comparative ,strains:2
comparative ,reported:2
comparative ,non-human:2
phylogenomic ,analysis:4
phylogenomic ,sars-cov-2:6
phylogenomic ,strains:2
phylogenomic ,reported:2
phylogenomic ,non-human:2
analysis ,strains:6
analysis ,reported:2
analysis ,non-human:2
sars-cov-2 ,strains:8
sars-cov-2 ,non-human:6
strains ,reported:2
strains ,non-human:2
reported ,non-human:2
protein ,coding:2
protein ,long:2
protein ,noncoding:2
protein ,rna:2
protein ,lncrna:2
protein ,transcriptional:2
protein ,landscape:2
coding ,long:2
coding ,noncoding:2
coding ,rna:2
coding ,lncrna:2
coding ,transcriptional:2
coding ,landscape:2
long ,noncoding:2
long ,rna:2
long ,lncrna:2
long ,transcriptional:2
long ,landscape:2
noncoding ,rna:2
noncoding ,lncrna:2
noncoding ,transcriptional:2
noncoding ,landscape:2
rna ,lncrna:2
rna ,transcriptional:2
rna ,landscape:2
lncrna ,transcriptional:2
lncrna ,landscape:2
transcriptional ,landscape:4
epidemiology ,outbreak:2
epidemiology ,cruise:2
epidemiology ,ship:2
epidemiology ,quarantined:2
epidemiology ,yokohama:2
epidemiology ,japan:2
covid-19 ,quarantined:4
covid-19 ,yokohama:2
covid-19 ,japan:12
outbreak ,cruise:4
outbreak ,ship:4
outbreak ,quarantined:2
outbreak ,yokohama:2
outbreak ,japan:6
cruise ,quarantined:2
cruise ,yokohama:2
cruise ,japan:4
ship ,quarantined:2
ship ,yokohama:2
ship ,japan:4
quarantined ,yokohama:2
quarantined ,japan:2
yokohama ,japan:2
ethics ,lessons:2
ethics ,seattles:2
ethics ,early:2
ethics ,experience:2
ethics ,covid-19:4
lessons ,seattles:2
lessons ,early:4
lessons ,experience:6
seattles ,early:2
seattles ,experience:2
seattles ,covid-19:2
early ,experience:18
first ,untreated:4
first ,wastewaters:2
detection ,untreated:4
detection ,wastewaters:2
detection ,italy:4
sars-cov-2 ,untreated:6
sars-cov-2 ,wastewaters:4
untreated ,wastewaters:2
untreated ,italy:2
wastewaters ,italy:2
clinical ,three:4
clinical ,sample-to-answer:2
clinical ,platforms:2
evaluation ,sample-to-answer:2
evaluation ,platforms:2
three ,sample-to-answer:2
three ,platforms:2
three ,detection:14
sample-to-answer ,platforms:2
sample-to-answer ,detection:2
sample-to-answer ,sars-cov-2:4
platforms ,detection:4
platforms ,sars-cov-2:2
detection ,stool:2
detection ,asymptomatic:2
detection ,child:2
novel ,rt-pcr:4
novel ,stool:2
novel ,specimen:2
novel ,child:2
coronavirus ,stool:2
coronavirus ,specimen:2
rt-pcr ,stool:4
rt-pcr ,specimen:2
rt-pcr ,asymptomatic:6
rt-pcr ,child:2
stool ,specimen:2
stool ,asymptomatic:4
stool ,child:2
specimen ,asymptomatic:2
specimen ,child:2
asymptomatic ,child:4
clinical ,sars-cov-2interaction:2
clinical ,renin:2
clinical ,angiotensin:2
clinical ,system:10
clinical ,jacc:2
implications ,sars-cov-2interaction:2
implications ,renin:2
implications ,angiotensin:2
implications ,system:6
implications ,jacc:2
sars-cov-2interaction ,renin:2
sars-cov-2interaction ,angiotensin:2
sars-cov-2interaction ,system:2
sars-cov-2interaction ,jacc:2
renin ,angiotensin:4
renin ,system:2
renin ,jacc:2
angiotensin ,system:6
angiotensin ,jacc:2
system ,jacc:2
new ,understanding:4
new ,damage:2
new ,outside:2
new ,respiratory:10
understanding ,damage:2
understanding ,outside:2
understanding ,respiratory:6
damage ,outside:2
damage ,respiratory:2
sars-cov-2 ,outside:6
infection ,outside:8
outside ,respiratory:4
ocular ,surface:16
ocular ,coronaviruses:2
surface ,covid-19:8
interaction ,drug:2
interaction ,candidates:2
interaction ,various:2
interaction ,receptors:2
interaction ,silico:4
interaction ,study:2
drug ,various:2
drug ,receptors:2
drug ,study:4
candidates ,various:2
candidates ,receptors:2
candidates ,silico:2
candidates ,study:2
various ,receptors:2
various ,silico:2
various ,study:2
receptors ,silico:2
receptors ,study:2
silico ,study:6
pandemic ,responses:6
pandemic ,planning:4
pandemic ,neutralize:2
pandemic ,prepare:2
responses ,planning:2
responses ,neutralize:2
responses ,prepare:2
responses ,future:4
planning ,neutralize:2
planning ,sars-cov-2:2
planning ,prepare:2
planning ,future:2
neutralize ,sars-cov-2:4
neutralize ,prepare:2
neutralize ,future:2
sars-cov-2 ,prepare:2
sars-cov-2 ,future:18
prepare ,future:2
thyroid ,disorders:2
thyroid ,sars-cov-2:2
thyroid ,infection:2
thyroid ,pathophysiological:2
thyroid ,mechanism:2
disorders ,sars-cov-2:8
disorders ,infection:4
disorders ,pathophysiological:2
disorders ,mechanism:2
sars-cov-2 ,pathophysiological:2
sars-cov-2 ,mechanism:10
infection ,pathophysiological:2
infection ,mechanism:4
pathophysiological ,mechanism:2
updated ,estimates:2
updated ,chronic:2
updated ,conditions:2
updated ,affecting:2
updated ,risk:2
estimates ,chronic:4
estimates ,conditions:4
estimates ,affecting:4
estimates ,complications:4
chronic ,conditions:6
chronic ,affecting:4
chronic ,risk:6
chronic ,complications:6
conditions ,affecting:4
conditions ,risk:6
conditions ,complications:4
affecting ,risk:6
affecting ,complications:4
risk ,complications:6
gastrointestinal ,associated:2
gastrointestinal ,impact:6
gastrointestinal ,gut:2
gastrointestinal ,microbiome:2
symptoms ,impact:2
symptoms ,gut:2
symptoms ,microbiome:2
associated ,impact:4
associated ,gut:2
associated ,microbiome:2
covid-19 ,gut:6
covid-19 ,microbiome:6
impact ,gut:2
impact ,microbiome:2
gut ,microbiome:2
potential ,causes:4
potential ,consequences:2
causes ,consequences:2
causes ,gastrointestinal:2
causes ,disorders:2
consequences ,gastrointestinal:2
consequences ,disorders:2
consequences ,sars-cov-2:10
gastrointestinal ,disorders:2
serological ,approaches:4
serological ,covid-19:30
serological ,epidemiologic:2
serological ,perspective:2
serological ,surveillance:2
approaches ,epidemiologic:2
approaches ,perspective:2
approaches ,surveillance:2
epidemiologic ,perspective:2
epidemiologic ,surveillance:4
perspective ,surveillance:6
protecting ,personnel:2
protecting ,2019-ncov:2
protecting ,infection:4
protecting ,risks:2
protecting ,lessons:2
healthcare ,personnel:4
healthcare ,2019-ncov:2
healthcare ,risks:2
healthcare ,lessons:2
personnel ,2019-ncov:2
personnel ,infection:2
personnel ,risks:2
personnel ,lessons:2
2019-ncov ,risks:2
2019-ncov ,lessons:4
infection ,risks:4
infection ,lessons:6
risks ,lessons:2
profile ,sars-cov-2:12
visualizing ,unseen:4
visualizing ,enemy:4
visualizing ,mobilizing:4
visualizing ,structural:4
visualizing ,biology:4
visualizing ,counter:4
visualizing ,covid-19:4
unseen ,enemy:4
unseen ,mobilizing:4
unseen ,structural:4
unseen ,biology:4
unseen ,counter:4
enemy ,mobilizing:4
enemy ,structural:4
enemy ,biology:4
enemy ,counter:4
mobilizing ,structural:4
mobilizing ,biology:4
mobilizing ,counter:4
mobilizing ,covid-19:4
structural ,biology:6
structural ,counter:4
biology ,counter:4
counter ,covid-19:4
centralized ,medical:2
centralized ,quarantine:2
centralized ,imported:2
centralized ,covid-19:2
centralized ,shanghai:2
centralized ,china:2
medical ,quarantine:2
medical ,imported:2
medical ,shanghai:2
quarantine ,imported:2
quarantine ,covid-19:12
quarantine ,shanghai:2
quarantine ,china:4
imported ,covid-19:6
imported ,shanghai:2
imported ,china:2
covid-19 ,shanghai:4
shanghai ,china:4
identification ,peptide:2
identification ,inhibitor:8
identification ,targeting:4
identification ,entry:4
potential ,peptide:2
potential ,inhibitor:12
potential ,entry:6
peptide ,inhibitor:2
peptide ,targeting:2
peptide ,entry:6
inhibitor ,sars-cov-2:12
inhibitor ,targeting:2
inhibitor ,entry:2
targeting ,entry:4
sars-cov-2 ,sites:6
detection ,sites:2
detection ,systematic:2
different ,respiratory:6
different ,sites:4
different ,systematic:2
different ,review:2
respiratory ,sites:2
respiratory ,systematic:6
sites ,systematic:2
sites ,review:2
preliminary ,epidemiological:2
preliminary ,analysis:6
preliminary ,children:6
preliminary ,adolescents:2
epidemiological ,children:8
epidemiological ,adolescents:2
analysis ,adolescents:2
children ,adolescents:10
adolescents ,novel:2
impact ,pre-existing:2
impact ,comorbidities:4
impact ,therapeutic:4
impact ,interventions:4
pre-existing ,comorbidities:2
pre-existing ,therapeutic:4
pre-existing ,interventions:2
comorbidities ,therapeutic:2
comorbidities ,interventions:2
comorbidities ,covid-19:12
covid-19 ,southeastern:2
covid-19 ,virginia:2
covid-19 ,wastewater-based:4
surveillance ,southeastern:2
surveillance ,virginia:2
surveillance ,using:6
surveillance ,wastewater-based:4
surveillance ,epidemiology:2
southeastern ,virginia:2
southeastern ,using:2
southeastern ,wastewater-based:2
southeastern ,epidemiology:2
virginia ,using:2
virginia ,wastewater-based:2
virginia ,epidemiology:2
using ,wastewater-based:2
using ,epidemiology:2
wastewater-based ,epidemiology:4
dual ,function:2
dual ,sialic:2
dual ,acid:2
dual ,gastrointestinal:2
dual ,sars-cov-2:4
dual ,infection:2
function ,sialic:2
function ,acid:2
function ,gastrointestinal:2
function ,sars-cov-2:16
function ,infection:2
sialic ,acid:4
sialic ,gastrointestinal:2
sialic ,sars-cov-2:2
sialic ,infection:2
acid ,gastrointestinal:2
gastrointestinal ,infection:14
irrigation ,system:2
irrigation ,covid-19:2
irrigation ,recurrence:2
irrigation ,potential:2
irrigation ,risk:2
irrigation ,factor:2
system ,recurrence:2
system ,risk:8
system ,factor:4
covid-19 ,recurrence:14
recurrence ,potential:2
recurrence ,risk:4
recurrence ,factor:2
potential ,risk:10
potential ,factor:4
genetic ,hypothesis:2
genetic ,pharmacogenetics:2
genetic ,side:2
genetic ,renin-angiotensin-system:2
hypothesis ,pharmacogenetics:2
hypothesis ,side:2
hypothesis ,renin-angiotensin-system:2
pharmacogenetics ,side:2
pharmacogenetics ,renin-angiotensin-system:2
side ,renin-angiotensin-system:2
relevant ,nutrition:2
relevant ,therapy:2
relevant ,covid-19:4
relevant ,constraints:2
relevant ,delivery:2
nutrition ,therapy:2
nutrition ,covid-19:10
nutrition ,constraints:2
nutrition ,delivery:2
therapy ,constraints:2
therapy ,delivery:2
covid-19 ,constraints:2
covid-19 ,delivery:32
constraints ,delivery:2
dacron ,swab:2
dacron ,pbs:2
dacron ,acceptable:2
dacron ,alternatives:2
dacron ,flocked:2
dacron ,viral:2
dacron ,transport:2
swab ,pbs:2
swab ,acceptable:2
swab ,alternatives:2
swab ,flocked:2
swab ,transport:2
pbs ,acceptable:2
pbs ,alternatives:2
pbs ,flocked:2
pbs ,viral:2
pbs ,transport:2
acceptable ,alternatives:2
acceptable ,flocked:2
acceptable ,viral:2
acceptable ,transport:2
alternatives ,flocked:2
alternatives ,viral:2
alternatives ,transport:2
flocked ,viral:2
flocked ,transport:2
viral ,transport:4
angiotensin ,converting:22
angiotensin ,enzyme-2:2
angiotensin ,therapeutic:2
angiotensin ,target:2
angiotensin ,covid-19:12
converting ,enzyme-2:2
converting ,therapeutic:2
converting ,target:2
converting ,covid-19:4
enzyme-2 ,therapeutic:2
enzyme-2 ,target:2
enzyme-2 ,covid-19:2
therapeutic ,target:18
target ,covid-19:28
dpp4 ,inhibition:4
dpp4 ,preventing:2
dpp4 ,sars-cov-2:2
dpp4 ,infection:2
dpp4 ,andor:2
dpp4 ,progression:2
dpp4 ,covid-19:6
inhibition ,preventing:2
inhibition ,infection:8
inhibition ,andor:2
inhibition ,progression:2
inhibition ,covid-19:14
preventing ,sars-cov-2:16
preventing ,infection:12
preventing ,andor:2
preventing ,progression:4
sars-cov-2 ,andor:4
sars-cov-2 ,progression:6
infection ,andor:6
infection ,progression:8
andor ,progression:2
andor ,covid-19:4
severe ,symptomatic:2
severe ,reinfection:4
symptomatic ,reinfection:2
symptomatic ,patient:2
reinfection ,patient:2
reinfection ,covid-19:6
managing ,covid-19:24
managing ,renal:2
managing ,transplant:2
managing ,recipients:2
managing ,review:2
managing ,recent:2
managing ,literature:2
covid-19 ,renal:14
covid-19 ,transplant:32
covid-19 ,recipients:12
renal ,transplant:6
renal ,recipients:2
renal ,review:6
renal ,recent:2
renal ,literature:2
transplant ,recipients:16
transplant ,review:2
transplant ,recent:2
transplant ,literature:2
recipients ,review:2
recipients ,recent:2
recipients ,literature:2
review ,recent:4
recent ,literature:4
neurocovid-19 ,clinical:2
neurocovid-19 ,neuroscience-based:2
neurocovid-19 ,approach:2
neurocovid-19 ,reduce:2
neurocovid-19 ,sars-cov-2:2
neurocovid-19 ,related:2
clinical ,neuroscience-based:2
clinical ,approach:6
clinical ,reduce:2
clinical ,related:4
neuroscience-based ,approach:2
neuroscience-based ,reduce:2
neuroscience-based ,sars-cov-2:2
neuroscience-based ,related:2
approach ,reduce:4
approach ,sars-cov-2:22
approach ,related:2
reduce ,related:2
immunopathology ,immunotherapeutic:2
immunopathology ,strategies:2
immunopathology ,severe:2
immunopathology ,acute:2
immunopathology ,respiratory:2
immunotherapeutic ,strategies:2
immunotherapeutic ,severe:2
immunotherapeutic ,acute:2
immunotherapeutic ,respiratory:2
strategies ,severe:4
strategies ,acute:4
strategies ,respiratory:4
potential ,plant:4
potential ,proteins:4
potential ,digested:2
potential ,silico:12
potential ,enzymes:4
plant ,proteins:2
plant ,digested:2
plant ,silico:2
plant ,gastrointestinal:2
plant ,enzymes:2
proteins ,digested:2
proteins ,silico:6
proteins ,gastrointestinal:2
proteins ,enzymes:2
digested ,silico:2
digested ,gastrointestinal:2
digested ,enzymes:2
silico ,gastrointestinal:2
silico ,enzymes:2
gastrointestinal ,enzymes:2
overview ,drug:2
overview ,research:4
overview ,china:2
therapeutic ,drug:8
therapeutic ,research:4
therapeutic ,china:2
drug ,research:4
drug ,china:4
research ,china:2
diagnosis ,control:6
treatment ,control:8
control ,sars-cov-2:20
control ,coronavirus:12
control ,disease:4
case ,recurrence:6
presentation ,positive:2
presentation ,rna:2
presentation ,recurrence:2
presentation ,patient:6
positive ,recurrence:12
positive ,patient:16
sars-cov-2 ,recurrence:14
rna ,recurrence:10
rna ,patient:8
recurrence ,patient:4
rescue ,sars-cov-2:2
rescue ,single:2
rescue ,bacterial:2
rescue ,artificial:2
rescue ,chromosome:2
sars-cov-2 ,single:8
single ,bacterial:2
single ,artificial:2
single ,chromosome:2
experimental ,aerosol:2
experimental ,survival:2
experimental ,artificial:2
experimental ,saliva:2
experimental ,tissue:2
experimental ,culture:2
aerosol ,survival:2
aerosol ,artificial:2
aerosol ,saliva:2
aerosol ,tissue:2
aerosol ,culture:2
survival ,artificial:2
survival ,saliva:2
survival ,tissue:2
survival ,culture:2
sars-cov-2 ,tissue:12
artificial ,saliva:2
artificial ,tissue:2
artificial ,culture:2
saliva ,tissue:2
saliva ,culture:2
tissue ,culture:2
sars-cov-2 ,state:6
sars-cov-2 ,knowledge:6
sars-cov-2 ,needs:2
wastewater ,state:2
wastewater ,knowledge:4
wastewater ,research:2
wastewater ,needs:2
state ,knowledge:6
state ,research:2
state ,needs:2
knowledge ,needs:2
covid-19 ,boosted:2
covid-19 ,nothing:4
covid-19 ,ad:2
covid-19 ,interim:4
vaccine ,boosted:2
vaccine ,nothing:2
vaccine ,ad:2
vaccine ,interim:2
boosted ,immunity:2
boosted ,nothing:2
boosted ,ad:2
boosted ,interim:2
immunity ,nothing:2
immunity ,ad:2
immunity ,interim:2
nothing ,ad:2
nothing ,interim:2
ad ,interim:2
behavioral ,practices:2
behavioral ,patients:2
behavioral ,multiple:2
behavioral ,sclerosis:2
behavioral ,covid-19:4
behavioral ,pandemic:4
practices ,patients:2
practices ,multiple:2
practices ,sclerosis:2
practices ,pandemic:8
patients ,multiple:6
patients ,sclerosis:2
patients ,pandemic:40
sclerosis ,covid-19:18
sclerosis ,pandemic:4
low ,humoral:2
low ,immune:2
low ,response:2
low ,ineffective:2
low ,clearance:2
low ,sars-cov-2:18
humoral ,ineffective:2
humoral ,clearance:2
humoral ,covid-19:4
immune ,ineffective:2
immune ,clearance:2
response ,ineffective:2
response ,clearance:4
ineffective ,clearance:2
ineffective ,sars-cov-2:2
ineffective ,covid-19:2
clearance ,sars-cov-2:4
clearance ,covid-19:6
lessons ,month:2
lessons ,co-infection:2
lessons ,influenza:2
lessons ,virus:2
month ,co-infection:2
month ,sars-cov-2:4
month ,influenza:2
month ,virus:2
recent ,towards:2
recent ,design:2
recent ,protease:2
advances ,towards:4
advances ,drug:2
advances ,design:2
advances ,targeting:4
advances ,protease:2
towards ,drug:4
towards ,targeting:2
towards ,protease:4
towards ,novel:2
drug ,protease:8
design ,protease:2
design ,novel:12
targeting ,protease:8
targeting ,coronavirus:6
protease ,coronavirus:8
mapping ,situation:2
mapping ,research:2
mapping ,disease-19:2
mapping ,covid-19:6
situation ,research:2
situation ,coronavirus:4
situation ,disease-19:2
research ,coronavirus:16
research ,disease-19:2
coronavirus ,disease-19:12
disease-19 ,covid-19:8
myocardial ,involvement:2
myocardial ,coronavirus:10
myocardial ,disease:8
myocardial ,19:2
involvement ,19:2
novel ,indicator:4
novel ,predicts:2
novel ,subjects:2
indicator ,predicts:2
indicator ,coronavirus:2
indicator ,infection:2
indicator ,subjects:2
predicts ,coronavirus:2
predicts ,infection:2
predicts ,subjects:2
coronavirus ,subjects:2
infection ,subjects:2
sars-cov-2-associated ,acute:2
sars-cov-2-associated ,hemorrhagic:2
sars-cov-2-associated ,necrotizing:2
sars-cov-2-associated ,encephalitis:2
sars-cov-2-associated ,ahne:2
sars-cov-2-associated ,presenting:2
acute ,hemorrhagic:2
acute ,necrotizing:2
acute ,encephalitis:2
acute ,ahne:2
hemorrhagic ,necrotizing:2
hemorrhagic ,encephalitis:2
hemorrhagic ,ahne:2
hemorrhagic ,presenting:2
necrotizing ,encephalitis:2
necrotizing ,ahne:2
necrotizing ,presenting:2
encephalitis ,ahne:2
encephalitis ,presenting:2
ahne ,presenting:2
dealing ,liver:2
dealing ,transplantation:2
dealing ,coronavirus:2
dealing ,disease:2
dealing ,pandemic:2
transplantation ,coronavirus:4
severe ,learned:2
severe ,immunopathogenesis:2
covid-19 ,immunopathogenesis:8
learned ,immunopathogenesis:2
rapid ,establishment:6
rapid ,laboratory:2
rapid ,diagnostics:4
establishment ,laboratory:2
establishment ,diagnostics:2
establishment ,novel:2
establishment ,coronavirus:2
establishment ,sars-cov-2:10
laboratory ,diagnostics:6
sars-cov-2 ,contribution:2
shedding ,asymptomatic:6
shedding ,contribution:2
shedding ,potential:2
asymptomatic ,contribution:2
asymptomatic ,potential:6
patients ,contribution:4
contribution ,potential:6
emergence ,novel:10
emergence ,sars-cov-2:16
emergence ,disease:4
emergence ,neuroinvasive:2
novel ,neuroinvasive:2
coronavirus ,neuroinvasive:2
disease ,neuroinvasive:2
obesity ,predictor:4
obesity ,poor:2
obesity ,prognosis:2
obesity ,covid-19:34
obesity ,systematic:4
obesity ,review:2
predictor ,poor:2
predictor ,prognosis:2
predictor ,covid-19:10
predictor ,systematic:4
predictor ,review:2
poor ,prognosis:4
poor ,systematic:2
poor ,review:2
prevention ,controlled:2
prevention ,modulation:2
prevention ,innate:2
treatment ,controlled:2
treatment ,modulation:2
treatment ,innate:2
covid-19 ,controlled:4
covid-19 ,modulation:8
disease ,controlled:2
disease ,modulation:4
disease ,innate:2
controlled ,modulation:2
controlled ,innate:2
modulation ,innate:2
collision ,meta-inflammation:2
collision ,sars-cov-2:2
collision ,pandemic:2
collision ,infection:2
meta-inflammation ,sars-cov-2:2
meta-inflammation ,pandemic:2
meta-inflammation ,infection:2
pandemic ,infection:14
neurological ,injuries:2
neurological ,direct:2
neurological ,viral:2
neurological ,bystander:2
injuries ,covid-19:6
injuries ,patients:2
injuries ,direct:2
injuries ,viral:2
injuries ,invasion:2
injuries ,bystander:2
covid-19 ,direct:6
covid-19 ,invasion:6
covid-19 ,bystander:4
patients ,direct:6
patients ,invasion:2
patients ,bystander:2
direct ,viral:2
direct ,invasion:2
direct ,bystander:2
viral ,invasion:4
viral ,bystander:2
invasion ,bystander:2
ozone ,effective:2
ozone ,disinfection:2
ozone ,measure:2
ozone ,novel:2
ozone ,coronavirus:2
effective ,disinfection:2
effective ,measure:4
effective ,novel:4
disinfection ,measure:4
disinfection ,novel:2
measure ,novel:2
measure ,coronavirus:2
can ,quantitative:2
can ,rt-pcr:4
can ,help:14
can ,better:4
can ,management:4
quantitative ,sars-cov-2:22
quantitative ,help:2
quantitative ,better:2
quantitative ,management:2
quantitative ,patients:8
rt-pcr ,help:2
rt-pcr ,better:2
rt-pcr ,management:2
rt-pcr ,patients:16
sars-cov-2 ,help:2
sars-cov-2 ,better:4
help ,better:2
help ,management:2
help ,patients:2
better ,management:2
better ,patients:2
tuberculosis ,overlapping:2
tuberculosis ,situation:2
tuberculosis ,pandemic:6
covid-19 ,overlapping:2
overlapping ,situation:2
overlapping ,pandemic:2
situation ,pandemic:6
stroke ,complication:2
stroke ,prognostic:2
stroke ,factor:2
complication ,prognostic:2
complication ,factor:2
prognostic ,factor:2
prognostic ,covid-19:16
can ,robots:4
can ,improve:2
can ,testing:2
can ,capacity:2
robots ,improve:2
robots ,testing:2
robots ,capacity:2
robots ,sars-cov-2:4
improve ,testing:4
improve ,capacity:2
improve ,sars-cov-2:2
characteristics ,ocular:2
characteristics ,findings:6
ocular ,findings:6
clinical ,newborns:8
clinical ,pediatrics:2
characteristics ,newborns:8
characteristics ,pediatrics:2
covid-19 ,pediatrics:2
infection ,newborns:8
infection ,pediatrics:4
newborns ,pediatrics:2
convalescent ,lessons:2
convalescent ,past:2
plasma ,lessons:2
plasma ,past:2
lessons ,past:6
potential ,large:2
potential ,first:2
potential ,generation:2
potential ,human-to-human:2
large ,first:2
large ,generation:2
large ,human-to-human:2
large ,transmission:2
large ,2019-ncov:2
first ,generation:2
first ,human-to-human:2
first ,transmission:4
generation ,human-to-human:2
generation ,transmission:2
can ,disinfection:2
can ,reduce:10
can ,risk:4
can ,transmission:4
can ,health:4
can ,care:2
disinfection ,robots:2
disinfection ,reduce:2
disinfection ,risk:2
disinfection ,health:2
disinfection ,care:2
robots ,reduce:2
robots ,risk:2
robots ,transmission:2
robots ,health:2
robots ,care:2
reduce ,risk:4
reduce ,transmission:8
reduce ,health:2
reduce ,care:2
risk ,health:10
risk ,care:12
transmission ,care:12
covid-19 ,reorganization:4
covid-19 ,endoscopy:14
covid-19 ,service:4
emergency ,reorganization:4
emergency ,endoscopy:2
emergency ,service:2
management ,reorganization:2
management ,endoscopy:2
management ,service:4
reorganization ,endoscopy:2
reorganization ,service:2
endoscopy ,service:2
repurposing ,old:2
repurposing ,antiviral:10
repurposing ,agents:4
repurposing ,coronaviruses:2
old ,antiviral:2
old ,agents:2
old ,coronaviruses:4
drugs ,agents:2
drugs ,coronaviruses:2
antiviral ,agents:12
antiviral ,coronaviruses:2
simple ,method:2
simple ,sars-cov-2:6
simple ,detection:4
simple ,rrt-pcr:2
simple ,without:2
simple ,use:2
simple ,commercial:2
method ,sars-cov-2:8
method ,detection:6
method ,rrt-pcr:2
method ,without:2
method ,use:2
method ,commercial:2
sars-cov-2 ,rrt-pcr:8
detection ,use:6
rrt-pcr ,without:4
rrt-pcr ,use:2
rrt-pcr ,commercial:2
without ,use:4
without ,commercial:2
use ,commercial:2
stabilizing ,cellular:2
stabilizing ,barriers:2
stabilizing ,raising:2
stabilizing ,shields:2
stabilizing ,covid-19:2
cellular ,barriers:2
cellular ,raising:2
cellular ,shields:2
barriers ,raising:2
barriers ,shields:2
barriers ,covid-19:2
raising ,shields:2
shields ,covid-19:4
prevention ,spread:4
prevention ,auschwitz-birkenau:2
prevention ,state:2
prevention ,museum:2
sars-cov-2 ,auschwitz-birkenau:2
sars-cov-2 ,museum:2
coronavirus ,auschwitz-birkenau:2
coronavirus ,state:8
coronavirus ,museum:2
spread ,auschwitz-birkenau:2
spread ,state:2
spread ,museum:2
auschwitz-birkenau ,state:2
auschwitz-birkenau ,museum:2
state ,museum:2
gynecological ,malignancies:2
gynecological ,asymptomatic:2
gynecological ,sars-cov-2:2
gynecological ,infection:2
malignancies ,asymptomatic:2
malignancies ,sars-cov-2:2
malignancies ,infection:2
diagnostic ,anti:2
diagnostic ,igm:2
diagnostic ,igg:4
diagnostic ,detecting:4
value ,rapid:2
value ,anti:2
value ,igm:2
value ,igg:2
value ,detecting:4
value ,tests:2
rapid ,anti:2
rapid ,igm:4
rapid ,detecting:2
rapid ,tests:16
anti ,igm:2
anti ,igg:2
anti ,detecting:2
anti ,tests:2
igm ,detecting:2
igm ,tests:2
igg ,detecting:2
igg ,tests:2
detecting ,tests:4
pandemic ,human:4
pandemic ,genetic:4
pandemic ,perspective:16
human ,genetic:10
effects ,gene-eden-vir:2
effects ,novirin:2
effects ,sars-cov:4
effects ,implications:2
gene-eden-vir ,novirin:2
gene-eden-vir ,sars-cov:2
gene-eden-vir ,implications:2
gene-eden-vir ,covid-19:2
novirin ,sars-cov:2
novirin ,implications:2
novirin ,covid-19:2
sars-cov ,implications:2
protein-reactive ,igg:2
protein-reactive ,memory:2
protein-reactive ,cell:2
protein-reactive ,production:2
protein-reactive ,human:2
protein-reactive ,sars-cov-2:2
protein-reactive ,infection:2
igg ,memory:2
igg ,cell:2
igg ,production:2
igg ,human:2
igg ,infection:2
memory ,cell:4
memory ,production:2
memory ,human:2
memory ,sars-cov-2:4
memory ,infection:2
cell ,production:2
cell ,human:12
cell ,infection:10
design ,potent:2
design ,membrane:2
design ,fusion:2
design ,emerging:4
potent ,membrane:2
potent ,fusion:2
potent ,inhibitors:8
potent ,sars-cov-2:22
potent ,emerging:2
membrane ,fusion:6
membrane ,inhibitors:2
membrane ,sars-cov-2:6
membrane ,emerging:2
fusion ,inhibitors:2
fusion ,emerging:2
inhibitors ,emerging:2
existing ,bitter:2
existing ,medicines:2
existing ,fighting:2
existing ,2019-ncov-associated:2
existing ,infectious:2
existing ,diseases:2
bitter ,medicines:2
bitter ,fighting:2
bitter ,2019-ncov-associated:2
bitter ,infectious:2
bitter ,diseases:2
medicines ,fighting:2
medicines ,2019-ncov-associated:2
medicines ,infectious:2
medicines ,diseases:2
fighting ,2019-ncov-associated:2
fighting ,infectious:2
fighting ,diseases:2
2019-ncov-associated ,infectious:2
2019-ncov-associated ,diseases:2
infectious ,diseases:8
repurposing ,therapeutics:6
repurposing ,potential:14
therapeutics ,treatment:2
therapeutics ,review:2
potential ,review:28
effects ,proactive:2
effects ,distancing:4
effects ,outbreaks:2
effects ,58:2
effects ,cities:2
effects ,china:4
proactive ,social:2
proactive ,distancing:2
proactive ,covid-19:6
proactive ,outbreaks:2
proactive ,58:2
proactive ,cities:2
proactive ,china:2
social ,outbreaks:2
social ,58:2
social ,cities:2
social ,china:4
distancing ,outbreaks:2
distancing ,58:2
distancing ,cities:2
distancing ,china:2
covid-19 ,58:2
covid-19 ,cities:4
outbreaks ,58:2
outbreaks ,cities:2
outbreaks ,china:4
58 ,cities:2
58 ,china:2
autopsies ,deceased:4
autopsies ,absolutely:2
covid-19 ,absolutely:2
deceased ,absolutely:2
genetic ,diversity:4
diversity ,evolution:2
rheumotologitsts ,view:2
rheumotologitsts ,use:2
rheumotologitsts ,hydroxychloroquine:2
rheumotologitsts ,treat:2
rheumotologitsts ,covid-19:2
view ,use:2
view ,hydroxychloroquine:2
view ,treat:2
sars-cov-2 ,impacts:6
sars-cov-2 ,nasa:2
sars-cov-2 ,ground:4
sars-cov-2 ,operations:2
sars-cov-2 ,protect:2
sars-cov-2 ,iss:2
sars-cov-2 ,astronauts:2
pandemic ,impacts:8
pandemic ,nasa:2
pandemic ,ground:2
pandemic ,operations:4
pandemic ,protect:4
pandemic ,iss:2
pandemic ,astronauts:2
impacts ,nasa:2
impacts ,ground:2
impacts ,operations:2
impacts ,protect:4
impacts ,iss:2
impacts ,astronauts:2
nasa ,ground:2
nasa ,operations:2
nasa ,protect:2
nasa ,iss:2
nasa ,astronauts:2
ground ,operations:2
ground ,protect:2
ground ,iss:2
ground ,astronauts:2
operations ,protect:2
operations ,iss:2
operations ,astronauts:2
protect ,iss:2
protect ,astronauts:2
iss ,astronauts:2
viral ,epidemiologic:2
viral ,clinical:16
viral ,characteristics:4
viral ,potential:10
viral ,options:2
epidemiologic ,potential:2
epidemiologic ,therapy:2
epidemiologic ,options:2
clinical ,potential:14
clinical ,options:2
characteristics ,therapy:2
characteristics ,options:4
therapy ,options:2
scientific ,research:6
scientific ,progress:2
scientific ,covid-19sars-cov-2:2
scientific ,first:2
scientific ,five:2
scientific ,months:2
research ,covid-19sars-cov-2:2
research ,first:4
research ,five:2
research ,months:2
progress ,covid-19sars-cov-2:2
progress ,first:2
progress ,five:2
progress ,months:2
covid-19sars-cov-2 ,first:2
covid-19sars-cov-2 ,five:2
covid-19sars-cov-2 ,months:2
first ,five:4
five ,months:2
gns561 ,exhibits:2
gns561 ,potent:2
gns561 ,vitro:2
gns561 ,antiviral:2
gns561 ,activity:2
gns561 ,sars-cov-2:2
exhibits ,potent:2
exhibits ,vitro:2
exhibits ,antiviral:2
exhibits ,activity:2
exhibits ,sars-cov-2:8
potent ,vitro:2
potent ,antiviral:6
potent ,activity:4
vitro ,antiviral:10
vitro ,activity:14
antiviral ,activity:20
co-infection ,disease:2
co-infection ,report:6
co-infection ,iran:2
coronavirus ,influenza:6
coronavirus ,iran:4
disease ,influenza:2
disease ,iran:4
influenza ,report:4
influenza ,iran:2
report ,iran:2
anti-sars-cov-2 ,virus:2
anti-sars-cov-2 ,levels:2
anti-sars-cov-2 ,convalescent:6
anti-sars-cov-2 ,plasma:6
anti-sars-cov-2 ,six:2
anti-sars-cov-2 ,donors:4
virus ,antibody:4
virus ,levels:2
virus ,convalescent:2
virus ,plasma:4
virus ,six:2
virus ,donors:2
antibody ,levels:2
antibody ,convalescent:4
antibody ,plasma:4
antibody ,six:6
antibody ,donors:2
levels ,convalescent:2
levels ,plasma:6
levels ,six:2
levels ,donors:2
convalescent ,six:2
convalescent ,donors:2
plasma ,six:2
plasma ,donors:4
six ,donors:2
pooled ,testing:10
pooled ,sars-cov-2:6
pooled ,hospitalized:2
pooled ,patients:4
testing ,hospitalized:6
sars-cov-2 ,heart:10
infection ,cardiovascular:10
infection ,heart:6
cardiovascular ,heart:2
disease ,heart:10
covid-19 ,heart:38
progress ,detection:4
progress ,human:2
progress ,samples:2
research ,detection:4
research ,novel:4
research ,human:4
research ,samples:2
novel ,samples:2
coronavirus ,samples:2
human ,samples:4
covid-2019 ,update:2
covid-2019 ,epidemiology:2
covid-2019 ,disease:4
covid-2019 ,spread:2
covid-2019 ,management:2
update ,epidemiology:2
update ,spread:2
update ,management:4
epidemiology ,spread:2
spread ,management:2
sars-cov-2covid-19 ,evolving:2
sars-cov-2covid-19 ,reality:2
sars-cov-2covid-19 ,global:2
sars-cov-2covid-19 ,response:2
sars-cov-2covid-19 ,knowledge:2
sars-cov-2covid-19 ,gaps:2
evolving ,reality:2
evolving ,global:2
evolving ,response:4
evolving ,knowledge:2
evolving ,gaps:2
reality ,global:2
reality ,response:2
reality ,knowledge:2
reality ,gaps:2
global ,response:2
global ,knowledge:2
global ,gaps:2
response ,knowledge:2
response ,gaps:2
knowledge ,gaps:6
immune ,environment:2
immune ,modulation:8
immune ,pneumonia:4
immune ,caused:2
immune ,sars-cov:10
environment ,modulation:2
environment ,pneumonia:2
environment ,caused:2
environment ,coronavirus:4
environment ,sars-cov:2
modulation ,pneumonia:2
modulation ,patients:2
modulation ,caused:2
modulation ,coronavirus:2
modulation ,sars-cov:2
pneumonia ,caused:12
patients ,caused:12
patients ,sars-cov:2
caused ,sars-cov:2
lips ,method:2
lips ,detection:2
lips ,sars-cov-2:2
lips ,antibodies:2
lips ,spike:2
lips ,nucleocapsid:2
method ,antibodies:2
method ,spike:2
method ,nucleocapsid:2
acute ,virus:12
acute ,integrative:2
kidney ,virus:4
kidney ,integrative:2
injury ,virus:6
injury ,integrative:2
sars-cov-2 ,integrative:8
virus ,integrative:2
patients ,integrative:4
covid-19 ,integrative:4
covid ,cardiovascular:2
covid ,effects:4
19 ,cardiovascular:2
19 ,effects:4
cardiovascular ,effects:6
standard ,operating:4
standard ,procedure:4
standard ,specimen:2
standard ,collection:2
standard ,packaging:2
standard ,transport:2
operating ,procedure:4
operating ,specimen:2
operating ,collection:2
operating ,packaging:2
operating ,transport:2
procedure ,specimen:2
procedure ,collection:2
procedure ,packaging:2
procedure ,transport:2
specimen ,collection:4
specimen ,packaging:2
specimen ,transport:8
collection ,packaging:2
collection ,transport:2
packaging ,transport:2
repurposing ,minocycline:2
repurposing ,management:6
repurposing ,mechanisms:2
repurposing ,opportunities:2
minocycline ,covid-19:2
minocycline ,management:2
minocycline ,mechanisms:2
minocycline ,opportunities:2
covid-19 ,opportunities:12
management ,mechanisms:2
management ,opportunities:2
mechanisms ,opportunities:2
multi-platform ,comparison:2
multi-platform ,sars-cov-2:2
multi-platform ,serology:2
multi-platform ,assays:2
multi-platform ,detection:2
comparison ,serology:4
serology ,assays:6
serology ,detection:2
strategies ,sars-cov-2-mediated:2
strategies ,eosinophilic:2
strategies ,disease:8
strategies ,association:2
prevent ,sars-cov-2-mediated:2
prevent ,eosinophilic:2
prevent ,disease:6
prevent ,association:2
sars-cov-2-mediated ,eosinophilic:2
sars-cov-2-mediated ,disease:2
sars-cov-2-mediated ,association:2
eosinophilic ,disease:2
eosinophilic ,association:2
can ,unconventional:2
can ,immunomodulatory:2
can ,agents:2
can ,alleviate:2
can ,symptoms:2
unconventional ,immunomodulatory:2
unconventional ,agents:2
unconventional ,help:2
unconventional ,alleviate:2
unconventional ,covid-19:2
unconventional ,symptoms:2
immunomodulatory ,agents:2
immunomodulatory ,help:2
immunomodulatory ,alleviate:2
immunomodulatory ,covid-19:8
immunomodulatory ,symptoms:2
agents ,help:2
agents ,alleviate:2
agents ,symptoms:2
help ,alleviate:2
help ,symptoms:2
alleviate ,covid-19:2
alleviate ,symptoms:2
arbidol ,analogs:2
arbidol ,inhibit:2
analogs ,inhibit:2
analogs ,sars-cov-2:2
immune ,therapeutic:2
immune ,option:2
immune ,case:4
modulation ,therapeutic:6
modulation ,option:2
modulation ,sars-cov-2:2
modulation ,outbreak:2
modulation ,case:2
therapeutic ,option:6
therapeutic ,case:2
option ,sars-cov-2:2
option ,outbreak:2
option ,case:2
outbreak ,case:8
ct ,scan:4
ct ,findings:24
ct ,five:2
ct ,mildly:2
ct ,symptomatic:2
ct ,covid:2
ct ,india:2
scan ,findings:2
scan ,five:2
scan ,mildly:2
scan ,symptomatic:2
scan ,covid:2
scan ,patients:2
scan ,india:2
findings ,five:2
findings ,mildly:2
findings ,symptomatic:2
findings ,covid:2
findings ,india:2
five ,mildly:2
five ,symptomatic:2
five ,covid:2
five ,patients:8
five ,india:2
mildly ,covid:2
mildly ,patients:6
mildly ,india:2
symptomatic ,covid:2
symptomatic ,patients:24
symptomatic ,india:2
covid ,india:2
patients ,india:2
current ,approaches:8
approaches ,laboratory:2
approaches ,testing:2
sars-cov-2 ,department:6
antibody ,characterization:4
antibody ,emergency:2
antibody ,department:2
antibody ,hospitalized:4
characterization ,emergency:2
characterization ,department:2
characterization ,hospitalized:2
emergency ,hospitalized:2
department ,hospitalized:2
airborne ,transmission:20
airborne ,sars-cov-2:20
airborne ,world:2
airborne ,face:4
airborne ,reality:2
transmission ,world:2
transmission ,face:8
transmission ,reality:2
sars-cov-2 ,world:6
sars-cov-2 ,reality:4
world ,face:2
world ,reality:2
face ,reality:2
covid-19 ,preclinical:4
covid-19 ,transgenic:2
covid-19 ,mice:2
preclinical ,models:2
preclinical ,human:2
preclinical ,angiotensin-converting:2
preclinical ,enzyme:2
preclinical ,transgenic:2
preclinical ,mice:2
models ,angiotensin-converting:2
models ,enzyme:2
models ,transgenic:4
human ,angiotensin-converting:4
human ,enzyme:4
human ,transgenic:6
human ,mice:6
angiotensin-converting ,transgenic:2
angiotensin-converting ,mice:2
enzyme ,transgenic:2
enzyme ,mice:2
transgenic ,mice:8
height ,storm:2
height ,healthcare:2
height ,staffs:2
height ,health:2
height ,conditions:2
height ,job:2
storm ,healthcare:2
storm ,staffs:2
storm ,health:2
storm ,conditions:2
storm ,job:2
healthcare ,staffs:2
healthcare ,health:10
healthcare ,conditions:2
healthcare ,job:2
staffs ,health:2
staffs ,conditions:2
staffs ,job:2
health ,conditions:6
health ,job:2
conditions ,job:2
covid-19 ,versus:6
covid-19 ,2019-2020:2
versus ,seasonal:2
versus ,influenza:2
versus ,2019-2020:2
versus ,usa:2
seasonal ,2019-2020:2
seasonal ,usa:2
influenza ,2019-2020:2
influenza ,usa:2
2019-2020 ,usa:2
mass ,spectrometric:2
mass ,identification:2
mass ,sars-cov-2:10
mass ,proteins:2
mass ,gargle:2
mass ,solution:2
spectrometric ,identification:2
spectrometric ,sars-cov-2:2
spectrometric ,proteins:2
spectrometric ,gargle:2
spectrometric ,solution:2
identification ,proteins:6
identification ,gargle:2
identification ,solution:2
sars-cov-2 ,gargle:4
sars-cov-2 ,solution:4
proteins ,gargle:2
proteins ,solution:2
gargle ,solution:2
occupational ,skin:2
occupational ,conditions:2
occupational ,front:2
occupational ,line:2
occupational ,survey:2
occupational ,among:8
occupational ,484:2
occupational ,chinese:2
skin ,conditions:2
skin ,front:2
skin ,line:2
skin ,survey:2
skin ,among:2
skin ,484:2
skin ,chinese:2
conditions ,front:2
conditions ,line:2
conditions ,survey:2
conditions ,among:4
conditions ,484:2
conditions ,chinese:2
front ,survey:2
front ,among:2
front ,484:2
front ,chinese:2
line ,survey:2
line ,among:2
line ,484:2
line ,chinese:2
survey ,among:8
survey ,484:2
survey ,chinese:2
among ,484:2
among ,chinese:4
484 ,chinese:2
antibody ,classroom:2
antibody ,exposure:2
antibody ,teacher:2
responses ,classroom:2
responses ,exposure:2
responses ,teacher:2
classroom ,exposure:2
classroom ,teacher:2
classroom ,coronavirus:2
classroom ,disease:2
exposure ,teacher:2
teacher ,coronavirus:2
teacher ,disease:2
protecting ,practical:2
protecting ,indications:2
healthcare ,practical:2
healthcare ,indications:2
workers ,practical:2
workers ,indications:2
sars-cov-2 ,practical:10
sars-cov-2 ,indications:4
infection ,practical:2
infection ,indications:2
practical ,indications:4
clinical ,validity:2
clinical ,serum:4
clinical ,antibodies:4
clinical ,case-control:2
clinical ,study:28
validity ,serum:2
validity ,antibodies:2
validity ,sars-cov-2:4
validity ,case-control:2
validity ,study:2
serum ,antibodies:12
serum ,sars-cov-2:26
serum ,case-control:2
serum ,study:2
antibodies ,case-control:2
antibodies ,study:2
sars-cov-2 ,case-control:4
sars-cov-2 ,glucose:2
sars-cov-2 ,homeostasis:2
sars-cov-2 ,antenatal:2
infection ,glucose:2
infection ,homeostasis:2
infection ,antenatal:2
glucose ,homeostasis:2
glucose ,pregnancy:2
glucose ,antenatal:2
homeostasis ,pregnancy:2
homeostasis ,antenatal:2
pregnancy ,antenatal:2
hypothesis ,potential:6
hypothesis ,pathogenesis:2
hypothesis ,infection-a:2
hypothesis ,review:2
hypothesis ,immune:4
potential ,infection-a:2
potential ,immune:14
pathogenesis ,infection-a:2
pathogenesis ,review:8
sars-cov-2 ,infection-a:2
infection-a ,review:2
infection-a ,immune:2
microbial ,coinfection:2
microbial ,covid-19:2
coinfection ,covid-19:12
outbreak ,kawasaki-like:4
outbreak ,children:4
outbreak ,sars-cov-:2
outbreak ,epidemic:10
kawasaki-like ,disease:14
kawasaki-like ,children:8
kawasaki-like ,sars-cov-:2
kawasaki-like ,epidemic:2
disease ,sars-cov-:2
disease ,epidemic:8
children ,sars-cov-:2
children ,epidemic:6
sars-cov- ,epidemic:2
coronavirus ,rhine-westphalia:2
coronavirus ,district:6
sars-cov-2 ,rhine-westphalia:2
sars-cov-2 ,district:4
outbreak ,north:2
outbreak ,rhine-westphalia:2
outbreak ,district:2
north ,rhine-westphalia:2
north ,district:2
rhine-westphalia ,district:2
pathogenic ,analysis:2
pathogenic ,suspected:2
pathogenic ,covid-19:6
pathogenic ,patients:4
pathogenic ,non-epidemic:2
pathogenic ,area:2
analysis ,suspected:2
analysis ,non-epidemic:2
analysis ,area:2
suspected ,non-epidemic:2
suspected ,area:2
covid-19 ,non-epidemic:2
covid-19 ,area:6
patients ,non-epidemic:2
patients ,area:2
sars-cov-2 ,non-epidemic:2
sars-cov-2 ,area:8
non-epidemic ,area:4
covid-19 ,nanomedicine:2
covid-19 ,uncovers:2
covid-19 ,blood-clot:2
nanomedicine ,uncovers:2
nanomedicine ,blood-clot:2
nanomedicine ,mystery:2
uncovers ,blood-clot:2
uncovers ,mystery:2
blood-clot ,mystery:2
outcomes ,infection:12
outcomes ,taking:2
outcomes ,aceiarb:2
patients ,taking:4
patients ,aceiarb:2
covid-19 ,taking:6
covid-19 ,aceiarb:2
infection ,taking:2
infection ,aceiarb:2
taking ,aceiarb:2
evidence ,induction:2
evidence ,labour:2
vertical ,induction:2
vertical ,labour:2
transmission ,induction:2
transmission ,labour:2
sars-cov-2 ,induction:2
sars-cov-2 ,labour:2
induction ,labour:2
infection ,dental:8
infection ,anesthesiology:4
infection ,time:2
infection ,preliminary:2
infection ,reconsideration:2
control ,dental:8
control ,anesthesiology:2
control ,time:2
control ,preliminary:2
control ,reconsideration:2
dental ,anesthesiology:2
dental ,time:2
dental ,preliminary:2
dental ,reconsideration:2
anesthesiology ,time:2
anesthesiology ,preliminary:2
anesthesiology ,reconsideration:2
time ,preliminary:2
time ,reconsideration:2
preliminary ,reconsideration:2
design ,multi-epitope:4
design ,using:6
design ,immunoinformatics:2
multi-epitope ,vaccine:14
multi-epitope ,sars-cov-2:8
multi-epitope ,using:2
multi-epitope ,immunoinformatics:4
vaccine ,using:4
vaccine ,immunoinformatics:6
sars-cov-2 ,immunoinformatics:4
using ,immunoinformatics:2
anosmia ,dysgeusia:4
anosmia ,absence:2
anosmia ,respiratory:2
anosmia ,diseases:2
dysgeusia ,absence:2
dysgeusia ,respiratory:2
dysgeusia ,diseases:2
dysgeusia ,covid-19:2
absence ,respiratory:4
absence ,diseases:2
absence ,covid-19:4
respiratory ,diseases:6
urologists ,know:2
urologists ,sars-cov-2:4
urologists ,risk:2
urologists ,analysis:2
urologists ,urological:2
know ,risk:2
know ,analysis:2
know ,urological:2
sars-cov-2 ,urological:4
risk ,analysis:10
risk ,urological:2
analysis ,urological:4
ocular ,hospitalised:2
ocular ,patient:2
ocular ,confirmed:2
ocular ,novel:4
manifestations ,hospitalised:2
manifestations ,patient:4
manifestations ,confirmed:2
hospitalised ,patient:2
hospitalised ,confirmed:2
hospitalised ,novel:2
impact ,consequences:4
impact ,single:2
impact ,university:2
consequences ,pandemic:12
consequences ,single:2
consequences ,university:2
sars-cov-2 ,university:4
pandemic ,single:2
pandemic ,university:4
single ,university:2
immune ,thrombocytopenia:8
immune ,itp:2
immune ,pediatric:4
immune ,patient:4
thrombocytopenia ,itp:2
thrombocytopenia ,pediatric:2
thrombocytopenia ,patient:6
thrombocytopenia ,positive:2
thrombocytopenia ,sars-cov-2:4
itp ,pediatric:2
itp ,patient:2
itp ,positive:2
itp ,sars-cov-2:2
pediatric ,patient:10
pediatric ,positive:4
pediatric ,sars-cov-2:26
erythema ,multiforme-like:2
erythema ,lesions:2
erythema ,children:2
erythema ,covid-19:6
multiforme-like ,lesions:2
multiforme-like ,children:2
multiforme-like ,covid-19:2
lesions ,children:2
cancer ,comprehensive:2
cancer ,review:8
coronavirus ,gulf:2
coronavirus ,cooperation:2
coronavirus ,council:2
coronavirus ,gcc:2
disease ,gulf:2
disease ,cooperation:2
disease ,council:2
disease ,gcc:2
covid-19 ,gulf:2
covid-19 ,cooperation:4
covid-19 ,council:2
covid-19 ,gcc:2
gulf ,cooperation:2
gulf ,council:2
gulf ,gcc:2
cooperation ,council:2
cooperation ,gcc:2
council ,gcc:2
hypercoagulation ,antithrombotic:2
hypercoagulation ,treatment:2
hypercoagulation ,coronavirus:2
hypercoagulation ,new:2
hypercoagulation ,challenge:2
antithrombotic ,treatment:4
antithrombotic ,coronavirus:2
antithrombotic ,new:2
antithrombotic ,challenge:2
treatment ,new:12
treatment ,challenge:2
covid-19 ,facts:14
epidemiology ,facts:2
clinical ,facts:2
insights ,genome:6
insights ,structure:4
insights ,evolution:4
insights ,pathogenesis:8
insights ,therapies:4
genome ,evolution:4
genome ,pathogenesis:4
genome ,therapies:2
structure ,evolution:2
structure ,pathogenesis:4
structure ,therapies:2
evolution ,pathogenesis:2
evolution ,therapies:2
pathogenesis ,therapies:2
active ,smoking:2
active ,worsen:2
smoking ,worsen:2
smoking ,covid-19:20
worsen ,covid-19:4
sars-cov-2 ,domestic:10
sars-cov-2 ,cats:8
infection ,domestic:4
infection ,cats:6
disease ,domestic:2
disease ,cats:2
transmission ,domestic:2
transmission ,cats:2
domestic ,cats:6
neurological ,complications:16
neurological ,possible:6
neurological ,neuroinvasion:2
neurological ,pathways:2
complications ,possible:4
complications ,neuroinvasion:2
complications ,pathways:2
covid-19 ,neuroinvasion:4
possible ,neuroinvasion:2
possible ,pathways:2
neuroinvasion ,pathways:2
vaccination ,strategies:4
vaccination ,combat:2
vaccination ,novel:2
vaccination ,corona:2
vaccination ,virus:2
strategies ,combat:4
strategies ,corona:2
strategies ,virus:2
combat ,novel:2
combat ,corona:2
combat ,virus:2
corona ,sars-cov-2:4
health-care ,organization:2
health-care ,management:2
health-care ,surveillance:2
health-care ,sars-cov-2:6
health-care ,infection:6
organization ,management:2
organization ,surveillance:2
organization ,sars-cov-2:2
organization ,infection:2
management ,surveillance:4
management ,infection:12
surveillance ,infection:6
role ,dipeptidyl:4
role ,peptidase-4:2
role ,patients:20
role ,infected:2
dipeptidyl ,peptidase-4:4
dipeptidyl ,inhibitors:2
dipeptidyl ,patients:2
dipeptidyl ,diabetes:2
dipeptidyl ,infected:2
peptidase-4 ,inhibitors:2
peptidase-4 ,patients:2
peptidase-4 ,diabetes:2
peptidase-4 ,infected:2
inhibitors ,patients:4
inhibitors ,diabetes:2
inhibitors ,infected:2
diabetes ,infected:2
digestive ,system:10
digestive ,manifestations:2
digestive ,clinical:2
digestive ,significance:2
digestive ,coronavirus:4
digestive ,disease:2
system ,manifestations:8
system ,significance:2
manifestations ,significance:2
manifestations ,disease:22
significance ,coronavirus:2
significance ,disease:2
development ,humanized:4
development ,tri-specific:2
development ,nanobodies:2
development ,potent:6
development ,neutralization:2
humanized ,tri-specific:2
humanized ,nanobodies:2
humanized ,potent:2
humanized ,neutralization:2
tri-specific ,nanobodies:2
tri-specific ,potent:2
tri-specific ,neutralization:2
nanobodies ,potent:2
nanobodies ,neutralization:2
potent ,neutralization:8
withanone ,withaferin-a:2
withanone ,predicted:4
withanone ,interact:4
withanone ,transmembrane:2
withanone ,protease:2
withaferin-a ,predicted:2
withaferin-a ,interact:2
withaferin-a ,transmembrane:2
withaferin-a ,protease:2
predicted ,interact:4
predicted ,transmembrane:2
predicted ,protease:2
interact ,transmembrane:2
interact ,protease:2
transmembrane ,protease:2
can ,disease:6
can ,affect:4
can ,eyes:2
can ,review:2
coronavirus ,affect:2
coronavirus ,eyes:4
disease ,affect:2
disease ,eyes:4
covid-19 ,affect:8
covid-19 ,eyes:2
affect ,eyes:2
affect ,review:2
eyes ,review:2
sars-cov-2 ,biosynthesis:2
spike ,biosynthesis:2
spike ,function:6
glycoprotein ,biosynthesis:2
glycoprotein ,structure:4
glycoprotein ,function:6
biosynthesis ,structure:2
biosynthesis ,function:2
structure ,function:6
case ,walking:2
case ,pneumonia:22
report ,walking:2
report ,pneumonia:12
report ,novel:16
report ,mild:6
walking ,pneumonia:2
walking ,novel:2
walking ,coronavirus:2
walking ,disease:2
walking ,covid-19:2
walking ,mild:2
pneumonia ,mild:6
novel ,mild:4
coronavirus ,mild:8
disease ,mild:8
laboratorys ,role:2
laboratorys ,combating:2
laboratorys ,covid-19:2
role ,combating:2
sars-cov-2 ,infertile:2
sars-cov-2 ,recommendations:30
sars-cov-2 ,europe:4
testing ,infertile:2
testing ,different:6
testing ,recommendations:2
testing ,europe:2
infertile ,patients:2
infertile ,different:2
infertile ,recommendations:2
infertile ,europe:2
patients ,different:6
patients ,recommendations:14
patients ,europe:2
different ,recommendations:2
different ,europe:2
recommendations ,europe:2
update ,cardiac:2
update ,involvement:2
bioinformatic ,study:2
bioinformatic ,discover:2
bioinformatic ,natural:2
bioinformatic ,molecules:2
bioinformatic ,activity:2
bioinformatic ,covid-19:4
study ,discover:2
study ,natural:2
study ,molecules:2
study ,activity:2
discover ,natural:2
discover ,molecules:2
discover ,activity:2
discover ,covid-19:4
natural ,molecules:2
natural ,activity:4
molecules ,activity:2
molecules ,covid-19:4
clinical ,factors:12
clinical ,associated:8
clinical ,long-term:2
clinical ,excretion:2
characteristics ,factors:6
characteristics ,associated:6
characteristics ,long-term:2
characteristics ,excretion:2
factors ,associated:24
factors ,long-term:2
factors ,viral:14
factors ,excretion:2
associated ,long-term:2
associated ,viral:18
associated ,excretion:2
long-term ,viral:4
long-term ,excretion:2
viral ,excretion:2
infectivity ,human:2
infectivity ,coronavirus:4
infectivity ,brain:2
human ,brain:4
coronavirus ,brain:2
accuracy ,rt-qpcr:2
accuracy ,sars-cov-2:4
accuracy ,detection:2
accuracy ,assay:2
accuracy ,without:2
accuracy ,prior:2
accuracy ,rna:2
accuracy ,extraction:2
rt-qpcr ,assay:4
rt-qpcr ,without:4
rt-qpcr ,prior:2
rt-qpcr ,rna:6
rt-qpcr ,extraction:2
sars-cov-2 ,prior:4
detection ,prior:2
assay ,without:2
assay ,prior:2
assay ,rna:6
assay ,extraction:2
without ,prior:2
prior ,rna:2
prior ,extraction:2
study ,semen:2
study ,urine:2
study ,samples:4
study ,volunteer:2
study ,positive:4
sars-cov-2 ,semen:6
sars-cov-2 ,urine:4
sars-cov-2 ,volunteer:2
semen ,urine:2
semen ,samples:2
semen ,volunteer:2
semen ,positive:2
urine ,samples:2
urine ,volunteer:2
urine ,positive:2
samples ,volunteer:2
samples ,positive:2
volunteer ,positive:2
medication ,therapy:2
medication ,strategies:2
medication ,coronavirus:2
medication ,disease:2
medication ,covid-19:6
medication ,recent:2
therapy ,strategies:4
strategies ,recent:2
exit ,strategy:4
exit ,resuming:2
exit ,nonemergency:2
exit ,neurosurgery:2
exit ,severe:2
exit ,acute:2
strategy ,resuming:2
strategy ,nonemergency:2
strategy ,neurosurgery:2
strategy ,severe:6
strategy ,acute:6
resuming ,nonemergency:2
resuming ,neurosurgery:2
resuming ,severe:2
resuming ,acute:2
nonemergency ,neurosurgery:2
nonemergency ,severe:2
nonemergency ,acute:2
neurosurgery ,severe:2
neurosurgery ,acute:2
sars-cov-2 ,anticipated:2
sars-cov-2 ,occurrence:12
rna ,anticipated:2
rna ,occurrence:2
rna ,low:4
rna ,prevalence:2
wastewater ,anticipated:2
wastewater ,covid-19:14
wastewater ,occurrence:6
wastewater ,low:2
wastewater ,prevalence:2
anticipated ,covid-19:2
anticipated ,occurrence:2
anticipated ,low:2
anticipated ,prevalence:2
covid-19 ,occurrence:4
occurrence ,low:2
occurrence ,prevalence:2
pulmonary ,rehabilitation:2
pulmonary ,guidelines:2
pulmonary ,principle:2
pulmonary ,4s:2
pulmonary ,infected:2
rehabilitation ,guidelines:2
rehabilitation ,principle:2
rehabilitation ,4s:2
rehabilitation ,patients:6
rehabilitation ,infected:2
guidelines ,principle:2
guidelines ,4s:2
guidelines ,patients:2
guidelines ,infected:2
principle ,4s:2
principle ,patients:2
principle ,infected:2
4s ,patients:2
4s ,infected:2
different ,longitudinal:2
different ,patterns:2
different ,nucleic:4
different ,acid:4
different ,serology:4
different ,results:4
different ,based:2
longitudinal ,patterns:2
longitudinal ,nucleic:2
longitudinal ,acid:2
longitudinal ,serology:2
longitudinal ,testing:2
longitudinal ,results:2
longitudinal ,based:2
patterns ,nucleic:2
patterns ,acid:2
patterns ,serology:2
patterns ,testing:2
patterns ,results:2
patterns ,based:2
nucleic ,serology:2
nucleic ,based:2
acid ,serology:2
acid ,based:4
serology ,results:2
serology ,based:2
testing ,based:2
results ,based:2
first ,ct:2
first ,characteristic:2
first ,appearance:4
ct ,characteristic:2
ct ,appearance:2
characteristic ,appearance:2
characteristic ,patients:4
characteristic ,coronavirus:2
characteristic ,disease:2
appearance ,patients:2
appearance ,coronavirus:2
appearance ,disease:2
co-infection ,parainfluenza:2
co-infection ,hemodialysis:2
sars-cov-2 ,parainfluenza:2
parainfluenza ,virus:2
parainfluenza ,hemodialysis:2
parainfluenza ,patient:2
virus ,hemodialysis:2
progress ,diagnosis:2
lung ,attack:2
lung ,covid-19-induced:2
lung ,cytokine:6
lung ,storm:4
lung ,pathogenic:2
lung ,mechanisms:4
attack ,covid-19-induced:2
attack ,cytokine:2
attack ,storm:2
attack ,pathogenic:2
attack ,mechanisms:2
covid-19-induced ,cytokine:2
covid-19-induced ,storm:2
covid-19-induced ,pathogenic:2
covid-19-induced ,mechanisms:4
cytokine ,pathogenic:2
cytokine ,mechanisms:2
storm ,pathogenic:2
storm ,mechanisms:2
pathogenic ,mechanisms:8
melanie ,saville:2
melanie ,end-to-end:2
melanie ,process:2
melanie ,needed:2
melanie ,sars-cov-2:2
melanie ,vaccine:2
saville ,end-to-end:2
saville ,process:2
saville ,needed:2
saville ,sars-cov-2:2
saville ,vaccine:2
end-to-end ,process:2
end-to-end ,needed:2
end-to-end ,sars-cov-2:2
end-to-end ,vaccine:2
process ,needed:2
process ,vaccine:2
needed ,sars-cov-2:4
needed ,vaccine:2
optimization ,fluorescent:2
optimization ,qpcr:2
optimization ,rna:2
optimization ,sars-cov-2:6
fluorescent ,qpcr:2
fluorescent ,detection:2
fluorescent ,rna:2
fluorescent ,sars-cov-2:2
qpcr ,detection:2
qpcr ,rna:2
qpcr ,sars-cov-2:2
sars-cov-2 ,complications:12
cardiovascular ,complications:6
cardiovascular ,molecular:2
cardiovascular ,mechanisms:6
complications ,mechanisms:2
implications ,preliminary:2
implications ,screening:2
implications ,diagnosis:2
implications ,characteristics:2
preliminary ,screening:2
preliminary ,diagnosis:2
preliminary ,characteristics:4
screening ,diagnosis:8
screening ,clinical:4
screening ,characteristics:2
sars-cov-2 ,southern:8
sars-cov-2 ,descriptive:2
sars-cov-2 ,series:20
infection ,southern:2
infection ,italy:6
infection ,descriptive:2
infection ,series:16
children ,southern:2
children ,italy:2
children ,descriptive:2
children ,case:8
children ,series:6
southern ,italy:2
southern ,descriptive:2
southern ,case:2
southern ,series:2
italy ,descriptive:2
italy ,case:4
italy ,series:2
descriptive ,case:2
descriptive ,series:2
case ,series:74
proteotyping ,sars-cov-2:2
proteotyping ,virus:2
proteotyping ,nasopharyngeal:2
proteotyping ,swabs:2
proteotyping ,proof-of-concept:2
proteotyping ,focused:2
sars-cov-2 ,proof-of-concept:2
sars-cov-2 ,focused:2
virus ,swabs:2
virus ,proof-of-concept:2
virus ,focused:2
nasopharyngeal ,proof-of-concept:2
nasopharyngeal ,focused:2
swabs ,proof-of-concept:2
swabs ,focused:2
proof-of-concept ,focused:2
adaptive ,immunity:8
adaptive ,sars-cov-2:8
relapsing ,viral:2
relapsing ,keratoconjunctivitis:2
relapsing ,covid-19:2
relapsing ,case:2
relapsing ,report:2
viral ,keratoconjunctivitis:2
viral ,report:6
keratoconjunctivitis ,covid-19:2
keratoconjunctivitis ,case:2
keratoconjunctivitis ,report:2
host ,driving:4
host ,evolution:4
immune ,driving:4
immune ,evolution:4
response ,driving:4
response ,evolution:4
driving ,sars-cov-2:8
driving ,evolution:4
online ,coronavirus:4
online ,platform:2
online ,national:2
online ,genomics:2
online ,center:2
coronavirus ,platform:2
coronavirus ,national:6
coronavirus ,genomics:2
coronavirus ,center:4
analysis ,platform:4
analysis ,national:4
analysis ,genomics:2
analysis ,center:2
platform ,national:2
platform ,genomics:2
platform ,data:2
platform ,center:2
national ,genomics:2
national ,data:2
national ,center:2
genomics ,data:2
genomics ,center:2
data ,center:2
inhaled ,systemic:2
inhaled ,heparin:2
inhaled ,repurposed:2
inhaled ,direct:2
inhaled ,antiviral:2
inhaled ,drug:2
inhaled ,prevention:2
systemic ,heparin:2
systemic ,repurposed:2
systemic ,direct:2
systemic ,antiviral:2
systemic ,drug:2
systemic ,prevention:2
heparin ,repurposed:2
heparin ,direct:2
heparin ,antiviral:2
heparin ,drug:2
heparin ,prevention:2
repurposed ,direct:2
repurposed ,antiviral:4
repurposed ,prevention:2
direct ,antiviral:2
direct ,drug:2
direct ,prevention:2
antiviral ,prevention:2
novel ,immunoglobulin:2
novel ,proteins:4
novel ,provide:2
immunoglobulin ,domain:2
immunoglobulin ,proteins:2
immunoglobulin ,provide:2
immunoglobulin ,insights:2
immunoglobulin ,evolution:2
domain ,proteins:2
domain ,provide:2
domain ,insights:2
domain ,evolution:2
proteins ,provide:2
proteins ,insights:2
proteins ,evolution:2
provide ,evolution:2
long-term ,herd:2
long-term ,immunity:2
long-term ,implications:2
long-term ,current:2
long-term ,past:2
herd ,sars-cov-2:4
herd ,implications:2
herd ,current:2
herd ,past:2
immunity ,current:2
immunity ,past:2
implications ,past:2
current ,past:4
neonatal ,late:2
neonatal ,onset:2
neonatal ,infection:16
neonatal ,severe:2
neonatal ,acute:2
neonatal ,respiratory:6
neonatal ,syndrome:2
neonatal ,coronavirus:10
late ,onset:2
late ,infection:6
late ,severe:8
late ,acute:10
late ,respiratory:4
late ,syndrome:4
late ,coronavirus:10
onset ,infection:4
onset ,severe:4
onset ,acute:10
onset ,respiratory:2
onset ,syndrome:4
onset ,coronavirus:6
isolation ,infectious:2
isolation ,urine:2
infectious ,urine:2
urine ,covid-19:2
urine ,patient:2
drug ,strategies:4
discovery ,strategies:2
blockers ,covid-19:10
cardiovascular ,considerations:12
cardiovascular ,internist:2
cardiovascular ,hospitalist:2
cardiovascular ,era:8
considerations ,internist:2
considerations ,hospitalist:2
considerations ,era:6
internist ,hospitalist:2
internist ,covid-19:2
internist ,era:2
hospitalist ,covid-19:2
hospitalist ,era:2
care ,ibd:2
care ,requiring:2
care ,hospitalisation:2
care ,pandemic:36
patient ,ibd:4
patient ,requiring:4
patient ,hospitalisation:2
patient ,pandemic:8
ibd ,requiring:2
ibd ,hospitalisation:2
ibd ,covid-19:6
ibd ,pandemic:4
requiring ,hospitalisation:2
requiring ,covid-19:2
requiring ,pandemic:2
hospitalisation ,covid-19:4
hospitalisation ,pandemic:2
structural ,2019-novel:4
structural ,ncov:4
modeling ,2019-novel:4
modeling ,coronavirus:12
modeling ,ncov:4
2019-novel ,spike:4
2019-novel ,protein:4
2019-novel ,reveals:4
coronavirus ,reveals:4
ncov ,spike:4
ncov ,protein:4
ncov ,reveals:4
importance ,conjunctiva:2
importance ,apotential:2
importance ,transmission:2
importance ,pathway:2
conjunctiva ,apotential:2
conjunctiva ,transmission:2
conjunctiva ,pathway:2
apotential ,transmission:2
apotential ,pathway:2
transmission ,pathway:4
bioinformatics ,function:2
bioinformatics ,sars-cov-2:2
bioinformatics ,spike:2
bioinformatics ,glycoprotein:2
studies ,function:2
studies ,spike:2
studies ,glycoprotein:2
transcriptional ,sars-cov-2:2
transcriptional ,infection:2
transcriptional ,dismantles:2
transcriptional ,pathogenic:2
transcriptional ,pathways:2
landscape ,sars-cov-2:6
landscape ,infection:2
landscape ,dismantles:2
landscape ,pathogenic:2
landscape ,pathways:2
sars-cov-2 ,dismantles:2
infection ,dismantles:2
infection ,pathogenic:2
infection ,pathways:2
dismantles ,pathogenic:2
dismantles ,pathways:2
pathogenic ,pathways:2
covid-19 ,pandemic-a:2
covid-19 ,focused:2
covid-19 ,clinicians:14
pandemic-a ,focused:2
pandemic-a ,review:2
pandemic-a ,clinicians:2
focused ,review:2
focused ,clinicians:2
review ,clinicians:2
sars-cov-2-specific ,antibody:6
sars-cov-2-specific ,detection:8
sars-cov-2-specific ,seroepidemiology:2
sars-cov-2-specific ,multiplex:2
sars-cov-2-specific ,analysis:2
antibody ,seroepidemiology:2
antibody ,multiplex:2
antibody ,analysis:2
detection ,seroepidemiology:2
detection ,multiplex:4
seroepidemiology ,multiplex:2
seroepidemiology ,analysis:2
multiplex ,analysis:2
review ,liver:8
review ,disease-what:2
review ,1st:2
review ,may:4
article ,liver:2
article ,disease-what:2
article ,know:2
article ,1st:2
article ,may:2
covid-19 ,disease-what:2
covid-19 ,1st:4
liver ,disease-what:2
liver ,know:6
liver ,1st:2
liver ,may:2
disease-what ,know:2
disease-what ,1st:2
disease-what ,may:2
know ,1st:2
know ,may:2
1st ,may:2
current ,drug:6
current ,candidates:2
current ,prevention:2
current ,treatment:14
targets ,candidates:2
candidates ,prevention:2
candidates ,treatment:2
identification ,repurposing:6
identification ,using:4
cell ,entry:12
cell ,inhibitors:2
cell ,drug:2
cell ,repurposing:2
cell ,using:4
entry ,inhibitors:8
entry ,drug:2
entry ,repurposing:2
entry ,using:2
inhibitors ,drug:8
inhibitors ,repurposing:8
inhibitors ,using:10
drug ,using:8
repurposing ,using:4
coronaviruses ,comorbidities:2
coronaviruses ,multi-organ:2
coronaviruses ,damage:6
pathogenesis ,comorbidities:2
pathogenesis ,multi-organ:2
pathogenesis ,damage:2
comorbidities ,multi-organ:2
comorbidities ,damage:2
comorbidities ,review:4
multi-organ ,damage:2
multi-organ ,review:2
damage ,review:2
international ,external:2
international ,quality:2
international ,assessment:4
international ,sars-cov-2:4
international ,molecular:2
international ,detection:2
external ,detection:4
disparities ,age-specific:2
disparities ,morbidity:2
disparities ,mortality:2
disparities ,sars-cov-2:12
disparities ,china:2
age-specific ,morbidity:2
age-specific ,mortality:2
age-specific ,sars-cov-2:10
age-specific ,china:2
morbidity ,mortality:8
morbidity ,sars-cov-2:4
morbidity ,china:2
mortality ,china:2
antibody ,dependent:2
antibody ,enhancement:2
antibody ,due:2
antibody ,original:2
antibody ,antigenic:2
antibody ,sin:2
antibody ,development:6
dependent ,enhancement:2
dependent ,due:2
dependent ,original:2
dependent ,antigenic:2
dependent ,sin:2
dependent ,development:2
enhancement ,due:2
enhancement ,original:2
enhancement ,antigenic:2
enhancement ,sin:2
enhancement ,development:2
due ,original:2
due ,antigenic:2
due ,sin:2
due ,development:2
original ,development:2
antigenic ,development:2
sin ,development:2
cannabinoid ,receptor:2
cannabinoid ,type:2
cannabinoid ,possible:2
cannabinoid ,target:2
cannabinoid ,sars-cov-2:2
cannabinoid ,cov-19:2
cannabinoid ,infection:2
receptor ,type:2
receptor ,possible:2
receptor ,target:2
receptor ,cov-19:2
receptor ,infection:10
type ,possible:2
type ,target:2
type ,cov-19:2
type ,infection:18
possible ,target:2
possible ,cov-19:2
target ,cov-19:2
target ,infection:8
sars-cov-2 ,cov-19:4
cov-19 ,infection:4
first ,environmental:2
first ,presence:2
environmental ,surveillance:4
environmental ,presence:2
environmental ,wastewater:2
surveillance ,presence:2
surveillance ,rna:2
surveillance ,wastewater:8
presence ,wastewater:4
covid-19 ,thromboprophylaxis:2
thromboprophylaxis ,recommendations:2
thromboprophylaxis ,clinical:2
thromboprophylaxis ,practice:2
recommendations ,clinical:10
clinical ,practice:20
chemistry ,biology:2
chemistry ,sars-cov-2:2
dynamic ,profile:4
dynamic ,anti-sars-cov-2:2
dynamic ,antibodies:6
dynamic ,using:2
dynamic ,four:2
profile ,detection:2
profile ,anti-sars-cov-2:4
profile ,antibodies:6
profile ,using:2
profile ,four:2
detection ,anti-sars-cov-2:8
anti-sars-cov-2 ,antibodies:12
anti-sars-cov-2 ,using:6
anti-sars-cov-2 ,four:2
antibodies ,four:2
using ,four:2
exercise ,medicine:2
exercise ,covid-19:4
exercise ,ppar:2
exercise ,emerging:2
exercise ,pharmacotherapy:2
medicine ,ppar:2
medicine ,emerging:2
medicine ,pharmacotherapy:2
covid-19 ,ppar:2
ppar ,emerging:2
ppar ,pharmacotherapy:2
emerging ,pharmacotherapy:4
severe ,2sars-cov-2:2
acute ,2sars-cov-2:2
respiratory ,2sars-cov-2:2
syndrome ,2sars-cov-2:2
coronavirus ,2sars-cov-2:2
2sars-cov-2 ,infection:2
2sars-cov-2 ,late:2
covid-19 ,cytology:2
pandemic ,cytology:2
implications ,cytology:2
implications ,laboratory:2
cytology ,laboratory:2
selective ,naked-eye:2
selective ,detection:2
selective ,sars-cov-2:2
selective ,mediated:2
selective ,gene:2
selective ,targeted:2
selective ,antisense:2
naked-eye ,detection:2
naked-eye ,sars-cov-2:2
naked-eye ,mediated:2
naked-eye ,gene:2
naked-eye ,targeted:2
naked-eye ,antisense:2
detection ,mediated:2
detection ,targeted:4
detection ,antisense:2
sars-cov-2 ,mediated:6
sars-cov-2 ,gene:22
sars-cov-2 ,antisense:2
mediated ,gene:2
mediated ,targeted:2
mediated ,antisense:2
gene ,targeted:2
gene ,antisense:2
targeted ,antisense:2
variations ,spike:4
variations ,protein:2
variations ,cell:2
variations ,epitopes:2
variations ,glycosylation:2
variations ,profiles:4
sars-cov-2 ,epitopes:22
sars-cov-2 ,glycosylation:2
sars-cov-2 ,profiles:12
spike ,cell:10
spike ,epitopes:8
spike ,glycosylation:2
spike ,profiles:2
protein ,cell:8
protein ,epitopes:8
protein ,glycosylation:2
protein ,profiles:4
cell ,glycosylation:2
cell ,profiles:2
epitopes ,glycosylation:2
epitopes ,profiles:2
glycosylation ,profiles:2
neurosurgical ,practice:6
neurosurgical ,severe:2
neurosurgical ,acute:2
neurosurgical ,respiratory:2
neurosurgical ,syndrome:2
neurosurgical ,coronavirus:6
practice ,severe:2
practice ,acute:2
practice ,respiratory:2
practice ,syndrome:2
otolaryngology ,residency:2
otolaryngology ,application:2
otolaryngology ,sars-cov-2:2
otolaryngology ,covid-19:14
otolaryngology ,pandemic:8
residency ,application:2
residency ,sars-cov-2:4
residency ,covid-19:2
residency ,pandemic:2
application ,sars-cov-2:12
application ,pandemic:2
sars-cov-2 ,diagnosed:2
sars-cov-2 ,local:4
infection ,diagnosed:2
infection ,culture:4
infection ,isolation:6
infection ,local:2
diagnosed ,cell:2
diagnosed ,culture:2
diagnosed ,isolation:2
diagnosed ,local:2
cell ,culture:6
cell ,isolation:2
cell ,local:2
culture ,isolation:2
culture ,local:2
isolation ,local:2
challenges ,system:2
challenges ,reserve:2
challenges ,supplies:2
challenges ,public:4
challenges ,health:6
challenges ,emergencies:2
system ,reserve:2
system ,medical:2
system ,supplies:2
system ,public:2
system ,health:10
system ,emergencies:2
reserve ,medical:2
reserve ,supplies:2
reserve ,public:2
reserve ,health:2
reserve ,emergencies:2
medical ,supplies:2
medical ,public:2
medical ,health:2
medical ,emergencies:2
supplies ,public:2
supplies ,health:2
supplies ,emergencies:2
panic ,pandemic:4
panic ,review:4
panic ,literature:4
panic ,links:4
panic ,disorder:2
pandemic ,literature:8
pandemic ,links:4
pandemic ,disorder:2
review ,links:4
review ,disorder:2
literature ,links:4
literature ,disorder:2
links ,disorder:2
intrauterine ,vertical:4
intrauterine ,transmission:10
intrauterine ,pregnancy:4
intrauterine ,covid-19:4
intrauterine ,case:4
intrauterine ,report:4
vertical ,pregnancy:8
vertical ,covid-19:10
vertical ,report:6
transmission ,pregnancy:10
transmission ,report:12
pregnancy ,case:12
pregnancy ,report:8
current ,smoking:4
current ,associated:4
smoking ,associated:4
rhabdomyolysis ,acute:4
rhabdomyolysis ,renal:2
rhabdomyolysis ,failure:2
rhabdomyolysis ,adolescent:2
acute ,renal:8
acute ,failure:14
acute ,adolescent:2
renal ,failure:6
renal ,adolescent:2
renal ,coronavirus:6
renal ,disease:2
failure ,adolescent:2
failure ,coronavirus:6
failure ,disease:2
adolescent ,coronavirus:2
adolescent ,disease:2
role ,neurotropism:2
role ,neuroinvasion:2
sars-cov-2 ,neurotropism:8
neurotropism ,neuroinvasion:2
neurotropism ,covid-19:4
neurotropism ,patients:2
neurotropism ,disease:2
neuroinvasion ,patients:2
neuroinvasion ,disease:2
aerosol-generating ,procedures:6
aerosol-generating ,infective:2
aerosol-generating ,risk:2
aerosol-generating ,healthcare:2
aerosol-generating ,workers:2
procedures ,infective:2
procedures ,risk:4
procedures ,healthcare:2
procedures ,workers:2
infective ,risk:2
infective ,healthcare:2
infective ,workers:2
risk ,healthcare:10
risk ,workers:14
covid-19 ,documented:2
covid-19 ,history:8
first ,documented:2
first ,history:4
documented ,coronavirus:2
documented ,pandemic:2
documented ,history:2
coronavirus ,history:6
pandemic ,history:2
potential ,fast:2
potential ,containment:2
potential ,trehalose:2
fast ,covid-19:6
fast ,containment:2
fast ,trehalose:2
covid-19 ,containment:12
covid-19 ,trehalose:2
containment ,trehalose:2
coincidence ,epidemics:2
coincidence ,coccidioidomycosis:2
coincidence ,sars-cov-2:2
coincidence ,case:2
coincidence ,report:2
epidemics ,coccidioidomycosis:2
epidemics ,case:2
epidemics ,report:2
coccidioidomycosis ,sars-cov-2:2
coccidioidomycosis ,case:2
coccidioidomycosis ,report:2
diagnostic ,dynamic:2
diagnostic ,variance:2
diagnostic ,serum:2
diagnostic ,antibody:6
value ,dynamic:2
value ,variance:2
value ,antibody:4
dynamic ,variance:2
dynamic ,serum:4
variance ,serum:2
variance ,antibody:2
variance ,disease:2
serum ,antibody:6
serum ,disease:4
first ,quarter:4
first ,university:4
first ,washington:2
first ,medicine:2
quarter ,sars-cov-2:2
quarter ,testing:2
quarter ,university:2
quarter ,washington:2
quarter ,medicine:2
sars-cov-2 ,washington:4
sars-cov-2 ,medicine:12
testing ,university:2
testing ,washington:2
testing ,medicine:2
university ,washington:2
university ,medicine:2
washington ,medicine:2
revealing ,regional:2
revealing ,disparities:2
revealing ,transmission:2
revealing ,potential:2
revealing ,sars-cov-2:2
regional ,disparities:2
regional ,transmission:4
regional ,potential:2
regional ,sars-cov-2:8
disparities ,transmission:2
disparities ,potential:2
single-use ,disposable:2
single-use ,flexible:2
single-use ,bronchoscopes:2
single-use ,future:2
single-use ,bronchoscopy:2
disposable ,flexible:2
disposable ,bronchoscopes:2
disposable ,future:2
disposable ,bronchoscopy:2
flexible ,bronchoscopes:2
flexible ,future:2
flexible ,bronchoscopy:2
bronchoscopes ,future:2
bronchoscopes ,bronchoscopy:2
future ,bronchoscopy:2
covid-19 ,african:8
pandemic ,african:2
african ,perspective:4
sars-cov-2 ,ophthalmology:6
sars-cov-2 ,standards:2
ophthalmology ,current:2
ophthalmology ,evidence:2
ophthalmology ,standards:2
ophthalmology ,practice:4
current ,standards:2
evidence ,standards:2
evidence ,practice:2
standards ,clinical:2
standards ,practice:2
involvement ,central:6
involvement ,nervous:14
involvement ,system:18
involvement ,patients:6
central ,patients:2
central ,covid-19:18
nervous ,patients:2
system ,patients:6
community ,responses:2
community ,early:2
community ,phase:2
community ,epidemic:4
community ,hong:2
community ,kong:2
responses ,early:6
responses ,phase:2
responses ,epidemic:2
responses ,hong:4
responses ,kong:4
early ,phase:6
early ,epidemic:8
early ,hong:2
early ,kong:2
phase ,covid-19:20
phase ,epidemic:4
phase ,hong:2
phase ,kong:2
epidemic ,hong:2
epidemic ,kong:2
decline ,humoral:2
decline ,responses:2
decline ,sars-cov-2:4
decline ,spike:2
decline ,convalescent:2
decline ,individuals:2
humoral ,spike:2
humoral ,convalescent:2
humoral ,individuals:2
responses ,spike:2
responses ,convalescent:4
responses ,individuals:4
sars-cov-2 ,convalescent:14
sars-cov-2 ,individuals:8
spike ,convalescent:2
spike ,individuals:2
convalescent ,individuals:6
case ,transient:4
case ,existence:2
case ,tract:2
transient ,existence:2
transient ,sars-cov-2:2
transient ,rna:2
transient ,respiratory:2
transient ,tract:2
existence ,sars-cov-2:4
existence ,rna:2
existence ,respiratory:2
existence ,tract:2
sars-cov-2 ,tract:10
rna ,tract:2
particulate ,matter:8
particulate ,sars-cov-2:4
particulate ,possible:4
particulate ,model:2
particulate ,covid-19:4
particulate ,transmission:2
matter ,sars-cov-2:4
matter ,possible:4
matter ,model:2
matter ,covid-19:4
matter ,transmission:2
possible ,model:2
model ,covid-19:42
model ,transmission:10
experimental ,models:2
experimental ,study:4
experimental ,central:2
experimental ,nervous:2
experimental ,infection:8
models ,study:4
models ,central:2
models ,nervous:2
models ,system:2
study ,central:2
study ,nervous:2
study ,system:2
study ,infection:16
central ,infection:6
panton-valentine ,leukocidin-secreting:2
panton-valentine ,staphylococcus:2
panton-valentine ,aureus:2
panton-valentine ,pneumonia:2
panton-valentine ,complicating:2
leukocidin-secreting ,staphylococcus:2
leukocidin-secreting ,aureus:2
leukocidin-secreting ,pneumonia:2
leukocidin-secreting ,complicating:2
staphylococcus ,aureus:2
staphylococcus ,pneumonia:2
staphylococcus ,complicating:2
aureus ,pneumonia:2
aureus ,complicating:2
pneumonia ,complicating:2
association ,pandemic:6
association ,meteorological:2
association ,parameters:2
association ,singapore:2
covid-19 ,meteorological:6
covid-19 ,parameters:14
pandemic ,meteorological:4
pandemic ,parameters:2
pandemic ,singapore:6
meteorological ,parameters:2
meteorological ,singapore:2
parameters ,singapore:2
hydroxychloroquine ,miracle:2
hydroxychloroquine ,infection:12
hydroxychloroquine ,-imaging:2
miracle ,cure:2
miracle ,covid-19:2
miracle ,infection:2
miracle ,-imaging:2
miracle ,clinical:2
cure ,infection:2
cure ,-imaging:2
covid-19 ,-imaging:2
infection ,-imaging:2
-imaging ,clinical:2
infectious ,risk:2
infectious ,patients:2
infectious ,long-term:2
infectious ,fecal:2
infectious ,2019-ncov:4
infectious ,nucleic:2
infectious ,acid:2
risk ,patients:48
risk ,long-term:2
risk ,fecal:2
risk ,nucleic:2
risk ,acid:2
covid-19 ,long-term:30
covid-19 ,fecal:10
patients ,long-term:6
patients ,fecal:14
patients ,nucleic:12
patients ,acid:14
long-term ,fecal:2
long-term ,2019-ncov:2
long-term ,nucleic:2
fecal ,2019-ncov:2
fecal ,nucleic:2
fecal ,acid:2
2019-ncov ,nucleic:2
2019-ncov ,acid:2
genetic ,grouping:2
genetic ,sequences:2
genetic ,using:4
genetic ,informative:2
genetic ,subtype:2
grouping ,sars-cov-2:2
grouping ,coronavirus:2
grouping ,sequences:2
grouping ,using:2
grouping ,informative:2
grouping ,subtype:2
sars-cov-2 ,sequences:12
sars-cov-2 ,informative:2
sars-cov-2 ,subtype:2
coronavirus ,sequences:4
coronavirus ,informative:2
coronavirus ,subtype:2
sequences ,using:2
sequences ,informative:2
sequences ,subtype:2
using ,informative:2
using ,subtype:2
informative ,subtype:2
ethical ,considerations:4
ethical ,health:2
ethical ,crisis:4
ethical ,sars-cov-2:6
ethical ,coronavirus:2
considerations ,health:2
considerations ,crisis:2
considerations ,coronavirus:12
crisis ,sars-cov-2:8
crisis ,coronavirus:2
clinical ,risk:12
clinical ,assessment:4
characteristics ,risk:4
characteristics ,assessment:2
characteristics ,born:6
characteristics ,mothers:6
risk ,newborns:4
risk ,born:2
risk ,mothers:2
assessment ,newborns:2
assessment ,born:2
assessment ,mothers:2
newborns ,born:4
newborns ,mothers:6
renin-angiotensin-aldosterone ,system:6
renin-angiotensin-aldosterone ,brief:2
renin-angiotensin-aldosterone ,history:2
renin-angiotensin-aldosterone ,questions:2
renin-angiotensin-aldosterone ,related:2
system ,brief:2
system ,history:2
system ,questions:2
system ,related:2
brief ,history:2
brief ,questions:2
brief ,related:2
history ,questions:2
history ,related:2
questions ,related:2
beekeepers ,tolerate:2
beekeepers ,bee:2
beekeepers ,stings:2
beekeepers ,protected:2
beekeepers ,sars-cov-2:2
beekeepers ,infections:2
tolerate ,bee:2
tolerate ,stings:2
tolerate ,protected:2
tolerate ,sars-cov-2:2
tolerate ,infections:2
bee ,stings:2
bee ,protected:2
bee ,sars-cov-2:2
bee ,infections:2
stings ,protected:2
stings ,sars-cov-2:2
stings ,infections:2
protected ,sars-cov-2:2
protected ,infections:2
pathophysiology ,clinical:2
pathophysiology ,effects:2
clinical ,effects:8
dermatology ,patients:2
dermatology ,attend:2
dermatology ,outpatient:2
dermatology ,clinics:2
patients ,attend:2
patients ,outpatient:6
patients ,clinics:2
attend ,outpatient:2
attend ,clinics:2
outpatient ,clinics:2
recent ,challenges:4
recent ,development:4
progress ,drug:4
challenges ,drug:4
drug ,development:8
estrogen ,regulates:2
estrogen ,expression:2
estrogen ,sars-cov-2:2
estrogen ,receptor:2
estrogen ,ace2:2
estrogen ,differentiated:2
regulates ,expression:2
regulates ,sars-cov-2:2
regulates ,receptor:2
regulates ,ace2:2
regulates ,differentiated:2
expression ,differentiated:2
sars-cov-2 ,differentiated:2
receptor ,differentiated:2
ace2 ,differentiated:2
sars-cov-2 ,fear:2
fear ,versus:2
fear ,data:2
versus ,data:2
anti-sars-cov-2 ,potential:8
anti-sars-cov-2 ,artemisinins:2
anti-sars-cov-2 ,vitro:4
potential ,artemisinins:2
potential ,vitro:4
artemisinins ,vitro:2
study ,treatment:10
study ,cytokine:2
study ,storm:2
study ,anti-2019-ncov:2
study ,prescriptions:2
study ,based:4
treatment ,anti-2019-ncov:2
treatment ,prescriptions:2
treatment ,based:4
cytokine ,anti-2019-ncov:2
cytokine ,prescriptions:2
cytokine ,based:2
storm ,anti-2019-ncov:2
storm ,prescriptions:2
storm ,based:2
anti-2019-ncov ,prescriptions:2
anti-2019-ncov ,based:2
prescriptions ,based:2
will ,battle:2
will ,novel:2
will ,coronavirus:6
will ,end:2
will ,wuhan:2
will ,seir:2
will ,modeling:2
battle ,coronavirus:4
battle ,end:2
battle ,wuhan:2
battle ,seir:2
battle ,modeling:2
novel ,end:2
novel ,seir:2
novel ,modeling:4
coronavirus ,end:4
coronavirus ,seir:2
end ,wuhan:2
end ,seir:2
end ,modeling:2
wuhan ,seir:2
wuhan ,modeling:2
seir ,modeling:4
ophthalmological ,care:2
ophthalmological ,sars-cov-2:4
ophthalmological ,positive:2
ophthalmological ,patients:2
ophthalmological ,intensive:2
ophthalmological ,units:2
care ,positive:4
care ,units:10
positive ,intensive:2
positive ,units:2
patients ,intensive:14
patients ,units:2
intensive ,units:8
extrapulmonary ,manifestations:4
extrapulmonary ,covid-19:4
extrapulmonary ,radiologic:2
extrapulmonary ,clinical:2
extrapulmonary ,overview:2
manifestations ,radiologic:2
covid-19 ,radiologic:4
radiologic ,clinical:2
radiologic ,overview:2
interpretation ,perinatal:2
interpretation ,neonatal:2
interpretation ,management:2
interpretation ,plan:2
interpretation ,prevention:4
perinatal ,neonatal:8
perinatal ,management:4
perinatal ,plan:4
perinatal ,prevention:4
neonatal ,management:6
neonatal ,prevention:4
management ,plan:4
management ,prevention:12
plan ,prevention:4
comparative ,replication:2
comparative ,immune:2
comparative ,activation:2
comparative ,profiles:2
replication ,immune:4
replication ,activation:2
replication ,profiles:2
replication ,sars-cov:4
immune ,activation:4
immune ,profiles:2
activation ,profiles:2
activation ,sars-cov-2:14
activation ,sars-cov:4
profiles ,sars-cov:2
differences ,acute:4
differences ,respiratory:4
differences ,syndrome:4
differences ,coronavirus:4
differences ,shedding:2
differences ,duration:2
severe ,shedding:8
severe ,duration:6
acute ,shedding:8
acute ,duration:6
respiratory ,shedding:10
respiratory ,duration:8
syndrome ,shedding:6
syndrome ,duration:6
coronavirus ,duration:8
epidemiology ,pediatric:2
severe ,pediatric:14
acute ,pediatric:8
respiratory ,pediatric:10
syndrome ,pediatric:16
developments ,evolution:2
developments ,implications:2
developments ,national:2
developments ,diagnostic:2
developments ,criteria:2
evolution ,implications:2
evolution ,national:2
evolution ,diagnostic:2
evolution ,criteria:2
implications ,national:2
implications ,diagnostic:4
implications ,criteria:2
national ,diagnostic:2
national ,criteria:2
25-hydroxyvitamin ,concentrations:2
25-hydroxyvitamin ,lower:2
25-hydroxyvitamin ,patients:2
25-hydroxyvitamin ,positive:2
25-hydroxyvitamin ,pcr:2
concentrations ,lower:2
concentrations ,patients:4
concentrations ,positive:2
concentrations ,pcr:2
lower ,patients:4
lower ,positive:2
lower ,pcr:2
patients ,pcr:6
positive ,pcr:8
can ,neurotropic:2
can ,free-living:2
can ,amoeba:2
can ,serve:4
neurotropic ,free-living:2
neurotropic ,amoeba:2
neurotropic ,serve:2
neurotropic ,model:2
neurotropic ,study:2
free-living ,amoeba:2
free-living ,serve:2
free-living ,model:2
free-living ,study:2
free-living ,sars-cov-2:2
amoeba ,serve:2
amoeba ,model:2
amoeba ,study:2
amoeba ,sars-cov-2:2
serve ,model:2
serve ,study:2
serve ,sars-cov-2:2
virucidal ,efficacy:2
virucidal ,different:2
virucidal ,oral:2
virucidal ,rinses:2
virucidal ,severe:2
virucidal ,acute:2
virucidal ,respiratory:2
efficacy ,oral:4
efficacy ,rinses:2
efficacy ,severe:10
efficacy ,acute:6
efficacy ,respiratory:8
different ,oral:2
different ,rinses:2
different ,severe:4
different ,acute:4
oral ,rinses:2
oral ,severe:6
oral ,acute:2
oral ,respiratory:2
rinses ,severe:2
rinses ,acute:2
rinses ,respiratory:2
case ,fulminant:4
case ,liver:8
case ,failure:4
case ,24-year-old:2
case ,man:4
fulminant ,liver:2
fulminant ,failure:6
fulminant ,24-year-old:2
fulminant ,man:2
fulminant ,coinfection:2
liver ,failure:6
liver ,24-year-old:2
liver ,man:2
liver ,coinfection:2
failure ,24-year-old:2
failure ,man:2
failure ,coinfection:2
24-year-old ,man:2
24-year-old ,coinfection:2
man ,coinfection:2
ace2 ,kidney:2
ace2 ,emergence:2
ace2 ,two:2
ace2 ,decades:2
ace2 ,discovery:2
kidney ,emergence:2
kidney ,two:4
kidney ,decades:2
kidney ,discovery:2
emergence ,two:2
emergence ,decades:2
emergence ,discovery:2
covid-19 ,two:58
covid-19 ,decades:2
two ,decades:2
two ,discovery:2
decades ,discovery:2
first ,cerebellitis:2
first ,associated:6
case ,cerebellitis:2
case ,associated:22
acute ,cerebellitis:2
cerebellitis ,associated:2
cerebellitis ,coronavirus:2
cerebellitis ,disease:2
cerebellitis ,covid-19:2
method ,prevent:2
method ,igm:2
method ,false:2
method ,positives:2
method ,gold:2
method ,immunochromatography:2
prevent ,igm:2
prevent ,false:2
prevent ,positives:2
prevent ,gold:2
prevent ,immunochromatography:2
sars-cov-2 ,false:2
sars-cov-2 ,positives:2
sars-cov-2 ,gold:6
sars-cov-2 ,immunochromatography:2
igm ,false:2
igm ,positives:2
igm ,gold:2
igm ,immunochromatography:2
false ,positives:2
false ,gold:2
false ,immunochromatography:2
positives ,gold:2
positives ,immunochromatography:2
gold ,immunochromatography:2
opportunity ,periodic:2
opportunity ,monitoring:2
opportunity ,covid-19:6
opportunity ,patients:2
opportunity ,asymptomatic:2
opportunity ,virus:2
periodic ,monitoring:2
periodic ,covid-19:2
periodic ,patients:2
periodic ,asymptomatic:2
periodic ,virus:2
monitoring ,patients:6
monitoring ,asymptomatic:2
monitoring ,virus:2
asymptomatic ,virus:4
incidence ,sars-cov-2:10
incidence ,asymptomatic:2
incidence ,patients:6
aggregate ,prevalence:2
aggregate ,chemosensory:2
aggregate ,sinonasal:2
aggregate ,dysfunction:2
aggregate ,sars-cov-2:2
prevalence ,chemosensory:2
prevalence ,sinonasal:4
prevalence ,dysfunction:8
chemosensory ,sinonasal:2
chemosensory ,dysfunction:6
chemosensory ,sars-cov-2:2
sinonasal ,dysfunction:4
sinonasal ,sars-cov-2:4
effects ,host:2
effects ,genetic:2
effects ,variations:2
effects ,response:2
effects ,susceptibility:2
effects ,severity:4
host ,genetic:8
host ,variations:4
host ,susceptibility:8
host ,severity:4
genetic ,response:4
genetic ,susceptibility:14
genetic ,severity:8
variations ,response:2
variations ,susceptibility:2
variations ,severity:2
response ,susceptibility:2
response ,severity:6
susceptibility ,severity:8
coronaviruses ,threats:2
coronaviruses ,health:4
coronaviruses ,prepared:2
emerging ,threats:2
emerging ,human:8
emerging ,prepared:2
threats ,human:2
threats ,health:2
threats ,prepared:2
human ,health:4
human ,prepared:2
health ,prepared:2
clinical ,cobas:2
clinical ,test:10
clinical ,platform:2
clinical ,switch:2
evaluation ,cobas:2
evaluation ,platform:2
evaluation ,switch:2
cobas ,sars-cov-2:2
cobas ,test:2
cobas ,diagnostic:2
cobas ,platform:2
cobas ,switch:2
sars-cov-2 ,switch:4
test ,diagnostic:14
test ,platform:2
test ,switch:2
diagnostic ,switch:2
platform ,switch:2
rapid ,production:4
rapid ,receptor:2
rapid ,binding:2
rapid ,domain:2
rapid ,rbd:2
rapid ,specific:4
production ,receptor:2
production ,binding:2
production ,domain:2
production ,rbd:2
production ,spike:4
production ,specific:2
sars-cov-2 ,rbd:14
sars-cov-2 ,specific:28
receptor ,rbd:4
receptor ,specific:2
binding ,rbd:6
binding ,specific:2
domain ,specific:2
pulmonary ,delivery:4
pulmonary ,fenretinide:2
pulmonary ,possible:2
pulmonary ,adjuvant:2
pulmonary ,treatment:8
delivery ,fenretinide:2
delivery ,possible:2
delivery ,adjuvant:2
fenretinide ,possible:2
fenretinide ,adjuvant:2
fenretinide ,treatment:2
fenretinide ,covid-19:2
possible ,adjuvant:2
adjuvant ,treatment:4
adjuvant ,covid-19:8
detection ,gold:2
detection ,nanospikes:2
antibodies ,protein:4
antibodies ,gold:2
antibodies ,nanospikes:2
sars-cov-2 ,nanospikes:2
spike ,gold:2
spike ,nanospikes:2
protein ,gold:2
protein ,nanospikes:2
gold ,nanospikes:2
presence ,isolation:2
presence ,ward:2
presence ,environment:2
presence ,28:2
presence ,days:2
presence ,exposure:2
sars-cov-2 ,ward:8
sars-cov-2 ,28:2
rna ,isolation:6
rna ,ward:6
rna ,environment:2
rna ,28:2
rna ,days:4
rna ,exposure:2
isolation ,ward:6
isolation ,environment:2
isolation ,28:2
isolation ,days:2
isolation ,exposure:2
ward ,environment:2
ward ,28:2
ward ,days:2
ward ,exposure:2
environment ,28:2
environment ,days:2
environment ,exposure:4
28 ,days:2
28 ,exposure:2
days ,exposure:2
development ,validation:8
development ,risk:6
development ,stratification:2
development ,model:6
development ,screening:4
development ,suspected:2
validation ,risk:2
validation ,stratification:2
validation ,model:4
validation ,screening:2
validation ,suspected:2
risk ,stratification:6
risk ,model:4
risk ,screening:2
risk ,suspected:2
stratification ,model:2
stratification ,screening:2
stratification ,suspected:4
model ,screening:4
model ,suspected:2
screening ,suspected:2
policy ,decisions:2
policy ,use:2
policy ,information:2
policy ,technology:2
policy ,fight:2
policy ,taiwan:2
decisions ,use:2
decisions ,information:2
decisions ,technology:2
decisions ,fight:2
decisions ,covid-19:2
decisions ,taiwan:2
use ,information:2
use ,technology:2
use ,fight:4
use ,taiwan:2
information ,technology:2
information ,taiwan:2
technology ,fight:2
technology ,taiwan:2
fight ,taiwan:2
neuropilin1 ,new:2
neuropilin1 ,potential:2
neuropilin1 ,sarscov2:2
neuropilin1 ,infection:2
neuropilin1 ,mediator:2
neuropilin1 ,implicated:2
new ,potential:10
new ,sarscov2:2
new ,mediator:2
new ,implicated:2
potential ,sarscov2:2
potential ,mediator:4
potential ,implicated:2
sarscov2 ,infection:4
sarscov2 ,mediator:2
sarscov2 ,implicated:2
infection ,mediator:2
infection ,implicated:2
mediator ,implicated:2
flattening-the-curve ,associated:2
flattening-the-curve ,reduced:2
flattening-the-curve ,covid-19:2
flattening-the-curve ,case:2
flattening-the-curve ,fatality:2
flattening-the-curve ,rates-:2
associated ,reduced:2
associated ,fatality:4
associated ,rates-:2
reduced ,covid-19:12
reduced ,case:2
reduced ,fatality:2
reduced ,rates-:2
covid-19 ,rates-:2
case ,rates-:2
fatality ,rates-:2
effects ,acute:4
effects ,respiratory:6
effects ,syndrome:4
effects ,pregnant:4
syndrome ,pregnant:4
coronavirus ,pregnant:20
infection ,pregnant:10
sars-cov-2 ,nursery:2
sars-cov-2 ,poland:4
cluster ,nursery:2
cluster ,poland:2
nursery ,poland:2
2019-new ,epidemic:2
2019-new ,evidence:2
2019-new ,virus:2
2019-new ,evolution:2
epidemic ,evidence:2
epidemic ,virus:2
epidemic ,evolution:2
evidence ,evolution:2
virus ,evolution:2
zinc ,enhance:4
zinc ,clinical:2
zinc ,efficacy:2
supplementation ,enhance:2
supplementation ,clinical:2
supplementation ,efficacy:2
enhance ,clinical:2
enhance ,efficacy:2
clinical ,efficacy:10
detection ,appearance:2
detection ,hungary:2
detection ,based:4
first ,virus:2
first ,hungary:2
first ,based:2
appearance ,sars-cov-2:2
appearance ,virus:2
appearance ,hungary:2
appearance ,based:2
sars-cov-2 ,hungary:2
virus ,hungary:2
virus ,based:2
hungary ,based:2
potential ,developing:4
potential ,rbd:4
potential ,recombinant:2
developing ,sars-cov:2
developing ,receptor-binding:2
developing ,domain:2
developing ,rbd:2
developing ,recombinant:2
sars-cov ,receptor-binding:4
sars-cov ,domain:2
sars-cov ,rbd:2
sars-cov ,recombinant:2
receptor-binding ,recombinant:2
domain ,recombinant:2
rbd ,recombinant:2
potential ,interaction:2
inhibitors ,ace2:4
inhibitors ,rbd:2
interaction ,ace2:10
interaction ,rbd:6
severe ,iran:2
acute ,iran:2
respiratory ,iran:2
syndrome ,iran:2
transmission ,iran:2
potential ,iran:2
obesity ,diabetes:4
obesity ,infectious:2
obesity ,disease:2
obesity ,spreading:2
obesity ,east:2
diabetes ,infectious:2
diabetes ,spreading:2
diabetes ,east:2
covid-19 ,spreading:6
covid-19 ,east:4
infectious ,disease:4
infectious ,spreading:2
infectious ,east:2
disease ,spreading:2
disease ,east:4
spreading ,east:2
diagnostic ,key:4
diagnostic ,features:2
diagnostic ,computed:4
diagnostic ,tomography:4
value ,key:2
value ,features:2
value ,computed:2
value ,tomography:2
key ,features:4
key ,computed:2
key ,tomography:2
key ,coronavirus:6
key ,disease:2
features ,tomography:6
features ,disease:24
computed ,tomography:26
computed ,coronavirus:18
computed ,disease:8
tomography ,coronavirus:10
tomography ,disease:6
case ,neonatal:4
case ,china:8
report ,neonatal:4
report ,china:2
neonatal ,disease:4
neonatal ,china:2
parental ,coronavirus:2
parental ,disease:2
parental ,testing:2
parental ,hospitalized:2
parental ,children:2
parental ,rethinking:2
coronavirus ,rethinking:2
disease ,rethinking:2
testing ,children:6
testing ,rethinking:2
hospitalized ,children:4
hospitalized ,rethinking:2
children ,rethinking:2
characteristics ,family:4
characteristics ,cluster:6
family ,severe:6
family ,acute:8
family ,respiratory:8
family ,syndrome:4
hypercoagulopathy ,adipose:2
hypercoagulopathy ,tissue:2
hypercoagulopathy ,exacerbated:2
hypercoagulopathy ,inflammation:2
hypercoagulopathy ,may:2
hypercoagulopathy ,explain:2
hypercoagulopathy ,higher:2
adipose ,tissue:4
adipose ,exacerbated:2
adipose ,inflammation:2
adipose ,may:2
adipose ,explain:2
adipose ,higher:2
tissue ,exacerbated:2
tissue ,inflammation:4
tissue ,may:2
tissue ,explain:2
tissue ,higher:2
exacerbated ,inflammation:2
exacerbated ,may:2
exacerbated ,explain:2
exacerbated ,higher:2
inflammation ,may:2
inflammation ,explain:2
inflammation ,higher:2
may ,explain:2
may ,higher:2
explain ,higher:2
sars-cov-2 ,northern:12
sars-cov-2 ,since:2
sars-cov-2 ,december:4
circulating ,northern:2
circulating ,italy:2
circulating ,since:2
circulating ,december:2
circulating ,evidence:2
northern ,italy:8
northern ,since:2
northern ,december:2
northern ,evidence:2
italy ,since:2
italy ,december:2
italy ,evidence:6
since ,december:2
since ,evidence:2
december ,evidence:2
emergence ,whether:2
emergence ,stay:2
emergence ,die:2
novel ,whether:2
novel ,stay:2
novel ,die:2
coronavirus ,whether:2
coronavirus ,stay:2
coronavirus ,die:2
covid-19 ,whether:2
covid-19 ,stay:6
covid-19 ,die:2
whether ,stay:2
whether ,die:2
stay ,die:2
covid-19 ,western:4
covid-19 ,blots:2
covid-19 ,skin:10
covid-19 ,determining:10
role ,western:2
role ,blots:2
role ,skin:2
role ,determining:2
western ,blots:2
western ,skin:2
western ,testing:2
western ,determining:2
blots ,skin:2
blots ,testing:2
blots ,determining:2
skin ,testing:2
skin ,determining:2
testing ,determining:2
dna ,nanoscaffold-based:2
dna ,sars-cov-2:4
dna ,detection:2
dna ,diagnosis:2
nanoscaffold-based ,sars-cov-2:2
nanoscaffold-based ,detection:2
nanoscaffold-based ,covid-19:2
nanoscaffold-based ,diagnosis:2
detection ,diagnosis:6
thoracoscopic ,bullectomy:2
thoracoscopic ,persistent:2
thoracoscopic ,air:2
thoracoscopic ,leak:2
thoracoscopic ,14-year-old:2
thoracoscopic ,child:2
bullectomy ,persistent:2
bullectomy ,air:2
bullectomy ,leak:2
bullectomy ,14-year-old:2
bullectomy ,child:2
persistent ,air:2
persistent ,leak:2
persistent ,14-year-old:2
persistent ,child:2
air ,leak:4
air ,14-year-old:2
air ,child:2
leak ,14-year-old:2
leak ,child:2
14-year-old ,child:2
gc ,usage:2
gc ,sars-cov-2:2
gc ,genes:2
gc ,might:2
gc ,adapt:2
gc ,environment:2
gc ,human:2
gc ,lung:2
gc ,expressed:2
usage ,genes:4
usage ,might:2
usage ,adapt:2
usage ,environment:2
usage ,human:2
usage ,lung:2
usage ,expressed:2
sars-cov-2 ,genes:12
sars-cov-2 ,adapt:2
sars-cov-2 ,expressed:6
genes ,might:4
genes ,adapt:2
genes ,environment:2
genes ,human:2
genes ,lung:2
genes ,expressed:2
might ,adapt:2
might ,environment:2
might ,human:2
might ,lung:2
might ,expressed:2
adapt ,environment:2
adapt ,human:2
adapt ,lung:2
adapt ,expressed:2
environment ,human:2
environment ,lung:2
environment ,expressed:2
human ,lung:6
human ,expressed:2
lung ,expressed:2
data ,infection:4
data ,rates:2
data ,among:4
data ,exposed:2
data ,healthcare:2
data ,workers:2
data ,reveal:2
analysis ,rates:2
analysis ,among:8
analysis ,exposed:2
analysis ,healthcare:4
analysis ,reveal:4
infection ,rates:8
infection ,exposed:2
infection ,reveal:2
rates ,among:2
rates ,exposed:2
rates ,healthcare:2
rates ,workers:2
rates ,reveal:2
among ,reveal:2
exposed ,reveal:2
healthcare ,reveal:2
workers ,reveal:2
ace2 ,testes:2
ace2 ,coronavirus:6
ace2 ,disease:6
receptor ,testes:2
receptor ,disease:2
expression ,testes:2
expression ,implications:6
expression ,coronavirus:6
expression ,disease:6
testes ,implications:4
testes ,coronavirus:2
testes ,disease:2
covid-19 ,cholecystitis:2
acute ,cholecystitis:2
cholecystitis ,case:2
cholecystitis ,report:2
factors ,prolonged:6
factors ,rna:10
factors ,shedding:6
factors ,patients:18
factors ,coronavirus:16
associated ,prolonged:10
associated ,rna:4
associated ,shedding:4
rna ,shedding:12
recurrence ,report:4
rna ,report:2
evolutionary ,potential:2
evolutionary ,intermediate:2
evolutionary ,animal:2
evolutionary ,host:6
evolutionary ,cross-species:2
evolutionary ,analyses:4
history ,potential:2
history ,intermediate:2
history ,animal:2
history ,host:2
history ,cross-species:2
history ,analyses:2
potential ,intermediate:4
potential ,animal:6
potential ,cross-species:2
potential ,analyses:4
intermediate ,animal:2
intermediate ,host:4
intermediate ,cross-species:2
intermediate ,analyses:2
animal ,cross-species:2
animal ,analyses:2
host ,cross-species:2
host ,analyses:2
cross-species ,analyses:2
thromboinflammatory ,response:2
thromboinflammatory ,sars-cov-2:2
thromboinflammatory ,sepsis:2
response ,sepsis:4
covid-19 ,senegal:2
outbreak ,senegal:2
predominance ,altered:2
predominance ,sense:2
predominance ,smell:2
predominance ,taste:2
predominance ,among:2
predominance ,long-lasting:2
predominance ,symptoms:2
altered ,sense:2
altered ,smell:2
altered ,taste:2
altered ,among:2
altered ,long-lasting:2
altered ,symptoms:2
sense ,smell:6
sense ,taste:6
sense ,among:2
sense ,long-lasting:2
sense ,symptoms:2
smell ,among:4
smell ,long-lasting:2
smell ,symptoms:4
taste ,among:2
taste ,long-lasting:2
taste ,symptoms:4
among ,long-lasting:2
among ,symptoms:8
long-lasting ,symptoms:2
potential ,effect:4
potential ,nk:2
potential ,cells:12
potential ,perspective:10
effect ,nk:2
effect ,cells:2
effect ,perspective:2
novel ,nk:2
novel ,cells:6
coronavirus ,nk:2
sars-cov-2 ,nk:4
nk ,cells:4
nk ,perspective:2
cells ,perspective:2
transmission ,update:2
transmission ,literature:4
update ,literature:2
functional ,mapping:2
functional ,b-cell:2
functional ,linear:2
functional ,epitopes:2
functional ,covid-19:2
functional ,convalescent:2
mapping ,b-cell:2
mapping ,linear:2
mapping ,epitopes:2
mapping ,sars-cov-2:10
mapping ,convalescent:2
b-cell ,linear:2
b-cell ,epitopes:2
b-cell ,sars-cov-2:2
b-cell ,covid-19:2
b-cell ,convalescent:2
linear ,epitopes:2
linear ,sars-cov-2:2
linear ,covid-19:2
linear ,convalescent:2
epitopes ,convalescent:2
analysis ,pattern:2
analysis ,prescriptions:2
analysis ,syndromes:2
analysis ,traditional:8
analysis ,chinese:8
analysis ,medicine:8
pattern ,prescriptions:2
pattern ,syndromes:2
pattern ,traditional:2
pattern ,chinese:2
pattern ,medicine:2
prescriptions ,syndromes:2
prescriptions ,traditional:2
prescriptions ,chinese:2
prescriptions ,medicine:2
syndromes ,traditional:2
syndromes ,chinese:2
syndromes ,medicine:2
comparison ,acute:4
comparison ,respiratory:2
comparison ,syndrome:2
comparison ,spike:2
comparison ,protein:2
comparison ,binding:2
severe ,binding:2
acute ,spike:10
acute ,protein:16
acute ,binding:2
respiratory ,spike:8
respiratory ,protein:10
respiratory ,binding:2
syndrome ,spike:2
syndrome ,protein:4
syndrome ,binding:2
analysis ,improved:2
analysis ,workflow:2
analysis ,endoscope:2
analysis ,reprocessing:2
analysis ,bedside:2
analysis ,endoscopic:4
improved ,workflow:2
improved ,endoscope:2
improved ,reprocessing:2
improved ,bedside:2
improved ,endoscopic:2
workflow ,endoscope:2
workflow ,reprocessing:2
workflow ,bedside:2
workflow ,endoscopic:2
endoscope ,reprocessing:2
endoscope ,bedside:2
endoscope ,endoscopic:2
reprocessing ,bedside:2
reprocessing ,endoscopic:2
bedside ,endoscopic:2
sars-cov-2 ,myocardial:6
sars-cov-2 ,nox2:2
myocardial ,role:2
myocardial ,nox2:2
injury ,role:2
injury ,nox2:2
role ,nox2:2
propagation ,inactivation:2
propagation ,safety:2
propagation ,testing:2
propagation ,sars-cov-2:2
inactivation ,safety:2
inactivation ,testing:2
inactivation ,sars-cov-2:20
safety ,testing:2
molecular ,diagnostics:4
molecular ,overview:2
diagnostics ,overview:4
renin-angiotensin ,endothelial:2
renin-angiotensin ,dysfunction:2
system ,endothelial:2
system ,dysfunction:2
three ,steps:2
three ,needed:2
three ,end:2
three ,pandemic:2
three ,bold:2
three ,public:2
three ,health:2
three ,leadership:2
steps ,needed:2
steps ,end:2
steps ,covid-19:4
steps ,pandemic:2
steps ,bold:2
steps ,public:2
steps ,health:2
steps ,leadership:2
needed ,end:2
needed ,covid-19:4
needed ,pandemic:2
needed ,bold:2
needed ,public:2
needed ,health:2
needed ,leadership:2
end ,covid-19:8
end ,pandemic:2
end ,bold:2
end ,public:2
end ,health:2
end ,leadership:2
covid-19 ,bold:2
covid-19 ,leadership:4
pandemic ,bold:2
pandemic ,leadership:4
bold ,public:2
bold ,health:2
bold ,leadership:2
public ,leadership:2
health ,leadership:4
comparative ,respiratory:6
review ,mers-cov:4
review ,influenza:4
sars-cov ,influenza:4
sars-cov ,respiratory:6
mers-cov ,influenza:2
mers-cov ,respiratory:4
influenza ,respiratory:10
development ,indigenous:2
development ,igg:4
development ,elisa:4
development ,anti-sars-cov-2:4
indigenous ,igg:2
indigenous ,elisa:2
indigenous ,detection:2
indigenous ,anti-sars-cov-2:2
igg ,elisa:8
igg ,detection:14
igg ,anti-sars-cov-2:14
elisa ,detection:4
elisa ,anti-sars-cov-2:8
toward ,therapeutics:2
toward ,viewpoint:2
toward ,nonprotein:2
toward ,amino:2
toward ,acid:2
toward ,based:2
covid-19 ,nonprotein:2
covid-19 ,amino:2
therapeutics ,viewpoint:2
therapeutics ,nonprotein:2
therapeutics ,amino:2
therapeutics ,acid:2
therapeutics ,based:2
viewpoint ,nonprotein:2
viewpoint ,amino:2
viewpoint ,acid:2
viewpoint ,based:2
nonprotein ,amino:2
nonprotein ,acid:2
nonprotein ,based:2
amino ,acid:8
amino ,based:2
early ,outpatient:2
early ,symptomatic:2
early ,high-risk:2
outpatient ,treatment:2
outpatient ,symptomatic:2
outpatient ,high-risk:2
treatment ,symptomatic:6
treatment ,high-risk:2
symptomatic ,high-risk:2
high-risk ,covid-19:8
high-risk ,patients:4
quercetin ,vitamin:2
quercetin ,experimental:2
quercetin ,synergistic:2
quercetin ,therapy:2
quercetin ,prevention:2
vitamin ,experimental:2
vitamin ,synergistic:2
vitamin ,therapy:2
vitamin ,prevention:6
experimental ,synergistic:2
experimental ,therapy:4
experimental ,prevention:2
synergistic ,therapy:2
synergistic ,prevention:2
electrolyte ,disturbances:2
electrolyte ,sars-cov-2:2
electrolyte ,infection:2
disturbances ,sars-cov-2:2
disturbances ,infection:2
teicoplanin ,alternative:2
teicoplanin ,drug:2
teicoplanin ,treatment:2
teicoplanin ,covid-19:2
alternative ,drug:8
alternative ,treatment:8
alternative ,covid-19:14
highly ,conserved:4
highly ,binding:4
highly ,region:2
highly ,ace2:2
highly ,receptor:4
highly ,humans:2
conserved ,binding:6
conserved ,region:2
conserved ,ace2:2
conserved ,receptor:4
conserved ,humans:2
binding ,region:2
binding ,ace2:8
binding ,humans:2
region ,ace2:2
region ,receptor:2
region ,humans:2
ace2 ,humans:2
receptor ,humans:2
deaths ,nine:2
deaths ,regions:2
deaths ,italy:6
deaths ,februarymarch:2
deaths ,mortality:2
deaths ,excess:2
deaths ,loupe:2
nine ,regions:2
nine ,italy:2
nine ,februarymarch:2
nine ,mortality:2
nine ,excess:2
nine ,loupe:2
regions ,italy:2
regions ,februarymarch:2
regions ,mortality:2
regions ,excess:2
regions ,loupe:2
italy ,februarymarch:2
italy ,mortality:4
italy ,excess:2
italy ,loupe:2
februarymarch ,mortality:2
februarymarch ,excess:2
februarymarch ,loupe:2
mortality ,excess:4
mortality ,loupe:2
excess ,loupe:2
pre-exposure ,prophylaxis:8
pre-exposure ,hydroxychloroquine:4
pre-exposure ,safe:2
pre-exposure ,rationale:2
prophylaxis ,hydroxychloroquine:10
prophylaxis ,safe:2
prophylaxis ,rationale:2
hydroxychloroquine ,safe:4
hydroxychloroquine ,rationale:2
safe ,rationale:2
sars-cov-2 ,12-bp:2
sars-cov-2 ,deletion:4
variant ,12-bp:2
variant ,deletion:2
variant ,gene:2
12-bp ,deletion:2
12-bp ,gene:2
deletion ,gene:2
can ,strike:2
can ,twice:2
covid-19 ,strike:2
covid-19 ,twice:2
strike ,twice:2
novel ,vaccine:14
novel ,employing:2
novel ,non-replicating:2
novel ,rabies:2
novel ,expressing:2
novel ,chimeric:2
vaccine ,employing:2
vaccine ,non-replicating:2
vaccine ,rabies:2
vaccine ,virus:6
vaccine ,expressing:2
vaccine ,chimeric:2
employing ,non-replicating:2
employing ,rabies:2
employing ,virus:2
employing ,expressing:2
employing ,chimeric:2
non-replicating ,rabies:2
non-replicating ,virus:2
non-replicating ,expressing:2
non-replicating ,chimeric:2
rabies ,virus:2
rabies ,expressing:2
rabies ,chimeric:2
virus ,expressing:2
virus ,chimeric:2
expressing ,chimeric:2
can ,bioactive:4
can ,lipids:2
can ,inactivate:2
bioactive ,lipids:2
bioactive ,inactivate:2
bioactive ,coronavirus:2
bioactive ,covid-19:6
lipids ,inactivate:2
lipids ,coronavirus:2
lipids ,covid-19:2
inactivate ,coronavirus:2
inactivate ,covid-19:2
scoping ,coronavirus:4
scoping ,case:2
scoping ,series:2
scoping ,sars-cov:2
scoping ,mers-cov:2
review ,case:28
review ,series:8
coronavirus ,series:10
coronavirus ,mers-cov:6
case ,sars-cov:2
case ,mers-cov:2
series ,sars-cov:2
series ,mers-cov:2
disease-2019 ,updated:2
covid-19 ,updated:14
association ,level:4
association ,ambient:2
association ,air:4
association ,pollution:4
level ,ambient:2
level ,air:2
level ,pollution:4
level ,covid-19:4
ambient ,air:6
ambient ,pollution:4
ambient ,covid-19:8
miller ,fisher:4
miller ,syndrome:4
miller ,covid-19:2
miller ,link:2
fisher ,syndrome:4
fisher ,covid-19:2
fisher ,link:2
syndrome ,link:2
covid-19 ,link:18
comparisons ,viral:2
comparisons ,shedding:2
comparisons ,time:2
comparisons ,sars-cov-2:4
comparisons ,different:2
comparisons ,samples:2
comparisons ,icu:2
viral ,time:4
viral ,different:2
viral ,icu:2
shedding ,time:4
shedding ,different:2
shedding ,samples:4
shedding ,icu:2
time ,different:4
time ,samples:2
time ,icu:2
sars-cov-2 ,icu:10
different ,samples:4
different ,icu:2
samples ,icu:2
gastroenterologist ,need:2
gastroenterologist ,know:2
gastroenterologist ,time:2
gastroenterologist ,sars-cov-2:2
gastroenterologist ,pandemia:2
need ,time:4
need ,pandemia:2
know ,time:2
know ,pandemia:2
time ,pandemia:2
sars-cov-2 ,pandemia:4
sars-cov-2 ,will:4
sars-cov-2 ,constantly:2
sars-cov-2 ,sweep:2
sars-cov-2 ,tracks:4
sars-cov-2 ,containing:2
sars-cov-2 ,cpg:4
sars-cov-2 ,motifs:2
will ,constantly:2
will ,sweep:2
will ,tracks:2
will ,vaccine:2
will ,containing:2
will ,cpg:2
will ,motifs:2
constantly ,sweep:2
constantly ,tracks:2
constantly ,vaccine:2
constantly ,containing:2
constantly ,cpg:2
constantly ,motifs:2
sweep ,tracks:2
sweep ,vaccine:2
sweep ,containing:2
sweep ,cpg:2
sweep ,motifs:2
tracks ,vaccine:2
tracks ,containing:2
tracks ,cpg:2
tracks ,motifs:2
vaccine ,containing:2
vaccine ,cpg:2
vaccine ,motifs:2
containing ,cpg:2
containing ,motifs:2
cpg ,motifs:2
interaction ,natural:2
interaction ,vaccine-induced:2
interaction ,immunity:2
interaction ,social:2
interaction ,distancing:2
natural ,vaccine-induced:2
natural ,immunity:2
natural ,social:2
natural ,distancing:4
vaccine-induced ,immunity:2
vaccine-induced ,social:2
vaccine-induced ,distancing:2
immunity ,social:2
immunity ,distancing:2
investigation ,semen:4
investigation ,acute:6
investigation ,stage:2
sars-cov-2 ,stage:6
semen ,patients:2
semen ,acute:4
semen ,stage:2
semen ,covid-19:2
patients ,stage:6
acute ,stage:2
stage ,covid-19:8
evidence ,perspective:2
evidence ,mrna-sars-cov-2:2
evidence ,vaccine:2
evidence ,development:2
based ,perspective:2
based ,mrna-sars-cov-2:2
perspective ,mrna-sars-cov-2:2
perspective ,vaccine:4
perspective ,development:4
mrna-sars-cov-2 ,vaccine:2
mrna-sars-cov-2 ,development:2
responding ,covid-19:10
responding ,navigate:2
responding ,public:2
responding ,health:2
responding ,emergency:2
responding ,legally:2
covid-19 ,navigate:2
covid-19 ,legally:2
navigate ,public:2
navigate ,health:2
navigate ,emergency:2
navigate ,legally:2
public ,legally:2
health ,legally:2
emergency ,legally:2
children ,epidemiology:2
children ,presentation:4
children ,diagnosis:2
children ,management:8
epidemiology ,presentation:2
presentation ,diagnosis:4
presentation ,management:6
retrospective ,analysis:12
retrospective ,clinical:10
retrospective ,characteristics:10
retrospective ,405:2
retrospective ,covid-19:34
analysis ,clinical:40
analysis ,characteristics:18
analysis ,405:2
clinical ,405:2
characteristics ,405:2
405 ,patients:2
405 ,covid-19:2
genetic ,sequence:2
genetic ,origin:4
genetic ,diagnosis:2
sequence ,origin:2
sequence ,diagnosis:2
sequence ,sars-cov-2:10
sars-cov-2 ,eye:2
sars-cov-2 ,published:4
covid-19 ,eye:10
covid-19 ,published:2
eye ,update:2
eye ,published:2
eye ,data:2
update ,published:2
update ,data:2
published ,data:2
covid-19 ,question:2
diagnostic ,question:2
perspective ,effects:2
perspective ,naringenin:2
potential ,naringenin:2
effects ,naringenin:2
naringenin ,covid-19:2
overview ,current:10
overview ,promising:2
overview ,approaches:4
overview ,development:6
overview ,effective:2
current ,promising:2
current ,effective:2
promising ,approaches:2
promising ,development:4
promising ,effective:2
approaches ,effective:2
development ,effective:2
paediatric ,gut:2
american ,association:2
american ,hip:2
american ,knee:2
american ,surgeons:2
american ,advocacy:2
american ,efforts:2
american ,response:2
association ,hip:2
association ,knee:2
association ,surgeons:4
association ,advocacy:2
association ,efforts:2
association ,response:4
hip ,knee:8
hip ,surgeons:2
hip ,advocacy:2
hip ,efforts:2
hip ,response:2
knee ,surgeons:2
knee ,advocacy:2
knee ,efforts:2
knee ,response:2
surgeons ,advocacy:2
surgeons ,efforts:2
surgeons ,response:2
advocacy ,efforts:2
advocacy ,response:2
efforts ,response:2
ventilation ,dental:2
ventilation ,clinic:2
ventilation ,effective:2
ventilation ,measure:2
ventilation ,control:2
ventilation ,droplets:2
dental ,clinic:2
dental ,effective:2
dental ,measure:2
dental ,droplets:2
clinic ,effective:2
clinic ,measure:2
clinic ,control:2
clinic ,droplets:2
effective ,control:2
effective ,droplets:2
measure ,control:2
measure ,droplets:2
control ,droplets:2
characteristics ,public:2
characteristics ,health:4
characteristics ,responses:4
public ,responses:6
health ,responses:8
transcriptome-based ,drug:2
transcriptome-based ,repositioning:2
transcriptome-based ,coronavirus:2
transcriptome-based ,disease:2
transcriptome-based ,covid-19:2
drug ,repositioning:8
drug ,disease:10
repositioning ,coronavirus:4
repositioning ,disease:2
repositioning ,covid-19:10
anaesthesia ,covid-19:2
anaesthesia ,infection:2
anaesthesia ,control:2
hypertension ,children:2
airborne ,control:2
transmission ,control:10
development ,multi-specific:2
development ,llama:2
development ,antibodies:6
development ,blocking:2
development ,sars-cov-2ace2:2
multi-specific ,humanized:2
multi-specific ,llama:2
multi-specific ,antibodies:2
multi-specific ,blocking:2
multi-specific ,sars-cov-2ace2:2
humanized ,llama:2
humanized ,antibodies:2
humanized ,blocking:2
humanized ,sars-cov-2ace2:2
llama ,antibodies:2
llama ,blocking:2
llama ,sars-cov-2ace2:2
antibodies ,blocking:2
antibodies ,sars-cov-2ace2:2
blocking ,sars-cov-2ace2:2
children ,brief:2
children ,overview:2
children ,three:4
children ,months:2
children ,experience:2
brief ,three:2
brief ,months:2
brief ,experience:2
overview ,three:2
overview ,experience:2
three ,months:4
three ,experience:2
months ,experience:2
extensive ,pneumatosis:2
extensive ,intestinalis:2
extensive ,portal:2
extensive ,venous:4
extensive ,gas:2
extensive ,mimicking:2
extensive ,mesenteric:2
pneumatosis ,intestinalis:4
pneumatosis ,portal:2
pneumatosis ,venous:2
pneumatosis ,gas:2
pneumatosis ,mimicking:2
pneumatosis ,mesenteric:2
intestinalis ,portal:2
intestinalis ,venous:2
intestinalis ,gas:2
intestinalis ,mimicking:2
intestinalis ,mesenteric:2
portal ,venous:4
portal ,gas:4
portal ,mimicking:2
portal ,mesenteric:2
venous ,gas:4
venous ,mimicking:2
venous ,mesenteric:2
gas ,mimicking:2
gas ,mesenteric:2
mimicking ,mesenteric:2
covid-19 ,older:24
older ,adults:16
retrospective ,evaluation:2
retrospective ,lateral:2
retrospective ,flow:2
retrospective ,assays:2
clinical ,lateral:2
clinical ,flow:2
lateral ,detection:8
flow ,detection:8
inflamm-aging ,older:2
inflamm-aging ,men:2
inflamm-aging ,susceptible:2
inflamm-aging ,sars-cov-2:2
inflamm-aging ,complicated:2
older ,men:2
older ,susceptible:2
older ,sars-cov-2:8
older ,complicated:2
men ,susceptible:2
men ,sars-cov-2:2
men ,complicated:2
susceptible ,sars-cov-2:8
susceptible ,complicated:2
sars-cov-2 ,complicated:4
immune ,mers-cov:2
responses ,sars-cov:2
responses ,mers-cov:2
mechanistic ,inferences:2
mechanistic ,clinical:2
mechanistic ,reports:2
mechanistic ,sars-cov-2:10
inferences ,clinical:2
inferences ,reports:2
inferences ,sars-cov-2:2
clinical ,reports:2
reports ,sars-cov-2:4
characteristics ,19:2
characteristics ,neonates:2
19 ,neonates:4
19 ,born:2
19 ,mothers:2
potent ,effect:2
potent ,silver:2
potent ,nanoparticles:2
antiviral ,effect:6
antiviral ,silver:2
antiviral ,nanoparticles:4
effect ,silver:2
effect ,nanoparticles:2
silver ,nanoparticles:2
silver ,sars-cov-2:2
nanoparticles ,sars-cov-2:2
biomedical ,application:4
biomedical ,drug:2
biomedical ,delivery:4
biomedical ,metabolic:2
biomedical ,pathway:2
biomedical ,antiviral:2
application ,drug:4
application ,delivery:4
application ,metabolic:2
application ,pathway:2
application ,antiviral:4
drug ,delivery:6
drug ,metabolic:2
drug ,pathway:2
delivery ,metabolic:2
delivery ,pathway:2
delivery ,antiviral:4
metabolic ,pathway:2
metabolic ,antiviral:2
pathway ,antiviral:2
perspective ,nephrology:2
update ,knowledge:2
update ,genetics:2
update ,evolution:2
update ,immunopathogenesis:2
current ,genetics:2
current ,evolution:2
current ,immunopathogenesis:2
knowledge ,genetics:2
knowledge ,evolution:2
knowledge ,immunopathogenesis:2
genetics ,evolution:2
genetics ,immunopathogenesis:4
evolution ,immunopathogenesis:2
accurate ,diagnosis:2
accurate ,covid-19:6
accurate ,novel:2
accurate ,immunogenic:2
accurate ,secreted:2
accurate ,sars-cov-2:6
accurate ,orf8:4
diagnosis ,immunogenic:2
diagnosis ,secreted:2
diagnosis ,orf8:2
covid-19 ,immunogenic:2
covid-19 ,secreted:2
covid-19 ,orf8:2
novel ,immunogenic:2
novel ,secreted:2
novel ,orf8:2
immunogenic ,secreted:2
immunogenic ,sars-cov-2:2
immunogenic ,orf8:2
secreted ,sars-cov-2:2
secreted ,orf8:2
sars-cov-2 ,orf8:4
occupational ,risks:2
occupational ,sars-cov-2:4
occupational ,infection:4
occupational ,polish:2
occupational ,experience:2
risks ,sars-cov-2:10
risks ,polish:2
risks ,experience:2
sars-cov-2 ,polish:2
infection ,polish:2
infection ,experience:8
polish ,experience:2
challenges ,management:4
challenges ,neurological:2
challenges ,psychiatric:2
challenges ,manifestations:2
management ,neurological:2
management ,psychiatric:2
management ,manifestations:4
neurological ,psychiatric:2
psychiatric ,manifestations:2
ocular ,review:4
surface ,review:2
surface ,transmission:4
surface ,manifestations:4
evolution ,infection:10
evolution ,four:2
evolution ,psoriatic:2
evolution ,patients:2
evolution ,treated:2
evolution ,biological:2
covid-19 ,psoriatic:2
infection ,psoriatic:4
infection ,treated:8
infection ,biological:4
four ,psoriatic:2
four ,treated:2
four ,biological:2
psoriatic ,patients:2
psoriatic ,treated:4
psoriatic ,biological:2
patients ,biological:2
treated ,biological:2
cell ,models:2
cell ,pathogenesis:2
cell ,immunity:12
animal ,pathogenesis:2
animal ,immunity:2
models ,pathogenesis:4
models ,immunity:2
cluster ,play:2
cluster ,important:2
cluster ,roles:2
cluster ,rapid:2
cluster ,evolution:2
infections ,play:2
infections ,important:2
infections ,roles:2
infections ,rapid:2
infections ,evolution:2
play ,important:2
play ,roles:2
play ,rapid:2
play ,evolution:2
play ,covid-19:12
important ,roles:2
important ,rapid:2
important ,evolution:2
roles ,rapid:2
roles ,evolution:2
roles ,covid-19:4
rapid ,evolution:2
postmortem ,lung:6
postmortem ,findings:8
postmortem ,patient:2
postmortem ,asthma:2
postmortem ,coronavirus:4
postmortem ,disease:2
lung ,patient:4
lung ,asthma:2
findings ,asthma:2
patient ,asthma:2
asthma ,coronavirus:4
asthma ,disease:4
reduced ,development:2
reduced ,children:2
reduced ,reveals:2
reduced ,molecular:2
reduced ,checkpoints:2
reduced ,gating:2
development ,children:2
development ,reveals:4
development ,molecular:6
development ,checkpoints:2
development ,gating:2
covid-19 ,reveals:8
covid-19 ,checkpoints:2
covid-19 ,gating:2
children ,reveals:2
children ,molecular:2
children ,checkpoints:2
children ,gating:2
reveals ,molecular:2
reveals ,checkpoints:2
reveals ,gating:2
molecular ,checkpoints:2
molecular ,gating:2
checkpoints ,gating:2
acute ,bilateral:2
acute ,follicular:2
acute ,conjunctivitis:2
acute ,two:4
onset ,bilateral:2
onset ,follicular:2
onset ,conjunctivitis:2
onset ,two:2
onset ,patients:4
onset ,confirmed:4
bilateral ,follicular:2
bilateral ,conjunctivitis:2
bilateral ,two:2
bilateral ,patients:2
bilateral ,confirmed:2
follicular ,conjunctivitis:2
follicular ,two:2
follicular ,patients:2
follicular ,confirmed:2
conjunctivitis ,two:2
conjunctivitis ,patients:4
conjunctivitis ,confirmed:2
two ,confirmed:2
patients ,confirmed:10
anal ,swab:4
anal ,potentially:2
anal ,optimal:2
anal ,specimen:2
anal ,detection:4
anal ,evaluate:2
swab ,potentially:2
swab ,optimal:2
swab ,specimen:6
swab ,evaluate:2
potentially ,optimal:2
potentially ,specimen:2
potentially ,sars-cov-2:6
potentially ,detection:2
potentially ,evaluate:2
optimal ,specimen:2
optimal ,sars-cov-2:8
optimal ,detection:2
optimal ,evaluate:2
specimen ,evaluate:2
sars-cov-2 ,evaluate:4
detection ,evaluate:2
different ,outcome:2
different ,members:2
outcome ,covid-19:22
outcome ,members:2
outcome ,family:2
covid-19 ,members:6
members ,family:4
covid-19 ,cause:14
covid-19 ,haemolysis:2
infection ,haemolysis:2
treatment ,cause:4
treatment ,haemolysis:2
hydroxychloroquine ,cause:2
hydroxychloroquine ,severe:8
hydroxychloroquine ,haemolysis:2
cause ,severe:6
cause ,haemolysis:2
severe ,haemolysis:2
antiviral ,disease:4
leptospira-zebra ,corona:2
leptospira-zebra ,herd:2
corona ,herd:2
continued ,epidemic:2
continued ,threat:2
continued ,sars-cov-2:2
continued ,implications:2
continued ,future:2
epidemic ,threat:2
epidemic ,future:4
threat ,implications:2
threat ,future:2
implications ,future:2
covid-19 ,series:52
covid-19 ,ems:2
covid-19 ,encounters:4
covid-19 ,linked:6
preliminary ,case:4
preliminary ,series:2
preliminary ,ems:2
preliminary ,encounters:2
preliminary ,linked:2
case ,characteristics:4
case ,ems:2
case ,encounters:2
case ,linked:2
series ,characteristics:4
series ,ems:2
series ,encounters:2
series ,linked:2
characteristics ,ems:2
characteristics ,encounters:2
characteristics ,linked:2
ems ,encounters:2
ems ,linked:2
encounters ,linked:2
covid-19 ,now:10
pregnancy ,now:2
now ,review:2
delayed ,initiation:2
delayed ,remdesivir:2
delayed ,covid-19-positive:2
initiation ,remdesivir:2
initiation ,covid-19-positive:2
initiation ,patient:2
remdesivir ,covid-19-positive:2
remdesivir ,patient:6
covid-19-positive ,patient:2
fully ,exploiting:2
fully ,type:2
fully ,interferons:2
fully ,todays:2
fully ,fight:2
fully ,covid-19:2
exploiting ,type:2
exploiting ,interferons:2
exploiting ,todays:2
exploiting ,fight:2
exploiting ,covid-19:2
type ,interferons:22
type ,todays:2
type ,fight:2
type ,covid-19:20
interferons ,todays:2
interferons ,fight:2
interferons ,covid-19:10
todays ,fight:2
todays ,covid-19:2
analysis ,variation:4
variation ,evolution:2
variation ,sars-cov-2:8
variation ,genome:4
gastrointestinal ,first:2
gastrointestinal ,manifestation:2
symptoms ,first:4
symptoms ,manifestation:2
first ,manifestation:4
chloroquine ,paradox:2
chloroquine ,may:4
chloroquine ,cause:2
chloroquine ,damage:2
chloroquine ,fight:2
paradox ,may:2
paradox ,cause:2
paradox ,damage:2
paradox ,help:2
paradox ,fight:2
paradox ,covid-19:4
may ,damage:4
may ,help:4
may ,fight:2
cause ,damage:4
cause ,help:2
cause ,fight:2
damage ,help:2
damage ,fight:2
damage ,covid-19:10
help ,fight:8
challenges ,sars-cov-2:14
challenges ,lessons:4
challenges ,learnt:2
challenges ,sars:4
challenges ,guangdong:2
challenges ,province:2
challenges ,china:4
sars-cov-2 ,learnt:2
sars-cov-2 ,sars:14
sars-cov-2 ,guangdong:4
lessons ,learnt:2
lessons ,sars:10
lessons ,guangdong:2
lessons ,province:2
lessons ,china:4
learnt ,sars:2
learnt ,guangdong:2
learnt ,province:2
learnt ,china:2
sars ,guangdong:2
sars ,province:2
sars ,china:4
guangdong ,province:4
guangdong ,china:4
guillain-barr-strohl ,syndrome:2
guillain-barr-strohl ,covid-19:2
guillain-barr-strohl ,case:2
guillain-barr-strohl ,report:2
guillain-barr-strohl ,literature:2
guillain-barr-strohl ,review:2
syndrome ,report:18
syndrome ,literature:6
case ,literature:18
report ,literature:12
report ,review:16
preliminary ,estimation:2
estimation ,basic:4
estimation ,reproduction:2
estimation ,number:4
estimation ,novel:6
basic ,coronavirus:6
reproduction ,coronavirus:4
number ,coronavirus:4
simultaneous ,diagnosis:2
simultaneous ,favorable:2
simultaneous ,evolution:2
simultaneous ,infection:2
simultaneous ,pneumocystis:2
diagnosis ,favorable:2
diagnosis ,evolution:2
diagnosis ,pneumocystis:2
favorable ,evolution:2
favorable ,infection:2
favorable ,pneumocystis:2
evolution ,pneumocystis:2
infection ,pneumocystis:2
hemodialysis ,patients:6
hemodialysis ,report:4
hemodialysis ,cases:2
patients ,report:14
patients ,cases:24
understanding ,verifying:2
understanding ,implementing:4
understanding ,emergency:2
understanding ,use:2
understanding ,authorization:2
understanding ,molecular:2
verifying ,implementing:2
verifying ,emergency:2
verifying ,use:2
verifying ,authorization:2
verifying ,molecular:2
implementing ,emergency:2
implementing ,use:2
implementing ,authorization:2
implementing ,molecular:2
emergency ,use:2
emergency ,molecular:2
use ,authorization:2
use ,molecular:2
authorization ,molecular:2
covid-19 ,adipokine:2
covid-19 ,1-7:2
covid-19 ,umbrella:2
underlying ,adipokine:2
underlying ,storm:2
underlying ,angiotensin:2
underlying ,1-7:2
underlying ,umbrella:2
adipokine ,storm:2
adipokine ,angiotensin:2
adipokine ,1-7:2
adipokine ,umbrella:2
storm ,angiotensin:2
storm ,1-7:2
storm ,umbrella:2
angiotensin ,1-7:2
angiotensin ,umbrella:2
1-7 ,umbrella:2
effect ,latitude:2
effect ,pm25:2
effect ,spreading:2
effect ,tropical:2
latitude ,pm25:2
latitude ,spreading:2
latitude ,sars-cov-2:2
latitude ,tropical:2
pm25 ,spreading:2
pm25 ,sars-cov-2:2
pm25 ,tropical:2
spreading ,sars-cov-2:10
spreading ,tropical:2
sars-cov-2 ,tropical:2
first ,proof:2
first ,capability:2
first ,india:4
proof ,capability:2
proof ,wastewater:2
proof ,surveillance:2
proof ,covid-19:4
proof ,india:2
capability ,wastewater:2
capability ,surveillance:2
capability ,covid-19:2
capability ,india:2
wastewater ,india:2
surveillance ,india:4
covid-19 ,india:18
infection ,response:16
infection ,implications:20
response ,human:4
response ,system:6
response ,possible:4
response ,implications:6
human ,immune:6
human ,system:6
human ,possible:2
human ,implications:4
immune ,possible:4
immune ,implications:4
system ,possible:2
coagulopathy ,endotheliopathy:2
coagulopathy ,vasculitis:2
coagulopathy ,covid-19:12
endotheliopathy ,vasculitis:2
endotheliopathy ,covid-19:2
vasculitis ,covid-19:6
extreme ,genomic:2
extreme ,cpg:2
extreme ,deficiency:2
extreme ,sars-cov-2:2
extreme ,evasion:2
extreme ,host:2
extreme ,antiviral:2
extreme ,defense:2
genomic ,cpg:2
genomic ,deficiency:2
genomic ,evasion:2
genomic ,host:4
genomic ,antiviral:2
genomic ,defense:2
cpg ,deficiency:4
cpg ,evasion:2
cpg ,host:2
cpg ,antiviral:2
cpg ,defense:2
deficiency ,evasion:2
deficiency ,host:2
deficiency ,antiviral:2
deficiency ,defense:2
sars-cov-2 ,evasion:8
sars-cov-2 ,defense:6
evasion ,host:2
evasion ,antiviral:2
evasion ,defense:2
host ,antiviral:2
host ,defense:4
antiviral ,defense:2
neutralizing ,responses:6
neutralizing ,covid-19:6
neutralizing ,patients:6
covid-19 ,oral:26
covid-19 ,experts:4
pandemic ,changes:2
pandemic ,dentists:2
pandemic ,oral:8
pandemic ,experts:2
pandemic ,narrative:8
changes ,dentists:2
changes ,oral:2
changes ,medicine:4
changes ,experts:2
changes ,narrative:2
dentists ,oral:2
dentists ,medicine:2
dentists ,experts:2
dentists ,narrative:2
oral ,medicine:2
oral ,experts:2
oral ,narrative:2
medicine ,experts:2
medicine ,narrative:4
experts ,narrative:2
pandemic ,medical:8
pandemic ,interventions:4
current ,medical:2
current ,interventions:4
medical ,interventions:4
covid-19 ,activities:4
covid-19 ,promoted:2
covid-19 ,university:14
emergency ,activities:2
emergency ,promoted:2
emergency ,university:2
emergency ,hospital:2
management ,activities:2
management ,promoted:2
management ,university:4
management ,hospital:10
activities ,promoted:2
activities ,university:2
activities ,hospital:2
promoted ,university:2
promoted ,hospital:2
university ,hospital:8
navigating ,challenges:2
navigating ,covid-19:6
navigating ,outbreak:2
navigating ,perspectives:2
navigating ,radiation:2
challenges ,perspectives:6
challenges ,radiation:2
covid-19 ,radiation:6
outbreak ,perspectives:4
outbreak ,radiation:2
perspectives ,radiation:2
current ,emerging:2
current ,directindirect:2
current ,negative:2
current ,impacts:2
emerging ,potential:4
emerging ,directindirect:2
emerging ,negative:2
emerging ,impacts:2
sars-cov-2 ,directindirect:2
sars-cov-2 ,negative:16
pandemic ,directindirect:2
pandemic ,negative:2
potential ,directindirect:2
potential ,negative:2
potential ,impacts:4
directindirect ,negative:2
directindirect ,impacts:2
negative ,impacts:2
mortality ,statistics:2
mortality ,england:2
mortality ,wales:2
mortality ,paradox:2
statistics ,england:2
statistics ,wales:2
statistics ,sars-cov-2:2
statistics ,paradox:2
england ,wales:2
england ,sars-cov-2:4
england ,paradox:2
wales ,sars-cov-2:2
wales ,paradox:2
sars-cov-2 ,paradox:2
atomistic ,simulation:2
atomistic ,reveals:2
atomistic ,structural:2
atomistic ,mechanisms:2
atomistic ,underlying:2
atomistic ,d614g:2
atomistic ,spike:2
simulation ,reveals:2
simulation ,structural:4
simulation ,mechanisms:2
simulation ,underlying:2
simulation ,d614g:2
simulation ,spike:2
reveals ,mechanisms:4
reveals ,underlying:2
reveals ,d614g:2
structural ,mechanisms:2
structural ,underlying:2
structural ,d614g:6
mechanisms ,d614g:2
mechanisms ,spike:2
underlying ,d614g:2
underlying ,spike:2
lockdown ,effective:2
lockdown ,vaccine:2
lockdown ,message:2
lockdown ,india:8
effective ,vaccine:2
effective ,message:2
effective ,india:2
vaccine ,message:2
vaccine ,india:2
covid-19 ,message:2
message ,india:2
identification ,sars-cov:2
identification ,rbd-targeting:2
identification ,monoclonal:2
identification ,antibodies:4
identification ,cross-reactive:2
sars-cov ,rbd-targeting:2
sars-cov ,monoclonal:4
sars-cov ,antibodies:2
sars-cov ,cross-reactive:4
rbd-targeting ,monoclonal:2
rbd-targeting ,antibodies:2
rbd-targeting ,cross-reactive:2
monoclonal ,antibodies:14
monoclonal ,cross-reactive:2
antibodies ,cross-reactive:4
lack ,antiviral:2
lack ,activity:2
lack ,darunavir:2
antiviral ,darunavir:2
activity ,darunavir:2
darunavir ,sars-cov-2:2
insufficient ,etiological:2
insufficient ,workup:2
insufficient ,covid-19-associated:2
insufficient ,acute:2
insufficient ,pancreatitis:2
etiological ,workup:2
etiological ,covid-19-associated:2
etiological ,acute:2
etiological ,pancreatitis:2
workup ,covid-19-associated:2
workup ,acute:2
workup ,pancreatitis:2
covid-19-associated ,acute:6
covid-19-associated ,pancreatitis:2
acute ,pancreatitis:8
changing ,epidemiology:2
changing ,sars-cov:2
changing ,context:2
changing ,covid-19:8
changing ,pandemic:6
epidemiology ,sars-cov:2
epidemiology ,context:4
sars-cov ,context:2
sars-cov ,pandemic:4
context ,pandemic:8
two ,infants:4
two ,china:2
infants ,china:2
remdesivir ,combination:2
remdesivir ,pulmonary:2
remdesivir ,iv:2
remdesivir ,administration:2
treatment ,combination:6
treatment ,iv:2
treatment ,administration:2
covid-19 ,iv:4
covid-19 ,administration:4
combination ,pulmonary:2
combination ,iv:2
combination ,administration:2
pulmonary ,iv:2
pulmonary ,administration:2
iv ,administration:2
dyspneic ,non-dyspneic:2
dyspneic ,silent:2
dyspneic ,hypoxemia:2
dyspneic ,covid-19:2
dyspneic ,possible:2
dyspneic ,neurological:2
non-dyspneic ,silent:2
non-dyspneic ,hypoxemia:2
non-dyspneic ,covid-19:2
non-dyspneic ,possible:2
non-dyspneic ,neurological:2
silent ,hypoxemia:2
silent ,covid-19:2
silent ,possible:2
silent ,neurological:2
hypoxemia ,covid-19:6
hypoxemia ,possible:2
hypoxemia ,neurological:2
covid-19 ,hiv-positive:4
covid-19 ,woman:14
covid-19 ,antiretroviral:2
pneumonia ,hiv-positive:2
pneumonia ,woman:2
pneumonia ,antiretroviral:2
pneumonia ,therapy:8
hiv-positive ,woman:2
hiv-positive ,antiretroviral:2
hiv-positive ,therapy:2
woman ,antiretroviral:2
woman ,therapy:2
antiretroviral ,therapy:2
computational ,alanine:2
computational ,scanning:2
computational ,structural:2
computational ,spike:2
alanine ,scanning:2
alanine ,structural:2
alanine ,analysis:2
alanine ,sars-cov-2:2
alanine ,spike:2
scanning ,structural:2
scanning ,analysis:2
scanning ,sars-cov-2:2
scanning ,spike:2
mechanism ,strategies:2
mechanism ,mediated:2
mechanism ,inflammatory:4
treatment ,mediated:2
treatment ,inflammatory:4
strategies ,mediated:2
strategies ,inflammatory:2
mediated ,inflammatory:2
impact ,sleep:2
sars-cov-2 ,sleep:6
lifting ,mask:2
lifting ,neurological:2
lifting ,manifestations:2
lifting ,covid-19:4
mask ,neurological:2
mask ,manifestations:2
mask ,covid-19:12
persistent ,rna:4
persistent ,positivity:2
persistent ,patient:4
persistent ,92:2
persistent ,days:2
persistent ,disease:2
persistent ,onset:2
sars-cov-2 ,92:2
sars-cov-2 ,onset:12
rna ,92:2
rna ,onset:2
positivity ,patient:2
positivity ,92:2
positivity ,days:2
positivity ,onset:2
patient ,92:2
patient ,days:4
patient ,onset:4
92 ,days:2
92 ,disease:2
92 ,onset:2
days ,disease:4
days ,onset:6
disease ,onset:4
extraction-free ,sars-cov-2:4
extraction-free ,detection:2
extraction-free ,rapid:4
extraction-free ,rt-qpcr:2
extraction-free ,universal:2
extraction-free ,primary:2
sars-cov-2 ,universal:16
sars-cov-2 ,primary:6
detection ,universal:2
detection ,primary:2
rapid ,rt-qpcr:2
rapid ,universal:2
rapid ,primary:2
rt-qpcr ,universal:2
rt-qpcr ,primary:2
universal ,primary:2
mafld ,covid-19:2
mafld ,patients:2
mafld ,insidious:2
mafld ,enemy:2
covid-19 ,insidious:2
patients ,insidious:2
patients ,enemy:2
insidious ,enemy:2
combination ,serological:2
combination ,total:2
combination ,antibody:2
combination ,rt-pcr:2
combination ,test:2
combination ,detection:4
serological ,total:2
serological ,antibody:2
serological ,rt-pcr:4
total ,antibody:2
total ,rt-pcr:2
total ,test:2
total ,detection:2
antibody ,rt-pcr:2
antibody ,test:4
rt-pcr ,test:6
ace2 ,human:24
ace2 ,heart:2
ace2 ,indicates:2
ace2 ,new:4
ace2 ,mechanism:4
ace2 ,injury:4
expression ,human:14
expression ,heart:2
expression ,indicates:2
expression ,new:4
expression ,potential:6
expression ,mechanism:2
expression ,injury:2
human ,heart:2
human ,indicates:2
human ,new:2
human ,potential:8
human ,mechanism:4
heart ,indicates:2
heart ,new:2
heart ,potential:2
heart ,mechanism:2
heart ,injury:2
indicates ,new:2
indicates ,potential:2
indicates ,mechanism:2
indicates ,injury:2
new ,mechanism:6
new ,injury:2
potential ,injury:4
mechanism ,injury:4
repurposing ,existing:6
repurposing ,endocrinology:2
repurposing ,perspective:2
existing ,drugs:10
existing ,covid-19:6
existing ,endocrinology:2
existing ,perspective:2
drugs ,endocrinology:2
drugs ,perspective:4
covid-19 ,endocrinology:6
endocrinology ,perspective:2
biological ,product:2
biological ,development:2
biological ,strategies:2
biological ,prevention:2
biological ,treatment:2
product ,development:2
product ,strategies:2
product ,prevention:2
product ,treatment:2
development ,strategies:6
development ,prevention:2
development ,treatment:2
strategies ,prevention:8
neurological ,point-of-view:2
diarrhoea ,atypical:2
diarrhoea ,presentation:2
diarrhoea ,covid-19:2
atypical ,presentation:8
atypical ,covid-19:14
ivermectin ,docks:2
ivermectin ,sars-cov-2:6
ivermectin ,spike:2
ivermectin ,receptor-binding:2
ivermectin ,domain:2
ivermectin ,attached:2
ivermectin ,ace2:2
docks ,sars-cov-2:2
docks ,spike:2
docks ,receptor-binding:2
docks ,domain:2
docks ,attached:2
docks ,ace2:2
sars-cov-2 ,attached:2
spike ,attached:2
receptor-binding ,attached:2
receptor-binding ,ace2:4
domain ,attached:2
domain ,ace2:4
attached ,ace2:2
outbreak ,investigation:4
outbreak ,residents:2
outbreak ,staff:6
outbreak ,independent:2
investigation ,among:4
investigation ,residents:2
investigation ,staff:2
investigation ,independent:2
covid-19 ,residents:10
among ,residents:4
among ,staff:14
among ,independent:4
residents ,staff:6
residents ,independent:4
staff ,independent:4
fighting ,common:2
fighting ,enemy:2
fighting ,covid-19:12
fighting ,practice:2
fighting ,building:2
fighting ,community:2
common ,enemy:2
common ,practice:2
common ,building:2
common ,community:2
enemy ,practice:2
enemy ,building:2
enemy ,community:2
covid-19 ,building:4
practice ,building:2
practice ,community:2
building ,community:2
sars-cov-2 ,sinusitis:2
complicated ,sinusitis:2
complicated ,co-infection:2
complicated ,human:2
complicated ,metapneumovirus:2
sinusitis ,co-infection:2
sinusitis ,human:2
sinusitis ,metapneumovirus:2
covid-19 ,warp:2
covid-19 ,speed:2
covid-19 ,mind:2
covid-19 ,melds:2
covid-19 ,warped:2
covid-19 ,minds:2
vaccines ,warp:2
vaccines ,speed:4
vaccines ,needs:2
vaccines ,mind:2
vaccines ,melds:2
vaccines ,warped:2
vaccines ,minds:2
warp ,speed:4
warp ,needs:2
warp ,mind:2
warp ,melds:2
warp ,warped:2
warp ,minds:2
speed ,needs:2
speed ,mind:2
speed ,melds:2
speed ,warped:2
speed ,minds:2
needs ,mind:2
needs ,melds:2
needs ,warped:2
needs ,minds:2
mind ,melds:2
mind ,warped:2
mind ,minds:2
melds ,warped:2
melds ,minds:2
warped ,minds:2
role ,physical:2
role ,rehabilitation:2
role ,medicine:4
role ,aftermath:2
physical ,rehabilitation:2
physical ,medicine:2
physical ,aftermath:2
physical ,sars-cov-2:2
rehabilitation ,medicine:2
rehabilitation ,aftermath:2
medicine ,aftermath:2
aftermath ,sars-cov-2:2
complications ,systematic:2
complications ,review:8
severe ,thrombocytopenia:4
severe ,critically:10
severe ,ill:14
immune ,critically:2
immune ,ill:2
thrombocytopenia ,critically:2
thrombocytopenia ,ill:2
thrombocytopenia ,covid-19:12
critically ,covid-19:28
critically ,patient:6
ill ,covid-19:34
ill ,patient:6
self-collection ,appropriate:2
self-collection ,alternative:2
self-collection ,sars-cov-2:2
self-collection ,pandemic:2
appropriate ,alternative:2
appropriate ,sars-cov-2:2
appropriate ,pandemic:2
alternative ,pandemic:2
risk ,outbreak:4
risk ,outside:4
estimation ,sars-cov-2:6
estimation ,acute:2
estimation ,respiratory:2
estimation ,outbreak:4
estimation ,outside:2
estimation ,china:2
acute ,outside:2
acute ,china:2
respiratory ,china:2
disease ,outside:2
outbreak ,outside:2
outside ,china:8
going ,remote:2
going ,maintaining:2
going ,normalcy:2
going ,pathology:2
going ,laboratories:2
going ,covid-19:2
remote ,maintaining:2
remote ,normalcy:2
remote ,pathology:2
remote ,laboratories:2
remote ,covid-19:4
maintaining ,normalcy:2
maintaining ,pathology:2
maintaining ,laboratories:2
maintaining ,covid-19:6
normalcy ,pathology:2
normalcy ,laboratories:2
normalcy ,covid-19:4
pathology ,laboratories:2
pathology ,covid-19:26
laboratories ,covid-19:8
indian ,publications:2
indian ,sars-cov-2:2
indian ,bibliometric:2
indian ,study:2
indian ,covid-19:4
indian ,database:2
publications ,sars-cov-2:2
publications ,bibliometric:4
publications ,study:2
publications ,covid-19:4
publications ,database:2
sars-cov-2 ,bibliometric:2
sars-cov-2 ,database:2
bibliometric ,study:2
bibliometric ,covid-19:6
bibliometric ,database:2
study ,database:2
covid-19 ,database:2
continuous ,hydroxychloroquine:2
continuous ,colchicine:2
continuous ,therapy:2
continuous ,prevent:2
continuous ,infection:2
hydroxychloroquine ,colchicine:2
hydroxychloroquine ,therapy:6
hydroxychloroquine ,prevent:6
colchicine ,therapy:2
colchicine ,prevent:2
colchicine ,infection:2
therapy ,prevent:4
prevent ,infection:6
prospective ,vaccination:2
prospective ,covid-19:20
prospective ,using:4
prospective ,shrna-plasmid-ldh:2
prospective ,nanoconjugate:2
vaccination ,using:2
vaccination ,shrna-plasmid-ldh:2
vaccination ,nanoconjugate:2
covid-19 ,shrna-plasmid-ldh:2
covid-19 ,nanoconjugate:2
using ,shrna-plasmid-ldh:2
using ,nanoconjugate:2
shrna-plasmid-ldh ,nanoconjugate:2
genomic ,evolution:4
genomic ,severe:8
genomic ,acute:8
genomic ,respiratory:8
genomic ,syndrome:4
genomic ,india:2
evolution ,india:2
severe ,india:2
acute ,india:2
respiratory ,india:2
syndrome ,india:2
coronavirus ,india:2
analysis ,rna:14
analysis ,sequences:6
analysis ,3636:2
analysis ,collected:6
analysis ,55:2
analysis ,countries:4
rna ,sequences:6
rna ,3636:2
rna ,collected:2
rna ,55:2
rna ,countries:2
rna ,reveals:2
sequences ,3636:2
sequences ,collected:2
sequences ,55:2
sequences ,countries:2
sequences ,reveals:2
3636 ,sars-cov-2:2
3636 ,collected:2
3636 ,55:2
3636 ,countries:2
3636 ,reveals:2
sars-cov-2 ,collected:6
sars-cov-2 ,55:2
sars-cov-2 ,countries:8
collected ,55:2
collected ,countries:2
collected ,reveals:2
55 ,countries:2
55 ,reveals:2
countries ,reveals:4
crisprcas13 ,potential:2
crisprcas13 ,therapeutic:2
crisprcas13 ,option:2
crisprcas13 ,covid-19:2
potential ,option:4
option ,covid-19:8
ribavirin ,remdesivir:2
ribavirin ,sofosbuvir:2
ribavirin ,galidesivir:2
ribavirin ,tenofovir:2
ribavirin ,sars-cov-2:2
ribavirin ,rna:2
remdesivir ,sofosbuvir:2
remdesivir ,galidesivir:2
remdesivir ,tenofovir:2
remdesivir ,sars-cov-2:14
remdesivir ,rna:4
sofosbuvir ,galidesivir:2
sofosbuvir ,tenofovir:2
sofosbuvir ,sars-cov-2:6
sofosbuvir ,rna:4
galidesivir ,tenofovir:2
galidesivir ,sars-cov-2:2
galidesivir ,rna:2
tenofovir ,sars-cov-2:2
tenofovir ,rna:2
passive ,immunity:2
passive ,coronavirus:2
passive ,disease:2
passive ,commentary:2
passive ,therapeutic:4
passive ,aspects:2
immunity ,coronavirus:6
immunity ,disease:4
immunity ,commentary:2
immunity ,therapeutic:2
immunity ,aspects:2
coronavirus ,commentary:2
disease ,commentary:2
disease ,aspects:6
commentary ,therapeutic:2
commentary ,aspects:2
therapeutic ,aspects:2
long-distance ,airborne:2
long-distance ,dispersal:2
long-distance ,sars-cov-2:2
long-distance ,covid-19:2
long-distance ,wards:2
airborne ,dispersal:2
airborne ,covid-19:10
airborne ,wards:2
dispersal ,sars-cov-2:2
dispersal ,wards:2
sars-cov-2 ,wards:4
covid-19 ,wards:4
strategies ,control:8
strategies ,caused:2
control ,pandemic:10
control ,caused:2
targeting ,receptors:2
targeting ,means:4
targeting ,reducing:2
targeting ,infectivity:2
targeting ,improving:2
sars-cov-2 ,means:2
sars-cov-2 ,reducing:8
sars-cov-2 ,improving:4
receptors ,means:2
receptors ,reducing:2
receptors ,infectivity:2
receptors ,improving:2
means ,reducing:2
means ,infectivity:2
means ,improving:2
reducing ,infectivity:2
reducing ,improving:2
infectivity ,improving:2
interplay ,type:2
interplay ,interferon:2
interplay ,response:2
type ,response:8
interferon ,response:4
co-infection ,dengue:4
co-infection ,clinical:4
co-infection ,challenge:2
dengue ,virus:4
dengue ,clinical:2
dengue ,challenge:2
virus ,challenge:2
clinical ,challenge:2
interrupting ,transmission:2
interrupting ,covid-19:2
interrupting ,lessons:2
interrupting ,containment:2
interrupting ,efforts:2
transmission ,lessons:4
transmission ,containment:2
transmission ,efforts:2
covid-19 ,efforts:8
lessons ,containment:2
lessons ,efforts:2
containment ,efforts:4
lower ,nasopharyngeal:2
lower ,viral:4
lower ,load:2
lower ,latest:2
lower ,phase:2
lower ,pandemic:2
nasopharyngeal ,viral:2
nasopharyngeal ,load:2
nasopharyngeal ,latest:2
nasopharyngeal ,phase:2
nasopharyngeal ,pandemic:2
viral ,latest:2
viral ,phase:2
viral ,pandemic:6
load ,latest:2
load ,phase:2
load ,pandemic:2
latest ,phase:2
phase ,pandemic:4
short-term ,dexamethasone:2
short-term ,sars-cov-2:4
short-term ,patients:4
dexamethasone ,sars-cov-2:2
dexamethasone ,patients:2
covid-19 ,disparate:2
covid-19 ,hispaniclatinx:2
pandemic ,disparate:2
pandemic ,hispaniclatinx:2
pandemic ,population:8
disparate ,health:2
disparate ,impact:2
disparate ,hispaniclatinx:2
disparate ,population:2
health ,hispaniclatinx:2
health ,population:8
impact ,hispaniclatinx:2
hispaniclatinx ,population:2
lung ,monitoring:2
lung ,infection:12
ultrasound ,monitoring:2
ultrasound ,infection:6
monitoring ,infection:4
treatment ,china:6
coronavirus ,sickle:2
coronavirus ,cell:6
coronavirus ,march:4
disease ,sickle:4
disease ,cell:4
disease ,united:6
disease ,states:4
disease ,march:2
among ,persons:2
among ,sickle:2
among ,cell:2
among ,united:2
among ,states:2
among ,march:6
persons ,sickle:2
persons ,cell:2
persons ,march:2
sickle ,cell:6
sickle ,united:2
sickle ,states:2
sickle ,march:2
cell ,united:2
cell ,states:2
cell ,march:2
united ,march:2
states ,march:2
bioinformatic ,analysis:6
bioinformatic ,indicates:2
bioinformatic ,sars-cov-2:4
bioinformatic ,unrelated:2
bioinformatic ,known:2
bioinformatic ,artificial:2
analysis ,indicates:2
analysis ,unrelated:2
analysis ,known:2
analysis ,artificial:2
indicates ,unrelated:2
indicates ,known:2
indicates ,artificial:2
sars-cov-2 ,unrelated:2
sars-cov-2 ,known:6
unrelated ,known:2
unrelated ,artificial:2
known ,artificial:2
rapid ,traditional:2
rapid ,chinese:2
rapid ,medicine:2
rapid ,prevention:2
rapid ,treatment:8
establishment ,traditional:2
establishment ,chinese:2
establishment ,medicine:2
establishment ,prevention:2
establishment ,treatment:2
traditional ,prevention:2
chinese ,prevention:2
medicine ,prevention:6
prevalence ,impact:4
prevalence ,cardiovascular:2
prevalence ,metabolic:2
prevalence ,diseases:2
prevalence ,china:4
impact ,cardiovascular:4
impact ,metabolic:2
impact ,diseases:8
cardiovascular ,metabolic:2
cardiovascular ,diseases:16
cardiovascular ,china:4
metabolic ,diseases:2
metabolic ,covid-19:10
metabolic ,china:2
diseases ,china:2
sars-cov-2 ,sodium:2
sars-cov-2 ,transport:10
sars-cov-2 ,diabolical:2
sodium ,transport:2
sodium ,diabolical:2
sodium ,strategy:2
transport ,diabolical:2
transport ,strategy:2
diabolical ,strategy:2
coronaviruses ,pandemics:2
coronaviruses ,can:2
coronaviruses ,help:2
pandemics ,can:2
pandemics ,neutralizing:2
pandemics ,antibodies:2
pandemics ,help:2
can ,neutralizing:2
can ,antibodies:2
neutralizing ,help:2
antibodies ,help:2
covid-19 ,agraphia:2
covid-19 ,conduction:2
covid-19 ,aphasia:2
presenting ,agraphia:2
presenting ,conduction:2
presenting ,aphasia:2
agraphia ,conduction:2
agraphia ,aphasia:2
agraphia ,patient:2
conduction ,aphasia:2
conduction ,patient:2
aphasia ,patient:2
evidence ,ocular:2
evidence ,surface:2
infection ,surface:2
infection ,sars-cov:8
infection ,2-pandemic:2
prevention ,anesthesiology:2
prevention ,2-pandemic:2
anesthesiology ,sars-cov:2
anesthesiology ,2-pandemic:2
sars-cov ,2-pandemic:2
blood ,nitrate:2
blood ,nitrite:2
blood ,modulating:2
blood ,nitric:2
blood ,oxide:2
blood ,bioavailability:2
blood ,potential:4
nitrate ,nitrite:2
nitrate ,modulating:2
nitrate ,nitric:2
nitrate ,oxide:2
nitrate ,bioavailability:2
nitrate ,potential:2
nitrite ,modulating:2
nitrite ,nitric:2
nitrite ,oxide:2
nitrite ,bioavailability:2
nitrite ,potential:2
modulating ,nitric:2
modulating ,oxide:2
modulating ,bioavailability:2
modulating ,potential:2
nitric ,oxide:8
nitric ,bioavailability:2
nitric ,potential:2
oxide ,bioavailability:2
oxide ,potential:2
bioavailability ,potential:2
endoplasmic ,potential:2
endoplasmic ,therapeutic:2
endoplasmic ,target:2
endoplasmic ,covid-19:2
endoplasmic ,infection:2
reticulum ,potential:2
reticulum ,therapeutic:2
reticulum ,target:2
reticulum ,covid-19:2
reticulum ,infection:2
potential ,target:16
one-step ,quantitative:4
one-step ,rt-pcr:2
one-step ,assay:4
one-step ,armored:2
one-step ,rna:2
one-step ,controls:2
one-step ,detection:2
quantitative ,armored:2
quantitative ,rna:2
quantitative ,controls:2
rt-pcr ,armored:2
rt-pcr ,rna:4
rt-pcr ,controls:2
assay ,armored:2
assay ,controls:2
armored ,rna:2
armored ,controls:2
armored ,detection:2
rna ,controls:2
controls ,detection:2
clinical ,critically:6
clinical ,ill:8
course ,critically:2
course ,ill:2
course ,patient:6
course ,severe:6
course ,acute:2
course ,respiratory:2
course ,syndrome:2
critically ,acute:8
critically ,respiratory:4
critically ,syndrome:2
ill ,acute:8
ill ,respiratory:4
ill ,syndrome:2
patient ,respiratory:6
patient ,syndrome:14
consensus ,recommendations:2
consensus ,care:4
consensus ,children:2
consensus ,receiving:2
consensus ,chronic:2
consensus ,dialysis:2
recommendations ,children:4
recommendations ,receiving:2
recommendations ,chronic:2
recommendations ,dialysis:2
care ,children:4
care ,receiving:2
care ,chronic:4
care ,dialysis:2
children ,receiving:2
children ,chronic:2
children ,dialysis:2
receiving ,chronic:2
receiving ,dialysis:2
chronic ,dialysis:2
nicotinic ,cholinergic:4
nicotinic ,system:4
nicotinic ,covid-19:4
nicotinic ,silico:2
nicotinic ,identification:2
cholinergic ,system:4
cholinergic ,covid-19:4
cholinergic ,silico:2
cholinergic ,identification:2
system ,silico:2
system ,identification:2
covid-19 ,silico:18
direct ,collateral:2
direct ,liver:2
direct ,damage:2
direct ,sars-cov-2-infected:2
collateral ,liver:2
collateral ,damage:4
collateral ,sars-cov-2-infected:2
collateral ,patients:4
liver ,damage:4
liver ,sars-cov-2-infected:2
damage ,sars-cov-2-infected:2
damage ,patients:10
sars-cov-2-infected ,patients:8
genome ,sequencing:14
genome ,diagnosis:2
genome ,africa:2
sequencing ,diagnosis:2
sequencing ,novel:2
sequencing ,coronavirus:4
sequencing ,africa:2
diagnosis ,africa:2
novel ,africa:2
coronavirus ,africa:6
overview ,disease:8
overview ,updates:2
overview ,advances:2
coronavirus ,updates:6
disease ,updates:6
disease ,advances:4
treatment ,updates:4
treatment ,advances:12
updates ,advances:2
evolution ,rna:2
evolution ,test:2
evolution ,results:2
severe ,results:6
respiratory ,test:6
respiratory ,results:6
syndrome ,test:2
syndrome ,results:2
coronavirus ,test:6
coronavirus ,results:4
rna ,test:4
test ,results:8
oropharyngeal ,secretion:2
oropharyngeal ,alternative:2
secretion ,alternative:2
secretion ,sars-cov-2:2
secretion ,detection:2
immune ,interferons:2
immune ,type:4
response ,interferons:2
sars-cov-2 ,interferons:10
infection ,role:32
infection ,interferons:8
role ,interferons:6
role ,type:8
covid-19 ,aprimer:2
covid-19 ,providers:4
aprimer ,healthcare:2
aprimer ,providers:2
healthcare ,providers:4
sars-cov-2 ,comes:2
sars-cov-2 ,knocking:2
sars-cov-2 ,lab:2
sars-cov-2 ,door:4
sars-cov-2 ,individual:4
sars-cov-2 ,scientists:2
sars-cov-2 ,experiences:2
comes ,knocking:2
comes ,lab:2
comes ,door:2
comes ,individual:2
comes ,scientists:2
comes ,experiences:2
knocking ,lab:2
knocking ,door:2
knocking ,individual:2
knocking ,scientists:2
knocking ,experiences:2
lab ,door:2
lab ,individual:2
lab ,scientists:2
lab ,experiences:2
door ,individual:2
door ,scientists:2
door ,experiences:2
individual ,scientists:2
individual ,experiences:2
scientists ,experiences:2
decoding ,sars-cov-2:4
decoding ,hijacking:2
decoding ,host:2
decoding ,mitochondria:2
decoding ,covid-19:4
decoding ,pathogenesis:2
sars-cov-2 ,hijacking:2
sars-cov-2 ,mitochondria:4
hijacking ,host:2
hijacking ,mitochondria:2
hijacking ,covid-19:2
hijacking ,pathogenesis:2
host ,mitochondria:4
host ,covid-19:18
host ,pathogenesis:2
mitochondria ,covid-19:6
mitochondria ,pathogenesis:4
responding ,whats:2
responding ,problem:2
covid-19 ,whats:4
covid-19 ,problem:4
whats ,problem:2
twin ,girls:2
twin ,infected:2
twin ,sars-cov-2:2
girls ,infected:2
girls ,sars-cov-2:2
can ,lipid:2
can ,arachidonic:2
can ,acid:2
can ,prevent:6
can ,ameliorate:2
bioactive ,lipid:2
bioactive ,arachidonic:2
bioactive ,acid:2
bioactive ,prevent:2
bioactive ,ameliorate:2
lipid ,arachidonic:2
lipid ,acid:2
lipid ,prevent:2
lipid ,ameliorate:2
lipid ,covid-19:8
arachidonic ,acid:2
arachidonic ,prevent:2
arachidonic ,ameliorate:2
arachidonic ,covid-19:2
acid ,prevent:2
acid ,ameliorate:2
prevent ,ameliorate:2
comparative ,bovine:2
comparative ,porcine:2
pathogenesis ,bovine:2
pathogenesis ,porcine:2
bovine ,porcine:2
bovine ,respiratory:2
bovine ,coronaviruses:2
porcine ,respiratory:2
porcine ,coronaviruses:2
respiratory ,coronaviruses:10
covid-19 ,pets:2
covid-19 ,animals:8
pandemic ,knowledge:6
pandemic ,pets:2
pandemic ,animals:2
current ,role:4
current ,pets:2
current ,animals:2
knowledge ,role:2
knowledge ,pets:2
knowledge ,animals:2
role ,pets:2
role ,animals:2
pets ,animals:2
targeting ,gut-lung:2
targeting ,microbiota:2
targeting ,axis:2
targeting ,high-fibre:2
targeting ,diet:2
targeting ,probiotics:2
gut-lung ,microbiota:2
gut-lung ,axis:2
gut-lung ,means:2
gut-lung ,high-fibre:2
gut-lung ,diet:2
gut-lung ,probiotics:2
microbiota ,axis:2
microbiota ,means:2
microbiota ,high-fibre:2
microbiota ,diet:2
microbiota ,probiotics:2
axis ,means:2
axis ,high-fibre:2
axis ,diet:2
axis ,probiotics:2
means ,high-fibre:2
means ,diet:2
means ,probiotics:2
high-fibre ,diet:2
high-fibre ,probiotics:2
diet ,probiotics:6
promising ,inhibitors:8
promising ,main:2
promising ,protease:2
promising ,novel:2
promising ,corona:2
promising ,virus:2
promising ,prevent:2
promising ,spread:2
inhibitors ,corona:2
inhibitors ,virus:4
inhibitors ,prevent:2
inhibitors ,spread:2
main ,corona:2
main ,virus:2
main ,prevent:2
main ,spread:2
protease ,corona:2
protease ,virus:2
protease ,prevent:2
protease ,spread:2
novel ,prevent:2
novel ,spread:4
corona ,prevent:2
corona ,spread:2
virus ,prevent:2
virus ,spread:4
prevent ,spread:4
surveillance ,among:2
surveillance ,frontline:2
surveillance ,health:8
surveillance ,care:2
surveillance ,workers:4
surveillance ,wuhan:2
sars-cov-2 ,frontline:6
infection ,frontline:4
among ,frontline:6
among ,health:32
among ,care:20
among ,wuhan:4
frontline ,health:8
frontline ,care:10
frontline ,wuhan:2
health ,wuhan:2
care ,wuhan:4
workers ,wuhan:2
testing ,systematic:6
testing ,review:12
testing ,guide:2
sars-cov-2 ,guide:2
systematic ,guide:2
review ,guide:2
clinical ,guide:2
early ,comprehensive:2
early ,testing:4
early ,essential:2
early ,protect:2
early ,trauma:4
early ,centers:4
comprehensive ,testing:2
comprehensive ,essential:2
comprehensive ,protect:2
comprehensive ,trauma:2
comprehensive ,centers:2
testing ,essential:2
testing ,protect:2
testing ,trauma:2
testing ,centers:4
covid-19 ,essential:10
covid-19 ,protect:12
covid-19 ,trauma:6
covid-19 ,centers:4
essential ,protect:2
essential ,trauma:2
essential ,centers:2
protect ,trauma:2
protect ,centers:2
trauma ,centers:2
covid-19 ,small:8
covid-19 ,bowel:18
coronavirus ,bowel:4
sars-cov-2 ,small:12
sars-cov-2 ,bowel:2
small ,bowel:2
can ,climatic:2
can ,factors:2
can ,differences:2
can ,incidence:2
can ,severity:4
climatic ,factors:6
climatic ,explain:2
climatic ,differences:2
climatic ,covid-19:4
climatic ,incidence:2
climatic ,severity:2
factors ,explain:2
factors ,differences:4
factors ,incidence:2
explain ,differences:2
explain ,covid-19:2
explain ,incidence:2
explain ,severity:2
differences ,incidence:2
differences ,severity:2
incidence ,severity:2
extensive ,meta-metagenomic:2
extensive ,search:2
extensive ,identifies:2
extensive ,sars-cov-2-homologous:2
extensive ,sequences:2
meta-metagenomic ,search:2
meta-metagenomic ,identifies:2
meta-metagenomic ,sars-cov-2-homologous:2
meta-metagenomic ,sequences:2
search ,identifies:2
search ,sars-cov-2-homologous:2
search ,sequences:2
identifies ,sars-cov-2-homologous:2
identifies ,sequences:2
sars-cov-2-homologous ,sequences:2
ocular ,features:2
ocular ,associated:2
ocular ,systemic:2
features ,associated:4
features ,systemic:2
associated ,systemic:2
associated ,findings:8
systemic ,findings:2
systemic ,sars-cov-2:8
systemic ,infection:4
bcg ,vaccination:18
bcg ,induce:2
bcg ,protective:2
bcg ,trained:2
bcg ,immunity:2
vaccination ,induce:2
vaccination ,protective:2
vaccination ,trained:2
vaccination ,immunity:2
induce ,protective:2
induce ,trained:2
induce ,immunity:2
induce ,sars-cov-2:4
protective ,trained:2
trained ,immunity:8
trained ,sars-cov-2:2
overview ,safety:2
overview ,application:2
overview ,antiviral:2
safety ,clinical:6
safety ,application:2
safety ,antiviral:6
safety ,research:2
clinical ,application:8
clinical ,antiviral:6
application ,research:4
clustering ,approach:2
clustering ,classify:2
clustering ,italian:2
clustering ,regions:2
clustering ,provinces:2
clustering ,based:2
clustering ,prevalence:2
approach ,classify:2
approach ,italian:2
approach ,regions:2
approach ,provinces:2
approach ,prevalence:2
classify ,italian:2
classify ,regions:2
classify ,provinces:2
classify ,based:2
classify ,prevalence:2
italian ,regions:4
italian ,provinces:2
italian ,based:2
italian ,prevalence:2
regions ,provinces:2
regions ,based:2
regions ,prevalence:2
provinces ,based:2
provinces ,prevalence:2
based ,prevalence:2
coronavirus ,lets:2
coronavirus ,prevent:4
coronavirus ,panic:2
covid-19 ,lets:4
covid-19 ,panic:6
lets ,prevent:2
lets ,panic:2
prevent ,panic:2
intrafamilial ,exposure:2
intrafamilial ,sars-cov-2:2
intrafamilial ,associated:2
intrafamilial ,cellular:2
intrafamilial ,immune:2
intrafamilial ,response:2
exposure ,associated:4
exposure ,cellular:2
exposure ,immune:4
exposure ,response:2
associated ,cellular:2
associated ,immune:4
associated ,response:4
cellular ,response:2
kidney ,infarction:2
neuromuscular ,presentations:2
neuromuscular ,patients:2
presentations ,patients:6
presentations ,covid-19:10
rapid ,inactivation:4
rapid ,deep-uv:2
rapid ,led:2
rapid ,irradiation:2
inactivation ,deep-uv:2
inactivation ,led:2
inactivation ,irradiation:2
sars-cov-2 ,deep-uv:2
sars-cov-2 ,led:2
sars-cov-2 ,irradiation:4
deep-uv ,led:2
deep-uv ,irradiation:2
led ,irradiation:2
chloroquine ,ace2:2
chloroquine ,blockers:2
chloroquine ,inhibit:4
chloroquine ,viropexis:2
hydroxychloroquine ,ace2:2
hydroxychloroquine ,blockers:2
hydroxychloroquine ,inhibit:2
hydroxychloroquine ,viropexis:2
ace2 ,blockers:2
ace2 ,inhibit:2
ace2 ,viropexis:2
blockers ,inhibit:2
blockers ,viropexis:2
inhibit ,viropexis:2
coronavirus ,membrane:2
coronavirus ,fusion:2
coronavirus ,mechanism:6
coronavirus ,offers:2
coronavirus ,target:4
membrane ,mechanism:2
membrane ,offers:2
membrane ,potential:2
membrane ,target:2
membrane ,antiviral:2
fusion ,mechanism:2
fusion ,offers:2
fusion ,potential:2
fusion ,target:2
fusion ,antiviral:2
mechanism ,offers:2
mechanism ,target:2
mechanism ,antiviral:4
offers ,potential:2
offers ,target:2
offers ,antiviral:2
target ,antiviral:6
cryopreservation ,ivf:2
cryopreservation ,time:2
cryopreservation ,covid-19:2
cryopreservation ,best:2
cryopreservation ,good:2
cryopreservation ,tissue:2
ivf ,time:2
ivf ,covid-19:4
ivf ,best:2
ivf ,good:2
ivf ,tissue:2
time ,best:2
time ,good:2
time ,tissue:2
covid-19 ,best:8
covid-19 ,good:6
covid-19 ,tissue:4
best ,good:2
best ,tissue:2
good ,tissue:2
targeting ,complement:4
targeting ,activation:4
complement ,activation:6
complement ,covid-19:16
activation ,covid-19:10
risks ,impact:2
risks ,angiotensin-converting:2
risks ,enzyme:2
risks ,inhibitors:2
risks ,angiotensin-receptor:2
impact ,angiotensin-converting:2
impact ,enzyme:2
impact ,inhibitors:2
impact ,angiotensin-receptor:2
angiotensin-converting ,inhibitors:12
angiotensin-converting ,angiotensin-receptor:4
enzyme ,inhibitors:14
enzyme ,angiotensin-receptor:4
inhibitors ,angiotensin-receptor:4
risk ,medical:4
risk ,staff:6
risk ,exposure:12
sars-cov-2 ,medical:14
sars-cov-2 ,staff:14
transmission ,medical:2
transmission ,staff:4
transmission ,patients:10
transmission ,exposure:2
medical ,exposure:2
staff ,exposure:4
patients ,exposure:4
snapshot ,sars-cov-2:4
snapshot ,genome:2
snapshot ,availability:2
snapshot ,april:2
snapshot ,implications:2
sars-cov-2 ,availability:2
genome ,availability:2
genome ,april:2
genome ,implications:2
availability ,april:2
availability ,implications:2
april ,implications:2
detection ,current:2
detection ,literature:4
detection ,future:2
detection ,perspectives:4
review ,future:4
review ,perspectives:4
literature ,future:2
literature ,perspectives:2
implications ,sarsr-cov:2
implications ,thalassemias:2
implications ,patients:6
implications ,fall:2
sarsr-cov ,infection:2
sarsr-cov ,thalassemias:2
sarsr-cov ,patients:2
sarsr-cov ,fall:2
infection ,thalassemias:2
infection ,fall:2
thalassemias ,patients:2
thalassemias ,fall:2
patients ,fall:2
antibody ,tests:16
antibody ,higher:2
antibody ,sensitivity:2
antibody ,15:2
antibody ,days:2
antibody ,symptom:2
antibody ,onset:2
antibody ,99:2
tests ,higher:2
tests ,sensitivity:2
tests ,15:2
tests ,days:2
tests ,symptom:2
tests ,onset:2
tests ,99:2
higher ,sensitivity:2
higher ,15:2
higher ,days:2
higher ,symptom:2
higher ,onset:2
higher ,99:2
sensitivity ,15:2
sensitivity ,days:2
sensitivity ,symptom:2
sensitivity ,onset:2
sensitivity ,99:2
15 ,days:2
15 ,symptom:2
15 ,onset:2
15 ,99:2
days ,symptom:2
days ,99:2
symptom ,onset:4
symptom ,99:2
onset ,99:2
study ,medication:4
study ,regularity:2
study ,traditional:8
study ,chinese:8
study ,medicine:6
medication ,regularity:2
medication ,traditional:2
medication ,chinese:2
medication ,medicine:2
medication ,treatment:4
regularity ,traditional:2
regularity ,chinese:2
regularity ,medicine:2
regularity ,treatment:2
status ,ent:2
status ,health:2
status ,care:2
status ,workers:2
status ,forefront:2
status ,fighting:2
ent ,health:2
ent ,care:2
ent ,workers:2
ent ,forefront:2
ent ,fighting:2
health ,forefront:2
health ,fighting:2
care ,forefront:2
care ,fighting:2
workers ,forefront:2
workers ,fighting:2
forefront ,fighting:2
forefront ,covid-19:2
acute ,myelitis:4
acute ,new:8
acute ,etiology:2
myelitis ,sars-cov-2:2
myelitis ,infection:2
myelitis ,new:2
myelitis ,etiology:2
sars-cov-2 ,etiology:2
infection ,etiology:2
new ,etiology:2
sars-cov-2 ,predictor:4
sars-cov-2 ,neuroinflammation:2
sars-cov-2 ,neurodegeneration:2
covid-19 ,neuroinflammation:4
covid-19 ,neurodegeneration:2
predictor ,neuroinflammation:2
predictor ,neurodegeneration:2
neuroinflammation ,neurodegeneration:2
anesthesia ,protection:2
anesthesia ,emergency:4
anesthesia ,cesarean:4
anesthesia ,section:4
anesthesia ,pregnant:2
anesthesia ,woman:2
protection ,emergency:2
protection ,cesarean:2
protection ,section:2
protection ,pregnant:2
protection ,woman:2
emergency ,pregnant:2
emergency ,woman:2
cesarean ,pregnant:2
cesarean ,woman:2
section ,pregnant:2
section ,woman:2
forensic ,dna:2
forensic ,testing:2
forensic ,sars-cov-2:4
forensic ,pandemic:4
dna ,testing:2
dna ,pandemic:2
perceived ,infection:2
perceived ,transmission:2
perceived ,routes:2
perceived ,control:2
perceived ,practices:2
perceived ,psychosocial:2
infection ,routes:4
infection ,psychosocial:2
transmission ,practices:2
transmission ,psychosocial:2
routes ,control:2
routes ,practices:2
routes ,psychosocial:2
control ,psychosocial:2
practices ,psychosocial:2
severe ,sars-cov:2
acute ,sars-cov:2
syndrome ,sars-cov:2
potential ,ageusia:2
potential ,anosmia:2
pathogenesis ,ageusia:2
pathogenesis ,anosmia:2
ageusia ,anosmia:8
ageusia ,covid-19:8
ageusia ,patients:2
anosmia ,patients:2
message ,human:2
message ,placenta:2
message ,structural:2
message ,immunomodulatory:2
message ,defense:2
human ,placenta:6
human ,structural:4
human ,immunomodulatory:2
human ,defense:2
placenta ,structural:2
placenta ,immunomodulatory:2
placenta ,defense:2
structural ,immunomodulatory:2
structural ,defense:2
immunomodulatory ,defense:2
prolonged ,course:2
prolonged ,covid-19:14
prolonged ,person:2
prolonged ,dementia:2
course ,covid-19:44
course ,person:2
course ,dementia:2
covid-19 ,person:2
covid-19 ,dementia:4
person ,dementia:2
integrated ,drug:2
integrated ,repurposing:2
integrated ,strategy:4
integrated ,rapid:2
integrated ,identification:2
integrated ,potential:2
drug ,strategy:4
drug ,rapid:2
repurposing ,strategy:2
repurposing ,rapid:4
strategy ,rapid:2
strategy ,identification:2
hyperglycemia ,hydroxychloroquine:2
hyperglycemia ,covid-19:6
hyperglycemia ,pandemic:2
hydroxychloroquine ,pandemic:2
cutaneous ,manifestations:26
cutaneous ,21st:2
cutaneous ,century:2
cutaneous ,worldwide:2
cutaneous ,fungal:2
cutaneous ,epidemic:2
cutaneous ,possibly:2
manifestations ,21st:2
manifestations ,century:2
manifestations ,worldwide:2
manifestations ,fungal:2
manifestations ,epidemic:2
manifestations ,possibly:2
21st ,worldwide:2
21st ,fungal:2
21st ,epidemic:2
21st ,possibly:2
century ,worldwide:2
century ,fungal:2
century ,epidemic:2
century ,possibly:2
worldwide ,fungal:2
worldwide ,epidemic:4
worldwide ,possibly:2
fungal ,epidemic:2
fungal ,possibly:2
epidemic ,possibly:2
covid-19 ,mathematical:10
covid-19 ,forecasting:10
covid-19 ,delhi:2
tuberculosis ,mathematical:2
tuberculosis ,model:2
tuberculosis ,based:2
tuberculosis ,forecasting:2
tuberculosis ,delhi:2
tuberculosis ,india:4
mathematical ,based:2
mathematical ,forecasting:2
mathematical ,delhi:2
mathematical ,india:2
model ,based:8
model ,forecasting:2
model ,delhi:2
model ,india:2
based ,forecasting:4
based ,delhi:2
based ,india:2
forecasting ,delhi:2
forecasting ,india:2
delhi ,india:2
conserved ,hla:2
conserved ,peptides:2
conserved ,five:2
conserved ,non-structural:2
conserved ,proteins:2
conserved ,sars-cov-2-an:2
hla ,binding:4
hla ,peptides:4
hla ,five:2
hla ,non-structural:2
hla ,proteins:2
hla ,sars-cov-2-an:2
binding ,peptides:4
binding ,five:2
binding ,non-structural:2
binding ,proteins:4
binding ,sars-cov-2-an:2
peptides ,five:2
peptides ,non-structural:2
peptides ,proteins:2
peptides ,sars-cov-2-an:2
five ,non-structural:2
five ,proteins:2
five ,sars-cov-2-an:2
non-structural ,proteins:2
non-structural ,sars-cov-2-an:2
proteins ,sars-cov-2-an:2
azithromycin ,prompt:2
azithromycin ,early:2
azithromycin ,use:2
azithromycin ,first:2
azithromycin ,signs:2
covid-19 ,prompt:2
covid-19 ,signs:4
prompt ,early:2
prompt ,use:2
prompt ,first:2
prompt ,signs:2
prompt ,infection:2
early ,use:6
early ,first:4
early ,signs:2
use ,first:8
use ,signs:2
use ,infection:10
first ,signs:2
signs ,infection:2
acute ,gouty:2
acute ,arthritis:2
acute ,favipiravir:2
acute ,treatment:18
gouty ,arthritis:2
gouty ,favipiravir:2
gouty ,treatment:2
gouty ,coronavirus:2
gouty ,disease:2
arthritis ,favipiravir:2
arthritis ,treatment:2
arthritis ,coronavirus:2
arthritis ,disease:2
favipiravir ,coronavirus:4
favipiravir ,disease:2
covid-19 ,psychotic:4
covid-19 ,relapse:4
associated ,psychotic:2
associated ,relapse:2
severe ,psychotic:2
severe ,relapse:2
psychotic ,relapse:2
switch ,oral:2
switch ,anticoagulants:2
switch ,parenteral:2
switch ,heparin:2
switch ,hospitalized:2
oral ,anticoagulants:2
oral ,parenteral:2
oral ,heparin:2
oral ,sars-cov-2:16
oral ,hospitalized:2
anticoagulants ,parenteral:2
anticoagulants ,heparin:2
anticoagulants ,sars-cov-2:2
anticoagulants ,hospitalized:2
parenteral ,heparin:2
parenteral ,sars-cov-2:4
parenteral ,hospitalized:2
heparin ,sars-cov-2:2
heparin ,hospitalized:2
angiotensin-converting ,ace2:8
angiotensin-converting ,sars-cov-2:12
angiotensin-converting ,pathophysiology:2
enzyme ,ace2:14
enzyme ,sars-cov-2:10
enzyme ,pathophysiology:2
ace2 ,pathophysiology:2
spillover ,sars-cov-2:2
spillover ,novel:2
spillover ,wild:2
spillover ,hosts:2
spillover ,north:2
spillover ,america:2
spillover ,conceptual:2
spillover ,model:2
sars-cov-2 ,wild:4
sars-cov-2 ,conceptual:2
novel ,wild:2
novel ,hosts:4
novel ,north:2
novel ,america:4
novel ,conceptual:2
wild ,hosts:2
wild ,north:2
wild ,america:2
wild ,conceptual:2
wild ,model:2
hosts ,north:2
hosts ,america:2
hosts ,conceptual:2
hosts ,model:2
north ,conceptual:2
north ,model:2
america ,conceptual:2
america ,model:2
conceptual ,model:4
venous ,thrombotic:2
venous ,risk:4
venous ,related:2
venous ,sars-cov-2:4
venous ,prevalence:4
venous ,recommendations:2
thrombotic ,risk:4
thrombotic ,related:2
thrombotic ,sars-cov-2:2
thrombotic ,prevalence:2
thrombotic ,recommendations:2
risk ,related:4
risk ,prevalence:6
risk ,recommendations:6
related ,prevalence:2
related ,recommendations:2
prevalence ,recommendations:2
facts ,reflections:2
facts ,anti-hypertensives:2
facts ,drugs:2
reflections ,covid-19:4
reflections ,anti-hypertensives:2
reflections ,drugs:2
covid-19 ,anti-hypertensives:2
anti-hypertensives ,drugs:2
role ,lipid:4
role ,metabolism:2
role ,target:4
lipid ,metabolism:2
lipid ,virus:4
lipid ,infection:2
lipid ,drug:2
lipid ,target:2
metabolism ,covid-19:4
metabolism ,virus:2
metabolism ,infection:4
metabolism ,drug:2
metabolism ,target:2
virus ,target:4
infection ,drug:8
preventing ,transmission:12
preventing ,rehabilitation:2
preventing ,pools:2
preventing ,therapeutic:2
preventing ,water:2
sars-cov-2 ,pools:4
transmission ,rehabilitation:4
transmission ,pools:2
transmission ,therapeutic:6
transmission ,water:8
rehabilitation ,pools:2
rehabilitation ,therapeutic:2
rehabilitation ,water:2
pools ,therapeutic:2
pools ,water:2
therapeutic ,water:2
dynamics ,model:4
dynamics ,two:2
dynamics ,modes:2
infection ,modes:2
model ,two:2
model ,modes:2
model ,immune:4
two ,modes:2
two ,immune:4
modes ,immune:2
transmission ,immune:2
samples ,may:2
samples ,escape:2
samples ,single:2
samples ,point:2
samples ,mutation:2
may ,escape:2
may ,detection:2
may ,single:2
may ,point:2
may ,mutation:2
escape ,single:2
escape ,point:2
escape ,mutation:2
detection ,single:2
detection ,point:2
detection ,mutation:2
single ,point:2
single ,mutation:2
point ,mutation:4
possible ,endocrine-metabolic:2
possible ,lesson:2
long-term ,endocrine-metabolic:2
long-term ,complications:2
long-term ,lesson:2
endocrine-metabolic ,complications:2
endocrine-metabolic ,covid-19:2
endocrine-metabolic ,lesson:2
complications ,lesson:2
new ,vaccine:4
new ,recombinant:2
new ,bcg:2
new ,answer:2
disease ,old:2
disease ,vaccine:12
disease ,recombinant:2
disease ,bcg:2
disease ,answer:2
old ,vaccine:2
old ,recombinant:2
old ,bcg:2
old ,answer:2
vaccine ,recombinant:2
vaccine ,answer:2
recombinant ,bcg:2
recombinant ,answer:2
bcg ,answer:2
bcg ,covid-19:22
answer ,covid-19:2
coronavirus ,cat:2
coronavirus ,flea:2
coronavirus ,questions:2
coronavirus ,regarding:2
cat ,flea:2
cat ,findings:2
cat ,questions:2
cat ,regarding:2
cat ,covid-19:2
flea ,findings:2
flea ,questions:2
flea ,regarding:2
flea ,covid-19:2
findings ,questions:2
findings ,regarding:4
questions ,regarding:2
regarding ,covid-19:12
weakness ,elevated:2
weakness ,creatinine:2
weakness ,kinase:2
weakness ,initial:2
weakness ,presentation:2
weakness ,coronavirus:2
elevated ,creatinine:2
elevated ,kinase:2
elevated ,initial:4
elevated ,presentation:2
elevated ,coronavirus:2
creatinine ,kinase:2
creatinine ,initial:2
creatinine ,presentation:2
creatinine ,coronavirus:2
kinase ,initial:2
kinase ,presentation:2
kinase ,coronavirus:2
initial ,presentation:10
presentation ,coronavirus:8
recovery ,covid-19:30
recovery ,b-cell-depleted:2
recovery ,multiple:2
recovery ,sclerosis:2
recovery ,patient:8
covid-19 ,b-cell-depleted:4
b-cell-depleted ,multiple:2
b-cell-depleted ,sclerosis:2
b-cell-depleted ,patient:2
multiple ,patient:6
sclerosis ,patient:4
evidence ,possible:4
evidence ,mechanisms:2
evidence ,rare:2
evidence ,maternal-fetal:2
possible ,maternal-fetal:2
mechanisms ,rare:2
mechanisms ,maternal-fetal:2
mechanisms ,transmission:8
rare ,maternal-fetal:2
rare ,transmission:2
rare ,sars-cov-2:6
maternal-fetal ,transmission:2
maternal-fetal ,sars-cov-2:2
reduced ,prevalence:2
reduced ,sars-cov-2:4
reduced ,infection:2
reduced ,abo:2
reduced ,blood:2
reduced ,group:2
prevalence ,abo:2
prevalence ,blood:6
prevalence ,group:4
sars-cov-2 ,abo:4
sars-cov-2 ,group:8
infection ,abo:6
infection ,group:6
abo ,blood:8
abo ,group:6
blood ,group:10
contamination ,inside:2
contamination ,ct:2
contamination ,gantry:2
contamination ,era:2
inside ,ct:2
inside ,gantry:2
inside ,sars-cov-2:6
inside ,era:2
ct ,gantry:2
ct ,era:2
gantry ,sars-cov-2:2
gantry ,era:2
treatment ,reached:2
sars-cov-2 ,far:8
sars-cov-2 ,reached:2
far ,reached:2
covid-19 ,severely:4
covid-19 ,immunosuppressed:2
covid-19 ,life-threatening:2
covid-19 ,eosinophilic:2
severely ,immunosuppressed:2
severely ,patient:2
severely ,life-threatening:2
severely ,eosinophilic:2
immunosuppressed ,patient:4
immunosuppressed ,life-threatening:2
immunosuppressed ,eosinophilic:2
patient ,life-threatening:2
patient ,eosinophilic:2
life-threatening ,eosinophilic:2
clinical ,sequelae:2
clinical ,predispose:2
sequelae ,novel:2
sequelae ,coronavirus:2
sequelae ,covid-19:4
sequelae ,infection:2
sequelae ,predispose:2
novel ,predispose:2
coronavirus ,predispose:2
covid-19 ,predispose:2
infection ,predispose:2
ongoing ,challenges:4
ongoing ,faced:2
ongoing ,global:4
ongoing ,control:2
challenges ,faced:2
challenges ,global:4
faced ,global:2
faced ,control:2
faced ,covid-19:2
faced ,pandemic:2
global ,control:4
acute ,chronic:6
acute ,liver:6
chronic ,liver:4
chronic ,failure:2
chronic ,novel:4
chronic ,severe:2
chronic ,respiratory:4
chronic ,syndrome:2
liver ,novel:6
liver ,severe:12
liver ,respiratory:4
liver ,syndrome:2
failure ,severe:8
failure ,syndrome:2
cohort ,four:2
cohort ,thousand:2
cohort ,hundred:2
cohort ,persons:2
cohort ,investigation:2
cohort ,covid-19:16
four ,thousand:2
four ,hundred:2
four ,persons:2
four ,investigation:2
thousand ,hundred:2
thousand ,persons:2
thousand ,investigation:2
thousand ,covid-19:2
hundred ,persons:2
hundred ,investigation:2
hundred ,covid-19:2
persons ,investigation:2
pathogen ,reduction:2
pathogen ,sars-cov-2:6
pathogen ,virus:2
pathogen ,plasma:2
pathogen ,whole:2
pathogen ,blood:2
pathogen ,using:2
pathogen ,riboflavin:2
reduction ,sars-cov-2:6
reduction ,virus:2
reduction ,plasma:2
reduction ,whole:2
reduction ,blood:2
reduction ,using:4
reduction ,riboflavin:2
sars-cov-2 ,plasma:12
sars-cov-2 ,whole:10
sars-cov-2 ,riboflavin:2
virus ,whole:4
virus ,blood:2
virus ,riboflavin:2
plasma ,whole:2
plasma ,blood:2
plasma ,using:8
plasma ,riboflavin:2
whole ,blood:2
whole ,using:6
whole ,riboflavin:2
blood ,using:4
blood ,riboflavin:2
using ,riboflavin:2
essential ,antiviral:2
essential ,agents:2
essential ,potential:4
essential ,treat:2
essential ,sars-cov-2:8
oils ,antiviral:2
oils ,agents:2
oils ,potential:2
oils ,treat:2
oils ,sars-cov-2:2
antiviral ,treat:2
agents ,sars-cov-2:4
antibodies ,potential:4
antibodies ,passive:2
antibodies ,immunization:2
sars-cov-2 ,passive:4
sars-cov-2 ,immunization:4
potential ,passive:2
potential ,immunization:2
therapeutic ,immunization:2
passive ,immunization:4
cytologic ,molecular:2
cytologic ,correlates:2
cytologic ,sars-cov-2:2
cytologic ,infection:2
cytologic ,nasopharynx:2
molecular ,correlates:2
molecular ,nasopharynx:2
correlates ,sars-cov-2:12
correlates ,infection:2
correlates ,nasopharynx:2
infection ,nasopharynx:2
covid-19 ,young:12
covid-19 ,arthroplasty:10
covid-19 ,surgeons:8
impact ,young:2
impact ,arthroplasty:2
impact ,surgeons:2
young ,arthroplasty:2
young ,surgeons:2
arthroplasty ,surgeons:2
sars-cov-2 ,asthmatic:2
pneumonia ,hospitalized:4
pneumonia ,asthmatic:4
pneumonia ,induce:2
hospitalized ,asthmatic:2
hospitalized ,induce:2
hospitalized ,severe:4
asthmatic ,patients:4
asthmatic ,induce:2
asthmatic ,severe:2
patients ,induce:2
induce ,severe:2
molecular ,mechanism:16
molecular ,evolution:2
mechanism ,evolution:2
evolution ,human:2
serum ,nucleocapsid:2
serum ,protein:2
serum ,sensitivity:2
serum ,specificity:2
serum ,early:2
sars-cov-2 ,sensitivity:14
sars-cov-2 ,specificity:6
nucleocapsid ,protein:14
nucleocapsid ,specificity:2
nucleocapsid ,early:2
protein ,sensitivity:2
protein ,specificity:2
protein ,early:2
sensitivity ,specificity:8
sensitivity ,early:2
specificity ,early:2
adamantanes ,might:2
adamantanes ,protective:2
adamantanes ,covid-19:2
adamantanes ,patients:2
adamantanes ,neurological:2
might ,protective:2
might ,patients:2
might ,neurological:2
protective ,patients:4
protective ,neurological:2
clinical ,13:2
features ,13:2
features ,cases:12
children ,13:2
sars-cov-2 ,13:2
infection ,13:2
analysis ,13:2
13 ,cases:2
similarities ,cutaneous:2
similarities ,histopathological:4
similarities ,patterns:2
similarities ,covid-19-positive:2
cutaneous ,histopathological:2
cutaneous ,patterns:2
cutaneous ,covid-19-positive:2
histopathological ,patterns:2
histopathological ,covid-19-positive:2
patterns ,covid-19-positive:2
severe ,travelers:2
severe ,vietnam:2
acute ,travelers:2
acute ,vietnam:2
respiratory ,travelers:2
respiratory ,vietnam:2
syndrome ,travelers:2
syndrome ,vietnam:2
coronavirus ,travelers:2
coronavirus ,vietnam:4
shedding ,travelers:2
shedding ,vietnam:2
travelers ,vietnam:2
identification ,additional:2
identification ,respiratory:4
identification ,pathogens:2
identification ,cases:2
sars-cov-2 ,additional:2
additional ,respiratory:2
additional ,pathogens:2
additional ,cases:2
respiratory ,cases:14
pathogens ,cases:4
sars-cov-2 ,perturbs:2
sars-cov-2 ,renin-angiotensin:6
sars-cov-2 ,energy:2
sars-cov-2 ,metabolism:2
perturbs ,renin-angiotensin:2
perturbs ,system:2
perturbs ,energy:2
perturbs ,metabolism:2
renin-angiotensin ,energy:2
renin-angiotensin ,metabolism:2
system ,energy:2
system ,metabolism:4
energy ,metabolism:2
managing ,pandemic:8
managing ,national:2
managing ,radiation:2
managing ,oncology:2
managing ,centre:4
managing ,singapore:2
covid-19 ,national:16
covid-19 ,oncology:14
covid-19 ,centre:8
pandemic ,national:4
pandemic ,radiation:4
pandemic ,oncology:10
pandemic ,centre:4
national ,radiation:2
national ,oncology:2
national ,centre:2
national ,singapore:2
radiation ,oncology:8
radiation ,centre:2
radiation ,singapore:2
oncology ,centre:2
oncology ,singapore:2
centre ,singapore:2
recurrent ,acute:2
recurrent ,pancreatitis:2
recurrent ,patient:4
recurrent ,covid-19:4
recurrent ,infection:4
pancreatitis ,covid-19:6
pancreatitis ,infection:2
surgery ,times:2
surgery ,covid-19-recommendations:2
surgery ,hospital:2
surgery ,patient:2
surgery ,management:8
times ,covid-19-recommendations:2
times ,hospital:2
times ,patient:2
times ,management:2
covid-19-recommendations ,hospital:2
covid-19-recommendations ,patient:2
covid-19-recommendations ,management:2
hospital ,patient:4
patient ,management:18
analysis ,patent:2
analysis ,information:2
analysis ,sharing:2
traditional ,information:2
traditional ,sharing:2
traditional ,platform:2
chinese ,information:2
chinese ,sharing:2
chinese ,platform:2
medicine ,information:2
medicine ,sharing:2
medicine ,platform:2
patent ,information:2
patent ,sharing:2
patent ,platform:2
information ,sharing:2
information ,platform:2
sharing ,platform:2
ischemic-hemorrhagic ,stroke:2
ischemic-hemorrhagic ,patients:2
ischemic-hemorrhagic ,covid-19:2
stroke ,patients:14
rapid ,visual:2
rapid ,reverse:4
visual ,detection:6
visual ,novel:2
visual ,sars-cov-2:6
visual ,reverse:2
novel ,reverse:4
coronavirus ,reverse:6
sars-cov-2 ,reverse:12
clinical ,presentation:20
presentation ,outcomes:4
presentation ,hospitalized:2
presentation ,adults:2
outcomes ,adults:4
hospitalized ,adults:2
coronavirus ,neonate:2
coronavirus ,neonatologist:2
coronavirus ,need:8
disease ,neonate:2
disease ,neonatologist:2
disease ,need:6
covid-19 ,neonate:4
covid-19 ,neonatologist:2
neonate ,neonatologist:2
neonate ,need:2
neonate ,know:2
neonatologist ,need:2
neonatologist ,know:2
antiviral ,type:6
antiviral ,ii:2
antiviral ,iii:2
antiviral ,interferons:6
antiviral ,counterbalances:2
antiviral ,ace2:2
activity ,type:2
activity ,ii:2
activity ,iii:2
activity ,interferons:2
activity ,counterbalances:2
activity ,ace2:2
type ,ii:2
type ,iii:10
type ,counterbalances:2
type ,ace2:4
ii ,iii:2
ii ,interferons:2
ii ,counterbalances:2
iii ,interferons:8
iii ,counterbalances:2
iii ,ace2:2
interferons ,counterbalances:2
interferons ,ace2:2
counterbalances ,ace2:2
involvement ,sars-cov-2:4
involvement ,infection:12
advances ,challenges:4
advances ,prevention:4
challenges ,prevention:2
pre-exposure ,sars-cov-2:2
pre-exposure ,pandemic:2
pre-exposure ,can:2
pre-exposure ,prep:2
pre-exposure ,prevent:2
prophylaxis ,sars-cov-2:4
prophylaxis ,pandemic:2
prophylaxis ,can:4
prophylaxis ,prep:2
prophylaxis ,prevent:4
sars-cov-2 ,prep:2
pandemic ,prep:2
pandemic ,prevent:2
can ,prep:2
prep ,prevent:2
influenza-associated ,pneumonia:2
influenza-associated ,reference:2
influenza-associated ,assess:2
influenza-associated ,seriousness:2
influenza-associated ,coronavirus:2
pneumonia ,reference:2
pneumonia ,assess:2
pneumonia ,seriousness:2
reference ,assess:2
reference ,seriousness:2
reference ,coronavirus:2
assess ,seriousness:2
assess ,coronavirus:2
seriousness ,coronavirus:2
increased ,expression:2
increased ,cd8:2
increased ,marker:2
increased ,t-cells:2
increased ,covid-19:14
increased ,patients:8
expression ,cd8:2
expression ,marker:2
expression ,t-cells:2
cd8 ,marker:2
cd8 ,t-cells:2
marker ,t-cells:2
marker ,covid-19:8
marker ,patients:8
t-cells ,covid-19:2
t-cells ,patients:2
phylogenetic ,network:2
phylogenetic ,genomes:2
network ,sars-cov-2:16
network ,genomes:2
analysis ,genomes:6
sars-cov-2 ,regulate:2
sars-cov-2 ,depletion:2
may ,regulate:2
may ,cellular:2
may ,responses:2
may ,depletion:2
may ,host:4
regulate ,cellular:2
regulate ,responses:2
regulate ,depletion:2
regulate ,specific:2
regulate ,host:2
cellular ,responses:2
cellular ,depletion:2
cellular ,specific:2
responses ,depletion:2
responses ,specific:10
responses ,host:2
depletion ,specific:2
depletion ,host:2
specific ,host:2
pandemic ,pathophysiology:2
pandemic ,manifestations:4
pandemic ,gastrointestinal:4
pathophysiology ,manifestations:2
pathophysiology ,gastrointestinal:2
effectiveness ,personal:2
effectiveness ,protective:4
effectiveness ,equipment:4
effectiveness ,preventing:4
personal ,equipment:24
personal ,preventing:2
personal ,severe:2
personal ,acute:2
protective ,equipment:26
protective ,preventing:2
protective ,severe:4
protective ,acute:4
equipment ,preventing:2
equipment ,severe:2
equipment ,acute:2
preventing ,severe:2
preventing ,acute:2
contact ,coronavirus:4
contact ,disease:2
contact ,outbreak:2
contact ,south:2
contact ,korea:2
tracing ,coronavirus:4
tracing ,disease:2
tracing ,outbreak:2
tracing ,south:2
tracing ,korea:2
outbreak ,korea:4
stopping ,sars-cov-2:2
stopping ,surge:2
stopping ,usa-cdc:2
stopping ,recommendations:2
stopping ,ground:2
stopping ,realities:2
sars-cov-2 ,surge:2
sars-cov-2 ,usa-cdc:2
sars-cov-2 ,realities:2
surge ,usa-cdc:2
surge ,recommendations:2
surge ,ground:2
surge ,realities:2
usa-cdc ,recommendations:2
usa-cdc ,ground:2
usa-cdc ,realities:2
recommendations ,ground:2
recommendations ,realities:2
ground ,realities:2
personal ,current:2
personal ,best:2
personal ,practices:2
personal ,orthopedic:2
personal ,teams:2
protective ,current:2
protective ,best:2
protective ,practices:2
protective ,orthopedic:4
protective ,teams:2
equipment ,current:2
equipment ,best:2
equipment ,practices:2
equipment ,orthopedic:2
equipment ,teams:2
current ,best:2
current ,practices:2
current ,orthopedic:2
current ,teams:2
best ,orthopedic:2
best ,teams:2
practices ,orthopedic:4
practices ,teams:2
orthopedic ,teams:2
primary ,stratification:2
primary ,identification:2
primary ,suspected:2
primary ,corona:2
primary ,virus:2
primary ,disease:2
stratification ,identification:2
stratification ,corona:2
stratification ,virus:2
stratification ,disease:2
identification ,suspected:2
identification ,corona:2
identification ,virus:2
suspected ,corona:4
suspected ,virus:4
suspected ,disease:2
corona ,disease:12
virus ,disease:22
collateral ,benefit:2
collateral ,covid-19:6
collateral ,control:2
collateral ,measures:2
collateral ,influenza:2
collateral ,activity:2
collateral ,taiwan:2
benefit ,covid-19:4
benefit ,control:2
benefit ,measures:2
benefit ,influenza:2
benefit ,activity:2
benefit ,taiwan:2
control ,activity:2
control ,taiwan:2
measures ,activity:2
influenza ,activity:4
influenza ,taiwan:2
activity ,taiwan:4
time-lapse ,sentinel:2
time-lapse ,surveillance:2
time-lapse ,sars-cov-2:2
time-lapse ,spread:2
time-lapse ,india:2
sentinel ,surveillance:2
sentinel ,sars-cov-2:2
sentinel ,spread:2
sentinel ,india:2
surveillance ,spread:2
spread ,india:4
diabetes ,infection:12
diabetes ,risk:14
systemic ,review:6
systemic ,vertical:2
systemic ,transmission:2
systemic ,possibility:2
systemic ,pregnant:2
systemic ,women:2
review ,vertical:4
review ,possibility:2
review ,pregnant:8
review ,women:8
vertical ,possibility:4
vertical ,pregnant:8
vertical ,women:4
transmission ,possibility:6
transmission ,pregnant:6
transmission ,women:2
possibility ,pregnant:4
possibility ,women:4
clinical ,real-time:4
clinical ,reverse:4
clinical ,transcription:2
clinical ,assay:12
validation ,sars-cov-2:20
validation ,real-time:2
validation ,reverse:4
validation ,transcription:4
validation ,pcr:4
validation ,assay:12
sars-cov-2 ,transcription:4
real-time ,assay:10
reverse ,assay:4
transcription ,assay:2
pcr ,assay:12
clinical ,140:2
characteristics ,140:2
140 ,patients:2
140 ,infected:2
140 ,sars-cov-2:2
140 ,wuhan:2
140 ,china:2
infected ,wuhan:2
infected ,china:2
hiv ,human:2
hiv ,coinfections:2
hiv ,historical:2
hiv ,perspective:2
human ,coinfections:2
human ,historical:2
coronavirus ,coinfections:2
coronavirus ,historical:4
coinfections ,historical:2
coinfections ,perspective:2
historical ,perspective:4
anterior ,acute:2
anterior ,uveitis:2
anterior ,report:2
anterior ,sars-cov-2:2
anterior ,patient:2
anterior ,managed:2
anterior ,adjunctive:2
acute ,uveitis:2
acute ,managed:2
uveitis ,report:2
uveitis ,sars-cov-2:4
uveitis ,patient:2
uveitis ,managed:2
uveitis ,adjunctive:2
report ,managed:2
report ,adjunctive:2
sars-cov-2 ,managed:4
sars-cov-2 ,adjunctive:4
patient ,managed:2
patient ,adjunctive:2
managed ,adjunctive:2
severe ,overview:4
severe ,viral:10
acute ,overview:4
acute ,viral:10
respiratory ,overview:4
respiratory ,viral:22
syndrome ,overview:2
syndrome ,viral:6
overview ,viral:2
novel ,disguise:2
coronavirus ,disguise:2
2019-ncov ,disguise:2
vitro ,microneutralization:2
vitro ,assay:2
vitro ,serology:2
vitro ,drug:6
vitro ,screening:6
microneutralization ,assay:2
microneutralization ,sars-cov-2:2
microneutralization ,serology:2
microneutralization ,drug:2
microneutralization ,screening:2
assay ,serology:4
assay ,drug:2
assay ,screening:2
serology ,drug:2
serology ,screening:2
drug ,screening:10
persistent ,infection:6
persistent ,risk:2
persistent ,cancer:2
risk ,cancer:12
angiotensin-converting ,severe:6
angiotensin-converting ,acute:4
angiotensin-converting ,respiratory:4
angiotensin-converting ,syndrome:2
angiotensin-converting ,coronavirus:8
enzyme ,severe:6
enzyme ,acute:4
enzyme ,respiratory:4
enzyme ,syndrome:2
enzyme ,coronavirus:10
italian ,society:10
italian ,interventional:2
italian ,cardiology:2
italian ,gise:2
italian ,position:4
italian ,paper:4
italian ,cath:2
society ,interventional:2
society ,cardiology:2
society ,gise:2
society ,position:6
society ,paper:4
society ,cath:2
interventional ,cardiology:2
interventional ,gise:2
interventional ,position:2
interventional ,paper:2
interventional ,cath:2
cardiology ,gise:2
cardiology ,position:2
cardiology ,paper:2
cardiology ,cath:2
gise ,position:2
gise ,paper:2
gise ,cath:2
position ,paper:14
position ,cath:2
paper ,cath:2
prognostic ,cardiovascular:2
prognostic ,biomarkers:2
prognostic ,review:4
value ,cardiovascular:2
value ,biomarkers:2
value ,covid-19:18
value ,review:4
cardiovascular ,biomarkers:2
cardiovascular ,review:12
biomarkers ,review:4
sars-cov-2 ,s1ps1p:2
infection ,s1ps1p:2
infection ,signaling:2
role ,s1ps1p:2
role ,signaling:4
role ,nervous:2
s1ps1p ,receptor:2
s1ps1p ,signaling:2
s1ps1p ,nervous:2
s1ps1p ,system:2
receptor ,signaling:2
receptor ,nervous:2
receptor ,system:6
signaling ,nervous:2
signaling ,system:2
testing ,points:2
testing ,remember:2
covid-19 ,points:4
covid-19 ,remember:4
points ,remember:2
infection ,outbreak:12
prevention ,dental:4
prevention ,care:4
prevention ,outbreak:4
dental ,outbreak:2
care ,outbreak:10
synergistic ,antiviral:6
synergistic ,effect:4
synergistic ,hydroxychloroquine:4
synergistic ,azithromycin:4
synergistic ,combination:4
antiviral ,hydroxychloroquine:4
antiviral ,azithromycin:4
antiviral ,combination:6
effect ,hydroxychloroquine:6
effect ,azithromycin:6
effect ,combination:4
hydroxychloroquine ,combination:4
azithromycin ,combination:4
age-related ,gene:2
age-related ,expression:2
age-related ,alterations:2
age-related ,sars-cov-2:6
age-related ,infection:2
age-related ,contribute:2
age-related ,poor:2
gene ,expression:26
gene ,alterations:2
gene ,infection:2
gene ,contribute:2
gene ,poor:2
expression ,alterations:2
expression ,contribute:4
expression ,poor:2
alterations ,sars-cov-2:4
alterations ,infection:2
alterations ,contribute:2
alterations ,poor:2
sars-cov-2 ,contribute:6
sars-cov-2 ,poor:6
infection ,contribute:2
infection ,poor:2
contribute ,poor:2
ace2 ,question:2
ace2 ,balance:2
ace2 ,dynamics:4
coronavirus ,question:2
coronavirus ,balance:2
coronavirus ,dynamics:8
question ,balance:2
question ,dynamics:2
balance ,dynamics:2
role ,inflammatory:4
role ,markers:2
role ,corona:2
role ,review:10
inflammatory ,markers:8
inflammatory ,corona:2
inflammatory ,virus:2
inflammatory ,disease:32
inflammatory ,covid-19:46
inflammatory ,patients:20
inflammatory ,review:10
markers ,corona:2
markers ,virus:2
markers ,disease:6
markers ,covid-19:6
markers ,patients:2
markers ,review:2
corona ,covid-19:6
corona ,patients:8
covid-19 ,denmark:2
covid-19 ,big:4
covid-19 ,country:10
pandemic ,denmark:2
pandemic ,big:2
pandemic ,lessons:10
pandemic ,small:2
pandemic ,country:2
denmark ,big:2
denmark ,lessons:2
denmark ,small:2
denmark ,country:2
big ,lessons:2
big ,small:2
big ,country:2
lessons ,small:2
lessons ,country:2
small ,country:2
evaluation ,eleven:2
evaluation ,antibodies:4
eleven ,rapid:2
eleven ,tests:2
eleven ,detection:2
eleven ,antibodies:2
eleven ,sars-cov-2:2
tests ,antibodies:8
covid-19 ,otolaryngologist:4
otolaryngologist ,practice:2
otolaryngologist ,review:4
otolaryngologist ,current:2
otolaryngologist ,knowledge:2
practice ,knowledge:4
review ,knowledge:6
might ,renin-angiotensin:2
might ,system:2
might ,blockers:2
might ,play:2
might ,role:2
might ,pandemic:2
renin-angiotensin ,play:4
renin-angiotensin ,pandemic:4
system ,blockers:4
system ,play:4
system ,pandemic:10
blockers ,play:2
blockers ,role:2
blockers ,pandemic:4
play ,pandemic:2
epidemic ,update:2
epidemic ,compared:2
epidemic ,regions:2
epidemic ,china:8
update ,hubei:2
update ,province:2
update ,compared:2
update ,regions:2
update ,china:2
covid-19 ,compared:6
covid-19 ,regions:4
hubei ,compared:2
hubei ,regions:2
hubei ,china:4
province ,compared:2
province ,regions:2
compared ,regions:2
compared ,china:2
regions ,china:2
stigma ,discrimination:2
stigma ,sad:2
stigma ,time:2
stigma ,sars-cov-2:2
stigma ,pandemic:2
discrimination ,sad:2
discrimination ,time:2
discrimination ,sars-cov-2:2
discrimination ,pandemic:2
sad ,time:2
sad ,sars-cov-2:2
sad ,pandemic:2
time ,pandemic:14
seropositive ,prevalence:2
seropositive ,antibodies:2
seropositive ,sars-cov-2:2
seropositive ,wuhan:2
seropositive ,china:2
prevalence ,wuhan:2
antibodies ,wuhan:2
antibodies ,china:2
areas ,academic:2
areas ,research:2
areas ,impact:2
areas ,covid-19:4
academic ,research:2
academic ,impact:2
academic ,covid-19:6
research ,impact:8
prevalence ,gastrointestinal:2
prevalence ,symptoms:4
prevalence ,fecal:2
prevalence ,viral:2
prevalence ,shedding:2
prevalence ,patients:20
gastrointestinal ,fecal:2
gastrointestinal ,viral:4
gastrointestinal ,shedding:4
symptoms ,fecal:2
symptoms ,shedding:2
fecal ,shedding:8
salivary ,detection:4
salivary ,sars-cov-2:4
salivary ,covid-19:4
salivary ,implications:2
salivary ,oral:2
salivary ,health-care:2
detection ,implications:4
detection ,oral:2
detection ,health-care:2
covid-19 ,health-care:10
implications ,oral:2
implications ,health-care:2
oral ,health-care:2
therapeutic ,facemasks:2
mathematical ,models:6
mathematical ,devising:2
mathematical ,optimal:2
mathematical ,sars-cov-2:2
mathematical ,strategy:2
mathematical ,eradication:2
models ,devising:2
models ,optimal:2
models ,strategy:2
models ,eradication:2
devising ,optimal:2
devising ,sars-cov-2:2
devising ,strategy:2
devising ,eradication:2
optimal ,strategy:4
optimal ,eradication:2
sars-cov-2 ,eradication:2
strategy ,eradication:2
28-year-old ,man:2
28-year-old ,india:2
28-year-old ,sars-cov-2:2
28-year-old ,pulmonary:2
28-year-old ,tuberculosis:2
28-year-old ,co-infection:2
man ,india:2
man ,pulmonary:2
man ,tuberculosis:2
man ,co-infection:2
india ,pulmonary:2
india ,co-infection:2
sars-cov-2 ,pulmonary:10
pulmonary ,co-infection:2
kidney ,target:2
heat ,inactivation:6
heat ,serum:2
heat ,interferes:2
heat ,immunoanalysis:2
heat ,antibodies:2
inactivation ,serum:2
inactivation ,interferes:2
inactivation ,immunoanalysis:2
inactivation ,antibodies:2
serum ,interferes:2
serum ,immunoanalysis:2
interferes ,immunoanalysis:2
interferes ,antibodies:2
immunoanalysis ,antibodies:2
mapping ,genome:2
mapping ,variation:2
mapping ,worldwide:2
mapping ,highlights:2
mapping ,impact:2
genome ,worldwide:2
genome ,highlights:2
genome ,impact:2
variation ,worldwide:2
variation ,highlights:2
variation ,impact:2
variation ,covid-19:8
sars-cov-2 ,worldwide:6
sars-cov-2 ,highlights:4
worldwide ,highlights:2
worldwide ,impact:2
highlights ,impact:2
highlights ,covid-19:4
severe ,cases:14
severe ,partially:2
severe ,explained:2
covid-19 ,distress:10
covid-19 ,partially:2
covid-19 ,explained:2
cases ,distress:4
cases ,partially:2
cases ,explained:2
cases ,central:2
respiratory ,partially:2
respiratory ,explained:2
distress ,partially:2
distress ,explained:2
distress ,central:2
partially ,explained:2
partially ,central:2
explained ,central:2
clinical ,indexes:2
clinical ,linked:4
biochemical ,indexes:2
biochemical ,infected:2
biochemical ,patients:2
biochemical ,linked:2
biochemical ,viral:2
indexes ,2019-ncov:2
indexes ,infected:2
indexes ,patients:2
indexes ,linked:2
indexes ,viral:2
2019-ncov ,linked:2
infected ,linked:2
patients ,linked:2
linked ,viral:2
covid-19 ,unanswered:4
unanswered ,questions:4
unanswered ,immune:2
unanswered ,response:2
unanswered ,pathogenesis:2
questions ,immune:2
questions ,response:2
questions ,pathogenesis:2
response ,pathogenesis:4
sars-cov-2 ,microbiological:4
microbiological ,diagnostic:2
microbiological ,dynamics:2
microbiological ,covid-19:6
microbiological ,pandemic:2
diagnostic ,dynamics:2
dynamics ,covid-19:24
dynamics ,pandemic:2
effects ,different:2
effects ,temperature:6
effects ,time:2
effects ,durations:2
effects ,virus:2
effects ,inactivation:2
effects ,results:2
different ,temperature:2
different ,durations:2
different ,virus:6
different ,inactivation:6
temperature ,time:2
temperature ,durations:2
temperature ,virus:2
temperature ,inactivation:2
temperature ,results:2
time ,durations:2
time ,virus:4
time ,inactivation:2
time ,results:2
durations ,virus:2
durations ,inactivation:2
durations ,results:2
virus ,inactivation:4
virus ,results:2
inactivation ,results:2
air ,risk:4
air ,factors:2
air ,might:2
air ,buffer:2
air ,severity:6
air ,mozambique:2
pollution ,risk:6
pollution ,factors:4
pollution ,might:2
pollution ,buffer:2
pollution ,severity:4
pollution ,mozambique:2
risk ,factors:64
risk ,might:2
risk ,buffer:2
risk ,severity:18
risk ,mozambique:2
factors ,might:2
factors ,buffer:2
factors ,mozambique:2
might ,buffer:2
might ,severity:2
might ,mozambique:2
buffer ,covid-19:2
buffer ,severity:2
buffer ,mozambique:2
covid-19 ,mozambique:2
severity ,mozambique:2
treatment ,emerging:8
treatment ,viruses:4
emerging ,viruses:4
emerging ,convalescent:2
emerging ,plasma:2
viruses ,convalescent:2
viruses ,plasma:2
influenza ,novel:2
influenza ,corona:2
influenza ,sars-cov-2-the:2
influenza ,contribution:2
influenza ,obesity:2
virus ,sars-cov-2-the:2
virus ,contribution:2
virus ,obesity:2
novel ,sars-cov-2-the:2
novel ,contribution:2
novel ,obesity:2
corona ,sars-cov-2-the:2
corona ,contribution:2
corona ,obesity:2
sars-cov-2-the ,contribution:2
sars-cov-2-the ,obesity:2
contribution ,obesity:2
structure ,treatment:2
severe ,clostridium:2
severe ,difficile:2
severe ,colitis:4
severe ,complication:2
clostridium ,difficile:2
clostridium ,colitis:2
clostridium ,potential:2
clostridium ,late:2
clostridium ,complication:2
clostridium ,associated:2
difficile ,colitis:2
difficile ,potential:2
difficile ,late:2
difficile ,complication:2
difficile ,associated:2
colitis ,potential:2
colitis ,late:2
colitis ,complication:2
colitis ,associated:2
energetics ,ic50:2
energetics ,based:2
energetics ,epitope:2
energetics ,screening:2
energetics ,sars:2
energetics ,cov-2:2
energetics ,covid:2
energetics ,19:2
energetics ,spike:2
energetics ,protein:2
ic50 ,based:2
ic50 ,epitope:2
ic50 ,screening:2
ic50 ,sars:2
ic50 ,cov-2:2
ic50 ,covid:2
ic50 ,19:2
ic50 ,spike:2
ic50 ,protein:2
based ,epitope:2
based ,sars:4
based ,cov-2:2
based ,covid:2
based ,19:2
based ,spike:4
based ,protein:4
epitope ,screening:2
epitope ,sars:2
epitope ,cov-2:2
epitope ,covid:2
epitope ,19:2
epitope ,spike:4
epitope ,protein:4
screening ,sars:4
screening ,cov-2:4
screening ,covid:6
screening ,19:2
screening ,protein:4
sars ,covid:2
sars ,19:2
cov-2 ,covid:2
cov-2 ,19:2
cov-2 ,spike:2
cov-2 ,protein:2
covid ,spike:2
covid ,protein:2
19 ,spike:2
19 ,protein:2
study ,outbreak:8
study ,belgian:2
study ,military:2
study ,education:2
study ,training:2
study ,center:2
sars-cov-2 ,belgian:2
sars-cov-2 ,military:4
sars-cov-2 ,education:2
sars-cov-2 ,training:6
sars-cov-2 ,center:4
outbreak ,belgian:2
outbreak ,military:2
outbreak ,education:2
outbreak ,training:2
outbreak ,center:4
belgian ,military:2
belgian ,education:2
belgian ,training:2
belgian ,center:2
military ,education:2
military ,training:2
military ,center:2
education ,training:4
education ,center:2
training ,center:2
challenges ,psychotropics:2
challenges ,context:2
psychotropics ,context:2
psychotropics ,sars-cov-2:2
psychotropics ,pandemic:2
context ,sars-cov-2:10
pulmonary ,time:2
pulmonary ,change:2
pulmonary ,paradigm:2
embolism ,patients:6
embolism ,time:2
embolism ,change:2
embolism ,paradigm:2
patients ,time:10
patients ,change:4
patients ,paradigm:2
covid-19 ,change:14
time ,change:8
time ,paradigm:2
change ,paradigm:4
disease ,updated:2
disease ,knowledge:6
updated ,based:2
updated ,current:2
updated ,knowledge:2
based ,knowledge:4
recommendations ,diagnosis:4
recommendations ,hepatobiliary:2
recommendations ,surgery:14
recommendations ,2019-ncov:2
diagnosis ,hepatobiliary:2
diagnosis ,surgery:2
treatment ,hepatobiliary:2
treatment ,surgery:2
hepatobiliary ,surgery:2
hepatobiliary ,2019-ncov:2
surgery ,2019-ncov:2
obstetrics ,covid-19:6
correlation ,ambient:2
correlation ,temperature:2
correlation ,covid-19:24
correlation ,incidence:2
correlation ,canada:2
ambient ,temperature:2
ambient ,incidence:2
ambient ,canada:2
temperature ,incidence:4
temperature ,canada:2
incidence ,canada:2
environmental ,testing:2
environmental ,severe:10
environmental ,acute:8
environmental ,respiratory:8
environmental ,syndrome:8
environmental ,coronavirus:10
surface ,testing:2
ivermectin ,antiviral:4
ivermectin ,properties:2
ivermectin ,possible:2
ivermectin ,new:2
ivermectin ,mechanism:2
ivermectin ,action:2
antiviral ,properties:4
antiviral ,possible:2
properties ,covid-19:8
properties ,possible:2
properties ,new:2
properties ,mechanism:2
properties ,action:2
covid-19 ,action:14
possible ,new:6
new ,action:4
mechanism ,action:10
olfactory ,rhinological:2
olfactory ,evaluations:2
olfactory ,sars-cov-2:2
olfactory ,patients:4
olfactory ,complaining:2
rhinological ,evaluations:2
rhinological ,sars-cov-2:2
rhinological ,patients:2
rhinological ,complaining:2
evaluations ,sars-cov-2:2
evaluations ,patients:2
evaluations ,complaining:2
sars-cov-2 ,complaining:2
patients ,complaining:2
immune ,metabolic:4
immune ,signatures:2
immune ,revealed:2
immune ,transcriptomics:2
immune ,data:2
immune ,reuse:2
metabolic ,signatures:2
metabolic ,revealed:2
metabolic ,transcriptomics:2
metabolic ,data:2
metabolic ,reuse:2
signatures ,covid-19:2
signatures ,revealed:2
signatures ,transcriptomics:2
signatures ,data:2
signatures ,reuse:2
covid-19 ,revealed:4
covid-19 ,transcriptomics:2
covid-19 ,reuse:4
revealed ,transcriptomics:2
revealed ,data:2
revealed ,reuse:2
transcriptomics ,data:2
transcriptomics ,reuse:2
data ,reuse:2
development ,thermal:2
severe ,thermal:2
acute ,thermal:2
respiratory ,thermal:2
syndrome ,thermal:2
coronavirus ,thermal:2
sars-cov-2 ,thermal:2
suggestions ,thoracic:2
suggestions ,surgery:2
suggestions ,clinical:4
suggestions ,practice:2
suggestions ,non-epidemic:2
suggestions ,area:2
thoracic ,surgery:8
thoracic ,clinical:4
thoracic ,practice:2
thoracic ,non-epidemic:2
thoracic ,area:2
surgery ,clinical:4
surgery ,non-epidemic:2
surgery ,area:2
clinical ,non-epidemic:2
clinical ,area:2
practice ,non-epidemic:2
practice ,area:2
improving ,efficacy:2
improving ,chloroquine:2
improving ,hydroxychloroquine:2
improving ,may:2
efficacy ,hydroxychloroquine:10
efficacy ,may:2
chloroquine ,sars-cov-2:8
hydroxychloroquine ,may:2
coronavirus ,perioperative:4
coronavirus ,resection:2
disease ,perioperative:4
disease ,period:4
disease ,resection:2
disease ,brief:2
perioperative ,period:2
perioperative ,lung:2
perioperative ,resection:2
perioperative ,brief:2
period ,lung:2
period ,resection:2
period ,brief:2
lung ,resection:2
lung ,brief:2
resection ,brief:2
epstein-barr ,virus:2
epstein-barr ,versus:2
epstein-barr ,novel:2
epstein-barr ,coronavirus-induced:2
epstein-barr ,hemophagocytic:2
virus ,versus:4
virus ,coronavirus-induced:2
virus ,hemophagocytic:2
versus ,coronavirus-induced:2
versus ,hemophagocytic:2
novel ,coronavirus-induced:2
novel ,hemophagocytic:2
coronavirus-induced ,hemophagocytic:2
lung ,base:2
lung ,abdominal:2
lung ,ct:10
base ,findings:2
base ,coronavirus:2
base ,disease:2
base ,covid-19:4
base ,abdominal:2
base ,ct:2
base ,patients:4
coronavirus ,abdominal:2
disease ,abdominal:2
abdominal ,ct:2
sars-cov-2 ,autoimmune:10
sars-cov-2 ,rheumatic:8
sars-cov-2 ,northeast:2
infection ,autoimmune:6
infection ,rheumatic:4
infection ,diseases:12
infection ,northeast:4
patients ,autoimmune:6
patients ,rheumatic:12
patients ,diseases:26
patients ,northeast:4
autoimmune ,rheumatic:4
autoimmune ,diseases:12
autoimmune ,northeast:2
rheumatic ,diseases:12
rheumatic ,northeast:2
diseases ,northeast:2
operating ,protocols:2
operating ,community:2
operating ,treatment:2
operating ,center:2
operating ,isolation:2
operating ,patients:2
protocols ,community:2
protocols ,treatment:4
protocols ,center:2
protocols ,isolation:2
protocols ,patients:2
community ,treatment:4
community ,center:2
community ,patients:4
treatment ,center:4
treatment ,isolation:4
center ,isolation:2
center ,patients:8
isolation ,patients:12
natural ,killer:10
natural ,cell:8
natural ,dysfunction:2
natural ,role:2
killer ,cell:8
killer ,dysfunction:2
killer ,role:2
killer ,covid-19:4
cell ,dysfunction:4
cell ,role:6
cell ,covid-19:38
dysfunction ,role:2
covid-19 ,susceptibility:30
covid-19 ,obstructive:2
susceptibility ,chronic:2
susceptibility ,obstructive:2
susceptibility ,pulmonary:2
susceptibility ,disease:2
chronic ,obstructive:2
chronic ,pulmonary:2
chronic ,disease:6
obstructive ,pulmonary:2
obstructive ,disease:2
pulmonary ,disease:8
anti-a ,isohaemagglutinin:2
anti-a ,titres:2
anti-a ,sars-cov-2:2
anti-a ,neutralization:2
anti-a ,implications:2
isohaemagglutinin ,titres:2
isohaemagglutinin ,sars-cov-2:2
isohaemagglutinin ,neutralization:2
isohaemagglutinin ,implications:2
titres ,sars-cov-2:4
titres ,neutralization:4
titres ,implications:2
sars-cov-2 ,neutralization:16
neutralization ,implications:2
spatial-temporal ,variations:2
spatial-temporal ,atmospheric:2
spatial-temporal ,factors:2
spatial-temporal ,contribute:2
spatial-temporal ,sars-cov-2:2
variations ,atmospheric:2
variations ,factors:2
variations ,contribute:2
atmospheric ,factors:2
atmospheric ,contribute:2
atmospheric ,sars-cov-2:2
factors ,contribute:2
phylogenetic ,phylodynamic:2
phylogenetic ,analyses:2
phylodynamic ,analyses:2
phylodynamic ,sars-cov-2:2
genomic ,variations:4
genomic ,associated:2
genomic ,mortality:2
genomic ,rate:2
variations ,associated:2
variations ,mortality:2
variations ,rate:2
variations ,covid-19:2
rapid ,assay:12
rapid ,real-time:4
rapid ,rt-pcr:4
antigen ,assay:2
antigen ,comparison:4
antigen ,real-time:2
antigen ,rt-pcr:2
assay ,comparison:8
comparison ,real-time:4
promising ,potential:4
allergic ,disorders:2
allergic ,susceptibility:2
allergic ,severity:4
allergic ,covid-19:4
allergic ,anationwide:2
disorders ,susceptibility:2
disorders ,severity:2
disorders ,covid-19:16
disorders ,anationwide:2
susceptibility ,anationwide:2
severity ,anationwide:2
covid-19 ,anationwide:2
can ,transmitted:2
can ,via:2
can ,rnas:2
can ,protein:4
can ,capsids:2
novel ,transmitted:2
novel ,via:2
novel ,rnas:2
novel ,capsids:2
coronavirus ,transmitted:2
coronavirus ,via:4
coronavirus ,rnas:2
coronavirus ,without:2
coronavirus ,capsids:2
transmitted ,via:2
transmitted ,rnas:2
transmitted ,without:2
transmitted ,protein:2
transmitted ,capsids:2
via ,rnas:2
via ,without:2
via ,protein:4
via ,capsids:2
rnas ,without:2
rnas ,protein:2
rnas ,capsids:2
without ,protein:2
without ,capsids:2
protein ,capsids:2
high ,expression:6
high ,ace2:4
high ,receptor:2
high ,2019-ncov:2
high ,epithelial:2
high ,oral:4
expression ,2019-ncov:6
expression ,epithelial:4
expression ,cells:6
expression ,oral:2
ace2 ,epithelial:4
ace2 ,cells:6
ace2 ,oral:2
receptor ,epithelial:2
receptor ,cells:2
receptor ,oral:2
2019-ncov ,epithelial:2
2019-ncov ,cells:4
2019-ncov ,oral:2
epithelial ,cells:8
epithelial ,oral:2
cells ,oral:2
antiviral ,activities:8
antiviral ,infection:10
activities ,type:4
activities ,interferons:4
activities ,sars-cov-2:8
activities ,infection:4
transmission ,droplets:4
transmission ,aerosols:4
transmission ,critical:6
covid-19 ,droplets:2
covid-19 ,aerosols:4
covid-19 ,critical:58
virus ,droplets:6
virus ,aerosols:2
virus ,critical:2
droplets ,aerosols:2
droplets ,critical:2
droplets ,review:2
aerosols ,critical:2
aerosols ,review:2
critical ,review:12
type ,potential:4
type ,treatment:6
interferons ,potential:8
interferons ,treatment:6
potential ,pregnancy:2
potential ,fetuses:2
potential ,newborns:2
effects ,pregnancy:4
effects ,fetuses:2
effects ,newborns:2
sars-cov-2 ,fetuses:2
sars-cov-2 ,newborns:6
infection ,fetuses:2
pregnancy ,fetuses:2
pregnancy ,newborns:2
fetuses ,newborns:2
novel ,sars-cov-2covid-19:4
novel ,machinery:2
drugs ,sars-cov-2covid-19:2
drugs ,machinery:2
targeting ,sars-cov-2covid-19:2
targeting ,machinery:2
sars-cov-2covid-19 ,machinery:2
comparing ,analytical:2
comparing ,performance:2
comparing ,three:2
comparing ,molecular:2
analytical ,performance:6
analytical ,three:4
analytical ,molecular:2
analytical ,diagnostic:2
performance ,three:2
performance ,molecular:4
performance ,diagnostic:12
three ,molecular:4
three ,diagnostic:4
dynamic ,rt-pcr:4
dynamic ,findings:2
dynamic ,301:2
dynamic ,wuhan:2
dynamic ,china:2
profile ,rt-pcr:2
profile ,findings:2
profile ,301:2
profile ,covid-19:4
profile ,patients:6
profile ,wuhan:2
profile ,china:2
rt-pcr ,findings:2
rt-pcr ,301:2
rt-pcr ,wuhan:2
rt-pcr ,china:2
findings ,301:2
findings ,wuhan:2
findings ,china:2
301 ,covid-19:2
301 ,patients:2
301 ,wuhan:2
301 ,china:2
raas ,increase:2
raas ,risk:4
inhibitors ,increase:4
inhibitors ,risk:6
increase ,risk:6
increase ,covid-19:12
duration ,infectiousness:2
duration ,correlation:2
duration ,rt-pcr:2
duration ,cycle:2
duration ,threshold:2
duration ,values:2
infectiousness ,correlation:2
infectiousness ,rt-pcr:2
infectiousness ,cycle:2
infectiousness ,threshold:2
infectiousness ,values:2
correlation ,rt-pcr:2
correlation ,cycle:2
correlation ,threshold:2
correlation ,values:2
rt-pcr ,cycle:2
rt-pcr ,threshold:2
rt-pcr ,values:2
insights ,mechanisms:2
insights ,remdesivir:2
insights ,lopinavirritonavir:2
antiviral ,remdesivir:12
antiviral ,lopinavirritonavir:6
mechanisms ,remdesivir:2
mechanisms ,lopinavirritonavir:2
remdesivir ,lopinavirritonavir:2
intermittent ,fasting:2
intermittent ,possible:2
intermittent ,priming:2
intermittent ,tool:2
intermittent ,host:2
intermittent ,defense:2
intermittent ,sars-cov-2:2
fasting ,possible:2
fasting ,priming:2
fasting ,tool:2
fasting ,host:2
fasting ,defense:2
fasting ,sars-cov-2:2
possible ,priming:2
possible ,tool:4
possible ,host:4
possible ,defense:2
priming ,tool:2
priming ,host:2
priming ,defense:2
priming ,sars-cov-2:4
tool ,host:2
tool ,defense:2
coronavirus ,focus:10
coronavirus ,galopping:2
covid-19 ,galopping:2
focus ,galopping:2
focus ,pandemic:8
galopping ,pandemic:2
vitro ,lopinavirritonavir:2
vitro ,severe:2
vitro ,acute:2
activity ,lopinavirritonavir:2
activity ,hydroxychloroquine:2
activity ,severe:4
activity ,acute:2
lopinavirritonavir ,hydroxychloroquine:2
lopinavirritonavir ,severe:2
lopinavirritonavir ,acute:2
hydroxychloroquine ,acute:4
covid-19 ,crosstalk:2
crosstalk ,hallmarks:2
crosstalk ,aging:2
hallmarks ,aging:2
cutaneous ,adult:2
cutaneous ,patients:6
cutaneous ,covid-19:18
cutaneous ,dermatologic:2
cutaneous ,conditions:2
manifestations ,adult:2
manifestations ,dermatologic:6
manifestations ,conditions:2
adult ,patients:10
adult ,covid-19:10
adult ,dermatologic:2
adult ,conditions:2
patients ,dermatologic:2
patients ,conditions:4
covid-19 ,dermatologic:8
dermatologic ,conditions:2
covid-19 ,syncope:2
covid-19 ,normal:4
patient ,syncope:2
patient ,normal:2
patient ,chest:4
patient ,x-ray:2
presenting ,syncope:2
presenting ,normal:2
presenting ,chest:2
presenting ,x-ray:2
syncope ,normal:2
syncope ,chest:2
syncope ,x-ray:2
normal ,chest:2
normal ,x-ray:2
sars-cov-2covid-19 ,physical:2
sars-cov-2covid-19 ,distancing:2
sars-cov-2covid-19 ,risk:2
sars-cov-2covid-19 ,circadian:2
sars-cov-2covid-19 ,rhythm:2
physical ,distancing:10
physical ,risk:2
physical ,circadian:2
physical ,rhythm:2
distancing ,risk:2
distancing ,circadian:2
distancing ,rhythm:2
risk ,circadian:2
risk ,rhythm:2
circadian ,rhythm:2
asymptomatic ,nasal:2
asymptomatic ,foreign:2
asymptomatic ,body:2
covid-19 ,child:12
covid-19 ,nasal:10
covid-19 ,foreign:4
covid-19 ,body:10
infection ,child:2
infection ,nasal:2
infection ,foreign:2
infection ,body:4
child ,nasal:2
child ,foreign:2
child ,body:2
nasal ,foreign:2
nasal ,body:2
foreign ,body:6
hand ,sanitizers:2
hand ,ingredients:2
hand ,mechanisms:2
hand ,action:2
hand ,modes:2
hand ,delivery:2
sanitizers ,review:2
sanitizers ,ingredients:2
sanitizers ,mechanisms:2
sanitizers ,action:2
sanitizers ,modes:2
sanitizers ,delivery:2
review ,ingredients:2
review ,mechanisms:4
review ,delivery:6
ingredients ,mechanisms:2
ingredients ,action:2
ingredients ,modes:2
ingredients ,delivery:2
mechanisms ,action:12
mechanisms ,modes:2
mechanisms ,delivery:2
action ,delivery:2
modes ,delivery:4
first ,mildly:2
first ,ill:4
first ,nonhospitalized:2
mildly ,ill:2
mildly ,nonhospitalized:2
mildly ,case:2
mildly ,coronavirus:4
mildly ,disease:2
ill ,nonhospitalized:2
ill ,case:4
nonhospitalized ,case:2
nonhospitalized ,coronavirus:2
nonhospitalized ,disease:2
nonhospitalized ,covid-19:2
obesity ,outcomes:4
obesity ,hospitalized:2
obesity ,patients-a:2
predictor ,outcomes:2
predictor ,hospitalized:2
predictor ,patients-a:2
outcomes ,patients-a:2
covid-19 ,patients-a:2
hospitalized ,patients-a:2
hospitalized ,systematic:4
patients-a ,systematic:2
strong ,homology:2
strong ,envelope:2
strong ,protein:2
strong ,mycobacterium:2
strong ,sp:2
strong ,antigen:2
homology ,sars-cov-2:2
homology ,envelope:2
homology ,protein:2
homology ,mycobacterium:2
homology ,sp:2
homology ,antigen:2
sars-cov-2 ,envelope:8
sars-cov-2 ,mycobacterium:2
sars-cov-2 ,sp:2
envelope ,protein:8
envelope ,mycobacterium:2
envelope ,sp:2
envelope ,antigen:2
protein ,mycobacterium:2
protein ,sp:2
protein ,antigen:2
mycobacterium ,sp:2
mycobacterium ,antigen:2
sp ,antigen:2
potential ,coronaviruses:14
neurological ,impact:6
neurological ,coronaviruses:8
neurological ,implications:2
neurological ,novel:4
impact ,coronaviruses:4
impact ,implications:4
coronaviruses ,implications:2
report ,one:2
can ,atmospheric:2
can ,pollution:2
can ,considered:4
can ,co-factor:2
can ,extremely:2
can ,high:2
can ,level:2
atmospheric ,pollution:2
atmospheric ,considered:2
atmospheric ,co-factor:2
atmospheric ,extremely:2
atmospheric ,high:2
atmospheric ,level:2
pollution ,considered:2
pollution ,co-factor:2
pollution ,extremely:2
pollution ,high:2
considered ,co-factor:2
considered ,extremely:2
considered ,high:2
considered ,level:2
co-factor ,extremely:2
co-factor ,high:2
co-factor ,level:2
extremely ,high:2
extremely ,level:2
high ,level:4
urticaria ,angioedema:2
urticaria ,prodromal:2
urticaria ,cutaneous:2
urticaria ,manifestation:2
urticaria ,sars-cov-2:2
angioedema ,prodromal:2
angioedema ,cutaneous:2
angioedema ,manifestation:2
angioedema ,sars-cov-2:2
prodromal ,cutaneous:2
prodromal ,manifestation:2
prodromal ,sars-cov-2:2
cutaneous ,manifestation:4
cutaneous ,sars-cov-2:10
delayed ,specific:2
delayed ,igm:2
delayed ,antibody:4
delayed ,responses:2
delayed ,observed:2
delayed ,among:4
delayed ,patients:2
delayed ,severe:4
specific ,igm:6
specific ,antibody:8
specific ,observed:2
specific ,among:4
specific ,covid-19:14
specific ,patients:8
specific ,severe:2
igm ,antibody:4
igm ,responses:4
igm ,observed:2
igm ,among:2
igm ,patients:4
igm ,severe:4
antibody ,observed:2
responses ,observed:2
responses ,among:4
observed ,among:2
observed ,covid-19:4
observed ,patients:4
observed ,severe:2
management ,juvenile:2
management ,idiopathic:2
management ,arthritis-associated:2
management ,uveitis:4
management ,duringthe:2
juvenile ,idiopathic:2
juvenile ,arthritis-associated:2
juvenile ,uveitis:2
juvenile ,duringthe:2
juvenile ,covid-19:2
idiopathic ,arthritis-associated:2
idiopathic ,uveitis:2
idiopathic ,duringthe:2
idiopathic ,covid-19:2
arthritis-associated ,uveitis:2
arthritis-associated ,duringthe:2
arthritis-associated ,covid-19:2
uveitis ,duringthe:2
uveitis ,covid-19:2
duringthe ,covid-19:2
srgio ,ferreira:2
srgio ,say:2
srgio ,physician:2
srgio ,war:2
srgio ,covid-19:2
ferreira ,say:2
ferreira ,physician:2
ferreira ,war:2
ferreira ,covid-19:2
say ,physician:2
say ,war:2
say ,covid-19:2
physician ,war:2
physician ,covid-19:6
war ,covid-19:4
detection ,tears:4
detection ,conjunctival:2
detection ,secretions:2
sars-cov-2 ,tears:2
sars-cov-2 ,secretions:2
tears ,conjunctival:4
tears ,secretions:4
tears ,coronavirus:4
conjunctival ,secretions:4
conjunctival ,coronavirus:4
secretions ,coronavirus:4
minimising ,duplicate:2
minimising ,reports:2
minimising ,estimating:2
minimising ,impact:2
minimising ,covid-19:2
duplicate ,reports:2
duplicate ,estimating:2
duplicate ,impact:2
duplicate ,covid-19:2
reports ,estimating:2
reports ,impact:4
reports ,covid-19:12
estimating ,impact:4
neurological ,disease:8
neurological ,practical:2
neurological ,considerations:2
impact ,practical:2
impact ,considerations:2
coronavirus ,practical:4
disease ,practical:10
disease ,considerations:14
practical ,considerations:8
exposure ,cough:2
exposure ,aerosols:2
exposure ,development:2
exposure ,pulmonary:2
exposure ,covid-19:6
cough ,aerosols:2
cough ,development:2
cough ,pulmonary:2
cough ,covid-19:4
aerosols ,development:2
aerosols ,pulmonary:2
development ,pulmonary:2
infection ,chronic:4
infection ,sialadenitis:2
novel ,cause:6
novel ,andor:2
novel ,sialadenitis:2
coronavirus ,cause:6
coronavirus ,chronic:2
coronavirus ,sialadenitis:2
cause ,acute:6
cause ,andor:2
cause ,chronic:4
cause ,sialadenitis:2
acute ,andor:2
acute ,sialadenitis:2
andor ,chronic:2
andor ,sialadenitis:2
chronic ,sialadenitis:2
biorisk ,assessment:2
biorisk ,infrastructure:2
biorisk ,biosafety:2
biorisk ,requirements:2
biorisk ,laboratories:2
assessment ,infrastructure:2
assessment ,biosafety:2
assessment ,requirements:2
assessment ,laboratories:2
infrastructure ,biosafety:2
infrastructure ,requirements:2
infrastructure ,laboratories:2
biosafety ,requirements:2
biosafety ,laboratories:4
requirements ,laboratories:2
detection ,low:6
detection ,levels:2
low ,levels:2
low ,nasopharyngeal:2
low ,swabs:2
low ,using:2
low ,three:2
levels ,rna:4
levels ,nasopharyngeal:2
levels ,swabs:2
levels ,using:2
levels ,three:2
rna ,nasopharyngeal:8
rna ,swabs:6
rna ,using:10
rna ,three:4
nasopharyngeal ,using:4
nasopharyngeal ,three:2
swabs ,using:4
swabs ,three:2
using ,three:4
epidemiological ,virological:2
epidemiological ,465:2
epidemiological ,hospitalized:2
epidemiological ,cases:10
clinical ,465:2
virological ,characteristics:2
virological ,465:2
virological ,hospitalized:2
virological ,cases:2
characteristics ,465:2
465 ,hospitalized:2
465 ,cases:2
hospitalized ,cases:2
covid-19 ,limiting:2
covid-19 ,professionals:8
limiting ,risks:2
limiting ,eye:2
limiting ,care:2
limiting ,professionals:2
risks ,eye:2
risks ,care:4
risks ,professionals:2
eye ,care:4
eye ,professionals:2
care ,professionals:4
control ,orthodontic:2
control ,practice:4
sars-cov-2 ,orthodontic:2
transmission ,orthodontic:2
orthodontic ,practice:2
covid-19 ,antirheumatic:2
immune ,hyperinflammation:2
immune ,repurposing:2
immune ,antirheumatic:2
system ,hyperinflammation:4
system ,repurposing:2
system ,antirheumatic:2
response ,hyperinflammation:2
response ,repurposing:4
response ,antirheumatic:2
hyperinflammation ,repurposing:2
hyperinflammation ,antirheumatic:2
repurposing ,antirheumatic:2
vaccine ,2003:2
vaccine ,present:2
vaccine ,overview:4
vaccine ,recent:2
development ,2003:2
development ,present:2
coronavirus ,present:2
2003 ,present:2
2003 ,overview:2
2003 ,recent:2
present ,overview:2
present ,recent:2
overview ,recent:2
sars-cov-2-specific ,healthcare:2
sars-cov-2-specific ,workers:2
sars-cov-2-specific ,germany:2
sars-cov-2-specific ,direct:2
antibody ,germany:2
antibody ,direct:2
detection ,healthcare:4
detection ,workers:4
detection ,germany:4
healthcare ,germany:2
healthcare ,direct:2
workers ,germany:4
workers ,direct:2
germany ,direct:2
seroconversion ,patients:2
seroconversion ,cancer:2
seroconversion ,oncology:2
seroconversion ,health:2
seroconversion ,care:2
seroconversion ,workers:2
seroconversion ,infected:2
patients ,oncology:6
patients ,health:8
patients ,workers:8
cancer ,oncology:4
cancer ,health:4
cancer ,care:12
cancer ,workers:2
cancer ,infected:6
oncology ,health:2
oncology ,care:2
oncology ,workers:2
oncology ,infected:2
health ,infected:2
care ,infected:2
workers ,infected:2
mystery ,mis-c:2
mystery ,post-sars-cov-2:2
mystery ,infection:2
mis-c ,post-sars-cov-2:2
mis-c ,infection:2
post-sars-cov-2 ,infection:2
gastrointestinal ,nutritional:2
gastrointestinal ,therapy:2
manifestations ,nutritional:2
manifestations ,therapy:2
nutritional ,therapy:2
nutritional ,covid-19:6
nutritional ,pandemic:2
therapy ,pandemic:14
clinical ,seven:4
features ,outcomes:10
features ,seven:2
features ,family:6
features ,cluster:6
outcomes ,seven:2
outcomes ,family:2
outcomes ,cluster:2
seven ,patients:2
seven ,family:2
seven ,cluster:2
patients ,family:4
patients ,cluster:2
standardize ,management:2
standardize ,procedures:2
standardize ,breast:2
standardize ,cancer:2
standardize ,patients:2
standardize ,outbreak:2
management ,procedures:2
management ,breast:2
management ,outbreak:20
procedures ,breast:2
procedures ,cancer:4
procedures ,patients:8
procedures ,outbreak:2
breast ,cancer:6
breast ,patients:4
breast ,outbreak:2
cancer ,outbreak:4
patients ,outbreak:16
development ,portable:2
development ,ultra-rapid:2
development ,ultra-sensitive:4
development ,cell-based:4
development ,biosensor:2
portable ,ultra-rapid:2
portable ,ultra-sensitive:2
portable ,cell-based:2
portable ,biosensor:2
ultra-rapid ,ultra-sensitive:2
ultra-rapid ,cell-based:2
ultra-rapid ,biosensor:2
ultra-sensitive ,cell-based:2
ultra-sensitive ,biosensor:2
cell-based ,biosensor:2
quantifying ,adhesive:2
quantifying ,strength:2
quantifying ,sars-cov-2:4
quantifying ,s-proteins:2
quantifying ,human:2
adhesive ,strength:2
adhesive ,sars-cov-2:2
adhesive ,s-proteins:2
adhesive ,human:2
strength ,sars-cov-2:2
strength ,s-proteins:2
strength ,human:2
sars-cov-2 ,s-proteins:2
s-proteins ,human:2
potential ,application:4
potential ,mesenchymal:10
potential ,stem:8
potential ,cell-derived:2
potential ,exosomes:6
therapeutic ,application:2
therapeutic ,mesenchymal:6
therapeutic ,stem:6
therapeutic ,cell-derived:2
therapeutic ,exosomes:4
application ,mesenchymal:4
application ,stem:4
application ,cell-derived:2
application ,exosomes:4
mesenchymal ,cell-derived:2
mesenchymal ,exosomes:8
stem ,cell-derived:4
stem ,exosomes:8
cell-derived ,exosomes:2
challenging ,pathway:2
challenging ,towards:2
challenging ,identification:2
challenging ,sars-cov-2covid-19:2
pathway ,towards:2
pathway ,identification:2
pathway ,sars-cov-2covid-19:2
towards ,identification:4
towards ,sars-cov-2covid-19:2
identification ,sars-cov-2covid-19:2
evaluation ,modelling:2
evaluation ,study:4
evaluation ,shows:2
evaluation ,limits:2
evaluation ,importing:2
evaluation ,risk:8
evaluation ,simulations:2
modelling ,study:4
modelling ,shows:2
modelling ,limits:2
modelling ,importing:2
modelling ,risk:2
modelling ,simulations:2
study ,shows:2
study ,limits:2
study ,importing:2
study ,simulations:2
shows ,limits:2
shows ,importing:2
shows ,risk:2
shows ,simulations:2
limits ,covid-19:2
limits ,importing:2
limits ,risk:2
limits ,simulations:2
covid-19 ,importing:2
covid-19 ,simulations:4
importing ,risk:2
importing ,simulations:2
risk ,simulations:2
considerations ,bedside:2
considerations ,urologic:2
considerations ,procedures:2
considerations ,severe:2
considerations ,acute:6
bedside ,urologic:2
bedside ,procedures:2
bedside ,patients:4
bedside ,severe:2
bedside ,acute:2
urologic ,procedures:2
urologic ,patients:4
urologic ,severe:2
urologic ,acute:2
interaction ,coronavirus:2
interaction ,ace:2
interaction ,angiotensin-converting:2
coronavirus ,ace:4
ace ,angiotensin-converting:2
safe ,extubation:2
safe ,covid-19:22
safe ,pandemic:6
extubation ,covid-19:2
extubation ,pandemic:2
severe ,pregnancy:8
severe ,systematic:4
infections ,pregnancy:6
infections ,systematic:8
pregnancy ,systematic:8
serologic ,detection:4
serologic ,infections:4
serologic ,hemodialysis:2
serologic ,centers:2
serologic ,multicenter:2
detection ,infections:4
detection ,centers:2
detection ,multicenter:2
sars-cov-2 ,centers:2
sars-cov-2 ,multicenter:10
infections ,hemodialysis:2
infections ,centers:2
infections ,multicenter:4
hemodialysis ,centers:2
hemodialysis ,multicenter:2
centers ,multicenter:2
covid-19 ,immunotherapeutics:2
immunopathogenesis ,immunotherapeutics:2
pathogenesis ,clinical:8
pathogenesis ,manifestationsand:2
clinical ,manifestationsand:2
clinical ,complications:4
manifestationsand ,complications:2
manifestationsand ,coronavirus:2
manifestationsand ,disease:2
complications ,coronavirus:10
complications ,disease:6
differential ,illness:2
differential ,investigation:2
differential ,novel:2
diagnosis ,illness:2
diagnosis ,investigation:2
illness ,investigation:2
illness ,novel:2
investigation ,novel:2
use ,mesenchymal:4
use ,stromal:2
use ,cells:4
use ,treatment:8
mesenchymal ,stromal:4
stromal ,cells:4
stromal ,treatment:2
stromal ,coronavirus:2
stromal ,disease:2
persistence ,severe:4
persistence ,acute:4
persistence ,respiratory:6
persistence ,syndrome:4
persistence ,coronavirus:10
clinical ,two:8
clinical ,serologic:2
performance ,two:4
performance ,serologic:4
two ,serologic:4
testing ,general:2
sars-cov-2 ,general:4
covid-19 ,general:6
general ,review:2
correlation ,cns:2
correlation ,tuberculosis:2
correlation ,pandemic:4
correlation ,neurological:4
cns ,tuberculosis:2
cns ,covid-19:6
cns ,pandemic:2
tuberculosis ,neurological:2
characteristics ,caused:2
lung ,children:2
lung ,preliminary:2
ultrasound ,children:2
ultrasound ,preliminary:2
ultrasound ,findings:8
children ,findings:2
preliminary ,findings:4
expert ,management:4
expert ,strategy:2
expert ,patients:4
expert ,hereditary:2
expert ,ataxia:2
consensus ,management:6
consensus ,strategy:2
consensus ,patients:2
consensus ,hereditary:2
consensus ,ataxia:2
management ,strategy:4
management ,hereditary:2
management ,ataxia:4
strategy ,patients:4
strategy ,hereditary:2
strategy ,ataxia:2
patients ,hereditary:2
patients ,ataxia:4
hereditary ,ataxia:2
covid-19 ,breaker:2
covid-19 ,rescue:10
breaker ,pcr:2
breaker ,rescue:2
pcr ,rescue:2
thrombocytopenia ,association:2
thrombocytopenia ,mortality:2
association ,mortality:16
mortality ,patients:40
first ,pediatric:4
first ,japan:2
first ,risk:2
pediatric ,japan:2
pediatric ,risk:4
japan ,risk:2
chadox1 ,ncov-19:4
chadox1 ,vaccination:2
chadox1 ,prevents:2
chadox1 ,sars-cov-2:4
chadox1 ,pneumonia:2
chadox1 ,rhesus:2
chadox1 ,macaques:2
ncov-19 ,vaccination:2
ncov-19 ,prevents:2
ncov-19 ,sars-cov-2:4
ncov-19 ,pneumonia:2
ncov-19 ,rhesus:2
ncov-19 ,macaques:2
vaccination ,prevents:2
vaccination ,pneumonia:2
vaccination ,rhesus:2
vaccination ,macaques:2
comparison ,polymerase:2
comparison ,chain:2
comparison ,reaction:2
two ,real-time:4
two ,polymerase:2
two ,chain:2
two ,reaction:2
two ,detection:8
real-time ,polymerase:6
real-time ,chain:8
real-time ,reaction:6
real-time ,assays:8
polymerase ,chain:14
polymerase ,reaction:8
polymerase ,assays:4
polymerase ,detection:2
chain ,reaction:8
chain ,assays:4
chain ,detection:4
reaction ,assays:4
reaction ,detection:2
sars-cov-2 ,next:4
sars-cov-2 ,generations:2
next ,generations:2
next ,impact:2
next ,reproductive:2
next ,tissues:2
generations ,impact:2
generations ,reproductive:2
generations ,tissues:2
impact ,reproductive:4
impact ,tissues:2
reproductive ,tissues:2
pharmacovigilance ,study:2
pharmacovigilance ,drug-induced:2
pharmacovigilance ,cardiac:2
pharmacovigilance ,injury:2
pharmacovigilance ,treatment:2
study ,drug-induced:2
study ,cardiac:2
study ,injury:2
drug-induced ,cardiac:2
drug-induced ,injury:4
drug-induced ,treatment:2
cardiac ,treatment:2
know ,diagnostic:4
know ,properties:2
know ,tests:2
know ,used:2
know ,rapid:2
diagnostic ,properties:4
diagnostic ,used:2
properties ,tests:2
properties ,used:2
properties ,rapid:2
properties ,review:2
tests ,used:2
tests ,review:6
used ,rapid:2
used ,review:2
radiographic ,severity:2
radiographic ,index:2
radiographic ,covid-19:4
radiographic ,pneumonia:4
radiographic ,relationship:2
radiographic ,age:2
radiographic ,sex:2
severity ,index:4
severity ,pneumonia:4
severity ,relationship:2
severity ,age:4
severity ,sex:2
index ,pneumonia:2
index ,relationship:2
index ,age:2
index ,sex:2
covid-19 ,relationship:14
covid-19 ,age:18
covid-19 ,sex:20
pneumonia ,relationship:2
pneumonia ,age:2
pneumonia ,sex:2
relationship ,age:2
relationship ,sex:2
age ,sex:6
coronavirus ,cerebrovascular-cardiovascular:2
coronavirus ,systems:4
disease ,cerebrovascular-cardiovascular:2
disease ,systems:2
cerebrovascular-cardiovascular ,systems:2
physical ,reduced:2
physical ,incidence:2
physical ,influenza:2
physical ,supports:2
physical ,favorable:2
distancing ,reduced:2
distancing ,incidence:2
distancing ,influenza:2
distancing ,supports:2
distancing ,favorable:2
reduced ,incidence:2
reduced ,influenza:2
reduced ,supports:2
reduced ,favorable:2
incidence ,supports:2
incidence ,favorable:2
influenza ,supports:2
influenza ,favorable:2
supports ,favorable:2
covid-19 ,united:18
covid-19 ,states:6
covid-19 ,admissions:4
covid-19 ,estimated:2
children ,united:2
children ,states:2
children ,intensive:2
children ,admissions:2
children ,estimated:2
united ,intensive:2
united ,care:2
united ,admissions:2
united ,estimated:2
states ,intensive:2
states ,care:2
states ,admissions:2
states ,estimated:2
intensive ,admissions:4
intensive ,estimated:4
care ,admissions:4
care ,estimated:4
admissions ,estimated:2
coronavirus ,humans:6
2019-ncov ,humans:2
evolution ,transmission:4
evolution ,humans:2
evolution ,causing:2
transmission ,causing:2
humans ,causing:2
disruption ,adaptive:2
disruption ,immunity:2
disruption ,enhances:2
disruption ,disease:2
disruption ,sars-cov-2-infected:2
disruption ,syrian:2
adaptive ,enhances:2
adaptive ,disease:2
adaptive ,sars-cov-2-infected:2
adaptive ,syrian:2
immunity ,enhances:2
immunity ,sars-cov-2-infected:2
immunity ,syrian:2
enhances ,disease:2
enhances ,sars-cov-2-infected:2
enhances ,syrian:2
disease ,sars-cov-2-infected:2
disease ,syrian:2
sars-cov-2-infected ,syrian:2
large-scale ,in-house:2
large-scale ,production:2
large-scale ,viral:2
large-scale ,transport:2
large-scale ,media:2
large-scale ,support:2
large-scale ,sars-cov-2:6
large-scale ,pcr:2
in-house ,production:2
in-house ,viral:2
in-house ,transport:2
in-house ,media:2
in-house ,support:2
in-house ,sars-cov-2:6
in-house ,pcr:2
production ,viral:2
production ,transport:2
production ,media:2
production ,support:2
production ,pcr:2
viral ,media:2
viral ,support:2
viral ,pcr:2
transport ,media:6
transport ,support:2
transport ,pcr:2
media ,support:2
media ,sars-cov-2:4
media ,pcr:2
support ,sars-cov-2:2
support ,pcr:2
sars-cov-2 ,mental:6
sars-cov-2 ,biological:10
sars-cov-2 ,social:10
mental ,biological:2
mental ,mechanisms:2
mental ,social:4
mental ,consequences:4
health ,biological:2
health ,mechanisms:2
health ,consequences:4
biological ,mechanisms:2
biological ,social:2
biological ,consequences:2
mechanisms ,social:2
mechanisms ,consequences:2
social ,consequences:4
household ,transmission:8
co-infection ,early:2
co-infection ,stage:2
co-infection ,covid-19:10
influenza ,early:2
influenza ,stage:2
virus ,early:4
virus ,stage:2
early ,stage:14
synergistic ,effects:4
synergistic ,anionic:2
synergistic ,surfactants:2
synergistic ,coronavirus:2
synergistic ,sars-cov-2:4
synergistic ,virucidal:2
effects ,anionic:2
effects ,surfactants:2
effects ,virucidal:2
anionic ,surfactants:2
anionic ,coronavirus:2
anionic ,sars-cov-2:2
anionic ,virucidal:2
surfactants ,coronavirus:2
surfactants ,sars-cov-2:2
surfactants ,virucidal:2
coronavirus ,virucidal:2
sars-cov-2 ,virucidal:2
early ,histologic:2
early ,findings:8
early ,pulmonary:4
early ,detected:2
early ,surgical:4
histologic ,findings:2
histologic ,pulmonary:2
histologic ,sars-cov-2:2
histologic ,infection:2
histologic ,detected:2
histologic ,surgical:2
findings ,pulmonary:4
findings ,detected:2
findings ,surgical:2
pulmonary ,infection:10
pulmonary ,detected:2
pulmonary ,surgical:4
sars-cov-2 ,surgical:8
infection ,surgical:6
detected ,surgical:2
advances ,use:2
advances ,chloroquine:2
advances ,hydroxychloroquine:2
use ,chloroquine:6
covid-19sars-cov-2 ,lysosomes:2
covid-19sars-cov-2 ,lysosomotropism:2
covid-19sars-cov-2 ,implicate:2
covid-19sars-cov-2 ,new:2
covid-19sars-cov-2 ,treatment:2
infection ,lysosomes:2
infection ,lysosomotropism:2
infection ,implicate:2
lysosomes ,lysosomotropism:2
lysosomes ,implicate:2
lysosomes ,new:2
lysosomes ,treatment:2
lysosomotropism ,implicate:2
lysosomotropism ,new:2
lysosomotropism ,treatment:2
implicate ,new:2
implicate ,treatment:2
sars ,treatment:2
sars ,patent:2
mers ,treatment:2
mers ,patent:2
sars-cov-2 ,patent:2
covid-19 ,patent:4
treatment ,patent:2
patent ,review:2
transcatheter ,drug:2
transcatheter ,delivery:2
transcatheter ,bronchial:2
transcatheter ,artery:2
transcatheter ,covid-19:2
transcatheter ,fiction:2
drug ,bronchial:2
drug ,artery:2
drug ,fiction:2
delivery ,bronchial:2
delivery ,artery:2
delivery ,fiction:2
bronchial ,artery:4
bronchial ,covid-19:2
bronchial ,fiction:2
artery ,covid-19:2
artery ,fiction:2
covid-19 ,fiction:2
phylogeography ,sars-cov-2:2
phylogeography ,pandemic:2
phylogeography ,spain:2
phylogeography ,story:2
phylogeography ,multiple:2
phylogeography ,introductions:2
sars-cov-2 ,story:2
sars-cov-2 ,introductions:6
pandemic ,spain:8
pandemic ,story:2
pandemic ,introductions:2
spain ,story:2
spain ,multiple:2
spain ,introductions:2
story ,multiple:2
story ,introductions:2
multiple ,introductions:4
transmission ,workers:4
transmission ,-observational:2
transmission ,results:2
risk ,-observational:2
risk ,results:2
sars-cov-2 ,-observational:2
healthcare ,-observational:2
healthcare ,results:6
workers ,-observational:2
workers ,results:6
-observational ,results:2
screening ,mothers:2
screening ,low-prevalence:2
screening ,region:2
screening ,determination:2
mothers ,low-prevalence:2
mothers ,region:2
mothers ,determination:2
covid-19 ,low-prevalence:2
covid-19 ,region:12
covid-19 ,determination:2
low-prevalence ,region:2
low-prevalence ,determination:2
region ,determination:2
evaluation ,covid19:2
evaluation ,id:2
evaluation ,now:2
evaluation ,eua:2
covid19 ,id:2
covid19 ,now:2
covid19 ,eua:2
covid19 ,assay:4
id ,now:6
id ,eua:2
id ,assay:2
now ,eua:2
now ,assay:2
eua ,assay:2
evaluation ,quotient:2
evaluation ,mosaiq:2
evaluation ,microarray:2
quotient ,mosaiq:2
quotient ,covid-19:2
quotient ,antibody:2
quotient ,microarray:2
quotient ,detection:2
mosaiq ,covid-19:2
mosaiq ,antibody:2
mosaiq ,microarray:2
mosaiq ,detection:2
covid-19 ,microarray:4
antibody ,microarray:2
microarray ,detection:2
evidence ,rna:2
evidence ,oropharyngeal:2
evidence ,swab:2
evidence ,specimen:2
evidence ,milan:2
evidence ,early:10
sars-cov-2 ,milan:2
rna ,oropharyngeal:2
rna ,specimen:2
rna ,milan:2
rna ,italy:2
rna ,early:2
oropharyngeal ,swab:4
oropharyngeal ,specimen:2
oropharyngeal ,milan:2
oropharyngeal ,italy:2
oropharyngeal ,early:2
swab ,milan:2
swab ,italy:2
swab ,early:2
specimen ,milan:2
specimen ,italy:2
specimen ,early:2
milan ,italy:2
milan ,early:2
italy ,early:4
analysis ,routes:2
genomic ,characteristics:4
genomic ,transmission:4
characteristics ,transmission:10
characteristics ,routes:2
facility-level ,approaches:2
facility-level ,covid-19:2
facility-level ,caseload:2
facility-level ,surpasses:2
facility-level ,surge:2
facility-level ,capacity:2
approaches ,caseload:2
approaches ,surpasses:2
approaches ,surge:2
approaches ,capacity:2
covid-19 ,caseload:2
covid-19 ,surpasses:2
covid-19 ,surge:4
caseload ,surpasses:2
caseload ,surge:2
caseload ,capacity:2
surpasses ,surge:2
surpasses ,capacity:2
surge ,capacity:2
distribution ,sars-cov-2:6
distribution ,pcr:2
distribution ,cycle:2
distribution ,threshold:2
distribution ,values:2
distribution ,provide:2
distribution ,practical:2
distribution ,insight:2
sars-cov-2 ,threshold:2
sars-cov-2 ,values:2
sars-cov-2 ,provide:4
pcr ,cycle:2
pcr ,threshold:2
pcr ,values:2
pcr ,provide:2
pcr ,practical:2
pcr ,insight:2
cycle ,provide:2
cycle ,practical:2
cycle ,insight:2
threshold ,provide:2
threshold ,practical:2
threshold ,insight:2
values ,provide:2
values ,practical:2
values ,insight:2
provide ,practical:2
provide ,insight:2
practical ,insight:2
oxygen-ozone ,therapy:2
oxygen-ozone ,adjuvant:2
oxygen-ozone ,current:2
oxygen-ozone ,emergency:2
oxygen-ozone ,sars-cov-2:2
oxygen-ozone ,infection:2
therapy ,adjuvant:10
therapy ,current:4
therapy ,emergency:2
adjuvant ,current:2
adjuvant ,emergency:2
adjuvant ,sars-cov-2:2
adjuvant ,infection:2
emergency ,infection:4
covid-19 ,ward:14
epidemic ,clinical:6
epidemic ,characteristics:10
epidemic ,pediatric:2
epidemic ,isolation:4
epidemic ,ward:2
clinical ,isolation:4
clinical ,ward:4
characteristics ,pediatric:8
characteristics ,isolation:2
characteristics ,ward:2
patients ,ward:4
pediatric ,isolation:2
pediatric ,ward:2
covid-19 ,paediatrician:2
paediatrician ,need:2
paediatrician ,know:2
recombinant ,protein:4
recombinant ,targeting:2
recombinant ,opsonizing:2
recombinant ,spike:4
recombinant ,glycoprotein:2
recombinant ,enhancing:2
protein ,opsonizing:2
protein ,glycoprotein:2
protein ,enhancing:2
targeting ,opsonizing:2
targeting ,glycoprotein:4
targeting ,enhancing:2
opsonizing ,spike:2
opsonizing ,glycoprotein:2
opsonizing ,enhancing:2
spike ,enhancing:2
glycoprotein ,enhancing:2
structural ,properties:2
functional ,properties:2
functional ,spike:4
functional ,protein:6
properties ,sars-cov-2:6
properties ,spike:2
properties ,protein:2
properties ,potential:4
protein ,potential:10
msphere ,influence:2
msphere ,thats:2
msphere ,racist-covid-19:2
msphere ,biological:2
msphere ,determinism:2
msphere ,limits:2
influence ,thats:2
influence ,racist-covid-19:2
influence ,biological:2
influence ,determinism:2
influence ,limits:2
thats ,racist-covid-19:2
thats ,biological:2
thats ,determinism:2
thats ,limits:2
racist-covid-19 ,biological:2
racist-covid-19 ,determinism:2
racist-covid-19 ,limits:2
biological ,determinism:2
biological ,limits:2
determinism ,limits:2
spike ,optimal:2
spike ,immunological:2
protein ,optimal:2
protein ,immunological:2
protein ,target:8
optimal ,immunological:2
optimal ,target:2
optimal ,vaccines:2
immunological ,target:2
immunological ,vaccines:2
target ,vaccines:2
management ,epigenomic:2
management ,networks:2
management ,entailed:2
epigenomic ,networks:2
epigenomic ,entailed:2
epigenomic ,coronavirus:2
epigenomic ,infections:2
epigenomic ,covid-19:2
networks ,entailed:2
networks ,coronavirus:2
networks ,infections:4
networks ,covid-19:4
entailed ,coronavirus:2
entailed ,infections:2
entailed ,covid-19:2
drug ,learned:2
therapy ,learned:2
novel ,zoonotic:4
novel ,expected:2
novel ,concern:2
zoonotic ,expected:2
zoonotic ,global:4
zoonotic ,health:2
zoonotic ,concern:2
pandemic ,expected:2
pandemic ,concern:2
expected ,global:2
expected ,health:2
expected ,concern:2
global ,health:10
global ,concern:2
health ,concern:2
temporal ,change:2
temporal ,sars-cov-2:10
temporal ,clinical:2
temporal ,specimens:2
temporal ,covid-19:10
temporal ,pneumonia:2
temporal ,patients:8
change ,sars-cov-2:12
change ,clinical:2
change ,specimens:2
change ,pneumonia:2
clinical ,specimens:10
specimens ,pneumonia:2
viral ,host:8
viral ,environmental:4
viral ,favor:2
viral ,anthropozoonotic:2
viral ,spillover:2
host ,environmental:2
host ,factors:8
host ,favor:2
host ,anthropozoonotic:2
host ,spillover:2
environmental ,favor:2
environmental ,anthropozoonotic:2
environmental ,spillover:2
factors ,favor:2
factors ,anthropozoonotic:2
factors ,spillover:2
favor ,anthropozoonotic:2
favor ,spillover:2
anthropozoonotic ,spillover:2
potential ,usefulness:2
potential ,pentoxifylline:6
potential ,non-specific:2
potential ,phosphodiesterase:2
usefulness ,pentoxifylline:2
usefulness ,non-specific:2
usefulness ,phosphodiesterase:2
usefulness ,inhibitor:2
pentoxifylline ,non-specific:2
pentoxifylline ,phosphodiesterase:2
pentoxifylline ,inhibitor:2
non-specific ,phosphodiesterase:2
non-specific ,inhibitor:2
phosphodiesterase ,inhibitor:2
third ,cranial:2
third ,nerve:2
third ,palsy:2
third ,presenting:2
third ,unilateral:2
third ,diplopia:2
third ,strabismus:2
cranial ,nerve:2
cranial ,palsy:2
cranial ,presenting:2
cranial ,unilateral:2
cranial ,diplopia:2
cranial ,strabismus:2
nerve ,palsy:2
nerve ,presenting:2
nerve ,unilateral:2
nerve ,diplopia:2
nerve ,strabismus:2
palsy ,presenting:2
palsy ,unilateral:2
palsy ,diplopia:2
palsy ,strabismus:2
presenting ,unilateral:2
presenting ,diplopia:2
presenting ,strabismus:2
unilateral ,diplopia:2
unilateral ,strabismus:2
diplopia ,strabismus:2
distribution ,pandemic:2
distribution ,monthly:2
distribution ,forecast:2
distribution ,based:2
distribution ,seasonal:2
sars-cov-2 ,monthly:2
sars-cov-2 ,forecast:2
sars-cov-2 ,seasonal:4
pandemic ,monthly:2
pandemic ,forecast:2
pandemic ,based:4
pandemic ,seasonal:2
monthly ,forecast:2
monthly ,based:2
monthly ,seasonal:2
forecast ,based:2
forecast ,seasonal:2
based ,seasonal:2
vitamin ,deficiency:12
vitamin ,outcome:2
vitamin ,patients:6
deficiency ,outcome:2
deficiency ,covid-19:6
deficiency ,patients:2
outcome ,patients:12
older ,know:2
adults ,know:2
role ,chest:8
role ,radiograph:2
role ,procalcitonin:2
role ,moxifloxacin:2
role ,diagnosis:6
chest ,radiograph:2
chest ,procalcitonin:2
chest ,moxifloxacin:2
chest ,diagnosis:6
radiograph ,procalcitonin:2
radiograph ,moxifloxacin:2
radiograph ,diagnosis:2
procalcitonin ,moxifloxacin:2
procalcitonin ,diagnosis:2
moxifloxacin ,diagnosis:2
rapid ,convenient:2
rapid ,efficient:2
rapid ,kit-independent:2
rapid ,rna:10
convenient ,efficient:2
convenient ,kit-independent:2
convenient ,detection:2
convenient ,sars-cov-2:2
convenient ,rna:2
efficient ,kit-independent:2
efficient ,detection:4
efficient ,sars-cov-2:4
efficient ,rna:4
kit-independent ,detection:2
kit-independent ,sars-cov-2:2
kit-independent ,rna:2
sequence ,homology:2
sequence ,bioinformatic:2
sequence ,approach:2
sequence ,can:2
sequence ,predict:2
homology ,bioinformatic:2
homology ,approach:2
homology ,can:2
homology ,predict:2
homology ,candidate:2
homology ,targets:2
bioinformatic ,approach:2
bioinformatic ,can:2
bioinformatic ,predict:2
bioinformatic ,candidate:2
bioinformatic ,targets:2
approach ,can:6
approach ,predict:2
approach ,candidate:4
approach ,targets:2
can ,predict:4
can ,candidate:2
can ,targets:2
predict ,candidate:2
predict ,targets:2
response ,d-dimers:2
d-dimers ,covid-19:2
schrdingers ,worker:2
schrdingers ,positive:2
schrdingers ,negative:2
schrdingers ,sars-cov-2:2
worker ,positive:2
worker ,negative:2
worker ,sars-cov-2:4
taste ,impairment:2
taste ,recovers:2
taste ,early:2
taste ,spontaneously:2
smell ,recovers:2
smell ,early:2
smell ,spontaneously:2
impairment ,sars-cov-2:4
impairment ,recovers:2
impairment ,early:2
impairment ,spontaneously:2
sars-cov-2 ,recovers:2
sars-cov-2 ,spontaneously:2
recovers ,early:2
recovers ,spontaneously:2
early ,spontaneously:2
sars-cov-2 ,occasionally:2
sars-cov-2 ,require:2
infection ,diagnostic:10
infection ,occasionally:2
infection ,require:2
diagnostic ,results:2
diagnostic ,occasionally:2
diagnostic ,require:2
diagnostic ,special:2
testing ,occasionally:2
testing ,require:2
testing ,special:2
results ,occasionally:2
results ,require:2
results ,special:2
occasionally ,require:2
occasionally ,special:2
require ,special:2
origins ,coronaviruses:2
inositol ,pulmonary:2
inositol ,function:2
inositol ,myo-inositol:2
inositol ,treatment:2
inositol ,downregulate:2
pulmonary ,function:4
pulmonary ,myo-inositol:2
pulmonary ,downregulate:2
function ,myo-inositol:2
function ,treatment:2
function ,downregulate:2
myo-inositol ,treatment:2
myo-inositol ,downregulate:2
treatment ,downregulate:2
intrauterine ,preterm:2
intrauterine ,infant:2
transmission ,preterm:4
transmission ,infant:2
sars-cov-2 ,preterm:6
infection ,preterm:8
preterm ,infant:2
features ,factors:2
features ,severe:12
features ,course:6
factors ,severe:14
factors ,course:6
associated ,course:4
high ,altitude:4
high ,reduces:2
high ,infection:12
high ,case-fatality:2
altitude ,reduces:2
altitude ,infection:2
altitude ,rate:2
altitude ,covid-19:4
altitude ,case-fatality:2
reduces ,infection:2
reduces ,rate:2
reduces ,covid-19:2
reduces ,case-fatality:2
infection ,case-fatality:2
rate ,case-fatality:2
sars-cov-2-induced ,kawasaki-like:2
sars-cov-2-induced ,hyperinflammatory:2
sars-cov-2-induced ,syndrome:6
sars-cov-2-induced ,novel:8
sars-cov-2-induced ,covid:2
sars-cov-2-induced ,phenotype:2
kawasaki-like ,hyperinflammatory:2
kawasaki-like ,syndrome:4
kawasaki-like ,novel:2
kawasaki-like ,covid:2
kawasaki-like ,phenotype:2
hyperinflammatory ,novel:2
hyperinflammatory ,covid:2
hyperinflammatory ,phenotype:2
syndrome ,phenotype:2
novel ,covid:2
novel ,phenotype:2
covid ,phenotype:4
promise ,mesenchymal:4
promise ,stem:4
promise ,cells:2
promise ,therapy:2
promise ,acute:2
promise ,respiratory:2
promise ,distress:2
mesenchymal ,therapy:8
mesenchymal ,acute:6
mesenchymal ,respiratory:4
mesenchymal ,distress:4
stem ,therapy:10
stem ,acute:4
stem ,respiratory:4
stem ,distress:4
cells ,therapy:6
cells ,acute:6
cells ,respiratory:4
cells ,distress:2
therapy ,acute:14
therapy ,respiratory:8
therapy ,distress:4
co-infection ,sars:2
co-infection ,cov-2:2
co-infection ,pediatric:2
co-infection ,germany:2
sars ,influenza:2
sars ,pediatric:2
sars ,patient:6
sars ,germany:2
cov-2 ,influenza:2
cov-2 ,pediatric:2
cov-2 ,patient:2
cov-2 ,germany:2
influenza ,pediatric:2
influenza ,germany:2
pediatric ,germany:2
patient ,germany:2
index ,case:2
index ,sars-cov-2:4
index ,scotland:2
case ,scotland:2
sars-cov-2 ,scotland:2
interpretive ,discrepancies:2
interpretive ,caused:2
interpretive ,target:2
interpretive ,values:2
interpretive ,inter-batch:2
interpretive ,variations:2
discrepancies ,caused:2
discrepancies ,target:2
discrepancies ,values:2
discrepancies ,inter-batch:2
discrepancies ,variations:2
caused ,target:2
caused ,values:2
caused ,inter-batch:2
caused ,variations:2
target ,values:2
target ,inter-batch:2
target ,variations:2
values ,inter-batch:2
values ,variations:2
inter-batch ,variations:2
prior ,infection:2
prior ,intestinal:2
prior ,coronaviruses:4
prior ,moderates:2
prior ,symptom:2
prior ,severity:2
infection ,coronaviruses:4
infection ,moderates:2
infection ,symptom:4
infection ,severity:6
intestinal ,coronaviruses:2
intestinal ,moderates:2
intestinal ,symptom:2
intestinal ,severity:2
coronaviruses ,moderates:2
coronaviruses ,symptom:2
coronaviruses ,severity:2
moderates ,symptom:2
moderates ,severity:2
symptom ,severity:4
clinical ,challenges:6
characteristics ,challenges:2
diagnostic ,challenges:4
diagnostic ,pediatric:2
challenges ,pediatric:2
novel ,neurodegenerative:2
novel ,disorders:2
coronavirus ,neurodegenerative:2
coronavirus ,disorders:2
disease ,neurodegenerative:2
disease ,disorders:2
covid-19 ,neurodegenerative:4
neurodegenerative ,disorders:2
standardized ,management:2
standardized ,guideline:2
standardized ,pediatric:2
standardized ,wards:2
standardized ,hematology:2
standardized ,oncology:2
management ,guideline:8
management ,pediatric:6
management ,wards:2
management ,hematology:2
management ,oncology:4
guideline ,pediatric:2
guideline ,wards:2
guideline ,hematology:2
guideline ,oncology:2
pediatric ,wards:2
pediatric ,hematology:2
pediatric ,oncology:2
wards ,hematology:2
wards ,oncology:2
hematology ,oncology:2
central ,complications:4
central ,associated:4
nervous ,complications:4
nervous ,associated:4
system ,complications:4
system ,associated:4
complications ,associated:6
complications ,infection:8
snowballing ,transmission:2
snowballing ,covid-19:2
snowballing ,sars-cov-2:2
snowballing ,wastewater:2
transmission ,wastewater:2
infection ,community:4
infection ,india:6
among ,community:4
among ,india:4
among ,use:2
community ,workers:2
community ,india:2
community ,use:2
health ,india:2
health ,use:2
workers ,india:4
workers ,use:4
india ,use:2
primer ,design:2
primer ,quantitative:2
primer ,real-time:2
primer ,pcr:2
primer ,emerging:2
primer ,coronavirus:4
design ,quantitative:2
design ,real-time:2
design ,pcr:2
quantitative ,real-time:6
quantitative ,pcr:8
quantitative ,coronavirus:6
real-time ,emerging:2
pcr ,emerging:2
serological ,experimental:2
serological ,domestic:2
serological ,companion:2
serological ,wild:2
survey ,experimental:2
survey ,domestic:2
survey ,companion:2
survey ,wild:2
experimental ,domestic:4
experimental ,companion:2
experimental ,wild:2
domestic ,companion:2
domestic ,wild:2
companion ,wild:2
predictive ,sudden:2
predictive ,olfactory:2
predictive ,loss:2
predictive ,diagnosis:4
predictive ,covid-19:18
value ,sudden:4
value ,olfactory:2
value ,loss:4
value ,diagnosis:4
sudden ,olfactory:2
sudden ,diagnosis:2
olfactory ,loss:6
olfactory ,diagnosis:2
loss ,diagnosis:2
saliva ,non-negligible:2
saliva ,factor:2
saliva ,spread:2
saliva ,covid-19:8
non-negligible ,factor:2
non-negligible ,spread:2
non-negligible ,covid-19:2
factor ,spread:2
prediction ,mirnas:4
prediction ,genomes:2
prediction ,hsa-mir:2
prediction ,databases:2
prediction ,identify:2
prediction ,key:2
mirnas ,genomes:2
mirnas ,hsa-mir:2
mirnas ,databases:2
mirnas ,identify:2
mirnas ,key:2
sars-cov-2 ,hsa-mir:2
sars-cov-2 ,databases:2
sars-cov-2 ,identify:4
genomes ,hsa-mir:2
genomes ,databases:2
genomes ,identify:2
genomes ,key:2
hsa-mir ,databases:2
hsa-mir ,identify:2
hsa-mir ,key:2
databases ,identify:2
databases ,key:2
identify ,key:4
factors ,negative:2
factors ,conversion:2
factors ,hospitalized:6
associated ,negative:4
associated ,conversion:2
associated ,hospitalized:8
negative ,conversion:4
negative ,viral:4
negative ,rna:4
negative ,hospitalized:2
conversion ,viral:2
conversion ,rna:2
conversion ,patients:2
conversion ,hospitalized:2
viral ,hospitalized:4
rna ,hospitalized:2
identification ,lungs:2
identification ,heart:2
identification ,kidney:2
identification ,specimens:2
identification ,transmission:2
lungs ,heart:4
lungs ,kidney:2
lungs ,specimens:2
lungs ,transmission:2
heart ,kidney:4
heart ,specimens:2
heart ,transmission:2
kidney ,specimens:2
kidney ,transmission:2
specimens ,transmission:2
covid-19 ,neurologist:2
review ,neurologist:2
pediatric ,neurologist:2
traditional ,effective:2
traditional ,novel:2
traditional ,coronavirus:2
chinese ,effective:2
chinese ,novel:2
chinese ,coronavirus:4
medicine ,effective:2
medicine ,novel:4
medicine ,coronavirus:8
strategy ,prevent:6
strategy ,control:4
strategy ,zoonoses:2
prevent ,zoonoses:2
control ,zoonoses:2
aspen ,report:2
aspen ,nutrition:2
aspen ,support:2
aspen ,practice:2
aspen ,processes:2
aspen ,covid-19:2
aspen ,first:2
report ,nutrition:2
report ,support:2
report ,practice:2
report ,processes:2
report ,first:14
nutrition ,support:4
nutrition ,practice:2
nutrition ,processes:2
nutrition ,first:2
support ,practice:2
support ,processes:2
support ,first:2
practice ,processes:2
practice ,first:4
processes ,covid-19:2
processes ,first:2
covid-19 ,ebm:2
pregnancy ,delivery:4
pregnancy ,period:2
pregnancy ,based:2
pregnancy ,ebm:2
delivery ,postpartum:2
delivery ,period:2
delivery ,based:2
delivery ,ebm:2
postpartum ,period:2
postpartum ,based:2
postpartum ,ebm:2
period ,based:2
period ,ebm:2
based ,ebm:2
pregnancy ,management:6
pregnancy ,challenges:2
defensin ,prevention:2
defensin ,sars-cov-2:2
defensin ,invasion:2
defensin ,covid-19:2
defensin ,disease:2
prevention ,invasion:2
sars-cov-2 ,invasion:6
invasion ,disease:2
overview ,dermatologists:2
sars-cov-2 ,adults:8
sars-cov-2 ,expect:4
sars-cov-2 ,regarding:2
covid-19 ,expect:4
older ,may:2
older ,expect:2
older ,regarding:2
older ,pathogenesis:2
adults ,may:2
adults ,expect:2
adults ,regarding:2
adults ,pathogenesis:2
may ,expect:2
may ,regarding:2
may ,pathogenesis:2
expect ,regarding:2
expect ,pathogenesis:2
regarding ,pathogenesis:2
performance ,four:4
performance ,high-throughput:6
characteristics ,high-throughput:6
characteristics ,immunoassays:2
four ,high-throughput:4
high-throughput ,immunoassays:2
high-throughput ,detection:2
immunoassays ,detection:6
systemic ,inflammatory:4
systemic ,response:4
systemic ,thrombosis:2
systemic ,due:2
systemic ,alterations:2
systemic ,gut:2
inflammatory ,response:12
inflammatory ,thrombosis:2
inflammatory ,due:2
inflammatory ,alterations:2
inflammatory ,gut:2
response ,thrombosis:2
response ,due:2
response ,alterations:2
response ,gut:2
thrombosis ,due:4
thrombosis ,alterations:2
thrombosis ,gut:2
due ,alterations:2
due ,gut:2
alterations ,gut:4
pharmacological ,therapies:4
pharmacological ,covid-19:22
pharmacological ,state:2
pharmacological ,art:2
pharmacological ,hopes:2
therapies ,state:6
therapies ,art:2
therapies ,hopes:2
covid-19 ,state:20
covid-19 ,art:8
state ,art:6
state ,hopes:2
art ,hopes:2
values ,limitations:2
values ,mathematical:2
values ,modelling:2
values ,covid-19:4
values ,world:2
limitations ,mathematical:2
limitations ,modelling:2
limitations ,covid-19:4
limitations ,world:2
mathematical ,modelling:4
mathematical ,world:2
modelling ,world:2
covid-19 ,world:8
covid-19 ,atmospheric:4
covid-19 ,daily:6
covid-19 ,growth:8
relationship ,atmospheric:2
relationship ,temperature:2
relationship ,daily:2
relationship ,new:2
relationship ,cases:2
relationship ,growth:2
atmospheric ,temperature:2
atmospheric ,daily:2
atmospheric ,new:2
atmospheric ,cases:2
atmospheric ,growth:2
temperature ,daily:2
temperature ,new:2
temperature ,cases:2
temperature ,growth:2
daily ,new:2
daily ,cases:2
daily ,growth:2
new ,growth:2
cases ,growth:4
updates ,pharmacology:2
updates ,chloroquine:2
pharmacology ,chloroquine:2
pharmacology ,coronavirus:2
pharmacology ,disease:2
chloroquine ,disease:4
first ,intensive:2
first ,care:2
wave ,intensive:2
wave ,care:2
facile ,biosensors:2
facile ,rapid:2
facile ,detection:2
facile ,covid-19:2
biosensors ,rapid:2
biosensors ,detection:2
biosensors ,covid-19:4
risk ,anaesthetists:2
risk ,intensivists:2
risk ,narrative:2
health ,anaesthetists:2
health ,intensivists:2
health ,narrative:6
covid-19 ,anaesthetists:2
covid-19 ,intensivists:4
anaesthetists ,intensivists:2
anaesthetists ,narrative:2
intensivists ,narrative:2
sars-cov-2 ,treated:10
sars-cov-2 ,anti:4
sars-cov-2 ,tnf:2
infection ,anti:2
infection ,tnf:2
patient ,hydroxychloroquine:4
patient ,anti:2
patient ,tnf:2
treated ,anti:2
treated ,tnf:2
hydroxychloroquine ,anti:2
hydroxychloroquine ,tnf:2
anti ,tnf:2
sars-cov-2-host ,dynamics:2
sars-cov-2-host ,increased:2
sars-cov-2-host ,risk:2
sars-cov-2-host ,adverse:2
sars-cov-2-host ,outcomes:2
sars-cov-2-host ,covid-19:2
sars-cov-2-host ,obesity:2
dynamics ,increased:2
dynamics ,risk:2
dynamics ,adverse:2
dynamics ,outcomes:2
dynamics ,obesity:2
increased ,risk:12
increased ,adverse:2
increased ,outcomes:4
increased ,obesity:2
risk ,adverse:4
risk ,outcomes:8
risk ,obesity:10
adverse ,outcomes:6
adverse ,covid-19:10
adverse ,obesity:4
age-related ,differences:6
age-related ,nasopharyngeal:2
age-related ,severe:2
age-related ,acute:2
age-related ,respiratory:2
age-related ,syndrome:2
differences ,nasopharyngeal:2
nasopharyngeal ,severe:2
nasopharyngeal ,acute:2
nasopharyngeal ,respiratory:2
nasopharyngeal ,syndrome:2
three ,italy:2
three ,epidemic:2
three ,possible:2
three ,involvement:2
italy ,epidemic:6
italy ,possible:2
italy ,involvement:2
epidemic ,possible:2
epidemic ,involvement:2
possible ,involvement:2
varicella-like ,exanthem:2
varicella-like ,associated:2
varicella-like ,covid-19:2
varicella-like ,8-year-old:2
varicella-like ,girl:2
varicella-like ,diagnostic:2
exanthem ,associated:2
exanthem ,covid-19:2
exanthem ,8-year-old:2
exanthem ,girl:2
exanthem ,diagnostic:2
associated ,8-year-old:2
associated ,girl:2
associated ,diagnostic:2
covid-19 ,8-year-old:2
covid-19 ,girl:2
8-year-old ,girl:2
8-year-old ,diagnostic:2
girl ,diagnostic:2
detection ,characterization:4
detection ,community-based:2
genetic ,characterization:4
genetic ,community-based:2
genetic ,infections:2
characterization ,community-based:2
characterization ,infections:2
community-based ,sars-cov-2:2
community-based ,infections:2
asymptomatic ,study:8
infection ,large:4
healthcare ,study:2
workers ,study:2
study ,large:2
review ,serologic:2
current ,advances:4
current ,serologic:2
advances ,serologic:2
advances ,testing:2
serologic ,testing:2
serologic ,covid-19:4
rationale ,use:6
rationale ,neutrophil-to-lymphocyte:2
rationale ,ratio:2
rationale ,early:2
rationale ,diagnosis:2
use ,neutrophil-to-lymphocyte:2
use ,ratio:2
use ,diagnosis:2
neutrophil-to-lymphocyte ,early:2
neutrophil-to-lymphocyte ,diagnosis:2
ratio ,early:2
ratio ,diagnosis:2
early ,diagnosis:10
hyperglycemia ,without:2
hyperglycemia ,diabetes:4
hyperglycemia ,new-onset:2
hyperglycemia ,associated:2
without ,diabetes:2
without ,new-onset:2
without ,associated:2
diabetes ,new-onset:2
new-onset ,associated:2
zoonotic ,reverse:2
zoonotic ,events:2
zoonotic ,impact:2
reverse ,events:2
reverse ,impact:2
reverse ,global:2
events ,impact:2
events ,global:4
impact ,global:6
negative ,transmission:2
negative ,hand-expressed:2
negative ,colostrum:2
transmission ,hand-expressed:2
transmission ,colostrum:2
sars-cov-2 ,hand-expressed:2
sars-cov-2 ,colostrum:2
hand-expressed ,colostrum:2
contribution ,monocytes:2
contribution ,macrophages:2
contribution ,local:2
contribution ,tissue:2
contribution ,inflammation:2
monocytes ,macrophages:2
monocytes ,local:2
monocytes ,tissue:2
monocytes ,inflammation:4
macrophages ,local:2
macrophages ,tissue:2
macrophages ,inflammation:2
local ,tissue:2
local ,inflammation:2
cardiovascular ,higher:2
cardiovascular ,risk:8
cardiovascular ,affecting:2
system ,higher:2
system ,affecting:2
higher ,risk:4
higher ,affecting:2
higher ,covid-19:10
affecting ,covid-19:4
clinical ,timing:2
clinical ,cessation:2
clinical ,rna:8
clinical ,shedding:6
predictors ,timing:2
predictors ,cessation:2
predictors ,viral:2
predictors ,rna:2
predictors ,shedding:2
timing ,cessation:2
timing ,viral:2
timing ,rna:2
timing ,shedding:4
timing ,patients:2
cessation ,viral:2
cessation ,rna:2
cessation ,shedding:2
cessation ,patients:4
issues ,cardiovascular:6
issues ,risk:4
issues ,management:4
issues ,people:2
issues ,diabetes:4
cardiovascular ,management:8
cardiovascular ,people:2
cardiovascular ,diabetes:6
risk ,people:2
management ,people:2
management ,diabetes:6
people ,diabetes:6
spike ,recognition:2
spike ,mammalian:2
spike ,predicts:2
spike ,host:4
spike ,range:2
spike ,optimized:4
protein ,recognition:2
protein ,mammalian:2
protein ,ace2:14
protein ,predicts:2
protein ,host:4
protein ,range:4
protein ,optimized:2
recognition ,mammalian:2
recognition ,ace2:6
recognition ,predicts:2
recognition ,host:4
recognition ,range:2
recognition ,optimized:2
mammalian ,ace2:2
mammalian ,predicts:2
mammalian ,host:2
mammalian ,range:2
mammalian ,optimized:2
ace2 ,predicts:2
ace2 ,range:2
ace2 ,optimized:2
predicts ,host:4
predicts ,range:2
predicts ,optimized:2
host ,range:4
host ,optimized:2
range ,optimized:2
early ,kidney:2
early ,transplantation:4
early ,recipients:2
early ,update:2
experience ,kidney:2
experience ,transplantation:2
experience ,recipients:2
experience ,update:2
kidney ,transplantation:2
kidney ,recipients:8
kidney ,update:2
transplantation ,recipients:2
transplantation ,update:2
recipients ,update:2
prevalence ,renal:2
prevalence ,impairment:2
prevalence ,systematic:2
impact ,renal:2
impact ,impairment:2
impact ,systematic:2
impact ,review:8
acute ,impairment:2
acute ,systematic:6
renal ,impairment:2
renal ,systematic:4
impairment ,systematic:2
impairment ,review:2
detection ,seroconversion:2
sars-cov-2 ,seroconversion:12
antibodies ,commercial:2
antibodies ,assays:4
antibodies ,seroconversion:2
using ,seroconversion:2
commercial ,seroconversion:2
assays ,seroconversion:4
two ,x-linked:2
two ,agammaglobulinemia:2
two ,develop:2
two ,pneumonia:8
two ,manifestation:2
x-linked ,agammaglobulinemia:2
x-linked ,patients:2
x-linked ,develop:2
x-linked ,pneumonia:2
x-linked ,covid-19:2
x-linked ,manifestation:2
agammaglobulinemia ,patients:2
agammaglobulinemia ,develop:2
agammaglobulinemia ,pneumonia:2
agammaglobulinemia ,covid-19:2
agammaglobulinemia ,manifestation:2
patients ,develop:2
develop ,pneumonia:2
develop ,covid-19:2
develop ,manifestation:2
pneumonia ,manifestation:2
functional ,pangenome:2
functional ,analysis:6
functional ,shows:2
functional ,key:2
functional ,features:2
functional ,preserved:2
functional ,sars:2
pangenome ,analysis:2
pangenome ,shows:2
pangenome ,key:2
pangenome ,features:2
pangenome ,protein:2
pangenome ,preserved:2
pangenome ,sars:2
analysis ,shows:2
analysis ,key:4
analysis ,preserved:2
analysis ,sars:4
shows ,key:2
shows ,features:2
shows ,protein:2
shows ,preserved:2
shows ,sars:2
key ,protein:4
key ,preserved:2
key ,sars:2
features ,protein:4
features ,preserved:2
features ,sars:4
protein ,preserved:2
preserved ,sars:2
potential ,prospective:4
rna-dependent ,prospective:2
rna ,prospective:2
polymerase ,prospective:2
inhibitors ,prospective:4
inhibitors ,therapeutics:4
prospective ,therapeutics:4
modified ,rehabilitation:2
modified ,exercises:2
modified ,mild:2
modified ,cases:2
modified ,covid-19:4
rehabilitation ,exercises:2
rehabilitation ,mild:2
rehabilitation ,cases:2
rehabilitation ,covid-19:10
exercises ,mild:2
exercises ,cases:2
exercises ,covid-19:2
mild ,cases:8
satellite-detected ,tropospheric:2
satellite-detected ,nitrogen:2
satellite-detected ,dioxide:2
satellite-detected ,spread:2
satellite-detected ,sars-cov-2:2
satellite-detected ,infection:2
tropospheric ,nitrogen:2
tropospheric ,dioxide:2
tropospheric ,spread:2
tropospheric ,sars-cov-2:2
tropospheric ,infection:2
nitrogen ,dioxide:2
nitrogen ,spread:2
nitrogen ,sars-cov-2:2
nitrogen ,infection:2
dioxide ,spread:2
dioxide ,sars-cov-2:2
dioxide ,infection:2
spread ,infection:6
experiencing ,community:2
experiencing ,covid:2
experiencing ,surge:2
community ,covid:4
community ,surge:2
covid ,surge:2
performance ,id:2
performance ,now:2
performance ,covid-19:12
performance ,rapid:8
performance ,nucleic:4
performance ,acid:4
performance ,amplification:4
performance ,test:8
abbott ,id:4
abbott ,now:4
abbott ,covid-19:2
abbott ,rapid:4
abbott ,nucleic:2
abbott ,acid:2
abbott ,amplification:2
abbott ,test:2
abbott ,using:2
id ,rapid:4
id ,nucleic:2
id ,acid:2
id ,amplification:2
id ,test:2
id ,using:2
now ,rapid:4
now ,nucleic:2
now ,acid:2
now ,amplification:2
now ,test:2
now ,using:2
rapid ,nucleic:4
rapid ,acid:4
rapid ,amplification:14
nucleic ,amplification:8
nucleic ,using:2
acid ,amplification:8
acid ,using:2
amplification ,test:4
amplification ,using:4
test ,using:2
natural ,history:6
natural ,current:6
natural ,knowledge:2
natural ,treatment:2
natural ,therapeutic:2
natural ,options:2
history ,current:2
history ,knowledge:2
history ,treatment:2
history ,therapeutic:2
history ,options:2
knowledge ,treatment:2
knowledge ,therapeutic:2
knowledge ,options:2
treatment ,therapeutic:6
susceptibility ,swine:2
susceptibility ,cells:2
susceptibility ,domestic:2
susceptibility ,pigs:2
swine ,cells:2
swine ,domestic:2
swine ,pigs:2
swine ,sars-cov-2:2
cells ,domestic:2
cells ,pigs:2
domestic ,pigs:2
pigs ,sars-cov-2:2
pulmonary ,pathology:8
pulmonary ,early-phase:4
pulmonary ,novel:6
pulmonary ,coronavirus:10
pulmonary ,pneumonia:12
pathology ,early-phase:4
pathology ,novel:2
pathology ,pneumonia:4
early-phase ,novel:2
early-phase ,coronavirus:2
early-phase ,covid-19:4
early-phase ,pneumonia:4
persistence ,virus:2
persistence ,feces:2
persistence ,case:2
persistence ,series:2
persistence ,children:2
virus ,feces:2
virus ,case:16
virus ,series:6
virus ,children:2
rna ,series:2
feces ,case:2
feces ,series:2
feces ,children:4
3-month-old ,child:2
3-month-old ,covid-19:2
3-month-old ,case:2
3-month-old ,report:2
child ,case:4
child ,report:4
severe ,virus:8
severe ,reactivation:2
severe ,following:2
severe ,cell:10
covid-19 ,reactivation:4
covid-19 ,following:10
virus ,reactivation:2
virus ,following:2
virus ,cell:2
reactivation ,following:2
reactivation ,treatment:2
reactivation ,cell:2
reactivation ,acute:2
following ,treatment:4
following ,cell:2
following ,acute:6
cell ,acute:6
nucleotide ,analogues:6
nucleotide ,inhibitors:4
nucleotide ,sars-cov-2:2
nucleotide ,polymerase:4
nucleotide ,key:2
nucleotide ,drug:2
nucleotide ,target:2
analogues ,inhibitors:6
analogues ,sars-cov-2:2
analogues ,polymerase:4
analogues ,key:2
analogues ,drug:2
analogues ,target:2
inhibitors ,key:4
inhibitors ,target:2
polymerase ,key:2
polymerase ,target:8
key ,drug:2
key ,target:2
understanding ,cell:2
understanding ,epitopes:2
understanding ,spike:2
understanding ,protein:2
understanding ,severe:2
understanding ,acute:2
cell ,respiratory:4
epitopes ,severe:2
epitopes ,acute:2
epitopes ,respiratory:2
analysis ,baseline:2
analysis ,liver:6
analysis ,biochemical:6
analysis ,parameters:4
analysis ,324:2
baseline ,liver:2
baseline ,biochemical:2
baseline ,parameters:2
baseline ,324:2
baseline ,cases:2
baseline ,novel:2
liver ,biochemical:2
liver ,parameters:2
liver ,324:2
liver ,cases:4
biochemical ,parameters:6
biochemical ,324:2
biochemical ,cases:2
parameters ,324:2
parameters ,cases:2
324 ,cases:2
324 ,novel:2
treatment ,close:2
treatment ,cure:2
treatment ,pharmacotherapies:2
close ,cure:2
close ,rapid:2
close ,review:2
close ,pharmacotherapies:2
cure ,rapid:2
cure ,review:2
cure ,pharmacotherapies:2
rapid ,pharmacotherapies:2
review ,pharmacotherapies:2
diarrhea ,early:2
diarrhea ,predominant:2
diarrhea ,manifestation:2
diarrhea ,coronavirus:2
diarrhea ,disease:2
early ,predominant:2
early ,manifestation:2
early ,disease:26
predominant ,manifestation:2
predominant ,coronavirus:2
predominant ,disease:2
manifestation ,disease:4
covid-19 ,clinician:2
diabetes ,clinician:2
diabetes ,need:2
diabetes ,know:2
clinician ,need:2
clinician ,know:2
model ,calculations:2
model ,aerosol:4
model ,indoor:2
calculations ,aerosol:2
calculations ,transmission:2
calculations ,infection:2
calculations ,risk:2
calculations ,covid-19:2
calculations ,indoor:2
aerosol ,transmission:10
aerosol ,infection:4
aerosol ,risk:4
aerosol ,covid-19:8
aerosol ,indoor:2
infection ,indoor:2
risk ,indoor:2
spatial ,temporal:2
spatial ,dynamics:2
spatial ,sars-cov-2:2
spatial ,covid-19:4
spatial ,patients:2
spatial ,systematic:2
temporal ,dynamics:2
temporal ,systematic:2
dynamics ,patients:10
dynamics ,systematic:2
evolutionary ,epidemiology:2
sars-cov-2 ,liver:12
sars-cov-2 ,directly:6
sars-cov-2 ,contributes:2
sars-cov-2 ,hepatic:4
infection ,liver:8
infection ,directly:2
infection ,contributes:2
infection ,hepatic:6
infection ,impairment:2
liver ,directly:2
liver ,contributes:2
liver ,hepatic:2
liver ,impairment:4
directly ,contributes:2
directly ,hepatic:2
directly ,impairment:2
contributes ,hepatic:2
contributes ,impairment:2
hepatic ,impairment:2
sars-cov-2 ,another:2
sars-cov-2 ,kind:2
sars-cov-2 ,aggressor:2
another ,kind:2
another ,liver:2
another ,aggressor:2
kind ,liver:2
kind ,aggressor:2
liver ,aggressor:2
ace2 ,pancreas:2
ace2 ,pancreatic:2
ace2 ,damage:2
expression ,pancreas:2
expression ,pancreatic:2
expression ,damage:2
pancreas ,may:2
pancreas ,cause:2
pancreas ,pancreatic:2
pancreas ,damage:2
pancreas ,sars-cov-2:2
pancreas ,infection:2
may ,pancreatic:2
may ,infection:6
cause ,pancreatic:2
pancreatic ,damage:2
pancreatic ,sars-cov-2:2
pancreatic ,infection:2
considerations ,treatment:2
considerations ,inflammatory:2
considerations ,neuro-ophthalmologic:2
considerations ,disorders:2
treatment ,neuro-ophthalmologic:2
treatment ,disorders:4
inflammatory ,neuro-ophthalmologic:2
inflammatory ,disorders:2
neuro-ophthalmologic ,disorders:2
use ,knowledge:2
use ,management:6
use ,tools:2
use ,viroinformatics:2
use ,example:2
use ,highly:4
knowledge ,management:2
knowledge ,tools:2
knowledge ,viroinformatics:2
knowledge ,example:2
knowledge ,study:4
knowledge ,highly:2
management ,tools:4
management ,viroinformatics:2
management ,example:2
management ,study:4
management ,highly:2
tools ,viroinformatics:2
tools ,example:2
tools ,study:2
tools ,highly:2
viroinformatics ,example:2
viroinformatics ,study:2
viroinformatics ,highly:2
example ,study:2
example ,highly:2
study ,highly:2
epidemiological ,differences:2
epidemiological ,disease:14
clinical ,differences:2
differences ,disease:2
differences ,patients:4
hypothesis ,role:2
hypothesis ,human:2
risks ,transmission:4
risks ,blood:2
risks ,serum:2
risks ,surgery:2
risks ,prospective:2
covid-19 ,serum:12
transmission ,blood:4
transmission ,serum:4
transmission ,surgery:2
transmission ,prospective:4
blood ,surgery:2
blood ,prospective:2
serum ,surgery:2
serum ,prospective:2
surgery ,prospective:2
monoclonal ,s2:2
monoclonal ,subunit:2
monoclonal ,spike:2
monoclonal ,sars-cov-1:2
monoclonal ,cross-react:2
antibodies ,s2:2
antibodies ,subunit:2
antibodies ,sars-cov-1:2
antibodies ,cross-react:2
s2 ,subunit:2
s2 ,spike:2
s2 ,sars-cov-1:2
s2 ,cross-react:2
subunit ,spike:4
subunit ,sars-cov-1:2
subunit ,cross-react:2
spike ,sars-cov-1:2
spike ,cross-react:2
sars-cov-1 ,cross-react:2
aerosol ,evidence:2
aerosol ,prevention:2
aerosol ,control:2
evidence ,prevention:2
evidence ,control:2
cov-seq ,new:2
cov-seq ,tool:2
cov-seq ,sars-cov-2:2
cov-seq ,genome:2
cov-seq ,analysis:2
cov-seq ,visualization:2
cov-seq ,development:2
new ,tool:2
new ,genome:2
new ,analysis:6
new ,visualization:2
new ,development:10
tool ,genome:6
tool ,analysis:2
tool ,visualization:2
tool ,development:2
sars-cov-2 ,visualization:2
genome ,visualization:2
genome ,development:4
analysis ,visualization:4
visualization ,development:2
sleep ,medicine:2
sleep ,covid-19:8
sleep ,new:2
sleep ,era:4
sleep ,begun:2
medicine ,new:4
medicine ,era:2
medicine ,begun:2
covid-19 ,begun:2
new ,begun:2
era ,begun:2
sars-cov-2 ,gaps:2
pandemic ,gaps:4
pandemic ,understanding:8
pandemic ,interaction:2
research ,gaps:2
research ,understanding:2
research ,interaction:2
gaps ,understanding:4
gaps ,interaction:2
understanding ,interaction:2
interaction ,human:6
interaction ,membrane-bound:2
interaction ,sars-cov-1:2
human ,membrane-bound:2
human ,sars-cov-1:2
ace2 ,membrane-bound:2
ace2 ,sars-cov-1:2
membrane-bound ,sars-cov-1:2
membrane-bound ,sars-cov-2:2
sars-cov-1 ,sars-cov-2:10
immunoinformatics-guided ,design:2
immunoinformatics-guided ,epitope-based:4
immunoinformatics-guided ,vaccine:2
immunoinformatics-guided ,severe:2
immunoinformatics-guided ,acute:2
design ,epitope-based:4
design ,severe:2
design ,acute:2
epitope-based ,vaccine:4
epitope-based ,severe:4
epitope-based ,acute:4
analysis ,54:2
analysis ,mortality:2
analysis ,republic:4
analysis ,korea:4
54 ,mortality:2
54 ,cases:2
54 ,coronavirus:2
54 ,disease:2
54 ,republic:2
54 ,korea:2
mortality ,cases:2
mortality ,coronavirus:16
mortality ,disease:14
mortality ,republic:2
mortality ,korea:2
cases ,republic:4
cases ,korea:4
coronavirus ,republic:2
disease ,republic:2
republic ,korea:4
vitamin ,risk:4
vitamin ,factor:2
vitamin ,correlation:2
deficiency ,risk:2
deficiency ,factor:2
deficiency ,correlation:2
risk ,correlation:2
factor ,sars-cov-2:14
factor ,infection:4
factor ,correlation:2
infection ,correlation:2
original ,logigramme:2
original ,make:2
original ,safe:2
original ,discharge:2
original ,community:2
original ,reintegration:2
logigramme ,make:2
logigramme ,safe:2
logigramme ,discharge:2
logigramme ,community:2
logigramme ,reintegration:2
make ,safe:2
make ,discharge:2
make ,community:2
make ,reintegration:2
safe ,discharge:2
safe ,community:2
safe ,reintegration:2
discharge ,community:2
discharge ,reintegration:2
community ,reintegration:2
systematic ,studies:2
systematic ,19:4
systematic ,viral:2
analysis ,19:4
analysis ,viral:12
studies ,corona:2
studies ,virus:4
studies ,19:2
corona ,19:2
corona ,viral:4
virus ,19:2
virus ,viral:6
19 ,viral:2
coronavirus ,docking:2
disease ,discovery:2
disease ,docking:2
drug ,molecular:10
drug ,docking:2
discovery ,molecular:4
discovery ,docking:2
challenges ,managing:4
challenges ,asymptomatic:2
challenges ,carriers:2
managing ,asymptomatic:2
managing ,carriers:2
managing ,sars-cov-2:2
asymptomatic ,carriers:8
carriers ,sars-cov-2:6
family ,three:2
family ,recovered:2
family ,cases:2
family ,pneumonia:2
family ,due:2
cluster ,three:2
cluster ,recovered:2
cluster ,pneumonia:2
cluster ,due:2
three ,recovered:2
three ,pneumonia:4
three ,due:2
three ,severe:2
three ,acute:2
three ,respiratory:2
recovered ,cases:4
recovered ,pneumonia:4
recovered ,due:2
recovered ,severe:4
recovered ,acute:2
recovered ,respiratory:2
cases ,due:2
persistently ,replicating:2
persistently ,sars-cov-2:4
persistently ,variant:2
persistently ,derived:2
persistently ,asymptomatic:2
replicating ,sars-cov-2:6
replicating ,variant:2
replicating ,derived:2
replicating ,asymptomatic:2
sars-cov-2 ,derived:6
variant ,derived:2
variant ,asymptomatic:2
derived ,asymptomatic:2
preoperative ,covid-19:2
preoperative ,testing:2
preoperative ,elective:2
preoperative ,vitreoretinal:2
preoperative ,surgeries:2
preoperative ,experience:2
covid-19 ,elective:8
covid-19 ,vitreoretinal:4
covid-19 ,surgeries:4
testing ,elective:2
testing ,vitreoretinal:2
testing ,surgeries:2
elective ,vitreoretinal:2
elective ,surgeries:4
elective ,experience:4
vitreoretinal ,surgeries:4
vitreoretinal ,experience:2
surgeries ,experience:2
transmission ,effectiveness:4
transmission ,government:2
dynamics ,outbreak:2
dynamics ,effectiveness:2
dynamics ,government:2
covid-19 ,effectiveness:20
covid-19 ,government:2
outbreak ,effectiveness:2
outbreak ,government:2
effectiveness ,government:2
signal ,hotspot:2
signal ,mutations:2
signal ,sars-cov-2:2
signal ,genomes:2
signal ,evolve:2
signal ,virus:2
signal ,spreads:2
hotspot ,mutations:2
hotspot ,sars-cov-2:2
hotspot ,genomes:2
hotspot ,evolve:2
hotspot ,virus:2
hotspot ,spreads:2
mutations ,genomes:2
mutations ,evolve:2
mutations ,virus:2
mutations ,spreads:2
sars-cov-2 ,evolve:2
sars-cov-2 ,spreads:4
genomes ,evolve:2
genomes ,virus:4
genomes ,spreads:2
evolve ,virus:2
evolve ,spreads:2
virus ,spreads:2
know ,environment:2
ct ,infected:2
findings ,infected:2
back ,basics:2
back ,propolis:2
back ,covid-19:2
basics ,propolis:2
basics ,covid-19:4
propolis ,covid-19:4
covid-19 ,nephrologists:2
covid-19 ,extent:2
covid-19 ,impasse:2
concern ,nephrologists:2
concern ,extent:2
concern ,emerging:2
concern ,impasse:2
nephrologists ,extent:2
nephrologists ,emerging:2
nephrologists ,impasse:2
extent ,emerging:2
extent ,impasse:2
emerging ,impasse:2
neurological ,consequences:4
neurological ,2019-ncov:2
neurological ,comprehensive:2
neurological ,literature:4
consequences ,2019-ncov:2
consequences ,infection:6
consequences ,comprehensive:2
consequences ,literature:2
consequences ,review:4
2019-ncov ,comprehensive:4
2019-ncov ,literature:2
2019-ncov ,review:4
infection ,comprehensive:6
covid-19 ,mast:6
covid-19 ,stress:10
mast ,cells:6
mast ,cytokine:2
mast ,storm:2
mast ,psychological:2
mast ,stress:2
mast ,neuroinflammation:2
cells ,cytokine:2
cells ,storm:2
cells ,psychological:2
cells ,stress:2
cells ,neuroinflammation:2
cytokine ,psychological:2
cytokine ,stress:2
cytokine ,neuroinflammation:2
storm ,psychological:2
storm ,stress:2
storm ,neuroinflammation:2
psychological ,stress:2
psychological ,neuroinflammation:2
stress ,neuroinflammation:2
air ,determinant:2
pollution ,determinant:2
determinant ,covid-19:4
outbreak ,overview:2
outbreak ,dentistry:4
overview ,dentistry:2
impact ,viruses:2
covid-19 ,reproductive:4
viruses ,reproductive:2
viruses ,health:2
reproductive ,health:4
chest-ct ,findings:2
chest-ct ,covid-19:2
chest-ct ,patients:2
chest-ct ,pre-existing:2
chest-ct ,malignancies:2
findings ,pre-existing:2
findings ,malignancies:2
covid-19 ,malignancies:2
patients ,malignancies:2
pre-existing ,malignancies:2
immunesenescence ,predisposing:2
immunesenescence ,risk:2
immunesenescence ,factor:2
immunesenescence ,development:2
immunesenescence ,covid-19:2
predisposing ,risk:2
predisposing ,factor:2
predisposing ,development:2
predisposing ,covid-19:2
factor ,development:2
reverse ,vaccinology:4
reverse ,assisted:2
reverse ,designing:2
reverse ,multiepitope-based:2
reverse ,subunit:2
reverse ,vaccine:4
vaccinology ,assisted:2
vaccinology ,designing:2
vaccinology ,multiepitope-based:2
vaccinology ,subunit:2
vaccinology ,vaccine:4
assisted ,designing:2
assisted ,multiepitope-based:2
assisted ,subunit:2
assisted ,vaccine:2
designing ,multiepitope-based:2
designing ,subunit:4
designing ,vaccine:6
multiepitope-based ,subunit:2
multiepitope-based ,vaccine:4
subunit ,vaccine:8
putative ,role:4
putative ,de-mono-adp-ribosylation:2
putative ,stat1:2
putative ,sars-cov-2:12
putative ,nsp3:2
putative ,protein:8
role ,de-mono-adp-ribosylation:2
role ,stat1:2
role ,nsp3:2
role ,protein:10
de-mono-adp-ribosylation ,stat1:2
de-mono-adp-ribosylation ,sars-cov-2:2
de-mono-adp-ribosylation ,nsp3:2
de-mono-adp-ribosylation ,protein:2
stat1 ,sars-cov-2:2
stat1 ,nsp3:2
stat1 ,protein:2
sars-cov-2 ,nsp3:4
nsp3 ,protein:2
perceived ,versus:2
perceived ,proven:2
perceived ,sars-cov-2-specific:2
perceived ,immune:2
perceived ,responses:2
perceived ,health-care:2
versus ,proven:2
versus ,sars-cov-2-specific:2
versus ,responses:8
versus ,health-care:2
proven ,sars-cov-2-specific:2
proven ,immune:2
proven ,responses:2
proven ,health-care:2
sars-cov-2-specific ,immune:2
sars-cov-2-specific ,responses:4
sars-cov-2-specific ,health-care:2
immune ,health-care:2
responses ,health-care:2
characteristics ,household:2
household ,covid-19:6
acute ,vision:4
vision ,loss:4
vision ,patient:2
vision ,covid-19:2
loss ,patient:2
clonal ,haematopoiesis:2
clonal ,covid-19:2
clonal ,possible:2
clonal ,deadly:2
clonal ,liaison:2
haematopoiesis ,covid-19:2
haematopoiesis ,possible:2
haematopoiesis ,deadly:2
haematopoiesis ,liaison:2
covid-19 ,deadly:2
covid-19 ,liaison:2
possible ,deadly:2
possible ,liaison:2
deadly ,liaison:2
practitioners ,specialized:2
practitioners ,oral:2
practitioners ,health:2
practitioners ,coronavirus:2
practitioners ,disease:2
practitioners ,professional:4
specialized ,oral:2
specialized ,health:2
specialized ,coronavirus:2
specialized ,disease:2
specialized ,professional:2
oral ,health:4
oral ,disease:4
oral ,professional:2
health ,professional:2
coronavirus ,professional:2
disease ,professional:2
impact ,preoperative:2
impact ,screening:2
impact ,system:8
impact ,head:4
impact ,neck:4
impact ,cancer:12
preoperative ,screening:4
preoperative ,system:2
preoperative ,head:2
preoperative ,neck:2
preoperative ,cancer:2
preoperative ,surgery:2
screening ,system:6
screening ,head:2
screening ,neck:2
screening ,cancer:2
screening ,surgery:6
system ,head:2
system ,neck:2
system ,cancer:4
system ,surgery:2
head ,cancer:10
head ,surgery:6
neck ,cancer:10
neck ,surgery:6
cancer ,surgery:6
immunomodulatory ,activity:2
immunomodulatory ,metformin:2
immunomodulatory ,potential:4
immunomodulatory ,implications:2
antiviral ,metformin:2
antiviral ,implications:2
activity ,metformin:2
activity ,potential:2
activity ,implications:2
metformin ,implications:2
cross-talk ,key:2
cross-talk ,players:2
cross-talk ,patients:2
cross-talk ,covid-19:2
cross-talk ,ischemic:2
cross-talk ,stroke:2
key ,players:2
key ,patients:6
key ,ischemic:2
key ,stroke:2
players ,patients:2
players ,covid-19:2
players ,ischemic:2
players ,stroke:2
patients ,ischemic:4
covid-19 ,ischemic:12
ischemic ,stroke:10
sars-cov-2 ,nose:2
nose ,risks:2
nose ,implications:2
nose ,primary:2
nose ,care:2
risks ,implications:2
risks ,primary:2
implications ,primary:2
primary ,care:16
role ,pharmacists:4
role ,fight:8
pharmacists ,fight:2
pharmacists ,covid-19:4
covid-19 ,observational:6
exposure ,family:2
exposure ,members:2
exposure ,healthcare:8
exposure ,workers:6
exposure ,observational:2
risk ,family:2
risk ,members:2
risk ,observational:2
family ,healthcare:2
family ,workers:2
family ,observational:2
members ,healthcare:2
members ,workers:4
members ,observational:2
healthcare ,observational:2
workers ,observational:2
clinical ,sensitivity:4
clinical ,single:4
clinical ,upper:4
clinical ,tract:2
clinical ,rt-pcr:10
sensitivity ,single:2
sensitivity ,upper:2
sensitivity ,tract:2
sensitivity ,rt-pcr:4
sensitivity ,test:4
single ,upper:2
single ,respiratory:2
single ,tract:2
single ,rt-pcr:2
single ,test:2
upper ,rt-pcr:2
upper ,test:2
tract ,rt-pcr:2
tract ,test:2
n-acetylcysteine ,potential:4
n-acetylcysteine ,therapeutic:2
n-acetylcysteine ,agent:2
n-acetylcysteine ,sars-cov-2:2
potential ,agent:6
therapeutic ,agent:6
epidemiological ,familial:2
epidemiological ,cluster:4
clinical ,familial:4
characteristics ,familial:2
familial ,covid-19:10
principles ,suggestions:2
principles ,biosafety:4
principles ,protection:2
principles ,biological:2
principles ,specimen:2
suggestions ,biosafety:2
suggestions ,protection:2
suggestions ,biological:2
suggestions ,specimen:2
biosafety ,protection:2
biosafety ,biological:2
biosafety ,specimen:2
protection ,biological:2
protection ,specimen:2
biological ,specimen:2
cause ,analysis:4
cause ,strategies:2
cause ,recurrence:2
analysis ,strategies:2
analysis ,recurrence:2
treatment ,recurrence:2
strategies ,recurrence:2
recurrence ,novel:2
recurrence ,coronavirus:2
transmission ,paucisymptomatic:2
potential ,paucisymptomatic:2
asymptomatic ,paucisymptomatic:2
paucisymptomatic ,severe:2
paucisymptomatic ,acute:2
paucisymptomatic ,respiratory:2
cross-reactive ,cause:2
cross-reactive ,neuropathology:2
cross-reactive ,covid-19:2
antibodies ,cause:2
antibodies ,neuropathology:2
cause ,neuropathology:2
neuropathology ,covid-19:6
link ,oral:2
link ,hygiene:2
link ,severity:4
link ,sars-cov-2:6
oral ,hygiene:4
oral ,severity:2
hygiene ,severity:2
hygiene ,sars-cov-2:4
retinal ,involvement:2
retinal ,ocular:2
retinal ,findings:2
retinal ,pneumonia:2
involvement ,findings:2
involvement ,pneumonia:2
ocular ,pneumonia:2
findings ,pneumonia:8
covid-19 ,ominous:2
sars-cov-2 ,ominous:2
sars-cov-2 ,association:18
heart ,ominous:2
heart ,association:2
ominous ,association:2
current ,neuropathogenesis:2
evidence ,neurological:4
evidence ,features:2
evidence ,diagnosis:2
evidence ,neuropathogenesis:2
neurological ,features:4
neurological ,diagnosis:2
neurological ,neuropathogenesis:2
features ,neuropathogenesis:2
diagnosis ,neuropathogenesis:2
positive ,anti-ssaro:2
positive ,antibody:4
positive ,using:2
anti-ssaro ,antibody:2
anti-ssaro ,woman:2
anti-ssaro ,sars-cov-2:2
anti-ssaro ,infection:2
anti-ssaro ,using:2
antibody ,woman:2
antibody ,infection:18
antibody ,using:10
woman ,infection:8
woman ,using:2
infection ,using:4
highly ,sensitive:8
highly ,detection:2
highly ,rna:2
highly ,multiplex:2
highly ,rrt-pcr:2
highly ,molecular:4
sensitive ,rna:4
sensitive ,multiplex:2
sensitive ,rrt-pcr:2
sensitive ,molecular:4
sars-cov-2 ,multiplex:10
rna ,multiplex:2
rna ,rrt-pcr:4
rna ,molecular:2
multiplex ,rrt-pcr:2
multiplex ,molecular:2
rrt-pcr ,molecular:4
clinical ,ausdiagnostics:2
clinical ,multiplex:2
clinical ,tandem:2
evaluation ,ausdiagnostics:4
evaluation ,multiplex:4
evaluation ,tandem:2
ausdiagnostics ,sars-cov-2:2
ausdiagnostics ,multiplex:2
ausdiagnostics ,tandem:2
ausdiagnostics ,pcr:2
ausdiagnostics ,assay:2
sars-cov-2 ,tandem:2
multiplex ,tandem:2
multiplex ,pcr:2
multiplex ,assay:4
tandem ,pcr:2
tandem ,assay:2
population-based ,estimates:2
population-based ,chronic:2
population-based ,conditions:2
population-based ,affecting:2
population-based ,risk:4
population-based ,complications:2
roles ,flavonoids:2
roles ,infection:2
flavonoids ,coronavirus:2
flavonoids ,infection:2
gustatory ,dysfunction:8
gustatory ,early:2
gustatory ,symptom:2
gustatory ,covid-19:10
gustatory ,screening:2
dysfunction ,early:2
dysfunction ,symptom:4
dysfunction ,screening:2
early ,symptom:2
early ,screening:4
symptom ,screening:4
case ,five:2
case ,patients:14
case ,remdesivir:2
report ,study:2
report ,five:4
report ,treated:2
report ,remdesivir:2
study ,five:2
study ,patients:22
study ,treated:2
study ,remdesivir:2
first ,treated:4
first ,remdesivir:4
five ,treated:2
five ,remdesivir:2
treated ,remdesivir:2
antibody ,serologic:4
antibody ,profiles:4
antibody ,two:6
kinetics ,serologic:2
kinetics ,profiles:2
kinetics ,using:2
serologic ,profiles:2
serologic ,infection:4
serologic ,using:2
profiles ,infection:4
profiles ,using:2
profiles ,two:4
using ,two:4
rheumatic ,disease:10
rheumatic ,consequences:2
rheumatic ,pandemic:2
disease ,consequences:2
emergency ,colorectal:2
emergency ,epicenter:2
colorectal ,surgery:4
colorectal ,covid-19:4
colorectal ,pandemic:2
colorectal ,epicenter:2
surgery ,epicenter:2
covid-19 ,epicenter:4
pandemic ,epicenter:2
sars-cov-2 ,zoonosis:2
sars-cov-2 ,threatens:2
new ,zoonosis:2
new ,threatens:2
new ,world:2
pandemic ,zoonosis:2
pandemic ,threatens:2
pandemic ,world:2
zoonosis ,threatens:2
zoonosis ,world:2
threatens ,world:2
fda-approved ,gold:2
fda-approved ,auranofin:2
fda-approved ,inhibits:4
fda-approved ,novel:2
fda-approved ,coronavirus:2
gold ,drug:2
gold ,auranofin:2
gold ,inhibits:2
gold ,novel:2
gold ,coronavirus:2
drug ,auranofin:2
drug ,inhibits:6
auranofin ,inhibits:2
auranofin ,novel:2
auranofin ,coronavirus:2
auranofin ,sars-cov-2:2
inhibits ,novel:2
inhibits ,coronavirus:2
olfactory ,gustatory:14
olfactory ,patient:6
olfactory ,ankylosing:2
gustatory ,patient:4
gustatory ,ankylosing:2
dysfunction ,patient:4
dysfunction ,ankylosing:2
covid-19 ,ankylosing:4
patient ,ankylosing:4
dental ,oral:2
dental ,health:6
dental ,clouds:2
care ,oral:4
care ,clouds:2
oral ,clouds:2
health ,clouds:2
clouds ,covid-19:2
review ,latest:2
review ,available:6
review ,drugs:10
latest ,available:2
latest ,drugs:2
latest ,therapies:2
latest ,sars-cov-2:2
available ,therapies:2
drugs ,therapies:4
analysis ,lymphocyte:2
analysis ,count:2
analysis ,type:6
analysis ,diabetic:2
lymphocyte ,count:2
lymphocyte ,type:2
lymphocyte ,diabetic:2
lymphocyte ,patients:6
lymphocyte ,coronavirus:4
count ,type:2
count ,diabetic:2
count ,patients:2
count ,coronavirus:2
type ,diabetic:6
type ,patients:10
type ,coronavirus:6
diabetic ,patients:12
diabetic ,coronavirus:4
seroprevalence ,people:2
seroprevalence ,loss:2
seroprevalence ,sense:2
sars-cov-2 ,people:10
sars-cov-2 ,sense:2
antibodies ,people:2
antibodies ,loss:2
antibodies ,sense:2
people ,acute:2
people ,loss:2
people ,sense:2
acute ,sense:2
loss ,sense:4
human ,leukocyte:4
human ,antigen:4
human ,susceptibility:4
human ,map:4
leukocyte ,antigen:4
leukocyte ,susceptibility:2
leukocyte ,map:2
leukocyte ,severe:4
leukocyte ,acute:2
leukocyte ,respiratory:2
leukocyte ,syndrome:2
antigen ,susceptibility:2
antigen ,map:2
antigen ,severe:2
antigen ,acute:2
antigen ,respiratory:2
antigen ,syndrome:2
susceptibility ,map:2
susceptibility ,severe:6
susceptibility ,acute:2
susceptibility ,respiratory:2
susceptibility ,syndrome:2
map ,severe:2
map ,acute:2
map ,respiratory:2
map ,syndrome:2
animal-to-human ,viral:2
animal-to-human ,transitions:2
animal-to-human ,sars-cov-2:2
animal-to-human ,evolutionarily:2
animal-to-human ,successful:2
animal-to-human ,one:2
viral ,transitions:2
viral ,evolutionarily:2
viral ,successful:2
viral ,one:2
transitions ,sars-cov-2:2
transitions ,evolutionarily:2
transitions ,successful:2
transitions ,one:2
sars-cov-2 ,evolutionarily:4
sars-cov-2 ,successful:10
evolutionarily ,successful:2
evolutionarily ,one:2
successful ,one:2
vaccine ,comprehensive:4
vaccine ,status:4
vaccine ,report:2
comprehensive ,report:2
status ,report:4
eye ,banking:2
eye ,era:2
banking ,coronavirus:2
banking ,disease:2
banking ,era:2
coronavirus ,era:8
disease ,era:6
faith ,community:2
faith ,sars-cov-2:2
faith ,outbreak:2
faith ,part:2
faith ,problem:2
community ,outbreak:2
community ,part:2
community ,problem:2
sars-cov-2 ,problem:2
outbreak ,part:2
outbreak ,problem:2
part ,problem:2
source ,pandemic:2
source ,ecology:2
source ,genetics:2
source ,coronaviruses:2
covid-19 ,ecology:2
covid-19 ,genetics:8
pandemic ,ecology:2
pandemic ,genetics:2
ecology ,genetics:4
ecology ,coronaviruses:2
genetics ,coronaviruses:2
estimated ,inactivation:2
estimated ,coronaviruses:2
estimated ,solar:2
estimated ,radiation:2
estimated ,special:2
estimated ,reference:2
inactivation ,coronaviruses:4
inactivation ,solar:2
inactivation ,radiation:2
inactivation ,special:2
inactivation ,reference:2
coronaviruses ,solar:2
coronaviruses ,radiation:2
coronaviruses ,special:2
coronaviruses ,reference:2
solar ,radiation:2
solar ,special:2
solar ,reference:2
radiation ,special:2
radiation ,reference:2
special ,reference:2
experience ,coronavirus:8
experience ,disease:6
experience ,cancer:4
experience ,oncology:2
experience ,hub:2
coronavirus ,cancer:18
coronavirus ,oncology:2
coronavirus ,hub:4
disease ,oncology:2
disease ,hub:4
cancer ,hub:2
oncology ,hub:2
covid-19 ,digestive:6
thrilling ,journey:2
thrilling ,sars-cov-2:2
thrilling ,intestine:2
thrilling ,pathogenesis:2
thrilling ,future:2
journey ,sars-cov-2:4
journey ,intestine:2
journey ,pathogenesis:2
journey ,future:2
sars-cov-2 ,intestine:4
intestine ,pathogenesis:2
intestine ,future:2
pathogenesis ,future:2
association ,hla:2
association ,gene:4
association ,polymorphisms:2
association ,silico:2
hla ,gene:2
hla ,polymorphisms:2
hla ,mortality:2
hla ,covid-19:2
hla ,silico:2
gene ,polymorphisms:4
gene ,mortality:4
gene ,covid-19:6
gene ,silico:2
polymorphisms ,mortality:2
polymorphisms ,covid-19:2
polymorphisms ,silico:2
mortality ,silico:2
posterior ,reversible:4
posterior ,encephalopathy:2
posterior ,syndrome:2
posterior ,pres:2
posterior ,neurological:2
posterior ,association:2
reversible ,syndrome:4
reversible ,pres:4
reversible ,neurological:2
reversible ,association:2
encephalopathy ,syndrome:4
encephalopathy ,pres:4
encephalopathy ,neurological:6
encephalopathy ,association:2
syndrome ,pres:4
syndrome ,neurological:4
pres ,neurological:2
pres ,association:2
neurological ,association:2
different ,characteristics:2
different ,corona:2
different ,cases:2
characteristics ,corona:4
characteristics ,virus:6
corona ,cases:4
rna ,cases:4
rna ,antibodies:6
shedding ,recovered:2
shedding ,cases:6
shedding ,presence:2
shedding ,antibodies:2
recovered ,presence:4
recovered ,antibodies:2
cases ,presence:2
cases ,antibodies:2
presence ,antibodies:2
inhibition ,previously:2
inhibition ,2019-ncovinfection:2
inhibition ,highly:2
inhibition ,potent:2
sars-cov-2 ,previously:4
sars-cov-2 ,2019-ncovinfection:2
previously ,2019-ncovinfection:2
previously ,highly:2
previously ,potent:2
2019-ncovinfection ,highly:2
2019-ncovinfection ,potent:2
highly ,potent:2
environment ,pollutants:2
environment ,impacts:2
environment ,dissemination:2
environment ,management:2
covid-19 ,pollutants:2
covid-19 ,impacts:12
pollutants ,impacts:2
pollutants ,dissemination:2
pollutants ,management:2
impacts ,dissemination:2
impacts ,management:2
dissemination ,management:2
covid-19 ,conspiracy:6
covid-19 ,theories:2
covid-19 ,vs:4
trends ,conspiracy:2
trends ,theories:2
trends ,vs:2
trends ,facts:2
conspiracy ,theories:2
conspiracy ,vs:2
conspiracy ,facts:2
theories ,vs:2
theories ,facts:2
vs ,facts:2
travel ,restrictions:2
travel ,sars-cov-2:4
travel ,transmission:2
travel ,effective:2
travel ,distance:2
travel ,approach:2
restrictions ,sars-cov-2:4
restrictions ,transmission:2
restrictions ,effective:2
restrictions ,distance:2
restrictions ,approach:2
sars-cov-2 ,effective:16
sars-cov-2 ,distance:2
transmission ,effective:2
transmission ,distance:2
transmission ,approach:4
effective ,distance:2
effective ,approach:2
distance ,approach:2
covid-19-related ,collapsing:2
covid-19-related ,glomerulopathy:2
covid-19-related ,kidney:2
covid-19-related ,transplant:2
covid-19-related ,recipient:2
collapsing ,glomerulopathy:6
collapsing ,kidney:2
collapsing ,transplant:4
collapsing ,recipient:2
glomerulopathy ,kidney:2
glomerulopathy ,transplant:4
glomerulopathy ,recipient:2
kidney ,transplant:22
kidney ,recipient:8
transplant ,recipient:16
bibliometric ,visualization:2
bibliometric ,analysis:8
bibliometric ,human:2
bibliometric ,coronaviruses:2
bibliometric ,prospects:2
visualization ,human:2
visualization ,coronaviruses:2
visualization ,prospects:2
analysis ,prospects:2
human ,prospects:2
coronaviruses ,prospects:2
application ,laboratory:4
application ,diagnostic:4
application ,technologies:2
application ,current:2
application ,progress:2
laboratory ,technologies:2
laboratory ,progress:2
diagnostic ,progress:2
technologies ,current:2
technologies ,progress:2
modeling ,viral:2
modeling ,dynamics:4
modeling ,infection:6
viral ,dynamics:8
aerosol ,contamination:4
aerosol ,observed:2
aerosol ,quarantine:2
aerosol ,isolation:4
surface ,contamination:10
surface ,observed:2
surface ,quarantine:2
surface ,isolation:2
contamination ,observed:2
contamination ,quarantine:2
contamination ,isolation:4
sars-cov-2 ,observed:4
sars-cov-2 ,quarantine:8
observed ,quarantine:2
observed ,isolation:2
virology ,clinical:2
virology ,features:2
virology ,severe:2
virology ,acute:2
virology ,respiratory:2
virology ,syndrome:2
features ,acute:2
features ,respiratory:2
features ,syndrome:6
safety ,prognosis:2
safety ,percutaneous:2
safety ,vs:2
safety ,surgical:2
safety ,tracheostomy:2
safety ,27:2
safety ,patients:4
prognosis ,percutaneous:2
prognosis ,vs:2
prognosis ,surgical:2
prognosis ,tracheostomy:2
prognosis ,27:2
percutaneous ,vs:2
percutaneous ,surgical:2
percutaneous ,tracheostomy:2
percutaneous ,27:2
percutaneous ,patients:2
vs ,surgical:2
vs ,tracheostomy:2
vs ,27:2
vs ,patients:4
surgical ,tracheostomy:4
surgical ,27:2
surgical ,patients:2
tracheostomy ,27:2
tracheostomy ,patients:6
27 ,patients:2
hydroxychloroquine ,tolerance:2
hydroxychloroquine ,haemodialysis:2
azithromycin ,tolerance:2
azithromycin ,haemodialysis:2
azithromycin ,patients:2
tolerance ,haemodialysis:2
tolerance ,patients:2
haemodialysis ,patients:2
strategies ,vaccine:4
coronavirus ,result:2
disease ,result:2
19 ,infection:4
19 ,result:2
19 ,acute:2
19 ,kidney:2
19 ,injury:2
infection ,result:2
result ,acute:2
result ,kidney:2
result ,injury:2
result ,analysis:2
kidney ,analysis:4
injury ,analysis:2
pandemic ,pathogenesis:4
pandemic ,diagnostics:2
overview ,epidemiology:4
overview ,pathogenesis:6
epidemiology ,diagnostics:2
pathogenesis ,diagnostics:4
children ,high:2
children ,risk:6
children ,thrombosis:2
children ,viscoelastic:2
sars-cov-2 ,viscoelastic:2
infection ,thrombosis:4
infection ,viscoelastic:2
high ,risk:4
high ,thrombosis:2
high ,viscoelastic:2
risk ,thrombosis:2
risk ,viscoelastic:2
thrombosis ,viscoelastic:2
sars-cov-2 ,replicate:4
sars-cov-2 ,embryonated:2
sars-cov-2 ,hens:2
sars-cov-2 ,eggs:2
sars-cov-2 ,mdck:2
sars-cov-2 ,lines:2
replicate ,embryonated:2
replicate ,hens:2
replicate ,eggs:2
replicate ,mdck:2
replicate ,cell:2
replicate ,lines:2
embryonated ,hens:2
embryonated ,eggs:2
embryonated ,mdck:2
embryonated ,cell:2
embryonated ,lines:2
hens ,eggs:2
hens ,mdck:2
hens ,cell:2
hens ,lines:2
eggs ,mdck:2
eggs ,cell:2
eggs ,lines:2
mdck ,cell:2
mdck ,lines:2
cell ,lines:2
types ,assays:2
types ,testing:4
types ,review:2
assays ,testing:4
assays ,review:2
clinical ,causing:2
laboratory ,virus:8
laboratory ,causing:2
diagnosis ,virus:6
virus ,causing:4
dendritic ,cells:2
dendritic ,sars-cov-2:2
dendritic ,infection:2
dendritic ,still:2
dendritic ,unclarified:2
dendritic ,connection:2
cells ,infection:10
cells ,still:2
cells ,unclarified:2
cells ,connection:2
sars-cov-2 ,still:2
sars-cov-2 ,unclarified:2
sars-cov-2 ,connection:4
infection ,still:2
infection ,unclarified:2
infection ,connection:2
still ,unclarified:2
still ,connection:2
unclarified ,connection:2
umifenovir ,treatment:2
umifenovir ,associated:2
umifenovir ,improved:2
umifenovir ,outcomes:2
umifenovir ,patients:2
treatment ,associated:4
treatment ,improved:2
treatment ,outcomes:2
associated ,improved:2
associated ,outcomes:4
improved ,outcomes:2
improved ,patients:2
will ,guidelines:2
will ,recommendations:2
will ,surgery:2
will ,pandemic:2
will ,still:4
guidelines ,recommendations:4
guidelines ,surgery:4
guidelines ,pandemic:10
guidelines ,still:2
recommendations ,pandemic:30
recommendations ,still:2
surgery ,still:2
pandemic ,still:2
vascular ,endothelial:4
vascular ,growth:2
vascular ,factor:2
vascular ,vegf:2
vascular ,vital:2
vascular ,target:2
vascular ,brain:2
vascular ,inflammation:4
endothelial ,growth:2
endothelial ,factor:2
endothelial ,vegf:2
endothelial ,vital:2
endothelial ,target:2
endothelial ,brain:2
endothelial ,inflammation:4
growth ,factor:4
growth ,vegf:2
growth ,vital:2
growth ,target:2
growth ,brain:2
growth ,inflammation:2
factor ,vegf:2
factor ,vital:2
factor ,target:2
factor ,brain:2
factor ,inflammation:2
vegf ,vital:2
vegf ,target:2
vegf ,brain:2
vegf ,inflammation:2
vital ,target:2
vital ,brain:2
vital ,inflammation:2
target ,brain:2
target ,inflammation:4
brain ,inflammation:2
approaching ,coronavirus:2
approaching ,disease:2
approaching ,mechanisms:2
approaching ,action:2
approaching ,repurposed:2
approaching ,drugs:2
coronavirus ,mechanisms:10
coronavirus ,action:4
coronavirus ,repurposed:2
disease ,mechanisms:8
disease ,action:4
disease ,repurposed:2
mechanisms ,repurposed:2
mechanisms ,drugs:4
action ,repurposed:4
action ,drugs:4
trinity ,covid-19:2
trinity ,immunity:2
trinity ,inflammation:2
trinity ,intervention:2
covid-19 ,intervention:8
immunity ,inflammation:2
immunity ,intervention:2
inflammation ,intervention:2
diagnosis ,emergency:4
diagnosis ,surgeries:2
diagnosis ,otorhinolaryngology:2
diagnosis ,head:4
diagnosis ,neck:4
treatment ,surgeries:2
treatment ,otorhinolaryngology:2
treatment ,head:2
treatment ,neck:2
emergency ,surgeries:2
emergency ,otorhinolaryngology:2
emergency ,head:2
emergency ,neck:2
surgeries ,otorhinolaryngology:2
surgeries ,head:2
surgeries ,neck:2
otorhinolaryngology ,head:2
otorhinolaryngology ,neck:2
nasopharyngeal ,collection:2
nasopharyngeal ,suspicion:2
swab ,suspicion:2
collection ,suspicion:2
collection ,covid-19:4
portable ,accurate:2
portable ,diagnostics:2
portable ,covid-19:2
portable ,combined:2
portable ,use:2
portable ,minipcr:2
accurate ,diagnostics:2
accurate ,combined:2
accurate ,use:2
accurate ,minipcr:2
diagnostics ,combined:2
diagnostics ,use:2
diagnostics ,minipcr:2
covid-19 ,combined:4
covid-19 ,minipcr:2
combined ,use:4
combined ,minipcr:2
use ,minipcr:2
persisting ,sars-cov-2:2
persisting ,viraemia:2
persisting ,rituximab:2
persisting ,therapy:2
persisting ,two:2
persisting ,cases:2
persisting ,fatal:2
persisting ,outcome:2
sars-cov-2 ,viraemia:2
sars-cov-2 ,rituximab:2
viraemia ,rituximab:2
viraemia ,therapy:2
viraemia ,two:2
viraemia ,cases:2
viraemia ,fatal:2
viraemia ,outcome:2
rituximab ,therapy:2
rituximab ,two:2
rituximab ,cases:2
rituximab ,fatal:2
rituximab ,outcome:2
therapy ,two:6
therapy ,cases:2
therapy ,fatal:2
therapy ,outcome:2
two ,fatal:2
two ,outcome:2
cases ,fatal:2
cases ,outcome:2
fatal ,outcome:6
ancestral ,origin:2
ancestral ,antigenic:2
ancestral ,resemblance:2
ancestral ,epidemiological:2
ancestral ,insights:2
ancestral ,novel:2
origin ,antigenic:2
origin ,resemblance:2
origin ,epidemiological:2
origin ,insights:4
origin ,novel:4
antigenic ,resemblance:2
antigenic ,epidemiological:2
antigenic ,insights:2
resemblance ,epidemiological:2
resemblance ,insights:2
resemblance ,novel:2
epidemiological ,insights:4
heart ,failure:12
heart ,time:2
failure ,time:2
potential ,false-negative:2
potential ,nucleic:2
potential ,acid:4
potential ,testing:6
potential ,results:2
false-negative ,nucleic:2
false-negative ,acid:2
false-negative ,testing:4
false-negative ,results:6
false-negative ,severe:4
false-negative ,acute:4
false-negative ,respiratory:4
nucleic ,respiratory:4
sars-cov-2 ,surfaces:22
rna ,contamination:4
rna ,hospital:4
contamination ,surfaces:6
contamination ,ward:2
contamination ,hospital:6
surfaces ,covid-19:4
surfaces ,ward:4
surfaces ,hospital:4
ward ,hospital:4
sars-cov ,sars-cov2:2
sars-cov ,guide:2
sars-cov ,better:2
sars-cov ,understanding:2
sars-cov2 ,guide:2
sars-cov2 ,better:2
potential ,guide:2
potential ,better:2
guide ,better:2
guide ,understanding:2
better ,understanding:2
sars-cov-2-related ,pneumonia:4
sars-cov-2-related ,cases:2
sars-cov-2-related ,picture:2
sars-cov-2-related ,russia:2
sars-cov-2-related ,march-may:2
pneumonia ,picture:2
pneumonia ,russia:2
pneumonia ,march-may:2
cases ,picture:2
cases ,russia:2
cases ,march-may:2
picture ,russia:2
picture ,march-may:2
russia ,march-may:2
coronavirus ,wearing:4
coronavirus ,masks:2
infection ,wearing:2
infection ,masks:2
prevention ,wearing:2
prevention ,masks:4
wearing ,masks:6
boceprevir ,gc-376:4
boceprevir ,calpain:4
boceprevir ,inhibitors:4
boceprevir ,ii:4
boceprevir ,xii:4
boceprevir ,inhibit:4
boceprevir ,sars-cov-2:4
boceprevir ,viral:4
gc-376 ,calpain:4
gc-376 ,inhibitors:4
gc-376 ,ii:4
gc-376 ,xii:4
gc-376 ,inhibit:4
gc-376 ,sars-cov-2:4
gc-376 ,viral:4
calpain ,inhibitors:4
calpain ,ii:4
calpain ,xii:4
calpain ,inhibit:4
calpain ,sars-cov-2:4
calpain ,viral:4
inhibitors ,ii:6
inhibitors ,xii:4
inhibitors ,inhibit:6
inhibitors ,viral:6
ii ,xii:4
ii ,inhibit:4
ii ,sars-cov-2:10
ii ,viral:4
xii ,inhibit:4
xii ,sars-cov-2:4
xii ,viral:4
inhibit ,viral:4
gastrointestinal ,nutrition:2
gastrointestinal ,practices:2
manifestations ,impact:4
manifestations ,nutrition:2
manifestations ,practices:2
impact ,nutrition:2
impact ,practices:2
nutrition ,practices:2
sars-cov-2 ,turned:4
sars-cov-2 ,discharged:6
sars-cov-2 ,arouses:2
sars-cov-2 ,concern:2
turned ,positive:2
turned ,discharged:2
turned ,patient:2
turned ,covid-19:4
turned ,arouses:2
turned ,concern:2
positive ,discharged:8
positive ,arouses:2
positive ,concern:2
discharged ,patient:2
discharged ,arouses:2
discharged ,concern:2
patient ,arouses:2
patient ,concern:2
covid-19 ,arouses:2
arouses ,concern:2
elective ,surgery:10
elective ,sars-cov-2:4
elective ,pandemic:6
elective ,morbimortality:2
surgery ,sars-cov-2:14
surgery ,morbimortality:2
sars-cov-2 ,morbimortality:2
pandemic ,morbimortality:2
covid-19 ,morbimortality:2
point ,bias:2
point ,variants:2
point ,results:2
point ,increased:2
point ,ability:2
point ,stimulate:2
mutation ,bias:2
mutation ,variants:2
mutation ,results:2
mutation ,increased:2
mutation ,ability:2
mutation ,stimulate:2
bias ,sars-cov-2:2
bias ,variants:2
bias ,results:2
bias ,increased:2
bias ,ability:2
bias ,stimulate:2
sars-cov-2 ,variants:12
sars-cov-2 ,increased:12
sars-cov-2 ,stimulate:2
variants ,results:2
variants ,increased:2
variants ,ability:2
variants ,stimulate:2
results ,increased:2
results ,ability:2
results ,stimulate:2
increased ,ability:2
increased ,stimulate:2
ability ,stimulate:2
clinical ,pathway:2
clinical ,initial:10
pathway ,hospitalized:2
pathway ,pediatric:2
pathway ,patients:6
pathway ,initial:2
pathway ,sars-cov-2:10
hospitalized ,pediatric:2
hospitalized ,initial:2
pediatric ,initial:2
patients ,initial:12
initial ,sars-cov-2:2
high-throughput ,wastewater:2
high-throughput ,analysis:2
high-throughput ,substance:2
high-throughput ,use:2
high-throughput ,assessment:2
high-throughput ,central:2
high-throughput ,new:2
high-throughput ,york:2
wastewater ,analysis:2
wastewater ,substance:2
wastewater ,use:2
wastewater ,assessment:4
wastewater ,central:2
wastewater ,new:2
wastewater ,york:2
analysis ,substance:2
analysis ,assessment:2
analysis ,york:4
substance ,use:2
substance ,assessment:2
substance ,central:2
substance ,new:2
substance ,york:2
use ,assessment:2
use ,central:2
use ,new:2
use ,york:2
assessment ,central:2
assessment ,new:6
assessment ,york:2
central ,york:2
metformin ,sars-cov-2:2
metformin ,mechanistic:2
metformin ,lessons:2
metformin ,air:2
metformin ,pollution:2
metformin ,weather:2
sars-cov-2 ,pollution:4
sars-cov-2 ,weather:6
mechanistic ,lessons:2
mechanistic ,air:2
mechanistic ,pollution:2
mechanistic ,weather:2
lessons ,air:2
lessons ,pollution:2
lessons ,weather:2
air ,weather:2
pollution ,weather:4
complement ,c5a-c5ar1:2
complement ,gpcr:2
complement ,axis:2
complement ,therapeutics:2
c5a-c5ar1 ,gpcr:2
c5a-c5ar1 ,axis:2
c5a-c5ar1 ,covid-19:2
c5a-c5ar1 ,therapeutics:2
gpcr ,axis:2
gpcr ,covid-19:2
gpcr ,therapeutics:2
axis ,covid-19:2
axis ,therapeutics:2
covid-19 ,vulnerability:2
vulnerability ,potential:2
vulnerability ,impact:2
vulnerability ,genetic:2
vulnerability ,susceptibility:2
vulnerability ,airborne:2
potential ,genetic:4
potential ,susceptibility:4
potential ,airborne:4
impact ,genetic:2
impact ,susceptibility:2
impact ,airborne:2
genetic ,airborne:2
susceptibility ,airborne:2
possibility ,haemodialysis:2
possibility ,unit:2
possibility ,report:2
sars-cov-2 ,haemodialysis:2
transmission ,haemodialysis:2
transmission ,unit:2
haemodialysis ,unit:2
haemodialysis ,report:4
unit ,report:2
biochemical ,indicators:2
biochemical ,exacerbation:2
indicators ,coronavirus:2
indicators ,disease:2
indicators ,exacerbation:2
indicators ,clinical:2
coronavirus ,exacerbation:4
disease ,exacerbation:4
exacerbation ,clinical:4
emerging ,pneumonia:2
neonatal ,resuscitation:4
neonatal ,mother:2
neonatal ,suspected:2
neonatal ,confirmed:2
neonatal ,novel:2
resuscitation ,mother:2
resuscitation ,suspected:2
resuscitation ,confirmed:2
resuscitation ,novel:2
mother ,suspected:2
mother ,confirmed:2
mother ,novel:2
suspected ,novel:2
new ,laboratory:4
challenge ,laboratory:2
laboratory ,medicine:4
geroscience ,mortality:2
perspective ,mortality:2
neurological ,involvement:8
involvement ,systematic:2
involvement ,review:8
covid-19 ,assays:6
covid-19 ,outside:6
patient ,negative:10
patient ,results:2
patient ,pcr:2
patient ,assays:2
multiple ,negative:2
multiple ,results:2
multiple ,pcr:2
multiple ,outside:2
multiple ,wuhan:2
negative ,results:8
negative ,pcr:4
negative ,assays:2
negative ,outside:2
negative ,wuhan:2
results ,assays:2
results ,outside:2
results ,wuhan:2
pcr ,outside:2
pcr ,wuhan:2
assays ,outside:2
assays ,wuhan:2
non-steroidal ,anti-inflammatory:2
non-steroidal ,drugs:2
non-steroidal ,prostaglandins:2
non-steroidal ,covid-19:2
anti-inflammatory ,drugs:2
anti-inflammatory ,prostaglandins:2
anti-inflammatory ,covid-19:4
drugs ,prostaglandins:2
prostaglandins ,covid-19:2
analysis ,convalescent:4
analysis ,plasma:4
analysis ,igg:6
analysis ,using:8
analysis ,two:8
analysis ,commercial:2
convalescent ,igg:4
convalescent ,using:4
convalescent ,two:2
convalescent ,commercial:2
plasma ,igg:2
plasma ,two:2
plasma ,commercial:2
igg ,two:2
simulated ,sunlight:4
simulated ,rapidly:4
simulated ,inactivates:2
simulated ,sars-cov-2:4
simulated ,surfaces:2
sunlight ,rapidly:4
sunlight ,inactivates:2
sunlight ,sars-cov-2:4
sunlight ,surfaces:2
rapidly ,inactivates:4
rapidly ,sars-cov-2:6
rapidly ,surfaces:2
inactivates ,sars-cov-2:6
inactivates ,surfaces:2
identification ,proficiency:2
identification ,testing:2
identification ,program:2
sars-cov-2 ,proficiency:2
sars-cov-2 ,program:6
proficiency ,testing:2
proficiency ,program:2
testing ,program:6
covid-19 ,benign:6
covid-19 ,hematology:4
benign ,hematology:2
benign ,emerging:2
benign ,challenges:2
benign ,special:2
benign ,considerations:2
hematology ,emerging:2
hematology ,challenges:2
hematology ,special:2
hematology ,considerations:2
emerging ,challenges:4
emerging ,special:2
emerging ,considerations:2
challenges ,special:2
challenges ,considerations:2
cardiac ,children:4
involvement ,children:2
tackling ,sars-cov-2:2
tackling ,proposed:2
tackling ,targets:2
tackling ,repurposed:2
tackling ,drugs:2
sars-cov-2 ,proposed:4
proposed ,targets:2
proposed ,repurposed:2
proposed ,drugs:2
targets ,repurposed:2
update ,recommendations:6
update ,sars-cov-2covid-19:4
update ,pregnancy:4
update ,birth:2
recommendations ,sars-cov-2covid-19:2
recommendations ,pregnancy:4
recommendations ,birth:2
sars-cov-2covid-19 ,pregnancy:2
sars-cov-2covid-19 ,birth:2
pregnancy ,birth:2
ig-like ,ace2:2
ig-like ,protein:2
ig-like ,therapeutics:2
ig-like ,revival:2
ig-like ,development:2
ig-like ,covid-19:2
ace2 ,therapeutics:4
ace2 ,revival:2
ace2 ,development:2
protein ,therapeutics:2
protein ,revival:2
protein ,development:4
therapeutics ,revival:2
revival ,development:2
revival ,covid-19:2
diabetes ,global:2
diabetes ,regional:2
diabetes ,perspectives:2
covid-19 ,regional:8
global ,regional:2
global ,perspectives:2
regional ,perspectives:2
coronavirus ,tunnel:2
vaccine ,light:2
vaccine ,end:2
vaccine ,tunnel:2
light ,end:2
light ,tunnel:2
end ,tunnel:2
rapid ,transcription:2
point-of-care ,detection:6
point-of-care ,using:4
point-of-care ,reverse:2
point-of-care ,transcription:2
using ,reverse:4
using ,transcription:2
understanding ,via:2
understanding ,comparative:2
understanding ,analysis:6
understanding ,dark:2
understanding ,proteomes:2
covid-19 ,dark:8
covid-19 ,proteomes:2
via ,comparative:2
via ,analysis:2
via ,dark:2
via ,proteomes:2
comparative ,dark:2
comparative ,proteomes:2
analysis ,dark:2
analysis ,proteomes:2
dark ,proteomes:2
dark ,sars-cov-2:2
proteomes ,sars-cov-2:2
asymptomatic ,sars:2
asymptomatic ,invisible:2
asymptomatic ,yet:2
asymptomatic ,invincible:2
sars ,infection:10
sars ,invisible:2
sars ,yet:2
sars ,invincible:2
coronavirus ,invisible:2
coronavirus ,yet:2
coronavirus ,invincible:2
infection ,invisible:2
infection ,yet:4
infection ,invincible:2
invisible ,yet:2
invisible ,invincible:2
yet ,invincible:2
management ,colon:2
management ,complicated:4
colon ,cancer:4
colon ,patient:4
colon ,complicated:2
colon ,covid-19:2
cancer ,complicated:2
patient ,complicated:2
complicated ,covid-19:18
preliminary ,estimate:2
preliminary ,excess:2
preliminary ,mortality:2
preliminary ,outbreak:2
preliminary ,new:2
preliminary ,york:2
estimate ,excess:2
estimate ,mortality:2
estimate ,covid-19:2
estimate ,outbreak:2
estimate ,new:2
estimate ,york:2
excess ,covid-19:2
excess ,outbreak:2
excess ,new:2
excess ,york:2
mortality ,outbreak:8
mortality ,new:2
mortality ,york:2
covid-19 ,york:20
outbreak ,york:2
analytical ,comparison:8
analytical ,nucleic:2
analytical ,acid:2
analytical ,amplification:2
analytical ,tests:2
clinical ,amplification:2
clinical ,tests:6
comparison ,three:6
comparison ,amplification:2
three ,nucleic:4
three ,acid:4
three ,amplification:2
three ,tests:6
nucleic ,tests:4
acid ,tests:4
amplification ,tests:4
interferon ,gamma:2
interferon ,tgf-1:2
interferon ,rantes:2
interferon ,expression:2
interferon ,upper:2
interferon ,airway:2
interferon ,samples:2
gamma ,tgf-1:2
gamma ,rantes:2
gamma ,expression:2
gamma ,upper:2
gamma ,airway:2
gamma ,samples:2
tgf-1 ,rantes:2
tgf-1 ,expression:2
tgf-1 ,upper:2
tgf-1 ,airway:2
tgf-1 ,samples:2
rantes ,expression:2
rantes ,upper:2
rantes ,airway:2
rantes ,samples:2
expression ,upper:4
expression ,airway:8
expression ,samples:2
upper ,airway:10
upper ,samples:4
airway ,samples:4
smell ,infection:4
taste ,infection:4
critical ,role:4
critical ,laboratory:2
critical ,medicine:2
critical ,coronavirus:10
critical ,disease:2
role ,laboratory:2
laboratory ,disease:8
medicine ,disease:2
withanone ,caffeic:2
withanone ,acid:2
withanone ,phenethyl:2
withanone ,ester:2
withanone ,main:2
caffeic ,acid:2
caffeic ,phenethyl:2
caffeic ,ester:2
caffeic ,predicted:2
caffeic ,interact:2
caffeic ,main:2
acid ,phenethyl:2
acid ,ester:2
acid ,predicted:2
acid ,interact:2
acid ,main:2
phenethyl ,ester:2
phenethyl ,predicted:2
phenethyl ,interact:2
phenethyl ,main:2
ester ,predicted:2
ester ,interact:2
ester ,main:2
predicted ,main:2
interact ,main:2
evaluation ,seven:2
evaluation ,testing:6
evaluation ,pooled:2
seven ,testing:2
seven ,pooled:2
commercial ,testing:4
commercial ,pooled:2
commercial ,clinical:2
rt-pcr ,testing:12
rt-pcr ,pooled:6
kits ,testing:2
kits ,pooled:2
kits ,clinical:2
covid-19 ,pooled:6
pooled ,clinical:4
air ,surface:8
air ,environmental:8
air ,personal:2
air ,protective:2
air ,equipment:2
air ,contamination:10
surface ,personal:2
surface ,protective:2
surface ,equipment:2
environmental ,personal:2
environmental ,protective:2
environmental ,equipment:2
personal ,contamination:4
protective ,contamination:4
equipment ,contamination:2
sars-cov-2 ,combating:4
combating ,coronavirus:4
combating ,emergence:2
effect ,persistence:2
effect ,common:2
effect ,surfaces:2
temperature ,persistence:2
temperature ,sars-cov-2:6
temperature ,common:2
temperature ,surfaces:2
persistence ,common:2
persistence ,surfaces:6
common ,surfaces:2
anti-filarial ,drug:2
anti-filarial ,diethylcarbamazine:2
anti-filarial ,useful:2
anti-filarial ,treat:2
anti-filarial ,covid-19:2
drug ,diethylcarbamazine:2
drug ,useful:2
drug ,treat:2
diethylcarbamazine ,useful:2
diethylcarbamazine ,treat:2
diethylcarbamazine ,covid-19:2
useful ,treat:2
useful ,covid-19:10
comprehensive ,proteomics:2
comprehensive ,approach:2
comprehensive ,covid:2
comprehensive ,19:2
comprehensive ,new:2
comprehensive ,perspectives:2
overview ,proteomics:2
overview ,approach:2
overview ,covid:2
overview ,19:2
overview ,new:2
overview ,perspectives:4
proteomics ,approach:4
proteomics ,covid:2
proteomics ,19:2
proteomics ,new:2
proteomics ,perspectives:2
approach ,covid:4
approach ,19:4
approach ,new:4
approach ,perspectives:2
covid ,new:2
covid ,perspectives:2
19 ,new:2
19 ,perspectives:2
new ,perspectives:2
descriptive ,study:4
descriptive ,covid-19:6
descriptive ,outbreak:2
descriptive ,among:2
descriptive ,passengers:2
descriptive ,crew:2
descriptive ,diamond:2
descriptive ,princess:2
study ,among:4
study ,passengers:2
study ,crew:2
study ,diamond:2
study ,princess:2
covid-19 ,passengers:2
covid-19 ,crew:2
covid-19 ,diamond:4
covid-19 ,princess:4
outbreak ,passengers:2
outbreak ,crew:2
outbreak ,diamond:4
outbreak ,princess:4
among ,passengers:4
among ,crew:2
among ,diamond:2
among ,princess:2
passengers ,crew:2
passengers ,diamond:2
passengers ,princess:2
crew ,diamond:2
crew ,princess:2
diamond ,princess:8
combined ,oropharyngealnares:2
combined ,swab:2
combined ,suitable:2
combined ,alternative:2
combined ,nasopharyngeal:2
oropharyngealnares ,swab:2
oropharyngealnares ,suitable:2
oropharyngealnares ,alternative:2
oropharyngealnares ,nasopharyngeal:2
swab ,suitable:2
swab ,alternative:4
suitable ,alternative:2
suitable ,nasopharyngeal:2
alternative ,nasopharyngeal:2
exploring ,alternative:2
exploring ,swabs:2
exploring ,use:2
exploring ,detection:2
exploring ,oropharynx:2
alternative ,use:2
alternative ,oropharynx:2
swabs ,use:2
swabs ,oropharynx:2
use ,oropharynx:2
sars-cov-2 ,oropharynx:2
detection ,oropharynx:2
molecular ,bacterial:2
molecular ,associated:2
molecular ,viral:2
pathogenesis ,bacterial:2
pathogenesis ,infection:16
pathogenesis ,viral:6
secondary ,bacterial:4
secondary ,infection:2
secondary ,associated:6
secondary ,viral:2
bacterial ,infection:4
bacterial ,associated:2
bacterial ,viral:4
oral ,mucosal:4
oral ,lesions:4
oral ,patients:10
oral ,report:4
oral ,four:4
oral ,cases:2
mucosal ,lesions:4
mucosal ,patients:2
mucosal ,infection:2
mucosal ,report:2
mucosal ,four:2
mucosal ,cases:2
lesions ,patients:2
lesions ,sars-cov-2:2
lesions ,infection:2
lesions ,report:4
lesions ,four:2
lesions ,cases:2
infection ,report:16
report ,four:6
gastrointestinal ,liver:6
liver ,manifestations:4
preparation ,quarantine:2
preparation ,cruise:2
preparation ,ship:2
preparation ,diamond:2
preparation ,princess:2
preparation ,japan:2
preparation ,due:2
quarantine ,cruise:2
quarantine ,ship:2
quarantine ,diamond:2
quarantine ,princess:2
quarantine ,japan:2
quarantine ,due:2
cruise ,diamond:6
cruise ,princess:6
cruise ,due:2
ship ,diamond:6
ship ,princess:6
ship ,due:2
diamond ,japan:2
diamond ,due:2
princess ,japan:2
princess ,due:2
japan ,due:2
convalescent ,useful:2
convalescent ,treating:4
convalescent ,sars:2
convalescent ,co-v2:2
plasma ,useful:2
plasma ,treating:4
plasma ,sars:2
plasma ,co-v2:2
useful ,treating:4
useful ,sars:2
useful ,co-v2:2
useful ,infection:2
treating ,co-v2:2
treating ,infection:2
sars ,co-v2:2
co-v2 ,infection:2
doubling ,time:4
doubling ,covid-19:2
doubling ,epidemic:4
doubling ,province:2
doubling ,china:2
time ,epidemic:4
time ,province:2
time ,china:2
combinatorial ,approach:2
combinatorial ,polypharmacological:2
combinatorial ,adjuvant:2
combinatorial ,2-deoxy-d-glucose:2
approach ,polypharmacological:2
approach ,adjuvant:2
approach ,2-deoxy-d-glucose:2
polypharmacological ,adjuvant:2
polypharmacological ,2-deoxy-d-glucose:2
adjuvant ,2-deoxy-d-glucose:2
society ,swallowing:2
society ,dysphagia:2
society ,japan:2
society ,statement:4
swallowing ,dysphagia:2
swallowing ,japan:2
swallowing ,position:2
swallowing ,statement:2
dysphagia ,japan:2
dysphagia ,position:2
dysphagia ,statement:2
japan ,position:2
japan ,statement:2
covid-19 ,turning:2
covid-19 ,point:8
new ,turning:2
new ,point:2
new ,practice:2
turning ,point:2
turning ,dental:2
turning ,practice:2
point ,dental:2
point ,practice:2
dermatologic ,complications:2
manifestations ,complications:4
detection ,humoral:2
detection ,cellular:2
detection ,immunity:2
sars-cov-2-specific ,humoral:2
sars-cov-2-specific ,cellular:2
sars-cov-2-specific ,immunity:4
sars-cov-2-specific ,covid-19:8
humoral ,cellular:2
humoral ,immunity:2
covid-19 ,catastrophic:2
catastrophic ,cause:2
catastrophic ,acute:2
catastrophic ,lung:2
catastrophic ,injury:4
cause ,lung:4
cause ,injury:2
acute ,lung:12
laboratory ,management:4
laboratory ,user-friendly:2
laboratory ,combination:2
management ,detection:2
management ,user-friendly:2
management ,combination:2
sars-cov-2 ,user-friendly:2
sars-cov-2 ,combination:8
detection ,user-friendly:2
user-friendly ,combination:2
immunologic ,aspects:2
immunologic ,characteristics:4
immunologic ,diagnosis:2
immunologic ,treatment:2
immunologic ,coronavirus:2
aspects ,characteristics:2
aspects ,diagnosis:2
aspects ,treatment:2
maternal ,perinatal:6
maternal ,covid-19:24
maternal ,systematic:2
maternal ,review:2
maternal ,108:2
perinatal ,outcomes:4
perinatal ,covid-19:12
perinatal ,systematic:2
perinatal ,review:2
perinatal ,108:2
outcomes ,review:6
outcomes ,108:2
covid-19 ,108:2
systematic ,108:2
review ,108:2
clinical ,treatment:18
characteristics ,critically:2
characteristics ,ill:4
treatment ,critically:6
treatment ,ill:6
critically ,patients:34
ill ,patients:36
avoiding ,health:2
avoiding ,worker:2
avoiding ,infection:2
avoiding ,containing:2
avoiding ,coronavirus:2
avoiding ,disease:2
health ,worker:6
health ,containing:4
worker ,infection:2
worker ,containing:2
worker ,coronavirus:2
worker ,disease:2
infection ,containing:4
containing ,disease:2
covid-19 ,hypogammaglobulinemia:2
plasma ,hypogammaglobulinemia:2
sars-cov-2 ,solid:4
sars-cov-2 ,transplantation:4
infection ,solid:2
infection ,organ:2
infection ,transplantation:6
solid ,organ:14
solid ,transplantation:10
organ ,transplantation:10
immune ,flare:2
immune ,mild:4
immune ,pregnancy:2
thrombocytopenia ,flare:2
thrombocytopenia ,mild:2
thrombocytopenia ,infection:2
thrombocytopenia ,pregnancy:2
thrombocytopenia ,case:4
flare ,mild:2
flare ,covid-19:2
flare ,infection:2
flare ,pregnancy:2
flare ,case:2
mild ,pregnancy:2
anaesthetic ,intensive:2
anaesthetic ,care:2
anaesthetic ,perspective:2
anaesthetic ,infection:2
anaesthetic ,control:2
anaesthetic ,measures:2
intensive ,perspective:2
intensive ,infection:4
intensive ,control:2
intensive ,measures:2
care ,perspective:4
care ,control:6
care ,measures:6
perspective ,infection:6
perspective ,control:2
perspective ,measures:2
infection ,measures:18
covid-19 ,childhood:2
cardiac ,childhood:2
cardiac ,state:2
cardiac ,art:2
involvement ,childhood:2
involvement ,state:2
involvement ,art:2
childhood ,state:2
childhood ,art:2
cardiac ,injuries:2
cardiac ,coronavirus:12
cardiac ,disease:12
injuries ,coronavirus:2
injuries ,disease:2
predicting ,angiotensin:2
predicting ,converting:2
predicting ,enzyme:2
predicting ,ace2:2
predicting ,utilizing:2
predicting ,capability:2
angiotensin ,enzyme:22
angiotensin ,utilizing:2
angiotensin ,capability:2
converting ,enzyme:16
converting ,ace2:6
converting ,utilizing:2
converting ,capability:2
enzyme ,utilizing:2
enzyme ,capability:2
ace2 ,utilizing:2
ace2 ,capability:2
utilizing ,capability:2
severe ,rapidly:2
severe ,progressive:2
severe ,setting:2
rapidly ,progressive:4
rapidly ,guillain-barr:2
rapidly ,syndrome:2
rapidly ,setting:2
rapidly ,acute:2
rapidly ,covid-19:8
progressive ,guillain-barr:2
progressive ,syndrome:2
progressive ,setting:2
progressive ,acute:2
progressive ,covid-19:6
guillain-barr ,setting:2
guillain-barr ,covid-19:10
syndrome ,setting:2
setting ,acute:4
setting ,covid-19:14
optimizing ,high-yield:2
optimizing ,production:2
optimizing ,sars-cov-2:6
optimizing ,soluble:2
optimizing ,spike:2
optimizing ,trimers:2
optimizing ,serology:2
high-yield ,production:2
high-yield ,sars-cov-2:2
high-yield ,soluble:2
high-yield ,spike:2
high-yield ,trimers:2
high-yield ,serology:2
production ,soluble:2
production ,trimers:2
production ,serology:2
sars-cov-2 ,soluble:2
sars-cov-2 ,trimers:2
soluble ,spike:2
soluble ,trimers:2
soluble ,serology:2
spike ,trimers:4
spike ,serology:4
trimers ,serology:2
sars-cov-2 ,advancements:2
pathogenesis ,advancements:2
advancements ,diagnostics:2
advancements ,treatment:2
diagnostics ,treatment:2
tracking ,onset:2
tracking ,date:2
tracking ,community:2
tracking ,spread:2
tracking ,western:2
tracking ,countries:2
onset ,date:2
onset ,community:2
onset ,spread:2
onset ,western:2
onset ,countries:2
date ,community:2
date ,spread:2
date ,sars-cov-2:2
date ,western:2
date ,countries:2
community ,spread:4
community ,western:2
community ,countries:2
spread ,western:2
spread ,countries:4
sars-cov-2 ,western:2
western ,countries:2
forecasting ,infections:2
forecasting ,e7:2
forecasting ,countries:2
forecasting ,proposing:2
forecasting ,policies:2
covid-19 ,e7:2
covid-19 ,countries:24
covid-19 ,proposing:2
covid-19 ,policies:6
infections ,e7:2
infections ,countries:2
infections ,proposing:2
infections ,policies:2
infections ,based:2
e7 ,countries:2
e7 ,proposing:2
e7 ,policies:2
e7 ,based:2
countries ,proposing:2
countries ,policies:2
countries ,based:2
proposing ,policies:2
proposing ,based:2
policies ,based:2
acute ,influenza:6
distress ,due:2
distress ,influenza:2
distress ,co-infection:2
syndrome ,due:2
syndrome ,influenza:6
due ,influenza:2
due ,co-infection:2
seir ,italian:2
seir ,epidemic:2
seir ,sars-cov-2:2
seir ,using:2
seir ,computational:2
seir ,swarm:2
modeling ,italian:2
modeling ,epidemic:4
modeling ,using:4
modeling ,computational:2
modeling ,swarm:2
italian ,epidemic:4
italian ,using:2
italian ,computational:2
italian ,swarm:2
epidemic ,using:2
epidemic ,computational:2
epidemic ,swarm:2
sars-cov-2 ,swarm:2
using ,computational:4
using ,swarm:2
computational ,swarm:2
prevalence ,health:10
prevalence ,care:6
prevalence ,personnel:2
prevalence ,new:2
prevalence ,york:2
prevalence ,city:2
sars-cov-2 ,personnel:8
antibodies ,health:4
antibodies ,care:8
antibodies ,personnel:2
antibodies ,new:2
antibodies ,york:2
antibodies ,city:2
health ,personnel:12
health ,york:2
health ,city:2
care ,personnel:8
care ,new:4
care ,york:2
care ,city:2
personnel ,new:2
personnel ,york:2
personnel ,city:2
prevalence ,residents:4
prevalence ,large:6
sars-cov-2 ,residents:10
infection ,residents:2
infection ,homeless:4
infection ,shelter:2
residents ,large:2
residents ,homeless:2
residents ,shelter:2
large ,homeless:2
large ,shelter:2
quantifying ,effect:2
quantifying ,remdesivir:2
quantifying ,rhesus:2
quantifying ,macaques:2
quantifying ,infected:2
effect ,remdesivir:4
effect ,rhesus:2
effect ,macaques:2
effect ,infected:2
remdesivir ,rhesus:6
remdesivir ,macaques:4
remdesivir ,infected:4
rhesus ,infected:4
macaques ,infected:4
laboratory ,techniques:2
testing ,techniques:2
techniques ,sars-cov-2:2
hospital ,reengineering:2
hospital ,outbreak:6
hospital ,1-month:2
hospital ,experience:4
hospital ,italian:2
reengineering ,covid-19:2
reengineering ,outbreak:2
reengineering ,1-month:2
reengineering ,experience:2
reengineering ,italian:2
covid-19 ,1-month:2
outbreak ,1-month:2
outbreak ,experience:4
1-month ,experience:2
1-month ,italian:2
experience ,italian:2
serial ,serum:2
serial ,rna:2
serial ,results:2
serial ,two:2
serial ,severe:2
serial ,respiratory:2
serum ,rna:8
serum ,results:2
serum ,two:2
serum ,cases:4
serum ,severe:6
serum ,respiratory:4
results ,two:6
results ,cases:2
two ,severe:6
two ,respiratory:4
infection ,recent:4
two ,following:2
two ,recent:2
two ,lung:4
two ,transplantation:2
patients ,following:2
patients ,recent:2
following ,recent:2
following ,lung:2
following ,transplantation:2
recent ,lung:2
recent ,transplantation:4
lung ,transplantation:6
aggressive ,surgical:2
aggressive ,treatment:2
aggressive ,outcome:2
aggressive ,colon:2
aggressive ,cancer:2
aggressive ,patient:2
surgical ,treatment:8
surgical ,outcome:2
surgical ,colon:2
surgical ,patient:8
treatment ,outcome:6
treatment ,colon:2
treatment ,cancer:18
outcome ,colon:2
outcome ,cancer:4
outcome ,patient:2
association ,renin-angiotensin:2
association ,system:2
mortality ,renin-angiotensin:2
mortality ,system:2
detection ,peripheral:2
detection ,blood:8
novel ,peripheral:2
novel ,blood:2
novel ,specimens:2
coronavirus ,peripheral:4
coronavirus ,specimens:4
rna ,peripheral:2
peripheral ,specimens:2
blood ,specimens:4
enhanced ,binding:4
enhanced ,sars-cov-2:8
enhanced ,spike:4
enhanced ,protein:2
enhanced ,receptor:4
enhanced ,distal:2
enhanced ,polybasic:2
binding ,distal:2
binding ,polybasic:2
sars-cov-2 ,distal:2
sars-cov-2 ,polybasic:2
spike ,distal:2
spike ,polybasic:2
protein ,receptor:10
protein ,distal:2
protein ,polybasic:2
receptor ,distal:2
receptor ,polybasic:2
distal ,polybasic:2
covid-19 ,hace2:2
pandemic ,structure:2
pandemic ,function:2
pandemic ,hace2:2
pandemic ,receptor:2
pandemic ,recognition:2
insights ,function:2
insights ,hace2:2
insights ,receptor:4
insights ,recognition:2
structure ,hace2:2
structure ,receptor:6
structure ,recognition:2
function ,hace2:2
function ,receptor:2
function ,recognition:2
hace2 ,receptor:2
hace2 ,recognition:2
artificial ,intelligence:18
artificial ,codify:2
artificial ,lung:2
artificial ,ct:2
artificial ,covid-19:16
artificial ,patients:2
intelligence ,codify:2
intelligence ,lung:2
intelligence ,ct:2
intelligence ,covid-19:14
intelligence ,patients:2
codify ,lung:2
codify ,ct:2
codify ,covid-19:2
codify ,patients:2
successful ,recovery:12
successful ,covid-19:22
successful ,pneumonia:10
successful ,patient:10
successful ,colombia:2
successful ,receiving:4
recovery ,pneumonia:6
recovery ,colombia:2
recovery ,receiving:4
covid-19 ,colombia:4
covid-19 ,receiving:12
pneumonia ,colombia:2
pneumonia ,receiving:4
patient ,colombia:2
patient ,receiving:6
colombia ,receiving:2
viricidal ,treatments:2
viricidal ,prevention:2
viricidal ,coronavirus:2
viricidal ,infection:2
treatments ,prevention:2
treatments ,coronavirus:8
treatments ,infection:4
perspectives ,impact:2
perspectives ,pandemic:8
perspectives ,sports:2
perspectives ,medicine:2
perspectives ,surgeon:2
impact ,sports:2
impact ,medicine:2
impact ,surgeon:2
covid-19 ,sports:2
covid-19 ,surgeon:4
pandemic ,sports:2
pandemic ,surgeon:2
sports ,medicine:2
sports ,surgeon:2
medicine ,surgeon:2
plasma ,recovered:4
plasma ,new:2
plasma ,critical:2
donors ,recovered:2
donors ,new:2
donors ,coronavirus:2
donors ,therapy:2
donors ,critical:2
recovered ,new:2
recovered ,coronavirus:8
recovered ,therapy:2
recovered ,critical:2
new ,therapy:2
new ,critical:2
therapy ,critical:4
endothelial ,contributes:2
endothelial ,covid-19-associated:2
dysfunction ,contributes:2
dysfunction ,covid-19-associated:2
dysfunction ,vascular:6
dysfunction ,inflammation:2
contributes ,covid-19-associated:2
contributes ,vascular:2
contributes ,inflammation:2
covid-19-associated ,vascular:2
covid-19-associated ,inflammation:2
imported ,locally:2
imported ,transmitted:2
imported ,mild:2
imported ,sars-cov-2:6
imported ,pneumonia:2
imported ,cases:2
imported ,japan:2
locally ,transmitted:2
locally ,mild:2
locally ,sars-cov-2:2
locally ,pneumonia:2
locally ,cases:2
locally ,japan:2
transmitted ,mild:2
transmitted ,sars-cov-2:6
transmitted ,pneumonia:2
transmitted ,cases:2
transmitted ,japan:2
mild ,japan:2
pneumonia ,japan:2
cases ,japan:4
histopathological ,findings:6
histopathological ,advanced:2
histopathological ,natural:2
histopathological ,evolution:2
histopathological ,sars-cov-2:4
findings ,advanced:2
findings ,natural:4
findings ,evolution:2
advanced ,natural:2
advanced ,evolution:2
natural ,evolution:2
sars-cov-2 ,attempted:2
sars-cov-2 ,suicide:2
sars-cov-2 ,delusional:2
pandemic ,attempted:2
pandemic ,suicide:2
pandemic ,delusional:2
attempted ,suicide:2
attempted ,patient:2
attempted ,delusional:2
suicide ,patient:2
suicide ,delusional:2
patient ,delusional:2
comparison ,accula:2
accula ,sars-cov-2:2
accula ,test:2
accula ,laboratory-developed:2
accula ,assay:2
sars-cov-2 ,laboratory-developed:2
test ,laboratory-developed:6
test ,assay:2
laboratory-developed ,assay:2
defense ,unified:2
defense ,health:2
defense ,system:2
defense ,context:2
defense ,pandemic:2
unified ,health:2
unified ,system:2
unified ,context:2
unified ,sars-cov-2:2
unified ,pandemic:2
health ,context:4
system ,context:2
diaphragmatic ,myoclonus:2
diaphragmatic ,due:2
diaphragmatic ,sars-cov-2:2
diaphragmatic ,infection:2
myoclonus ,due:2
myoclonus ,sars-cov-2:2
myoclonus ,infection:2
due ,infection:4
within-host ,viral:2
within-host ,kinetics:2
within-host ,sars-cov-2:4
covid-19 ,male:14
covid-19 ,fertility:8
impact ,male:4
impact ,fertility:4
secondary ,publication:2
secondary ,standard:2
secondary ,operating:2
secondary ,procedure:2
secondary ,post-mortem:2
secondary ,inspection:2
publication ,standard:2
publication ,operating:2
publication ,procedure:2
publication ,post-mortem:2
publication ,inspection:2
standard ,post-mortem:2
standard ,inspection:2
operating ,post-mortem:2
operating ,inspection:2
procedure ,post-mortem:2
procedure ,inspection:2
post-mortem ,inspection:2
transmission ,opportunities:2
prevention ,opportunities:2
potential ,opportunities:2
sars-cov-2 ,consultant:2
infection ,consultant:2
coronavirus ,consultant:2
disease ,consultant:2
gastrointestinal ,consultant:2
tracking ,genomic:2
tracking ,footprints:2
tracking ,transmission:2
genomic ,footprints:2
footprints ,sars-cov-2:2
footprints ,transmission:2
identification ,destabilizing:2
identification ,snps:2
identification ,sars-cov2-ace2:2
identification ,protein:10
identification ,spike:6
destabilizing ,snps:2
destabilizing ,sars-cov2-ace2:2
destabilizing ,protein:2
destabilizing ,spike:2
snps ,sars-cov2-ace2:2
snps ,protein:2
snps ,spike:2
sars-cov2-ace2 ,protein:2
sars-cov2-ace2 ,spike:2
epidemiologic ,heart:2
epidemiologic ,transplant:2
epidemiologic ,recipients:2
clinical ,heart:2
clinical ,transplant:4
clinical ,recipients:2
characteristics ,heart:2
characteristics ,transplant:2
characteristics ,recipients:2
heart ,transplant:6
heart ,recipients:2
candesartan ,ameliorate:2
candesartan ,covid-19:2
candesartan ,cytokine:2
candesartan ,storm:2
ameliorate ,cytokine:2
ameliorate ,storm:2
prediction ,analysis:4
prediction ,sars-cov-2-targeting:2
prediction ,microrna:2
prediction ,human:2
prediction ,lung:4
prediction ,epithelium:2
analysis ,sars-cov-2-targeting:2
analysis ,microrna:2
analysis ,lung:2
analysis ,epithelium:2
sars-cov-2-targeting ,microrna:2
sars-cov-2-targeting ,human:2
sars-cov-2-targeting ,lung:2
sars-cov-2-targeting ,epithelium:2
microrna ,human:2
microrna ,lung:2
microrna ,epithelium:2
human ,epithelium:4
lung ,epithelium:2
natural ,compounds:8
natural ,endocytosis:2
natural ,promising:2
natural ,approach:2
compounds ,inhibitors:2
compounds ,endocytosis:2
compounds ,promising:2
compounds ,approach:2
inhibitors ,endocytosis:2
inhibitors ,approach:4
sars-cov-2 ,endocytosis:2
endocytosis ,promising:2
endocytosis ,approach:2
promising ,approach:6
global ,overview:4
global ,findings:2
global ,among:2
global ,pediatric:2
pandemic ,findings:4
pandemic ,among:10
pandemic ,pediatric:6
overview ,findings:2
overview ,among:2
overview ,pediatric:4
current ,findings:4
current ,among:2
current ,pediatric:2
findings ,among:4
among ,pediatric:4
impact ,among:4
impact ,healthcare:8
impact ,workers:2
impact ,hospitals:2
novel ,healthcare:6
novel ,workers:4
novel ,hospitals:4
coronavirus ,healthcare:14
coronavirus ,hospitals:4
among ,hospitals:4
healthcare ,hospitals:2
workers ,hospitals:4
rapid ,assessment:4
rapid ,regional:2
rapid ,community:4
rapid ,convenience:2
assessment ,regional:2
assessment ,community:2
assessment ,transmission:10
assessment ,convenience:2
regional ,community:2
regional ,convenience:2
sars-cov-2 ,convenience:2
community ,convenience:2
transmission ,convenience:2
quantitative ,microbial:2
quantitative ,risk:4
quantitative ,assessment:4
quantitative ,workers:2
quantitative ,wastewater:2
microbial ,risk:2
microbial ,assessment:2
microbial ,sars-cov-2:2
microbial ,workers:2
microbial ,wastewater:2
risk ,wastewater:2
assessment ,workers:2
workers ,wastewater:2
malignant ,cerebral:2
malignant ,ischemia:2
malignant ,covid-19:2
malignant ,infected:2
malignant ,patient:2
malignant ,case:2
malignant ,review:2
cerebral ,ischemia:2
cerebral ,infected:2
cerebral ,patient:6
cerebral ,case:6
cerebral ,review:2
ischemia ,infected:2
ischemia ,review:2
infected ,review:4
patient ,review:4
outbreak ,fear:2
outbreak ,serenity:2
covid-19 ,fear:2
covid-19 ,serenity:2
infection ,fear:2
infection ,serenity:2
children ,fear:2
children ,serenity:2
fear ,serenity:2
multiplex ,reverse:2
multiplex ,transcription:2
multiplex ,loop-mediated:2
multiplex ,isothermal:2
multiplex ,amplification:2
multiplex ,combined:2
reverse ,loop-mediated:8
reverse ,isothermal:8
reverse ,amplification:8
reverse ,combined:2
transcription ,loop-mediated:8
transcription ,isothermal:6
transcription ,amplification:6
transcription ,combined:2
loop-mediated ,isothermal:8
loop-mediated ,amplification:8
loop-mediated ,combined:2
isothermal ,combined:2
amplification ,combined:2
research ,disease:4
research ,field:2
research ,disinfection:2
research ,technology:2
coronavirus ,field:2
coronavirus ,technology:2
disease ,field:2
disease ,disinfection:2
field ,disinfection:2
field ,technology:2
field ,prevention:4
disinfection ,technology:2
disinfection ,prevention:2
technology ,prevention:2
remdesivir ,direct-acting:2
remdesivir ,inhibits:2
remdesivir ,rna-dependent:2
remdesivir ,polymerase:2
direct-acting ,antiviral:2
direct-acting ,inhibits:2
direct-acting ,rna-dependent:2
direct-acting ,rna:2
direct-acting ,polymerase:2
antiviral ,inhibits:2
antiviral ,rna-dependent:2
antiviral ,rna:4
antiviral ,polymerase:4
inhibits ,rna-dependent:2
inhibits ,rna:2
inhibits ,polymerase:2
fatal ,infection:4
fatal ,renal:2
fatal ,transplant:2
fatal ,recipient:2
sars-cov-2 ,transplant:6
sars-cov-2 ,recipient:4
infection ,transplant:6
infection ,recipient:4
renal ,recipient:4
preliminary ,b-:2
preliminary ,t-cell:2
preliminary ,responses:2
analysis ,b-:2
analysis ,t-cell:2
analysis ,responses:6
b- ,t-cell:2
b- ,responses:2
b- ,sars-cov-2:2
t-cell ,responses:2
t-cell ,sars-cov-2:2
coronavirus ,stroke:8
coronavirus ,pathophysiological:2
disease ,pathophysiological:2
stroke ,clinical:2
stroke ,manifestations:2
stroke ,pathophysiological:2
clinical ,pathophysiological:4
manifestations ,pathophysiological:2
comparison ,efficacy:4
comparison ,pcr:8
diagnostic ,efficacy:4
diagnostic ,two:2
efficacy ,two:2
efficacy ,pcr:2
efficacy ,test:6
efficacy ,kits:4
two ,pcr:4
two ,kits:2
pcr ,test:4
pcr ,kits:2
test ,kits:4
daily ,persistent:2
daily ,headache:2
daily ,viral:4
daily ,illness:2
daily ,worldwide:2
daily ,pandemic:2
daily ,may:2
persistent ,headache:4
persistent ,illness:2
persistent ,worldwide:2
persistent ,pandemic:2
persistent ,may:2
headache ,viral:2
headache ,illness:2
headache ,worldwide:2
headache ,pandemic:2
headache ,may:2
viral ,illness:2
viral ,worldwide:2
viral ,may:2
illness ,worldwide:2
illness ,pandemic:2
illness ,may:2
worldwide ,may:4
pandemic ,may:2
potential ,alzheimers:2
potential ,preventative:6
potential ,mitigation:4
novel ,role:8
novel ,alzheimers:2
novel ,preventative:2
role ,alzheimers:2
role ,preventative:2
role ,mitigation:4
covid-19 ,alzheimers:8
covid-19 ,preventative:6
covid-19 ,mitigation:4
alzheimers ,disease:8
alzheimers ,preventative:2
alzheimers ,mitigation:2
disease ,preventative:2
disease ,mitigation:2
preventative ,mitigation:2
ivermectin ,closer:2
ivermectin ,look:2
ivermectin ,remedy:2
closer ,look:4
closer ,potential:2
closer ,remedy:2
look ,potential:4
look ,remedy:2
potential ,remedy:2
rapid ,differential:2
rapid ,seven:4
rapid ,coronaviruses:2
rapid ,based:4
differential ,seven:2
differential ,human:4
differential ,respiratory:2
differential ,coronaviruses:2
differential ,based:2
diagnosis ,seven:2
diagnosis ,human:4
diagnosis ,coronaviruses:2
diagnosis ,based:4
seven ,human:2
seven ,respiratory:2
seven ,coronaviruses:2
seven ,based:2
respiratory ,based:4
coronaviruses ,based:2
epidemiology ,information:2
clinical ,information:2
full-genome ,sequences:2
full-genome ,first:2
full-genome ,two:2
full-genome ,sars-cov-2:2
full-genome ,viruses:2
full-genome ,india:2
sequences ,first:4
sequences ,two:4
sequences ,viruses:4
sequences ,india:2
first ,viruses:2
two ,viruses:2
two ,india:2
sars-cov-2 ,viruses:14
viruses ,india:2
transcriptome ,viral:2
transcriptome ,growth:2
transcriptome ,analysis:4
transcriptome ,sars-cov-2-infected:2
transcriptome ,vero:2
transcriptome ,ccl-81:2
transcriptome ,cells:2
viral ,growth:2
viral ,vero:2
viral ,ccl-81:2
viral ,cells:2
growth ,analysis:2
growth ,sars-cov-2-infected:2
growth ,vero:2
growth ,ccl-81:2
growth ,cells:2
analysis ,sars-cov-2-infected:6
analysis ,vero:2
analysis ,ccl-81:2
analysis ,cells:4
sars-cov-2-infected ,vero:2
sars-cov-2-infected ,ccl-81:2
sars-cov-2-infected ,cells:6
vero ,ccl-81:2
vero ,cells:6
ccl-81 ,cells:2
potential ,candidates:2
potential ,identified:2
anti-sars-cov-2 ,drug:2
anti-sars-cov-2 ,candidates:2
anti-sars-cov-2 ,identified:2
anti-sars-cov-2 ,virtual:2
anti-sars-cov-2 ,screening:2
drug ,identified:2
drug ,virtual:4
candidates ,identified:2
candidates ,virtual:2
candidates ,screening:2
identified ,virtual:2
identified ,screening:2
use ,whole:2
use ,genome:2
use ,sequencing:2
use ,data:2
use ,silico:2
use ,specificity:2
use ,evaluation:2
whole ,genome:12
whole ,sequencing:8
whole ,data:2
whole ,first:2
whole ,silico:2
whole ,specificity:2
whole ,evaluation:2
genome ,data:2
genome ,first:2
genome ,silico:4
genome ,specificity:2
genome ,evaluation:2
sequencing ,data:2
sequencing ,first:4
sequencing ,silico:2
sequencing ,specificity:2
sequencing ,evaluation:2
data ,first:2
data ,silico:2
data ,specificity:2
data ,evaluation:2
first ,silico:2
first ,specificity:2
first ,evaluation:4
silico ,specificity:2
silico ,evaluation:6
specificity ,evaluation:2
expression ,epithelium:2
sars-cov-2 ,airway:12
sars-cov-2 ,epithelium:4
ace2 ,airway:6
ace2 ,epithelium:2
receptor ,human:8
receptor ,airway:2
receptor ,epithelium:2
human ,airway:4
airway ,epithelium:2
structural ,binding:4
structural ,modes:2
structural ,rna-dependent:2
structural ,polymerases:2
insights ,binding:2
insights ,modes:2
insights ,viral:2
insights ,rna-dependent:2
insights ,rna:4
insights ,polymerases:2
binding ,modes:2
binding ,viral:2
binding ,rna-dependent:2
binding ,rna:4
binding ,polymerases:2
modes ,viral:2
modes ,rna-dependent:2
modes ,rna:2
modes ,polymerases:2
viral ,rna-dependent:2
viral ,polymerases:2
rna-dependent ,polymerases:2
rna ,polymerases:4
covid-19 ,distinct:6
covid-19 ,sars-cov-2-negative:2
covid-19 ,community-acquired:2
distinct ,sars-cov-2-negative:2
distinct ,community-acquired:2
distinct ,pneumonia:2
sars-cov-2-negative ,community-acquired:2
sars-cov-2-negative ,pneumonia:2
rapid ,anti-coronavirus:2
rapid ,effect:2
rapid ,remdesivir:2
review ,anti-coronavirus:2
review ,effect:4
anti-coronavirus ,effect:2
anti-coronavirus ,remdesivir:2
possible ,cause:2
possible ,inflammatory:2
possible ,storm:6
possible ,septic:2
possible ,shock:2
possible ,patients:8
possible ,diagnosed:2
cause ,inflammatory:2
cause ,storm:2
cause ,septic:2
cause ,shock:2
cause ,patients:2
cause ,diagnosed:2
inflammatory ,storm:6
inflammatory ,septic:2
inflammatory ,shock:4
inflammatory ,diagnosed:2
storm ,septic:2
storm ,shock:2
storm ,diagnosed:2
septic ,shock:2
septic ,patients:2
septic ,diagnosed:2
shock ,patients:4
shock ,diagnosed:2
patients ,diagnosed:4
novel ,clinicians:4
coronavirus ,clinicians:4
sars-cov-2 ,clinicians:6
overview ,emergency:6
overview ,clinicians:6
emergency ,clinicians:4
nuclear ,medicine:2
nuclear ,sars-cov-2:2
nuclear ,pandemia:2
nuclear ,18f-fdg-petct:2
nuclear ,tovisualize:2
nuclear ,covid-19:2
medicine ,pandemia:2
medicine ,18f-fdg-petct:2
medicine ,tovisualize:2
sars-cov-2 ,18f-fdg-petct:2
sars-cov-2 ,tovisualize:2
pandemia ,18f-fdg-petct:2
pandemia ,tovisualize:2
pandemia ,covid-19:18
18f-fdg-petct ,tovisualize:2
18f-fdg-petct ,covid-19:2
tovisualize ,covid-19:2
drug ,pregnancy:2
therapy ,pregnancy:2
strategies ,infection:6
strategies ,pregnancy:2
delivery ,infected:2
delivery ,fast:2
pregnant ,fast:2
women ,fast:2
infected ,fast:2
sars-cov-2 ,fast:6
fast ,review:2
covid-19-associated ,critical:2
covid-19-associated ,illness-report:2
covid-19-associated ,first:2
covid-19-associated ,300:2
covid-19-associated ,patients:2
covid-19-associated ,admitted:2
critical ,illness-report:2
critical ,first:2
critical ,300:2
critical ,admitted:2
illness-report ,first:2
illness-report ,300:2
illness-report ,patients:2
illness-report ,admitted:2
first ,300:2
first ,admitted:2
300 ,patients:2
300 ,admitted:2
patients ,admitted:12
physicochemical ,properties:2
physicochemical ,sars-cov-2:2
physicochemical ,drug:2
physicochemical ,targeting:2
physicochemical ,virus:2
physicochemical ,inactivation:2
properties ,drug:2
properties ,targeting:2
properties ,virus:2
properties ,inactivation:2
drug ,inactivation:2
targeting ,virus:6
targeting ,inactivation:2
case ,kidney:4
case ,transplant:8
report ,kidney:2
report ,transplant:4
kidney ,patient:6
kidney ,mild:2
transplant ,patient:4
transplant ,mild:2
immunomodulatory ,drugs:2
immunomodulatory ,management:6
immunomodulatory ,sars-cov-2:2
drugs ,management:2
non-specific ,laboratory:2
non-specific ,tests:2
non-specific ,patients:2
non-specific ,covid-19:4
laboratory ,tests:14
laboratory ,patients:12
tests ,patients:12
surface ,coating:2
surface ,rapidly:2
surface ,inactivates:2
coating ,rapidly:2
coating ,inactivates:2
coating ,sars-cov-2:2
singapore ,response:2
singapore ,successful:2
singapore ,model:2
singapore ,framework:2
pandemic ,successful:2
pandemic ,model:8
pandemic ,framework:2
response ,successful:2
response ,model:4
response ,framework:2
successful ,model:2
successful ,framework:2
model ,framework:2
covid-19 ,anaethesiologists:2
anaethesiologists ,intensivists:2
anaethesiologists ,know:2
intensivists ,know:2
d-dimer ,mortality:8
d-dimer ,covid-19:10
d-dimer ,self-fulfilling:2
d-dimer ,prophecy:2
mortality ,self-fulfilling:2
mortality ,prophecy:2
covid-19 ,self-fulfilling:2
covid-19 ,prophecy:2
self-fulfilling ,prophecy:2
clinical ,gastrointestinal:4
clinical ,symptoms:6
characteristics ,gastrointestinal:2
characteristics ,symptoms:2
molecular ,simulations:4
molecular ,network:8
molecular ,modeling:2
molecular ,reveal:4
molecular ,allosteric:2
molecular ,signaling:2
simulations ,network:2
simulations ,modeling:2
simulations ,reveal:2
simulations ,allosteric:2
simulations ,signaling:2
network ,modeling:2
network ,reveal:2
network ,allosteric:2
network ,signaling:2
modeling ,reveal:2
modeling ,allosteric:2
modeling ,signaling:2
reveal ,allosteric:2
reveal ,signaling:2
allosteric ,signaling:2
mass ,spectrometry:6
spectrometry ,covid-19:2
covid-19 ,veterinarians:2
covid-19 ,zoonotic-:2
covid-19 ,reverse-zoonotic:2
veterinarians ,one:2
veterinarians ,health:2
veterinarians ,zoonotic-:2
veterinarians ,reverse-zoonotic:2
one ,health:8
one ,zoonotic-:2
one ,reverse-zoonotic:2
health ,zoonotic-:2
health ,reverse-zoonotic:2
zoonotic- ,reverse-zoonotic:2
dynamic ,change:2
dynamic ,process:2
dynamic ,target:2
dynamic ,genes:2
dynamic ,testing:2
change ,process:2
change ,target:2
change ,genes:2
change ,rt-pcr:2
change ,testing:4
process ,target:2
process ,genes:2
process ,rt-pcr:2
process ,testing:2
target ,genes:2
target ,rt-pcr:2
target ,testing:2
genes ,rt-pcr:2
genes ,testing:2
combinational ,approach:2
combinational ,restore:2
combinational ,cytokine:2
combinational ,balance:2
combinational ,inhibit:2
combinational ,virus:2
combinational ,growth:2
combinational ,may:2
approach ,restore:2
approach ,cytokine:2
approach ,balance:2
approach ,inhibit:2
approach ,growth:2
approach ,may:2
restore ,cytokine:2
restore ,balance:2
restore ,inhibit:2
restore ,virus:2
restore ,growth:2
restore ,may:2
cytokine ,balance:2
cytokine ,inhibit:4
cytokine ,virus:4
cytokine ,growth:2
cytokine ,may:2
balance ,inhibit:2
balance ,virus:2
balance ,growth:2
balance ,may:2
inhibit ,virus:2
inhibit ,growth:2
inhibit ,may:2
virus ,growth:2
virus ,may:6
growth ,may:2
ocular ,first:2
ocular ,sign:2
ocular ,interest:2
manifestation ,sign:2
manifestation ,interest:2
first ,sign:2
first ,interest:2
sign ,coronavirus:2
sign ,disease:2
sign ,covid-19:12
sign ,interest:2
coronavirus ,interest:2
disease ,interest:2
covid-19 ,interest:2
reliability ,induced:2
reliability ,sputum:2
reliability ,test:2
reliability ,greater:2
reliability ,throat:2
reliability ,swab:2
induced ,sputum:2
induced ,test:2
induced ,greater:2
induced ,throat:2
induced ,swab:2
sputum ,test:2
sputum ,greater:2
sputum ,swab:2
test ,greater:2
test ,throat:4
test ,swab:2
greater ,throat:2
greater ,swab:2
throat ,swab:2
timely ,update:2
timely ,global:2
timely ,covid-19:6
timely ,vaccine:2
timely ,development:2
update ,vaccine:2
update ,development:2
global ,vaccine:4
global ,development:4
acute ,cerebellar:2
acute ,strokes:2
acute ,anoxic:2
acute ,brain:2
acute ,cardiopulmonary:2
acute ,arrest:2
cerebellar ,strokes:2
cerebellar ,anoxic:2
cerebellar ,brain:2
cerebellar ,injury:2
cerebellar ,cardiopulmonary:2
cerebellar ,arrest:2
strokes ,anoxic:2
strokes ,brain:2
strokes ,injury:2
strokes ,cardiopulmonary:2
strokes ,arrest:2
anoxic ,brain:2
anoxic ,injury:2
anoxic ,cardiopulmonary:2
anoxic ,arrest:2
brain ,injury:4
brain ,cardiopulmonary:2
brain ,arrest:2
injury ,cardiopulmonary:2
injury ,arrest:2
cardiopulmonary ,arrest:2
just ,antibodies:2
just ,cells:2
just ,mediate:2
just ,immunity:2
just ,covid-19:2
antibodies ,cells:2
antibodies ,mediate:4
antibodies ,immunity:2
cells ,mediate:2
cells ,immunity:4
mediate ,immunity:2
mediate ,covid-19:4
proteomics ,cells:4
proteomics ,reveals:2
proteomics ,therapy:2
proteomics ,targets:2
sars-cov-2-infected ,reveals:4
sars-cov-2-infected ,therapy:2
sars-cov-2-infected ,targets:2
host ,cells:4
host ,reveals:2
host ,therapy:2
cells ,reveals:2
cells ,targets:2
reveals ,therapy:2
reveals ,targets:2
therapy ,targets:2
gross ,histopathological:2
gross ,pulmonary:2
gross ,findings:2
gross ,covid-19:2
gross ,associated:2
gross ,death:2
histopathological ,pulmonary:2
histopathological ,covid-19:8
histopathological ,associated:4
histopathological ,death:2
pulmonary ,death:2
findings ,death:4
associated ,death:4
smell ,disorders:8
smell ,outbreak:4
smell ,cross-sectional:4
smell ,study:2
smell ,355:2
taste ,disorders:10
taste ,outbreak:4
taste ,cross-sectional:4
taste ,study:2
taste ,355:2
disorders ,outbreak:2
disorders ,cross-sectional:2
disorders ,study:2
disorders ,355:2
covid-19 ,cross-sectional:4
covid-19 ,355:2
outbreak ,cross-sectional:2
outbreak ,355:2
cross-sectional ,study:6
cross-sectional ,355:2
study ,355:2
coronavirus ,immunological:2
disease ,immunological:2
disease ,emerging:10
covid-19 ,immunological:16
immunological ,approaches:2
immunological ,emerging:2
approaches ,emerging:4
inhaled ,corticosteroids:2
inhaled ,covid-19:4
inhaled ,systematic:2
inhaled ,review:2
inhaled ,clinical:2
inhaled ,perspective:2
corticosteroids ,systematic:2
corticosteroids ,review:2
corticosteroids ,clinical:2
corticosteroids ,perspective:2
systematic ,perspective:4
review ,perspective:6
hiv ,prevention:2
hiv ,context:2
hiv ,bronx:2
hiv ,york:2
prevention ,context:2
prevention ,bronx:2
prevention ,new:2
prevention ,york:2
treatment ,context:2
treatment ,bronx:2
treatment ,york:2
context ,bronx:2
context ,new:2
context ,york:2
covid-19 ,bronx:2
bronx ,new:2
bronx ,york:2
virus ,shedding:8
virus ,mildly:2
virus ,symptomatic:2
virus ,infected:4
shedding ,dynamics:2
shedding ,mildly:2
shedding ,symptomatic:2
shedding ,infected:2
dynamics ,asymptomatic:2
dynamics ,mildly:2
dynamics ,symptomatic:2
dynamics ,infected:4
asymptomatic ,infected:4
mildly ,infected:2
symptomatic ,infected:2
infection ,practice:2
high ,repatriation:2
high ,flights:2
high ,greece:2
high ,three:2
prevalence ,repatriation:2
prevalence ,flights:2
prevalence ,greece:2
prevalence ,three:2
sars-cov-2 ,repatriation:2
sars-cov-2 ,flights:2
sars-cov-2 ,greece:4
infection ,repatriation:2
infection ,flights:2
infection ,greece:2
infection ,three:4
repatriation ,flights:2
repatriation ,greece:2
repatriation ,three:2
flights ,greece:2
flights ,three:2
greece ,three:2
report ,series:4
report ,healthy:2
report ,term:2
report ,newborns:2
report ,convalescent:2
report ,mothers:4
series ,healthy:2
series ,term:2
series ,newborns:2
series ,convalescent:2
series ,mothers:4
healthy ,term:2
healthy ,newborns:2
healthy ,convalescent:2
healthy ,mothers:2
healthy ,covid-19:6
term ,newborns:2
term ,convalescent:2
term ,mothers:4
term ,covid-19:4
newborns ,convalescent:2
convalescent ,mothers:2
evaluating ,efficacy:4
evaluating ,rt-qpcr:2
evaluating ,sars-cov-2:2
evaluating ,direct:2
evaluating ,approaches:2
evaluating ,comparison:2
efficacy ,rt-qpcr:2
efficacy ,direct:2
efficacy ,approaches:2
rt-qpcr ,direct:4
rt-qpcr ,approaches:2
rt-qpcr ,comparison:2
direct ,approaches:2
direct ,rna:10
approaches ,comparison:2
approaches ,rna:2
comparison ,rna:6
evaluation ,world:2
evaluation ,health:4
evaluation ,organization-recommended:2
evaluation ,hand:2
evaluation ,hygiene:2
evaluation ,formulations:2
world ,health:6
world ,organization-recommended:2
world ,hand:2
world ,hygiene:2
world ,formulations:2
health ,organization-recommended:2
health ,hand:4
health ,hygiene:6
health ,formulations:2
organization-recommended ,hand:2
organization-recommended ,hygiene:2
organization-recommended ,formulations:2
hand ,hygiene:6
hand ,formulations:2
hygiene ,formulations:2
potential ,factors:2
potential ,influencing:2
potential ,repeated:2
potential ,sars:4
potential ,outbreaks:2
factors ,influencing:4
factors ,repeated:2
factors ,sars:2
factors ,outbreaks:2
factors ,china:2
influencing ,repeated:2
influencing ,sars:2
influencing ,outbreaks:2
influencing ,china:2
repeated ,sars:2
repeated ,outbreaks:2
repeated ,china:2
sars ,outbreaks:2
biological ,therapy:2
biological ,reactivation:2
biological ,acovid-19:2
therapy ,reactivation:2
therapy ,acovid-19:2
covid-19 ,acovid-19:2
infection ,reactivation:2
infection ,acovid-19:2
reactivation ,acovid-19:2
invited ,commentary:2
invited ,evidence:2
invited ,based:2
invited ,management:2
invited ,guideline:2
invited ,covid-19:2
commentary ,evidence:2
commentary ,based:2
commentary ,management:4
commentary ,guideline:2
commentary ,covid-19:10
evidence ,management:6
evidence ,guideline:4
based ,management:4
based ,guideline:4
guideline ,covid-19:10
sars-cov2 ,vertical:2
sars-cov2 ,transmission:2
sars-cov2 ,adverse:2
sars-cov2 ,effects:2
sars-cov2 ,newborn:2
sars-cov2 ,revealed:2
vertical ,adverse:2
vertical ,effects:2
vertical ,newborn:4
vertical ,revealed:2
transmission ,adverse:2
transmission ,effects:6
transmission ,newborn:4
transmission ,revealed:2
adverse ,effects:4
adverse ,newborn:2
adverse ,revealed:2
effects ,newborn:2
effects ,revealed:2
newborn ,revealed:2
molecular ,insights:4
molecular ,genome:2
serological ,assays:18
serological ,insights:2
serological ,genome:2
serological ,clinical:6
assays ,insights:2
assays ,genome:2
insights ,clinical:4
curcumin ,traditional:2
curcumin ,spice:2
curcumin ,component:2
curcumin ,can:2
curcumin ,hold:2
curcumin ,promise:2
curcumin ,covid-19:4
traditional ,spice:2
traditional ,component:2
traditional ,can:2
traditional ,hold:2
traditional ,promise:2
spice ,component:2
spice ,can:2
spice ,hold:2
spice ,promise:2
spice ,covid-19:2
component ,can:2
component ,hold:2
component ,promise:2
component ,covid-19:4
can ,hold:2
can ,promise:2
hold ,promise:2
hold ,covid-19:2
promise ,covid-19:2
non-infectious ,status:2
non-infectious ,indicated:2
non-infectious ,detectable:2
non-infectious ,igg:2
non-infectious ,antibody:2
non-infectious ,sars-cov-2:2
status ,indicated:2
status ,detectable:2
status ,igg:2
status ,antibody:2
status ,sars-cov-2:20
indicated ,detectable:2
indicated ,igg:2
indicated ,antibody:2
indicated ,sars-cov-2:2
detectable ,igg:2
detectable ,antibody:2
sars-cov-2-related ,deaths:2
sars-cov-2-related ,routine:2
sars-cov-2-related ,forensic:2
sars-cov-2-related ,autopsy:2
sars-cov-2-related ,practice:2
sars-cov-2-related ,histopathological:2
deaths ,routine:2
deaths ,forensic:2
deaths ,autopsy:2
deaths ,practice:2
deaths ,histopathological:2
routine ,forensic:2
routine ,autopsy:2
routine ,practice:2
routine ,histopathological:2
forensic ,autopsy:2
forensic ,practice:6
forensic ,histopathological:2
autopsy ,practice:2
autopsy ,histopathological:2
practice ,histopathological:2
investigation ,genetic:2
investigation ,variation:2
investigation ,ace2:4
investigation ,structural:2
investigation ,recognition:2
genetic ,variation:2
genetic ,ace2:12
genetic ,structural:4
genetic ,recognition:2
variation ,ace2:4
variation ,recognition:2
ace2 ,structural:4
structural ,recognition:8
lessons ,epidemic:2
lessons ,prevention:8
lessons ,future:6
lessons ,infectious:2
learned ,2019-ncov:2
learned ,epidemic:2
learned ,prevention:2
learned ,future:4
learned ,infectious:2
2019-ncov ,prevention:4
2019-ncov ,future:4
epidemic ,infectious:2
prevention ,future:2
prevention ,infectious:2
future ,infectious:2
risk ,associated:12
risk ,progression:4
risk ,cohort:2
risk ,infected:4
factors ,disease:12
factors ,progression:4
factors ,cohort:2
factors ,infected:2
associated ,progression:8
associated ,cohort:2
associated ,infected:4
disease ,cohort:2
disease ,infected:6
progression ,cohort:2
progression ,patients:4
progression ,infected:2
cohort ,infected:2
covid-19 ,babies:2
covid-19 ,pediatricians:2
pregnant ,babies:2
pregnant ,pediatricians:2
pregnant ,need:2
pregnant ,know:2
women ,babies:2
women ,pediatricians:2
women ,need:2
women ,know:2
babies ,pediatricians:2
babies ,need:2
babies ,know:2
pediatricians ,need:2
pediatricians ,know:2
negative ,nasopharyngeal:4
negative ,swabs:4
negative ,early:2
negative ,course:2
nasopharyngeal ,early:2
nasopharyngeal ,course:2
swabs ,early:2
swabs ,course:2
swabs ,covid-19:4
early ,course:2
sars-cov-2 ,encephalitis:4
sars-cov-2 ,20-year:2
sars-cov-2 ,old:10
sars-cov-2 ,healthy:8
sars-cov-2 ,female:2
encephalitis ,20-year:2
encephalitis ,old:2
encephalitis ,healthy:2
encephalitis ,female:2
20-year ,old:2
20-year ,healthy:2
20-year ,female:2
old ,healthy:2
old ,female:2
healthy ,female:2
epidemiological ,81:2
clinical ,81:2
characteristics ,81:2
81 ,children:2
81 ,covid-19:2
propolis ,potential:2
propolis ,sars-cov-2:4
propolis ,infection:2
propolis ,mechanisms:2
infection ,mechanisms:10
living ,coronavirus:2
living ,brief:2
living ,report:2
brief ,report:4
duration ,gastrointestinal:2
duration ,viral:4
duration ,children:2
respiratory ,gastrointestinal:4
gastrointestinal ,children:2
sars-cov-2 ,coagulation:10
sars-cov-2 ,organs:4
coagulation ,disorders:2
coagulation ,different:2
coagulation ,organs:2
disorders ,different:2
disorders ,organs:2
different ,organs:2
covid-19 ,another:4
living ,another:2
living ,pandemic:4
another ,pandemic:2
two ,trillion:2
two ,dollar:2
two ,barn:2
two ,science:2
two ,prevention:2
two ,lessons:2
two ,disaster:2
trillion ,dollar:2
trillion ,barn:2
trillion ,science:2
trillion ,prevention:2
trillion ,lessons:2
trillion ,disaster:2
dollar ,barn:2
dollar ,science:2
dollar ,prevention:2
dollar ,lessons:2
dollar ,disaster:2
barn ,science:2
barn ,prevention:2
barn ,lessons:2
barn ,disaster:2
science ,prevention:2
science ,lessons:4
science ,disaster:2
prevention ,disaster:2
lessons ,disaster:2
early ,tracheostomy:2
early ,tube:2
early ,management:10
experience ,tracheostomy:4
experience ,tube:2
experience ,management:14
tracheostomy ,tube:2
tracheostomy ,management:4
tracheostomy ,covid-19:10
tube ,management:2
tube ,covid-19:2
evaluation ,fully-automated:2
three ,fully-automated:2
three ,antibody:6
three ,assays:8
fully-automated ,sars-cov-2:2
fully-automated ,antibody:2
fully-automated ,assays:2
comparison ,analysis:4
comparison ,different:6
comparison ,transport:2
comparison ,mediums:2
comparison ,suitable:4
analysis ,swabs:2
analysis ,transport:4
analysis ,mediums:2
analysis ,suitable:2
different ,swabs:2
different ,transport:2
different ,mediums:2
different ,suitable:2
swabs ,transport:2
swabs ,mediums:2
swabs ,suitable:2
transport ,mediums:2
transport ,suitable:2
mediums ,suitable:2
mediums ,sars-cov-2:2
suitable ,sars-cov-2:2
chilblain-like ,acral:2
chilblain-like ,lesions:6
chilblain-like ,covid-19:8
chilblain-like ,pandemic:4
chilblain-like ,covid:2
chilblain-like ,toes:2
acral ,lesions:2
acral ,covid-19:2
acral ,pandemic:2
acral ,covid:2
acral ,toes:2
lesions ,pandemic:6
lesions ,covid:2
lesions ,toes:4
covid-19 ,covid:4
covid-19 ,toes:4
pandemic ,covid:6
pandemic ,toes:4
covid ,toes:2
performance ,tests:12
fatal ,previously:2
fatal ,50-year-old:2
fatal ,man:2
outcome ,coronavirus:2
outcome ,disease:4
outcome ,previously:2
outcome ,healthy:2
outcome ,50-year-old:2
outcome ,man:2
coronavirus ,previously:2
coronavirus ,healthy:2
coronavirus ,50-year-old:2
coronavirus ,man:4
disease ,previously:2
disease ,healthy:2
disease ,50-year-old:2
disease ,man:8
previously ,healthy:4
previously ,50-year-old:2
previously ,man:2
healthy ,50-year-old:2
healthy ,man:2
50-year-old ,man:2
ribavirin ,therapy:2
ribavirin ,severe:2
ribavirin ,covid-19:2
ribavirin ,retrospective:2
ribavirin ,cohort:2
ribavirin ,study:2
therapy ,severe:12
therapy ,retrospective:4
therapy ,cohort:2
therapy ,study:4
severe ,cohort:2
severe ,study:8
retrospective ,cohort:2
retrospective ,study:18
practical ,guidelines:2
practical ,collection:2
practical ,manipulation:2
practical ,inactivation:2
guidelines ,collection:2
guidelines ,manipulation:2
guidelines ,inactivation:2
guidelines ,sars-cov-2:6
collection ,manipulation:2
collection ,inactivation:2
manipulation ,inactivation:2
manipulation ,sars-cov-2:2
sars-cov ,response:6
sars-cov ,challenge:2
sars-cov ,forensic:2
sars-cov ,infectious:2
response ,challenge:4
response ,forensic:2
response ,infectious:2
challenge ,forensic:2
challenge ,infectious:2
forensic ,infectious:2
coronavirus3d ,3d:2
coronavirus3d ,structural:2
coronavirus3d ,visualization:2
coronavirus3d ,covid-19:2
coronavirus3d ,genomic:2
coronavirus3d ,divergence:2
3d ,structural:2
3d ,visualization:2
3d ,covid-19:6
3d ,genomic:2
3d ,divergence:2
structural ,visualization:2
structural ,genomic:2
structural ,divergence:2
visualization ,covid-19:2
visualization ,genomic:2
visualization ,divergence:2
covid-19 ,divergence:2
genomic ,divergence:2
exploring ,epidemiological:2
exploring ,behavior:2
exploring ,novel:4
exploring ,coronavirus:2
exploring ,covid-19:12
exploring ,outbreak:2
epidemiological ,behavior:4
behavior ,coronavirus:4
behavior ,covid-19:8
behavior ,outbreak:2
clinical ,guidance:12
clinical ,perinatal:4
clinical ,era:4
guidance ,perinatal:2
guidance ,care:12
guidance ,era:2
guidance ,coronavirus:4
guidance ,disease:6
perinatal ,care:2
perinatal ,era:2
perinatal ,coronavirus:4
perinatal ,disease:4
care ,era:4
clinically ,practiced:2
clinically ,commercially:2
clinically ,viable:2
clinically ,nanobio:2
clinically ,engineered:2
clinically ,analytical:2
clinically ,methods:2
practiced ,commercially:2
practiced ,viable:2
practiced ,nanobio:2
practiced ,engineered:2
practiced ,analytical:2
practiced ,methods:2
commercially ,viable:2
commercially ,nanobio:2
commercially ,engineered:2
commercially ,analytical:2
commercially ,methods:2
viable ,nanobio:2
viable ,engineered:2
viable ,analytical:2
viable ,methods:2
nanobio ,engineered:2
nanobio ,analytical:2
nanobio ,methods:2
engineered ,analytical:2
engineered ,methods:2
analytical ,methods:2
evaluation ,antigen-based:2
novel ,antigen-based:2
novel ,test:6
antigen-based ,rapid:2
antigen-based ,detection:2
antigen-based ,test:2
antigen-based ,diagnosis:2
test ,diagnosis:6
chemokine ,receptor:2
chemokine ,antagonist:2
chemokine ,cenicriviroc:2
chemokine ,inhibits:2
chemokine ,replication:2
receptor ,cenicriviroc:2
receptor ,inhibits:2
receptor ,replication:2
antagonist ,cenicriviroc:2
antagonist ,inhibits:2
antagonist ,replication:2
cenicriviroc ,inhibits:2
cenicriviroc ,replication:2
antibody ,response:24
antibody ,family:2
response ,family:4
structural ,molecular:4
structural ,interaction:2
structural ,mechanism:6
structural ,selected:2
structural ,drugs:2
molecular ,interaction:8
molecular ,selected:2
basis ,interaction:2
basis ,mechanism:4
basis ,selected:2
basis ,drugs:2
interaction ,mechanism:2
interaction ,selected:2
interaction ,drugs:4
mechanism ,selected:2
mechanism ,drugs:4
selected ,drugs:2
multi-omics-based ,identification:2
multi-omics-based ,sars-cov-2:2
multi-omics-based ,infection:2
multi-omics-based ,biology:2
multi-omics-based ,candidate:2
multi-omics-based ,drugs:2
identification ,infection:6
identification ,biology:2
identification ,candidate:6
identification ,drugs:4
sars-cov-2 ,candidate:20
infection ,biology:2
infection ,candidate:2
infection ,drugs:6
biology ,candidate:2
biology ,drugs:2
candidate ,drugs:8
human ,factors:4
human ,associated:4
genetic ,factors:4
genetic ,associated:4
genetic ,infection:6
factors ,susceptibility:4
factors ,infection:14
associated ,susceptibility:2
susceptibility ,infection:14
effect ,transfusion:2
effect ,recovery:2
transfusion ,recovery:2
transfusion ,patients:4
transfusion ,coronavirus:2
convalescent ,recovery:2
recovery ,plasma:2
recovery ,patients:4
recovery ,coronavirus:6
room-temperature-storable ,pcr:2
room-temperature-storable ,mixes:2
room-temperature-storable ,sars-cov-2:2
room-temperature-storable ,detection:2
pcr ,mixes:2
mixes ,sars-cov-2:2
mixes ,detection:2
environmental ,sampling:4
de-escalation ,urology:2
de-escalation ,measures:2
de-escalation ,covid-19:2
de-escalation ,pandemia:2
de-escalation ,stepwise:2
de-escalation ,recommendations:2
urology ,measures:2
urology ,covid-19:8
urology ,pandemia:2
urology ,stepwise:2
urology ,recommendations:2
measures ,pandemia:2
measures ,stepwise:2
measures ,recommendations:4
covid-19 ,stepwise:4
pandemia ,stepwise:2
pandemia ,recommendations:6
stepwise ,recommendations:2
covid19 ,inhibitors:2
covid19 ,prospective:2
covid19 ,therapeutics:2
attenuated ,interferon:2
attenuated ,proinflammatory:2
attenuated ,response:2
attenuated ,sars-cov-2-infected:2
attenuated ,human:2
interferon ,proinflammatory:2
interferon ,sars-cov-2-infected:2
interferon ,human:4
proinflammatory ,response:2
proinflammatory ,sars-cov-2-infected:2
proinflammatory ,human:2
response ,sars-cov-2-infected:2
sars-cov-2-infected ,human:2
consideration ,aerosol:2
consideration ,transmission:2
consideration ,public:2
consideration ,health:2
aerosol ,public:2
aerosol ,health:4
coronavirus ,entered:2
coronavirus ,middle:2
coronavirus ,east:2
coronavirus ,study:20
disease ,entered:2
disease ,africa:4
disease ,middle:2
disease ,study:8
entered ,africa:2
entered ,middle:2
entered ,east:2
entered ,case:2
entered ,study:2
africa ,middle:2
africa ,east:2
africa ,case:4
africa ,study:2
middle ,case:2
middle ,study:2
east ,case:2
east ,study:4
comparison ,serological:2
comparison ,real:2
comparison ,life:2
different ,serological:4
different ,real:2
different ,life:2
serological ,real:2
serological ,life:2
assays ,real:2
assays ,life:2
real ,life:4
silico ,pharmacokinetic:2
silico ,molecular:14
silico ,docking:10
silico ,studies:6
silico ,natural:2
silico ,flavonoids:4
pharmacokinetic ,molecular:2
pharmacokinetic ,docking:2
pharmacokinetic ,studies:2
pharmacokinetic ,natural:2
pharmacokinetic ,flavonoids:2
molecular ,studies:6
molecular ,natural:2
molecular ,flavonoids:2
docking ,studies:4
docking ,natural:2
docking ,flavonoids:2
studies ,natural:2
studies ,flavonoids:2
natural ,flavonoids:4
covid-19 ,bronchogram:2
covid-19 ,indication:2
bronchogram ,potential:2
bronchogram ,indication:2
bronchogram ,prolonged:2
bronchogram ,treatment:2
potential ,indication:2
potential ,prolonged:2
indication ,prolonged:2
indication ,treatment:2
prolonged ,treatment:2
mother ,child:4
mother ,sars-cov-2:6
mother ,transmission:6
mother ,fact:2
mother ,fantasy:2
child ,sars-cov-2:6
child ,transmission:6
child ,fact:2
child ,fantasy:2
sars-cov-2 ,fact:2
sars-cov-2 ,fantasy:2
transmission ,fact:2
transmission ,fantasy:2
fact ,fantasy:2
transmission ,outbreaks:4
transmission ,associated:8
dynamics ,outbreaks:2
dynamics ,associated:2
dynamics ,child:2
dynamics ,care:2
dynamics ,facilities:2
covid-19 ,facilities:4
outbreaks ,associated:2
outbreaks ,child:2
outbreaks ,care:2
outbreaks ,facilities:2
associated ,child:4
associated ,care:6
associated ,facilities:2
child ,care:2
child ,facilities:2
care ,facilities:4
sars-cov-2 ,molecules:8
entry ,small:2
entry ,molecules:2
entry ,peptides:4
entry ,virus:2
inhibitors ,small:2
inhibitors ,molecules:2
inhibitors ,peptides:2
inhibitors ,host:2
small ,peptides:2
small ,targeting:4
small ,virus:4
small ,host:2
molecules ,peptides:2
molecules ,targeting:2
molecules ,virus:2
molecules ,host:2
peptides ,virus:2
peptides ,host:2
virus ,host:8
new ,at-home:2
new ,test:2
new ,detecting:2
new ,tracking:4
at-home ,antibody:2
at-home ,test:2
at-home ,detecting:2
at-home ,tracking:2
at-home ,covid-19:4
antibody ,detecting:2
antibody ,tracking:2
test ,detecting:2
test ,tracking:2
detecting ,tracking:2
tracking ,covid-19:6
unfolding ,sars-cov-2:4
unfolding ,viral:2
unfolding ,genome:2
unfolding ,understand:2
unfolding ,gene:2
unfolding ,expression:2
unfolding ,regulation:2
sars-cov-2 ,understand:2
viral ,genome:4
viral ,understand:2
viral ,gene:2
viral ,expression:2
viral ,regulation:2
genome ,understand:2
genome ,gene:2
genome ,expression:2
genome ,regulation:2
understand ,gene:2
understand ,expression:2
understand ,regulation:2
gene ,regulation:4
expression ,regulation:4
coronavirus ,environments:2
coronavirus ,occurrence:2
coronavirus ,concentration:2
water ,environments:2
water ,occurrence:2
water ,persistence:4
water ,concentration:2
water ,methods:2
environments ,occurrence:2
environments ,persistence:2
environments ,concentration:2
environments ,methods:2
occurrence ,persistence:4
occurrence ,concentration:2
occurrence ,methods:2
persistence ,concentration:2
persistence ,methods:2
concentration ,methods:4
pharmacological ,options:2
pharmacological ,treating:2
pharmacological ,sasr-cov-2:2
pharmacological ,infectioncovid-19:2
options ,treating:2
options ,sasr-cov-2:2
options ,infectioncovid-19:2
treating ,sasr-cov-2:2
treating ,infectioncovid-19:2
sasr-cov-2 ,infectioncovid-19:2
macrophages ,heterogeneity:2
macrophages ,important:2
macrophages ,determining:2
macrophages ,covid-19:4
macrophages ,lethality:2
heterogeneity ,important:2
heterogeneity ,determining:2
heterogeneity ,covid-19:4
heterogeneity ,lethality:2
important ,determining:2
important ,lethality:2
determining ,lethality:2
covid-19 ,lethality:4
clinically ,significant:2
clinically ,anticardiolipin:2
clinically ,antibodies:2
clinically ,associated:2
clinically ,covid-19:6
significant ,anticardiolipin:2
significant ,antibodies:2
significant ,associated:2
significant ,covid-19:2
anticardiolipin ,antibodies:2
anticardiolipin ,associated:2
anticardiolipin ,covid-19:2
antibodies ,associated:2
sars-cov-2 ,lopinavirritonavir:2
recent ,reports:2
recent ,antiviral:2
recent ,therapies:6
recent ,based:2
recent ,lopinavirritonavir:2
reports ,antiviral:2
reports ,therapies:2
reports ,based:2
reports ,lopinavirritonavir:2
antiviral ,therapies:2
antiviral ,based:2
therapies ,based:2
therapies ,lopinavirritonavir:2
based ,lopinavirritonavir:2
early ,population:2
early ,prevention:2
diagnosis ,population:2
population ,prevention:2
population ,coronavirus:6
population ,disease:4
comparative ,three:2
comparative ,laboratory:4
comparative ,based:2
comparative ,serological:4
analysis ,three:2
analysis ,laboratory:6
analysis ,assays:4
three ,laboratory:2
three ,based:2
three ,serological:4
laboratory ,based:6
laboratory ,serological:2
laboratory ,assays:4
based ,serological:2
based ,assays:2
geographical ,distance:2
geographical ,epicenter:2
geographical ,covid-19:4
geographical ,predicts:2
geographical ,burnout:2
distance ,epicenter:2
distance ,covid-19:4
distance ,predicts:2
distance ,burnout:2
epicenter ,predicts:2
epicenter ,burnout:2
covid-19 ,predicts:4
covid-19 ,burnout:2
predicts ,burnout:2
immediate ,long-term:2
immediate ,complication:2
immediate ,covid-19:4
immediate ,may:2
immediate ,type:2
immediate ,diabetes:2
immediate ,mellitus:2
long-term ,may:2
long-term ,type:2
long-term ,diabetes:2
long-term ,mellitus:2
complication ,may:2
complication ,type:2
complication ,diabetes:2
complication ,mellitus:2
may ,type:2
may ,diabetes:4
may ,mellitus:2
type ,diabetes:10
type ,mellitus:10
close ,biology:2
close ,sars-cov-2:6
close ,potential:2
close ,influence:2
close ,weather:2
look ,biology:2
look ,sars-cov-2:2
look ,influence:2
look ,weather:2
biology ,potential:2
biology ,influence:2
biology ,weather:2
sars-cov-2 ,influence:14
potential ,weather:2
influence ,weather:2
approaches ,management:2
approaches ,patients:2
approaches ,oral:2
approaches ,maxillofacial:2
approaches ,surgery:2
management ,oral:4
management ,maxillofacial:6
patients ,maxillofacial:4
patients ,surgery:8
oral ,maxillofacial:8
oral ,surgery:6
maxillofacial ,surgery:6
evaluation ,edi:2
evaluation ,enzyme:2
evaluation ,linked:2
evaluation ,immunosorbent:4
edi ,enzyme:4
edi ,linked:4
edi ,immunosorbent:2
edi ,assays:2
edi ,detection:2
enzyme ,linked:4
enzyme ,immunosorbent:2
enzyme ,assays:2
enzyme ,detection:2
linked ,immunosorbent:2
linked ,assays:2
linked ,detection:2
immunosorbent ,assays:2
immunosorbent ,detection:4
acute ,symptomatic:2
acute ,hyponatremia:2
acute ,siadh:2
acute ,isolated:2
acute ,presentation:10
symptomatic ,hyponatremia:2
symptomatic ,setting:2
symptomatic ,siadh:2
symptomatic ,isolated:2
symptomatic ,presentation:2
hyponatremia ,setting:2
hyponatremia ,siadh:2
hyponatremia ,isolated:2
hyponatremia ,presentation:2
setting ,siadh:2
setting ,isolated:2
setting ,presentation:2
siadh ,isolated:2
siadh ,presentation:2
isolated ,presentation:2
influence ,airborne:2
influence ,transmission:2
influence ,pandemic:4
influence ,review:2
airborne ,pandemic:2
airborne ,review:2
transmission ,pandemic:6
hypothesis ,angiotensin-converting:2
hypothesis ,enzyme:2
hypothesis ,inhibitors:2
hypothesis ,angiotensin:4
hypothesis ,receptor:2
angiotensin-converting ,angiotensin:6
angiotensin-converting ,receptor:14
enzyme ,receptor:16
inhibitors ,angiotensin:8
inhibitors ,receptor:6
dynamic ,asymmetry:2
dynamic ,exposes:2
dynamic ,2019-ncov:2
dynamic ,prefusion:2
dynamic ,spike:4
asymmetry ,exposes:2
asymmetry ,2019-ncov:2
asymmetry ,prefusion:2
asymmetry ,spike:2
exposes ,2019-ncov:2
exposes ,prefusion:2
exposes ,spike:2
impact ,suffering:2
impact ,musculoskeletal:2
impact ,tumours:2
covid-19 ,suffering:4
covid-19 ,musculoskeletal:4
covid-19 ,tumours:2
pandemic ,suffering:2
pandemic ,musculoskeletal:2
pandemic ,tumours:2
patients ,suffering:8
patients ,musculoskeletal:2
patients ,tumours:2
suffering ,musculoskeletal:2
suffering ,tumours:2
musculoskeletal ,tumours:2
reduction ,contagion:2
reduction ,risks:2
reduction ,covid-19:4
reduction ,air-conditioned:2
reduction ,work:2
contagion ,risks:2
contagion ,sars-cov-2:2
contagion ,air-conditioned:2
contagion ,work:2
risks ,air-conditioned:2
risks ,work:2
sars-cov-2 ,air-conditioned:2
covid-19 ,air-conditioned:2
air-conditioned ,work:2
point ,testing:2
point ,residents:2
point ,subset:2
point ,connecticut:2
prevalence ,testing:2
prevalence ,subset:2
prevalence ,connecticut:2
testing ,residents:2
testing ,subset:2
testing ,connecticut:2
residents ,subset:2
residents ,connecticut:2
sars-cov-2 ,subset:2
sars-cov-2 ,connecticut:2
subset ,connecticut:2
epidemiologic ,26:2
epidemiologic ,arising:2
clinical ,26:4
clinical ,arising:2
characteristics ,26:4
characteristics ,arising:2
26 ,cases:2
26 ,arising:2
cases ,arising:2
covid-19 ,arising:8
alterations ,smell:4
alterations ,taste:4
alterations ,mildly:2
alterations ,symptomatic:2
alterations ,outpatients:2
smell ,mildly:2
smell ,symptomatic:2
taste ,mildly:2
taste ,symptomatic:2
mildly ,outpatients:2
mildly ,sars-cov-2:2
symptomatic ,outpatients:2
hospital-wide ,sars-cov-2:2
hospital-wide ,antibody:2
hospital-wide ,screening:2
hospital-wide ,3056:2
hospital-wide ,staff:2
hospital-wide ,tertiary:2
hospital-wide ,center:2
sars-cov-2 ,3056:2
sars-cov-2 ,tertiary:12
antibody ,screening:2
antibody ,3056:2
antibody ,staff:2
antibody ,tertiary:2
antibody ,center:2
screening ,3056:2
screening ,staff:2
screening ,tertiary:2
screening ,center:8
3056 ,staff:2
3056 ,tertiary:2
3056 ,center:2
staff ,tertiary:2
staff ,center:2
tertiary ,center:4
faeces ,wastewater:2
faeces ,treatment:2
faeces ,know:2
wastewater ,treatment:4
wastewater ,know:2
wastewater ,review:6
treatment ,know:2
man-specific ,galnacttn-specific:2
man-specific ,neu5ac-specific:2
man-specific ,seaweed:2
man-specific ,lectins:2
man-specific ,glycan:2
galnacttn-specific ,neu5ac-specific:2
galnacttn-specific ,seaweed:2
galnacttn-specific ,lectins:2
galnacttn-specific ,glycan:2
neu5ac-specific ,seaweed:2
neu5ac-specific ,lectins:2
neu5ac-specific ,glycan:2
seaweed ,lectins:2
seaweed ,glycan:2
lectins ,glycan:2
epidemiology ,seasonal:2
epidemiology ,coronaviruses:2
epidemiology ,establishing:2
seasonal ,establishing:2
seasonal ,context:2
seasonal ,emergence:2
coronaviruses ,establishing:2
coronaviruses ,emergence:2
establishing ,context:2
establishing ,emergence:2
context ,emergence:2
clinical ,symptomatic:8
epidemiological ,family:6
epidemiological ,symptomatic:4
features ,symptomatic:4
family ,symptomatic:2
cluster ,symptomatic:4
sars-cov-2 ,ace2-dependent:2
receptor ,ace2-dependent:2
receptor ,cardiovascular:4
ace2-dependent ,implications:2
ace2-dependent ,cardiovascular:2
ace2-dependent ,system:2
implications ,cardiovascular:6
covid-19 ,schools:4
covid-19 ,french:6
covid-19 ,society:12
schools ,guidelines:2
schools ,french:2
schools ,pediatric:2
schools ,society:2
guidelines ,french:2
guidelines ,pediatric:2
guidelines ,society:4
french ,pediatric:2
french ,society:2
pediatric ,society:4
lung ,microbiome:2
lung ,possible:4
lung ,link:2
microbiome ,coronavirus:2
microbiome ,disease:2
microbiome ,possible:2
microbiome ,link:2
coronavirus ,link:4
disease ,link:6
coronavirus ,clinicaloutcomes:2
historical ,disease:2
historical ,mechanisms:2
historical ,clinicaloutcomes:2
perspective ,disease:6
perspective ,clinicaloutcomes:2
disease ,clinicaloutcomes:2
mechanisms ,clinicaloutcomes:2
pregnant ,barriers:2
pregnant ,easily:2
pregnant ,crossed:2
woman ,barriers:2
woman ,easily:2
woman ,crossed:2
sars-cov-2 ,barriers:2
sars-cov-2 ,easily:2
sars-cov-2 ,crossed:2
infection ,barriers:2
infection ,easily:2
infection ,crossed:2
barriers ,easily:2
barriers ,crossed:2
easily ,crossed:2
experimental ,cattle:2
infection ,cattle:2
cattle ,sars-cov-2:2
systematic ,comparison:2
systematic ,two:2
systematic ,animal-to-human:2
systematic ,transmitted:2
systematic ,human:4
systematic ,coronaviruses:4
comparison ,animal-to-human:2
comparison ,transmitted:2
comparison ,human:2
comparison ,coronaviruses:2
two ,animal-to-human:2
two ,transmitted:4
two ,coronaviruses:4
animal-to-human ,transmitted:2
animal-to-human ,human:2
animal-to-human ,coronaviruses:2
transmitted ,human:2
transmitted ,coronaviruses:4
potential ,cardiovascular:4
effects ,coronaviruses:2
effects ,system:6
effects ,review:4
coronaviruses ,cardiovascular:2
coronaviruses ,system:4
interleukin-6 ,role:6
interleukin-6 ,severity:4
interleukin-6 ,covid-19:8
interleukin-6 ,intensive:2
interleukin-6 ,care:2
interleukin-6 ,unit:2
interleukin-6 ,stay:2
interleukin-6 ,length:2
role ,severity:10
role ,intensive:2
role ,care:2
role ,unit:2
role ,stay:2
role ,length:2
severity ,intensive:2
severity ,care:2
severity ,unit:2
severity ,stay:2
severity ,length:2
covid-19 ,length:2
intensive ,stay:2
intensive ,length:2
care ,stay:2
care ,length:2
unit ,stay:2
unit ,length:2
stay ,length:2
predictors ,mortality:6
predictors ,covid-19:16
predictors ,pneumonia:6
predictors ,caused:4
mortality ,pneumonia:4
mortality ,caused:8
targets ,cell:2
targets ,humans:2
cell ,responses:6
cell ,humans:2
responses ,humans:2
laboratory ,emerging:4
laboratory ,human:4
laboratory ,infections:2
laboratory ,state:2
diagnosis ,emerging:2
diagnosis ,infections:2
diagnosis ,state:2
emerging ,infections:4
emerging ,state:2
human ,state:2
infections ,state:2
coronavirus ,purulent:2
coronavirus ,fulminant:6
coronavirus ,myopericarditis:4
disease ,presenting:4
disease ,purulent:2
disease ,fulminant:2
disease ,myopericarditis:2
covid-19 ,purulent:2
covid-19 ,fulminant:8
covid-19 ,myopericarditis:4
presenting ,purulent:2
presenting ,fulminant:4
presenting ,myopericarditis:2
purulent ,fulminant:2
purulent ,myopericarditis:2
fulminant ,myopericarditis:4
sixty-eight ,consecutive:2
sixty-eight ,patients:2
sixty-eight ,assessed:2
sixty-eight ,covid-19:2
sixty-eight ,infection:2
sixty-eight ,experience:2
consecutive ,patients:2
consecutive ,assessed:2
consecutive ,covid-19:4
consecutive ,infection:2
consecutive ,experience:2
patients ,assessed:2
patients ,experience:18
assessed ,covid-19:2
assessed ,infection:4
assessed ,experience:2
polymorphic ,forms:2
polymorphic ,valinomycin:2
polymorphic ,investigated:2
polymorphic ,nmr:2
polymorphic ,crystallography:2
forms ,valinomycin:2
forms ,investigated:2
forms ,nmr:2
forms ,crystallography:2
valinomycin ,investigated:2
valinomycin ,nmr:2
valinomycin ,crystallography:2
investigated ,nmr:2
investigated ,crystallography:2
nmr ,crystallography:2
novel ,practice:2
novel ,recommendations:2
novel ,obstetric:2
coronavirus ,recommendations:6
coronavirus ,obstetric:2
practice ,obstetric:2
recommendations ,obstetric:4
tomorrow ,never:2
tomorrow ,dies:2
tomorrow ,recent:2
tomorrow ,advances:2
tomorrow ,diagnosis:2
tomorrow ,treatment:2
tomorrow ,prevention:2
never ,dies:2
never ,recent:2
never ,advances:2
never ,diagnosis:2
never ,treatment:2
never ,prevention:2
dies ,recent:2
dies ,advances:2
dies ,diagnosis:2
dies ,treatment:2
dies ,prevention:2
recent ,treatment:2
advances ,diagnosis:2
gargle ,lavage:2
gargle ,viable:2
gargle ,alternative:2
gargle ,swab:2
gargle ,detection:2
lavage ,viable:2
lavage ,alternative:2
lavage ,swab:2
lavage ,detection:2
lavage ,sars-cov-2:2
viable ,alternative:2
viable ,swab:2
viable ,detection:2
viable ,sars-cov-2:10
clinical ,urothelial:2
clinical ,cancers:2
guidance ,management:8
guidance ,patients:8
guidance ,urothelial:2
guidance ,cancers:2
management ,urothelial:2
management ,cancers:2
patients ,urothelial:2
patients ,cancers:4
urothelial ,cancers:2
sars-cov-2 ,relevance:4
sars-cov-2 ,symptom:6
sars-cov-2 ,granularity:2
variants ,relevance:2
variants ,symptom:2
variants ,granularity:2
variants ,epidemiology:2
variants ,immunity:2
relevance ,symptom:2
relevance ,granularity:2
relevance ,epidemiology:2
relevance ,immunity:2
symptom ,granularity:2
symptom ,epidemiology:2
symptom ,immunity:2
granularity ,epidemiology:2
granularity ,immunity:2
epidemiology ,immunity:2
transmission ,personnel:2
transmission ,exposures:2
transmission ,hospitalized:2
covid-19 ,personnel:4
covid-19 ,exposures:4
health ,exposures:2
health ,hospitalized:2
care ,exposures:2
care ,hospitalized:2
personnel ,exposures:2
personnel ,hospitalized:2
exposures ,hospitalized:2
asymptomatic ,atypical:2
asymptomatic ,manifestations:2
asymptomatic ,comparison:4
infection ,atypical:2
infection ,manifestations:14
infection ,comparison:8
atypical ,manifestations:6
atypical ,comparison:2
atypical ,viral:2
manifestations ,comparison:2
manifestations ,viral:2
contamination ,patient:2
contamination ,surroundings:2
sars-cov-2 ,surroundings:2
sars-cov-2 ,personal:4
patient ,surroundings:2
patient ,personal:2
patient ,protective:2
surroundings ,personal:2
surroundings ,protective:2
worldwide ,ace:2
worldwide ,id:2
worldwide ,polymorphism:2
worldwide ,affect:2
worldwide ,recovery:2
worldwide ,rate:2
worldwide ,ecological:2
ace ,id:2
ace ,polymorphism:2
ace ,may:2
ace ,affect:2
ace ,covid-19:6
ace ,recovery:2
ace ,rate:2
ace ,ecological:2
id ,polymorphism:2
id ,may:2
id ,affect:2
id ,recovery:2
id ,rate:2
id ,ecological:2
polymorphism ,may:2
polymorphism ,affect:2
polymorphism ,covid-19:4
polymorphism ,recovery:2
polymorphism ,rate:2
polymorphism ,ecological:2
may ,affect:4
may ,recovery:2
may ,rate:2
may ,ecological:2
affect ,recovery:2
affect ,rate:2
affect ,ecological:2
covid-19 ,ecological:4
recovery ,rate:2
recovery ,ecological:2
rate ,ecological:2
false-negative ,real-time:2
false-negative ,reverse-transcriptase:2
false-negative ,polymerase:4
false-negative ,chain:4
false-negative ,reaction:2
results ,real-time:2
results ,reverse-transcriptase:2
results ,polymerase:2
results ,chain:2
results ,reaction:2
real-time ,reverse-transcriptase:2
reverse-transcriptase ,polymerase:2
reverse-transcriptase ,chain:2
reverse-transcriptase ,reaction:2
updated ,overview:6
updated ,emergency:2
studying ,effects:2
studying ,ace2:2
studying ,mutations:2
studying ,stability:2
studying ,dynamics:2
studying ,dissociation:2
effects ,ace2:4
effects ,mutations:2
effects ,stability:2
effects ,dynamics:2
effects ,dissociation:2
ace2 ,mutations:4
ace2 ,stability:2
ace2 ,dissociation:2
mutations ,stability:2
mutations ,dynamics:2
mutations ,dissociation:2
stability ,dynamics:2
stability ,dissociation:2
dynamics ,dissociation:2
repositioning ,alternative:2
repositioning ,treatment:4
alternative ,coronavirus:4
fighting ,quick:2
fighting ,review:2
fighting ,diagnoses:2
fighting ,therapies:2
fighting ,vaccines:2
covid-19 ,quick:2
covid-19 ,diagnoses:10
quick ,review:2
quick ,diagnoses:2
quick ,therapies:2
quick ,vaccines:2
review ,diagnoses:2
review ,vaccines:4
diagnoses ,therapies:2
diagnoses ,vaccines:2
therapies ,vaccines:6
can ,nanotechnology:4
can ,fight:4
nanotechnology ,help:4
nanotechnology ,fight:2
nanotechnology ,covid-19:6
investigating ,genomic:2
investigating ,landscape:2
investigating ,novel:2
investigating ,coronavirus:2
investigating ,2019-ncov:2
investigating ,identify:2
genomic ,landscape:2
landscape ,novel:2
landscape ,coronavirus:6
landscape ,2019-ncov:2
landscape ,identify:2
novel ,identify:4
coronavirus ,identify:4
2019-ncov ,identify:2
guidelines ,tonometry:2
guidelines ,use:2
guidelines ,era:2
recommendations ,tonometry:2
recommendations ,use:2
recommendations ,era:2
tonometry ,use:2
tonometry ,covid-19:2
tonometry ,era:2
use ,era:6
prevalence ,first:2
prevalence ,responders:2
prevalence ,lubbock:2
prevalence ,texas:2
coronavirus ,responders:2
coronavirus ,lubbock:2
coronavirus ,texas:4
antibody ,first:2
antibody ,responders:2
antibody ,lubbock:2
antibody ,texas:2
among ,first:4
among ,responders:2
among ,lubbock:2
among ,texas:2
first ,responders:2
first ,lubbock:2
first ,texas:2
responders ,lubbock:2
responders ,texas:2
lubbock ,texas:2
reverse-transcription ,recombinase-aided:4
reverse-transcription ,amplification:4
reverse-transcription ,assay:4
reverse-transcription ,rapid:4
recombinase-aided ,amplification:4
recombinase-aided ,assay:4
recombinase-aided ,rapid:4
transcriptomic ,analysis:4
transcriptomic ,covid19:2
transcriptomic ,lungs:2
transcriptomic ,bronchoalveolar:4
transcriptomic ,lavage:4
transcriptomic ,fluid:4
transcriptomic ,samples:2
analysis ,covid19:2
analysis ,lungs:2
analysis ,bronchoalveolar:2
analysis ,lavage:2
analysis ,fluid:2
covid19 ,lungs:2
covid19 ,bronchoalveolar:2
covid19 ,lavage:2
covid19 ,fluid:2
covid19 ,samples:2
lungs ,bronchoalveolar:2
lungs ,lavage:2
lungs ,fluid:2
lungs ,samples:2
bronchoalveolar ,samples:2
lavage ,samples:2
fluid ,samples:4
science ,religion:2
science ,government:2
science ,sars-cov-2:6
science ,time:2
science ,synergy:2
religion ,government:2
religion ,sars-cov-2:2
religion ,time:2
religion ,synergy:2
government ,sars-cov-2:2
government ,time:2
government ,synergy:2
sars-cov-2 ,synergy:2
time ,synergy:2
saliva ,testing:4
potential ,specimen:2
specimen ,covid-19:6
specimen ,testing:8
analysis ,29:2
clinical ,29:2
features ,29:2
29 ,patients:2
29 ,novel:2
29 ,coronavirus:2
copper ,beneficial:2
copper ,covid-19:4
copper ,patients:2
beneficial ,covid-19:4
beneficial ,patients:2
immunoinformatics-guided ,designing:2
immunoinformatics-guided ,subunit:2
immunoinformatics-guided ,vaccines:2
designing ,epitope-based:2
designing ,vaccines:4
epitope-based ,subunit:2
epitope-based ,vaccines:4
subunit ,vaccines:6
evidence ,circulation:6
evidence ,identification:2
evidence ,first:2
evidence ,swiss:2
sars-cov-2 ,circulation:4
sars-cov-2 ,swiss:2
circulation ,identification:2
circulation ,first:2
circulation ,swiss:2
identification ,first:2
identification ,swiss:2
first ,swiss:2
thrombocytopenia ,independently:2
thrombocytopenia ,associated:2
thrombocytopenia ,poor:2
thrombocytopenia ,outcome:2
independently ,associated:2
independently ,poor:2
independently ,outcome:2
independently ,patients:2
associated ,poor:4
associated ,outcome:2
poor ,outcome:4
poor ,patients:10
lessons ,children:2
lessons ,key:2
lessons ,hypotheses:2
lessons ,guide:4
lessons ,preventative:2
covid-19 ,hypotheses:6
children ,key:4
children ,hypotheses:2
children ,guide:2
children ,preventative:2
key ,hypotheses:2
key ,guide:2
key ,preventative:2
hypotheses ,guide:2
hypotheses ,preventative:2
guide ,preventative:2
sars-cov-2 ,intra-host:2
sars-cov-2 ,plasticity:2
sars-cov-2 ,low-frequency:2
sars-cov-2 ,polymorphic:2
exhibits ,intra-host:2
exhibits ,genomic:2
exhibits ,plasticity:2
exhibits ,low-frequency:2
exhibits ,polymorphic:2
intra-host ,genomic:2
intra-host ,plasticity:2
intra-host ,low-frequency:2
intra-host ,polymorphic:2
genomic ,plasticity:2
genomic ,low-frequency:2
genomic ,polymorphic:2
plasticity ,low-frequency:2
plasticity ,polymorphic:2
low-frequency ,polymorphic:2
high ,contagiousness:2
high ,rapid:2
high ,spread:2
high ,acute:8
high ,respiratory:12
high ,syndrome:6
contagiousness ,rapid:2
contagiousness ,spread:2
contagiousness ,severe:2
contagiousness ,acute:2
contagiousness ,respiratory:2
contagiousness ,syndrome:2
spread ,severe:2
spread ,acute:2
spread ,respiratory:2
spread ,syndrome:2
transmission ,transfusion:2
blood ,transfusion:6
blood ,case:2
blood ,report:2
transfusion ,case:2
transfusion ,report:2
poor ,self-reported:2
poor ,adherence:2
poor ,covid-19-related:2
poor ,quarantineisolation:2
poor ,requests:2
self-reported ,adherence:2
self-reported ,covid-19-related:2
self-reported ,quarantineisolation:2
self-reported ,requests:2
adherence ,covid-19-related:2
adherence ,quarantineisolation:2
adherence ,requests:2
covid-19-related ,quarantineisolation:2
covid-19-related ,requests:2
quarantineisolation ,requests:2
inoculum ,time:2
inoculum ,sars-cov-2:2
inoculum ,exposure:2
inoculum ,risk:2
inoculum ,disease:2
inoculum ,severity:2
time ,exposure:2
time ,severity:2
exposure ,severity:2
sars-cov-2 ,illness:8
detection ,illness:2
influenza-like ,illness:2
potential ,immunotherapeutic:2
potential ,hypoxia:2
potential ,due:2
potential ,covi-flu:2
immunotherapeutic ,targets:2
immunotherapeutic ,hypoxia:2
immunotherapeutic ,due:2
immunotherapeutic ,covi-flu:2
targets ,hypoxia:2
targets ,due:2
targets ,covi-flu:2
hypoxia ,due:2
hypoxia ,covi-flu:2
due ,covi-flu:2
acute ,abdomen:6
abdomen ,patients:2
abdomen ,sars-cov-2:4
abdomen ,infection:4
abdomen ,co-infection:2
patients ,co-infection:6
infection ,co-infection:2
head-to-head ,comparison:2
head-to-head ,two:2
head-to-head ,sars-cov-2:2
head-to-head ,serology:2
head-to-head ,assays:2
two ,serology:2
pathological ,testes:2
pathological ,patients:8
pathological ,implications:2
findings ,testes:2
findings ,implications:2
testes ,covid-19:2
testes ,patients:2
testes ,clinical:2
targeting ,crucial:2
targeting ,factors:2
crucial ,host:2
crucial ,factors:2
crucial ,sars-cov-2:2
arbidolifn-2b ,therapy:2
arbidolifn-2b ,patients:2
arbidolifn-2b ,corona:2
arbidolifn-2b ,virus:2
arbidolifn-2b ,disease:2
arbidolifn-2b ,retrospective:2
therapy ,corona:2
therapy ,virus:2
corona ,retrospective:2
virus ,retrospective:2
disease ,retrospective:8
mobilizing ,research:2
mobilizing ,ecosystem:2
mobilizing ,scientific:2
mobilizing ,advances:2
mobilizing ,towards:2
mobilizing ,positive:2
mobilizing ,impact:2
research ,ecosystem:2
research ,towards:2
research ,positive:2
ecosystem ,scientific:2
ecosystem ,advances:2
ecosystem ,towards:2
ecosystem ,positive:2
ecosystem ,impact:2
scientific ,advances:4
scientific ,towards:2
scientific ,positive:2
scientific ,impact:2
advances ,positive:2
advances ,impact:2
towards ,positive:2
towards ,impact:2
positive ,impact:2
research ,repositioning:2
research ,specific:2
progress ,repositioning:2
progress ,drugs:2
progress ,specific:2
progress ,therapeutic:2
repositioning ,drugs:4
repositioning ,specific:2
repositioning ,therapeutic:2
drugs ,specific:2
specific ,therapeutic:2
hospital ,population-based:2
hospital ,evidence:2
hospital ,early:4
hospital ,circulation:2
hospital ,east:2
population-based ,evidence:2
population-based ,covid-19:2
population-based ,early:2
population-based ,circulation:2
population-based ,east:2
evidence ,east:2
covid-19 ,circulation:4
early ,circulation:2
early ,east:2
circulation ,east:2
self-protection ,medical:2
self-protection ,workers:2
self-protection ,ophthalmology:2
self-protection ,clinic:2
self-protection ,covid-19:2
self-protection ,epidemic:2
medical ,workers:4
medical ,ophthalmology:2
medical ,clinic:2
medical ,epidemic:2
workers ,ophthalmology:2
workers ,clinic:2
workers ,epidemic:2
ophthalmology ,clinic:2
ophthalmology ,epidemic:2
clinic ,covid-19:4
clinic ,epidemic:2
development ,execution:2
development ,preparedness:2
development ,plan:2
development ,medical:2
execution ,pandemic:2
execution ,preparedness:2
execution ,plan:2
execution ,therapeutic:2
execution ,medical:2
pandemic ,preparedness:8
pandemic ,plan:4
preparedness ,plan:2
preparedness ,therapeutic:2
preparedness ,medical:2
plan ,therapeutic:2
plan ,medical:2
therapeutic ,medical:2
can ,air-conditioning:2
can ,systems:2
can ,contribute:4
can ,spread:2
can ,sarsmerscovid-19:2
air-conditioning ,systems:2
air-conditioning ,contribute:2
air-conditioning ,spread:2
air-conditioning ,sarsmerscovid-19:2
systems ,contribute:2
systems ,spread:2
systems ,sarsmerscovid-19:2
contribute ,spread:2
contribute ,sarsmerscovid-19:2
spread ,sarsmerscovid-19:2
coronavirus ,metagenomic:2
coronavirus ,tool:8
discovery ,metagenomic:2
discovery ,sequencing:2
discovery ,tool:2
discovery ,pandemic:4
discovery ,preparedness:2
metagenomic ,sequencing:2
metagenomic ,tool:2
metagenomic ,pandemic:2
metagenomic ,preparedness:2
sequencing ,tool:2
sequencing ,pandemic:2
sequencing ,preparedness:2
tool ,pandemic:4
tool ,preparedness:4
current ,diagnostics:6
diagnostics ,disease:4
preventing ,airborne:4
preventing ,hospitals:2
preventing ,nursing:2
preventing ,homes:2
airborne ,hospitals:2
airborne ,nursing:2
airborne ,homes:2
transmission ,hospitals:2
transmission ,nursing:4
transmission ,homes:2
hospitals ,nursing:2
hospitals ,homes:2
implications ,anesthesiological:2
covid-19 ,anesthesiological:2
sars-cov-2 ,anesthesiological:2
anesthesiological ,practice:2
restructuring ,academic:2
restructuring ,dermatology:2
restructuring ,practice:2
restructuring ,covid-19:2
restructuring ,pandemic:2
academic ,dermatology:2
academic ,practice:2
academic ,pandemic:2
dermatology ,practice:2
dermatology ,pandemic:6
unresponsive ,covid-19:2
unresponsive ,patient:2
geriatrics ,times:2
geriatrics ,corona:2
times ,corona:2
reduced ,maximal:2
reduced ,aerobic:2
reduced ,capacity:2
reduced ,young:2
reduced ,adult:2
reduced ,recruits:2
maximal ,aerobic:2
maximal ,capacity:2
maximal ,covid-19:2
maximal ,young:2
maximal ,adult:2
maximal ,recruits:2
aerobic ,capacity:2
aerobic ,covid-19:2
aerobic ,young:2
aerobic ,adult:2
aerobic ,recruits:2
capacity ,young:2
capacity ,adult:2
capacity ,recruits:2
covid-19 ,recruits:2
young ,adult:8
young ,recruits:2
adult ,recruits:2
coronaviruses ,challenge:2
coronaviruses ,today:2
coronaviruses ,call:2
coronaviruses ,extended:2
coronaviruses ,postmortem:2
coronaviruses ,brain:2
challenge ,today:2
challenge ,call:2
challenge ,extended:2
challenge ,postmortem:2
challenge ,brain:2
today ,call:2
today ,extended:2
today ,human:2
today ,postmortem:2
today ,brain:2
call ,extended:2
call ,human:2
call ,postmortem:2
call ,brain:2
extended ,human:2
extended ,postmortem:2
extended ,brain:2
human ,postmortem:2
postmortem ,brain:4
respond ,coronavirus:4
respond ,sars-cov-2:2
respond ,outbreak:2
respond ,german:2
respond ,perspective:2
coronavirus ,german:2
sars-cov-2 ,german:2
outbreak ,german:2
outbreak ,perspective:6
german ,perspective:2
inside ,lungs:2
inside ,covid-19:4
inside ,disease:2
alternative ,methods:2
alternative ,sterilization:2
alternative ,dental:2
alternative ,practices:2
methods ,sterilization:2
methods ,dental:2
methods ,practices:2
sterilization ,dental:2
sterilization ,practices:2
sterilization ,covid-19:2
dental ,practices:4
standard ,procedures:2
standard ,dialysis:2
standard ,epidemic:2
procedures ,dialysis:2
procedures ,epidemic:2
dialysis ,covid-19:4
dialysis ,epidemic:2
emerging ,genetic:2
emerging ,diversity:2
emerging ,among:2
emerging ,isolates:2
emerging ,lessons:4
emerging ,today:2
genetic ,among:8
genetic ,isolates:4
genetic ,lessons:2
genetic ,today:2
diversity ,among:2
diversity ,clinical:2
diversity ,isolates:2
diversity ,lessons:2
diversity ,today:2
among ,clinical:8
among ,isolates:2
among ,lessons:2
among ,today:2
clinical ,isolates:2
clinical ,lessons:6
clinical ,today:2
isolates ,lessons:2
isolates ,today:2
sars-cov-2 ,today:4
lessons ,today:2
laboratory ,characteristics:14
laboratory ,pregnant:2
laboratory ,compared:2
laboratory ,non-pregnant:2
laboratory ,women:2
laboratory ,infected:4
characteristics ,pregnant:4
characteristics ,compared:2
characteristics ,non-pregnant:2
characteristics ,women:12
pregnant ,compared:2
pregnant ,non-pregnant:2
compared ,non-pregnant:2
compared ,women:2
compared ,infected:2
non-pregnant ,women:2
non-pregnant ,infected:2
clinical ,cardiac:2
clinical ,troponin:2
clinical ,measurement:2
utility ,cardiac:2
utility ,troponin:2
utility ,measurement:2
utility ,covid-19:8
utility ,infection:4
cardiac ,troponin:4
cardiac ,measurement:2
cardiac ,infection:2
troponin ,measurement:2
troponin ,covid-19:6
troponin ,infection:2
measurement ,covid-19:2
measurement ,infection:4
rapid ,anti-sars-cov-2:2
rapid ,lanthanide-doped:2
sensitive ,anti-sars-cov-2:2
sensitive ,igg:2
sensitive ,using:4
sensitive ,lanthanide-doped:2
detection ,lanthanide-doped:2
anti-sars-cov-2 ,lanthanide-doped:2
igg ,lanthanide-doped:2
using ,lanthanide-doped:2
characteristics ,recovered:2
characteristics ,recurrent:2
characteristics ,positive:8
characteristics ,rt-pcr:2
recovered ,recurrent:2
recovered ,rt-pcr:4
patients ,recurrent:2
recurrent ,positive:2
recurrent ,rt-pcr:2
positive ,rt-pcr:8
pharmacological ,perspective:4
pharmacological ,glycyrrhizin:2
pharmacological ,may:2
pharmacological ,efficacious:2
pharmacological ,therapeutic:4
pharmacological ,agent:2
perspective ,glycyrrhizin:2
perspective ,may:4
perspective ,efficacious:2
perspective ,therapeutic:4
perspective ,agent:2
glycyrrhizin ,may:2
glycyrrhizin ,efficacious:2
glycyrrhizin ,therapeutic:2
glycyrrhizin ,agent:2
may ,efficacious:2
may ,therapeutic:4
may ,agent:2
efficacious ,therapeutic:2
efficacious ,agent:2
sars-cov-2 ,equity:2
vaccine ,access:2
vaccine ,equity:2
development ,access:2
development ,equity:2
access ,equity:2
case ,saliva:2
case ,specimens:2
case ,37:2
case ,days:6
case ,onset:4
report ,confirmed:6
report ,saliva:2
report ,specimens:2
report ,37:2
report ,days:4
report ,onset:4
sars-cov-2 ,37:2
confirmed ,saliva:2
confirmed ,specimens:4
confirmed ,37:2
confirmed ,days:2
saliva ,specimens:10
saliva ,37:2
saliva ,days:2
saliva ,onset:2
specimens ,37:2
specimens ,days:2
specimens ,onset:2
37 ,days:2
37 ,onset:2
pathways ,community:2
pathways ,protection:2
covid-19 ,protection:30
community ,protection:2
covid-19 ,answers:2
covid-19 ,infectiology:2
questions ,answers:4
questions ,infectiology:2
answers ,infectiology:2
insights ,possible:2
insights ,development:2
possible ,vaccine:4
possible ,development:4
maternal ,neonatal:6
maternal ,response:4
neonatal ,covid-19:16
molecular ,relationships:2
molecular ,different:4
molecular ,species:2
molecular ,health:2
basis ,covid-19:4
basis ,relationships:2
basis ,different:2
basis ,species:2
basis ,one:2
basis ,health:2
covid-19 ,relationships:2
covid-19 ,species:2
relationships ,different:2
relationships ,species:2
relationships ,one:2
relationships ,health:2
different ,species:2
different ,one:2
different ,health:2
species ,one:2
species ,health:2
renin-angiotensin ,therapeutic:2
renin-angiotensin ,target:2
system ,therapeutic:4
system ,target:4
neurological ,damage:4
neurological ,linked:2
neurological ,human:2
damage ,linked:2
damage ,human:2
linked ,coronaviruses:2
linked ,sars-cov-2:6
linked ,human:2
histopathology ,ultrastructural:2
histopathology ,findings:2
histopathology ,fatal:4
histopathology ,covid-19:4
histopathology ,infections:2
ultrastructural ,findings:2
ultrastructural ,fatal:2
ultrastructural ,covid-19:2
ultrastructural ,infections:2
findings ,fatal:2
findings ,infections:4
fatal ,infections:2
liver ,six:2
liver ,months:2
know ,six:2
know ,months:2
six ,months:2
six ,pandemic:2
months ,pandemic:4
postpartum ,consciousness:2
postpartum ,disturbance:2
postpartum ,can:2
postpartum ,cause:2
postpartum ,posterior:2
postpartum ,reversible:2
consciousness ,disturbance:2
consciousness ,can:2
consciousness ,covid-19:2
consciousness ,cause:2
consciousness ,posterior:2
consciousness ,reversible:2
disturbance ,can:2
disturbance ,covid-19:2
disturbance ,cause:2
disturbance ,posterior:2
disturbance ,reversible:2
can ,posterior:2
can ,reversible:2
covid-19 ,posterior:2
covid-19 ,reversible:4
cause ,posterior:2
cause ,reversible:2
cytokine ,covid19:2
cytokine ,neural:2
cytokine ,hypothesis:4
storm ,covid19:2
storm ,neural:2
storm ,hypothesis:2
covid19 ,neural:2
covid19 ,hypothesis:4
neural ,hypothesis:6
sensitivity ,syndrome:2
sensitivity ,coronavirus:4
sensitivity ,nucleic:2
sensitivity ,acid:2
syndrome ,nucleic:2
coronavirus ,nucleic:4
designing ,novel:2
designing ,mrna:2
designing ,sars-cov-2:2
designing ,immunoinformatics:2
designing ,approach:2
novel ,mrna:2
novel ,immunoinformatics:2
mrna ,vaccine:2
mrna ,sars-cov-2:2
mrna ,immunoinformatics:2
mrna ,approach:2
vaccine ,approach:6
immunoinformatics ,approach:4
biological ,spike:2
biological ,protein:4
biological ,pro330-leu650:2
characteristics ,spike:2
characteristics ,protein:2
characteristics ,pro330-leu650:2
sars-cov-2 ,pro330-leu650:2
spike ,pro330-leu650:2
protein ,pro330-leu650:2
validation ,chemiluminescent:2
validation ,specific:2
validation ,antibody:2
chemiluminescent ,assay:2
chemiluminescent ,specific:2
chemiluminescent ,sars-cov-2:2
chemiluminescent ,antibody:2
assay ,specific:2
assay ,antibody:8
repurpose ,open:2
repurpose ,data:2
repurpose ,discover:2
repurpose ,therapeutics:2
repurpose ,covid-19:4
repurpose ,using:2
repurpose ,deep:2
repurpose ,learning:2
open ,data:2
open ,discover:2
open ,therapeutics:2
open ,covid-19:10
open ,using:2
open ,deep:2
open ,learning:2
data ,discover:2
data ,therapeutics:2
data ,using:2
data ,deep:2
data ,learning:4
discover ,therapeutics:2
discover ,using:2
discover ,deep:2
discover ,learning:2
therapeutics ,using:2
therapeutics ,deep:2
therapeutics ,learning:2
newly ,covid-19:2
newly ,disease:4
newly ,systemic:2
newly ,review:2
emerged ,covid-19:2
emerged ,disease:4
emerged ,systemic:2
emerged ,review:2
covid-19 ,systemic:12
disease ,systemic:2
sars-cov-2 ,answers:4
sars-cov-2 ,many:6
myocardial ,answers:2
myocardial ,many:2
myocardial ,questions:2
injury ,answers:2
injury ,many:2
injury ,questions:2
answers ,many:2
many ,questions:2
commentary ,iron:2
commentary ,chelators:2
commentary ,prove:2
commentary ,useful:2
commentary ,adjunct:2
iron ,chelators:2
iron ,prove:2
iron ,useful:2
iron ,adjunct:2
iron ,covid-19:10
chelators ,prove:2
chelators ,useful:2
chelators ,adjunct:2
chelators ,covid-19:2
prove ,useful:2
prove ,adjunct:2
prove ,covid-19:2
useful ,adjunct:2
adjunct ,covid-19:6
ifcc ,interim:4
ifcc ,guidelines:4
ifcc ,molecular:4
ifcc ,testing:4
ifcc ,sars-cov-2:4
ifcc ,infection:2
interim ,guidelines:4
interim ,molecular:2
interim ,testing:4
interim ,sars-cov-2:4
interim ,infection:2
guidelines ,molecular:2
guidelines ,testing:4
guidelines ,infection:2
neuropathology ,patients:2
neuropathology ,germany:2
neuropathology ,post-mortem:2
neuropathology ,case:2
neuropathology ,series:2
patients ,germany:2
patients ,post-mortem:2
patients ,series:8
covid-19 ,germany:4
covid-19 ,post-mortem:6
germany ,post-mortem:2
germany ,case:2
germany ,series:2
post-mortem ,case:4
post-mortem ,series:2
sources ,routes:2
sources ,sars-cov-2:4
sources ,transmission:2
sources ,water:2
sources ,systems:2
sources ,africa:2
routes ,water:2
routes ,systems:2
routes ,africa:2
sars-cov-2 ,systems:2
transmission ,systems:2
transmission ,africa:2
water ,systems:2
water ,africa:2
systems ,africa:2
tropism ,replication:2
tropism ,competence:2
tropism ,innate:2
tropism ,immune:2
tropism ,responses:2
tropism ,coronavirus:2
replication ,competence:2
replication ,innate:2
replication ,responses:2
competence ,innate:2
competence ,immune:2
competence ,responses:2
competence ,coronavirus:2
innate ,coronavirus:2
measures ,protect:2
measures ,health:10
measures ,safety:2
measures ,massachusetts:2
measures ,employees:2
measures ,must:2
measures ,work:2
protect ,health:4
protect ,safety:2
protect ,massachusetts:2
protect ,employees:2
protect ,must:2
protect ,work:2
health ,safety:6
health ,massachusetts:2
health ,employees:2
health ,must:2
safety ,massachusetts:2
safety ,employees:2
safety ,must:2
safety ,work:4
massachusetts ,employees:2
massachusetts ,must:2
massachusetts ,work:2
employees ,must:2
employees ,work:2
must ,work:2
non-invasive ,cpap:2
non-invasive ,mild:2
non-invasive ,moderate:2
non-invasive ,ards:2
non-invasive ,secondary:2
non-invasive ,sars-cov-2:4
cpap ,mild:2
cpap ,moderate:2
cpap ,ards:2
cpap ,secondary:2
cpap ,sars-cov-2:2
mild ,moderate:4
mild ,ards:2
mild ,secondary:2
moderate ,ards:2
moderate ,secondary:2
ards ,secondary:2
ards ,sars-cov-2:6
age-specific ,infection:2
age-specific ,fatality:2
age-specific ,ratio:2
age-specific ,associated:2
age-specific ,risk:2
age-specific ,factors:2
age-specific ,italy:2
fatality ,risk:4
fatality ,factors:2
fatality ,italy:6
ratio ,associated:4
ratio ,risk:2
ratio ,factors:2
ratio ,italy:2
associated ,italy:2
risk ,italy:6
factors ,italy:2
misinformation ,covid-19:2
misinformation ,internet:2
misinformation ,infodemiology:2
misinformation ,study:2
covid-19 ,internet:4
covid-19 ,infodemiology:2
internet ,infodemiology:2
internet ,study:2
infodemiology ,study:2
mild ,clinical:12
mild ,manifestations:2
mild ,related:2
mild ,two:4
manifestations ,related:2
manifestations ,pneumonia:4
manifestations ,two:2
related ,patients:6
survey ,current:2
survey ,status:2
survey ,subclinical:2
survey ,disease:2
survey ,covid-19:10
current ,subclinical:2
status ,subclinical:2
subclinical ,coronavirus:2
subclinical ,disease:2
subclinical ,covid-19:4
preliminary ,report:6
preliminary ,uk:2
preliminary ,france:4
preliminary ,spain:2
case ,cluster:6
case ,uk:2
case ,france:2
case ,spain:2
report ,cluster:4
report ,uk:2
report ,france:2
report ,spain:2
sars-cov-2 ,uk:4
sars-cov-2 ,france:10
cluster ,uk:2
cluster ,france:2
cluster ,spain:2
uk ,france:2
uk ,spain:2
france ,spain:2
covid-19 ,bone:2
covid-19 ,marrow:2
covid-19 ,reflecting:2
covid-19 ,single:14
bone ,marrow:4
bone ,transplant:2
bone ,recipients:2
bone ,reflecting:2
bone ,single:2
bone ,centre:2
marrow ,transplant:2
marrow ,recipients:2
marrow ,reflecting:2
marrow ,single:2
marrow ,centre:2
transplant ,reflecting:2
transplant ,single:4
transplant ,centre:2
recipients ,reflecting:2
recipients ,single:2
recipients ,centre:2
reflecting ,single:2
reflecting ,centre:2
renal ,transplantation:2
renal ,period:2
renal ,spain:2
transplantation ,period:2
transplantation ,spain:2
covid-19 ,spain:8
period ,spain:2
evaluation ,transport:2
evaluation ,media:2
evaluation ,specimen:2
evaluation ,conditions:2
transport ,conditions:2
transport ,detection:4
media ,specimen:4
media ,conditions:2
media ,detection:2
specimen ,conditions:2
conditions ,detection:4
negligible ,risk:2
negligible ,covid-19:2
negligible ,resurgence:2
negligible ,caused:2
negligible ,work:2
negligible ,resuming:2
negligible ,china:2
negligible ,outside:2
risk ,resurgence:2
risk ,caused:2
risk ,work:4
risk ,resuming:2
covid-19 ,resurgence:2
covid-19 ,resuming:10
resurgence ,caused:2
resurgence ,work:2
resurgence ,resuming:2
resurgence ,china:2
resurgence ,outside:2
caused ,work:2
caused ,resuming:2
caused ,outside:2
work ,resuming:2
work ,china:2
work ,outside:2
resuming ,china:2
resuming ,outside:2
cholesterol ,new:2
cholesterol ,game:2
cholesterol ,player:2
cholesterol ,accelerating:2
cholesterol ,vasculopathy:2
cholesterol ,caused:2
cholesterol ,sars-cov-2:6
new ,game:2
new ,player:2
new ,accelerating:2
new ,vasculopathy:2
game ,player:2
game ,accelerating:2
game ,vasculopathy:2
game ,caused:2
game ,sars-cov-2:2
player ,accelerating:2
player ,vasculopathy:2
player ,caused:2
player ,sars-cov-2:4
accelerating ,vasculopathy:2
accelerating ,caused:2
accelerating ,sars-cov-2:2
vasculopathy ,caused:2
natural ,protection:2
natural ,ocular:2
natural ,surface:2
natural ,viral:4
natural ,infections:4
natural ,hypothesis:2
protection ,ocular:2
protection ,surface:2
protection ,viral:2
protection ,infections:2
protection ,hypothesis:2
ocular ,infections:2
ocular ,hypothesis:2
surface ,viral:2
surface ,infections:2
surface ,hypothesis:2
viral ,infections:20
viral ,hypothesis:4
infections ,hypothesis:2
covid-19-related ,stroke:2
overcome ,cardiovascular:2
overcome ,challenges:2
overcome ,covid-19:4
overcome ,patients:2
overcome ,guide:2
overcome ,common:2
cardiovascular ,challenges:2
cardiovascular ,guide:2
cardiovascular ,common:2
challenges ,patients:4
challenges ,guide:2
challenges ,common:2
patients ,guide:4
patients ,common:6
guide ,common:2
spreading ,france:2
spreading ,late:2
spreading ,december:2
france ,late:2
france ,december:2
late ,december:2
silico ,antimalarial:2
potential ,approved:8
potential ,antimalarial:2
approved ,antimalarial:2
antimalarial ,drugs:4
antimalarial ,repurposing:2
antimalarial ,covid-19:4
involvement ,severe:4
involvement ,acute:4
involvement ,respiratory:6
involvement ,syndrome:6
insights ,disease:6
insights ,outbreak:2
insights ,management:2
laboratory ,verification:2
laboratory ,rt-pcr:2
laboratory ,assay:2
verification ,rt-pcr:2
verification ,assay:4
verification ,sars-cov-2:4
immuno-epidemiology ,pathophysiology:2
immuno-epidemiology ,coronavirus:2
immuno-epidemiology ,disease:2
immuno-epidemiology ,covid-19:2
pathophysiology ,coronavirus:6
report ,epidemiological:2
report ,features:2
guillain-barr ,sars-cov-2:10
guillain-barr ,pandemic:4
guillain-barr ,case:10
guillain-barr ,report:8
guillain-barr ,review:8
pandemic ,case:18
pandemic ,report:8
first ,cerebrospinal:2
first ,fluid:4
case ,sequencing:2
case ,cerebrospinal:2
case ,fluid:2
sars-cov-2 ,cerebrospinal:4
sequencing ,cerebrospinal:2
sequencing ,fluid:2
sequencing ,patient:2
cerebrospinal ,fluid:6
cerebrospinal ,patient:2
fluid ,patient:2
sars-cov-2 ,enough:4
children ,today:2
children ,enough:2
transmission ,today:2
transmission ,enough:2
evidence ,today:2
evidence ,enough:4
today ,enough:2
remdesivir ,hope:4
antiviral ,hope:2
structural ,potent:4
structural ,neutralization:4
structural ,betacoronaviruses:2
structural ,single-domain:2
basis ,potent:4
basis ,neutralization:4
basis ,betacoronaviruses:2
basis ,single-domain:2
potent ,betacoronaviruses:2
potent ,single-domain:2
neutralization ,betacoronaviruses:2
neutralization ,single-domain:2
betacoronaviruses ,single-domain:2
risk ,virus:4
risk ,contamination:2
risk ,surgical:2
risk ,smoke:4
risk ,minimally:2
risk ,invasive:2
virus ,contamination:8
virus ,surgical:2
virus ,smoke:2
virus ,minimally:2
virus ,invasive:2
contamination ,surgical:2
contamination ,smoke:2
contamination ,minimally:2
contamination ,invasive:2
surgical ,smoke:2
surgical ,minimally:2
surgical ,invasive:2
smoke ,minimally:2
smoke ,invasive:2
minimally ,invasive:2
effects ,disease:10
effects ,solid:2
effects ,organ:4
effects ,transplantation:2
coronavirus ,solid:2
coronavirus ,organ:4
disease ,solid:2
disease ,organ:2
unique ,presentation:2
unique ,delirium:2
unique ,patient:2
unique ,otherwise:2
unique ,asymptomatic:2
unique ,covid-19:4
presentation ,delirium:2
presentation ,otherwise:2
presentation ,asymptomatic:2
delirium ,patient:2
delirium ,otherwise:2
delirium ,asymptomatic:2
delirium ,covid-19:14
patient ,otherwise:2
otherwise ,asymptomatic:2
otherwise ,covid-19:2
proteomics ,informatics:2
proteomics ,understanding:2
proteomics ,phases:2
proteomics ,identifying:2
proteomics ,biomarkers:2
informatics ,understanding:2
informatics ,phases:2
informatics ,identifying:2
informatics ,biomarkers:2
understanding ,phases:2
understanding ,identifying:2
understanding ,biomarkers:2
phases ,identifying:2
phases ,biomarkers:2
identifying ,biomarkers:2
comparison ,sensitivity:4
comparison ,nucleoprotein:2
diagnostic ,sensitivity:2
diagnostic ,nucleoprotein:2
sensitivity ,nucleoprotein:2
sars-cov-2 ,nucleoprotein:4
development ,diagnostics:4
diagnostics ,vaccines:2
diagnostics ,therapeutics:4
evaluation ,euroimmun:4
evaluation ,elisa:4
euroimmun ,anti-sars-cov-2:4
euroimmun ,elisa:4
euroimmun ,assay:2
euroimmun ,detection:2
euroimmun ,iga:2
euroimmun ,igg:4
anti-sars-cov-2 ,assay:2
anti-sars-cov-2 ,iga:2
elisa ,assay:4
elisa ,iga:2
assay ,iga:2
detection ,iga:2
evidence ,targeting:2
evidence ,cns:2
evidence ,tissue:2
evidence ,distribution:2
evidence ,host-virus:2
covid-19 ,distribution:12
covid-19 ,host-virus:2
virus ,cns:2
virus ,tissue:2
virus ,distribution:2
virus ,host-virus:2
targeting ,cns:2
targeting ,tissue:2
targeting ,distribution:2
cns ,tissue:2
cns ,distribution:2
cns ,host-virus:2
tissue ,distribution:2
tissue ,host-virus:2
distribution ,host-virus:2
sars-cov-2 ,endothelial:4
sars-cov-2 ,chilblains:2
endothelial ,infection:4
endothelial ,causes:2
endothelial ,chilblains:2
endothelial ,histopathological:2
infection ,causes:4
infection ,chilblains:2
infection ,histopathological:2
causes ,covid-19:8
causes ,chilblains:2
causes ,histopathological:2
chilblains ,histopathological:2
potential ,combating:2
therapeutic ,combating:2
therapeutic ,repurposing:4
targets ,combating:2
targets ,repurposing:4
targets ,clinical:2
combating ,clinical:4
drug ,clinical:6
repurposing ,clinical:2
insights ,transfusion:2
insights ,medicine:2
transfusion ,medicine:4
low ,performance:2
low ,rapid:2
low ,antigen:2
low ,test:2
low ,frontline:2
low ,testing:6
performance ,antigen:2
performance ,frontline:2
performance ,testing:4
rapid ,frontline:2
antigen ,frontline:2
antigen ,testing:2
antigen ,covid-19:6
detection ,frontline:2
detection ,testing:6
test ,frontline:2
test ,testing:2
frontline ,testing:2
predictive ,accuracy:2
predictive ,hierarchical:2
predictive ,logistic:2
predictive ,model:2
predictive ,cumulative:2
predictive ,case:4
accuracy ,hierarchical:2
accuracy ,logistic:2
accuracy ,model:2
accuracy ,cumulative:2
accuracy ,case:2
hierarchical ,logistic:2
hierarchical ,model:2
hierarchical ,cumulative:2
hierarchical ,sars-cov-2:2
hierarchical ,case:2
logistic ,model:2
logistic ,cumulative:2
logistic ,sars-cov-2:2
logistic ,case:2
model ,cumulative:2
model ,case:2
cumulative ,case:2
sars-cov-2 ,gastroenterological:2
sars-cov-2 ,service:4
infection ,gastroenterological:2
infection ,service:2
among ,gastroenterological:2
among ,service:2
healthcare ,gastroenterological:2
healthcare ,service:2
workers ,gastroenterological:2
workers ,service:2
gastroenterological ,service:2
masks ,danger:2
masks ,analysis:2
masks ,social:2
masks ,attitudes:2
masks ,towards:2
masks ,order:2
protection ,danger:2
protection ,analysis:2
protection ,social:2
protection ,attitudes:2
protection ,towards:2
protection ,order:2
danger ,analysis:2
danger ,social:2
danger ,attitudes:2
danger ,towards:2
danger ,order:2
analysis ,social:6
analysis ,attitudes:2
analysis ,towards:2
analysis ,order:2
social ,attitudes:2
social ,towards:2
social ,order:2
attitudes ,towards:6
attitudes ,order:2
towards ,order:2
sars-cov-2 ,disrupts:4
sars-cov-2 ,disease-specific:2
sars-cov-2 ,trial:4
disrupts ,clinical:2
disrupts ,research:2
disrupts ,role:2
disrupts ,rare:2
disrupts ,disease-specific:2
disrupts ,trial:2
clinical ,role:2
clinical ,rare:2
clinical ,disease-specific:2
clinical ,trial:12
research ,role:2
research ,rare:2
research ,disease-specific:2
role ,rare:2
role ,disease-specific:2
role ,trial:2
rare ,disease-specific:2
rare ,trial:2
disease-specific ,trial:2
sars-cov-2 ,serosurvey:6
sars-cov-2 ,veneto:2
serosurvey ,health:2
serosurvey ,care:2
serosurvey ,workers:2
serosurvey ,veneto:2
serosurvey ,region:2
health ,veneto:2
health ,region:2
care ,veneto:2
care ,region:2
workers ,veneto:2
workers ,region:2
veneto ,region:2
sars-cov-2 ,song:2
sars-cov-2 ,recalls:2
sars-cov-2 ,melody:2
new ,song:2
new ,recalls:2
new ,melody:2
song ,recalls:2
song ,old:2
song ,melody:2
recalls ,old:2
recalls ,melody:2
old ,melody:2
kinetics ,specific:2
kinetics ,igm:2
kinetics ,igg:2
kinetics ,responses:2
kinetics ,covid-19:8
specific ,igg:8
igg ,patients:6
epidemiological ,6635:2
epidemiological ,pooled:2
clinical ,6635:2
characteristics ,6635:2
characteristics ,pooled:2
6635 ,covid-19:2
6635 ,patients:2
6635 ,pooled:2
brief ,validation:2
brief ,novel:2
brief ,genexpert:2
brief ,xpress:2
brief ,pcr:2
brief ,assay:2
validation ,novel:2
validation ,genexpert:2
validation ,xpress:2
novel ,genexpert:2
novel ,xpress:2
novel ,pcr:4
novel ,assay:8
genexpert ,xpress:2
genexpert ,sars-cov-2:2
genexpert ,pcr:2
genexpert ,assay:2
xpress ,sars-cov-2:6
xpress ,pcr:2
xpress ,assay:2
role ,large-scale:2
role ,platform:2
role ,control:6
large-scale ,testing:10
large-scale ,platform:2
large-scale ,prevention:2
large-scale ,control:2
testing ,platform:2
testing ,prevention:2
testing ,control:2
platform ,prevention:2
platform ,control:2
positive ,rate:2
positive ,detection:2
positive ,4880:2
positive ,cases:6
positive ,one:2
rate ,rt-pcr:2
rate ,detection:2
rate ,4880:2
rate ,one:2
rt-pcr ,infection:4
rt-pcr ,4880:2
rt-pcr ,cases:2
rt-pcr ,one:2
detection ,4880:2
detection ,cases:2
detection ,one:2
sars-cov-2 ,4880:2
infection ,4880:2
infection ,one:4
4880 ,cases:2
4880 ,one:2
cases ,one:2
coinfection ,characteristics:2
coinfection ,children:2
psychopharmacotherapeutic ,guidelines:2
psychopharmacotherapeutic ,challenge:2
psychopharmacotherapeutic ,health:2
psychopharmacotherapeutic ,crisis:2
guidelines ,challenge:2
guidelines ,health:6
guidelines ,crisis:2
challenge ,health:2
challenge ,crisis:2
covid-19 ,asthma:12
covid-19 ,reflection:2
asthma ,reflection:2
asthma ,pandemic:4
reflection ,pandemic:2
haplotype ,networks:2
haplotype ,sars-cov-2:2
haplotype ,infections:2
haplotype ,diamond:2
haplotype ,princess:2
haplotype ,cruise:2
haplotype ,ship:2
networks ,sars-cov-2:6
networks ,diamond:2
networks ,princess:2
networks ,cruise:2
networks ,ship:2
sars-cov-2 ,diamond:2
sars-cov-2 ,princess:2
sars-cov-2 ,cruise:6
sars-cov-2 ,ship:4
infections ,diamond:2
infections ,princess:2
infections ,cruise:2
infections ,ship:2
acute ,olfactorytaste:2
onset ,olfactorytaste:2
onset ,disorders:2
onset ,associated:4
onset ,high:2
onset ,viral:2
onset ,burden:2
olfactorytaste ,disorders:2
olfactorytaste ,associated:2
olfactorytaste ,high:2
olfactorytaste ,viral:2
olfactorytaste ,burden:2
disorders ,associated:2
disorders ,high:2
disorders ,viral:2
disorders ,burden:2
associated ,high:8
associated ,burden:2
high ,viral:6
high ,burden:4
viral ,burden:2
digestive ,protection:2
digestive ,management:2
digestive ,sars-cov-2:2
system ,protection:2
system ,management:4
protection ,management:2
protection ,sars-cov-2:14
rationality ,asari:2
rationality ,radix:2
rationality ,et:2
rationality ,rhizoma:2
rationality ,qingfei:2
rationality ,paidu:2
rationality ,decoction:2
rationality ,based:2
asari ,radix:2
asari ,et:2
asari ,rhizoma:2
asari ,qingfei:2
asari ,paidu:2
asari ,decoction:2
asari ,based:2
radix ,et:2
radix ,rhizoma:2
radix ,qingfei:2
radix ,paidu:2
radix ,decoction:2
radix ,based:2
et ,rhizoma:2
et ,qingfei:2
et ,paidu:2
et ,decoction:2
et ,based:2
rhizoma ,qingfei:2
rhizoma ,paidu:2
rhizoma ,decoction:2
rhizoma ,based:2
qingfei ,paidu:2
qingfei ,decoction:2
qingfei ,based:2
paidu ,decoction:2
paidu ,based:2
decoction ,based:2
intussusception ,child:2
intussusception ,covid-19:2
intussusception ,usa:2
child ,usa:2
possible ,routes:4
possible ,invasion:2
possible ,context:2
routes ,invasion:2
routes ,brain:2
routes ,context:2
routes ,symptoms:2
invasion ,brain:2
invasion ,context:2
invasion ,symptoms:2
brain ,context:2
brain ,neurological:4
brain ,symptoms:2
context ,neurological:2
context ,symptoms:2
coagulation ,dysfunction:4
safety ,amiodarone:2
safety ,patient:4
efficacy ,amiodarone:2
efficacy ,patient:2
efficacy ,covid-19:20
amiodarone ,patient:2
amiodarone ,covid-19:4
diabetes ,knowledge:2
diabetes ,progress:2
knowledge ,progress:2
pathophysiology ,transmission:4
transmission ,treatment:2
viral ,assessment:6
load ,assessment:2
load ,respiratory:4
load ,samples:4
assessment ,respiratory:2
assessment ,samples:2
respiratory ,samples:2
interferon-induced ,transmembrane:2
interferon-induced ,protein:2
interferon-induced ,ifitm3:2
interferon-induced ,upregulated:2
interferon-induced ,explicitly:2
transmembrane ,protein:2
transmembrane ,ifitm3:2
transmembrane ,upregulated:2
transmembrane ,explicitly:2
protein ,ifitm3:2
protein ,upregulated:2
protein ,explicitly:2
ifitm3 ,upregulated:2
ifitm3 ,explicitly:2
upregulated ,explicitly:2
povidone-iodine ,use:2
povidone-iodine ,sinonasal:2
povidone-iodine ,oral:4
povidone-iodine ,cavities:2
povidone-iodine ,review:2
povidone-iodine ,safety:2
use ,sinonasal:2
use ,oral:2
use ,cavities:2
use ,safety:2
sinonasal ,oral:2
sinonasal ,cavities:2
sinonasal ,review:4
sinonasal ,safety:2
oral ,cavities:2
oral ,review:2
oral ,safety:2
cavities ,review:2
cavities ,safety:2
review ,safety:8
nanomedicine ,promising:2
nanomedicine ,approach:2
nanomedicine ,fordiagnosis:2
nanomedicine ,treatment:2
nanomedicine ,prophylaxis:2
promising ,fordiagnosis:2
promising ,prophylaxis:2
approach ,fordiagnosis:2
approach ,treatment:8
approach ,prophylaxis:2
fordiagnosis ,treatment:2
fordiagnosis ,prophylaxis:2
treatment ,prophylaxis:4
water ,sanitation:4
water ,shortfalls:2
water ,exacerbate:2
water ,risks:2
sanitation ,shortfalls:2
sanitation ,exacerbate:2
sanitation ,sars-cov-2:4
sanitation ,transmission:2
sanitation ,risks:2
shortfalls ,exacerbate:2
shortfalls ,sars-cov-2:2
shortfalls ,transmission:2
shortfalls ,risks:2
exacerbate ,sars-cov-2:2
exacerbate ,transmission:2
exacerbate ,risks:2
coronavirus ,cared:2
coronavirus ,childrens:2
disease ,cared:2
disease ,texas:2
disease ,childrens:2
disease ,hospital:10
children ,cared:2
children ,texas:2
children ,childrens:2
children ,hospital:4
children ,initial:2
cared ,texas:2
cared ,childrens:2
cared ,hospital:2
cared ,initial:2
texas ,childrens:2
texas ,hospital:2
texas ,initial:2
childrens ,hospital:4
childrens ,initial:2
hospital ,initial:2
expression ,cell:2
expression ,wide:2
expression ,variety:2
sars-cov-2 ,wide:2
sars-cov-2 ,variety:2
cell ,gene:2
cell ,wide:2
cell ,variety:2
receptor ,gene:8
receptor ,wide:2
receptor ,variety:2
gene ,ace2:12
gene ,wide:2
gene ,variety:2
gene ,human:8
ace2 ,wide:2
ace2 ,variety:2
wide ,variety:2
wide ,human:2
variety ,human:2
potential ,methods:4
treatment ,methods:2
treatment ,targeting:2
methods ,targeting:2
methods ,2019-ncov:2
methods ,infection:4
targeting ,2019-ncov:2
targeting ,infection:6
detection ,mass:4
severe ,mass:4
acute ,mass:4
syndrome ,mass:2
coronavirus ,mass:4
sars-cov-2covid-19 ,aprimer:2
sars-cov-2covid-19 ,cardiologists:2
aprimer ,cardiologists:2
evaluating ,effectiveness:4
evaluating ,social:2
evaluating ,distancing:2
evaluating ,interventions:2
evaluating ,delay:2
evaluating ,flatten:2
effectiveness ,social:2
effectiveness ,distancing:2
effectiveness ,interventions:6
effectiveness ,delay:2
effectiveness ,flatten:2
social ,delay:2
social ,flatten:2
distancing ,delay:2
distancing ,flatten:2
interventions ,delay:2
interventions ,flatten:2
delay ,flatten:2
ace2 ,resulting:2
ace2 ,ards:2
covid-19 ,resulting:2
resulting ,ards:2
neurological ,know:2
neurological ,far:2
manifestations ,know:2
manifestations ,far:2
review ,far:2
architecture ,sars-cov-2:4
architecture ,transcriptome:2
sars-cov-2 ,transcriptome:4
array-based ,analysis:2
array-based ,sars-cov-2:2
array-based ,coronaviruses:2
array-based ,influenza:2
array-based ,antibodies:2
analysis ,influenza:2
analysis ,antibodies:4
coronaviruses ,influenza:4
influenza ,antibodies:2
recurrence ,nucleic:2
recurrence ,acid:2
recurrence ,test:2
recurrence ,patients:6
positive ,test:6
test ,patients:8
cellular ,convalescents:2
cellular ,pcr-confirmed:2
cellular ,infection:2
immunity ,convalescents:2
immunity ,pcr-confirmed:2
immunity ,infection:2
covid-19 ,convalescents:2
covid-19 ,pcr-confirmed:2
convalescents ,pcr-confirmed:2
convalescents ,infection:2
pcr-confirmed ,infection:2
high-throughput ,assay:2
high-throughput ,circulating:2
high-throughput ,antibodies:2
high-throughput ,directed:2
high-throughput ,protein:2
assay ,circulating:2
assay ,antibodies:2
assay ,directed:2
assay ,protein:2
circulating ,antibodies:2
circulating ,directed:2
circulating ,protein:2
antibodies ,directed:2
directed ,protein:2
therapeutic ,convalescent:2
therapeutic ,plasma:6
therapeutic ,treating:2
therapeutic ,critically-ill:2
potential ,convalescent:2
potential ,plasma:4
potential ,treating:6
potential ,critically-ill:2
convalescent ,critically-ill:2
plasma ,critically-ill:2
therapy ,treating:2
therapy ,critically-ill:2
treating ,critically-ill:2
high-dose ,intravenous:2
high-dose ,immunoglobulins:2
high-dose ,severe:4
high-dose ,acute:2
high-dose ,viral:2
intravenous ,immunoglobulins:2
intravenous ,severe:4
intravenous ,acute:2
intravenous ,viral:2
immunoglobulins ,treatment:4
immunoglobulins ,severe:2
immunoglobulins ,acute:2
immunoglobulins ,viral:2
treatment ,viral:4
repurposing ,protease:10
repurposing ,extracellular:2
repurposing ,vesicles:2
antiviral ,protease:4
antiviral ,inhibitors:4
antiviral ,using:2
antiviral ,extracellular:2
antiviral ,vesicles:2
protease ,using:8
protease ,extracellular:2
protease ,vesicles:2
inhibitors ,extracellular:2
inhibitors ,vesicles:2
using ,extracellular:2
using ,vesicles:2
extracellular ,potential:2
vesicles ,potential:2
viable ,air:2
viable ,hospital:2
viable ,room:2
viable ,patients:4
sars-cov-2 ,room:4
air ,room:4
air ,patients:8
hospital ,room:2
hospital ,patients:18
room ,covid-19:10
room ,patients:6
electronic ,health:4
electronic ,record-based:2
electronic ,surveillance:2
electronic ,community:2
electronic ,transmitted:2
electronic ,covid-19:2
health ,record-based:2
health ,transmitted:2
record-based ,surveillance:2
record-based ,community:2
record-based ,transmitted:2
record-based ,covid-19:2
surveillance ,community:4
surveillance ,transmitted:2
community ,transmitted:2
transmitted ,covid-19:4
mutation ,profile:2
mutation ,4500:2
mutation ,isolations:2
mutation ,reveals:2
mutation ,prevalent:2
profile ,4500:2
profile ,isolations:2
profile ,reveals:2
profile ,prevalent:2
4500 ,sars-cov-2:2
4500 ,isolations:2
4500 ,reveals:2
4500 ,prevalent:2
sars-cov-2 ,isolations:2
sars-cov-2 ,prevalent:2
isolations ,reveals:2
isolations ,prevalent:2
reveals ,prevalent:2
sars-cov-2 ,orf3b:2
sars-cov-2 ,whose:2
orf3b ,potent:2
orf3b ,interferon:2
orf3b ,antagonist:2
orf3b ,whose:2
orf3b ,activity:2
orf3b ,increased:2
potent ,interferon:2
potent ,antagonist:2
potent ,whose:2
potent ,increased:2
interferon ,antagonist:2
interferon ,whose:2
interferon ,activity:2
interferon ,increased:2
antagonist ,whose:2
antagonist ,activity:2
antagonist ,increased:2
whose ,activity:2
whose ,increased:2
activity ,increased:2
management ,pneumothorax:2
management ,mechanically:2
management ,ventilated:2
pneumothorax ,mechanically:2
pneumothorax ,ventilated:2
pneumothorax ,patients:2
pneumothorax ,early:2
mechanically ,ventilated:4
mechanically ,covid-19:2
mechanically ,patients:2
mechanically ,early:2
ventilated ,covid-19:2
ventilated ,patients:2
ventilated ,early:2
serological ,respond:2
serological ,epidemic:2
serological ,useful:2
serological ,complement:2
detection ,respond:2
detection ,epidemic:2
detection ,useful:2
detection ,complement:2
2019-ncov ,respond:2
2019-ncov ,useful:2
2019-ncov ,complement:2
respond ,epidemic:4
respond ,useful:2
respond ,complement:2
epidemic ,useful:2
epidemic ,complement:2
useful ,complement:2
lymphopenia ,covid-19:4
lymphopenia ,therapeutic:4
lymphopenia ,opportunities:2
viral ,exanthema:2
viral ,manifestation:2
exanthema ,manifestation:2
exanthema ,sars-cov-2:2
exanthema ,infection:2
exanthema ,case:2
exanthema ,report:2
manifestation ,case:6
manifestation ,report:2
recombination ,afterthought:2
seroprevalence ,testing:2
seroprevalence ,healthcare:8
seroprevalence ,occupations:2
sars-cov-2 ,occupations:2
testing ,occupations:2
healthcare ,occupations:2
can ,infect:2
can ,eye-an:2
can ,overview:2
can ,receptor:2
can ,status:2
can ,ocular:4
sars-cov-2 ,infect:2
sars-cov-2 ,eye-an:2
infect ,eye-an:2
infect ,overview:2
infect ,receptor:2
infect ,status:2
infect ,ocular:2
eye-an ,overview:2
eye-an ,receptor:2
eye-an ,status:2
eye-an ,ocular:2
overview ,receptor:2
overview ,status:2
overview ,ocular:2
receptor ,status:2
receptor ,ocular:2
status ,ocular:2
spreading ,west:2
spreading ,africa:2
spreading ,assessment:2
spreading ,risk:2
spreading ,factors:2
sars-cov-2 ,west:4
west ,africa:2
west ,assessment:2
west ,risk:2
west ,factors:2
africa ,assessment:2
africa ,risk:2
africa ,factors:2
assessment ,factors:4
covid-19 ,filariasis:2
covid-19 ,wuchereria:2
covid-19 ,bancrofti:2
unfolding ,filariasis:2
unfolding ,first:2
unfolding ,case:2
unfolding ,wuchereria:2
unfolding ,bancrofti:2
filariasis ,first:2
filariasis ,case:2
filariasis ,sars-cov-2:2
filariasis ,wuchereria:2
filariasis ,bancrofti:2
first ,wuchereria:2
first ,bancrofti:2
case ,wuchereria:2
case ,bancrofti:2
sars-cov-2 ,wuchereria:2
sars-cov-2 ,bancrofti:2
wuchereria ,bancrofti:2
comparison ,elecsys:2
comparison ,anti-sars-cov-2:4
comparison ,immunoassay:4
comparison ,edi:2
comparison ,enzyme:2
comparison ,linked:2
elecsys ,immunoassay:4
elecsys ,edi:2
elecsys ,enzyme:2
elecsys ,linked:2
anti-sars-cov-2 ,immunoassay:6
anti-sars-cov-2 ,edi:2
anti-sars-cov-2 ,enzyme:2
anti-sars-cov-2 ,linked:2
immunoassay ,edi:2
immunoassay ,enzyme:4
immunoassay ,linked:2
sexgender ,differences:2
sexgender ,ace2:2
sexgender ,expression:2
sexgender ,lungs:2
sexgender ,contribute:2
sexgender ,large:2
differences ,ace2:2
differences ,expression:4
differences ,lungs:2
differences ,contribute:2
differences ,large:2
ace2 ,lungs:4
ace2 ,contribute:2
ace2 ,large:2
expression ,lungs:2
expression ,large:2
lungs ,contribute:2
lungs ,large:2
contribute ,large:2
novel ,disease-2019:2
novel ,mechanism:4
novel ,action:2
disease-2019 ,mechanism:2
disease-2019 ,action:2
disease-2019 ,detection:2
mechanism ,detection:2
action ,detection:2
masks ,virus:2
masks ,infections:2
masks ,including:2
prevention ,respiratory:2
prevention ,including:2
respiratory ,including:2
virus ,including:2
infections ,including:2
including ,sars-cov-2:8
universal ,screening:8
universal ,women:6
universal ,admitted:6
universal ,delivery:2
universal ,large:2
universal ,managed:2
screening ,large:2
screening ,managed:2
women ,large:2
women ,managed:2
admitted ,large:2
admitted ,managed:2
delivery ,large:2
delivery ,managed:2
large ,managed:2
sars-cov-2 ,virological:2
infection ,virological:2
virological ,diagnosis:2
haemoptysis ,first:2
haemoptysis ,presentation:2
haemoptysis ,covid-19:2
haemoptysis ,case:2
haemoptysis ,report:2
first ,presentation:6
rapid ,in-vitro:2
in-vitro ,inactivation:2
in-vitro ,severe:2
in-vitro ,acute:2
in-vitro ,respiratory:2
in-vitro ,syndrome:2
in-vitro ,coronavirus:2
pulmonary ,increased:2
pulmonary ,levels:2
pulmonary ,d-dimer:2
embolism ,increased:2
embolism ,levels:2
embolism ,d-dimer:2
embolism ,coronavirus:8
increased ,levels:2
increased ,d-dimer:2
increased ,coronavirus:4
levels ,d-dimer:8
levels ,patients:14
levels ,coronavirus:4
d-dimer ,patients:8
outbreak ,three:2
outbreak ,nursing:2
outbreak ,homes:2
outbreak ,bergen:2
covid-19 ,nursing:12
covid-19 ,homes:8
covid-19 ,bergen:2
three ,nursing:2
three ,homes:2
three ,bergen:2
nursing ,bergen:2
homes ,bergen:2
development ,evaluation:8
development ,rapid:16
development ,simple:4
development ,assay:12
evaluation ,simple:4
evaluation ,based:6
rapid ,simple:2
simple ,diagnostic:2
simple ,assay:2
simple ,covid-19:4
simple ,based:2
diagnostic ,assay:2
diagnostic ,based:4
assay ,covid-19:4
assay ,based:4
mask ,use:2
mask ,risk:2
mask ,adjusted:2
mask ,strategy:2
use ,adjusted:2
use ,strategy:6
covid-19 ,adjusted:2
risk ,adjusted:2
risk ,strategy:2
adjusted ,strategy:2
transcriptomic ,reveals:2
transcriptomic ,novel:2
transcriptomic ,mechanisms:2
transcriptomic ,sars-cov-2:2
transcriptomic ,infection:2
transcriptomic ,human:2
analysis ,mechanisms:2
reveals ,novel:2
reveals ,infection:6
reveals ,human:2
novel ,mechanisms:6
mechanisms ,human:6
predictive ,national:2
predictive ,warning:2
predictive ,score:4
predictive ,news2:2
predictive ,intensive:2
predictive ,care:2
predictive ,unit:2
value ,national:2
value ,warning:2
value ,score:2
value ,news2:2
value ,intensive:2
value ,care:2
value ,unit:2
national ,early:2
national ,warning:2
national ,score:2
national ,news2:2
national ,intensive:2
national ,care:2
national ,unit:2
early ,warning:8
early ,score:2
early ,news2:2
early ,intensive:4
early ,care:6
early ,unit:4
warning ,score:2
warning ,news2:2
warning ,intensive:2
warning ,care:2
warning ,unit:2
score ,news2:2
score ,intensive:2
score ,care:2
score ,unit:2
news2 ,intensive:2
news2 ,care:2
news2 ,unit:2
recent ,patents:2
recent ,nanotechnologies:2
patents ,advances:2
patents ,nanotechnologies:2
patents ,coronavirus:2
advances ,nanotechnologies:2
nanotechnologies ,coronavirus:2
use ,pioglitazone:2
use ,people:2
use ,type:2
use ,diabetes:2
use ,mellitus:2
pioglitazone ,people:2
pioglitazone ,type:2
pioglitazone ,diabetes:2
pioglitazone ,mellitus:2
pioglitazone ,coronavirus:2
pioglitazone ,disease:2
people ,type:2
people ,mellitus:2
people ,disease:4
type ,disease:4
mellitus ,disease:10
activating ,resources:2
activating ,covid-19:4
activating ,pandemic:2
activating ,invivo:2
activating ,models:2
activating ,vaccines:2
resources ,covid-19:2
resources ,pandemic:2
resources ,invivo:2
resources ,models:2
resources ,vaccines:2
covid-19 ,invivo:2
pandemic ,invivo:2
pandemic ,models:4
invivo ,models:2
invivo ,vaccines:2
models ,vaccines:2
storm ,arrived:2
storm ,impact:2
storm ,medical:2
storm ,students:2
arrived ,impact:2
arrived ,sars-cov-2:2
arrived ,medical:2
arrived ,students:2
impact ,medical:4
impact ,students:2
sars-cov-2 ,students:2
medical ,students:8
will ,hydroxychloroquine:2
will ,game-changer:2
will ,combining:2
hydroxychloroquine ,still:2
hydroxychloroquine ,game-changer:2
hydroxychloroquine ,combining:2
still ,game-changer:2
still ,combining:2
game-changer ,covid-19:2
game-changer ,combining:2
covid-19 ,combining:2
two ,seriously:2
two ,ill:2
two ,born:4
two ,pneumonia-:2
two ,case:4
two ,report:6
seriously ,ill:2
seriously ,neonates:2
seriously ,born:2
seriously ,mothers:2
seriously ,covid-19:2
seriously ,pneumonia-:2
seriously ,case:2
seriously ,report:2
ill ,neonates:2
ill ,born:2
ill ,mothers:2
ill ,pneumonia-:2
ill ,report:2
neonates ,pneumonia-:2
neonates ,case:2
neonates ,report:2
born ,pneumonia-:2
born ,case:2
born ,report:2
mothers ,pneumonia-:2
mothers ,case:4
covid-19 ,pneumonia-:2
pneumonia- ,case:2
pneumonia- ,report:2
viral ,spike:2
viral ,g614:2
viral ,mutation:4
viral ,exhibits:2
viral ,higher:4
viral ,fatality:4
viral ,rate:6
spike ,g614:2
spike ,mutation:4
spike ,exhibits:2
spike ,higher:2
spike ,case:2
spike ,fatality:2
spike ,rate:2
g614 ,mutation:2
g614 ,exhibits:2
g614 ,higher:2
g614 ,case:2
g614 ,fatality:2
g614 ,rate:2
mutation ,exhibits:2
mutation ,case:2
mutation ,fatality:2
exhibits ,higher:2
exhibits ,case:2
exhibits ,fatality:2
exhibits ,rate:2
higher ,case:2
higher ,fatality:2
prevalence ,subsequent:2
prevalence ,cohorting:2
prevalence ,residential:2
prevalence ,substance:2
covid-19 ,subsequent:2
covid-19 ,cohorting:4
covid-19 ,residential:2
covid-19 ,substance:4
infection ,subsequent:2
infection ,cohorting:2
infection ,residential:2
infection ,substance:2
subsequent ,cohorting:2
subsequent ,residential:2
subsequent ,substance:2
cohorting ,residential:2
cohorting ,substance:2
residential ,substance:2
headache ,patients:4
headache ,severe:2
headache ,acute:4
headache ,respiratory:2
headache ,syndrome:2
headache ,coronavirus:4
headache ,infection:2
epidemiological ,aspects:2
epidemiological ,psychological:2
epidemiological ,reactions:2
epidemiological ,dental:2
aspects ,psychological:2
aspects ,reactions:2
aspects ,dental:2
psychological ,reactions:2
psychological ,dental:2
reactions ,covid-19:4
reactions ,dental:2
human-induced ,pluripotent:2
human-induced ,stem:2
human-induced ,cell-derived:2
human-induced ,cardiomyocytes:2
human-induced ,platform:2
human-induced ,study:2
pluripotent ,stem:2
pluripotent ,cell-derived:2
pluripotent ,cardiomyocytes:2
pluripotent ,platform:2
pluripotent ,study:2
stem ,cardiomyocytes:2
stem ,platform:2
stem ,study:2
cell-derived ,cardiomyocytes:2
cell-derived ,platform:2
cell-derived ,study:2
cardiomyocytes ,platform:2
cardiomyocytes ,study:2
platform ,study:2
opening ,closing:2
opening ,doors:2
opening ,lockdown:2
opening ,italy:2
opening ,without:2
opening ,forgetting:2
opening ,lung:2
closing ,doors:2
closing ,lockdown:2
closing ,italy:2
closing ,without:2
closing ,forgetting:2
closing ,lung:2
doors ,lockdown:2
doors ,italy:2
doors ,without:2
doors ,forgetting:2
doors ,lung:2
lockdown ,italy:4
lockdown ,without:2
lockdown ,forgetting:2
lockdown ,lung:2
italy ,without:2
italy ,forgetting:2
italy ,lung:2
without ,forgetting:2
without ,lung:2
forgetting ,lung:2
covid-19 ,efficient:8
covid-19 ,aggressive:2
transmission ,efficient:2
transmission ,aggressive:2
efficient ,aggressive:2
efficient ,viral:2
aggressive ,viral:2
spatio-temporal ,analysis:2
spatio-temporal ,exploring:2
spatio-temporal ,effect:2
spatio-temporal ,temperature:2
spatio-temporal ,covid-19:4
spatio-temporal ,early:2
analysis ,exploring:4
analysis ,effect:2
analysis ,temperature:4
analysis ,early:4
exploring ,effect:2
exploring ,temperature:2
exploring ,early:2
temperature ,early:2
blocking ,high-affinity:2
blocking ,interaction-synapse:2
blocking ,spike:4
blocking ,human:4
high-affinity ,interaction-synapse:2
high-affinity ,spike:2
high-affinity ,human:2
interaction-synapse ,sars-cov-2:2
interaction-synapse ,spike:2
interaction-synapse ,human:2
covid-19 ,underpinning:4
underpinning ,research:2
underpinning ,detection:2
underpinning ,therapeutics:2
underpinning ,vaccines:2
research ,therapeutics:2
research ,vaccines:4
detection ,therapeutics:2
detection ,vaccines:2
another ,side:2
another ,alzheimers:2
another ,disease:2
another ,patients:2
another ,drug-drug:2
side ,alzheimers:2
side ,disease:2
side ,patients:2
side ,drug-drug:2
covid-19 ,drug-drug:2
alzheimers ,patients:2
alzheimers ,drug-drug:2
disease ,drug-drug:2
patients ,drug-drug:2
possible ,novel:4
modes ,novel:2
modes ,coronavirus:2
early ,insights:4
early ,statistical:2
early ,mathematical:4
early ,modeling:2
early ,key:2
insights ,statistical:2
insights ,mathematical:2
insights ,modeling:2
insights ,key:2
insights ,epidemiologic:2
statistical ,mathematical:2
statistical ,modeling:4
statistical ,key:2
statistical ,epidemiologic:2
mathematical ,modeling:2
mathematical ,key:2
mathematical ,epidemiologic:2
modeling ,key:2
modeling ,epidemiologic:2
key ,epidemiologic:2
procalcitonin ,levels:2
procalcitonin ,covid-19:2
procalcitonin ,patients:2
levels ,covid-19:18
stroke ,covid19:2
stroke ,large-vessel:2
covid19 ,large-vessel:2
covid19 ,disease:2
large-vessel ,disease:2
peptide-based ,magnetic:2
peptide-based ,chemiluminescence:2
peptide-based ,enzyme:2
peptide-based ,immunoassay:2
peptide-based ,serological:2
magnetic ,chemiluminescence:2
magnetic ,enzyme:2
magnetic ,immunoassay:2
magnetic ,serological:2
chemiluminescence ,enzyme:2
chemiluminescence ,serological:4
enzyme ,serological:2
immunoassay ,serological:6
cancer ,encounters:2
cancer ,china:2
cancer ,suffered:2
cancer ,experienced:2
encounters ,china:2
encounters ,suffered:2
encounters ,experienced:2
covid-19 ,suffered:2
covid-19 ,experienced:2
china ,suffered:2
china ,experienced:2
suffered ,experienced:2
role ,echocardiography:6
role ,compromise:2
role ,among:2
echocardiography ,sars-cov-2:2
echocardiography ,pandemic:4
echocardiography ,compromise:2
echocardiography ,among:2
sars-cov-2 ,compromise:2
pandemic ,compromise:2
compromise ,among:2
potential ,carotid:2
potential ,body:2
role ,carotid:2
role ,body:2
carotid ,body:2
carotid ,covid-19:2
sars-cov-2 ,cystic:8
sars-cov-2 ,fibrosis:6
infection ,cystic:4
infection ,fibrosis:2
infection ,overview:10
patients ,cystic:4
patients ,fibrosis:4
patients ,overview:4
cystic ,fibrosis:8
cystic ,overview:2
fibrosis ,overview:2
high ,rates:4
high ,disease:6
high ,death:2
high ,due:2
high ,rheumatic:2
rates ,severe:2
rates ,disease:4
rates ,death:4
rates ,due:2
rates ,sars-cov-2:14
rates ,rheumatic:2
severe ,death:4
severe ,rheumatic:2
death ,due:4
death ,sars-cov-2:6
death ,rheumatic:2
due ,rheumatic:2
sars-cov-2 ,infection-induced:4
sars-cov-2 ,friends:2
sars-cov-2 ,foes:2
infection-induced ,immune:2
infection-induced ,responses:2
infection-induced ,friends:2
infection-induced ,foes:2
immune ,friends:2
immune ,foes:2
responses ,friends:2
responses ,foes:2
friends ,foes:8
variant ,analysis:4
variant ,genomes:2
special ,features:2
special ,daily:2
special ,practice:4
features ,daily:2
features ,practice:2
sars-cov-2 ,daily:4
daily ,practice:2
ace2 ,enhance:4
ace2 ,viral:2
ace2 ,aggravate:2
ace2 ,underlying:2
ace2 ,diseases:2
enhance ,viral:2
enhance ,infection:2
enhance ,aggravate:2
enhance ,underlying:2
enhance ,diseases:2
viral ,aggravate:2
viral ,underlying:2
infection ,aggravate:2
infection ,underlying:2
aggravate ,underlying:2
aggravate ,diseases:2
underlying ,diseases:2
response ,d-dimer:2
response ,patients:20
response ,mortality:6
association ,d-dimer:4
multisystem ,children:18
multisystem ,mis-c:4
multisystem ,insights:2
inflammatory ,children:20
inflammatory ,mis-c:4
inflammatory ,insights:2
syndrome ,mis-c:4
syndrome ,insights:2
children ,mis-c:4
children ,insights:4
mis-c ,covid-19:2
mis-c ,insights:2
multiplexing ,primerprobe:2
multiplexing ,sets:2
multiplexing ,detection:2
multiplexing ,sars-cov-2:2
multiplexing ,qrt-pcr:2
primerprobe ,sets:2
primerprobe ,detection:2
primerprobe ,sars-cov-2:2
primerprobe ,qrt-pcr:2
sets ,detection:4
sets ,sars-cov-2:4
sets ,qrt-pcr:2
detection ,qrt-pcr:6
sars-cov-2 ,qrt-pcr:6
comparison ,cepheid:2
comparison ,xpert:2
comparison ,xpress:2
comparison ,abbott:4
comparison ,id:2
comparison ,now:2
comparison ,roche:2
comparison ,cobas:4
cepheid ,xpert:6
cepheid ,xpress:6
cepheid ,abbott:2
cepheid ,id:2
cepheid ,now:2
cepheid ,roche:2
cepheid ,cobas:2
cepheid ,rapid:2
xpert ,xpress:6
xpert ,abbott:2
xpert ,id:2
xpert ,now:2
xpert ,roche:2
xpert ,cobas:2
xpert ,rapid:2
xpress ,abbott:2
xpress ,id:2
xpress ,now:2
xpress ,roche:2
xpress ,cobas:2
xpress ,rapid:2
abbott ,roche:2
abbott ,cobas:2
id ,roche:2
id ,cobas:2
now ,roche:2
now ,cobas:2
roche ,cobas:2
roche ,rapid:2
cobas ,rapid:2
diarrhea ,associated:2
diarrhea ,prolonged:2
diarrhea ,symptoms:2
diarrhea ,viral:2
diarrhea ,carriage:2
diarrhea ,corona:2
diarrhea ,virus:2
associated ,carriage:2
associated ,corona:2
associated ,virus:4
prolonged ,symptoms:2
prolonged ,carriage:2
prolonged ,corona:2
prolonged ,virus:2
symptoms ,carriage:4
symptoms ,corona:2
symptoms ,virus:2
viral ,carriage:2
carriage ,corona:2
carriage ,virus:2
effectiveness ,targeting:2
effectiveness ,air:2
effectiveness ,travellers:4
effectiveness ,delaying:4
effectiveness ,local:2
effectiveness ,outbreaks:2
interventions ,targeting:2
interventions ,air:2
interventions ,travellers:2
interventions ,delaying:2
interventions ,local:2
interventions ,outbreaks:2
targeting ,air:2
targeting ,travellers:2
targeting ,delaying:2
targeting ,local:2
targeting ,outbreaks:2
air ,travellers:2
air ,delaying:2
air ,local:2
air ,outbreaks:2
travellers ,delaying:2
travellers ,local:2
travellers ,outbreaks:2
delaying ,local:2
delaying ,outbreaks:2
local ,outbreaks:2
performance ,serological:8
performance ,determine:2
performance ,immunoglobulin:2
performance ,status:2
evaluation ,determine:2
evaluation ,immunoglobulin:2
evaluation ,status:2
serological ,determine:2
serological ,immunoglobulin:2
serological ,status:2
assays ,determine:2
assays ,immunoglobulin:2
assays ,status:2
determine ,immunoglobulin:2
determine ,status:2
immunoglobulin ,status:2
screening ,maternity:2
screening ,populations:2
screening ,pandemic:4
maternity ,populations:2
maternity ,covid-19:4
maternity ,pandemic:2
populations ,pandemic:2
implications ,mutations:4
implications ,rna:4
implications ,structure:2
implications ,host:2
implications ,microrna:2
sars-cov-2 ,microrna:2
mutations ,genomic:4
mutations ,rna:4
mutations ,structure:2
mutations ,host:2
mutations ,microrna:2
genomic ,rna:2
genomic ,structure:2
genomic ,microrna:2
rna ,host:4
rna ,microrna:2
structure ,host:2
structure ,microrna:2
host ,microrna:2
serological ,diagnosis:10
serological ,infection:6
chemiluminescence ,diagnosis:2
chemiluminescence ,infection:2
immunoassay ,diagnosis:2
immunoassay ,infection:2
anti-sars-cov-2 ,csf:2
anti-sars-cov-2 ,blood-brain:2
anti-sars-cov-2 ,barrier:2
anti-sars-cov-2 ,dysfunction:2
antibodies ,csf:2
antibodies ,blood-brain:2
antibodies ,barrier:2
antibodies ,dysfunction:2
csf ,blood-brain:2
csf ,barrier:2
csf ,dysfunction:2
blood-brain ,barrier:2
blood-brain ,dysfunction:2
barrier ,dysfunction:2
drug ,therapeutics:2
drug ,ongoing:2
drug ,global:2
drug ,efforts:2
targets ,therapeutics:2
targets ,ongoing:2
targets ,global:2
targets ,efforts:2
therapeutics ,ongoing:2
therapeutics ,global:2
therapeutics ,efforts:2
ongoing ,efforts:2
global ,efforts:2
diagnostic ,yield:2
diagnostic ,point-of-care:2
diagnostic ,ultrasound:2
diagnostic ,imaging:2
diagnostic ,lung:2
yield ,point-of-care:2
yield ,ultrasound:2
yield ,imaging:2
yield ,lung:2
yield ,patients:2
point-of-care ,imaging:2
point-of-care ,patients:2
ultrasound ,imaging:4
ultrasound ,patients:6
imaging ,lung:6
considerations ,around:2
considerations ,spike:2
considerations ,protein:2
considerations ,particular:2
considerations ,attention:2
around ,sars-cov-2:4
around ,spike:2
around ,protein:2
around ,particular:2
around ,attention:2
sars-cov-2 ,particular:2
sars-cov-2 ,attention:4
spike ,particular:2
spike ,attention:2
protein ,particular:2
protein ,attention:2
particular ,attention:2
consequences ,chemical:2
consequences ,disinfectants:2
consequences ,safe:2
consequences ,preventive:2
consequences ,measures:2
chemical ,impact:2
chemical ,disinfectants:2
chemical ,safe:2
chemical ,preventive:2
chemical ,measures:2
impact ,disinfectants:2
impact ,safe:2
impact ,preventive:2
impact ,measures:14
disinfectants ,safe:2
disinfectants ,preventive:2
disinfectants ,measures:2
safe ,preventive:2
safe ,measures:2
preventive ,measures:12
sars-cov-2 ,margins:2
sars-cov-2 ,cell-based:2
sars-cov-2 ,medicinal:4
sars-cov-2 ,products:8
safety ,margins:2
safety ,cell-based:2
safety ,biological:2
safety ,medicinal:2
safety ,products:2
margins ,cell-based:2
margins ,biological:2
margins ,medicinal:2
margins ,products:2
cell-based ,biological:2
cell-based ,medicinal:2
cell-based ,products:2
biological ,medicinal:2
biological ,products:2
medicinal ,products:4
igm ,serologic:2
igm ,test:2
igm ,diagnosis:2
igg ,serologic:2
igg ,test:4
igg ,diagnosis:2
rapid ,serologic:2
serologic ,test:2
serologic ,diagnosis:2
mechanistic ,overview:2
mechanistic ,using:2
mechanistic ,angiotensin-converting:2
mechanistic ,enzyme:2
overview ,using:2
overview ,angiotensin-converting:2
overview ,enzyme:2
using ,angiotensin-converting:2
using ,enzyme:2
monoclonal ,anti-infective:2
antibodies ,anti-infective:2
antibodies ,therapy:2
anti-infective ,therapy:2
evaluation ,six:4
evaluation ,mid-:2
evaluation ,high-volume:2
evaluation ,point-of-care:6
six ,commercial:2
six ,mid-:2
six ,high-volume:2
six ,point-of-care:2
commercial ,mid-:2
commercial ,high-volume:2
commercial ,antibody:6
commercial ,point-of-care:2
mid- ,high-volume:2
mid- ,antibody:2
mid- ,point-of-care:2
high-volume ,antibody:2
high-volume ,point-of-care:2
antibody ,point-of-care:2
community ,centers:2
community ,asymptomatic:2
community ,mildly:2
community ,symptomatic:2
treatment ,centers:2
treatment ,mildly:2
centers ,isolation:2
centers ,asymptomatic:2
centers ,mildly:2
centers ,symptomatic:2
isolation ,asymptomatic:2
isolation ,mildly:2
isolation ,symptomatic:2
neonatal ,late-onset:2
neonatal ,sars:2
neonatal ,cov-2:2
late-onset ,infection:2
late-onset ,sars:2
late-onset ,cov-2:2
infection ,cov-2:4
clinical ,profile:6
risk ,profile:2
profile ,associated:2
profile ,infection:4
profile ,complications:2
robust ,persistent:2
robust ,sars-cov-2:6
robust ,infection:2
robust ,human:2
robust ,intestinal:2
robust ,brush:2
robust ,border:2
persistent ,human:2
persistent ,intestinal:2
persistent ,brush:2
persistent ,border:2
sars-cov-2 ,brush:2
sars-cov-2 ,border:2
infection ,brush:2
infection ,border:2
human ,intestinal:4
human ,brush:2
human ,border:2
intestinal ,brush:2
intestinal ,border:2
brush ,border:2
lactoferrin ,potential:2
lactoferrin ,preventative:2
lactoferrin ,adjunct:2
lactoferrin ,treatment:4
lactoferrin ,covid-19:6
potential ,adjunct:2
preventative ,adjunct:2
preventative ,treatment:2
adjunct ,treatment:2
guidance ,otolaryngology:2
guidance ,health:4
guidance ,workers:2
guidance ,performing:2
guidance ,aerosol:2
guidance ,generating:2
otolaryngology ,health:2
otolaryngology ,care:4
otolaryngology ,workers:2
otolaryngology ,performing:2
otolaryngology ,aerosol:2
otolaryngology ,generating:2
health ,performing:2
health ,generating:2
care ,performing:2
care ,aerosol:2
care ,generating:2
workers ,performing:2
workers ,aerosol:2
workers ,generating:2
performing ,aerosol:2
performing ,generating:2
aerosol ,generating:4
field ,indoor:2
field ,air:2
field ,measurement:2
field ,sars-cov-2:2
field ,patient:2
field ,rooms:2
field ,largest:2
indoor ,measurement:2
indoor ,patient:2
indoor ,rooms:2
indoor ,largest:2
air ,measurement:2
air ,patient:2
air ,rooms:2
air ,largest:2
measurement ,sars-cov-2:4
measurement ,patient:2
measurement ,rooms:2
measurement ,largest:2
sars-cov-2 ,rooms:2
sars-cov-2 ,largest:2
patient ,rooms:2
patient ,largest:2
rooms ,largest:2
sars-cov-2 ,course:22
detection ,load:6
detection ,infectivity:4
detection ,course:2
viral ,course:4
load ,infectivity:2
load ,course:2
infectivity ,course:2
infectivity ,infection:2
course ,infection:6
covid19-world ,shiny:2
covid19-world ,application:2
covid19-world ,perform:2
covid19-world ,comprehensive:2
covid19-world ,country-specific:2
covid19-world ,data:2
shiny ,application:2
shiny ,perform:2
shiny ,comprehensive:2
shiny ,country-specific:2
shiny ,data:2
application ,perform:2
application ,comprehensive:2
application ,country-specific:2
application ,data:2
perform ,comprehensive:2
perform ,country-specific:2
perform ,data:2
comprehensive ,country-specific:2
comprehensive ,data:2
country-specific ,data:2
cytokine ,overview:2
cytokine ,involvement:2
storm ,overview:2
storm ,involvement:2
overview ,involvement:2
artificial ,approach:2
artificial ,fighting:2
artificial ,repurposing:4
artificial ,drugs:2
intelligence ,approach:2
intelligence ,fighting:2
intelligence ,repurposing:4
approach ,fighting:2
approach ,repurposing:10
approach ,drugs:4
fighting ,repurposing:2
fighting ,drugs:2
designing ,efficient:2
designing ,multi-epitope:4
designing ,displaying:2
designing ,interactions:2
designing ,diverse:2
efficient ,multi-epitope:2
efficient ,vaccine:2
efficient ,displaying:2
efficient ,interactions:2
efficient ,diverse:2
multi-epitope ,displaying:2
multi-epitope ,interactions:2
multi-epitope ,diverse:2
vaccine ,displaying:2
vaccine ,interactions:2
vaccine ,diverse:2
displaying ,interactions:2
displaying ,diverse:2
interactions ,diverse:2
virology ,diagnosis:2
virology ,in-line:2
virology ,treatment:2
pathogenesis ,diagnosis:6
pathogenesis ,in-line:2
diagnosis ,in-line:2
in-line ,treatment:2
in-line ,covid-19:2
cancer ,research:4
cancer ,pandemic:14
cancer ,systematic:6
patients ,research:2
research ,systematic:2
pandemic ,systematic:8
identification ,repurposed:2
identification ,human:4
repurposed ,inhibitor:2
repurposed ,spike:2
repurposed ,protein:2
repurposed ,human:2
drug ,inhibitor:2
drug ,protein:6
drug ,human:2
inhibitor ,spike:2
inhibitor ,protein:4
inhibitor ,human:2
high-fluorescent ,lymphocytes:2
high-fluorescent ,increased:2
high-fluorescent ,patients:2
high-fluorescent ,covid-19:2
lymphocytes ,increased:2
lymphocytes ,patients:2
lymphocytes ,covid-19:2
japanese ,case:2
japanese ,covid-19:6
japanese ,autopsy:2
japanese ,report:4
case ,autopsy:2
covid-19 ,autopsy:18
autopsy ,report:2
digestive ,involvement:4
digestive ,novel:2
digestive ,infection:2
digestive ,prevention:2
digestive ,control:2
system ,prevention:6
system ,control:4
involvement ,novel:6
involvement ,prevention:2
involvement ,control:2
novel ,control:4
approaches ,challenges:6
approaches ,vaccine:2
clinical ,observation:2
observation ,management:4
observation ,covid-19:4
observation ,patients:2
interaction ,spike:6
interaction ,protein:8
interaction ,similarity:2
spike ,similarity:2
protein ,rbd:2
protein ,similarity:2
rbd ,similarity:2
sars-cov-2 ,similarity:2
ace2 ,similarity:2
detection ,cat:2
detection ,owned:2
detection ,covid-19-affected:2
detection ,spain:2
sars-cov-2 ,owned:2
sars-cov-2 ,covid-19-affected:2
cat ,owned:2
cat ,covid-19-affected:2
cat ,patient:2
cat ,spain:2
owned ,covid-19-affected:2
owned ,patient:2
owned ,spain:2
covid-19-affected ,patient:2
covid-19-affected ,spain:2
patient ,spain:2
ibd ,time:2
ibd ,corona:2
ibd ,vigilance:2
ibd ,immune-mediated:2
ibd ,diseases:2
time ,corona:4
time ,vigilance:2
time ,immune-mediated:2
time ,diseases:2
corona ,vigilance:2
corona ,immune-mediated:2
corona ,diseases:2
vigilance ,immune-mediated:2
vigilance ,diseases:2
immune-mediated ,diseases:4
coronavirus ,sanitation:2
coronavirus ,worried:2
disease ,basic:4
disease ,sanitation:2
disease ,worried:2
basic ,sanitation:2
basic ,early:2
basic ,worried:2
sanitation ,early:2
sanitation ,worried:2
early ,worried:2
clinical ,identifies:2
analytical ,serological:2
analytical ,test:2
analytical ,identifies:2
performance ,identifies:2
automated ,serological:4
automated ,test:4
automated ,identifies:2
serological ,identifies:2
test ,identifies:2
covid-19 ,elderly:16
long-term ,care:10
long-term ,facilities:2
long-term ,elderly:2
long-term ,laboratory:4
long-term ,screening:2
care ,elderly:2
care ,laboratory:4
care ,screening:4
facilities ,elderly:2
facilities ,laboratory:2
facilities ,screening:2
elderly ,laboratory:2
elderly ,screening:2
laboratory ,screening:2
covid-19 ,consequences:26
ace2 ,cardiovascular:6
ace2 ,consequences:2
cardiovascular ,consequences:4
routine ,vaccinations:2
routine ,sars-cov-2:4
routine ,epidemics:2
vaccinations ,sars-cov-2:2
vaccinations ,epidemics:2
increased ,infection:4
increased ,staff:2
increased ,working:2
increased ,across:2
increased ,different:2
increased ,care:4
increased ,homes:2
risk ,working:2
risk ,across:8
risk ,different:4
risk ,homes:2
sars-cov-2 ,working:2
sars-cov-2 ,across:6
infection ,staff:4
infection ,working:2
infection ,across:6
staff ,working:2
staff ,across:2
staff ,different:2
staff ,care:4
staff ,homes:4
working ,across:2
working ,different:2
working ,care:2
working ,homes:2
across ,different:2
across ,care:2
across ,homes:2
different ,care:2
different ,homes:2
care ,homes:2
epidemiological ,prevalence:2
study ,features:10
prevalence ,features:2
molecular ,adp-ribose:2
molecular ,binding:6
molecular ,mac1:2
molecular ,domain:2
molecular ,nsp3:2
basis ,adp-ribose:2
basis ,binding:4
basis ,mac1:2
basis ,domain:2
basis ,nsp3:2
adp-ribose ,binding:2
adp-ribose ,mac1:2
adp-ribose ,domain:2
adp-ribose ,sars-cov-2:2
adp-ribose ,nsp3:2
binding ,mac1:2
binding ,nsp3:2
mac1 ,domain:2
mac1 ,sars-cov-2:2
mac1 ,nsp3:2
domain ,nsp3:2
first ,neonates:2
first ,severe:10
long-term ,conditions:4
conditions ,severe:2
conditions ,acute:2
conditions ,syndrome:2
covid-19 ,exist:2
associated ,myocarditis:2
associated ,exist:2
viral ,myocarditis:2
viral ,exist:2
myocarditis ,exist:2
specific ,risk:2
specific ,factors:2
specific ,transmission:2
specific ,health:2
specific ,care:2
specific ,workers:4
risk ,among:16
factors ,among:14
factors ,health:6
factors ,care:6
factors ,workers:6
transmission ,among:10
well ,infant:2
well ,coronavirus:2
well ,disease:2
well ,high:2
well ,viral:2
well ,load:2
infant ,disease:2
infant ,high:2
infant ,viral:2
infant ,load:2
coronavirus ,load:4
disease ,load:4
high ,load:4
every ,orthopaedic:2
every ,surgeon:2
every ,know:2
every ,covid-19:2
every ,review:2
every ,current:2
orthopaedic ,surgeon:2
orthopaedic ,know:2
orthopaedic ,covid-19:16
orthopaedic ,review:2
orthopaedic ,current:2
surgeon ,know:2
surgeon ,review:2
surgeon ,current:2
covid-19 ,official:2
italy ,considerations:2
italy ,official:2
italy ,data:2
considerations ,official:2
considerations ,data:2
official ,data:2
ace2 ,tmprss2:22
ace2 ,distribution:2
ace2 ,extrapulmonary:2
ace2 ,organ:6
ace2 ,patients:6
tmprss2 ,distribution:2
tmprss2 ,extrapulmonary:2
tmprss2 ,organ:2
tmprss2 ,injury:2
tmprss2 ,patients:2
distribution ,extrapulmonary:2
distribution ,organ:2
distribution ,injury:2
distribution ,patients:4
extrapulmonary ,organ:2
extrapulmonary ,injury:2
extrapulmonary ,patients:2
organ ,injury:2
organ ,patients:4
pharmacological ,hypothesis:2
pharmacological ,tpc2:2
pharmacological ,antagonist:2
pharmacological ,tetrandrine:2
hypothesis ,tpc2:2
hypothesis ,antagonist:2
hypothesis ,tetrandrine:2
hypothesis ,therapeutic:4
tpc2 ,antagonist:2
tpc2 ,tetrandrine:2
tpc2 ,potential:2
tpc2 ,therapeutic:2
antagonist ,tetrandrine:2
antagonist ,potential:2
antagonist ,therapeutic:2
tetrandrine ,potential:2
tetrandrine ,therapeutic:2
pathogenesis ,interferons:4
cytokine ,therapeutic:4
cytokine ,interferons:2
storm ,therapeutic:2
storm ,potential:2
storm ,interferons:2
therapeutic ,interferons:2
pregnancy ,viral:2
melatonin ,potential:4
melatonin ,adjuvant:4
melatonin ,improve:2
melatonin ,clinical:8
melatonin ,outcomes:2
melatonin ,individuals:2
potential ,adjuvant:8
potential ,improve:2
potential ,individuals:2
adjuvant ,improve:2
adjuvant ,clinical:2
adjuvant ,outcomes:2
adjuvant ,individuals:2
improve ,clinical:2
improve ,outcomes:2
improve ,individuals:2
clinical ,individuals:2
outcomes ,individuals:2
psychological ,experience:2
psychological ,obstetric:2
psychological ,patients:2
psychological ,care:2
psychological ,workers:4
experience ,obstetric:2
experience ,health:2
experience ,care:6
experience ,workers:2
obstetric ,health:2
obstetric ,care:6
obstetric ,workers:2
genome ,divergence:2
genome ,originating:2
composition ,divergence:4
composition ,novel:2
composition ,coronavirus:4
composition ,2019-ncov:2
composition ,originating:2
divergence ,novel:2
divergence ,coronavirus:4
divergence ,2019-ncov:2
divergence ,originating:2
novel ,originating:2
coronavirus ,originating:2
2019-ncov ,originating:2
covid-19 ,pre-pandemic:2
covid-19 ,commitment:2
covid-19 ,perceptions:8
pre-pandemic ,period:2
pre-pandemic ,survey:2
pre-pandemic ,time:2
pre-pandemic ,commitment:2
pre-pandemic ,perceptions:2
period ,survey:2
period ,time:2
period ,commitment:2
period ,perceptions:2
survey ,time:2
survey ,commitment:2
survey ,perceptions:2
time ,commitment:2
time ,perceptions:2
commitment ,perceptions:2
role ,self-reported:2
role ,smell:4
role ,taste:4
role ,disorders:4
role ,suspected:4
role ,covid19:2
self-reported ,smell:4
self-reported ,taste:4
self-reported ,disorders:2
self-reported ,suspected:2
self-reported ,covid19:2
smell ,suspected:2
smell ,covid19:2
taste ,suspected:2
taste ,covid19:2
disorders ,suspected:2
disorders ,covid19:2
suspected ,covid19:2
covid-19-associated ,apnea:2
covid-19-associated ,circumoral:2
covid-19-associated ,cyanosis:2
covid-19-associated ,3-week-old:2
apnea ,circumoral:2
apnea ,cyanosis:2
apnea ,3-week-old:2
circumoral ,cyanosis:2
circumoral ,3-week-old:2
cyanosis ,3-week-old:2
two ,serological:4
two ,approaches:2
two ,antibodies:6
two ,different:6
serological ,antibodies:8
approaches ,detection:2
approaches ,antibodies:2
approaches ,different:2
antibodies ,different:2
sars-cov-2 ,antibiotics:2
sars-cov-2 ,inflammasome:4
sars-cov-2 ,modulators:2
vs ,sars-cov-1:2
vs ,management:2
vs ,antibiotics:2
vs ,inflammasome:2
vs ,modulators:2
sars-cov-1 ,management:2
sars-cov-1 ,antibiotics:2
sars-cov-1 ,inflammasome:2
sars-cov-1 ,modulators:2
management ,antibiotics:2
management ,inflammasome:2
management ,modulators:2
antibiotics ,inflammasome:2
antibiotics ,modulators:2
inflammasome ,modulators:2
protein ,map:2
protein ,identifies:2
protein ,existing:2
protein ,drugs:2
interaction ,map:2
interaction ,identifies:2
interaction ,existing:2
map ,identifies:2
map ,existing:2
map ,drugs:2
map ,targeting:2
map ,sars-cov-2:2
identifies ,existing:4
identifies ,drugs:2
identifies ,targeting:2
identifies ,sars-cov-2:2
existing ,targeting:2
existing ,sars-cov-2:2
expansion ,sars-cov-2-specific:2
expansion ,antibody-secreting:2
expansion ,cells:4
expansion ,generation:2
sars-cov-2-specific ,antibody-secreting:2
sars-cov-2-specific ,generation:2
antibody-secreting ,cells:2
antibody-secreting ,generation:2
cells ,generation:2
remdesivir ,gs-5734:6
remdesivir ,therapeutic:4
remdesivir ,option:2
remdesivir ,2019-ncov:2
remdesivir ,main:2
remdesivir ,protease:2
remdesivir ,silico:2
gs-5734 ,therapeutic:4
gs-5734 ,option:2
gs-5734 ,2019-ncov:2
gs-5734 ,main:2
gs-5734 ,protease:2
gs-5734 ,silico:2
therapeutic ,main:2
therapeutic ,protease:2
therapeutic ,silico:4
option ,main:2
option ,protease:2
option ,silico:2
2019-ncov ,main:2
main ,silico:14
protease ,silico:6
surgical ,diabetic:4
surgical ,foot:4
surgical ,ulcers:4
surgical ,covid-19:28
surgical ,pandemic:16
surgical ,china:4
treatment ,diabetic:4
treatment ,foot:4
treatment ,ulcers:4
diabetic ,foot:4
diabetic ,ulcers:4
diabetic ,pandemic:4
diabetic ,china:4
foot ,ulcers:4
foot ,covid-19:4
foot ,pandemic:4
foot ,china:4
ulcers ,covid-19:4
ulcers ,pandemic:4
ulcers ,china:4
creutzfeldt-jakob ,disease:2
creutzfeldt-jakob ,man:2
creutzfeldt-jakob ,covid-19:2
creutzfeldt-jakob ,sars-cov-2-accelerated:2
disease ,sars-cov-2-accelerated:2
man ,covid-19:6
man ,sars-cov-2-accelerated:2
covid-19 ,sars-cov-2-accelerated:2
covid-19 ,infants-low:2
covid-19 ,silver:6
covid-19 ,lining:6
newborns ,infants-low:2
newborns ,severe:2
newborns ,silver:2
newborns ,lining:2
newborns ,dark:2
infants-low ,risk:2
infants-low ,severe:2
infants-low ,disease:2
infants-low ,silver:2
infants-low ,lining:2
infants-low ,dark:2
risk ,silver:2
risk ,lining:2
risk ,dark:2
severe ,silver:2
severe ,lining:2
severe ,dark:2
disease ,silver:2
disease ,lining:2
disease ,dark:2
silver ,lining:6
silver ,dark:4
lining ,dark:4
dynamic ,chest:2
dynamic ,ct:2
dynamic ,evaluation:2
dynamic ,three:2
dynamic ,cases:2
dynamic ,novel:2
dynamic ,pneumonia:2
chest ,evaluation:6
chest ,three:2
chest ,cases:2
chest ,novel:4
chest ,coronavirus:22
ct ,evaluation:6
ct ,three:4
evaluation ,cases:4
evaluation ,pneumonia:4
three ,novel:2
three ,coronavirus:2
neurotropism ,presenting:2
neurotropism ,acute:2
neurotropism ,manic:2
neurotropism ,episode:2
sars-cov-2 ,presenting:8
sars-cov-2 ,manic:2
sars-cov-2 ,episode:2
covid-19 ,manic:2
covid-19 ,episode:2
presenting ,manic:2
presenting ,episode:2
immunosuppressive ,status:2
immunosuppressive ,affecting:2
immunosuppressive ,children:2
immunosuppressive ,adults:2
immunosuppressive ,sars-cov-2:6
status ,affecting:2
status ,adults:2
affecting ,children:2
affecting ,adults:2
affecting ,sars-cov-2:4
children ,adults:14
presentation ,known:2
presentation ,community-transmitted:2
diagnosis ,known:2
diagnosis ,community-transmitted:2
first ,known:6
first ,community-transmitted:2
known ,community-transmitted:2
known ,case:2
community-transmitted ,case:2
brain ,abnormalities:2
brain ,covid-19:18
brain ,acutesubacute:2
brain ,phase:2
brain ,rapid:2
brain ,systematic:2
brain ,review:2
abnormalities ,covid-19:6
abnormalities ,acutesubacute:2
abnormalities ,phase:2
abnormalities ,rapid:2
abnormalities ,systematic:2
abnormalities ,review:4
covid-19 ,acutesubacute:2
acutesubacute ,phase:2
acutesubacute ,rapid:2
acutesubacute ,systematic:2
acutesubacute ,review:2
phase ,rapid:2
phase ,systematic:2
phase ,review:4
rapid ,systematic:4
sars-cov-2 ,cytokines:2
infection ,cytokines:2
role ,cytokines:2
cytokines ,covid-19:6
cytokines ,disease:4
will ,children:4
will ,reveal:4
will ,secret:4
will ,dilemma:4
children ,reveal:4
children ,secret:4
children ,dilemma:4
reveal ,secret:4
reveal ,coronavirus:4
reveal ,dilemma:4
secret ,coronavirus:4
secret ,dilemma:4
coronavirus ,dilemma:4
covid-19 ,ms:4
covid-19 ,disease-modifying:4
ms ,disease-modifying:2
ms ,therapies:2
disease-modifying ,therapies:2
epitope-based ,immunoinformatics:2
epitope-based ,approach:2
epitope-based ,nucleocapsid:2
epitope-based ,protein:2
immunoinformatics ,nucleocapsid:2
immunoinformatics ,protein:2
immunoinformatics ,severe:2
immunoinformatics ,acute:2
approach ,nucleocapsid:2
approach ,protein:2
approach ,severe:2
approach ,acute:2
nucleocapsid ,acute:4
update ,particular:2
update ,reference:2
sars-cov-2covid-19 ,particular:2
sars-cov-2covid-19 ,reference:2
sars-cov-2covid-19 ,clinical:2
particular ,reference:2
particular ,clinical:2
reference ,clinical:2
clinical ,demographic:4
clinical ,sporadic:2
demographic ,characteristics:2
demographic ,cluster:2
demographic ,cases:2
demographic ,sporadic:2
characteristics ,sporadic:2
cluster ,sporadic:2
cases ,sporadic:2
computational ,target-based:2
computational ,drug:10
computational ,repurposing:8
computational ,elbasvir:2
computational ,antiviral:2
computational ,predicted:2
target-based ,drug:4
target-based ,repurposing:2
target-based ,elbasvir:2
target-based ,antiviral:2
target-based ,predicted:2
drug ,elbasvir:2
repurposing ,elbasvir:2
repurposing ,predicted:2
elbasvir ,antiviral:2
elbasvir ,predicted:2
antiviral ,predicted:2
covid-19 ,design:6
covid-19 ,reverse:4
covid-19 ,vaccinology:2
coronavirus ,vaccinology:2
coronavirus ,machine:2
coronavirus ,learning:4
vaccine ,machine:2
vaccine ,learning:2
design ,reverse:2
design ,vaccinology:2
design ,learning:2
using ,vaccinology:2
using ,machine:4
reverse ,machine:2
reverse ,learning:2
vaccinology ,machine:2
vaccinology ,learning:2
universal ,serial:2
universal ,laboratory:4
universal ,testing:10
universal ,long-term:2
universal ,care:2
universal ,skilled:2
serial ,laboratory:2
serial ,testing:4
serial ,long-term:2
serial ,care:2
serial ,skilled:2
laboratory ,skilled:2
testing ,long-term:2
testing ,care:10
testing ,skilled:2
sars-cov-2 ,skilled:4
long-term ,skilled:2
care ,skilled:2
network ,controllability-based:2
network ,prioritization:2
network ,candidates:2
network ,drug:2
controllability-based ,prioritization:2
controllability-based ,candidates:2
controllability-based ,sars-cov-2:2
controllability-based ,drug:2
prioritization ,candidates:2
prioritization ,sars-cov-2:2
prioritization ,drug:2
rapid ,setting:2
rapid ,shows:2
point-of-care ,community:2
point-of-care ,screening:2
point-of-care ,setting:2
point-of-care ,shows:2
testing ,setting:2
sars-cov-2 ,setting:4
community ,screening:6
community ,setting:2
community ,shows:2
screening ,setting:2
screening ,shows:2
setting ,shows:2
sars-cov-2 ,bystander:2
sars-cov-2 ,culprit:2
kidney ,bystander:2
kidney ,culprit:2
bystander ,culprit:4
link ,course:2
link ,infection:4
link ,pharmacological:2
link ,agents:2
course ,pharmacological:2
course ,agents:2
infection ,pharmacological:4
infection ,agents:2
pharmacological ,agents:6
coronavirus ,multiple:4
coronavirus ,simultaneous:2
coronavirus ,intracerebral:2
disease ,complicated:6
disease ,multiple:4
disease ,simultaneous:2
disease ,intracerebral:2
complicated ,multiple:2
complicated ,simultaneous:2
complicated ,intracerebral:2
multiple ,simultaneous:4
multiple ,intracerebral:2
simultaneous ,intracerebral:2
multiple ,real-time:2
multiple ,rt-pcr:2
multiple ,panel:4
multiple ,can:2
multiple ,mitigate:2
multiple ,risk:2
multiple ,loss:2
assays ,rt-pcr:2
assays ,panel:2
assays ,can:2
assays ,mitigate:2
assays ,risk:2
assays ,loss:2
real-time ,can:2
real-time ,mitigate:2
real-time ,risk:2
real-time ,loss:2
rt-pcr ,panel:2
rt-pcr ,mitigate:2
rt-pcr ,risk:2
rt-pcr ,loss:2
sars-cov-2 ,mitigate:6
panel ,can:2
panel ,mitigate:2
panel ,risk:2
panel ,loss:2
can ,mitigate:2
can ,loss:2
mitigate ,risk:2
mitigate ,loss:2
risk ,loss:2
case ,italian:4
fatality ,analysis:4
fatality ,italian:2
fatality ,outbreak:2
rate ,italian:2
rate ,outbreak:2
analysis ,italian:4
serial ,virus:2
serial ,whole:2
serial ,genome:2
serial ,sequencing:2
serial ,inform:2
serial ,infection:2
testing ,virus:2
testing ,whole:2
testing ,genome:2
testing ,sequencing:2
testing ,inform:2
sars-cov-2 ,inform:2
virus ,genome:2
virus ,inform:2
whole ,inform:2
whole ,infection:2
genome ,inform:2
genome ,infection:2
sequencing ,inform:2
sequencing ,infection:2
inform ,infection:2
brainstem ,involvement:2
brainstem ,respiratory:2
brainstem ,failure:2
brainstem ,covid-19:2
involvement ,failure:2
development ,lateral:6
development ,flow:6
development ,strip:4
development ,membrane:2
development ,sensitive:6
lateral ,strip:4
lateral ,membrane:2
lateral ,assay:8
lateral ,sensitive:2
flow ,strip:4
flow ,membrane:2
flow ,assay:8
flow ,sensitive:2
strip ,membrane:2
strip ,assay:2
strip ,rapid:4
strip ,sensitive:2
strip ,detection:4
membrane ,assay:2
membrane ,rapid:2
membrane ,sensitive:2
membrane ,detection:2
assay ,sensitive:2
bibliometric ,using:2
bibliometric ,vosviewer:2
analysis ,vosviewer:2
analysis ,publications:2
using ,vosviewer:2
using ,publications:2
vosviewer ,publications:2
vosviewer ,covid-19:2
prevention ,protection:2
prevention ,healthcare:8
prevention ,workers:2
prevention ,exposed:2
protection ,measures:4
protection ,healthcare:8
protection ,workers:8
protection ,exposed:2
measures ,healthcare:4
measures ,workers:2
measures ,exposed:2
sars-cov-2 ,deconfinement:2
seroprevalence ,key:2
seroprevalence ,factor:2
seroprevalence ,deconfinement:2
seroprevalence ,france:2
key ,factor:2
key ,deconfinement:2
key ,france:2
factor ,deconfinement:2
factor ,france:2
deconfinement ,france:2
diagnostic ,serial:2
diagnostic ,interval:2
diagnostic ,indicator:2
diagnostic ,contact:2
diagnostic ,tracing:2
diagnostic ,effectiveness:2
serial ,novel:4
serial ,indicator:2
serial ,contact:2
serial ,tracing:2
serial ,effectiveness:2
interval ,novel:2
interval ,indicator:2
interval ,contact:2
interval ,tracing:2
interval ,effectiveness:2
novel ,contact:2
novel ,tracing:2
novel ,effectiveness:4
indicator ,contact:2
indicator ,tracing:2
indicator ,effectiveness:2
contact ,effectiveness:2
tracing ,effectiveness:2
can ,metabolism-targeted:2
can ,therapeutic:2
can ,intervention:2
can ,successfully:4
can ,subjugate:2
metabolism-targeted ,therapeutic:2
metabolism-targeted ,intervention:2
metabolism-targeted ,successfully:2
metabolism-targeted ,subjugate:2
therapeutic ,successfully:2
therapeutic ,subjugate:2
intervention ,successfully:2
intervention ,subjugate:2
successfully ,subjugate:2
cutaneous ,due:2
cutaneous ,infectioncovid-19:2
manifestations ,due:2
manifestations ,infectioncovid-19:2
due ,infectioncovid-19:2
sars-cov-2 ,infectioncovid-19:4
sars-cov-2 ,induces:8
sars-cov-2 ,kawasaki-like:4
induces ,covid-19:4
induces ,causes:2
induces ,kawasaki-like:2
induces ,disease:2
induces ,children:2
induces ,role:2
covid-19 ,kawasaki-like:6
causes ,kawasaki-like:2
causes ,disease:2
causes ,children:2
causes ,role:2
kawasaki-like ,role:2
children ,role:4
human ,interface:2
human ,transmission:10
human ,critical:4
human ,appraisal:2
animal ,interface:2
animal ,covid-19:8
animal ,transmission:2
animal ,critical:2
animal ,appraisal:2
interface ,sars-cov-2:4
interface ,covid-19:2
interface ,transmission:2
interface ,critical:2
interface ,appraisal:2
sars-cov-2 ,critical:18
sars-cov-2 ,appraisal:2
covid-19 ,appraisal:2
transmission ,appraisal:2
critical ,appraisal:2
characteristics ,current:2
characteristics ,advances:2
characteristics ,research:4
role ,cyclophilin:2
role ,replication:4
role ,antiviral:2
role ,activities:2
cyclophilin ,coronavirus:2
cyclophilin ,replication:2
cyclophilin ,antiviral:2
cyclophilin ,activities:2
coronavirus ,activities:2
replication ,antiviral:2
replication ,activities:2
practice ,oral:2
practice ,maxillofacial:2
practice ,radiology:2
practice ,outbreak:2
oral ,radiology:2
oral ,outbreak:2
maxillofacial ,radiology:2
maxillofacial ,covid-19:6
maxillofacial ,outbreak:2
radiology ,covid-19:6
radiology ,outbreak:2
covid-19-related ,cardiovascular:2
covid-19-related ,practical:2
covid-19-related ,considerations:2
cardiovascular ,practical:2
pro- ,anti-inflammatory:2
pro- ,responses:2
pro- ,severe:2
pro- ,covid-19-induced:2
pro- ,acute:2
pro- ,respiratory:2
anti-inflammatory ,responses:2
anti-inflammatory ,severe:2
anti-inflammatory ,covid-19-induced:2
anti-inflammatory ,acute:2
anti-inflammatory ,respiratory:2
responses ,covid-19-induced:2
severe ,covid-19-induced:2
covid-19-induced ,acute:2
covid-19-induced ,respiratory:2
paintings ,spains:2
paintings ,covid-19:2
paintings ,pandemic:2
spains ,covid-19:2
spains ,pandemic:2
neurological ,mechanisms:4
manifestations ,severe:6
manifestations ,mechanisms:4
severe ,mechanisms:2
meta-analysis ,impact:4
meta-analysis ,liver:4
meta-analysis ,dysfunction:2
impact ,dysfunction:2
liver ,dysfunction:6
modeling ,impact:2
modeling ,word:2
modeling ,mouth:2
modeling ,e-government:2
modeling ,online:2
modeling ,social:2
modeling ,presence:2
impact ,word:2
impact ,mouth:2
impact ,e-government:2
impact ,online:6
impact ,presence:2
word ,mouth:2
word ,e-government:2
word ,online:2
word ,social:2
word ,presence:2
mouth ,e-government:2
mouth ,online:2
mouth ,social:2
mouth ,presence:2
e-government ,online:2
e-government ,social:2
e-government ,presence:2
online ,social:2
online ,presence:2
social ,presence:2
get ,short:2
get ,history:2
get ,covid-19:6
get ,coronavirus-related:2
short ,history:2
short ,covid-19:8
short ,coronavirus-related:2
history ,coronavirus-related:2
covid-19 ,coronavirus-related:2
growth ,hormone:2
growth ,insufficiency:2
growth ,missing:2
growth ,link:2
growth ,obesity:2
growth ,male:2
growth ,gender:2
growth ,age:2
hormone ,insufficiency:2
hormone ,missing:2
hormone ,link:2
hormone ,obesity:2
hormone ,male:2
hormone ,gender:2
hormone ,age:2
insufficiency ,missing:2
insufficiency ,link:2
insufficiency ,obesity:2
insufficiency ,male:2
insufficiency ,gender:2
insufficiency ,age:2
missing ,link:6
missing ,obesity:4
missing ,male:2
missing ,gender:2
missing ,age:2
link ,obesity:8
link ,male:2
link ,gender:2
link ,age:2
obesity ,male:4
obesity ,gender:2
obesity ,age:2
male ,gender:4
male ,age:4
gender ,age:4
cotton-tipped ,plastic:2
cotton-tipped ,swabs:2
cotton-tipped ,sars-cov-2:2
cotton-tipped ,rt-qpcr:2
cotton-tipped ,diagnosis:2
cotton-tipped ,prevent:2
cotton-tipped ,supply:2
plastic ,swabs:2
plastic ,sars-cov-2:4
plastic ,rt-qpcr:2
plastic ,diagnosis:2
plastic ,prevent:2
plastic ,supply:2
swabs ,rt-qpcr:2
swabs ,prevent:2
swabs ,supply:2
sars-cov-2 ,supply:4
rt-qpcr ,diagnosis:2
rt-qpcr ,prevent:2
rt-qpcr ,supply:2
diagnosis ,prevent:2
diagnosis ,supply:2
prevent ,supply:2
rna ,wards:2
rna ,hygiene:2
detection ,isolation:4
detection ,wards:2
detection ,hygiene:2
hospital ,isolation:2
hospital ,wards:2
hospital ,hygiene:2
isolation ,wards:2
isolation ,hygiene:4
isolation ,monitoring:2
wards ,hygiene:2
wards ,monitoring:2
hygiene ,monitoring:2
putative ,roles:4
putative ,peptidylarginine:2
putative ,deiminases:2
putative ,covid-19:4
roles ,peptidylarginine:2
roles ,deiminases:2
peptidylarginine ,deiminases:2
peptidylarginine ,covid-19:2
deiminases ,covid-19:2
white ,paper:2
white ,ivermectin:2
white ,potential:2
white ,therapy:2
white ,covid-19:4
paper ,ivermectin:2
paper ,potential:2
paper ,therapy:2
paper ,covid-19:6
ivermectin ,therapy:2
microfluidic ,immunoassays:2
microfluidic ,sensitive:2
microfluidic ,simultaneous:2
microfluidic ,detection:2
immunoassays ,sensitive:2
immunoassays ,simultaneous:2
sensitive ,simultaneous:2
simultaneous ,detection:2
current ,state:8
current ,antivirals:4
current ,gene:2
future ,state:2
future ,vaccines:2
future ,antivirals:4
future ,gene:2
future ,therapies:4
state ,vaccines:2
state ,antivirals:2
state ,gene:2
vaccines ,antivirals:2
vaccines ,gene:2
antivirals ,gene:2
antivirals ,therapies:2
gene ,therapies:2
vascular ,endothelium:2
vascular ,cornerstone:2
vascular ,organ:2
vascular ,severe:2
vascular ,sars-cov-2:6
endothelium ,cornerstone:2
endothelium ,organ:2
endothelium ,dysfunction:2
endothelium ,severe:2
endothelium ,sars-cov-2:2
cornerstone ,organ:2
cornerstone ,dysfunction:2
cornerstone ,severe:2
cornerstone ,sars-cov-2:2
organ ,dysfunction:2
organ ,severe:2
dysfunction ,severe:4
multi-center ,evaluation:2
multi-center ,cepheid:2
multi-center ,xpert:2
multi-center ,xpress:2
multi-center ,sars-cov-2:2
multi-center ,point-of-care:2
multi-center ,test:2
evaluation ,cepheid:4
evaluation ,xpert:4
evaluation ,xpress:4
cepheid ,sars-cov-2:4
cepheid ,point-of-care:2
cepheid ,test:4
xpert ,sars-cov-2:4
xpert ,point-of-care:2
xpert ,test:4
xpress ,point-of-care:2
xpress ,test:4
point-of-care ,test:4
sars-cov-2 ,predicts:6
viral ,predicts:2
viral ,mortality:2
viral ,without:2
viral ,cancer:2
load ,predicts:2
load ,mortality:2
load ,without:2
load ,cancer:2
predicts ,mortality:2
predicts ,without:2
predicts ,cancer:2
mortality ,without:4
mortality ,cancer:10
patients ,without:6
without ,cancer:4
covid-19-positive ,mothers:2
covid-19-positive ,dangerous:2
covid-19-positive ,term:2
covid-19-positive ,well:2
covid-19-positive ,newborn:2
covid-19-positive ,babies:2
mothers ,dangerous:2
mothers ,well:2
mothers ,newborn:2
mothers ,babies:2
dangerous ,term:2
dangerous ,well:2
dangerous ,newborn:2
dangerous ,babies:2
term ,well:2
term ,newborn:2
term ,babies:2
well ,newborn:2
well ,babies:2
newborn ,babies:2
polycythemia ,sars-cov-2:2
polycythemia ,positive:2
polycythemia ,patients:2
polycythemia ,early:2
polycythemia ,screening:2
polycythemia ,marker:2
sars-cov-2 ,marker:2
positive ,early:2
positive ,screening:2
positive ,marker:2
patients ,screening:6
early ,marker:2
screening ,marker:2
obstetric ,anesthesia:6
obstetric ,pandemic:6
obstetric ,brief:2
obstetric ,overview:2
obstetric ,published:2
anesthesia ,sars-cov-2:4
anesthesia ,pandemic:4
anesthesia ,brief:2
anesthesia ,overview:2
anesthesia ,published:2
pandemic ,published:2
brief ,published:2
overview ,published:2
comparison ,laboratory:6
comparison ,developed:2
commercial ,laboratory:2
commercial ,developed:2
assays ,developed:2
assays ,tests:2
laboratory ,developed:2
developed ,tests:4
developed ,detection:2
guarantee ,best:2
guarantee ,care:2
guarantee ,patients:2
guarantee ,cancer:2
guarantee ,covid-19:2
best ,care:2
best ,patients:2
best ,cancer:2
preliminary ,occurrence:2
preliminary ,wastewater:2
preliminary ,czech:2
preliminary ,republic:2
study ,occurrence:2
study ,czech:2
study ,republic:2
sars-cov-2 ,czech:2
sars-cov-2 ,republic:2
occurrence ,czech:2
occurrence ,republic:2
wastewater ,czech:2
wastewater ,republic:2
czech ,republic:2
comparison ,serum:2
test ,commercial:4
test ,anti-sars-cov-2:2
test ,immunoassays:2
test ,serum:2
performance ,commercial:4
performance ,anti-sars-cov-2:2
performance ,serum:2
commercial ,anti-sars-cov-2:2
commercial ,immunoassays:4
commercial ,serum:2
anti-sars-cov-2 ,immunoassays:2
anti-sars-cov-2 ,serum:2
immunoassays ,serum:2
computational ,inference:2
computational ,selection:2
computational ,underlying:2
computational ,evolution:2
computational ,novel:2
inference ,selection:2
inference ,underlying:2
inference ,evolution:4
inference ,novel:2
selection ,underlying:2
selection ,evolution:2
selection ,novel:2
underlying ,evolution:2
underlying ,novel:2
insight ,asymptomatic:2
insight ,infection:4
insight ,transmission:2
severe ,pre-eclampsia:2
severe ,complicated:6
severe ,fatty:2
severe ,hellp:2
pre-eclampsia ,complicated:2
pre-eclampsia ,acute:2
pre-eclampsia ,fatty:2
pre-eclampsia ,liver:2
pre-eclampsia ,disease:2
pre-eclampsia ,pregnancy:2
pre-eclampsia ,hellp:2
complicated ,acute:6
complicated ,fatty:2
complicated ,liver:4
complicated ,pregnancy:4
complicated ,hellp:2
acute ,fatty:2
acute ,pregnancy:6
acute ,hellp:2
fatty ,liver:4
fatty ,disease:4
fatty ,pregnancy:2
fatty ,hellp:2
liver ,pregnancy:4
liver ,hellp:2
disease ,hellp:2
pregnancy ,hellp:2
clinical ,asymptomatic:18
clinical ,mildly:2
course ,asymptomatic:8
course ,mildly:2
course ,symptomatic:2
symptomatic ,coronavirus:6
echocardiography ,front-line:2
echocardiography ,perspective:2
echocardiography ,expanding:2
echocardiography ,ultrasound:2
pandemic ,front-line:4
pandemic ,expanding:2
pandemic ,ultrasound:6
front-line ,perspective:2
front-line ,expanding:2
front-line ,role:2
front-line ,ultrasound:2
perspective ,expanding:2
perspective ,role:4
perspective ,ultrasound:2
expanding ,role:2
expanding ,ultrasound:2
role ,ultrasound:4
oxidative ,stress:8
oxidative ,key:2
oxidative ,player:2
oxidative ,severe:2
oxidative ,acute:2
oxidative ,respiratory:2
oxidative ,syndrome:2
oxidative ,coronavirus:2
stress ,key:2
stress ,player:2
stress ,severe:2
stress ,acute:2
stress ,respiratory:2
stress ,syndrome:2
stress ,coronavirus:2
key ,player:4
key ,acute:2
key ,respiratory:2
key ,syndrome:2
player ,severe:2
player ,acute:4
player ,respiratory:2
player ,syndrome:2
player ,coronavirus:2
interleukin-6 ,blockade:4
interleukin-6 ,treatment:4
interleukin-6 ,associated:2
interleukin-6 ,cytokine:2
interleukin-6 ,release:2
interleukin-6 ,syndrome:2
blockade ,treatment:2
blockade ,covid-19:4
blockade ,associated:2
blockade ,cytokine:2
blockade ,release:2
blockade ,syndrome:2
treatment ,release:2
associated ,cytokine:8
associated ,release:2
cytokine ,release:8
release ,syndrome:6
burden ,risk:2
burden ,assessment:2
burden ,surveillance:2
burden ,management:4
burden ,sars-cov-2:2
burden ,infection:2
risk ,surveillance:2
assessment ,surveillance:2
assessment ,management:4
assessment ,infection:14
ace2 ,much:2
ace2 ,just:2
much ,just:2
much ,receptor:2
just ,receptor:2
just ,sars-cov-2:2
cellular ,nanosponges:2
cellular ,inhibit:2
cellular ,infectivity:2
nanosponges ,inhibit:2
nanosponges ,sars-cov-2:2
nanosponges ,infectivity:2
inhibit ,infectivity:2
decrease ,non-classical:2
decrease ,intermediate:2
decrease ,monocyte:2
decrease ,subsets:2
decrease ,severe:2
decrease ,acute:2
non-classical ,intermediate:2
non-classical ,monocyte:2
non-classical ,subsets:2
non-classical ,severe:2
non-classical ,acute:2
intermediate ,monocyte:2
intermediate ,subsets:2
intermediate ,severe:2
intermediate ,acute:2
monocyte ,subsets:2
monocyte ,severe:2
monocyte ,acute:2
subsets ,severe:2
subsets ,acute:2
study ,infectivity:2
study ,carriers:2
infectivity ,asymptomatic:2
infectivity ,carriers:2
assessing ,oligonucleotide:2
assessing ,designs:2
assessing ,early:2
assessing ,lab:2
assessing ,developed:2
assessing ,pcr:2
assessing ,diagnostic:2
assessing ,tests:2
oligonucleotide ,designs:2
oligonucleotide ,early:2
oligonucleotide ,lab:2
oligonucleotide ,developed:2
oligonucleotide ,pcr:2
oligonucleotide ,diagnostic:2
oligonucleotide ,tests:2
designs ,early:2
designs ,lab:2
designs ,developed:2
designs ,pcr:2
designs ,diagnostic:2
designs ,tests:2
early ,lab:2
early ,developed:2
early ,pcr:2
early ,diagnostic:2
early ,tests:2
lab ,developed:2
lab ,pcr:2
lab ,diagnostic:2
lab ,tests:2
developed ,pcr:2
developed ,diagnostic:2
respiratory ,dysfunction:2
respiratory ,presentation:4
respiratory ,myasthenia:2
respiratory ,gravis:2
respiratory ,misdiagnosed:2
dysfunction ,first:2
dysfunction ,presentation:2
dysfunction ,myasthenia:2
dysfunction ,gravis:2
dysfunction ,misdiagnosed:2
first ,myasthenia:2
first ,gravis:2
first ,misdiagnosed:2
presentation ,myasthenia:2
presentation ,gravis:2
presentation ,misdiagnosed:2
myasthenia ,gravis:2
myasthenia ,misdiagnosed:2
gravis ,misdiagnosed:2
elevated ,monocyte:2
elevated ,distribution:2
elevated ,width:2
elevated ,covid-19:8
elevated ,patients:4
elevated ,contribution:2
monocyte ,distribution:2
monocyte ,width:2
monocyte ,covid-19:2
monocyte ,patients:4
monocyte ,contribution:2
distribution ,width:2
distribution ,contribution:2
width ,covid-19:2
width ,patients:2
width ,contribution:2
covid-19 ,contribution:6
acute ,treated:4
acute ,surgical:4
acute ,embolectomy:2
pulmonary ,treated:2
pulmonary ,embolectomy:2
embolism ,sars-cov-2:2
embolism ,infection:2
embolism ,treated:2
embolism ,surgical:2
embolism ,embolectomy:2
sars-cov-2 ,embolectomy:2
infection ,embolectomy:2
treated ,surgical:2
treated ,embolectomy:2
surgical ,embolectomy:2
anxiety ,depression:6
anxiety ,symptoms:2
anxiety ,pregnant:2
anxiety ,women:2
depression ,symptoms:2
depression ,pregnant:2
depression ,women:2
symptoms ,pregnant:2
symptoms ,women:2
geographical ,profiles:2
geographical ,outbreak:2
geographical ,tokyo:2
geographical ,analysis:2
geographical ,primary:2
geographical ,care:2
profiles ,covid-19:6
profiles ,outbreak:2
profiles ,tokyo:2
profiles ,analysis:2
profiles ,primary:2
profiles ,care:2
covid-19 ,tokyo:2
covid-19 ,primary:12
outbreak ,tokyo:2
outbreak ,primary:2
tokyo ,analysis:2
tokyo ,primary:2
tokyo ,care:2
analysis ,primary:2
patients ,bowel:14
inflammatory ,bowel:24
inflammatory ,increased:2
inflammatory ,risk:2
bowel ,disease:24
bowel ,increased:2
bowel ,risk:2
disease ,increased:4
characteristics ,comorbid:2
laboratory ,comorbid:2
laboratory ,diabetes:2
findings ,comorbid:2
findings ,diabetes:4
covid-19 ,comorbid:2
patients ,comorbid:2
comorbid ,diabetes:2
pharmacological ,development:2
pharmacological ,direct:2
pharmacological ,acting:2
pharmacological ,emerging:2
pharmacological ,needed:2
pharmacological ,therapy:2
development ,direct:2
development ,acting:2
development ,agents:4
development ,emerging:2
development ,needed:2
development ,therapy:2
direct ,acting:2
direct ,agents:2
direct ,emerging:2
direct ,needed:2
direct ,therapy:2
acting ,agents:4
acting ,emerging:2
acting ,needed:2
acting ,therapy:4
agents ,emerging:2
agents ,needed:2
agents ,therapy:4
emerging ,needed:2
emerging ,therapy:4
needed ,therapy:2
face ,radiation:2
face ,oncology:2
face ,clinics:2
face ,based:2
face ,evidence:2
face ,source:2
face ,mistakes:2
masks ,radiation:2
masks ,oncology:2
masks ,clinics:2
masks ,based:2
masks ,evidence:2
masks ,source:2
masks ,mistakes:2
radiation ,clinics:2
radiation ,based:2
radiation ,evidence:2
radiation ,source:2
radiation ,mistakes:2
oncology ,clinics:2
oncology ,based:2
oncology ,evidence:2
oncology ,source:2
oncology ,mistakes:2
clinics ,based:2
clinics ,evidence:2
clinics ,source:2
clinics ,mistakes:2
based ,source:2
based ,mistakes:2
evidence ,source:2
evidence ,mistakes:2
source ,mistakes:2
laboratory ,mini-review:2
diagnosis ,mini-review:2
covid-19 ,mini-review:6
cluster ,among:2
cluster ,italian:2
cluster ,tourists:2
cluster ,visiting:2
cluster ,india:2
cluster ,march:2
sars-cov-2 ,tourists:2
sars-cov-2 ,visiting:2
sars-cov-2 ,march:8
infection ,italian:6
infection ,tourists:2
infection ,visiting:2
infection ,march:2
among ,italian:4
among ,tourists:2
among ,visiting:2
italian ,tourists:2
italian ,visiting:2
italian ,india:2
italian ,march:2
tourists ,visiting:2
tourists ,india:2
tourists ,march:2
visiting ,india:2
visiting ,march:2
india ,march:2
coronavirus ,fatality:2
coronavirus ,perception:2
coronavirus ,us:2
coronavirus ,adult:2
coronavirus ,residents:2
covid-19 ,perception:8
fatality ,perception:2
fatality ,us:4
fatality ,adult:2
fatality ,residents:2
fatality ,march:2
risk ,perception:10
risk ,us:4
risk ,adult:2
risk ,residents:2
risk ,march:4
perception ,us:2
perception ,adult:2
perception ,residents:2
perception ,march:2
us ,adult:2
us ,residents:2
us ,march:2
adult ,residents:2
adult ,march:2
residents ,march:2
patients ,hbv:2
patients ,greater:2
sars-cov-2 ,hbv:2
sars-cov-2 ,greater:6
hbv ,co-infection:2
hbv ,risk:2
hbv ,greater:2
hbv ,liver:2
hbv ,injury:2
co-infection ,risk:2
co-infection ,greater:2
co-infection ,liver:2
co-infection ,injury:2
risk ,greater:4
risk ,liver:4
greater ,liver:2
greater ,injury:2
oral ,saliva:2
covid-19 ,icu:8
need ,icu:2
need ,delirium:2
know ,icu:2
know ,delirium:2
icu ,delirium:4
icu ,pandemic:4
delirium ,sars-cov-2:4
delirium ,pandemic:4
corona ,versus:2
corona ,existence:2
corona ,human:2
corona ,earth:2
corona ,computational:2
corona ,biophysical:2
virus ,existence:2
virus ,earth:2
virus ,computational:2
virus ,biophysical:2
versus ,existence:2
versus ,human:2
versus ,earth:2
versus ,computational:2
versus ,biophysical:2
existence ,human:4
existence ,earth:2
existence ,computational:2
existence ,biophysical:2
human ,earth:2
human ,computational:4
human ,biophysical:2
earth ,computational:2
earth ,biophysical:2
computational ,biophysical:2
design ,engineered:4
design ,ace2:2
design ,therapeutics:2
engineered ,ace2:2
engineered ,novel:2
engineered ,therapeutics:2
engineered ,covid-19:2
ace2 ,novel:2
safe ,tracheotomy:2
safe ,patients:6
tracheotomy ,patients:4
tracheotomy ,covid-19:8
transmission ,ventilation:2
transmission ,environments:2
transmission ,technical:2
transmission ,notes:2
sars-cov-2 ,ventilation:2
sars-cov-2 ,environments:2
sars-cov-2 ,notes:2
ventilation ,indoor:4
ventilation ,environments:2
ventilation ,technical:2
ventilation ,notes:2
indoor ,environments:2
indoor ,technical:2
indoor ,notes:2
environments ,technical:2
environments ,notes:2
technical ,notes:2
covid-19 ,switzerland:4
covid-19 ,importance:18
covid-19 ,contact:10
covid-19 ,tracing:6
epidemic ,switzerland:2
epidemic ,importance:2
epidemic ,contact:2
epidemic ,tracing:2
switzerland ,importance:2
switzerland ,testing:2
switzerland ,contact:2
switzerland ,tracing:2
importance ,testing:2
importance ,contact:2
importance ,tracing:2
testing ,contact:2
testing ,tracing:2
airborne ,rapidly:2
airborne ,inactivated:2
airborne ,simulated:2
airborne ,sunlight:2
sars-cov-2 ,inactivated:4
rapidly ,inactivated:2
inactivated ,simulated:2
inactivated ,sunlight:2
acidic ,electrolyzed:2
acidic ,water:2
acidic ,potently:2
acidic ,inactivates:2
acidic ,sars-cov-2:2
acidic ,depending:2
acidic ,amount:2
electrolyzed ,water:2
electrolyzed ,potently:2
electrolyzed ,inactivates:2
electrolyzed ,sars-cov-2:2
electrolyzed ,depending:2
electrolyzed ,amount:2
water ,potently:2
water ,inactivates:2
water ,depending:2
water ,amount:2
potently ,inactivates:2
potently ,sars-cov-2:6
potently ,depending:2
potently ,amount:2
inactivates ,depending:2
inactivates ,amount:2
sars-cov-2 ,depending:2
sars-cov-2 ,amount:2
depending ,amount:2
learning ,lessons:2
learning ,guide:2
learning ,interventions:2
lessons ,interventions:2
guide ,treatment:2
guide ,prevention:2
guide ,interventions:2
treatment ,interventions:2
spironolactone ,may:2
spironolactone ,provide:2
spironolactone ,protection:2
spironolactone ,sars-cov-2:2
spironolactone ,targeting:2
spironolactone ,androgens:2
may ,protection:2
may ,targeting:2
may ,androgens:2
provide ,protection:2
provide ,targeting:2
provide ,androgens:2
protection ,targeting:2
protection ,androgens:2
sars-cov-2 ,androgens:2
targeting ,androgens:2
sars-cov-2 ,bcg-vaccinated:2
sars-cov-2 ,unvaccinated:2
rates ,bcg-vaccinated:2
rates ,unvaccinated:2
rates ,young:2
rates ,adults:2
bcg-vaccinated ,unvaccinated:2
bcg-vaccinated ,young:2
bcg-vaccinated ,adults:2
unvaccinated ,young:2
unvaccinated ,adults:2
young ,adults:2
placental ,pathology:4
significant ,relaxation:2
significant ,sars-cov-2-targeted:2
significant ,non-pharmaceutical:2
significant ,interventions:2
significant ,may:2
relaxation ,sars-cov-2-targeted:2
relaxation ,non-pharmaceutical:2
relaxation ,interventions:2
relaxation ,may:2
sars-cov-2-targeted ,non-pharmaceutical:2
sars-cov-2-targeted ,interventions:2
sars-cov-2-targeted ,may:2
non-pharmaceutical ,interventions:6
non-pharmaceutical ,may:2
interventions ,may:2
adsorptive ,granulocyte:2
adsorptive ,monocyte:2
adsorptive ,apheresis:2
adsorptive ,potentially:2
adsorptive ,relevant:2
adsorptive ,therapeutic:2
granulocyte ,monocyte:2
granulocyte ,apheresis:2
granulocyte ,potentially:2
granulocyte ,relevant:2
granulocyte ,therapeutic:2
monocyte ,apheresis:2
monocyte ,potentially:2
monocyte ,relevant:2
monocyte ,therapeutic:2
apheresis ,potentially:2
apheresis ,relevant:2
apheresis ,therapeutic:2
potentially ,relevant:2
potentially ,therapeutic:2
relevant ,therapeutic:2
impact ,ace2:2
impact ,connection:2
covid-19 ,connection:2
pandemic ,male:2
pandemic ,fertility:2
pandemic ,ace2:4
pandemic ,connection:2
male ,ace2:2
male ,connection:2
fertility ,ace2:2
fertility ,connection:2
ace2 ,connection:2
rapid ,deterioration:2
rapid ,hospital-acquired:2
rapid ,patient:4
rapid ,extracorporeal:2
deterioration ,hospital-acquired:2
deterioration ,covid-19:4
deterioration ,patient:2
deterioration ,extracorporeal:2
hospital-acquired ,covid-19:2
hospital-acquired ,patient:2
hospital-acquired ,extracorporeal:2
covid-19 ,extracorporeal:6
patient ,extracorporeal:2
finding ,camel-ot:2
finding ,holy:2
finding ,grail:2
finding ,pandemic:4
finding ,sars-cov-2:2
camel-ot ,holy:2
camel-ot ,grail:2
camel-ot ,pandemic:2
camel-ot ,sars-cov-2:2
holy ,grail:2
holy ,pandemic:2
holy ,sars-cov-2:2
grail ,pandemic:2
grail ,sars-cov-2:2
rehabilitative ,covid-19:2
rehabilitative ,patients:2
rehabilitative ,acute:2
rehabilitative ,lower:2
rehabilitative ,extremity:2
rehabilitative ,ischemia:2
covid-19 ,extremity:4
patients ,extremity:2
patients ,ischemia:2
acute ,lower:2
acute ,extremity:2
lower ,extremity:4
extremity ,ischemia:2
detection ,coronavirus-2:2
severe ,tears:2
acute ,tears:2
respiratory ,tears:2
syndrome ,tears:2
coronavirus-2 ,tears:2
quantitative ,airborne:2
quantitative ,transmission:2
assessment ,airborne:4
risk ,airborne:2
characteristics ,unexpected:2
characteristics ,diagnoses:2
characteristics ,resuscitation:2
characteristics ,room:2
unexpected ,diagnoses:2
unexpected ,resuscitation:2
unexpected ,room:2
unexpected ,patients:2
covid-19 ,resuscitation:2
diagnoses ,resuscitation:2
diagnoses ,room:2
diagnoses ,patients:4
resuscitation ,room:2
resuscitation ,patients:2
analysis ,vaginal:2
analysis ,delivery:2
analysis ,china:8
vaginal ,delivery:6
vaginal ,outcomes:2
vaginal ,among:2
vaginal ,pregnant:4
vaginal ,wuhan:2
vaginal ,china:2
delivery ,outcomes:2
delivery ,among:4
delivery ,wuhan:2
delivery ,china:2
outcomes ,among:8
outcomes ,china:2
among ,pregnant:10
among ,women:10
among ,china:2
pregnant ,wuhan:2
pregnant ,china:2
women ,wuhan:2
women ,china:2
light ,corona:2
light ,guided-wave:2
light ,readout:2
light ,spike:2
light ,protein-host-receptor:2
corona ,guided-wave:2
corona ,readout:2
corona ,coronavirus:2
corona ,spike:2
corona ,protein-host-receptor:2
guided-wave ,readout:2
guided-wave ,coronavirus:2
guided-wave ,spike:2
guided-wave ,protein-host-receptor:2
readout ,coronavirus:2
readout ,spike:2
readout ,protein-host-receptor:2
coronavirus ,protein-host-receptor:2
spike ,protein-host-receptor:2
surgical ,considerations:4
surgical ,awake:2
surgical ,tracheotomy:2
considerations ,awake:2
considerations ,tracheotomy:2
considerations ,pandemic:8
awake ,tracheotomy:2
awake ,covid-19:2
awake ,pandemic:2
tracheotomy ,pandemic:4
recurrent ,pneumonia:2
recurrent ,new:2
recurrent ,discharge:2
pneumonia ,infection:6
pneumonia ,discharge:2
patient ,new:12
patient ,discharge:2
new ,discharge:2
coronavirus ,discharge:2
infection ,discharge:4
ipscs-derived ,platform:2
ipscs-derived ,feasible:2
ipscs-derived ,tool:2
ipscs-derived ,probing:2
ipscs-derived ,neurotropism:2
ipscs-derived ,sars-cov-2:2
platform ,feasible:2
platform ,tool:2
platform ,probing:2
platform ,neurotropism:2
feasible ,tool:2
feasible ,probing:2
feasible ,neurotropism:2
feasible ,sars-cov-2:4
tool ,probing:2
tool ,neurotropism:2
probing ,neurotropism:2
probing ,sars-cov-2:4
sars-cov-2covid-19 ,viral:2
sars-cov-2covid-19 ,genomics:2
sars-cov-2covid-19 ,epidemiology:2
sars-cov-2covid-19 ,vaccines:4
sars-cov-2covid-19 ,therapeutic:2
viral ,genomics:2
viral ,epidemiology:2
viral ,vaccines:2
viral ,therapeutic:6
genomics ,epidemiology:2
genomics ,vaccines:2
genomics ,therapeutic:4
epidemiology ,therapeutic:4
covid-19-associated ,kidney:2
covid-19-associated ,injury:2
covid-19-associated ,case:10
covid-19-associated ,series:2
covid-19-associated ,biopsy:2
covid-19-associated ,findings:2
kidney ,series:2
kidney ,biopsy:4
kidney ,findings:6
injury ,case:4
injury ,series:4
injury ,biopsy:2
injury ,findings:2
case ,biopsy:2
case ,findings:6
series ,biopsy:4
series ,findings:6
biopsy ,findings:4
immunoglobulin ,fragment:2
immunoglobulin ,fab2:2
immunoglobulin ,rbd:2
immunoglobulin ,potently:2
immunoglobulin ,neutralizes:2
immunoglobulin ,sars-cov-2:2
fragment ,fab2:2
fragment ,rbd:2
fragment ,potently:2
fragment ,neutralizes:2
fragment ,sars-cov-2:2
fab2 ,rbd:2
fab2 ,potently:2
fab2 ,neutralizes:2
fab2 ,sars-cov-2:2
rbd ,potently:2
rbd ,neutralizes:2
potently ,neutralizes:2
neutralizes ,sars-cov-2:4
environmental ,imported:2
environmental ,case:2
environmental ,incubation:2
contamination ,imported:2
contamination ,case:2
contamination ,incubation:2
sars-cov-2 ,incubation:6
imported ,case:6
imported ,incubation:2
case ,incubation:2
vitro ,doxycycline:2
antiviral ,doxycycline:2
activity ,doxycycline:2
doxycycline ,sars-cov-2:2
pulmonary ,nanostructured:2
pulmonary ,lipid:2
pulmonary ,carriers:2
pulmonary ,effective:2
pulmonary ,repurposing:2
delivery ,nanostructured:2
delivery ,lipid:2
delivery ,carriers:4
delivery ,effective:4
delivery ,repurposing:2
nanostructured ,lipid:2
nanostructured ,carriers:2
nanostructured ,effective:2
nanostructured ,repurposing:2
lipid ,carriers:2
lipid ,effective:2
lipid ,repurposing:2
carriers ,effective:2
carriers ,repurposing:2
effective ,repurposing:2
nocturnal ,oxygen:2
nocturnal ,therapy:2
nocturnal ,option:2
nocturnal ,early:2
nocturnal ,covid-19:2
oxygen ,therapy:10
oxygen ,option:2
oxygen ,early:2
therapy ,option:2
therapy ,early:4
option ,early:2
mutations ,phosphorylation:2
mutations ,sites:2
mutations ,encoded:2
mutations ,nucleocapsid:2
mutations ,protein:2
phosphorylation ,sites:2
phosphorylation ,sars-cov-2:2
phosphorylation ,encoded:2
phosphorylation ,nucleocapsid:2
phosphorylation ,protein:2
sites ,encoded:2
sites ,nucleocapsid:2
sites ,protein:2
sars-cov-2 ,encoded:2
encoded ,nucleocapsid:2
encoded ,protein:4
effectiveness ,face:2
effectiveness ,airborne:2
face ,preventing:4
masks ,preventing:2
masks ,airborne:2
masks ,transmission:6
establishment ,reference:2
establishment ,sequence:2
establishment ,variation:2
establishment ,analysis:2
reference ,sequence:2
reference ,sars-cov-2:2
reference ,variation:2
reference ,analysis:2
sequence ,variation:2
sequence ,analysis:6
comprehensive ,severe:2
comprehensive ,acute:4
comprehensive ,respiratory:4
comprehensive ,syndrome:2
higher ,load:2
higher ,death:2
viral ,death:2
load ,associated:2
load ,death:2
mesenchymal ,covid-19-progress:2
mesenchymal ,challenges:2
stem ,covid-19-progress:2
stem ,challenges:2
cells ,covid-19-progress:2
cells ,challenges:2
treatment ,covid-19-progress:2
covid-19-progress ,challenges:2
identification ,analysis:10
identification ,ongoing:2
identification ,registered:2
identification ,clinical:2
identification ,intervention:2
identification ,trials:2
analysis ,ongoing:2
analysis ,registered:2
analysis ,intervention:4
analysis ,trials:2
ongoing ,registered:2
ongoing ,intervention:2
registered ,clinical:4
registered ,intervention:2
registered ,trials:4
clinical ,intervention:4
intervention ,trials:2
alternative ,splicing:2
alternative ,ace2:2
alternative ,possibly:2
alternative ,generates:2
alternative ,variants:2
alternative ,may:2
alternative ,limit:2
alternative ,entry:2
splicing ,ace2:2
splicing ,possibly:2
splicing ,generates:2
splicing ,variants:2
splicing ,may:2
splicing ,limit:2
splicing ,entry:2
ace2 ,possibly:2
ace2 ,generates:2
ace2 ,variants:4
ace2 ,limit:2
possibly ,generates:2
possibly ,variants:2
possibly ,may:2
possibly ,limit:2
possibly ,entry:2
generates ,variants:2
generates ,may:2
generates ,limit:2
generates ,entry:2
variants ,may:2
variants ,limit:2
variants ,entry:2
may ,limit:2
may ,entry:2
limit ,entry:2
protecting ,covid-19:6
protecting ,pandemic:4
protecting ,nanotechnology:2
healthcare ,pandemic:24
healthcare ,nanotechnology:2
workers ,pandemic:20
workers ,nanotechnology:2
pandemic ,nanotechnology:2
ad ,hoc:2
ad ,laboratory-based:2
ad ,surveillance:2
ad ,sars-cov-2:2
ad ,real-time:2
ad ,rt-pcr:2
ad ,using:2
hoc ,laboratory-based:2
hoc ,surveillance:2
hoc ,sars-cov-2:2
hoc ,real-time:2
hoc ,rt-pcr:2
hoc ,using:2
laboratory-based ,surveillance:2
laboratory-based ,sars-cov-2:2
laboratory-based ,real-time:2
laboratory-based ,rt-pcr:2
laboratory-based ,using:2
surveillance ,real-time:2
surveillance ,rt-pcr:2
real-time ,using:2
intussusception ,children:2
intussusception ,severe:2
intussusception ,acute:2
intussusception ,respiratory:2
intussusception ,syndrome:2
intussusception ,coronavirus-2:2
children ,coronavirus-2:2
rapid ,sars-cov-2-infected:2
rapid ,patients:4
rapid ,emergency:4
rapid ,department:4
identification ,sars-cov-2-infected:2
identification ,patients:8
identification ,emergency:2
identification ,department:2
sars-cov-2-infected ,emergency:2
sars-cov-2-infected ,department:2
patients ,department:4
vaccine ,repurposing:6
vaccine ,preventing:2
vaccine ,covid:2
vaccine ,19:2
vaccine ,can:2
vaccine ,mmr:2
vaccine ,vaccines:6
vaccine ,reduce:2
repurposing ,preventing:2
repurposing ,covid:4
repurposing ,19:2
repurposing ,can:2
repurposing ,mmr:2
repurposing ,vaccines:2
repurposing ,reduce:2
approach ,preventing:4
approach ,mmr:2
approach ,vaccines:2
preventing ,covid:2
preventing ,19:2
preventing ,can:2
preventing ,mmr:2
preventing ,vaccines:2
preventing ,reduce:2
covid ,can:2
covid ,mmr:2
covid ,vaccines:2
covid ,reduce:2
19 ,can:2
19 ,mmr:2
19 ,vaccines:2
19 ,reduce:2
can ,mmr:2
can ,vaccines:2
mmr ,vaccines:2
mmr ,reduce:2
vaccines ,reduce:2
platform ,rna:2
platform ,virus:2
platform ,cloning:2
rna ,cloning:2
virus ,cloning:2
fetal ,transient:2
fetal ,skin:2
fetal ,edema:2
fetal ,two:2
fetal ,pregnant:2
fetal ,women:2
fetal ,coronavirus:2
fetal ,disease:2
transient ,skin:2
transient ,edema:2
transient ,two:2
transient ,pregnant:2
transient ,women:2
transient ,coronavirus:2
transient ,disease:2
skin ,edema:2
skin ,two:2
skin ,pregnant:2
skin ,women:2
skin ,coronavirus:2
skin ,disease:2
edema ,two:2
edema ,pregnant:2
edema ,women:2
edema ,coronavirus:2
edema ,disease:2
two ,pregnant:2
two ,women:2
two ,disease:12
pregnant ,disease:18
women ,coronavirus:12
women ,disease:10
putative ,new:2
putative ,sars-cov:2
putative ,3c:2
putative ,encoded:2
putative ,orf:2
putative ,overlapping:2
putative ,orf3a:2
new ,sars-cov:2
new ,protein:4
new ,3c:2
new ,encoded:2
new ,orf:2
new ,overlapping:2
new ,orf3a:2
sars-cov ,protein:2
sars-cov ,3c:2
sars-cov ,encoded:2
sars-cov ,orf:2
sars-cov ,overlapping:2
sars-cov ,orf3a:2
protein ,3c:2
protein ,orf:2
protein ,overlapping:2
protein ,orf3a:2
3c ,encoded:2
3c ,orf:2
3c ,overlapping:2
3c ,orf3a:2
encoded ,orf:2
encoded ,overlapping:2
encoded ,orf3a:2
orf ,overlapping:2
orf ,orf3a:2
overlapping ,orf3a:2
vitro ,projection:2
vitro ,optimized:2
vitro ,dosing:2
vitro ,design:2
antiviral ,projection:2
antiviral ,optimized:2
antiviral ,dosing:2
activity ,projection:2
activity ,optimized:2
activity ,dosing:2
activity ,design:2
projection ,optimized:2
projection ,dosing:2
projection ,design:2
optimized ,dosing:2
optimized ,design:2
dosing ,design:2
academician ,cong:2
academician ,bin:2
academician ,autopsy:2
academician ,sars-cov-2:2
academician ,infection:2
academician ,needed:2
academician ,strengthened:2
cong ,bin:2
cong ,autopsy:2
cong ,sars-cov-2:2
cong ,infection:2
cong ,needed:2
cong ,strengthened:2
bin ,autopsy:2
bin ,sars-cov-2:2
bin ,infection:2
bin ,needed:2
bin ,strengthened:2
autopsy ,infection:4
autopsy ,needed:2
autopsy ,strengthened:2
infection ,needed:2
infection ,strengthened:2
needed ,strengthened:2
sars-cov-2 ,transfusion:4
transfusion ,transmitted:2
clinical ,value:2
clinical ,emergency:4
clinical ,department:4
value ,emergency:2
value ,department:2
value ,screening:2
emergency ,screening:2
department ,screening:2
department ,diagnosis:2
department ,covid-19:22
deciphering ,role:2
deciphering ,host:2
deciphering ,genetics:2
deciphering ,susceptibility:2
deciphering ,severe:2
role ,genetics:6
role ,susceptibility:8
host ,genetics:6
genetics ,susceptibility:4
genetics ,severe:4
cardiac ,assessment:2
cardiac ,myocardial:6
cardiac ,jacc:2
cardiac ,review:6
cardiac ,topic:2
troponin ,assessment:2
troponin ,myocardial:4
troponin ,injury:4
troponin ,jacc:2
troponin ,review:2
troponin ,topic:2
assessment ,myocardial:2
assessment ,injury:4
assessment ,jacc:2
assessment ,review:2
assessment ,topic:2
myocardial ,jacc:2
myocardial ,review:4
myocardial ,topic:2
injury ,jacc:2
injury ,review:10
injury ,topic:2
covid-19 ,jacc:2
covid-19 ,topic:2
jacc ,review:2
jacc ,topic:2
review ,topic:2
diagnosing ,disease:2
diagnosing ,tools:2
diagnosing ,detection:2
tools ,detection:2
influence ,male:2
influence ,fertility:2
influence ,known:2
covid-19 ,known:4
male ,known:2
fertility ,known:2
historic ,study:2
historic ,solidarity-researchs:2
historic ,answer:2
historic ,sars-cov-2:2
historic ,pandemic:2
study ,solidarity-researchs:2
study ,answer:2
solidarity-researchs ,answer:2
solidarity-researchs ,sars-cov-2:2
solidarity-researchs ,pandemic:2
answer ,sars-cov-2:2
answer ,pandemic:2
pharmacologic ,treatments:2
pharmacologic ,coronavirus:2
pharmacologic ,disease:2
pharmacologic ,covid-19:2
pharmacologic ,review:2
treatments ,disease:2
treatments ,review:8
oral ,cavity:2
oral ,relevant:2
cavity ,relevant:2
cavity ,pandemic:2
relevant ,sars-cov-2:4
relevant ,pandemic:2
impact ,interleukin-6:2
impact ,blockade:2
impact ,tocilizumab:4
impact ,viral:8
impact ,kinetics:2
interleukin-6 ,tocilizumab:2
interleukin-6 ,viral:2
interleukin-6 ,kinetics:2
blockade ,tocilizumab:2
blockade ,sars-cov-2:2
blockade ,viral:2
blockade ,kinetics:2
tocilizumab ,viral:2
tocilizumab ,kinetics:2
challenges ,use:4
challenges ,saliva:2
challenges ,detection:2
challenges ,cov-2:2
challenges ,rna:2
challenges ,symptomatic:2
use ,saliva:4
use ,sars:2
use ,cov-2:2
use ,rna:2
use ,symptomatic:4
saliva ,sars:2
saliva ,cov-2:2
saliva ,rna:2
saliva ,symptomatic:2
detection ,sars:2
detection ,cov-2:2
detection ,symptomatic:2
sars ,rna:4
sars ,symptomatic:2
cov-2 ,rna:4
cov-2 ,symptomatic:2
coronavirus ,spontaneous:4
coronavirus ,pneumothorax:4
diseases ,pneumonia:2
diseases ,spontaneous:2
diseases ,pneumothorax:2
pneumonia ,spontaneous:2
pneumonia ,pneumothorax:6
sars-cov-2 ,observations:2
sars-cov-2 ,hypotheses:4
viral ,observations:2
viral ,hypotheses:2
sepsis ,observations:2
sepsis ,hypotheses:2
observations ,hypotheses:2
systematic ,preoperative:2
systematic ,chest:2
systematic ,ct:2
systematic ,urological:2
preoperative ,sars-cov-2:2
preoperative ,chest:2
preoperative ,ct:2
preoperative ,urological:2
sars-cov-2 ,chest:4
screening ,chest:4
screening ,ct:2
screening ,urological:2
chest ,urological:2
ct ,urological:2
covid-19 ,discontinue:2
infection ,discontinue:2
infection ,retrospective:2
strategies ,discontinue:2
strategies ,isolation:2
strategies ,retrospective:2
discontinue ,isolation:2
discontinue ,retrospective:2
isolation ,retrospective:2
covid-19 ,evidence-based:8
pandemic ,guideline:4
pandemic ,evidence-based:6
guideline ,evidence-based:4
guideline ,medicine:2
evidence-based ,medicine:4
suramin ,inhibits:2
suramin ,sars-cov-2:2
suramin ,infection:2
suramin ,cell:2
suramin ,culture:2
suramin ,interfering:2
suramin ,early:2
inhibits ,infection:4
inhibits ,cell:2
inhibits ,culture:2
inhibits ,interfering:2
inhibits ,early:2
sars-cov-2 ,interfering:2
infection ,interfering:2
cell ,interfering:2
cell ,early:2
culture ,interfering:2
culture ,early:2
interfering ,early:2
multiple ,thrombotic:2
multiple ,events:2
multiple ,67-year-old:2
multiple ,man:4
multiple ,weeks:2
multiple ,testing:2
multiple ,positive:2
thrombotic ,events:4
thrombotic ,67-year-old:2
thrombotic ,man:2
thrombotic ,weeks:2
thrombotic ,testing:2
thrombotic ,positive:2
events ,67-year-old:2
events ,man:2
events ,weeks:2
events ,testing:2
events ,positive:2
67-year-old ,man:2
67-year-old ,weeks:2
67-year-old ,testing:2
67-year-old ,positive:2
man ,weeks:2
man ,testing:2
man ,positive:2
weeks ,testing:2
weeks ,positive:2
experience ,diagnosing:2
experience ,managing:2
experience ,oral:2
experience ,maxillofacial:2
experience ,surgery:10
diagnosing ,managing:2
diagnosing ,patients:2
diagnosing ,oral:2
diagnosing ,maxillofacial:2
diagnosing ,surgery:2
managing ,patients:6
managing ,oral:2
managing ,maxillofacial:2
managing ,surgery:2
snatching ,crown:2
snatching ,sars-cov-2:2
crown ,sars-cov-2:2
can ,risks:2
can ,dentists:2
reduce ,risks:2
reduce ,dentists:2
risks ,dentists:2
sars-cov-2 ,dentists:2
searching ,effective:2
searching ,therapy:2
searching ,coronavirus:4
searching ,pandemic:2
searching ,see:2
searching ,light:2
effective ,therapy:2
effective ,pandemic:2
effective ,see:2
effective ,light:2
therapy ,see:2
therapy ,light:2
coronavirus ,see:2
pandemic ,light:2
see ,light:2
frying ,pan:2
frying ,fire:2
frying ,due:2
frying ,diligence:2
frying ,warranted:2
frying ,ade:2
pan ,fire:2
pan ,due:2
pan ,diligence:2
pan ,warranted:2
pan ,ade:2
fire ,due:2
fire ,diligence:2
fire ,warranted:2
fire ,ade:2
due ,diligence:2
due ,warranted:2
due ,ade:2
diligence ,warranted:2
diligence ,ade:2
warranted ,ade:2
cholesterol ,metabolite:2
cholesterol ,27-hydroxycholesterol:2
cholesterol ,inhibits:4
cholesterol ,markedly:2
metabolite ,27-hydroxycholesterol:2
metabolite ,inhibits:2
metabolite ,sars-cov-2:2
metabolite ,markedly:2
27-hydroxycholesterol ,inhibits:2
27-hydroxycholesterol ,sars-cov-2:2
27-hydroxycholesterol ,markedly:2
inhibits ,markedly:2
sars-cov-2 ,markedly:2
continuous ,thrombocytopenia:2
continuous ,sars-cov-2:4
continuous ,nucleic:2
continuous ,acid:2
continuous ,negative:2
continuous ,non-severe:2
thrombocytopenia ,nucleic:2
thrombocytopenia ,acid:2
thrombocytopenia ,negative:2
thrombocytopenia ,non-severe:2
sars-cov-2 ,non-severe:2
nucleic ,negative:6
nucleic ,non-severe:2
acid ,negative:4
acid ,non-severe:2
negative ,non-severe:2
targeting ,rbd:2
targeting ,interface:4
targeting ,supervised:2
targeting ,computational:4
targeting ,data-driven:2
targeting ,approach:6
sars-cov-2 ,supervised:2
sars-cov-2 ,data-driven:2
rbd ,interface:2
rbd ,supervised:2
rbd ,computational:2
rbd ,data-driven:2
rbd ,approach:2
interface ,supervised:2
interface ,computational:2
interface ,data-driven:2
interface ,approach:2
supervised ,computational:2
supervised ,data-driven:2
supervised ,approach:2
computational ,data-driven:2
computational ,approach:6
data-driven ,approach:2
herd ,understanding:2
immunity ,understanding:2
structured ,review:2
structured ,placental:2
structured ,morphology:2
structured ,histopathological:2
structured ,lesions:2
structured ,associated:2
review ,placental:2
review ,morphology:2
review ,histopathological:2
review ,lesions:2
review ,associated:12
placental ,morphology:2
placental ,histopathological:2
placental ,lesions:2
placental ,associated:2
morphology ,histopathological:2
morphology ,lesions:2
morphology ,associated:2
histopathological ,lesions:2
lesions ,associated:2
suggestions ,design:2
suggestions ,evidence-based:2
suggestions ,traditional:2
suggestions ,chinese:2
suggestions ,medicine:2
suggestions ,study:2
design ,evidence-based:2
design ,traditional:2
design ,chinese:2
design ,medicine:2
design ,clinical:2
design ,study:4
evidence-based ,traditional:2
evidence-based ,chinese:2
evidence-based ,clinical:2
evidence-based ,study:2
traditional ,clinical:4
medicine ,clinical:4
ct ,clinical:16
ct ,course:2
imaging ,course:4
imaging ,asymptomatic:2
imaging ,pneumonia:14
course ,cases:2
course ,pneumonia:10
asymptomatic ,cases:6
management ,durable:2
management ,left:2
management ,ventricular:2
management ,assist:2
management ,device:2
management ,recipient:2
covid-19 ,durable:2
covid-19 ,left:2
covid-19 ,ventricular:6
covid-19 ,assist:2
covid-19 ,device:10
covid-19 ,recipient:6
durable ,left:2
durable ,ventricular:2
durable ,assist:2
durable ,device:2
durable ,recipient:2
left ,ventricular:2
left ,assist:2
left ,device:2
left ,recipient:2
ventricular ,assist:2
ventricular ,device:2
ventricular ,recipient:2
assist ,device:2
assist ,recipient:2
device ,recipient:2
remdesivir ,viral:2
remdesivir ,diseases:2
molecular ,biochemical:2
molecular ,monitoring:2
serological ,biochemical:2
serological ,monitoring:2
serological ,ifcc:4
biochemical ,diagnosis:2
biochemical ,monitoring:2
biochemical ,ifcc:2
diagnosis ,monitoring:2
diagnosis ,ifcc:2
monitoring ,ifcc:2
covid-19 ,ifcc:2
universal ,severe:2
universal ,acute:2
universal ,respiratory:2
universal ,syndrome:2
universal ,coronavirus:6
decontamination ,rna:4
decontamination ,viruses:4
decontamination ,level:4
decontamination ,meltblown:4
sars-cov-2 ,meltblown:4
rna ,viruses:4
rna ,n95:4
rna ,level:6
rna ,meltblown:4
viruses ,n95:4
viruses ,level:4
viruses ,meltblown:4
n95 ,level:4
n95 ,meltblown:4
level ,meltblown:4
lessons ,immunity:2
lessons ,infections:2
immunity ,infections:2
disrupting ,electrical:2
disrupting ,circuit:2
disrupting ,new:2
disrupting ,onset:2
disrupting ,atrial:2
disrupting ,fibrillation:2
disrupting ,patient:2
electrical ,circuit:2
electrical ,new:2
electrical ,onset:2
electrical ,atrial:2
electrical ,fibrillation:2
electrical ,patient:2
circuit ,new:2
circuit ,onset:2
circuit ,atrial:2
circuit ,fibrillation:2
circuit ,patient:2
new ,onset:8
new ,atrial:2
new ,fibrillation:2
onset ,atrial:2
onset ,fibrillation:2
atrial ,fibrillation:6
fibrillation ,patient:2
proton ,pump:2
proton ,inhibitors:2
proton ,risk:2
proton ,factors:2
proton ,viral:2
proton ,infections:2
proton ,even:2
proton ,covid-19:2
pump ,inhibitors:2
pump ,risk:2
pump ,factors:2
pump ,viral:2
pump ,infections:2
pump ,even:2
pump ,covid-19:2
inhibitors ,factors:2
inhibitors ,infections:2
inhibitors ,even:2
risk ,viral:10
risk ,infections:2
risk ,even:2
factors ,infections:2
factors ,even:2
viral ,even:2
infections ,even:2
even ,covid-19:2
validation ,verification:2
validation ,abbott:2
validation ,realtime:2
validation ,analytical:2
verification ,abbott:2
verification ,realtime:2
verification ,analytical:2
abbott ,realtime:2
abbott ,analytical:2
realtime ,sars-cov-2:2
realtime ,assay:2
realtime ,analytical:2
assay ,analytical:2
enhanced ,networks:2
enhanced ,hydrogen-bonding:2
receptor ,networks:2
receptor ,hydrogen-bonding:2
binding ,networks:2
binding ,hydrogen-bonding:2
sars-cov-2 ,hydrogen-bonding:2
networks ,hydrogen-bonding:2
characterisation ,covid-19:4
characterisation ,pandemic:2
characterisation ,paediatric:2
characterisation ,age:2
characterisation ,group:2
characterisation ,systematic:2
characterisation ,review:2
covid-19 ,group:12
pandemic ,paediatric:2
pandemic ,age:2
pandemic ,group:2
paediatric ,age:2
paediatric ,group:4
paediatric ,systematic:2
paediatric ,review:2
age ,group:2
age ,systematic:2
age ,review:2
group ,systematic:2
group ,review:2
arrhythmias ,review:2
pulmonary-proteoliposome ,new:2
pulmonary-proteoliposome ,therapeutic:2
pulmonary-proteoliposome ,approach:2
pulmonary-proteoliposome ,coronaviruses:2
new ,therapeutic:4
therapeutic ,coronaviruses:2
dengue ,case:2
dengue ,report:2
virus ,report:6
co-infection ,case:2
double-edged ,sword:2
double-edged ,hypothesis:2
double-edged ,covid-19-induced:2
double-edged ,salivary:2
double-edged ,biomarkers:2
sword ,hypothesis:2
sword ,covid-19-induced:2
sword ,salivary:2
sword ,biomarkers:2
hypothesis ,covid-19-induced:2
hypothesis ,salivary:2
hypothesis ,biomarkers:2
covid-19-induced ,salivary:2
covid-19-induced ,biomarkers:2
salivary ,biomarkers:2
universal ,labor:2
universal ,admission:2
universal ,covid-19:12
universal ,pandemic:4
screening ,labor:2
sars-cov-2 ,labor:2
labor ,admission:2
labor ,covid-19:4
labor ,pandemic:2
admission ,covid-19:4
admission ,pandemic:2
spatio-temporal ,patterns:2
spatio-temporal ,2019-ncov:2
spatio-temporal ,epidemic:2
spatio-temporal ,county:2
spatio-temporal ,level:2
spatio-temporal ,hubei:2
patterns ,2019-ncov:2
patterns ,epidemic:2
patterns ,county:2
patterns ,level:2
patterns ,hubei:2
2019-ncov ,county:2
2019-ncov ,level:2
2019-ncov ,hubei:2
epidemic ,county:2
epidemic ,level:2
county ,level:2
county ,hubei:2
level ,hubei:2
inflammatory ,cell:6
inflammatory ,infiltration:2
inflammatory ,adrenals:2
cell ,adrenals:2
infiltration ,adrenals:2
infiltration ,covid-19:4
adrenals ,covid-19:2
least ,68:2
least ,vaccine:2
least ,candidates:2
least ,development:2
68 ,vaccine:2
68 ,candidates:2
68 ,development:2
vaccine ,candidates:14
candidates ,development:4
effects ,covid-19sars-cov-2:2
effects ,pandemic:12
effects ,outbreak:4
effects ,otolaryngology:4
effects ,activity:2
covid-19sars-cov-2 ,pandemic:4
covid-19sars-cov-2 ,outbreak:2
covid-19sars-cov-2 ,otolaryngology:2
covid-19sars-cov-2 ,activity:2
pandemic ,activity:6
outbreak ,otolaryngology:2
outbreak ,activity:6
otolaryngology ,activity:2
prophylactic ,therapeutic:4
prophylactic ,remdesivir:2
prophylactic ,gs-5734:2
prophylactic ,treatment:4
prophylactic ,rhesus:2
prophylactic ,macaque:2
therapeutic ,rhesus:2
therapeutic ,macaque:2
remdesivir ,macaque:2
gs-5734 ,treatment:2
gs-5734 ,rhesus:2
gs-5734 ,macaque:2
treatment ,rhesus:2
treatment ,macaque:2
rhesus ,macaque:2
silico ,analysis:10
silico ,interactions:4
silico ,certain:2
analysis ,interactions:6
analysis ,certain:2
analysis ,flavonoids:2
interactions ,certain:2
interactions ,flavonoids:2
certain ,flavonoids:2
obesity ,comorbidity:4
obesity ,strongly:2
obesity ,associated:2
obesity ,mexico:2
comorbidity ,strongly:2
comorbidity ,mexico:2
strongly ,associated:2
strongly ,mexico:2
associated ,mexico:2
covid-19 ,mexico:6
coronaviruses ,gastrointestinal:4
gastrointestinal ,diseases:4
sars-cov-2 ,dementia:2
pandemic ,dementia:2
population ,dementia:2
population ,recommendations:2
dementia ,recommendations:2
sars-cov-2 ,perinatal:6
perinatal ,aspects:2
impact ,neurosurgical:2
impact ,practice:4
impact ,india:8
impact ,survey:4
impact ,personal:2
covid-19 ,neurosurgical:4
covid-19 ,personal:10
pandemic ,neurosurgical:4
pandemic ,india:2
pandemic ,survey:4
pandemic ,personal:6
neurosurgical ,india:2
neurosurgical ,survey:2
neurosurgical ,personal:2
practice ,india:2
practice ,survey:2
practice ,personal:4
india ,survey:2
india ,personal:2
survey ,personal:2
antibodies ,breast:2
antibodies ,milk:2
antibodies ,maternal:2
antibodies ,woman:2
breast ,maternal:2
breast ,woman:2
breast ,covid-19:2
milk ,maternal:2
milk ,woman:2
milk ,covid-19:2
maternal ,woman:2
coronavirus ,attack:4
coronavirus ,rate:2
coronavirus ,hiv-infected:4
coronavirus ,preexposure:2
disease ,attack:4
disease ,rate:2
disease ,hiv-infected:4
disease ,preexposure:2
attack ,rate:8
attack ,hiv-infected:2
attack ,patients:2
attack ,preexposure:2
rate ,hiv-infected:2
rate ,patients:8
rate ,preexposure:2
hiv-infected ,patients:2
hiv-infected ,preexposure:2
patients ,preexposure:2
analysis ,inactivation:2
analysis ,specimen:2
analysis ,media:4
inactivation ,specimen:2
inactivation ,transport:2
inactivation ,media:2
inactivation ,nucleic:2
inactivation ,acid:2
specimen ,nucleic:4
specimen ,acid:4
transport ,nucleic:2
transport ,acid:2
media ,nucleic:2
media ,acid:2
ifcc ,antibodies:2
interim ,serological:2
interim ,antibodies:2
guidelines ,serological:2
guidelines ,antibodies:2
serological ,testing:10
testing ,antibodies:2
early ,ct:6
early ,manifestations:2
ct ,manifestations:2
period ,prevalence:2
period ,sars-cov-2:16
period ,unselected:2
period ,sample:2
period ,pregnant:2
period ,women:2
period ,jena:2
prevalence ,unselected:2
prevalence ,sample:2
prevalence ,pregnant:2
prevalence ,women:2
prevalence ,jena:2
sars-cov-2 ,unselected:2
sars-cov-2 ,sample:14
sars-cov-2 ,jena:2
unselected ,sample:2
unselected ,pregnant:4
unselected ,women:4
unselected ,jena:2
sample ,pregnant:2
sample ,women:2
sample ,jena:2
pregnant ,jena:2
women ,jena:2
unrecognized ,threat:2
unrecognized ,secondary:2
unrecognized ,bacterial:2
unrecognized ,infections:2
unrecognized ,covid-19:2
threat ,secondary:2
threat ,bacterial:2
threat ,infections:2
secondary ,infections:4
bacterial ,infections:2
bacterial ,covid-19:8
disinfection ,corona:2
disinfection ,virus:2
disinfection ,laboratories:2
corona ,histopathology:2
corona ,laboratories:2
virus ,histopathology:2
virus ,laboratories:2
histopathology ,laboratories:2
model ,taking:2
model ,care:2
model ,patients:4
model ,early:2
model ,childhood:2
model ,caries:2
taking ,care:2
taking ,early:2
taking ,childhood:2
taking ,caries:2
taking ,sars-cov-2:4
care ,childhood:2
care ,caries:2
patients ,childhood:2
patients ,caries:2
early ,childhood:2
early ,caries:2
childhood ,caries:2
childhood ,sars-cov-2:2
caries ,sars-cov-2:2
asthma ,prevalence:2
asthma ,patients:6
asthma ,sars-cov-2:2
asthma ,infection:2
asthma ,detected:2
asthma ,rt-pcr:2
prevalence ,detected:4
prevalence ,rt-pcr:2
patients ,detected:6
detected ,rt-pcr:2
ent ,practice:2
ent ,experience:2
ent ,outpatient:2
ent ,department:2
ent ,ward:2
practice ,experience:2
practice ,outpatient:2
practice ,ward:2
experience ,outpatient:2
experience ,department:4
experience ,ward:2
outpatient ,department:2
outpatient ,ward:2
department ,ward:2
expect ,neurological:2
expect ,symptoms:2
expect ,epidemic:2
neurological ,epidemic:4
symptoms ,epidemic:2
atypical ,acute:4
atypical ,pulmonary:2
atypical ,embolism:2
atypical ,severe:2
atypical ,respiratory:2
presentation ,pulmonary:6
presentation ,embolism:4
presentation ,severe:4
pulmonary ,severe:10
pulmonary ,respiratory:8
embolism ,severe:2
embolism ,respiratory:2
rapid ,direct:4
rapid ,without:2
rapid ,extraction:4
direct ,nucleic:2
direct ,acid:2
direct ,amplification:2
direct ,test:2
direct ,without:6
direct ,extraction:4
nucleic ,without:2
nucleic ,rna:4
nucleic ,extraction:4
acid ,without:2
acid ,rna:4
acid ,extraction:4
amplification ,without:2
amplification ,rna:2
amplification ,extraction:2
amplification ,sars-cov-2:10
test ,without:2
test ,extraction:2
detailed ,report:2
detailed ,measures:2
detailed ,taken:2
detailed ,department:2
detailed ,conservative:2
detailed ,dentistry:2
report ,measures:2
report ,taken:2
report ,department:4
report ,conservative:2
report ,dentistry:2
measures ,taken:2
measures ,department:2
measures ,conservative:2
measures ,dentistry:2
taken ,department:2
taken ,conservative:2
taken ,dentistry:2
department ,conservative:2
department ,dentistry:2
conservative ,dentistry:2
strict ,quarantine:2
strict ,measures:2
strict ,can:2
strict ,curb:2
strict ,coronavirus:2
strict ,disease:2
strict ,covid-19:2
strict ,outbreak:2
quarantine ,measures:2
quarantine ,can:2
quarantine ,curb:2
quarantine ,coronavirus:2
quarantine ,disease:2
quarantine ,outbreak:4
measures ,can:2
measures ,curb:2
measures ,disease:6
measures ,outbreak:6
can ,curb:2
curb ,coronavirus:2
curb ,disease:2
curb ,covid-19:2
curb ,outbreak:2
early ,patterns:2
early ,travellers:2
transmission ,patterns:2
transmission ,travellers:2
patterns ,coronavirus:4
patterns ,disease:4
patterns ,travellers:2
disease ,travellers:2
covid-19 ,travellers:2
sars-cov-2 ,havoc:2
emergence ,viral:2
emergence ,pathogen:2
emergence ,causing:2
emergence ,havoc:2
emergence ,human:4
emergence ,existence:2
viral ,pathogen:2
viral ,causing:2
viral ,havoc:2
viral ,human:6
viral ,existence:2
pathogen ,causing:2
pathogen ,havoc:2
pathogen ,human:2
pathogen ,existence:2
causing ,havoc:2
causing ,human:2
causing ,existence:2
havoc ,human:2
havoc ,existence:2
application ,biosafety:2
application ,principles:4
application ,analysis:2
application ,samples:2
biosafety ,analysis:2
biosafety ,clinical:4
biosafety ,samples:2
principles ,laboratory:2
principles ,analysis:2
principles ,clinical:2
principles ,samples:2
laboratory ,samples:2
androgen-deprivation ,therapies:2
androgen-deprivation ,prostate:2
androgen-deprivation ,cancer:2
androgen-deprivation ,risk:2
androgen-deprivation ,infection:2
therapies ,prostate:2
therapies ,cancer:4
therapies ,risk:2
therapies ,infection:2
prostate ,cancer:12
prostate ,risk:4
prostate ,infection:2
clinical ,netherlands:2
characteristics ,netherlands:2
coronavirus ,netherlands:2
disease ,netherlands:2
cytokine ,cancer:2
storms ,cancer:2
storms ,covid-19:2
special ,report:4
special ,early:2
special ,use:2
special ,icd-10-cm:2
special ,code:2
special ,u071:2
special ,identify:2
report ,early:4
report ,use:2
report ,icd-10-cm:2
report ,code:2
report ,u071:2
report ,identify:2
early ,icd-10-cm:2
early ,code:2
early ,u071:2
early ,identify:2
use ,icd-10-cm:2
use ,code:2
use ,u071:2
use ,novel:4
icd-10-cm ,code:2
icd-10-cm ,u071:2
icd-10-cm ,covid-19:2
icd-10-cm ,identify:2
icd-10-cm ,novel:2
code ,u071:2
code ,covid-19:4
code ,identify:2
code ,novel:2
u071 ,covid-19:2
u071 ,identify:2
u071 ,novel:2
topical ,recombinant:2
topical ,human:2
topical ,acidic:2
topical ,fibroblast:2
topical ,growth:2
topical ,factor:2
topical ,effective:2
topical ,therapeutic:2
recombinant ,human:2
recombinant ,acidic:2
recombinant ,fibroblast:2
recombinant ,growth:2
recombinant ,factor:2
recombinant ,effective:2
recombinant ,therapeutic:2
human ,acidic:2
human ,fibroblast:2
human ,growth:2
human ,factor:2
human ,effective:4
human ,therapeutic:2
acidic ,fibroblast:2
acidic ,growth:2
acidic ,factor:2
acidic ,effective:2
acidic ,therapeutic:2
fibroblast ,growth:2
fibroblast ,factor:2
fibroblast ,effective:2
fibroblast ,therapeutic:2
growth ,effective:2
growth ,therapeutic:2
factor ,effective:2
factor ,therapeutic:2
effective ,therapeutic:2
use ,angiotensin-converting:2
use ,enzyme:2
use ,inhibitors:2
use ,angiotensin:2
use ,ii:2
use ,receptor:2
angiotensin-converting ,ii:2
angiotensin-converting ,blockers:6
enzyme ,ii:2
enzyme ,blockers:6
inhibitors ,blockers:6
ii ,receptor:2
ii ,blockers:2
risk ,flexible:2
risk ,laryngoscopy:2
risk ,systematic:6
risk ,review:4
sars-cov-2 ,flexible:4
sars-cov-2 ,laryngoscopy:2
transmission ,flexible:2
transmission ,laryngoscopy:2
transmission ,systematic:6
flexible ,laryngoscopy:2
flexible ,systematic:2
flexible ,review:2
laryngoscopy ,systematic:2
laryngoscopy ,review:2
understanding ,gender:2
understanding ,perspective:6
covid-19 ,gender:8
pandemic ,gender:2
gender ,perspective:2
prospect ,sars-cov-2:4
prospect ,spike:2
prospect ,protein:2
prospect ,potential:2
prospect ,role:2
prospect ,vaccine:2
prospect ,therapeutic:2
spike ,therapeutic:2
protein ,vaccine:6
protein ,therapeutic:2
role ,vaccine:2
role ,therapeutic:8
radiological ,diagnosis:4
radiological ,disease:2
radiological ,practical:2
radiological ,guide:2
diagnosis ,practical:2
diagnosis ,guide:4
coronavirus ,guide:2
disease ,guide:2
covid-19 ,practical:16
practical ,guide:2
inflammatory ,systematic:4
bowel ,systematic:4
bowel ,review:6
introductions ,early:4
introductions ,spread:2
introductions ,france:2
introductions ,24:2
introductions ,january:2
introductions ,23:2
introductions ,march:2
early ,spread:12
early ,france:2
early ,24:2
early ,january:2
early ,23:2
early ,march:2
spread ,france:2
spread ,24:2
spread ,january:2
spread ,23:2
spread ,march:2
sars-cov-2 ,24:2
sars-cov-2 ,23:2
france ,24:2
france ,january:2
france ,23:2
france ,march:4
24 ,january:2
24 ,23:2
24 ,march:2
january ,23:2
january ,march:2
23 ,march:2
rapid ,quantitative:2
rapid ,convalescent:2
rapid ,serum:2
quantitative ,specific:2
quantitative ,igg:2
quantitative ,convalescent:2
quantitative ,serum:2
detection ,specific:2
detection ,convalescent:2
detection ,serum:2
specific ,convalescent:2
igg ,serum:4
convalescent ,serum:2
children ,understanding:6
children ,immune:2
children ,responses:2
understanding ,immune:2
understanding ,responses:4
understanding ,origin:2
understanding ,therapeutics:2
origin ,therapeutics:2
prediction ,potential:6
prediction ,rna-dependent:2
prediction ,rna:2
prediction ,polymerase:2
antiviral ,mycophenolic:2
antiviral ,acid:2
antiviral ,imd-0354:2
activities ,mycophenolic:2
activities ,acid:2
activities ,imd-0354:2
mycophenolic ,acid:2
mycophenolic ,imd-0354:2
mycophenolic ,sars-cov-2:2
acid ,imd-0354:2
imd-0354 ,sars-cov-2:2
community ,system:2
community ,critical:2
community ,foundation:2
community ,prevention:2
community ,control:4
system ,critical:4
system ,foundation:2
system ,epidemic:2
critical ,foundation:2
critical ,epidemic:2
critical ,prevention:2
critical ,control:2
foundation ,epidemic:2
foundation ,prevention:2
foundation ,control:2
neurological ,learned:2
neurological ,go:2
consequences ,learned:2
consequences ,go:2
covid-19 ,go:4
learned ,go:2
human ,evolved:2
human ,reduce:2
human ,cg:2
human ,dinucleotide:2
human ,open:2
human ,reading:2
human ,frames:2
sars-cov-2 ,evolved:2
sars-cov-2 ,cg:2
sars-cov-2 ,dinucleotide:2
sars-cov-2 ,open:4
sars-cov-2 ,reading:2
sars-cov-2 ,frames:2
evolved ,reduce:2
evolved ,cg:2
evolved ,dinucleotide:2
evolved ,open:2
evolved ,reading:2
evolved ,frames:2
reduce ,cg:2
reduce ,dinucleotide:2
reduce ,open:2
reduce ,reading:2
reduce ,frames:2
cg ,dinucleotide:2
cg ,open:2
cg ,reading:2
cg ,frames:2
dinucleotide ,open:2
dinucleotide ,reading:2
dinucleotide ,frames:2
open ,reading:6
open ,frames:4
reading ,frames:4
genome-wide ,analysis:2
genome-wide ,sars-cov-2:2
genome-wide ,virus:2
genome-wide ,strains:2
genome-wide ,circulating:2
genome-wide ,worldwide:2
analysis ,circulating:2
analysis ,worldwide:2
virus ,strains:2
virus ,circulating:2
virus ,worldwide:2
strains ,circulating:2
strains ,worldwide:2
circulating ,worldwide:2
absence ,sars-cov-2:6
absence ,transmission:4
absence ,children:2
absence ,isolation:2
absence ,guardians:2
absence ,south:2
sars-cov-2 ,guardians:2
transmission ,isolation:2
transmission ,guardians:2
transmission ,south:2
children ,isolation:2
children ,guardians:2
children ,south:2
isolation ,guardians:2
isolation ,south:2
guardians ,south:2
use ,mouthwashes:2
use ,dentistry:2
mouthwashes ,covid-19:2
mouthwashes ,dentistry:2
panuveitis ,optic:2
panuveitis ,neuritis:2
panuveitis ,possible:2
panuveitis ,initial:2
panuveitis ,presentation:2
panuveitis ,novel:2
optic ,neuritis:2
optic ,possible:2
optic ,initial:2
optic ,presentation:2
optic ,novel:2
neuritis ,possible:2
neuritis ,initial:2
neuritis ,presentation:2
neuritis ,novel:2
possible ,initial:2
possible ,presentation:2
initial ,novel:4
presentation ,novel:4
unsynchronized ,changes:2
unsynchronized ,ct:2
unsynchronized ,image:2
unsynchronized ,nucleic:2
unsynchronized ,acid:2
unsynchronized ,detection:2
unsynchronized ,covid-19:2
changes ,ct:6
changes ,image:2
changes ,nucleic:2
changes ,acid:2
changes ,detection:2
ct ,image:2
ct ,nucleic:2
ct ,acid:2
ct ,detection:2
image ,nucleic:2
image ,acid:2
image ,detection:2
image ,covid-19:6
influence ,storage:2
influence ,conditions:2
influence ,nucleic:2
influence ,acid:2
influence ,detection:2
influence ,throat:2
storage ,conditions:2
storage ,sars-cov-2:6
storage ,nucleic:4
storage ,acid:4
storage ,detection:4
storage ,throat:2
conditions ,nucleic:2
conditions ,acid:2
conditions ,throat:2
sars-cov-2 ,throat:8
sars-cov-2 ,genital:2
sars-cov-2 ,sexual:6
possible ,contamination:2
possible ,genital:2
possible ,area:2
possible ,sexual:2
contamination ,genital:2
contamination ,area:2
contamination ,implications:2
contamination ,sexual:2
genital ,area:2
genital ,implications:2
genital ,sexual:2
area ,implications:2
area ,sexual:2
implications ,sexual:6
assessing ,sars-cov-2:6
assessing ,rna:2
assessing ,levels:6
assessing ,lymphocytet:2
assessing ,cell:2
assessing ,counts:2
assessing ,patients:4
sars-cov-2 ,lymphocytet:2
sars-cov-2 ,counts:4
rna ,lymphocytet:2
rna ,cell:4
rna ,counts:2
levels ,lymphocytet:2
levels ,cell:2
levels ,counts:2
lymphocytet ,cell:2
lymphocytet ,counts:2
lymphocytet ,covid-19:2
lymphocytet ,patients:2
cell ,counts:4
cell ,patients:10
counts ,covid-19:2
counts ,patients:4
comparative ,structural:4
comparative ,epitopes:4
comparative ,proteins:2
analysis ,proteins:6
structural ,epitopes:2
characteristics ,epitopes:2
characteristics ,proteins:2
epitopes ,proteins:4
covid-19 ,up-to-date:2
anosmia ,review:2
anosmia ,based:2
anosmia ,up-to-date:2
anosmia ,knowledge:2
review ,up-to-date:2
based ,up-to-date:2
up-to-date ,knowledge:2
epidemic ,impacts:4
epidemic ,happiness:2
epidemic ,factors:2
epidemic ,worsen:2
epidemic ,vs:2
epidemic ,protect:2
outbreak ,impacts:2
outbreak ,happiness:2
outbreak ,factors:4
outbreak ,worsen:2
outbreak ,vs:2
outbreak ,protect:2
impacts ,happiness:2
impacts ,factors:2
impacts ,worsen:2
impacts ,vs:2
happiness ,factors:2
happiness ,worsen:2
happiness ,vs:2
happiness ,protect:2
factors ,worsen:2
factors ,vs:2
factors ,protect:2
worsen ,vs:2
worsen ,protect:2
vs ,protect:2
sars-cov-2 ,immunocompromised:2
sars-cov-2 ,cell-mediated:2
infection ,immunocompromised:2
infection ,versus:6
immunocompromised ,patients:4
immunocompromised ,humoral:2
immunocompromised ,versus:2
immunocompromised ,cell-mediated:2
patients ,humoral:4
patients ,versus:2
patients ,cell-mediated:2
humoral ,versus:2
humoral ,cell-mediated:2
versus ,cell-mediated:2
potential ,beneficial:2
potential ,microbes:2
potential ,face:2
contribution ,beneficial:2
contribution ,microbes:2
contribution ,face:2
contribution ,pandemic:2
beneficial ,microbes:2
beneficial ,face:2
beneficial ,pandemic:2
microbes ,face:2
microbes ,covid-19:2
microbes ,pandemic:2
convalescent ,critically:4
convalescent ,ill:4
convalescent ,severe:4
convalescent ,acute:2
plasma ,critically:6
plasma ,ill:6
covid-19 ,publics:2
covid-19 ,epistemic:2
covid-19 ,democracy:2
covid-19 ,matters:4
science ,policy:2
science ,experts:2
science ,publics:2
science ,epistemic:2
science ,democracy:2
science ,matters:2
policy ,experts:2
policy ,publics:2
policy ,epistemic:2
policy ,democracy:2
policy ,matters:2
experts ,publics:2
experts ,epistemic:2
experts ,democracy:2
experts ,matters:2
publics ,epistemic:2
publics ,democracy:2
publics ,matters:2
epistemic ,democracy:2
epistemic ,matters:2
democracy ,matters:2
sunlight ,ultraviolet:2
sunlight ,radiation:2
sunlight ,dose:2
sunlight ,negatively:4
sunlight ,correlated:2
sunlight ,percent:2
ultraviolet ,radiation:2
ultraviolet ,dose:2
ultraviolet ,negatively:2
ultraviolet ,correlated:2
ultraviolet ,percent:2
radiation ,dose:2
radiation ,negatively:2
radiation ,correlated:2
radiation ,percent:2
dose ,negatively:2
dose ,correlated:2
dose ,percent:2
negatively ,correlated:2
negatively ,percent:2
correlated ,percent:2
stroke ,novel:4
stroke ,infection:10
stroke ,humans:2
stroke ,systematic:2
stroke ,review:4
novel ,systematic:6
infection ,humans:2
humans ,systematic:2
humans ,review:2
renin-angiotensin ,systematic:2
renin-angiotensin ,review:4
inhibitors ,systematic:2
inhibitors ,review:2
risk ,nosocomial:2
risk ,experience:2
nosocomial ,transmission:8
nosocomial ,coronavirus:8
nosocomial ,disease:6
nosocomial ,experience:4
transmission ,experience:2
smoking ,environmental:2
smoking ,pollution:2
smoking ,weather:2
smoking ,conditions:2
smoking ,risk:2
smoking ,factors:2
environmental ,pollution:2
environmental ,weather:2
environmental ,risk:4
pollution ,conditions:2
weather ,conditions:4
weather ,risk:2
weather ,factors:2
conditions ,factors:2
strategic ,implementation:2
strategic ,dental:2
strategic ,infection:2
strategic ,control:2
strategic ,resource-poor:2
strategic ,jurisdictions:2
implementation ,dental:2
implementation ,infection:2
implementation ,control:2
implementation ,resource-poor:2
implementation ,jurisdictions:2
dental ,resource-poor:2
dental ,jurisdictions:2
infection ,resource-poor:2
infection ,jurisdictions:2
control ,resource-poor:2
control ,jurisdictions:2
resource-poor ,jurisdictions:2
pharmacological ,chloroquine:2
pharmacological ,old:2
pharmacological ,drug:2
perspective ,chloroquine:2
perspective ,old:2
perspective ,drug:2
chloroquine ,infection:4
chloroquine ,old:2
chloroquine ,drug:4
infection ,old:6
old ,drug:2
fahrs ,syndrome:2
fahrs ,presenting:2
fahrs ,seizures:2
fahrs ,sars-cov-2:2
fahrs ,covid-19:2
fahrs ,pneumonia-a:2
fahrs ,case:2
syndrome ,seizures:2
syndrome ,pneumonia-a:2
presenting ,seizures:2
presenting ,pneumonia-a:2
presenting ,case:12
seizures ,sars-cov-2:2
seizures ,covid-19:2
seizures ,pneumonia-a:2
seizures ,case:2
sars-cov-2 ,pneumonia-a:2
covid-19 ,pneumonia-a:2
pneumonia-a ,case:2
emerging ,mutation:2
emerging ,hot:2
emerging ,spots:2
emerging ,include:2
emerging ,rna-dependent-rna:2
emerging ,polymerase:2
sars-cov-2 ,hot:4
sars-cov-2 ,spots:2
sars-cov-2 ,include:2
sars-cov-2 ,rna-dependent-rna:2
mutation ,hot:2
mutation ,spots:2
mutation ,include:2
mutation ,novel:2
mutation ,rna-dependent-rna:2
mutation ,polymerase:2
hot ,spots:2
hot ,include:2
hot ,novel:2
hot ,rna-dependent-rna:2
hot ,polymerase:2
spots ,include:2
spots ,novel:2
spots ,rna-dependent-rna:2
spots ,polymerase:2
include ,novel:2
include ,rna-dependent-rna:2
include ,polymerase:2
novel ,rna-dependent-rna:2
novel ,polymerase:4
rna-dependent-rna ,polymerase:2
global ,population:2
global ,composed:2
global ,six:2
global ,major:2
global ,subtypes:2
population ,composed:2
population ,six:2
population ,major:2
population ,subtypes:2
sars-cov-2 ,composed:2
sars-cov-2 ,major:8
sars-cov-2 ,subtypes:2
composed ,six:2
composed ,major:2
composed ,subtypes:2
six ,major:2
six ,subtypes:2
major ,subtypes:2
pulmonary ,benign:2
pathology ,patient:2
pathology ,benign:2
early-phase ,patient:2
early-phase ,benign:2
pneumonia ,benign:2
patient ,benign:4
hematological ,findings:2
hematological ,coronavirus:4
hematological ,disease:4
hematological ,indications:2
hematological ,progression:2
findings ,indications:2
findings ,progression:4
coronavirus ,indications:2
coronavirus ,progression:4
disease ,indications:2
indications ,progression:2
structural ,features:4
structural ,targets:2
features ,spike:4
features ,targets:2
spike ,targets:2
protein ,targets:2
innate ,immunity:4
innate ,sars-cov-2:4
innate ,strategies:2
innate ,activation:2
innate ,trigger:2
innate ,hypoxia:2
immunity ,evasion:2
immunity ,strategies:2
immunity ,activation:2
immunity ,trigger:2
immunity ,hypoxia:2
sars-cov-2 ,trigger:2
sars-cov-2 ,hypoxia:2
evasion ,strategies:2
evasion ,activation:4
evasion ,trigger:2
evasion ,hypoxia:2
strategies ,activation:2
strategies ,trigger:2
strategies ,hypoxia:2
activation ,trigger:4
activation ,hypoxia:2
trigger ,hypoxia:2
postmortem ,kidney:2
postmortem ,pathology:2
postmortem ,patients:4
postmortem ,covid-19:8
kidney ,pathology:2
pathology ,findings:2
pathology ,patients:4
intravenous ,thrombolysis:2
intravenous ,stroke:2
intravenous ,covid-19:4
intravenous ,positive:2
intravenous ,filipino:2
intravenous ,patient:2
intravenous ,case:2
thrombolysis ,stroke:2
thrombolysis ,covid-19:2
thrombolysis ,positive:2
thrombolysis ,filipino:2
thrombolysis ,patient:2
thrombolysis ,case:2
stroke ,positive:4
stroke ,filipino:2
stroke ,patient:6
covid-19 ,filipino:2
positive ,filipino:2
filipino ,patient:2
filipino ,case:2
current ,narrative:6
pharmacological ,treatments:6
pharmacological ,narrative:2
pharmacological ,review:4
treatments ,sars-cov-2:8
treatments ,narrative:2
pulmonary ,lessons:2
pulmonary ,autopsy:2
pulmonary ,experience:4
pulmonary ,european:2
pathology ,lessons:2
pathology ,autopsy:2
pathology ,experience:2
pathology ,european:2
lessons ,autopsy:4
lessons ,european:2
autopsy ,experience:2
autopsy ,european:2
experience ,european:2
oxygen ,via:2
oxygen ,high:2
oxygen ,flow:2
oxygen ,nasal:6
oxygen ,cannula:4
oxygen ,severe:2
oxygen ,respiratory:4
oxygen ,failure:2
oxygen ,caused:2
therapy ,via:4
therapy ,high:4
therapy ,flow:2
therapy ,nasal:4
therapy ,cannula:4
therapy ,failure:2
therapy ,caused:4
via ,high:2
via ,flow:2
via ,nasal:2
via ,cannula:2
via ,severe:4
via ,respiratory:4
via ,failure:2
via ,caused:2
high ,flow:2
high ,nasal:2
high ,cannula:2
high ,failure:4
high ,caused:2
flow ,nasal:2
flow ,cannula:2
flow ,failure:2
flow ,caused:2
nasal ,cannula:6
nasal ,severe:4
nasal ,respiratory:2
nasal ,failure:2
nasal ,caused:2
cannula ,severe:2
cannula ,respiratory:2
cannula ,failure:2
cannula ,caused:2
failure ,caused:2
genetics ,immune:2
genetics ,response:2
genetics ,sars-cov-2:4
surgery ,operative:2
surgery ,procedures:2
sars-cov-2 ,operative:2
sars-cov-2 ,procedures:4
recommendations ,operative:2
recommendations ,procedures:6
operative ,procedures:4
novel ,transcription:2
novel ,loop-mediated:2
novel ,isothermal:2
novel ,amplification:2
reverse ,method:2
transcription ,method:2
loop-mediated ,method:2
isothermal ,method:2
amplification ,method:2
yin ,yang:2
yin ,aceace2:2
yin ,pathways:2
yin ,rationale:2
yin ,use:2
yang ,aceace2:2
yang ,pathways:2
yang ,rationale:2
yang ,use:2
aceace2 ,pathways:2
aceace2 ,rationale:2
aceace2 ,use:2
pathways ,rationale:2
pathways ,use:2
calcineurin ,inhibitors:2
calcineurin ,revisited:2
calcineurin ,new:2
calcineurin ,paradigm:2
calcineurin ,covid-19:2
inhibitors ,revisited:2
inhibitors ,new:6
inhibitors ,paradigm:2
revisited ,new:2
revisited ,paradigm:2
revisited ,covid-19:4
sodium ,status:2
sodium ,kidney:2
sodium ,involvement:2
sodium ,covid-19:2
sodium ,infection:2
status ,kidney:2
status ,involvement:4
status ,infection:4
kidney ,involvement:4
sars-cov-2 ,shopping:2
sars-cov-2 ,list:2
shopping ,list:2
silico ,chinese:2
silico ,herbal:2
silico ,medicine:2
screening ,chinese:4
screening ,herbal:2
screening ,medicine:2
potential ,chinese:10
potential ,herbal:4
potential ,medicine:4
herbal ,covid-19:12
biomedical ,science:2
biomedical ,tackle:2
biomedical ,covid-19:4
biomedical ,pandemic:2
biomedical ,current:2
biomedical ,status:2
biomedical ,future:2
science ,tackle:2
science ,current:2
science ,status:2
science ,future:2
tackle ,covid-19:4
tackle ,pandemic:2
tackle ,current:2
tackle ,status:2
tackle ,future:2
pandemic ,status:4
immunomodulatory-based ,therapy:2
immunomodulatory-based ,potential:2
immunomodulatory-based ,promising:2
immunomodulatory-based ,treatment:2
immunomodulatory-based ,strategy:2
therapy ,strategy:2
promising ,strategy:2
age-related ,immunological:2
age-related ,responses:2
differences ,immunological:2
differences ,responses:2
immunological ,responses:4
genetic ,polymorphisms:2
genetic ,angiotensin:2
genetic ,converting:2
genetic ,enzyme:4
genetic ,gene:4
genetic ,play:2
genetic ,role:10
polymorphisms ,angiotensin:2
polymorphisms ,converting:2
polymorphisms ,enzyme:2
polymorphisms ,ace2:2
polymorphisms ,play:2
polymorphisms ,role:2
angiotensin ,gene:2
angiotensin ,play:2
angiotensin ,role:4
converting ,gene:2
converting ,play:2
converting ,role:4
enzyme ,gene:8
enzyme ,play:2
enzyme ,role:4
ace2 ,play:2
gene ,play:2
gene ,role:4
research ,features:2
research ,mechanisms:2
research ,combined:2
progress ,clinical:4
progress ,features:2
progress ,mechanisms:2
progress ,combined:2
clinical ,combined:4
features ,mechanisms:8
features ,combined:2
mechanisms ,combined:2
detectable ,serum:2
detectable ,acute:4
detectable ,respiratory:4
detectable ,syndrome:4
detectable ,coronavirus:4
detectable ,load:2
serum ,acute:2
serum ,syndrome:2
serum ,load:6
severe ,load:2
acute ,load:2
syndrome ,load:2
understanding ,lens:2
understanding ,population:2
understanding ,health:2
understanding ,science:4
lens ,population:2
lens ,health:2
population ,science:2
health ,science:2
post ,lockdown:2
post ,covid-19:8
post ,seroprevalence:2
post ,circulation:2
post ,time:2
post ,delivery:2
lockdown ,seroprevalence:2
lockdown ,circulation:2
lockdown ,time:4
lockdown ,delivery:2
covid-19 ,seroprevalence:2
seroprevalence ,circulation:2
seroprevalence ,time:2
seroprevalence ,delivery:2
circulation ,time:2
circulation ,delivery:2
time ,delivery:2
experiences ,resuming:2
experiences ,services:4
experiences ,ent:2
experiences ,departments:2
experiences ,wuhan:2
resuming ,services:2
resuming ,ent:2
resuming ,departments:2
resuming ,wuhan:2
services ,ent:2
services ,departments:2
services ,wuhan:2
services ,covid-19:18
ent ,departments:2
ent ,wuhan:2
departments ,wuhan:2
departments ,covid-19:2
complication ,presenting:2
complication ,stemi:2
complication ,due:2
complication ,avoidance:2
complication ,medical:2
complication ,care:2
late ,presenting:6
late ,stemi:2
late ,due:2
late ,avoidance:2
late ,medical:2
late ,care:2
presenting ,stemi:2
presenting ,due:2
presenting ,avoidance:2
presenting ,medical:2
presenting ,care:2
stemi ,due:2
stemi ,avoidance:2
stemi ,medical:2
stemi ,care:2
due ,avoidance:2
due ,medical:2
due ,care:4
avoidance ,medical:4
avoidance ,care:4
medical ,care:8
establishment ,validation:4
establishment ,pseudovirus:2
establishment ,neutralization:2
establishment ,assay:2
validation ,pseudovirus:2
validation ,neutralization:2
pseudovirus ,neutralization:2
pseudovirus ,assay:4
pseudovirus ,sars-cov-2:6
neutralization ,assay:4
orf6 ,orf8:2
orf6 ,nucleocapsid:2
orf6 ,proteins:2
orf6 ,sars-cov-2:2
orf6 ,inhibit:2
orf6 ,type:2
orf6 ,interferon:2
orf8 ,nucleocapsid:2
orf8 ,proteins:2
orf8 ,inhibit:2
orf8 ,type:2
orf8 ,interferon:2
nucleocapsid ,inhibit:2
nucleocapsid ,type:2
nucleocapsid ,interferon:2
proteins ,inhibit:2
proteins ,type:2
proteins ,interferon:2
inhibit ,type:2
inhibit ,interferon:2
detection ,quantification:4
detection ,droplet:4
detection ,digital:4
quantification ,droplet:4
quantification ,digital:4
quantification ,pcr:4
quantification ,real-time:2
sars-cov-2 ,droplet:10
sars-cov-2 ,digital:8
droplet ,digital:8
droplet ,pcr:8
droplet ,real-time:2
digital ,pcr:8
digital ,real-time:2
h2s ,potential:2
h2s ,defense:2
h2s ,covid-19:2
potential ,defense:2
defense ,covid-19:4
public ,literacy:2
public ,face:4
health ,literacy:4
health ,face:2
literacy ,face:2
literacy ,covid-19:2
literacy ,pandemic:2
literacy ,emergency:2
face ,emergency:2
ct ,according:2
ct ,presentation:6
features ,according:2
features ,presentation:2
sars-cov-2 ,according:6
pneumonia ,according:2
pneumonia ,presentation:4
according ,clinical:2
according ,presentation:2
detection ,bat:2
detection ,sarbecovirus:2
detection ,phylogenetically:2
detection ,related:2
characterization ,bat:2
characterization ,sarbecovirus:2
characterization ,phylogenetically:2
characterization ,related:2
bat ,sarbecovirus:2
bat ,phylogenetically:2
bat ,related:4
sarbecovirus ,phylogenetically:2
sarbecovirus ,related:2
phylogenetically ,related:2
genomic ,colombia:2
epidemiology ,colombia:2
severe ,colombia:2
acute ,colombia:2
respiratory ,colombia:2
syndrome ,colombia:2
coronavirus ,colombia:2
covid-19 ,declined:2
mortality ,declined:2
rate ,declined:2
sars-cov-2 ,exerts:2
sars-cov-2 ,distinctive:2
sars-cov-2 ,interacting:2
exerts ,distinctive:2
exerts ,strategy:2
exerts ,interacting:2
exerts ,ace2:2
exerts ,human:2
distinctive ,strategy:2
distinctive ,interacting:2
distinctive ,ace2:2
distinctive ,human:2
strategy ,interacting:2
strategy ,ace2:2
strategy ,human:2
interacting ,ace2:2
interacting ,human:2
immune ,lessons:4
immune ,learned:2
immune ,sars:2
responses ,potential:4
responses ,vaccines:2
responses ,lessons:4
responses ,learned:2
responses ,sars:4
potential ,vaccines:6
potential ,lessons:2
potential ,learned:2
vaccines ,lessons:4
vaccines ,learned:2
vaccines ,sars:4
assessing ,effects:2
assessing ,exposure:2
assessing ,re-positive:2
assessing ,patient:2
assessing ,healthcare:2
effects ,exposure:2
effects ,re-positive:2
effects ,patient:4
effects ,healthcare:4
exposure ,re-positive:2
exposure ,patient:4
sars-cov-2 ,re-positive:2
re-positive ,patient:2
re-positive ,healthcare:2
patient ,healthcare:2
sars-cov-2 ,rationale:4
inflammatory ,clinical:10
inflammatory ,features:2
inflammatory ,rationale:2
inflammatory ,immunological:2
syndrome ,rationale:2
syndrome ,immunological:4
clinical ,rationale:4
clinical ,immunological:4
features ,rationale:2
features ,immunological:4
rationale ,immunological:2
evolutionary ,d614g:2
evolutionary ,spike:2
evolutionary ,protein:4
evolutionary ,mutation:4
evolutionary ,now:2
structural ,analyses:2
structural ,mutation:2
structural ,now:2
analyses ,d614g:2
analyses ,spike:2
analyses ,protein:2
analyses ,mutation:2
analyses ,now:2
d614g ,mutation:4
d614g ,now:2
spike ,now:2
protein ,mutation:6
protein ,now:2
mutation ,now:2
mental ,state:2
mental ,risk:2
mental ,factors:4
mental ,chinese:2
mental ,medical:2
mental ,staff:2
mental ,students:2
state ,risk:2
state ,factors:2
state ,chinese:2
state ,medical:2
state ,staff:2
state ,students:2
risk ,chinese:2
risk ,students:2
factors ,chinese:2
factors ,medical:2
factors ,staff:4
factors ,students:2
chinese ,medical:2
chinese ,staff:2
chinese ,students:2
staff ,students:2
lack ,antibody-mediated:2
lack ,cross-protection:2
lack ,sars-cov:2
antibody-mediated ,cross-protection:2
antibody-mediated ,sars-cov-2:2
antibody-mediated ,sars-cov:2
cross-protection ,sars-cov-2:2
cross-protection ,sars-cov:2
correlation ,d-xylose:2
correlation ,severity:8
correlation ,morbidity-related:2
correlation ,factors:2
d-xylose ,severity:2
d-xylose ,morbidity-related:2
d-xylose ,factors:2
d-xylose ,covid-19:2
severity ,morbidity-related:2
morbidity-related ,factors:2
morbidity-related ,covid-19:2
questions ,asked:2
questions ,two:2
questions ,examples:2
questions ,dilemmas:2
questions ,publication:2
questions ,ethics:2
asked ,two:2
asked ,examples:2
asked ,dilemmas:2
asked ,publication:2
asked ,ethics:2
two ,examples:2
two ,dilemmas:2
two ,publication:2
two ,ethics:2
examples ,dilemmas:2
examples ,publication:2
examples ,ethics:2
dilemmas ,publication:2
dilemmas ,ethics:2
publication ,ethics:2
planning ,covid-19:8
planning ,vaccines:2
planning ,safety:2
planning ,surveillance:2
vaccines ,safety:2
vaccines ,surveillance:2
safety ,surveillance:2
headache ,pleocytosis:2
headache ,csf:2
headache ,associated:4
headache ,covid-19:6
headache ,case:2
headache ,report:2
pleocytosis ,csf:2
pleocytosis ,associated:2
pleocytosis ,covid-19:2
pleocytosis ,case:2
pleocytosis ,report:2
csf ,associated:2
csf ,covid-19:2
csf ,case:2
csf ,report:2
associated ,report:8
neurological ,article:2
manifestations ,article:2
sars ,covs:2
sars ,moving:2
sars ,toward:2
sars ,biased:2
sars ,codon:2
sars ,usage:2
mers ,covs:2
mers ,moving:2
mers ,toward:2
mers ,biased:2
mers ,codon:2
mers ,usage:2
covs ,sars-cov-2:2
covs ,moving:2
covs ,toward:2
covs ,biased:2
covs ,codon:2
covs ,usage:2
sars-cov-2 ,moving:2
sars-cov-2 ,toward:6
sars-cov-2 ,biased:2
moving ,toward:2
moving ,biased:2
moving ,codon:2
moving ,usage:2
toward ,biased:2
toward ,codon:2
toward ,usage:2
biased ,codon:2
biased ,usage:2
silico ,admet:2
silico ,searching:2
silico ,inhibitors:6
admet ,molecular:2
admet ,docking:2
admet ,study:2
admet ,searching:2
admet ,potential:2
admet ,inhibitors:2
molecular ,searching:2
molecular ,potential:4
molecular ,inhibitors:4
docking ,searching:2
docking ,potential:2
docking ,inhibitors:2
study ,searching:2
study ,inhibitors:4
searching ,potential:2
searching ,inhibitors:2
prospects ,sars-cov-2:4
prospects ,pandemic:2
prospects ,africa:2
pandemic ,africa:4
flight-associated ,transmission:2
flight-associated ,severe:2
flight-associated ,acute:2
flight-associated ,respiratory:2
flight-associated ,syndrome:2
flight-associated ,coronavirus:2
pentoxifylline ,oxypurinol:2
pentoxifylline ,drugs:2
pentoxifylline ,prevent:2
pentoxifylline ,cytokine:4
pentoxifylline ,release:2
oxypurinol ,potential:2
oxypurinol ,drugs:2
oxypurinol ,prevent:2
oxypurinol ,cytokine:2
oxypurinol ,release:2
potential ,prevent:4
potential ,release:2
drugs ,prevent:2
drugs ,cytokine:2
drugs ,release:2
prevent ,cytokine:4
prevent ,release:2
addressing ,multiple:2
addressing ,gastroenterological:2
addressing ,aspects:2
addressing ,coronavirus:4
addressing ,disease:4
multiple ,gastroenterological:2
multiple ,aspects:2
gastroenterological ,aspects:2
gastroenterological ,coronavirus:2
gastroenterological ,disease:2
ultrasonography ,sars-cov:2
ultrasonography ,infection:2
ultrasonography ,review:2
ultrasonography ,know:2
ultrasonography ,yet:2
sars-cov ,know:2
sars-cov ,yet:2
infection ,know:2
review ,yet:2
know ,yet:2
role ,neutrophil:2
role ,chemoattractant:2
role ,cxcl5:2
role ,infection-induced:2
role ,lung:6
neutrophil ,chemoattractant:2
neutrophil ,cxcl5:2
neutrophil ,sars-cov-2:2
neutrophil ,infection-induced:2
neutrophil ,lung:4
chemoattractant ,cxcl5:2
chemoattractant ,sars-cov-2:2
chemoattractant ,infection-induced:2
chemoattractant ,lung:2
cxcl5 ,sars-cov-2:2
cxcl5 ,infection-induced:2
cxcl5 ,lung:2
infection-induced ,lung:2
clinical ,115:2
features ,115:2
children ,115:2
sars-cov-2 ,115:2
infection ,115:2
analysis ,115:4
115 ,cases:4
synergistic ,plant-based:2
synergistic ,molecules:2
antiviral ,plant-based:2
antiviral ,molecules:2
effects ,plant-based:2
effects ,molecules:2
sars-cov-2 ,plant-based:2
plant-based ,molecules:2
use ,corticosteroids:4
use ,critically:4
use ,ill:4
corticosteroids ,critically:2
corticosteroids ,ill:2
corticosteroids ,patients:4
corticosteroids ,sars-cov-2:2
critically ,sars-cov-2:10
ill ,sars-cov-2:8
spike ,beat:2
risk ,turin:2
sars-cov-2 ,turin:2
infection ,turin:2
healthcare ,turin:2
healthcare ,italy:2
workers ,turin:2
workers ,italy:2
turin ,italy:2
onabotulinumtoxina ,infiltration:2
onabotulinumtoxina ,nerve:2
onabotulinumtoxina ,blocks:2
onabotulinumtoxina ,patients:2
onabotulinumtoxina ,headache:2
infiltration ,nerve:2
infiltration ,blocks:2
infiltration ,patients:2
infiltration ,headache:2
nerve ,blocks:2
nerve ,patients:2
nerve ,headache:2
blocks ,patients:2
blocks ,headache:2
biological ,rationale:2
biological ,repurposing:2
biological ,bcg:2
biological ,vaccine:2
rationale ,repurposing:2
rationale ,bcg:2
rationale ,vaccine:2
repurposing ,bcg:2
diagnostic ,performances:2
diagnostic ,thresholds:2
diagnostic ,harmonization:2
performances ,thresholds:2
performances ,key:2
performances ,harmonization:2
performances ,serological:2
thresholds ,key:2
thresholds ,harmonization:2
thresholds ,serological:2
key ,harmonization:2
key ,serological:2
harmonization ,serological:2
maternal ,consequences:2
maternal ,infection:2
neonatal ,consequences:2
consequences ,coronavirus:2
interferon-2b ,spray:2
interferon-2b ,inhalation:2
interferon-2b ,shorten:2
interferon-2b ,virus:2
interferon-2b ,shedding:2
interferon-2b ,time:2
interferon-2b ,sars-cov-2:2
spray ,inhalation:2
spray ,shorten:2
spray ,virus:2
spray ,shedding:2
spray ,time:2
spray ,sars-cov-2:2
inhalation ,shorten:2
inhalation ,virus:2
inhalation ,shedding:2
inhalation ,time:2
inhalation ,sars-cov-2:2
shorten ,virus:2
shorten ,shedding:4
shorten ,time:2
shorten ,sars-cov-2:2
coronavirus ,renin-angiotensin:6
coronavirus ,closer:2
coronavirus ,look:2
disease ,renin-angiotensin:4
disease ,closer:2
disease ,look:2
covid-19 ,closer:2
renin-angiotensin ,closer:2
renin-angiotensin ,look:2
system ,closer:2
system ,look:2
natural ,pathobiology:2
natural ,clinical:4
natural ,manifestations:2
history ,pathobiology:2
history ,clinical:2
history ,manifestations:2
history ,sars-cov-2:6
pathobiology ,clinical:2
pathobiology ,manifestations:2
pathobiology ,sars-cov-2:2
comparison ,automated:8
automated ,antigen:2
automated ,covid-19:2
automated ,infection:2
antigen ,infection:2
test ,infection:4
guidance ,special:2
guidance ,liver:2
guidance ,kidney:2
guidance ,transplant:2
guidance ,recipients:2
guidance ,diagnosed:2
special ,care:4
special ,liver:2
special ,kidney:2
special ,transplant:2
special ,recipients:2
special ,diagnosed:2
care ,liver:6
care ,kidney:2
care ,transplant:2
care ,recipients:2
care ,diagnosed:2
liver ,kidney:2
liver ,transplant:12
liver ,recipients:2
liver ,diagnosed:2
kidney ,diagnosed:4
transplant ,diagnosed:4
recipients ,diagnosed:2
complete ,post-mortem:2
complete ,data:2
complete ,fatal:2
complete ,case:2
complete ,covid-19:4
complete ,clinical:2
complete ,radiological:2
post-mortem ,data:2
post-mortem ,fatal:2
post-mortem ,clinical:2
post-mortem ,radiological:2
data ,fatal:2
data ,radiological:2
fatal ,case:4
fatal ,clinical:2
fatal ,radiological:2
case ,clinical:14
case ,radiological:2
sars-cov-2 ,psoriatic:2
sars-cov-2 ,il-17:2
infection ,il-17:2
infection ,inhibitor:4
psoriatic ,patient:2
psoriatic ,il-17:2
psoriatic ,inhibitor:2
patient ,il-17:2
patient ,inhibitor:2
treated ,il-17:2
treated ,inhibitor:2
il-17 ,inhibitor:2
loss ,patients:2
comparison ,commonly:2
comparison ,used:2
analytical ,sensitivity:2
analytical ,seven:4
analytical ,commonly:2
analytical ,used:2
analytical ,commercial:2
sensitivity ,seven:2
sensitivity ,commonly:2
sensitivity ,used:2
sensitivity ,commercial:2
seven ,commonly:2
seven ,used:2
commonly ,used:2
commonly ,commercial:2
used ,commercial:2
review ,early:8
review ,experience:4
review ,lung:8
review ,ultrasound:6
early ,lung:4
early ,ultrasound:4
experience ,lung:2
experience ,ultrasound:2
experience ,diagnosis:2
lung ,diagnosis:4
ultrasound ,diagnosis:4
ultrasound ,management:2
neurological ,due:2
symptoms ,due:4
symptoms ,coronavirus:4
symptoms ,disease:6
due ,coronavirus:12
sars-cov-2 ,topology:2
sars-cov-2 ,eukaryotic:2
sars-cov-2 ,membranes:2
envelope ,topology:2
envelope ,eukaryotic:2
envelope ,membranes:2
protein ,topology:2
protein ,eukaryotic:2
protein ,membranes:2
topology ,eukaryotic:2
topology ,membranes:2
eukaryotic ,membranes:2
antibody ,results:6
antibody ,tell:2
antibody ,us:2
tests ,results:4
tests ,tell:2
tests ,us:2
covid-19 ,tell:2
results ,tell:2
results ,us:2
tell ,us:4
rate ,venous:2
rate ,thromboembolism:2
rate ,prospective:2
rate ,all-comers:2
rate ,cohort:2
venous ,thromboembolism:18
venous ,prospective:4
venous ,all-comers:2
venous ,cohort:2
venous ,covid-19:20
thromboembolism ,prospective:4
thromboembolism ,all-comers:2
thromboembolism ,cohort:2
thromboembolism ,covid-19:20
prospective ,all-comers:2
prospective ,cohort:6
all-comers ,cohort:2
all-comers ,covid-19:2
detection ,contamination:2
evaluation ,nucleic:4
evaluation ,acid:4
evaluation ,contamination:2
evaluation ,corona:2
nucleic ,contamination:2
nucleic ,corona:2
nucleic ,virus:2
acid ,contamination:2
acid ,corona:2
acid ,virus:4
contamination ,corona:2
reduction ,functional:2
reduction ,exhaustion:2
reduction ,cells:2
reduction ,patients:4
reduction ,coronavirus:2
reduction ,disease:2
functional ,exhaustion:2
functional ,cells:2
functional ,patients:4
functional ,coronavirus:2
functional ,disease:2
exhaustion ,cells:2
exhaustion ,patients:2
exhaustion ,coronavirus:2
exhaustion ,disease:2
covid-19 ,front-line:4
covid-19 ,england:2
prepared ,front-line:2
prepared ,healthcare:2
prepared ,workers:2
prepared ,england:2
front-line ,healthcare:2
front-line ,workers:2
front-line ,england:2
healthcare ,england:2
workers ,england:2
prominent ,changes:2
prominent ,blood:2
prominent ,coagulation:4
prominent ,patients:2
prominent ,sars-cov-2:2
prominent ,infection:2
changes ,blood:4
changes ,coagulation:4
changes ,patients:22
changes ,infection:6
blood ,coagulation:4
coagulation ,patients:10
coagulation ,infection:2
efficacy ,internet-based:2
efficacy ,integrated:2
efficacy ,intervention:2
efficacy ,depression:2
efficacy ,anxiety:2
internet-based ,integrated:2
internet-based ,intervention:2
internet-based ,depression:2
internet-based ,anxiety:2
integrated ,intervention:2
integrated ,depression:2
integrated ,anxiety:2
intervention ,depression:2
intervention ,anxiety:2
anti-cd20 ,therapy:2
anti-cd20 ,jeopardise:2
anti-cd20 ,efficacy:2
anti-cd20 ,sars-cov-2:2
anti-cd20 ,vaccine:2
therapy ,jeopardise:2
therapy ,efficacy:2
therapy ,vaccine:2
jeopardise ,efficacy:2
jeopardise ,sars-cov-2:2
jeopardise ,vaccine:2
efficacy ,vaccine:2
characteristics ,241:2
characteristics ,births:2
outcomes ,241:2
outcomes ,births:2
outcomes ,severe:12
outcomes ,acute:6
outcomes ,respiratory:6
241 ,births:2
241 ,women:2
241 ,severe:2
241 ,acute:2
241 ,respiratory:2
births ,women:2
births ,severe:2
births ,acute:2
births ,respiratory:2
presenting ,hepatic:2
presenting ,failure:4
presenting ,report:6
fulminant ,hepatic:4
fulminant ,report:2
hepatic ,failure:4
hepatic ,case:2
hepatic ,report:2
failure ,report:2
65-year-old ,woman:2
65-year-old ,history:2
65-year-old ,type:2
65-year-old ,diabetes:2
65-year-old ,mellitus:2
65-year-old ,hypertension:2
woman ,history:2
woman ,type:2
woman ,diabetes:2
woman ,mellitus:2
woman ,hypertension:2
history ,type:2
history ,diabetes:2
history ,mellitus:2
history ,hypertension:4
type ,hypertension:2
mellitus ,hypertension:4
insights ,transmission:4
insights ,ocular:2
insights ,surface:2
performing ,nasopharyngeal:2
performing ,oropharyngeal:2
performing ,swab:2
performing ,2019-novel:2
performing ,coronavirus:4
nasopharyngeal ,2019-novel:2
nasopharyngeal ,coronavirus:4
oropharyngeal ,2019-novel:2
oropharyngeal ,coronavirus:2
swab ,2019-novel:2
swab ,coronavirus:2
current ,antiviral:2
current ,strategies:8
perspective ,antiviral:2
perspective ,strategies:2
antiviral ,strategies:2
infection ,ophthalmology:4
control ,ophthalmology:4
measures ,ophthalmology:4
ophthalmology ,outbreak:6
covid-19-a ,novel:2
covid-19-a ,zoonotic:2
covid-19-a ,disease:2
covid-19-a ,review:2
covid-19-a ,virus:2
covid-19-a ,public:2
zoonotic ,review:2
zoonotic ,virus:2
zoonotic ,public:2
covid-19 ,discharge:6
patients ,discharge:6
patients ,fatality:4
clinical ,discharge:2
clinical ,rate:2
clinical ,fatality:2
characteristics ,discharge:2
characteristics ,rate:4
characteristics ,fatality:2
discharge ,rate:2
discharge ,fatality:2
characterization ,severe:6
characterization ,acute:8
characterization ,respiratory:6
characterization ,syndrome:4
characterization ,stability:2
severe ,stability:4
acute ,stability:4
respiratory ,stability:4
syndrome ,stability:4
coronavirus ,stability:8
work ,inpatient:2
work ,care:2
work ,units:2
work ,associated:4
work ,increased:2
inpatient ,care:6
inpatient ,units:2
inpatient ,associated:2
inpatient ,increased:2
inpatient ,risk:2
inpatient ,sars-cov-2:4
units ,associated:2
units ,increased:2
units ,risk:2
associated ,increased:8
will ,teledermatology:2
will ,silver:2
will ,lining:2
teledermatology ,silver:2
teledermatology ,lining:2
teledermatology ,covid-19:2
treatment ,children:4
treatment ,position:6
treatment ,paper:4
treatment ,italian:2
treatment ,society:2
children ,position:2
children ,paper:2
children ,italian:6
children ,society:4
summary ,20:2
summary ,tracheal:2
summary ,intubation:2
summary ,anesthesiologists:2
summary ,patients:2
summary ,severe:4
20 ,tracheal:2
20 ,intubation:2
20 ,anesthesiologists:2
20 ,patients:2
20 ,severe:2
tracheal ,intubation:2
tracheal ,anesthesiologists:2
tracheal ,patients:2
tracheal ,severe:2
intubation ,anesthesiologists:2
intubation ,patients:4
intubation ,severe:2
anesthesiologists ,patients:2
anesthesiologists ,severe:2
sars-cov-2 ,raging:2
storm ,raging:2
multicentre ,comparison:2
multicentre ,quantitative:2
multicentre ,pcr-based:2
multicentre ,assays:2
multicentre ,detect:2
multicentre ,sars-cov-2:6
comparison ,quantitative:2
comparison ,pcr-based:2
comparison ,detect:2
quantitative ,pcr-based:2
quantitative ,assays:2
quantitative ,detect:2
pcr-based ,assays:2
pcr-based ,detect:2
pcr-based ,sars-cov-2:4
children ,newborns:2
newborns ,systematic:4
newborns ,review:4
simulation-based ,training:4
simulation-based ,assessment:2
simulation-based ,mobile:2
simulation-based ,pre-hospital:2
simulation-based ,sars-cov-2:2
training ,assessment:2
training ,mobile:2
training ,pre-hospital:2
assessment ,mobile:2
assessment ,pre-hospital:2
mobile ,pre-hospital:2
mobile ,sars-cov-2:2
pre-hospital ,sars-cov-2:2
detectable ,feces:2
detectable ,three:2
detectable ,children:2
detectable ,recovery:2
detectable ,period:2
viral ,three:4
viral ,recovery:2
viral ,period:4
rna ,recovery:4
rna ,period:2
feces ,three:2
feces ,recovery:2
feces ,period:2
three ,recovery:2
three ,period:4
children ,recovery:2
children ,period:2
recovery ,period:2
sars-cov-2 ,outpatients-most:2
infections ,cancer:4
infections ,outpatients-most:2
infections ,infected:2
infections ,asymptomatic:12
cancer ,outpatients-most:2
cancer ,asymptomatic:4
outpatients-most ,infected:2
outpatients-most ,patients:2
outpatients-most ,asymptomatic:2
chest ,ct-scan:2
chest ,finding:2
chest ,asymptomatic:4
chest ,prospective:2
chest ,542:2
ct-scan ,finding:2
ct-scan ,asymptomatic:2
ct-scan ,covid-19:2
ct-scan ,pneumonia:2
ct-scan ,prospective:2
ct-scan ,542:2
finding ,asymptomatic:2
finding ,covid-19:6
finding ,pneumonia:2
finding ,prospective:2
finding ,542:2
asymptomatic ,prospective:2
asymptomatic ,542:2
covid-19 ,542:2
pneumonia ,prospective:2
pneumonia ,542:2
prospective ,542:2
detection ,japan:2
detection ,outbreak:2
wastewater ,japan:2
wastewater ,outbreak:2
ms ,pregnancy:2
can ,3d:2
can ,printing:2
can ,oral:2
can ,drugs:2
can ,current:2
can ,similar:2
3d ,printing:2
3d ,oral:2
3d ,drugs:2
3d ,help:2
3d ,fight:2
3d ,current:2
3d ,pandemic:2
3d ,similar:2
printing ,oral:2
printing ,drugs:2
printing ,help:2
printing ,fight:2
printing ,current:2
printing ,covid-19:2
printing ,pandemic:4
printing ,similar:2
oral ,drugs:2
oral ,help:2
oral ,fight:2
oral ,current:2
oral ,similar:2
drugs ,help:2
drugs ,current:4
drugs ,pandemic:4
drugs ,similar:2
help ,current:2
help ,pandemic:2
help ,similar:2
fight ,current:4
fight ,pandemic:4
fight ,similar:2
current ,similar:2
pandemic ,similar:2
analysis ,respiratory:6
codon ,severe:2
codon ,acute:2
codon ,respiratory:4
codon ,syndrome:2
codon ,corona:2
codon ,virus:4
usage ,severe:2
usage ,acute:2
usage ,respiratory:4
usage ,syndrome:2
usage ,corona:2
usage ,virus:2
severe ,corona:2
acute ,corona:2
respiratory ,corona:2
syndrome ,corona:2
syndrome ,virus:4
new ,severe:8
new ,syndrome:8
new ,wuhan:2
severe ,wuhan:2
acute ,wuhan:2
respiratory ,wuhan:2
syndrome ,wuhan:2
evolutionary ,non-structural:2
evolutionary ,nsp6:2
analysis ,mutation:2
analysis ,non-structural:2
analysis ,nsp6:2
sars-cov-2 ,non-structural:2
sars-cov-2 ,nsp6:2
mutation ,non-structural:2
mutation ,nsp6:2
non-structural ,protein:4
non-structural ,nsp6:2
protein ,nsp6:2
pre-exposure ,high-risk:2
pre-exposure ,healthcare:2
pre-exposure ,workers:2
prophylaxis ,high-risk:2
prophylaxis ,healthcare:2
prophylaxis ,workers:2
hydroxychloroquine ,high-risk:2
hydroxychloroquine ,workers:2
high-risk ,healthcare:2
high-risk ,workers:2
clinical ,55:2
outcomes ,55:2
outcomes ,syndrome:4
55 ,patients:2
55 ,severe:2
55 ,acute:2
55 ,respiratory:2
55 ,syndrome:2
55 ,coronavirus:2
overview ,prevention:2
overview ,management:2
overview ,light:2
overview ,unani:2
overview ,medicine:2
covid-19 ,unani:2
prevention ,light:2
prevention ,unani:2
management ,light:4
management ,unani:2
management ,medicine:4
light ,unani:2
light ,medicine:2
unani ,medicine:2
validation ,detection:2
validation ,across:2
validation ,multiple:4
validation ,specimen:2
validation ,types:2
detection ,across:4
across ,multiple:2
across ,specimen:2
across ,types:2
multiple ,specimen:2
multiple ,types:4
specimen ,types:4
quantifying ,improvement:2
quantifying ,confirmation:2
quantifying ,efficiency:2
quantifying ,severe:2
quantifying ,acute:2
improvement ,confirmation:2
improvement ,efficiency:2
improvement ,severe:4
improvement ,acute:4
confirmation ,efficiency:2
confirmation ,severe:2
confirmation ,acute:2
efficiency ,severe:2
efficiency ,acute:2
thyroid ,cancer:6
thyroid ,era:2
thyroid ,covid-19:10
fecal ,clinical:4
fecal ,significance:2
fecal ,load:2
viral ,significance:4
shedding ,significance:2
shedding ,load:2
clinical ,load:8
significance ,load:4
management ,ophthalmology:2
pediatric ,ophthalmology:2
pediatric ,outbreak:6
ophthalmology ,patients:2
potential ,danger:2
potential ,suboptimal:2
danger ,suboptimal:2
danger ,antibody:2
danger ,responses:2
suboptimal ,antibody:2
suboptimal ,responses:2
suboptimal ,covid-19:2
preliminary ,data:2
preliminary ,quantitative:2
preliminary ,point:2
preliminary ,care:2
preliminary ,test:2
preliminary ,antibodies:2
data ,quantitative:2
data ,point:2
data ,care:2
data ,test:4
data ,antibodies:2
quantitative ,point:2
quantitative ,care:2
quantitative ,test:2
quantitative ,antibodies:2
point ,care:4
point ,test:4
point ,antibodies:2
care ,test:4
test ,antibodies:4
apparent ,occult:2
apparent ,infections:2
apparent ,medical:2
apparent ,staff:2
apparent ,covid-19:2
apparent ,designated:2
apparent ,hospital:2
occult ,infections:2
occult ,medical:2
occult ,staff:2
occult ,covid-19:2
occult ,designated:2
occult ,hospital:2
infections ,medical:2
infections ,staff:2
infections ,designated:2
infections ,hospital:2
medical ,designated:2
staff ,designated:2
covid-19 ,designated:4
designated ,hospital:6
autopsy ,time:2
autopsy ,protocol:2
time ,protocol:2
time ,lessons:4
sars-cov-2 ,protocol:8
protocol ,lessons:2
antioxidant ,therapy:2
antioxidant ,useful:2
antioxidant ,complementary:2
antioxidant ,measure:2
antioxidant ,covid-19:4
antioxidant ,treatment:2
therapy ,useful:4
therapy ,complementary:2
therapy ,measure:2
useful ,complementary:2
useful ,measure:2
useful ,treatment:2
complementary ,measure:2
complementary ,covid-19:2
complementary ,treatment:2
measure ,covid-19:2
measure ,treatment:2
recommendations ,nail:2
recommendations ,psoriasis:2
treatment ,nail:2
treatment ,psoriasis:4
nail ,psoriasis:2
nail ,covid-19:2
nail ,pandemic:2
psoriasis ,covid-19:6
psoriasis ,pandemic:4
neurological ,meningoencephalitis:2
manifestations ,meningoencephalitis:2
manifestations ,encephalopathy:2
covid-19 ,meningoencephalitis:2
covid-19 ,encephalopathy:8
meningoencephalitis ,encephalopathy:2
potential ,short-term:4
potential ,outcome:2
potential ,uncontrolled:2
potential ,lombardy:2
short-term ,outcome:2
short-term ,uncontrolled:2
short-term ,covid-19:6
short-term ,epidemic:2
short-term ,lombardy:2
outcome ,uncontrolled:2
outcome ,epidemic:6
outcome ,lombardy:2
uncontrolled ,covid-19:2
uncontrolled ,epidemic:2
uncontrolled ,lombardy:2
epidemic ,lombardy:4
novel ,resistance:2
novel ,african:2
novel ,populations:2
novel ,worth:2
coronavirus ,resistance:2
coronavirus ,african:2
coronavirus ,populations:4
coronavirus ,worth:2
sars-cov-2 ,resistance:2
sars-cov-2 ,populations:2
sars-cov-2 ,worth:2
resistance ,african:2
resistance ,populations:2
resistance ,cause:2
resistance ,worth:2
african ,populations:2
african ,cause:2
african ,worth:2
populations ,cause:2
populations ,worth:2
cause ,worth:2
possible ,4-aminoquinolines:2
mechanisms ,4-aminoquinolines:2
action ,4-aminoquinolines:2
clinical ,tools:2
clinical ,cardiorespiratory:2
clinical ,rehabilitation:2
clinical ,primary:4
tools ,cardiorespiratory:2
tools ,assessment:2
tools ,rehabilitation:2
tools ,primary:2
tools ,care:4
cardiorespiratory ,assessment:2
cardiorespiratory ,rehabilitation:2
cardiorespiratory ,primary:2
cardiorespiratory ,care:2
assessment ,rehabilitation:2
assessment ,primary:2
assessment ,care:2
rehabilitation ,primary:2
rehabilitation ,care:4
origin ,theories:2
origin ,keys:2
origin ,unknowns:2
origin ,emerged:2
sars-cov-2 ,theories:2
sars-cov-2 ,keys:2
theories ,keys:2
theories ,unknowns:2
theories ,emerged:2
theories ,disease:2
keys ,unknowns:2
keys ,emerged:2
keys ,disease:4
unknowns ,emerged:2
preparedness ,european:2
preparedness ,diagnostic:4
preparedness ,microbiology:2
preparedness ,labs:2
preparedness ,detection:2
preparedness ,sars-cov-2:4
european ,diagnostic:2
european ,microbiology:2
european ,labs:2
european ,detection:2
european ,sars-cov-2:2
diagnostic ,microbiology:2
diagnostic ,labs:2
microbiology ,labs:2
microbiology ,sars-cov-2:2
labs ,detection:2
labs ,sars-cov-2:2
antibody ,binding:2
antibody ,glycoprotein:2
antibody ,correlates:2
binding ,glycoprotein:2
binding ,correlates:2
binding ,predict:2
glycoprotein ,correlates:2
glycoprotein ,predict:2
correlates ,predict:2
features ,first:2
first ,cluster:2
management ,prostate:2
prostate ,patients:6
prostate ,covid-19:8
prostate ,pandemic:2
inhibition ,type:2
inhibition ,iii:2
inhibition ,interferons:2
sars-cov-2 ,iii:6
three-tiered ,covid-19:2
three-tiered ,cohorting:2
three-tiered ,strategy:2
three-tiered ,implications:2
three-tiered ,memory-care:2
covid-19 ,memory-care:2
cohorting ,strategy:2
cohorting ,implications:2
cohorting ,memory-care:2
strategy ,implications:2
strategy ,memory-care:2
implications ,memory-care:2
coronavirus ,doubling:2
disease ,doubling:2
epidemic ,united:4
epidemic ,states:4
doubling ,united:2
doubling ,states:2
time ,united:4
time ,states:2
identifying ,kidney:2
identifying ,transplant:2
identifying ,recipient:2
identifying ,covid:2
identifying ,phenotype:2
identifying ,aid:2
identifying ,test:2
identifying ,utilization:2
kidney ,covid:2
kidney ,phenotype:2
kidney ,aid:2
kidney ,test:2
kidney ,utilization:2
transplant ,covid:2
transplant ,phenotype:2
transplant ,aid:2
transplant ,test:2
transplant ,utilization:2
recipient ,covid:2
recipient ,phenotype:2
recipient ,aid:2
recipient ,test:2
recipient ,utilization:2
covid ,aid:2
covid ,test:2
covid ,utilization:2
phenotype ,aid:2
phenotype ,test:2
phenotype ,utilization:2
aid ,test:2
aid ,utilization:2
test ,utilization:2
rationale ,ozone-therapy:2
rationale ,adjuvant:2
rationale ,therapy:2
rationale ,covid-19:4
rationale ,narrative:2
rationale ,review:2
ozone-therapy ,adjuvant:2
ozone-therapy ,therapy:2
ozone-therapy ,covid-19:2
ozone-therapy ,narrative:2
ozone-therapy ,review:2
adjuvant ,narrative:2
adjuvant ,review:2
therapy ,narrative:2
therapy ,review:8
pituitary ,apoplexy:2
pituitary ,associated:2
pituitary ,acute:2
pituitary ,pregnancy:2
apoplexy ,associated:2
apoplexy ,acute:2
apoplexy ,covid-19:2
apoplexy ,infection:2
apoplexy ,pregnancy:2
associated ,pregnancy:2
relative ,contributions:2
relative ,transmission:2
relative ,routes:2
relative ,covid-19:4
relative ,among:2
relative ,healthcare:2
contributions ,transmission:2
contributions ,routes:2
contributions ,covid-19:6
contributions ,among:2
contributions ,healthcare:2
routes ,among:2
routes ,healthcare:2
knowledge ,attitude:6
knowledge ,healthcare:6
knowledge ,workers:4
knowledge ,towards:8
attitude ,practice:2
attitude ,healthcare:4
attitude ,workers:4
attitude ,towards:4
attitude ,coronavirus:4
attitude ,disease:2
practice ,workers:2
practice ,towards:2
practice ,disease:6
healthcare ,towards:4
healthcare ,disease:8
workers ,towards:4
workers ,disease:6
towards ,disease:2
first ,tocilizumab:4
first ,iceland:2
case ,tocilizumab:8
case ,iceland:2
covid-19 ,tocilizumab:16
covid-19 ,iceland:2
treated ,tocilizumab:2
treated ,iceland:2
tocilizumab ,iceland:2
covid-19 ,hemoptysis:2
covid-19 ,segmental:2
covid-19 ,emboli:2
pneumonia ,hemoptysis:2
pneumonia ,segmental:2
pneumonia ,emboli:2
hemoptysis ,acute:2
hemoptysis ,segmental:2
hemoptysis ,pulmonary:2
hemoptysis ,emboli:2
hemoptysis ,associated:2
acute ,segmental:4
acute ,emboli:2
segmental ,pulmonary:2
segmental ,emboli:2
segmental ,associated:2
pulmonary ,emboli:2
emboli ,associated:2
case ,masquerading:2
case ,surgical:2
case ,abdomen:4
report ,masquerading:2
report ,surgical:2
report ,abdomen:2
covid-19 ,abdomen:2
masquerading ,acute:2
masquerading ,surgical:2
masquerading ,abdomen:2
surgical ,abdomen:2
reduce ,potential:2
reduce ,vertical:2
potential ,vertical:6
risk ,vertical:2
controlling ,covid-19:6
controlling ,pandemic:4
controlling ,vietnam:2
controlling ,lessons:2
controlling ,limited:2
controlling ,resource:2
covid-19 ,vietnam:6
covid-19 ,limited:8
covid-19 ,resource:10
pandemic ,vietnam:2
pandemic ,limited:2
pandemic ,resource:4
vietnam ,lessons:2
vietnam ,limited:2
vietnam ,resource:2
lessons ,limited:2
lessons ,resource:2
limited ,resource:2
dispersion ,new:2
dispersion ,coronavirus:2
dispersion ,sars-cov-2:2
dispersion ,airlines:2
dispersion ,temporal:2
dispersion ,estimates:2
new ,airlines:2
new ,temporal:2
new ,estimates:2
coronavirus ,airlines:2
coronavirus ,temporal:4
coronavirus ,estimates:4
sars-cov-2 ,airlines:2
sars-cov-2 ,estimates:6
airlines ,temporal:2
airlines ,estimates:2
temporal ,estimates:2
viral ,antibody:6
viral ,responses:4
load ,antibody:4
load ,responses:2
load ,case:2
load ,convalescent:2
load ,plasma:2
antibody ,case:4
responses ,case:2
responses ,plasma:2
case ,convalescent:2
case ,plasma:2
repurposing ,fda-approved:2
repurposing ,toremifene:2
repurposing ,treat:4
repurposing ,blocking:2
repurposing ,spike:4
fda-approved ,toremifene:2
fda-approved ,treat:2
fda-approved ,covid-19:2
fda-approved ,blocking:2
fda-approved ,spike:2
toremifene ,treat:2
toremifene ,covid-19:2
toremifene ,blocking:2
toremifene ,spike:2
treat ,blocking:2
treat ,spike:2
covid-19 ,blocking:2
nursing ,standard:2
nursing ,internet-based:2
nursing ,rehabilitation:2
nursing ,patients:2
nursing ,coronavirus:2
standard ,internet-based:2
standard ,rehabilitation:2
standard ,coronavirus:2
internet-based ,rehabilitation:2
internet-based ,patients:2
internet-based ,coronavirus:2
rehabilitation ,coronavirus:2
body ,mass:2
body ,index:2
body ,prognosis:2
body ,systematic:4
body ,review:4
mass ,index:2
mass ,prognosis:2
mass ,infection:2
mass ,systematic:2
mass ,review:2
index ,prognosis:2
index ,systematic:2
index ,review:2
prognosis ,infection:4
childcare ,exposure:2
childcare ,severe:2
childcare ,acute:2
childcare ,respiratory:2
childcare ,syndrome:2
childcare ,coronavirus:2
childcare ,4-year-old:2
exposure ,4-year-old:2
severe ,4-year-old:2
acute ,4-year-old:2
respiratory ,4-year-old:2
syndrome ,4-year-old:2
coronavirus ,4-year-old:2
case ,recovery:4
case ,triple:2
case ,mycobacterium:2
report ,recovery:4
report ,triple:2
report ,mycobacterium:2
covid-19 ,triple:2
covid-19 ,mycobacterium:2
recovery ,triple:2
recovery ,infection:2
recovery ,mycobacterium:2
triple ,infection:2
triple ,mycobacterium:2
infection ,mycobacterium:2
chilblain-like ,serological:2
chilblain-like ,study:2
chilblain-like ,case:2
lesions ,serological:2
lesions ,study:2
lesions ,case:4
pandemic ,serological:2
serological ,study:6
serological ,case:6
rapid ,ambulatory:2
rapid ,management:2
rapid ,suspected:2
rapid ,cases:4
viral ,diagnosis:4
viral ,ambulatory:2
viral ,management:4
viral ,suspected:2
viral ,cases:10
diagnosis ,ambulatory:2
diagnosis ,suspected:6
diagnosis ,cases:4
ambulatory ,management:4
ambulatory ,suspected:2
ambulatory ,covid-19:4
ambulatory ,cases:2
management ,suspected:10
management ,cases:6
suspected ,cases:10
analysis ,variability:2
analysis ,populations:2
analysis ,highlights:2
analysis ,possible:2
analysis ,link:2
ace2 ,variability:2
ace2 ,among:4
ace2 ,populations:2
ace2 ,highlights:2
ace2 ,possible:2
ace2 ,link:4
genetic ,variability:4
genetic ,populations:2
genetic ,highlights:2
genetic ,possible:2
genetic ,link:2
variability ,among:4
variability ,populations:2
variability ,highlights:2
variability ,possible:2
variability ,link:2
among ,populations:2
among ,highlights:2
among ,possible:2
among ,link:2
populations ,highlights:2
populations ,possible:2
populations ,link:2
highlights ,possible:2
highlights ,link:2
hypertension ,raas:2
hypertension ,blockade:2
hypertension ,risk:4
hypertension ,covid-19:14
hypertension ,patients:8
raas ,blockade:2
raas ,patients:4
blockade ,risk:2
blockade ,patients:2
overview ,testing:2
overview ,otolaryngologists:2
covid-19 ,otolaryngologists:2
testing ,implications:4
testing ,otolaryngologists:2
implications ,otolaryngologists:2
coronavirus ,neurology:2
coronavirus ,neurosurgery:2
disease ,neurology:2
disease ,neurosurgery:2
disease ,scoping:2
covid-19 ,neurology:10
covid-19 ,neurosurgery:4
neurology ,neurosurgery:2
neurology ,scoping:2
neurology ,review:2
neurosurgery ,scoping:2
neurosurgery ,review:2
covid-19-associated ,cardiovascular:2
covid-19-associated ,morbidity:2
covid-19-associated ,older:2
covid-19-associated ,adults:2
covid-19-associated ,position:2
covid-19-associated ,paper:2
cardiovascular ,morbidity:2
cardiovascular ,older:2
cardiovascular ,adults:2
cardiovascular ,position:2
cardiovascular ,paper:2
morbidity ,older:2
morbidity ,adults:2
morbidity ,position:2
morbidity ,paper:2
older ,position:2
older ,paper:2
adults ,position:2
adults ,paper:2
rates ,symptomatic:2
rates ,patients:4
rates ,autoimmune:2
rates ,liver:2
rates ,diseases:2
symptomatic ,infection:6
symptomatic ,autoimmune:2
symptomatic ,liver:2
symptomatic ,diseases:2
autoimmune ,liver:2
reliable ,non-invasive:2
reliable ,specimen:2
reliable ,detection:4
non-invasive ,specimen:2
non-invasive ,detection:2
clinical ,subclinical:2
features ,asymptomatic:4
features ,subclinical:2
asymptomatic ,subclinical:2
subclinical ,children:2
pandemic ,paradigm:2
pandemic ,change:4
pandemic ,scientific:4
paradigm ,global:2
paradigm ,scientific:2
paradigm ,research:2
change ,global:2
change ,scientific:2
change ,research:2
global ,scientific:4
global ,research:8
clinical ,104:2
clinical ,people:6
characteristics ,104:2
characteristics ,people:4
covid-19 ,104:2
104 ,people:2
104 ,sars-cov-2:2
104 ,infection:2
covid-19 ,risen:2
scientific ,community:2
scientific ,risen:2
scientific ,challenge:2
community ,risen:2
community ,challenge:2
risen ,challenge:2
longitudinal ,changes:2
longitudinal ,clinical:4
longitudinal ,features:4
longitudinal ,28:2
longitudinal ,children:2
longitudinal ,shenzhen:2
changes ,clinical:8
changes ,features:6
changes ,28:2
changes ,children:2
changes ,shenzhen:2
clinical ,shenzhen:2
features ,28:2
features ,shenzhen:2
28 ,children:2
28 ,shenzhen:2
children ,shenzhen:2
covid-19 ,shenzhen:4
sars-cov-2-encoded ,proteome:2
sars-cov-2-encoded ,human:2
sars-cov-2-encoded ,genetics:2
sars-cov-2-encoded ,interaction-based:2
sars-cov-2-encoded ,ribosomal:2
proteome ,genetics:2
proteome ,interaction-based:2
proteome ,ribosomal:2
human ,genetics:2
human ,interaction-based:2
human ,ribosomal:2
genetics ,interaction-based:2
genetics ,ribosomal:2
interaction-based ,ribosomal:2
comprehensive ,updated:2
second-trimester ,miscarriage:2
second-trimester ,pregnant:2
second-trimester ,woman:2
second-trimester ,sars-cov-2:2
second-trimester ,infection:2
miscarriage ,pregnant:2
miscarriage ,woman:2
miscarriage ,sars-cov-2:2
miscarriage ,infection:2
devilishly ,radical:2
devilishly ,network:2
devilishly ,covid-19:2
devilishly ,oxidative:2
devilishly ,stress:2
devilishly ,neutrophil:2
devilishly ,extracellular:2
radical ,network:2
radical ,covid-19:4
radical ,oxidative:2
radical ,stress:2
radical ,neutrophil:2
radical ,extracellular:2
network ,oxidative:2
network ,stress:2
network ,neutrophil:2
network ,extracellular:2
covid-19 ,oxidative:4
covid-19 ,neutrophil:4
oxidative ,neutrophil:2
oxidative ,extracellular:2
stress ,neutrophil:2
stress ,extracellular:2
neutrophil ,extracellular:8
high ,asymptomatic:6
high ,haemodialysis:2
high ,learning:2
high ,day:2
prevalence ,haemodialysis:2
prevalence ,learning:2
prevalence ,day:2
asymptomatic ,haemodialysis:2
asymptomatic ,learning:2
asymptomatic ,day:2
covid-19 ,haemodialysis:4
covid-19 ,day:2
haemodialysis ,learning:2
haemodialysis ,day:2
learning ,day:2
testing ,tests:4
testing ,faces:2
testing ,methodological:2
testing ,challenges:6
covid-19 ,faces:2
covid-19 ,methodological:2
tests ,faces:2
tests ,methodological:2
tests ,challenges:2
faces ,methodological:2
faces ,challenges:2
methodological ,challenges:2
endoscopic ,mask:2
endoscopic ,innovation:2
endoscopic ,protective:2
endoscopic ,measures:2
endoscopic ,changes:2
endoscopic ,coronavirus:2
mask ,innovation:2
mask ,protective:2
mask ,measures:2
mask ,changes:2
mask ,coronavirus:4
innovation ,protective:2
innovation ,measures:2
innovation ,changes:2
innovation ,coronavirus:2
protective ,changes:2
protective ,coronavirus:4
measures ,changes:4
extrapulmonary ,children:2
extrapulmonary ,comprehensive:2
extrapulmonary ,review:2
children ,comprehensive:2
comparative ,computational:2
comparative ,nucleocapsid:2
computational ,nucleocapsid:2
computational ,protein:4
analysis ,nucleocapsid:4
nucleocapsid ,epitopes:2
sars-cov-2 ,glycoprotein-binding:2
spike ,glycoprotein-binding:2
spike ,expressed:2
spike ,upper:2
spike ,tract:2
glycoprotein-binding ,proteins:2
glycoprotein-binding ,expressed:2
glycoprotein-binding ,upper:2
glycoprotein-binding ,respiratory:2
glycoprotein-binding ,tract:2
proteins ,expressed:2
proteins ,upper:2
proteins ,tract:2
expressed ,upper:2
expressed ,respiratory:2
expressed ,tract:2
simplified ,quantitative:2
simplified ,real-time:2
simplified ,pcr:2
simplified ,assay:2
simplified ,monitoring:2
simplified ,sars-cov-2:2
simplified ,growth:2
quantitative ,monitoring:2
quantitative ,growth:2
real-time ,growth:2
pcr ,monitoring:2
pcr ,growth:2
assay ,monitoring:4
assay ,growth:2
monitoring ,growth:2
sars-cov-2 ,growth:4
isolation ,period:2
isolation ,longer:2
isolation ,lesson:2
isolation ,child:2
isolation ,infected:2
period ,longer:4
period ,lesson:2
period ,child:2
period ,infected:2
longer ,lesson:2
longer ,child:2
longer ,infected:2
lesson ,child:2
lesson ,infected:2
point ,storm:2
healthcare ,india:2
healthcare ,case-control:2
healthcare ,investigation:2
workers ,case-control:2
workers ,investigation:2
infection ,case-control:2
infection ,investigation:2
india ,case-control:2
india ,investigation:2
case-control ,investigation:2
unpredictable ,fall:2
unpredictable ,severe:2
unpredictable ,emergent:2
unpredictable ,cardiovascular:2
unpredictable ,diseases:2
unpredictable ,hospital:2
unpredictable ,admissions:2
fall ,severe:2
fall ,emergent:2
fall ,cardiovascular:2
fall ,diseases:2
fall ,hospital:2
fall ,admissions:2
severe ,emergent:2
severe ,cardiovascular:4
severe ,diseases:4
severe ,hospital:2
severe ,admissions:2
emergent ,cardiovascular:2
emergent ,diseases:2
emergent ,hospital:2
emergent ,admissions:2
cardiovascular ,hospital:2
cardiovascular ,admissions:2
diseases ,hospital:2
diseases ,admissions:2
hospital ,admissions:2
immune-boosting ,antioxidant:2
immune-boosting ,anti-inflammatory:2
immune-boosting ,food:2
immune-boosting ,supplements:2
immune-boosting ,targeting:2
antioxidant ,anti-inflammatory:2
antioxidant ,food:2
antioxidant ,supplements:2
antioxidant ,targeting:2
anti-inflammatory ,food:2
anti-inflammatory ,supplements:2
anti-inflammatory ,targeting:2
food ,supplements:2
food ,targeting:2
supplements ,targeting:2
elevated ,ace-2:2
elevated ,expression:2
elevated ,olfactory:2
elevated ,neuroepithelium:2
elevated ,implications:2
elevated ,anosmia:2
ace-2 ,expression:2
ace-2 ,olfactory:2
ace-2 ,neuroepithelium:2
ace-2 ,implications:2
ace-2 ,anosmia:2
expression ,olfactory:2
expression ,neuroepithelium:2
expression ,anosmia:2
olfactory ,neuroepithelium:2
olfactory ,implications:2
olfactory ,anosmia:2
neuroepithelium ,implications:2
neuroepithelium ,anosmia:2
implications ,anosmia:2
using ,influenza:2
using ,networks:2
using ,estimate:2
using ,state-specific:2
using ,prevalence:4
influenza ,surveillance:2
influenza ,networks:2
influenza ,estimate:2
influenza ,state-specific:2
influenza ,prevalence:2
surveillance ,networks:2
surveillance ,estimate:2
surveillance ,state-specific:2
surveillance ,prevalence:2
networks ,estimate:2
networks ,state-specific:2
networks ,prevalence:2
estimate ,state-specific:2
estimate ,prevalence:2
state-specific ,prevalence:2
inflammation ,link:2
inflammation ,role:8
inflammation ,nutrition:2
inflammation ,potential:2
inflammation ,mitigation:2
link ,role:2
link ,nutrition:2
link ,potential:4
link ,mitigation:2
role ,nutrition:4
nutrition ,potential:4
nutrition ,mitigation:2
role ,probiotics:2
role ,combat:4
role ,viral:8
role ,infections:8
role ,emphasis:2
probiotics ,combat:2
probiotics ,viral:2
probiotics ,infections:2
probiotics ,emphasis:2
probiotics ,covid-19:2
combat ,viral:2
combat ,infections:2
combat ,emphasis:2
viral ,emphasis:2
infections ,emphasis:4
emphasis ,covid-19:2
development ,multiplex:2
development ,real-time:4
development ,rt-pcr:2
new ,multiplex:2
new ,real-time:2
new ,rt-pcr:2
new ,assay:4
multiplex ,real-time:2
multiplex ,rt-pcr:2
multiplex ,severe:2
multiplex ,acute:2
multiplex ,respiratory:4
assay ,severe:6
assay ,acute:6
assay ,respiratory:6
overview ,pharmacological:2
overview ,interventions:2
overview ,vaccines:2
pharmacological ,interventions:2
pharmacological ,vaccines:2
interventions ,vaccines:2
emerging ,viral:6
emerging ,strain:2
emerging ,deletion:2
emerging ,nsp1:2
sars-cov-2 ,strain:2
sars-cov-2 ,nsp1:6
viral ,strain:2
viral ,deletion:2
viral ,nsp1:4
strain ,deletion:2
strain ,nsp1:2
deletion ,nsp1:2
steps ,implementation:2
steps ,importance:2
steps ,quality:2
steps ,management:2
steps ,diagnostic:2
implementation ,importance:2
implementation ,quality:2
implementation ,management:2
implementation ,diagnostic:4
importance ,quality:2
importance ,management:4
importance ,diagnostic:2
quality ,management:6
quality ,diagnostic:2
management ,diagnostic:2
coronavirus ,jolts:2
coronavirus ,labs:2
coronavirus ,warp:2
coronavirus ,speed:2
jolts ,labs:2
jolts ,warp:2
jolts ,speed:2
labs ,warp:2
labs ,speed:2
clinical ,gansu:2
characteristics ,gansu:2
extremely ,high-dose:2
extremely ,insulin:2
extremely ,requirement:2
extremely ,diabetic:2
extremely ,patient:2
extremely ,covid-19:4
extremely ,case:4
high-dose ,insulin:2
high-dose ,requirement:2
high-dose ,diabetic:2
high-dose ,covid-19:4
high-dose ,case:2
insulin ,requirement:2
insulin ,diabetic:2
insulin ,patient:2
insulin ,covid-19:2
insulin ,case:2
requirement ,diabetic:2
requirement ,patient:2
requirement ,covid-19:2
requirement ,case:2
diabetic ,case:2
surgical ,society:2
surgical ,guidance:2
surgical ,operative:2
surgical ,peri-operative:2
surgical ,care:2
surgical ,adult:2
infection ,society:2
infection ,guidance:2
infection ,operative:2
infection ,peri-operative:2
infection ,adult:2
society ,guidance:4
society ,operative:2
society ,peri-operative:2
society ,care:4
society ,adult:2
guidance ,operative:2
guidance ,peri-operative:2
guidance ,adult:4
operative ,peri-operative:2
operative ,care:2
operative ,adult:2
peri-operative ,care:2
peri-operative ,adult:2
care ,adult:2
covid-19 ,non-reassuring:2
covid-19 ,fetal:4
pregnancy ,non-reassuring:2
pregnancy ,fetal:4
pregnancy ,heart:2
pregnancy ,rate:2
pregnancy ,pathology:2
non-reassuring ,fetal:2
non-reassuring ,heart:2
non-reassuring ,rate:2
non-reassuring ,placental:2
non-reassuring ,pathology:2
fetal ,heart:2
fetal ,rate:2
fetal ,placental:2
fetal ,pathology:2
heart ,rate:4
heart ,placental:2
heart ,pathology:2
rate ,placental:2
rate ,pathology:2
breathing ,enough:2
breathing ,spread:2
breathing ,influenza:2
breathing ,virus:2
breathing ,sars-cov-2:2
enough ,spread:2
enough ,influenza:2
enough ,virus:2
spread ,influenza:2
differential ,covid-19:6
differential ,symptomatic:2
differential ,university:2
diagnosis ,symptomatic:2
diagnosis ,university:2
symptomatic ,university:2
patients ,university:2
thyrotoxicosis ,patients:2
thyrotoxicosis ,covid-19:2
thyrotoxicosis ,thyrcov:2
thyrotoxicosis ,study:2
patients ,thyrcov:2
covid-19 ,thyrcov:2
thyrcov ,study:2
g-quadruplex ,based:2
g-quadruplex ,biosensor:2
g-quadruplex ,potential:2
g-quadruplex ,tool:2
g-quadruplex ,sars-cov-2:2
g-quadruplex ,detection:2
based ,biosensor:2
based ,tool:2
biosensor ,potential:2
biosensor ,tool:2
biosensor ,sars-cov-2:4
potential ,tool:2
tool ,detection:4
point-of-care ,selenium:2
point-of-care ,nanoparticle-based:2
point-of-care ,combined:2
selenium ,nanoparticle-based:2
selenium ,test:2
selenium ,combined:2
selenium ,detection:2
nanoparticle-based ,test:2
nanoparticle-based ,combined:2
nanoparticle-based ,detection:2
test ,combined:2
combined ,detection:2
case ,shedding:4
case ,60:2
case ,woman:6
report ,shedding:2
report ,60:2
viral ,60:2
viral ,days:2
viral ,woman:2
shedding ,60:2
shedding ,days:2
shedding ,woman:2
60 ,days:2
60 ,woman:2
60 ,covid-19:2
days ,woman:2
days ,covid-19:2
rifampicin-induced ,pneumonitis:2
rifampicin-induced ,mimicking:2
rifampicin-induced ,severe:2
rifampicin-induced ,covid-19:2
rifampicin-induced ,pneumonia:2
rifampicin-induced ,infection:2
pneumonitis ,mimicking:4
pneumonitis ,severe:2
pneumonitis ,covid-19:8
pneumonitis ,pneumonia:6
pneumonitis ,infection:2
mimicking ,severe:4
mimicking ,covid-19:4
mimicking ,pneumonia:4
mimicking ,infection:4
novel ,resource:2
coronavirus ,resource:2
nutritional ,considerations:2
nutritional ,frail:2
nutritional ,older:2
nutritional ,patients:2
considerations ,frail:2
considerations ,older:2
frail ,older:2
frail ,patients:2
frail ,covid-19:2
older ,patients:14
outbreak ,orthopaedic:2
italy ,perspectives:2
italy ,orthopaedic:2
italy ,hospital:4
perspectives ,orthopaedic:2
perspectives ,hospital:2
orthopaedic ,hospital:2
minimization ,spreading:2
minimization ,sars-cov-2:2
minimization ,via:2
minimization ,household:2
minimization ,waste:2
minimization ,produced:2
minimization ,subjects:2
spreading ,via:2
spreading ,household:2
spreading ,waste:2
spreading ,produced:2
spreading ,subjects:2
sars-cov-2 ,waste:4
sars-cov-2 ,produced:4
sars-cov-2 ,subjects:4
via ,household:2
via ,waste:2
via ,produced:2
via ,subjects:2
household ,waste:2
household ,produced:2
household ,subjects:2
waste ,produced:2
waste ,subjects:2
produced ,subjects:2
global ,fatality:2
global ,reveals:2
global ,hubei-like:2
global ,countries:2
global ,potentially:2
covid-19 ,hubei-like:2
covid-19 ,potentially:4
fatality ,reveals:2
fatality ,hubei-like:2
fatality ,countries:2
fatality ,potentially:2
analysis ,hubei-like:2
analysis ,potentially:2
reveals ,hubei-like:2
reveals ,potentially:2
hubei-like ,countries:2
hubei-like ,potentially:2
countries ,potentially:2
infection ,precautions:4
infection ,routine:4
infection ,anesthesia:4
prevention ,precautions:2
prevention ,routine:2
prevention ,anesthesia:2
precautions ,routine:2
precautions ,anesthesia:4
precautions ,care:4
precautions ,sars-cov-2:2
routine ,anesthesia:2
routine ,care:2
anesthesia ,care:6
short ,perspective:2
short ,clinical:2
short ,study:2
short ,diagnosis:2
short ,rt-pcr:2
perspective ,study:4
perspective ,diagnosis:2
perspective ,rt-pcr:2
study ,diagnosis:2
study ,rt-pcr:4
diagnosis ,rt-pcr:4
within-host ,diversity:2
within-host ,covid-19:4
within-host ,patients:2
within-host ,variable:2
within-host ,disease:2
diversity ,covid-19:2
diversity ,patients:4
diversity ,variable:2
diversity ,disease:2
sars-cov-2 ,variable:8
covid-19 ,variable:4
patients ,variable:2
variable ,disease:2
olfactory ,gyrus:2
olfactory ,intracerebral:2
olfactory ,hemorrhage:2
olfactory ,infection:6
gyrus ,intracerebral:2
gyrus ,hemorrhage:2
gyrus ,patient:2
gyrus ,covid-19:2
gyrus ,infection:2
intracerebral ,patient:2
intracerebral ,covid-19:2
hemorrhage ,patient:2
hemorrhage ,covid-19:6
attenuated ,novel:2
attenuated ,sars:2
attenuated ,coronavirus:2
attenuated ,infection:2
attenuated ,allogeneic:2
attenuated ,hematopoietic:2
attenuated ,stem:2
novel ,allogeneic:2
novel ,hematopoietic:2
novel ,stem:4
sars ,allogeneic:2
sars ,hematopoietic:2
sars ,stem:2
coronavirus ,allogeneic:2
coronavirus ,hematopoietic:2
infection ,allogeneic:2
infection ,hematopoietic:2
infection ,stem:4
allogeneic ,hematopoietic:2
allogeneic ,stem:2
hematopoietic ,stem:2
consensus ,summary:2
consensus ,report:2
consensus ,cepibc:2
consensus ,march:2
consensus ,12-13:2
consensus ,meeting:2
consensus ,assessment:2
consensus ,risk:2
summary ,report:2
summary ,cepibc:2
summary ,march:2
summary ,12-13:2
summary ,meeting:2
summary ,assessment:2
summary ,risk:2
report ,cepibc:2
report ,12-13:2
report ,meeting:2
report ,assessment:2
report ,risk:2
cepibc ,march:2
cepibc ,12-13:2
cepibc ,meeting:2
cepibc ,assessment:2
cepibc ,risk:2
march ,12-13:2
march ,meeting:2
march ,assessment:2
12-13 ,meeting:2
12-13 ,assessment:2
12-13 ,risk:2
meeting ,assessment:2
meeting ,risk:4
importation ,sars-cov-2:2
importation ,infection:2
importation ,leads:2
importation ,major:2
importation ,covid-19:4
importation ,epidemic:2
importation ,taiwan:2
sars-cov-2 ,taiwan:4
infection ,major:4
infection ,epidemic:4
infection ,taiwan:2
leads ,major:2
leads ,epidemic:2
leads ,taiwan:2
major ,covid-19:8
major ,epidemic:2
major ,taiwan:2
epidemic ,taiwan:2
recurrence ,viral:2
recurrence ,recovered:2
positive ,viral:6
viral ,recovered:6
prediction ,repurposed:2
prediction ,treating:2
prediction ,injury:2
repurposed ,treating:2
repurposed ,lung:2
repurposed ,injury:2
drugs ,treating:2
drugs ,lung:2
drugs ,injury:2
treating ,injury:2
treating ,covid-19:16
prolonged ,fecal:2
prolonged ,quantitative:2
fecal ,pediatric:2
fecal ,quantitative:2
shedding ,quantitative:2
pediatric ,quantitative:2
clinical ,150:2
clinical ,nanyang:2
clinical ,city:2
analysis ,150:2
analysis ,nanyang:2
analysis ,city:4
150 ,cases:2
150 ,novel:2
150 ,coronavirus:2
150 ,infection:2
150 ,nanyang:2
150 ,city:2
cases ,nanyang:2
cases ,city:2
novel ,nanyang:2
novel ,city:2
coronavirus ,nanyang:2
coronavirus ,city:4
infection ,nanyang:2
infection ,city:4
nanyang ,city:2
impact ,lockdown:16
impact ,case:4
impact ,fatality:2
impact ,rate:2
impact ,mutations:2
lockdown ,case:2
lockdown ,fatality:2
lockdown ,rate:2
lockdown ,viral:2
lockdown ,mutations:2
lockdown ,spread:2
covid-19 ,mutations:4
case ,mutations:2
case ,spread:2
fatality ,mutations:2
fatality ,spread:2
rate ,mutations:2
rate ,spread:2
viral ,mutations:6
viral ,spread:4
mutations ,spread:2
covid-19 ,city:16
covid-19 ,center:20
obstetrics ,experience:2
obstetrics ,new:2
obstetrics ,york:2
obstetrics ,city:2
obstetrics ,medical:2
obstetrics ,center:2
experience ,new:4
experience ,york:4
experience ,city:4
experience ,medical:2
experience ,center:8
new ,medical:2
new ,center:4
york ,medical:2
york ,center:4
city ,medical:2
city ,center:4
medical ,center:8
covid-19 ,deaths:12
covid-19 ,rates:10
cases ,deaths:4
cases ,fatality:2
cases ,rates:2
cases ,surge:2
cases ,underlying:2
cases ,causes:2
deaths ,fatality:2
deaths ,rates:2
deaths ,surge:2
deaths ,underlying:4
deaths ,causes:2
fatality ,rates:6
fatality ,surge:2
fatality ,underlying:2
fatality ,causes:2
rates ,surge:2
rates ,italy:4
rates ,underlying:2
rates ,causes:2
surge ,italy:2
surge ,underlying:2
surge ,causes:2
italy ,underlying:4
italy ,causes:2
underlying ,causes:2
nasoseptal ,flap:2
nasoseptal ,necrosis:2
nasoseptal ,endoscopic:2
nasoseptal ,skull:2
nasoseptal ,base:2
nasoseptal ,surgery:2
nasoseptal ,setting:2
flap ,necrosis:2
flap ,endoscopic:2
flap ,skull:2
flap ,base:2
flap ,surgery:2
flap ,setting:2
necrosis ,endoscopic:2
necrosis ,skull:2
necrosis ,base:2
necrosis ,surgery:2
necrosis ,setting:2
endoscopic ,skull:4
endoscopic ,base:4
endoscopic ,surgery:4
endoscopic ,setting:2
skull ,base:8
skull ,surgery:6
skull ,setting:2
base ,surgery:6
base ,setting:2
surgery ,setting:2
update ,target:2
update ,structures:2
target ,structures:2
target ,systematic:4
target ,review:4
structures ,systematic:2
structures ,review:2
sars-cov-2 ,endometrium:2
sars-cov-2 ,infection-related:2
infection ,endometrium:2
infection ,infection-related:2
risk ,endometrium:2
risk ,infection-related:2
assessment ,endometrium:2
assessment ,infection-related:2
endometrium ,viral:2
endometrium ,infection-related:2
viral ,infection-related:2
guidance ,restarting:2
guidance ,inflammatory:4
guidance ,bowel:4
guidance ,therapy:4
guidance ,withheld:2
restarting ,inflammatory:2
restarting ,bowel:2
restarting ,disease:2
restarting ,therapy:2
restarting ,patients:2
restarting ,withheld:2
inflammatory ,withheld:2
bowel ,therapy:2
bowel ,withheld:2
disease ,withheld:2
therapy ,withheld:2
patients ,withheld:2
sars-cov-2 ,rhinology:2
sars-cov-2 ,american:2
pandemic ,rhinology:2
pandemic ,american:2
impact ,rhinology:2
impact ,american:2
rhinology ,research:2
rhinology ,survey:2
rhinology ,american:2
research ,survey:2
research ,american:2
survey ,american:2
reduction ,effective:2
reduction ,reproduction:2
reduction ,number:2
reduction ,higher:2
reduction ,countries:2
effective ,reproduction:4
effective ,number:4
effective ,higher:2
effective ,countries:2
reproduction ,covid-19:2
reproduction ,higher:2
reproduction ,countries:2
number ,higher:2
number ,countries:2
higher ,countries:2
covid-19 ,knowing:2
covid-19 ,unknown:2
vaccines ,knowing:2
vaccines ,unknown:2
knowing ,unknown:2
rate ,positivity:6
rate ,pregnant:2
rate ,women:2
rate ,admitted:2
positivity ,asymptomatic:2
positivity ,pregnant:2
positivity ,women:2
positivity ,admitted:2
asymptomatic ,women:2
asymptomatic ,admitted:2
urgent ,need:8
urgent ,evaluating:2
urgent ,agonists:2
urgent ,angiotensin-1-7mas:2
urgent ,receptor:2
urgent ,axis:2
need ,evaluating:2
need ,agonists:2
need ,angiotensin-1-7mas:2
need ,receptor:2
need ,axis:2
evaluating ,agonists:2
evaluating ,angiotensin-1-7mas:2
evaluating ,receptor:2
evaluating ,axis:2
agonists ,angiotensin-1-7mas:2
agonists ,receptor:2
agonists ,axis:2
angiotensin-1-7mas ,receptor:2
angiotensin-1-7mas ,axis:2
receptor ,axis:2
sars-cov-2-specific ,cell:2
sars-cov-2-specific ,cases:2
sars-cov-2-specific ,sars:2
sars-cov-2-specific ,uninfected:2
cell ,cases:2
cell ,sars:2
cell ,uninfected:2
immunity ,cases:2
immunity ,sars:4
immunity ,uninfected:2
cases ,sars:4
cases ,uninfected:2
covid-19 ,uninfected:2
sars ,uninfected:2
sex ,mechanisms:2
sex ,biomarkers:2
differences ,mechanisms:2
differences ,biomarkers:2
mechanisms ,biomarkers:2
potential ,harmful:2
potential ,discontinuing:2
potential ,ace-inhibitors:2
potential ,arbs:2
harmful ,effects:2
harmful ,discontinuing:2
harmful ,ace-inhibitors:2
harmful ,arbs:2
harmful ,covid-19:2
effects ,discontinuing:2
effects ,ace-inhibitors:2
effects ,arbs:2
discontinuing ,ace-inhibitors:2
discontinuing ,arbs:2
discontinuing ,covid-19:2
ace-inhibitors ,arbs:2
ace-inhibitors ,covid-19:2
arbs ,covid-19:4
utilizing ,drug:2
utilizing ,repurposing:2
utilizing ,covid-19:6
utilizing ,efficacy:2
utilizing ,limitations:2
utilizing ,challenges:2
drug ,efficacy:4
drug ,limitations:2
repurposing ,efficacy:2
repurposing ,limitations:2
repurposing ,challenges:2
efficacy ,limitations:2
efficacy ,challenges:2
limitations ,challenges:2
diagnosis ,dengue-endemic:2
diagnosis ,area:2
covid-19 ,dengue-endemic:2
dengue-endemic ,area:2
high ,incidence:10
high ,false-positive:2
high ,results:2
high ,igg:2
incidence ,false-positive:2
incidence ,results:2
incidence ,igg:2
incidence ,antibody:2
false-positive ,results:2
false-positive ,igg:2
false-positive ,antibody:2
false-positive ,sars-cov-2:4
results ,igg:2
effect ,pandemic:10
effect ,ophthalmologists:2
effect ,practicing:2
effect ,saudi:2
effect ,arabia:2
coronavirus ,ophthalmologists:6
coronavirus ,practicing:2
coronavirus ,saudi:2
coronavirus ,arabia:2
pandemic ,ophthalmologists:6
pandemic ,practicing:2
pandemic ,saudi:6
pandemic ,arabia:6
ophthalmologists ,practicing:2
ophthalmologists ,saudi:2
ophthalmologists ,arabia:2
practicing ,saudi:2
practicing ,arabia:2
saudi ,arabia:10
epidemiological ,viral:2
epidemiological ,cohort:2
viral ,features:6
viral ,cohort:2
features ,cohort:2
cohort ,symptomatic:2
occupational ,health:4
occupational ,responses:2
occupational ,covid-19:10
occupational ,lessons:2
occupational ,can:2
occupational ,learn:2
occupational ,sars:2
health ,lessons:2
health ,learn:2
health ,sars:4
responses ,can:2
responses ,learn:2
lessons ,can:4
lessons ,learn:2
can ,learn:6
can ,sars:2
learn ,sars:2
institutions ,disclose:2
institutions ,names:2
institutions ,employees:2
institutions ,covid-19:2
disclose ,names:2
disclose ,employees:2
disclose ,covid-19:2
names ,employees:2
names ,covid-19:2
employees ,covid-19:2
recommendations ,management:18
sars-cov-2 ,continue:2
sars-cov-2 ,circulate:2
sars-cov-2 ,opinion:6
will ,continue:2
will ,circulate:2
will ,human:2
will ,population:2
will ,opinion:2
continue ,circulate:2
continue ,human:2
continue ,population:2
continue ,opinion:2
circulate ,human:2
circulate ,population:2
circulate ,opinion:2
human ,population:2
human ,opinion:2
population ,opinion:2
computational ,identification:4
computational ,biological:2
computational ,processes:2
computational ,sequence:2
identification ,biological:2
identification ,processes:2
identification ,sequence:2
human ,biological:2
human ,processes:2
human ,sequence:4
biological ,processes:2
biological ,sequence:2
processes ,protein:2
processes ,sequence:2
screening ,299:2
screening ,hospitalized:2
screening ,children:6
screening ,hemato-oncological:2
sars-cov-2 ,299:2
sars-cov-2 ,hemato-oncological:2
299 ,hospitalized:2
299 ,children:2
299 ,hemato-oncological:2
hospitalized ,hemato-oncological:2
children ,hemato-oncological:2
superantigenic ,character:2
superantigenic ,insert:2
superantigenic ,unique:2
superantigenic ,sars-cov-2:2
superantigenic ,spike:2
superantigenic ,supported:2
superantigenic ,skewed:2
character ,insert:2
character ,unique:2
character ,sars-cov-2:2
character ,spike:2
character ,supported:2
character ,skewed:2
insert ,unique:2
insert ,sars-cov-2:2
insert ,spike:2
insert ,supported:2
insert ,skewed:2
unique ,sars-cov-2:2
unique ,supported:2
unique ,skewed:2
sars-cov-2 ,supported:2
sars-cov-2 ,skewed:2
spike ,supported:2
spike ,skewed:2
supported ,skewed:2
potential ,integrins:2
role ,integrins:2
integrins ,host:2
integrins ,cell:2
integrins ,entry:2
integrins ,sars-cov-2:2
design ,assistance:2
design ,protocol:2
design ,restart:2
design ,scheduled:2
design ,urologic:2
design ,surgery:2
assistance ,protocol:2
assistance ,restart:2
assistance ,scheduled:2
assistance ,urologic:2
assistance ,surgery:2
protocol ,restart:2
protocol ,scheduled:2
protocol ,urologic:2
protocol ,surgery:4
restart ,scheduled:2
restart ,urologic:2
restart ,surgery:2
scheduled ,urologic:2
scheduled ,surgery:2
urologic ,surgery:4
current ,used:2
current ,treating:2
current ,mechanisms:4
current ,immune:2
approaches ,used:2
approaches ,treating:2
approaches ,molecular:2
approaches ,immune:2
used ,treating:2
used ,molecular:2
used ,mechanisms:2
used ,immune:4
treating ,molecular:2
treating ,mechanisms:4
treating ,immune:2
mechanisms ,immune:6
laboratory ,coronaviruses:2
detection ,coronaviruses:4
methods ,human:2
methods ,coronaviruses:2
containment ,large:4
containment ,sars-cov-2:2
containment ,outbreak:8
containment ,among:2
containment ,healthcare:2
containment ,workers:2
containment ,pediatric:2
large ,pediatric:2
outbreak ,healthcare:2
outbreak ,workers:6
healthcare ,pediatric:2
workers ,pediatric:2
phenotypic ,expression:2
phenotypic ,bitter:2
phenotypic ,taste:2
phenotypic ,receptor:2
phenotypic ,t2r38:2
phenotypic ,show:2
phenotypic ,association:2
expression ,bitter:2
expression ,taste:2
expression ,t2r38:2
expression ,show:2
expression ,association:4
bitter ,taste:2
bitter ,receptor:2
bitter ,t2r38:2
bitter ,show:2
bitter ,association:2
taste ,receptor:2
taste ,t2r38:2
taste ,show:2
taste ,association:2
receptor ,t2r38:2
receptor ,show:2
receptor ,association:2
t2r38 ,show:2
t2r38 ,association:2
show ,association:2
identification ,high-affinity:2
high-affinity ,towards:2
inhibitors ,towards:2
sars-cov-2 ,towards:6
main ,towards:2
deep ,dive:2
deep ,testing:4
deep ,management:2
deep ,australian:2
deep ,high:2
deep ,performance:2
dive ,testing:2
dive ,management:2
dive ,covid-19:4
dive ,australian:2
dive ,high:2
dive ,performance:2
testing ,management:4
testing ,australian:2
testing ,high:2
management ,australian:2
management ,high:2
management ,performance:2
covid-19 ,australian:2
australian ,high:2
australian ,performance:2
high ,performance:2
mobility ,habits:2
mobility ,influenced:2
mobility ,spread:2
mobility ,covid-19:2
mobility ,pandemic:2
mobility ,results:2
habits ,influenced:2
habits ,spread:2
habits ,covid-19:4
habits ,pandemic:2
habits ,results:2
influenced ,spread:2
influenced ,covid-19:2
influenced ,pandemic:2
influenced ,results:2
spread ,results:2
pandemic ,results:2
municipal ,solid:2
municipal ,waste:2
municipal ,management:2
municipal ,sars-cov-2:2
municipal ,outbreak:2
municipal ,lockdown:2
municipal ,ease:2
solid ,waste:2
solid ,management:2
solid ,outbreak:2
solid ,lockdown:2
solid ,ease:2
waste ,management:2
waste ,outbreak:2
waste ,lockdown:2
waste ,ease:2
management ,lockdown:2
management ,ease:2
sars-cov-2 ,lockdown:8
sars-cov-2 ,ease:2
outbreak ,lockdown:4
outbreak ,ease:2
lockdown ,ease:4
transmission ,reveal:2
transmission ,impracticality:2
transmission ,herd:2
transmission ,immunity:2
dynamics ,impracticality:2
dynamics ,herd:2
dynamics ,immunity:2
reveal ,impracticality:2
reveal ,covid-19:2
reveal ,herd:2
reveal ,immunity:2
impracticality ,covid-19:2
impracticality ,herd:2
impracticality ,immunity:2
detection ,passenger:2
detection ,aircraft:2
detection ,cruise:2
detection ,ship:2
sars-cov-2 ,passenger:2
sars-cov-2 ,aircraft:2
rna ,commercial:2
rna ,passenger:2
rna ,aircraft:2
rna ,cruise:2
rna ,ship:2
commercial ,passenger:2
commercial ,aircraft:2
commercial ,cruise:2
commercial ,ship:2
passenger ,aircraft:2
passenger ,cruise:2
passenger ,ship:2
aircraft ,cruise:2
aircraft ,ship:2
measuring ,serologic:2
measuring ,response:2
measuring ,severe:2
measuring ,acute:2
measuring ,respiratory:2
measuring ,syndrome:2
measuring ,coronavirus:2
serologic ,response:2
serologic ,severe:2
serologic ,acute:2
serologic ,respiratory:2
serologic ,syndrome:2
serologic ,coronavirus:2
response ,severe:6
response ,acute:4
response ,respiratory:4
response ,syndrome:2
morbilliform ,rash:2
morbilliform ,uncommon:2
morbilliform ,herald:2
morbilliform ,sars-cov-2:2
rash ,uncommon:2
rash ,herald:2
rash ,sars-cov-2:2
uncommon ,herald:2
uncommon ,sars-cov-2:2
herald ,sars-cov-2:2
impact ,heat-inactivation:2
impact ,detection:2
impact ,igm:2
impact ,igg:2
impact ,antibody:2
heat-inactivation ,detection:2
heat-inactivation ,sars-cov-2:2
heat-inactivation ,igm:2
heat-inactivation ,igg:2
heat-inactivation ,antibody:2
detection ,igm:2
hyperinflammation ,utility:2
hyperinflammation ,immunomodulatory:2
hyperinflammation ,medications:2
hyperinflammation ,children:2
utility ,immunomodulatory:2
utility ,medications:2
utility ,children:2
immunomodulatory ,medications:2
immunomodulatory ,children:2
medications ,children:2
mechanism ,response:2
mechanism ,associated:2
mechanism ,comorbidities:2
inflammatory ,comorbidities:2
response ,comorbidities:2
associated ,comorbidities:2
characteristics ,1573:2
characteristics ,healthcare:4
characteristics ,workers:6
characteristics ,underwent:2
characteristics ,nasopharyngeal:2
characteristics ,swab:4
characteristics ,testing:6
1573 ,healthcare:2
1573 ,workers:2
1573 ,underwent:2
1573 ,nasopharyngeal:2
1573 ,swab:2
1573 ,testing:2
healthcare ,underwent:2
healthcare ,nasopharyngeal:2
healthcare ,swab:2
workers ,underwent:2
workers ,nasopharyngeal:2
workers ,swab:2
underwent ,nasopharyngeal:2
underwent ,swab:2
underwent ,testing:2
nasopharyngeal ,testing:2
swab ,testing:4
sars-cov-2 ,expected:2
pregnancy ,better:2
pregnancy ,expected:2
better ,expected:2
exploring ,genomic:2
exploring ,proteomic:2
exploring ,variations:2
exploring ,spike:2
exploring ,glycoprotein:2
genomic ,proteomic:2
genomic ,spike:4
genomic ,glycoprotein:2
proteomic ,variations:2
proteomic ,sars-cov-2:6
proteomic ,spike:2
proteomic ,glycoprotein:2
variations ,glycoprotein:2
prevalence ,thromboembolism:2
prevalence ,critically:2
prevalence ,ill:2
venous ,critically:2
venous ,ill:4
venous ,patients:8
thromboembolism ,critically:2
thromboembolism ,ill:4
thromboembolism ,patients:12
primary ,management:4
primary ,coronavirus:4
care ,management:18
oral ,methioninase:2
oral ,methionine-restriction:2
oral ,therapy:2
methioninase ,covid-19:2
methioninase ,methionine-restriction:2
methioninase ,therapy:2
covid-19 ,methionine-restriction:2
methionine-restriction ,therapy:2
universal ,work:2
universal ,everyone:2
testing ,work:2
testing ,everyone:2
covid-19 ,everyone:2
work ,everyone:2
generation ,chicken:2
generation ,igy:2
generation ,spike:2
generation ,protein:2
generation ,epitope:2
generation ,mapping:2
chicken ,igy:2
chicken ,sars-cov-2:2
chicken ,spike:2
chicken ,protein:2
chicken ,epitope:2
chicken ,mapping:2
igy ,sars-cov-2:2
igy ,spike:2
igy ,protein:2
igy ,epitope:2
igy ,mapping:2
sars-cov-2 ,epitope:4
spike ,mapping:4
protein ,mapping:2
epitope ,mapping:2
natural ,angiotensin-converting:2
natural ,enzyme:2
flavonoids ,potential:2
flavonoids ,angiotensin-converting:2
flavonoids ,enzyme:2
flavonoids ,inhibitors:2
potential ,angiotensin-converting:6
potential ,enzyme:6
minireview ,progress:2
minireview ,structural:2
minireview ,study:2
minireview ,sars-cov-2:4
minireview ,proteins:2
progress ,study:2
progress ,proteins:2
structural ,study:2
study ,proteins:2
challenge ,concomitant:2
challenge ,infections:2
challenge ,disease:2
challenge ,pandemic:2
concomitant ,infections:2
concomitant ,coronavirus:2
concomitant ,disease:2
concomitant ,pandemic:2
infections ,pandemic:4
solid ,transplant:4
solid ,healthcare:2
solid ,providers:2
solid ,know:2
organ ,transplant:4
organ ,healthcare:2
organ ,providers:2
organ ,know:2
transplant ,healthcare:2
transplant ,providers:2
transplant ,know:2
healthcare ,know:2
providers ,know:2
vertical ,infection:8
vertical ,preterm:4
vertical ,birth:4
transmission ,birth:2
sars-cov-2 ,birth:4
infection ,birth:6
preterm ,birth:4
covid-19 ,psychiatric:4
covid-19 ,facility:8
transmission ,psychiatric:2
transmission ,long-term:2
transmission ,facility:4
psychiatric ,long-term:2
psychiatric ,care:2
psychiatric ,rehabilitation:2
psychiatric ,facility:2
long-term ,rehabilitation:2
long-term ,facility:4
care ,facility:4
rehabilitation ,facility:2
forecasting ,timeframe:2
forecasting ,2019-ncov:2
forecasting ,human:2
forecasting ,cells:2
forecasting ,interaction:2
forecasting ,reverse:2
timeframe ,2019-ncov:2
timeframe ,human:2
timeframe ,cells:2
timeframe ,interaction:2
timeframe ,reverse:2
2019-ncov ,interaction:2
2019-ncov ,reverse:2
human ,cells:10
human ,reverse:2
cells ,interaction:4
cells ,reverse:2
interaction ,reverse:2
alpha-lipoic ,acid:2
alpha-lipoic ,may:2
alpha-lipoic ,protect:2
alpha-lipoic ,patients:2
alpha-lipoic ,diabetes:2
alpha-lipoic ,covid-19:2
alpha-lipoic ,infection:2
acid ,may:2
acid ,protect:2
acid ,diabetes:2
may ,protect:2
may ,patients:10
protect ,patients:4
protect ,diabetes:2
protect ,infection:4
re-analysis ,single:2
re-analysis ,transcriptome:2
re-analysis ,reveals:2
re-analysis ,nr3c1-cxcl8-neutrophil:2
single ,cell:2
single ,transcriptome:2
single ,reveals:2
single ,nr3c1-cxcl8-neutrophil:2
cell ,transcriptome:2
cell ,reveals:2
cell ,nr3c1-cxcl8-neutrophil:2
transcriptome ,reveals:2
transcriptome ,nr3c1-cxcl8-neutrophil:2
reveals ,nr3c1-cxcl8-neutrophil:2
molecular ,biologic:2
molecular ,matrix:2
diagnosis ,different:2
diagnosis ,biologic:2
diagnosis ,matrix:2
diagnosis ,diagnostic:2
covid-19 ,biologic:4
covid-19 ,matrix:2
different ,biologic:2
different ,matrix:2
different ,diagnostic:2
biologic ,matrix:2
biologic ,diagnostic:2
matrix ,diagnostic:2
transmission ,onset:2
transmission ,distribution:2
onset ,distribution:2
onset ,covid-19:8
impact ,oncologic:2
impact ,degenerative:2
impact ,spine:2
sars-cov-2 ,oncologic:2
sars-cov-2 ,degenerative:2
sars-cov-2 ,spine:2
pandemic ,oncologic:2
pandemic ,degenerative:2
pandemic ,spine:2
oncologic ,degenerative:2
oncologic ,spine:2
oncologic ,surgery:2
degenerative ,spine:2
degenerative ,surgery:2
spine ,surgery:2
computational ,immune:2
computational ,proteomics:2
computational ,target:2
immune ,proteomics:2
immune ,approach:4
immune ,target:6
proteomics ,target:2
approach ,target:2
covid-19 ,hsp60:2
covid-19 ,culprit:6
covid-19 ,worse:4
hypertension ,hsp60:2
hypertension ,culprit:2
hypertension ,severe:6
hypertension ,course:2
hypertension ,worse:2
hsp60 ,culprit:2
hsp60 ,severe:2
hsp60 ,course:2
hsp60 ,worse:2
culprit ,severe:2
culprit ,course:2
culprit ,worse:2
severe ,worse:2
course ,worse:2
health ,university:4
health ,hospital:2
health ,quarantine:4
care ,university:2
care ,hospital:10
care ,quarantine:2
workers ,university:2
workers ,hospital:6
workers ,quarantine:2
university ,quarantine:2
hospital ,quarantine:2
lopinavirritonavir ,combination:4
lopinavirritonavir ,therapy:4
lopinavirritonavir ,amongst:2
lopinavirritonavir ,symptomatic:2
lopinavirritonavir ,coronavirus:2
lopinavirritonavir ,disease:2
combination ,amongst:2
combination ,symptomatic:2
combination ,coronavirus:6
combination ,disease:4
therapy ,amongst:2
therapy ,symptomatic:2
amongst ,symptomatic:2
amongst ,coronavirus:2
amongst ,disease:2
symptomatic ,disease:4
can ,mesenchymal:2
can ,cell:2
can ,therapy:2
can ,interim:2
mesenchymal ,interim:2
mesenchymal ,management:2
mesenchymal ,covid-19:6
stem ,interim:2
stem ,management:2
cell ,therapy:4
cell ,interim:2
cell ,management:4
therapy ,interim:2
therapy ,management:8
interim ,management:2
covid-19 ,concomitant:4
covid-19 ,infective:2
covid-19 ,endocarditis:4
concomitant ,infective:2
concomitant ,endocarditis:2
concomitant ,case:4
concomitant ,report:4
concomitant ,review:2
infective ,endocarditis:2
infective ,case:2
infective ,report:2
infective ,review:2
endocarditis ,case:2
endocarditis ,report:2
endocarditis ,review:2
blocking ,inflammation:2
blocking ,way:2
blocking ,rationale:2
blocking ,cxcr2:2
blocking ,antagonists:2
inflammation ,way:2
inflammation ,rationale:2
inflammation ,cxcr2:2
inflammation ,antagonists:2
inflammation ,treatment:2
way ,rationale:2
way ,cxcr2:2
way ,antagonists:2
rationale ,cxcr2:2
rationale ,antagonists:2
rationale ,treatment:2
cxcr2 ,antagonists:2
cxcr2 ,treatment:2
antagonists ,treatment:2
arterial ,venous:2
arterial ,strokes:2
arterial ,setting:2
arterial ,covid-19:10
venous ,strokes:2
venous ,setting:2
strokes ,setting:2
strokes ,covid-19:2
effectiveness ,surgical:2
effectiveness ,kf94:2
effectiveness ,blocking:2
surgical ,kf94:2
surgical ,n95:2
surgical ,respirator:2
surgical ,masks:2
surgical ,blocking:2
kf94 ,n95:2
kf94 ,respirator:2
kf94 ,masks:2
kf94 ,blocking:2
kf94 ,sars-cov-2:2
n95 ,masks:4
n95 ,blocking:2
respirator ,masks:2
respirator ,blocking:2
masks ,blocking:2
implications ,pediatric:2
implications ,rheumatology:2
covid-19 ,rheumatology:4
pediatric ,rheumatology:2
proteins ,neutrophil:2
proteins ,degranulation:2
proteins ,upregulated:2
proteins ,nasopharyngeal:2
associated ,neutrophil:2
associated ,degranulation:2
associated ,upregulated:2
associated ,nasopharyngeal:2
neutrophil ,degranulation:2
neutrophil ,upregulated:2
neutrophil ,nasopharyngeal:2
degranulation ,upregulated:2
degranulation ,nasopharyngeal:2
upregulated ,nasopharyngeal:2
evaluation ,electrochemiluminescent:2
electrochemiluminescent ,sars-cov-2:2
electrochemiluminescent ,antibody:2
electrochemiluminescent ,assay:2
clinical ,pregnant:10
presentation ,disease:6
presentation ,pregnant:2
phylogenomic ,proximity:2
phylogenomic ,proteomic:2
proximity ,comparative:2
proximity ,proteomic:2
proximity ,analysis:2
proximity ,sars-cov-2:2
comparative ,proteomic:2
proteomic ,analysis:4
case ,memory:2
case ,impairment:2
case ,delayed:8
memory ,impairment:2
memory ,delayed:2
memory ,presentation:2
memory ,stroke:2
impairment ,delayed:2
impairment ,presentation:2
impairment ,stroke:2
delayed ,presentation:4
delayed ,stroke:2
presentation ,stroke:2
sars-cov-2 ,oncology:8
sars-cov-2 ,professionals:6
seroprevalence ,oncology:2
seroprevalence ,professionals:2
seroprevalence ,patients:2
oncology ,healthcare:2
oncology ,professionals:2
healthcare ,patients:4
professionals ,patients:2
multicentre ,observational:4
multicentre ,study:6
multicentre ,neonates:2
multicentre ,exposed:2
multicentre ,china:2
observational ,study:4
observational ,neonates:2
observational ,exposed:2
observational ,sars-cov-2:2
observational ,china:2
study ,neonates:2
study ,exposed:2
study ,china:4
neonates ,exposed:2
neonates ,china:4
exposed ,china:2
covid-19-associated ,fusobacterium:2
covid-19-associated ,nucleatum:2
covid-19-associated ,bacteremia:2
covid-19-associated ,belgium:2
fusobacterium ,nucleatum:2
fusobacterium ,bacteremia:2
fusobacterium ,belgium:2
nucleatum ,bacteremia:2
nucleatum ,belgium:2
bacteremia ,belgium:2
vascular ,underpinning:2
vascular ,covid-19:14
rapid ,sars-cov-1:2
rapid ,viability:2
rapid ,susceptibility:2
review ,sars-cov-1:2
review ,viability:2
review ,susceptibility:6
sars-cov-1 ,viability:2
sars-cov-1 ,susceptibility:2
sars-cov-1 ,treatment:2
sars-cov-2 ,viability:4
viability ,susceptibility:2
viability ,treatment:2
susceptibility ,treatment:2
knowledge ,practices:8
knowledge ,toward:6
knowledge ,saudi:2
knowledge ,arabian:2
knowledge ,population:2
attitudes ,practices:6
attitudes ,toward:4
attitudes ,covid-19:10
attitudes ,saudi:2
attitudes ,arabian:2
attitudes ,population:4
practices ,toward:2
practices ,saudi:2
practices ,arabian:2
practices ,population:2
toward ,saudi:2
toward ,arabian:2
toward ,population:2
covid-19 ,saudi:10
covid-19 ,arabian:2
saudi ,arabian:2
saudi ,population:2
arabian ,population:2
clinical ,characterization:6
immunological ,virological:2
immunological ,characterization:2
immunological ,patients:4
virological ,characterization:2
characterization ,patients:2
serological ,respiratory:4
serological ,syndrome:4
serological ,coronavirus:4
assays ,severe:2
assays ,acute:2
assays ,respiratory:2
assays ,syndrome:2
sars-cov-2 ,adolescents:4
sars-cov-2 ,norway:2
children ,norway:2
children ,confirmed:2
adolescents ,norway:2
adolescents ,confirmed:2
adolescents ,infection:4
norway ,confirmed:2
norway ,infection:2
confirmed ,infection:2
otorhinolaryngological ,aspects:2
otorhinolaryngological ,disease:2
otorhinolaryngological ,course:2
otorhinolaryngological ,children:2
otorhinolaryngological ,infected:2
aspects ,course:2
aspects ,children:2
aspects ,infected:2
course ,children:4
course ,infected:4
autopsy ,registry:2
autopsy ,can:4
autopsy ,facilitate:2
autopsy ,research:2
registry ,can:2
registry ,facilitate:2
registry ,covid-19:4
registry ,research:2
can ,facilitate:2
can ,research:2
facilitate ,covid-19:2
facilitate ,research:2
perform ,nasopharyngeal:2
perform ,swab:2
perform ,adults:2
perform ,children:2
perform ,covid-19:2
perform ,era:2
nasopharyngeal ,adults:2
nasopharyngeal ,children:2
nasopharyngeal ,era:2
swab ,adults:2
swab ,children:4
swab ,era:2
adults ,era:2
children ,era:2
tracheostomy ,novel:2
tracheostomy ,corona:2
tracheostomy ,virus:2
tracheostomy ,pandemic:4
corona ,pandemic:4
anti-covid ,drugs:2
anti-covid ,repurposing:2
anti-covid ,existing:2
anti-covid ,search:2
anti-covid ,new:2
anti-covid ,complex:2
anti-covid ,entities:2
drugs ,search:4
drugs ,complex:2
drugs ,entities:4
repurposing ,search:2
repurposing ,new:4
repurposing ,complex:2
repurposing ,entities:2
existing ,search:2
existing ,new:2
existing ,complex:2
existing ,entities:2
search ,new:2
search ,complex:2
search ,entities:2
new ,complex:2
new ,entities:2
complex ,entities:2
influenza ,airways:2
influenza ,clarification:2
virus ,airways:2
virus ,clarification:2
sars-cov-2 ,airways:4
sars-cov-2 ,clarification:2
airways ,clarification:2
highlight ,immune:2
highlight ,pathogenic:2
highlight ,response:2
highlight ,hematopathologic:2
highlight ,effect:2
highlight ,sars-cov:2
immune ,hematopathologic:2
immune ,effect:2
pathogenic ,response:2
pathogenic ,hematopathologic:2
pathogenic ,effect:2
pathogenic ,sars-cov:2
response ,hematopathologic:2
response ,effect:2
hematopathologic ,effect:2
hematopathologic ,sars-cov:2
effect ,sars-cov:4
application ,prospect:2
application ,polysaccharides:2
application ,development:4
application ,anti-novel:2
prospect ,polysaccharides:2
prospect ,development:2
prospect ,anti-novel:2
prospect ,coronavirus:2
polysaccharides ,development:2
polysaccharides ,anti-novel:2
polysaccharides ,coronavirus:2
development ,anti-novel:2
anti-novel ,coronavirus:2
diagnosis ,cancer-specific:2
diagnosis ,patient:10
diagnosis ,concerns:2
diagnosis ,inventory:2
head ,cancer-specific:2
head ,patient:2
head ,concerns:2
head ,inventory:2
neck ,cancer-specific:2
neck ,patient:2
neck ,concerns:2
neck ,inventory:2
cancer-specific ,patient:2
cancer-specific ,concerns:2
cancer-specific ,inventory:2
patient ,concerns:2
patient ,inventory:2
concerns ,inventory:2
clinical ,predictive:4
clinical ,models:2
predictive ,models:6
predictive ,systematic:2
predictive ,study:2
models ,systematic:2
systematic ,study:4
controls ,minimize:2
controls ,disruption:2
controls ,pharmaceutical:2
controls ,supply:2
controls ,chain:2
minimize ,disruption:2
minimize ,pharmaceutical:2
minimize ,supply:2
minimize ,chain:2
disruption ,pharmaceutical:2
disruption ,supply:2
disruption ,chain:4
pharmaceutical ,supply:2
pharmaceutical ,chain:2
supply ,chain:2
coronavirus ,call:4
disease ,call:6
disease ,center:6
outbreak ,call:2
call ,center:2
call ,south:2
call ,korea:2
center ,south:2
center ,korea:2
integrative ,modeling:2
integrative ,quantitative:2
integrative ,plasma:2
integrative ,lipoprotein:2
integrative ,metabolic:2
integrative ,amino:2
integrative ,acid:2
modeling ,quantitative:2
modeling ,plasma:2
modeling ,lipoprotein:2
modeling ,metabolic:2
modeling ,amino:2
modeling ,acid:2
quantitative ,plasma:2
quantitative ,lipoprotein:2
quantitative ,metabolic:2
quantitative ,amino:2
quantitative ,acid:2
plasma ,lipoprotein:2
plasma ,metabolic:2
plasma ,amino:2
plasma ,acid:2
lipoprotein ,metabolic:2
lipoprotein ,amino:2
lipoprotein ,acid:2
metabolic ,amino:2
metabolic ,acid:2
acute ,original:2
acute ,antigenic:2
acute ,sin:2
respiratory ,original:2
respiratory ,antigenic:2
respiratory ,sin:2
syndrome ,original:2
syndrome ,antigenic:2
syndrome ,sin:2
coronavirus ,original:4
coronavirus ,sin:2
sars-cov-2 ,eclampsia:2
infection ,eclampsia:2
pregnancy ,risk:2
pregnancy ,factor:2
pregnancy ,eclampsia:2
pregnancy ,neurological:2
risk ,eclampsia:2
risk ,neurological:2
factor ,eclampsia:2
factor ,neurological:2
eclampsia ,neurological:2
emerging ,first:2
emerging ,sars:4
emerging ,second:2
emerging ,mers:2
emerging ,third:2
coronaviruses ,first:2
coronaviruses ,second:2
coronaviruses ,mers:2
coronaviruses ,third:2
first ,sars:2
first ,second:2
first ,mers:2
first ,third:2
sars ,second:2
sars ,third:2
second ,mers:2
second ,third:2
second ,sars-cov-2:2
mers ,third:2
third ,sars-cov-2:2
real ,asymptomatic:2
real ,infection:2
real ,might:2
real ,rare:2
real ,importance:2
real ,careful:2
asymptomatic ,might:2
asymptomatic ,rare:2
asymptomatic ,importance:2
asymptomatic ,careful:2
sars-cov-2 ,careful:2
infection ,might:2
infection ,rare:2
infection ,importance:4
infection ,careful:2
might ,rare:2
might ,importance:2
might ,careful:2
rare ,importance:2
rare ,careful:2
importance ,careful:2
pulmonary ,edema:2
pulmonary ,covid19-a:2
pulmonary ,neural:2
pulmonary ,hypothesis:2
edema ,covid19-a:2
edema ,neural:2
edema ,hypothesis:2
covid19-a ,neural:2
covid19-a ,hypothesis:2
neuroinvasive ,primary:2
neuroinvasive ,pathogen:2
neuroinvasive ,sars-:2
neuroinvasive ,cov2:2
neuroinvasive ,summarizing:2
potential ,primary:2
potential ,pathogen:4
potential ,sars-:2
potential ,cov2:2
potential ,summarizing:2
primary ,respiratory:2
primary ,pathogen:2
primary ,sars-:2
primary ,cov2:2
primary ,summarizing:2
respiratory ,pathogen:2
respiratory ,sars-:2
respiratory ,cov2:2
respiratory ,summarizing:2
pathogen ,sars-:2
pathogen ,cov2:2
pathogen ,summarizing:2
sars- ,cov2:4
sars- ,summarizing:2
cov2 ,summarizing:2
covid-19 ,hygiene:4
survey ,awareness:2
survey ,hygiene:2
survey ,practices:2
survey ,dental:2
survey ,health:2
knowledge ,awareness:2
knowledge ,hygiene:2
knowledge ,among:4
knowledge ,dental:2
knowledge ,health:2
awareness ,hygiene:2
awareness ,practices:2
awareness ,among:4
awareness ,dental:4
awareness ,health:2
hygiene ,practices:2
hygiene ,among:4
hygiene ,dental:2
practices ,health:2
among ,dental:4
identification ,novel:4
identification ,mutations:2
identification ,isolates:2
identification ,turkey:2
novel ,mutations:2
novel ,isolates:2
novel ,turkey:2
mutations ,isolates:2
mutations ,turkey:2
sars-cov-2 ,turkey:4
isolates ,turkey:2
artesunate ,alternative:2
artesunate ,drug:2
artesunate ,chloroquine:2
artesunate ,covid-19:2
artesunate ,treatment:4
alternative ,chloroquine:2
prevalence ,verona:2
prevalence ,italy:2
prevalence ,april-may:2
sars-cov-2 ,verona:2
sars-cov-2 ,april-may:2
verona ,italy:2
verona ,april-may:2
italy ,april-may:2
covid-19 ,cystic:4
isolation ,early:2
isolation ,isolate:2
characterization ,early:2
characterization ,isolate:2
characterization ,epidemic:2
early ,isolate:2
sars-cov-2 ,isolate:2
isolate ,epidemic:2
ace2 ,scarf:2
ace2 ,dorsal:2
ace2 ,root:2
ace2 ,ganglion:2
ace2 ,nociceptors:2
scarf ,expression:2
scarf ,human:2
scarf ,dorsal:2
scarf ,root:2
scarf ,ganglion:2
scarf ,nociceptors:2
scarf ,implications:2
expression ,dorsal:2
expression ,root:2
expression ,ganglion:2
expression ,nociceptors:2
human ,dorsal:2
human ,root:2
human ,ganglion:2
human ,nociceptors:2
dorsal ,root:2
dorsal ,ganglion:2
dorsal ,nociceptors:2
dorsal ,implications:2
root ,ganglion:2
root ,nociceptors:2
root ,implications:2
ganglion ,nociceptors:2
ganglion ,implications:2
nociceptors ,implications:2
metagenomic ,analysis:2
metagenomic ,reveals:2
metagenomic ,clinical:2
metagenomic ,sars-cov-2:2
metagenomic ,infection:2
metagenomic ,bacterial:2
metagenomic ,viral:2
analysis ,bacterial:2
reveals ,clinical:2
reveals ,bacterial:2
reveals ,viral:2
clinical ,bacterial:4
recommendations ,sepd:2
recommendations ,aeg:2
recommendations ,general:2
recommendations ,operation:2
sepd ,aeg:2
sepd ,general:2
sepd ,operation:2
aeg ,general:2
aeg ,operation:2
general ,operation:2
epigenetic ,ace2:2
epigenetic ,interferon-regulated:2
epigenetic ,genes:2
epigenetic ,might:2
epigenetic ,suggest:2
dysregulation ,ace2:4
dysregulation ,interferon-regulated:2
dysregulation ,genes:2
dysregulation ,might:2
dysregulation ,suggest:2
ace2 ,interferon-regulated:2
ace2 ,might:2
ace2 ,suggest:2
interferon-regulated ,genes:2
interferon-regulated ,might:2
interferon-regulated ,suggest:2
genes ,suggest:2
might ,suggest:2
impact ,imposed:2
impact ,delay:2
impact ,elective:4
impact ,neurosurgery:2
impact ,informed:2
imposed ,delay:2
imposed ,elective:2
imposed ,pediatric:2
imposed ,neurosurgery:2
imposed ,informed:2
delay ,elective:2
delay ,pediatric:2
delay ,neurosurgery:2
delay ,informed:2
elective ,pediatric:2
elective ,neurosurgery:2
elective ,informed:2
pediatric ,neurosurgery:2
pediatric ,informed:2
neurosurgery ,informed:2
putative ,tobacco:2
putative ,mosaic:2
putative ,virus:4
putative ,smokers:2
putative ,resistance:2
role ,tobacco:2
role ,mosaic:2
role ,smokers:2
role ,resistance:2
tobacco ,mosaic:2
tobacco ,virus:2
tobacco ,smokers:2
tobacco ,resistance:2
tobacco ,covid-19:4
mosaic ,virus:2
mosaic ,smokers:2
mosaic ,resistance:2
mosaic ,covid-19:2
virus ,smokers:2
virus ,resistance:2
smokers ,resistance:2
smokers ,covid-19:2
resistance ,covid-19:6
disruption ,sleep:2
disruption ,quality:2
disruption ,consequence:2
disruption ,severe:2
disruption ,covid-19:6
disruption ,infection:4
sleep ,consequence:2
sleep ,severe:2
sleep ,infection:2
quality ,consequence:2
quality ,severe:2
quality ,infection:2
consequence ,severe:2
consequence ,covid-19:2
consequence ,infection:2
absence ,nosocomial:2
absence ,coronavirus:2
absence ,disease:2
absence ,due:2
nosocomial ,covid-19:6
nosocomial ,due:2
transmission ,due:2
covid-19 ,due:12
systematic ,stool:2
systematic ,potential:6
review ,stool:2
meta-analysis ,sars-cov-2:6
meta-analysis ,stool:2
meta-analysis ,testing:2
meta-analysis ,potential:2
sars-cov-2 ,stool:4
stool ,testing:2
stool ,potential:2
molecular ,first:6
molecular ,wave:4
epidemiology ,first:2
epidemiology ,wave:2
wave ,severe:2
wave ,acute:2
wave ,respiratory:2
wave ,syndrome:2
design ,peptide-based:2
design ,subunit:2
peptide-based ,subunit:2
peptide-based ,vaccine:2
peptide-based ,novel:2
peptide-based ,coronavirus:2
peptide-based ,sars-cov-2:4
subunit ,novel:2
subunit ,coronavirus:2
subunit ,sars-cov-2:2
known ,urologist:2
known ,medical:2
known ,management:2
known ,covid-19s:2
urologist ,medical:2
urologist ,management:2
urologist ,covid-19s:2
medical ,management:2
medical ,covid-19s:2
management ,covid-19s:2
elective ,tracheostomy:4
elective ,patients:4
elective ,standardized:2
tracheostomy ,standardized:2
covid-19 ,standardized:2
patients ,standardized:2
experience ,standardized:2
sars-cov-2 ,diabetes:8
sars-cov-2 ,mellitus:6
infection ,mellitus:2
infection ,hypertension:2
patients ,mellitus:6
cardiovascular ,susceptibility:2
risk ,susceptibility:6
treatment ,people:2
treatment ,covid19:4
treatment ,selecting:2
treatment ,best:2
treatment ,armamentarium:4
options ,people:2
options ,covid19:2
options ,selecting:2
options ,best:2
options ,armamentarium:2
people ,covid19:2
people ,selecting:2
people ,best:2
people ,armamentarium:2
covid19 ,selecting:2
covid19 ,best:2
covid19 ,armamentarium:2
selecting ,best:2
selecting ,armamentarium:2
best ,armamentarium:2
impact ,routine:2
impact ,infant:2
impact ,bcg:4
impact ,vaccination:6
routine ,infant:2
routine ,bcg:4
routine ,vaccination:2
routine ,covid-19:8
infant ,bcg:2
infant ,vaccination:2
clinical ,obstetric:2
clinical ,neonatal:2
features ,obstetric:2
features ,neonatal:2
features ,pregnant:2
obstetric ,neonatal:2
obstetric ,outcomes:2
obstetric ,pregnant:2
neonatal ,outcomes:6
neonatal ,pregnant:2
neonatal ,patients:2
pregnant ,patients:6
covid-19 ,resource-poor:2
pandemic ,resource-poor:2
pandemic ,countries:2
resource-poor ,countries:2
resource-poor ,challenges:2
resource-poor ,experiences:2
countries ,challenges:2
countries ,experiences:2
similarity ,case:2
similarity ,fatality:2
similarity ,rates:2
similarity ,cfr:2
similarity ,covid-19sars-cov-2:2
similarity ,italy:2
similarity ,china:2
case ,rates:2
case ,cfr:2
case ,covid-19sars-cov-2:2
fatality ,cfr:2
fatality ,covid-19sars-cov-2:2
fatality ,china:2
rates ,cfr:2
rates ,covid-19sars-cov-2:2
rates ,china:2
cfr ,covid-19sars-cov-2:2
cfr ,italy:2
cfr ,china:2
covid-19sars-cov-2 ,italy:2
covid-19sars-cov-2 ,china:2
italy ,china:2
perception ,health:2
perception ,conditions:2
perception ,test:2
perception ,availability:2
perception ,predictors:2
perception ,adults:2
health ,test:6
health ,availability:2
health ,predictors:2
health ,adults:4
conditions ,test:2
conditions ,availability:2
conditions ,predictors:2
conditions ,adults:2
test ,availability:2
test ,predictors:2
test ,adults:4
availability ,predictors:2
availability ,adults:2
predictors ,adults:2
severe ,glial:2
acute ,glial:2
respiratory ,glial:2
syndrome ,glial:2
syndrome ,cells:2
coronavirus ,glial:2
sars-cov-2 ,glial:2
glial ,cells:2
severe ,upper:2
severe ,limb:2
severe ,deep:2
acute ,upper:6
acute ,limb:8
acute ,deep:4
respiratory ,limb:2
respiratory ,deep:4
syndrome ,upper:2
syndrome ,limb:2
syndrome ,deep:2
coronavirus ,upper:2
coronavirus ,limb:2
coronavirus ,deep:6
infection ,upper:2
infection ,limb:2
infection ,deep:2
upper ,limb:6
upper ,deep:2
limb ,deep:2
rapid ,advice:2
rapid ,guideline:2
advice ,guideline:2
advice ,diagnosis:2
advice ,treatment:2
advice ,novel:2
advice ,coronavirus:2
guideline ,diagnosis:2
guideline ,treatment:2
guideline ,novel:2
guideline ,coronavirus:2
severe ,history:4
acute ,history:4
respiratory ,history:4
syndrome ,history:2
emergence ,history:2
analysis ,gastrointestinal:2
analysis ,hepatic:2
analysis ,manifestations:2
intoxication ,endogenous:2
intoxication ,angiotensin:2
intoxication ,ii:2
intoxication ,covid-19:2
intoxication ,hypothesis:2
endogenous ,angiotensin:2
endogenous ,ii:2
endogenous ,covid-19:2
endogenous ,hypothesis:2
ii ,covid-19:8
ii ,hypothesis:2
probable ,molecular:2
probable ,mechanism:2
probable ,remdesivir:2
probable ,treatment:2
probable ,need:2
molecular ,remdesivir:2
molecular ,treatment:4
molecular ,need:2
mechanism ,remdesivir:4
mechanism ,need:2
remdesivir ,need:2
host-directed ,therapies:2
host-directed ,potential:4
host-directed ,solution:2
host-directed ,combat:2
host-directed ,covid-19:2
therapies ,solution:2
therapies ,combat:2
potential ,solution:2
solution ,combat:2
solution ,covid-19:6
turning ,rural:2
turning ,villages:2
turning ,home:2
turning ,front:2
turning ,social:2
turning ,stability-examination:2
rural ,villages:4
rural ,home:2
rural ,front:2
rural ,social:2
rural ,stability-examination:2
villages ,home:2
villages ,front:2
villages ,social:2
villages ,stability-examination:2
home ,front:2
home ,social:2
home ,stability-examination:2
front ,social:2
front ,stability-examination:2
social ,stability-examination:2
treatment ,covid-19-exacerbated:2
treatment ,asthma:2
treatment ,systemic:6
treatment ,corticosteroids:4
covid-19-exacerbated ,asthma:2
covid-19-exacerbated ,systemic:2
covid-19-exacerbated ,corticosteroids:2
covid-19-exacerbated ,used:2
asthma ,systemic:2
asthma ,corticosteroids:4
asthma ,used:2
systemic ,corticosteroids:2
systemic ,used:2
corticosteroids ,used:2
covid-19 ,across:8
covid-19 ,asia:2
covid-19 ,pacific:2
tale ,two:2
tale ,pandemics:2
tale ,across:2
tale ,asia:2
tale ,pacific:2
tale ,region:2
two ,across:2
two ,asia:2
two ,pacific:2
two ,region:2
pandemics ,across:2
pandemics ,asia:2
pandemics ,pacific:2
pandemics ,region:2
across ,asia:2
across ,pacific:2
across ,region:2
asia ,pacific:2
asia ,region:2
pacific ,region:2
poor ,prolonged:2
poor ,persistence:2
poor ,rna:2
outcome ,prolonged:2
outcome ,persistence:2
outcome ,rna:4
de ,novo:2
de ,status:2
de ,epilepticus:2
de ,patients:2
de ,covid-19:4
novo ,status:2
novo ,epilepticus:2
novo ,patients:2
novo ,covid-19:2
status ,epilepticus:6
status ,patients:8
epilepticus ,patients:2
epilepticus ,covid-19:6
complete ,blood:2
complete ,count:2
complete ,might:2
complete ,help:2
complete ,identify:2
complete ,subjects:2
complete ,high:2
complete ,probability:2
blood ,count:2
blood ,might:2
blood ,help:2
blood ,identify:2
blood ,subjects:2
blood ,high:4
blood ,probability:2
count ,might:2
count ,help:2
count ,identify:2
count ,subjects:2
count ,high:2
count ,probability:2
might ,identify:2
might ,subjects:2
might ,high:2
might ,probability:2
help ,identify:4
help ,subjects:2
help ,high:2
help ,probability:2
identify ,subjects:2
identify ,high:2
identify ,probability:2
subjects ,high:2
subjects ,probability:2
high ,probability:2
basic ,epidemiological:2
basic ,parameter:2
basic ,values:2
basic ,data:2
basic ,real-world:2
basic ,mega-cities:2
epidemiological ,parameter:2
epidemiological ,values:2
epidemiological ,real-world:2
epidemiological ,mega-cities:2
parameter ,values:2
parameter ,data:2
parameter ,real-world:2
parameter ,mega-cities:2
values ,data:2
values ,real-world:2
values ,mega-cities:2
data ,real-world:2
data ,mega-cities:2
real-world ,mega-cities:2
sars-cov-2 ,technological:2
sars-cov-2 ,initiative:2
sars-cov-2 ,strengthen:2
sars-cov-2 ,warning:2
sequencing ,technological:2
sequencing ,initiative:2
sequencing ,strengthen:2
sequencing ,early:2
sequencing ,warning:2
technological ,initiative:2
technological ,strengthen:2
technological ,early:2
technological ,warning:2
initiative ,strengthen:2
initiative ,early:2
initiative ,warning:2
strengthen ,early:2
strengthen ,warning:2
infectivity ,virulence:2
infectivity ,pathogenicity:2
infectivity ,host-pathogen:2
infectivity ,interactions:2
infectivity ,sars:2
virulence ,pathogenicity:2
virulence ,host-pathogen:2
virulence ,interactions:2
virulence ,sars:2
pathogenicity ,host-pathogen:2
pathogenicity ,interactions:2
pathogenicity ,sars:2
host-pathogen ,interactions:4
host-pathogen ,sars:2
interactions ,sars:2
biological ,plausibility:2
biological ,interactions:2
biological ,dietary:2
biological ,fat:2
biological ,resveratrol:2
biological ,ace2:2
plausibility ,interactions:2
plausibility ,dietary:2
plausibility ,fat:2
plausibility ,resveratrol:2
plausibility ,ace2:2
interactions ,dietary:2
interactions ,fat:2
interactions ,resveratrol:2
dietary ,fat:2
dietary ,resveratrol:2
dietary ,ace2:2
fat ,resveratrol:2
fat ,ace2:2
resveratrol ,ace2:2
association ,coronavirus:8
association ,rising:2
association ,concern:2
coronavirus ,rising:2
coronavirus ,concern:2
disease ,rising:2
stroke ,rising:2
stroke ,concern:2
rising ,concern:2
clinical ,high:2
clinical ,saliva:4
significance ,high:2
significance ,saliva:2
high ,saliva:2
viral ,saliva:6
load ,saliva:6
enlightening ,role:2
enlightening ,cytokine:2
enlightening ,storm:2
enlightening ,coronavirus:2
enlightening ,infection:2
role ,cytokine:10
role ,storm:8
cytokine ,infection:8
storm ,coronavirus:6
storm ,infection:4
race ,clock:2
race ,creation:2
race ,sars-cov-2:4
race ,laboratory:2
race ,month:2
clock ,creation:2
clock ,sars-cov-2:4
clock ,laboratory:2
clock ,month:2
creation ,sars-cov-2:4
creation ,laboratory:2
creation ,month:2
laboratory ,month:2
prevalence ,cancer:2
prevalence ,cohort:2
prevalence ,results:4
prevalence ,consequences:2
asymptomatic ,cohort:6
asymptomatic ,results:4
asymptomatic ,consequences:2
cancer ,cohort:2
cancer ,results:2
cancer ,consequences:2
cohort ,results:6
cohort ,consequences:4
results ,consequences:2
alteration ,reduction:4
alteration ,taste:4
alteration ,loss:2
alteration ,main:2
alteration ,causes:2
alteration ,potential:2
alteration ,implications:2
reduction ,taste:2
reduction ,loss:2
reduction ,main:2
reduction ,causes:2
reduction ,potential:2
reduction ,implications:2
taste ,main:2
taste ,causes:2
taste ,potential:2
taste ,implications:2
loss ,main:2
loss ,causes:2
loss ,potential:2
loss ,implications:2
main ,causes:2
main ,implications:2
causes ,implications:2
understanding ,nepal:2
covid-19 ,nepal:6
comparative ,symptomatic:2
comparative ,asymptomatic:2
comparative ,infection:4
analysis ,symptomatic:2
lesson ,saboteur:2
lesson ,high-mw:2
lesson ,kininogen:2
lesson ,impact:2
lesson ,coronavirus-induced:2
lesson ,disease:4
saboteur ,high-mw:2
saboteur ,kininogen:2
saboteur ,impact:2
saboteur ,coronavirus-induced:2
saboteur ,disease:2
high-mw ,kininogen:2
high-mw ,impact:2
high-mw ,coronavirus-induced:2
high-mw ,disease:2
kininogen ,impact:2
kininogen ,coronavirus-induced:2
kininogen ,disease:2
impact ,coronavirus-induced:2
coronavirus-induced ,disease:2
nasopharyngeal ,andor:2
nasopharyngeal ,serology:2
nasopharyngeal ,sars:2
oropharyngeal ,andor:2
oropharyngeal ,serology:2
oropharyngeal ,sars:2
oropharyngeal ,covid-19:2
swabs ,andor:2
swabs ,serology:2
swabs ,sars:2
andor ,serology:2
andor ,sars:2
serology ,sars:2
serology ,covid-19:10
isolation ,respiratory:2
isolation ,syndrome:2
isolation ,coronavirus:8
cancellation ,mass:2
cancellation ,gatherings:2
cancellation ,mgs:2
cancellation ,decision:2
cancellation ,making:2
cancellation ,time:2
cancellation ,covid-19:2
mass ,gatherings:4
mass ,mgs:2
mass ,decision:2
mass ,making:2
mass ,time:2
gatherings ,mgs:2
gatherings ,decision:2
gatherings ,making:2
gatherings ,time:2
gatherings ,covid-19:4
mgs ,decision:2
mgs ,making:2
mgs ,time:2
mgs ,covid-19:2
decision ,making:6
decision ,time:2
decision ,covid-19:4
making ,time:2
making ,covid-19:8
sars-cov-2 ,blistering:2
influence ,immunosuppressive:2
influence ,therapy:2
influence ,autoimmune:2
influence ,blistering:2
immunosuppressive ,therapy:10
immunosuppressive ,autoimmune:2
immunosuppressive ,blistering:2
therapy ,autoimmune:4
therapy ,blistering:2
autoimmune ,blistering:2
assessment ,specimen:2
assessment ,pooling:4
assessment ,conserve:2
assessment ,sars:2
assessment ,cov-2:2
assessment ,resources:2
specimen ,pooling:2
specimen ,conserve:2
specimen ,sars:2
specimen ,cov-2:2
specimen ,resources:2
pooling ,conserve:2
pooling ,sars:2
pooling ,cov-2:2
pooling ,testing:10
pooling ,resources:2
conserve ,sars:2
conserve ,cov-2:2
conserve ,testing:2
conserve ,resources:2
sars ,testing:2
sars ,resources:2
cov-2 ,testing:2
cov-2 ,resources:2
testing ,resources:4
covid-19 ,seen:2
pandemic ,seen:2
pandemic ,frontline:4
seen ,frontline:2
central ,manifestations:4
nervous ,manifestations:4
covid-19 ,dilemma:6
diagnostic ,dilemma:2
diagnostic ,clinicians:2
dilemma ,clinicians:2
dilemma ,perspective:2
clinicians ,perspective:2
lack ,cross-neutralization:2
lack ,sars:2
lack ,patient:2
lack ,sera:2
lack ,towards:2
cross-neutralization ,sars:2
cross-neutralization ,patient:2
cross-neutralization ,sera:2
cross-neutralization ,towards:2
sars ,sera:2
sars ,towards:4
patient ,sera:2
patient ,towards:4
sera ,towards:2
sera ,sars-cov-2:2
candidate ,covid-19:16
lack ,susceptibility:2
lack ,mers-cov:2
lack ,poultry:2
susceptibility ,mers-cov:2
susceptibility ,poultry:2
sars-cov-2 ,poultry:2
mers-cov ,poultry:2
diagnostic ,portable:2
diagnostic ,biosensors:2
methods ,portable:2
methods ,biosensors:2
potential ,portable:2
potential ,biosensors:2
portable ,biosensors:2
portable ,coronavirus:2
portable ,disease:2
biosensors ,coronavirus:2
biosensors ,disease:2
isolation ,sars-cov-2-related:2
isolation ,malayan:2
isolation ,pangolins:2
sars-cov-2-related ,coronavirus:2
sars-cov-2-related ,malayan:2
coronavirus ,malayan:2
coronavirus ,pangolins:4
malayan ,pangolins:2
breastfed ,13month-old:2
breastfed ,infant:2
breastfed ,mother:2
breastfed ,covid-19:2
breastfed ,pneumonia:2
breastfed ,case:2
breastfed ,report:2
13month-old ,infant:2
13month-old ,mother:2
13month-old ,covid-19:2
13month-old ,pneumonia:2
13month-old ,case:2
13month-old ,report:2
infant ,mother:2
infant ,pneumonia:2
infant ,report:4
mother ,pneumonia:2
mother ,case:4
mother ,report:4
utility ,lateral:2
utility ,flow:2
utility ,tests:2
utility ,sars-cov-2:4
utility ,monitorization:2
lateral ,tests:4
lateral ,sars-cov-2:12
lateral ,infection:2
lateral ,monitorization:2
flow ,tests:4
flow ,sars-cov-2:12
flow ,infection:2
flow ,monitorization:2
tests ,infection:6
tests ,monitorization:2
sars-cov-2 ,monitorization:2
infection ,monitorization:2
expressions ,significances:2
expressions ,angiotensin-converting:2
expressions ,enzyme:2
expressions ,gene:2
significances ,angiotensin-converting:2
significances ,enzyme:2
significances ,gene:2
angiotensin-converting ,gene:6
presence ,duration:2
presence ,symptoms:2
presence ,febrile:2
presence ,infants:2
presence ,without:2
duration ,symptoms:2
duration ,febrile:2
duration ,infants:2
duration ,without:2
symptoms ,febrile:2
symptoms ,infants:2
symptoms ,without:4
febrile ,infants:4
febrile ,without:2
febrile ,sars-cov-2:6
infants ,without:2
asymptomatic ,risk:6
asymptomatic ,transfusion:2
symptomatic ,risk:2
symptomatic ,transfusion:2
risk ,transfusion:2
community ,prevalence:2
community ,influenzalike:2
community ,illnesses:2
prevalence ,influenzalike:2
prevalence ,illnesses:2
sars-cov-2 ,influenzalike:2
sars-cov-2 ,illnesses:2
among ,influenzalike:2
among ,illnesses:2
patients ,influenzalike:2
patients ,illnesses:2
influenzalike ,illnesses:2
convalescent ,male:2
convalescent ,gender:2
convalescent ,older:2
convalescent ,age:2
convalescent ,hospitalisation:2
plasma ,male:2
plasma ,gender:2
plasma ,older:2
plasma ,age:2
plasma ,hospitalisation:2
male ,older:2
male ,hospitalisation:2
gender ,older:2
gender ,hospitalisation:2
older ,age:2
older ,hospitalisation:2
age ,hospitalisation:2
olfactory ,abnormalities:2
olfactory ,cases:2
gustatory ,abnormalities:2
gustatory ,cases:2
abnormalities ,cases:2
neuroradiological ,features:2
neuroradiological ,mild:2
neuroradiological ,severe:2
neuroradiological ,sars-cov-2:2
neuroradiological ,infection:2
features ,mild:4
severe ,close:2
severe ,contact:2
acute ,via:2
acute ,close:2
acute ,contact:2
respiratory ,close:2
respiratory ,contact:2
syndrome ,via:2
syndrome ,close:2
syndrome ,contact:2
coronavirus ,close:2
via ,close:2
via ,contact:2
close ,contact:6
sars-cov-2 ,controls:4
sars-cov-2 ,killer:4
spike ,controls:2
spike ,natural:2
spike ,killer:2
spike ,activation:4
spike ,via:2
protein ,controls:2
protein ,natural:2
protein ,killer:2
protein ,activation:2
controls ,natural:2
controls ,killer:2
controls ,cell:2
controls ,activation:2
controls ,via:2
natural ,activation:2
natural ,via:2
killer ,activation:2
killer ,via:2
cell ,activation:6
activation ,via:2
hyperbaric ,therapy:4
hyperbaric ,preventing:2
hyperbaric ,mechanical:2
hyperbaric ,ventilation:2
oxygen ,preventing:2
oxygen ,mechanical:2
oxygen ,ventilation:2
therapy ,preventing:2
therapy ,mechanical:2
therapy ,ventilation:2
preventing ,mechanical:2
preventing ,ventilation:2
preventing ,patients:2
mechanical ,ventilation:14
mechanical ,covid-19:12
mechanical ,patients:8
ventilation ,covid-19:8
ventilation ,patients:8
cytokine ,prospects:2
cytokine ,immunotherapy:2
storm ,prospects:2
storm ,immunotherapy:2
prospects ,immunotherapy:2
prospects ,covid-19:4
research ,pneumonia:2
progress ,pneumonia:2
drug ,pneumonia:2
treatment ,pneumonia:10
understanding ,contact:2
understanding ,system:2
understanding ,key:2
pathophysiology ,contact:2
pathophysiology ,system:2
pathophysiology ,key:2
contact ,system:2
contact ,key:2
system ,key:4
evaluation ,conjunctival:4
evaluation ,swab:4
evaluation ,patients:8
evaluation ,infection:4
conjunctival ,pcr:2
conjunctival ,results:2
conjunctival ,patients:4
conjunctival ,infection:2
swab ,pcr:2
swab ,results:2
swab ,patients:2
swab ,infection:2
pcr ,infection:2
results ,patients:12
evolutionary ,study:2
evolutionary ,covid-19:6
evolutionary ,severe:4
evolutionary ,acute:4
evolutionary ,respiratory:4
evolutionary ,syndrome:4
study ,acute:6
study ,respiratory:6
study ,syndrome:6
case ,stent:2
case ,thrombosis:8
series ,stent:2
series ,thrombosis:2
series ,pandemic:2
stent ,thrombosis:2
stent ,covid-19:2
stent ,pandemic:2
thrombosis ,covid-19:32
thrombosis ,pandemic:2
therapeutic ,b-1a:2
therapeutic ,cells:4
potential ,b-1a:2
b-1a ,cells:2
b-1a ,covid-19:2
management ,mother-infant:2
management ,dyad:2
management ,confirmed:2
mother-infant ,dyad:2
mother-infant ,suspected:2
mother-infant ,confirmed:2
mother-infant ,sars-cov-2:2
dyad ,suspected:2
dyad ,confirmed:2
dyad ,sars-cov-2:4
imaging ,covid-19-related:2
imaging ,myocardial:2
imaging ,injury:2
covid-19-related ,myocardial:2
covid-19-related ,injury:2
distribution ,contamination:2
distribution ,environmental:2
distribution ,surfaces:2
environmental ,surfaces:4
practice ,anesthesia:2
practice ,scenario:2
practice ,design:2
practice ,cesarean:2
practice ,section:2
practice ,patients:2
anesthesia ,scenario:2
anesthesia ,design:2
anesthesia ,patients:2
scenario ,design:2
scenario ,emergency:2
scenario ,cesarean:2
scenario ,section:2
scenario ,patients:4
design ,emergency:2
design ,cesarean:2
design ,section:2
design ,patients:4
cesarean ,patients:4
section ,patients:2
cytokine ,current:2
cytokine ,evidence:6
cytokine ,strategies:2
storm ,current:2
storm ,evidence:6
storm ,strategies:2
evidence ,treatment:8
evidence ,strategies:4
clinical ,properties:4
clinical ,methods:2
clinical ,pregnancies:2
properties ,methods:2
properties ,infection:2
properties ,pregnancies:2
diagnostic ,pregnancies:2
methods ,pregnancies:2
covid-19 ,pregnancies:6
infection ,pregnancies:2
mast ,activated:2
mast ,sars-cov-2:2
mast ,release:2
mast ,histamine:2
mast ,increases:2
mast ,il-1:2
mast ,levels:2
cells ,activated:2
cells ,release:2
cells ,histamine:2
cells ,increases:2
cells ,il-1:2
activated ,sars-cov-2:2
activated ,release:2
activated ,histamine:2
activated ,increases:2
activated ,il-1:2
activated ,levels:2
sars-cov-2 ,release:2
sars-cov-2 ,histamine:2
sars-cov-2 ,increases:6
sars-cov-2 ,il-1:2
release ,histamine:2
release ,increases:2
release ,il-1:2
release ,levels:2
histamine ,increases:2
histamine ,il-1:2
histamine ,levels:2
increases ,il-1:2
increases ,levels:2
il-1 ,levels:2
two ,hits:2
two ,renin-angiotensin:2
two ,system:2
two ,may:2
two ,play:2
two ,key:2
two ,role:2
hits ,renin-angiotensin:2
hits ,system:2
hits ,may:2
hits ,play:2
hits ,key:2
hits ,role:2
hits ,severe:2
hits ,covid-19:2
renin-angiotensin ,may:2
renin-angiotensin ,key:2
system ,may:4
may ,key:2
may ,severe:4
play ,key:2
play ,severe:2
diarrhea ,covid-19:2
diarrhea ,infection:2
diarrhea ,pathogenesis:2
diarrhea ,epidemiology:2
diarrhea ,prevention:2
pathogenesis ,prevention:2
epidemiology ,prevention:4
clinical ,25:4
clinical ,infections:6
analysis ,25:2
25 ,infections:2
25 ,children:2
impact ,ischemic:2
impact ,stroke:2
influenza ,three:2
influenza ,cases:2
co-infection ,three:2
co-infection ,cases:4
coronavirus ,elderly:2
coronavirus ,lockdown:2
coronavirus ,uk:4
coronavirus ,cohort:4
elderly ,late:2
elderly ,lockdown:2
elderly ,uk:2
elderly ,cohort:2
late ,lockdown:2
late ,uk:2
late ,cohort:2
lockdown ,uk:2
lockdown ,cohort:2
uk ,cohort:2
covid-19-associated ,encephalitis:2
covid-19-associated ,mimicking:2
covid-19-associated ,glial:2
covid-19-associated ,tumor:2
encephalitis ,mimicking:2
encephalitis ,glial:2
encephalitis ,tumor:2
mimicking ,glial:2
mimicking ,tumor:2
glial ,tumor:2
molecular ,architecture:2
molecular ,early:2
molecular ,dissemination:2
molecular ,massive:2
molecular ,second:2
architecture ,early:2
architecture ,dissemination:2
architecture ,massive:2
architecture ,second:2
architecture ,wave:2
early ,dissemination:2
early ,massive:2
early ,second:2
early ,wave:2
dissemination ,massive:2
dissemination ,second:2
dissemination ,wave:2
massive ,second:2
massive ,wave:2
second ,wave:4
detection ,cystic:2
detection ,fibrosis:2
detection ,regional:2
detection ,lazio:2
cystic ,regional:2
cystic ,lazio:2
fibrosis ,regional:2
fibrosis ,lazio:2
patients ,regional:4
patients ,lazio:2
regional ,lazio:2
covid-19 ,cadd:2
cadd ,rescue:2
convalescent ,possible:4
convalescent ,mechanisms:2
convalescent ,action:2
plasma ,possible:4
plasma ,mechanisms:2
plasma ,action:2
takotsubo ,syndrome:4
takotsubo ,associated:2
takotsubo ,covid-19:2
statistical ,explorations:2
statistical ,univariate:2
statistical ,timeseries:2
statistical ,analysis:2
statistical ,covid-19:4
statistical ,datasets:2
explorations ,univariate:2
explorations ,timeseries:2
explorations ,analysis:2
explorations ,covid-19:2
explorations ,datasets:2
univariate ,timeseries:2
univariate ,analysis:2
univariate ,covid-19:2
univariate ,datasets:2
timeseries ,analysis:2
timeseries ,covid-19:2
timeseries ,datasets:2
analysis ,datasets:2
covid-19 ,datasets:2
kawasaki ,disease:12
kawasaki ,epidemic:2
kawasaki ,pitfalls:2
disease ,pitfalls:2
epidemic ,pitfalls:2
olfactory ,sinonasal:2
olfactory ,symptomatology:2
olfactory ,prevalence:8
dysfunction ,symptomatology:2
sinonasal ,symptomatology:2
sinonasal ,covid-19:4
symptomatology ,covid-19:8
symptomatology ,prevalence:2
platelet ,gene:2
platelet ,expression:2
platelet ,function:2
platelet ,patients:2
gene ,function:2
gene ,patients:4
expression ,function:2
function ,patients:4
serological ,findings:2
serological ,first:2
molecular ,findings:2
molecular ,case:2
findings ,first:4
findings ,study:4
evaluation ,shedding:4
evaluation ,specimens:6
shedding ,specimens:2
obesity ,critical:2
obesity ,factor:4
obesity ,pandemic:2
critical ,risk:6
critical ,factor:4
critical ,pandemic:8
risk ,pandemic:6
factor ,pandemic:4
role ,antimalarials:2
role ,management:8
antimalarials ,management:2
antimalarials ,covid-19:4
positive ,form:2
positive ,hospital:2
positive ,chongqing:2
results ,discharged:2
results ,form:2
results ,hospital:2
results ,chongqing:2
patients ,form:2
patients ,chongqing:2
covid-19 ,form:2
covid-19 ,chongqing:2
discharged ,form:2
discharged ,hospital:2
discharged ,chongqing:2
form ,hospital:2
form ,chongqing:2
hospital ,chongqing:2
vitro ,efficacy:2
vitro ,copper:2
vitro ,iodine:2
vitro ,complex:2
vitro ,ppe:2
vitro ,disinfectant:2
efficacy ,copper:2
efficacy ,iodine:2
efficacy ,complex:2
efficacy ,ppe:2
efficacy ,disinfectant:2
copper ,iodine:2
copper ,complex:2
copper ,ppe:2
copper ,disinfectant:2
copper ,sars-cov-2:2
iodine ,complex:2
iodine ,ppe:2
iodine ,disinfectant:2
iodine ,sars-cov-2:2
complex ,ppe:2
complex ,disinfectant:2
complex ,sars-cov-2:2
ppe ,disinfectant:2
ppe ,sars-cov-2:2
disinfectant ,sars-cov-2:2
evaluation ,deep:2
evaluation ,throat:2
evaluation ,saliva:6
evaluation ,lower:2
evaluation ,respiratory:10
evaluation ,tract:4
testing ,throat:2
testing ,lower:2
testing ,tract:2
testing ,specimens:4
deep ,throat:4
deep ,saliva:4
deep ,lower:2
deep ,tract:2
deep ,specimens:2
throat ,saliva:4
throat ,lower:2
throat ,respiratory:2
throat ,tract:2
saliva ,lower:2
saliva ,tract:2
lower ,respiratory:8
lower ,tract:6
lower ,specimens:4
tract ,specimens:2
bioinformatic ,correlation:2
bioinformatic ,immune:2
bioinformatic ,infiltration:2
analysis ,correlation:6
analysis ,immune:6
analysis ,infiltration:2
correlation ,immune:4
correlation ,infiltration:2
immune ,infiltration:6
multicenter ,cepheid:2
multicenter ,xpert:2
multicenter ,xpress:2
multicenter ,test:4
reconciling ,early-outbreak:2
reconciling ,estimates:2
reconciling ,basic:2
reconciling ,reproductive:2
reconciling ,number:2
early-outbreak ,estimates:2
early-outbreak ,basic:2
early-outbreak ,reproductive:2
early-outbreak ,number:2
estimates ,basic:2
estimates ,reproductive:2
estimates ,number:2
basic ,reproductive:4
reproductive ,number:2
coronavirus ,publications:2
coronavirus ,science:2
coronavirus ,rapidly:4
mapping ,scientific:2
mapping ,publications:2
mapping ,science:2
mapping ,advances:2
mapping ,rapidly:2
scientific ,publications:2
scientific ,science:2
scientific ,rapidly:2
publications ,science:2
publications ,advances:2
publications ,rapidly:2
science ,advances:2
science ,rapidly:2
advances ,rapidly:2
renin-angiotensin ,management:2
renin-angiotensin ,hypertension:4
system ,hypertension:6
inhibitors ,hypertension:2
management ,hypertension:2
coronavirus ,ankylosing:2
coronavirus ,spondylitis:2
disease ,ankylosing:2
disease ,spondylitis:2
covid-19 ,spondylitis:2
patient ,spondylitis:2
ankylosing ,spondylitis:2
ankylosing ,treated:2
spondylitis ,treated:2
air ,virus:4
air ,tertiary:2
air ,wuhan:2
surface ,virus:2
surface ,tertiary:2
surface ,hospital:2
surface ,wuhan:2
contamination ,tertiary:2
contamination ,wuhan:2
virus ,tertiary:2
virus ,hospital:2
tertiary ,hospital:10
tertiary ,wuhan:2
hospital ,wuhan:4
laboratory ,information:2
laboratory ,system:2
laboratory ,requirements:2
laboratory ,manage:2
laboratory ,report:2
information ,system:2
information ,requirements:2
information ,manage:2
information ,pandemic:2
information ,report:2
system ,requirements:2
system ,manage:2
system ,report:2
requirements ,manage:2
requirements ,covid-19:2
requirements ,pandemic:2
requirements ,report:2
manage ,pandemic:4
manage ,report:2
undetectable ,viral:2
undetectable ,rna:2
undetectable ,oocytes:2
undetectable ,sars-cov-2:6
undetectable ,positive:2
undetectable ,women:2
viral ,oocytes:2
rna ,oocytes:2
rna ,women:2
oocytes ,sars-cov-2:2
oocytes ,positive:2
oocytes ,women:2
positive ,women:2
unusual ,simultaneous:2
unusual ,cerebral:2
unusual ,infarcts:2
unusual ,multiple:2
unusual ,arterial:2
unusual ,territories:2
simultaneous ,cerebral:2
simultaneous ,infarcts:2
simultaneous ,arterial:2
simultaneous ,territories:2
cerebral ,infarcts:2
cerebral ,arterial:2
cerebral ,territories:2
infarcts ,multiple:2
infarcts ,arterial:2
infarcts ,territories:2
multiple ,arterial:2
multiple ,territories:2
arterial ,territories:2
development ,automatic:2
development ,integrated:2
development ,gene:2
development ,system:2
automatic ,integrated:2
automatic ,gene:2
automatic ,detection:2
automatic ,system:2
automatic ,novel:2
automatic ,severe:2
automatic ,acute:2
integrated ,gene:2
integrated ,detection:2
integrated ,system:2
integrated ,novel:2
integrated ,severe:2
integrated ,acute:2
gene ,system:4
gene ,severe:8
gene ,acute:4
clinical ,nursing:2
nursing ,care:4
nursing ,guidance:2
nursing ,management:2
nursing ,patient:4
guidance ,patient:2
guidance ,covid-19:8
family ,diagnosed:2
family ,kidney:2
family ,transplant:2
cluster ,diagnosed:2
cluster ,kidney:2
cluster ,transplant:2
diagnosed ,coronavirus:4
diagnosed ,disease:4
diagnosed ,covid-19:8
coronavirus ,transplant:10
disease ,transplant:10
cellular ,senescence:2
cellular ,potential:2
cellular ,mediator:2
cellular ,severity:2
cellular ,elderly:2
senescence ,potential:2
senescence ,mediator:2
senescence ,covid-19:2
senescence ,severity:2
senescence ,elderly:2
potential ,severity:2
potential ,elderly:4
mediator ,covid-19:4
mediator ,severity:2
mediator ,elderly:2
severity ,elderly:2
evaluation ,lockdowns:2
evaluation ,epidemic:6
evaluation ,italy:2
evaluation ,spain:2
evaluation ,one:2
lockdowns ,sars-cov-2:2
lockdowns ,epidemic:4
lockdowns ,italy:2
lockdowns ,spain:2
lockdowns ,one:2
epidemic ,spain:2
epidemic ,one:2
italy ,spain:2
italy ,one:2
spain ,one:4
recommendations ,diabetes:2
recommendations ,mellitus:2
recommendations ,factors:2
care ,diabetes:2
care ,mellitus:2
diabetes ,factors:6
mellitus ,risk:6
mellitus ,factors:2
toilets ,dominate:2
toilets ,environmental:2
toilets ,detection:2
toilets ,severe:2
toilets ,acute:2
toilets ,respiratory:2
toilets ,syndrome:2
dominate ,environmental:2
dominate ,detection:2
dominate ,severe:2
dominate ,acute:2
dominate ,respiratory:2
dominate ,syndrome:2
environmental ,detection:4
diagnostic ,methodological:2
diagnostic ,studies:2
diagnostic ,urinary:2
diagnostic ,shedding:2
methodological ,evaluation:2
methodological ,studies:2
methodological ,urinary:2
methodological ,shedding:2
evaluation ,studies:2
evaluation ,urinary:2
studies ,urinary:2
studies ,shedding:2
urinary ,shedding:2
complicated ,report:4
complicated ,coagulation:2
pregnancy ,coagulation:2
case ,coagulation:2
report ,severe:12
report ,liver:2
report ,coagulation:2
severe ,coagulation:6
liver ,coagulation:4
infection ,equipment:2
infection ,radiographers:2
infection ,personal:2
infection ,protection:8
control ,ct:2
control ,equipment:2
control ,radiographers:2
control ,personal:2
control ,protection:2
ct ,equipment:2
ct ,radiographers:2
ct ,personal:2
ct ,protection:2
equipment ,radiographers:2
equipment ,protection:2
radiographers ,personal:2
radiographers ,protection:2
personal ,protection:2
covid-19 ,interplay:4
extracellular ,intriguing:2
extracellular ,interplay:2
vesicles ,intriguing:2
vesicles ,interplay:2
intriguing ,interplay:2
structural ,receptor:2
basis ,receptor:2
basis ,recognition:4
recognition ,sars-cov-2:6
effect ,infection:4
effect ,mers-cov:2
infection ,mers-cov:2
reduce ,likelihood:2
reduce ,coronavirus-19:2
reduce ,cov-19:2
reduce ,infection:2
likelihood ,coronavirus-19:2
likelihood ,cov-19:2
likelihood ,sars-cov-2:2
likelihood ,infection:2
coronavirus-19 ,cov-19:2
coronavirus-19 ,sars-cov-2:2
coronavirus-19 ,infection:2
social ,media:6
social ,use:2
social ,predictor:2
social ,handwashing:2
social ,evidence:2
media ,use:2
media ,predictor:2
media ,handwashing:2
media ,pandemic:2
media ,evidence:2
use ,predictor:2
use ,handwashing:2
predictor ,handwashing:2
predictor ,pandemic:2
predictor ,evidence:2
handwashing ,pandemic:2
handwashing ,evidence:2
impacts ,reopening:2
impacts ,strategies:2
impacts ,modeling:2
impacts ,study:2
impacts ,piedmont:2
reopening ,strategies:4
reopening ,covid-19:4
reopening ,modeling:2
reopening ,study:2
reopening ,piedmont:2
strategies ,epidemic:2
strategies ,modeling:4
strategies ,study:2
strategies ,piedmont:2
covid-19 ,modeling:22
covid-19 ,piedmont:2
epidemic ,study:2
epidemic ,piedmont:2
modeling ,study:4
modeling ,piedmont:2
study ,piedmont:2
loss ,outbreak:2
loss ,tale:2
loss ,many:2
loss ,countries:2
smell ,tale:2
smell ,many:2
smell ,countries:2
taste ,tale:2
taste ,many:2
taste ,countries:2
covid-19 ,many:4
outbreak ,tale:2
outbreak ,many:2
outbreak ,countries:4
tale ,many:2
tale ,countries:2
many ,countries:2
environmental ,associated:2
environmental ,persistently:2
environmental ,infected:2
contamination ,associated:2
contamination ,persistently:2
contamination ,infected:2
associated ,persistently:2
persistently ,infected:2
covid-19 ,ophthalmologists:2
ophthalmologists ,perspective:2
novel ,onset:4
novel ,dizziness:2
coronavirus ,dizziness:2
pneumonia ,onset:2
pneumonia ,dizziness:2
onset ,dizziness:2
dizziness ,case:2
dizziness ,report:2
effect ,heat:2
effect ,inactivation:2
effect ,blood:2
effect ,samples:2
effect ,efficacy:2
effect ,three:2
heat ,blood:2
heat ,samples:4
heat ,efficacy:2
heat ,three:2
heat ,detection:2
inactivation ,blood:2
inactivation ,samples:4
inactivation ,efficacy:2
inactivation ,three:2
inactivation ,detection:4
blood ,samples:4
blood ,efficacy:2
samples ,efficacy:2
samples ,three:2
efficacy ,three:4
persistent ,immunocompromised:2
persistent ,temporarily:2
persistent ,responsive:2
persistent ,two:2
covid-19 ,immunocompromised:4
covid-19 ,temporarily:2
covid-19 ,responsive:2
immunocompromised ,patient:4
immunocompromised ,temporarily:2
immunocompromised ,responsive:2
immunocompromised ,two:2
patient ,temporarily:2
patient ,responsive:2
patient ,two:2
temporarily ,responsive:2
temporarily ,two:2
responsive ,two:2
clinical ,older:10
clinical ,younger:2
characteristics ,older:4
characteristics ,younger:2
older ,younger:2
older ,infected:2
younger ,patients:2
younger ,infected:2
younger ,sars-cov-2:2
community-acquired ,respiratory:2
community-acquired ,infections:2
community-acquired ,amongst:2
community-acquired ,hospitalized:2
community-acquired ,inpatients:2
viral ,amongst:2
viral ,inpatients:2
respiratory ,amongst:2
respiratory ,hospitalized:2
respiratory ,inpatients:2
infections ,amongst:2
infections ,hospitalized:2
infections ,inpatients:2
amongst ,hospitalized:2
amongst ,inpatients:2
hospitalized ,inpatients:2
73-year-old ,man:2
73-year-old ,history:2
73-year-old ,hypertension:2
73-year-old ,ischemic:2
73-year-old ,heart:2
73-year-old ,disease:2
man ,history:2
man ,hypertension:2
man ,ischemic:2
man ,heart:2
history ,ischemic:2
history ,heart:2
history ,disease:2
hypertension ,ischemic:2
hypertension ,heart:2
ischemic ,heart:2
ischemic ,disease:2
primer ,viral-associated:2
primer ,olfactory:2
primer ,loss:2
primer ,era:4
primer ,covid-19:16
viral-associated ,olfactory:2
viral-associated ,loss:2
viral-associated ,era:2
viral-associated ,covid-19:2
olfactory ,era:2
loss ,era:2
breath ,diagnostics:2
breath ,era:2
breath ,sars-cov-2-clinical:2
breath ,research:2
breath ,arena:2
diagnostics ,era:2
diagnostics ,sars-cov-2-clinical:2
diagnostics ,research:2
diagnostics ,arena:2
era ,sars-cov-2-clinical:2
era ,research:4
era ,arena:2
sars-cov-2-clinical ,research:2
sars-cov-2-clinical ,arena:2
research ,arena:2
impact ,virus:4
impact ,future:2
impact ,cadaveric:2
impact ,dissection:2
impact ,anatomical:2
sars-cov-2 ,cadaveric:2
sars-cov-2 ,dissection:2
sars-cov-2 ,anatomical:2
virus ,future:2
virus ,cadaveric:2
virus ,dissection:2
virus ,anatomical:2
pandemic ,cadaveric:2
pandemic ,dissection:2
pandemic ,anatomical:2
future ,cadaveric:2
future ,dissection:2
future ,anatomical:2
cadaveric ,dissection:2
cadaveric ,anatomical:2
dissection ,anatomical:2
presenting ,limb:2
presenting ,ischemia:2
probable ,exit:2
probable ,strategy:2
probable ,low:2
probable ,resource:2
probable ,country:2
probable ,like:2
probable ,nepal:2
probable ,open:2
exit ,covid-19:2
exit ,low:2
exit ,resource:2
exit ,country:2
exit ,like:2
exit ,nepal:2
exit ,open:2
strategy ,low:2
strategy ,resource:2
strategy ,country:2
strategy ,like:2
strategy ,nepal:2
strategy ,open:2
covid-19 ,like:2
low ,resource:4
low ,country:2
low ,like:2
low ,nepal:2
low ,open:2
resource ,country:2
resource ,like:2
resource ,nepal:2
resource ,open:2
country ,like:2
country ,nepal:2
country ,open:2
like ,nepal:2
like ,open:2
nepal ,open:2
urology ,corona-virus:2
urology ,pandemic-aguideline:2
urology ,420:2
corona-virus ,pandemic-aguideline:2
corona-virus ,420:2
pandemic-aguideline ,420:2
association ,viral:2
association ,load:4
association ,serum:4
association ,biomakers:2
association ,among:8
association ,cases:2
viral ,biomakers:2
viral ,among:2
load ,biomakers:2
load ,among:2
load ,cases:2
serum ,biomakers:2
serum ,among:4
biomakers ,among:2
biomakers ,covid-19:2
biomakers ,cases:2
brief ,summary:4
brief ,potential:2
brief ,prophylactic:2
brief ,treatment:2
brief ,drugs:2
summary ,potential:2
summary ,sars-cov-2:2
summary ,prophylactic:2
summary ,treatment:2
summary ,drugs:2
potential ,prophylactic:6
sars-cov-2 ,prophylactic:2
prophylactic ,drugs:2
systematic ,distress:2
systematic ,syndrome:6
review ,distress:4
cases ,syndrome:4
sars-cov-2 ,belgium:2
natural ,transmission:2
natural ,human:4
natural ,cat:2
natural ,belgium:2
natural ,march:2
transmission ,cat:2
transmission ,belgium:2
transmission ,march:4
human ,cat:2
human ,belgium:2
human ,march:2
cat ,belgium:2
cat ,march:2
belgium ,march:2
altered ,cytokine:2
altered ,levels:2
altered ,immune:2
altered ,responses:2
altered ,patients:4
altered ,sars-cov-2:2
altered ,infection:2
cytokine ,levels:2
cytokine ,responses:6
levels ,immune:2
levels ,responses:2
ace2 ,imbalance:2
ace2 ,key:4
ace2 ,player:2
ace2 ,poor:2
ace2 ,outcomes:4
imbalance ,key:2
imbalance ,player:2
imbalance ,poor:2
imbalance ,outcomes:2
imbalance ,patients:2
key ,poor:2
key ,outcomes:2
player ,poor:2
player ,outcomes:2
player ,covid-19:4
player ,patients:2
infection ,dogs:8
dogs ,sars-cov-2:8
characteristics ,outcome:8
outcome ,severe:4
outcome ,acute:2
outcome ,respiratory:2
outcome ,syndrome:2
fda-approved ,ivermectin:2
fda-approved ,replication:2
fda-approved ,vitro:2
drug ,replication:2
ivermectin ,inhibits:2
ivermectin ,replication:2
ivermectin ,vitro:2
inhibits ,vitro:4
replication ,vitro:4
whereabouts ,sars-cov-2:2
whereabouts ,human:2
whereabouts ,body:2
whereabouts ,systematic:2
whereabouts ,review:2
human ,body:4
rhinologic ,practice:2
rhinologic ,special:2
rhinologic ,considerations:2
rhinologic ,covid-19:4
rhinologic ,visit:2
rhinologic ,planning:2
rhinologic ,personal:2
practice ,considerations:2
practice ,visit:2
practice ,planning:2
special ,visit:2
special ,planning:2
special ,personal:2
considerations ,visit:2
considerations ,planning:2
considerations ,personal:2
covid-19 ,visit:2
visit ,planning:2
visit ,personal:2
planning ,personal:2
sars-cov-2 ,micturition:2
sars-cov-2 ,syncope:2
infection ,micturition:2
infection ,syncope:2
associated ,micturition:2
associated ,syncope:2
associated ,experience:2
micturition ,syncope:2
micturition ,experience:2
micturition ,case:2
syncope ,experience:2
syncope ,case:2
experience ,case:4
outcomes ,maternal-newborn:2
outcomes ,dyads:2
maternal-newborn ,dyads:2
maternal-newborn ,maternal:2
maternal-newborn ,sars-cov-2:2
dyads ,maternal:2
dyads ,sars-cov-2:2
maternal ,sars-cov-2:6
therapeutic ,effectiveness:2
therapeutic ,interferon-2b:2
therapeutic ,cuban:2
therapeutic ,experience:2
effectiveness ,interferon-2b:2
effectiveness ,cuban:2
effectiveness ,experience:2
interferon-2b ,covid-19:2
interferon-2b ,cuban:2
interferon-2b ,experience:2
covid-19 ,cuban:2
cuban ,experience:2
optimizing ,rt-pcr:2
optimizing ,detection:2
optimizing ,developing:2
optimizing ,countries:2
optimizing ,using:2
optimizing ,pool:2
rt-pcr ,developing:2
rt-pcr ,countries:2
rt-pcr ,pool:2
detection ,developing:2
detection ,countries:2
detection ,pool:2
sars-cov-2 ,developing:4
sars-cov-2 ,pool:2
developing ,countries:2
developing ,using:2
developing ,pool:2
countries ,using:2
countries ,pool:2
using ,pool:2
covid-19 ,malaysia:6
among ,germany:2
among ,malaysia:2
health ,germany:2
health ,malaysia:2
workers ,malaysia:2
germany ,malaysia:2
among ,systemic:2
among ,autoimmune:2
among ,diseases:6
patients ,systemic:4
systemic ,autoimmune:2
systemic ,diseases:4
sars-cov-2 ,population-based:2
whole ,amplification:2
whole ,effective:2
whole ,population-based:2
genome ,amplification:2
genome ,effective:2
genome ,population-based:2
amplification ,sequencing:2
amplification ,effective:2
amplification ,population-based:2
sequencing ,effective:2
sequencing ,population-based:2
effective ,population-based:2
heterogeneous ,antibodies:2
heterogeneous ,sars-cov-2:2
heterogeneous ,spike:2
heterogeneous ,receptor:2
heterogeneous ,binding:2
heterogeneous ,domain:2
antibodies ,receptor:4
antibodies ,binding:4
antibodies ,domain:2
critical ,evaluation:2
critical ,glucocorticoids:4
critical ,management:2
critical ,severe:16
evaluation ,glucocorticoids:2
evaluation ,management:2
evaluation ,severe:2
glucocorticoids ,management:2
glucocorticoids ,severe:4
glucocorticoids ,covid-19:6
therapeutic ,measures:2
measures ,review:6
measures ,current:2
measures ,status:2
evaluation ,multiplexed:2
evaluation ,determining:2
evaluation ,levels:4
evaluation ,functional:2
novel ,multiplexed:2
novel ,determining:2
novel ,igg:2
novel ,levels:2
novel ,functional:2
multiplexed ,assay:2
multiplexed ,determining:2
multiplexed ,igg:2
multiplexed ,levels:2
multiplexed ,functional:2
assay ,determining:2
assay ,levels:2
assay ,functional:2
determining ,igg:2
determining ,levels:2
determining ,functional:2
igg ,levels:2
igg ,functional:2
levels ,functional:2
development ,status:2
safe ,hospital:2
safe ,preparedness:2
safe ,era:2
safe ,swiss:2
safe ,cheese:2
safe ,model:2
hospital ,preparedness:4
hospital ,era:2
hospital ,swiss:2
hospital ,cheese:2
hospital ,model:2
preparedness ,era:2
preparedness ,covid-19:12
preparedness ,swiss:2
preparedness ,cheese:2
preparedness ,model:2
era ,swiss:2
era ,cheese:2
era ,model:2
covid-19 ,swiss:2
covid-19 ,cheese:2
swiss ,cheese:2
swiss ,model:2
cheese ,model:2
neuropathogenesis ,infection:2
rapid ,gel:2
rapid ,card:2
rapid ,agglutination:2
rapid ,serological:10
rapid ,following:2
gel ,card:2
gel ,agglutination:2
gel ,assays:2
gel ,serological:2
gel ,analysis:2
gel ,following:2
gel ,sars-cov-2:2
card ,agglutination:2
card ,assays:2
card ,serological:2
card ,analysis:2
card ,following:2
card ,sars-cov-2:2
agglutination ,assays:2
agglutination ,serological:2
agglutination ,analysis:2
agglutination ,following:2
agglutination ,sars-cov-2:2
assays ,following:2
serological ,following:2
analysis ,following:2
testing ,cardiovascular:2
testing ,autonomic:2
testing ,function:2
testing ,era:2
testing ,lessons:4
cardiovascular ,autonomic:2
cardiovascular ,function:2
cardiovascular ,lessons:2
autonomic ,function:2
autonomic ,covid-19:4
autonomic ,era:2
autonomic ,lessons:2
function ,era:2
function ,lessons:2
era ,lessons:2
interferon ,-1a:2
interferon ,ifn-1a:2
interferon ,covid-19:6
interferon ,patients:2
interferon ,intercop:2
interferon ,study:2
interferon ,protocol:2
-1a ,ifn-1a:2
-1a ,covid-19:2
-1a ,patients:2
-1a ,intercop:2
-1a ,study:2
-1a ,protocol:2
ifn-1a ,covid-19:2
ifn-1a ,patients:2
ifn-1a ,intercop:2
ifn-1a ,study:2
ifn-1a ,protocol:2
covid-19 ,intercop:2
patients ,intercop:2
patients ,protocol:8
intercop ,study:2
intercop ,protocol:2
study ,protocol:4
penn ,medicine:2
penn ,head:2
penn ,neck:2
penn ,cancer:2
penn ,service:2
penn ,line:2
penn ,covid-19:2
penn ,management:2
penn ,guidelines:2
medicine ,head:2
medicine ,neck:2
medicine ,cancer:2
medicine ,service:2
medicine ,line:2
medicine ,guidelines:2
head ,service:2
head ,line:2
head ,covid-19:12
head ,management:6
head ,guidelines:4
neck ,service:2
neck ,line:2
neck ,covid-19:12
neck ,management:6
neck ,guidelines:4
cancer ,service:2
cancer ,line:2
cancer ,guidelines:2
service ,line:2
service ,guidelines:2
line ,covid-19:4
line ,management:2
line ,guidelines:2
management ,guidelines:12
outcomes ,universal:2
outcomes ,testing:4
outcomes ,program:2
outcomes ,admitted:4
universal ,program:2
universal ,pregnant:4
testing ,pregnant:2
testing ,women:4
testing ,admitted:2
program ,pregnant:2
program ,women:2
program ,admitted:2
treatment ,evolving:4
armamentarium ,covid-19:2
armamentarium ,evolving:2
armamentarium ,strategies:2
armamentarium ,evidence:2
armamentarium ,far:2
covid-19 ,evolving:10
evolving ,strategies:2
evolving ,evidence:2
evolving ,far:2
strategies ,far:2
evidence ,far:2
covid-19 ,n-acetylcysteine:2
covid-19 ,nac:2
potential ,copper:2
potential ,nac:2
potential ,combination:2
role ,copper:2
role ,n-acetylcysteine:2
role ,nac:2
role ,combination:2
copper ,n-acetylcysteine:2
copper ,nac:2
copper ,combination:2
n-acetylcysteine ,nac:2
n-acetylcysteine ,combination:2
nac ,combination:2
drug ,intensive:2
drug ,approaches:4
discovery ,using:8
discovery ,intensive:2
discovery ,approaches:4
using ,intensive:2
using ,approaches:4
intensive ,approaches:2
characteristics ,social:4
characteristics ,care:2
outcomes ,health:4
outcomes ,social:2
outcomes ,care:2
outcomes ,workers:2
outcomes ,positive:2
health ,positive:4
social ,care:4
social ,workers:2
social ,testing:4
social ,positive:2
workers ,positive:2
dynamic ,viral:2
dynamic ,severe:2
dynamic ,acute:2
dynamic ,respiratory:2
dynamic ,syndrome:2
clinical ,convalescent:2
clinical ,re-positive:4
features ,convalescent:2
features ,re-positive:2
features ,nucleic:2
features ,acid:2
covid-19 ,re-positive:4
convalescent ,re-positive:2
convalescent ,nucleic:2
convalescent ,acid:2
patients ,re-positive:4
re-positive ,nucleic:2
re-positive ,acid:2
current ,regarding:2
current ,components:2
current ,anti-2019-ncov:2
findings ,components:2
findings ,anti-2019-ncov:2
regarding ,natural:2
regarding ,components:2
regarding ,potential:2
regarding ,anti-2019-ncov:2
natural ,components:2
natural ,anti-2019-ncov:2
components ,anti-2019-ncov:2
potential ,anti-2019-ncov:2
case ,late-onset:2
case ,rash:4
case ,loss:2
case ,taste:2
case ,smell:2
covid-19 ,late-onset:2
covid-19 ,rash:4
covid-19 ,transient:2
late-onset ,rash:2
late-onset ,transient:2
late-onset ,loss:2
late-onset ,taste:2
late-onset ,smell:2
rash ,transient:2
rash ,loss:2
rash ,taste:2
rash ,smell:2
transient ,loss:2
transient ,taste:2
transient ,smell:2
receiving ,ade:2
receiving ,coronaviruses:2
ade ,coronaviruses:2
assessment ,screening:4
assessment ,strategies:2
assessment ,permit:2
assessment ,safe:2
assessment ,reopening:2
sars-cov-2 ,permit:2
sars-cov-2 ,safe:6
sars-cov-2 ,reopening:2
screening ,strategies:2
screening ,permit:2
screening ,safe:4
screening ,reopening:2
strategies ,permit:2
strategies ,safe:4
permit ,safe:2
permit ,reopening:2
safe ,reopening:2
naked ,king:2
naked ,pandemic:2
naked ,production:2
naked ,communication:2
king ,pandemic:2
king ,production:2
king ,communication:2
pandemic ,production:2
pandemic ,communication:2
production ,communication:2
review ,burden:4
review ,definitions:2
burden ,clinical:2
burden ,definitions:2
burden ,cases:2
clinical ,definitions:2
definitions ,management:2
definitions ,covid-19:2
definitions ,cases:2
multisystem ,mast:2
multisystem ,cell:2
multisystem ,activation:2
inflammatory ,mast:2
inflammatory ,activation:2
syndrome ,mast:2
syndrome ,cell:4
syndrome ,activation:4
mast ,cell:2
mast ,activation:2
clinical ,multidisciplinary:2
features ,multidisciplinary:2
features ,treatment:4
multidisciplinary ,treatment:6
multidisciplinary ,outcome:2
multidisciplinary ,covid-19:8
multidisciplinary ,pneumonia:2
outcome ,pneumonia:6
clinical ,diabetic:2
clinical ,ketoacidosis:2
characteristics ,combined:2
characteristics ,diabetic:4
characteristics ,ketoacidosis:2
outcome ,combined:2
outcome ,diabetic:2
outcome ,ketoacidosis:2
patients ,combined:2
patients ,ketoacidosis:4
combined ,diabetic:2
combined ,ketoacidosis:2
diabetic ,ketoacidosis:8
keeping ,emerging:2
keeping ,evidence:2
keeping ,almost:2
keeping ,real:2
keeping ,time:2
emerging ,evidence:4
emerging ,almost:2
emerging ,real:2
emerging ,time:2
evidence ,almost:2
evidence ,real:2
evidence ,time:4
almost ,real:2
almost ,time:2
estimated ,community:2
estimated ,seroprevalence:2
estimated ,sars-cov-2:2
estimated ,antibodies:2
estimated ,two:2
estimated ,georgia:2
estimated ,counties:2
community ,seroprevalence:2
community ,antibodies:2
community ,georgia:2
community ,counties:2
seroprevalence ,two:2
seroprevalence ,georgia:2
seroprevalence ,counties:2
sars-cov-2 ,counties:2
antibodies ,georgia:2
antibodies ,counties:2
two ,georgia:2
two ,counties:2
georgia ,counties:2
impact ,epidemic:10
impact ,high-volume:2
impact ,facility:2
impact ,gynecological:4
impact ,oncology:4
covid-19 ,high-volume:2
covid-19 ,gynecological:4
epidemic ,high-volume:2
epidemic ,facility:2
epidemic ,gynecological:2
epidemic ,oncology:2
high-volume ,facility:2
high-volume ,gynecological:2
high-volume ,oncology:2
facility ,gynecological:2
facility ,oncology:2
gynecological ,oncology:2
covid-19 ,specialist:2
among ,specialist:2
among ,infectious:2
among ,setting:2
healthcare ,specialist:2
healthcare ,infectious:2
healthcare ,diseases:2
healthcare ,setting:2
workers ,specialist:2
workers ,infectious:2
workers ,diseases:2
workers ,setting:2
specialist ,infectious:2
specialist ,diseases:2
specialist ,setting:2
infectious ,setting:2
diseases ,setting:2
preventing ,among:2
preventing ,operating:2
preventing ,room:2
preventing ,staff:2
preventing ,pandemic:2
transmission ,operating:2
transmission ,room:2
among ,operating:2
among ,room:2
operating ,room:8
operating ,staff:2
operating ,covid-19:4
operating ,pandemic:4
room ,staff:2
room ,pandemic:4
staff ,pandemic:2
renin ,axis:2
renin ,converting:2
renin ,enzyme:2
renin ,coronavirus:2
angiotensin ,axis:2
angiotensin ,coronavirus:4
axis ,converting:2
axis ,enzyme:2
axis ,coronavirus:2
converting ,coronavirus:2
evolution ,viral:2
evolution ,quasispecies:2
viral ,quasispecies:2
quasispecies ,sars-cov-2:2
quasispecies ,infection:2
characteristics ,nonsurge:2
outcomes ,nonsurge:2
coronavirus ,nonsurge:2
disease ,nonsurge:2
patients ,nonsurge:2
covid-19 ,seniors:2
covid-19 ,home:4
seniors ,findings:2
seniors ,lessons:2
seniors ,mass:2
seniors ,screening:2
seniors ,nursing:2
seniors ,home:2
findings ,lessons:2
findings ,mass:2
findings ,screening:2
findings ,nursing:2
findings ,home:2
lessons ,mass:2
lessons ,screening:2
lessons ,nursing:2
lessons ,home:2
mass ,nursing:2
mass ,home:2
screening ,nursing:2
screening ,home:2
nursing ,home:2
superspreaders ,generate:2
superspreaders ,new:2
superspreaders ,hypothesis:2
superspreaders ,explain:2
generate ,new:2
generate ,hypothesis:2
generate ,explain:2
new ,hypothesis:2
new ,explain:2
hypothesis ,explain:2
emergency ,triage:4
emergency ,era:2
emergency ,sheba:2
emergency ,medical:6
emergency ,center:2
department ,triage:2
department ,era:2
department ,sheba:2
department ,medical:2
department ,center:2
triage ,era:2
triage ,covid-19:6
triage ,sheba:2
triage ,medical:2
triage ,center:2
era ,sheba:2
era ,medical:2
era ,center:2
covid-19 ,sheba:2
sheba ,medical:2
sheba ,center:2
detection ,fecal:2
detection ,confirmed:4
rna ,confirmed:2
fecal ,specimens:2
fecal ,confirmed:2
covid-19 ,intrinsic:2
intrinsic ,capacity:2
vaccine ,hesitancy:4
vaccine ,next:2
vaccine ,fight:2
hesitancy ,next:2
hesitancy ,challenge:2
hesitancy ,fight:2
hesitancy ,covid-19:4
next ,challenge:2
next ,fight:2
next ,covid-19:8
challenge ,fight:2
case ,pregnant:6
case ,preterm:2
case ,delivery:6
novel ,pregnant:4
novel ,woman:2
novel ,preterm:2
novel ,delivery:2
coronavirus ,woman:2
coronavirus ,preterm:6
coronavirus ,delivery:4
pregnant ,preterm:6
woman ,preterm:2
woman ,delivery:4
preterm ,delivery:4
emergence ,ancient:2
emergence ,convalescent:2
emergence ,plasma:2
emergence ,cp:2
emergence ,therapy:2
emergence ,manage:2
emergence ,pandemic:4
ancient ,convalescent:2
ancient ,plasma:2
ancient ,cp:2
ancient ,therapy:2
ancient ,manage:2
ancient ,covid-19:2
ancient ,pandemic:2
convalescent ,cp:2
convalescent ,manage:2
convalescent ,pandemic:2
plasma ,cp:2
plasma ,manage:2
plasma ,pandemic:2
cp ,therapy:2
cp ,manage:2
cp ,covid-19:2
cp ,pandemic:2
therapy ,manage:2
sub-continental ,atmosphere:2
sub-continental ,inherent:2
sub-continental ,immune:2
sub-continental ,system:2
sub-continental ,may:2
sub-continental ,impact:2
sub-continental ,novel:2
atmosphere ,inherent:2
atmosphere ,immune:2
atmosphere ,system:2
atmosphere ,may:2
atmosphere ,impact:2
atmosphere ,novel:2
inherent ,immune:2
inherent ,system:2
inherent ,may:2
inherent ,impact:2
inherent ,novel:2
immune ,may:2
immune ,impact:2
immune ,novel:10
may ,impact:6
may ,novel:4
mechano-genomic ,regulation:2
mechano-genomic ,coronaviruses:2
mechano-genomic ,interplay:2
mechano-genomic ,ageing:2
regulation ,coronaviruses:2
regulation ,interplay:2
regulation ,ageing:2
coronaviruses ,interplay:2
coronaviruses ,ageing:2
interplay ,ageing:2
swimming ,pool:2
swimming ,safety:2
swimming ,prevention:2
swimming ,time:2
swimming ,covid-19:2
swimming ,consensus:2
swimming ,document:2
pool ,safety:2
pool ,prevention:2
pool ,time:2
pool ,covid-19:2
pool ,consensus:2
pool ,document:2
safety ,time:4
safety ,consensus:2
safety ,document:2
prevention ,time:2
prevention ,consensus:2
prevention ,document:2
time ,consensus:2
time ,document:2
covid-19 ,consensus:8
covid-19 ,document:2
consensus ,document:2
ophthalmology ,blind:2
ophthalmology ,toward:2
ophthalmology ,fight:2
ophthalmology ,blindness:2
sars-cov-2 ,blind:2
sars-cov-2 ,fight:6
sars-cov-2 ,blindness:2
blind ,toward:2
blind ,fight:2
blind ,blindness:2
toward ,fight:2
toward ,blindness:2
fight ,blindness:2
sars-cov-2-related ,mortality:2
sars-cov-2-related ,rural:2
sars-cov-2-related ,latin:2
sars-cov-2-related ,american:2
sars-cov-2-related ,population:2
mortality ,rural:2
mortality ,latin:2
mortality ,american:2
mortality ,population:2
rural ,latin:2
rural ,american:2
rural ,population:2
latin ,american:4
latin ,population:2
american ,population:2
late ,occurrence:2
late ,pulmonary:4
late ,embolsim:2
late ,pneumonia:2
late ,case:4
late ,series:2
occurrence ,pulmonary:2
occurrence ,embolsim:2
occurrence ,pneumonia:2
occurrence ,case:2
occurrence ,series:2
pulmonary ,embolsim:2
pulmonary ,case:10
pulmonary ,series:2
embolsim ,sars-cov-2:2
embolsim ,pneumonia:2
embolsim ,case:2
embolsim ,series:2
pneumonia ,series:4
endocrinology ,time:4
endocrinology ,management:4
endocrinology ,thyroid:2
endocrinology ,nodules:2
endocrinology ,cancer:2
time ,management:4
time ,thyroid:4
time ,nodules:2
time ,cancer:2
covid-19 ,nodules:2
management ,thyroid:2
management ,nodules:2
thyroid ,nodules:2
nodules ,cancer:2
covid-19 ,ras:4
covid-19 ,unravelling:2
covid-19 ,unclear:2
ras ,unravelling:2
ras ,unclear:2
ras ,relationship:2
unravelling ,unclear:2
unravelling ,relationship:2
unclear ,relationship:2
liver ,immunosuppression:2
transplant ,immunosuppression:2
transplant ,pandemic:4
immunosuppression ,covid-19:2
immunosuppression ,pandemic:4
potential ,tissue:2
potential ,hypercoagulability:2
role ,tissue:4
role ,factor:2
role ,hypercoagulability:4
tissue ,factor:4
tissue ,pathogenesis:2
tissue ,hypercoagulability:2
factor ,pathogenesis:2
factor ,hypercoagulability:2
pathogenesis ,hypercoagulability:2
retrospective ,on-site:2
retrospective ,treatment:2
retrospective ,coronavirus:4
analysis ,on-site:2
on-site ,treatment:2
on-site ,coronavirus:2
on-site ,disease:2
severe ,structure:4
severe ,pathogenic:2
acute ,structure:4
acute ,pathogenic:4
respiratory ,gene:2
respiratory ,structure:4
respiratory ,pathogenic:4
syndrome ,gene:2
syndrome ,structure:2
syndrome ,pathogenic:2
gene ,structure:2
gene ,pathogenic:2
structure ,pathogenic:4
obstetric ,hospital:2
obstetric ,preparedness:4
obstetric ,critical:2
hospital ,pandemic:6
hospital ,critical:2
preparedness ,critical:2
preparedness ,care:2
impact ,hydroxychloroquinechloroquine:2
impact ,therapy:8
impact ,two:2
impact ,sides:2
impact ,coin:2
hydroxychloroquinechloroquine ,covid-19:2
hydroxychloroquinechloroquine ,therapy:2
hydroxychloroquinechloroquine ,two:2
hydroxychloroquinechloroquine ,sides:2
hydroxychloroquinechloroquine ,coin:2
covid-19 ,sides:4
covid-19 ,coin:4
therapy ,sides:2
therapy ,coin:2
two ,sides:4
two ,coin:4
sides ,coin:4
exploring ,structural:2
exploring ,proteins:2
exploring ,multi-epitope:2
exploring ,vaccine:2
exploring ,development:2
structural ,multi-epitope:2
structural ,development:2
proteins ,multi-epitope:2
proteins ,vaccine:2
proteins ,development:4
multi-epitope ,development:2
repurposing ,chlorpromazine:4
repurposing ,recovery:4
repurposing ,study:6
chlorpromazine ,treat:2
chlorpromazine ,covid-19:4
chlorpromazine ,recovery:4
chlorpromazine ,study:4
treat ,recovery:2
treat ,study:2
recovery ,study:4
remote ,monitoring:4
remote ,patients:2
remote ,quarantine:2
remote ,era:2
remote ,sars-cov-2:2
remote ,pandemic:2
monitoring ,quarantine:4
monitoring ,era:2
monitoring ,pandemic:4
patients ,quarantine:2
patients ,era:8
quarantine ,era:2
quarantine ,pandemic:4
era ,pandemic:6
inappropriate ,nasopharyngeal:2
inappropriate ,sampling:2
inappropriate ,sars-cov-2:4
inappropriate ,detection:2
inappropriate ,relevant:2
inappropriate ,cause:2
nasopharyngeal ,sampling:2
nasopharyngeal ,relevant:2
nasopharyngeal ,cause:2
sampling ,relevant:2
sampling ,cause:2
detection ,relevant:2
detection ,cause:2
relevant ,cause:2
fourth ,water:2
fourth ,digital:2
fourth ,revolution:2
fourth ,encountered:2
fourth ,covid-19:4
water ,digital:2
water ,revolution:2
water ,encountered:2
digital ,revolution:2
digital ,encountered:2
revolution ,encountered:2
revolution ,covid-19:2
encountered ,covid-19:2
type ,restrict:2
type ,human:4
type ,airway:4
iii ,restrict:2
iii ,infection:4
iii ,human:4
iii ,airway:2
interferons ,restrict:2
interferons ,human:2
interferons ,airway:2
restrict ,sars-cov-2:2
restrict ,infection:2
restrict ,human:2
restrict ,airway:2
infection ,airway:2
bioinformatic ,identification:2
bioinformatic ,single-stranded:2
bioinformatic ,rna:2
bioinformatic ,sequences:2
analysis ,single-stranded:2
identification ,single-stranded:2
identification ,rna:10
identification ,sequences:2
single-stranded ,rna:2
single-stranded ,sequences:2
prediction ,transition:2
prediction ,subexponential:2
prediction ,exponential:2
prediction ,transmission:2
transition ,subexponential:2
transition ,exponential:2
transition ,transmission:2
subexponential ,exponential:2
subexponential ,transmission:2
exponential ,transmission:2
recommendations ,sample:2
recommendations ,pooling:2
recommendations ,cepheid:2
recommendations ,genexpert:2
recommendations ,system:2
recommendations ,using:2
sample ,pooling:12
sample ,cepheid:2
sample ,genexpert:2
sample ,system:2
sample ,using:2
pooling ,cepheid:2
pooling ,genexpert:2
pooling ,system:2
pooling ,using:2
cepheid ,genexpert:2
cepheid ,system:2
cepheid ,using:2
genexpert ,system:2
genexpert ,using:2
system ,using:2
whole ,phylogenetic:2
whole ,analysis:4
whole ,two:2
whole ,strains:2
whole ,isolated:2
whole ,italy:2
genome ,phylogenetic:2
genome ,two:4
genome ,strains:2
genome ,isolated:2
genome ,italy:2
phylogenetic ,two:2
phylogenetic ,strains:2
phylogenetic ,isolated:2
analysis ,isolated:2
two ,strains:2
two ,isolated:2
strains ,isolated:2
strains ,italy:2
isolated ,italy:2
serological ,immunochromatographic:2
serological ,approach:2
immunochromatographic ,approach:2
immunochromatographic ,diagnosis:2
immunochromatographic ,sars-cov-2:2
immunochromatographic ,infected:2
approach ,diagnosis:2
approach ,infected:2
diagnosis ,infected:2
bacterial ,fungal:2
bacterial ,coinfection:2
bacterial ,among:4
bacterial ,hospitalized:2
bacterial ,patients:4
fungal ,coinfection:2
fungal ,among:2
fungal ,hospitalized:2
fungal ,patients:6
coinfection ,among:2
coinfection ,hospitalized:2
among ,hospitalized:12
coding ,potential:2
coding ,sequence:2
coding ,conservation:2
coding ,sars-cov-2:4
coding ,related:2
coding ,animal:2
coding ,viruses:2
potential ,sequence:2
potential ,conservation:2
potential ,related:2
potential ,viruses:4
sequence ,conservation:2
sequence ,related:2
sequence ,animal:2
sequence ,viruses:2
conservation ,sars-cov-2:4
conservation ,related:2
conservation ,animal:2
conservation ,viruses:2
related ,animal:2
related ,viruses:2
animal ,viruses:2
sars-cov-2 ,ion:4
sars-cov-2 ,channel:2
sars-cov-2 ,inhibited:2
sars-cov-2 ,gliclazide:2
protein ,ion:2
protein ,channel:2
protein ,inhibited:2
protein ,gliclazide:2
potential ,ion:2
potential ,channel:4
potential ,inhibited:2
potential ,gliclazide:2
ion ,channel:2
ion ,can:2
ion ,inhibited:2
ion ,gliclazide:2
channel ,can:2
channel ,inhibited:2
channel ,gliclazide:2
can ,inhibited:2
can ,gliclazide:2
inhibited ,gliclazide:2
critical ,myopathy:4
illness ,myopathy:4
myopathy ,covid-19:2
comment ,neuroinvasive:2
comment ,potential:2
comment ,sars-cov-2:2
comment ,may:2
comment ,play:2
comment ,role:2
betacoronavirus ,genomes:2
betacoronavirus ,genomic:2
betacoronavirus ,information:2
betacoronavirus ,used:2
betacoronavirus ,deal:2
betacoronavirus ,past:2
genomes ,genomic:4
genomes ,information:2
genomes ,used:2
genomes ,deal:2
genomes ,past:2
genomic ,information:2
genomic ,used:2
genomic ,deal:2
genomic ,past:2
information ,used:2
information ,deal:2
information ,past:2
used ,deal:2
used ,past:2
deal ,past:2
non-communicable ,diseases:2
non-communicable ,inequalities:2
non-communicable ,increase:2
non-communicable ,risk:2
non-communicable ,death:2
non-communicable ,among:2
non-communicable ,covid-19:2
diseases ,inequalities:2
diseases ,increase:2
diseases ,risk:2
diseases ,death:2
inequalities ,increase:2
inequalities ,risk:2
inequalities ,death:2
inequalities ,among:2
inequalities ,covid-19:2
increase ,death:2
increase ,among:4
death ,among:4
long-acting ,antivirals:2
long-acting ,chemovaccines:2
long-acting ,preventing:2
long-acting ,viral:2
long-acting ,infections:2
antivirals ,chemovaccines:2
antivirals ,preventing:2
antivirals ,viral:2
antivirals ,infections:2
chemovaccines ,preventing:2
chemovaccines ,viral:2
chemovaccines ,infections:2
preventing ,viral:2
preventing ,infections:2
sars-cov-2 ,illustrating:2
sars-cov-2 ,limiting:2
outbreak ,illustrating:2
outbreak ,limiting:2
outbreak ,spread:2
illustrating ,challenges:2
illustrating ,limiting:2
illustrating ,spread:2
challenges ,limiting:2
challenges ,spread:2
limiting ,spread:2
efficacy ,serological:2
efficacy ,tests:2
efficacy ,asymptomatic:2
efficacy ,hd:2
efficacy ,patients:6
serological ,asymptomatic:4
serological ,hd:2
tests ,asymptomatic:2
tests ,hd:2
covid-19 ,hd:2
asymptomatic ,hd:2
hd ,patients:2
severe ,olfactory:2
severe ,gustatory:2
severe ,dysfunctions:2
severe ,japanese:2
olfactory ,dysfunctions:4
olfactory ,japanese:2
olfactory ,pediatric:2
gustatory ,dysfunctions:4
gustatory ,japanese:2
gustatory ,pediatric:2
dysfunctions ,japanese:2
dysfunctions ,pediatric:2
dysfunctions ,patient:2
japanese ,pediatric:2
japanese ,patient:2
clinical ,focusing:2
clinical ,airway:2
presentation ,systematic:2
presentation ,focusing:2
presentation ,upper:2
presentation ,airway:2
covid-19 ,focusing:2
covid-19 ,airway:8
systematic ,focusing:2
systematic ,upper:2
systematic ,airway:2
review ,focusing:2
review ,upper:2
review ,airway:2
focusing ,upper:2
focusing ,airway:2
covid-19 ,basic:6
cardiovascular ,basic:2
cardiovascular ,clinical:10
cardiovascular ,perspectives:2
basic ,mechanisms:2
basic ,perspectives:2
mechanisms ,perspectives:4
clinical ,perspectives:8
properties ,coronavirus:2
hydroxychloroquine ,coronavirus:2
hydroxychloroquine ,disease:2
disease ,facts:2
first-in-man ,case:2
first-in-man ,report:2
first-in-man ,selective:2
first-in-man ,c-reactive:2
first-in-man ,protein:2
first-in-man ,apheresis:2
first-in-man ,patient:2
case ,selective:2
case ,c-reactive:2
case ,protein:2
case ,apheresis:2
report ,selective:2
report ,c-reactive:2
report ,protein:2
report ,apheresis:2
selective ,c-reactive:2
selective ,protein:2
selective ,apheresis:2
selective ,patient:2
c-reactive ,protein:4
c-reactive ,apheresis:2
c-reactive ,patient:2
protein ,apheresis:2
protein ,patient:2
apheresis ,patient:2
collaborative ,multidisciplinary:2
collaborative ,approach:2
collaborative ,management:2
collaborative ,coronavirus:2
collaborative ,disease:2
multidisciplinary ,approach:2
multidisciplinary ,management:4
multidisciplinary ,coronavirus:2
multidisciplinary ,disease:2
approach ,management:8
approach ,disease:4
neuropathogenesis ,neurologic:2
neuropathogenesis ,manifestations:2
neuropathogenesis ,coronaviruses:2
neuropathogenesis ,age:2
neurologic ,manifestations:4
neurologic ,coronaviruses:2
neurologic ,age:2
manifestations ,age:2
coronaviruses ,age:2
accumulated ,clinical:2
accumulated ,experiences:2
accumulated ,successful:2
accumulated ,treatment:2
accumulated ,1377:2
accumulated ,severe:2
clinical ,experiences:4
clinical ,successful:2
clinical ,1377:2
experiences ,successful:2
experiences ,treatment:2
experiences ,1377:2
experiences ,severe:2
successful ,1377:2
successful ,severe:6
treatment ,1377:2
1377 ,severe:2
anti-frameshifting ,ligand:2
anti-frameshifting ,active:2
anti-frameshifting ,sars:2
anti-frameshifting ,coronavirus-2:2
anti-frameshifting ,resistant:2
anti-frameshifting ,natural:2
ligand ,active:2
ligand ,sars:2
ligand ,coronavirus-2:2
ligand ,resistant:2
ligand ,natural:2
active ,sars:2
active ,coronavirus-2:2
active ,resistant:2
active ,natural:2
sars ,resistant:2
sars ,natural:2
coronavirus-2 ,resistant:2
coronavirus-2 ,natural:4
resistant ,natural:2
difficult ,airway:2
difficult ,aerosol-generating:2
difficult ,procedures:2
difficult ,covid-19:2
difficult ,timeless:2
airway ,aerosol-generating:2
airway ,procedures:2
airway ,timeless:2
aerosol-generating ,covid-19:4
aerosol-generating ,timeless:2
procedures ,timeless:2
covid-19 ,timeless:2
evolution ,early:2
evolution ,cross-coronavirus:2
evolution ,immunity:2
early ,cross-coronavirus:2
early ,immunity:2
sars-cov-2 ,cross-coronavirus:2
cross-coronavirus ,immunity:2
travellers ,give:2
travellers ,wings:2
give ,wings:2
give ,novel:2
give ,coronavirus:2
give ,2019-ncov:2
wings ,novel:2
wings ,coronavirus:2
wings ,2019-ncov:2
lets ,talk:2
lets ,sex:2
lets ,context:2
talk ,sex:2
talk ,context:2
talk ,covid-19:2
sex ,context:2
incubation ,disease:2
incubation ,publicly:2
incubation ,reported:2
period ,publicly:2
period ,reported:2
coronavirus ,publicly:2
disease ,publicly:2
disease ,reported:4
association ,climate:2
association ,variables:2
association ,global:2
association ,transmission:2
climate ,variables:2
climate ,global:2
climate ,transmission:2
variables ,global:2
variables ,transmission:4
variables ,sars-cov-2:4
global ,transmission:2
systematic ,efficacy:6
systematic ,safety:4
systematic ,chloroquine:6
systematic ,treatment:2
review ,efficacy:8
review ,chloroquine:10
safety ,treatment:6
rapamycin ,potential:2
rapamycin ,repurpose:2
rapamycin ,drug:2
rapamycin ,candidate:2
rapamycin ,treatment:2
rapamycin ,covid-19:2
potential ,repurpose:2
potential ,candidate:4
repurpose ,drug:2
repurpose ,candidate:2
repurpose ,treatment:2
drug ,candidate:6
candidate ,treatment:6
dental ,provision:2
care ,provision:2
provision ,coronavirus:2
provision ,disease:2
provision ,covid-19:2
provision ,pandemic:2
rapid ,modification:2
rapid ,workflows:2
rapid ,fellow:2
rapid ,staffing:2
rapid ,single:2
rapid ,transplant:2
rapid ,center:2
modification ,workflows:2
modification ,fellow:2
modification ,staffing:2
modification ,single:2
modification ,transplant:2
modification ,center:2
workflows ,fellow:2
workflows ,staffing:2
workflows ,single:2
workflows ,transplant:2
workflows ,center:2
fellow ,staffing:2
fellow ,single:2
fellow ,transplant:2
fellow ,center:2
staffing ,single:2
staffing ,transplant:2
staffing ,center:2
single ,center:10
transplant ,center:2
logic ,time:2
logic ,coronavirus:2
potential ,repositioning:4
potential ,control:2
drug ,short-term:2
drug ,control:2
repositioning ,short-term:2
repositioning ,strategy:2
repositioning ,control:2
short-term ,strategy:2
short-term ,control:2
sars-cov-2 ,olfaction:2
sars-cov-2 ,urgent:2
olfaction ,brain:2
olfaction ,infection:2
olfaction ,urgent:2
olfaction ,need:2
olfaction ,clinical:2
olfaction ,samples:2
brain ,infection:8
brain ,urgent:2
brain ,need:2
brain ,clinical:2
brain ,samples:2
infection ,urgent:2
urgent ,clinical:2
urgent ,samples:2
need ,clinical:2
need ,samples:4
hospitals ,safe:2
hospitals ,prospective:2
hospitals ,study:2
hospitals ,prevalence:2
hospitals ,outcome:2
safe ,prospective:2
safe ,study:2
safe ,prevalence:2
safe ,outcome:2
prospective ,study:8
prospective ,sars-cov-2:10
prospective ,prevalence:2
prospective ,outcome:2
study ,outcome:2
prevalence ,outcome:2
reversible ,myocardial:2
reversible ,injury:2
reversible ,associated:2
reversible ,sars-cov-2:2
reversible ,infant:2
myocardial ,associated:4
myocardial ,infant:2
injury ,infant:2
associated ,infant:2
inflammation ,thrombosis:4
inflammation ,destruction:2
inflammation ,three-headed:2
inflammation ,cerberus:2
inflammation ,trauma-:2
thrombosis ,destruction:2
thrombosis ,three-headed:2
thrombosis ,cerberus:2
thrombosis ,trauma-:2
destruction ,three-headed:2
destruction ,cerberus:2
destruction ,trauma-:2
three-headed ,cerberus:2
three-headed ,trauma-:2
cerberus ,trauma-:2
identification ,south:2
identification ,america:2
novel ,candidate:4
novel ,epitopes:2
novel ,south:2
candidate ,epitopes:4
candidate ,proteins:2
candidate ,south:2
candidate ,america:2
epitopes ,south:2
epitopes ,america:2
proteins ,south:2
proteins ,america:2
south ,america:2
cancer ,affected:2
cancer ,milan:2
cancer ,lombardy:2
patients ,affected:8
patients ,milan:2
patients ,lombardy:2
affected ,covid-19:10
affected ,experience:2
affected ,milan:2
affected ,lombardy:2
covid-19 ,milan:2
experience ,milan:2
experience ,lombardy:2
milan ,lombardy:2
anosmia ,primary:2
anosmia ,symptoms:2
ageusia ,primary:2
ageusia ,symptoms:2
primary ,symptoms:4
protected ,code:2
protected ,stroke:2
protected ,covid-19:2
protected ,pandemic:2
code ,stroke:2
code ,pandemic:2
stroke ,pandemic:2
covid-19 ,n95:4
covid-19 ,respirator:2
covid-19 ,shortage:6
covid-19 ,closing:4
covid-19 ,gap:4
n95 ,shortage:2
n95 ,closing:2
n95 ,gap:2
respirator ,shortage:2
respirator ,closing:2
respirator ,gap:2
shortage ,closing:2
shortage ,gap:2
closing ,gap:4
silico ,validation:2
silico ,coumarin:4
silico ,derivatives:6
validation ,coumarin:2
validation ,derivatives:2
validation ,potential:2
validation ,inhibitors:2
validation ,main:2
coumarin ,derivatives:4
coumarin ,potential:2
coumarin ,inhibitors:2
coumarin ,main:2
derivatives ,potential:2
derivatives ,inhibitors:4
derivatives ,main:4
remodeling ,immune:2
remodeling ,response:2
remodeling ,aging:2
remodeling ,immunosenescence:2
remodeling ,potential:2
immune ,aging:4
immune ,immunosenescence:2
response ,aging:4
response ,immunosenescence:2
aging ,immunosenescence:2
aging ,potential:4
immunosenescence ,potential:2
covid-19 ,sca:2
covid-19 ,friend:8
sca ,old:2
sca ,friend:2
sca ,comes:2
sca ,rescue:2
old ,friend:4
old ,comes:2
old ,rescue:2
friend ,comes:2
friend ,rescue:2
comes ,rescue:2
detection ,tissue:4
formalin-fixed ,tissue:4
paraffin-embedded ,tissue:4
tissue ,specimens:2
tuberous ,sclerosis:2
tuberous ,complex:2
tuberous ,tsc:2
tuberous ,lymphangioleiomyomatosis:2
tuberous ,covid-19:2
sclerosis ,complex:2
sclerosis ,tsc:2
sclerosis ,lymphangioleiomyomatosis:2
complex ,tsc:2
complex ,lymphangioleiomyomatosis:2
complex ,covid-19:4
tsc ,lymphangioleiomyomatosis:2
tsc ,covid-19:2
lymphangioleiomyomatosis ,covid-19:2
mesenchymal ,mystery:2
stem ,mystery:2
cell ,mystery:2
treatment ,mystery:2
identification ,common:2
identification ,deletions:2
identification ,severe:2
identification ,acute:2
common ,deletions:2
common ,spike:4
common ,protein:2
common ,severe:4
common ,acute:2
common ,respiratory:4
deletions ,spike:2
deletions ,protein:2
deletions ,severe:2
deletions ,acute:2
deletions ,respiratory:2
covid-19 ,anger:2
cytokine ,anger:2
cytokine ,inflammation:2
storm ,anger:2
storm ,inflammation:4
anger ,inflammation:2
impact ,nationwide:2
impact ,transmissibility:2
impact ,italy:6
nationwide ,lockdown:2
nationwide ,transmissibility:2
nationwide ,italy:2
lockdown ,transmissibility:2
sars-cov-2 ,transmissibility:4
transmissibility ,italy:2
application ,portable:2
application ,instrument:2
application ,rapid:4
application ,reliable:2
application ,detection:2
portable ,instrument:2
portable ,rapid:4
portable ,reliable:2
portable ,detection:4
portable ,sars-cov-2:4
instrument ,rapid:2
instrument ,reliable:2
instrument ,detection:2
instrument ,sars-cov-2:2
rapid ,reliable:6
rnai ,suppressor:2
rnai ,hidden:2
rnai ,weapon:2
rnai ,sars-cov:2
suppressor ,hidden:2
suppressor ,weapon:2
suppressor ,sars-cov:2
hidden ,weapon:2
hidden ,sars-cov:2
weapon ,sars-cov:2
statistical ,course:2
statistical ,sars-cov-2:4
statistical ,outbreak:2
modeling ,course:2
modeling ,outbreak:6
course ,outbreak:2
comparison ,point-of-care:2
comparison ,high-complexity:2
point-of-care ,assay:4
point-of-care ,high-complexity:2
assay ,high-complexity:2
high-complexity ,detection:2
new ,loss:4
new ,smell:4
new ,taste:4
new ,household:2
new ,contacts:2
new ,home-isolated:2
onset ,loss:4
onset ,smell:4
onset ,taste:4
onset ,household:2
onset ,contacts:2
onset ,home-isolated:2
loss ,household:2
loss ,contacts:2
loss ,home-isolated:2
smell ,household:2
smell ,contacts:2
smell ,home-isolated:2
taste ,household:2
taste ,contacts:2
taste ,home-isolated:2
household ,home-isolated:2
contacts ,home-isolated:2
contriving ,multi-epitope:2
contriving ,subunit:2
contriving ,vaccine:2
contriving ,covid-19:2
contriving ,immunoinformatics:2
multi-epitope ,subunit:2
multi-epitope ,covid-19:2
subunit ,covid-19:2
subunit ,immunoinformatics:2
covid-19 ,immunoinformatics:2
vitro ,virucidal:2
vitro ,echinaforce:2
vitro ,echinacea:2
vitro ,purpurea:2
vitro ,preparation:2
virucidal ,activity:2
virucidal ,echinaforce:2
virucidal ,echinacea:2
virucidal ,purpurea:2
virucidal ,preparation:2
activity ,echinaforce:2
activity ,echinacea:2
activity ,purpurea:2
activity ,preparation:2
echinaforce ,echinacea:2
echinaforce ,purpurea:2
echinaforce ,preparation:2
echinacea ,purpurea:2
echinacea ,preparation:2
purpurea ,preparation:2
results ,pilot:2
results ,external:4
results ,quality:4
results ,assessment:4
results ,eqa:2
results ,scheme:4
first ,pilot:2
first ,external:4
first ,quality:4
first ,assessment:4
first ,eqa:2
first ,scheme:4
pilot ,external:2
pilot ,quality:2
pilot ,assessment:2
pilot ,eqa:2
pilot ,scheme:2
external ,eqa:2
external ,scheme:4
quality ,eqa:2
quality ,scheme:4
assessment ,eqa:2
assessment ,scheme:4
eqa ,scheme:2
quantitative ,phylogenomic:2
quantitative ,evidence:2
quantitative ,reveals:2
quantitative ,spatially:2
quantitative ,structured:2
phylogenomic ,evidence:2
phylogenomic ,reveals:2
phylogenomic ,spatially:2
phylogenomic ,structured:2
evidence ,reveals:2
evidence ,spatially:2
evidence ,structured:2
reveals ,spatially:2
reveals ,structured:2
spatially ,structured:2
spatially ,sars-cov-2:2
structured ,sars-cov-2:2
sars-cov-2 ,legionella:2
sars-cov-2 ,person:4
sars-cov-2 ,returning:2
sars-cov-2 ,nile:2
legionella ,co-infection:2
legionella ,person:2
legionella ,returning:2
legionella ,nile:2
legionella ,cruise:2
co-infection ,person:2
co-infection ,returning:2
co-infection ,nile:2
co-infection ,cruise:2
person ,returning:2
person ,nile:2
person ,cruise:2
returning ,nile:2
returning ,cruise:2
nile ,cruise:2
two ,automated:4
automated ,three:6
automated ,rapid:4
automated ,lateral:2
automated ,flow:2
automated ,immunoassays:4
three ,rapid:4
rapid ,immunoassays:4
featuring ,covid-19:2
featuring ,cases:2
featuring ,via:2
featuring ,screening:2
featuring ,symptomatic:2
featuring ,patients:2
featuring ,epidemiologic:2
featuring ,link:2
cases ,via:2
cases ,screening:2
cases ,symptomatic:2
cases ,link:2
via ,screening:2
via ,symptomatic:2
via ,patients:4
via ,epidemiologic:2
via ,link:2
screening ,symptomatic:2
screening ,epidemiologic:2
screening ,link:2
symptomatic ,epidemiologic:2
symptomatic ,link:2
patients ,epidemiologic:4
patients ,link:2
epidemiologic ,link:2
gene ,pattern:2
gene ,differences:2
gene ,primary:2
gene ,pulmonary:2
gene ,epithelial:2
gene ,cells:2
expression ,pattern:4
expression ,primary:2
expression ,pulmonary:2
pattern ,differences:2
pattern ,primary:2
pattern ,human:2
pattern ,pulmonary:2
pattern ,epithelial:2
pattern ,cells:2
differences ,primary:2
differences ,human:2
differences ,pulmonary:4
differences ,epithelial:2
differences ,cells:2
primary ,human:2
primary ,pulmonary:2
primary ,epithelial:2
primary ,cells:2
human ,pulmonary:2
human ,epithelial:4
pulmonary ,epithelial:2
pulmonary ,cells:2
evaluation ,3c-like:2
evaluation ,protease:2
evaluation ,inhibitors:2
evaluation ,self-assembled:2
evaluation ,monolayer:2
sars-cov-2 ,self-assembled:2
sars-cov-2 ,monolayer:2
3c-like ,inhibitors:8
3c-like ,using:2
3c-like ,self-assembled:2
3c-like ,monolayer:2
protease ,self-assembled:2
protease ,monolayer:2
inhibitors ,self-assembled:2
inhibitors ,monolayer:2
using ,self-assembled:2
using ,monolayer:2
self-assembled ,monolayer:2
case ,returning:2
case ,macau:2
case ,taiwan:2
case ,course:4
covid-19 ,returning:4
covid-19 ,macau:4
pneumonia ,returning:2
pneumonia ,macau:2
pneumonia ,taiwan:2
returning ,macau:2
returning ,taiwan:2
returning ,clinical:2
returning ,course:2
macau ,taiwan:2
macau ,clinical:2
macau ,course:2
taiwan ,clinical:2
taiwan ,course:2
establishment ,drug-target:2
establishment ,microarray:2
validation ,drug-target:2
validation ,microarray:2
drug-target ,microarray:2
drug-target ,sars-cov-2:2
microarray ,sars-cov-2:4
vaccines ,based:2
vaccines ,virus-like:2
vaccines ,nano-particles:2
vaccines ,use:2
vaccines ,middle:4
vaccines ,east:2
based ,virus-like:2
based ,nano-particles:2
based ,use:2
based ,middle:2
based ,east:2
virus-like ,nano-particles:2
virus-like ,use:2
virus-like ,middle:2
virus-like ,east:2
virus-like ,respiratory:4
nano-particles ,use:2
nano-particles ,middle:2
nano-particles ,east:2
nano-particles ,respiratory:2
use ,middle:2
use ,east:2
use ,respiratory:6
optimal ,size:2
optimal ,sample:2
optimal ,pooling:2
optimal ,rna:2
optimal ,pool:4
optimal ,testing:4
optimal ,avant-garde:2
optimal ,scaling:2
size ,sample:2
size ,pooling:2
size ,rna:2
size ,pool:2
size ,testing:2
size ,avant-garde:2
size ,scaling:2
sample ,rna:6
sample ,pool:2
sample ,testing:4
sample ,avant-garde:2
sample ,scaling:2
pooling ,rna:4
pooling ,pool:2
pooling ,avant-garde:2
pooling ,scaling:2
rna ,pool:2
rna ,testing:8
rna ,avant-garde:2
rna ,scaling:2
pool ,testing:4
pool ,avant-garde:2
pool ,scaling:2
testing ,avant-garde:2
testing ,scaling:2
avant-garde ,scaling:2
antibodies ,work:2
antibodies ,time:2
work ,time:2
work ,severe:2
work ,acute:2
work ,respiratory:2
work ,syndrome:2
time ,severe:4
time ,acute:4
time ,respiratory:6
time ,syndrome:4
duration ,asymptomatic:2
duration ,cases:2
duration ,novel:2
viral ,mild:2
shedding ,mild:2
early ,immune:4
insights ,immune:4
insights ,responses:4
glucocorticoids ,save:2
glucocorticoids ,lives:2
glucocorticoids ,patients:2
save ,lives:2
save ,covid-19:2
save ,patients:2
lives ,covid-19:2
lives ,patients:2
promising ,cure:2
promising ,global:2
promising ,panic:2
cure ,global:2
cure ,panic:2
global ,panic:2
child ,household:2
child ,transmitted:2
household ,transmitted:2
complicated ,appendicitis:2
complicated ,common:2
complicated ,epidemic:2
complicated ,period:2
complicated ,novel:2
appendicitis ,common:2
appendicitis ,epidemic:2
appendicitis ,period:2
appendicitis ,novel:2
common ,epidemic:2
common ,period:2
common ,novel:2
epidemiology ,emergency:2
epidemiology ,department:2
epidemiology ,patients:2
epidemiology ,suspected:2
clinical ,suspected:2
features ,emergency:2
features ,department:2
features ,suspected:2
emergency ,suspected:4
department ,suspected:2
network ,sequence:2
network ,structure:4
network ,dynamics:2
network ,key:2
network ,proteins:2
analysis ,structure:4
analysis ,dynamics:2
sequence ,dynamics:2
sequence ,key:2
sequence ,proteins:2
structure ,dynamics:2
structure ,key:2
structure ,proteins:2
dynamics ,key:2
dynamics ,proteins:2
key ,proteins:4
proteins ,coronavirus:6
high-flow ,nasal:6
high-flow ,oxygen:4
high-flow ,safe:2
high-flow ,efficient:2
high-flow ,treatment:2
high-flow ,covid-19:4
high-flow ,patients:6
nasal ,safe:2
nasal ,efficient:2
nasal ,treatment:2
nasal ,patients:6
oxygen ,safe:2
oxygen ,efficient:2
oxygen ,treatment:2
safe ,efficient:4
safe ,treatment:2
efficient ,treatment:2
efficient ,patients:2
severe ,neutralizing:4
severe ,titers:2
acute ,neutralizing:2
acute ,titers:2
respiratory ,neutralizing:2
respiratory ,titers:2
syndrome ,neutralizing:2
syndrome ,titers:2
coronavirus ,titers:2
neutralizing ,titers:2
antibody ,titers:2
repurposing ,mechanism-based:2
repurposing ,insights:2
drugs ,protease:8
drugs ,mechanism-based:2
drugs ,insights:4
main ,mechanism-based:2
main ,insights:4
protease ,mechanism-based:2
protease ,insights:4
sars-cov-2 ,mechanism-based:2
mechanism-based ,insights:2
infection ,organoids:4
infection ,2d:2
infection ,cortical:2
infection ,neurons:2
infection ,pseudovirus:2
brain ,organoids:2
brain ,2d:2
brain ,cortical:2
brain ,neurons:2
brain ,pseudovirus:2
organoids ,2d:2
organoids ,cortical:2
organoids ,neurons:2
organoids ,sars-cov-2:4
organoids ,pseudovirus:2
2d ,cortical:2
2d ,neurons:2
2d ,sars-cov-2:2
2d ,pseudovirus:2
cortical ,neurons:2
cortical ,sars-cov-2:2
cortical ,pseudovirus:2
neurons ,sars-cov-2:4
neurons ,pseudovirus:2
neutrophil ,cd4:2
neutrophil ,lymphocyte:2
neutrophil ,ratio:2
neutrophil ,potential:2
neutrophil ,biomarker:2
neutrophil ,predicting:2
neutrophil ,virus:2
cd4 ,lymphocyte:4
cd4 ,ratio:2
cd4 ,potential:2
cd4 ,biomarker:2
cd4 ,predicting:2
cd4 ,virus:2
lymphocyte ,ratio:2
lymphocyte ,potential:2
lymphocyte ,biomarker:2
lymphocyte ,predicting:2
lymphocyte ,virus:2
ratio ,potential:2
ratio ,biomarker:2
ratio ,predicting:2
ratio ,virus:2
potential ,biomarker:2
potential ,predicting:4
biomarker ,predicting:2
biomarker ,virus:2
predicting ,virus:2
sars-cov-2-a ,tough:2
sars-cov-2-a ,opponent:2
sars-cov-2-a ,immune:2
sars-cov-2-a ,system:2
tough ,opponent:2
tough ,immune:2
tough ,system:2
opponent ,immune:2
opponent ,system:2
small ,changed:2
small ,world:2
small ,special:2
small ,role:2
small ,anosmia:2
virus ,changed:2
virus ,world:2
virus ,special:2
virus ,anosmia:2
changed ,world:2
changed ,special:2
changed ,role:2
changed ,anosmia:2
world ,special:2
world ,role:2
world ,anosmia:2
special ,role:2
special ,anosmia:2
role ,anosmia:2
course ,middle-aged:2
course ,male:2
sars-cov-2 ,middle-aged:2
pneumonia ,middle-aged:2
pneumonia ,male:2
middle-aged ,male:2
middle-aged ,patient:2
male ,patient:2
sinus ,node:2
sinus ,dysfunction:2
sinus ,young:2
sinus ,patient:4
sinus ,covid-19:4
node ,dysfunction:2
node ,young:2
node ,patient:2
node ,covid-19:2
dysfunction ,young:2
young ,patient:4
perinatal ,control:2
neonatal ,control:2
management ,control:2
plan ,control:2
sensitivity ,different:2
sensitivity ,rt-qpcr:2
sensitivity ,solutions:2
different ,rt-qpcr:2
different ,solutions:2
rt-qpcr ,solutions:2
solutions ,sars-cov-2:6
solutions ,detection:4
severe ,injury:8
severe ,seven-case:2
severe ,series:4
covid-19 ,seven-case:2
patients ,seven-case:2
liver ,seven-case:2
liver ,series:2
injury ,seven-case:2
seven-case ,series:2
analysis ,protocols:4
clinical ,protocols:4
study ,protocols:2
protocols ,traditional:2
protocols ,chinese:2
protocols ,medicine:2
personal ,ent:2
personal ,activity:2
protective ,ent:2
protective ,activity:2
protective ,pandemic:6
equipment ,ent:2
equipment ,activity:2
equipment ,pandemic:4
ent ,activity:2
ent ,pandemic:4
risk ,aerosols:2
risk ,rational:2
risk ,masks:2
sars-cov-2 ,aerosols:2
sars-cov-2 ,rational:8
transmission ,rational:2
transmission ,use:6
aerosols ,rational:2
aerosols ,use:2
aerosols ,masks:2
rational ,use:6
rational ,masks:2
use ,masks:4
targeting ,tmprss2:2
tmprss2 ,sars-cov-2:20
tmprss2 ,infection:2
sars-cov-2 ,biomarkers:4
antibodies ,inflammatory:2
antibodies ,biomarkers:2
antibodies ,severity:2
serum ,inflammatory:2
serum ,biomarkers:2
inflammatory ,biomarkers:4
inflammatory ,severity:2
biomarkers ,clinical:2
biomarkers ,severity:2
clinical ,severity:4
severe ,hyperphosphatasemia:2
hyperphosphatasemia ,acute:2
hyperphosphatasemia ,respiratory:2
hyperphosphatasemia ,syndrome:2
hyperphosphatasemia ,coronavirus:2
angiotensin-converting ,polymorphism:2
angiotensin-converting ,lung:2
angiotensin-converting ,injury:2
enzyme ,polymorphism:2
enzyme ,lung:2
enzyme ,injury:2
gene ,polymorphism:2
gene ,lung:2
gene ,injury:2
polymorphism ,severe:2
polymorphism ,lung:2
polymorphism ,injury:2
polymorphism ,patients:2
comparison ,lateral:2
comparison ,flow:2
comparison ,elisa:2
comparison ,antibody:6
commercial ,lateral:2
commercial ,flow:2
commercial ,elisa:2
lateral ,elisa:2
lateral ,antibody:6
flow ,elisa:2
flow ,antibody:6
immunoassays ,elisa:2
immunoassays ,antibody:2
elisa ,sars-cov-2:4
elisa ,antibody:2
takotsubo ,sars-cov-2:4
takotsubo ,pneumonia:2
takotsubo ,possible:2
takotsubo ,cardiovascular:2
syndrome ,pneumonia:2
syndrome ,cardiovascular:4
pneumonia ,possible:2
pneumonia ,cardiovascular:2
possible ,cardiovascular:2
subunit ,emerging:2
subunit ,pathogenic:2
subunit ,human:2
subunit ,coronaviruses:2
vaccines ,emerging:4
vaccines ,pathogenic:2
vaccines ,human:4
emerging ,pathogenic:2
children ,implications:2
epidemiological ,implications:2
high ,attack:4
high ,attendees:2
high ,wedding:2
high ,events:4
high ,bali:2
high ,indonesia:2
covid-19 ,attack:6
covid-19 ,attendees:2
covid-19 ,wedding:4
covid-19 ,events:6
covid-19 ,bali:2
attack ,among:2
attack ,attendees:2
attack ,wedding:2
attack ,events:2
attack ,bali:2
attack ,indonesia:2
rate ,among:2
rate ,attendees:2
rate ,wedding:2
rate ,events:2
rate ,bali:2
rate ,indonesia:2
among ,events:2
among ,bali:2
among ,indonesia:2
attendees ,events:2
attendees ,bali:2
attendees ,indonesia:2
wedding ,events:2
wedding ,bali:2
wedding ,indonesia:2
events ,bali:2
events ,indonesia:2
bali ,indonesia:2
covid-19 ,ophthalmological:2
ophthalmological ,aspects:2
ophthalmological ,sars-cov:2
ophthalmological ,global:2
ophthalmological ,pandemic:2
aspects ,sars-cov:2
aspects ,global:2
sars-cov ,global:2
approaches ,based:2
approaches ,artificial:2
approaches ,intelligence:2
approaches ,internet:2
approaches ,intelligent:2
approaches ,things:2
based ,artificial:2
based ,intelligence:2
based ,internet:2
based ,intelligent:2
based ,things:2
artificial ,internet:2
artificial ,intelligent:2
artificial ,things:2
intelligence ,internet:2
intelligence ,intelligent:2
intelligence ,things:2
internet ,intelligent:2
internet ,things:2
intelligent ,things:2
characteristics ,sars-cov-2-positive:2
newborns ,sars-cov-2-positive:2
newborns ,retrospective:2
born ,sars-cov-2-positive:2
born ,retrospective:2
sars-cov-2-positive ,mothers:2
sars-cov-2-positive ,retrospective:4
mothers ,retrospective:2
bentonite ,clay:2
bentonite ,potential:2
bentonite ,natural:2
bentonite ,sanitizer:2
bentonite ,preventing:2
bentonite ,neurological:2
bentonite ,disorders:2
clay ,potential:2
clay ,natural:2
clay ,sanitizer:2
clay ,preventing:2
clay ,neurological:2
clay ,disorders:2
potential ,sanitizer:2
potential ,preventing:4
natural ,sanitizer:2
natural ,preventing:2
natural ,neurological:2
natural ,disorders:2
sanitizer ,preventing:2
sanitizer ,neurological:2
sanitizer ,disorders:2
preventing ,neurological:2
preventing ,disorders:2
scent ,dog:2
scent ,identification:2
scent ,samples:2
scent ,covid-19:2
scent ,patients:2
scent ,pilot:2
scent ,study:2
dog ,identification:2
dog ,samples:2
dog ,covid-19:2
dog ,patients:2
dog ,pilot:2
dog ,study:2
identification ,samples:2
identification ,pilot:2
identification ,study:2
samples ,patients:2
samples ,pilot:2
covid-19 ,pilot:2
patients ,pilot:2
pilot ,study:8
comprehensive ,glycan:2
comprehensive ,complement:2
comprehensive ,spike:2
comprehensive ,proteins:2
comprehensive ,using:2
analysis ,glycan:6
analysis ,complement:4
glycan ,complement:2
glycan ,sars-cov-2:6
glycan ,spike:6
glycan ,proteins:2
glycan ,using:2
complement ,sars-cov-2:4
complement ,spike:4
complement ,proteins:4
complement ,using:2
proteins ,using:4
inpatient ,patients:8
inpatient ,covid-19:4
inpatient ,guide:2
inpatient ,hospitalists:2
care ,guide:2
care ,hospitalists:2
patients ,hospitalists:2
covid-19 ,hospitalists:4
guide ,hospitalists:2
clinical ,sars-cov-2-infected:2
characteristics ,sars-cov-2-infected:2
outcome ,four:2
outcome ,sars-cov-2-infected:2
four ,sars-cov-2-infected:2
sars-cov-2-infected ,cancer:2
potential ,anti-covid-19:6
potential ,stage:2
potential ,life:2
anti-covid-19 ,therapeutics:2
anti-covid-19 ,block:2
anti-covid-19 ,early:2
anti-covid-19 ,stage:2
anti-covid-19 ,viral:2
anti-covid-19 ,life:2
therapeutics ,block:2
therapeutics ,early:2
therapeutics ,stage:2
therapeutics ,viral:2
therapeutics ,life:2
block ,early:2
block ,stage:2
block ,viral:2
block ,life:2
early ,viral:2
early ,life:6
stage ,viral:2
stage ,life:2
viral ,life:2
multiple ,outbreaks:2
multiple ,linked:2
multiple ,wedding:2
multiple ,reception:2
multiple ,rural:2
multiple ,maine:2
multiple ,august:2
covid-19 ,reception:2
covid-19 ,rural:2
covid-19 ,maine:2
covid-19 ,august:2
outbreaks ,linked:2
outbreaks ,wedding:2
outbreaks ,reception:2
outbreaks ,rural:2
outbreaks ,maine:2
outbreaks ,august:2
linked ,wedding:2
linked ,reception:2
linked ,rural:2
linked ,maine:2
linked ,august:2
wedding ,reception:2
wedding ,rural:2
wedding ,maine:2
wedding ,august:2
reception ,rural:2
reception ,maine:2
reception ,august:2
rural ,maine:2
rural ,august:2
maine ,august:2
neuropathology ,spectrum:2
neuropathology ,vascular:2
neuropathology ,acute:2
neuropathology ,disseminated:2
covid-19 ,disseminated:4
spectrum ,vascular:2
spectrum ,acute:2
spectrum ,disseminated:2
vascular ,acute:2
vascular ,disseminated:2
acute ,disseminated:2
chilblains ,children:4
chilblains ,setting:2
children ,setting:2
children ,pandemic:10
setting ,pandemic:2
hand ,disinfection:2
hand ,combat:2
hand ,covid-19:6
disinfection ,combat:2
clinical ,series:10
clinical ,literature:8
presentation ,series:2
presentation ,literature:2
series ,literature:4
biosensors ,managing:2
biosensors ,cytokine:2
biosensors ,storm:2
biosensors ,challenges:2
biosensors ,ahead:2
managing ,cytokine:4
managing ,storm:6
managing ,ahead:2
cytokine ,challenges:2
cytokine ,ahead:2
storm ,challenges:2
storm ,ahead:2
challenges ,ahead:4
sars-cov-2 ,el:2
rt-pcr ,results:8
rt-pcr ,cohort:2
rt-pcr ,workers:2
rt-pcr ,el:2
asymptomatic ,el:2
patients ,el:2
results ,el:2
cohort ,workers:2
cohort ,el:2
workers ,el:2
operational ,k9s:2
operational ,covid-19:6
operational ,world:2
k9s ,covid-19:2
k9s ,world:2
rapid ,response:4
rapid ,arthroplasty:2
rapid ,divisions:2
response ,arthroplasty:2
response ,divisions:2
response ,two:2
covid-19 ,divisions:2
pandemic ,arthroplasty:4
pandemic ,divisions:2
pandemic ,two:4
arthroplasty ,divisions:2
arthroplasty ,two:2
divisions ,two:2
universal ,hyperacute:2
universal ,stroke:2
laboratory ,hyperacute:2
laboratory ,stroke:2
testing ,hyperacute:2
testing ,stroke:2
sars-cov-2 ,hyperacute:2
sars-cov-2 ,stroke:12
hyperacute ,stroke:2
hyperacute ,covid-19:2
possibility ,mother-to-child:2
possibility ,coronavirus:2
possibility ,infection:2
mother-to-child ,vertical:2
mother-to-child ,transmission:2
mother-to-child ,coronavirus:2
mother-to-child ,infection:2
transmission ,retrospective:4
transmission ,25:2
characteristics ,25:2
retrospective ,25:4
study ,25:4
one-step ,rapid:2
one-step ,quantification:2
one-step ,sars-cov-2:2
one-step ,virus:2
one-step ,particles:2
one-step ,via:2
one-step ,low-cost:2
rapid ,quantification:4
rapid ,particles:2
rapid ,via:4
rapid ,low-cost:2
quantification ,virus:4
quantification ,particles:2
quantification ,via:2
quantification ,low-cost:2
sars-cov-2 ,low-cost:2
virus ,particles:2
virus ,via:2
virus ,low-cost:2
particles ,via:2
particles ,low-cost:2
via ,low-cost:2
growth ,detection:2
growth ,quantification:2
growth ,inactivation:2
quantification ,inactivation:2
thermodynamics ,interaction:2
thermodynamics ,spike:2
thermodynamics ,protein:2
thermodynamics ,severe:2
thermodynamics ,acute:2
interaction ,severe:4
interaction ,acute:4
inhibitors ,future:2
inhibitors ,opportunities:2
sars-cov-2 ,opportunities:4
entry ,current:2
entry ,future:2
entry ,opportunities:2
current ,opportunities:2
future ,opportunities:2
discovery ,putative:2
discovery ,allosteric:2
discovery ,site:2
discovery ,protein:2
putative ,allosteric:2
putative ,site:2
putative ,spike:2
putative ,using:2
allosteric ,site:2
allosteric ,sars-cov-2:2
allosteric ,spike:2
allosteric ,protein:2
allosteric ,using:2
site ,sars-cov-2:6
site ,spike:4
site ,protein:4
site ,using:2
protein ,using:2
ribosomal ,proteins:2
ribosomal ,possible:2
ribosomal ,tool:2
ribosomal ,blocking:2
ribosomal ,sars-cov:2
ribosomal ,virus:2
ribosomal ,replication:2
proteins ,possible:2
proteins ,tool:2
proteins ,blocking:2
proteins ,sars-cov:2
proteins ,virus:4
proteins ,replication:2
possible ,blocking:2
possible ,sars-cov:4
possible ,virus:4
possible ,replication:2
tool ,blocking:2
tool ,sars-cov:2
tool ,virus:2
tool ,replication:2
blocking ,sars-cov:2
blocking ,virus:2
blocking ,replication:2
sars-cov ,virus:4
virus ,replication:2
shell ,analysis:4
shell ,predicts:2
shell ,greater:2
shell ,resilience:2
shell ,sars-cov-2:2
shell ,covid-19:2
disorder ,analysis:4
disorder ,predicts:2
disorder ,greater:2
disorder ,resilience:2
analysis ,predicts:2
analysis ,greater:2
analysis ,resilience:2
predicts ,greater:2
predicts ,resilience:2
greater ,resilience:2
greater ,covid-19:4
resilience ,sars-cov-2:2
resilience ,covid-19:6
rates ,co-infection:2
rates ,respiratory:2
rates ,pathogens:2
co-infection ,pathogens:4
prevalence ,presentation:2
clinical ,healthcare:4
clinical ,workers:4
presentation ,among:2
presentation ,healthcare:4
presentation ,workers:4
successful ,clazakizumab:2
successful ,heart:2
treatment ,clazakizumab:2
treatment ,heart:2
severe ,clazakizumab:2
severe ,heart:4
covid-19 ,clazakizumab:2
pneumonia ,clazakizumab:2
pneumonia ,heart:2
clazakizumab ,heart:2
pediatric ,residents:2
pediatric ,life:2
pediatric ,changed:2
residents ,life:2
residents ,changed:2
residents ,pandemic:2
life ,changed:2
life ,covid-19:12
life ,pandemic:6
changed ,covid-19:4
changed ,pandemic:2
predictive ,ability:2
predictive ,symptomatology:2
predictive ,active:2
predictive ,search:2
predictive ,lagos:2
ability ,symptomatology:2
ability ,covid-19:4
ability ,active:2
ability ,case:2
ability ,search:2
ability ,lagos:2
symptomatology ,active:2
symptomatology ,case:2
symptomatology ,search:2
symptomatology ,lagos:2
covid-19 ,search:8
covid-19 ,lagos:2
active ,case:6
active ,search:2
active ,lagos:2
case ,search:2
case ,lagos:2
search ,lagos:2
transmission ,discharge:2
transmission ,criteria:2
risk ,discharge:2
risk ,criteria:2
patients ,meeting:2
patients ,criteria:4
covid-19 ,meeting:2
meeting ,discharge:2
meeting ,criteria:2
discharge ,criteria:2
sars-cov-2 ,aerosols-arguing:2
aerosols-arguing ,evidence:2
small ,non-coding:2
small ,rnas:2
small ,encode:2
small ,answers:2
small ,controlling:2
non-coding ,rnas:2
non-coding ,encode:2
non-coding ,answers:2
non-coding ,controlling:2
non-coding ,sars-cov-2:2
rnas ,encode:2
rnas ,answers:2
rnas ,controlling:2
rnas ,sars-cov-2:2
encode ,answers:2
encode ,controlling:2
encode ,sars-cov-2:2
answers ,controlling:2
controlling ,sars-cov-2:4
laboratory ,host:2
laboratory ,immunity:2
laboratory ,different:4
laboratory ,severity:2
tests ,host:2
tests ,immunity:2
tests ,different:2
tests ,severity:2
host ,immunity:2
host ,patients:4
host ,different:2
immunity ,different:2
immunity ,severity:4
patients ,severity:14
different ,severity:2
optimized ,qrt-pcr:2
optimized ,approach:2
optimized ,detection:2
optimized ,intra-:2
optimized ,extra-cellular:2
optimized ,sars-cov-2:6
qrt-pcr ,approach:2
qrt-pcr ,intra-:2
qrt-pcr ,extra-cellular:2
approach ,detection:4
approach ,intra-:2
approach ,extra-cellular:2
detection ,intra-:2
detection ,extra-cellular:2
intra- ,extra-cellular:2
intra- ,sars-cov-2:2
extra-cellular ,sars-cov-2:2
targeting ,system:2
targeting ,pulmonary:2
targeting ,inflammation:4
targeting ,cardiovascular:2
immune ,pulmonary:2
system ,pulmonary:2
system ,inflammation:2
pulmonary ,inflammation:4
pulmonary ,cardiovascular:2
inflammation ,cardiovascular:2
potential ,cross-reactive:2
potential ,immunity:2
potential ,common:2
potential ,pathogens:4
cross-reactive ,immunity:4
cross-reactive ,common:4
cross-reactive ,human:2
cross-reactive ,pathogens:2
immunity ,common:2
immunity ,human:2
immunity ,pathogens:2
common ,human:6
common ,pathogens:2
human ,pathogens:2
mask ,wearing:4
mask ,pre-symptomatic:2
mask ,patients:2
mask ,prevents:2
mask ,sars-cov-2:2
mask ,transmission:4
wearing ,pre-symptomatic:2
wearing ,patients:2
wearing ,prevents:2
wearing ,sars-cov-2:2
wearing ,transmission:4
pre-symptomatic ,patients:2
pre-symptomatic ,prevents:2
pre-symptomatic ,sars-cov-2:2
pre-symptomatic ,transmission:2
patients ,prevents:2
prevents ,transmission:2
early ,support:2
early ,pregnant:4
support ,pregnant:2
linking ,ace2:2
linking ,angiotensin:2
linking ,ii:2
linking ,pulmonary:2
linking ,immunovascular:2
linking ,dysregulation:2
ace2 ,pulmonary:2
ace2 ,immunovascular:2
angiotensin ,pulmonary:2
angiotensin ,immunovascular:2
angiotensin ,dysregulation:2
ii ,pulmonary:2
ii ,immunovascular:2
ii ,dysregulation:2
pulmonary ,immunovascular:2
pulmonary ,dysregulation:2
immunovascular ,dysregulation:2
italian ,pediatric:4
italian ,respiratory:2
italian ,recommendations:2
italian ,pulmonary:2
pediatric ,recommendations:4
pediatric ,pulmonary:2
respiratory ,society:2
respiratory ,recommendations:2
society ,recommendations:10
society ,pulmonary:2
recommendations ,pulmonary:2
expert ,opinion:2
expert ,follow-up:2
expert ,uveitis:2
expert ,sars-cov-2:2
opinion ,management:2
opinion ,follow-up:2
opinion ,uveitis:2
opinion ,patients:2
management ,follow-up:4
follow-up ,uveitis:2
follow-up ,patients:12
follow-up ,sars-cov-2:2
uveitis ,patients:2
potential ,applications:2
potential ,biotechnology:4
applications ,plant:2
applications ,biotechnology:2
applications ,sars-cov-2:4
plant ,biotechnology:2
plant ,sars-cov-2:2
biotechnology ,sars-cov-2:2
nasal ,swab:2
nasal ,preferred:2
nasal ,clinical:2
nasal ,specimen:2
nasal ,testing:2
nasal ,children:4
swab ,preferred:2
swab ,clinical:4
preferred ,clinical:2
preferred ,specimen:2
preferred ,covid-19:4
preferred ,testing:2
preferred ,children:2
clinical ,specimen:4
specimen ,children:2
making ,waves:4
making ,wastewater-based:2
making ,epidemiology:2
making ,approaches:2
making ,challenges:4
waves ,wastewater-based:2
waves ,epidemiology:2
waves ,covid-19:4
waves ,approaches:2
waves ,challenges:2
wastewater-based ,approaches:2
wastewater-based ,challenges:2
epidemiology ,approaches:2
epidemiology ,challenges:2
early ,implementation:2
early ,protective:2
early ,measures:2
early ,defines:2
early ,outcomes:2
implementation ,protective:2
implementation ,measures:4
implementation ,defines:2
implementation ,surgical:2
implementation ,outcomes:2
protective ,defines:2
protective ,surgical:4
protective ,outcomes:2
measures ,defines:2
measures ,surgical:2
measures ,outcomes:2
defines ,surgical:2
defines ,outcomes:2
surgical ,outcomes:2
secretion ,severe:2
secretion ,acute:2
secretion ,respiratory:2
secretion ,syndrome:2
secretion ,coronavirus:2
secretion ,urine:2
severe ,urine:2
acute ,urine:2
respiratory ,urine:2
syndrome ,urine:2
coronavirus ,urine:2
exploring ,sight:2
exploring ,antigens:2
exploring ,design:2
exploring ,candidate:2
sight ,antigens:2
sight ,sars-cov-2:2
sight ,design:2
sight ,candidate:2
antigens ,design:2
antigens ,candidate:2
design ,candidate:2
covid-19 ,despite:8
covid-19 ,pcr-analysis:2
associated ,despite:2
associated ,repeatedly:2
associated ,pcr-analysis:2
pneumonia ,despite:6
pneumonia ,repeatedly:2
pneumonia ,pcr-analysis:2
despite ,repeatedly:2
despite ,negative:2
despite ,pcr-analysis:2
repeatedly ,negative:2
repeatedly ,pcr-analysis:2
negative ,pcr-analysis:2
short ,report:2
short ,usefulness:2
short ,point-of-care:2
short ,ultrasound:2
short ,pediatric:2
short ,sars-cov-2:4
report ,usefulness:2
report ,point-of-care:2
report ,ultrasound:2
report ,pediatric:6
usefulness ,point-of-care:2
usefulness ,ultrasound:4
usefulness ,pediatric:2
usefulness ,sars-cov-2:2
point-of-care ,pediatric:2
ultrasound ,pediatric:2
important ,aspects:2
important ,prevention:2
important ,health:2
important ,personnel:2
important ,hospitals:2
aspects ,prevention:2
aspects ,health:4
aspects ,personnel:2
aspects ,hospitals:2
prevention ,health:2
prevention ,personnel:2
prevention ,hospitals:2
health ,hospitals:2
personnel ,hospitals:2
status ,cerebrospinal:2
status ,fluid:2
status ,stroke:2
cerebrospinal ,patients:2
cerebrospinal ,covid-19:2
cerebrospinal ,stroke:2
fluid ,patients:2
fluid ,stroke:2
large ,national:2
large ,covid-19:16
large ,linked:2
large ,air:2
large ,travel:2
large ,ireland:2
large ,summer:2
national ,outbreak:2
national ,linked:2
national ,air:2
national ,travel:2
national ,ireland:2
national ,summer:2
outbreak ,linked:2
outbreak ,travel:2
outbreak ,ireland:2
outbreak ,summer:2
covid-19 ,travel:4
covid-19 ,ireland:2
covid-19 ,summer:4
linked ,air:2
linked ,travel:2
linked ,ireland:2
linked ,summer:2
air ,travel:2
air ,ireland:2
air ,summer:2
travel ,ireland:2
travel ,summer:2
ireland ,summer:2
patients ,undetectable:2
covid-19 ,undetectable:2
neurological ,show:2
neurological ,undetectable:2
manifestations ,show:2
manifestations ,undetectable:2
show ,undetectable:2
show ,sars-cov-2:2
follow-up ,studies:2
follow-up ,covid-19:14
follow-up ,recovered:2
follow-up ,mandatory:2
studies ,recovered:2
studies ,patients:4
studies ,mandatory:2
covid-19 ,mandatory:2
recovered ,mandatory:2
patients ,mandatory:2
imaging ,diagnostics:2
imaging ,pathology:2
imaging ,sars-cov-2-related:2
imaging ,diseases:2
diagnostics ,pathology:2
diagnostics ,sars-cov-2-related:2
diagnostics ,diseases:2
pathology ,sars-cov-2-related:2
pathology ,diseases:2
sars-cov-2-related ,diseases:2
novel ,nucleotidyl-transferase:2
novel ,structures:2
coronavirus ,polymerase:2
coronavirus ,nucleotidyl-transferase:2
coronavirus ,structures:2
polymerase ,nucleotidyl-transferase:2
polymerase ,structures:2
nucleotidyl-transferase ,structures:2
nucleotidyl-transferase ,potential:2
structures ,potential:2
air ,around:2
air ,hospitalized:2
environmental ,around:2
environmental ,hospitalized:2
environmental ,patients:6
sampling ,around:2
sampling ,hospitalized:2
sampling ,patients:2
around ,hospitalized:2
around ,patients:2
existing ,treatment:2
phenotypic ,changes:2
phenotypic ,cells:2
phenotypic ,covid-19:2
phenotypic ,patients:2
changes ,cells:2
assessment ,direct:2
assessment ,quantitation:2
assessment ,droplet:4
assessment ,digital:4
assessment ,pcr:4
direct ,quantitation:2
direct ,droplet:2
direct ,digital:2
direct ,pcr:2
quantitation ,sars-cov-2:2
quantitation ,droplet:2
quantitation ,digital:2
quantitation ,pcr:2
self-collected ,anterior:2
self-collected ,nasal:2
self-collected ,saliva:4
self-collected ,specimens:2
self-collected ,versus:4
self-collected ,health:2
self-collected ,care:2
anterior ,nasal:2
anterior ,saliva:2
anterior ,specimens:2
anterior ,versus:2
anterior ,health:2
anterior ,care:4
nasal ,saliva:2
nasal ,specimens:4
nasal ,versus:2
nasal ,health:2
nasal ,care:2
saliva ,versus:2
saliva ,health:2
saliva ,care:2
specimens ,versus:2
specimens ,health:2
specimens ,care:2
versus ,health:2
versus ,care:4
call ,consistency:2
call ,official:2
call ,naming:2
call ,caused:2
call ,severe:2
call ,acute:2
consistency ,official:2
consistency ,naming:2
consistency ,disease:2
consistency ,caused:2
consistency ,severe:2
consistency ,acute:2
official ,naming:2
official ,disease:2
official ,caused:2
official ,severe:2
official ,acute:2
naming ,disease:2
naming ,caused:2
naming ,severe:2
naming ,acute:2
asymptomatic ,carriage:2
asymptomatic ,know:2
carriage ,transmission:2
carriage ,sars-cov-2:4
carriage ,know:2
transmission ,know:2
high ,mortality:6
high ,cancer:2
high ,patients:14
high ,symptoms:2
high ,without:2
mortality ,symptoms:2
rate ,cancer:2
rate ,symptoms:2
rate ,without:2
cancer ,symptoms:2
germanys ,first:2
germanys ,covid-19:2
germanys ,deceased:2
germanys ,59-year-old:2
germanys ,man:2
germanys ,presenting:2
germanys ,diffuse:2
first ,deceased:2
first ,59-year-old:2
first ,man:2
first ,presenting:4
first ,diffuse:2
covid-19 ,59-year-old:2
covid-19 ,diffuse:2
deceased ,59-year-old:2
deceased ,man:2
deceased ,presenting:2
deceased ,diffuse:2
59-year-old ,man:2
59-year-old ,presenting:2
59-year-old ,diffuse:2
man ,presenting:2
man ,diffuse:2
presenting ,diffuse:2
therapeutic ,dilemma:2
therapeutic ,repression:2
therapeutic ,severe:12
therapeutic ,acute:6
therapeutic ,syndrome:4
dilemma ,repression:2
dilemma ,severe:2
dilemma ,acute:2
dilemma ,respiratory:2
dilemma ,syndrome:2
repression ,severe:2
repression ,acute:2
repression ,respiratory:2
repression ,syndrome:2
emergence ,transmission:2
emergence ,potential:2
emergence ,therapeutic:2
emergence ,targets:2
transmission ,targets:2
targets ,pandemic:2
high ,throughput:8
high ,virtual:4
high ,screening:4
high ,reveals:2
high ,multi-target:2
high ,binding:2
high ,natural:2
throughput ,virtual:4
throughput ,screening:4
throughput ,reveals:2
throughput ,sars-cov-2:4
throughput ,multi-target:2
throughput ,binding:2
throughput ,natural:2
virtual ,reveals:4
virtual ,sars-cov-2:12
virtual ,multi-target:2
virtual ,binding:4
virtual ,natural:2
screening ,multi-target:2
screening ,binding:4
screening ,natural:2
reveals ,multi-target:2
reveals ,binding:2
reveals ,natural:2
sars-cov-2 ,multi-target:2
multi-target ,binding:2
multi-target ,natural:2
binding ,natural:2
coronavirus-2 ,coronavirus:2
coronavirus-2 ,disease:2
neonatal ,pandemic:2
neonatal ,observation:2
neonatal ,cohort:2
management ,outcomes:2
management ,cohort:2
outcomes ,pandemic:6
outcomes ,observation:2
outcomes ,cohort:2
pandemic ,observation:2
pandemic ,cohort:4
observation ,cohort:2
comparison ,epidemiological:6
comparison ,patients:6
virtual ,admet:2
virtual ,free:2
virtual ,energy:2
virtual ,analysis:2
virtual ,anti-viral:2
screening ,admet:2
screening ,free:2
screening ,energy:2
screening ,analysis:6
screening ,anti-viral:2
admet ,binding:2
admet ,free:2
admet ,energy:2
admet ,analysis:2
admet ,anti-viral:2
binding ,free:4
binding ,energy:2
binding ,analysis:6
binding ,anti-viral:2
free ,analysis:2
free ,anti-viral:2
energy ,analysis:2
energy ,anti-viral:2
analysis ,anti-viral:2
renin-angiotensin ,interaction:2
renin-angiotensin ,underlying:2
renin-angiotensin ,mechanisms:2
system ,interaction:2
system ,underlying:2
system ,mechanisms:4
interaction ,underlying:2
case ,importance:2
report ,importance:2
report ,coinfection:4
importance ,disease:2
importance ,coinfection:2
novel ,coinfection:4
coronavirus ,coinfection:6
disease ,coinfection:2
coronavirus ,heart:4
heart ,population:2
transplant ,population:2
susceptibility ,elderly:2
susceptibility ,ace-2:2
susceptibility ,overexpression:2
elderly ,sars-cov-2:4
elderly ,infection:4
elderly ,ace-2:2
elderly ,overexpression:2
sars-cov-2 ,ace-2:4
sars-cov-2 ,overexpression:2
infection ,ace-2:2
infection ,overexpression:2
ace-2 ,overexpression:2
inflammatory ,questions:2
inflammatory ,arising:2
inflammatory ,patient:6
inflammatory ,care:2
bowel ,questions:2
bowel ,arising:2
bowel ,patient:4
bowel ,care:2
disease ,questions:2
disease ,arising:2
questions ,arising:2
questions ,patient:2
questions ,care:2
arising ,patient:2
arising ,care:2
covid-19 ,hyperferritinemic:2
covid-19 ,syndromes:4
covid-19 ,depletion:2
part ,hyperferritinemic:2
part ,syndromes:2
part ,role:2
part ,iron:2
part ,depletion:2
hyperferritinemic ,syndromes:2
hyperferritinemic ,role:2
hyperferritinemic ,iron:2
hyperferritinemic ,depletion:2
syndromes ,role:2
syndromes ,iron:2
syndromes ,depletion:2
role ,iron:2
role ,depletion:2
iron ,depletion:2
critically-ill ,covid-19:2
critically-ill ,patient:2
case ,isopropanol:2
case ,ingestion:2
report ,isopropanol:2
report ,ingestion:2
isopropanol ,ingestion:2
isopropanol ,sars-cov-2:2
isopropanol ,pandemic:2
ingestion ,sars-cov-2:2
ingestion ,pandemic:2
long-term ,modeling:2
long-term ,infection:6
long-term ,vitro:2
long-term ,cultured:2
long-term ,polarized:2
long-term ,human:2
modeling ,vitro:2
modeling ,cultured:2
modeling ,polarized:2
modeling ,human:2
sars-cov-2 ,cultured:2
sars-cov-2 ,polarized:2
infection ,vitro:2
infection ,cultured:2
infection ,polarized:2
vitro ,cultured:2
vitro ,polarized:2
vitro ,human:2
cultured ,polarized:2
cultured ,human:2
polarized ,human:2
performance ,immunoassay:4
evaluation ,abbott:4
evaluation ,architect:2
evaluation ,immunoassay:2
evaluation ,comparison:4
abbott ,immunoassay:2
architect ,immunoassay:2
architect ,comparison:2
igg ,immunoassay:4
igg ,comparison:4
maxillofacial ,pandemic:2
case ,systemic:4
case ,inflammatory:4
case ,response:10
case ,fast:2
case ,pediatric:10
report ,systemic:2
report ,inflammatory:4
report ,response:2
report ,fast:2
systemic ,fast:2
systemic ,recovery:2
systemic ,pediatric:2
systemic ,patient:2
inflammatory ,fast:2
inflammatory ,recovery:2
inflammatory ,pediatric:12
response ,fast:2
response ,recovery:2
response ,pediatric:4
response ,patient:4
fast ,recovery:2
fast ,pediatric:2
fast ,patient:2
recovery ,pediatric:2
ankaferd ,hemostat:2
ankaferd ,abs:2
ankaferd ,potential:2
ankaferd ,mucosal:2
ankaferd ,topical:2
ankaferd ,agent:2
ankaferd ,management:2
hemostat ,abs:2
hemostat ,potential:2
hemostat ,mucosal:2
hemostat ,topical:2
hemostat ,agent:2
hemostat ,management:2
abs ,potential:2
abs ,mucosal:2
abs ,topical:2
abs ,agent:2
abs ,management:2
potential ,mucosal:2
potential ,topical:2
potential ,management:8
mucosal ,agent:2
mucosal ,management:4
topical ,agent:2
topical ,management:2
agent ,management:2
epidemiological ,fifty-six:2
clinical ,fifty-six:2
characteristics ,fifty-six:2
fifty-six ,cases:2
fifty-six ,covid-19:2
lung ,innervation:2
lung ,eye:2
lung ,neuroimmune:2
lung ,interactions:4
innervation ,eye:2
innervation ,cytokine:2
innervation ,storm:2
innervation ,neuroimmune:2
innervation ,interactions:2
eye ,cytokine:6
eye ,storm:6
eye ,neuroimmune:2
eye ,interactions:2
cytokine ,neuroimmune:2
cytokine ,interactions:2
storm ,neuroimmune:2
storm ,interactions:2
neuroimmune ,interactions:2
first ,holistic:2
first ,immunological:2
first ,model:2
first ,implications:2
first ,prevention:2
holistic ,immunological:2
holistic ,model:2
holistic ,implications:2
holistic ,prevention:2
immunological ,model:2
immunological ,implications:4
immunological ,prevention:2
model ,implications:2
model ,prevention:2
strategies ,halt:2
strategies ,spread:2
strategies ,organ:2
halt ,novel:2
halt ,coronavirus:2
halt ,sars-cov-2:2
halt ,spread:2
halt ,organ:2
spread ,organ:2
ocular ,critical:2
ocular ,current:2
manifestations ,critical:2
critical ,current:2
immunosuppressive ,maintenance:2
immunosuppressive ,kidney:2
immunosuppressive ,transplant:2
immunosuppressive ,recipientwith:2
therapy ,maintenance:2
therapy ,kidney:6
therapy ,transplant:2
therapy ,recipientwith:2
maintenance ,kidney:2
maintenance ,transplant:2
maintenance ,recipientwith:2
kidney ,recipientwith:2
transplant ,recipientwith:2
role ,early:6
role ,secretory:2
role ,pathway:2
early ,secretory:2
early ,pathway:2
secretory ,pathway:2
secretory ,sars-cov-2:2
secretory ,infection:2
pathway ,infection:2
ace2 ,correlated:2
ace2 ,immune:2
ace2 ,infiltration:2
ace2 ,serves:2
ace2 ,prognostic:2
ace2 ,biomarker:2
correlated ,immune:4
correlated ,infiltration:2
correlated ,serves:2
correlated ,prognostic:2
correlated ,biomarker:2
immune ,serves:2
immune ,prognostic:4
immune ,biomarker:2
infiltration ,serves:2
infiltration ,prognostic:2
infiltration ,biomarker:2
serves ,prognostic:2
serves ,biomarker:2
prognostic ,biomarker:2
children ,pregnancy:2
children ,epidemiologic:4
pregnancy ,neonates:2
pregnancy ,epidemiologic:2
neonates ,epidemiologic:2
review ,epidemiologic:2
treatments ,emerging:2
treatments ,drugs:2
emerging ,drugs:2
single-cell ,sars-cov-2:6
single-cell ,spike:2
single-cell ,protein:2
single-cell ,priming:2
analysis ,priming:2
receptor ,priming:2
ace2 ,priming:2
spike ,priming:2
protein ,priming:2
challenges ,cares:2
challenges ,promote:2
challenges ,rational:2
challenges ,chloroquine:2
challenges ,hydroxychloroquine:2
cares ,promote:2
cares ,rational:2
cares ,use:2
cares ,chloroquine:2
cares ,hydroxychloroquine:2
promote ,rational:2
promote ,use:2
promote ,chloroquine:2
promote ,hydroxychloroquine:2
rational ,chloroquine:2
rational ,hydroxychloroquine:2
mass ,structural:2
mass ,biology:2
mass ,techniques:2
mass ,studies:2
spectrometry ,structural:2
spectrometry ,biology:2
spectrometry ,techniques:2
spectrometry ,studies:2
structural ,techniques:2
biology ,techniques:2
biology ,studies:2
techniques ,studies:2
feedback ,post:2
feedback ,covid-19:2
feedback ,rehabilitation:2
post ,rehabilitation:2
covid-19 ,pharmacokinetic:4
outbreak ,pharmacotherapy:2
outbreak ,based:2
outbreak ,pharmacokinetic:2
challenges ,pharmacotherapy:2
challenges ,based:2
challenges ,pharmacokinetic:2
pharmacotherapy ,based:2
pharmacotherapy ,pharmacokinetic:2
based ,pharmacokinetic:2
approach ,towards:2
approach ,development:2
approach ,monoclonal:2
approach ,igy:2
approach ,antibodies:2
approach ,sars:2
approach ,cov-2:2
towards ,development:4
towards ,monoclonal:2
towards ,igy:2
towards ,antibodies:2
towards ,cov-2:2
development ,monoclonal:4
development ,igy:2
development ,sars:2
development ,cov-2:2
monoclonal ,igy:2
monoclonal ,sars:2
monoclonal ,cov-2:2
igy ,antibodies:2
igy ,sars:2
igy ,cov-2:2
antibodies ,sars:2
antibodies ,cov-2:2
presentation ,critically:2
presentation ,ill:2
presentation ,patients:8
initial ,critically:2
initial ,ill:2
initial ,severe:4
management ,critically:6
management ,ill:4
sars-cov-2covid-19 ,systematic:2
sars-cov-2covid-19 ,review:2
sars-cov-2covid-19 ,requirements:2
sars-cov-2covid-19 ,personal:2
sars-cov-2covid-19 ,protective:2
systematic ,requirements:2
systematic ,personal:2
systematic ,protective:4
review ,requirements:2
review ,personal:4
review ,protective:2
requirements ,personal:2
requirements ,protective:2
triaging ,respiratory:2
triaging ,protective:2
triaging ,equipment:2
triaging ,assumed:2
triaging ,risk:2
triaging ,sars-cov-2:2
respiratory ,protective:8
respiratory ,equipment:4
respiratory ,assumed:2
protective ,assumed:2
equipment ,assumed:2
equipment ,risk:4
equipment ,sars-cov-2:2
assumed ,risk:2
assumed ,sars-cov-2:4
covid-19 ,knew:2
covid-19 ,everything:6
covid-19 ,didnt:2
covid-19 ,understand:4
knew ,everything:2
knew ,didnt:2
knew ,understand:2
knew ,anything:2
everything ,didnt:2
everything ,understand:2
everything ,anything:2
didnt ,understand:2
didnt ,anything:2
understand ,anything:2
direct ,analytical:2
direct ,limits:2
direct ,across:2
direct ,seven:2
comparison ,limits:2
comparison ,across:2
sars-cov-2 ,limits:4
analytical ,limits:2
analytical ,detection:4
analytical ,across:2
limits ,detection:2
limits ,across:2
limits ,seven:2
across ,seven:2
coronavirus ,phase:2
coronavirus ,consider:2
disease ,phase:2
disease ,trials:8
disease ,consider:2
covid-19 ,consider:4
outbreak ,phase:6
outbreak ,trials:2
outbreak ,consider:2
phase ,trials:2
phase ,consider:2
trials ,consider:2
new ,inner:2
new ,hospital:2
new ,data:2
new ,retrospective:2
york ,inner:2
york ,hospital:2
york ,current:2
york ,data:2
york ,retrospective:2
inner ,city:2
inner ,hospital:2
inner ,covid-19:2
inner ,experience:2
inner ,current:2
inner ,data:2
inner ,retrospective:2
city ,hospital:2
city ,current:2
city ,data:4
city ,retrospective:2
hospital ,current:2
hospital ,data:2
hospital ,retrospective:2
experience ,current:2
experience ,data:2
experience ,retrospective:2
current ,retrospective:2
data ,retrospective:2
immunoinformatic ,analysis:4
immunoinformatic ,sars-cov-2:6
immunoinformatic ,envelope:2
immunoinformatic ,protein:4
immunoinformatic ,strategy:2
immunoinformatic ,assess:2
analysis ,envelope:2
analysis ,strategy:2
analysis ,assess:2
sars-cov-2 ,assess:2
envelope ,strategy:2
envelope ,assess:2
protein ,strategy:2
protein ,assess:2
strategy ,assess:2
covid-19 ,neuropsychology:2
covid-19 ,neuropsychological:2
clinical ,neuropsychology:2
clinical ,neuropsychological:2
neuropsychology ,review:2
neuropsychology ,neuropsychological:2
neuropsychology ,literature:2
review ,neuropsychological:2
neuropsychological ,literature:2
fatal ,complicating:2
fatal ,report:2
aspergillosis ,severe:4
aspergillosis ,sars-cov-2:2
aspergillosis ,infection:2
aspergillosis ,case:2
aspergillosis ,report:2
complicating ,severe:4
complicating ,sars-cov-2:2
complicating ,infection:2
complicating ,case:2
complicating ,report:2
critical ,type:4
critical ,iii:2
critical ,interferon:2
critical ,controlling:2
critical ,infection:4
role ,iii:2
role ,interferon:4
role ,controlling:2
type ,controlling:2
iii ,interferon:2
iii ,controlling:2
interferon ,controlling:2
interferon ,infection:2
controlling ,human:2
clinical ,manifestation:8
manifestation ,laboratory:2
manifestation ,characteristics:2
laboratory ,infection:8
sars-cov-2 ,placenta:4
infection ,placenta:2
atypical ,clinical:2
atypical ,picture:2
atypical ,older:2
atypical ,patients:2
clinical ,picture:2
picture ,covid-19:2
picture ,older:2
picture ,patients:2
knowledge-based ,structural:2
knowledge-based ,models:2
knowledge-based ,sars-cov-2:2
knowledge-based ,proteins:2
knowledge-based ,complexes:2
structural ,models:4
structural ,complexes:2
models ,proteins:2
models ,complexes:2
sars-cov-2 ,complexes:2
proteins ,complexes:2
assessment ,efficiency:2
assessment ,latent:2
assessment ,period:2
transmission ,efficiency:2
transmission ,latent:2
transmission ,period:8
efficiency ,latent:2
efficiency ,infection:4
efficiency ,period:2
latent ,infection:2
latent ,period:2
infection ,period:4
novel ,target:6
novel ,disable:2
novel ,natural:4
novel ,killer:2
novel ,core:2
coronavirus ,disable:2
coronavirus ,natural:4
coronavirus ,killer:2
coronavirus ,core:2
sars-cov-2 ,disable:2
sars-cov-2 ,core:2
target ,disable:2
target ,natural:2
target ,killer:2
target ,cells:2
target ,core:2
disable ,natural:2
disable ,killer:2
disable ,cells:2
disable ,core:2
disable ,immune:2
natural ,cells:2
natural ,core:2
natural ,immune:2
killer ,cells:2
killer ,core:2
killer ,immune:2
cells ,core:2
cells ,immune:6
core ,immune:2
noncoding ,rnas:4
noncoding ,implication:2
noncoding ,cardiovascular:2
noncoding ,diseases:2
noncoding ,covid-19:2
noncoding ,era:2
rnas ,implication:2
rnas ,cardiovascular:2
rnas ,diseases:2
rnas ,covid-19:2
rnas ,era:2
implication ,cardiovascular:2
implication ,diseases:2
implication ,era:2
diseases ,era:8
reconsidering ,technical:2
reconsidering ,aspects:2
reconsidering ,quality:2
reconsidering ,management:2
reconsidering ,background:2
reconsidering ,faecal:2
technical ,aspects:2
technical ,quality:2
technical ,management:2
technical ,background:2
technical ,faecal:2
aspects ,quality:2
aspects ,management:2
aspects ,background:2
aspects ,faecal:2
quality ,background:2
quality ,faecal:2
management ,background:2
management ,faecal:2
background ,faecal:2
approach ,critical:2
approach ,illness:2
approach ,myopathy:2
approach ,polyneuropathy:2
approach ,older:2
critical ,polyneuropathy:2
critical ,older:4
illness ,polyneuropathy:2
illness ,older:4
myopathy ,polyneuropathy:2
myopathy ,older:2
myopathy ,sars-cov-2:4
polyneuropathy ,older:2
polyneuropathy ,sars-cov-2:2
extent ,infectious:2
extent ,sars-cov-2:2
extent ,aerosolisation:2
extent ,result:2
infectious ,aerosolisation:2
infectious ,result:2
sars-cov-2 ,aerosolisation:2
sars-cov-2 ,result:4
aerosolisation ,result:2
covid-19 ,asking:2
covid-19 ,right:6
faecal-oral ,transmission:2
faecal-oral ,asking:2
faecal-oral ,right:2
faecal-oral ,questions:2
transmission ,asking:2
transmission ,right:2
transmission ,questions:2
asking ,right:2
asking ,questions:2
right ,questions:2
coronavirus ,short:2
disease ,short:2
covid-19 ,hematological:8
short ,review:2
short ,hematological:2
short ,manifestations:2
review ,hematological:6
saliva ,source:2
saliva ,appropriate:2
saliva ,protection:2
saliva ,measures:2
potential ,source:4
potential ,appropriate:2
potential ,protection:2
source ,appropriate:2
source ,protection:2
source ,measures:2
covid-19 ,appropriate:2
appropriate ,protection:2
appropriate ,measures:2
using ,serpins:2
using ,cysteine:2
using ,cross-specificity:2
using ,possibly:2
using ,trap:2
using ,mpro:2
serpins ,cysteine:2
serpins ,protease:2
serpins ,cross-specificity:2
serpins ,possibly:2
serpins ,trap:2
serpins ,sars-cov-2:2
serpins ,mpro:2
cysteine ,protease:2
cysteine ,cross-specificity:2
cysteine ,possibly:2
cysteine ,trap:2
cysteine ,sars-cov-2:2
cysteine ,mpro:2
protease ,cross-specificity:2
protease ,possibly:2
protease ,trap:2
protease ,mpro:4
cross-specificity ,possibly:2
cross-specificity ,trap:2
cross-specificity ,sars-cov-2:2
cross-specificity ,mpro:2
possibly ,trap:2
possibly ,sars-cov-2:4
possibly ,mpro:2
trap ,sars-cov-2:2
trap ,mpro:2
sars-cov-2 ,mpro:12
need ,health:4
need ,policy:2
need ,perspective:2
need ,protect:2
need ,healthcare:2
need ,workers:2
health ,policy:6
health ,perspective:6
policy ,perspective:2
policy ,protect:2
policy ,healthcare:2
policy ,workers:2
perspective ,protect:2
perspective ,healthcare:2
perspective ,workers:4
protect ,healthcare:2
protect ,workers:2
novel ,biologic:2
novel ,psoriasis:2
novel ,successful:2
coronavirus ,biologic:2
coronavirus ,psoriasis:4
coronavirus ,successful:4
disease ,biologic:2
disease ,psoriasis:2
disease ,successful:2
biologic ,therapy:2
biologic ,psoriasis:2
biologic ,successful:2
therapy ,psoriasis:2
therapy ,successful:4
psoriasis ,successful:2
immune-modulating ,drug:2
immune-modulating ,mp1032:2
immune-modulating ,sars-cov-2:2
immune-modulating ,antiviral:2
immune-modulating ,activity:2
immune-modulating ,vitro:2
drug ,mp1032:2
mp1032 ,sars-cov-2:2
mp1032 ,antiviral:2
mp1032 ,activity:2
mp1032 ,vitro:2
serum-igg ,responses:2
serum-igg ,sars-cov-2:2
serum-igg ,mild:2
serum-igg ,severe:2
serum-igg ,covid-19:2
serum-igg ,infection:2
responses ,mild:8
clinical ,affecting:2
clinical ,duration:2
clinical ,positive:12
characteristics ,affecting:2
characteristics ,duration:2
characteristics ,nucleic:6
characteristics ,acid:2
factors ,affecting:6
factors ,duration:4
factors ,positive:4
factors ,nucleic:2
factors ,acid:2
affecting ,duration:2
affecting ,positive:2
affecting ,nucleic:2
affecting ,acid:2
duration ,positive:2
duration ,nucleic:2
duration ,acid:2
comparison ,targeting:4
comparison ,envelope:2
comparison ,gene:2
laboratory-developed ,targeting:4
laboratory-developed ,envelope:2
laboratory-developed ,gene:2
laboratory-developed ,three:2
test ,targeting:4
test ,envelope:2
test ,gene:4
test ,three:4
targeting ,envelope:2
targeting ,three:2
envelope ,gene:2
envelope ,three:2
gene ,three:2
unravelling ,host-pathogen:2
unravelling ,interactions:2
unravelling ,cerna:2
unravelling ,network:2
unravelling ,sars-cov-2:4
unravelling ,infection:2
host-pathogen ,cerna:2
host-pathogen ,network:2
host-pathogen ,sars-cov-2:2
host-pathogen ,infection:2
interactions ,cerna:2
interactions ,network:2
interactions ,infection:4
cerna ,network:2
cerna ,sars-cov-2:2
cerna ,infection:2
network ,infection:2
anticoagulant ,therapy:4
anticoagulant ,patients:4
anticoagulant ,coronavirus:2
anticoagulant ,disease:2
anticoagulant ,urgent:2
anticoagulant ,need:2
therapy ,urgent:2
patients ,urgent:2
coronavirus ,urgent:2
disease ,urgent:2
international ,responses:2
international ,outbreak:2
international ,rapid:2
international ,review:2
public ,rapid:2
health ,rapid:2
responses ,rapid:2
responses ,review:2
outbreak ,rapid:2
outbreak ,review:4
compromised ,specific:2
compromised ,humoral:2
compromised ,immune:4
compromised ,response:2
compromised ,sars-cov-2:2
specific ,humoral:4
specific ,immune:2
specific ,response:4
preparedness ,response:2
preparedness ,saudi:2
preparedness ,arabia:2
preparedness ,building:2
preparedness ,mers:2
preparedness ,experience:2
response ,saudi:2
response ,arabia:2
response ,building:2
response ,mers:2
response ,experience:2
covid-19 ,arabia:6
saudi ,building:2
saudi ,mers:2
saudi ,experience:2
arabia ,building:2
arabia ,mers:2
arabia ,experience:2
building ,mers:2
building ,experience:2
mers ,experience:2
covid-19 ,worker:4
outbreak ,protecting:2
outbreak ,worker:2
italy ,protecting:2
italy ,worker:2
italy ,health:4
italy ,response:2
italy ,italian:4
protecting ,worker:2
protecting ,health:2
protecting ,response:2
protecting ,italian:2
worker ,response:2
worker ,italian:2
health ,italian:2
response ,italian:4
cardiovascular ,pharmacology:2
cardiovascular ,time:2
cardiovascular ,focus:6
pharmacology ,time:2
pharmacology ,covid-19:4
pharmacology ,focus:2
time ,focus:2
clinical ,histopathological:2
clinical ,similarities:2
serological ,histopathological:2
serological ,similarities:2
histopathological ,severe:2
similarities ,severe:2
similarities ,covid-19:4
heart ,brake:2
heart ,unusual:2
heart ,cardiac:2
heart ,manifestation:2
brake ,unusual:2
brake ,cardiac:2
brake ,manifestation:2
brake ,covid-19:2
unusual ,cardiac:2
unusual ,manifestation:2
cardiac ,manifestation:2
potential ,algal:2
potential ,produce:2
algal ,biotechnology:2
algal ,produce:2
algal ,antiviral:2
algal ,compounds:2
biotechnology ,produce:2
biotechnology ,antiviral:2
biotechnology ,compounds:2
produce ,antiviral:2
produce ,compounds:2
environmental ,hospital:2
contamination ,designated:2
contamination ,coronavirus:4
designated ,coronavirus:2
spread ,northern:2
spread ,italy:4
spread ,pollution:6
spread ,role:12
northern ,pollution:2
northern ,role:2
italy ,pollution:4
italy ,role:6
pollution ,role:8
comparison ,bacterial:2
comparison ,sepsis:2
clinical ,sepsis:2
laboratory ,bacterial:2
laboratory ,sepsis:2
tests ,bacterial:2
tests ,sepsis:2
bacterial ,sepsis:2
falling ,dynamics:2
falling ,sars-cov-2:2
falling ,function:2
falling ,respiratory:2
falling ,droplet:2
falling ,size:2
falling ,human:2
dynamics ,function:2
dynamics ,respiratory:2
dynamics ,droplet:2
dynamics ,size:2
dynamics ,human:4
sars-cov-2 ,size:2
function ,respiratory:2
function ,droplet:2
function ,size:2
function ,human:2
respiratory ,droplet:2
respiratory ,size:2
droplet ,size:2
droplet ,human:2
size ,human:2
assessment ,flight:2
assessment ,among:4
assessment ,tourist:2
sars-cov-2 ,tourist:2
transmission ,international:2
transmission ,tourist:2
international ,flight:2
international ,among:2
international ,tourist:2
flight ,among:2
flight ,tourist:2
among ,tourist:2
stress-induced ,cardiomyopathy:2
stress-induced ,precipitated:2
stress-induced ,covid-19:2
stress-induced ,influenza:2
stress-induced ,coinfection:2
cardiomyopathy ,precipitated:2
cardiomyopathy ,covid-19:2
cardiomyopathy ,influenza:2
cardiomyopathy ,coinfection:2
precipitated ,covid-19:2
precipitated ,influenza:2
precipitated ,coinfection:2
influenza ,coinfection:6
assessment ,serological:2
assessment ,tests:2
assessment ,diagnosis:2
tests ,diagnosis:4
changes ,positivity:2
changes ,rate:2
changes ,outpatients:2
changes ,seattle:2
changes ,washington:2
sars-cov-2 ,seattle:2
positivity ,outpatients:2
positivity ,seattle:2
positivity ,washington:2
rate ,outpatients:2
rate ,seattle:2
rate ,washington:2
outpatients ,seattle:2
outpatients ,washington:2
seattle ,washington:2
unlikely ,sars-cov-2:2
unlikely ,vertical:2
unlikely ,transmission:2
unlikely ,mother:2
unlikely ,child:2
unlikely ,case:2
unlikely ,report:2
vertical ,mother:4
vertical ,child:2
antimalarial ,artemisinin-based:2
antimalarial ,combination:2
antimalarial ,therapies:2
antimalarial ,act:2
antimalarial ,africa:2
artemisinin-based ,combination:2
artemisinin-based ,therapies:2
artemisinin-based ,act:2
artemisinin-based ,covid-19:2
artemisinin-based ,africa:2
combination ,therapies:2
combination ,act:2
combination ,africa:2
therapies ,act:2
therapies ,africa:2
act ,covid-19:4
act ,africa:2
effects ,surgery:2
effects ,italy:4
effects ,experience:2
pandemic ,italy:8
pandemic ,experience:8
otolaryngology ,surgery:4
otolaryngology ,italy:4
otolaryngology ,experience:2
surgery ,italy:4
italy ,experience:2
high ,intensities:2
high ,population:2
high ,movement:2
intensities ,population:2
intensities ,movement:2
intensities ,associated:2
intensities ,incidence:2
population ,associated:4
population ,incidence:2
movement ,associated:2
movement ,incidence:2
associated ,incidence:6
asymptomatic ,seroconversion:2
asymptomatic ,immunoglobulins:2
asymptomatic ,pediatric:2
asymptomatic ,dialysis:2
seroconversion ,immunoglobulins:2
seroconversion ,pediatric:4
seroconversion ,dialysis:2
immunoglobulins ,sars-cov-2:2
immunoglobulins ,pediatric:2
immunoglobulins ,dialysis:2
sars-cov-2 ,dialysis:4
pediatric ,dialysis:2
conceptual ,understanding:2
conceptual ,rapid:2
conceptual ,covid-19-related:2
conceptual ,increase:2
conceptual ,food:2
model ,understanding:2
model ,rapid:6
model ,covid-19-related:2
model ,increase:2
model ,food:2
understanding ,rapid:2
understanding ,covid-19-related:2
understanding ,increase:2
understanding ,food:2
rapid ,covid-19-related:2
rapid ,increase:2
rapid ,food:2
covid-19-related ,increase:2
covid-19-related ,food:2
increase ,food:2
evaluation ,positive:4
evaluation ,pediatric:2
evaluation ,emergency:2
evaluation ,department:2
pcr ,cases:2
pcr ,pediatric:2
pcr ,emergency:2
pcr ,department:2
positive ,emergency:2
positive ,department:2
cases ,pediatric:6
cases ,emergency:2
cases ,department:2
evaluation ,qiastat-dx:2
evaluation ,panel:6
qiastat-dx ,respiratory:2
qiastat-dx ,sars-cov-2:2
qiastat-dx ,panel:2
qiastat-dx ,first:2
qiastat-dx ,rapid:2
qiastat-dx ,multiplex:2
respiratory ,panel:4
panel ,first:2
panel ,rapid:2
panel ,multiplex:2
first ,rapid:2
first ,multiplex:2
rapid ,multiplex:2
airborne ,route:4
airborne ,bad:2
airborne ,use:2
airborne ,ventilation:2
airborne ,systems:4
airborne ,non-negligible:2
airborne ,factors:2
route ,bad:2
route ,use:2
route ,ventilation:2
route ,systems:2
route ,non-negligible:2
route ,factors:2
bad ,use:2
bad ,ventilation:2
bad ,systems:2
bad ,non-negligible:2
bad ,factors:2
use ,ventilation:2
use ,systems:2
use ,non-negligible:2
use ,factors:2
ventilation ,systems:4
ventilation ,non-negligible:2
ventilation ,factors:4
systems ,non-negligible:2
systems ,factors:2
non-negligible ,factors:2
haematological ,cancers:2
haematological ,risk:2
haematological ,severe:2
haematological ,covid-19:2
haematological ,exploration:2
haematological ,critical:2
cancers ,risk:2
cancers ,severe:2
cancers ,covid-19:2
cancers ,exploration:2
cancers ,critical:2
risk ,exploration:2
severe ,exploration:2
covid-19 ,exploration:4
exploration ,critical:2
association ,number:2
association ,in-person:2
association ,health:2
association ,care:4
association ,visits:2
association ,infection:8
number ,in-person:2
number ,health:2
number ,care:2
number ,visits:2
number ,sars-cov-2:6
number ,infection:2
in-person ,health:2
in-person ,care:2
in-person ,visits:2
in-person ,sars-cov-2:2
in-person ,infection:2
health ,visits:4
care ,visits:2
visits ,sars-cov-2:2
visits ,infection:2
nosocomial ,large:4
nosocomial ,acute:4
nosocomial ,nhs:2
nosocomial ,trust:2
nosocomial ,south-west:2
nosocomial ,london:2
covid-19 ,trust:2
covid-19 ,south-west:2
covid-19 ,london:2
experience ,large:2
experience ,acute:2
experience ,trust:2
experience ,south-west:2
experience ,london:2
large ,acute:2
large ,trust:2
large ,south-west:2
large ,london:2
acute ,nhs:2
acute ,trust:2
acute ,south-west:2
acute ,london:2
nhs ,trust:2
nhs ,south-west:2
nhs ,london:2
trust ,south-west:2
trust ,london:2
south-west ,london:2
performance ,verification:2
performance ,anti-sars-cov-2-specific:2
performance ,antibody:8
verification ,anti-sars-cov-2-specific:2
verification ,antibody:2
verification ,detection:2
verification ,using:2
anti-sars-cov-2-specific ,antibody:2
anti-sars-cov-2-specific ,detection:2
anti-sars-cov-2-specific ,using:2
bcg ,early:2
bcg ,life:4
bcg ,improve:2
bcg ,outcome:2
bcg ,elderly:2
vaccination ,early:2
vaccination ,life:6
vaccination ,improve:2
vaccination ,outcome:2
vaccination ,elderly:2
early ,improve:2
early ,outcome:2
early ,elderly:2
life ,improve:2
life ,outcome:2
life ,elderly:2
improve ,covid-19:6
improve ,outcome:2
improve ,elderly:2
outcome ,elderly:2
unknown ,sars-cov-2:2
unknown ,pneumonia:2
unknown ,detected:2
unknown ,petct:2
unknown ,patients:2
unknown ,cancer:2
sars-cov-2 ,petct:4
pneumonia ,detected:2
pneumonia ,petct:6
pneumonia ,cancer:2
detected ,petct:4
detected ,cancer:2
petct ,patients:6
petct ,cancer:2
air ,caused:2
air ,multi-center:2
environmental ,caused:2
environmental ,multi-center:2
contamination ,caused:2
contamination ,patients:4
contamination ,multi-center:2
caused ,multi-center:2
covid-19 ,multi-center:2
patients ,multi-center:2
evaluating ,association:2
evaluating ,clinical:2
evaluating ,characteristics:2
evaluating ,neutralizing:2
evaluating ,antibody:2
association ,characteristics:4
association ,neutralizing:2
association ,antibody:2
clinical ,neutralizing:2
characteristics ,neutralizing:2
magnetic ,beads:4
magnetic ,combined:2
magnetic ,carbon:2
magnetic ,black-based:2
magnetic ,screen-printed:2
magnetic ,electrodes:2
beads ,combined:2
beads ,carbon:2
beads ,black-based:2
beads ,screen-printed:2
beads ,electrodes:2
combined ,carbon:2
combined ,black-based:2
combined ,screen-printed:2
combined ,electrodes:2
carbon ,black-based:2
carbon ,screen-printed:2
carbon ,electrodes:2
black-based ,screen-printed:2
black-based ,electrodes:2
screen-printed ,electrodes:2
racial ,andor:2
racial ,ethnic:4
racial ,socioeconomic:2
racial ,disparities:6
racial ,sars-cov-2:6
racial ,infection:2
racial ,among:2
andor ,ethnic:2
andor ,socioeconomic:2
andor ,disparities:2
andor ,among:2
ethnic ,socioeconomic:4
ethnic ,disparities:4
ethnic ,sars-cov-2:6
ethnic ,infection:4
ethnic ,among:2
socioeconomic ,disparities:2
socioeconomic ,sars-cov-2:6
socioeconomic ,infection:4
socioeconomic ,among:2
disparities ,infection:2
disparities ,among:2
observations ,global:2
observations ,epidemiology:2
observations ,covid-19:2
observations ,prepandemic:2
observations ,period:2
global ,epidemiology:2
global ,prepandemic:2
global ,period:2
epidemiology ,prepandemic:2
covid-19 ,prepandemic:2
prepandemic ,period:4
different ,types:8
different ,specimens:2
types ,clinical:6
types ,specimens:4
progress ,possible:2
progress ,effects:2
progress ,bcg:2
progress ,prevention:2
possible ,effects:4
possible ,bcg:2
effects ,bcg:2
effects ,vaccine:2
bcg ,prevention:2
vaccine ,prevention:2
covid-19 ,underappreciated:2
covid-19 ,hazard:2
ophthalmology ,underappreciated:2
ophthalmology ,occupational:2
ophthalmology ,hazard:2
underappreciated ,occupational:2
underappreciated ,hazard:2
occupational ,hazard:2
covid-19 ,-a:2
diagnosis ,-a:2
-a ,review:2
-a ,current:2
-a ,methods:2
enzyme-based ,immunodetection:2
enzyme-based ,assay:2
enzyme-based ,quantify:2
enzyme-based ,sars-cov-2:2
enzyme-based ,infection:2
immunodetection ,assay:2
immunodetection ,quantify:2
immunodetection ,sars-cov-2:2
immunodetection ,infection:2
assay ,quantify:2
assay ,infection:2
quantify ,sars-cov-2:2
quantify ,infection:2
daily ,kinetics:2
daily ,innate:2
daily ,adaptive:2
daily ,immune:2
daily ,response:2
daily ,assessment:2
viral ,innate:4
viral ,adaptive:2
viral ,response:6
kinetics ,innate:2
kinetics ,adaptive:2
kinetics ,immune:2
kinetics ,response:4
kinetics ,assessment:2
innate ,adaptive:4
innate ,assessment:2
adaptive ,immune:6
adaptive ,response:2
adaptive ,assessment:2
adaptive ,covid-19:4
immune ,assessment:2
response ,assessment:2
appropriate ,use:2
appropriate ,laparoscopy:2
appropriate ,open:2
appropriate ,procedures:2
appropriate ,current:2
use ,laparoscopy:2
use ,open:2
use ,procedures:2
use ,current:4
laparoscopy ,open:2
laparoscopy ,procedures:2
laparoscopy ,current:2
open ,procedures:2
open ,current:2
procedures ,current:2
sars-cov-2 ,immunology:6
virology ,immunology:2
virology ,vaccine:2
virology ,development:2
epidemiology ,immunology:2
epidemiology ,vaccine:2
epidemiology ,development:2
immunology ,vaccine:2
immunology ,development:2
escalating ,infection:2
escalating ,control:2
escalating ,response:2
escalating ,rapidly:2
escalating ,evolving:2
escalating ,epidemiology:2
infection ,rapidly:2
infection ,evolving:2
control ,response:2
control ,rapidly:2
control ,evolving:2
response ,rapidly:2
response ,epidemiology:2
rapidly ,evolving:4
rapidly ,epidemiology:2
evolving ,epidemiology:2
universal ,children:2
universal ,undergoing:2
universal ,orthopaedic:2
universal ,surgery:2
screening ,undergoing:2
screening ,orthopaedic:2
covid-19 ,undergoing:14
children ,undergoing:2
children ,orthopaedic:2
children ,surgery:2
undergoing ,orthopaedic:2
undergoing ,surgery:2
orthopaedic ,surgery:6
cardiac ,surgery:6
cardiac ,pandemic:4
cardiac ,perioperative:2
surgery ,coronavirus:6
surgery ,disease:6
surgery ,perioperative:2
pandemic ,perioperative:2
epidemiology ,risk:2
epidemiology ,factors:2
epidemiology ,health:2
epidemiology ,care:2
epidemiology ,workers:2
network ,pharmacology:2
network ,docking:2
network ,targets:2
pharmacology ,molecular:4
pharmacology ,docking:2
pharmacology ,analysis:4
pharmacology ,targets:2
docking ,targets:2
analysis ,targets:2
subcutaneous ,insulin:2
subcutaneous ,administration:2
subcutaneous ,adequate:2
subcutaneous ,management:2
subcutaneous ,hyperglycemic:2
insulin ,administration:2
insulin ,adequate:2
insulin ,management:2
insulin ,hyperglycemic:2
administration ,adequate:2
administration ,management:2
administration ,hyperglycemic:2
adequate ,management:2
adequate ,hyperglycemic:2
management ,hyperglycemic:2
mask ,crisis:2
mask ,outbreak:2
crisis ,outbreak:4
prevalence ,surface:2
prevalence ,contamination:2
prevalence ,radiation:2
prevalence ,oncology:2
prevalence ,clinic:4
surface ,radiation:2
surface ,oncology:2
surface ,clinic:2
contamination ,radiation:2
contamination ,oncology:2
contamination ,clinic:2
sars-cov-2 ,radiation:2
sars-cov-2 ,clinic:6
radiation ,clinic:2
oncology ,clinic:2
toward ,comprehensive:2
toward ,understanding:2
comprehensive ,understanding:4
susceptibility ,tree:2
susceptibility ,shrew:2
tree ,shrew:2
tree ,sars-cov-2:4
tree ,infection:2
shrew ,sars-cov-2:2
shrew ,infection:2
first ,confirmed:4
first ,australia:2
confirmed ,untreated:2
confirmed ,wastewater:2
confirmed ,australia:2
detection ,australia:2
sars-cov-2 ,australia:2
untreated ,wastewater:4
untreated ,australia:2
wastewater ,australia:2
covidiagnosis-net ,deep:2
covidiagnosis-net ,bayes-squeezenet:2
covidiagnosis-net ,based:2
covidiagnosis-net ,diagnosis:2
covidiagnosis-net ,coronavirus:2
covidiagnosis-net ,disease:2
deep ,bayes-squeezenet:2
deep ,based:4
deep ,diagnosis:2
deep ,disease:2
bayes-squeezenet ,based:2
bayes-squeezenet ,diagnosis:2
bayes-squeezenet ,coronavirus:2
bayes-squeezenet ,disease:2
beach ,tourism:2
beach ,times:2
beach ,covid-19:2
beach ,pandemic:2
beach ,critical:2
beach ,issues:2
beach ,knowledge:2
beach ,gaps:2
tourism ,times:2
tourism ,covid-19:2
tourism ,pandemic:2
tourism ,critical:2
tourism ,issues:2
tourism ,knowledge:2
tourism ,gaps:2
times ,critical:2
times ,issues:2
times ,knowledge:2
times ,gaps:2
covid-19 ,gaps:8
pandemic ,issues:8
critical ,issues:4
critical ,knowledge:2
critical ,gaps:2
issues ,knowledge:2
issues ,gaps:2
battling ,covid-19:4
battling ,pandemic:2
battling ,sphingosine-1-phosphate:2
battling ,analogs:2
battling ,adjunctive:2
covid-19 ,sphingosine-1-phosphate:2
covid-19 ,analogs:2
covid-19 ,adjunctive:4
pandemic ,sphingosine-1-phosphate:2
pandemic ,analogs:2
pandemic ,adjunctive:2
sphingosine-1-phosphate ,analogs:2
sphingosine-1-phosphate ,adjunctive:2
analogs ,adjunctive:2
transmission ,infections:4
transmission ,households:2
transmission ,tennessee:2
transmission ,wisconsin:2
sars-cov-2 ,households:4
sars-cov-2 ,tennessee:2
sars-cov-2 ,wisconsin:2
infections ,households:2
infections ,tennessee:2
infections ,wisconsin:2
households ,tennessee:2
households ,wisconsin:2
tennessee ,wisconsin:2
presepsin ,risk:2
presepsin ,stratification:2
presepsin ,sars-cov-2:2
presepsin ,patients:2
stratification ,sars-cov-2:2
stratification ,patients:2
bio-mission ,interleukin-6:2
bio-mission ,pathogenesis:2
bio-mission ,covid-19:2
bio-mission ,brief:2
bio-mission ,look:2
interleukin-6 ,pathogenesis:4
interleukin-6 ,brief:2
interleukin-6 ,look:2
pathogenesis ,brief:2
pathogenesis ,look:2
brief ,look:2
association ,high:4
association ,ace2:2
association ,adipose:2
association ,tissue:2
high ,gene:2
high ,adipose:2
high ,tissue:2
level ,gene:2
level ,expression:4
level ,ace2:4
level ,adipose:2
level ,tissue:2
level ,mortality:2
gene ,adipose:2
gene ,tissue:2
expression ,adipose:2
expression ,tissue:2
expression ,mortality:4
ace2 ,adipose:2
ace2 ,tissue:2
ace2 ,mortality:4
adipose ,mortality:2
tissue ,mortality:2
impact ,utilisation:2
impact ,emergency:8
coronavirus ,utilisation:2
disease ,utilisation:2
disease ,emergency:2
pandemic ,utilisation:2
utilisation ,emergency:2
diving ,sars-cov-2:2
diving ,covid-19:2
diving ,infection:2
diving ,fitness:2
diving ,dive:2
diving ,assessment:2
diving ,medical:2
sars-cov-2 ,fitness:2
sars-cov-2 ,dive:2
covid-19 ,fitness:2
infection ,fitness:2
infection ,dive:2
infection ,medical:2
fitness ,dive:2
fitness ,assessment:2
fitness ,medical:2
dive ,assessment:2
dive ,medical:2
assessment ,medical:2
covid-19 ,immunologist:2
perspective ,immunologist:2
analysis ,ifn:2
analysis ,response:4
analysis ,cell:4
analysis ,activation:2
analysis ,covid-19hiv-1:2
type ,ifn:2
type ,cell:2
type ,activation:4
type ,severe:2
type ,covid-19hiv-1:2
ifn ,response:2
ifn ,cell:2
ifn ,activation:2
ifn ,severe:2
ifn ,covid-19hiv-1:2
response ,cell:4
response ,activation:2
response ,covid-19hiv-1:2
cell ,covid-19hiv-1:2
activation ,severe:4
activation ,covid-19hiv-1:2
severe ,covid-19hiv-1:2
intensive ,2019-coronavirus:2
care ,2019-coronavirus:2
2019-coronavirus ,epidemic:2
comparative ,study:6
comparative ,features:4
comparative ,viral:2
study ,laboratory:2
laboratory ,features:6
laboratory ,viral:2
palindromic ,rna:2
palindromic ,sequence:2
palindromic ,common:2
palindromic ,breakpoint:2
palindromic ,contributor:2
palindromic ,copy-choice:2
rna ,sequence:2
rna ,common:2
rna ,breakpoint:2
rna ,contributor:2
rna ,copy-choice:2
sequence ,common:2
sequence ,breakpoint:2
sequence ,contributor:2
sequence ,copy-choice:2
common ,breakpoint:2
common ,contributor:2
common ,copy-choice:2
breakpoint ,contributor:2
breakpoint ,copy-choice:2
contributor ,copy-choice:2
incidence ,virus:4
incidence ,transmission:2
incidence ,three:2
incidence ,dental:2
incidence ,offices:2
incidence ,6-month:2
covid-19 ,offices:2
covid-19 ,6-month:2
virus ,three:2
virus ,dental:4
virus ,offices:2
virus ,6-month:2
transmission ,three:2
transmission ,offices:2
transmission ,6-month:2
three ,dental:2
three ,offices:2
three ,6-month:2
dental ,offices:2
dental ,6-month:2
offices ,6-month:2
impact ,microbiota:2
impact ,paradigm:2
impact ,evolving:2
impact ,herd:2
impact ,immunity:4
microbiota ,paradigm:2
microbiota ,evolving:2
microbiota ,herd:2
microbiota ,immunity:2
microbiota ,viral:2
microbiota ,diseases:2
paradigm ,evolving:2
paradigm ,herd:2
paradigm ,immunity:2
paradigm ,viral:2
evolving ,herd:2
evolving ,immunity:2
evolving ,viral:2
evolving ,diseases:2
herd ,viral:2
herd ,diseases:2
immunity ,viral:2
immunity ,diseases:2
emerging ,role:2
emerging ,il-6:2
emerging ,nlrp3:2
emerging ,inflammasome:2
emerging ,targets:2
role ,il-6:4
role ,nlrp3:4
role ,inflammasome:4
role ,targets:2
il-6 ,nlrp3:2
il-6 ,inflammasome:2
il-6 ,potential:2
il-6 ,therapeutic:2
il-6 ,targets:2
nlrp3 ,inflammasome:10
nlrp3 ,potential:2
nlrp3 ,therapeutic:2
nlrp3 ,targets:2
inflammasome ,potential:2
inflammasome ,therapeutic:2
inflammasome ,targets:2
factors ,impact:4
factors ,lopinavirritonavir:2
associated ,lopinavirritonavir:2
prolonged ,impact:2
prolonged ,lopinavirritonavir:2
viral ,lopinavirritonavir:2
shedding ,impact:2
shedding ,lopinavirritonavir:4
impact ,lopinavirritonavir:2
novel ,ophthalmologists:4
disease ,ophthalmologists:2
ophthalmologists ,perspectives:2
covid-19 ,androgen-targeted:2
androgen-targeted ,therapy:2
androgen-targeted ,prostate:2
androgen-targeted ,cancer:2
androgen-targeted ,patients:2
therapy ,prostate:2
therapy ,cancer:4
acute ,multivessel:2
acute ,coronary:8
acute ,occlusion:2
acute ,revealing:2
acute ,young:4
acute ,adult:6
multivessel ,coronary:2
multivessel ,occlusion:2
multivessel ,revealing:2
multivessel ,covid-19:2
multivessel ,young:2
multivessel ,adult:2
coronary ,occlusion:2
coronary ,revealing:2
coronary ,covid-19:8
coronary ,young:2
coronary ,adult:2
occlusion ,revealing:2
occlusion ,young:2
occlusion ,adult:2
revealing ,young:2
revealing ,adult:2
sars-cov-2 ,scenarios:2
epidemiology ,different:2
epidemiology ,scenarios:2
epidemiology ,turkey:2
control ,different:2
control ,scenarios:2
control ,turkey:2
different ,scenarios:2
different ,turkey:2
scenarios ,turkey:2
site-specific ,glycan:2
site-specific ,analysis:2
site-specific ,sars-cov-2:2
site-specific ,spike:2
seroprevalence ,specific:2
seroprevalence ,district:2
seroprevalence ,srinagar:2
seroprevalence ,northern:2
sars-cov-2 ,srinagar:2
specific ,antibodies:6
specific ,district:2
specific ,srinagar:2
specific ,northern:2
igg ,antibodies:12
igg ,district:2
igg ,srinagar:2
igg ,northern:2
antibodies ,district:2
antibodies ,srinagar:2
antibodies ,northern:2
district ,srinagar:2
district ,northern:2
srinagar ,northern:2
core ,elements:2
core ,national:2
core ,covid-19:4
core ,strategy:2
core ,lessons:2
core ,learned:2
core ,us:2
elements ,national:2
elements ,covid-19:2
elements ,strategy:2
elements ,lessons:2
elements ,learned:2
elements ,us:2
national ,strategy:2
national ,lessons:2
national ,learned:2
national ,us:2
strategy ,lessons:2
strategy ,learned:2
strategy ,us:2
lessons ,us:2
learned ,us:2
identifying ,repurposing:4
identifying ,antiviral:2
identifying ,drugs:2
repurposing ,severe:2
repurposing ,acute:2
repurposing ,respiratory:2
antiviral ,severe:2
antiviral ,acute:2
antiviral ,respiratory:2
drugs ,severe:4
drugs ,acute:4
drugs ,respiratory:4
sars-cov-2 ,danish:2
transmission ,genetic:2
transmission ,data:2
transmission ,danish:2
routes ,genetic:2
routes ,data:2
routes ,danish:2
routes ,case:2
routes ,study:2
genetic ,data:2
genetic ,danish:2
genetic ,case:2
genetic ,study:2
data ,danish:2
data ,study:2
danish ,case:2
danish ,study:2
in-silico ,homology:2
in-silico ,assisted:2
in-silico ,identification:2
in-silico ,inhibitor:4
in-silico ,rna:2
in-silico ,binding:2
homology ,assisted:2
homology ,identification:2
homology ,inhibitor:2
homology ,rna:2
homology ,binding:2
assisted ,identification:2
assisted ,inhibitor:2
assisted ,rna:2
assisted ,binding:2
identification ,binding:2
inhibitor ,rna:2
inhibitor ,binding:2
adaptation ,russian:2
adaptation ,population:2
adaptation ,sars-cov-2:4
adaptation ,asymptomatic:2
adaptation ,course:2
russian ,population:2
russian ,sars-cov-2:2
russian ,asymptomatic:2
russian ,course:2
population ,asymptomatic:4
population ,course:2
persistent ,smell:2
persistent ,loss:2
persistent ,following:2
persistent ,undetectable:2
smell ,following:2
smell ,undetectable:2
loss ,following:2
loss ,undetectable:2
following ,undetectable:2
many ,small:2
many ,steps:2
many ,towards:2
many ,drug:2
small ,steps:2
small ,towards:2
small ,drug:2
steps ,towards:2
steps ,drug:2
towards ,covid-19:8
repeated ,leftover:2
repeated ,serosurvey:2
repeated ,sars-cov-2:6
repeated ,igg:2
repeated ,antibodies:4
repeated ,greece:2
repeated ,march:2
repeated ,april:2
leftover ,serosurvey:2
leftover ,sars-cov-2:2
leftover ,igg:2
leftover ,antibodies:2
leftover ,greece:2
leftover ,march:2
leftover ,april:2
serosurvey ,igg:2
serosurvey ,antibodies:2
serosurvey ,greece:2
serosurvey ,march:2
serosurvey ,april:2
igg ,greece:2
igg ,march:2
igg ,april:2
antibodies ,greece:2
antibodies ,march:2
antibodies ,april:2
greece ,march:2
greece ,april:2
march ,april:2
current ,gaps:2
understanding ,knowledge:2
understanding ,future:2
knowledge ,perspective:2
knowledge ,future:2
gaps ,perspective:2
gaps ,future:2
perspective ,future:2
dexamethasone ,covid-19:2
dexamethasone ,fast:2
severe ,epidemic:2
acute ,epidemic:2
respiratory ,epidemic:2
syndrome ,epidemic:2
iteratively ,pruned:2
iteratively ,deep:2
iteratively ,learning:2
iteratively ,ensembles:2
iteratively ,covid-19:2
iteratively ,detection:2
iteratively ,chest:2
iteratively ,x-rays:2
pruned ,deep:2
pruned ,learning:2
pruned ,ensembles:2
pruned ,covid-19:2
pruned ,detection:2
pruned ,chest:2
pruned ,x-rays:2
deep ,ensembles:2
deep ,chest:2
deep ,x-rays:2
learning ,ensembles:2
learning ,chest:2
learning ,x-rays:2
ensembles ,covid-19:2
ensembles ,detection:2
ensembles ,chest:2
ensembles ,x-rays:2
covid-19 ,x-rays:4
detection ,chest:2
detection ,x-rays:2
chest ,x-rays:4
development ,immunoassay:6
lateral ,immunoassay:6
lateral ,igg:2
flow ,immunoassay:6
flow ,igg:2
immunoassay ,strip:2
immunoassay ,rapid:4
immunoassay ,detection:2
immunoassay ,antibody:2
strip ,igg:2
strip ,antibody:2
rapid ,antibody:8
evaluation ,chemical:2
evaluation ,protocols:2
evaluation ,inactivating:2
evaluation ,infectious:2
chemical ,protocols:2
chemical ,inactivating:2
chemical ,sars-cov-2:2
chemical ,infectious:2
chemical ,samples:2
protocols ,inactivating:2
protocols ,samples:4
inactivating ,sars-cov-2:4
inactivating ,infectious:2
inactivating ,samples:2
infectious ,samples:2
rhinologic ,procedures:2
rhinologic ,era:2
rhinologic ,health-care:2
rhinologic ,provider:2
rhinologic ,protection:2
procedures ,era:2
procedures ,health-care:2
procedures ,provider:2
procedures ,protection:2
era ,health-care:2
era ,provider:2
era ,protection:2
covid-19 ,provider:2
health-care ,provider:2
health-care ,protection:2
provider ,protection:2
possible ,deferral:2
possible ,diagnostic:2
possible ,procedures:2
deferral ,diagnostic:2
deferral ,therapeutic:2
deferral ,procedures:2
deferral ,patients:2
diagnostic ,procedures:2
therapeutic ,procedures:2
liver ,symptoms:2
injury ,gastrointestinal:4
injury ,symptoms:2
secondary ,hlh:2
secondary ,uncommon:2
hlh ,uncommon:2
hlh ,severe:2
hlh ,covid-19:2
uncommon ,severe:2
uncommon ,covid-19:4
tobacco ,nicotine:2
tobacco ,flavor-less:2
tobacco ,electronic:2
tobacco ,cigarettes:2
tobacco ,induces:2
tobacco ,ace2:2
nicotine ,flavor-less:2
nicotine ,electronic:2
nicotine ,cigarettes:2
nicotine ,induces:2
nicotine ,ace2:2
flavor-less ,electronic:2
flavor-less ,cigarettes:2
flavor-less ,induces:2
flavor-less ,ace2:2
electronic ,cigarettes:2
electronic ,induces:2
electronic ,ace2:2
cigarettes ,induces:2
cigarettes ,ace2:2
induces ,ace2:2
unexpected ,sars-cov-2:4
unexpected ,cardiorespiratory:2
unexpected ,arrest:2
unexpected ,myopathy:2
unexpected ,patient:6
unexpected ,undergoing:2
sars-cov-2 ,cardiorespiratory:2
sars-cov-2 ,arrest:2
sars-cov-2 ,undergoing:8
cardiorespiratory ,arrest:2
cardiorespiratory ,myopathy:2
cardiorespiratory ,patient:2
cardiorespiratory ,undergoing:2
arrest ,myopathy:2
arrest ,patient:2
arrest ,undergoing:2
myopathy ,patient:2
myopathy ,undergoing:2
patient ,undergoing:6
igg ,targeting:2
igg ,nucleocapsid:2
igg ,spike:2
igg ,protein:2
igg ,four:2
targeting ,nucleocapsid:2
targeting ,four:2
nucleocapsid ,four:2
spike ,four:2
protein ,four:2
coronavirus ,affected:2
coronavirus ,protracted:2
coronavirus ,conflict:2
health ,systems:4
health ,affected:4
health ,protracted:2
health ,conflict:2
health ,case:6
systems ,affected:2
systems ,protracted:2
systems ,conflict:2
systems ,case:2
affected ,protracted:2
affected ,conflict:2
affected ,case:2
protracted ,conflict:2
protracted ,case:2
conflict ,case:2
vaccine ,infections:2
vaccine ,stand:2
candidates ,infections:2
candidates ,stand:2
coronavirus ,stand:2
infections ,stand:2
covid-19 ,stand:4
lopinavirritonavir ,shorten:2
lopinavirritonavir ,duration:2
lopinavirritonavir ,sars:2
lopinavirritonavir ,cov-2:2
lopinavirritonavir ,patients:4
shorten ,duration:2
shorten ,sars:2
shorten ,cov-2:2
shorten ,patients:2
duration ,sars:2
duration ,cov-2:2
sars ,shedding:2
sars ,patients:6
cov-2 ,shedding:2
cov-2 ,patients:4
liver ,times:2
liver ,hepatologists:2
times ,hepatologists:2
times ,know:2
covid-19 ,hepatologists:2
hepatologists ,know:2
clinical ,clusters:2
clinical ,beijing:2
epidemiological ,clusters:4
epidemiological ,beijing:2
features ,clusters:2
features ,beijing:2
covid-19 ,clusters:12
family ,clusters:2
family ,beijing:2
family ,china:4
clusters ,beijing:2
clusters ,china:4
beijing ,china:2
recent ,approaches:2
recent ,pathways:2
advances ,pathways:2
approaches ,targeting:2
approaches ,pathways:2
challenges ,targeting:2
challenges ,pathways:2
covid-19 ,make:4
covid-19 ,between-country:2
covid-19 ,comparisons:2
make ,between-country:2
make ,comparisons:2
between-country ,comparisons:2
cell-based ,elisa:2
cell-based ,improve:2
cell-based ,serological:2
cell-based ,analysis:2
cell-based ,anti-sars-cov-2:2
cell-based ,igg:2
elisa ,improve:2
elisa ,serological:4
elisa ,analysis:2
improve ,serological:2
improve ,analysis:2
improve ,anti-sars-cov-2:2
improve ,igg:2
serological ,anti-sars-cov-2:2
serological ,igg:2
analysis ,anti-sars-cov-2:4
acute ,preterm:2
respiratory ,preterm:2
distress ,preterm:2
distress ,pregnant:2
distress ,patient:2
syndrome ,preterm:4
preterm ,patient:2
pregnant ,patient:4
sars-cov-2 ,strategically:2
sars-cov-2 ,mimics:2
sars-cov-2 ,proteolytic:4
sars-cov-2 ,enac:2
strategically ,mimics:2
strategically ,proteolytic:2
strategically ,activation:2
strategically ,human:2
strategically ,enac:2
mimics ,proteolytic:2
mimics ,activation:2
mimics ,human:2
mimics ,enac:2
proteolytic ,activation:2
proteolytic ,human:2
proteolytic ,enac:2
activation ,human:4
activation ,enac:2
human ,enac:2
use ,sars-cov-2-infected:2
use ,deceased:2
use ,organ:2
use ,donors:2
use ,always:2
use ,just:2
use ,say:2
sars-cov-2-infected ,deceased:2
sars-cov-2-infected ,organ:2
sars-cov-2-infected ,donors:2
sars-cov-2-infected ,always:2
sars-cov-2-infected ,just:2
sars-cov-2-infected ,say:2
deceased ,organ:2
deceased ,donors:4
deceased ,always:2
deceased ,just:2
deceased ,say:2
organ ,always:2
organ ,just:2
organ ,say:2
donors ,always:2
donors ,just:2
donors ,say:2
always ,just:2
always ,say:2
just ,say:2
dynamic ,changes:6
dynamic ,throat:2
dynamic ,swabs:2
changes ,throat:2
changes ,swabs:2
changes ,rna:2
changes ,serum:4
changes ,antibodies:4
throat ,rna:2
throat ,serum:2
throat ,antibodies:2
swabs ,serum:2
swabs ,antibodies:2
neurological ,sars:4
neurological ,mers:4
manifestations ,sars:2
manifestations ,mers:2
modeling ,sicily:2
modeling ,italy:4
novel ,sicily:2
novel ,italy:2
coronavirus ,sicily:2
coronavirus ,italy:6
sars-cov-2 ,sicily:2
outbreak ,sicily:2
sicily ,italy:2
increased ,use:2
increased ,blood:2
increased ,transfusions:2
increased ,manage:2
increased ,urological:2
increased ,conditions:2
use ,blood:2
use ,transfusions:2
use ,manage:2
use ,urological:2
use ,conditions:2
blood ,transfusions:2
blood ,manage:2
blood ,urological:2
blood ,conditions:2
transfusions ,manage:2
transfusions ,urological:2
transfusions ,conditions:2
manage ,urological:2
manage ,conditions:2
urological ,conditions:2
hydroxychloroquine ,aerosol:2
hydroxychloroquine ,might:2
hydroxychloroquine ,markedly:2
hydroxychloroquine ,reduce:2
hydroxychloroquine ,even:2
aerosol ,might:2
aerosol ,markedly:2
aerosol ,reduce:2
aerosol ,even:2
aerosol ,prevent:4
might ,markedly:2
might ,reduce:2
might ,even:2
might ,prevent:2
markedly ,reduce:2
markedly ,even:2
markedly ,prevent:2
markedly ,severe:2
reduce ,even:2
reduce ,prevent:2
reduce ,severe:4
even ,prevent:2
even ,severe:2
prevent ,severe:4
iga-ab ,response:2
iga-ab ,spike:2
iga-ab ,glycoprotein:2
iga-ab ,sars-cov-2:2
iga-ab ,patients:2
iga-ab ,covid-19:2
response ,spike:4
response ,glycoprotein:2
spike ,patients:2
glycoprotein ,patients:2
glycoprotein ,covid-19:2
low ,incidence:2
low ,mortality:2
low ,southern:2
low ,europe:2
low ,proposal:2
incidence ,mortality:8
incidence ,southern:2
incidence ,europe:2
incidence ,proposal:2
mortality ,southern:2
mortality ,europe:2
mortality ,proposal:2
sars-cov-2 ,proposal:4
southern ,europe:2
southern ,proposal:2
europe ,proposal:2
sars-cov-2 ,subcutaneous:2
sars-cov-2 ,emphysema:2
sars-cov-2 ,mediastinal:2
pneumonia ,subcutaneous:2
pneumonia ,emphysema:2
pneumonia ,mediastinal:2
subcutaneous ,emphysema:6
subcutaneous ,mediastinal:2
emphysema ,mediastinal:2
repurposing ,05:2
repurposing ,povidone:2
repurposing ,iodine:2
repurposing ,solution:2
repurposing ,otorhinolaryngology:2
repurposing ,practice:2
05 ,povidone:2
05 ,iodine:2
05 ,solution:2
05 ,otorhinolaryngology:2
05 ,practice:2
05 ,covid:2
povidone ,iodine:2
povidone ,solution:2
povidone ,otorhinolaryngology:2
povidone ,practice:2
povidone ,covid:2
iodine ,solution:2
iodine ,otorhinolaryngology:2
iodine ,practice:2
iodine ,covid:2
solution ,otorhinolaryngology:2
solution ,practice:2
solution ,covid:2
otorhinolaryngology ,practice:2
otorhinolaryngology ,covid:2
practice ,covid:2
drugs ,using:2
drugs ,plasma:2
drugs ,recovered:2
drugs ,patients:2
using ,recovered:2
using ,patients:12
using ,treatment:2
recovered ,treatment:2
convalescent ,cancer:2
plasma ,cancer:2
severe ,cancer:2
geolocated ,twitter:2
geolocated ,social:2
geolocated ,media:2
geolocated ,data:2
geolocated ,describe:2
geolocated ,geographic:2
geolocated ,spread:2
twitter ,social:2
twitter ,media:2
twitter ,data:2
twitter ,describe:2
twitter ,geographic:2
twitter ,spread:2
social ,data:4
social ,describe:2
social ,geographic:2
social ,spread:4
media ,data:2
media ,describe:2
media ,geographic:2
media ,spread:2
data ,describe:2
data ,geographic:2
data ,spread:2
describe ,geographic:2
describe ,spread:2
geographic ,spread:2
covid-19-associated ,exploration:2
covid-19-associated ,mechanisms:2
coagulopathy ,exploration:2
coagulopathy ,mechanisms:2
exploration ,mechanisms:4
outcomes ,hiv-positive:2
among ,hiv-positive:2
hiv-positive ,patients:2
hiv-positive ,hospitalized:2
epicovid19 ,protocol:2
epicovid19 ,repeated:2
epicovid19 ,serological:2
epicovid19 ,surveys:2
epicovid19 ,sars-cov-2:2
epicovid19 ,antibodies:2
protocol ,repeated:2
protocol ,serological:4
protocol ,surveys:2
protocol ,antibodies:4
repeated ,serological:2
repeated ,surveys:2
serological ,surveys:2
surveys ,sars-cov-2:2
surveys ,antibodies:2
evidence ,article:2
based ,article:2
management ,article:4
guideline ,review:2
guideline ,article:2
pandemic ,article:2
biosafety ,biosecurity:2
biosafety ,approaches:2
biosafety ,restraincontain:2
biosafety ,counter:2
biosecurity ,approaches:2
biosecurity ,restraincontain:2
biosecurity ,counter:2
approaches ,restraincontain:2
approaches ,counter:2
restraincontain ,counter:2
optimizing ,hydroxychloroquine:2
optimizing ,dosing:2
optimizing ,patients:2
optimizing ,covid-19:4
optimizing ,integrative:2
hydroxychloroquine ,dosing:2
hydroxychloroquine ,integrative:2
dosing ,patients:2
dosing ,covid-19:2
dosing ,integrative:2
quantification ,antibodies:2
quantification ,eight:2
quantification ,commercially:2
quantification ,available:2
sars-cov-2 ,eight:2
sars-cov-2 ,commercially:4
antibodies ,eight:2
antibodies ,commercially:2
eight ,commercially:2
eight ,available:2
beyond ,sars-cov-2:2
beyond ,lessons:2
beyond ,african:2
beyond ,governments:2
beyond ,can:2
beyond ,apply:2
beyond ,preparation:2
sars-cov-2 ,governments:2
sars-cov-2 ,apply:2
sars-cov-2 ,preparation:2
lessons ,african:2
lessons ,governments:2
lessons ,apply:2
lessons ,preparation:2
african ,governments:2
african ,can:2
african ,apply:2
african ,preparation:2
governments ,can:2
governments ,apply:2
governments ,preparation:2
can ,apply:2
can ,preparation:2
apply ,preparation:2
emergence ,austria:2
coronavirus ,austria:2
disease ,austria:2
covid-19 ,austria:4
thyroid ,progress:2
thyroid ,prospects:2
progress ,prospects:2
agent-based ,modelling:2
agent-based ,sars-cov-2:2
agent-based ,epidemic:2
agent-based ,prediction:2
agent-based ,intervention:2
modelling ,sars-cov-2:8
modelling ,epidemic:4
modelling ,prediction:2
modelling ,intervention:2
sars-cov-2 ,intervention:4
epidemic ,prediction:2
epidemic ,intervention:2
prediction ,intervention:2
hijaking ,sars-cov-2:2
hijaking ,potential:2
hijaking ,role:2
hijaking ,jak:2
hijaking ,inhibitors:2
hijaking ,management:2
sars-cov-2 ,jak:2
potential ,jak:2
role ,jak:2
jak ,inhibitors:2
jak ,management:2
poor ,glucose:2
poor ,control:2
poor ,increase:4
poor ,severity:2
poor ,mortality:2
glucose ,control:2
glucose ,increase:2
glucose ,severity:2
glucose ,mortality:2
glucose ,patients:2
control ,increase:2
control ,severity:4
control ,mortality:4
control ,patients:2
increase ,severity:4
increase ,mortality:4
increase ,patients:4
effects ,functional:2
effects ,receptor:4
functional ,receptor:4
functional ,cardiovascular:2
functional ,system:2
ace2 ,system:2
primary ,comorbidities:2
primary ,outcomes:4
primary ,431:2
primary ,hospitalized:2
primary ,patients:6
symptoms ,comorbidities:6
symptoms ,outcomes:2
symptoms ,431:2
symptoms ,hospitalized:2
comorbidities ,outcomes:2
comorbidities ,431:2
comorbidities ,hospitalized:2
comorbidities ,patients:8
outcomes ,431:2
431 ,hospitalized:2
431 ,patients:2
covid-19 ,immunopathologic:2
covid-19 ,assault:2
immunopathologic ,assault:2
dipeptidyl ,dpp4:4
dipeptidyl ,inhibition:2
dipeptidyl ,covid-19:4
peptidase-4 ,dpp4:2
peptidase-4 ,inhibition:2
peptidase-4 ,covid-19:2
navigating ,immunosuppression:2
navigating ,pandemic:4
navigating ,guide:2
navigating ,dermatologist:2
immunosuppression ,guide:2
immunosuppression ,dermatologist:2
pandemic ,guide:2
pandemic ,dermatologist:2
guide ,dermatologist:2
prevention ,disruption:2
prevention ,pathogen:2
prevention ,transfer:2
prevention ,chain:2
prevention ,elective:2
infection ,pathogen:2
infection ,transfer:4
infection ,chain:2
disruption ,pathogen:2
disruption ,transfer:2
disruption ,elective:2
pathogen ,transfer:2
pathogen ,chain:2
pathogen ,elective:2
transfer ,chain:2
transfer ,elective:2
chain ,elective:2
recent ,apprise:2
recent ,terrible:2
recent ,insinuations:2
apprise ,coronavirus:2
apprise ,terrible:2
apprise ,insinuations:2
coronavirus ,terrible:2
coronavirus ,insinuations:2
terrible ,insinuations:2
chilblains ,time:2
chilblains ,new:2
chilblains ,evidence:4
chilblains ,serology:2
chilblains ,assay:2
children ,time:8
children ,new:4
children ,serology:4
children ,assay:2
time ,new:2
time ,serology:2
new ,evidence:2
new ,serology:2
evidence ,serology:2
evidence ,assay:2
assessment ,sample:2
sample ,molecular:4
sample ,screening:4
pooling ,sars-cov-2:14
pooling ,molecular:4
age-related ,testing:2
age-related ,northern:2
age-related ,region:2
age-related ,new:2
age-related ,zealand:2
differences ,testing:2
differences ,northern:2
differences ,region:2
differences ,new:2
differences ,zealand:2
sars-cov-2 ,zealand:2
testing ,northern:2
testing ,region:2
testing ,new:2
testing ,zealand:2
northern ,region:2
northern ,new:2
northern ,zealand:2
region ,new:2
region ,zealand:2
new ,zealand:4
vertical ,hypotheses:2
vertical ,evidences:2
transmission ,hypotheses:2
transmission ,evidences:4
sars-cov-2 ,evidences:4
hypotheses ,evidences:2
neutralizing ,mediate:2
neutralizing ,virus-immune:2
neutralizing ,pathology:2
antibodies ,virus-immune:2
antibodies ,pathology:2
mediate ,virus-immune:2
mediate ,pathology:2
virus-immune ,pathology:2
virus-immune ,covid-19:2
successful ,cytokine:2
successful ,storm:2
successful ,treating:2
recovery ,severe:2
recovery ,cytokine:2
recovery ,storm:2
recovery ,treating:2
severe ,cytokine:10
severe ,storm:10
cytokine ,treating:2
storm ,treating:2
direct ,activation:2
direct ,alternative:2
direct ,complement:2
direct ,pathway:2
direct ,spike:2
direct ,proteins:2
activation ,alternative:2
activation ,pathway:2
activation ,proteins:2
alternative ,complement:2
alternative ,pathway:2
alternative ,spike:2
alternative ,proteins:2
complement ,pathway:2
pathway ,spike:2
pathway ,proteins:2
platelets ,surrogate:2
platelets ,lung:2
platelets ,inflammation:2
platelets ,covid-19:4
platelets ,patients:2
surrogate ,lung:2
surrogate ,inflammation:2
surrogate ,covid-19:2
surrogate ,patients:2
lung ,inflammation:8
inflammation ,patients:8
practical ,management:12
practical ,inflammatory:2
practical ,bowel:2
practical ,patients:8
management ,inflammatory:6
management ,bowel:6
attitudes ,lockdown:2
attitudes ,among:2
attitudes ,general:2
attitudes ,france:2
attitudes ,march:2
lockdown ,among:2
lockdown ,general:2
lockdown ,population:2
lockdown ,france:2
lockdown ,march:2
among ,general:4
among ,population:4
among ,france:4
general ,population:4
general ,france:2
general ,march:2
population ,france:2
population ,march:2
sars-cov-2 ,remain:2
sars-cov-2 ,appliances:2
virus ,remain:2
virus ,viable:2
virus ,oral:2
virus ,appliances:2
virus ,days:2
may ,remain:2
may ,viable:2
may ,oral:2
may ,appliances:2
may ,days:2
remain ,viable:2
remain ,oral:2
remain ,appliances:2
remain ,days:2
viable ,oral:2
viable ,appliances:2
viable ,days:2
oral ,appliances:2
oral ,days:2
appliances ,days:2
covid-19 ,underlines:2
covid-19 ,build:2
covid-19 ,restaurants:2
pandemic ,underlines:2
pandemic ,build:2
pandemic ,resilience:2
pandemic ,commercial:2
pandemic ,restaurants:2
underlines ,need:2
underlines ,build:2
underlines ,resilience:2
underlines ,commercial:2
underlines ,restaurants:2
need ,build:2
need ,resilience:2
need ,commercial:2
need ,restaurants:2
build ,resilience:2
build ,commercial:2
build ,restaurants:2
resilience ,commercial:2
resilience ,restaurants:2
commercial ,restaurants:2
sars ,cov-2covid-19:2
sars ,evidence-based:2
sars ,recommendation:2
sars ,diagnosis:2
sars ,therapy:2
cov-2covid-19 ,evidence-based:2
cov-2covid-19 ,recommendation:2
cov-2covid-19 ,diagnosis:2
cov-2covid-19 ,therapy:2
evidence-based ,recommendation:2
evidence-based ,diagnosis:2
evidence-based ,therapy:2
recommendation ,therapy:2
intrauterine ,review:2
evaluation ,igm-igg:2
evaluation ,combined:4
performance ,igm-igg:2
performance ,combined:2
two ,igm-igg:2
two ,combined:2
sars-cov-2 ,igm-igg:2
rapid ,igm-igg:2
rapid ,combined:2
igm-igg ,combined:2
igm-igg ,antibody:2
igm-igg ,tests:2
combined ,antibody:2
combined ,tests:2
role ,oxidized:2
role ,ldl-induced:2
role ,trained:2
role ,macrophages:2
oxidized ,ldl-induced:2
oxidized ,trained:2
oxidized ,macrophages:2
oxidized ,pathogenesis:2
oxidized ,covid-19:2
ldl-induced ,trained:2
ldl-induced ,macrophages:2
ldl-induced ,pathogenesis:2
ldl-induced ,covid-19:2
trained ,macrophages:2
trained ,pathogenesis:2
trained ,covid-19:2
macrophages ,pathogenesis:2
sars-cov-2 ,jumping:2
sars-cov-2 ,species:4
sars-cov-2 ,barrier:6
jumping ,species:2
jumping ,barrier:2
jumping ,zoonotic:2
jumping ,lessons:2
jumping ,sars:2
jumping ,mers:2
jumping ,recent:2
species ,barrier:2
species ,zoonotic:2
species ,lessons:2
species ,sars:2
species ,mers:2
species ,recent:2
barrier ,zoonotic:2
barrier ,lessons:2
barrier ,sars:2
barrier ,mers:2
barrier ,recent:2
zoonotic ,lessons:2
zoonotic ,sars:2
zoonotic ,mers:2
zoonotic ,recent:2
lessons ,mers:2
lessons ,recent:2
sars ,recent:2
mers ,recent:2
clinical ,fully:2
evaluation ,fully:4
sars-cov-2 ,fully:6
rt-pcr ,fully:2
rt-pcr ,automated:2
rt-pcr ,system:4
assay ,fully:2
assay ,automated:4
assay ,system:2
fully ,automated:10
fully ,system:2
automated ,system:2
heat ,warning:2
heat ,public:2
heat ,workers:2
heat ,health:2
heat ,time:2
heat ,covid-19:4
heat ,pandemic:2
warning ,public:2
warning ,workers:2
warning ,health:2
warning ,time:2
warning ,covid-19:4
warning ,pandemic:2
public ,workers:2
public ,time:4
workers ,time:4
health ,time:4
sars-cov-2 ,quarantined:4
quarantined ,domestic:2
quarantined ,cats:2
quarantined ,households:2
quarantined ,close:2
quarantined ,contacts:2
domestic ,covid-19:2
domestic ,households:2
domestic ,close:2
domestic ,contacts:2
cats ,covid-19:2
cats ,households:2
cats ,close:4
cats ,contacts:2
covid-19 ,households:2
covid-19 ,contacts:6
households ,close:2
households ,contacts:2
close ,contacts:4
precision ,medicine:2
precision ,approach:2
precision ,managing:2
precision ,novel:2
precision ,coronavirus:2
precision ,pneumonia:2
medicine ,approach:2
medicine ,managing:2
medicine ,pneumonia:2
approach ,managing:2
approach ,pneumonia:2
managing ,novel:2
managing ,coronavirus:2
managing ,pneumonia:2
sofosbuvir ,repurposed:2
sofosbuvir ,antiviral:2
sofosbuvir ,drug:2
sofosbuvir ,covid-19:2
sofosbuvir ,convinced:2
repurposed ,convinced:2
antiviral ,convinced:2
drug ,convinced:2
covid-19 ,convinced:2
neuroimmune ,correlates:2
neuroimmune ,nervous:2
neuroimmune ,system:2
neuroimmune ,involvement:2
neuroimmune ,covid-19:2
neuroimmune ,commentary:2
correlates ,nervous:2
correlates ,system:2
correlates ,involvement:2
correlates ,covid-19:4
correlates ,commentary:2
nervous ,commentary:2
system ,commentary:2
involvement ,commentary:2
strategies ,follow:2
strategies ,hernia:2
strategies ,surgery:6
strategies ,covid:2
strategies ,19:2
strategies ,pandemia:2
follow ,hernia:2
follow ,surgery:2
follow ,covid:2
follow ,19:2
follow ,pandemia:2
hernia ,surgery:2
hernia ,covid:2
hernia ,19:2
hernia ,pandemia:2
surgery ,covid:4
surgery ,19:2
surgery ,pandemia:8
covid ,pandemia:2
19 ,pandemia:2
examination ,patients:2
examination ,covid-19:6
cov ,impact:2
cov ,stress:2
cov ,exposure:2
cov ,analysis:2
cov ,among:2
cov ,hospital:2
cov ,staff:2
cov ,2hospitals:2
cov ,france:2
impact ,stress:2
impact ,exposure:2
impact ,analysis:4
impact ,hospital:6
impact ,staff:2
impact ,2hospitals:2
impact ,france:2
stress ,exposure:2
stress ,analysis:2
stress ,among:6
stress ,hospital:4
stress ,staff:4
stress ,2hospitals:2
stress ,france:2
exposure ,analysis:2
exposure ,among:2
exposure ,hospital:6
exposure ,2hospitals:2
exposure ,france:2
analysis ,hospital:4
analysis ,staff:2
analysis ,2hospitals:2
analysis ,france:2
among ,hospital:6
among ,2hospitals:2
hospital ,2hospitals:2
hospital ,france:2
staff ,2hospitals:2
staff ,france:2
2hospitals ,france:2
role ,mediators:2
role ,associated:4
il-6 ,mediators:2
il-6 ,cytokine:2
il-6 ,storm:2
il-6 ,associated:2
mediators ,cytokine:2
mediators ,storm:2
mediators ,associated:2
storm ,associated:4
use ,medical:2
use ,face:2
use ,versus:2
use ,particulate:2
use ,respirators:2
use ,component:2
medical ,face:2
medical ,masks:4
medical ,versus:4
medical ,particulate:2
medical ,respirators:4
medical ,component:2
medical ,personal:2
face ,versus:2
face ,particulate:2
face ,respirators:2
face ,component:2
face ,personal:4
masks ,versus:2
masks ,particulate:2
masks ,respirators:6
masks ,component:2
masks ,personal:2
versus ,particulate:2
versus ,respirators:2
versus ,component:2
versus ,personal:2
particulate ,respirators:2
particulate ,component:2
particulate ,personal:2
respirators ,component:2
respirators ,personal:2
component ,personal:2
era ,rise:2
era ,science:2
era ,collectivism:2
covid-19 ,rise:2
covid-19 ,collectivism:2
rise ,science:2
rise ,collectivism:2
rise ,cancer:2
rise ,research:2
science ,collectivism:2
science ,cancer:2
science ,research:2
collectivism ,cancer:2
collectivism ,research:2
toxic ,erythema:2
toxic ,eosinophilia:2
toxic ,associated:2
toxic ,tocilizumab:2
toxic ,therapy:2
toxic ,covid-19:4
erythema ,eosinophilia:2
erythema ,associated:2
erythema ,tocilizumab:2
erythema ,therapy:2
eosinophilia ,associated:2
eosinophilia ,tocilizumab:2
eosinophilia ,therapy:2
eosinophilia ,covid-19:2
associated ,tocilizumab:4
associated ,therapy:2
tocilizumab ,therapy:4
prostaglandin ,d2:2
prostaglandin ,mediator:2
prostaglandin ,lymphopenia:2
prostaglandin ,therapeutic:2
prostaglandin ,target:2
prostaglandin ,covid-19:2
d2 ,mediator:2
d2 ,lymphopenia:2
d2 ,therapeutic:2
d2 ,target:2
d2 ,covid-19:2
mediator ,lymphopenia:2
mediator ,therapeutic:2
mediator ,target:2
lymphopenia ,target:2
nutritional ,support:2
nutritional ,coronavirus:2
nutritional ,disease:2
rapid ,expansion:4
rapid ,temporary:2
rapid ,airborne-infection:2
rapid ,isolation:4
rapid ,rooms:2
expansion ,temporary:2
expansion ,reliable:2
expansion ,airborne-infection:2
expansion ,isolation:2
expansion ,rooms:2
temporary ,reliable:2
temporary ,airborne-infection:2
temporary ,isolation:2
temporary ,rooms:2
reliable ,airborne-infection:2
reliable ,isolation:2
reliable ,rooms:2
airborne-infection ,isolation:2
airborne-infection ,rooms:2
isolation ,rooms:6
establishing ,managing:2
establishing ,quarantine:2
establishing ,isolation:2
establishing ,centre:2
establishing ,pandemic:2
managing ,quarantine:2
managing ,isolation:2
quarantine ,centre:2
isolation ,centre:2
isolation ,pandemic:2
prevention ,seeking:2
prevention ,practical:4
prevention ,timely:2
prevention ,solution:2
management ,seeking:2
management ,timely:2
management ,solution:2
covid-19 ,seeking:4
seeking ,practical:2
seeking ,timely:2
seeking ,solution:2
practical ,timely:2
practical ,solution:2
timely ,solution:2
providing ,evidence:2
providing ,ongoing:2
providing ,health:2
providing ,care:4
providing ,workers:2
providing ,mask:2
providing ,debate:2
evidence ,ongoing:4
evidence ,health:2
evidence ,care:4
evidence ,workers:2
evidence ,mask:2
evidence ,debate:2
ongoing ,health:2
ongoing ,care:2
ongoing ,workers:2
ongoing ,mask:2
ongoing ,debate:2
health ,mask:2
health ,debate:2
care ,mask:2
care ,debate:2
workers ,mask:2
workers ,debate:2
mask ,debate:2
viewpoint ,origin:2
viewpoint ,sars-cov-2:2
infectability ,human:2
infectability ,brainsphere:2
infectability ,neurons:2
infectability ,suggests:2
infectability ,neurotropism:2
infectability ,sars-cov-2:2
human ,brainsphere:2
human ,neurons:2
human ,suggests:2
human ,neurotropism:2
brainsphere ,neurons:2
brainsphere ,suggests:2
brainsphere ,neurotropism:2
brainsphere ,sars-cov-2:2
neurons ,suggests:2
neurons ,neurotropism:2
suggests ,neurotropism:2
suggests ,sars-cov-2:4
susceptibility ,uv:2
susceptibility ,irradiation:2
sars-cov-2 ,uv:2
uv ,irradiation:2
rapid ,large-scale:4
rapid ,effective:2
rapid ,non-adaptive:2
large-scale ,effective:2
large-scale ,detection:2
large-scale ,covid-19:6
large-scale ,via:2
large-scale ,non-adaptive:2
effective ,detection:2
effective ,via:2
effective ,non-adaptive:2
effective ,testing:2
detection ,via:2
detection ,non-adaptive:2
covid-19 ,non-adaptive:2
via ,non-adaptive:2
via ,testing:2
non-adaptive ,testing:2
sample-to-answer ,nucleic:2
sample-to-answer ,acid:2
sample-to-answer ,testing:2
sample-to-answer ,tertiary:2
sample-to-answer ,care:2
sample-to-answer ,emergency:2
nucleic ,tertiary:2
nucleic ,care:2
nucleic ,emergency:2
acid ,tertiary:2
acid ,care:2
acid ,emergency:2
testing ,tertiary:4
testing ,emergency:2
tertiary ,care:8
tertiary ,emergency:2
mesenchymal ,new:2
mesenchymal ,piece:2
mesenchymal ,puzzle:2
stem ,new:2
stem ,piece:2
stem ,puzzle:2
cells ,new:2
cells ,piece:2
cells ,puzzle:2
new ,piece:2
new ,puzzle:2
piece ,puzzle:2
piece ,covid-19:2
piece ,treatment:2
puzzle ,covid-19:4
puzzle ,treatment:2
antecedent ,immunosuppressive:2
antecedent ,therapy:2
antecedent ,immune-mediated:2
antecedent ,inflammatory:2
antecedent ,diseases:2
immunosuppressive ,immune-mediated:2
immunosuppressive ,inflammatory:2
immunosuppressive ,diseases:2
therapy ,immune-mediated:2
therapy ,diseases:4
immune-mediated ,inflammatory:2
inflammatory ,diseases:6
sars ,options:2
sars ,state-of-the-art:2
coronavirus-2 ,vaccines:2
coronavirus-2 ,options:2
coronavirus-2 ,state-of-the-art:2
vaccines ,state-of-the-art:2
options ,state-of-the-art:2
overview ,replication:4
novel ,replication:2
infection ,replication:2
impact ,24:2
impact ,sickle:2
impact ,one:2
impact ,center:2
covid-19 ,sickle:4
infection ,24:2
infection ,sickle:2
infection ,center:2
24 ,patients:2
24 ,sickle:2
24 ,cell:2
24 ,disease:2
24 ,one:2
24 ,center:2
patients ,sickle:2
patients ,one:2
sickle ,one:2
sickle ,center:2
cell ,one:2
cell ,center:2
one ,center:2
responding ,pandemic:4
responding ,new:2
responding ,surgical:2
responding ,patient:2
responding ,flow:2
responding ,utilizing:2
pandemic ,flow:2
pandemic ,utilizing:2
new ,surgical:4
new ,flow:2
new ,utilizing:2
surgical ,flow:2
surgical ,utilizing:2
patient ,flow:2
patient ,utilizing:2
flow ,utilizing:2
targeting ,prefusion:2
targeting ,conformation:2
targeting ,virtual:4
sars-cov-2 ,prefusion:4
sars-cov-2 ,conformation:2
spike ,virtual:2
glycoprotein ,prefusion:2
glycoprotein ,conformation:2
glycoprotein ,virtual:2
prefusion ,virtual:2
conformation ,virtual:2
evaluation ,k18-hace2:2
evaluation ,mice:2
evaluation ,model:2
k18-hace2 ,mice:2
k18-hace2 ,model:2
k18-hace2 ,sars-cov-2:2
k18-hace2 ,infection:2
mice ,model:4
mice ,sars-cov-2:10
mice ,infection:6
side-by-side ,comparison:2
side-by-side ,three:2
side-by-side ,fully:2
side-by-side ,automated:2
side-by-side ,sars-cov-2:2
side-by-side ,antibody:2
side-by-side ,assays:2
comparison ,fully:4
three ,fully:2
fully ,antibody:2
fully ,assays:2
automated ,assays:4
immune ,resetting:2
immune ,strategy:2
immune ,sars-cov-2-induced:2
response ,resetting:2
response ,strategy:2
response ,overcome:2
response ,sars-cov-2-induced:2
resetting ,novel:2
resetting ,strategy:2
resetting ,overcome:2
resetting ,sars-cov-2-induced:2
novel ,strategy:6
novel ,overcome:2
strategy ,overcome:2
strategy ,sars-cov-2-induced:2
overcome ,sars-cov-2-induced:2
histopathological ,patient:2
histopathological ,affected:2
histopathological ,ischemic:2
histopathological ,gangrenous:2
findings ,affected:2
findings ,ischemic:2
findings ,gangrenous:2
covid-19 ,gangrenous:2
patient ,affected:2
patient ,ischemic:4
patient ,gangrenous:2
affected ,ischemic:2
affected ,gangrenous:2
ischemic ,gangrenous:2
mait ,cells:2
mait ,covid-19:2
mait ,heroes:2
mait ,villains:2
cells ,heroes:2
cells ,villains:2
covid-19 ,heroes:2
covid-19 ,villains:2
heroes ,villains:2
laboratory ,clinicians:2
laboratory ,updating:2
laboratory ,article:2
diagnosis ,clinicians:2
diagnosis ,updating:2
diagnosis ,article:4
clinicians ,updating:2
clinicians ,article:2
updating ,article:2
implications ,different:2
implications ,specimen:4
implications ,types:2
implications ,nucleic:2
implications ,acid:4
implications ,two:2
different ,specimen:2
specimen ,two:2
types ,nucleic:2
types ,acid:2
types ,two:2
nucleic ,two:2
acid ,two:4
testing ,two:2
identifying ,potential:2
identifying ,undocumented:2
identifying ,covid-19:2
identifying ,using:2
identifying ,publicly:2
identifying ,reported:2
potential ,undocumented:2
potential ,publicly:2
potential ,reported:2
undocumented ,covid-19:2
undocumented ,using:2
undocumented ,publicly:2
undocumented ,reported:2
using ,publicly:2
using ,reported:2
infection ,cutaneous:6
virus ,can:4
virus ,cause:2
virus ,cutaneous:2
can ,different:2
can ,cutaneous:2
can ,manifestations:2
cause ,different:2
cause ,cutaneous:2
cause ,manifestations:2
different ,cutaneous:2
different ,manifestations:2
protection ,disinfection:2
protection ,policies:2
disinfection ,policies:2
policies ,sars-cov-2:2
complement ,coagulation:4
complement ,key:2
complement ,triggers:2
complement ,covid-19-induced:2
complement ,multiorgan:4
complement ,pathology:2
coagulation ,key:2
coagulation ,triggers:2
coagulation ,covid-19-induced:2
coagulation ,multiorgan:2
coagulation ,pathology:2
key ,triggers:2
key ,covid-19-induced:2
key ,multiorgan:2
key ,pathology:2
triggers ,covid-19-induced:2
triggers ,multiorgan:2
triggers ,pathology:2
covid-19-induced ,multiorgan:2
covid-19-induced ,pathology:2
multiorgan ,pathology:2
underreporting ,covid-19:2
underreporting ,curious:2
underreporting ,case:2
underreporting ,indian:2
underreporting ,subcontinent:2
covid-19 ,curious:2
covid-19 ,subcontinent:2
curious ,case:2
curious ,indian:2
curious ,subcontinent:2
case ,indian:2
case ,subcontinent:2
indian ,subcontinent:2
olfactory ,taste:2
olfactory ,disorders:2
olfactory ,systematic:2
olfactory ,review:2
disorders ,systematic:2
disorders ,review:2
hypothesis ,pentoxifylline:2
hypothesis ,modulator:2
pentoxifylline ,modulator:2
pentoxifylline ,therapeutic:2
pentoxifylline ,covid-19:2
potential ,modulator:2
cytokine ,modulator:2
modulator ,therapeutic:2
modulator ,covid-19:4
case ,canakinumab:2
case ,treatment:8
report ,canakinumab:2
report ,treatment:12
canakinumab ,treatment:2
canakinumab ,patient:2
canakinumab ,covid-19:2
canakinumab ,acute:2
psychological ,effects:4
psychological ,covid:2
psychological ,19:2
psychological ,pandemic:2
psychological ,healthcare:2
psychological ,globally:2
effects ,workers:2
effects ,globally:2
covid ,healthcare:2
covid ,workers:2
covid ,globally:2
19 ,pandemic:4
19 ,healthcare:2
19 ,workers:2
19 ,globally:2
pandemic ,globally:2
healthcare ,globally:2
workers ,globally:2
prevalence ,infections:2
prevalence ,two:4
prevalence ,academic:2
sars-cov-2 ,academic:2
asymptomatic ,two:2
asymptomatic ,academic:2
asymptomatic ,health:2
infections ,two:2
infections ,large:2
infections ,academic:2
infections ,health:2
two ,large:2
two ,academic:2
two ,health:2
large ,academic:6
large ,health:2
academic ,health:2
assessing ,relationship:4
assessing ,surface:2
assessing ,pm25:2
assessing ,pm10:2
assessing ,particulate:2
relationship ,surface:2
relationship ,levels:4
relationship ,pm25:2
relationship ,pm10:2
relationship ,particulate:2
surface ,levels:2
surface ,pm25:2
surface ,pm10:2
surface ,particulate:2
levels ,pm25:2
levels ,pm10:2
levels ,particulate:2
pm25 ,pm10:2
pm25 ,particulate:2
pm10 ,particulate:2
diagnostic ,augurix:2
diagnostic ,serology:4
accuracy ,augurix:2
accuracy ,covid-19:10
accuracy ,igg:2
accuracy ,serology:2
accuracy ,rapid:2
accuracy ,test:4
augurix ,covid-19:2
augurix ,igg:2
augurix ,serology:2
augurix ,rapid:2
augurix ,test:2
igg ,serology:2
specific ,serological:2
specific ,pattern:2
specific ,healthcare:2
specific ,italian:2
serological ,pattern:2
serological ,healthcare:2
serological ,workers:2
serological ,italian:2
pattern ,healthcare:2
pattern ,workers:2
pattern ,italian:2
pattern ,covid-19:8
healthcare ,italian:2
workers ,italian:2
mathematical ,deep:2
mathematical ,learning:2
mathematical ,predicting:2
mathematical ,number:2
mathematical ,individuals:2
models ,predicting:2
models ,number:2
models ,individuals:2
deep ,predicting:2
deep ,number:2
deep ,individuals:2
learning ,predicting:2
learning ,number:2
learning ,individuals:2
predicting ,number:2
predicting ,individuals:2
number ,individuals:2
boning ,amino-bisphophonates:2
boning ,immunostimulants:2
boning ,endosomal:2
boning ,disruptors:2
amino-bisphophonates ,immunostimulants:2
amino-bisphophonates ,endosomal:2
amino-bisphophonates ,disruptors:2
immunostimulants ,endosomal:2
immunostimulants ,disruptors:2
endosomal ,disruptors:2
application ,bayesian:2
application ,phylogenetic:2
application ,inference:2
application ,modelling:2
application ,evolutionary:2
application ,genetic:2
bayesian ,phylogenetic:2
bayesian ,inference:2
bayesian ,modelling:2
bayesian ,evolutionary:2
bayesian ,genetic:2
phylogenetic ,inference:2
phylogenetic ,modelling:2
phylogenetic ,evolutionary:2
phylogenetic ,genetic:2
inference ,modelling:2
inference ,evolutionary:2
inference ,genetic:2
modelling ,evolutionary:2
modelling ,genetic:2
evolutionary ,genetic:2
antibiotic ,consumption:2
antibiotic ,stewardship:2
antibiotic ,hospital:2
antibiotic ,outside:2
antibiotic ,early:2
antibiotic ,coronavirus:2
consumption ,stewardship:2
consumption ,hospital:2
consumption ,outside:2
consumption ,early:2
consumption ,coronavirus:2
stewardship ,hospital:2
stewardship ,outside:2
stewardship ,early:2
stewardship ,coronavirus:2
hospital ,outside:2
outside ,early:2
risk ,pneumonia:2
risk ,aquatic:2
risk ,mammals:2
covid-19 ,aquatic:2
covid-19 ,mammals:2
pneumonia ,aquatic:2
pneumonia ,mammals:2
aquatic ,mammals:2
angiotensin-converting ,old:2
angiotensin-converting ,door:2
angiotensin-converting ,new:2
enzyme ,old:2
enzyme ,door:2
enzyme ,new:2
old ,door:2
old ,severe:2
old ,acute:2
old ,respiratory:2
door ,new:2
door ,severe:2
door ,acute:2
door ,respiratory:2
role ,altering:2
role ,rna-binding:2
role ,mirna-directed:2
sars-cov-2 ,altering:2
sars-cov-2 ,rna-binding:2
sars-cov-2 ,mirna-directed:2
altering ,rna-binding:2
altering ,protein:2
altering ,mirna-directed:2
rna-binding ,protein:2
rna-binding ,mirna-directed:2
protein ,mirna-directed:2
covid-19 ,export:2
covid-19 ,controls:2
sars-cov-2 ,export:2
export ,controls:2
coagulation ,modifiers:2
coagulation ,targeting:4
coagulation ,main:2
coagulation ,protease:2
coagulation ,mpro:2
modifiers ,targeting:2
modifiers ,sars-cov-2:2
modifiers ,main:2
modifiers ,protease:2
modifiers ,mpro:2
modifiers ,covid-19:4
targeting ,main:6
targeting ,mpro:2
main ,mpro:2
mpro ,covid-19:2
halo ,reversed:2
halo ,atypical:2
halo ,computed:2
halo ,tomography:2
halo ,manifestations:2
reversed ,atypical:2
reversed ,computed:2
reversed ,tomography:2
reversed ,manifestations:2
atypical ,computed:2
atypical ,tomography:2
computed ,manifestations:2
tomography ,manifestations:2
implications ,crisis:2
implications ,cancer:2
infection ,crisis:2
crisis ,clinical:4
crisis ,cancer:4
crisis ,care:4
preparedness ,ophthalmology:2
molecular ,rational:2
molecular ,design:4
basis ,infection:4
basis ,rational:2
basis ,design:2
basis ,potential:4
basis ,antiviral:2
infection ,rational:2
infection ,design:4
rational ,design:6
rational ,potential:2
rational ,antiviral:2
design ,potential:4
consideration ,respiratory:2
consideration ,support:2
consideration ,strategy:2
consideration ,severe:2
consideration ,acute:2
respiratory ,strategy:6
support ,strategy:2
characteristics ,timing:2
characteristics ,initial:4
characteristics ,shedding:2
timing ,initial:2
timing ,virus:2
timing ,severe:2
timing ,acute:2
timing ,respiratory:2
initial ,virus:2
initial ,shedding:2
initial ,acute:4
initial ,respiratory:2
sleep ,health:2
sleep ,early:2
sleep ,coronavirus:2
sleep ,disease:2
sleep ,outbreak:2
sleep ,united:2
health ,early:4
health ,united:2
early ,outbreak:4
early ,united:6
outbreak ,united:2
detection ,residue:2
detection ,object:2
sars-cov-2 ,residue:4
sars-cov-2 ,object:2
rna ,residue:2
rna ,object:2
residue ,object:2
residue ,surfaces:2
residue ,nucleic:2
residue ,acid:2
residue ,testing:2
object ,surfaces:2
object ,nucleic:2
object ,acid:2
object ,testing:2
surfaces ,nucleic:2
surfaces ,acid:2
surfaces ,testing:2
kidney ,allograft:2
kidney ,immunosuppression:2
kidney ,disease-2019:2
allograft ,recipients:2
allograft ,immunosuppression:2
allograft ,coronavirus:2
allograft ,disease-2019:2
recipients ,immunosuppression:2
recipients ,coronavirus:2
recipients ,disease-2019:2
immunosuppression ,coronavirus:2
immunosuppression ,disease-2019:2
metformin ,one:2
metformin ,options:2
metformin ,reduce:2
metformin ,mortality:2
metformin ,severe:2
one ,possible:2
one ,options:2
one ,reduce:2
one ,mortality:2
one ,severe:2
possible ,reduce:2
possible ,mortality:2
options ,reduce:2
options ,mortality:2
reduce ,mortality:2
mortality ,severe:10
managing ,care:2
managing ,sinonasal:2
managing ,anterior:2
managing ,skull:2
managing ,base:2
managing ,cancers:2
care ,sinonasal:2
care ,skull:2
care ,base:2
care ,cancers:2
patients ,sinonasal:2
patients ,anterior:2
patients ,skull:2
sinonasal ,anterior:2
sinonasal ,skull:2
sinonasal ,base:2
sinonasal ,cancers:2
anterior ,skull:2
anterior ,base:2
anterior ,cancers:2
skull ,cancers:2
base ,cancers:2
leads ,neurological:2
leads ,dysfunction:2
neurological ,dysfunction:4
novel ,taiwan:4
novel ,reports:2
coronavirus ,taiwan:2
coronavirus ,reports:4
disease ,taiwan:2
disease ,reports:4
taiwan ,reports:2
taiwan ,two:2
taiwan ,cases:2
reports ,two:4
reports ,cases:2
arbidol ,monotherapy:2
arbidol ,superior:2
arbidol ,lopinavirritonavir:4
arbidol ,treating:2
arbidol ,covid-19:4
monotherapy ,superior:2
monotherapy ,lopinavirritonavir:2
monotherapy ,treating:2
monotherapy ,covid-19:2
superior ,lopinavirritonavir:2
superior ,treating:2
superior ,covid-19:2
lopinavirritonavir ,treating:2
lopinavirritonavir ,covid-19:6
coronavirus ,database:2
coronavirus ,cov-rdb:2
coronavirus ,designed:2
antiviral ,database:2
antiviral ,cov-rdb:2
antiviral ,online:2
antiviral ,designed:2
research ,database:2
research ,cov-rdb:2
research ,online:2
research ,designed:2
database ,cov-rdb:2
database ,designed:2
cov-rdb ,online:2
cov-rdb ,designed:2
online ,designed:2
predicting ,covid-19:6
predicting ,incidence:2
predicting ,using:4
predicting ,anosmia:2
predicting ,symptomatology:2
incidence ,using:2
incidence ,anosmia:2
incidence ,symptomatology:2
using ,anosmia:2
using ,symptomatology:2
anosmia ,symptomatology:2
short-term ,effects:2
short-term ,ambient:4
short-term ,ozone:2
short-term ,pm25:2
short-term ,meteorological:2
short-term ,factors:2
effects ,ambient:2
effects ,ozone:2
effects ,pm25:2
effects ,meteorological:2
effects ,factors:2
ambient ,ozone:2
ambient ,pm25:2
ambient ,meteorological:2
ambient ,factors:2
ozone ,pm25:2
ozone ,meteorological:2
ozone ,factors:2
ozone ,covid-19:2
pm25 ,meteorological:2
pm25 ,factors:2
pm25 ,covid-19:2
meteorological ,factors:4
severe ,sars-cov2:4
severe ,ace2:6
severe ,receptor:6
severe ,matter:2
respiratory ,receptor:6
respiratory ,matter:2
sars-cov2 ,ace2:2
sars-cov2 ,receptor:2
sars-cov2 ,matter:2
infection ,matter:2
ace2 ,matter:2
receptor ,matter:2
impact ,vitamin:2
impact ,deficiency:2
impact ,covid-19-a:2
impact ,prospective:2
impact ,covild:2
vitamin ,covid-19-a:2
vitamin ,prospective:2
vitamin ,analysis:2
vitamin ,covild:2
deficiency ,covid-19-a:2
deficiency ,prospective:2
deficiency ,analysis:2
deficiency ,covild:2
covid-19-a ,prospective:2
covid-19-a ,analysis:2
covid-19-a ,covild:2
prospective ,analysis:2
prospective ,covild:2
analysis ,covild:2
diagnostic ,chest:4
diagnostic ,x-ray:2
diagnostic ,pneumonia:2
performance ,chest:2
performance ,x-ray:2
performance ,pneumonia:2
x-ray ,pneumonia:2
x-ray ,sars-cov-2:2
evaluation ,tools:2
evaluation ,positioning:2
performance ,tools:2
performance ,positioning:2
sars-cov-2 ,tools:6
sars-cov-2 ,positioning:2
serological ,tools:2
serological ,positioning:2
tools ,positioning:2
laboratory ,children:2
distinct ,early:2
distinct ,serological:2
distinct ,signatures:2
distinct ,track:2
distinct ,sars-cov-2:2
distinct ,survival:2
early ,serological:4
early ,signatures:2
early ,track:2
early ,survival:4
serological ,signatures:2
serological ,track:2
serological ,survival:2
signatures ,track:2
signatures ,sars-cov-2:2
signatures ,survival:2
track ,sars-cov-2:6
track ,survival:2
role ,sex:2
role ,mitochondria:2
genetic ,sex:2
genetic ,mitochondria:2
sex ,mitochondria:2
sex ,response:4
sex ,infection:6
mitochondria ,response:2
mitochondria ,infection:2
broad ,differential:2
broad ,animal:2
broad ,angiotensin-converting:2
broad ,enzyme:2
broad ,receptor:2
broad ,usage:2
differential ,animal:2
differential ,angiotensin-converting:2
differential ,enzyme:2
differential ,receptor:2
differential ,usage:2
animal ,angiotensin-converting:2
animal ,enzyme:2
animal ,receptor:2
animal ,usage:2
angiotensin-converting ,usage:2
enzyme ,usage:2
receptor ,usage:4
characterization ,accessory:2
characterization ,genes:2
characterization ,genomes:2
accessory ,genes:2
accessory ,coronavirus:2
accessory ,genomes:2
genes ,coronavirus:2
genes ,genomes:2
coronavirus ,genomes:4
will ,plant-made:2
will ,biopharmaceuticals:2
will ,play:2
will ,role:2
will ,fight:2
plant-made ,biopharmaceuticals:2
plant-made ,play:2
plant-made ,role:2
plant-made ,fight:2
plant-made ,covid-19:2
biopharmaceuticals ,play:2
biopharmaceuticals ,role:2
biopharmaceuticals ,fight:2
biopharmaceuticals ,covid-19:2
play ,fight:4
susceptibility ,raccoon:2
susceptibility ,dogs:4
susceptibility ,experimental:2
raccoon ,dogs:2
raccoon ,experimental:2
raccoon ,sars-cov-2:2
raccoon ,infection:2
dogs ,experimental:4
covid ,therapies:2
covid ,anti-cancer:2
covid ,drugs:2
covid ,systematic:2
covid ,review:2
covid ,recent:2
covid ,literature:2
19 ,therapies:2
19 ,anti-cancer:2
19 ,drugs:2
19 ,review:4
19 ,recent:2
19 ,literature:2
therapies ,anti-cancer:2
therapies ,systematic:4
therapies ,literature:2
anti-cancer ,drugs:2
anti-cancer ,systematic:2
anti-cancer ,review:2
anti-cancer ,recent:2
anti-cancer ,literature:2
drugs ,systematic:2
drugs ,literature:4
systematic ,recent:2
povidone-iodine ,solution:2
povidone-iodine ,sars-cov-2:2
povidone-iodine ,prophylaxis:2
povidone-iodine ,procedures:2
povidone-iodine ,upper:2
solution ,prophylaxis:2
solution ,procedures:2
solution ,upper:2
prophylaxis ,procedures:2
prophylaxis ,upper:2
procedures ,upper:2
inappropriate ,risk:2
inappropriate ,perception:2
inappropriate ,infection:2
inappropriate ,among:2
inappropriate ,italian:2
inappropriate ,hcws:2
inappropriate ,eve:2
risk ,italian:2
risk ,hcws:2
risk ,eve:2
perception ,sars-cov-2:2
perception ,infection:2
perception ,among:2
perception ,italian:4
perception ,hcws:2
perception ,eve:2
sars-cov-2 ,hcws:2
sars-cov-2 ,eve:2
infection ,hcws:2
infection ,eve:2
among ,hcws:2
among ,eve:2
italian ,hcws:2
italian ,eve:2
hcws ,eve:2
covid-19 ,preconditioning:2
oxidative ,preconditioning:2
oxidative ,potential:2
oxidative ,therapeutic:2
oxidative ,approach:2
preconditioning ,potential:2
preconditioning ,therapeutic:2
preconditioning ,approach:2
potential ,approach:8
age-dependent ,progression:2
age-dependent ,sars-cov-2:2
age-dependent ,infection:2
age-dependent ,syrian:2
age-dependent ,hamsters:2
progression ,syrian:2
progression ,hamsters:2
sars-cov-2 ,syrian:4
sars-cov-2 ,hamsters:6
infection ,syrian:4
infection ,hamsters:4
syrian ,hamsters:4
profile ,specific:2
profile ,first:2
profile ,report:2
specific ,first:2
specific ,report:2
antibodies ,first:2
antibodies ,report:2
immune ,mirror:2
immune ,image:2
immune ,sepsis:4
response ,mirror:2
response ,image:2
covid-19 ,mirror:2
covid-19 ,sepsis:6
mirror ,image:2
mirror ,sepsis:2
image ,sepsis:2
food-derived ,antioxidants:2
food-derived ,covid-19:2
antioxidants ,covid-19:2
mouse ,model:4
mouse ,sars-cov-2:6
mouse ,reveals:2
mouse ,inflammatory:2
mouse ,role:2
mouse ,type:2
mouse ,interferon:2
mouse ,signaling:2
model ,reveals:4
model ,inflammatory:2
model ,role:2
model ,type:2
model ,interferon:2
model ,signaling:2
reveals ,inflammatory:2
reveals ,role:2
reveals ,type:2
reveals ,interferon:2
reveals ,signaling:2
inflammatory ,type:2
inflammatory ,interferon:2
inflammatory ,signaling:2
type ,signaling:4
interferon ,signaling:2
features ,admitted:2
features ,pneumology:2
patients ,pneumology:2
novel ,admitted:2
novel ,pneumology:2
coronavirus ,admitted:2
coronavirus ,pneumology:2
admitted ,pneumology:2
bacillus ,calmette-guerin:2
bacillus ,vaccination:4
bacillus ,policy:2
bacillus ,consumption:2
bacillus ,ammonium:2
calmette-guerin ,vaccination:2
calmette-guerin ,policy:2
calmette-guerin ,consumption:2
calmette-guerin ,ammonium:2
vaccination ,policy:2
vaccination ,consumption:2
vaccination ,ammonium:2
policy ,consumption:2
policy ,ammonium:2
consumption ,ammonium:2
utility ,stool:2
utility ,pcr:4
utility ,diagnosis:4
utility ,comparison:2
utility ,two:2
utility ,commercial:2
stool ,pcr:2
stool ,diagnosis:2
stool ,covid-19:2
stool ,comparison:2
stool ,two:2
stool ,commercial:2
pcr ,diagnosis:2
diagnosis ,comparison:4
diagnosis ,two:2
diagnosis ,commercial:2
development ,multicenter:2
development ,performance:2
development ,fully:6
development ,automated:4
development ,igm:2
multicenter ,performance:2
multicenter ,fully:2
multicenter ,automated:2
multicenter ,igm:2
performance ,fully:2
performance ,igm:2
evaluation ,igm:2
fully ,igm:2
automated ,igm:2
replication-competent ,vesicular:6
replication-competent ,stomatitis:6
replication-competent ,virus:4
replication-competent ,vaccine:2
replication-competent ,vector:2
replication-competent ,protects:2
vesicular ,stomatitis:6
vesicular ,virus:4
vesicular ,vaccine:2
vesicular ,vector:2
vesicular ,protects:2
stomatitis ,virus:4
stomatitis ,vaccine:2
stomatitis ,vector:2
stomatitis ,protects:2
virus ,vector:4
virus ,protects:2
vaccine ,vector:4
vaccine ,protects:2
vector ,protects:2
neutrophils ,neutrophil:2
neutrophils ,extracellular:2
neutrophils ,traps:2
neutrophils ,drive:2
neutrophils ,necroinflammation:2
neutrophil ,traps:6
neutrophil ,drive:2
neutrophil ,necroinflammation:2
extracellular ,traps:6
extracellular ,drive:2
extracellular ,necroinflammation:2
traps ,drive:2
traps ,necroinflammation:2
traps ,covid-19:2
drive ,necroinflammation:2
drive ,covid-19:2
necroinflammation ,covid-19:2
pathological ,inflammation:2
pathological ,key:2
pathological ,role:2
pathological ,monocytes:2
inflammation ,key:2
patients ,monocytes:2
role ,monocytes:2
lower ,prevalence:2
lower ,antibodies:2
lower ,neutralizing:2
lower ,group:2
lower ,french:2
lower ,blood:2
prevalence ,neutralizing:2
prevalence ,french:2
antibodies ,group:4
antibodies ,french:2
antibodies ,blood:6
neutralizing ,group:2
neutralizing ,french:2
neutralizing ,blood:2
sars-cov-2 ,french:2
group ,french:2
french ,blood:2
emerging ,cardiological:2
emerging ,issues:2
cardiological ,issues:2
cardiological ,covid-19:4
cardiological ,pandemic:2
head ,survivorship:2
head ,care:4
head ,times:2
head ,pandemic:8
neck ,survivorship:2
neck ,care:4
neck ,times:2
neck ,pandemic:6
survivorship ,care:2
survivorship ,times:2
survivorship ,sars-cov-2:2
survivorship ,pandemic:2
care ,times:4
times ,sars-cov-2:6
essential ,new:2
essential ,informations:2
essential ,clinical:2
essential ,recognition:2
essential ,infection:4
new ,informations:2
new ,recognition:2
informations ,clinical:2
informations ,recognition:2
informations ,covid-19:2
informations ,infection:2
clinical ,recognition:2
recognition ,infection:2
sars-cov-2 ,familial:2
familial ,reveals:2
familial ,asymptomatic:4
familial ,transmission:4
cluster ,reveals:2
reveals ,asymptomatic:2
reveals ,transmission:2
single-cell ,rna:4
single-cell ,provides:2
single-cell ,insights:2
rna ,ace2:2
rna ,expression:6
rna ,provides:2
analysis ,provides:4
analysis ,insights:6
ace2 ,provides:2
ace2 ,insights:8
expression ,provides:2
expression ,insights:2
provides ,insights:4
provides ,sars-cov-2:4
collateral ,benefits:2
collateral ,respiratory:2
collateral ,infections:2
collateral ,fighting:2
benefits ,respiratory:2
benefits ,infections:2
benefits ,fighting:2
benefits ,covid-19:4
respiratory ,fighting:2
infections ,fighting:2
hsv-1 ,zika:2
hsv-1 ,virus:2
hsv-1 ,sars-cov-2:2
hsv-1 ,replicate:2
hsv-1 ,human:2
hsv-1 ,cornea:2
zika ,virus:4
zika ,sars-cov-2:2
zika ,replicate:2
zika ,human:2
zika ,cornea:2
virus ,replicate:2
virus ,cornea:2
sars-cov-2 ,cornea:2
replicate ,human:2
replicate ,cornea:2
human ,cornea:2
epidural ,blood:2
epidural ,patch:2
epidural ,postdural:2
epidural ,puncture:2
epidural ,headache:2
epidural ,patient:2
epidural ,coronavirus:2
blood ,patch:2
blood ,postdural:2
blood ,puncture:2
blood ,headache:2
blood ,patient:4
patch ,postdural:2
patch ,puncture:2
patch ,headache:2
patch ,patient:2
patch ,coronavirus:2
postdural ,puncture:2
postdural ,headache:2
postdural ,patient:2
postdural ,coronavirus:2
puncture ,headache:2
puncture ,patient:2
puncture ,coronavirus:2
headache ,patient:2
big ,challenge:2
big ,sars-cov-2:2
big ,latency:2
big ,testes:2
big ,reservoir:2
challenge ,latency:2
challenge ,testes:2
challenge ,reservoir:2
sars-cov-2 ,latency:4
sars-cov-2 ,testes:2
sars-cov-2 ,reservoir:4
latency ,testes:2
latency ,reservoir:2
testes ,reservoir:2
evidence-based ,considerations:2
evidence-based ,exploring:2
evidence-based ,relations:2
evidence-based ,sars-cov-2:6
considerations ,exploring:2
considerations ,relations:2
exploring ,relations:2
exploring ,pandemic:2
relations ,sars-cov-2:2
relations ,pandemic:2
trial ,test:2
trial ,efficacy:6
trial ,melatonin:4
test ,melatonin:2
efficacy ,melatonin:4
melatonin ,covid-19:8
assessment ,severity:2
assessment ,mortality:2
assessment ,glycemic:2
assessment ,control:2
assessment ,antidiabetic:2
assessment ,agents:2
risk ,mortality:14
risk ,glycemic:2
risk ,control:2
risk ,antidiabetic:2
risk ,agents:4
severity ,glycemic:2
severity ,antidiabetic:2
severity ,agents:2
mortality ,glycemic:2
mortality ,antidiabetic:2
mortality ,agents:2
glycemic ,control:2
glycemic ,antidiabetic:2
glycemic ,agents:2
control ,antidiabetic:2
control ,agents:2
antidiabetic ,agents:2
global ,cataloguing:2
global ,variations:2
global ,untranslated:2
global ,regions:2
global ,viral:2
global ,genome:2
cataloguing ,variations:2
cataloguing ,untranslated:2
cataloguing ,regions:2
cataloguing ,viral:2
cataloguing ,genome:2
variations ,untranslated:2
variations ,regions:2
variations ,viral:2
variations ,genome:2
untranslated ,regions:2
untranslated ,viral:2
untranslated ,genome:2
regions ,viral:2
regions ,genome:2
airborne ,severe:2
airborne ,acute:2
airborne ,respiratory:2
airborne ,syndrome:2
airborne ,coronavirus-2:2
transmission ,coronavirus-2:2
case ,chest:6
case ,imaging:4
series ,chest:4
series ,imaging:4
series ,manifestation:4
chest ,imaging:14
chest ,manifestation:2
imaging ,manifestation:2
surveillance ,testing:6
surveillance ,clinical:2
surveillance ,laboratories:2
coronavirus ,laboratories:2
disease ,laboratories:2
testing ,laboratories:2
clinical ,laboratories:6
cancer ,postpone:2
treatment ,postpone:2
coronavirus ,postpone:2
disease ,postpone:2
pandemic ,postpone:2
times ,infection:2
times ,detectable:2
times ,longer:2
infection ,detectable:2
detectable ,longer:2
sars-cov-2 ,presented:4
presented ,air:2
presented ,intensive:2
presented ,care:2
presented ,unit:2
presented ,icu:2
air ,intensive:2
air ,care:4
air ,unit:2
air ,icu:2
intensive ,icu:2
care ,icu:2
unit ,icu:2
crowned ,killers:2
crowned ,rsum:2
crowned ,genome:2
crowned ,structure:2
crowned ,receptors:2
crowned ,origin:2
crowned ,sars-cov-2:2
killers ,rsum:2
killers ,genome:2
killers ,structure:2
killers ,receptors:2
killers ,origin:2
killers ,sars-cov-2:2
rsum ,genome:2
rsum ,structure:2
rsum ,receptors:2
rsum ,origin:2
rsum ,sars-cov-2:2
genome ,receptors:2
genome ,origin:2
structure ,receptors:2
structure ,origin:2
receptors ,origin:2
synthesis ,systematic:2
synthesis ,review:2
synthesis ,reported:2
synthesis ,neonatal:2
synthesis ,sars-cov-2:2
synthesis ,infections:2
systematic ,reported:4
systematic ,neonatal:4
review ,reported:4
review ,neonatal:6
reported ,neonatal:2
reported ,infections:2
neonatal ,infections:2
novel ,biparatopic:2
novel ,hybrid:2
novel ,antibody-ace2:2
novel ,fusion:4
novel ,blocks:2
biparatopic ,hybrid:2
biparatopic ,antibody-ace2:2
biparatopic ,fusion:2
biparatopic ,blocks:2
biparatopic ,sars-cov-2:2
biparatopic ,infection:2
hybrid ,antibody-ace2:2
hybrid ,fusion:2
hybrid ,blocks:2
hybrid ,sars-cov-2:2
hybrid ,infection:2
antibody-ace2 ,fusion:2
antibody-ace2 ,blocks:2
antibody-ace2 ,sars-cov-2:2
antibody-ace2 ,infection:2
fusion ,blocks:2
fusion ,infection:2
blocks ,sars-cov-2:6
blocks ,infection:4
high ,following:2
high ,exposure:2
high ,choir:2
high ,practice:2
high ,skagit:2
high ,county:2
sars-cov-2 ,attack:4
sars-cov-2 ,choir:2
sars-cov-2 ,skagit:2
sars-cov-2 ,county:2
attack ,following:2
attack ,exposure:2
attack ,choir:2
attack ,practice:2
attack ,skagit:2
attack ,county:2
rate ,following:2
rate ,exposure:2
rate ,choir:2
rate ,practice:2
rate ,skagit:2
rate ,county:2
following ,exposure:2
following ,choir:2
following ,practice:2
following ,skagit:2
following ,county:2
exposure ,choir:2
exposure ,practice:2
exposure ,skagit:2
exposure ,county:2
choir ,practice:2
choir ,skagit:2
choir ,county:2
practice ,skagit:2
practice ,county:2
skagit ,county:2
acute ,damage:2
kidney ,damage:2
injury ,damage:2
repositioning ,8565:2
repositioning ,existing:2
8565 ,existing:2
8565 ,drugs:2
8565 ,covid-19:2
liver ,current:2
liver ,insights:2
liver ,challenges:2
injury ,current:2
injury ,insights:2
injury ,challenges:2
severe ,current:2
severe ,insights:2
severe ,challenges:2
infection ,insights:6
infection ,challenges:2
current ,insights:2
insights ,challenges:2
clinical ,investigation:2
pathological ,investigation:2
pathological ,severe:2
investigation ,severe:6
lifting ,mobility:2
lifting ,restrictions:2
lifting ,effect:2
lifting ,superspreading:2
lifting ,events:2
mobility ,restrictions:2
mobility ,effect:2
mobility ,superspreading:2
mobility ,events:2
restrictions ,effect:2
restrictions ,superspreading:2
restrictions ,events:2
effect ,superspreading:2
effect ,events:2
superspreading ,events:4
preventing ,blocking:2
preventing ,tissue:2
preventing ,serine:2
preventing ,protease:2
sars-cov-2 ,serine:2
infection ,blocking:4
infection ,tissue:2
infection ,serine:2
infection ,protease:2
blocking ,tissue:2
blocking ,serine:2
blocking ,protease:2
tissue ,serine:2
tissue ,protease:2
serine ,protease:2
family ,infections:2
human ,chaperones:2
human ,share:2
human ,antigenic:2
human ,epitopes:6
human ,potentially:2
molecular ,chaperones:2
molecular ,share:2
molecular ,antigenic:2
molecular ,epitopes:2
molecular ,potentially:2
chaperones ,share:2
chaperones ,sars-cov-2:2
chaperones ,antigenic:2
chaperones ,epitopes:2
chaperones ,potentially:2
share ,sars-cov-2:2
share ,antigenic:2
share ,epitopes:2
share ,potentially:2
antigenic ,epitopes:2
antigenic ,potentially:2
epitopes ,potentially:2
comparison ,virus:2
comparison ,concentration:2
comparison ,methods:2
comparison ,rt-qpcr-based:2
comparison ,recovery:2
comparison ,murine:2
virus ,concentration:2
virus ,methods:2
virus ,rt-qpcr-based:2
virus ,recovery:2
virus ,murine:4
concentration ,rt-qpcr-based:2
concentration ,recovery:2
concentration ,murine:2
methods ,rt-qpcr-based:2
methods ,recovery:2
methods ,murine:2
rt-qpcr-based ,recovery:2
rt-qpcr-based ,murine:2
recovery ,murine:2
children ,know:4
children ,far:2
elevated ,plasminogen:2
elevated ,common:2
elevated ,risk:2
elevated ,factor:2
elevated ,susceptibility:2
plasminogen ,common:2
plasminogen ,risk:2
plasminogen ,factor:2
plasminogen ,covid-19:2
plasminogen ,susceptibility:2
common ,risk:2
common ,factor:2
common ,susceptibility:2
factor ,susceptibility:2
sars-cov-2 ,neovison:2
sars-cov-2 ,vison:2
sars-cov-2 ,denmark:2
transmission ,mink:2
transmission ,neovison:2
transmission ,vison:2
transmission ,denmark:2
mink ,neovison:2
mink ,vison:2
mink ,humans:2
mink ,denmark:2
neovison ,vison:2
neovison ,humans:2
neovison ,denmark:2
vison ,humans:2
vison ,denmark:2
humans ,denmark:2
covid-19 ,lost:2
liver ,cancer:2
liver ,clinical:6
liver ,trials:2
liver ,everything:2
liver ,lost:2
cancer ,trials:2
cancer ,everything:2
cancer ,lost:2
clinical ,everything:2
clinical ,lost:2
trials ,everything:2
trials ,lost:2
everything ,lost:2
impact ,household:2
impact ,quarantine:2
impact ,mainland:2
household ,quarantine:2
household ,mainland:2
household ,china:2
quarantine ,infection:2
quarantine ,mainland:2
sars-cov-2 ,mainland:2
infection ,mainland:2
mainland ,china:4
solid ,covid-19:8
solid ,pandemic:2
organ ,pandemic:2
ischaemic ,stroke:2
ischaemic ,sars-cov-2:2
ischaemic ,infection:2
ischaemic ,causal:2
ischaemic ,incidental:2
ischaemic ,association:2
stroke ,causal:2
stroke ,incidental:2
sars-cov-2 ,causal:2
sars-cov-2 ,incidental:2
infection ,causal:2
infection ,incidental:2
causal ,incidental:2
causal ,association:2
incidental ,association:2
clinical ,prevention:4
clinical ,control:4
manifestation ,diagnosis:2
manifestation ,prevention:2
manifestation ,control:2
perspectives ,early:2
perspectives ,quality:2
perspectives ,evidence:2
perspectives ,guiding:2
early ,quality:2
early ,guiding:2
early ,therapeutic:2
quality ,evidence:2
quality ,guiding:2
quality ,therapeutic:2
evidence ,guiding:2
guiding ,therapeutic:2
guiding ,management:2
therapeutic ,management:4
olfactory ,highly:2
olfactory ,prevalent:2
olfactory ,symptom:2
olfactory ,public:2
olfactory ,health:2
dysfunction ,highly:2
dysfunction ,prevalent:2
dysfunction ,public:2
dysfunction ,health:2
highly ,prevalent:2
highly ,symptom:2
highly ,public:2
highly ,health:2
prevalent ,symptom:2
prevalent ,covid-19:2
prevalent ,public:2
prevalent ,health:2
symptom ,public:2
symptom ,health:4
disease ,neonates:4
children ,china:6
preparing ,emerging:2
preparing ,respiratory:2
preparing ,pathogens:2
preparing ,sars-cov:2
preparing ,mers-cov:2
emerging ,respiratory:4
emerging ,pathogens:2
emerging ,sars-cov:2
emerging ,mers-cov:2
pathogens ,sars-cov:2
pathogens ,mers-cov:2
effectiveness ,glucocorticoid:2
effectiveness ,therapy:2
effectiveness ,patients:8
effectiveness ,coronavirus:2
effectiveness ,disease:2
glucocorticoid ,therapy:2
glucocorticoid ,patients:2
glucocorticoid ,severe:2
glucocorticoid ,coronavirus:2
glucocorticoid ,disease:2
first ,manic-like:2
first ,previous:2
report ,manic-like:2
report ,symptoms:2
report ,previous:2
report ,history:2
manic-like ,symptoms:2
manic-like ,covid-19:2
manic-like ,patient:2
manic-like ,previous:2
manic-like ,history:2
symptoms ,patient:2
symptoms ,previous:2
symptoms ,history:2
covid-19 ,previous:2
patient ,previous:2
patient ,history:2
previous ,history:2
genomic ,perspective:2
genomic ,origin:4
genomic ,emergence:4
perspective ,origin:2
perspective ,emergence:2
origin ,emergence:2
low ,disease:2
low ,severity:2
low ,post-liver:2
low ,transplant:2
prevalence ,disease:6
prevalence ,severity:4
prevalence ,post-liver:2
prevalence ,transplant:2
disease ,post-liver:2
severity ,post-liver:2
severity ,transplant:2
covid-19 ,post-liver:2
post-liver ,transplant:2
clinical ,improvement:2
improvement ,patient:2
improvement ,coronavirus:2
improvement ,disease:2
meta-analysis ,diagnostic:6
meta-analysis ,test:2
meta-analysis ,accuracy:2
meta-analysis ,commercial:2
meta-analysis ,assays:2
test ,assays:2
accuracy ,commercial:2
accuracy ,assays:2
impact ,meteorological:2
impact ,evidence:2
impact ,top:2
impact ,20:2
meteorological ,evidence:2
meteorological ,top:2
meteorological ,20:2
factors ,pandemic:2
factors ,evidence:2
factors ,top:2
factors ,20:2
pandemic ,20:2
evidence ,top:2
evidence ,20:2
top ,20:2
immune ,including:4
immune ,young:2
immune ,infants:2
response ,including:2
response ,young:2
response ,infants:2
pediatric ,including:2
pediatric ,young:2
pediatric ,infants:2
patients ,including:2
patients ,young:2
patients ,infants:2
including ,young:2
including ,infants:2
young ,infants:2
stroke ,series:2
respiratory ,rhesus:2
respiratory ,macaques:2
respiratory ,inoculated:2
disease ,rhesus:2
disease ,macaques:2
disease ,inoculated:2
rhesus ,inoculated:2
macaques ,inoculated:2
inoculated ,sars-cov-2:2
national ,institutes:2
national ,health:4
national ,social:4
national ,behavioral:2
national ,research:2
national ,response:6
institutes ,health:2
institutes ,social:2
institutes ,behavioral:2
institutes ,research:2
institutes ,response:2
health ,behavioral:4
health ,research:6
social ,behavioral:2
social ,research:2
social ,response:2
behavioral ,research:2
behavioral ,response:2
research ,response:2
hla ,immunological:2
hla ,features:2
hla ,sars-cov-2-induced:2
hla ,guillain-barr:2
hla ,syndrome:2
immunological ,sars-cov-2-induced:2
immunological ,guillain-barr:2
features ,sars-cov-2-induced:2
features ,guillain-barr:2
sars-cov-2-induced ,guillain-barr:2
neurological ,catastrophe:2
neurological ,queue:2
damage ,catastrophe:2
damage ,queue:2
coronaviruses ,catastrophe:2
coronaviruses ,queue:2
catastrophe ,queue:2
drug ,cytokine:2
drug ,management:4
drug ,response:2
repurposing ,cytokine:2
cytokine ,management:2
cytokine ,response:6
cytokine ,review:2
management ,response:4
sars-cov-2covid-19 ,simply:2
sars-cov-2covid-19 ,fade:2
sars-cov-2covid-19 ,away:2
simply ,fade:2
simply ,away:2
fade ,away:2
air ,status:2
air ,malaysia:2
air ,movement:2
air ,control:2
air ,order:2
air ,mco:2
air ,due:4
quality ,status:2
quality ,malaysia:2
quality ,movement:2
quality ,control:2
quality ,order:2
quality ,mco:2
quality ,due:4
status ,malaysia:2
status ,movement:2
status ,control:2
status ,order:2
status ,mco:2
status ,due:2
malaysia ,movement:2
malaysia ,control:2
malaysia ,order:2
malaysia ,mco:2
malaysia ,due:2
movement ,control:2
movement ,order:2
movement ,mco:2
movement ,due:2
control ,order:2
control ,mco:2
control ,due:2
order ,mco:2
order ,due:2
mco ,due:2
rapid ,simplexa:2
sensitive ,simplexa:2
sensitive ,covid-19:6
sensitive ,direct:2
detection ,simplexa:2
sars-cov-2 ,simplexa:2
rna ,simplexa:2
using ,simplexa:2
using ,direct:2
simplexa ,covid-19:2
simplexa ,direct:2
temporal ,course:2
temporal ,antibody:2
temporal ,positivity:2
course ,antibody:2
course ,positivity:2
antibody ,positivity:2
positivity ,patients:2
positivity ,covid-19:4
pandemic ,ahead:4
light ,shadow:2
light ,rapid:2
light ,serological:2
light ,tests:2
light ,infection:2
light ,results:2
shadow ,rapid:2
shadow ,serological:2
shadow ,tests:2
shadow ,sars-cov-2:2
shadow ,infection:2
shadow ,results:2
rapid ,results:2
serological ,results:4
need ,speed:2
need ,human:2
need ,protective:2
need ,efficacious:2
speed ,human:2
speed ,sars-cov-2:2
speed ,samples:2
speed ,protective:2
speed ,efficacious:2
human ,protective:2
human ,efficacious:2
sars-cov-2 ,efficacious:2
samples ,protective:2
samples ,efficacious:2
protective ,efficacious:2
review ,reports:4
case ,reports:6
monitoring ,approaches:2
monitoring ,health-care:2
monitoring ,workers:2
approaches ,health-care:2
approaches ,workers:2
approaches ,pandemic:2
health-care ,workers:8
health-care ,pandemic:2
tertiary ,experience:2
tertiary ,multiple:2
tertiary ,myeloma:2
tertiary ,patients:12
tertiary ,covid-19:14
tertiary ,lessons:2
center ,multiple:2
center ,myeloma:2
center ,lessons:2
experience ,multiple:2
experience ,myeloma:2
multiple ,myeloma:2
multiple ,lessons:2
myeloma ,patients:2
myeloma ,covid-19:2
myeloma ,lessons:2
patients ,lessons:2
antiviral ,antibody:2
antiviral ,medicine:2
agents ,antibody:2
agents ,traditional:2
agents ,chinese:4
agents ,medicine:2
antibody ,traditional:2
antibody ,chinese:2
antibody ,medicine:2
development ,traditional:2
development ,chinese:2
development ,medicine:2
drugs ,pneumonia:2
soluble ,angiotensin-converting:2
soluble ,enzyme:2
soluble ,potential:2
soluble ,approach:2
soluble ,coronavirus:2
angiotensin-converting ,approach:2
enzyme ,approach:2
critical ,differences:2
critical ,binding:2
critical ,features:4
critical ,spike:2
critical ,proteins:2
differences ,binding:2
differences ,features:4
differences ,spike:4
differences ,proteins:4
binding ,features:2
features ,proteins:2
pandemic ,3d-printed:2
pandemic ,swab:2
pandemic ,detecting:4
printing ,novel:2
printing ,3d-printed:2
printing ,swab:2
printing ,detecting:2
printing ,sars-cov-2:2
novel ,3d-printed:2
novel ,swab:2
3d-printed ,swab:2
3d-printed ,detecting:2
3d-printed ,sars-cov-2:2
swab ,detecting:2
airborne ,pathogen:2
airborne ,projection:2
airborne ,ophthalmic:2
airborne ,examination:2
pathogen ,projection:2
pathogen ,ophthalmic:2
pathogen ,examination:2
projection ,ophthalmic:2
projection ,examination:2
ophthalmic ,examination:2
broad-spectrum ,host-based:2
broad-spectrum ,antivirals:4
broad-spectrum ,targeting:2
broad-spectrum ,interferon:2
broad-spectrum ,lipogenesis:2
host-based ,antivirals:2
host-based ,targeting:2
host-based ,interferon:2
host-based ,lipogenesis:2
antivirals ,targeting:2
antivirals ,interferon:2
antivirals ,lipogenesis:2
targeting ,interferon:2
targeting ,lipogenesis:2
interferon ,lipogenesis:2
liver ,retrospective:4
liver ,115:2
impairment ,retrospective:2
impairment ,analysis:2
impairment ,115:2
impairment ,cases:2
covid-19 ,115:2
patients ,115:2
retrospective ,115:2
retrospective ,cases:4
case ,describing:2
case ,epidemiology:2
series ,describing:2
series ,epidemiology:2
describing ,epidemiology:2
describing ,clinical:2
describing ,characteristics:2
describing ,covid-19:4
epidemiology ,characteristics:2
review ,vaccine:12
review ,development:4
review ,progress:2
promising ,vaccine:2
promising ,progress:2
development ,disease:8
progress ,disease:4
management ,rhinosinusitis:2
complicated ,pediatric:2
complicated ,rhinosinusitis:2
complicated ,era:2
pediatric ,rhinosinusitis:2
pediatric ,era:4
rhinosinusitis ,covid-19:2
rhinosinusitis ,era:2
protective ,adaptive:2
protective ,syndrome:2
protective ,coronaviruses:2
adaptive ,severe:4
adaptive ,acute:4
adaptive ,respiratory:2
adaptive ,syndrome:2
adaptive ,coronaviruses:2
immunity ,severe:2
immunity ,acute:4
immunity ,respiratory:2
immunity ,syndrome:2
immunity ,coronaviruses:2
severe ,coronaviruses:2
acute ,coronaviruses:2
syndrome ,coronaviruses:2
isolation ,phylogenetic:2
isolation ,analysis:2
isolation ,variants:2
isolation ,collected:2
isolation ,russia:2
phylogenetic ,variants:2
phylogenetic ,collected:2
phylogenetic ,russia:2
analysis ,variants:8
analysis ,russia:2
sars-cov-2 ,russia:2
variants ,collected:2
variants ,russia:2
collected ,russia:2
emmprinbasigin ,biological:2
emmprinbasigin ,modulator:2
emmprinbasigin ,oral:2
emmprinbasigin ,cancer:2
emmprinbasigin ,covid-19:2
emmprinbasigin ,interaction:2
biological ,modulator:2
biological ,oral:2
biological ,cancer:2
biological ,interaction:2
modulator ,oral:2
modulator ,cancer:2
modulator ,interaction:2
oral ,cancer:2
oral ,interaction:2
cancer ,interaction:2
indomethacin ,resveratrol:2
indomethacin ,potential:4
indomethacin ,treatment:2
indomethacin ,adjuncts:2
resveratrol ,treatment:2
resveratrol ,adjuncts:2
potential ,adjuncts:4
treatment ,adjuncts:2
pathophysiology ,wound:2
pathophysiology ,care:2
pathophysiology ,professionals:2
coronavirus ,wound:2
coronavirus ,professionals:2
disease ,wound:2
disease ,professionals:2
wound ,care:2
wound ,professionals:2
evaluation ,lung:2
novel ,quantitative:6
novel ,lung:6
disease ,quantitative:2
covid-19 ,quantitative:2
using ,quantitative:2
using ,lung:2
using ,ct:2
quantitative ,lung:4
quantitative ,ct:4
post-exposure ,prophylaxis:12
post-exposure ,pre-emptive:2
post-exposure ,therapy:2
post-exposure ,severe:4
post-exposure ,acute:4
post-exposure ,respiratory:2
prophylaxis ,pre-emptive:2
prophylaxis ,therapy:4
prophylaxis ,severe:4
prophylaxis ,acute:4
prophylaxis ,respiratory:2
pre-emptive ,therapy:2
pre-emptive ,severe:2
pre-emptive ,acute:2
pre-emptive ,respiratory:2
efficacy ,nucleic:2
efficacy ,acid:2
three ,kits:2
kits ,nucleic:2
kits ,acid:2
protocol ,management:2
protocol ,maxillofacial:2
protocol ,injuries:2
protocol ,wake:2
management ,injuries:2
management ,wake:2
maxillofacial ,injuries:2
maxillofacial ,wake:2
injuries ,wake:2
wake ,covid-19:2
managing ,outbreak:2
managing ,nigeria:2
managing ,matters:2
managing ,arising:2
outbreak ,nigeria:2
outbreak ,matters:2
outbreak ,arising:2
nigeria ,matters:2
nigeria ,arising:2
matters ,arising:2
cd147 ,target:2
cd147 ,covid-19:2
cd147 ,treatment:2
cd147 ,suggested:2
cd147 ,effects:2
cd147 ,azithromycin:2
cd147 ,stem:2
target ,treatment:6
target ,suggested:2
target ,effects:2
target ,azithromycin:2
target ,stem:2
treatment ,suggested:2
treatment ,effects:4
suggested ,effects:2
suggested ,azithromycin:2
suggested ,stem:2
effects ,azithromycin:2
effects ,stem:2
azithromycin ,stem:2
neonatal ,postresuscitation:2
neonatal ,infants:4
neonatal ,born:4
neonatal ,mothers:4
resuscitation ,postresuscitation:2
resuscitation ,care:2
resuscitation ,infants:2
resuscitation ,born:2
resuscitation ,mothers:2
postresuscitation ,care:2
postresuscitation ,infants:2
postresuscitation ,born:2
postresuscitation ,mothers:2
care ,infants:2
care ,born:2
care ,mothers:2
infants ,mothers:4
effective ,screening:2
effective ,neutralizing:2
effective ,antibodies:2
effective ,patient:2
effective ,serum:4
effective ,using:2
screening ,neutralizing:4
screening ,antibodies:4
screening ,patient:2
screening ,serum:2
neutralizing ,patient:2
neutralizing ,serum:2
neutralizing ,using:4
antibodies ,patient:2
patient ,serum:2
patient ,using:4
serum ,using:2
molecular ,phylogenetic:4
molecular ,preliminary:2
phylogenetic ,covid-19:2
phylogenetic ,patients:2
phylogenetic ,preliminary:2
patients ,preliminary:4
real-time ,audio:2
real-time ,visual:2
real-time ,display:2
real-time ,genome:2
audio ,visual:2
audio ,display:2
audio ,coronavirus:2
audio ,genome:2
visual ,display:2
visual ,genome:2
display ,genome:2
structural ,modelling:4
structural ,reveal:2
structural ,new:2
structural ,action:2
modelling ,studies:2
modelling ,reveal:2
modelling ,new:2
modelling ,mechanism:2
studies ,reveal:2
studies ,new:2
studies ,mechanism:2
studies ,action:2
reveal ,new:2
reveal ,mechanism:2
reveal ,action:2
outbreak ,epicentre:2
severe ,kawasaki-like:2
severe ,italian:2
severe ,epicentre:2
kawasaki-like ,italian:2
kawasaki-like ,epicentre:2
disease ,italian:2
disease ,epicentre:2
italian ,epicentre:2
evaluation ,ion:2
evaluation ,ampliseq:2
evaluation ,research:2
evaluation ,massive:2
evaluation ,parallel:2
ion ,ampliseq:2
ion ,research:2
ion ,panel:2
ion ,massive:2
ion ,parallel:2
ampliseq ,sars-cov-2:2
ampliseq ,research:2
ampliseq ,panel:2
ampliseq ,massive:2
ampliseq ,parallel:2
sars-cov-2 ,massive:6
sars-cov-2 ,parallel:2
research ,panel:2
research ,massive:2
research ,parallel:2
panel ,massive:2
panel ,parallel:2
massive ,parallel:2
urgent ,reconsideration:2
urgent ,lung:2
urgent ,edema:2
urgent ,preventable:2
urgent ,outcome:2
urgent ,covid-19:10
reconsideration ,lung:2
reconsideration ,edema:2
reconsideration ,preventable:2
reconsideration ,outcome:2
reconsideration ,covid-19:2
lung ,edema:2
lung ,preventable:2
lung ,outcome:2
edema ,preventable:2
edema ,outcome:2
edema ,covid-19:2
preventable ,outcome:2
preventable ,covid-19:2
three ,unsuspected:2
three ,diagnoses:2
unsuspected ,ct:2
unsuspected ,diagnoses:2
unsuspected ,covid-19:2
ct ,diagnoses:2
massive ,transient:2
massive ,damage:2
massive ,olfactory:2
massive ,epithelium:2
massive ,associated:2
massive ,infection:4
transient ,damage:2
transient ,olfactory:2
transient ,epithelium:2
transient ,associated:2
transient ,infection:2
damage ,olfactory:2
damage ,epithelium:2
damage ,associated:2
olfactory ,epithelium:2
olfactory ,associated:2
epithelium ,associated:2
epithelium ,infection:2
open ,science:2
open ,approaches:2
science ,approaches:2
covid-19 ,exposes:2
exposes ,gaps:2
exposes ,infection:2
exposes ,prevention:2
exposes ,control:2
gaps ,infection:4
gaps ,prevention:2
gaps ,control:2
physical ,exercise:2
physical ,multimodal:2
physical ,tool:2
physical ,covid-19:16
physical ,used:2
exercise ,multimodal:2
exercise ,tool:2
exercise ,used:2
multimodal ,tool:2
multimodal ,covid-19:2
multimodal ,used:2
tool ,covid-19:10
tool ,used:2
good ,bad:2
good ,application:2
good ,raas:2
good ,inhibitors:2
good ,patients:2
good ,cardiovascular:2
bad ,application:2
bad ,raas:2
bad ,inhibitors:2
bad ,covid-19:4
bad ,patients:2
bad ,cardiovascular:2
application ,raas:2
application ,inhibitors:2
application ,patients:2
application ,cardiovascular:2
raas ,cardiovascular:2
inhibitors ,cardiovascular:2
racial ,workplace:2
racial ,seroprevalence:2
racial ,baton:2
racial ,rouge:2
workplace ,disparities:2
workplace ,seroprevalence:2
workplace ,sars-cov-2:2
workplace ,baton:2
workplace ,rouge:2
disparities ,seroprevalence:2
disparities ,baton:2
disparities ,rouge:2
seroprevalence ,baton:2
seroprevalence ,rouge:2
sars-cov-2 ,baton:2
sars-cov-2 ,rouge:2
baton ,rouge:2
emerging ,therapeutics:2
emerging ,management:2
emerging ,covid:2
emerging ,19:2
therapeutics ,management:2
therapeutics ,covid:2
therapeutics ,19:2
evaluation ,realstar:2
evaluation ,kit:2
evaluation ,ruo:2
evaluation ,performances:2
evaluation ,limit:2
realstar ,sars-cov-2:2
realstar ,rt-pcr:4
realstar ,kit:4
realstar ,ruo:2
realstar ,performances:2
realstar ,limit:2
sars-cov-2 ,ruo:2
sars-cov-2 ,limit:2
rt-pcr ,kit:6
rt-pcr ,ruo:2
rt-pcr ,performances:2
rt-pcr ,limit:2
kit ,ruo:2
kit ,performances:2
kit ,limit:2
ruo ,performances:2
ruo ,limit:2
performances ,limit:2
pandemic ,lesson:4
pandemic ,must:2
pandemic ,forget:2
covid ,lesson:2
covid ,must:2
covid ,forget:4
19 ,lesson:2
19 ,must:2
19 ,forget:2
lesson ,must:2
lesson ,forget:2
must ,forget:2
ethical ,dimensions:2
ethical ,prevention:2
ethical ,planning:2
ethical ,assisted-living:2
ethical ,facilities:2
dimensions ,prevention:2
dimensions ,planning:2
dimensions ,assisted-living:2
dimensions ,facilities:2
prevention ,planning:2
prevention ,assisted-living:2
prevention ,facilities:2
planning ,assisted-living:2
planning ,facilities:2
assisted-living ,facilities:2
development ,minimal:2
development ,physiologically-based:2
development ,pharmacokinetic:2
development ,simulate:2
minimal ,physiologically-based:2
minimal ,pharmacokinetic:2
minimal ,model:2
minimal ,simulate:2
physiologically-based ,pharmacokinetic:2
physiologically-based ,model:2
physiologically-based ,simulate:2
pharmacokinetic ,model:2
pharmacokinetic ,simulate:2
model ,simulate:2
look ,behind:2
look ,scenes:2
look ,national:2
look ,strategies:2
look ,infection:2
look ,control:2
behind ,scenes:2
behind ,national:2
behind ,strategies:2
behind ,infection:2
behind ,control:2
scenes ,covid-19:2
scenes ,national:2
scenes ,strategies:2
scenes ,infection:2
scenes ,control:2
national ,strategies:2
national ,infection:6
national ,control:2
special ,elderly:2
special ,head:2
special ,neck:2
special ,cancer:2
considerations ,elderly:2
considerations ,head:2
considerations ,neck:2
elderly ,patients:8
elderly ,head:2
elderly ,neck:2
elderly ,cancer:2
patients ,head:2
patients ,neck:2
nervous ,pathogenesis:2
nervous ,clinical:4
nervous ,manifestation:2
system ,manifestation:2
pathogenesis ,manifestation:2
immune ,diagnosis:2
eleven ,faces:2
eleven ,coronavirus:2
eleven ,disease:2
faces ,coronavirus:2
faces ,disease:2
variplex ,test:2
variplex ,system:2
variplex ,fails:2
variplex ,reliably:2
variplex ,detect:2
variplex ,sars-cov-2:2
variplex ,directly:2
variplex ,respiratory:2
test ,system:2
test ,fails:2
test ,reliably:2
test ,detect:4
test ,directly:2
system ,fails:2
system ,reliably:2
system ,detect:2
system ,directly:4
fails ,reliably:2
fails ,detect:2
fails ,sars-cov-2:2
fails ,directly:2
fails ,respiratory:2
reliably ,detect:2
reliably ,sars-cov-2:2
reliably ,directly:2
reliably ,respiratory:2
detect ,directly:2
directly ,respiratory:2
sars-cov ,main:2
sars-cov ,protease:2
sars-cov ,residue:2
sars-cov ,interaction:2
sars-cov ,networks:2
sars-cov ,change:2
sars-cov ,bound:2
sars-cov-2 ,bound:6
main ,residue:2
main ,interaction:4
main ,networks:2
main ,change:2
main ,bound:2
protease ,residue:2
protease ,interaction:2
protease ,networks:2
protease ,change:2
protease ,bound:2
residue ,interaction:2
residue ,networks:2
residue ,change:2
residue ,bound:2
interaction ,networks:2
interaction ,change:2
interaction ,bound:2
networks ,change:2
networks ,bound:2
change ,bound:2
biochemical ,pathogenesis:2
biochemical ,infection:2
biochemical ,vital:2
biochemical ,organs:2
parameters ,pathogenesis:2
parameters ,sars-cov-2:2
parameters ,infection:2
parameters ,vital:2
parameters ,organs:2
pathogenesis ,vital:2
pathogenesis ,organs:2
sars-cov-2 ,vital:2
infection ,vital:2
infection ,organs:2
vital ,organs:2
evaluation ,variation:2
evaluation ,d-dimer:2
evaluation ,among:4
evaluation ,bacterial:4
variation ,d-dimer:2
variation ,levels:2
variation ,among:2
variation ,bacterial:2
variation ,pneumonia:2
d-dimer ,among:2
d-dimer ,bacterial:2
d-dimer ,pneumonia:2
levels ,among:2
levels ,bacterial:2
levels ,pneumonia:2
among ,pneumonia:4
bacterial ,pneumonia:2
rapid ,implementation:6
rapid ,validation:2
rapid ,cold-chain:2
rapid ,free:2
implementation ,validation:2
implementation ,cold-chain:2
implementation ,free:2
implementation ,sars-cov-2:8
validation ,cold-chain:2
validation ,free:2
validation ,diagnostic:2
cold-chain ,free:2
cold-chain ,sars-cov-2:2
cold-chain ,diagnostic:2
free ,sars-cov-2:4
free ,diagnostic:2
impact ,department:4
impact ,early:2
impact ,findings:2
pandemic ,department:14
pandemic ,early:14
emergency ,early:2
emergency ,findings:2
department ,early:2
department ,findings:2
previous ,active:2
previous ,tuberculosis:2
previous ,increases:2
previous ,risk:2
previous ,death:2
previous ,prolongs:2
previous ,recovery:2
active ,tuberculosis:4
active ,increases:2
active ,risk:2
active ,death:2
active ,prolongs:2
active ,recovery:2
tuberculosis ,increases:2
tuberculosis ,risk:2
tuberculosis ,death:2
tuberculosis ,prolongs:2
tuberculosis ,recovery:2
increases ,risk:2
increases ,death:2
increases ,prolongs:2
increases ,recovery:2
risk ,prolongs:2
risk ,recovery:2
death ,prolongs:2
death ,recovery:2
prolongs ,recovery:2
covid-19-associated ,meningoencephalitis:2
covid-19-associated ,treated:2
covid-19-associated ,intravenous:2
covid-19-associated ,immunoglobulin:2
meningoencephalitis ,treated:2
meningoencephalitis ,intravenous:2
meningoencephalitis ,immunoglobulin:2
treated ,intravenous:2
treated ,immunoglobulin:2
janus ,kinase:2
janus ,inhibitor:2
janus ,baricitinib:2
janus ,ideal:2
janus ,option:2
janus ,management:2
kinase ,inhibitor:4
kinase ,baricitinib:2
kinase ,ideal:2
kinase ,option:2
kinase ,management:2
inhibitor ,baricitinib:2
inhibitor ,ideal:2
inhibitor ,option:2
inhibitor ,management:2
baricitinib ,ideal:2
baricitinib ,option:2
baricitinib ,management:2
ideal ,option:4
ideal ,management:4
option ,management:4
covid-19 ,cardio-oncology:6
clinical ,primer:4
clinical ,cardio-oncology:4
trials ,primer:4
trials ,cardiovascular:4
trials ,cardio-oncology:4
primer ,cardiovascular:4
primer ,cardio-oncology:4
cardiovascular ,cardio-oncology:4
search ,medications:2
search ,treat:2
search ,via:2
search ,silico:2
search ,molecular:2
search ,docking:2
search ,models:2
medications ,treat:2
medications ,covid-19:4
medications ,via:2
medications ,silico:2
medications ,molecular:2
medications ,docking:2
medications ,models:2
treat ,via:2
treat ,silico:2
treat ,molecular:2
treat ,docking:2
treat ,models:2
via ,silico:2
via ,molecular:4
via ,docking:2
via ,models:2
silico ,models:2
molecular ,models:4
docking ,models:2
clinical ,self-collected:2
clinical ,quantitative:2
evaluation ,self-collected:2
evaluation ,reverse:2
self-collected ,quantitative:2
self-collected ,reverse:2
saliva ,quantitative:2
saliva ,reverse:2
quantitative ,reverse:2
basic ,principles:2
basic ,replication:2
basic ,immunology:2
basic ,sars-cov-2:4
principles ,replication:2
principles ,immunology:2
replication ,immunology:2
urgency ,utilizing:2
urgency ,covid-19:2
urgency ,biospecimens:2
urgency ,research:2
urgency ,heart:2
utilizing ,biospecimens:2
utilizing ,research:2
utilizing ,heart:2
covid-19 ,biospecimens:2
biospecimens ,research:2
biospecimens ,heart:2
research ,heart:2
knowledge ,cross:2
knowledge ,sectional:2
attitude ,among:2
attitude ,covid-19:2
attitude ,cross:2
attitude ,sectional:2
among ,towards:2
among ,cross:2
among ,sectional:2
healthcare ,cross:2
healthcare ,sectional:2
workers ,cross:2
workers ,sectional:2
towards ,cross:2
towards ,sectional:2
covid-19 ,sectional:2
cross ,sectional:2
mechanical ,ventilator:2
mechanical ,shared:2
mechanical ,resource:2
mechanical ,pandemic:2
ventilator ,shared:2
ventilator ,resource:2
ventilator ,pandemic:2
shared ,resource:2
shared ,pandemic:2
public ,agency:2
public ,swedens:2
public ,brief:2
public ,report:2
public ,pregnant:2
public ,postpartum:2
public ,women:2
health ,agency:2
health ,swedens:2
health ,brief:2
health ,report:4
health ,pregnant:4
health ,postpartum:2
health ,women:4
agency ,swedens:2
agency ,brief:2
agency ,report:2
agency ,pregnant:2
agency ,postpartum:2
agency ,women:2
swedens ,brief:2
swedens ,report:2
swedens ,pregnant:2
swedens ,postpartum:2
swedens ,women:2
brief ,pregnant:2
brief ,postpartum:2
brief ,women:2
report ,postpartum:2
report ,women:4
pregnant ,postpartum:2
postpartum ,women:2
immunocompromised ,coronavirus:2
immunocompromised ,disease:2
immunocompromised ,review:2
bioengineering ,tools:2
bioengineering ,speed:2
bioengineering ,discovery:2
bioengineering ,preclinical:2
bioengineering ,testing:2
bioengineering ,vaccines:2
tools ,speed:2
tools ,discovery:2
tools ,preclinical:2
tools ,testing:2
tools ,vaccines:2
speed ,discovery:2
speed ,preclinical:2
speed ,testing:2
discovery ,preclinical:2
discovery ,testing:2
discovery ,vaccines:2
preclinical ,testing:2
preclinical ,vaccines:2
testing ,vaccines:2
children ,approach:2
proposal ,low-dose:2
proposal ,long-pitch:2
proposal ,dual-source:2
proposal ,chest:2
proposal ,ct:2
proposal ,protocol:2
low-dose ,long-pitch:2
low-dose ,dual-source:2
low-dose ,chest:2
low-dose ,ct:2
low-dose ,protocol:2
long-pitch ,dual-source:2
long-pitch ,chest:2
long-pitch ,ct:2
long-pitch ,protocol:2
dual-source ,chest:2
dual-source ,ct:2
dual-source ,protocol:2
chest ,protocol:2
ct ,protocol:2
rt-qpcr ,testing:4
rt-qpcr ,primer:2
testing ,primer:2
sars-cov-2 ,primer:6
pandemic ,view:2
pandemic ,york:8
pandemic ,city:2
view ,new:2
view ,york:2
view ,city:2
perspective ,antibody-dependent:2
perspective ,enhancement:2
potential ,antibody-dependent:2
potential ,enhancement:2
case ,mexico:2
case ,detection:4
report ,newborn:2
report ,mexico:2
report ,detection:2
newborn ,infant:2
newborn ,severe:2
newborn ,covid-19:8
newborn ,mexico:2
newborn ,detection:2
infant ,severe:2
infant ,mexico:2
infant ,detection:2
severe ,mexico:2
mexico ,detection:2
research ,genetic:2
research ,structure:2
research ,pathogenic:2
research ,mechanism:2
progress ,genetic:2
progress ,structure:2
progress ,pathogenic:2
progress ,mechanism:2
genetic ,structure:4
genetic ,pathogenic:2
genetic ,mechanism:2
structure ,mechanism:2
pathogenic ,mechanism:2
mechanism ,clinical:2
complex ,obstetric:2
complex ,patient:2
complex ,cystic:2
complex ,fibrosis:2
obstetric ,patient:2
obstetric ,cystic:2
obstetric ,fibrosis:2
patient ,cystic:2
patient ,fibrosis:2
multicenter ,neumodx:2
evaluation ,neumodx:2
neumodx ,sars-cov-2:2
neumodx ,test:2
stability ,rna:2
stability ,sequences:2
stability ,derived:2
stability ,genome:2
stability ,cells:2
rna ,derived:2
rna ,genome:4
rna ,cells:2
sequences ,derived:2
sequences ,human:4
sequences ,cells:2
derived ,coronavirus:2
derived ,genome:2
derived ,human:2
derived ,cells:4
genome ,human:4
genome ,cells:2
preliminary ,investigation:2
preliminary ,statistical:2
preliminary ,correlations:2
investigation ,statistical:2
investigation ,correlations:2
statistical ,correlations:2
psoriasis ,health:2
psoriasis ,care:2
psoriasis ,time:2
psoriasis ,insights:2
health ,insights:2
care ,time:6
care ,insights:2
time ,insights:2
anosmia ,associated:4
anosmia ,age-matched:2
dysgeusia ,associated:2
dysgeusia ,sars-cov-2:2
dysgeusia ,infection:2
dysgeusia ,age-matched:2
associated ,age-matched:2
sars-cov-2 ,age-matched:2
infection ,age-matched:2
emergence ,progress:2
emergence ,toward:2
emergence ,treatment:2
emergence ,vaccine:2
novel ,toward:6
progress ,toward:2
toward ,treatment:2
treatment ,vaccine:2
grl-0920 ,indole:2
grl-0920 ,chloropyridinyl:2
grl-0920 ,ester:2
grl-0920 ,completely:2
grl-0920 ,blocks:2
grl-0920 ,sars-cov-2:2
grl-0920 ,infection:2
indole ,chloropyridinyl:2
indole ,ester:2
indole ,completely:2
indole ,blocks:2
indole ,sars-cov-2:2
indole ,infection:2
chloropyridinyl ,ester:2
chloropyridinyl ,completely:2
chloropyridinyl ,blocks:2
chloropyridinyl ,sars-cov-2:2
chloropyridinyl ,infection:2
ester ,completely:2
ester ,blocks:2
ester ,sars-cov-2:2
ester ,infection:2
completely ,blocks:2
completely ,sars-cov-2:2
completely ,infection:4
incorporating ,spaces:2
incorporating ,recommendations:2
incorporating ,covid-19:2
incorporating ,ward:2
incorporating ,care:2
incorporating ,approach:2
incorporating ,royal:2
spaces ,recommendations:2
spaces ,covid-19:2
spaces ,ward:2
spaces ,care:2
spaces ,approach:2
spaces ,royal:2
recommendations ,ward:2
recommendations ,approach:2
recommendations ,royal:2
covid-19 ,royal:2
ward ,care:2
ward ,approach:2
ward ,royal:2
care ,approach:4
care ,royal:2
approach ,royal:2
fighting ,host:2
fighting ,reaction:2
fighting ,sars-cov-2:4
fighting ,critically:2
fighting ,ill:2
fighting ,patients:2
fighting ,possible:2
host ,reaction:2
host ,critically:2
host ,ill:2
reaction ,sars-cov-2:8
reaction ,critically:2
reaction ,ill:2
reaction ,patients:2
reaction ,possible:2
critically ,possible:2
ill ,possible:2
mutations ,identified:2
mutations ,eastern:2
mutations ,india:2
mutations ,possible:2
sars-cov-2 ,identified:4
sars-cov-2 ,eastern:2
viral ,identified:2
viral ,eastern:2
viral ,india:2
viral ,implications:2
rna ,identified:2
rna ,eastern:2
rna ,india:2
rna ,possible:2
identified ,eastern:2
identified ,india:2
identified ,possible:2
identified ,implications:2
eastern ,india:2
eastern ,possible:2
eastern ,implications:2
india ,possible:2
india ,implications:2
accurate ,serology:2
accurate ,common:2
accurate ,human:2
accurate ,coronaviruses:2
accurate ,using:4
accurate ,multiplex:2
serology ,common:2
serology ,human:2
serology ,coronaviruses:2
serology ,using:2
serology ,multiplex:2
common ,coronaviruses:4
common ,using:2
common ,multiplex:2
human ,multiplex:2
coronaviruses ,using:2
coronaviruses ,multiplex:2
using ,multiplex:2
assessment ,knowledge:4
assessment ,attitudes:2
assessment ,practices:2
assessment ,towards:2
assessment ,coronavirus:6
knowledge ,new:2
attitudes ,new:2
practices ,towards:4
practices ,new:4
practices ,coronavirus:2
towards ,new:2
endothelial ,mesenchymal:2
endothelial ,transition:2
endothelial ,precursor:2
endothelial ,post-covid-19:2
endothelial ,interstitial:2
mesenchymal ,transition:2
mesenchymal ,precursor:2
mesenchymal ,post-covid-19:2
mesenchymal ,interstitial:2
transition ,precursor:2
transition ,post-covid-19:2
transition ,interstitial:2
precursor ,post-covid-19:2
precursor ,interstitial:2
post-covid-19 ,interstitial:2
e-mental ,health:2
e-mental ,intervention:2
e-mental ,support:2
e-mental ,burdened:2
e-mental ,people:2
e-mental ,times:2
e-mental ,covid-19:2
health ,intervention:2
health ,support:4
health ,burdened:2
health ,people:2
health ,times:6
intervention ,support:2
intervention ,burdened:2
intervention ,people:2
intervention ,times:2
support ,burdened:2
support ,people:2
support ,times:4
burdened ,people:2
burdened ,times:2
burdened ,covid-19:2
people ,times:2
complications ,outcomes:2
complications ,pregnancy:2
inflammation ,prothrombotic:2
thrombosis ,prothrombotic:2
patients ,prothrombotic:2
covid-19 ,prothrombotic:2
psychopharmacotherapy ,covid-19:2
psychopharmacotherapy ,pandemic:2
national ,sero-surveillance:2
national ,monitor:2
national ,trend:2
national ,sars-cov-2:2
national ,transmission:2
sero-surveillance ,monitor:2
sero-surveillance ,trend:2
sero-surveillance ,sars-cov-2:2
sero-surveillance ,infection:2
sero-surveillance ,transmission:2
monitor ,trend:2
monitor ,sars-cov-2:2
monitor ,infection:2
monitor ,transmission:2
trend ,sars-cov-2:2
trend ,infection:2
trend ,transmission:4
changes ,perspective:2
changes ,internal:2
changes ,pediatric:2
covid-19 ,internal:2
perspective ,internal:2
perspective ,pediatric:4
perspective ,medicine:2
internal ,pediatric:2
internal ,medicine:2
pediatric ,medicine:2
optimal ,indoor:2
optimal ,air:2
optimal ,conditions:2
optimal ,inactivation:2
optimal ,enthalpy-based:2
indoor ,conditions:2
indoor ,inactivation:2
indoor ,enthalpy-based:2
air ,conditions:2
air ,inactivation:2
air ,enthalpy-based:2
conditions ,inactivation:2
conditions ,enthalpy-based:2
sars-cov-2 ,enthalpy-based:2
inactivation ,enthalpy-based:2
international ,society:2
international ,gynecologic:2
international ,endoscopy:4
international ,isge:2
international ,guidelines:2
society ,gynecologic:2
society ,endoscopy:2
society ,isge:2
gynecologic ,endoscopy:2
gynecologic ,isge:2
gynecologic ,guidelines:2
endoscopy ,isge:2
endoscopy ,guidelines:2
isge ,guidelines:2
alveolar ,macrophage:2
alveolar ,dysfunction:2
alveolar ,cytokine:2
alveolar ,storm:2
alveolar ,pathogenesis:2
alveolar ,two:2
alveolar ,severe:2
macrophage ,dysfunction:2
macrophage ,cytokine:2
macrophage ,storm:2
macrophage ,pathogenesis:2
macrophage ,two:2
macrophage ,severe:2
dysfunction ,cytokine:2
dysfunction ,storm:2
dysfunction ,pathogenesis:4
dysfunction ,two:2
cytokine ,two:2
storm ,two:2
pathogenesis ,two:2
re-tasking ,use:2
re-tasking ,pre-existing:2
re-tasking ,medications:2
re-tasking ,potential:2
re-tasking ,therapeutic:2
re-tasking ,options:2
use ,pre-existing:2
use ,medications:2
use ,potential:6
use ,therapeutic:10
use ,options:2
pre-existing ,medications:2
pre-existing ,potential:2
pre-existing ,options:2
medications ,potential:2
medications ,therapeutic:2
medications ,options:2
elevated ,carcinoembryonic:2
elevated ,antigen:2
elevated ,pneumonia:2
carcinoembryonic ,antigen:2
carcinoembryonic ,patients:2
carcinoembryonic ,covid-19:2
carcinoembryonic ,pneumonia:2
antigen ,patients:2
antigen ,pneumonia:2
clinical ,influenza:2
clinical ,comparative:2
clinical ,nord:2
features ,influenza:2
features ,nord:2
covid-19 ,nord:2
influenza ,study:2
influenza ,nord:2
comparative ,nord:2
study ,nord:2
platform ,incorporating:2
platform ,trimeric:2
platform ,antigens:2
platform ,self-assembling:2
platform ,nanoparticles:2
incorporating ,trimeric:2
incorporating ,antigens:2
incorporating ,self-assembling:2
incorporating ,nanoparticles:2
trimeric ,antigens:2
trimeric ,self-assembling:2
trimeric ,nanoparticles:2
antigens ,self-assembling:2
antigens ,nanoparticles:2
self-assembling ,nanoparticles:2
sars-cov-2 ,conundrums:2
diagnostic ,design:2
diagnostic ,conundrums:2
diagnostic ,context:2
diagnostic ,male:2
diagnostic ,factor:2
design ,conundrums:2
design ,context:2
design ,male:2
design ,factor:2
conundrums ,context:2
conundrums ,male:2
conundrums ,factor:2
context ,male:2
context ,factor:2
male ,factor:2
systems ,biology:2
systems ,workflow:2
systems ,drug:2
systems ,vaccine:2
systems ,repurposing:2
systems ,identifying:2
biology ,workflow:2
biology ,drug:2
biology ,vaccine:2
biology ,repurposing:2
biology ,identifying:2
workflow ,drug:2
workflow ,vaccine:2
workflow ,repurposing:2
workflow ,identifying:2
drug ,identifying:2
vaccine ,identifying:2
clinical ,pre-existing:2
clinical ,compromised:2
outcomes ,compromised:2
outcomes ,immune:2
covid-19 ,compromised:4
patients ,compromised:2
pre-existing ,compromised:2
pre-existing ,immune:2
coping ,covid:2
coping ,research:2
coping ,team:2
coping ,learned:2
coping ,stay:2
coping ,engaged:2
coping ,time:2
covid ,research:2
covid ,team:2
covid ,learned:2
covid ,stay:2
covid ,engaged:2
covid ,time:4
research ,team:2
research ,learned:2
research ,stay:2
research ,engaged:2
research ,time:2
team ,learned:2
team ,stay:2
team ,engaged:2
team ,time:2
learned ,stay:2
learned ,engaged:2
learned ,time:4
stay ,engaged:2
stay ,time:2
engaged ,time:2
review ,safe:4
review ,handling:4
review ,bodies:2
review ,involving:2
management ,safe:4
management ,handling:2
management ,bodies:2
management ,involving:2
safe ,handling:6
safe ,bodies:2
safe ,cases:2
safe ,involving:2
handling ,bodies:2
handling ,cases:2
handling ,involving:2
handling ,covid-19:8
bodies ,cases:2
bodies ,involving:2
bodies ,covid-19:2
cases ,involving:2
involving ,covid-19:4
under-reported ,role:2
under-reported ,toxic:2
under-reported ,substance:2
under-reported ,exposures:2
under-reported ,covid-19:2
under-reported ,pandemic:2
role ,toxic:2
role ,substance:2
role ,exposures:2
toxic ,substance:2
toxic ,exposures:2
toxic ,pandemic:2
substance ,exposures:2
substance ,pandemic:2
exposures ,pandemic:2
vaccine ,time:6
vaccine ,consider:2
vaccine ,studies:2
development ,time:2
development ,consider:2
development ,studies:2
time ,consider:2
time ,challenge:2
time ,studies:2
consider ,challenge:2
consider ,studies:2
challenge ,studies:2
coronavirus ,viruses:4
chilblains ,observed:2
chilblains ,outbreak:2
chilblains ,occur:2
chilblains ,patients:2
observed ,outbreak:2
observed ,occur:2
covid-19 ,occur:2
outbreak ,occur:2
occur ,patients:2
ultrasensitive ,visual:2
ultrasensitive ,detection:2
ultrasensitive ,sars-cov-2:2
ultrasensitive ,using:2
ultrasensitive ,all-in-one:2
ultrasensitive ,dual:2
visual ,using:2
visual ,all-in-one:2
visual ,dual:2
detection ,all-in-one:2
detection ,dual:2
sars-cov-2 ,all-in-one:2
using ,all-in-one:2
using ,dual:2
all-in-one ,dual:2
unravelling ,lead:2
unravelling ,antiviral:2
unravelling ,phytochemicals:2
unravelling ,inhibition:2
unravelling ,mpro:2
lead ,antiviral:4
lead ,phytochemicals:2
lead ,inhibition:2
lead ,sars-cov-2:2
lead ,mpro:2
antiviral ,inhibition:2
antiviral ,mpro:2
phytochemicals ,inhibition:2
phytochemicals ,sars-cov-2:2
phytochemicals ,mpro:2
inhibition ,mpro:2
analysis ,research:6
amplifying ,immunogenicity:2
amplifying ,prospective:2
amplifying ,covid-19:2
amplifying ,vaccines:2
amplifying ,glycoengineering:2
immunogenicity ,prospective:2
immunogenicity ,covid-19:2
immunogenicity ,glycoengineering:2
prospective ,vaccines:4
prospective ,glycoengineering:2
covid-19 ,glycoengineering:2
vaccines ,glycoengineering:2
detection ,diverse:2
detection ,protocol:2
detection ,validate:2
sars-cov-2 ,diverse:2
sars-cov-2 ,validate:2
rna ,diverse:2
rna ,protocol:2
rna ,validate:2
antibodies ,diverse:2
antibodies ,samples:4
antibodies ,validate:2
diverse ,samples:2
diverse ,protocol:2
diverse ,validate:2
samples ,protocol:2
samples ,validate:2
protocol ,validate:2
case ,targeting:2
case ,th17:2
case ,il-17a:2
case ,infections:2
targeting ,th17:2
targeting ,cells:2
targeting ,il-17a:2
targeting ,infections:2
th17 ,cells:2
th17 ,il-17a:2
th17 ,sars-cov-2:2
th17 ,infections:2
cells ,il-17a:2
cells ,infections:2
il-17a ,sars-cov-2:2
il-17a ,infections:2
medical ,options:2
severe ,contamination:4
severe ,inanimate:2
acute ,contamination:2
acute ,inanimate:2
respiratory ,contamination:2
respiratory ,inanimate:2
syndrome ,contamination:2
syndrome ,inanimate:2
coronavirus ,inanimate:2
rna ,inanimate:2
contamination ,inanimate:2
case ,bilateral:4
case ,spontaneous:6
case ,pneumothorax-a:2
report ,covid-19-associated:8
report ,bilateral:4
report ,spontaneous:2
report ,pneumothorax-a:2
covid-19-associated ,bilateral:2
covid-19-associated ,spontaneous:2
covid-19-associated ,pneumothorax-a:2
covid-19-associated ,literature:2
bilateral ,spontaneous:2
bilateral ,pneumothorax-a:2
bilateral ,literature:2
spontaneous ,pneumothorax-a:2
spontaneous ,literature:2
pneumothorax-a ,literature:2
focus ,novel:2
added ,value:2
added ,pirfenidone:2
added ,fight:2
added ,inflammation:2
added ,fibrotic:2
added ,state:2
added ,induced:2
value ,pirfenidone:2
value ,fight:2
value ,inflammation:2
value ,fibrotic:2
value ,state:2
value ,induced:2
pirfenidone ,fight:2
pirfenidone ,inflammation:2
pirfenidone ,fibrotic:2
pirfenidone ,state:2
pirfenidone ,induced:2
fight ,inflammation:2
fight ,fibrotic:2
fight ,state:2
fight ,induced:2
inflammation ,fibrotic:2
inflammation ,state:2
inflammation ,induced:2
fibrotic ,state:2
fibrotic ,induced:2
state ,induced:2
review ,presence:4
review ,survival:2
review ,disinfectionremoval:2
presence ,survival:2
presence ,disinfectionremoval:2
presence ,methods:2
survival ,disinfectionremoval:2
survival ,methods:2
survival ,coronavirus:6
disinfectionremoval ,methods:2
disinfectionremoval ,coronavirus:2
sars-cov-2 ,dupilumab:2
asymptomatic ,dupilumab:2
infection ,dupilumab:2
patient ,dupilumab:2
treatment ,dupilumab:2
comparison ,primer-probe:2
comparison ,sets:2
comparison ,among:2
comparison ,master:2
comparison ,mixes:2
primer-probe ,among:2
primer-probe ,different:2
primer-probe ,master:2
primer-probe ,mixes:2
primer-probe ,laboratory:2
sets ,among:2
sets ,different:2
sets ,master:2
sets ,mixes:2
sets ,laboratory:2
among ,different:2
among ,master:2
among ,mixes:2
among ,laboratory:4
different ,master:2
different ,mixes:2
master ,mixes:2
master ,laboratory:2
mixes ,laboratory:2
multisystem ,child:2
multisystem ,coronavirus:4
multisystem ,disease:2
multisystem ,19:2
inflammatory ,child:2
inflammatory ,coronavirus:6
inflammatory ,19:2
child ,disease:2
child ,19:2
associated ,19:2
current ,feline:2
current ,infectious:2
current ,peritonitis:2
status ,treatment:4
status ,feline:2
status ,infectious:2
status ,peritonitis:2
treatment ,feline:2
treatment ,infectious:2
treatment ,peritonitis:2
options ,feline:2
options ,infectious:2
options ,peritonitis:2
options ,sars-cov-2:4
feline ,infectious:2
feline ,peritonitis:2
feline ,sars-cov-2:2
infectious ,peritonitis:2
peritonitis ,sars-cov-2:2
happy ,hypoxemia:4
happy ,covid-19-a:2
happy ,neural:2
happy ,hypothesis:2
hypoxemia ,covid-19-a:2
hypoxemia ,neural:2
hypoxemia ,hypothesis:4
covid-19-a ,neural:2
covid-19-a ,hypothesis:2
emergence ,diversity:2
emergence ,recurrent:2
emergence ,mutations:2
genomic ,recurrent:2
diversity ,recurrent:2
diversity ,mutations:2
recurrent ,mutations:2
walk-through ,screening:2
walk-through ,center:2
walk-through ,covid-19:2
walk-through ,accessible:2
walk-through ,efficient:2
screening ,accessible:2
screening ,efficient:4
center ,accessible:2
center ,efficient:4
covid-19 ,accessible:2
accessible ,efficient:2
cytokine ,new:4
cytokine ,scenario:2
cytokine ,old:2
cytokine ,concern:2
release ,patients:2
release ,new:4
release ,scenario:2
release ,old:2
release ,concern:2
syndrome ,scenario:2
syndrome ,old:2
syndrome ,concern:2
covid-19 ,scenario:4
patients ,new:8
patients ,old:2
new ,scenario:2
new ,concern:2
scenario ,old:2
scenario ,concern:2
old ,concern:2
covid-19 ,tehran:2
covid-19 ,iran:14
anosmia ,tehran:2
anosmia ,iran:2
tehran ,iran:2
extensive ,dvt:2
extensive ,pulmonary:2
extensive ,embolism:2
extensive ,leading:2
extensive ,diagnosis:2
extensive ,coronavirus:2
extensive ,disease:2
dvt ,pulmonary:2
dvt ,embolism:2
dvt ,leading:2
dvt ,diagnosis:2
dvt ,coronavirus:2
dvt ,disease:2
pulmonary ,leading:2
embolism ,leading:2
embolism ,diagnosis:2
embolism ,disease:6
leading ,diagnosis:2
leading ,coronavirus:2
leading ,disease:4
genetic ,gateways:2
genetic ,implications:2
genetic ,risk:4
gateways ,covid-19:2
gateways ,infection:2
gateways ,implications:2
gateways ,risk:2
gateways ,severity:2
implications ,risk:4
implications ,severity:2
targeting ,sphk-s1p-sipr:2
sphk-s1p-sipr ,pathway:2
sphk-s1p-sipr ,potential:2
sphk-s1p-sipr ,therapeutic:2
sphk-s1p-sipr ,approach:2
pathway ,potential:4
pathway ,approach:2
analysis ,susceptibility:2
analysis ,recommendations:4
susceptibility ,pregnancy:2
susceptibility ,recommendations:2
novel ,challenges:4
novel ,responsibilities:2
coronavirus ,responsibilities:2
disease ,challenges:4
disease ,responsibilities:2
covid-19 ,responsibilities:2
new ,responsibilities:2
challenges ,responsibilities:2
open ,access:2
open ,covid-19-related:2
open ,publications:2
open ,first:2
open ,quarter:2
access ,covid-19-related:2
access ,publications:2
access ,first:2
access ,quarter:2
covid-19-related ,publications:2
covid-19-related ,first:2
covid-19-related ,quarter:2
publications ,first:2
publications ,quarter:2
natural ,selection:2
natural ,versus:2
natural ,creation:2
natural ,review:4
natural ,origin:2
selection ,versus:2
selection ,creation:2
selection ,review:2
selection ,origin:2
selection ,sars-cov-2:4
versus ,creation:2
versus ,review:2
versus ,origin:2
creation ,review:2
creation ,origin:2
review ,origin:2
simulating ,covid-19:2
simulating ,university:2
simulating ,environment:2
university ,environment:2
state-of-the-art ,tools:2
state-of-the-art ,identify:2
state-of-the-art ,druggable:2
state-of-the-art ,protein:2
state-of-the-art ,ligand:2
state-of-the-art ,sars-cov-2:2
tools ,identify:2
tools ,druggable:2
tools ,protein:2
tools ,ligand:2
identify ,druggable:2
identify ,protein:2
identify ,ligand:2
druggable ,protein:2
druggable ,ligand:2
druggable ,sars-cov-2:4
protein ,ligand:2
ligand ,sars-cov-2:2
alltest ,rapid:2
alltest ,lateral:2
alltest ,flow:2
alltest ,immunoassays:2
alltest ,reliable:2
alltest ,diagnosing:2
alltest ,sars-cov-2:2
rapid ,diagnosing:2
lateral ,reliable:2
lateral ,diagnosing:2
flow ,reliable:2
flow ,diagnosing:2
immunoassays ,reliable:2
immunoassays ,diagnosing:2
reliable ,diagnosing:2
diagnosing ,sars-cov-2:2
clinical ,blue-green:2
clinical ,neutrophil:2
clinical ,monocyte:2
clinical ,cytoplasmic:2
clinical ,inclusions:2
significance ,blue-green:2
significance ,neutrophil:2
significance ,monocyte:2
significance ,cytoplasmic:2
significance ,inclusions:2
blue-green ,neutrophil:2
blue-green ,monocyte:2
blue-green ,cytoplasmic:2
blue-green ,inclusions:2
neutrophil ,monocyte:2
neutrophil ,cytoplasmic:2
neutrophil ,inclusions:2
monocyte ,cytoplasmic:2
monocyte ,inclusions:2
cytoplasmic ,inclusions:2
mild ,course:4
mild ,receiving:2
mild ,therapeutic:2
mild ,monoclonal:2
clinical ,receiving:2
clinical ,monoclonal:2
course ,receiving:2
course ,therapeutic:2
course ,monoclonal:2
covid-19 ,monoclonal:2
patients ,receiving:2
patients ,monoclonal:2
receiving ,therapeutic:2
receiving ,monoclonal:2
vaccines ,report:2
covid-19 ,post-exposure:8
covid-19 ,prophylaxis:18
time ,post-exposure:2
time ,prophylaxis:2
pharmacokinetics ,favipiravir:2
pharmacokinetics ,critically:2
pharmacokinetics ,ill:2
pharmacokinetics ,patients:2
pharmacokinetics ,covid-19:2
favipiravir ,critically:2
favipiravir ,ill:2
favipiravir ,patients:4
favipiravir ,covid-19:4
investigation ,demands:2
investigation ,antenatal:2
investigation ,care:2
investigation ,services:2
investigation ,002:2
investigation ,pregnant:2
investigation ,women:2
demands ,antenatal:2
demands ,care:2
demands ,services:2
demands ,among:2
demands ,002:2
demands ,pregnant:2
demands ,women:2
antenatal ,care:6
antenatal ,services:2
antenatal ,among:2
antenatal ,002:2
antenatal ,pregnant:2
antenatal ,women:4
care ,002:2
care ,pregnant:6
care ,women:8
services ,among:2
services ,002:2
services ,pregnant:2
services ,women:2
among ,002:2
002 ,pregnant:2
002 ,women:2
consistent ,detection:2
consistent ,novel:2
consistent ,coronavirus:2
consistent ,saliva:2
overview ,lessons:2
overview ,past:2
immune ,past:2
response ,lessons:2
response ,past:2
infection ,past:4
targeting ,dimerization:2
targeting ,coronaviruses:2
dimerization ,main:2
dimerization ,protease:2
dimerization ,coronaviruses:2
dimerization ,potential:2
main ,coronaviruses:2
protease ,coronaviruses:2
antibody ,potency:2
antibody ,effector:2
antibody ,function:2
antibody ,combinations:2
antibody ,protection:2
potency ,effector:2
potency ,function:2
potency ,combinations:2
potency ,protection:2
potency ,therapy:2
effector ,function:2
effector ,combinations:2
effector ,protection:2
effector ,therapy:2
function ,combinations:2
function ,protection:2
function ,therapy:4
combinations ,protection:2
combinations ,therapy:2
protection ,therapy:4
prevalence ,italians:2
prevalence ,immigrants:2
prevalence ,area:2
sars-cov-2 ,italians:2
sars-cov-2 ,immigrants:2
covid-19 ,italians:2
covid-19 ,immigrants:2
italians ,immigrants:2
italians ,area:2
immigrants ,area:2
strategy ,future:2
strategy ,epidemics:2
strategy ,similar:2
strategy ,2019-ncov:2
strategy ,outbreak:2
prevent ,future:2
prevent ,epidemics:2
prevent ,similar:2
prevent ,2019-ncov:2
future ,epidemics:4
future ,similar:2
future ,outbreak:2
epidemics ,similar:2
epidemics ,2019-ncov:2
epidemics ,outbreak:2
similar ,2019-ncov:2
similar ,outbreak:2
vitamins ,help:2
vitamins ,fight:2
vitamins ,covid-19:4
epidemiological ,671:2
epidemiological ,henan:4
clinical ,671:2
clinical ,henan:2
characteristics ,671:2
characteristics ,henan:4
671 ,covid-19:2
671 ,patients:2
671 ,henan:2
covid-19 ,henan:2
patients ,henan:2
computational ,search:2
computational ,potential:2
computational ,drugs:2
computational ,fdaapproved:2
computational ,small:2
search ,fdaapproved:2
search ,small:2
potential ,fdaapproved:2
potential ,small:4
covid-19 ,fdaapproved:2
drugs ,fdaapproved:2
drugs ,small:2
fdaapproved ,small:2
rigidity ,sars-cov-2:2
rigidity ,spike:2
rigidity ,receptor-binding:2
rigidity ,motif:2
rigidity ,hallmark:2
sars-cov-2 ,motif:4
sars-cov-2 ,hallmark:2
spike ,motif:4
spike ,hallmark:2
receptor-binding ,hallmark:2
motif ,hallmark:2
isolation ,sharing:2
isolation ,novel:4
rapid ,sharing:2
sharing ,novel:2
sharing ,coronavirus:2
sharing ,sars-cov-2:2
model ,treatment:2
sars ,reasons:2
sars ,epidemiology:2
sars ,ill:2
sars ,disease:2
sars ,therapeutic:2
cov-2 ,reasons:2
cov-2 ,epidemiology:2
cov-2 ,ill:2
cov-2 ,disease:2
cov-2 ,cases:2
cov-2 ,therapeutic:2
reasons ,epidemiology:2
reasons ,severe:2
reasons ,ill:2
reasons ,disease:2
reasons ,cases:2
reasons ,therapeutic:2
epidemiology ,ill:2
epidemiology ,cases:4
ill ,cases:2
ill ,therapeutic:8
suggestions ,care:2
suggestions ,patients:2
suggestions ,liver:2
suggestions ,disease:4
suggestions ,coronavirus:4
anatomic ,pathology:2
anatomic ,laboratory:2
anatomic ,adjustments:2
anatomic ,era:2
anatomic ,covid-19:2
anatomic ,pandemic:2
pathology ,laboratory:2
pathology ,adjustments:2
pathology ,era:2
pathology ,pandemic:2
laboratory ,adjustments:2
laboratory ,era:2
adjustments ,era:2
adjustments ,covid-19:4
adjustments ,pandemic:4
infections ,impact:2
impact ,pregnancy:4
resuming ,hip:2
resuming ,knee:2
resuming ,arthroplasty:2
resuming ,ethical:2
resuming ,implications:2
hip ,arthroplasty:4
hip ,covid-19:6
hip ,ethical:2
hip ,implications:2
knee ,arthroplasty:4
knee ,covid-19:6
knee ,ethical:2
knee ,implications:2
arthroplasty ,ethical:2
arthroplasty ,implications:2
covid-19 ,ethical:10
ethical ,implications:2
systematic ,prophylactic:2
systematic ,role:4
systematic ,hydroxychloroquine:2
review ,prophylactic:2
review ,hydroxychloroquine:8
prophylactic ,role:2
prophylactic ,chloroquine:2
prophylactic ,hydroxychloroquine:4
role ,chloroquine:2
role ,hydroxychloroquine:2
managing ,vitreoretinal:2
managing ,surgeries:2
managing ,lockdown:2
managing ,india:2
managing ,experiences:2
vitreoretinal ,lockdown:2
vitreoretinal ,india:2
vitreoretinal ,experiences:2
surgeries ,lockdown:2
surgeries ,india:2
surgeries ,experiences:2
lockdown ,experiences:2
india ,experiences:2
obesity ,perspective:2
obesity ,european:2
obesity ,association:2
obesity ,study:2
perspective ,european:2
perspective ,association:2
european ,association:2
european ,study:2
association ,study:2
ahr ,ido1:2
ahr ,pathogenesis:2
ahr ,covid-19:2
ahr ,systemic:2
ahr ,activation:2
ahr ,syndrome:2
ido1 ,pathogenesis:2
ido1 ,covid-19:2
ido1 ,systemic:2
ido1 ,activation:2
ido1 ,syndrome:2
pathogenesis ,systemic:2
pathogenesis ,activation:2
systemic ,activation:2
systemic ,syndrome:2
data ,analytics:2
data ,big:2
data ,can:4
data ,help:4
data ,scientists:2
data ,managing:2
data ,diffusion:2
analytics ,big:2
analytics ,can:2
analytics ,help:2
analytics ,scientists:2
analytics ,managing:2
analytics ,covid-19:2
analytics ,diffusion:2
big ,can:2
big ,help:2
big ,scientists:2
big ,managing:2
big ,diffusion:2
can ,scientists:2
can ,managing:2
can ,diffusion:2
help ,scientists:2
help ,managing:2
help ,diffusion:2
scientists ,managing:2
scientists ,covid-19:2
scientists ,diffusion:2
managing ,diffusion:2
covid-19 ,diffusion:4
mobile ,health:2
mobile ,platform:2
mobile ,disseminate:2
mobile ,validated:2
mobile ,institutional:2
mobile ,measurements:2
health ,platform:2
health ,disseminate:2
health ,validated:2
health ,institutional:2
health ,measurements:2
platform ,disseminate:2
platform ,validated:2
platform ,institutional:2
platform ,measurements:2
disseminate ,validated:2
disseminate ,institutional:2
disseminate ,measurements:2
validated ,institutional:2
validated ,measurements:2
institutional ,measurements:2
study ,combining:2
study ,virtual:4
study ,screening:8
study ,treatments:2
combining ,virtual:2
combining ,screening:2
combining ,antiviral:2
combining ,treatments:2
combining ,sars-cov-2:4
virtual ,antiviral:2
virtual ,treatments:2
screening ,antiviral:2
screening ,treatments:2
antiviral ,treatments:2
retrospective ,interventions:2
retrospective ,performed:2
retrospective ,emergency:2
retrospective ,medical:4
retrospective ,teams:2
analysis ,interventions:2
analysis ,performed:2
analysis ,emergency:2
analysis ,medical:4
analysis ,teams:2
interventions ,performed:2
interventions ,emergency:2
interventions ,teams:2
performed ,medical:2
performed ,teams:2
emergency ,teams:2
medical ,teams:2
potential ,hosts:2
intermediate ,hosts:4
intermediate ,sars-cov-2:4
transthoracic ,echocardiographic:2
transthoracic ,findings:2
transthoracic ,patients:2
transthoracic ,admitted:2
transthoracic ,sars-cov-2:2
echocardiographic ,findings:2
echocardiographic ,patients:2
echocardiographic ,admitted:2
echocardiographic ,sars-cov-2:2
findings ,admitted:2
practical ,cushings:2
considerations ,management:8
considerations ,cushings:2
management ,cushings:2
cushings ,disease:2
cushings ,covid-19:2
inhaled ,furosemide:2
inhaled ,potential:2
inhaled ,therapeutic:2
furosemide ,potential:2
furosemide ,therapeutic:2
furosemide ,covid-19:2
clinical ,aged:2
clinical ,80years:2
characteristics ,aged:4
characteristics ,80years:2
coronavirus ,aged:2
coronavirus ,80years:2
disease ,aged:2
disease ,80years:2
patients ,aged:2
patients ,80years:2
aged ,80years:2
mortality ,psychological:2
mortality ,burden:2
psychological ,burden:2
psychological ,caused:2
psychological ,response:2
burden ,caused:2
burden ,response:2
burden ,outbreak:2
protection ,nephrology:2
protection ,health:4
protection ,professionals:2
protection ,pandemic:2
nephrology ,health:2
nephrology ,professionals:2
nephrology ,pandemic:2
health ,professionals:6
professionals ,pandemic:4
comparative ,receptor:4
comparative ,ace2:2
comparative ,evolutionarily:2
comparative ,related:2
analysis ,evolutionarily:2
analysis ,related:2
receptor ,evolutionarily:2
receptor ,related:2
ace2 ,evolutionarily:2
evolutionarily ,related:2
snps ,rna:2
snps ,modifications:2
snps ,concerns:2
snps ,mutation-based:2
snps ,evolutionary:2
snps ,studies:2
rna ,modifications:2
rna ,concerns:2
rna ,mutation-based:2
rna ,evolutionary:2
rna ,studies:2
modifications ,concerns:2
modifications ,mutation-based:2
modifications ,evolutionary:2
modifications ,studies:2
concerns ,mutation-based:2
concerns ,evolutionary:2
concerns ,studies:2
mutation-based ,evolutionary:2
mutation-based ,studies:2
evolutionary ,studies:2
computed ,imaging:4
computed ,patients:10
computed ,pneumonia:8
tomographic ,imaging:4
tomographic ,patients:2
tomographic ,coronavirus:6
tomographic ,disease:2
tomographic ,pneumonia:4
mathematical ,reveals:2
mathematical ,influence:2
mathematical ,population:2
mathematical ,heterogeneity:2
mathematical ,herd:2
model ,influence:2
model ,population:2
model ,heterogeneity:2
model ,herd:2
reveals ,influence:2
reveals ,population:2
reveals ,heterogeneity:2
reveals ,herd:2
influence ,population:2
influence ,heterogeneity:2
influence ,herd:2
population ,heterogeneity:2
population ,herd:2
heterogeneity ,herd:2
covid-19 ,circadian:2
covid-19 ,clock:2
management ,circadian:2
management ,clock:2
light ,circadian:2
light ,clock:2
circadian ,clock:4
unraveling ,epidemiology:2
unraveling ,geographical:2
unraveling ,distribution:2
unraveling ,genomic:2
unraveling ,evolution:2
epidemiology ,geographical:2
epidemiology ,distribution:2
geographical ,distribution:2
geographical ,genomic:2
geographical ,evolution:2
distribution ,genomic:2
distribution ,evolution:2
role ,screening:2
role ,hemodialysis:2
role ,wards:2
role ,results:2
role ,single:2
role ,center:2
screening ,hemodialysis:2
screening ,wards:2
screening ,results:2
screening ,single:2
hemodialysis ,wards:2
hemodialysis ,results:4
hemodialysis ,single:2
hemodialysis ,center:2
wards ,results:2
wards ,single:2
wards ,center:2
results ,single:2
results ,center:2
management ,conjunctivitis:2
management ,causes:2
management ,red:2
management ,eye:2
conjunctivitis ,causes:2
conjunctivitis ,red:2
conjunctivitis ,eye:2
conjunctivitis ,covid-19:6
causes ,red:2
causes ,eye:2
red ,eye:2
red ,covid-19:6
surfactant-based ,prophylaxis:2
surfactant-based ,therapy:2
surfactant-based ,covid-19:2
surfactant-based ,possibility:2
prophylaxis ,possibility:2
therapy ,possibility:2
covid-19 ,possibility:4
systematic ,registered:2
systematic ,trials:4
review ,registered:2
registered ,coronavirus:2
registered ,disease:2
recommendations ,identification:2
recommendations ,transfer:2
identification ,transfer:2
identification ,children:2
identification ,critical:2
transfer ,children:2
transfer ,critical:2
children ,critical:2
preliminary ,results:4
preliminary ,detection:2
preliminary ,sewerage:2
preliminary ,system:2
preliminary ,niteri:2
results ,detection:4
results ,sewerage:2
results ,system:2
results ,niteri:2
sars-cov-2 ,sewerage:2
sars-cov-2 ,niteri:2
detection ,sewerage:2
detection ,niteri:2
sewerage ,system:2
sewerage ,niteri:2
system ,niteri:2
sars-cov-2 ,river:2
river ,water:2
river ,implications:2
river ,low:2
river ,sanitation:2
river ,countries:2
water ,implications:2
water ,low:2
water ,countries:2
implications ,low:2
implications ,sanitation:2
implications ,countries:4
low ,sanitation:2
low ,countries:2
sanitation ,countries:2
iron ,metabolism:2
iron ,lymphocyte:2
iron ,characterisation:2
iron ,infection:2
iron ,icu:2
metabolism ,lymphocyte:2
metabolism ,characterisation:2
metabolism ,icu:2
lymphocyte ,characterisation:2
lymphocyte ,covid-19:4
lymphocyte ,infection:2
lymphocyte ,icu:2
characterisation ,infection:2
characterisation ,icu:2
infection ,icu:2
making ,coronavirus:2
making ,detection:2
making ,presence:2
making ,persistence:2
making ,water:2
waves ,coronavirus:2
waves ,detection:2
waves ,presence:2
waves ,persistence:2
waves ,water:2
detection ,presence:2
detection ,persistence:2
detection ,water:2
presence ,persistence:2
presence ,water:4
demographic ,comorbidities:2
demographic ,data:2
demographic ,description:2
demographic ,population:2
demographic ,mexico:2
comorbidities ,data:2
comorbidities ,description:2
comorbidities ,population:2
comorbidities ,mexico:2
data ,description:2
data ,population:2
data ,mexico:2
description ,population:2
description ,mexico:2
population ,mexico:2
imaging ,pediatrics:2
findings ,pediatrics:2
sars-cov-2 ,pediatrics:2
pediatrics ,systematic:2
pediatrics ,review:2
diabetes ,systematic:2
diabetes ,review:2
diabetes ,current:4
diabetes ,evidences:2
systematic ,evidences:2
review ,evidences:2
current ,evidences:2
obesity-driven ,deficiencies:2
obesity-driven ,specialized:2
obesity-driven ,pro-resolving:2
obesity-driven ,mediators:2
obesity-driven ,may:2
obesity-driven ,drive:2
obesity-driven ,adverse:2
deficiencies ,specialized:2
deficiencies ,pro-resolving:2
deficiencies ,mediators:2
deficiencies ,may:2
deficiencies ,drive:2
deficiencies ,adverse:2
specialized ,pro-resolving:2
specialized ,mediators:2
specialized ,may:2
specialized ,drive:2
specialized ,adverse:2
pro-resolving ,mediators:2
pro-resolving ,may:2
pro-resolving ,drive:2
pro-resolving ,adverse:2
mediators ,may:2
mediators ,drive:2
mediators ,adverse:2
may ,drive:2
may ,adverse:2
drive ,adverse:2
potential ,long-term:4
potential ,outbreak:2
long-term ,impact:4
long-term ,outbreak:2
hospitalization ,critical:2
hospitalization ,care:2
hospitalization ,109:2
hospitalization ,decedents:2
hospitalization ,covid-19:4
hospitalization ,pneumonia:2
hospitalization ,wuhan:2
critical ,109:2
critical ,decedents:2
critical ,pneumonia:8
critical ,wuhan:2
care ,109:2
care ,decedents:2
care ,pneumonia:2
109 ,decedents:2
109 ,covid-19:2
109 ,pneumonia:2
109 ,wuhan:2
decedents ,covid-19:2
decedents ,pneumonia:2
decedents ,wuhan:2
emerging ,reemerging:2
reemerging ,respiratory:2
reemerging ,viral:2
reemerging ,infections:2
reemerging ,covid-19:2
proteomics ,insights:2
proteomics ,molecular:2
proteomics ,basis:2
proteomics ,sars-cov-2:4
proteomics ,infection:2
proteomics ,can:4
insights ,basis:2
insights ,can:2
molecular ,can:2
basis ,can:2
covid-19 ,closely:2
sars ,closely:2
mers ,closely:2
mers ,related:2
closely ,related:6
understanding ,coagulopathy:2
understanding ,spectrum:2
coagulopathy ,spectrum:2
evidence-based ,guidelines:2
evidence-based ,management:4
evidence-based ,head:2
evidence-based ,neck:2
evidence-based ,mucosal:2
evidence-based ,malignancies:2
guidelines ,mucosal:2
guidelines ,malignancies:2
management ,malignancies:2
head ,malignancies:2
neck ,malignancies:2
mucosal ,malignancies:2
role ,adipocytes:2
role ,adipocyte-like:2
role ,cells:4
adipocytes ,adipocyte-like:2
adipocytes ,cells:2
adipocytes ,severity:2
adipocytes ,covid-19:2
adipocyte-like ,cells:2
adipocyte-like ,severity:2
adipocyte-like ,covid-19:2
cells ,severity:2
guillain-barr ,infection:4
guillain-barr ,instant:2
guillain-barr ,systematic:4
syndrome ,instant:2
sars-cov-2 ,instant:2
infection ,instant:2
instant ,systematic:2
instant ,review:2
thromboembolic ,risk:2
thromboembolic ,anticoagulant:2
thromboembolic ,therapy:2
thromboembolic ,covid-19:4
thromboembolic ,patients:4
thromboembolic ,emerging:2
risk ,anticoagulant:2
risk ,therapy:4
risk ,emerging:2
anticoagulant ,covid-19:4
anticoagulant ,emerging:2
covid-19 ,hospitalizations:4
infant ,hospitalizations:2
infant ,seasonal:2
infant ,respiratory:2
infant ,virus:4
infant ,infections:2
infant ,new:2
hospitalizations ,seasonal:2
hospitalizations ,respiratory:2
hospitalizations ,virus:2
hospitalizations ,infections:2
hospitalizations ,new:2
seasonal ,respiratory:2
seasonal ,virus:2
seasonal ,infections:2
seasonal ,new:2
infections ,new:2
evaluation ,plaque:2
evaluation ,reduction:2
lateral ,using:4
lateral ,plaque:2
lateral ,reduction:2
flow ,using:4
flow ,plaque:2
flow ,reduction:2
assay ,reduction:2
using ,plaque:2
plaque ,reduction:2
novel ,inside:2
novel ,body:2
coronavirus ,inside:2
coronavirus ,body:2
dynamics ,inside:2
dynamics ,body:2
inside ,human:2
inside ,body:2
unusual ,case:2
unusual ,coronavirus:2
unusual ,disease:2
unusual ,delayed:2
unusual ,chest:2
unusual ,ct:2
unusual ,evidence:2
case ,ct:2
case ,evidence:4
coronavirus ,delayed:6
disease ,delayed:6
disease ,chest:14
disease ,evidence:2
delayed ,chest:2
delayed ,ct:2
delayed ,evidence:2
chest ,evidence:2
ct ,evidence:2
possible ,infected:4
possible ,mother:2
possible ,newborn:2
vertical ,infected:4
transmission ,infected:4
infected ,mother:2
mother ,newborn:2
multiscale ,comparative:2
multiscale ,model:2
multiscale ,receptor:2
multiscale ,binding:2
multiscale ,novel:2
multiscale ,coronavirus:2
comparative ,model:4
comparative ,binding:4
comparative ,novel:4
comparative ,coronavirus:6
model ,receptor:2
model ,binding:2
model ,coronavirus:4
high-risk ,aerosol-generating:2
high-risk ,procedures:2
high-risk ,respiratory:2
high-risk ,protective:2
aerosol-generating ,respiratory:2
aerosol-generating ,protective:2
procedures ,protective:2
proof ,evidence:2
proof ,supporting:2
proof ,abnormal:2
proof ,immunothrombosis:2
proof ,severe:2
proof ,naked:2
evidence ,abnormal:2
evidence ,immunothrombosis:2
evidence ,naked:2
supporting ,abnormal:2
supporting ,immunothrombosis:2
supporting ,covid-19:6
supporting ,naked:2
abnormal ,immunothrombosis:2
abnormal ,severe:2
abnormal ,naked:2
immunothrombosis ,severe:2
immunothrombosis ,naked:2
severe ,naked:2
covid-19 ,naked:2
calcium ,channel:2
calcium ,blockers:2
calcium ,possible:2
calcium ,potential:2
calcium ,therapeutic:2
calcium ,strategy:2
channel ,blockers:2
channel ,possible:2
channel ,therapeutic:2
channel ,strategy:2
blockers ,possible:2
blockers ,potential:4
blockers ,therapeutic:2
blockers ,strategy:2
possible ,strategy:6
therapeutic ,strategy:12
covid-19 ,acutepulmonary:2
covid-19 ,right-sided:2
complicated ,acutepulmonary:2
complicated ,embolism:2
complicated ,right-sided:2
complicated ,heart:4
complicated ,failure:2
acutepulmonary ,embolism:2
acutepulmonary ,right-sided:2
acutepulmonary ,heart:2
acutepulmonary ,failure:2
embolism ,right-sided:2
embolism ,heart:2
embolism ,failure:2
right-sided ,heart:2
right-sided ,failure:2
smell ,analysis:2
smell ,different:2
taste ,analysis:2
taste ,different:2
alterations ,cross-sectional:2
alterations ,analysis:2
alterations ,different:2
cross-sectional ,different:2
proteasome ,inhibitors:2
proteasome ,possible:2
proteasome ,therapy:2
proteasome ,sars-cov-2:2
inhibitors ,possible:2
inhibitors ,therapy:2
overview ,history:2
history ,pediatric:2
history ,perspectives:2
pediatric ,perspectives:2
sars-cov-2 ,antigen-detecting:2
sars-cov-2 ,half-strip:2
coronavirus ,nucleocapsid:4
coronavirus ,antigen-detecting:2
coronavirus ,half-strip:2
coronavirus ,lateral:2
coronavirus ,flow:2
coronavirus ,assay:2
nucleocapsid ,antigen-detecting:2
nucleocapsid ,half-strip:2
nucleocapsid ,lateral:2
nucleocapsid ,flow:2
nucleocapsid ,assay:2
antigen-detecting ,half-strip:2
antigen-detecting ,lateral:2
antigen-detecting ,flow:2
antigen-detecting ,assay:2
half-strip ,lateral:2
half-strip ,flow:2
half-strip ,assay:2
immunity ,review:2
immunity ,applications:2
immunity ,phase:2
immunity ,candidates:4
review ,applications:2
review ,candidates:4
applications ,phase:2
applications ,vaccine:2
applications ,candidates:2
phase ,vaccine:2
phase ,candidates:2
large-scale ,asymptomatic:2
large-scale ,healthcare:2
large-scale ,personnel:2
large-scale ,severe:2
large-scale ,acute:2
testing ,asymptomatic:4
testing ,personnel:2
asymptomatic ,personnel:2
healthcare ,severe:4
healthcare ,acute:2
personnel ,severe:2
personnel ,acute:2
grief ,covid-19:2
grief ,pandemic:2
grief ,older:2
grief ,adults:2
pandemic ,older:4
pandemic ,adults:2
evaluation ,co-infections:2
bacterial ,co-infections:2
bacterial ,respiratory:2
bacterial ,tract:2
co-infections ,respiratory:2
co-infections ,tract:2
tract ,patients:2
describing ,pattern:2
describing ,epidemic:2
describing ,vietnam:2
pattern ,epidemic:2
pattern ,vietnam:2
epidemic ,vietnam:2
review ,agents:4
review ,chinese:6
review ,herbal:6
review ,medicines:4
therapeutic ,chinese:4
therapeutic ,herbal:2
therapeutic ,medicines:2
agents ,herbal:2
agents ,medicines:2
chinese ,sars-cov-2:6
herbal ,medicines:4
herbal ,sars-cov-2:2
medicines ,sars-cov-2:2
diffuse ,thrombotic:2
diffuse ,microangiopathy:2
diffuse ,main:2
alveolar ,thrombotic:2
alveolar ,microangiopathy:2
alveolar ,main:2
damage ,thrombotic:2
damage ,microangiopathy:2
damage ,main:2
thrombotic ,microangiopathy:4
thrombotic ,main:2
microangiopathy ,main:2
disequilibrium ,classic:2
disequilibrium ,renin-angiotensin:2
disequilibrium ,system:2
disequilibrium ,opposing:2
disequilibrium ,arm:2
classic ,renin-angiotensin:2
classic ,system:2
classic ,opposing:2
classic ,arm:2
renin-angiotensin ,opposing:2
renin-angiotensin ,arm:2
system ,opposing:2
system ,arm:2
opposing ,arm:2
can ,occurrence:2
can ,cases:4
can ,considerations:2
can ,using:2
can ,simple:2
predict ,occurrence:2
predict ,cases:2
predict ,considerations:2
predict ,using:2
predict ,simple:2
predict ,model:4
occurrence ,cases:2
occurrence ,considerations:2
occurrence ,using:2
occurrence ,simple:2
occurrence ,model:2
cases ,considerations:4
cases ,using:4
cases ,simple:2
cases ,model:2
considerations ,using:2
considerations ,simple:2
considerations ,model:2
using ,simple:2
using ,model:6
simple ,model:4
possible ,role:12
possible ,highly:2
possible ,standardized:2
possible ,mixture:2
possible ,active:2
possible ,compounds:2
therapeutic ,highly:2
therapeutic ,standardized:2
therapeutic ,mixture:2
therapeutic ,active:2
role ,highly:2
role ,standardized:2
role ,mixture:2
role ,active:2
role ,compounds:2
highly ,standardized:2
highly ,mixture:2
highly ,active:2
highly ,compounds:2
standardized ,mixture:2
standardized ,active:2
standardized ,compounds:2
mixture ,active:2
mixture ,compounds:2
active ,compounds:2
understanding ,antibody:2
understanding ,testing:2
understanding ,lessons:2
understanding ,hiv:2
science ,antibody:2
science ,testing:2
science ,hiv:2
antibody ,lessons:2
antibody ,hiv:2
testing ,hiv:2
impaired ,cytotoxic:2
impaired ,cd8:2
impaired ,cell:4
impaired ,response:2
impaired ,elderly:2
impaired ,covid-19:2
impaired ,patients:4
cytotoxic ,cd8:2
cytotoxic ,cell:2
cytotoxic ,response:2
cytotoxic ,elderly:2
cytotoxic ,covid-19:2
cytotoxic ,patients:2
cd8 ,cell:4
cd8 ,response:2
cd8 ,elderly:2
cell ,elderly:2
response ,elderly:4
digestive ,review:2
subacute ,associated:2
thyroiditis ,associated:2
thyroiditis ,covid-19:2
spanish ,risk:2
spanish ,management:2
spanish ,framework:2
spanish ,across:2
spanish ,17:2
spanish ,radiation:2
spanish ,oncology:2
spanish ,centers:2
risk ,framework:2
risk ,17:2
risk ,radiation:2
risk ,oncology:2
risk ,centers:2
management ,framework:2
management ,across:2
management ,17:2
management ,radiation:2
management ,centers:2
framework ,across:2
framework ,17:2
framework ,radiation:2
framework ,oncology:2
framework ,centers:2
across ,17:2
across ,radiation:2
across ,oncology:2
across ,centers:2
17 ,radiation:2
17 ,oncology:2
17 ,centers:2
radiation ,centers:2
oncology ,centers:2
covid-19 ,experiments:2
covid-19 ,hypothetical:4
natural ,experiments:2
natural ,arising:2
natural ,physical:2
natural ,hypothetical:2
experiments ,arising:2
experiments ,physical:2
experiments ,distancing:2
experiments ,hypothetical:2
arising ,physical:2
arising ,distancing:2
arising ,hypothetical:2
physical ,hypothetical:2
distancing ,hypothetical:2
lung ,macrophage:2
lung ,friend:2
lung ,foe:2
macrophage ,sars-cov-2:2
macrophage ,infection:2
macrophage ,friend:2
macrophage ,foe:2
sars-cov-2 ,friend:2
sars-cov-2 ,foe:2
infection ,friend:2
infection ,foe:2
friend ,foe:6
composition ,spike:2
composition ,proteins:2
composition ,host:2
composition ,ace2:2
composition ,receptors:2
divergence ,spike:2
divergence ,proteins:2
divergence ,host:2
divergence ,ace2:2
divergence ,receptors:2
coronavirus ,receptors:2
spike ,receptors:2
proteins ,host:2
proteins ,ace2:4
proteins ,receptors:2
host ,receptors:4
ace2 ,receptors:2
disease ,maternal:6
pregnancy ,reports:2
pregnancy ,maternal:6
case ,maternal:2
reports ,maternal:2
rational ,polymerase:2
rational ,chain:2
rational ,reaction:2
rational ,tests:2
rational ,within:2
rational ,institutions:2
use ,polymerase:2
use ,chain:2
use ,reaction:2
use ,tests:2
use ,within:2
use ,institutions:2
sars-cov-2 ,chain:6
sars-cov-2 ,institutions:4
polymerase ,tests:4
polymerase ,within:2
polymerase ,institutions:2
chain ,tests:4
chain ,within:2
chain ,institutions:2
reaction ,tests:2
reaction ,within:2
reaction ,institutions:2
tests ,within:2
tests ,institutions:2
within ,institutions:2
spectrum ,neurological:2
spectrum ,manifestations:4
spectrum ,review:2
diagnostic ,role:4
role ,computed:4
role ,tomography:4
chest ,computed:18
chest ,tomography:14
infections ,young:2
infections ,people:2
children ,young:2
children ,people:2
young ,people:2
exercise ,severe:2
exercise ,acute:2
exercise ,respiratory:2
exercise ,syndrome:2
exercise ,coronavirus-2:2
exercise ,sars-cov-2:2
exercise ,era:2
severe ,era:2
acute ,era:2
respiratory ,era:2
syndrome ,era:2
coronavirus-2 ,era:2
recommendations ,protective:2
recommendations ,orthopedic:2
recommendations ,surgeons:4
protective ,surgeons:2
measures ,orthopedic:2
measures ,surgeons:2
orthopedic ,surgeons:2
orthopedic ,covid-19:6
atrial ,epidemiological:2
atrial ,association:2
atrial ,pharmacological:2
fibrillation ,covid-19:2
fibrillation ,epidemiological:2
fibrillation ,association:2
fibrillation ,pharmacological:2
epidemiological ,association:2
epidemiological ,pharmacological:2
association ,pharmacological:2
learning ,anticoagulation:2
covid-19 ,anticoagulation:6
sars-cov-2 ,inflammation:4
sars-cov-2 ,even:2
sars-cov-2 ,courses:2
cause ,inflammation:2
cause ,even:2
cause ,mild:4
cause ,clinical:2
cause ,courses:2
lung ,even:2
lung ,mild:2
lung ,clinical:6
lung ,courses:4
inflammation ,even:2
inflammation ,mild:2
inflammation ,courses:2
even ,mild:2
even ,clinical:2
even ,courses:2
mild ,courses:2
clinical ,courses:4
inanimate ,surfaces:4
inanimate ,potential:2
inanimate ,source:2
inanimate ,2019-ncov:2
inanimate ,spread:2
inanimate ,disinfection:2
surfaces ,potential:4
surfaces ,source:2
surfaces ,2019-ncov:2
surfaces ,spread:2
surfaces ,disinfection:2
potential ,spread:6
source ,2019-ncov:2
source ,spread:2
source ,disinfection:2
2019-ncov ,disinfection:2
spread ,disinfection:2
vasculitis-related ,stroke:2
vasculitis-related ,young:2
vasculitis-related ,presenting:2
vasculitis-related ,feature:2
vasculitis-related ,novel:2
vasculitis-related ,coronavirus:2
stroke ,young:2
stroke ,presenting:4
stroke ,feature:2
young ,presenting:2
young ,feature:2
young ,novel:2
young ,coronavirus:4
presenting ,feature:2
presenting ,novel:2
feature ,novel:2
feature ,coronavirus:2
impact ,spanish:2
impact ,public:6
impact ,visits:2
impact ,covid-:2
impact ,19:2
impact ,diagnosed:2
spanish ,public:2
spanish ,health:2
spanish ,measures:2
spanish ,emergency:2
spanish ,visits:2
spanish ,covid-:2
spanish ,19:2
spanish ,diagnosed:2
public ,measures:6
public ,visits:2
public ,covid-:2
public ,19:2
public ,diagnosed:2
health ,covid-:2
health ,19:2
health ,diagnosed:2
measures ,emergency:2
measures ,visits:2
measures ,covid-:2
measures ,19:2
measures ,diagnosed:2
emergency ,visits:2
emergency ,covid-:2
emergency ,diagnosed:2
visits ,covid-:2
visits ,19:2
visits ,diagnosed:2
covid- ,19:8
covid- ,diagnosed:2
19 ,diagnosed:2
covid-19 ,brazilian:6
pandemic ,brazilian:6
pandemic ,reality:2
outbreak ,brazilian:2
outbreak ,reality:2
brazilian ,reality:2
brazilian ,first:2
brazilian ,case:2
reality ,first:2
reality ,case:2
children ,outside:4
children ,wuhan:2
incidental ,findings:4
incidental ,suggestive:2
incidental ,covid-19:4
incidental ,asymptomatic:4
incidental ,patients:4
incidental ,undergoing:2
findings ,suggestive:2
findings ,asymptomatic:4
findings ,undergoing:2
suggestive ,covid-19:2
suggestive ,asymptomatic:2
suggestive ,patients:2
suggestive ,undergoing:2
asymptomatic ,undergoing:2
patients ,undergoing:16
p38 ,mapk:2
p38 ,inhibition:2
p38 ,promising:2
p38 ,therapeutic:2
p38 ,approach:2
p38 ,covid-19:2
mapk ,inhibition:2
mapk ,promising:2
mapk ,therapeutic:2
mapk ,approach:2
mapk ,covid-19:2
inhibition ,promising:4
promising ,therapeutic:2
establishment ,replication-competent:2
establishment ,vesicular:2
establishment ,stomatitis:2
establishment ,virus-based:2
establishment ,recombinant:2
replication-competent ,virus-based:2
replication-competent ,recombinant:2
vesicular ,virus-based:2
vesicular ,recombinant:2
stomatitis ,virus-based:2
stomatitis ,recombinant:2
virus-based ,recombinant:2
beyond ,fever:2
beyond ,cough:2
beyond ,dyspnea:2
beyond ,neurology:2
beyond ,covid-19:6
fever ,cough:2
fever ,dyspnea:2
fever ,neurology:2
cough ,dyspnea:2
cough ,neurology:2
dyspnea ,neurology:2
dyspnea ,covid-19:2
encephalopathy ,encephalitis:2
encephalopathy ,associated:4
encephalopathy ,cerebrospinal:2
encephalopathy ,fluid:2
encephalopathy ,cytokine:2
encephalitis ,associated:4
encephalitis ,cerebrospinal:2
encephalitis ,fluid:2
encephalitis ,cytokine:2
associated ,cerebrospinal:2
associated ,fluid:2
cerebrospinal ,cytokine:2
fluid ,cytokine:2
prevalence ,specific:2
prevalence ,neutralising:2
prevalence ,donors:2
sars-cov-2 ,neutralising:2
specific ,neutralising:2
specific ,blood:2
specific ,donors:2
neutralising ,antibodies:2
neutralising ,blood:2
neutralising ,donors:2
antibodies ,donors:2
racial ,pandemic:2
racial ,analysis:2
racial ,covid-19:2
ethnic ,pandemic:2
ethnic ,analysis:2
ethnic ,covid-19:2
disparities ,pandemic:2
disparities ,analysis:2
disparities ,covid-19:2
pandemic ,analysis:6
nosocomial ,outbreak:6
nosocomial ,containment:2
nosocomial ,hanoi:2
nosocomial ,vietnam:2
nosocomial ,march-april:2
coronavirus ,containment:2
coronavirus ,hanoi:2
coronavirus ,march-april:2
disease ,containment:2
disease ,hanoi:2
disease ,vietnam:2
disease ,march-april:2
outbreak ,hanoi:2
outbreak ,vietnam:2
outbreak ,march-april:2
containment ,hanoi:2
containment ,vietnam:2
containment ,march-april:2
hanoi ,vietnam:2
hanoi ,march-april:2
vietnam ,march-april:2
coronavirus ,2019-historical:2
coronavirus ,context:2
coronavirus ,virology:4
coronavirus ,immunotherapy:2
disease ,2019-historical:2
disease ,context:2
disease ,virology:4
disease ,immunotherapy:2
2019-historical ,context:2
2019-historical ,virology:2
2019-historical ,pathogenesis:2
2019-historical ,immunotherapy:2
context ,virology:2
context ,pathogenesis:2
context ,immunotherapy:2
virology ,immunotherapy:2
pathogenesis ,immunotherapy:2
topological ,analysis:2
topological ,sars:2
topological ,cov-2:2
topological ,main:2
topological ,protease:2
analysis ,cov-2:2
analysis ,main:8
analysis ,protease:2
sars ,main:6
sars ,protease:4
cov-2 ,main:4
cov-2 ,protease:4
large ,scale:2
large ,genomic:2
large ,analysis:2
large ,3067:2
large ,genomes:2
large ,reveals:2
large ,clonal:2
scale ,genomic:2
scale ,analysis:2
scale ,3067:2
scale ,sars-cov-2:2
scale ,genomes:2
scale ,reveals:2
scale ,clonal:2
genomic ,3067:2
genomic ,reveals:2
genomic ,clonal:2
analysis ,3067:2
analysis ,clonal:2
3067 ,sars-cov-2:2
3067 ,genomes:2
3067 ,reveals:2
3067 ,clonal:2
sars-cov-2 ,clonal:6
genomes ,reveals:2
genomes ,clonal:2
reveals ,clonal:2
aging ,male:2
aging ,sex:2
aging ,obesity:2
aging ,metabolic:2
aging ,inflammation:2
aging ,create:2
aging ,perfect:2
aging ,storm:2
male ,sex:2
male ,metabolic:2
male ,inflammation:2
male ,create:2
male ,perfect:2
male ,storm:2
sex ,obesity:4
sex ,metabolic:2
sex ,inflammation:2
sex ,create:2
sex ,perfect:2
sex ,storm:2
obesity ,inflammation:2
obesity ,create:2
obesity ,perfect:2
obesity ,storm:2
metabolic ,inflammation:2
metabolic ,create:2
metabolic ,perfect:2
metabolic ,storm:2
inflammation ,create:2
inflammation ,perfect:2
create ,perfect:2
create ,storm:2
perfect ,storm:4
covid-19 ,internists:2
covid-19 ,north-south:2
internists ,resilience:2
internists ,north-south:2
internists ,italy:2
internists ,outbreak:2
resilience ,north-south:2
resilience ,italy:2
resilience ,outbreak:2
north-south ,italy:2
north-south ,outbreak:2
animal ,mechanisms:2
animal ,infection:4
animal ,pathology:2
models ,mechanisms:2
models ,pathology:2
mechanisms ,pathology:2
infection ,pathology:2
imbalanced ,host:2
imbalanced ,response:2
imbalanced ,sars-cov-2:2
imbalanced ,drives:2
imbalanced ,development:2
imbalanced ,covid-19:2
host ,drives:2
host ,development:2
response ,drives:2
sars-cov-2 ,drives:4
drives ,development:2
drives ,covid-19:2
review ,initial:2
review ,implications:10
initial ,data:2
initial ,pregnancy:2
initial ,outbreak:2
initial ,implications:2
data ,pregnancy:2
data ,implications:2
pregnancy ,outbreak:2
pregnancy ,implications:2
outbreak ,implications:4
performance ,triage:2
performance ,questionnaire:2
performance ,detect:2
performance ,suspected:2
performance ,cases:2
performance ,severe:4
extended ,triage:2
extended ,questionnaire:2
extended ,detect:2
extended ,suspected:2
extended ,cases:2
extended ,severe:4
triage ,questionnaire:2
triage ,detect:2
triage ,suspected:4
triage ,cases:2
triage ,severe:2
questionnaire ,detect:2
questionnaire ,suspected:2
questionnaire ,cases:2
questionnaire ,severe:2
detect ,suspected:2
detect ,cases:2
suspected ,severe:4
pediatric ,rigid:2
pediatric ,bronchoscopy:2
pediatric ,foreign:2
pediatric ,body:2
pediatric ,removal:2
rigid ,bronchoscopy:2
rigid ,foreign:2
rigid ,body:2
rigid ,removal:2
rigid ,covid-19:2
rigid ,pandemic:2
bronchoscopy ,foreign:2
bronchoscopy ,body:2
bronchoscopy ,removal:2
bronchoscopy ,covid-19:6
bronchoscopy ,pandemic:4
foreign ,removal:2
foreign ,pandemic:2
body ,removal:2
body ,pandemic:2
removal ,covid-19:2
removal ,pandemic:2
rare ,presentation:2
rare ,pulmonary:2
rare ,embolism:2
rare ,amidst:2
rare ,coronavirus:4
rare ,disease:6
rare ,era:2
rare ,utility:2
presentation ,amidst:2
presentation ,era:2
presentation ,utility:2
pulmonary ,amidst:2
pulmonary ,era:2
pulmonary ,utility:2
embolism ,amidst:2
embolism ,era:2
embolism ,utility:2
amidst ,disease:2
amidst ,era:2
amidst ,utility:2
disease ,utility:2
era ,utility:2
superior ,mesenteric:2
superior ,artery:2
superior ,thrombosis:2
superior ,acute:2
superior ,intestinal:2
superior ,ischemia:2
superior ,consequence:2
mesenteric ,artery:2
mesenteric ,thrombosis:4
mesenteric ,intestinal:2
mesenteric ,consequence:2
artery ,thrombosis:2
artery ,acute:6
artery ,intestinal:2
artery ,ischemia:2
artery ,consequence:2
thrombosis ,acute:8
thrombosis ,intestinal:2
thrombosis ,ischemia:4
thrombosis ,consequence:2
acute ,intestinal:2
acute ,consequence:2
intestinal ,ischemia:2
intestinal ,consequence:2
ischemia ,consequence:2
projecting ,transmission:2
projecting ,dynamics:2
projecting ,sars-cov-2:2
projecting ,postpandemic:2
projecting ,period:2
transmission ,postpandemic:2
dynamics ,postpandemic:2
dynamics ,period:2
sars-cov-2 ,postpandemic:2
postpandemic ,period:2
humanity ,tested:2
kinetics ,relation:2
kinetics ,severity:2
viral ,relation:2
viral ,severity:6
load ,response:2
load ,relation:2
load ,severity:4
antibody ,relation:2
response ,relation:2
relation ,covid-19:6
handling ,processing:2
handling ,blood:2
handling ,specimens:2
handling ,patients:2
processing ,blood:2
processing ,specimens:2
processing ,patients:2
processing ,covid-19:2
processing ,safe:2
blood ,safe:2
specimens ,safe:2
petct ,covid-19:16
petct ,organizing:2
covid-19 ,organizing:6
organizing ,pneumonia:4
radiology ,imaging:2
radiology ,pulmonary:2
radiology ,damage:2
imaging ,pulmonary:2
imaging ,damage:2
pulmonary ,damage:2
new ,advanced:2
new ,silico:2
new ,discovery:4
new ,method:2
advanced ,silico:2
advanced ,drug:2
advanced ,discovery:2
advanced ,method:2
advanced ,novel:2
advanced ,coronavirus:2
silico ,discovery:6
silico ,method:2
silico ,novel:4
silico ,coronavirus:4
drug ,method:2
method ,coronavirus:2
silico ,therapeutics:2
silico ,multiple:2
molecular ,repurposing:6
molecular ,therapeutics:2
docking ,repurposing:2
docking ,therapeutics:2
docking ,multiple:2
analysis ,repurposing:2
analysis ,multiple:4
repurposing ,multiple:2
therapeutics ,multiple:2
status ,pituitary:2
status ,surgery:2
pituitary ,surgery:2
pituitary ,pandemic:2
extended ,orf8:2
extended ,gene:2
extended ,region:2
extended ,valuable:2
extended ,epidemiological:2
extended ,investigation:2
orf8 ,gene:2
orf8 ,region:2
orf8 ,valuable:2
orf8 ,epidemiological:2
orf8 ,investigation:2
orf8 ,severe:2
gene ,region:2
gene ,valuable:2
gene ,epidemiological:2
gene ,investigation:2
region ,valuable:2
region ,epidemiological:2
region ,investigation:2
region ,severe:2
valuable ,epidemiological:2
valuable ,investigation:2
valuable ,severe:2
epidemiological ,investigation:4
epidemiological ,severe:4
critical ,needs:2
critical ,assessment:4
critical ,research:2
critical ,companion:2
critical ,animals:2
critical ,livestock:2
needs ,assessment:2
needs ,companion:2
needs ,animals:2
needs ,livestock:2
assessment ,research:2
assessment ,companion:2
assessment ,animals:2
assessment ,livestock:2
research ,companion:2
research ,animals:2
research ,livestock:2
companion ,livestock:4
animals ,livestock:4
covid-19 ,abscess:2
related ,mortality:4
related ,management:4
related ,hepatic:2
related ,abscess:2
mortality ,management:2
mortality ,hepatic:2
mortality ,abscess:2
management ,hepatic:6
management ,abscess:2
hepatic ,abscess:2
characteristics ,symptomatic:6
characteristics ,mild:2
symptomatic ,mild:4
ent ,surgery:2
sars-cov-2 ,multidisciplinary:2
infection ,multidisciplinary:2
pregnancy ,multidisciplinary:2
multidisciplinary ,review:4
point ,view:6
point ,patients:2
point ,supplemented:2
point ,vitamin:2
view ,patients:2
view ,supplemented:2
view ,vitamin:2
covid-19 ,supplemented:2
patients ,supplemented:2
supplemented ,vitamin:2
operational ,strategies:2
operational ,trauma:2
operational ,hub:2
operational ,early:2
operational ,coronavirus:2
operational ,disease:2
operational ,pandemic:2
strategies ,trauma:2
strategies ,hub:2
strategies ,early:2
trauma ,hub:2
trauma ,coronavirus:2
trauma ,disease:2
trauma ,pandemic:4
hub ,early:4
hub ,pandemic:2
laboratory ,associated:2
laboratory ,severe:6
laboratory ,illness:2
laboratory ,mortality:2
laboratory ,hospitalized:2
findings ,severe:4
findings ,illness:2
findings ,mortality:4
findings ,hospitalized:4
associated ,illness:4
associated ,among:4
illness ,mortality:2
illness ,among:2
illness ,hospitalized:2
mortality ,among:6
mortality ,hospitalized:4
knowledge ,synthesis:2
knowledge ,100:2
knowledge ,million:2
knowledge ,biomedical:4
knowledge ,documents:2
knowledge ,augments:2
knowledge ,deep:2
knowledge ,expression:2
synthesis ,100:2
synthesis ,million:2
synthesis ,biomedical:2
synthesis ,documents:2
synthesis ,augments:2
synthesis ,deep:2
synthesis ,expression:2
100 ,million:2
100 ,biomedical:2
100 ,documents:2
100 ,augments:2
100 ,deep:2
100 ,expression:2
million ,biomedical:2
million ,documents:2
million ,augments:2
million ,deep:2
million ,expression:2
biomedical ,documents:2
biomedical ,augments:2
biomedical ,deep:2
biomedical ,expression:2
documents ,augments:2
documents ,deep:2
documents ,expression:2
augments ,deep:2
augments ,expression:2
deep ,expression:2
using ,heat:2
using ,kill:2
heat ,kill:2
heat ,sars-cov-2:6
kill ,sars-cov-2:2
viral ,loads:2
viral ,anal:2
loads ,throat:2
loads ,anal:2
loads ,swabs:2
loads ,children:2
loads ,infected:2
loads ,sars-cov-2:2
throat ,anal:2
throat ,children:2
throat ,infected:2
anal ,children:2
anal ,infected:2
swabs ,children:2
swabs ,infected:2
severe ,ocular:6
acute ,ocular:6
respiratory ,nucleocapsid:2
respiratory ,ocular:6
syndrome ,nucleocapsid:2
syndrome ,ocular:2
nucleocapsid ,ocular:2
protein ,ocular:2
sars-cov-2 ,25-hydroxyvitamin:2
positivity ,rates:4
positivity ,associated:2
positivity ,circulating:2
positivity ,25-hydroxyvitamin:2
positivity ,levels:2
rates ,associated:2
rates ,circulating:2
rates ,25-hydroxyvitamin:2
rates ,levels:2
associated ,circulating:2
associated ,25-hydroxyvitamin:2
circulating ,25-hydroxyvitamin:2
circulating ,levels:2
25-hydroxyvitamin ,levels:2
induction ,trained:2
induction ,immunity:2
induction ,-glucan:2
induction ,serve:2
induction ,defense:2
trained ,-glucan:2
trained ,serve:2
trained ,defense:2
immunity ,-glucan:2
immunity ,serve:2
immunity ,defense:2
-glucan ,serve:2
-glucan ,defense:2
serve ,defense:2
covid-19 ,bateman:2
covid-19 ,siz:2
pandemic ,predictions:2
pandemic ,using:12
pandemic ,modified:2
pandemic ,bateman:2
pandemic ,siz:2
pandemic ,observational:2
predictions ,using:4
predictions ,modified:2
predictions ,bateman:2
predictions ,siz:2
predictions ,model:2
predictions ,observational:2
using ,modified:2
using ,bateman:2
using ,siz:2
using ,observational:2
modified ,bateman:2
modified ,siz:2
modified ,model:2
modified ,observational:2
bateman ,siz:2
bateman ,model:2
bateman ,observational:2
siz ,model:2
siz ,observational:2
model ,observational:2
update ,characteristics:4
update ,pneumonia:2
epidemiological ,pneumonia:4
3d-printable ,headlight:2
3d-printable ,face:2
3d-printable ,shield:2
3d-printable ,adapter:2
3d-printable ,personal:2
3d-printable ,protective:2
3d-printable ,equipment:2
headlight ,face:2
headlight ,shield:2
headlight ,adapter:2
headlight ,personal:2
headlight ,protective:2
headlight ,equipment:2
face ,shield:2
face ,adapter:2
face ,protective:2
face ,equipment:2
shield ,adapter:2
shield ,personal:2
shield ,protective:2
shield ,equipment:2
adapter ,personal:2
adapter ,protective:2
adapter ,equipment:2
prevalence ,hws:2
prevalence ,diagnostic:2
prevalence ,test:2
sars-cov-2 ,hws:2
infection ,hws:2
health ,hws:2
health ,diagnostic:2
workers ,hws:2
workers ,diagnostic:2
workers ,test:2
hws ,diagnostic:2
hws ,test:2
outlook ,diagnostic:2
outlook ,purposes:2
outlook ,2019-novel:2
outlook ,coronavirus:2
outlook ,disease:2
diagnostic ,purposes:2
diagnostic ,2019-novel:2
purposes ,2019-novel:2
purposes ,coronavirus:2
purposes ,disease:2
2019-novel ,disease:2
neurological ,identified:2
neurological ,treatment:2
disorders ,identified:2
identified ,treatment:2
identified ,infection:2
twenty ,years:2
twenty ,progress:2
twenty ,angiotensin:2
twenty ,converting:2
twenty ,enzyme:2
twenty ,link:2
years ,progress:2
years ,angiotensin:2
years ,converting:2
years ,enzyme:2
years ,link:2
progress ,angiotensin:2
progress ,converting:2
progress ,enzyme:2
progress ,link:2
angiotensin ,link:2
converting ,link:2
enzyme ,link:2
impact ,building:2
impact ,ventilation:4
impact ,systems:2
impact ,habitual:2
impact ,indoor:2
impact ,incense:2
impact ,burning:2
building ,ventilation:2
building ,systems:2
building ,habitual:2
building ,indoor:2
building ,incense:2
building ,burning:2
ventilation ,habitual:2
ventilation ,incense:2
ventilation ,burning:2
systems ,habitual:2
systems ,indoor:2
systems ,incense:2
systems ,burning:2
habitual ,indoor:2
habitual ,incense:2
habitual ,burning:2
indoor ,incense:2
indoor ,burning:2
incense ,burning:2
acute ,myocardial:2
possible ,hla:2
possible ,class-i:2
possible ,genotype:2
possible ,progression:2
role ,hla:2
role ,class-i:2
role ,genotype:2
role ,progression:4
hla ,class-i:2
hla ,genotype:2
hla ,sars-cov-2:4
hla ,infection:2
hla ,progression:2
class-i ,genotype:2
class-i ,sars-cov-2:2
class-i ,infection:2
class-i ,progression:2
genotype ,sars-cov-2:2
genotype ,infection:2
genotype ,progression:2
coevolution ,dynamics:2
coevolution ,allostery:2
coevolution ,conspire:2
coevolution ,shaping:2
coevolution ,cooperative:2
coevolution ,binding:2
dynamics ,allostery:2
dynamics ,conspire:2
dynamics ,shaping:2
dynamics ,cooperative:2
dynamics ,binding:2
allostery ,conspire:2
allostery ,shaping:2
allostery ,cooperative:2
allostery ,binding:2
conspire ,shaping:2
conspire ,cooperative:2
conspire ,binding:2
shaping ,cooperative:2
shaping ,binding:2
cooperative ,binding:2
urgent ,safety:2
urgent ,considerations:2
urgent ,dermatologic:2
urgent ,surgeons:2
urgent ,pandemic:6
safety ,considerations:4
safety ,dermatologic:2
safety ,surgeons:2
safety ,pandemic:6
considerations ,dermatologic:2
considerations ,surgeons:2
dermatologic ,surgeons:2
dermatologic ,pandemic:4
surgeons ,pandemic:2
coagulopathy ,focus:2
coagulopathy ,vascular:2
coagulopathy ,thrombotic:4
coagulopathy ,events:4
covid-19 ,thrombotic:10
focus ,vascular:2
focus ,thrombotic:2
focus ,events:2
vascular ,thrombotic:2
vascular ,events:2
microwave-generated ,steam:4
microwave-generated ,decontamination:4
microwave-generated ,n95:2
microwave-generated ,respirators:2
microwave-generated ,utilizing:2
microwave-generated ,universally:2
steam ,decontamination:4
steam ,n95:2
steam ,respirators:2
steam ,utilizing:2
steam ,universally:2
decontamination ,respirators:2
decontamination ,utilizing:2
decontamination ,universally:2
n95 ,respirators:2
n95 ,utilizing:2
n95 ,universally:2
respirators ,utilizing:2
respirators ,universally:2
utilizing ,universally:2
etiology ,management:2
etiology ,injury:2
etiology ,patients:2
management ,injury:2
postmortem ,imaging:2
postmortem ,deaths:2
imaging ,deaths:2
lung ,cases:6
lung ,deaths:2
assessment ,ivf:2
assessment ,laboratory:4
management ,ivf:2
risk ,ivf:2
risk ,laboratory:2
sars-cov-2 ,ivf:2
infection ,ivf:2
ivf ,laboratory:4
clinical ,confirmed:4
characteristics ,confirmed:8
characteristics ,systematic:4
confirmed ,newborns:2
confirmed ,systematic:2
confirmed ,review:2
advancement ,biosensors:2
advancement ,inflammatory:2
advancement ,biomarkers:2
advancement ,sars-cov-2:2
biosensors ,inflammatory:2
biosensors ,biomarkers:2
biosensors ,sars-cov-2:2
polyunsaturated ,fatty:2
polyunsaturated ,acid:2
polyunsaturated ,biosynthesis:2
polyunsaturated ,pathway:2
polyunsaturated ,genetics:2
polyunsaturated ,implications:2
fatty ,acid:4
fatty ,biosynthesis:2
fatty ,pathway:2
fatty ,genetics:2
fatty ,implications:2
acid ,biosynthesis:2
acid ,pathway:2
acid ,genetics:2
biosynthesis ,pathway:2
biosynthesis ,genetics:2
biosynthesis ,implications:2
pathway ,genetics:2
pathway ,implications:2
genetics ,implications:2
evaluation ,upper:2
three ,commercial:2
three ,upper:2
commercial ,upper:2
assays ,upper:2
molecular ,upper:2
detection ,upper:2
validity ,serological:2
validity ,diagnostic:2
validity ,kit:2
validity ,available:2
validity ,iran:2
serological ,kit:2
serological ,available:4
serological ,iran:2
diagnostic ,available:2
diagnostic ,iran:2
kit ,available:2
kit ,iran:2
available ,iran:2
telomeres ,covid-19:2
characteristics ,beijing:2
infection ,beijing:2
hemostatic ,abnormalities:2
hemostatic ,guided:2
hemostatic ,review:2
abnormalities ,guided:2
guided ,review:2
hypertension ,prevalence:2
hypertension ,human:2
hypertension ,role:2
hypertension ,ace:2
prevalence ,human:2
prevalence ,role:2
prevalence ,ace:2
prevalence ,system:2
human ,ace:2
disease ,ace:2
role ,ace:2
ace ,system:2
lung ,scintigraphy:2
lung ,features:4
lung ,young:2
scintigraphy ,imaging:2
scintigraphy ,features:2
scintigraphy ,young:2
scintigraphy ,patient:2
scintigraphy ,covid-19:2
imaging ,young:2
imaging ,patient:2
features ,young:2
features ,patient:6
psychotic ,symptoms:2
psychotic ,patients:4
psychotic ,retrospective:2
psychotic ,descriptive:2
psychotic ,study:2
symptoms ,retrospective:2
symptoms ,descriptive:2
symptoms ,study:2
patients ,descriptive:2
retrospective ,descriptive:2
possibilities ,employment:2
possibilities ,pregnant:2
possibilities ,women:2
possibilities ,health:2
possibilities ,care:2
possibilities ,system:2
employment ,pregnant:2
employment ,women:2
employment ,health:2
employment ,care:2
employment ,system:2
pregnant ,system:2
women ,system:2
care ,system:2
italian ,pandemic:2
italian ,dental:2
italian ,care:2
italian ,access:2
italian ,decade:2
italian ,study:4
response ,dental:4
response ,access:2
response ,decade:2
response ,study:6
coronavirus ,access:2
coronavirus ,decade:2
pandemic ,access:2
pandemic ,decade:2
dental ,access:2
dental ,decade:2
dental ,study:2
care ,access:2
care ,decade:2
care ,study:6
access ,decade:2
access ,study:2
decade ,study:2
covid-19 ,aesthetic:2
pandemic ,consensus:2
pandemic ,preferred:2
pandemic ,aesthetic:2
consensus ,guidelines:2
consensus ,preferred:2
consensus ,practices:2
consensus ,aesthetic:2
guidelines ,preferred:2
guidelines ,aesthetic:2
preferred ,practices:2
preferred ,aesthetic:2
practices ,aesthetic:2
pathogenesis ,virus:4
pathogenesis ,decrease:2
pathogenesis ,high-altitude:2
sars-cov-2 ,decrease:2
sars-cov-2 ,high-altitude:2
virus ,decrease:2
virus ,high-altitude:2
decrease ,high-altitude:2
type ,hypersensitivity:2
type ,vasculitis:2
hypersensitivity ,covid-19:4
hypersensitivity ,vasculitis:2
sars-cov-2covid-19 ,advances:2
sars-cov-2covid-19 ,developing:2
sars-cov-2covid-19 ,potential:2
sars-cov-2covid-19 ,therapeutics:2
advances ,developing:2
advances ,therapeutics:2
advances ,vaccines:6
developing ,therapeutics:2
developing ,vaccines:2
analysis ,individual:2
analysis ,potent:2
sars-cov-2-infected ,individual:2
sars-cov-2-infected ,development:2
sars-cov-2-infected ,potent:2
individual ,reveals:2
individual ,development:2
individual ,potent:2
reveals ,potent:2
mesenteric ,two:2
mesenteric ,patients:2
mesenteric ,cases:2
thrombosis ,two:2
thrombosis ,cases:6
thrombosis ,report:8
protocol ,national:2
protocol ,probability:2
protocol ,survey:2
protocol ,using:2
protocol ,home:2
protocol ,specimen:2
protocol ,collection:2
protocol ,methods:2
national ,probability:2
national ,survey:2
national ,using:2
national ,home:2
national ,specimen:2
national ,collection:2
national ,methods:2
probability ,survey:2
probability ,using:2
probability ,home:2
probability ,specimen:2
probability ,collection:2
probability ,methods:2
survey ,using:2
survey ,home:2
survey ,specimen:2
survey ,collection:2
survey ,methods:2
using ,home:2
using ,specimen:2
using ,methods:4
home ,specimen:2
home ,collection:4
home ,methods:4
specimen ,methods:2
collection ,methods:4
association ,abo:2
association ,blood:2
association ,group:2
association ,meta-analysis:2
abo ,meta-analysis:2
blood ,meta-analysis:2
group ,meta-analysis:2
infection ,meta-analysis:2
estimation ,airborne:2
estimation ,viral:2
estimation ,emission:2
estimation ,quanta:2
estimation ,rate:2
airborne ,viral:2
airborne ,emission:2
airborne ,quanta:2
airborne ,rate:2
viral ,emission:2
viral ,quanta:2
emission ,quanta:2
emission ,rate:2
emission ,sars-cov-2:2
quanta ,rate:2
quanta ,sars-cov-2:2
high ,cardiorespiratory:2
high ,fitness:2
high ,confer:2
high ,protection:2
high ,proinflammatory:2
cardiorespiratory ,fitness:2
cardiorespiratory ,confer:2
cardiorespiratory ,protection:2
cardiorespiratory ,proinflammatory:2
fitness ,confer:2
fitness ,protection:2
fitness ,proinflammatory:2
confer ,protection:2
confer ,proinflammatory:2
protection ,proinflammatory:2
ocular ,comorbidities:2
ocular ,detection:2
manifestation ,comorbidities:2
manifestation ,detection:2
manifestation ,severe:2
manifestation ,acute:2
manifestation ,respiratory:2
comorbidities ,detection:2
evaluations ,serological:2
evaluations ,test:2
evaluations ,diagnosis:2
evaluations ,novel:2
evaluations ,coronavirus:2
serological ,novel:2
coagulopathies ,thrombotic:2
coagulopathies ,risk:2
coagulopathies ,anticoagulation:2
coagulopathies ,covid-19:2
thrombotic ,anticoagulation:2
risk ,anticoagulation:2
impending ,central:2
impending ,retinal:2
impending ,vein:2
impending ,occlusion:2
impending ,patient:2
impending ,coronavirus:2
impending ,disease:2
central ,retinal:4
central ,vein:4
central ,occlusion:4
central ,patient:2
central ,disease:4
retinal ,patient:2
retinal ,coronavirus:2
retinal ,disease:2
vein ,patient:2
vein ,coronavirus:2
vein ,disease:2
occlusion ,patient:2
occlusion ,coronavirus:2
occlusion ,disease:2
clinical ,repositioning:2
trials ,drug:4
trials ,repositioning:2
trials ,treatment:2
impact ,mortality:6
impact ,andor:2
impact ,invasive:2
impact ,mechanical:2
tocilizumab ,mortality:4
tocilizumab ,andor:4
tocilizumab ,invasive:2
tocilizumab ,mechanical:2
tocilizumab ,ventilation:2
mortality ,andor:4
mortality ,invasive:2
mortality ,mechanical:2
mortality ,ventilation:2
andor ,invasive:2
andor ,mechanical:2
andor ,ventilation:2
invasive ,mechanical:2
invasive ,ventilation:2
impact ,complete:2
impact ,total:2
impact ,death:2
impact ,rates:2
impact ,hierarchical:2
complete ,lockdown:2
complete ,total:2
complete ,infection:2
complete ,death:2
complete ,rates:2
complete ,hierarchical:2
lockdown ,total:2
lockdown ,infection:2
lockdown ,death:2
lockdown ,rates:2
lockdown ,hierarchical:2
total ,infection:2
total ,death:2
total ,rates:2
total ,hierarchical:2
infection ,hierarchical:2
death ,hierarchical:2
rates ,hierarchical:2
ethical ,implementation:2
ethical ,immunity:2
ethical ,passports:2
ethical ,pandemic:6
implementation ,immunity:2
implementation ,passports:2
implementation ,covid-19:6
implementation ,pandemic:2
immunity ,passports:4
immunity ,pandemic:2
passports ,covid-19:2
passports ,pandemic:2
thrombosis ,pneumonia:2
thrombosis ,clot:2
thrombosis ,thickens:2
covid-19 ,clot:4
covid-19 ,thickens:2
pneumonia ,clot:2
pneumonia ,thickens:2
clot ,thickens:2
cns ,penetration:2
cns ,ability:2
cns ,critical:2
cns ,factor:2
cns ,drugs:2
cns ,treatment:2
penetration ,ability:2
penetration ,critical:2
penetration ,factor:2
penetration ,drugs:2
penetration ,treatment:2
penetration ,sars-cov-2:2
ability ,critical:2
ability ,factor:2
ability ,drugs:2
ability ,treatment:2
critical ,drugs:4
critical ,treatment:4
factor ,drugs:2
factor ,treatment:2
covid-19 ,non-pharmacological:2
review ,effectiveness:4
review ,non-pharmacological:2
review ,interventions:4
effectiveness ,non-pharmacological:2
non-pharmacological ,interventions:2
outbreak ,perception:2
perception ,dentists:2
italian ,dentists:2
epidemiologic ,controlling:2
epidemiologic ,pandemic:2
epidemiologic ,types:2
epidemiologic ,challenges:2
surveillance ,controlling:2
surveillance ,pandemic:4
surveillance ,types:2
surveillance ,challenges:2
controlling ,types:2
controlling ,challenges:2
covid-19 ,types:4
pandemic ,types:2
types ,challenges:2
use ,machine:4
use ,learning:2
use ,artificial:2
use ,intelligence:2
use ,predict:2
machine ,artificial:2
machine ,predict:2
machine ,sars-cov-2:2
machine ,infection:4
learning ,artificial:2
learning ,intelligence:2
learning ,predict:2
learning ,sars-cov-2:4
learning ,infection:4
artificial ,predict:2
artificial ,infection:2
intelligence ,predict:2
intelligence ,sars-cov-2:2
intelligence ,infection:2
predict ,infection:2
chronic ,kidney:6
chronic ,injury:2
chronic ,spanish:2
chronic ,outbreak:4
kidney ,spanish:2
kidney ,outbreak:2
disease ,spanish:2
acute ,spanish:2
injury ,spanish:2
injury ,outbreak:2
covid-19 ,spanish:6
spanish ,outbreak:4
waning ,antibody:2
waning ,responses:2
waning ,asymptomatic:2
waning ,symptomatic:2
waning ,sars-cov-2:2
waning ,infection:2
antibody ,symptomatic:2
responses ,symptomatic:2
limited ,specificity:2
limited ,serologic:2
limited ,tests:4
limited ,sars-cov-2:4
limited ,antibody:4
limited ,detection:2
limited ,benin:2
specificity ,serologic:2
specificity ,tests:2
specificity ,antibody:2
specificity ,detection:2
specificity ,benin:2
serologic ,tests:2
serologic ,benin:2
tests ,benin:2
sars-cov-2 ,benin:2
antibody ,benin:2
detection ,benin:2
infection ,update:8
infection ,information:4
infection ,proposed:2
pregnancy ,information:4
pregnancy ,proposed:2
pregnancy ,care:4
update ,information:2
update ,proposed:2
update ,care:2
information ,proposed:2
information ,care:4
proposed ,care:2
use ,online:2
use ,surveys:2
use ,assess:2
use ,peoples:2
use ,perceptions:2
use ,infectious:2
rapid ,online:2
rapid ,surveys:2
rapid ,assess:2
rapid ,peoples:2
rapid ,perceptions:2
rapid ,infectious:2
online ,surveys:2
online ,assess:2
online ,peoples:2
online ,perceptions:2
online ,infectious:2
online ,disease:2
surveys ,assess:2
surveys ,peoples:2
surveys ,perceptions:2
surveys ,infectious:2
surveys ,disease:2
assess ,peoples:2
assess ,perceptions:2
assess ,infectious:2
assess ,disease:2
peoples ,perceptions:2
peoples ,infectious:2
peoples ,disease:4
perceptions ,infectious:2
perceptions ,disease:2
association ,race:4
association ,ethnicity:2
association ,comorbidities:2
association ,survival:2
race ,ethnicity:4
race ,comorbidities:2
race ,survival:2
race ,among:4
race ,patients:4
ethnicity ,comorbidities:2
ethnicity ,survival:2
ethnicity ,among:2
ethnicity ,patients:2
comorbidities ,survival:2
comorbidities ,among:4
survival ,among:2
rely ,screening:2
rely ,tests:2
rely ,management:2
rely ,alone:2
rely ,polymerase:2
rely ,chain:2
screening ,tests:2
screening ,management:4
screening ,alone:2
screening ,polymerase:2
screening ,chain:2
tests ,management:2
tests ,alone:2
management ,alone:2
management ,polymerase:2
management ,chain:2
alone ,polymerase:2
alone ,chain:2
perspective ,pneumonia:2
pneumonia ,systematic:2
socioeconomic ,correlates:2
socioeconomic ,influenza:2
socioeconomic ,h1n1:2
socioeconomic ,outbreaks:2
correlates ,influenza:2
correlates ,h1n1:2
correlates ,outbreaks:2
sars-cov-2 ,h1n1:2
influenza ,h1n1:2
influenza ,outbreaks:4
h1n1 ,outbreaks:2
cardiovascular ,health:4
cardiovascular ,among:2
cardiovascular ,cancer:2
among ,cancer:2
sars-cov-2 ,concerned:2
concerned ,nervous:2
concerned ,system:2
companion ,likely:2
companion ,spread:2
companion ,covid-19:4
companion ,may:2
companion ,get:2
companion ,infected:2
animals ,likely:2
animals ,spread:2
animals ,may:2
animals ,get:2
animals ,infected:2
likely ,spread:2
likely ,covid-19:2
likely ,may:2
likely ,get:2
likely ,infected:2
spread ,may:4
spread ,get:2
spread ,infected:2
may ,get:2
may ,infected:2
get ,infected:2
facing ,pandemic:4
facing ,covid-19:6
facing ,regional:2
facing ,childrens:2
facing ,hospital:2
facing ,italy:2
sars-cov-2 ,childrens:2
pandemic ,regional:2
pandemic ,childrens:2
covid-19 ,childrens:2
regional ,childrens:2
regional ,hospital:2
regional ,italy:2
childrens ,italy:2
challenges ,controversies:2
controversies ,testing:2
controversies ,covid-19:6
coronavirus ,conjunctivitis:2
disease ,conjunctivitis:2
presenting ,conjunctivitis:2
public ,interventions:6
public ,mitigate:2
public ,early:4
public ,spread:2
public ,poland:2
health ,interventions:4
health ,mitigate:2
health ,spread:2
health ,poland:2
interventions ,mitigate:4
interventions ,spread:4
interventions ,sars-cov-2:4
interventions ,poland:2
mitigate ,early:4
mitigate ,spread:4
mitigate ,poland:2
early ,poland:2
spread ,poland:2
impact ,laboratory:2
impact ,utilization:2
covid-19 ,utilization:2
pandemic ,utilization:4
laboratory ,utilization:2
features ,meta-analysis:2
severe ,meta-analysis:2
effects ,induced:4
effects ,lockdown:4
effects ,maritime:2
effects ,settings:2
effects ,coastal:2
covid-19 ,induced:6
covid-19 ,maritime:2
covid-19 ,settings:6
covid-19 ,coastal:2
induced ,lockdown:2
induced ,measures:2
induced ,maritime:2
induced ,settings:2
induced ,coastal:2
lockdown ,measures:6
lockdown ,maritime:2
lockdown ,settings:2
lockdown ,coastal:2
measures ,maritime:2
measures ,settings:2
measures ,coastal:2
maritime ,settings:2
maritime ,coastal:2
settings ,coastal:2
receptor ,expressed:2
receptor ,many:2
receptor ,different:4
receptor ,types:2
ace-2 ,expressed:2
ace-2 ,many:2
ace-2 ,different:2
ace-2 ,cell:2
ace-2 ,types:2
expressed ,many:2
expressed ,different:2
expressed ,cell:2
expressed ,types:2
many ,different:2
many ,cell:2
many ,types:2
different ,cell:2
cell ,types:2
genomic ,syndrome-coronavirus:2
diversity ,severe:2
diversity ,acute:2
diversity ,respiratory:2
diversity ,syndrome-coronavirus:2
syndrome-coronavirus ,patients:2
transformation ,large:2
transformation ,multi-speciality:2
transformation ,hospital:2
transformation ,dedicated:2
transformation ,covid-19:2
transformation ,centre:2
large ,multi-speciality:2
large ,dedicated:2
large ,centre:2
multi-speciality ,hospital:2
multi-speciality ,dedicated:2
multi-speciality ,covid-19:2
multi-speciality ,centre:2
hospital ,dedicated:2
hospital ,centre:2
dedicated ,covid-19:4
dedicated ,centre:2
systematic ,repurposing:2
systematic ,use:4
systematic ,favipiravir:2
review ,favipiravir:2
repurposing ,use:2
repurposing ,favipiravir:2
use ,favipiravir:2
considerations ,people:2
considerations ,diabetes:2
poor ,sensitivity:2
poor ,accupower:2
poor ,real:2
poor ,time:2
poor ,rt-pcr:2
poor ,kit:2
poor ,bioneer:2
poor ,south:2
sensitivity ,accupower:2
sensitivity ,real:2
sensitivity ,time:2
sensitivity ,bioneer:2
sensitivity ,south:2
accupower ,sars-cov-2:2
accupower ,real:2
accupower ,time:2
accupower ,rt-pcr:2
accupower ,kit:2
accupower ,bioneer:2
accupower ,south:2
sars-cov-2 ,bioneer:2
real ,rt-pcr:2
real ,bioneer:2
real ,south:2
time ,bioneer:2
time ,south:2
rt-pcr ,bioneer:2
rt-pcr ,south:2
kit ,bioneer:2
kit ,south:2
bioneer ,south:2
successful ,transfer:2
successful ,anti-sars-cov-2:2
successful ,immunity:2
successful ,using:2
successful ,convalescent:2
successful ,mm:2
transfer ,anti-sars-cov-2:2
transfer ,immunity:2
transfer ,using:2
transfer ,convalescent:2
transfer ,plasma:2
transfer ,mm:2
anti-sars-cov-2 ,immunity:2
anti-sars-cov-2 ,mm:2
immunity ,using:2
immunity ,convalescent:6
immunity ,plasma:2
immunity ,mm:2
using ,mm:2
convalescent ,mm:2
plasma ,mm:2
impact ,delirium:2
impact ,outcomes:2
impact ,older:2
impact ,adults:2
impact ,hospitalised:2
delirium ,outcomes:2
delirium ,older:2
delirium ,adults:2
delirium ,hospitalised:2
outcomes ,older:4
outcomes ,hospitalised:2
older ,hospitalised:2
adults ,hospitalised:2
hospitalised ,covid-19:8
development ,clinical:8
development ,loop-mediated:4
clinical ,rapid:6
clinical ,sensitive:2
clinical ,loop-mediated:2
application ,sensitive:2
application ,loop-mediated:2
rapid ,loop-mediated:2
sensitive ,loop-mediated:2
rhabdomyolysis ,report:6
rhabdomyolysis ,four:2
rhabdomyolysis ,cases:2
novel ,real-time:4
2019-ncov ,real-time:2
2019-ncov ,rt-pcr:2
effect ,female:2
effect ,sexual:2
effect ,behavior:2
covid-19 ,female:6
covid-19 ,sexual:8
pandemic ,female:2
pandemic ,sexual:6
pandemic ,behavior:2
female ,sexual:2
female ,behavior:2
sexual ,behavior:2
transfer ,factor:2
transfer ,option:2
transfer ,managing:2
transfer ,covid-19:2
transfer ,pandemic:2
factor ,option:2
factor ,managing:2
option ,managing:2
option ,pandemic:2
need ,return:2
need ,basics:2
need ,predictive:2
need ,modelling:2
need ,outbreak:2
return ,basics:2
return ,predictive:2
return ,modelling:2
return ,disease:2
return ,outbreak:2
basics ,predictive:2
basics ,modelling:2
basics ,disease:2
basics ,outbreak:2
predictive ,modelling:2
predictive ,disease:2
predictive ,outbreak:2
modelling ,disease:2
modelling ,outbreak:2
sequential ,battery:2
sequential ,covid-19:2
sequential ,testing:2
sequential ,maximize:2
sequential ,negative:2
sequential ,predictive:2
sequential ,value:2
battery ,covid-19:2
battery ,testing:2
battery ,maximize:2
battery ,negative:2
battery ,predictive:2
battery ,value:2
covid-19 ,maximize:2
testing ,maximize:2
testing ,negative:2
testing ,predictive:2
testing ,value:8
maximize ,negative:2
maximize ,predictive:2
maximize ,value:2
negative ,predictive:2
negative ,value:2
ct ,original:2
ct ,district:2
features ,original:2
features ,district:2
disease ,district:4
covid-19 ,original:2
covid-19 ,district:4
original ,district:2
health-related ,concerns:2
health-related ,precautions:2
health-related ,covid-19:2
health-related ,pandemic:2
health-related ,comparison:2
concerns ,precautions:2
concerns ,comparison:2
precautions ,covid-19:6
precautions ,pandemic:4
precautions ,comparison:2
pandemic ,comparison:2
changed ,information:2
changed ,needs:2
changed ,italian:2
changed ,citizens:2
information ,needs:2
information ,italian:2
information ,citizens:2
needs ,italian:2
needs ,citizens:2
differential ,immune:2
differential ,activation:2
differential ,profile:2
differential ,sars-cov-2:4
differential ,sars-cov:4
differential ,infection:2
immune ,profile:2
activation ,profile:2
activation ,infection:2
profile ,sars-cov:2
profile ,human:2
emergence ,threatening:2
emergence ,health:2
novel ,threatening:2
human ,threatening:2
coronavirus ,threatening:2
threatening ,health:2
assessment ,mental:2
assessment ,health:2
assessment ,professionals:2
assessment ,depending:2
mental ,among:4
mental ,professionals:4
mental ,depending:2
health ,depending:2
factors ,professionals:4
factors ,depending:2
among ,professionals:2
among ,depending:2
professionals ,depending:2
vitro ,analysis:2
vitro ,renin-angiotensin:2
vitro ,system:2
vitro ,inflammatory:2
vitro ,gene:2
vitro ,transcripts:2
analysis ,renin-angiotensin:2
analysis ,inflammatory:4
analysis ,gene:2
analysis ,transcripts:4
renin-angiotensin ,inflammatory:2
renin-angiotensin ,gene:2
renin-angiotensin ,transcripts:2
system ,inflammatory:4
system ,transcripts:2
inflammatory ,gene:2
inflammatory ,transcripts:2
gene ,transcripts:2
effect ,orthopedic:2
effect ,practices:2
effect ,new:2
effect ,york:2
pandemic ,orthopedic:2
orthopedic ,new:2
orthopedic ,york:2
practices ,york:2
neurosurgical ,disease:2
use ,lung:4
use ,ultrasound:2
use ,narrative:2
lung ,pandemic:8
lung ,narrative:4
ultrasound ,narrative:2
whole-genome ,sequencing:2
whole-genome ,track:2
whole-genome ,sars-cov-2:2
whole-genome ,transmission:2
whole-genome ,nosocomial:2
whole-genome ,outbreaks:2
sequencing ,track:2
sequencing ,nosocomial:2
sequencing ,outbreaks:2
track ,transmission:2
track ,nosocomial:2
track ,outbreaks:2
sars-cov-2 ,nosocomial:4
nosocomial ,outbreaks:2
prevention ,laboratories:2
control ,laboratories:2
sars-cov-2 ,laboratories:4
infection ,laboratories:4
potential ,compromised:2
potential ,air:2
potential ,quality:2
potential ,corona:2
link ,compromised:2
link ,air:4
link ,quality:2
link ,transmission:2
link ,novel:2
link ,corona:2
compromised ,air:2
compromised ,quality:2
compromised ,transmission:2
compromised ,novel:2
compromised ,corona:2
air ,transmission:8
air ,novel:2
quality ,transmission:2
quality ,novel:2
quality ,corona:2
transmission ,corona:2
inpatient ,outpatient:2
inpatient ,case:2
inpatient ,prioritization:2
inpatient ,neuro-oncologic:2
outpatient ,case:2
outpatient ,prioritization:2
outpatient ,neuro-oncologic:2
case ,prioritization:2
case ,neuro-oncologic:2
prioritization ,patients:4
prioritization ,neuro-oncologic:2
patients ,neuro-oncologic:2
current ,targeted:2
current ,impact:4
state ,vaccine:2
state ,development:2
state ,targeted:2
state ,impact:2
vaccine ,targeted:2
vaccine ,therapies:2
vaccine ,impact:2
development ,targeted:4
development ,therapies:2
development ,impact:2
targeted ,therapies:2
targeted ,covid-19:8
targeted ,impact:2
therapies ,impact:2
covid-19 ,makes:2
covid-19 ,forget:2
makes ,cells:2
makes ,forget:2
makes ,remember:2
cells ,forget:2
cells ,remember:2
forget ,remember:2
time ,treat:2
time ,applying:2
time ,syndromes:2
treat ,applying:2
treat ,lessons:2
treat ,learned:2
treat ,viral:2
treat ,syndromes:2
applying ,lessons:2
applying ,learned:2
applying ,viral:2
applying ,syndromes:2
applying ,sars-cov-2:4
lessons ,viral:6
lessons ,syndromes:2
learned ,viral:2
learned ,syndromes:2
viral ,syndromes:2
syndromes ,sars-cov-2:4
pathogenesis-directed ,therapy:2
pathogenesis-directed ,novel:2
pathogenesis-directed ,coronavirus:2
pathogenesis-directed ,disease:2
quantitative ,lesion:2
quantitative ,features:2
quantitative ,temporal:2
quantitative ,changes:2
quantitative ,chest:2
lung ,lesion:2
lung ,temporal:2
lung ,changes:2
lung ,chest:10
lesion ,features:2
lesion ,temporal:2
lesion ,changes:2
lesion ,chest:2
lesion ,ct:2
lesion ,patients:2
features ,temporal:2
temporal ,changes:2
temporal ,chest:2
temporal ,ct:4
changes ,chest:4
possible ,agents:2
possible ,comprehensive:2
therapeutic ,comprehensive:2
agents ,comprehensive:2
identification ,iga:2
identification ,saliva:2
identification ,one:2
identification ,sample:2
identification ,two:2
identification ,tests:4
iga ,antibodies:2
iga ,saliva:2
iga ,one:2
iga ,sample:2
iga ,two:2
iga ,tests:2
antibodies ,saliva:2
antibodies ,one:2
antibodies ,sample:2
saliva ,one:2
saliva ,sample:6
saliva ,two:2
saliva ,tests:2
one ,sample:2
one ,tests:2
sample ,two:4
sample ,tests:2
vaccines ,act:2
vaccines ,deciphering:2
vaccines ,hesitancy:2
vaccines ,time:4
act ,deciphering:2
act ,vaccine:2
act ,hesitancy:2
act ,time:2
deciphering ,vaccine:2
deciphering ,hesitancy:2
deciphering ,time:2
hesitancy ,time:2
assisted ,reproduction:2
assisted ,coronavirus:2
assisted ,italy:2
reproduction ,italy:2
coronavirus ,covid-:2
covid- ,critical:2
covid- ,review:2
covid- ,history:2
covid- ,pathogenesis:2
covid- ,transmission:2
19 ,critical:2
19 ,history:2
19 ,pathogenesis:2
critical ,history:2
critical ,pathogenesis:2
review ,history:2
history ,pathogenesis:2
pathogenesis ,transmission:6
physician ,health:2
physician ,times:2
genomic ,guangdong:2
genomic ,province:2
genomic ,china:2
epidemiology ,guangdong:2
current ,multiple:2
current ,molecules:2
status ,multiple:2
status ,drug:2
status ,molecules:2
multiple ,drug:2
multiple ,molecules:2
multiple ,vaccines:2
multiple ,update:2
drug ,molecules:2
drug ,vaccines:2
molecules ,vaccines:2
molecules ,update:2
vaccines ,update:2
clinical ,lupus:2
management ,lupus:2
lupus ,patients:2
lupus ,covid-19:6
lupus ,pandemic:2
covid-19 ,dangerous:2
air ,dangerous:2
pollution ,dangerous:2
dangerous ,association:2
lower ,incidence:2
lower ,high:2
lower ,altitude:2
lower ,facts:2
lower ,confounders:2
incidence ,altitude:2
incidence ,facts:2
incidence ,confounders:2
covid-19 ,confounders:2
high ,facts:2
high ,confounders:2
altitude ,facts:2
altitude ,confounders:2
facts ,confounders:2
broad ,spectrum:2
broad ,antiviral:2
broad ,agent:2
broad ,niclosamide:2
broad ,therapeutic:2
broad ,potential:2
spectrum ,antiviral:2
spectrum ,agent:2
spectrum ,niclosamide:2
spectrum ,therapeutic:2
spectrum ,potential:4
antiviral ,niclosamide:2
antiviral ,therapeutic:2
agent ,niclosamide:2
niclosamide ,therapeutic:2
niclosamide ,potential:2
can ,paediatric:2
can ,cohorts:2
can ,solve:2
can ,puzzle:2
data ,paediatric:2
data ,cohorts:2
data ,solve:2
data ,puzzle:2
paediatric ,cohorts:2
paediatric ,solve:2
paediatric ,puzzle:2
cohorts ,solve:2
cohorts ,covid-19:2
cohorts ,puzzle:2
solve ,puzzle:2
rates ,maternal:2
rates ,perinatal:2
rates ,mortality:4
rates ,vertical:2
rates ,transmission:6
rates ,pregnancies:2
maternal ,mortality:4
maternal ,vertical:2
maternal ,transmission:4
maternal ,pregnancies:2
perinatal ,mortality:2
perinatal ,vertical:2
perinatal ,transmission:2
perinatal ,pregnancies:2
mortality ,vertical:2
mortality ,transmission:2
mortality ,pregnancies:2
vertical ,pregnancies:2
transmission ,pregnancies:2
changes ,laboratory:4
changes ,cardiac:2
changes ,markers:2
changes ,mechanisms:2
changes ,injury:4
laboratory ,cardiac:2
laboratory ,markers:2
laboratory ,mechanisms:2
laboratory ,injury:2
cardiac ,markers:2
cardiac ,mechanisms:2
markers ,mechanisms:2
markers ,injury:2
sialoside-binding ,pocket:2
sialoside-binding ,sars-cov-2:2
sialoside-binding ,spike:2
sialoside-binding ,glycoprotein:2
sialoside-binding ,structurally:2
sialoside-binding ,resembles:2
pocket ,sars-cov-2:4
pocket ,spike:4
pocket ,glycoprotein:2
pocket ,structurally:2
pocket ,resembles:2
sars-cov-2 ,structurally:2
sars-cov-2 ,resembles:4
spike ,structurally:2
spike ,resembles:2
glycoprotein ,structurally:2
glycoprotein ,resembles:2
structurally ,resembles:2
modeling ,inactivation:2
modeling ,viruses:2
modeling ,coronaviridae:2
modeling ,family:2
modeling ,response:2
inactivation ,viruses:2
inactivation ,coronaviridae:2
inactivation ,family:2
inactivation ,response:2
viruses ,coronaviridae:2
viruses ,family:2
viruses ,response:2
coronaviridae ,family:2
coronaviridae ,response:2
twenty-year ,span:2
twenty-year ,global:2
twenty-year ,coronavirus:2
twenty-year ,research:2
twenty-year ,trends:2
twenty-year ,bibliometric:2
twenty-year ,analysis:2
span ,global:2
span ,coronavirus:2
span ,research:2
span ,trends:2
span ,bibliometric:2
span ,analysis:2
global ,trends:2
global ,bibliometric:2
coronavirus ,bibliometric:4
research ,bibliometric:4
trends ,bibliometric:2
trends ,analysis:2
rna ,air:2
detection ,ward:2
air ,surfaces:2
air ,ward:2
renin-angiotensin-aldosterone ,role:2
renin-angiotensin-aldosterone ,pathogenesis:2
renin-angiotensin-aldosterone ,potential:2
diabetes ,factor:6
diabetes ,19:2
mellitus ,factor:4
mellitus ,19:2
risk ,19:2
factor ,coronavirus:2
factor ,disease:2
factor ,19:2
early ,hungary:2
early ,post-lockdown:2
early ,scenarios:2
phase ,hungary:2
phase ,post-lockdown:2
phase ,scenarios:2
covid-19 ,hungary:2
outbreak ,hungary:2
outbreak ,post-lockdown:2
outbreak ,scenarios:2
hungary ,post-lockdown:2
hungary ,scenarios:2
post-lockdown ,scenarios:2
coronavirus ,neurologists:2
disease ,point:2
disease ,view:2
disease ,neurologists:2
covid-19 ,neurologists:4
point ,neurologists:2
view ,neurologists:2
molecular ,interface:2
molecular ,protein:2
basis ,drug:4
basis ,repurposing:2
basis ,study:2
basis ,interface:2
basis ,protein:2
drug ,interface:2
repurposing ,interface:2
repurposing ,protein:2
study ,interface:2
study ,protein:2
sars-cov-2 ,reinfection:4
reinfection ,recurrence:2
reinfection ,possible:2
reinfection ,case:4
reinfection ,report:4
recurrence ,possible:2
possible ,report:2
mask ,children:2
mask ,overcome:2
children ,overcome:2
protective ,health:4
protective ,americans:2
protective ,taking:2
protective ,response:2
health ,americans:2
health ,taking:2
measures ,americans:2
measures ,taking:2
measures ,response:4
americans ,taking:2
americans ,response:2
americans ,covid-19:2
taking ,response:2
effect ,disease:8
effect ,maternal:2
effect ,perinatal:2
effect ,neonatal:2
pathophysiological ,characteristics:2
pathophysiological ,therapeutic:2
pathophysiological ,approaches:2
pathophysiological ,pulmonary:2
pathophysiological ,injury:2
characteristics ,approaches:2
characteristics ,pulmonary:2
characteristics ,injury:6
therapeutic ,pulmonary:4
therapeutic ,injury:4
approaches ,pulmonary:2
approaches ,injury:2
pulmonary ,injury:2
covid-19 ,immunodeficiency:6
covid-19 ,33:2
people ,living:8
people ,human:4
people ,immunodeficiency:4
people ,virus:2
people ,case:2
people ,series:2
people ,33:2
living ,human:4
living ,immunodeficiency:4
living ,virus:2
living ,case:2
living ,series:2
living ,33:2
human ,immunodeficiency:8
human ,case:4
human ,series:2
human ,33:2
immunodeficiency ,virus:6
immunodeficiency ,case:6
immunodeficiency ,series:2
immunodeficiency ,33:2
virus ,33:2
case ,33:2
series ,33:2
potential ,preanalytical:2
potential ,analytical:2
potential ,vulnerabilities:2
potential ,laboratory:2
preanalytical ,analytical:2
preanalytical ,vulnerabilities:2
preanalytical ,laboratory:2
preanalytical ,diagnosis:2
analytical ,vulnerabilities:2
analytical ,laboratory:2
analytical ,diagnosis:2
vulnerabilities ,laboratory:2
vulnerabilities ,diagnosis:2
prediction ,evolution:2
prediction ,cell:4
prediction ,epitopes:4
prediction ,surface:2
prediction ,protein:2
evolution ,cell:2
evolution ,epitopes:2
evolution ,surface:2
evolution ,protein:2
surface ,protein:4
pregnancy ,reported:2
pregnancy ,cases:2
covid-19 ,pennsylvania:2
infection ,facility:2
infection ,pennsylvania:2
infection ,usa:2
control ,long-term:2
control ,facility:2
control ,pennsylvania:2
control ,usa:2
measures ,long-term:2
measures ,facility:2
measures ,pennsylvania:2
measures ,usa:2
long-term ,pennsylvania:2
long-term ,usa:2
care ,pennsylvania:2
care ,usa:2
facility ,pennsylvania:2
facility ,usa:2
pennsylvania ,usa:2
fdg-petct ,findings:2
fdg-petct ,highly:2
fdg-petct ,suspicious:2
fdg-petct ,covid-19:4
fdg-petct ,italian:4
fdg-petct ,case:2
fdg-petct ,series:2
findings ,highly:4
findings ,suspicious:2
findings ,italian:2
highly ,suspicious:2
highly ,italian:2
highly ,case:2
highly ,series:4
suspicious ,covid-19:2
suspicious ,italian:2
suspicious ,case:2
suspicious ,series:2
italian ,series:2
personal ,healthcare:4
personal ,workers:4
protective ,healthcare:4
protective ,workers:4
equipment ,healthcare:4
equipment ,workers:2
high ,hemodialysis:2
high ,detected:2
prevalence ,hemodialysis:2
asymptomatic ,hemodialysis:2
asymptomatic ,detected:2
covid-19 ,detected:4
infection ,hemodialysis:2
hemodialysis ,detected:2
impact ,international:6
impact ,travel:4
impact ,border:2
impact ,control:6
international ,travel:4
international ,border:2
international ,control:2
international ,measures:2
international ,global:4
international ,spread:4
travel ,border:2
travel ,control:2
travel ,measures:2
travel ,global:4
travel ,spread:6
border ,control:2
border ,measures:2
border ,global:2
border ,spread:2
control ,spread:6
measures ,global:2
impact ,neurodegenerative:2
impact ,neuropsychiatric:2
sars-cov-2 ,neurodegenerative:2
sars-cov-2 ,neuropsychiatric:2
infection ,neurodegenerative:2
infection ,neuropsychiatric:2
neurodegenerative ,neuropsychiatric:2
neurodegenerative ,diseases:2
neuropsychiatric ,diseases:2
rapid ,early:4
rapid ,warning:2
rapid ,models:2
assessment ,early:4
assessment ,warning:2
assessment ,models:2
early ,models:2
warning ,models:2
human ,clonal:2
human ,expansion:2
human ,convergent:2
human ,antibody:8
human ,responses:2
cell ,clonal:2
cell ,expansion:2
cell ,convergent:2
cell ,antibody:2
clonal ,expansion:2
clonal ,convergent:2
clonal ,antibody:2
clonal ,responses:2
expansion ,convergent:2
expansion ,antibody:2
expansion ,responses:2
convergent ,antibody:2
convergent ,responses:2
convergent ,sars-cov-2:2
development ,subtraction-derived:2
development ,sars-cov-2-specific:4
novel ,subtraction-derived:2
novel ,sars-cov-2-specific:2
genome ,subtraction-derived:2
genome ,sars-cov-2-specific:2
subtraction-derived ,sars-cov-2-specific:2
impact ,admitted:2
covid-19 ,admitted:4
pandemic ,admitted:2
infection ,admitted:2
infection ,hospital:8
admitted ,hospital:6
status ,occupational:2
status ,protection:2
status ,fangcang:2
status ,shelter:2
status ,hospital:2
occupational ,protection:2
occupational ,fangcang:2
occupational ,shelter:2
occupational ,hospital:2
protection ,fangcang:2
protection ,shelter:2
protection ,hospital:4
covid-19 ,fangcang:2
covid-19 ,shelter:2
fangcang ,shelter:2
fangcang ,hospital:2
shelter ,hospital:2
optimized ,pseudotyping:2
optimized ,conditions:2
optimized ,glycoprotein:2
pseudotyping ,conditions:2
pseudotyping ,sars-cov-2:2
pseudotyping ,spike:2
pseudotyping ,glycoprotein:2
conditions ,spike:2
conditions ,glycoprotein:2
electrical ,storm:2
electrical ,covid-19:2
alternative ,approach:2
alternative ,minimize:2
alternative ,risk:2
alternative ,similar:2
approach ,minimize:2
approach ,risk:2
approach ,similar:2
minimize ,risk:2
minimize ,coronavirus:2
minimize ,covid-19:2
minimize ,similar:2
risk ,similar:2
coronavirus ,similar:2
pooling ,rt-qpcr:2
pooling ,1000:2
pooling ,individuals:2
pooling ,healthy:2
rt-qpcr ,1000:2
rt-qpcr ,individuals:2
rt-qpcr ,healthy:2
testing ,1000:2
testing ,individuals:2
testing ,healthy:2
sars-cov-2 ,1000:2
1000 ,individuals:2
1000 ,healthy:2
individuals ,healthy:2
inhibition ,pikfyve:2
inhibition ,kinase:2
inhibition ,prevents:2
inhibition ,zaire:2
inhibition ,ebolavirus:2
pikfyve ,kinase:2
pikfyve ,prevents:2
pikfyve ,infection:2
pikfyve ,zaire:2
pikfyve ,ebolavirus:2
pikfyve ,sars-cov-2:2
kinase ,prevents:2
kinase ,infection:2
kinase ,zaire:2
kinase ,ebolavirus:2
kinase ,sars-cov-2:4
prevents ,infection:2
prevents ,zaire:2
prevents ,ebolavirus:2
infection ,zaire:2
infection ,ebolavirus:2
zaire ,ebolavirus:2
zaire ,sars-cov-2:2
ebolavirus ,sars-cov-2:2
sars-cov-2 ,durability:2
cell ,specificity:2
cell ,function:2
cell ,durability:2
immunity ,specificity:2
immunity ,function:2
immunity ,durability:2
immunity ,role:4
specificity ,function:2
specificity ,durability:2
specificity ,role:2
function ,durability:2
function ,role:4
durability ,role:2
monitoring ,viral:2
monitoring ,load:2
monitoring ,rt-pcr:2
monitoring ,caused:2
monitoring ,decision:2
monitoring ,making:2
monitoring ,continue:2
monitoring ,ecmo:2
monitoring ,therapy:2
viral ,caused:2
viral ,decision:2
viral ,making:2
viral ,continue:2
viral ,ecmo:2
load ,rt-pcr:2
load ,caused:2
load ,decision:2
load ,making:2
load ,continue:2
load ,ecmo:2
load ,therapy:2
rt-pcr ,caused:2
rt-pcr ,decision:2
rt-pcr ,making:2
rt-pcr ,continue:2
rt-pcr ,ecmo:2
rt-pcr ,therapy:2
caused ,decision:2
caused ,making:2
caused ,continue:2
caused ,ecmo:2
decision ,continue:2
decision ,ecmo:2
decision ,therapy:2
making ,continue:2
making ,ecmo:2
making ,therapy:2
continue ,ecmo:2
continue ,therapy:2
ecmo ,therapy:2
index ,quantify:2
index ,environmental:2
index ,risk:2
index ,exposure:2
index ,future:2
index ,epidemics:2
quantify ,environmental:2
quantify ,risk:2
quantify ,exposure:2
quantify ,future:2
quantify ,epidemics:2
environmental ,exposure:2
environmental ,future:2
environmental ,epidemics:2
risk ,future:4
risk ,epidemics:2
exposure ,future:2
exposure ,epidemics:2
analysis ,tissues:2
2019-ncov ,different:4
2019-ncov ,tissues:2
receptor ,tissues:2
ace2 ,different:4
expression ,different:4
different ,tissues:2
time ,universal:2
time ,masking:2
time ,now:2
universal ,masking:4
universal ,public:2
universal ,disease:2
universal ,now:2
masking ,public:2
masking ,coronavirus:2
masking ,disease:2
masking ,now:2
public ,now:2
coronavirus ,now:2
disease ,now:2
mass ,gathering:2
mass ,events:2
mass ,undetected:2
mass ,transmission:2
mass ,vulnerable:2
gathering ,events:2
gathering ,undetected:2
gathering ,transmission:2
gathering ,sars-cov-2:2
gathering ,vulnerable:2
events ,undetected:2
events ,transmission:2
events ,vulnerable:2
undetected ,transmission:2
undetected ,sars-cov-2:2
undetected ,vulnerable:2
transmission ,vulnerable:2
sars-cov-2 ,vulnerable:6
thoughts ,suggestions:4
thoughts ,arrangement:2
thoughts ,analysis:4
thoughts ,summary:2
thoughts ,medical:2
thoughts ,data:2
suggestions ,arrangement:2
suggestions ,analysis:4
suggestions ,summary:2
suggestions ,medical:2
suggestions ,data:2
arrangement ,analysis:2
arrangement ,summary:2
arrangement ,medical:2
arrangement ,data:2
analysis ,summary:2
summary ,medical:2
summary ,data:2
medical ,data:2
disease ,arrhythmias:2
cardiac ,arrhythmias:2
potential ,microvascular:2
potential ,pathology:2
role ,microvascular:2
role ,pathology:2
role ,neurological:4
role ,manifestations:4
microvascular ,pathology:2
microvascular ,neurological:2
microvascular ,manifestations:4
pathology ,neurological:2
pathology ,manifestations:2
molecular ,enlightening:2
molecular ,nigerians:2
targets ,enlightening:2
targets ,nigerians:2
covid-19 ,enlightening:2
covid-19 ,nigerians:2
drug ,enlightening:2
drug ,nigerians:2
development ,enlightening:2
development ,nigerians:2
enlightening ,nigerians:2
thrombotic ,occlusive:2
thrombotic ,vasculopathy:2
thrombotic ,skin:2
thrombotic ,biopsy:2
thrombotic ,livedoid:2
thrombotic ,lesion:2
occlusive ,vasculopathy:2
occlusive ,skin:2
occlusive ,biopsy:2
occlusive ,livedoid:2
occlusive ,lesion:2
vasculopathy ,skin:2
vasculopathy ,biopsy:2
vasculopathy ,livedoid:2
vasculopathy ,lesion:2
skin ,biopsy:2
skin ,livedoid:2
skin ,lesion:2
biopsy ,livedoid:2
biopsy ,lesion:2
livedoid ,lesion:2
colorectal ,obesity-related:2
colorectal ,morbidity:2
surgery ,obesity-related:2
surgery ,morbidity:2
obesity-related ,morbidity:2
obesity-related ,covid-19:4
morbidity ,covid-19:6
strategy ,battle:2
strategy ,hospital:2
strategy ,identify:2
battle ,disease:2
battle ,hospital:2
battle ,identify:2
battle ,use:2
disease ,identify:2
hospital ,identify:2
hospital ,use:2
diagnostic ,peripheral:2
diagnostic ,hematologic:2
diagnostic ,markers:2
value ,peripheral:2
value ,hematologic:2
value ,markers:2
peripheral ,hematologic:2
peripheral ,markers:2
peripheral ,disease:2
hematologic ,markers:2
hematologic ,coronavirus:2
hematologic ,disease:2
markers ,coronavirus:2
five-compartment ,model:2
five-compartment ,age-specific:2
five-compartment ,transmissibility:2
five-compartment ,sars-cov-2:2
model ,age-specific:2
age-specific ,transmissibility:2
comparative ,main:2
comparative ,haematological:2
comparative ,indexes:2
comparative ,rna:2
analysis ,haematological:2
analysis ,indexes:2
main ,haematological:2
main ,indexes:2
main ,rna:2
main ,detection:2
haematological ,indexes:2
haematological ,rna:2
haematological ,detection:2
indexes ,rna:2
indexes ,detection:2
clinical ,225:2
clinical ,tertiary:4
clinical ,hospital:2
clinical ,near:2
characteristics ,225:2
characteristics ,tertiary:4
characteristics ,hospital:4
characteristics ,near:2
225 ,patients:2
225 ,covid-19:2
225 ,tertiary:2
225 ,hospital:2
225 ,near:2
patients ,near:2
covid-19 ,near:2
tertiary ,near:2
hospital ,near:2
colorimetric ,test:2
colorimetric ,fast:2
colorimetric ,detection:2
colorimetric ,sars-cov-2:2
colorimetric ,nasal:2
colorimetric ,throat:2
colorimetric ,swabs:2
test ,fast:2
test ,nasal:2
test ,swabs:2
fast ,detection:4
fast ,nasal:2
fast ,throat:2
fast ,swabs:2
detection ,nasal:6
nasal ,throat:2
nasal ,swabs:4
mechanisms ,pathogenesis:2
treating ,sars-cov-2-positive:2
treating ,patient:2
treating ,proposal:2
treating ,pragmatic:2
sars-cov-2-positive ,patient:2
sars-cov-2-positive ,cancer:2
sars-cov-2-positive ,proposal:2
sars-cov-2-positive ,pragmatic:2
patient ,proposal:2
patient ,pragmatic:2
cancer ,proposal:2
cancer ,pragmatic:2
proposal ,pragmatic:2
efforts ,vaccine:2
efforts ,development:2
efforts ,successes:2
covid-19 ,successes:2
vaccine ,successes:2
development ,successes:2
challenges ,successes:2
understanding ,discordant:2
understanding ,test:2
understanding ,results:2
understanding ,examination:2
understanding ,data:2
discordant ,sars-cov-2:2
discordant ,test:2
discordant ,results:2
discordant ,examination:2
discordant ,data:2
test ,examination:2
results ,examination:2
results ,data:2
examination ,data:2
epidemiologic ,infections:2
epidemiologic ,involving:2
clinical ,involving:2
characteristics ,involving:2
novel ,involving:2
coronavirus ,involving:2
infections ,involving:2
routine ,slit:2
routine ,lamp:2
routine ,examination:2
routine ,procedures:2
routine ,risk:2
routine ,severe:2
routine ,acute:2
routine ,respiratory:2
slit ,lamp:2
slit ,examination:2
slit ,procedures:2
slit ,risk:2
slit ,severe:2
slit ,acute:2
slit ,respiratory:2
lamp ,examination:2
lamp ,procedures:2
lamp ,risk:2
lamp ,severe:2
lamp ,acute:2
lamp ,respiratory:2
examination ,procedures:2
examination ,risk:2
examination ,severe:2
examination ,acute:2
examination ,respiratory:2
dynamic ,peripheral:2
dynamic ,blood:2
dynamic ,lymphocyte:2
dynamic ,subsets:2
dynamic ,adult:2
changes ,peripheral:2
changes ,lymphocyte:2
changes ,subsets:2
changes ,adult:2
peripheral ,adult:2
peripheral ,patients:4
blood ,adult:2
lymphocyte ,adult:2
subsets ,adult:2
subsets ,patients:2
critical ,demand:2
critical ,intensive:2
critical ,supply:2
critical ,japan:2
care ,demand:4
care ,supply:2
care ,japan:2
demand ,intensive:4
demand ,supply:2
demand ,patients:4
demand ,japan:2
demand ,covid-19:2
intensive ,supply:2
intensive ,japan:2
supply ,patients:2
supply ,japan:2
supply ,covid-19:2
autopsy ,known:2
autopsy ,death:2
autopsy ,severe:2
autopsy ,acute:2
autopsy ,respiratory:2
autopsy ,syndrome:2
findings ,known:2
findings ,acute:4
findings ,respiratory:2
findings ,syndrome:2
first ,death:2
known ,death:2
known ,severe:4
known ,acute:4
known ,respiratory:4
known ,syndrome:4
death ,acute:2
death ,respiratory:2
death ,syndrome:2
covid-19 ,education:4
covid-19 ,pakistan:6
dental ,education:2
dental ,pakistan:2
education ,pakistan:2
mscs ,transplantation:2
mscs ,may:2
mscs ,potential:2
mscs ,therapeutic:2
mscs ,strategy:2
mscs ,covid-19:2
mscs ,treatment:2
transplantation ,may:2
transplantation ,potential:4
transplantation ,therapeutic:2
transplantation ,strategy:2
may ,strategy:2
may ,treatment:2
pathophysiology ,children:2
pathophysiology ,fare:2
pathophysiology ,better:2
pathophysiology ,adults:2
covid-19 ,fare:2
children ,fare:2
fare ,better:2
fare ,adults:2
better ,adults:2
high ,proportion:2
high ,infections:2
high ,long-term:2
high ,care:4
proportion ,asymptomatic:2
proportion ,sars-cov-2:4
proportion ,infections:2
proportion ,long-term:2
proportion ,care:2
asymptomatic ,long-term:4
asymptomatic ,care:2
infections ,long-term:4
global ,package:2
research ,coronaviruses:4
research ,package:2
coronaviruses ,package:2
assessment ,mitigation:2
assessment ,aerosol:4
mitigation ,aerosol:2
mitigation ,airborne:2
mitigation ,sars-cov-2:2
mitigation ,transmission:2
mitigation ,laboratory:2
aerosol ,airborne:4
aerosol ,laboratory:2
airborne ,laboratory:2
transmission ,laboratory:4
amantadine ,drug:2
amantadine ,mitigate:2
amantadine ,effects:2
amantadine ,covid-19:2
drug ,mitigate:2
drug ,effects:2
mitigate ,effects:2
mitigate ,covid-19:8
detectable ,human:2
endocrine ,significance:2
endocrine ,sars-cov-2s:2
endocrine ,reliance:2
significance ,sars-cov-2s:2
significance ,reliance:2
significance ,ace2:2
sars-cov-2s ,reliance:2
sars-cov-2s ,ace2:2
reliance ,ace2:2
covid-19-associated ,vasculitis:2
covid-19-associated ,vasculopathy:2
vasculitis ,vasculopathy:2
hypothesis ,pathobiology:2
hypothesis ,treatment:6
hypothesis ,centrality:2
hypothesis ,ace1ace2:2
pathobiology ,treatment:2
pathobiology ,covid-19:2
pathobiology ,centrality:2
pathobiology ,ace1ace2:2
treatment ,centrality:2
treatment ,ace1ace2:2
covid-19 ,centrality:2
covid-19 ,ace1ace2:4
centrality ,ace1ace2:2
hydroxychloroquine ,post-exposure:4
hydroxychloroquine ,among:2
hydroxychloroquine ,naval:2
hydroxychloroquine ,personnel:2
post-exposure ,among:2
post-exposure ,naval:2
post-exposure ,personnel:2
prophylaxis ,among:2
prophylaxis ,naval:2
prophylaxis ,personnel:2
covid-19 ,naval:2
among ,naval:2
among ,personnel:6
naval ,personnel:2
impact ,restrictions:2
impact ,care:6
impact ,plastic:2
restrictions ,medical:2
restrictions ,care:2
restrictions ,plastic:2
restrictions ,surgery:2
medical ,plastic:2
medical ,surgery:2
care ,plastic:2
care ,surgery:2
plastic ,surgery:4
triage ,tool:2
triage ,patients:6
triage ,room:2
triage ,aifell:2
triage ,score:2
tool ,suspected:2
tool ,patients:2
tool ,emergency:2
tool ,room:2
tool ,aifell:2
tool ,score:2
suspected ,room:2
suspected ,aifell:2
suspected ,score:2
covid-19 ,aifell:2
patients ,aifell:2
patients ,score:6
emergency ,room:2
emergency ,aifell:2
emergency ,score:2
room ,aifell:2
room ,score:2
aifell ,score:2
clinical ,hyperglycemia:2
clinical ,intensive:4
clinical ,unit:2
study ,hyperglycemia:2
study ,intensive:4
study ,unit:2
hyperglycemia ,sars-cov-2:2
hyperglycemia ,infection:2
hyperglycemia ,intensive:2
hyperglycemia ,care:2
hyperglycemia ,unit:2
infection ,unit:4
phenotypic ,characterization:2
phenotypic ,acute:2
phenotypic ,headache:2
phenotypic ,attributed:2
phenotypic ,sars-cov-2:4
phenotypic ,ichd-3:2
characterization ,headache:2
characterization ,attributed:2
characterization ,ichd-3:2
acute ,attributed:2
acute ,ichd-3:2
headache ,attributed:2
headache ,sars-cov-2:4
headache ,ichd-3:2
attributed ,sars-cov-2:2
attributed ,ichd-3:2
sars-cov-2 ,ichd-3:2
efficacy ,post-exposure:2
efficacy ,prophylaxis:4
efficacy ,prevent:2
post-exposure ,prevent:2
prevent ,acute:2
chest ,clinical:16
chest ,follow-up:4
chest ,discharged:2
computed ,follow-up:2
computed ,discharged:2
tomography ,clinical:2
tomography ,follow-up:2
tomography ,discharged:2
tomography ,patients:8
clinical ,follow-up:2
follow-up ,discharged:6
specific ,organization:2
specific ,in-hospital:2
specific ,belatacept:2
specific ,infusion:2
specific ,avoid:2
specific ,nosocomial:2
organization ,in-hospital:2
organization ,belatacept:2
organization ,infusion:2
organization ,avoid:2
organization ,nosocomial:2
in-hospital ,belatacept:2
in-hospital ,infusion:2
in-hospital ,avoid:2
in-hospital ,nosocomial:2
belatacept ,infusion:2
belatacept ,avoid:2
belatacept ,nosocomial:2
infusion ,avoid:2
infusion ,nosocomial:2
avoid ,nosocomial:2
host ,alteration:2
host ,prevent:2
host ,hype:2
host ,hope:2
cell ,alteration:2
cell ,prevent:2
cell ,viral:4
cell ,hype:2
cell ,hope:2
receptor ,alteration:2
receptor ,prevent:2
receptor ,viral:2
receptor ,hype:2
receptor ,hope:2
alteration ,prevent:2
alteration ,sars-cov-2:2
alteration ,viral:2
alteration ,entry:2
alteration ,hype:2
alteration ,hope:2
prevent ,viral:2
prevent ,entry:2
prevent ,hype:2
prevent ,hope:2
sars-cov-2 ,hype:2
viral ,entry:6
viral ,hype:2
viral ,hope:2
entry ,hype:2
entry ,hope:2
hype ,hope:4
n95 ,mask:2
n95 ,major:2
n95 ,urban:2
n95 ,hospital:2
n95 ,response:2
n95 ,process:2
n95 ,procedure:2
mask ,reuse:2
mask ,major:2
mask ,urban:2
mask ,hospital:2
mask ,response:2
mask ,process:2
mask ,procedure:2
reuse ,major:2
reuse ,urban:2
reuse ,hospital:2
reuse ,response:2
reuse ,process:2
reuse ,procedure:2
major ,urban:2
major ,hospital:2
major ,response:2
major ,process:2
major ,procedure:2
urban ,hospital:2
urban ,response:2
urban ,process:2
urban ,procedure:2
hospital ,response:2
hospital ,process:2
hospital ,procedure:2
covid-19 ,process:4
covid-19 ,procedure:2
response ,process:2
response ,procedure:2
process ,procedure:2
connecting ,clusters:2
connecting ,covid-19:2
connecting ,epidemiological:2
connecting ,serological:2
connecting ,investigation:2
clusters ,serological:2
clusters ,investigation:4
epidemiological ,serological:2
successful ,covid-19-associated:2
successful ,acute:4
successful ,respiratory:4
successful ,failure:2
recovery ,covid-19-associated:2
recovery ,acute:4
recovery ,respiratory:4
recovery ,failure:2
covid-19-associated ,respiratory:2
covid-19-associated ,failure:2
changes ,hematological:4
changes ,immunological:2
changes ,parameters:4
hematological ,immunological:2
hematological ,parameters:2
hematological ,patients:8
immunological ,parameters:2
parameters ,patients:4
kidney ,molecular:2
kidney ,determinants:2
kidney ,clinical:6
kidney ,implications:4
disease ,determinants:2
molecular ,determinants:2
molecular ,implications:2
determinants ,clinical:2
determinants ,implications:2
adapting ,pandemic:2
adapting ,conducting:2
adapting ,oncology:2
adapting ,trials:2
adapting ,sars-cov-2:2
pandemic ,conducting:2
conducting ,oncology:2
conducting ,trials:2
conducting ,sars-cov-2:2
oncology ,trials:2
pandemic ,troponin:2
pandemic ,indirect:2
pandemic ,myocardial:2
pandemic ,injury:2
pandemic ,inflammation:2
troponin ,indirect:2
troponin ,inflammation:2
indirect ,myocardial:2
indirect ,injury:2
indirect ,inflammation:2
myocardial ,inflammation:4
injury ,inflammation:2
effects ,surgery-anational:2
effects ,cross-sectional:2
effects ,study:6
sars-cov-2 ,surgery-anational:2
pandemic ,surgery-anational:2
pandemic ,cross-sectional:2
surgery-anational ,cross-sectional:2
surgery-anational ,study:2
massive ,cutback:2
massive ,orthopaedic:2
massive ,healthcare:2
massive ,services:2
massive ,due:2
massive ,covid-19:6
massive ,pandemic:2
cutback ,orthopaedic:2
cutback ,healthcare:2
cutback ,services:2
cutback ,due:2
cutback ,covid-19:2
cutback ,pandemic:2
orthopaedic ,healthcare:2
orthopaedic ,services:2
orthopaedic ,due:2
orthopaedic ,pandemic:6
healthcare ,services:6
healthcare ,due:2
services ,due:2
services ,pandemic:8
due ,pandemic:4
sars-cov-2-mediated ,inflammatory:4
sars-cov-2-mediated ,response:2
sars-cov-2-mediated ,lungs:2
sars-cov-2-mediated ,look:2
sars-cov-2-mediated ,rage:2
inflammatory ,lungs:4
inflammatory ,look:2
inflammatory ,rage:2
response ,lungs:2
response ,look:2
response ,rage:2
lungs ,look:2
lungs ,rage:2
look ,rage:2
sexual ,health:4
sexual ,era:2
health ,era:2
laser ,irradiated:2
laser ,phenothiazines:2
laser ,new:2
laser ,potential:2
laser ,treatment:2
laser ,covid-19:2
laser ,explored:2
irradiated ,phenothiazines:2
irradiated ,new:2
irradiated ,potential:2
irradiated ,treatment:2
irradiated ,covid-19:2
irradiated ,explored:2
phenothiazines ,new:2
phenothiazines ,potential:2
phenothiazines ,treatment:2
phenothiazines ,covid-19:2
phenothiazines ,explored:2
new ,explored:2
potential ,explored:2
treatment ,explored:2
covid-19 ,explored:2
roles ,challenges:2
roles ,coordinated:2
roles ,public:2
roles ,health:2
roles ,laboratory:2
roles ,response:4
challenges ,coordinated:2
challenges ,response:2
coordinated ,public:2
coordinated ,health:2
coordinated ,laboratory:2
coordinated ,response:2
impact ,delivery:4
impact ,knowledge:2
pregnancy ,knowledge:2
delivery ,current:2
delivery ,knowledge:2
pathophysiological ,background:2
pathophysiological ,practice:2
pathophysiological ,lung:2
pathophysiological ,ultrasound:2
pathophysiological ,covid-19:4
background ,clinical:2
background ,practice:2
background ,lung:2
background ,ultrasound:2
background ,covid-19:2
clinical ,ultrasound:2
practice ,lung:2
practice ,ultrasound:2
treatment ,courses:4
treatment ,intensive:6
treatment ,care:6
severe ,courses:2
severe ,intensive:6
severe ,care:6
severe ,medicine:2
covid-19 ,courses:4
courses ,intensive:2
courses ,care:2
courses ,medicine:2
high ,obesity:2
high ,coronavirus-2:2
prevalence ,obesity:4
prevalence ,coronavirus-2:2
obesity ,severe:4
obesity ,acute:4
obesity ,respiratory:4
obesity ,syndrome:2
obesity ,coronavirus-2:2
critical ,medical:2
critical ,ecology:2
critical ,urban:2
critical ,environment:2
critical ,pragmatic:2
medical ,ecology:2
medical ,urban:2
medical ,environment:2
medical ,pragmatic:2
ecology ,sars-cov-2:6
ecology ,urban:2
ecology ,environment:2
ecology ,pragmatic:2
sars-cov-2 ,urban:2
sars-cov-2 ,pragmatic:4
urban ,environment:2
urban ,pragmatic:2
environment ,pragmatic:2
genetic ,cluster:2
genetic ,identification:2
genetic ,responsible:2
cluster ,analysis:2
cluster ,identification:2
cluster ,responsible:2
analysis ,responsible:2
sars-cov-2 ,responsible:6
identification ,responsible:4
igg ,seroconversion:2
igg ,pathophysiology:2
igg ,severe:2
igg ,acute:2
igg ,respiratory:2
igg ,syndrome:2
seroconversion ,pathophysiology:2
seroconversion ,severe:2
seroconversion ,acute:2
seroconversion ,respiratory:2
seroconversion ,syndrome:2
pathophysiology ,severe:2
pathophysiology ,acute:2
pathophysiology ,respiratory:2
pathophysiology ,syndrome:2
heparin-binding ,peptides:2
heparin-binding ,novel:2
heparin-binding ,therapies:2
heparin-binding ,stop:2
heparin-binding ,sars-cov-2:2
heparin-binding ,cellular:2
heparin-binding ,entry:2
peptides ,novel:2
peptides ,therapies:2
peptides ,stop:2
peptides ,cellular:2
novel ,therapies:2
novel ,stop:2
novel ,cellular:2
novel ,entry:2
therapies ,stop:2
therapies ,cellular:2
therapies ,entry:2
stop ,cellular:2
stop ,entry:2
cellular ,entry:2
considerations ,target:4
considerations ,oxygen:2
considerations ,saturation:2
target ,oxygen:2
target ,saturation:2
target ,patients:2
oxygen ,saturation:4
saturation ,covid-19:4
saturation ,patients:2
intraoperative ,coagulopathy:2
intraoperative ,cesarean:2
intraoperative ,section:2
intraoperative ,unsuspected:2
intraoperative ,initial:2
coagulopathy ,cesarean:2
coagulopathy ,section:2
coagulopathy ,unsuspected:2
coagulopathy ,initial:2
cesarean ,unsuspected:2
cesarean ,initial:2
section ,unsuspected:2
section ,initial:2
unsuspected ,initial:2
friends ,knowns:2
friends ,unknowns:2
friends ,natural:2
friends ,killer:2
friends ,cell:2
friends ,biology:2
friends ,covid-19:6
foes ,knowns:2
foes ,unknowns:2
foes ,natural:2
foes ,killer:2
foes ,cell:2
foes ,biology:2
foes ,covid-19:6
knowns ,natural:2
knowns ,killer:2
knowns ,cell:2
knowns ,biology:2
unknowns ,natural:2
unknowns ,killer:2
unknowns ,cell:2
unknowns ,biology:2
natural ,biology:2
killer ,biology:2
cell ,biology:2
cerebral ,nervous:2
cerebral ,system:2
cerebral ,vasculitis:2
cerebral ,pneumonia:2
nervous ,vasculitis:2
nervous ,patient:2
nervous ,pneumonia:2
system ,vasculitis:2
system ,patient:2
system ,pneumonia:2
vasculitis ,patient:2
vasculitis ,pneumonia:2
pathophysiology ,happy:2
pathophysiology ,hypoxemia:2
happy ,covid-19:2
covid19 ,potential:2
covid19 ,cardiovascular:2
covid19 ,issues:2
covid19 ,pediatric:2
covid19 ,patients:4
potential ,issues:4
potential ,pediatric:2
cardiovascular ,pediatric:2
issues ,pediatric:2
issues ,patients:4
sars-cov-2 ,insect:2
sars-cov-2 ,elicits:2
spike ,produced:2
spike ,insect:2
spike ,cells:6
spike ,elicits:2
spike ,neutralization:4
spike ,titres:2
produced ,insect:2
produced ,cells:2
produced ,elicits:2
produced ,high:2
produced ,neutralization:2
produced ,titres:2
insect ,cells:2
insect ,elicits:2
insect ,high:2
insect ,neutralization:2
insect ,titres:2
cells ,elicits:2
cells ,neutralization:2
cells ,titres:2
elicits ,high:2
elicits ,neutralization:2
elicits ,titres:2
high ,neutralization:2
high ,titres:2
tuberculosis ,lessons:4
tuberculosis ,past:2
tuberculosis ,viral:2
tuberculosis ,outbreaks:2
tuberculosis ,possible:2
tuberculosis ,future:2
lessons ,outbreaks:2
lessons ,possible:2
past ,viral:2
past ,outbreaks:2
viral ,outbreaks:2
viral ,future:4
outbreaks ,possible:2
outbreaks ,future:2
possible ,future:2
effect ,adacolumn:2
effect ,ulcerative:2
effect ,colitis:2
adacolumn ,ulcerative:2
adacolumn ,colitis:2
adacolumn ,covid-19:2
ulcerative ,colitis:4
ulcerative ,covid-19:4
colitis ,covid-19:4
covid-19 ,histologic:2
radiologic ,histologic:2
radiologic ,features:2
histologic ,features:2
discussion ,prospect:2
discussion ,infusion:2
discussion ,nk:2
discussion ,cells:2
discussion ,treatment:2
discussion ,sars-cov-2:2
prospect ,infusion:2
prospect ,nk:2
prospect ,cells:2
prospect ,treatment:2
infusion ,nk:2
infusion ,cells:2
infusion ,treatment:2
infusion ,sars-cov-2:2
nk ,treatment:2
implementing ,video:2
implementing ,call:2
implementing ,visit:2
implementing ,system:2
implementing ,coronavirus:2
implementing ,disease:2
implementing ,unit:2
video ,call:2
video ,visit:2
video ,system:2
video ,coronavirus:2
video ,disease:2
video ,unit:2
call ,visit:2
call ,system:2
call ,unit:2
visit ,system:2
visit ,coronavirus:2
visit ,disease:2
visit ,unit:2
system ,unit:2
coronavirus ,unit:4
disease ,unit:2
dandelion ,clock-like:2
dandelion ,sign:2
dandelion ,ct:2
dandelion ,diagnose:2
dandelion ,covid-19:2
clock-like ,sign:2
clock-like ,ct:2
clock-like ,diagnose:2
clock-like ,covid-19:2
sign ,ct:2
sign ,diagnose:2
ct ,diagnose:2
diagnose ,covid-19:2
pneumatosis ,covid-19:2
intestinalis ,covid-19:2
silico ,proteinase:2
drug ,main:10
drug ,proteinase:2
drug ,proteins:2
repurposing ,proteinase:2
repurposing ,proteins:2
sars-cov-2 ,proteinase:2
main ,proteinase:2
main ,spike:2
main ,proteins:2
proteinase ,spike:2
proteinase ,proteins:2
prevalence ,recovery:4
prevalence ,gustatory:6
prevalence ,dysfunctions:2
recovery ,olfactory:4
recovery ,gustatory:4
recovery ,dysfunctions:2
dysfunctions ,covid-19:4
air ,non-health:2
air ,settings:2
air ,among:2
air ,641:2
surface ,non-health:2
surface ,care:2
surface ,settings:2
surface ,among:2
surface ,641:2
contamination ,non-health:2
contamination ,care:2
contamination ,settings:2
contamination ,among:2
contamination ,641:2
non-health ,care:2
non-health ,settings:2
non-health ,among:2
non-health ,641:2
non-health ,environmental:2
care ,settings:6
care ,641:2
care ,environmental:2
settings ,among:2
settings ,641:2
settings ,environmental:2
among ,641:2
among ,environmental:2
641 ,environmental:2
universal ,current:2
universal ,evidence:2
universal ,controversies:2
masking ,covid-19:2
masking ,pandemic:2
masking ,current:2
masking ,evidence:2
masking ,controversies:2
pandemic ,controversies:2
current ,controversies:2
evidence ,controversies:2
need ,improve:2
need ,diagnostic:2
need ,testing:4
need ,methods:2
need ,novel:4
know ,improve:2
know ,testing:2
know ,methods:2
improve ,diagnostic:2
improve ,methods:2
improve ,novel:2
testing ,methods:4
testing ,novel:4
health ,mass:2
surveillance ,response:2
surveillance ,mass:2
response ,mass:2
response ,workers:4
mass ,testing:2
mass ,workers:2
thrombosis ,associated:8
thrombosis ,possible:2
thrombosis ,role:6
thrombosis ,abo:2
thrombosis ,blood:2
associated ,possible:2
associated ,abo:2
associated ,blood:2
covid-19 ,abo:2
possible ,abo:2
possible ,blood:2
role ,abo:2
role ,blood:2
mesenchymal ,syndrome:2
mesenchymal ,basic:2
stem ,syndrome:2
stem ,basic:2
cell ,distress:2
cell ,basic:2
therapy ,syndrome:2
therapy ,basic:2
acute ,basic:2
respiratory ,basic:2
distress ,basic:2
syndrome ,basic:2
covid-19 ,description:4
covid-19 ,alemtuzumab:2
multiple ,description:2
multiple ,two:4
multiple ,cases:4
multiple ,alemtuzumab:2
sclerosis ,description:2
sclerosis ,two:4
sclerosis ,cases:4
sclerosis ,alemtuzumab:2
description ,two:2
description ,cases:4
description ,alemtuzumab:2
two ,alemtuzumab:2
cases ,alemtuzumab:2
evidences ,virus:2
evidences ,air:2
evidences ,indoors:2
evidences ,using:2
evidences ,several:2
evidences ,untouched:2
sars-cov-2 ,indoors:2
sars-cov-2 ,several:4
sars-cov-2 ,untouched:2
virus ,indoors:2
virus ,several:2
virus ,untouched:2
air ,indoors:2
air ,using:2
air ,several:2
air ,untouched:2
transmission ,indoors:2
transmission ,several:2
transmission ,untouched:2
indoors ,using:2
indoors ,several:2
indoors ,untouched:2
using ,several:2
using ,untouched:2
several ,untouched:2
comprehensive ,longitudinal:2
comprehensive ,humoral:2
comprehensive ,responses:2
comprehensive ,specific:2
comprehensive ,four:2
longitudinal ,analysis:4
longitudinal ,humoral:2
longitudinal ,responses:4
longitudinal ,specific:2
longitudinal ,four:2
analysis ,humoral:4
analysis ,specific:2
analysis ,four:2
humoral ,four:2
responses ,four:2
specific ,four:2
factors ,perception:2
factors ,knowledge:2
factors ,contracting:2
associated ,perception:2
associated ,knowledge:4
associated ,contracting:2
perception ,knowledge:2
perception ,contracting:2
risk ,knowledge:2
risk ,contracting:2
knowledge ,contracting:2
understanding ,immunologic:2
understanding ,neurologic:2
understanding ,manifestations:2
immunologic ,neurologic:2
immunologic ,manifestations:2
characteristics ,neurologic:2
characteristics ,manifestations:6
prevalence ,covid-19-like:2
prevalence ,people:2
prevalence ,living:2
prevalence ,hiv:2
covid-19-like ,symptoms:4
covid-19-like ,among:2
covid-19-like ,people:2
covid-19-like ,living:2
covid-19-like ,hiv:2
covid-19-like ,using:2
symptoms ,people:2
symptoms ,living:2
symptoms ,hiv:2
symptoms ,using:4
among ,living:2
among ,hiv:2
among ,using:2
people ,hiv:2
people ,using:2
living ,hiv:4
living ,using:2
hiv ,using:2
culture-based ,virus:2
culture-based ,isolation:2
culture-based ,evaluate:2
culture-based ,potential:2
culture-based ,infectivity:2
culture-based ,clinical:2
virus ,isolation:2
virus ,evaluate:2
virus ,infectivity:6
isolation ,evaluate:2
isolation ,potential:2
evaluate ,potential:4
evaluate ,infectivity:2
evaluate ,clinical:4
potential ,infectivity:6
infectivity ,clinical:2
limited ,role:2
limited ,bronchoalveolar:2
limited ,lavage:2
limited ,exclude:2
limited ,negative:2
limited ,upper:2
role ,bronchoalveolar:2
role ,lavage:2
role ,exclude:2
role ,negative:2
role ,upper:2
bronchoalveolar ,exclude:2
bronchoalveolar ,covid-19:2
bronchoalveolar ,negative:2
bronchoalveolar ,upper:2
lavage ,exclude:2
lavage ,covid-19:2
lavage ,negative:2
lavage ,upper:2
exclude ,covid-19:2
exclude ,negative:2
exclude ,upper:2
negative ,upper:2
development ,high:2
development ,throughput:2
development ,pcr:2
fully ,high:2
fully ,throughput:2
fully ,pcr:2
fully ,detection:2
automated ,high:2
automated ,throughput:2
automated ,pcr:2
automated ,detection:4
high ,pcr:2
high ,detection:4
throughput ,pcr:2
throughput ,detection:2
evaluation ,genetic:2
evaluation ,score:2
evaluation ,severity:2
evaluation ,human:2
genetic ,score:2
risk ,score:4
risk ,human:2
score ,severity:6
score ,using:4
score ,human:2
severity ,using:2
severity ,human:2
guide ,laboratory:2
guide ,corona:4
guide ,virus:4
guide ,disease-19:2
laboratory ,corona:2
laboratory ,disease-19:2
diagnosis ,corona:4
diagnosis ,disease-19:2
genetic ,angiotensin-converting:2
genetic ,hace2:2
genetic ,various:2
variability ,human:2
variability ,angiotensin-converting:2
variability ,enzyme:2
variability ,hace2:2
variability ,various:2
human ,hace2:2
human ,among:2
human ,various:2
angiotensin-converting ,hace2:2
angiotensin-converting ,among:2
angiotensin-converting ,various:2
enzyme ,hace2:2
enzyme ,among:2
enzyme ,various:2
hace2 ,among:2
hace2 ,various:2
among ,various:2
flight ,covid-19:2
flight ,patient:2
flight ,experience:2
flight ,wuhan:2
flight ,evacuee:2
flight ,case:2
flight ,report:2
covid-19 ,evacuee:2
patient ,experience:2
patient ,evacuee:2
experience ,wuhan:4
experience ,evacuee:2
experience ,report:2
wuhan ,evacuee:2
wuhan ,case:4
wuhan ,report:2
evacuee ,case:2
evacuee ,report:2
inhibiting ,fusion:2
inhibiting ,cellular:2
inhibiting ,membrane:2
inhibiting ,system:2
inhibiting ,therapeutic:2
inhibiting ,options:2
inhibiting ,prevent:2
fusion ,cellular:2
fusion ,system:2
fusion ,therapeutic:2
fusion ,options:2
fusion ,prevent:2
cellular ,membrane:2
cellular ,system:2
cellular ,therapeutic:2
cellular ,options:2
cellular ,prevent:2
membrane ,system:2
membrane ,therapeutic:2
membrane ,options:2
membrane ,prevent:2
system ,options:2
system ,prevent:2
therapeutic ,prevent:2
options ,prevent:2
novel ,hungarian:2
novel ,population:2
novel ,cross-sectional:2
novel ,nationwide:2
coronavirus ,hungarian:2
coronavirus ,cross-sectional:2
coronavirus ,nationwide:2
epidemic ,hungarian:2
epidemic ,population:2
epidemic ,cross-sectional:2
epidemic ,nationwide:2
hungarian ,population:2
hungarian ,cross-sectional:2
hungarian ,nationwide:2
population ,cross-sectional:2
cross-sectional ,nationwide:2
review ,date:2
remdesivir ,date:2
data ,date:2
protecting ,children:2
protecting ,long-term:2
protecting ,conditions:2
children ,long-term:2
children ,conditions:2
long-term ,pandemic:2
conditions ,pandemic:4
starting ,regional:2
starting ,collaborative:2
starting ,research:2
starting ,group:2
starting ,covid-19:2
starting ,pregnancy:2
regional ,collaborative:2
regional ,research:2
regional ,group:2
regional ,pregnancy:2
collaborative ,research:2
collaborative ,group:2
collaborative ,covid-19:2
collaborative ,pregnancy:2
research ,group:2
research ,pregnancy:2
group ,pregnancy:2
environmental ,healthcare:2
environmental ,premises:2
contamination ,healthcare:2
contamination ,premises:2
sars-cov-2 ,premises:2
healthcare ,premises:2
correlation ,elisa:2
correlation ,method:2
correlation ,three:2
correlation ,automated:2
correlation ,serological:2
correlation ,tests:2
elisa ,method:2
elisa ,three:2
elisa ,automated:4
elisa ,tests:2
method ,three:2
method ,automated:2
method ,serological:2
method ,tests:2
automated ,tests:4
clinical ,comorbiditiesand:2
clinical ,365:2
characteristics ,comorbiditiesand:2
characteristics ,among:4
characteristics ,365:2
comorbiditiesand ,outcome:2
comorbiditiesand ,among:2
comorbiditiesand ,365:2
comorbiditiesand ,patients:2
outcome ,among:2
outcome ,365:2
among ,365:2
365 ,patients:2
response ,comments:2
response ,cross-species:2
response ,transmission:2
response ,newly:2
response ,identified:2
comments ,cross-species:2
comments ,transmission:2
comments ,newly:2
comments ,identified:2
characterisation ,sars-cov-2:4
characterisation ,lentiviral:2
characterisation ,pseudotypes:2
characterisation ,correlation:2
sars-cov-2 ,lentiviral:2
sars-cov-2 ,pseudotypes:2
lentiviral ,pseudotypes:2
lentiviral ,correlation:2
pseudotypes ,correlation:2
modelling ,insights:2
modelling ,pandemic:4
many ,faces:2
many ,interstitial:2
many ,pneumonia:2
many ,case:2
many ,presumed:2
many ,infection:2
faces ,interstitial:2
faces ,pneumonia:2
faces ,case:2
faces ,presumed:2
faces ,sars-cov-2:2
faces ,infection:2
interstitial ,case:2
interstitial ,presumed:2
interstitial ,sars-cov-2:4
interstitial ,infection:2
pneumonia ,presumed:2
case ,presumed:2
presumed ,sars-cov-2:2
presumed ,infection:2
structures ,human:2
structures ,antibodies:2
structures ,bound:2
structures ,spike:2
structures ,reveal:2
structures ,common:2
structures ,epitopes:2
human ,bound:2
human ,reveal:2
antibodies ,bound:2
antibodies ,reveal:2
antibodies ,common:2
antibodies ,epitopes:2
bound ,spike:4
bound ,reveal:2
bound ,common:2
bound ,epitopes:2
sars-cov-2 ,reveal:4
reveal ,common:2
reveal ,epitopes:2
common ,epitopes:2
sars-cov-2 ,scarcity:2
sars-cov-2 ,mrsa:2
detection ,setting:2
detection ,scarcity:2
detection ,mrsa:2
setting ,viral:4
setting ,swabs:2
setting ,scarcity:2
setting ,mrsa:2
viral ,scarcity:2
viral ,mrsa:2
swabs ,scarcity:2
swabs ,mrsa:2
scarcity ,mrsa:2
deep ,drug:2
deep ,screening:4
deep ,novel:2
deep ,2019-ncov:2
learning ,based:2
learning ,drug:2
learning ,screening:4
learning ,novel:2
learning ,2019-ncov:2
based ,drug:4
based ,2019-ncov:4
screening ,novel:6
screening ,2019-ncov:4
liver ,update:2
adaptive ,responses:4
adaptive ,infection:2
adaptive ,versus:2
adaptive ,mild:2
adaptive ,individuals:2
immune ,individuals:2
infection ,individuals:4
severe ,versus:6
severe ,individuals:2
versus ,mild:8
versus ,individuals:2
mild ,individuals:6
transmission ,fecal-oral:8
transmission ,aerosols-borne:2
sars-cov-2 ,fecal-oral:8
sars-cov-2 ,aerosols-borne:2
via ,fecal-oral:2
via ,aerosols-borne:2
via ,routes:2
via ,environmental:2
fecal-oral ,aerosols-borne:2
fecal-oral ,routes:2
fecal-oral ,environmental:2
aerosols-borne ,routes:2
aerosols-borne ,environmental:2
routes ,environmental:2
multinational ,report:2
multinational ,characterise:2
multinational ,sars-cov-2:4
multinational ,infection:2
multinational ,people:2
multinational ,cystic:2
report ,characterise:2
report ,people:2
report ,cystic:2
characterise ,sars-cov-2:2
characterise ,infection:2
characterise ,people:2
characterise ,cystic:2
people ,cystic:2
urologic ,covid-19:2
urologic ,pandemic:2
urologic ,changing:2
urologic ,way:2
urologic ,operate:2
surgery ,changing:4
surgery ,way:2
surgery ,operate:2
covid-19 ,operate:2
pandemic ,operate:2
changing ,way:2
changing ,operate:2
way ,operate:2
clinical ,clinically:2
clinical ,diagnosed:2
characteristics ,clinically:2
characteristics ,diagnosed:2
confirmed ,clinically:2
confirmed ,diagnosed:2
clinically ,diagnosed:2
clinically ,patients:4
animal ,emerging:4
animal ,progress:2
animal ,new:2
animal ,insights:2
models ,emerging:4
models ,progress:2
models ,new:4
models ,insights:2
emerging ,progress:2
emerging ,insights:2
progress ,new:2
progress ,insights:2
recommendations ,cardiovascular:2
recommendations ,prevention:4
cardiovascular ,prevention:2
cardiovascular ,pandemic:10
consequences ,physical:2
consequences ,distancing:2
consequences ,emanating:2
physical ,emanating:2
physical ,pandemic:2
distancing ,emanating:2
distancing ,pandemic:2
emanating ,covid-19:2
emanating ,pandemic:2
focus ,potential:2
focus ,role:4
focus ,lung:2
focus ,ultrasound:2
potential ,lung:6
potential ,ultrasound:2
severe ,high-risk:2
severe ,predisposing:2
severe ,died:2
coronavirus ,high-risk:2
coronavirus ,predisposing:2
coronavirus ,died:4
disease ,high-risk:2
disease ,predisposing:2
disease ,died:2
patient ,high-risk:2
patient ,predisposing:2
patient ,factors:2
patient ,died:2
high-risk ,predisposing:2
high-risk ,factors:2
high-risk ,died:2
predisposing ,factors:2
predisposing ,died:2
factors ,died:2
pregnant ,meta-analysis:2
women ,meta-analysis:2
novel ,targets:2
novel ,injury:2
therapeutic ,sars-cov-2-induced:2
therapeutic ,lung:2
targets ,sars-cov-2-induced:2
targets ,acute:2
targets ,lung:2
targets ,injury:2
targets ,targeting:2
sars-cov-2-induced ,acute:6
sars-cov-2-induced ,lung:2
sars-cov-2-induced ,injury:2
sars-cov-2-induced ,targeting:2
acute ,targeting:4
lung ,targeting:2
injury ,targeting:2
pathogenicity ,hace2:2
pathogenicity ,transgenic:2
pathogenicity ,mice:2
sars-cov-2 ,hace2:4
sars-cov-2 ,transgenic:8
hace2 ,transgenic:4
hace2 ,mice:2
overview ,lethal:2
overview ,human:2
lethal ,human:2
lethal ,coronaviruses:2
human ,dark:2
human ,cloud:2
human ,silver:2
human ,lining:2
immunodeficiency ,dark:2
immunodeficiency ,cloud:2
immunodeficiency ,silver:2
immunodeficiency ,lining:2
virus ,dark:2
virus ,cloud:2
virus ,silver:2
virus ,lining:2
dark ,cloud:2
cloud ,silver:2
cloud ,lining:2
cloud ,covid-19:2
predictive ,using:4
predictive ,laboratory:2
predictive ,chest:2
predictive ,image:2
score ,diagnosis:2
score ,clinical:2
score ,laboratory:2
score ,chest:4
score ,image:2
diagnosis ,image:2
using ,laboratory:4
using ,chest:4
using ,image:2
clinical ,image:2
laboratory ,chest:2
laboratory ,image:2
chest ,image:2
disruption ,joint:2
disruption ,arthroplasty:2
disruption ,services:2
disruption ,europe:2
disruption ,pandemic:2
joint ,arthroplasty:2
joint ,services:2
joint ,europe:2
joint ,covid-19:4
joint ,pandemic:2
arthroplasty ,services:2
arthroplasty ,europe:2
services ,europe:2
europe ,covid-19:2
europe ,pandemic:2
remdesivir ,critical:2
covid-19 ,pre-clinical:2
critical ,pharmacology:2
critical ,pre-clinical:2
critical ,clinical:8
emergency ,security:2
emergency ,interface:2
management ,health:6
management ,security:2
management ,interface:2
health ,security:2
health ,interface:2
security ,interface:2
unexpected ,bp:2
unexpected ,sensitivity:2
unexpected ,angiotensin:2
unexpected ,ii:2
bp ,sensitivity:2
bp ,angiotensin:2
bp ,ii:2
bp ,patient:2
bp ,coronavirus:2
bp ,disease:2
sensitivity ,angiotensin:2
sensitivity ,ii:2
sensitivity ,patient:2
sensitivity ,disease:2
angiotensin ,patient:2
angiotensin ,disease:2
ii ,patient:2
ii ,coronavirus:2
ii ,disease:2
severe ,recent:4
severe ,transplantation:2
severe ,allograft:2
covid-19 ,allograft:2
recent ,heart:2
recent ,complicated:2
recent ,allograft:2
heart ,transplantation:4
heart ,allograft:2
transplantation ,complicated:2
transplantation ,allograft:2
complicated ,allograft:2
evidence ,rome:2
evidence ,pre-pandemic:2
sars-cov-2 ,rome:2
sars-cov-2 ,pre-pandemic:2
circulation ,rome:2
circulation ,italy:2
circulation ,pre-pandemic:2
rome ,italy:2
rome ,pre-pandemic:2
italy ,pre-pandemic:2
transcriptomic ,characteristics:2
transcriptomic ,peripheral:2
transcriptomic ,blood:2
characteristics ,bronchoalveolar:2
characteristics ,lavage:2
characteristics ,fluid:2
characteristics ,peripheral:6
characteristics ,blood:6
bronchoalveolar ,peripheral:2
bronchoalveolar ,blood:2
lavage ,peripheral:2
lavage ,blood:2
fluid ,peripheral:2
fluid ,blood:2
18f-fdg ,petct:10
18f-fdg ,asymptomatic:4
18f-fdg ,patients:2
18f-fdg ,covid-19:10
18f-fdg ,submerged:2
18f-fdg ,iceberg:2
petct ,asymptomatic:6
petct ,submerged:2
petct ,iceberg:2
asymptomatic ,submerged:2
asymptomatic ,iceberg:2
patients ,submerged:2
patients ,iceberg:2
covid-19 ,submerged:2
covid-19 ,iceberg:2
submerged ,iceberg:2
occurrence ,fates:2
occurrence ,potential:4
occurrence ,treatment:2
occurrence ,approaches:2
occurrence ,removal:4
occurrence ,viruses:2
fates ,potential:2
fates ,treatment:2
fates ,approaches:2
fates ,removal:2
fates ,viruses:2
potential ,removal:2
treatment ,removal:2
approaches ,removal:2
approaches ,viruses:2
removal ,viruses:2
early ,mechanical:2
early ,ventilation:2
predictors ,mechanical:2
predictors ,ventilation:2
nonpolio ,enterovirus:2
nonpolio ,activity:2
nonpolio ,covid-19:2
nonpolio ,pandemic:2
nonpolio ,taiwan:2
enterovirus ,activity:2
enterovirus ,covid-19:2
enterovirus ,pandemic:2
enterovirus ,taiwan:2
pandemic ,taiwan:2
rna ,target:6
rna ,therapy:2
polymerase ,therapy:2
target ,therapy:4
successful ,anesthesia:2
successful ,management:6
successful ,type:2
successful ,aortic:2
successful ,dissection:2
anesthesia ,management:2
anesthesia ,patient:2
anesthesia ,type:2
anesthesia ,aortic:2
anesthesia ,dissection:2
management ,type:2
management ,aortic:4
management ,dissection:4
patient ,type:2
patient ,aortic:2
patient ,dissection:2
type ,aortic:4
type ,dissection:4
aortic ,dissection:6
epidemiology ,antibodies:2
epidemiology ,among:2
epidemiology ,firefightersparamedics:2
epidemiology ,us:2
epidemiology ,fire:2
sars-cov-2 ,firefightersparamedics:2
sars-cov-2 ,fire:2
antibodies ,among:12
antibodies ,firefightersparamedics:2
antibodies ,us:2
antibodies ,fire:2
among ,firefightersparamedics:2
among ,fire:2
firefightersparamedics ,us:2
firefightersparamedics ,fire:2
us ,fire:2
endothelial ,cell:4
endothelial ,contributions:2
cell ,contributions:2
sex-specific ,sars-cov-2:2
sex-specific ,mortality:2
sex-specific ,among:2
sex-specific ,hormone-modulated:2
sex-specific ,ace2:2
sex-specific ,expression:2
sex-specific ,risk:2
sars-cov-2 ,hormone-modulated:2
mortality ,hormone-modulated:2
among ,hormone-modulated:2
among ,expression:4
hormone-modulated ,ace2:2
hormone-modulated ,expression:2
hormone-modulated ,risk:2
ace2 ,risk:8
expression ,risk:8
obesity ,severity:2
obesity ,air:2
obesity ,pollution:2
missing ,covid-19:4
missing ,severity:2
missing ,air:2
missing ,pollution:2
link ,pollution:2
simple ,algorithm:2
simple ,helps:2
simple ,early:2
simple ,identification:2
simple ,infection:2
simple ,patients:2
algorithm ,helps:2
algorithm ,early:2
algorithm ,identification:2
algorithm ,sars-cov-2:2
algorithm ,infection:2
algorithm ,patients:2
helps ,early:2
helps ,identification:2
helps ,sars-cov-2:2
helps ,infection:2
helps ,patients:2
early ,identification:4
updates ,guidelines:2
updates ,psoriasis:2
updates ,atopic:2
updates ,dermatitis:2
updates ,eczema:2
treatment ,guidelines:2
treatment ,atopic:2
treatment ,dermatitis:2
treatment ,eczema:2
guidelines ,psoriasis:2
guidelines ,atopic:2
guidelines ,dermatitis:2
guidelines ,eczema:2
psoriasis ,atopic:2
psoriasis ,dermatitis:2
psoriasis ,eczema:2
atopic ,dermatitis:2
atopic ,eczema:2
dermatitis ,eczema:2
brassy ,sounding:2
brassy ,musical:2
brassy ,instruments:2
brassy ,need:2
brassy ,increased:2
brassy ,safe:2
brassy ,distancing:2
brassy ,requirements:2
sounding ,musical:2
sounding ,instruments:2
sounding ,need:2
sounding ,increased:2
sounding ,safe:2
sounding ,distancing:2
sounding ,requirements:2
musical ,instruments:2
musical ,need:2
musical ,increased:2
musical ,safe:2
musical ,distancing:2
musical ,requirements:2
instruments ,need:2
instruments ,increased:2
instruments ,safe:2
instruments ,distancing:2
instruments ,requirements:2
need ,increased:2
need ,safe:2
need ,distancing:2
need ,requirements:2
increased ,safe:2
increased ,distancing:2
increased ,requirements:2
safe ,distancing:2
safe ,requirements:2
distancing ,requirements:2
newcastle ,disease:2
newcastle ,virus:2
newcastle ,vaccine:2
newcastle ,vector:2
newcastle ,sars-cov-2:2
disease ,vector:2
vector ,sars-cov-2:2
stem ,cell-based:2
cell-based ,therapy:2
cell-based ,coronavirus:2
cell-based ,disease:2
novel ,awareness:4
novel ,dental:2
novel ,interns:2
corona ,awareness:2
corona ,among:2
corona ,dental:2
corona ,interns:2
virus ,awareness:2
virus ,among:2
virus ,interns:2
disease ,awareness:2
disease ,interns:2
covid-19 ,interns:2
awareness ,interns:2
among ,interns:2
dental ,interns:2
road ,rapid-molecular:2
road ,point:2
road ,care:2
road ,test:2
road ,detect:2
road ,novel:2
road ,sars-coronavirus:2
toward ,rapid-molecular:2
toward ,point:2
toward ,care:2
toward ,test:2
toward ,detect:2
toward ,sars-coronavirus:2
rapid-molecular ,point:2
rapid-molecular ,care:2
rapid-molecular ,test:2
rapid-molecular ,detect:2
rapid-molecular ,novel:2
rapid-molecular ,sars-coronavirus:2
point ,detect:2
point ,sars-coronavirus:2
care ,detect:2
care ,novel:2
care ,sars-coronavirus:2
test ,sars-coronavirus:2
detect ,novel:2
detect ,sars-coronavirus:2
novel ,sars-coronavirus:2
targeting ,nlrp3:2
targeting ,inflammasome:2
targeting ,severe:6
nlrp3 ,severe:4
nlrp3 ,covid-19:6
inflammasome ,severe:4
inflammasome ,covid-19:6
role ,animal:2
host ,review:2
genetic ,review:2
genetic ,animal:2
factors ,review:2
factors ,animal:2
coronavirus ,susceptibility:2
susceptibility ,animal:4
extra-pulmonary ,clinical:4
extra-pulmonary ,manifestations:4
extra-pulmonary ,novel:2
extra-pulmonary ,coronavirus:2
extra-pulmonary ,pneumonia:2
first ,bosnia:2
first ,herzegovina:2
two ,months:2
two ,bosnia:2
two ,herzegovina:2
months ,bosnia:2
months ,herzegovina:2
covid-19 ,bosnia:2
covid-19 ,herzegovina:2
pandemic ,bosnia:2
pandemic ,herzegovina:2
bosnia ,herzegovina:2
prolonged ,upper:2
prolonged ,tract:2
prolonged ,asymptomatic:2
persistence ,upper:2
persistence ,tract:2
persistence ,asymptomatic:2
upper ,asymptomatic:2
tract ,asymptomatic:2
musculoskeletal ,consequences:2
phillyrin ,kd-1:2
phillyrin ,exerts:2
phillyrin ,anti-viral:2
phillyrin ,anti-inflammatory:2
phillyrin ,activities:2
phillyrin ,novel:2
kd-1 ,exerts:2
kd-1 ,anti-viral:2
kd-1 ,anti-inflammatory:2
kd-1 ,activities:2
kd-1 ,novel:2
exerts ,anti-viral:4
exerts ,anti-inflammatory:4
exerts ,activities:2
exerts ,novel:4
anti-viral ,anti-inflammatory:4
anti-inflammatory ,activities:2
anti-inflammatory ,novel:6
novel ,genes:2
novel ,variations:2
sars-cov-2covid-19 ,origin:2
sars-cov-2covid-19 ,pathogenesis:2
sars-cov-2covid-19 ,genes:2
sars-cov-2covid-19 ,genetic:2
sars-cov-2covid-19 ,variations:2
origin ,pathogenesis:4
origin ,genes:2
origin ,variations:2
pathogenesis ,genes:2
pathogenesis ,genetic:4
pathogenesis ,variations:2
genes ,genetic:4
genes ,variations:4
practical ,strategies:2
practical ,safe:4
practical ,effective:2
practical ,delivery:2
practical ,aerosolized:2
practical ,medications:2
strategies ,delivery:2
strategies ,aerosolized:2
strategies ,medications:2
safe ,effective:2
safe ,delivery:2
safe ,aerosolized:2
safe ,medications:2
effective ,aerosolized:2
effective ,medications:2
delivery ,aerosolized:2
delivery ,medications:2
aerosolized ,medications:2
designing ,combat:4
designing ,emerging:2
designing ,coronavirus:2
designing ,disease:2
multi-epitope ,vaccines:2
multi-epitope ,combat:2
multi-epitope ,emerging:2
multi-epitope ,coronavirus:2
multi-epitope ,disease:2
vaccines ,combat:2
vaccines ,disease:4
combat ,emerging:2
combat ,disease:2
covid-19 ,approaching:4
covid-19 ,peak:4
outbreak ,progression:2
outbreak ,regions:2
outbreak ,approaching:2
outbreak ,peak:2
outbreak ,end:2
progression ,italian:2
progression ,regions:2
progression ,approaching:2
progression ,peak:2
progression ,end:2
italian ,approaching:2
italian ,peak:4
italian ,end:2
regions ,approaching:2
regions ,peak:2
regions ,end:2
approaching ,peak:2
approaching ,end:2
peak ,end:2
vaginal ,case:2
vaginal ,report:2
delivery ,report:2
evaluation ,tears:2
evaluation ,secretions:2
tears ,patients:2
secretions ,patients:2
sars-cov-2 ,less:2
sars-cov-2 ,90days:2
infection ,infants:2
infection ,less:4
infection ,90days:2
infants ,less:2
infants ,90days:2
infants ,old:2
less ,90days:2
less ,old:2
90days ,old:2
zincii-the ,overlooked:2
zincii-the ,minence:2
zincii-the ,grise:2
zincii-the ,chloroquines:2
zincii-the ,fight:2
zincii-the ,covid-19:2
overlooked ,minence:2
overlooked ,grise:2
overlooked ,chloroquines:2
overlooked ,fight:2
overlooked ,covid-19:4
minence ,grise:2
minence ,chloroquines:2
minence ,fight:2
minence ,covid-19:2
grise ,chloroquines:2
grise ,fight:2
grise ,covid-19:2
chloroquines ,fight:2
thoughts ,alveolar:2
thoughts ,phase:2
thoughts ,covid-19:4
alveolar ,phase:2
alveolar ,covid-19:4
epidemiological ,daegu:2
clinical ,daegu:2
characteristics ,daegu:2
coronavirus ,daegu:2
disease ,daegu:2
addressing ,impact:2
addressing ,covid-19:4
addressing ,pandemic:2
silico ,insights:2
silico ,sars:2
silico ,cov-2:2
silico ,suggest:2
silico ,nadh:2
silico ,endogenous:2
insights ,cov-2:2
insights ,suggest:2
insights ,nadh:2
insights ,endogenous:2
sars ,suggest:2
sars ,nadh:2
sars ,endogenous:2
cov-2 ,suggest:2
cov-2 ,nadh:2
cov-2 ,endogenous:2
main ,suggest:2
main ,nadh:2
main ,endogenous:2
protease ,suggest:2
protease ,nadh:2
protease ,endogenous:2
suggest ,nadh:2
suggest ,endogenous:2
nadh ,endogenous:2
nicotine ,can:2
nicotine ,inhibit:2
nicotine ,cytokine:2
nicotine ,storm:2
nicotine ,lungs:2
nicotine ,prevent:2
nicotine ,lessen:2
can ,inhibit:2
can ,cytokine:2
can ,storm:2
can ,lungs:2
can ,lessen:2
inhibit ,storm:2
inhibit ,lungs:2
inhibit ,prevent:2
inhibit ,lessen:2
cytokine ,lungs:2
cytokine ,lessen:2
storm ,lungs:4
storm ,prevent:2
storm ,lessen:2
lungs ,prevent:2
lungs ,lessen:2
prevent ,lessen:2
development ,reverse:6
development ,transcription:2
development ,isothermal:4
development ,amplification:4
development ,assays:6
reverse ,assays:6
transcription ,assays:4
loop-mediated ,assays:2
isothermal ,assays:4
amplification ,assays:4
evaluating ,use:2
evaluating ,posterior:2
evaluating ,oropharyngeal:2
evaluating ,saliva:2
evaluating ,point-of-care:2
evaluating ,assay:2
use ,posterior:2
use ,oropharyngeal:2
use ,point-of-care:2
use ,assay:2
posterior ,oropharyngeal:4
posterior ,saliva:4
posterior ,point-of-care:2
posterior ,assay:2
oropharyngeal ,saliva:4
oropharyngeal ,point-of-care:2
oropharyngeal ,assay:2
saliva ,point-of-care:2
saliva ,assay:2
crosstalk ,coronavirus:2
crosstalk ,disease:2
crosstalk ,cardiovascular:2
coronavirus ,cardiovascular:14
tracing ,origins:2
tracing ,sars-cov-2:4
tracing ,phylogenies:2
origins ,phylogenies:2
sars-cov-2 ,phylogenies:2
coronavirus ,phylogenies:2
management ,cerebellar:2
patients ,cerebellar:2
patients ,current:8
cerebellar ,ataxia:2
cerebellar ,covid-19:2
cerebellar ,pandemic:2
cerebellar ,current:2
ataxia ,covid-19:2
ataxia ,pandemic:2
ataxia ,current:2
glycyrrhizin ,alternative:2
glycyrrhizin ,drug:2
glycyrrhizin ,treatment:2
glycyrrhizin ,covid-19:2
glycyrrhizin ,infection:2
alternative ,infection:2
covid-19-associated ,guillain-barr:2
covid-19-associated ,syndrome:6
covid-19-associated ,early:2
covid-19-associated ,pandemic:2
covid-19-associated ,experience:2
guillain-barr ,early:4
guillain-barr ,experience:2
syndrome ,experience:2
treatment ,high:2
treatment ,dose:2
treatment ,oral:2
treatment ,zinc:4
treatment ,salts:2
treatment ,four:2
sars-cov-2 ,dose:2
sars-cov-2 ,salts:2
high ,dose:2
high ,zinc:2
high ,salts:2
high ,report:4
high ,four:2
dose ,oral:2
dose ,zinc:2
dose ,salts:2
dose ,report:2
dose ,four:2
dose ,patients:2
oral ,zinc:2
oral ,salts:2
zinc ,salts:2
zinc ,report:2
zinc ,four:2
zinc ,patients:2
salts ,report:2
salts ,four:2
salts ,patients:2
modeling ,contact:2
modeling ,tracing:2
modeling ,context:2
modeling ,relaxed:2
modeling ,physical:2
contact ,strategies:2
contact ,context:2
contact ,relaxed:2
contact ,physical:2
tracing ,strategies:2
tracing ,context:2
tracing ,relaxed:2
tracing ,physical:2
strategies ,context:2
strategies ,relaxed:2
strategies ,physical:2
covid-19 ,relaxed:2
context ,relaxed:2
context ,physical:2
relaxed ,physical:2
chest ,hospitalized:2
chest ,infection:6
imaging ,hospitalized:2
hospitalized ,case:2
hospitalized ,series:2
ambroxol ,hydrochloride:2
ambroxol ,inhibits:2
ambroxol ,interaction:2
ambroxol ,severe:2
ambroxol ,acute:2
ambroxol ,respiratory:2
hydrochloride ,inhibits:2
hydrochloride ,interaction:2
hydrochloride ,severe:2
hydrochloride ,acute:2
hydrochloride ,respiratory:2
inhibits ,interaction:2
inhibits ,severe:2
inhibits ,acute:2
inhibits ,respiratory:2
interaction ,respiratory:2
model ,approach:2
model ,estimating:2
model ,dosage:2
model ,regimen:2
model ,indomethacin:2
model ,potential:4
based ,estimating:2
based ,dosage:2
based ,regimen:2
based ,indomethacin:2
approach ,estimating:2
approach ,dosage:2
approach ,regimen:2
approach ,indomethacin:2
estimating ,dosage:2
estimating ,regimen:2
estimating ,indomethacin:2
estimating ,potential:2
dosage ,regimen:2
dosage ,indomethacin:2
dosage ,potential:2
regimen ,indomethacin:2
regimen ,potential:2
multiple ,embolic:2
multiple ,magnetic:2
multiple ,resonance:2
multiple ,imaging:2
multiple ,brain:2
embolic ,stroke:2
embolic ,magnetic:2
embolic ,resonance:2
embolic ,imaging:2
embolic ,brain:2
embolic ,covid-19:2
stroke ,magnetic:2
stroke ,resonance:2
stroke ,imaging:2
stroke ,brain:2
magnetic ,resonance:2
magnetic ,imaging:2
magnetic ,brain:2
magnetic ,covid-19:2
resonance ,imaging:2
resonance ,brain:2
resonance ,covid-19:2
imaging ,brain:2
outbreak ,covid-19-an:2
coronavirus ,covid-19-an:2
disease ,covid-19-an:2
disease ,global:6
covid-19-an ,emerging:2
covid-19-an ,global:2
covid-19-an ,health:2
fulminant ,rare:2
fulminant ,devastating:2
fulminant ,manifestation:4
hepatic ,rare:2
hepatic ,devastating:2
hepatic ,manifestation:2
failure ,rare:2
failure ,devastating:2
failure ,manifestation:2
rare ,devastating:2
rare ,manifestation:2
devastating ,manifestation:2
devastating ,coronavirus:2
multi-pronged ,approach:2
multi-pronged ,targeting:2
multi-pronged ,sars-cov-2:2
multi-pronged ,proteins:2
multi-pronged ,using:2
multi-pronged ,ultra-large:2
multi-pronged ,virtual:2
approach ,proteins:2
approach ,using:2
approach ,ultra-large:2
approach ,virtual:2
targeting ,proteins:4
targeting ,using:2
targeting ,ultra-large:2
sars-cov-2 ,ultra-large:2
proteins ,ultra-large:2
proteins ,virtual:2
using ,ultra-large:2
using ,virtual:2
ultra-large ,virtual:2
potential ,remedies:2
potential ,critical:4
drugs ,remedies:2
remedies ,treatment:2
remedies ,covid-19:2
remedies ,critical:2
remedies ,review:2
cerebral ,deep:4
cerebral ,venous:8
cerebral ,thrombosis:8
cerebral ,report:4
deep ,venous:4
deep ,case:2
deep ,report:2
venous ,thrombosis:8
venous ,case:6
venous ,report:6
emergency ,trauma:4
emergency ,careduring:2
emergency ,recommendations:4
surgery ,trauma:4
surgery ,careduring:2
trauma ,careduring:2
trauma ,recommendations:4
careduring ,covid-19:2
careduring ,pandemic:2
careduring ,recommendations:2
epidemic ,tianjin:2
epidemic ,well-developed:2
epidemic ,city:2
characteristics ,outbreak:4
characteristics ,tianjin:2
characteristics ,well-developed:2
characteristics ,city:2
covid-19 ,tianjin:2
covid-19 ,well-developed:2
outbreak ,tianjin:2
outbreak ,well-developed:2
outbreak ,city:4
tianjin ,well-developed:2
tianjin ,city:2
well-developed ,city:2
value ,urine:2
value ,biochemical:2
value ,parameters:2
value ,prediction:2
urine ,biochemical:2
urine ,parameters:2
urine ,prediction:2
urine ,severity:2
biochemical ,prediction:2
biochemical ,severity:4
parameters ,prediction:2
parameters ,severity:2
prediction ,severity:2
deciphering ,sars-cov-2:4
deciphering ,virologic:2
deciphering ,immunologic:2
deciphering ,features:2
sars-cov-2 ,virologic:2
sars-cov-2 ,immunologic:2
virologic ,immunologic:2
virologic ,features:2
immunologic ,features:4
nervous ,features:2
nervous ,molecular:2
nervous ,mechanisms:2
system ,features:2
system ,molecular:2
features ,molecular:2
belief ,covid-19:4
belief ,conspiracy:2
belief ,theory:2
belief ,predictor:2
belief ,mental:2
belief ,health:4
covid-19 ,theory:4
conspiracy ,theory:2
conspiracy ,predictor:2
conspiracy ,mental:2
conspiracy ,health:4
theory ,predictor:2
theory ,mental:2
theory ,health:2
predictor ,mental:2
predictor ,health:2
renin-angiotensin-system ,ras:2
renin-angiotensin-system ,covid-19:2
renin-angiotensin-system ,prescription:2
renin-angiotensin-system ,blockers:2
ras ,prescription:2
ras ,blockers:2
covid-19 ,prescription:2
prescription ,blockers:2
seasonality ,uncertainty:2
seasonality ,covid-19:4
seasonality ,growth:2
seasonality ,rates:2
uncertainty ,global:2
uncertainty ,covid-19:2
uncertainty ,growth:2
uncertainty ,rates:2
global ,growth:2
global ,rates:2
growth ,rates:2
otolaryngology ,preventive:2
otolaryngology ,precautionary:2
otolaryngology ,measures:2
covid-19 ,precautionary:6
preventive ,care:2
preventive ,precautionary:2
care ,precautionary:2
precautionary ,measures:2
orbital ,cellulitis:2
orbital ,sinusitis:2
orbital ,intracranial:2
orbital ,abnormalities:2
orbital ,two:2
orbital ,adolescents:2
cellulitis ,sinusitis:2
cellulitis ,intracranial:2
cellulitis ,abnormalities:2
cellulitis ,two:2
cellulitis ,adolescents:2
sinusitis ,intracranial:2
sinusitis ,abnormalities:2
sinusitis ,two:2
sinusitis ,adolescents:2
intracranial ,abnormalities:2
intracranial ,two:2
intracranial ,adolescents:2
abnormalities ,two:2
abnormalities ,adolescents:2
two ,adolescents:2
role ,corticosteroid:2
role ,systemic:2
corticosteroid ,management:2
corticosteroid ,covid-19:6
corticosteroid ,systemic:4
corticosteroid ,review:2
management ,systemic:4
ophthalmological ,emergencies:2
ophthalmological ,outbreak:2
emergencies ,sars-cov-2:2
emergencies ,outbreak:2
part ,triggered:2
part ,panic:2
part ,attack:2
part ,severe:4
sars-cov-2 ,triggered:8
sars-cov-2 ,panic:2
triggered ,panic:2
triggered ,attack:2
triggered ,severe:2
triggered ,covid-19:4
panic ,attack:2
panic ,severe:2
attack ,severe:2
entangling ,covid-19:2
entangling ,associated:2
entangling ,thrombosis:2
entangling ,secondary:2
entangling ,antiphospholipid:2
entangling ,antibody:2
covid-19 ,antiphospholipid:4
associated ,antiphospholipid:4
associated ,antibody:2
thrombosis ,secondary:2
thrombosis ,antiphospholipid:2
thrombosis ,antibody:2
secondary ,antiphospholipid:2
secondary ,antibody:2
antiphospholipid ,antibody:2
sars-cov-2 ,isothermal:4
sars-cov-2 ,inexpensive:2
detection ,isothermal:4
detection ,inexpensive:2
using ,isothermal:2
using ,inexpensive:2
isothermal ,rapid:6
isothermal ,inexpensive:2
amplification ,inexpensive:2
rapid ,inexpensive:2
can ,phytotherapy:2
can ,polyphenols:2
can ,powerful:2
can ,prevention:2
phytotherapy ,polyphenols:2
phytotherapy ,serve:2
phytotherapy ,powerful:2
phytotherapy ,approach:2
phytotherapy ,prevention:2
polyphenols ,serve:2
polyphenols ,powerful:2
polyphenols ,approach:2
polyphenols ,prevention:2
serve ,powerful:2
serve ,approach:2
serve ,prevention:2
powerful ,approach:2
powerful ,prevention:2
approach ,prevention:2
clinical ,69:2
features ,69:2
features ,wuhan:2
69 ,cases:2
69 ,coronavirus:2
69 ,disease:2
69 ,wuhan:2
69 ,china:2
cases ,wuhan:2
changing ,landscape:2
changing ,sars-cov-2:2
changing ,implications:2
changing ,maternal-infant:2
changing ,dyad:2
landscape ,implications:2
landscape ,maternal-infant:2
landscape ,dyad:2
sars-cov-2 ,maternal-infant:2
implications ,maternal-infant:2
implications ,dyad:2
maternal-infant ,dyad:2
itchy ,erythematous:2
itchy ,papular:2
itchy ,skin:2
itchy ,rash:2
itchy ,possible:2
itchy ,early:2
itchy ,sign:2
itchy ,covid-19:2
itchy ,case:2
erythematous ,papular:2
erythematous ,skin:2
erythematous ,rash:2
erythematous ,possible:2
erythematous ,early:2
erythematous ,sign:2
erythematous ,covid-19:2
erythematous ,case:2
papular ,skin:2
papular ,rash:2
papular ,possible:2
papular ,early:2
papular ,sign:2
papular ,covid-19:2
papular ,case:2
skin ,rash:2
skin ,possible:2
skin ,early:2
skin ,sign:2
skin ,case:4
rash ,possible:2
rash ,early:2
rash ,sign:2
possible ,early:6
possible ,sign:2
early ,sign:4
early ,case:6
sign ,case:4
g-quadruplexes ,present:2
g-quadruplexes ,human:2
g-quadruplexes ,coronaviruses:2
g-quadruplexes ,including:2
g-quadruplexes ,sars-cov-2:2
present ,human:2
present ,coronaviruses:2
present ,including:2
human ,including:4
covid-19 ,topical:2
topical ,issues:2
topical ,clinic:2
topical ,activities:2
topical ,pandemic:2
issues ,clinic:2
issues ,activities:2
clinic ,activities:2
clinic ,pandemic:2
activities ,pandemic:2
genomic ,determinants:2
genomic ,pathogenicity:2
genomic ,human:2
genomic ,coronaviruses:2
determinants ,pathogenicity:2
determinants ,sars-cov-2:2
determinants ,coronaviruses:2
pathogenicity ,human:2
pathogenicity ,coronaviruses:2
dysregulation ,type:2
dysregulation ,interferon:2
dysregulation ,responses:2
dysregulation ,covid-19:6
type ,responses:4
interferon ,responses:4
angiotensin ,increase:2
angiotensin ,risk:2
angiotensin ,poor:2
angiotensin ,outcomes:2
converting ,inhibitors:2
converting ,increase:2
converting ,risk:2
converting ,poor:2
converting ,outcomes:2
enzyme ,increase:2
enzyme ,risk:2
enzyme ,poor:2
enzyme ,outcomes:2
inhibitors ,poor:2
inhibitors ,outcomes:2
increase ,outcomes:2
risk ,poor:2
severe ,air:2
severe ,pollution:2
severe ,links:2
severe ,higher:2
air ,links:2
air ,higher:2
air ,mortality:2
pollution ,links:2
pollution ,higher:2
pollution ,mortality:2
pollution ,patients:2
links ,higher:2
links ,mortality:2
links ,covid-19:6
links ,patients:2
higher ,patients:4
sars-cov-2 ,covid:2
sars-cov-2 ,hypertensive:2
covid ,infection:2
covid ,hypertensive:2
19 ,hypertensive:2
infection ,hypertensive:2
hypertensive ,patients:2
happens ,peoples:2
happens ,lungs:2
happens ,get:2
happens ,coronavirus:2
happens ,disease:2
peoples ,lungs:2
peoples ,get:2
peoples ,coronavirus:2
lungs ,get:2
get ,coronavirus:2
get ,disease:2
silico ,prediction:2
antibody ,differing:2
antibody ,severities:2
responses ,differing:2
responses ,severities:2
sars-cov-2 ,differing:2
sars-cov-2 ,severities:2
patients ,differing:2
patients ,severities:2
differing ,severities:2
epicentre ,espnic:2
epicentre ,covid:2
epicentre ,pediatric:2
epicentre ,neonatal:2
epicentre ,registry:2
epicentre ,initiative:2
epicentre ,background:2
espnic ,covid:2
espnic ,pediatric:2
espnic ,neonatal:2
espnic ,registry:2
espnic ,initiative:2
espnic ,background:2
covid ,pediatric:2
covid ,neonatal:2
covid ,registry:2
covid ,initiative:2
covid ,background:2
pediatric ,neonatal:2
pediatric ,registry:2
pediatric ,initiative:2
pediatric ,background:2
neonatal ,registry:2
neonatal ,initiative:2
neonatal ,background:2
registry ,initiative:2
registry ,background:2
initiative ,background:2
protective ,sars:2
protective ,subunit:2
protective ,vaccine:2
protective ,candidates:2
protective ,based:2
protective ,spike:2
protective ,protein:2
immunity ,subunit:2
immunity ,based:2
immunity ,spike:2
immunity ,protein:2
sars ,subunit:2
sars ,candidates:4
subunit ,candidates:2
subunit ,based:2
subunit ,protein:2
candidates ,based:2
candidates ,spike:2
candidates ,protein:2
prostate ,factor:2
prostate ,males:2
prostate ,protocol:2
prostate ,systematic:2
cancer ,factor:2
cancer ,males:2
cancer ,protocol:2
risk ,males:2
risk ,protocol:2
factor ,males:2
factor ,protocol:2
factor ,systematic:2
covid-19 ,males:4
males ,protocol:2
males ,systematic:2
protocol ,systematic:4
sars-cov-2 ,lgmlgg:2
sars-cov-2 ,confirms:2
lgmlgg ,antibody:2
lgmlgg ,detection:2
lgmlgg ,confirms:2
lgmlgg ,infection:2
lgmlgg ,three:2
lgmlgg ,negative:2
antibody ,confirms:2
antibody ,negative:2
detection ,confirms:2
detection ,negative:4
confirms ,infection:2
confirms ,three:2
confirms ,negative:2
infection ,negative:2
three ,negative:2
ophthalmic ,manifestations:4
ophthalmic ,coronavirus:4
first ,100:2
first ,hospital:2
first ,madrid:2
first ,2-month:2
first ,follow-up:4
100 ,cases:2
100 ,covid-19:2
100 ,hospital:2
100 ,madrid:2
100 ,2-month:2
100 ,follow-up:2
cases ,hospital:2
cases ,madrid:2
cases ,2-month:2
cases ,follow-up:2
covid-19 ,madrid:2
covid-19 ,2-month:2
hospital ,madrid:2
hospital ,2-month:2
hospital ,follow-up:2
madrid ,2-month:2
madrid ,follow-up:2
2-month ,follow-up:2
importations ,covid-19:2
importations ,african:2
importations ,countries:2
importations ,risk:2
importations ,onward:2
importations ,spread:2
covid-19 ,onward:2
african ,countries:2
african ,risk:4
african ,onward:2
african ,spread:2
countries ,risk:4
countries ,onward:2
risk ,onward:2
risk ,spread:2
onward ,spread:2
cutaneous ,clinical:6
cutaneous ,characteristics:2
conquest ,covid-19:2
conquest ,publish:2
conquest ,death:2
covid-19 ,publish:2
publish ,death:2
covid-19 ,fat:2
suspicion ,revealed:2
suspicion ,fat:2
suspicion ,embolism:2
suspicion ,syndrome:2
revealed ,fat:2
revealed ,embolism:2
revealed ,syndrome:2
fat ,embolism:2
fat ,syndrome:2
embolism ,syndrome:2
comprehensive ,mapping:2
comprehensive ,druggable:2
comprehensive ,cavities:2
comprehensive ,within:2
mapping ,druggable:2
mapping ,cavities:2
mapping ,within:2
druggable ,cavities:2
druggable ,within:2
cavities ,within:2
cavities ,sars-cov-2:2
risk ,interactions:2
risk ,age:4
risk ,groups:2
risk ,peak:2
interactions ,coronavirus:2
interactions ,across:2
interactions ,age:2
interactions ,groups:2
interactions ,peak:2
coronavirus ,across:2
coronavirus ,age:2
coronavirus ,groups:2
coronavirus ,peak:2
infection ,age:4
infection ,groups:2
infection ,peak:2
across ,age:4
across ,groups:2
across ,peak:2
age ,groups:2
age ,peak:2
groups ,peak:2
socio-economic ,implications:2
socio-economic ,coronavirus:2
socio-economic ,pandemic:2
socio-economic ,covid-19:4
socio-economic ,review:2
open ,development:2
open ,clinical:2
open ,validation:2
open ,multiple:2
open ,3d-printed:2
open ,nasopharyngeal:2
development ,multiple:2
development ,3d-printed:2
development ,nasopharyngeal:2
clinical ,3d-printed:2
clinical ,nasopharyngeal:2
validation ,3d-printed:2
validation ,nasopharyngeal:2
multiple ,3d-printed:2
multiple ,nasopharyngeal:2
3d-printed ,nasopharyngeal:2
new ,right:2
new ,ventricular:2
new ,failure:2
new ,young:2
onset ,right:2
onset ,ventricular:2
onset ,failure:2
onset ,young:2
severe ,right:2
severe ,ventricular:2
severe ,young:4
right ,ventricular:4
right ,failure:2
right ,associated:2
right ,young:2
ventricular ,failure:2
ventricular ,associated:2
ventricular ,young:2
failure ,associated:4
failure ,young:2
associated ,young:2
chest ,severe:2
chest ,acute:2
chest ,respiratory:2
chest ,syndrome:2
computed ,severe:2
computed ,acute:2
computed ,respiratory:2
computed ,syndrome:2
tomography ,severe:2
tomography ,acute:2
tomography ,respiratory:2
tomography ,syndrome:2
perspectives ,use:2
perspectives ,botulinum:2
perspectives ,toxin:2
perspectives ,multifaceted:2
perspectives ,candidate:2
use ,botulinum:2
use ,toxin:2
use ,multifaceted:2
use ,candidate:2
therapeutic ,botulinum:2
therapeutic ,toxin:2
therapeutic ,multifaceted:2
therapeutic ,candidate:4
botulinum ,toxin:4
botulinum ,multifaceted:2
botulinum ,candidate:2
toxin ,multifaceted:2
toxin ,candidate:2
multifaceted ,candidate:2
role ,variants:2
role ,expression:2
genetic ,variants:10
genetic ,expression:6
variants ,gene:2
variants ,expression:4
variants ,susceptibility:2
variants ,severity:2
gene ,susceptibility:2
gene ,severity:2
expression ,susceptibility:4
expression ,severity:6
development ,platform:2
development ,virus-like:2
development ,particle:2
development ,vlp-based:2
novel ,platform:2
novel ,virus-like:2
novel ,particle:2
novel ,vlp-based:2
platform ,virus-like:2
platform ,particle:2
platform ,vlp-based:2
virus-like ,particle:2
virus-like ,vlp-based:2
virus-like ,vaccine:2
particle ,vlp-based:2
particle ,vaccine:2
vlp-based ,vaccine:2
children ,account:2
children ,small:2
children ,proportion:2
children ,diagnoses:2
account ,small:2
account ,proportion:2
account ,diagnoses:2
account ,sars-cov-2:2
account ,infection:2
small ,proportion:2
small ,diagnoses:2
small ,infection:4
proportion ,diagnoses:2
proportion ,infection:2
diagnoses ,sars-cov-2:2
diagnoses ,infection:2
remdesivir ,approval:2
first ,approval:2
computer ,simulations:2
computer ,interaction:2
computer ,sars-cov-2:2
computer ,spike:2
computer ,glycoprotein:2
simulations ,interaction:2
simulations ,sars-cov-2:2
simulations ,spike:2
simulations ,glycoprotein:2
interaction ,glycoprotein:2
diseases ,current:4
diseases ,status:2
diseases ,future:2
diseases ,perspectives:2
diseases ,narrative:2
status ,narrative:4
future ,narrative:2
perspectives ,narrative:2
single-cell ,profiles:2
single-cell ,tmprss2:2
single-cell ,potential:2
single-cell ,vertical:2
expression ,profiles:4
expression ,tmprss2:14
expression ,vertical:2
profiles ,ace2:4
profiles ,tmprss2:2
profiles ,reveals:2
profiles ,potential:2
profiles ,vertical:2
ace2 ,vertical:2
tmprss2 ,reveals:2
tmprss2 ,potential:6
tmprss2 ,vertical:2
reveals ,potential:8
reveals ,vertical:2
symptoms ,healthcare:4
symptoms ,workers:4
symptoms ,pcr:2
symptoms ,results:2
predictive ,healthcare:2
predictive ,workers:2
predictive ,pcr:2
predictive ,results:2
healthcare ,pcr:2
workers ,pcr:2
pathogenesis ,first:2
pathogenesis ,drug:2
pathogenesis ,trials:2
models ,first:2
models ,drug:2
models ,trials:2
first ,drug:2
sars-cov-2-reactive ,cells:4
sars-cov-2-reactive ,healthy:2
sars-cov-2-reactive ,donors:2
sars-cov-2-reactive ,patients:4
sars-cov-2-reactive ,covid-19:2
cells ,healthy:2
cells ,donors:2
healthy ,donors:2
healthy ,patients:2
donors ,patients:2
donors ,covid-19:4
recognizing ,covid-19-related:2
recognizing ,myocarditis:2
recognizing ,possible:2
recognizing ,pathophysiology:2
recognizing ,proposed:2
covid-19-related ,myocarditis:2
covid-19-related ,possible:2
covid-19-related ,pathophysiology:2
covid-19-related ,proposed:2
myocarditis ,possible:2
myocarditis ,pathophysiology:2
myocarditis ,proposed:2
possible ,pathophysiology:4
pathophysiology ,proposed:2
public ,first:4
public ,wave:2
public ,research:4
public ,agendafor:2
public ,cooperation:2
health ,first:2
health ,wave:2
health ,agendafor:2
health ,cooperation:2
first ,agendafor:2
first ,cooperation:2
wave ,research:2
wave ,agendafor:2
wave ,cooperation:2
research ,agendafor:2
research ,cooperation:2
agendafor ,cooperation:2
agendafor ,covid-19:2
plans ,reactivate:2
plans ,gastroenterology:2
plans ,practices:2
plans ,following:2
plans ,covid-19:2
plans ,pandemic:2
reactivate ,gastroenterology:2
reactivate ,practices:2
reactivate ,following:2
reactivate ,covid-19:2
reactivate ,pandemic:2
gastroenterology ,practices:2
gastroenterology ,following:2
gastroenterology ,covid-19:6
gastroenterology ,pandemic:4
practices ,following:2
following ,pandemic:2
comparison ,positive:4
comparison ,negative:2
clinical ,negative:2
characteristics ,rna:2
characteristics ,negative:2
rapid ,investigate:2
rapid ,health-care:2
implementation ,sequencing:2
implementation ,investigate:2
implementation ,cases:2
implementation ,health-care:2
sars-cov-2 ,investigate:2
sequencing ,investigate:2
sequencing ,cases:2
sequencing ,health-care:2
investigate ,cases:2
investigate ,health-care:2
cases ,health-care:2
call ,strengthened:2
call ,evidence:2
call ,targeted:2
call ,non-pharmaceutical:2
call ,interventions:2
strengthened ,evidence:2
strengthened ,targeted:2
strengthened ,non-pharmaceutical:2
strengthened ,interventions:2
evidence ,targeted:2
evidence ,non-pharmaceutical:2
evidence ,interventions:2
targeted ,non-pharmaceutical:2
targeted ,interventions:2
cardiothoracic ,surgery:2
cardiothoracic ,covid-19:2
cardiothoracic ,experience:2
cardiothoracic ,different:2
cardiothoracic ,strategies:2
surgery ,different:2
experience ,different:2
experience ,strategies:2
different ,strategies:2
validation ,sars-cov-2surrogate:2
validation ,virus:2
validation ,neutralisation:2
clinical ,sars-cov-2surrogate:2
clinical ,neutralisation:2
evaluation ,sars-cov-2surrogate:2
evaluation ,neutralisation:2
sars-cov-2surrogate ,virus:2
sars-cov-2surrogate ,neutralisation:2
virus ,neutralisation:2
differential ,tropism:2
differential ,bat:2
differential ,cells:2
tropism ,sars-cov:2
tropism ,sars-cov-2:4
tropism ,bat:2
tropism ,cells:2
sars-cov ,bat:2
sars-cov ,cells:2
sars-cov-2 ,bat:8
bat ,cells:2
global ,nervous:2
global ,system:2
threat ,nervous:2
threat ,system:2
transmission ,mode:2
mode ,associated:2
mode ,coronavirus:2
mode ,disease:2
mode ,review:4
comorbidities ,clinical:2
comorbidities ,signs:2
comorbidities ,laboratory:2
comorbidities ,findings:2
comorbidities ,imaging:2
comorbidities ,features:2
clinical ,signs:4
signs ,symptoms:2
signs ,laboratory:4
signs ,findings:4
signs ,imaging:2
signs ,features:2
symptoms ,laboratory:2
symptoms ,findings:2
symptoms ,imaging:2
symptoms ,features:2
laboratory ,imaging:2
digital ,technologies-enabled:2
digital ,smart:2
digital ,manufacturing:2
digital ,industry:2
digital ,40:2
technologies-enabled ,smart:2
technologies-enabled ,manufacturing:2
technologies-enabled ,industry:2
technologies-enabled ,40:2
smart ,manufacturing:2
smart ,industry:2
smart ,40:2
manufacturing ,industry:2
manufacturing ,40:2
industry ,40:2
onset ,occupational:2
onset ,hand:2
onset ,eczema:2
onset ,among:2
onset ,healthcare:2
onset ,workers:2
occupational ,hand:2
occupational ,eczema:2
occupational ,healthcare:2
occupational ,workers:2
hand ,eczema:2
hand ,among:4
hand ,healthcare:2
hand ,workers:4
eczema ,among:2
eczema ,healthcare:2
eczema ,workers:2
eczema ,sars-cov-2:2
digital ,surveillance:2
digital ,contact:2
digital ,tracking:2
digital ,infected:2
digital ,persons:2
surveillance ,tools:2
surveillance ,contact:2
surveillance ,tracking:2
surveillance ,infected:2
surveillance ,persons:2
tools ,contact:2
tools ,tracking:2
tools ,infected:2
tools ,persons:2
contact ,tracking:2
contact ,infected:2
contact ,persons:2
tracking ,infected:2
tracking ,persons:2
infected ,persons:2
pathogenesis ,transgenic:2
pathogenesis ,mice:2
pathogenesis ,expressing:2
pathogenesis ,human:2
sars-cov-2 ,expressing:4
transgenic ,expressing:2
mice ,expressing:2
expressing ,human:2
infection ,recipients:2
severe ,abdomen:2
infection ,suspected:4
children ,suspected:2
children ,abdomen:2
suspected ,acute:4
suspected ,abdomen:2
suspected ,series:4
acute ,series:4
abdomen ,series:2
prevalence ,admitted:2
prevalence ,childbirth:2
prevalence ,southern:2
sars-cov-2 ,childbirth:2
among ,admitted:2
among ,childbirth:2
among ,southern:6
patients ,childbirth:2
patients ,southern:2
admitted ,childbirth:2
admitted ,southern:2
childbirth ,southern:2
detection ,raw:4
detection ,treated:2
detection ,suitability:2
sars-cov-2 ,suitability:2
raw ,treated:2
raw ,wastewater:2
raw ,germany:2
raw ,suitability:2
treated ,wastewater:2
treated ,germany:2
treated ,suitability:2
wastewater ,germany:2
wastewater ,suitability:2
germany ,suitability:2
prospective ,challenges:2
preliminary ,ct:2
preliminary ,disease:2
transmission ,cancer:2
transmission ,tertiary:2
transmission ,hospital:2
cancer ,tertiary:4
cancer ,hospital:4
impact ,ties:2
impact ,sars:2
impact ,memory:2
impact ,awareness:2
social ,ties:2
social ,sars:2
social ,memory:2
social ,public:4
social ,awareness:2
social ,novel:2
ties ,sars:2
ties ,memory:2
ties ,public:2
ties ,awareness:2
ties ,novel:2
sars ,memory:2
sars ,public:2
sars ,awareness:2
memory ,public:2
memory ,awareness:2
memory ,novel:2
direct ,rrt-pcr:2
rrt-pcr ,extraction:2
anosmia ,price:2
anosmia ,pay:2
anosmia ,immune-induced:2
anosmia ,scorched-earth:2
anosmia ,policy:2
price ,pay:2
price ,immune-induced:2
price ,scorched-earth:2
price ,policy:2
pay ,immune-induced:2
pay ,scorched-earth:2
pay ,policy:2
immune-induced ,scorched-earth:2
immune-induced ,policy:2
scorched-earth ,policy:2
respiratory ,surveillance:4
respiratory ,wards:2
respiratory ,reduce:2
respiratory ,nosocomial:4
surveillance ,wards:2
surveillance ,strategy:2
surveillance ,reduce:2
surveillance ,nosocomial:2
surveillance ,transmission:4
wards ,strategy:2
wards ,reduce:2
wards ,nosocomial:2
wards ,transmission:2
strategy ,reduce:4
strategy ,nosocomial:2
strategy ,transmission:2
reduce ,nosocomial:2
know ,2019-ncov:2
know ,iran:2
know ,early:2
know ,stage:2
2019-ncov ,iran:2
2019-ncov ,stage:2
iran ,early:2
iran ,stage:2
structure ,binding:4
binding ,2019-ncov:4
investigation ,pathogenic:2
investigation ,agents:2
investigation ,causing:2
investigation ,respiratory:4
investigation ,tract:2
investigation ,infections:2
pathogenic ,agents:2
pathogenic ,causing:2
pathogenic ,tract:2
agents ,causing:2
agents ,acute:4
agents ,respiratory:2
agents ,tract:2
agents ,infections:2
causing ,acute:2
causing ,tract:2
causing ,infections:2
acute ,tract:2
tract ,infections:2
lithium ,candidate:2
lithium ,treatment:2
lithium ,covid-19:2
lithium ,promises:2
lithium ,pitfalls:2
candidate ,promises:2
candidate ,pitfalls:2
treatment ,promises:2
treatment ,pitfalls:2
covid-19 ,promises:2
covid-19 ,pitfalls:4
promises ,pitfalls:2
modeling ,role:2
modeling ,asymptomatics:2
modeling ,spread:2
modeling ,application:2
role ,asymptomatics:2
role ,application:2
asymptomatics ,infection:2
asymptomatics ,spread:2
asymptomatics ,application:2
spread ,application:2
review ,corpse:2
review ,suspected:2
safe ,corpse:2
safe ,suspected:2
handling ,corpse:2
handling ,suspected:2
corpse ,suspected:2
corpse ,covid-19:2
adverse ,lopinavirritonavir:2
adverse ,critically:2
adverse ,ill:2
adverse ,patients:2
effects ,lopinavirritonavir:2
effects ,critically:2
effects ,ill:2
lopinavirritonavir ,critically:2
lopinavirritonavir ,ill:2
ophthalmic ,neuro-ophthalmic:2
ophthalmic ,disease:2
neuro-ophthalmic ,manifestations:2
neuro-ophthalmic ,coronavirus:2
neuro-ophthalmic ,disease:2
epidemiology ,egypt:2
sars-cov-2 ,egypt:4
evaluation ,immunochromatographic:4
three ,immunochromatographic:2
three ,antibodies:2
immunochromatographic ,tests:2
immunochromatographic ,detection:2
immunochromatographic ,antibodies:2
covid-19 ,interview:2
covid-19 ,professor:2
covid-19 ,paediatrics:2
covid-19 ,vana:2
paediatric ,challenges:2
paediatric ,interview:2
paediatric ,professor:2
paediatric ,paediatrics:2
paediatric ,vana:2
challenges ,interview:2
challenges ,professor:2
challenges ,paediatrics:2
challenges ,vana:2
interview ,professor:2
interview ,paediatrics:2
interview ,vana:2
professor ,paediatrics:2
professor ,vana:2
paediatrics ,vana:2
sars-cov-2 ,pcr-negative:2
serological ,changes:2
serological ,disease:2
serological ,management:2
serological ,pcr-negative:2
serological ,patient:2
testing ,changes:2
testing ,pcr-negative:2
testing ,patient:2
changes ,management:2
changes ,pcr-negative:2
changes ,patient:4
disease ,pcr-negative:2
management ,pcr-negative:2
pcr-negative ,patient:2
home-based ,testing:2
home-based ,sars-cov-2:2
home-based ,leveraging:2
home-based ,prehospital:2
home-based ,resources:2
home-based ,vulnerable:2
testing ,leveraging:2
testing ,prehospital:2
testing ,vulnerable:2
sars-cov-2 ,leveraging:2
sars-cov-2 ,prehospital:2
sars-cov-2 ,resources:2
leveraging ,prehospital:2
leveraging ,resources:2
leveraging ,vulnerable:2
prehospital ,resources:2
prehospital ,vulnerable:2
resources ,vulnerable:2
mass-spectrometric ,detection:2
mass-spectrometric ,sars-cov-2:2
mass-spectrometric ,virus:2
mass-spectrometric ,scrapings:2
mass-spectrometric ,epithelium:2
detection ,scrapings:2
detection ,epithelium:2
sars-cov-2 ,scrapings:2
virus ,scrapings:2
virus ,epithelium:2
scrapings ,epithelium:2
dj ,vu:2
dj ,stimulating:2
dj ,open:2
dj ,drug:2
dj ,discovery:2
dj ,sars-cov-2:2
vu ,stimulating:2
vu ,open:2
vu ,drug:2
vu ,discovery:2
vu ,sars-cov-2:2
stimulating ,open:2
stimulating ,drug:2
stimulating ,discovery:2
stimulating ,sars-cov-2:2
open ,drug:2
open ,discovery:2
clinical ,complicated:2
spectrum ,risk:2
spectrum ,factors:2
spectrum ,complicated:2
spectrum ,disease:4
spectrum ,course:2
spectrum ,children:2
risk ,complicated:2
risk ,course:4
factors ,complicated:2
factors ,children:4
complicated ,course:2
complicated ,children:2
multisystem ,report:2
multisystem ,clinical:2
children ,report:4
mis-c ,report:2
mis-c ,clinical:2
report ,clinical:4
covid-19 ,take:4
covid-19 ,17months:2
research ,vaccine:6
research ,might:2
research ,take:2
research ,17months:2
vaccine ,application:2
vaccine ,might:2
vaccine ,take:2
vaccine ,17months:2
application ,might:2
application ,take:2
application ,17months:2
might ,take:2
might ,17months:2
take ,17months:2
coinfection ,virus:4
influence ,hospitalizations:2
influence ,tertiary:2
influence ,dermatology:2
pandemic ,hospitalizations:2
pandemic ,tertiary:4
hospitalizations ,tertiary:2
hospitalizations ,dermatology:2
tertiary ,dermatology:2
challenging ,times:2
challenging ,ethics:2
challenging ,nursing:2
challenging ,pandemic:2
times ,ethics:2
times ,nursing:2
ethics ,nursing:2
ethics ,pandemic:2
nursing ,pandemic:2
combined ,therapy:2
combined ,traditional:2
combined ,chinese:2
combined ,medicine:2
combined ,formula:4
combined ,western:2
therapy ,traditional:4
therapy ,chinese:4
therapy ,medicine:6
therapy ,formula:2
therapy ,western:2
traditional ,formula:2
chinese ,formula:2
medicine ,formula:2
formula ,western:2
chest ,accuracy:2
chest ,diagnosing:2
chest ,peak:2
chest ,italian:2
chest ,epidemic:2
ct ,accuracy:2
ct ,diagnosing:2
ct ,peak:2
ct ,italian:2
ct ,epidemic:2
accuracy ,diagnosing:2
accuracy ,peak:2
accuracy ,italian:2
accuracy ,epidemic:2
diagnosing ,peak:2
diagnosing ,italian:2
diagnosing ,epidemic:2
peak ,epidemic:2
covid-19 ,decision-making:2
elderly ,insights:2
elderly ,pathogenesis:2
elderly ,clinical:4
elderly ,decision-making:2
insights ,decision-making:2
pathogenesis ,decision-making:2
clinical ,decision-making:2
protease ,candidate:4
protease ,inhibit:2
protease ,severe:2
protease ,acute:2
protease ,respiratory:2
protease ,syndrome:2
inhibitors ,candidate:4
inhibitors ,drugs:10
inhibitors ,severe:4
inhibitors ,acute:4
inhibitors ,respiratory:2
inhibitors ,syndrome:2
candidate ,inhibit:2
candidate ,severe:4
candidate ,acute:2
candidate ,respiratory:2
candidate ,syndrome:2
drugs ,inhibit:4
drugs ,syndrome:2
inhibit ,severe:2
inhibit ,acute:2
inhibit ,respiratory:2
inhibit ,syndrome:2
inhibition ,s-protein:2
inhibition ,rbd:2
inhibition ,hace2:2
inhibition ,interaction:4
inhibition ,control:2
inhibition ,sarscov-2:2
s-protein ,rbd:2
s-protein ,hace2:2
s-protein ,interaction:2
s-protein ,control:2
s-protein ,sarscov-2:2
s-protein ,infection:2
rbd ,hace2:2
rbd ,control:2
rbd ,sarscov-2:2
rbd ,infection:2
hace2 ,interaction:2
hace2 ,control:2
hace2 ,sarscov-2:2
hace2 ,infection:4
interaction ,control:2
interaction ,sarscov-2:2
interaction ,infection:4
control ,sarscov-2:2
sarscov-2 ,infection:2
prioritizing ,potential:2
prioritizing ,ace2:2
prioritizing ,inhibitors:2
prioritizing ,covid-19:4
prioritizing ,pandemic:2
prioritizing ,insights:2
potential ,insights:4
inhibitors ,pandemic:2
inhibitors ,insights:4
potential ,strategies:6
potential ,bromhexine:2
new ,strategies:2
new ,role:2
new ,bromhexine:2
treatment ,bromhexine:2
strategies ,role:2
strategies ,bromhexine:2
covid-19 ,bromhexine:2
role ,bromhexine:2
heparin ,therapy:2
heparin ,covid-19:2
heparin ,current:2
heparin ,evidence:2
heparin ,future:2
heparin ,possibilities:2
therapy ,evidence:2
therapy ,future:2
therapy ,possibilities:2
covid-19 ,possibilities:2
current ,possibilities:2
evidence ,future:2
evidence ,possibilities:2
future ,possibilities:2
attitudes ,professional:2
attitudes ,approaches:2
attitudes ,dental:2
attitudes ,practitioners:2
professional ,approaches:2
professional ,dental:2
approaches ,dental:2
approaches ,practitioners:2
dental ,practitioners:2
sars-cov-2 ,numbers:4
covid-19 ,numbers:2
recurrent ,mutation:2
recurrent ,position:2
recurrent ,26340:2
recurrent ,associated:2
recurrent ,failure:2
mutation ,position:2
mutation ,26340:2
mutation ,failure:2
position ,26340:2
position ,sars-cov-2:10
position ,associated:2
position ,failure:4
26340 ,sars-cov-2:2
26340 ,associated:2
26340 ,failure:2
sars-cov-2 ,failure:6
mutations ,rbd:2
mutations ,responsible:2
mutations ,stronger:2
sars-cov-2 ,stronger:2
spike ,responsible:2
spike ,stronger:2
rbd ,responsible:2
rbd ,stronger:2
responsible ,stronger:2
responsible ,ace2:2
responsible ,binding:2
stronger ,ace2:2
stronger ,binding:2
journey ,remdesivir:2
journey ,ebola:2
journey ,covid-19:2
remdesivir ,ebola:4
ebola ,covid-19:4
acute ,mimicking:2
respiratory ,mimicking:2
syndrome ,mimicking:2
coronavirus ,mimicking:2
sars-cov-2 ,mimicking:2
rare ,case:2
rare ,pneumopericardium:2
rare ,secondary:4
rare ,covid-19:4
case ,pneumopericardium:2
case ,secondary:2
pneumopericardium ,secondary:2
pneumopericardium ,covid-19:2
computed ,ct:6
computed ,utility:2
computed ,diagnosis:2
computed ,triage:2
computed ,covid-19:6
tomography ,ct:4
tomography ,utility:2
tomography ,diagnosis:2
tomography ,triage:2
tomography ,covid-19:4
ct ,utility:2
ct ,diagnosis:2
ct ,triage:2
utility ,triage:2
diagnosis ,triage:2
pharmacologic ,treatment:2
pharmacologic ,transplant:2
pharmacologic ,recipients:2
pharmacologic ,infected:2
pharmacologic ,sars-cov-2:2
treatment ,transplant:2
treatment ,recipients:2
transplant ,infected:2
recipients ,infected:2
recipients ,sars-cov-2:2
mouse-adapted ,model:2
mouse-adapted ,sars-cov-2:4
mouse-adapted ,test:2
mouse-adapted ,covid-19:2
mouse-adapted ,countermeasures:2
model ,test:2
model ,countermeasures:2
sars-cov-2 ,countermeasures:2
test ,countermeasures:2
covid-19 ,countermeasures:2
protective ,role:2
protective ,ace2:2
protective ,downregulation:2
protective ,infection:4
protective ,leading:2
role ,downregulation:2
role ,leading:2
ace2 ,downregulation:2
ace2 ,leading:2
downregulation ,sars-cov-2:2
downregulation ,infection:2
downregulation ,leading:2
sars-cov-2 ,leading:2
infection ,leading:2
lung ,facts:2
lung ,artifacts:2
lung ,outbreak:2
ultrasound ,facts:2
ultrasound ,artifacts:2
ultrasound ,era:2
ultrasound ,outbreak:2
facts ,artifacts:2
facts ,era:2
facts ,outbreak:2
artifacts ,era:2
artifacts ,covid-19:2
artifacts ,outbreak:2
primum ,non:4
primum ,nocere:4
primum ,chloroquine:2
primum ,hydroxychloroquine:2
primum ,safe:2
non ,nocere:4
non ,chloroquine:2
non ,hydroxychloroquine:2
non ,safe:2
nocere ,chloroquine:2
nocere ,hydroxychloroquine:2
nocere ,safe:2
chloroquine ,safe:2
antiviral ,evidence:2
antiviral ,supporting:2
treatment ,supporting:2
evidence ,remdesivir:4
supporting ,remdesivir:2
probable ,vertical:2
probable ,transmission:2
probable ,infection:2
children ,demographic:2
coronavirus ,demographic:2
disease ,demographic:2
review ,demographic:2
prostate ,pandemia:2
prostate ,current:2
prostate ,recommendations:2
cancer ,pandemia:4
cancer ,current:2
cancer ,recommendations:8
pandemia ,current:2
current ,recommendations:4
biosafety ,measures:2
biosafety ,preventing:2
biosafety ,infection:2
biosafety ,covid-19:2
measures ,preventing:2
measures ,clinical:2
measures ,laboratories:2
preventing ,clinical:2
preventing ,laboratories:2
mitigating ,coronavirus:6
mitigating ,induced:2
mitigating ,dysfunctional:2
mitigating ,immunity:2
mitigating ,at-risk:2
mitigating ,populations:2
coronavirus ,induced:4
coronavirus ,dysfunctional:2
coronavirus ,at-risk:2
induced ,dysfunctional:2
induced ,immunity:4
induced ,at-risk:2
induced ,populations:2
dysfunctional ,immunity:2
dysfunctional ,at-risk:2
dysfunctional ,populations:2
immunity ,at-risk:2
immunity ,populations:2
at-risk ,populations:2
can ,brain:4
learn ,brain:2
learn ,autopsy:2
brain ,autopsy:2
structure-activity ,relationship:2
structure-activity ,interactions:2
structure-activity ,sars-cov-2:2
structure-activity ,spike:2
relationship ,interactions:2
relationship ,sars-cov-2:4
relationship ,spike:2
interactions ,spike:4
characterization ,heparin:2
characterization ,syndrome-related:2
heparin ,severe:2
heparin ,acute:2
heparin ,respiratory:2
heparin ,syndrome-related:2
organ-specific ,manifestations:2
organ-specific ,covid-19:2
organ-specific ,infection:2
co-infection ,among:2
co-infection ,covid-2019:2
respiratory ,covid-2019:2
pathogens ,among:2
pathogens ,covid-2019:2
among ,covid-2019:2
covid-2019 ,cases:2
re-organising ,primary:2
re-organising ,health:2
re-organising ,care:2
re-organising ,respond:2
re-organising ,coronavirus:2
re-organising ,epidemic:2
re-organising ,cape:2
primary ,health:6
primary ,respond:2
primary ,epidemic:2
primary ,cape:2
health ,respond:2
health ,epidemic:4
health ,cape:2
care ,respond:2
care ,cape:2
respond ,cape:2
coronavirus ,cape:2
epidemic ,cape:2
covid-19 ,specifics:2
diabetic ,related:2
diabetic ,risks:2
diabetic ,specifics:2
diabetic ,management:2
patients ,risks:4
patients ,specifics:2
related ,risks:2
related ,specifics:2
risks ,specifics:2
risks ,management:2
specifics ,management:2
acute ,cor:2
acute ,pulmonale:2
acute ,covid-19-related:2
acute ,ards:2
acute ,almitrine:2
acute ,infusion:2
cor ,pulmonale:2
cor ,covid-19-related:2
cor ,ards:2
cor ,improvement:2
cor ,almitrine:2
cor ,infusion:2
pulmonale ,covid-19-related:2
pulmonale ,ards:2
pulmonale ,improvement:2
pulmonale ,almitrine:2
pulmonale ,infusion:2
covid-19-related ,ards:2
covid-19-related ,improvement:2
covid-19-related ,almitrine:2
covid-19-related ,infusion:2
ards ,improvement:2
ards ,almitrine:2
ards ,infusion:2
improvement ,almitrine:2
improvement ,infusion:2
almitrine ,infusion:2
cutaneous ,susceptibility:2
cutaneous ,according:2
cutaneous ,expression:2
susceptibility ,according:2
infection ,according:4
according ,expression:2
multiple ,disease-modifying:2
multiple ,therapy:8
multiple ,implications:4
sclerosis ,disease-modifying:2
sclerosis ,therapy:6
sclerosis ,implications:4
disease-modifying ,therapy:2
disease-modifying ,pandemic:2
disease-modifying ,implications:2
therapy ,implications:4
covid-19 ,definite:2
outbreak ,patient:2
outbreak ,definite:2
iran ,first:2
iran ,patient:4
iran ,definite:2
iran ,diagnosis:2
first ,definite:2
patient ,definite:2
definite ,diagnosis:2
risk ,redetectable:2
risk ,positivity:2
risk ,recovered:4
factors ,redetectable:2
factors ,positivity:2
factors ,recovered:2
redetectable ,positivity:2
redetectable ,recovered:2
redetectable ,covid-19:2
redetectable ,children:2
positivity ,recovered:2
positivity ,children:2
recovered ,children:2
nigella ,sativa:4
nigella ,potential:2
nigella ,phytotherapy:2
nigella ,coronavirus:2
nigella ,disease:2
nigella ,mini:2
sativa ,potential:2
sativa ,phytotherapy:2
sativa ,coronavirus:2
sativa ,disease:2
sativa ,mini:2
potential ,phytotherapy:2
potential ,mini:2
phytotherapy ,coronavirus:2
phytotherapy ,disease:2
phytotherapy ,mini:2
coronavirus ,mini:2
covid-19 ,low-resource:2
covid-19 ,nation:4
containment ,low-resource:2
containment ,nation:2
containment ,first:2
containment ,four:2
containment ,months:2
efforts ,low-resource:2
efforts ,nation:2
efforts ,first:2
efforts ,four:2
efforts ,months:2
low-resource ,nation:2
low-resource ,first:2
low-resource ,four:2
low-resource ,months:2
nation ,first:2
nation ,four:2
nation ,months:2
first ,four:2
four ,months:2
covid-19 ,coexisting:2
coexisting ,human:2
coexisting ,immunodeficiency:2
coexisting ,virus:2
coexisting ,case:2
coexisting ,report:2
human ,report:2
immunodeficiency ,report:2
coagulopathy ,thromboembolic:2
coagulopathy ,patients:2
thromboembolic ,events:4
thromboembolic ,sars-cov-2:2
thromboembolic ,infection:2
events ,patients:2
events ,infection:2
effects ,cocooning:2
effects ,rates:2
effects ,relaxing:2
cocooning ,coronavirus:2
cocooning ,disease:2
cocooning ,rates:2
cocooning ,relaxing:2
cocooning ,social:2
cocooning ,distancing:2
coronavirus ,rates:2
coronavirus ,relaxing:2
coronavirus ,social:6
coronavirus ,distancing:6
disease ,relaxing:2
disease ,distancing:6
rates ,relaxing:2
rates ,social:4
rates ,distancing:4
relaxing ,social:2
relaxing ,distancing:2
response ,classification:2
response ,cutaneous:2
response ,manifestations:2
classification ,cutaneous:2
classification ,manifestations:2
classification ,covid-19:4
cutaneous ,rapid:2
manifestations ,rapid:2
social ,network:2
social ,methods:2
social ,exploring:2
social ,contact:4
social ,tracing:2
network ,methods:2
network ,exploring:2
network ,contact:2
network ,tracing:2
network ,data:4
analysis ,methods:4
analysis ,contact:2
analysis ,tracing:2
methods ,exploring:2
methods ,contact:2
methods ,tracing:2
methods ,data:2
exploring ,contact:2
exploring ,tracing:2
exploring ,data:2
sars-cov-2 ,contact:6
contact ,data:2
tracing ,data:2
effects ,quarantine:4
effects ,mental:4
effects ,health:6
effects ,populations:2
effects ,affected:2
quarantine ,mental:2
quarantine ,populations:2
quarantine ,affected:2
mental ,populations:2
mental ,affected:2
health ,populations:2
populations ,affected:2
severe ,forms:2
fatal ,forms:2
fatal ,children:2
forms ,covid-19:2
forms ,children:2
inhibitors ,proteins:2
consensus ,study:2
consensus ,group:2
consensus ,point-of-care:2
consensus ,lung:2
consensus ,ultrasound:2
consensus ,intensive:2
study ,group:4
study ,point-of-care:2
study ,lung:4
study ,ultrasound:4
group ,point-of-care:2
group ,lung:2
group ,ultrasound:2
group ,intensive:2
group ,care:4
point-of-care ,intensive:2
point-of-care ,care:2
lung ,intensive:4
lung ,care:4
ultrasound ,intensive:4
ultrasound ,care:4
molecular ,epidemiological:2
molecular ,virus:2
epidemiological ,characterization:2
epidemiological ,virus:2
characterization ,virus:2
transmission ,terminal:2
transmission ,stages:2
transmission ,incubation:4
covid-19 ,terminal:4
covid-19 ,stages:6
terminal ,stages:2
terminal ,incubation:2
terminal ,period:2
terminal ,familial:2
stages ,incubation:2
stages ,period:2
stages ,familial:2
incubation ,familial:2
period ,familial:2
aeg-seed ,position:2
aeg-seed ,paper:2
aeg-seed ,resumption:2
aeg-seed ,endoscopic:2
aeg-seed ,activity:2
aeg-seed ,peak:2
position ,resumption:2
position ,endoscopic:2
position ,activity:2
position ,peak:2
paper ,resumption:2
paper ,endoscopic:2
paper ,activity:2
paper ,peak:2
resumption ,endoscopic:2
resumption ,activity:2
resumption ,peak:2
endoscopic ,activity:2
endoscopic ,peak:2
activity ,peak:2
coronavirus ,in-home:2
coronavirus ,room:2
coronavirus ,construction:2
disease ,in-home:2
disease ,isolation:2
disease ,room:2
disease ,construction:2
in-home ,isolation:2
in-home ,room:2
in-home ,construction:2
isolation ,room:2
isolation ,construction:2
room ,construction:2
temporal ,spreading:2
covid4rheum ,analytical:2
covid4rheum ,twitter:2
covid4rheum ,study:2
covid4rheum ,time:2
covid4rheum ,covid-19:2
covid4rheum ,pandemic:2
analytical ,twitter:2
analytical ,study:2
analytical ,time:2
twitter ,study:4
twitter ,time:2
twitter ,covid-19:4
twitter ,pandemic:2
study ,time:2
pooling ,samples:2
pooling ,increase:2
pooling ,throughput:2
sars-cov-2 ,increase:2
samples ,increase:2
samples ,testing:2
samples ,throughput:2
increase ,molecular:2
increase ,testing:2
increase ,throughput:2
molecular ,throughput:2
testing ,throughput:2
simulating ,social:2
simulating ,distancing:2
simulating ,measures:2
simulating ,household:2
simulating ,close:2
simulating ,contact:2
simulating ,transmission:2
social ,measures:8
social ,household:2
social ,close:2
social ,transmission:4
distancing ,measures:6
distancing ,household:2
distancing ,close:2
distancing ,contact:2
distancing ,transmission:4
measures ,household:2
measures ,close:2
measures ,contact:2
household ,close:2
household ,contact:2
discovering ,small-molecule:2
discovering ,therapeutics:2
discovering ,sars-cov-2:2
small-molecule ,therapeutics:2
small-molecule ,sars-cov-2:2
prediction ,model:2
prediction ,outcome:2
prediction ,pneumonia:2
prediction ,laboratory:2
prediction ,findings:2
model ,outcome:2
model ,pneumonia:2
model ,laboratory:4
model ,findings:2
outcome ,based:2
outcome ,laboratory:2
outcome ,findings:2
pneumonia ,based:2
pneumonia ,laboratory:4
based ,findings:2
cd45 ,critical:2
cd45 ,regulator:2
cd45 ,immune:2
cd45 ,cells:2
cd45 ,predict:2
cd45 ,severe:2
cd45 ,non-severe:2
cd45 ,covid-19:2
critical ,regulator:2
critical ,immune:4
critical ,cells:4
critical ,predict:2
critical ,non-severe:2
regulator ,immune:2
regulator ,cells:2
regulator ,predict:2
regulator ,severe:2
regulator ,non-severe:2
regulator ,covid-19:2
immune ,predict:2
immune ,non-severe:2
cells ,predict:2
cells ,non-severe:2
predict ,severe:4
predict ,non-severe:2
severe ,non-severe:2
non-severe ,covid-19:2
potential ,innate:2
potential ,evasion:2
potential ,sars-coronavirus:2
potential ,via:2
drugs ,early:2
drugs ,innate:2
drugs ,immune:2
drugs ,evasion:2
drugs ,sars-coronavirus:2
drugs ,via:2
targeting ,early:2
targeting ,evasion:2
targeting ,sars-coronavirus:2
targeting ,via:2
early ,innate:2
early ,evasion:2
early ,sars-coronavirus:2
early ,via:2
innate ,sars-coronavirus:2
innate ,via:2
immune ,sars-coronavirus:2
immune ,via:6
evasion ,sars-coronavirus:2
evasion ,via:2
sars-coronavirus ,via:2
sentiment ,analysis:2
sentiment ,emotion:2
sentiment ,understanding:2
sentiment ,covid-19:2
sentiment ,pandemic:2
sentiment ,spain:2
analysis ,emotion:2
analysis ,spain:2
emotion ,understanding:2
emotion ,covid-19:2
emotion ,pandemic:2
emotion ,spain:2
understanding ,spain:2
clinical ,disease-2019:4
course ,disease-2019:2
course ,pregnancy:2
disease-2019 ,pregnancy:2
communicate ,families:2
communicate ,patients:2
communicate ,complete:2
communicate ,isolation:2
families ,patients:2
families ,complete:2
families ,isolation:2
patients ,complete:2
complete ,isolation:2
immune ,addressing:2
immune ,pharmacological:2
immune ,challenge:2
response ,addressing:2
response ,pharmacological:2
addressing ,pharmacological:2
addressing ,challenge:2
addressing ,targeting:2
pharmacological ,challenge:2
challenge ,targeting:2
potential ,super:2
potential ,events:2
potential ,narrative:2
role ,super:2
role ,events:2
role ,narrative:2
super ,spread:2
super ,events:2
super ,sars-cov-2:2
super ,pandemic:2
super ,narrative:2
spread ,events:2
spread ,narrative:2
events ,pandemic:2
events ,narrative:2
rapid ,telehealth:2
rapid ,capabilities:2
rapid ,within:2
rapid ,pediatric:2
rapid ,portal:4
development ,telehealth:2
development ,capabilities:2
development ,within:2
development ,pediatric:2
development ,patient:2
development ,portal:2
telehealth ,capabilities:2
telehealth ,within:2
telehealth ,pediatric:2
telehealth ,patient:2
telehealth ,portal:2
capabilities ,within:2
capabilities ,pediatric:2
capabilities ,patient:2
capabilities ,portal:2
within ,pediatric:2
within ,patient:2
within ,portal:2
pediatric ,portal:2
patient ,portal:2
high-density ,amplicon:2
high-density ,sequencing:2
high-density ,identifies:2
high-density ,community:2
high-density ,spread:2
high-density ,ongoing:2
high-density ,evolution:2
amplicon ,sequencing:2
amplicon ,identifies:2
amplicon ,community:2
amplicon ,spread:2
amplicon ,ongoing:2
amplicon ,evolution:2
sequencing ,identifies:2
sequencing ,community:2
sequencing ,spread:2
sequencing ,ongoing:2
sequencing ,evolution:2
identifies ,community:2
identifies ,spread:2
identifies ,ongoing:2
identifies ,evolution:2
community ,ongoing:2
community ,evolution:2
spread ,ongoing:2
spread ,evolution:2
ongoing ,evolution:2
two ,known:2
two ,therapies:2
two ,useful:2
two ,adjuvant:2
two ,critical:2
known ,therapies:2
known ,useful:2
known ,adjuvant:2
known ,therapy:2
known ,critical:2
known ,patients:2
therapies ,useful:2
therapies ,adjuvant:2
therapies ,therapy:2
therapies ,critical:2
therapies ,patients:2
useful ,adjuvant:2
useful ,critical:2
useful ,patients:6
adjuvant ,critical:2
adjuvant ,patients:2
non-convulsive ,status:2
non-convulsive ,epilepticus:2
non-convulsive ,covid-19:2
non-convulsive ,clozapine:2
non-convulsive ,induced:2
status ,clozapine:2
status ,induced:2
epilepticus ,clozapine:2
epilepticus ,induced:2
covid-19 ,clozapine:2
clozapine ,induced:2
guideline ,homology:2
guideline ,modeling:2
guideline ,proteins:2
guideline ,newly:2
guideline ,discovered:2
homology ,modeling:2
homology ,proteins:2
homology ,newly:2
homology ,discovered:2
modeling ,proteins:2
modeling ,newly:2
modeling ,discovered:2
proteins ,newly:2
proteins ,discovered:2
newly ,discovered:2
oral ,patient:2
oral ,new:2
oral ,signs:2
oral ,secondary:2
oral ,manifestations:2
mucosal ,covid-19:2
mucosal ,patient:2
mucosal ,new:2
mucosal ,signs:2
mucosal ,secondary:2
mucosal ,manifestations:2
lesions ,patient:4
lesions ,new:2
lesions ,signs:2
lesions ,secondary:2
lesions ,manifestations:2
patient ,signs:2
patient ,secondary:2
new ,signs:2
new ,secondary:2
signs ,secondary:2
signs ,manifestations:2
secondary ,manifestations:2
path ,reopening:2
path ,surgery:4
path ,covid-19:4
path ,pandemic:2
path ,neurosurgery:2
path ,experience:2
reopening ,surgery:2
reopening ,pandemic:2
reopening ,neurosurgery:2
reopening ,experience:2
surgery ,neurosurgery:2
pandemic ,neurosurgery:2
neurosurgery ,experience:2
mortality ,systematic:2
mortality ,review:2
liaison ,respiratory:2
liaison ,failure:2
liaison ,high:2
liaison ,blood:2
liaison ,pressure:2
liaison ,evidence:2
respiratory ,pressure:2
failure ,blood:2
failure ,pressure:2
failure ,evidence:2
high ,pressure:2
high ,evidence:2
blood ,pressure:2
blood ,evidence:4
pressure ,evidence:2
whole ,targeted:2
whole ,drug:2
whole ,discovery:2
whole ,computational:2
whole ,methods:2
genome ,targeted:2
genome ,drug:2
genome ,discovery:2
genome ,using:4
genome ,computational:2
genome ,methods:2
analysis ,targeted:2
analysis ,drug:4
analysis ,discovery:2
targeted ,drug:4
targeted ,discovery:2
targeted ,using:2
targeted ,computational:2
targeted ,methods:2
drug ,methods:2
discovery ,computational:2
discovery ,methods:2
computational ,methods:2
cytokine ,leukocyte:2
cytokine ,changes:2
cytokine ,mild:2
cytokine ,versus:2
storm ,leukocyte:2
storm ,changes:2
storm ,mild:2
storm ,versus:2
leukocyte ,changes:2
leukocyte ,mild:2
leukocyte ,versus:2
leukocyte ,sars-cov-2:4
leukocyte ,infection:2
changes ,mild:4
changes ,versus:2
changes ,severe:4
case ,influenza:2
case ,louisiana:2
series ,coinfection:4
series ,influenza:2
series ,louisiana:2
coinfection ,louisiana:2
sars-cov-2 ,louisiana:2
influenza ,louisiana:2
virus ,louisiana:2
convalescent ,protocol:2
convalescent ,covid-:2
convalescent ,19:2
convalescent ,suffering:2
plasma ,protocol:2
plasma ,covid-:2
plasma ,19:2
plasma ,suffering:2
possible ,protocol:2
possible ,covid-:2
possible ,19:2
possible ,suffering:2
treatment ,protocol:2
treatment ,covid-:2
treatment ,19:2
treatment ,suffering:4
protocol ,covid-:2
protocol ,19:2
protocol ,suffering:2
covid- ,patients:2
covid- ,suffering:2
19 ,suffering:2
acute ,pericarditis:4
pericarditis ,severe:2
pericarditis ,respiratory:2
pericarditis ,syndrome:2
pericarditis ,coronavirus:2
pericarditis ,case:2
pericarditis ,report:2
lions ,tigers:4
lions ,kittens:2
lions ,ace2:2
lions ,susceptibility:2
lions ,covid-19:2
tigers ,kittens:2
tigers ,ace2:2
tigers ,susceptibility:2
tigers ,covid-19:2
kittens ,ace2:2
kittens ,susceptibility:2
kittens ,covid-19:2
dermatological ,diseases:2
dermatological ,presented:2
dermatological ,patients:4
dermatological ,psoriasis:2
diseases ,presented:2
diseases ,psoriasis:2
presented ,covid-19:4
presented ,patients:2
presented ,psoriasis:2
patients ,psoriasis:2
kawasaki ,shock:2
kawasaki ,syndrome:2
kawasaki ,kawasaki-like:4
kawasaki ,pediatric:2
kawasaki ,inflammatory:2
shock ,syndrome:4
shock ,kawasaki-like:2
shock ,disease:2
shock ,pediatric:4
kawasaki-like ,pediatric:2
kawasaki-like ,inflammatory:2
amiodarone ,era:2
amiodarone ,treatment:2
amiodarone ,symptomatic:2
amiodarone ,patients:2
amiodarone ,drug:2
era ,treatment:2
era ,symptomatic:2
era ,drug:2
symptomatic ,drug:2
patients ,drug:2
virtual ,admetox:2
virtual ,predictions:2
virtual ,concept:2
virtual ,future:2
screening ,admetox:2
screening ,predictions:2
screening ,concept:2
screening ,future:2
admetox ,predictions:2
admetox ,drug:2
admetox ,repurposing:2
admetox ,concept:2
admetox ,future:2
predictions ,drug:2
predictions ,repurposing:2
predictions ,concept:2
predictions ,future:2
drug ,concept:2
drug ,future:2
repurposing ,concept:2
repurposing ,future:2
concept ,future:2
report ,nurses:2
report ,infected:2
five ,nurses:2
five ,infected:2
five ,severe:2
five ,acute:2
five ,respiratory:2
five ,syndrome:2
five ,coronavirus:2
nurses ,infected:2
nurses ,severe:2
nurses ,acute:2
nurses ,respiratory:2
nurses ,syndrome:2
nurses ,coronavirus:2
covid-2019 ,comprehensive:2
covid-2019 ,pathology:2
covid-2019 ,insight:2
comprehensive ,pathology:2
comprehensive ,insight:2
pathology ,insight:2
morning ,vs:2
morning ,evening:2
morning ,administration:2
morning ,antiviral:2
morning ,therapy:2
morning ,covid-19:2
morning ,patients:2
vs ,evening:2
vs ,administration:2
vs ,antiviral:2
vs ,therapy:2
evening ,administration:2
evening ,antiviral:2
evening ,therapy:2
evening ,covid-19:2
evening ,patients:2
administration ,antiviral:2
administration ,therapy:2
administration ,patients:2
genetic ,influencing:2
genetic ,coronavirus-associated:2
genetic ,phenotypes:2
variants ,human:2
variants ,host:4
variants ,influencing:2
variants ,coronavirus-associated:2
variants ,phenotypes:2
human ,host:4
human ,influencing:2
human ,coronavirus-associated:2
human ,phenotypes:2
host ,influencing:2
host ,coronavirus-associated:2
host ,phenotypes:2
influencing ,coronavirus-associated:2
influencing ,phenotypes:2
coronavirus-associated ,phenotypes:2
brief ,clinical:2
brief ,evaluation:2
brief ,six:2
brief ,high-throughput:2
brief ,igg:2
brief ,antibody:2
brief ,assays:2
clinical ,six:2
clinical ,high-throughput:2
clinical ,igg:4
six ,high-throughput:2
six ,igg:2
six ,assays:2
high-throughput ,igg:2
high-throughput ,antibody:2
high-throughput ,assays:4
scientific ,overview:2
tracheal ,stenosis:4
tracheal ,tracheostomy:2
tracheal ,mechanical:2
tracheal ,ventilation:2
tracheal ,covid-19:2
stenosis ,tracheostomy:2
stenosis ,mechanical:2
stenosis ,ventilation:2
stenosis ,covid-19:2
tracheostomy ,mechanical:4
tracheostomy ,ventilation:4
active ,implications:2
active ,dermatologists:2
active ,sars-cov-2:4
active ,era:2
active ,personal:2
active ,experience:2
implications ,dermatologists:2
implications ,era:2
implications ,personal:4
implications ,experience:2
dermatologists ,sars-cov-2:2
dermatologists ,era:2
dermatologists ,personal:2
dermatologists ,experience:2
era ,personal:2
era ,experience:2
personal ,experience:2
myocardial ,localization:2
myocardial ,cardiogenic:2
myocardial ,shock:2
localization ,coronavirus:2
localization ,covid-19:4
localization ,cardiogenic:2
localization ,shock:2
coronavirus ,cardiogenic:2
coronavirus ,shock:2
covid-19 ,cardiogenic:2
covid-19 ,shock:6
cardiogenic ,shock:4
development ,simulation:2
development ,glycosylated:2
development ,models:2
development ,ace2-fc:2
development ,fusion:2
simulation ,fully:2
simulation ,glycosylated:2
simulation ,molecular:4
simulation ,models:2
simulation ,ace2-fc:2
simulation ,fusion:2
fully ,glycosylated:2
fully ,molecular:2
fully ,models:2
fully ,ace2-fc:2
fully ,fusion:2
glycosylated ,molecular:2
glycosylated ,models:2
glycosylated ,ace2-fc:2
glycosylated ,fusion:2
molecular ,ace2-fc:2
molecular ,fusion:2
models ,ace2-fc:2
models ,fusion:2
ace2-fc ,fusion:2
time ,scale:2
time ,resolution:2
time ,olfactory:4
time ,dysfunction:4
scale ,resolution:2
scale ,olfactory:2
scale ,dysfunction:2
scale ,covid-19:2
resolution ,olfactory:2
resolution ,dysfunction:2
resolution ,covid-19:2
repurposing ,quaternary:2
repurposing ,ammonium:2
repurposing ,compounds:2
repurposing ,treatments:2
quaternary ,ammonium:4
quaternary ,compounds:4
quaternary ,potential:2
quaternary ,treatments:2
quaternary ,covid-19:2
ammonium ,compounds:4
ammonium ,potential:2
ammonium ,treatments:2
ammonium ,covid-19:2
compounds ,treatments:2
self-reported ,alteration:2
self-reported ,sense:2
self-reported ,patients:2
self-reported ,covid-19:6
alteration ,sense:2
alteration ,smell:2
alteration ,patients:4
alteration ,covid-19:4
sense ,patients:2
sense ,covid-19:6
case ,chilblains-like:2
case ,toes:2
report ,chilblains-like:2
report ,toes:2
chilblains-like ,lesions:2
chilblains-like ,covid-19:2
chilblains-like ,toes:2
chilblains-like ,pandemic:2
prolonged ,presence:4
prolonged ,nucleic:4
prolonged ,acid:4
prolonged ,clinically:2
prolonged ,recovered:2
presence ,nucleic:2
presence ,acid:2
presence ,clinically:2
viral ,clinically:2
nucleic ,clinically:2
nucleic ,recovered:2
acid ,clinically:2
acid ,recovered:2
clinically ,recovered:2
home ,medical:2
home ,nutrition:4
home ,sars-cov-2:8
home ,pandemic:2
home ,position:2
home ,paper:2
medical ,nutrition:2
medical ,position:2
medical ,paper:2
nutrition ,sars-cov-2:4
nutrition ,pandemic:2
nutrition ,position:2
nutrition ,paper:2
sars-cov-2 ,paper:2
pandemic ,position:4
pandemic ,paper:2
prospective ,clinical:6
prospective ,pilot:2
prospective ,effects:4
prospective ,hydrogen:2
prospective ,peroxide:2
prospective ,mouthrinse:2
clinical ,pilot:2
clinical ,hydrogen:2
clinical ,peroxide:2
clinical ,mouthrinse:2
pilot ,effects:2
pilot ,hydrogen:2
pilot ,peroxide:2
pilot ,mouthrinse:2
study ,hydrogen:2
study ,peroxide:2
study ,mouthrinse:2
effects ,hydrogen:2
effects ,peroxide:2
effects ,mouthrinse:2
hydrogen ,peroxide:4
hydrogen ,mouthrinse:2
peroxide ,mouthrinse:2
preliminary ,india:2
report ,india:2
children ,india:2
antiviral ,options:2
diagnosis ,severe:6
diagnosis ,acute:6
diagnosis ,syndrome:4
management ,syndrome:4
immediate ,impact:2
immediate ,transplant:2
immediate ,activity:2
immediate ,netherlands:2
impact ,transplant:2
impact ,activity:2
impact ,netherlands:2
covid-19 ,netherlands:6
transplant ,activity:2
transplant ,netherlands:2
activity ,netherlands:2
sars-cov-2 ,novaferon:2
sars-cov-2 ,randomized:2
clearance ,patients:2
clearance ,novaferon:2
clearance ,treatment:2
clearance ,randomized:2
covid-19 ,novaferon:2
covid-19 ,randomized:2
patients ,novaferon:2
patients ,randomized:2
novaferon ,treatment:2
novaferon ,randomized:2
treatment ,randomized:2
first ,national:4
results ,national:4
national ,external:2
national ,quality:2
national ,assessment:2
national ,scheme:2
national ,detection:2
scheme ,detection:2
development ,transcription-loop-mediated:2
reverse ,transcription-loop-mediated:2
transcription-loop-mediated ,isothermal:2
transcription-loop-mediated ,amplification:2
cardiovascular ,therapeutic:2
implications ,therapeutic:2
implications ,considerations:2
therapeutic ,considerations:2
ai-aided ,design:2
ai-aided ,novel:2
ai-aided ,targeted:2
ai-aided ,covalent:2
ai-aided ,inhibitors:2
ai-aided ,sars-cov-2:2
design ,targeted:2
design ,covalent:2
novel ,targeted:2
novel ,covalent:2
targeted ,covalent:2
targeted ,inhibitors:2
covalent ,inhibitors:4
covalent ,sars-cov-2:4
similarities ,differences:6
similarities ,early:2
similarities ,pulmonary:2
similarities ,ct:2
similarities ,features:2
similarities ,pneumonia:2
similarities ,caused:2
differences ,early:2
differences ,ct:2
differences ,pneumonia:2
differences ,caused:2
early ,features:2
early ,pneumonia:6
early ,caused:2
pulmonary ,ct:4
pulmonary ,features:2
pulmonary ,caused:2
ct ,caused:2
features ,caused:2
sars-cov-2 ,minks:2
sars-cov-2 ,netherlands:2
infection ,farmed:2
infection ,minks:2
infection ,netherlands:2
farmed ,minks:2
farmed ,netherlands:2
farmed ,april:2
farmed ,may:2
minks ,netherlands:2
minks ,april:2
minks ,may:2
netherlands ,april:2
netherlands ,may:2
april ,may:2
clinical ,correlated:2
clinical ,status:4
course ,correlated:2
course ,immune:4
course ,status:2
correlated ,status:2
correlated ,covid-19:2
correlated ,pneumonia:2
immune ,status:4
status ,pneumonia:2
comprehensive ,cutaneous:2
comprehensive ,associated:2
review ,cutaneous:4
cutaneous ,associated:2
prevention ,solid:2
prevention ,tumors:2
control ,solid:2
control ,tumors:2
strategies ,solid:2
strategies ,tumors:2
diagnosis ,solid:2
diagnosis ,tumors:2
treatment ,solid:2
treatment ,tumors:2
solid ,tumors:2
sars-cov-2 ,replacement:2
infection ,replacement:2
patients ,renal:8
patients ,replacement:6
renal ,replacement:4
renal ,therapy:4
renal ,report:4
replacement ,therapy:6
replacement ,report:2
therapy ,report:2
birth ,infant:2
birth ,outcomes:4
birth ,following:2
birth ,laboratory-confirmed:2
infant ,following:2
infant ,laboratory-confirmed:2
outcomes ,following:2
outcomes ,laboratory-confirmed:2
following ,laboratory-confirmed:2
laboratory-confirmed ,sars-cov-2:6
laboratory-confirmed ,infection:2
evaluation ,breast:2
evaluation ,milk:2
evaluation ,18:2
evaluation ,infected:2
evaluation ,women:2
sars-cov-2 ,18:2
breast ,18:2
breast ,infected:2
breast ,women:2
milk ,18:2
milk ,infected:2
milk ,women:2
18 ,infected:2
18 ,women:2
marine ,predators:2
marine ,algorithm:2
marine ,forecasting:2
marine ,confirmed:2
marine ,cases:2
marine ,covid-19:4
marine ,italy:2
predators ,algorithm:2
predators ,forecasting:2
predators ,confirmed:2
predators ,cases:2
predators ,covid-19:2
predators ,italy:2
algorithm ,forecasting:2
algorithm ,confirmed:2
algorithm ,cases:2
algorithm ,covid-19:4
algorithm ,italy:2
forecasting ,italy:2
confirmed ,italy:2
antithrombotic ,treatments:2
antithrombotic ,patients:4
antithrombotic ,sars-cov-2:2
antithrombotic ,infection:2
antithrombotic ,current:2
treatments ,patients:2
dangerous ,pathogens:2
dangerous ,potential:2
dangerous ,problem:2
dangerous ,public:2
dangerous ,health:2
pathogens ,problem:2
pathogens ,public:2
pathogens ,health:2
potential ,problem:2
potential ,public:4
potential ,health:4
problem ,public:2
problem ,health:2
epitope-based ,peptide:2
epitope-based ,predicted:2
epitope-based ,novel:4
epitope-based ,coronavirus:2
epitope-based ,disease:2
epitope-based ,caused:2
peptide ,vaccines:2
peptide ,predicted:2
peptide ,novel:2
peptide ,coronavirus:4
peptide ,disease:2
peptide ,caused:2
vaccines ,predicted:2
vaccines ,caused:2
predicted ,novel:2
predicted ,coronavirus:4
predicted ,disease:2
predicted ,caused:2
novel ,caused:2
abdominal ,wall:2
abdominal ,surgery:2
abdominal ,time:2
abdominal ,reestablish:2
abdominal ,postponed:2
wall ,surgery:2
wall ,sars-cov-2:2
wall ,time:2
wall ,reestablish:2
wall ,postponed:2
surgery ,time:2
surgery ,reestablish:2
surgery ,postponed:2
sars-cov-2 ,reestablish:2
sars-cov-2 ,postponed:2
time ,reestablish:2
time ,postponed:2
reestablish ,postponed:2
understanding ,sars-cov-2-mediated:2
understanding ,inflammatory:4
understanding ,mechanisms:2
sars-cov-2-mediated ,responses:2
sars-cov-2-mediated ,mechanisms:2
inflammatory ,responses:6
inflammatory ,mechanisms:2
responses ,mechanisms:2
healthcare ,mexico:2
workers ,mexico:2
anti-inflammatory ,roles:2
anti-inflammatory ,hydrogen:2
anti-inflammatory ,sulfide:2
anti-inflammatory ,rationale:2
anti-inflammatory ,considering:2
antiviral ,roles:2
antiviral ,hydrogen:2
antiviral ,sulfide:2
antiviral ,rationale:2
antiviral ,considering:2
roles ,hydrogen:2
roles ,sulfide:2
roles ,rationale:2
roles ,considering:2
hydrogen ,sulfide:4
hydrogen ,rationale:2
hydrogen ,considering:2
sulfide ,rationale:2
sulfide ,considering:2
rationale ,considering:2
antibody ,primary-:2
antibody ,secondary-care:2
antibody ,physicians:2
antibody ,moderate:2
kinetics ,primary-:2
kinetics ,secondary-care:2
kinetics ,physicians:2
kinetics ,moderate:2
primary- ,secondary-care:2
primary- ,physicians:2
primary- ,mild:2
primary- ,moderate:2
secondary-care ,physicians:2
secondary-care ,mild:2
secondary-care ,moderate:2
physicians ,mild:2
physicians ,moderate:2
sars-cov-2 ,spanish:4
sars-cov-2 ,15-day:2
spanish ,intensive:2
spanish ,care:2
spanish ,units:2
spanish ,early:2
spanish ,experience:2
spanish ,15-day:2
spanish ,survival:2
intensive ,experience:4
intensive ,15-day:2
intensive ,survival:2
care ,15-day:2
care ,survival:2
units ,early:2
units ,experience:2
units ,15-day:2
units ,survival:2
early ,15-day:2
experience ,15-day:2
experience ,survival:2
15-day ,survival:2
weakly-supervised ,framework:2
weakly-supervised ,covid-19:2
weakly-supervised ,classification:2
weakly-supervised ,lesion:2
weakly-supervised ,localization:2
framework ,classification:2
framework ,lesion:2
framework ,localization:2
covid-19 ,lesion:4
classification ,lesion:2
classification ,localization:2
lesion ,localization:2
covid-19 ,preterm:2
covid-19 ,birth:6
infection ,women:2
infection ,delivery:8
infection ,weight:2
pregnant ,birth:4
pregnant ,weight:2
women ,preterm:2
women ,birth:4
women ,weight:2
preterm ,weight:2
delivery ,birth:2
delivery ,weight:2
delivery ,vertical:2
birth ,weight:2
weight ,vertical:2
primum ,sars-cov-2:2
primum ,pandemic:2
primum ,course:2
primum ,oldest:2
non ,sars-cov-2:2
non ,pandemic:2
non ,course:2
non ,oldest:2
nocere ,sars-cov-2:2
nocere ,pandemic:2
nocere ,course:2
nocere ,oldest:2
sars-cov-2 ,oldest:2
pandemic ,course:6
pandemic ,oldest:2
course ,oldest:2
sars-cov-2 ,orf1b:2
sars-cov-2 ,ntng1:2
orf1b ,gene:2
orf1b ,sequence:2
orf1b ,ntng1:2
orf1b ,human:2
orf1b ,chromosome:2
gene ,sequence:2
gene ,ntng1:2
gene ,chromosome:2
sequence ,ntng1:2
sequence ,chromosome:2
ntng1 ,human:2
ntng1 ,chromosome:2
human ,chromosome:2
diabetes ,prolonged:2
diabetes ,viral:2
diabetes ,shedding:2
diabetes ,lower:2
mellitus ,prolonged:2
mellitus ,viral:2
mellitus ,shedding:2
mellitus ,lower:2
risk ,prolonged:2
risk ,shedding:4
risk ,lower:6
factor ,prolonged:2
factor ,viral:2
factor ,shedding:2
factor ,lower:2
prolonged ,lower:2
shedding ,lower:2
false ,negative:2
false ,rt-pcr:2
false ,prolonged:2
false ,nucleic:2
false ,acid:2
false ,conversion:2
false ,covid-19:2
false ,rather:2
negative ,rt-pcr:6
negative ,prolonged:2
negative ,rather:2
rt-pcr ,prolonged:2
rt-pcr ,nucleic:2
rt-pcr ,acid:2
rt-pcr ,conversion:2
rt-pcr ,rather:2
prolonged ,conversion:2
prolonged ,rather:2
nucleic ,conversion:2
nucleic ,rather:2
acid ,conversion:2
acid ,rather:2
conversion ,covid-19:2
conversion ,rather:2
covid-19 ,rather:2
clinical ,evidences:2
clinical ,macrolide:2
clinical ,antibiotics:2
evidences ,antiviral:2
evidences ,properties:2
evidences ,macrolide:2
evidences ,antibiotics:2
antiviral ,macrolide:2
antiviral ,antibiotics:2
properties ,macrolide:2
properties ,antibiotics:2
macrolide ,antibiotics:2
seasonal ,activity:2
seasonal ,japan:2
influenza ,japan:2
activity ,japan:2
95-year-old ,patientwith:2
95-year-old ,unexpected:2
95-year-old ,coronavirus:2
95-year-old ,disease:2
95-year-old ,masked:2
95-year-old ,aspiration:2
patientwith ,unexpected:2
patientwith ,coronavirus:2
patientwith ,disease:2
patientwith ,masked:2
patientwith ,aspiration:2
unexpected ,masked:2
unexpected ,aspiration:2
coronavirus ,masked:2
coronavirus ,aspiration:2
disease ,masked:2
disease ,aspiration:2
masked ,aspiration:2
time ,length:2
time ,negativization:2
time ,cycle:2
time ,threshold:2
time ,values:2
time ,182:2
time ,healthcare:2
length ,negativization:2
length ,cycle:2
length ,threshold:2
length ,values:2
length ,182:2
length ,healthcare:2
length ,workers:2
negativization ,cycle:2
negativization ,threshold:2
negativization ,values:2
negativization ,182:2
negativization ,healthcare:2
negativization ,workers:2
cycle ,182:2
cycle ,healthcare:2
cycle ,workers:2
threshold ,182:2
threshold ,healthcare:2
threshold ,workers:2
values ,182:2
values ,healthcare:2
values ,workers:2
182 ,healthcare:2
182 ,workers:2
pancreatic ,injury:2
pancreatic ,patients:4
identificadas ,las:2
identificadas ,principales:2
identificadas ,manifestaciones:2
identificadas ,en:2
identificadas ,la:2
identificadas ,piel:2
identificadas ,de:2
identificadas ,covid-19:2
las ,principales:2
las ,manifestaciones:2
las ,en:2
las ,la:2
las ,piel:2
las ,de:2
las ,covid-19:2
principales ,manifestaciones:2
principales ,en:2
principales ,la:2
principales ,piel:2
principales ,de:2
principales ,covid-19:2
manifestaciones ,en:2
manifestaciones ,la:2
manifestaciones ,piel:2
manifestaciones ,de:2
manifestaciones ,covid-19:2
en ,la:2
en ,piel:2
en ,de:2
en ,covid-19:2
la ,piel:2
la ,de:2
la ,covid-19:2
piel ,de:2
piel ,covid-19:2
challenges ,opportunities:6
challenges ,biotechnology:2
challenges ,research:2
challenges ,community:2
opportunities ,biotechnology:2
opportunities ,research:2
opportunities ,community:2
biotechnology ,research:2
biotechnology ,community:2
research ,community:2
successful ,recurrence:2
successful ,positive:2
successful ,rna:2
recovery ,recurrence:2
recovery ,positive:2
endoscopic ,nasopharyngoscopy:2
endoscopic ,ent:2
endoscopic ,specialist:2
endoscopic ,safety:2
endoscopic ,covid:2
endoscopic ,19:2
endoscopic ,era:2
endoscopic ,back:2
nasopharyngoscopy ,ent:2
nasopharyngoscopy ,specialist:2
nasopharyngoscopy ,safety:2
nasopharyngoscopy ,covid:2
nasopharyngoscopy ,19:2
nasopharyngoscopy ,era:2
nasopharyngoscopy ,back:2
ent ,specialist:2
ent ,safety:2
ent ,covid:2
ent ,19:2
ent ,era:2
ent ,back:2
specialist ,safety:2
specialist ,covid:2
specialist ,19:2
specialist ,era:2
specialist ,back:2
safety ,covid:2
safety ,19:2
safety ,era:2
safety ,back:2
covid ,era:2
covid ,back:2
19 ,era:2
19 ,back:2
era ,back:2
national ,clinical:2
national ,guidance:2
national ,management:2
national ,cardiovascular:2
national ,intervention:2
guidance ,cardiovascular:2
guidance ,intervention:2
management ,intervention:2
cardiovascular ,intervention:2
covid-19 ,spreads:2
spreads ,within:2
spreads ,infected:2
spreads ,hosts:2
spreads ,know:2
spreads ,far:2
within ,infected:2
within ,hosts:2
within ,know:2
within ,far:2
infected ,hosts:2
infected ,know:2
infected ,far:2
hosts ,know:2
hosts ,far:2
convalescent ,tempering:2
convalescent ,expectations:2
plasma ,tempering:2
plasma ,expectations:2
treatment ,tempering:2
treatment ,expectations:2
covid-19 ,tempering:2
covid-19 ,expectations:2
tempering ,expectations:2
helping ,couples:2
helping ,shadow:2
helping ,covid-19:2
couples ,shadow:2
couples ,covid-19:2
shadow ,covid-19:2
-glucosidase ,inhibitors:2
-glucosidase ,host-directed:2
-glucosidase ,antiviral:2
-glucosidase ,agents:2
-glucosidase ,potential:2
inhibitors ,host-directed:2
inhibitors ,agents:2
host-directed ,antiviral:4
host-directed ,agents:2
covid-19 ,ventilatory:2
covid-19 ,phenotypes:2
ventilatory ,phenotypes:2
ventilatory ,obesity:2
ventilatory ,relationship:2
phenotypes ,obesity:2
phenotypes ,relationship:2
obesity ,relationship:2
therapeutic ,chloroquine:2
therapeutic ,hydroxychloroquine:2
use ,viral:4
chloroquine ,viral:2
hydroxychloroquine ,viral:2
asymptomatic ,20:2
sars-cov-2 ,20:2
infection ,20:2
children ,20:2
clinical ,20:2
analysis ,20:4
20 ,cases:2
current ,guidance:2
current ,german:2
current ,society:2
current ,rheumatology:2
current ,care:4
guidance ,german:2
guidance ,rheumatology:2
german ,society:4
german ,rheumatology:4
german ,care:2
german ,patients:4
society ,rheumatology:4
society ,patients:4
rheumatology ,care:2
rheumatology ,patients:4
endogenous ,deficiency:2
endogenous ,glutathione:2
endogenous ,likely:2
endogenous ,cause:2
endogenous ,serious:2
deficiency ,glutathione:2
deficiency ,likely:2
deficiency ,cause:2
deficiency ,serious:2
glutathione ,likely:2
glutathione ,cause:2
glutathione ,serious:2
likely ,cause:2
likely ,serious:2
cause ,serious:2
comprehensive ,flexible:2
comprehensive ,collection:2
comprehensive ,coding:2
comprehensive ,regions:2
flexible ,collection:2
flexible ,coding:2
flexible ,regions:2
collection ,coding:2
collection ,regions:2
sars-cov-2 ,regions:2
coding ,regions:2
enzyme-linked ,immunosorbent:4
enzyme-linked ,assay:2
enzyme-linked ,detection:2
enzyme-linked ,severe:2
enzyme-linked ,acute:2
enzyme-linked ,respiratory:2
immunosorbent ,assay:2
immunosorbent ,severe:2
immunosorbent ,acute:2
immunosorbent ,respiratory:2
antimicrobial ,nanomaterials:2
antimicrobial ,coatings:2
antimicrobial ,current:2
antimicrobial ,mechanisms:2
antimicrobial ,future:2
antimicrobial ,perspectives:2
nanomaterials ,coatings:2
nanomaterials ,current:2
nanomaterials ,mechanisms:2
nanomaterials ,future:2
nanomaterials ,perspectives:2
coatings ,current:2
coatings ,mechanisms:2
coatings ,future:2
coatings ,perspectives:2
mechanisms ,future:2
multimodality ,pneumonia:2
multimodality ,diagnosis:2
multimodality ,follow-up:2
imaging ,diagnosis:2
imaging ,follow-up:4
pneumonia ,follow-up:4
diagnosis ,follow-up:2
implications ,colombia:2
sars-cov-2 ,colombia:2
incretin-based ,therapies:2
incretin-based ,role:2
incretin-based ,covid-19:2
incretin-based ,era:2
incretin-based ,evolving:2
incretin-based ,insights:2
therapies ,role:2
therapies ,era:2
therapies ,evolving:2
role ,era:2
role ,evolving:2
role ,insights:2
era ,evolving:2
era ,insights:2
evolving ,insights:2
knowledge ,sudanese:2
knowledge ,residents:2
attitudes ,sudanese:2
attitudes ,residents:2
practices ,sudanese:2
practices ,residents:2
sudanese ,residents:2
sudanese ,towards:2
sudanese ,covid-19:2
residents ,towards:2
epidemiology ,caused:2
seroprevalence ,among:16
seroprevalence ,pregnant:2
seroprevalence ,women:2
seroprevalence ,estonia:2
seroprevalence ,call:2
sars-cov-2 ,estonia:2
sars-cov-2 ,call:4
antibodies ,pregnant:2
antibodies ,estonia:2
antibodies ,call:2
among ,estonia:2
among ,call:2
pregnant ,estonia:2
pregnant ,call:2
women ,estonia:2
women ,call:2
estonia ,call:2
infectivity ,respiratory:4
infectivity ,syndrome:4
ischemic ,necrosis:2
ischemic ,lower:2
ischemic ,extremity:2
ischemic ,case:4
ischemic ,report:2
necrosis ,lower:2
necrosis ,extremity:2
necrosis ,covid-19:2
necrosis ,case:2
necrosis ,report:2
lower ,case:4
lower ,report:2
extremity ,case:2
extremity ,report:2
perspective ,erythropoietin:2
perspective ,adjuvant:2
perspective ,therapy:2
perspective ,acute:4
perspective ,lung:2
erythropoietin ,potential:2
erythropoietin ,adjuvant:2
erythropoietin ,therapy:2
erythropoietin ,acute:2
erythropoietin ,lung:2
adjuvant ,acute:2
adjuvant ,lung:2
therapy ,lung:4
molecular ,noscapine:2
binding ,mechanism:4
binding ,pharmacology:2
binding ,noscapine:2
mechanism ,pharmacology:2
mechanism ,comparative:2
mechanism ,analysis:4
mechanism ,noscapine:2
pharmacology ,comparative:2
pharmacology ,noscapine:2
comparative ,noscapine:2
analysis ,noscapine:2
prognostic ,nt-probnp:2
prognostic ,patients:8
prognostic ,severe:4
value ,nt-probnp:2
value ,patients:4
value ,severe:2
nt-probnp ,patients:2
nt-probnp ,severe:2
nt-probnp ,covid-19:2
ivermectin ,broad-spectrum:2
ivermectin ,host-directed:2
ivermectin ,real:2
ivermectin ,deal:2
broad-spectrum ,host-directed:2
broad-spectrum ,antiviral:2
broad-spectrum ,real:2
broad-spectrum ,deal:2
host-directed ,real:2
host-directed ,deal:2
antiviral ,real:2
antiviral ,deal:2
real ,deal:2
computational ,insights:2
computational ,tetracyclines:2
computational ,mpro:2
insights ,tetracyclines:2
insights ,mpro:2
tetracyclines ,inhibitors:2
tetracyclines ,sars-cov-2:2
tetracyclines ,mpro:2
inhibitors ,mpro:4
transmission ,australian:2
transmission ,educational:2
transmission ,cohort:2
sars-cov-2 ,australian:2
sars-cov-2 ,educational:2
australian ,educational:2
australian ,settings:2
australian ,prospective:2
australian ,cohort:2
educational ,settings:2
educational ,prospective:2
educational ,cohort:2
settings ,prospective:2
settings ,cohort:2
dual-functional ,plasmonic:2
dual-functional ,photothermal:2
dual-functional ,biosensors:2
dual-functional ,highly:2
dual-functional ,accurate:2
dual-functional ,severe:2
dual-functional ,acute:2
plasmonic ,photothermal:2
plasmonic ,biosensors:2
plasmonic ,highly:2
plasmonic ,accurate:2
plasmonic ,severe:2
plasmonic ,acute:2
photothermal ,biosensors:2
photothermal ,highly:2
photothermal ,accurate:2
photothermal ,severe:2
photothermal ,acute:2
biosensors ,highly:2
biosensors ,accurate:2
biosensors ,severe:2
biosensors ,acute:2
highly ,accurate:2
highly ,severe:2
accurate ,severe:2
accurate ,acute:2
cutaneous ,experiences:2
cutaneous ,barcelona:2
cutaneous ,rome:2
manifestations ,experiences:2
manifestations ,barcelona:2
manifestations ,rome:2
covid-19 ,barcelona:2
covid-19 ,rome:2
experiences ,barcelona:2
experiences ,rome:2
barcelona ,rome:2
saliva ,severe:2
saliva ,acute:2
saliva ,syndrome:2
specimens ,severe:2
specimens ,acute:2
specimens ,syndrome:2
diet ,supplementation:2
diet ,nutraceuticals:2
diet ,sars-cov-2:2
diet ,infection:2
supplementation ,probiotics:2
supplementation ,nutraceuticals:2
supplementation ,sars-cov-2:2
supplementation ,infection:2
probiotics ,nutraceuticals:2
probiotics ,sars-cov-2:2
probiotics ,infection:2
nutraceuticals ,sars-cov-2:2
nutraceuticals ,infection:2
codon ,bias:2
codon ,may:2
codon ,insufficient:2
codon ,identifying:2
codon ,hosts:2
codon ,novel:2
bias ,analysis:2
bias ,may:2
bias ,insufficient:2
bias ,identifying:2
bias ,hosts:2
bias ,novel:2
bias ,virus:2
analysis ,may:2
analysis ,insufficient:2
analysis ,identifying:2
may ,insufficient:2
may ,identifying:2
may ,hosts:2
insufficient ,identifying:2
insufficient ,hosts:2
insufficient ,novel:2
insufficient ,virus:2
identifying ,hosts:2
identifying ,novel:2
identifying ,virus:2
hosts ,virus:2
increased ,incidence:4
increased ,morbidity:4
increased ,mortality:4
increased ,human:2
increased ,nl63:2
incidence ,morbidity:2
incidence ,human:2
incidence ,nl63:2
morbidity ,human:2
morbidity ,coronavirus:2
morbidity ,nl63:2
morbidity ,associated:2
mortality ,human:2
mortality ,nl63:2
human ,nl63:2
coronavirus ,nl63:2
nl63 ,associated:2
pathogenesis ,polymorphism:2
pathogenesis ,features:2
pathogenesis ,laboratory:2
genetic ,polymorphism:2
genetic ,features:2
genetic ,laboratory:2
polymorphism ,clinical:2
polymorphism ,features:2
polymorphism ,laboratory:2
recommendations ,spanish:2
recommendations ,association:2
recommendations ,neurogastroenterology:2
recommendations ,motility:2
spanish ,association:2
spanish ,neurogastroenterology:2
spanish ,motility:2
association ,neurogastroenterology:2
association ,motility:2
neurogastroenterology ,motility:2
measuring ,sars-cov-2:2
measuring ,neutralizing:2
measuring ,antibody:2
measuring ,activity:2
measuring ,using:2
measuring ,pseudotyped:2
measuring ,chimeric:2
sars-cov-2 ,pseudotyped:2
neutralizing ,activity:2
neutralizing ,pseudotyped:2
neutralizing ,chimeric:2
antibody ,activity:4
antibody ,pseudotyped:2
antibody ,chimeric:2
activity ,using:2
activity ,pseudotyped:2
activity ,chimeric:2
using ,pseudotyped:2
using ,chimeric:2
pseudotyped ,chimeric:2
lactoferrin ,review:2
case ,compartment:2
report ,compartment:2
treatment ,compartment:2
compartment ,syndrome:2
compartment ,novel:2
compartment ,coronavirus:2
analytical ,lateral:2
analytical ,flow:2
analytical ,exposure:2
analytical ,screening:2
performance ,lateral:2
performance ,flow:2
performance ,exposure:2
performance ,screening:2
lateral ,exposure:2
lateral ,screening:2
flow ,exposure:2
flow ,screening:2
immunoassay ,exposure:2
immunoassay ,screening:2
exposure ,screening:2
sars-cov-2 ,also:2
sars-cov-2 ,enteric:2
also ,enteric:2
also ,pathogen:2
also ,potential:2
also ,fecal-oral:2
also ,transmission:2
enteric ,pathogen:2
enteric ,potential:2
enteric ,fecal-oral:4
enteric ,transmission:2
pathogen ,fecal-oral:2
pathogen ,transmission:2
potential ,fecal-oral:2
traditional ,potential:4
current ,urology:2
current ,spain:2
situation ,urology:2
situation ,practice:2
situation ,spain:2
urology ,practice:2
urology ,spain:2
urology ,pandemic:4
practice ,spain:2
masked ,education:2
masked ,benefits:2
masked ,burdens:2
masked ,wearing:2
masked ,face:2
masked ,masks:2
masked ,schools:2
education ,benefits:2
education ,burdens:2
education ,wearing:2
education ,face:2
education ,masks:2
education ,schools:2
benefits ,burdens:2
benefits ,wearing:2
benefits ,face:2
benefits ,masks:2
benefits ,schools:2
burdens ,wearing:2
burdens ,face:2
burdens ,masks:2
burdens ,schools:2
wearing ,face:6
wearing ,schools:2
masks ,schools:2
successful ,remdesivir:2
successful ,corticosteroids:2
remdesivir ,corticosteroids:2
corticosteroids ,patient:4
correlation ,chest:6
correlation ,computed:2
correlation ,tomography:2
correlation ,lung:2
correlation ,ultrasonography:2
chest ,ultrasonography:2
computed ,lung:4
computed ,ultrasonography:2
tomography ,lung:4
tomography ,ultrasonography:2
lung ,ultrasonography:2
ultrasonography ,patients:2
breastfeeding ,mothers:2
breastfeeding ,covid-19:8
breastfeeding ,infection:4
breastfeeding ,case:2
breastfeeding ,series:2
mothers ,infection:4
new ,multidimensional:2
new ,solutions:4
new ,oncological:2
models ,care:2
models ,multidimensional:2
models ,solutions:2
models ,oncological:2
models ,patients:4
care ,multidimensional:2
care ,solutions:2
care ,oncological:2
multidimensional ,solutions:2
multidimensional ,oncological:2
multidimensional ,patients:2
solutions ,oncological:2
solutions ,patients:2
oncological ,patients:4
meta-analysis ,performance:4
meta-analysis ,serological:2
meta-analysis ,tests:4
in-flight ,cluster:2
in-flight ,covid-19:2
in-flight ,retrospective:2
in-flight ,case:2
in-flight ,series:2
transmission ,series:2
cluster ,retrospective:2
cluster ,series:2
retrospective ,case:4
retrospective ,series:4
holder ,pasteurization:2
holder ,donated:2
holder ,human:2
holder ,milk:2
holder ,effective:2
holder ,inactivating:2
holder ,sars-cov-2:2
pasteurization ,donated:2
pasteurization ,human:2
pasteurization ,milk:2
pasteurization ,effective:2
pasteurization ,inactivating:2
pasteurization ,sars-cov-2:2
donated ,human:2
donated ,milk:2
donated ,effective:2
donated ,inactivating:2
donated ,sars-cov-2:2
human ,milk:2
human ,inactivating:2
milk ,effective:2
milk ,inactivating:2
effective ,inactivating:2
clinical ,biofire:2
clinical ,21:2
evaluation ,biofire:2
evaluation ,21:2
biofire ,respiratory:2
biofire ,panel:2
biofire ,21:2
biofire ,detection:2
respiratory ,21:2
panel ,21:2
21 ,detection:2
secondary ,sclerosing:2
secondary ,cholangitis:2
secondary ,critically:2
secondary ,ill:4
secondary ,patients:2
sclerosing ,cholangitis:2
sclerosing ,critically:2
sclerosing ,ill:2
sclerosing ,patients:2
sclerosing ,rare:2
sclerosing ,disease:2
cholangitis ,critically:2
cholangitis ,ill:2
cholangitis ,patients:2
cholangitis ,rare:2
cholangitis ,disease:2
critically ,rare:2
ill ,rare:2
patients ,rare:4
longitudinal ,anti-sars-cov-2:2
longitudinal ,antibody:2
longitudinal ,profile:2
longitudinal ,neutralization:2
longitudinal ,activity:2
anti-sars-cov-2 ,neutralization:2
anti-sars-cov-2 ,activity:4
antibody ,profile:2
antibody ,neutralization:6
profile ,neutralization:2
profile ,activity:2
neutralization ,activity:2
bowel ,ischemia:2
bowel ,sars:2
bowel ,cov-2-like:2
bowel ,illness:2
bowel ,negative:2
bowel ,real-time:2
ischemia ,sars:2
ischemia ,cov-2-like:2
ischemia ,illness:2
ischemia ,negative:2
ischemia ,real-time:2
patient ,cov-2-like:2
patient ,illness:2
patient ,real-time:2
sars ,cov-2-like:2
sars ,illness:2
sars ,negative:2
sars ,real-time:2
cov-2-like ,illness:2
cov-2-like ,negative:2
cov-2-like ,real-time:2
illness ,negative:2
illness ,real-time:2
negative ,real-time:2
reducing ,aerosol:2
reducing ,generation:2
reducing ,ventilator:2
reducing ,weaning:2
reducing ,coronavirus:2
reducing ,disease:2
aerosol ,generation:4
aerosol ,ventilator:2
aerosol ,weaning:2
aerosol ,disease:2
generation ,ventilator:2
generation ,weaning:2
generation ,coronavirus:2
generation ,disease:2
ventilator ,weaning:2
ventilator ,coronavirus:2
ventilator ,disease:2
weaning ,coronavirus:2
weaning ,disease:2
effect ,hip:2
effect ,knee:2
effect ,arthroplasty:2
effect ,surgical:4
effect ,volume:2
effect ,united:2
covid-19 ,volume:4
hip ,surgical:2
hip ,volume:2
hip ,united:2
knee ,surgical:2
knee ,volume:2
knee ,united:2
arthroplasty ,surgical:2
arthroplasty ,volume:2
arthroplasty ,united:2
surgical ,volume:2
surgical ,united:2
volume ,united:2
self-collected ,healthcare:2
self-collected ,worker-collected:2
self-collected ,swabs:4
self-collected ,diagnosis:2
self-collected ,severe:2
versus ,healthcare:2
versus ,worker-collected:2
versus ,swabs:2
versus ,diagnosis:2
healthcare ,worker-collected:2
healthcare ,swabs:2
healthcare ,diagnosis:2
worker-collected ,swabs:2
worker-collected ,diagnosis:2
worker-collected ,severe:2
dietary ,therapy:2
dietary ,herbal:2
dietary ,medicine:2
dietary ,covid-19:4
dietary ,prevention:2
dietary ,review:2
therapy ,herbal:2
herbal ,prevention:2
medicine ,review:6
prevention ,review:6
role ,vitamin:6
role ,preventing:2
vitamin ,preventing:2
vitamin ,progression:2
vitamin ,severity:8
preventing ,severity:2
progression ,severity:2
epidemiological ,26:2
epidemiological ,asymptomatic:6
epidemiological ,acute:2
26 ,asymptomatic:2
26 ,severe:2
26 ,acute:2
coronavirus ,non-contrast:2
covid-19 ,non-contrast:2
infection ,non-contrast:2
infection ,computed:2
pregnancy ,non-contrast:2
pregnancy ,chest:2
pregnancy ,computed:2
non-contrast ,chest:2
non-contrast ,computed:2
machine ,reveals:2
machine ,prolonged:2
machine ,exposure:2
machine ,air:2
machine ,pollution:2
machine ,associated:2
learning ,reveals:2
learning ,prolonged:2
learning ,exposure:2
learning ,air:2
learning ,pollution:2
learning ,associated:2
reveals ,prolonged:2
reveals ,exposure:2
reveals ,air:2
reveals ,pollution:2
reveals ,associated:2
prolonged ,exposure:2
prolonged ,air:2
prolonged ,pollution:2
exposure ,air:4
exposure ,pollution:2
pollution ,associated:4
advances ,possible:2
telemedicine ,coronavirus:2
telemedicine ,sars-cov-2:2
structural ,conservation:2
structural ,programmed:2
structural ,-1:2
structural ,ribosomal:2
structural ,frameshift:2
functional ,conservation:2
functional ,programmed:2
functional ,-1:2
functional ,ribosomal:2
functional ,frameshift:2
conservation ,programmed:2
conservation ,-1:2
conservation ,ribosomal:2
conservation ,frameshift:2
programmed ,-1:2
programmed ,ribosomal:2
programmed ,frameshift:2
-1 ,ribosomal:2
-1 ,frameshift:2
ribosomal ,frameshift:2
saliva ,sampling:2
saliva ,lysis:2
saliva ,excellent:2
saliva ,increase:2
saliva ,number:2
sampling ,direct:2
sampling ,lysis:2
sampling ,excellent:2
sampling ,option:2
sampling ,increase:2
sampling ,number:2
direct ,lysis:2
direct ,excellent:2
direct ,option:2
direct ,increase:4
direct ,number:2
lysis ,excellent:2
lysis ,option:2
lysis ,increase:2
lysis ,number:2
excellent ,option:2
excellent ,increase:2
excellent ,number:2
option ,increase:2
option ,number:2
increase ,number:2
parallels ,mutual:2
parallels ,lessons:2
parallels ,tuberculosis:2
parallels ,covid-19:2
parallels ,transmission:2
parallels ,prevention:2
mutual ,lessons:2
mutual ,tuberculosis:2
mutual ,covid-19:2
mutual ,transmission:2
mutual ,prevention:2
tuberculosis ,transmission:2
tuberculosis ,prevention:2
pulmonary ,thromboembolism:2
pulmonary ,contributing:2
pulmonary ,cause:2
pulmonary ,insufficiency:2
thromboembolism ,contributing:2
thromboembolism ,cause:2
thromboembolism ,severe:4
thromboembolism ,respiratory:2
thromboembolism ,insufficiency:2
contributing ,cause:2
contributing ,severe:2
contributing ,respiratory:2
contributing ,insufficiency:2
cause ,respiratory:4
cause ,insufficiency:2
severe ,insufficiency:2
respiratory ,insufficiency:2
structure-guided ,covalent:2
structure-guided ,stabilization:2
structure-guided ,coronavirus:2
structure-guided ,spike:2
structure-guided ,glycoprotein:2
structure-guided ,trimers:2
covalent ,stabilization:2
covalent ,coronavirus:4
covalent ,spike:2
covalent ,glycoprotein:2
covalent ,trimers:2
stabilization ,coronavirus:2
stabilization ,spike:2
stabilization ,glycoprotein:2
stabilization ,trimers:2
coronavirus ,trimers:2
glycoprotein ,trimers:2
utilization ,results:2
utilization ,repeat:2
utilization ,sars-cov-2:2
utilization ,rt-pcr:2
utilization ,testing:2
utilization ,presumptive:2
utilization ,low:2
results ,repeat:2
results ,presumptive:2
results ,low:2
repeat ,sars-cov-2:4
repeat ,rt-pcr:2
repeat ,testing:6
repeat ,presumptive:2
repeat ,low:4
sars-cov-2 ,presumptive:2
rt-pcr ,presumptive:2
rt-pcr ,low:2
testing ,presumptive:2
presumptive ,low:2
predicting ,mortality:2
predicting ,due:2
predicting ,sars-cov-2:2
predicting ,mechanistic:2
predicting ,score:4
predicting ,relating:2
predicting ,obesity:2
mortality ,due:4
mortality ,mechanistic:2
mortality ,score:2
mortality ,relating:2
mortality ,obesity:2
due ,mechanistic:2
due ,score:2
due ,relating:2
due ,obesity:2
sars-cov-2 ,score:2
sars-cov-2 ,relating:2
mechanistic ,score:2
mechanistic ,relating:2
mechanistic ,obesity:2
score ,relating:2
score ,obesity:2
relating ,obesity:2
inhibition ,infections:2
inhibition ,engineered:2
inhibition ,human:2
inhibition ,tissues:2
inhibition ,using:2
inhibition ,clinical-grade:2
sars-cov-2 ,engineered:4
sars-cov-2 ,clinical-grade:2
infections ,engineered:2
infections ,tissues:2
infections ,using:2
infections ,clinical-grade:2
engineered ,human:2
engineered ,using:4
engineered ,clinical-grade:2
human ,tissues:2
human ,clinical-grade:2
tissues ,using:2
tissues ,clinical-grade:2
using ,clinical-grade:2
infection ,taiwanese:2
infection ,confront:2
control ,taiwanese:2
control ,hospital:2
control ,confront:2
measures ,taiwanese:2
measures ,confront:2
taiwanese ,hospital:2
taiwanese ,confront:2
taiwanese ,covid-19:2
hospital ,confront:2
confront ,covid-19:2
envelope ,membrane:2
envelope ,proteins:2
envelope ,structural:2
envelope ,differences:2
envelope ,linked:2
envelope ,virus:2
membrane ,proteins:2
membrane ,structural:4
membrane ,differences:2
membrane ,linked:2
membrane ,virus:2
proteins ,linked:2
structural ,differences:2
structural ,linked:2
structural ,virus:2
differences ,linked:2
differences ,virus:2
linked ,virus:2
cardiological ,point-of-view:2
viable ,various:2
viable ,specimens:2
various ,specimens:2
various ,patients:2
smoking ,gun:2
smoking ,fight:2
smoking ,rhace-2:2
gun ,fight:2
gun ,covid-19:2
gun ,rhace-2:2
fight ,rhace-2:2
covid-19 ,rhace-2:2
comprehensive ,chinese:2
comprehensive ,experience:2
comprehensive ,ophthalmology:2
chinese ,experience:2
chinese ,ophthalmology:2
experience ,ophthalmology:2
study ,epidemiology:2
study ,italy:4
study ,early:2
study ,days:2
study ,secondary:4
epidemiology ,italy:2
epidemiology ,early:2
epidemiology ,days:2
epidemiology ,secondary:2
epidemiology ,effects:2
italy ,days:2
italy ,secondary:2
early ,days:2
early ,secondary:2
early ,effects:2
days ,secondary:2
days ,effects:2
secondary ,effects:2
audiological ,profile:2
audiological ,patients:2
audiological ,sars-co-v-2:2
audiological ,pcr-positive:2
audiological ,cases:2
profile ,sars-co-v-2:2
profile ,pcr-positive:2
profile ,cases:2
patients ,sars-co-v-2:2
patients ,pcr-positive:2
sars-co-v-2 ,pcr-positive:2
sars-co-v-2 ,cases:2
pcr-positive ,cases:2
redesigning ,emergency:2
redesigning ,department:2
redesigning ,operations:2
redesigning ,amidst:2
redesigning ,viral:2
redesigning ,pandemic:2
emergency ,operations:2
emergency ,amidst:2
emergency ,viral:2
department ,operations:2
department ,amidst:2
department ,viral:2
operations ,amidst:2
operations ,viral:2
amidst ,viral:2
amidst ,pandemic:2
coronavirus ,paucisymptomatic:2
disease ,paucisymptomatic:2
paucisymptomatic ,patient:2
paucisymptomatic ,epidemiological:2
patient ,epidemiological:4
coagulation ,venous:2
coagulation ,thromboembolism:2
coagulation ,risk:2
coagulation ,african:2
coagulation ,americans:2
coagulation ,potential:2
status ,venous:2
status ,thromboembolism:2
status ,risk:4
status ,african:2
status ,americans:2
venous ,african:2
venous ,americans:2
venous ,potential:4
thromboembolism ,risk:4
thromboembolism ,african:2
thromboembolism ,americans:2
thromboembolism ,potential:2
risk ,americans:2
african ,americans:2
african ,potential:2
americans ,potential:2
behavior ,global:2
behavior ,social:2
behavior ,lockdown:2
behavior ,unlocks:2
behavior ,time:2
behavior ,sleep:2
global ,social:2
global ,lockdown:6
global ,unlocks:2
global ,time:2
global ,sleep:2
social ,lockdown:4
social ,unlocks:2
social ,time:2
lockdown ,unlocks:2
lockdown ,sleep:2
unlocks ,time:2
unlocks ,sleep:2
time ,sleep:2
image-proven ,thromboembolism:2
image-proven ,patients:2
image-proven ,severe:2
image-proven ,covid-19:2
image-proven ,tertiary:2
image-proven ,critical:2
thromboembolism ,tertiary:2
thromboembolism ,critical:2
severe ,tertiary:2
tertiary ,critical:2
clinics ,hhv-6:2
clinics ,infection:2
clinics ,covid-19:2
clinics ,pandemic:2
clinics ,pityriasis:2
clinics ,rosea:2
clinics ,kawasaki:2
hhv-6 ,infection:2
hhv-6 ,covid-19:2
hhv-6 ,pandemic:2
hhv-6 ,pityriasis:2
hhv-6 ,rosea:2
hhv-6 ,kawasaki:2
infection ,pityriasis:2
infection ,rosea:2
infection ,kawasaki:2
covid-19 ,pityriasis:2
covid-19 ,rosea:2
covid-19 ,kawasaki:4
pandemic ,pityriasis:2
pandemic ,rosea:2
pandemic ,kawasaki:2
pityriasis ,rosea:2
pityriasis ,kawasaki:2
rosea ,kawasaki:2
covid-19 ,real:4
pandemic ,real:2
pandemic ,opportunity:2
pandemic ,digital:2
real ,opportunity:2
real ,digital:2
real ,health:2
opportunity ,digital:2
opportunity ,health:2
digital ,health:2
reduced ,numbers:2
reduced ,cells:2
reduced ,correlates:2
reduced ,persistent:2
numbers ,cells:2
numbers ,correlates:2
numbers ,persistent:2
cells ,correlates:2
cells ,persistent:2
correlates ,persistent:2
respiratory ,facial:2
respiratory ,current:4
respiratory ,context:2
facial ,protection:2
facial ,current:2
facial ,perspectives:2
facial ,context:2
protection ,current:2
protection ,perspectives:2
protection ,context:2
current ,context:2
perspectives ,context:4
analysis ,hematologic:2
anti-sars-cov-2 ,hematologic:2
anti-sars-cov-2 ,patients:4
igg ,hematologic:2
antibodies ,hematologic:2
antibodies ,patients:10
hematologic ,patients:2
linear ,regression:2
linear ,analysis:2
linear ,predict:2
linear ,number:2
linear ,deaths:2
linear ,india:2
linear ,due:2
regression ,analysis:4
regression ,predict:2
regression ,number:2
regression ,deaths:2
regression ,india:2
regression ,due:2
analysis ,predict:2
analysis ,number:2
analysis ,deaths:4
analysis ,due:4
predict ,number:2
predict ,deaths:2
predict ,india:2
predict ,due:2
number ,deaths:2
number ,india:2
number ,due:2
deaths ,india:2
deaths ,due:2
india ,due:2
neuropathogens ,nasal:2
neuropathogens ,cleansing:2
neuropathogens ,use:2
neuropathogens ,clay:2
neuropathogens ,montmorillonite:2
neuropathogens ,coupled:2
nasal ,cleansing:2
nasal ,use:2
nasal ,clay:2
nasal ,montmorillonite:2
nasal ,coupled:2
cleansing ,use:2
cleansing ,clay:2
cleansing ,montmorillonite:2
cleansing ,coupled:2
use ,clay:2
use ,montmorillonite:2
use ,coupled:2
clay ,montmorillonite:2
clay ,coupled:2
montmorillonite ,coupled:2
pulmonary ,artery:2
pulmonary ,thrombectomy:2
pulmonary ,life-saving:2
pulmonary ,presumed:2
artery ,thrombectomy:2
artery ,life-saving:2
artery ,treatment:2
artery ,patient:4
artery ,presumed:2
thrombectomy ,life-saving:2
thrombectomy ,treatment:2
thrombectomy ,patient:4
thrombectomy ,presumed:2
life-saving ,treatment:2
life-saving ,patient:2
life-saving ,presumed:2
treatment ,presumed:2
patient ,presumed:2
inference ,longitudinal:2
inference ,laboratory:2
inference ,tests:2
inference ,characterizes:2
inference ,temporal:2
longitudinal ,laboratory:2
longitudinal ,tests:2
longitudinal ,characterizes:2
longitudinal ,temporal:2
longitudinal ,evolution:2
laboratory ,characterizes:2
laboratory ,temporal:2
laboratory ,evolution:2
tests ,characterizes:2
tests ,temporal:2
tests ,evolution:2
characterizes ,temporal:2
characterizes ,evolution:2
temporal ,evolution:2
neutralizing ,correlate:2
neutralizing ,protection:4
neutralizing ,humans:2
antibodies ,correlate:2
antibodies ,protection:2
antibodies ,humans:2
correlate ,protection:2
correlate ,humans:2
protection ,humans:2
liver ,outcomes:4
liver ,among:2
liver ,hospitalized:6
liver ,systematic:6
among ,systematic:2
bcg ,mortality:4
bcg ,across:2
bcg ,173:2
bcg ,countries:2
bcg ,ecological:2
bcg ,study:2
vaccination ,mortality:4
vaccination ,across:2
vaccination ,173:2
vaccination ,countries:2
vaccination ,ecological:2
vaccination ,study:2
mortality ,across:2
mortality ,173:2
mortality ,countries:4
mortality ,ecological:2
mortality ,study:2
covid-19 ,173:2
across ,173:2
across ,countries:2
across ,ecological:2
across ,study:2
173 ,countries:2
173 ,ecological:2
173 ,study:2
countries ,ecological:2
countries ,study:2
ecological ,study:2
managing ,hyperglycemia:2
managing ,inflammatory:2
hyperglycemia ,inflammatory:2
hyperglycemia ,storm:2
pragmatic ,randomized:2
pragmatic ,controlled:2
pragmatic ,trial:2
pragmatic ,reports:2
pragmatic ,lack:2
pragmatic ,efficacy:4
randomized ,controlled:4
randomized ,trial:6
randomized ,reports:2
randomized ,lack:2
randomized ,efficacy:4
controlled ,trial:4
controlled ,reports:2
controlled ,lack:2
controlled ,efficacy:2
trial ,reports:2
trial ,lack:2
reports ,lack:2
reports ,efficacy:2
lack ,efficacy:4
automated ,rna:2
automated ,extraction:2
automated ,patient:2
automated ,nasopharyngeal:2
automated ,samples:2
extraction ,patient:2
extraction ,nasopharyngeal:2
extraction ,samples:2
extraction ,using:4
patient ,samples:6
nasopharyngeal ,samples:4
samples ,using:2
inhibition ,coronavirus:2
inhibition ,entry:4
inhibition ,vitro:2
inhibition ,ex:2
inhibition ,vivo:2
inhibition ,lipid-conjugated:2
inhibition ,peptide:2
coronavirus ,entry:4
coronavirus ,vitro:2
coronavirus ,ex:2
coronavirus ,vivo:2
coronavirus ,lipid-conjugated:2
entry ,vitro:2
entry ,ex:2
entry ,vivo:2
entry ,lipid-conjugated:2
vitro ,ex:2
vitro ,vivo:2
vitro ,lipid-conjugated:2
vitro ,peptide:2
ex ,vivo:2
ex ,lipid-conjugated:2
ex ,peptide:2
vivo ,lipid-conjugated:2
vivo ,peptide:2
lipid-conjugated ,peptide:2
asymptomatic ,source:2
asymptomatic ,systematic:2
patients ,source:2
source ,infections:2
source ,systematic:2
source ,review:2
testing ,natural:2
testing ,products:2
testing ,trials:2
testing ,targeting:2
natural ,trials:2
natural ,targeting:2
products ,clinical:2
products ,trials:2
products ,targeting:2
clinical ,targeting:2
trials ,targeting:2
coronavirus ,cov-19sars-cov-2:2
coronavirus ,affects:2
coronavirus ,less:4
cov-19sars-cov-2 ,affects:2
cov-19sars-cov-2 ,women:2
cov-19sars-cov-2 ,less:2
cov-19sars-cov-2 ,men:2
cov-19sars-cov-2 ,clinical:2
cov-19sars-cov-2 ,response:2
affects ,women:2
affects ,less:2
affects ,men:2
affects ,clinical:2
affects ,response:2
women ,less:2
women ,men:2
women ,clinical:10
women ,response:2
less ,men:2
less ,clinical:2
less ,response:2
men ,clinical:2
men ,response:2
committee ,recommendations:2
committee ,resuming:2
committee ,cardiac:2
committee ,surgery:2
committee ,activity:2
committee ,sars-cov-2:2
recommendations ,resuming:2
recommendations ,cardiac:4
recommendations ,activity:2
resuming ,cardiac:2
resuming ,surgery:4
resuming ,activity:2
resuming ,sars-cov-2:2
cardiac ,activity:2
cardiac ,sars-cov-2:2
surgery ,activity:2
sars-cov-2 ,low-risk:2
health ,low-risk:2
health ,settings:2
health ,modes:2
care ,worker:2
care ,protection:4
care ,low-risk:2
care ,review:4
care ,modes:2
worker ,protection:2
worker ,low-risk:2
worker ,settings:2
worker ,review:4
worker ,modes:2
protection ,low-risk:2
protection ,settings:2
protection ,review:2
protection ,modes:2
low-risk ,settings:2
low-risk ,review:2
low-risk ,modes:2
settings ,review:2
settings ,modes:2
covid-19 ,sarcoidosis:4
patient ,sarcoidosis:2
patient ,long-term:2
sarcoidosis ,receiving:2
sarcoidosis ,long-term:2
sarcoidosis ,hydroxychloroquine:2
receiving ,long-term:2
receiving ,hydroxychloroquine:2
long-term ,hydroxychloroquine:2
antibody ,spike:4
antibody ,protein:4
antibody ,nucleoprotein:2
antibody ,evaluated:2
response ,protein:2
response ,nucleoprotein:2
response ,evaluated:2
sars-cov-2 ,evaluated:2
spike ,nucleoprotein:2
spike ,evaluated:2
protein ,nucleoprotein:2
protein ,evaluated:2
nucleoprotein ,evaluated:2
humidifier ,use:2
humidifier ,prone:2
humidifier ,positioning:2
humidifier ,patient:2
humidifier ,severe:2
humidifier ,covid-19:2
humidifier ,pneumonia:2
use ,prone:2
use ,positioning:2
use ,patient:4
use ,severe:4
use ,pneumonia:2
prone ,positioning:4
prone ,patient:4
prone ,severe:2
prone ,covid-19:6
prone ,pneumonia:2
positioning ,patient:4
positioning ,severe:2
positioning ,covid-19:2
positioning ,pneumonia:2
model ,emergency:2
model ,department:2
model ,expansion:2
emergency ,expansion:2
department ,expansion:2
expansion ,covid-19:2
expansion ,pandemic:2
sars ,perspective:4
mers ,perspective:4
neurological ,perspective:4
comparison ,unsupervised:2
comparison ,home:2
comparison ,self-collected:2
comparison ,midnasal:2
unsupervised ,home:2
unsupervised ,self-collected:2
unsupervised ,midnasal:2
unsupervised ,swabs:2
home ,self-collected:2
home ,midnasal:2
home ,swabs:2
self-collected ,midnasal:2
midnasal ,swabs:2
investigation ,importance:2
investigation ,climatic:2
investigation ,factors:2
investigation ,worldwide:2
investigation ,intensity:2
importance ,climatic:2
importance ,factors:2
importance ,worldwide:2
importance ,intensity:2
climatic ,worldwide:2
climatic ,intensity:2
factors ,worldwide:2
factors ,intensity:2
covid-19 ,intensity:2
worldwide ,intensity:2
sudden ,onset:4
sudden ,acute:2
sudden ,taste:2
sudden ,smell:4
sudden ,coronavirus:2
sudden ,disease:2
loss ,coronavirus:4
loss ,disease:4
taste ,coronavirus:6
taste ,disease:6
smell ,coronavirus:6
smell ,disease:6
genomic ,phylogenetic:2
genomic ,imported:2
genomic ,case:2
phylogenetic ,characterisation:2
phylogenetic ,imported:2
phylogenetic ,case:2
characterisation ,imported:2
characterisation ,case:2
sensitivity ,assessment:4
sensitivity ,droplet:2
sensitivity ,digital:2
sensitivity ,pcr:2
immune ,life:2
immune ,history:2
immune ,vaccination:2
immune ,next:2
life ,history:2
life ,dynamics:2
life ,next:2
history ,vaccination:2
history ,next:2
vaccination ,dynamics:2
vaccination ,next:2
dynamics ,next:2
immunopathology ,sars-cov-2:6
immunopathology ,infection:2
immunopathology ,cells:2
immunopathology ,mediators:2
immunopathology ,prognostic:2
sars-cov-2 ,mediators:4
sars-cov-2 ,prognostic:2
infection ,mediators:2
infection ,prognostic:2
immune ,mediators:2
cells ,mediators:2
cells ,prognostic:2
mediators ,prognostic:2
role ,prognosis:2
interleukin-6 ,prognosis:2
interleukin-6 ,severe:2
pathogenesis ,prognosis:2
prognosis ,severe:2
painful ,lesson:2
painful ,covid-19:2
painful ,pandemic:2
painful ,need:2
painful ,broad-spectrum:2
lesson ,need:2
lesson ,broad-spectrum:2
covid-19 ,broad-spectrum:2
pandemic ,broad-spectrum:2
need ,broad-spectrum:2
potential ,methanol:2
potential ,toxicity:2
potential ,importance:6
potential ,standardised:2
potential ,alcohol-based:2
methanol ,toxicity:2
methanol ,importance:2
methanol ,using:2
methanol ,standardised:2
methanol ,alcohol-based:2
toxicity ,importance:2
toxicity ,using:2
toxicity ,standardised:2
toxicity ,alcohol-based:2
importance ,using:2
importance ,standardised:2
importance ,alcohol-based:2
using ,standardised:2
using ,alcohol-based:2
standardised ,alcohol-based:2
covid-19 ,personalized:4
covid-19 ,cardiometabolic:2
covid-19 ,reducing:14
personalized ,cardiometabolic:2
personalized ,approach:2
personalized ,reducing:2
personalized ,complications:2
cardiometabolic ,approach:2
cardiometabolic ,reducing:2
cardiometabolic ,complications:2
approach ,reducing:4
approach ,complications:2
reducing ,complications:4
sex-specific ,immunobiological:2
sex-specific ,factors:2
sex-specific ,differences:2
sex-specific ,angiotensin:2
sex-specific ,converting:2
immunobiological ,factors:2
immunobiological ,differences:2
immunobiological ,angiotensin:2
immunobiological ,converting:2
factors ,angiotensin:2
factors ,converting:2
differences ,angiotensin:2
differences ,converting:2
feasibility ,prone:2
feasibility ,position:2
feasibility ,coronary:2
feasibility ,angiography:2
feasibility ,patient:2
feasibility ,covid-19:2
prone ,position:4
prone ,coronary:2
prone ,angiography:2
position ,coronary:2
position ,angiography:2
position ,patient:2
coronary ,angiography:2
coronary ,patient:4
angiography ,patient:2
angiography ,covid-19:2
quality ,improvement:2
quality ,tool:2
quality ,rapid:2
quality ,identification:2
quality ,risk:2
quality ,factors:2
improvement ,tool:2
improvement ,rapid:2
improvement ,identification:2
improvement ,risk:2
improvement ,factors:2
improvement ,sars-cov-2:2
tool ,rapid:8
tool ,identification:6
tool ,risk:2
tool ,factors:2
rapid ,risk:2
rapid ,factors:2
identification ,risk:4
identification ,factors:4
oncology ,navigating:2
oncology ,steer:2
oncology ,course:2
navigating ,steer:2
navigating ,course:2
covid-19 ,steer:2
pandemic ,steer:2
steer ,course:2
type ,cancer:2
type ,susceptible:2
type ,sars-cox-2:2
type ,evidence:2
cancer ,susceptible:2
cancer ,sars-cox-2:2
cancer ,evidence:2
patients ,susceptible:2
patients ,sars-cox-2:2
patients ,evidence:4
susceptible ,sars-cox-2:2
susceptible ,evidence:2
sars-cox-2 ,evidence:2
can ,probiotics:2
can ,diet:2
can ,promote:2
can ,beneficial:2
can ,modulation:2
can ,purine:2
can ,control:2
probiotics ,promote:2
probiotics ,beneficial:2
probiotics ,immune:2
probiotics ,modulation:2
probiotics ,purine:2
probiotics ,control:2
diet ,promote:2
diet ,beneficial:2
diet ,immune:2
diet ,modulation:2
diet ,purine:2
diet ,control:2
promote ,beneficial:2
promote ,immune:2
promote ,modulation:2
promote ,purine:2
promote ,control:2
beneficial ,immune:2
beneficial ,modulation:2
beneficial ,purine:2
beneficial ,control:2
immune ,purine:2
immune ,control:2
modulation ,purine:2
modulation ,control:2
purine ,control:2
covid-19 ,genotype:2
covid-19 ,ace-i:2
influence ,ace:2
influence ,genotype:2
influence ,ace-i:2
influence ,arbs:2
influence ,course:2
ace ,genotype:2
ace ,ace-i:2
ace ,arbs:2
ace ,course:2
genotype ,ace-i:2
genotype ,arbs:2
genotype ,course:2
ace-i ,arbs:2
ace-i ,course:2
arbs ,course:2
veno-venous ,extracorporeal:4
veno-venous ,membrane:4
veno-venous ,oxygenation:4
veno-venous ,support:2
veno-venous ,covid-19:2
veno-venous ,respiratory:2
extracorporeal ,membrane:8
extracorporeal ,oxygenation:6
extracorporeal ,support:2
extracorporeal ,respiratory:2
membrane ,oxygenation:6
membrane ,support:2
membrane ,covid-19:4
membrane ,respiratory:2
oxygenation ,support:2
oxygenation ,covid-19:4
oxygenation ,respiratory:2
assess ,adapt:2
assess ,act:2
assess ,paediatric:2
assess ,surgery:2
assess ,divisions:2
assess ,initial:2
assess ,approach:4
assess ,rapidly:2
adapt ,act:2
adapt ,paediatric:2
adapt ,surgery:2
adapt ,divisions:2
adapt ,initial:2
adapt ,approach:2
adapt ,rapidly:2
act ,paediatric:2
act ,surgery:2
act ,divisions:2
act ,initial:2
act ,approach:2
act ,rapidly:2
paediatric ,surgery:2
paediatric ,divisions:2
paediatric ,initial:2
paediatric ,approach:2
paediatric ,rapidly:2
surgery ,divisions:2
surgery ,initial:2
surgery ,approach:2
surgery ,rapidly:2
divisions ,initial:2
divisions ,approach:2
divisions ,rapidly:2
initial ,approach:2
initial ,rapidly:2
approach ,rapidly:2
workplace ,responses:2
workplace ,covid-19:2
workplace ,associated:2
workplace ,mental:4
workplace ,health:4
workplace ,work:2
workplace ,performance:2
responses ,associated:2
responses ,mental:2
responses ,work:2
responses ,performance:2
associated ,mental:2
associated ,health:2
associated ,performance:2
mental ,work:2
mental ,performance:2
health ,performance:2
work ,performance:2
severe ,tunisia:2
covid-19 ,tunisia:4
critically ,tunisia:2
ill ,tunisia:2
carbohydrate-binding ,protein:2
carbohydrate-binding ,edible:2
carbohydrate-binding ,lablab:2
carbohydrate-binding ,beans:2
carbohydrate-binding ,effectively:2
carbohydrate-binding ,blocks:2
protein ,edible:2
protein ,lablab:2
protein ,beans:2
protein ,effectively:2
protein ,blocks:2
edible ,lablab:2
edible ,beans:2
edible ,effectively:2
edible ,blocks:2
lablab ,beans:2
lablab ,effectively:2
lablab ,blocks:2
beans ,effectively:2
beans ,blocks:2
effectively ,blocks:2
covid-19 ,ethnicity:4
ethnicity ,novel:2
ethnicity ,pathophysiological:2
ethnicity ,role:2
ethnicity ,inflammation:2
novel ,pathophysiological:2
novel ,inflammation:2
pathophysiological ,role:2
pathophysiological ,inflammation:2
rapid ,covid:2
rapid ,rcs:2
covid ,rcs:2
covid ,tool:2
screening ,rcs:2
screening ,tool:2
rcs ,tool:2
sofosbuvir ,terminated:2
sofosbuvir ,resistant:2
sofosbuvir ,proofreader:2
terminated ,rna:2
terminated ,resistant:2
terminated ,sars-cov-2:2
terminated ,proofreader:2
rna ,resistant:2
rna ,proofreader:2
resistant ,sars-cov-2:2
resistant ,proofreader:2
sars-cov-2 ,proofreader:2
clinical ,anal:2
imaging ,discharged:2
imaging ,positive:2
imaging ,anal:2
findings ,discharged:2
findings ,positive:2
findings ,anal:4
discharged ,anal:2
patients ,anal:4
positive ,anal:2
time-related ,changes:2
time-related ,sex:2
time-related ,distribution:2
time-related ,covid-19:2
time-related ,incidence:2
time-related ,proportion:2
time-related ,italy:2
changes ,sex:2
changes ,distribution:2
changes ,incidence:4
changes ,proportion:2
changes ,italy:2
sex ,distribution:2
sex ,incidence:2
sex ,proportion:2
sex ,italy:2
distribution ,incidence:2
distribution ,proportion:2
distribution ,italy:2
covid-19 ,proportion:2
incidence ,proportion:2
incidence ,italy:4
proportion ,italy:2
worldwide ,effects:2
worldwide ,coronavirus:2
worldwide ,disease:2
worldwide ,tuberculosis:2
worldwide ,services:2
effects ,tuberculosis:2
effects ,services:2
coronavirus ,tuberculosis:2
coronavirus ,services:4
disease ,tuberculosis:2
disease ,services:4
tuberculosis ,services:2
periodontal ,pockets:2
periodontal ,potential:2
periodontal ,reservoir:2
periodontal ,sars-cov-2:2
pockets ,potential:2
pockets ,reservoir:2
pockets ,sars-cov-2:2
potential ,reservoir:2
epidemiological ,retrospective:2
epidemiological ,east:2
clinical ,east:2
features ,retrospective:2
features ,east:2
sars-cov-2 ,east:4
retrospective ,east:2
serological ,differentiation:2
serological ,sars:2
serological ,infections:2
differentiation ,covid-19:4
differentiation ,sars:2
differentiation ,infections:2
sars ,infections:6
new ,genetic:2
new ,susceptibility:2
new ,tmprss2:2
insights ,genetic:4
insights ,susceptibility:2
insights ,tmprss2:2
genetic ,tmprss2:6
susceptibility ,tmprss2:4
covid-19 ,tmprss2:2
cytokine ,elderly:2
gaining ,insights:2
gaining ,immune:2
gaining ,responses:2
gaining ,novel:2
gaining ,coronavirus:2
gaining ,covid-19:2
responses ,novel:2
cerebral ,covid-19-associated:2
cerebral ,coagulopathy:2
venous ,covid-19-associated:2
venous ,coagulopathy:2
thrombosis ,covid-19-associated:2
thrombosis ,coagulopathy:4
coagulopathy ,case:2
coagulopathy ,report:2
prone ,management:2
prone ,patients:2
prone ,commentary:2
position ,management:4
position ,commentary:2
patients ,commentary:2
cardiovascular ,think:2
cardiovascular ,ahead:2
cardiovascular ,protect:2
cardiovascular ,hearts:2
disease ,think:2
disease ,ahead:2
disease ,protect:4
disease ,hearts:2
covid-19 ,think:2
covid-19 ,hearts:2
pandemic ,think:2
pandemic ,hearts:2
think ,ahead:2
think ,protect:2
think ,hearts:2
ahead ,protect:2
ahead ,hearts:2
protect ,hearts:2
child ,protection:2
child ,time:2
protection ,time:2
covid-19 ,migration:2
outbreak ,migration:2
outbreak ,society:2
outbreak ,environment:2
migration ,effects:2
migration ,society:2
migration ,global:2
migration ,environment:2
migration ,prevention:2
effects ,society:2
effects ,global:2
effects ,environment:2
society ,global:2
society ,environment:4
society ,prevention:2
global ,environment:2
global ,prevention:2
environment ,prevention:2
thoughts ,death:2
thoughts ,cases:2
thoughts ,report:2
suggestions ,death:2
suggestions ,cases:2
suggestions ,report:2
suggestions ,covid-19:6
analysis ,report:2
death ,report:2
evaluation ,extraction:2
evaluation ,methods:4
simple ,nucleic:2
simple ,acid:2
simple ,extraction:2
simple ,methods:2
nucleic ,methods:2
acid ,methods:2
extraction ,methods:2
false-positive ,serology:2
false-positive ,children:2
false-positive ,kawasaki:2
false-positive ,disease:2
sars-cov-2 ,kawasaki:6
serology ,kawasaki:2
serology ,disease:2
children ,kawasaki:2
high-throughput ,transcription-mediated:4
high-throughput ,amplification:2
high-throughput ,hologic:2
high-throughput ,panther:2
transcription-mediated ,panther:2
amplification ,panther:2
hologic ,panther:2
relationship ,weather:2
relationship ,case:2
relationship ,study:2
relationship ,tropical:2
relationship ,country:2
covid-19 ,weather:4
covid-19 ,tropical:4
weather ,case:2
weather ,study:2
weather ,tropical:2
weather ,country:2
case ,tropical:2
case ,country:2
study ,tropical:2
study ,country:2
tropical ,country:2
extracellular ,hmgb1:2
extracellular ,therapeutic:2
extracellular ,target:2
extracellular ,severe:2
extracellular ,pulmonary:2
extracellular ,inflammation:2
extracellular ,including:2
hmgb1 ,therapeutic:2
hmgb1 ,target:2
hmgb1 ,severe:2
hmgb1 ,pulmonary:2
hmgb1 ,inflammation:2
hmgb1 ,including:2
therapeutic ,inflammation:2
therapeutic ,including:2
target ,severe:4
target ,pulmonary:2
target ,including:2
severe ,inflammation:4
severe ,including:2
pulmonary ,including:2
inflammation ,including:2
considerations ,postacute:2
considerations ,rehabilitation:2
considerations ,survivors:2
postacute ,rehabilitation:2
postacute ,survivors:2
postacute ,covid-19:2
rehabilitation ,survivors:2
survivors ,covid-19:2
covid-19 ,viral-host:2
covid-19 ,interactome:2
covid-19 ,analyzed:2
covid-19 ,based-approach:2
viral-host ,interactome:2
viral-host ,analyzed:2
viral-host ,network:2
viral-host ,based-approach:2
viral-host ,model:2
viral-host ,study:2
interactome ,analyzed:2
interactome ,network:2
interactome ,based-approach:2
interactome ,model:2
interactome ,study:2
analyzed ,network:2
analyzed ,based-approach:2
analyzed ,model:2
analyzed ,study:2
network ,based-approach:2
network ,model:2
network ,study:2
based-approach ,model:2
based-approach ,study:2
potent ,human:2
potent ,antibody:4
potent ,heavy-chain:2
potent ,variable:2
potent ,domains:2
neutralization ,human:2
neutralization ,heavy-chain:2
neutralization ,variable:2
neutralization ,domains:2
sars-cov-2 ,heavy-chain:2
sars-cov-2 ,domains:8
human ,heavy-chain:2
human ,variable:2
human ,domains:2
antibody ,heavy-chain:2
antibody ,variable:4
antibody ,domains:2
heavy-chain ,variable:2
heavy-chain ,domains:2
variable ,domains:2
chest ,ct-based:2
chest ,differential:2
chest ,28:2
chest ,suspected:6
chest ,corona:2
chest ,virus:2
ct-based ,differential:2
ct-based ,diagnosis:2
ct-based ,28:2
ct-based ,patients:2
ct-based ,suspected:2
ct-based ,corona:2
ct-based ,virus:2
differential ,28:2
differential ,suspected:2
differential ,corona:2
differential ,virus:2
diagnosis ,28:2
28 ,suspected:2
28 ,corona:2
28 ,virus:2
validation ,commercially:2
validation ,available:2
validation ,serological:2
validation ,immunoassay:4
commercially ,serological:2
commercially ,immunoassay:2
available ,immunoassay:2
coronavirus ,rheumatic:2
covid-19 ,rheumatic:8
pregnancy ,patients:2
pregnancy ,rheumatic:2
forecasting ,spread:2
forecasting ,pandemic:2
forecasting ,saudi:2
forecasting ,arabia:2
forecasting ,using:2
forecasting ,arima:4
spread ,saudi:4
spread ,arabia:2
spread ,using:2
spread ,arima:2
covid-19 ,arima:4
pandemic ,arima:2
saudi ,using:2
saudi ,arima:2
arabia ,using:2
arabia ,arima:2
using ,arima:2
short ,epidemiological:2
short ,overview:2
short ,current:2
short ,situation:2
short ,pandemic:2
epidemiological ,overview:2
epidemiological ,situation:2
epidemiological ,pandemic:4
overview ,situation:2
universal ,shelter-in-place:2
universal ,versus:2
universal ,advanced:2
universal ,automated:2
universal ,contact:2
universal ,tracing:2
universal ,targeted:2
shelter-in-place ,versus:2
shelter-in-place ,advanced:2
shelter-in-place ,automated:2
shelter-in-place ,contact:2
shelter-in-place ,tracing:2
shelter-in-place ,targeted:2
versus ,advanced:2
versus ,automated:2
versus ,contact:2
versus ,tracing:2
versus ,targeted:2
advanced ,automated:2
advanced ,contact:2
advanced ,tracing:2
advanced ,targeted:2
automated ,contact:2
automated ,tracing:2
automated ,targeted:2
contact ,targeted:2
tracing ,targeted:2
factors ,determining:4
factors ,pneumonia:2
factors ,country:2
factors ,routine:2
factors ,bcg:2
determining ,pneumonia:2
determining ,severity:2
determining ,country:2
determining ,routine:2
determining ,bcg:2
pneumonia ,country:2
pneumonia ,routine:2
pneumonia ,bcg:2
severity ,country:2
severity ,routine:2
severity ,bcg:2
country ,routine:2
country ,bcg:2
development ,elecsys:2
development ,highly:6
validation ,elecsys:2
validation ,anti-sars-cov-2:2
validation ,highly:2
elecsys ,highly:2
anti-sars-cov-2 ,highly:2
immunoassay ,highly:2
identification ,key:4
identification ,interactions:2
key ,interactions:2
key ,main:2
key ,protease:2
key ,inhibitor:2
interactions ,main:2
interactions ,protease:2
interactions ,inhibitor:2
main ,inhibitor:4
protease ,inhibitor:6
structure-based ,lead:2
structure-based ,optimization:2
structure-based ,herbal:2
structure-based ,medicine:2
structure-based ,rutin:2
structure-based ,inhibiting:2
lead ,optimization:2
lead ,herbal:2
lead ,medicine:2
lead ,rutin:2
lead ,inhibiting:2
optimization ,herbal:2
optimization ,medicine:2
optimization ,rutin:2
optimization ,inhibiting:2
herbal ,rutin:2
herbal ,inhibiting:2
medicine ,rutin:2
medicine ,inhibiting:2
rutin ,inhibiting:2
hypertension ,related:2
hypertension ,diseases:2
hypertension ,era:2
hypertension ,report:2
hypertension ,japanese:2
related ,diseases:2
related ,era:2
related ,report:2
related ,japanese:2
diseases ,report:4
diseases ,japanese:2
era ,report:2
era ,japanese:2
follow-up ,testing:4
follow-up ,viral:4
follow-up ,nucleic:4
follow-up ,acid:4
follow-up ,moderate:4
follow-up ,type:4
testing ,viral:4
testing ,discharged:6
testing ,moderate:4
testing ,type:4
viral ,discharged:4
viral ,moderate:4
viral ,type:4
nucleic ,discharged:4
nucleic ,moderate:4
nucleic ,type:4
acid ,discharged:4
acid ,moderate:4
acid ,type:4
discharged ,moderate:4
discharged ,type:4
patients ,moderate:4
moderate ,type:4
organ-protective ,effect:2
organ-protective ,angiotensin-converting:2
organ-protective ,enzyme:2
effect ,angiotensin-converting:2
effect ,enzyme:2
capillary ,electrophoresis:2
capillary ,pcr:2
capillary ,fragments:2
capillary ,5-labelled:2
capillary ,primers:2
capillary ,testing:2
electrophoresis ,pcr:2
electrophoresis ,fragments:2
electrophoresis ,5-labelled:2
electrophoresis ,primers:2
electrophoresis ,testing:2
pcr ,fragments:2
pcr ,5-labelled:2
pcr ,primers:2
pcr ,testing:4
fragments ,5-labelled:2
fragments ,primers:2
fragments ,testing:2
5-labelled ,primers:2
5-labelled ,testing:2
primers ,testing:2
first ,drug-induced:2
first ,liver:2
first ,injury:2
case ,drug-induced:2
case ,use:2
drug-induced ,liver:2
drug-induced ,associated:2
drug-induced ,use:2
drug-induced ,tocilizumab:2
liver ,associated:6
liver ,use:2
liver ,tocilizumab:2
injury ,use:2
injury ,tocilizumab:2
associated ,use:4
use ,tocilizumab:4
myocardial ,biomarkers:2
myocardial ,complications:2
myocardial ,mortality:2
injury ,biomarkers:2
injury ,complications:2
injury ,mortality:4
biomarkers ,cardiac:2
biomarkers ,complications:2
biomarkers ,associated:4
biomarkers ,mortality:4
cardiac ,associated:2
cardiac ,mortality:2
complications ,mortality:2
interactions ,antihyperglycemic:2
interactions ,drugs:2
interactions ,renin-angiotensin:2
interactions ,system:2
antihyperglycemic ,drugs:2
antihyperglycemic ,renin-angiotensin:2
antihyperglycemic ,system:2
drugs ,renin-angiotensin:2
drugs ,system:2
covid-19 ,adaptation:2
covid-19 ,protocols:6
new ,adaptation:2
new ,ivf:2
new ,protocols:2
adaptation ,ivf:2
adaptation ,laboratory:2
adaptation ,protocols:2
ivf ,protocols:2
laboratory ,protocols:2
household ,clustering:2
household ,community:2
household ,settings:2
household ,study:2
household ,rural:2
clustering ,sars-cov-2:2
clustering ,community:2
clustering ,settings:2
clustering ,study:2
clustering ,rural:2
sars-cov-2 ,rural:2
community ,settings:2
community ,study:2
community ,rural:2
settings ,study:2
settings ,rural:2
study ,rural:4
novel ,broad:2
novel ,range:2
novel ,anti-infective:2
novel ,ricin:2
novel ,chain:2
binding ,mechanisms:2
binding ,fusion:4
binding ,broad:2
binding ,range:2
binding ,anti-infective:2
binding ,ricin:2
binding ,chain:2
mechanisms ,fusion:2
mechanisms ,broad:2
mechanisms ,range:2
mechanisms ,anti-infective:2
mechanisms ,protein:2
mechanisms ,ricin:2
mechanisms ,chain:2
fusion ,broad:2
fusion ,range:2
fusion ,anti-infective:2
fusion ,protein:2
fusion ,ricin:2
fusion ,chain:2
broad ,range:4
broad ,anti-infective:2
broad ,protein:2
broad ,ricin:2
broad ,chain:2
range ,anti-infective:2
range ,ricin:2
range ,chain:2
anti-infective ,protein:2
anti-infective ,ricin:2
anti-infective ,chain:2
protein ,ricin:2
protein ,chain:2
ricin ,chain:2
situ ,detection:4
situ ,sars-cov-2:4
situ ,lungs:2
situ ,airways:2
situ ,patients:2
situ ,covid-19:2
detection ,lungs:2
detection ,airways:2
lungs ,airways:2
lungs ,patients:2
airways ,patients:2
airways ,covid-19:4
influence ,vaccination:2
influence ,tuberculosis:2
vaccination ,tuberculosis:2
beta-adrenergic ,blockers:2
beta-adrenergic ,potential:2
beta-adrenergic ,treatment:2
beta-adrenergic ,covid-19:2
beta-adrenergic ,patients:2
blockers ,treatment:2
blockers ,patients:2
evaluating ,safety:2
evaluating ,human:2
evaluating ,anti-sars-cov-2:2
evaluating ,convalescent:2
evaluating ,plasma:2
efficacy ,human:2
efficacy ,anti-sars-cov-2:2
efficacy ,convalescent:2
efficacy ,plasma:2
safety ,human:2
safety ,anti-sars-cov-2:2
safety ,convalescent:2
safety ,plasma:2
human ,anti-sars-cov-2:2
human ,convalescent:2
human ,plasma:2
rnaemia ,corresponds:2
rnaemia ,disease:4
rnaemia ,severity:2
rnaemia ,antibody:2
rnaemia ,response:2
rnaemia ,hospitalized:2
corresponds ,disease:2
corresponds ,severity:2
corresponds ,antibody:2
corresponds ,response:2
corresponds ,hospitalized:2
severity ,hospitalized:2
response ,hospitalized:2
covid-19 ,intense:2
covid-19 ,burning:2
patient ,intense:2
patient ,burning:2
patient ,pain:2
intense ,burning:2
intense ,pain:2
burning ,pain:2
kawasaki-like ,hypothesis:2
children ,hypothesis:2
immunological ,know:2
aspects ,know:2
four ,viral:2
four ,apocalypse:2
four ,pathogenesis:2
horsemen ,viral:2
horsemen ,apocalypse:2
horsemen ,pathogenesis:2
horsemen ,sars-cov-2:2
horsemen ,infection:2
viral ,apocalypse:2
apocalypse ,pathogenesis:2
apocalypse ,sars-cov-2:2
apocalypse ,infection:2
case ,multisystem:4
case ,temporally:2
pediatric ,multisystem:10
pediatric ,temporally:2
pediatric ,associated:4
temperature ,regional:2
temperature ,climate:2
temperature ,communitarian:2
temperature ,contagion:2
regional ,climate:2
regional ,effects:2
regional ,communitarian:2
regional ,contagion:2
climate ,effects:2
climate ,communitarian:2
climate ,covid-19:4
climate ,contagion:2
effects ,communitarian:2
effects ,contagion:2
communitarian ,covid-19:2
communitarian ,contagion:2
characteristics ,admitted:4
outcomes ,hospital:2
outcomes ,confirmed:2
pregnant ,hospital:2
pregnant ,confirmed:2
women ,hospital:2
women ,confirmed:2
admitted ,confirmed:2
hospital ,confirmed:2
dynamic ,linkage:2
dynamic ,test:2
dynamic ,results:2
dynamic ,public:2
dynamic ,health:2
dynamic ,englands:2
dynamic ,second:2
linkage ,covid-19:2
linkage ,test:2
linkage ,results:2
linkage ,public:2
linkage ,health:2
linkage ,englands:2
linkage ,second:2
covid-19 ,englands:2
covid-19 ,second:4
test ,public:2
test ,englands:2
test ,second:2
results ,public:2
results ,health:2
results ,englands:2
results ,second:2
public ,englands:2
public ,second:2
health ,englands:2
health ,second:2
englands ,second:2
mechanistic ,insights:4
mechanistic ,host:2
mechanistic ,cell:2
mechanistic ,fusion:2
mechanistic ,sars-cov-1:2
mechanistic ,atomic:2
insights ,host:2
insights ,cell:2
insights ,fusion:2
insights ,sars-cov-1:2
insights ,atomic:2
host ,fusion:2
host ,sars-cov-1:2
host ,atomic:2
cell ,sars-cov-1:2
cell ,atomic:2
fusion ,sars-cov-1:2
fusion ,atomic:2
sars-cov-1 ,atomic:2
sars-cov-2 ,atomic:2
behavior ,pr:2
behavior ,interval:2
behavior ,increasing:2
behavior ,heart:2
behavior ,rate:2
behavior ,patients:4
pr ,interval:2
pr ,increasing:2
pr ,heart:2
pr ,rate:2
pr ,patients:2
pr ,covid-19:2
interval ,increasing:2
interval ,heart:2
interval ,rate:2
interval ,patients:2
increasing ,heart:2
increasing ,rate:2
increasing ,patients:2
heart ,patients:8
containing ,covid-19:6
containing ,outside:2
containing ,isolation:2
containing ,ward:2
containing ,impact:4
containing ,control:2
outside ,isolation:2
outside ,ward:2
outside ,impact:2
outside ,control:2
isolation ,impact:2
isolation ,control:2
ward ,impact:2
ward ,infection:2
ward ,control:2
facing ,obstetricians:2
facing ,gynecologists:2
sars-cov-2 ,obstetricians:2
sars-cov-2 ,gynecologists:2
outbreak ,obstetricians:2
outbreak ,gynecologists:2
obstetricians ,gynecologists:4
delayed ,diagnosis:2
delayed ,postintubation:2
delayed ,tracheal:2
delayed ,stenosis:2
delayed ,due:2
diagnosis ,postintubation:2
diagnosis ,tracheal:2
diagnosis ,stenosis:2
diagnosis ,due:2
postintubation ,tracheal:2
postintubation ,stenosis:2
postintubation ,due:2
postintubation ,coronavirus:2
postintubation ,disease:2
tracheal ,due:2
tracheal ,coronavirus:2
tracheal ,disease:2
stenosis ,due:2
stenosis ,coronavirus:2
stenosis ,disease:2
antibody ,according:2
antibody ,atlanta:2
profiles ,according:2
profiles ,mild:2
profiles ,severe:2
profiles ,atlanta:2
according ,mild:2
according ,severe:2
according ,atlanta:2
mild ,atlanta:2
severe ,atlanta:2
sars-cov-2 ,atlanta:2
infection ,atlanta:2
rapid ,methods:2
serological ,methods:4
model-based ,evaluation:2
model-based ,efficacy:2
model-based ,covid-19:2
model-based ,social:2
model-based ,distancing:2
model-based ,testing:2
evaluation ,efficacy:2
evaluation ,social:2
evaluation ,distancing:2
efficacy ,social:2
efficacy ,distancing:2
efficacy ,testing:2
distancing ,testing:2
encephalitic ,syndrome:2
encephalitic ,anosmia:2
encephalitic ,covid-19:2
encephalitic ,clinical:2
encephalitic ,presentations:2
syndrome ,anosmia:4
syndrome ,presentations:2
anosmia ,clinical:2
anosmia ,presentations:2
clinical ,presentations:2
cases ,aortic:4
aortic ,thrombosis:6
aortic ,patients:4
aortic ,covid-19:8
exploring ,pharmacological:2
exploring ,approaches:2
exploring ,managing:2
exploring ,cytokine:2
exploring ,storm:2
exploring ,associated:2
pharmacological ,approaches:4
pharmacological ,managing:2
pharmacological ,cytokine:2
pharmacological ,storm:2
pharmacological ,associated:4
approaches ,managing:2
approaches ,cytokine:2
approaches ,storm:2
approaches ,associated:2
managing ,associated:2
immune ,systematic:4
system ,therapy:8
therapy ,systematic:2
tracheal ,swab:2
tracheal ,front:2
tracheal ,neck:2
tracheal ,airway:2
tracheal ,sars-cov-2:2
tracheal ,bronchial:2
tracheal ,foreign:2
tracheal ,body:2
swab ,front:2
swab ,neck:2
swab ,airway:2
swab ,bronchial:2
swab ,foreign:2
swab ,body:2
front ,neck:2
front ,airway:2
front ,sars-cov-2:2
front ,bronchial:2
front ,foreign:2
front ,body:2
neck ,airway:2
neck ,bronchial:2
neck ,foreign:2
neck ,body:2
airway ,bronchial:2
airway ,foreign:2
airway ,body:2
sars-cov-2 ,bronchial:2
sars-cov-2 ,foreign:2
bronchial ,foreign:2
bronchial ,body:2
covid-19 ,individual:2
covid-19 ,susceptibilityreceptivity:2
individual ,genetic:2
individual ,susceptibilityreceptivity:2
individual ,role:2
individual ,ace1ace2:2
individual ,genes:2
genetic ,susceptibilityreceptivity:2
genetic ,ace1ace2:2
susceptibilityreceptivity ,role:2
susceptibilityreceptivity ,ace1ace2:2
susceptibilityreceptivity ,genes:2
role ,ace1ace2:2
role ,genes:2
ace1ace2 ,genes:2
severe ,related:2
severe ,nightclub:2
acute ,related:4
acute ,nightclub:2
respiratory ,related:2
respiratory ,nightclub:2
syndrome ,related:6
syndrome ,nightclub:2
coronavirus ,nightclub:2
outbreak ,related:4
outbreak ,nightclub:2
related ,nightclub:2
systemic ,innate:2
systemic ,adaptive:2
systemic ,immune:2
systemic ,responses:4
systemic ,relates:2
innate ,relates:2
adaptive ,relates:2
immune ,relates:2
responses ,relates:2
sars-cov-2 ,relates:2
clarification ,misleading:2
clarification ,perceptions:2
clarification ,covid-19:2
clarification ,fatality:2
clarification ,testing:2
clarification ,rates:2
misleading ,perceptions:2
misleading ,covid-19:2
misleading ,fatality:2
misleading ,testing:2
misleading ,rates:2
perceptions ,fatality:2
perceptions ,testing:2
perceptions ,rates:2
fatality ,testing:2
testing ,rates:2
preliminary ,serological:2
preliminary ,assay:2
preliminary ,severe:2
preliminary ,acute:2
preliminary ,respiratory:2
preliminary ,syndrome:2
study ,assay:2
serological ,assay:4
assay ,syndrome:2
architecture ,inactivated:2
architecture ,postfusion:2
architecture ,spikes:2
architecture ,revealed:2
inactivated ,postfusion:2
inactivated ,spikes:2
inactivated ,revealed:2
sars-cov-2 ,postfusion:2
sars-cov-2 ,spikes:2
sars-cov-2 ,revealed:4
postfusion ,spikes:2
postfusion ,revealed:2
spikes ,revealed:2
fecal-oral ,children:2
fecal-oral ,time:2
fecal-oral ,change:2
transmission ,change:6
children ,change:4
small ,particle:2
small ,aerosol:2
small ,exposure:2
small ,african:2
small ,green:2
small ,monkeys:2
small ,mers-cov:2
small ,model:4
particle ,aerosol:2
particle ,exposure:2
particle ,african:2
particle ,green:2
particle ,monkeys:2
particle ,mers-cov:2
particle ,model:2
aerosol ,exposure:4
aerosol ,african:2
aerosol ,green:2
aerosol ,monkeys:2
aerosol ,mers-cov:2
exposure ,mers-cov:2
exposure ,model:2
african ,mers-cov:2
african ,model:2
green ,mers-cov:2
green ,model:2
monkeys ,mers-cov:2
monkeys ,model:2
mers-cov ,model:2
analysis ,multi-sample:2
analysis ,pools:2
analysis ,mass:2
multi-sample ,pools:2
multi-sample ,detection:2
multi-sample ,sars-cov-2:2
multi-sample ,rna:2
multi-sample ,mass:2
pools ,detection:2
pools ,rna:2
pools ,mass:2
rna ,mass:2
filtration ,efficiencies:2
filtration ,nanoscale:2
filtration ,aerosol:2
filtration ,cloth:2
filtration ,mask:2
filtration ,materials:2
filtration ,used:2
filtration ,slow:2
efficiencies ,nanoscale:2
efficiencies ,aerosol:2
efficiencies ,cloth:2
efficiencies ,mask:2
efficiencies ,materials:2
efficiencies ,used:2
efficiencies ,slow:2
nanoscale ,aerosol:2
nanoscale ,cloth:2
nanoscale ,mask:2
nanoscale ,materials:2
nanoscale ,used:2
nanoscale ,slow:2
aerosol ,cloth:2
aerosol ,mask:2
aerosol ,materials:2
aerosol ,used:2
aerosol ,slow:2
cloth ,mask:4
cloth ,materials:2
cloth ,used:2
cloth ,slow:2
mask ,materials:4
mask ,used:2
mask ,slow:2
materials ,used:2
materials ,slow:2
used ,slow:2
coronavirus ,haematologists:2
disease ,haematologists:2
covid-19 ,haematologists:2
haematologists ,perspective:2
anesthetic ,surgical:2
anesthetic ,tracheostomy:2
anesthetic ,patient:2
anesthetic ,covid-19:4
tracheostomy ,patient:2
systematic ,vaccine:2
systematic ,candidates:2
safety ,immunogenicity:2
safety ,chadox1:2
safety ,ncov-19:2
safety ,vaccine:2
immunogenicity ,chadox1:2
immunogenicity ,ncov-19:2
immunogenicity ,vaccine:2
immunogenicity ,sars-cov-2:2
chadox1 ,vaccine:2
ncov-19 ,vaccine:2
potential ,preimmune:2
potential ,igm:2
sars-cov-2 ,preimmune:2
preimmune ,igm:2
preimmune ,epitopes:2
igm ,epitopes:2
experimental ,cats:2
experimental ,pathogenesis:2
domestic ,dogs:2
domestic ,pathogenesis:2
dogs ,cats:6
dogs ,pathogenesis:2
cats ,pathogenesis:2
key ,zinc:2
key ,elderly:2
key ,immunity:2
key ,possible:2
key ,approach:2
role ,zinc:2
role ,elderly:2
role ,approach:2
zinc ,elderly:2
zinc ,immunity:2
zinc ,possible:2
zinc ,approach:2
elderly ,immunity:2
elderly ,possible:2
elderly ,approach:2
immunity ,possible:2
immunity ,approach:2
possible ,approach:2
hydroxychloroquine ,safety:4
hydroxychloroquine ,preventing:2
efficacy ,preventing:4
efficacy ,infection:2
safety ,preventing:2
safety ,infection:2
risk ,laparoscopic:2
risk ,may:6
covid-19 ,laparoscopic:2
covid-19 ,smoke:2
transmission ,laparoscopic:2
transmission ,smoke:2
transmission ,may:4
transmission ,lower:2
laparoscopic ,smoke:2
laparoscopic ,may:2
laparoscopic ,lower:2
smoke ,may:2
smoke ,lower:2
may ,lower:2
evaluation ,prevention:2
evaluation ,control:2
evaluation ,interventions:2
evaluation ,impact:2
prevention ,impact:4
control ,interventions:4
interventions ,epidemic:4
sars-cov-2 ,age:8
receptor ,small:2
receptor ,intestine:2
receptor ,correlates:2
receptor ,age:2
ace2 ,intestine:2
ace2 ,correlates:2
ace2 ,age:2
gene ,small:2
gene ,intestine:2
gene ,correlates:2
gene ,age:2
expression ,intestine:2
expression ,correlates:2
expression ,age:2
small ,intestine:2
small ,correlates:2
small ,age:2
intestine ,correlates:2
intestine ,age:2
correlates ,age:2
long-term ,changed:2
long-term ,bodys:2
long-term ,immune:2
long-term ,status:2
infection ,changed:2
infection ,bodys:2
sars-cov-2 ,changed:2
sars-cov-2 ,bodys:2
changed ,bodys:2
changed ,immune:2
changed ,status:2
bodys ,immune:2
bodys ,status:2
stability ,issues:2
stability ,rt-pcr:2
stability ,testing:2
stability ,hospitalized:2
stability ,patients:2
issues ,rt-pcr:2
issues ,testing:2
issues ,sars-cov-2:4
issues ,hospitalized:2
rt-pcr ,hospitalized:2
zika ,host:2
zika ,interactions:2
zika ,bench:2
zika ,bedside:2
zika ,beyond:2
virus ,interactions:2
virus ,bench:2
virus ,bedside:2
virus ,beyond:2
host ,interactions:4
host ,bench:2
host ,bedside:2
host ,beyond:2
interactions ,bench:2
interactions ,bedside:2
interactions ,beyond:2
bench ,beyond:2
bedside ,beyond:2
genetic ,open:2
genetic ,reading:2
genetic ,fram-8:2
genetic ,proteins:2
characterization ,open:2
characterization ,reading:2
characterization ,fram-8:2
characterization ,proteins:2
structural ,open:2
structural ,reading:2
structural ,fram-8:2
open ,fram-8:2
open ,proteins:2
reading ,fram-8:2
reading ,proteins:2
fram-8 ,proteins:2
targeting ,zinc:2
targeting ,metalloenzymes:2
targeting ,disease:2
zinc ,metalloenzymes:2
zinc ,coronavirus:2
zinc ,disease:2
metalloenzymes ,coronavirus:2
metalloenzymes ,disease:2
virus ,gone:2
virus ,amino:2
virus ,mutation:4
virus ,protein:2
virus ,indian:2
virus ,isolate:2
gone ,viral:2
gone ,amino:2
gone ,acid:2
gone ,mutation:2
gone ,protein:2
gone ,indian:2
gone ,isolate:2
viral ,amino:2
viral ,protein:4
viral ,indian:2
viral ,isolate:2
amino ,mutation:2
amino ,protein:4
amino ,indian:2
amino ,isolate:2
acid ,mutation:2
acid ,protein:6
acid ,indian:2
acid ,isolate:2
mutation ,indian:2
mutation ,isolate:2
protein ,indian:2
protein ,isolate:2
indian ,isolate:2
genome-wide ,computational:2
genome-wide ,prediction:2
genome-wide ,mirnas:2
genome-wide ,severe:2
genome-wide ,acute:2
genome-wide ,respiratory:2
genome-wide ,syndrome:2
computational ,prediction:2
computational ,mirnas:2
computational ,severe:2
computational ,acute:2
computational ,respiratory:2
computational ,syndrome:2
prediction ,severe:4
prediction ,acute:2
prediction ,respiratory:2
prediction ,syndrome:2
mirnas ,severe:2
mirnas ,acute:2
mirnas ,respiratory:2
mirnas ,syndrome:2
epidemiological ,incubation:2
epidemiological ,period:4
epidemiological ,7015:2
epidemiological ,confirmed:2
characteristics ,incubation:2
characteristics ,period:4
characteristics ,7015:2
incubation ,7015:2
incubation ,confirmed:2
incubation ,cases:2
period ,7015:2
period ,confirmed:2
period ,cases:4
7015 ,confirmed:2
7015 ,cases:2
covid-19 ,microbleeds:2
associated ,unusual:2
associated ,pattern:2
associated ,brain:4
associated ,microbleeds:2
associated ,critically:2
unusual ,pattern:2
unusual ,brain:2
unusual ,microbleeds:2
unusual ,critically:2
pattern ,brain:2
pattern ,microbleeds:2
pattern ,critically:2
brain ,microbleeds:2
brain ,critically:2
microbleeds ,critically:2
mild ,cladribine-treated:2
mild ,multiple:2
mild ,sclerosis:2
covid-19 ,cladribine-treated:2
symptoms ,cladribine-treated:2
symptoms ,multiple:2
symptoms ,sclerosis:2
symptoms ,two:2
symptoms ,cases:4
cladribine-treated ,multiple:2
cladribine-treated ,sclerosis:2
cladribine-treated ,two:2
cladribine-treated ,cases:2
update ,approaches:2
update ,emerging:2
update ,therapies:2
therapeutic ,therapies:2
therapeutic ,virus:2
approaches ,therapies:2
emerging ,therapies:2
emerging ,virus:2
therapies ,virus:2
brief ,interplay:2
brief ,vitamin:2
brief ,angiotensin-converting:2
brief ,enzyme:2
review ,interplay:2
review ,vitamin:2
review ,angiotensin-converting:2
review ,enzyme:2
interplay ,vitamin:2
interplay ,angiotensin-converting:2
interplay ,enzyme:2
vitamin ,angiotensin-converting:2
vitamin ,enzyme:2
coronavirus ,antimicrobial:2
disease ,antimicrobial:2
children ,antimicrobial:2
characteristics ,antimicrobial:2
antimicrobial ,treatment:2
critical ,adjustments:2
critical ,department:2
critical ,orthopaedics:2
adjustments ,department:2
adjustments ,orthopaedics:2
department ,orthopaedics:2
orthopaedics ,covid-19:2
orthopaedics ,pandemic:2
male ,genital:2
male ,damage:2
male ,patients:2
male ,available:2
male ,data:2
male ,relevant:2
genital ,damage:2
genital ,covid-19:2
genital ,patients:2
genital ,available:2
genital ,data:2
genital ,relevant:2
damage ,available:2
damage ,data:2
damage ,relevant:2
patients ,available:2
patients ,data:2
patients ,relevant:2
available ,data:2
available ,relevant:2
data ,relevant:2
computationally ,optimized:2
computationally ,sars-cov-2:2
computationally ,mhc:2
computationally ,class:2
computationally ,ii:2
computationally ,vaccine:2
computationally ,formulations:2
optimized ,mhc:2
optimized ,class:2
optimized ,ii:2
optimized ,vaccine:2
optimized ,formulations:2
sars-cov-2 ,mhc:2
sars-cov-2 ,class:6
sars-cov-2 ,formulations:2
mhc ,class:2
mhc ,ii:2
mhc ,vaccine:2
mhc ,formulations:2
class ,ii:4
class ,vaccine:2
class ,formulations:2
ii ,vaccine:2
ii ,formulations:2
vaccine ,formulations:2
antiviral ,green:2
antiviral ,tea:2
antiviral ,black:2
antiviral ,polyphenols:2
antiviral ,prophylaxis:4
activity ,green:2
activity ,tea:2
activity ,black:2
activity ,polyphenols:2
activity ,prophylaxis:2
green ,tea:2
green ,black:2
green ,polyphenols:2
green ,prophylaxis:2
tea ,black:2
tea ,polyphenols:2
tea ,prophylaxis:2
black ,polyphenols:2
black ,prophylaxis:2
polyphenols ,prophylaxis:2
ageusia ,common:2
ageusia ,sign:2
ageusia ,case:2
ageusia ,series:2
ageusia ,four:2
ageusia ,countries:2
anosmia ,common:2
anosmia ,sign:2
anosmia ,case:4
anosmia ,series:2
anosmia ,four:2
anosmia ,countries:2
common ,sign:2
common ,case:2
common ,series:2
common ,four:2
common ,countries:2
sign ,series:2
sign ,four:2
sign ,countries:2
case ,four:2
case ,countries:2
series ,four:4
series ,countries:2
four ,countries:2
ifso ,endoscopy:2
ifso ,committee:2
ifso ,position:2
ifso ,statement:2
ifso ,practice:2
ifso ,bariatric:2
endoscopy ,committee:2
endoscopy ,position:4
endoscopy ,statement:2
endoscopy ,practice:2
endoscopy ,bariatric:2
committee ,position:2
committee ,statement:2
committee ,practice:2
committee ,bariatric:2
position ,practice:2
position ,bariatric:2
statement ,practice:2
statement ,bariatric:2
practice ,bariatric:2
necessity ,detection:2
necessity ,sars-cov-2:2
necessity ,rna:2
necessity ,multiple:2
necessity ,types:2
necessity ,specimens:2
rna ,multiple:2
rna ,types:2
multiple ,specimens:2
inflammation ,intussusceptive:2
inflammation ,angiogenesis:2
inflammation ,everything:2
intussusceptive ,angiogenesis:2
intussusceptive ,covid-19:2
intussusceptive ,everything:2
angiogenesis ,covid-19:2
angiogenesis ,everything:2
sofosbuvir ,potential:2
sofosbuvir ,alternative:2
sofosbuvir ,treat:2
sofosbuvir ,epidemic:2
potential ,alternative:2
alternative ,treat:2
alternative ,epidemic:2
treat ,epidemic:2
neonatal ,current:2
neonatal ,evidence:2
neonatal ,practical:2
neonatal ,approach:2
respiratory ,care:2
respiratory ,practical:2
respiratory ,approach:2
current ,practical:2
current ,approach:2
evidence ,practical:2
evidence ,approach:2
practical ,approach:4
telepsychiatry ,adults:2
telepsychiatry ,adolescents:2
telepsychiatry ,useful:2
telepsychiatry ,tool:2
telepsychiatry ,covid-19:2
adults ,adolescents:2
adults ,useful:2
adults ,tool:2
adolescents ,useful:2
adolescents ,tool:2
adolescents ,covid-19:6
useful ,tool:2
novel ,negative:4
coronavirus ,negative:4
covid-19 ,cubas:2
case ,cubas:2
case ,screening:2
detection ,cubas:2
detection ,active:2
detection ,screening:2
cubas ,active:2
cubas ,screening:2
cubas ,approach:2
active ,screening:2
active ,approach:2
screening ,approach:2
in-silico ,evaluation:2
in-silico ,different:2
in-silico ,saikosaponins:2
in-silico ,potency:2
evaluation ,different:6
evaluation ,saikosaponins:2
evaluation ,potency:2
different ,saikosaponins:2
different ,potency:2
saikosaponins ,potency:2
patterns ,viral:2
patterns ,clearance:2
patterns ,natural:2
patterns ,course:2
patterns ,asymptomatic:2
clearance ,natural:2
clearance ,course:2
clearance ,asymptomatic:2
natural ,course:2
natural ,asymptomatic:2
effect ,college:2
effect ,students:2
effect ,wuhan:2
novel ,college:2
novel ,students:2
coronavirus ,college:2
coronavirus ,students:2
pandemic ,college:2
pandemic ,students:2
pandemic ,wuhan:4
college ,students:2
college ,wuhan:2
students ,wuhan:2
pres ,covid-19:2
pres ,patient:2
alterations ,fecal:2
alterations ,fungal:2
alterations ,microbiome:2
alterations ,patients:6
alterations ,time:4
fecal ,fungal:2
fecal ,microbiome:2
fecal ,time:2
fungal ,microbiome:2
fungal ,time:2
microbiome ,patients:2
microbiome ,time:2
liu ,shen:2
liu ,capsule:2
liu ,shows:2
liu ,antiviral:2
liu ,anti-inflammatory:2
liu ,abilities:2
liu ,novel:2
shen ,capsule:2
shen ,shows:2
shen ,antiviral:2
shen ,anti-inflammatory:2
shen ,abilities:2
shen ,novel:2
capsule ,shows:2
capsule ,antiviral:2
capsule ,anti-inflammatory:2
capsule ,abilities:2
capsule ,novel:2
shows ,antiviral:2
shows ,anti-inflammatory:2
shows ,abilities:2
shows ,novel:2
antiviral ,abilities:2
anti-inflammatory ,abilities:2
abilities ,novel:2
association ,genomic:2
association ,trends:2
association ,status:4
genomic ,load:2
genomic ,trends:2
genomic ,clinical:4
genomic ,status:2
load ,trends:2
load ,status:2
trends ,clinical:2
trends ,status:2
nurse ,infected:2
nurse ,covid-19:2
nurse ,provisional:2
nurse ,dengue:2
nurse ,patient:2
infected ,provisional:2
infected ,dengue:2
covid-19 ,provisional:2
provisional ,dengue:2
provisional ,patient:2
dengue ,patient:2
bcg ,strategy:2
bcg ,implemented:2
bcg ,reduce:2
bcg ,hype:2
vaccination ,strategy:2
vaccination ,implemented:2
vaccination ,reduce:2
vaccination ,hype:2
vaccination ,hope:2
strategy ,implemented:2
strategy ,impact:4
strategy ,hype:2
strategy ,hope:2
implemented ,reduce:2
implemented ,impact:2
implemented ,covid-19:2
implemented ,hype:2
implemented ,hope:2
reduce ,impact:2
reduce ,hype:2
reduce ,hope:2
impact ,hype:2
impact ,hope:2
covid-19 ,hype:4
covid-19 ,hope:4
characteristics ,considerations:2
homo ,sapiens:2
homo ,versus:2
homo ,sars-cov-2:2
sapiens ,versus:2
sapiens ,sars-cov-2:2
prevalence ,mortality:2
prevalence ,-thalassaemias:2
prevalence ,due:2
prevalence ,outbreak:2
mortality ,-thalassaemias:2
mortality ,novel:2
-thalassaemias ,due:2
-thalassaemias ,outbreak:2
-thalassaemias ,novel:2
-thalassaemias ,coronavirus:2
due ,outbreak:2
due ,novel:2
dark ,side:2
dark ,spoon:2
dark ,glucose:2
dark ,ketones:2
dark ,possible:2
dark ,role:2
side ,spoon:2
side ,glucose:2
side ,ketones:2
side ,possible:2
side ,role:2
spoon ,glucose:2
spoon ,ketones:2
spoon ,covid-19:2
spoon ,possible:2
spoon ,role:2
glucose ,ketones:2
glucose ,covid-19:2
glucose ,possible:2
glucose ,role:2
ketones ,covid-19:2
ketones ,possible:2
ketones ,role:2
antimalarials ,antivirals:2
antimalarials ,believe:2
antivirals ,covid-19:4
antivirals ,believe:2
covid-19 ,believe:2
practical ,cancer:2
practical ,novel:2
approach ,cancer:2
approach ,patients:2
cancer ,novel:2
serological ,related:2
serological ,aim:2
serological ,well:2
tests ,related:2
tests ,aim:2
tests ,well:2
related ,aim:2
related ,testing:2
related ,well:2
aim ,testing:2
aim ,well:2
testing ,well:2
inhibition ,cyclophilin:2
inhibition ,inhibitor:2
inhibition ,alisporivir:2
inhibition ,debio:2
sars-cov-2 ,cyclophilin:2
sars-cov-2 ,alisporivir:2
sars-cov-2 ,debio:2
infection ,cyclophilin:2
infection ,alisporivir:2
infection ,debio:2
cyclophilin ,inhibitor:4
cyclophilin ,alisporivir:4
cyclophilin ,debio:2
inhibitor ,alisporivir:4
inhibitor ,debio:2
alisporivir ,debio:2
recovery ,moderate:2
recovery ,disease:4
recovery ,liver:2
recovery ,transplant:2
recovery ,recipient:2
moderate ,coronavirus:2
moderate ,disease:2
moderate ,liver:2
moderate ,transplant:2
moderate ,recipient:2
coronavirus ,recipient:4
disease ,recipient:2
liver ,recipient:4
interactions ,receptor-binding:2
interactions ,domain:4
interactions ,sars-cov-1:2
receptor-binding ,sars-cov-1:2
domain ,sars-cov-1:2
immunoglobulins ,covid-19:2
immunoglobulins ,infection:2
immunoglobulins ,proceed:2
immunoglobulins ,caution:2
treatment ,proceed:2
treatment ,caution:2
covid-19 ,proceed:2
covid-19 ,caution:4
infection ,proceed:2
infection ,caution:2
proceed ,caution:2
library ,nucleotide:2
library ,analogues:2
library ,terminate:2
library ,rna:2
library ,synthesis:2
library ,catalyzed:2
library ,polymerases:2
nucleotide ,terminate:2
nucleotide ,rna:2
nucleotide ,synthesis:2
nucleotide ,catalyzed:2
nucleotide ,polymerases:2
analogues ,terminate:2
analogues ,rna:2
analogues ,synthesis:2
analogues ,catalyzed:2
analogues ,polymerases:2
terminate ,rna:2
terminate ,synthesis:2
terminate ,catalyzed:2
terminate ,polymerases:2
rna ,synthesis:2
rna ,catalyzed:2
synthesis ,catalyzed:2
synthesis ,polymerases:2
catalyzed ,polymerases:2
exposure ,novel:4
exposure ,renal:2
exposure ,replacement:2
exposure ,therapy:2
novel ,renal:4
novel ,replacement:2
coronavirus ,replacement:2
smoking ,sars-cov-2:2
smoking ,review:4
smoking ,reviews:2
smoking ,considering:2
smoking ,implications:2
sars-cov-2 ,reviews:2
sars-cov-2 ,considering:2
covid-19 ,reviews:2
covid-19 ,considering:2
review ,reviews:2
review ,considering:2
reviews ,considering:2
reviews ,implications:2
considering ,implications:2
autophagyvirophagy ,disposal:2
autophagyvirophagy ,strategy:2
autophagyvirophagy ,combat:2
autophagyvirophagy ,covid-19:2
disposal ,strategy:2
disposal ,combat:2
disposal ,covid-19:2
restructured ,society:2
restructured ,environment:2
restructured ,review:2
restructured ,potential:2
restructured ,technological:2
restructured ,strategies:2
society ,review:4
society ,potential:2
society ,technological:2
society ,strategies:2
environment ,review:2
environment ,technological:2
environment ,strategies:2
review ,technological:2
review ,strategies:4
potential ,technological:2
technological ,strategies:2
fever ,loss:2
fever ,vision:2
fever ,acute:2
fever ,promyelocytic:2
fever ,leukemia:2
fever ,pandemic:2
fever ,ward:2
loss ,promyelocytic:2
loss ,leukemia:2
loss ,pandemic:2
loss ,ward:2
vision ,promyelocytic:2
vision ,leukemia:2
vision ,pandemic:2
vision ,ward:2
acute ,promyelocytic:2
acute ,leukemia:4
acute ,ward:2
promyelocytic ,leukemia:2
promyelocytic ,pandemic:2
promyelocytic ,ward:2
leukemia ,pandemic:2
leukemia ,ward:2
pandemic ,ward:2
impact ,lung:2
impact ,scheduling:2
covid-19 ,scheduling:2
pandemic ,scheduling:2
lung ,treatment:6
lung ,scheduling:2
cancer ,scheduling:2
treatment ,scheduling:2
risk ,endoscopy:2
stratification ,personal:2
stratification ,protective:2
stratification ,equipment:2
stratification ,use:2
stratification ,pediatric:2
stratification ,endoscopy:2
personal ,pediatric:4
personal ,endoscopy:2
protective ,pediatric:4
protective ,endoscopy:2
equipment ,use:6
equipment ,pediatric:4
equipment ,endoscopy:2
use ,pediatric:2
use ,endoscopy:2
pediatric ,endoscopy:2
acute ,appendicitis:2
acute ,four:2
appendicitis ,four:2
appendicitis ,children:2
appendicitis ,sars-cov-2:2
appendicitis ,infection:2
four ,children:2
sleep ,breathing:2
sleep ,disorders:2
sleep ,italian:2
sleep ,thoracic:2
sleep ,society:2
breathing ,disorders:2
breathing ,covid-19:2
breathing ,era:2
breathing ,italian:2
breathing ,thoracic:2
breathing ,society:2
disorders ,era:2
disorders ,italian:2
disorders ,thoracic:2
disorders ,society:2
covid-19 ,thoracic:8
era ,italian:2
era ,thoracic:2
era ,society:2
italian ,thoracic:4
thoracic ,society:2
suggestions ,surgical:2
suggestions ,treatment:2
surgical ,coronavirus:6
surgical ,disease:4
experience ,pregnant:4
experience ,women:4
experience ,newborns:2
experience ,novel:2
management ,pregnant:6
management ,women:4
management ,newborns:2
pregnant ,newborns:2
women ,newborns:2
women ,novel:2
effectiveness ,preventive:2
effectiveness ,measures:4
effectiveness ,systematic:2
preventive ,systematic:2
preventive ,review:4
measures ,systematic:2
transforming ,surgical:2
transforming ,department:2
transforming ,outbreak:2
transforming ,new:2
transforming ,coronavirus:2
transforming ,pandemic:2
surgical ,outbreak:4
department ,outbreak:4
department ,new:2
first ,person-to-person:2
known ,person-to-person:2
known ,transmission:2
person-to-person ,transmission:2
person-to-person ,severe:2
person-to-person ,acute:2
person-to-person ,respiratory:2
person-to-person ,syndrome:2
viral ,challenges:2
viral ,developing:2
viral ,vaccination:2
viral ,strategies:2
emerging ,developing:2
emerging ,vaccination:2
diseases ,challenges:2
diseases ,developing:2
diseases ,vaccination:2
diseases ,strategies:2
challenges ,developing:2
challenges ,vaccination:2
challenges ,strategies:2
developing ,vaccination:2
developing ,strategies:2
high ,discover:2
high ,inhibitors:2
high ,main:2
high ,protease:2
throughput ,discover:2
throughput ,inhibitors:2
throughput ,main:2
throughput ,protease:2
virtual ,discover:2
virtual ,inhibitors:6
virtual ,protease:4
screening ,discover:2
screening ,inhibitors:10
screening ,protease:6
discover ,inhibitors:2
discover ,main:2
discover ,protease:2
intra- ,intermolecular:2
intra- ,atomic-scale:2
intra- ,interactions:2
intra- ,receptor:2
intra- ,binding:2
intra- ,domain:2
intermolecular ,atomic-scale:2
intermolecular ,interactions:2
intermolecular ,receptor:2
intermolecular ,binding:2
intermolecular ,domain:2
atomic-scale ,interactions:2
atomic-scale ,receptor:2
atomic-scale ,binding:2
atomic-scale ,domain:2
interactions ,receptor:4
interactions ,binding:4
maternal ,full-term:2
maternal ,combined:2
maternal ,covid-2019:2
infant ,full-term:2
infant ,pregnancy:2
infant ,combined:2
infant ,covid-2019:2
outcomes ,full-term:2
outcomes ,combined:2
outcomes ,covid-2019:2
full-term ,pregnancy:2
full-term ,combined:2
full-term ,covid-2019:2
pregnancy ,combined:2
pregnancy ,covid-2019:2
combined ,covid-2019:2
angiotensin-converting ,covid:2
angiotensin-converting ,19:2
angiotensin-converting ,gate:2
angiotensin-converting ,way:2
angiotensin-converting ,multiple:2
angiotensin-converting ,organ:2
angiotensin-converting ,failure:2
enzyme ,covid:2
enzyme ,19:2
enzyme ,gate:2
enzyme ,way:2
enzyme ,multiple:2
enzyme ,organ:2
enzyme ,failure:2
ace2 ,covid:2
ace2 ,19:2
ace2 ,gate:2
ace2 ,way:2
ace2 ,failure:4
covid ,gate:2
covid ,way:2
covid ,multiple:2
covid ,organ:2
covid ,failure:4
19 ,gate:2
19 ,way:2
19 ,multiple:2
19 ,organ:2
19 ,failure:4
gate ,way:2
gate ,multiple:2
gate ,organ:2
gate ,failure:2
way ,multiple:2
way ,organ:2
way ,failure:2
multiple ,organ:4
multiple ,failure:4
whither ,covid-19:2
whither ,vaccines:2
optimization ,cdc:2
optimization ,protocol:2
optimization ,molecular:2
optimization ,diagnosis:2
optimization ,timely:2
cdc ,protocol:2
cdc ,molecular:2
cdc ,diagnosis:2
cdc ,covid-19:2
cdc ,timely:2
protocol ,molecular:2
protocol ,diagnosis:2
protocol ,timely:2
molecular ,timely:2
clinical ,outbreak:6
rhabdomyolysis ,kidney:2
rhabdomyolysis ,injury:2
rhabdomyolysis ,severe:2
rhabdomyolysis ,infection:2
kidney ,severe:2
intestinal ,dysbiosis:2
intestinal ,contribute:2
intestinal ,aberrant:2
intestinal ,inflammatory:2
intestinal ,response:2
intestinal ,severe:2
dysbiosis ,contribute:2
dysbiosis ,aberrant:2
dysbiosis ,inflammatory:2
dysbiosis ,response:2
dysbiosis ,severe:2
contribute ,aberrant:2
contribute ,inflammatory:2
contribute ,response:2
contribute ,severe:4
aberrant ,inflammatory:2
aberrant ,response:2
aberrant ,severe:2
inflammatory ,severe:2
temporal ,correlation:2
temporal ,neurological:2
temporal ,gastrointestinal:2
temporal ,symptoms:2
correlation ,gastrointestinal:2
correlation ,symptoms:2
neurological ,gastrointestinal:2
analysis ,property:2
analysis ,efficacy:2
analysis ,staging:2
property ,efficacy:2
property ,traditional:2
property ,chinese:2
property ,medicine:2
property ,staging:2
efficacy ,traditional:2
efficacy ,chinese:2
efficacy ,medicine:2
efficacy ,staging:2
traditional ,staging:2
chinese ,staging:2
medicine ,staging:2
clinical ,pathogen:2
clinical ,admitted:2
manifestations ,pathogen:2
manifestations ,admitted:2
pathogen ,characteristics:2
pathogen ,children:2
pathogen ,admitted:2
children ,admitted:4
two ,consecutive:2
two ,negative:4
two ,rt-pcr:2
two ,enough:2
two ,rule:2
consecutive ,negative:2
consecutive ,rt-pcr:2
consecutive ,results:2
consecutive ,enough:2
consecutive ,rule:2
negative ,enough:2
negative ,rule:2
rt-pcr ,enough:2
rt-pcr ,rule:2
results ,enough:2
results ,rule:2
enough ,rule:2
enough ,covid-19:4
rule ,covid-19:2
utilization ,deceased:2
utilization ,donors:2
utilization ,argument:2
utilization ,using:2
deceased ,pandemic:2
deceased ,argument:2
deceased ,using:2
donors ,pandemic:2
donors ,argument:2
donors ,using:2
pandemic ,argument:2
argument ,using:2
covid-19 ,-weather:2
covid-19 ,baseline:4
covid-19 ,veracity:2
environmental ,-weather:2
environmental ,markers:2
environmental ,unfolding:2
environmental ,baseline:2
environmental ,levels:2
environmental ,veracity:2
-weather ,markers:2
-weather ,unfolding:2
-weather ,baseline:2
-weather ,levels:2
-weather ,veracity:2
markers ,unfolding:2
markers ,baseline:2
markers ,levels:2
markers ,veracity:2
unfolding ,baseline:2
unfolding ,levels:2
unfolding ,veracity:2
baseline ,levels:2
baseline ,veracity:2
levels ,veracity:2
infections ,mers:4
infections ,narrative:4
children ,mers:2
children ,narrative:2
sars ,narrative:2
mers ,narrative:2
evidence ,cutaneous:2
evidence ,manifestation:2
chilblains ,cutaneous:2
chilblains ,manifestation:2
evidence-based ,treatment:2
evidence-based ,identifying:2
evidence-based ,knowns:2
treatment ,identifying:2
treatment ,knowns:2
sars-cov-2 ,identifying:2
pandemic ,identifying:2
pandemic ,knowns:2
identifying ,knowns:2
pharmacies ,frontline:2
pharmacies ,responding:2
pharmacies ,covid-19:2
pharmacies ,pandemic:2
frontline ,responding:2
antibody ,cocktail:2
antibody ,prevents:2
antibody ,mutational:2
antibody ,escape:2
antibody ,seen:2
cocktail ,sars-cov-2:2
cocktail ,spike:2
cocktail ,protein:2
cocktail ,prevents:2
cocktail ,rapid:2
cocktail ,mutational:2
cocktail ,escape:2
cocktail ,seen:2
sars-cov-2 ,mutational:4
sars-cov-2 ,seen:2
spike ,prevents:2
spike ,mutational:2
spike ,escape:2
spike ,seen:2
protein ,prevents:2
protein ,rapid:2
protein ,mutational:2
protein ,escape:2
protein ,seen:2
prevents ,rapid:2
prevents ,mutational:2
prevents ,escape:2
prevents ,seen:2
rapid ,mutational:2
rapid ,escape:2
rapid ,seen:2
mutational ,escape:2
mutational ,seen:2
escape ,seen:2
sars-cov-2 ,invades:2
sars-cov-2 ,lombardy:2
invades ,west:2
invades ,face:2
invades ,covid-19:2
invades ,epidemic:2
invades ,lombardy:2
invades ,northern:2
west ,face:2
west ,covid-19:4
west ,epidemic:2
west ,lombardy:2
west ,northern:2
face ,epidemic:2
face ,lombardy:2
face ,northern:2
epidemic ,northern:4
lombardy ,northern:2
gustatory ,patients:2
mental ,systematic:2
mental ,current:2
health ,systematic:2
health ,current:4
consequences ,systematic:2
consequences ,current:2
detecting ,re-emergent:2
detecting ,elimination:2
detecting ,modelling:2
detecting ,study:2
re-emergent ,covid-19:2
re-emergent ,pandemic:2
re-emergent ,elimination:2
re-emergent ,modelling:2
re-emergent ,study:2
covid-19 ,elimination:2
pandemic ,elimination:2
elimination ,modelling:2
elimination ,study:2
revisiting ,immune:2
revisiting ,balance:2
revisiting ,theory:2
revisiting ,neurological:2
revisiting ,insight:2
revisiting ,epidemic:2
immune ,balance:2
immune ,theory:2
immune ,neurological:2
immune ,insight:4
immune ,epidemic:2
balance ,theory:2
balance ,neurological:2
balance ,insight:2
balance ,epidemic:2
theory ,neurological:2
theory ,insight:2
theory ,epidemic:2
neurological ,insight:2
insight ,epidemic:2
pathogenesis ,covid-19-induced:2
pathogenesis ,ards:2
pathogenesis ,ageing:2
pathogenesis ,population:2
covid-19-induced ,ards:2
covid-19-induced ,implications:2
covid-19-induced ,ageing:2
covid-19-induced ,population:2
ards ,implications:2
ards ,ageing:2
ards ,population:2
implications ,ageing:2
implications ,population:2
ageing ,population:2
primer ,mathematical:2
primer ,models:2
gastrointestinal ,acute:4
gastrointestinal ,syndrome:2
hepatic ,severe:2
hepatic ,acute:2
hepatic ,respiratory:2
hepatic ,syndrome:2
covid-19 ,ibuprofen:6
pandemic ,ibuprofen:2
therapy ,ibuprofen:2
therapy ,renin-angiotensin:4
therapy ,blockers:2
ibuprofen ,renin-angiotensin:2
ibuprofen ,system:2
ibuprofen ,blockers:2
covid-19 ,multicenter:4
patients ,multicenter:2
hypertension ,multicenter:2
severe ,multicenter:4
disease ,multicenter:4
exploring ,genetics:2
exploring ,ecology:2
exploring ,climatic:2
exploring ,factors:2
exploring ,possible:2
genetics ,climatic:2
genetics ,factors:2
genetics ,possible:2
ecology ,climatic:2
ecology ,factors:2
ecology ,possible:2
sars-cov-2 ,climatic:2
climatic ,possible:2
factors ,possible:2
covid-19 ,practitioners:2
pandemic ,important:2
pandemic ,contact:2
pandemic ,practitioners:2
important ,considerations:2
important ,contact:2
important ,lens:2
important ,practitioners:2
considerations ,contact:2
considerations ,lens:2
considerations ,practitioners:2
contact ,lens:2
contact ,practitioners:2
lens ,practitioners:2
stress ,anxiety:2
stress ,depression:2
stress ,insomnia:2
stress ,adults:2
stress ,outside:2
stress ,hubei:2
stress ,province:2
anxiety ,insomnia:2
anxiety ,adults:2
anxiety ,outside:2
anxiety ,hubei:2
anxiety ,province:2
depression ,insomnia:2
depression ,adults:2
depression ,outside:2
depression ,hubei:2
depression ,province:2
insomnia ,adults:2
insomnia ,outside:2
insomnia ,hubei:2
insomnia ,province:2
adults ,outside:2
adults ,hubei:2
adults ,province:2
outside ,hubei:4
outside ,province:2
presented ,deep:2
presented ,vein:2
presented ,thrombosis:2
presented ,unusual:2
presented ,presenting:2
deep ,unusual:2
deep ,presenting:2
vein ,unusual:2
vein ,presenting:2
thrombosis ,unusual:2
thrombosis ,presenting:2
unusual ,presenting:2
autophagy ,sars-cov-2:4
autophagy ,infection:2
autophagy ,apossible:2
autophagy ,smart:2
sars-cov-2 ,apossible:2
sars-cov-2 ,smart:2
infection ,apossible:2
infection ,smart:2
apossible ,smart:2
apossible ,targeting:2
smart ,targeting:2
covid-19 ,toolset:2
orthopaedic ,safe:2
orthopaedic ,care:2
orthopaedic ,toolset:2
orthopaedic ,guidelines:4
orthopaedic ,diagnosis:2
orthopaedic ,management:2
safe ,care:2
safe ,toolset:2
safe ,guidelines:2
safe ,diagnosis:2
care ,toolset:2
care ,guidelines:4
care ,diagnosis:2
toolset ,guidelines:2
toolset ,diagnosis:2
toolset ,management:2
guidelines ,diagnosis:2
capturing ,patient-reported:2
capturing ,outcomes:2
capturing ,covid-19:2
capturing ,pandemic:2
capturing ,development:2
patient-reported ,outcomes:2
patient-reported ,covid-19:2
patient-reported ,pandemic:2
patient-reported ,development:2
outcomes ,development:2
targeted ,site-specific:2
targeted ,delivery:2
targeted ,vehicles:2
targeted ,therapeutics:2
targeted ,patients:2
site-specific ,delivery:2
site-specific ,vehicles:2
site-specific ,therapeutics:2
site-specific ,covid-19:2
site-specific ,patients:2
delivery ,vehicles:2
delivery ,therapeutics:2
delivery ,patients:2
vehicles ,therapeutics:2
vehicles ,covid-19:2
vehicles ,patients:2
therapeutics ,patients:4
minimal ,impact:2
minimal ,outbreak:2
minimal ,postoperative:2
minimal ,morbidity:2
minimal ,mortality:2
impact ,postoperative:2
impact ,morbidity:2
outbreak ,postoperative:2
outbreak ,morbidity:2
postoperative ,morbidity:2
postoperative ,mortality:2
anosmia ,presenting:2
anosmia ,symptom:2
anosmia ,healthcare:2
anosmia ,workers:2
presenting ,symptom:4
presenting ,infection:8
presenting ,healthcare:2
presenting ,workers:2
symptom ,healthcare:2
symptom ,workers:2
current ,supporting:2
current ,risk:2
current ,using:4
current ,ibuprofen:2
evidence ,risk:4
evidence ,using:2
evidence ,ibuprofen:4
supporting ,risk:2
supporting ,using:4
supporting ,ibuprofen:2
supporting ,patients:2
risk ,ibuprofen:2
using ,ibuprofen:2
ibuprofen ,patients:2
renin-angiotensin ,inhibition:4
renin-angiotensin ,angiotensin:4
renin-angiotensin ,converting:4
system ,inhibition:4
system ,converting:4
inhibition ,role:2
inhibition ,angiotensin:2
inhibition ,converting:2
nanotechnologies ,underutilized:2
nanotechnologies ,global:2
nanotechnologies ,uprising:2
underutilized ,global:2
underutilized ,uprising:2
global ,uprising:2
covid-19 ,reaction:2
pandemic ,reaction:2
impact ,rapid:2
impact ,reaction:2
impact ,urology:2
rapid ,reaction:4
rapid ,urology:2
reaction ,urology:2
loss ,burning:2
loss ,watering:2
loss ,eyes:2
taste ,burning:2
taste ,watering:2
taste ,eyes:2
smell ,burning:2
smell ,watering:2
smell ,eyes:2
burning ,watering:2
burning ,eyes:2
burning ,coronavirus:2
burning ,disease:2
watering ,eyes:2
watering ,coronavirus:2
watering ,disease:2
coding-complete ,genome:2
coding-complete ,sequences:2
coding-complete ,two:2
coding-complete ,sars-cov-2:2
coding-complete ,isolates:2
coding-complete ,egypt:2
genome ,egypt:2
sequences ,isolates:2
sequences ,egypt:2
two ,isolates:2
two ,egypt:2
isolates ,egypt:2
susceptibility ,sars:2
susceptibility ,mers:2
susceptibility ,health:2
susceptibility ,perspective:2
sars ,animal:4
mers ,animal:2
mers ,health:2
animal ,health:6
animal ,perspective:2
cytokines ,friends:2
cytokines ,foes:2
immune ,asynchrony:2
immune ,immunotherapies:2
asynchrony ,covid-19:2
asynchrony ,pathogenesis:2
asynchrony ,potential:2
asynchrony ,immunotherapies:2
covid-19 ,immunotherapies:2
pathogenesis ,immunotherapies:2
potential ,immunotherapies:2
mechanistic ,target:2
mechanistic ,rapamycin:2
mechanistic ,mtor:2
mechanistic ,novel:2
mechanistic ,considerations:2
mechanistic ,antiviral:2
target ,rapamycin:2
target ,mtor:2
rapamycin ,mtor:2
rapamycin ,novel:2
rapamycin ,considerations:2
rapamycin ,antiviral:2
mtor ,novel:2
mtor ,considerations:2
mtor ,antiviral:2
novel ,considerations:2
considerations ,antiviral:2
modular ,framework:2
modular ,development:2
modular ,targeted:2
modular ,covid-19:2
modular ,blood:2
modular ,transcript:2
framework ,development:2
framework ,targeted:2
framework ,blood:2
framework ,transcript:2
development ,blood:2
development ,transcript:2
targeted ,blood:2
targeted ,transcript:2
covid-19 ,transcript:2
blood ,transcript:2
risk ,oxford:2
risk ,royal:2
risk ,college:2
risk ,general:2
factors ,oxford:2
factors ,royal:2
factors ,college:2
factors ,general:2
sars-cov-2 ,oxford:2
sars-cov-2 ,royal:2
sars-cov-2 ,college:2
among ,oxford:2
among ,royal:2
among ,college:2
patients ,oxford:2
patients ,royal:2
patients ,college:2
patients ,general:2
oxford ,royal:2
oxford ,college:2
oxford ,general:2
royal ,college:2
royal ,general:2
college ,general:2
mortality ,correlating:2
mortality ,major:2
covid-19 ,correlating:2
disease ,correlating:2
disease ,major:2
patients ,correlating:2
patients ,major:2
correlating ,association:2
correlating ,major:2
association ,major:2
pharmacokinetic ,basis:2
pharmacokinetic ,hydroxychloroquine:2
pharmacokinetic ,response:2
pharmacokinetic ,implications:2
basis ,hydroxychloroquine:2
basis ,response:2
basis ,implications:2
hydroxychloroquine ,response:2
outcomes ,diabetic:2
outcomes ,infected:2
diabetic ,infected:2
diabetic ,sars-cov-2:2
role ,biomarkers:2
biomarkers ,diagnosis:2
biomarkers ,systematic:2
diagnosis ,systematic:2
operative ,team:2
operative ,checklist:2
operative ,aerosol:2
operative ,generating:2
operative ,minimise:2
operative ,exposure:2
team ,checklist:2
team ,aerosol:2
team ,generating:2
team ,procedures:2
team ,minimise:2
team ,exposure:2
checklist ,aerosol:2
checklist ,generating:2
checklist ,procedures:2
checklist ,minimise:2
checklist ,exposure:2
aerosol ,procedures:4
aerosol ,minimise:2
generating ,procedures:2
generating ,minimise:2
generating ,exposure:2
procedures ,minimise:2
procedures ,exposure:2
minimise ,exposure:2
role ,anticoagulation:2
role ,covid-19-induced:2
anticoagulation ,covid-19-induced:2
anticoagulation ,hypercoagulability:2
covid-19-induced ,hypercoagulability:2
late ,arrival:2
late ,disease:4
late ,africa:2
late ,mitigating:2
arrival ,coronavirus:2
arrival ,disease:2
arrival ,covid-19:2
arrival ,africa:2
arrival ,mitigating:2
disease ,mitigating:4
covid-19 ,mitigating:4
africa ,mitigating:2
clinical ,injury:8
clinical ,japanese:2
features ,liver:2
features ,injury:6
features ,japanese:2
liver ,japanese:2
injury ,japanese:2
patients ,japanese:2
qt ,prolongation:2
qt ,torsades:2
qt ,de:2
qt ,pointes:2
qt ,sudden:2
qt ,death:2
qt ,short:2
qt ,courses:2
prolongation ,torsades:2
prolongation ,de:2
prolongation ,pointes:2
prolongation ,sudden:2
prolongation ,death:2
prolongation ,short:2
prolongation ,courses:2
torsades ,de:2
torsades ,pointes:2
torsades ,sudden:2
torsades ,death:2
torsades ,short:2
torsades ,courses:2
de ,pointes:2
de ,sudden:2
de ,death:2
de ,short:2
de ,courses:2
pointes ,sudden:2
pointes ,death:2
pointes ,short:2
pointes ,courses:2
sudden ,death:2
sudden ,short:2
sudden ,courses:2
death ,short:2
death ,courses:2
short ,courses:2
molecular ,several:2
molecular ,in-house:2
molecular ,protocols:2
analysis ,several:2
analysis ,in-house:2
analysis ,rrt-pcr:2
several ,in-house:2
several ,rrt-pcr:2
several ,protocols:2
several ,detection:2
in-house ,rrt-pcr:2
in-house ,protocols:2
in-house ,detection:2
rrt-pcr ,protocols:2
protocols ,detection:4
strategies ,targeting:2
strategies ,sars:2
strategies ,cov-2:2
strategies ,small:2
strategies ,molecule:2
strategies ,inhibitors-the:2
strategies ,status:2
targeting ,sars:2
targeting ,cov-2:2
targeting ,molecule:2
targeting ,inhibitors-the:2
targeting ,current:2
targeting ,status:2
sars ,small:2
sars ,molecule:2
sars ,inhibitors-the:2
sars ,current:2
sars ,status:2
cov-2 ,small:2
cov-2 ,molecule:2
cov-2 ,inhibitors-the:2
cov-2 ,current:2
cov-2 ,status:2
small ,molecule:2
small ,inhibitors-the:2
small ,current:2
small ,status:2
molecule ,inhibitors-the:2
molecule ,current:2
molecule ,status:2
inhibitors-the ,current:2
inhibitors-the ,status:2
pathogenesis ,clinicians:2
treatment ,clinicians:2
related ,tools:2
analysis ,cardiopulmonary:2
analysis ,findings:2
analysis ,fatalities:2
analysis ,high:4
analysis ,incidence:2
cardiopulmonary ,findings:2
cardiopulmonary ,covid-19:2
cardiopulmonary ,fatalities:2
cardiopulmonary ,high:2
cardiopulmonary ,incidence:2
findings ,fatalities:2
findings ,high:2
findings ,incidence:2
covid-19 ,fatalities:4
fatalities ,high:2
fatalities ,incidence:2
reasoned ,action:2
reasoned ,approach:2
reasoned ,compliance:2
reasoned ,recommended:2
reasoned ,behaviours:2
reasoned ,prevent:2
action ,approach:2
action ,compliance:2
action ,recommended:2
action ,behaviours:2
action ,prevent:2
approach ,compliance:2
approach ,recommended:2
approach ,behaviours:2
approach ,prevent:2
compliance ,recommended:2
compliance ,behaviours:2
compliance ,prevent:2
recommended ,behaviours:2
recommended ,prevent:2
behaviours ,prevent:2
covid-19 ,menu:2
adults ,menu:2
adults ,hospital:2
adults ,blood:2
adults ,science:2
adults ,laboratories:2
test ,menu:2
test ,hospital:2
test ,blood:4
test ,science:2
test ,laboratories:2
menu ,hospital:2
menu ,blood:2
menu ,science:2
menu ,laboratories:2
hospital ,blood:2
hospital ,science:2
hospital ,laboratories:2
blood ,science:2
blood ,laboratories:2
science ,laboratories:2
chloroquine ,possible:2
can ,melatonin:2
melatonin ,reduce:2
melatonin ,severity:2
melatonin ,pandemic:2
reduce ,severity:2
reduce ,pandemic:2
case ,covid-19-related:4
case ,pneumothorax-case:2
case ,highlighting:2
case ,significant:2
report ,covid-19-related:2
report ,pneumothorax-case:2
report ,highlighting:2
report ,significant:2
covid-19-related ,pneumothorax-case:2
covid-19-related ,series:2
covid-19-related ,highlighting:2
covid-19-related ,significant:2
pneumothorax-case ,series:2
pneumothorax-case ,highlighting:2
pneumothorax-case ,significant:2
series ,highlighting:2
series ,significant:2
highlighting ,significant:2
case ,rhabdomyolysis:4
presenting ,mild:2
presenting ,rhabdomyolysis:2
mild ,rhabdomyolysis:2
seroconversion ,humans:2
seroconversion ,detailed:2
seroconversion ,protocol:2
seroconversion ,serological:4
seroconversion ,assay:2
humans ,detailed:2
humans ,protocol:2
humans ,serological:2
humans ,assay:2
detailed ,protocol:2
detailed ,serological:2
protocol ,assay:2
world ,war:2
world ,first:2
world ,battle:2
world ,front:2
world ,viral:2
world ,invasion:2
war ,first:2
war ,battle:2
war ,front:2
war ,viral:2
war ,invasion:2
covid-19 ,front:2
first ,battle:2
first ,front:2
first ,invasion:2
battle ,front:2
battle ,viral:2
battle ,invasion:2
front ,viral:2
front ,invasion:2
expression ,entry:6
expression ,genes:4
pattern ,entry:2
pattern ,genes:2
pattern ,ace2:2
pattern ,tmprss2:2
pattern ,respiratory:2
entry ,genes:4
entry ,tmprss2:6
entry ,respiratory:2
genes ,tmprss2:2
genes ,respiratory:2
tmprss2 ,respiratory:2
coronavirus ,allergic:2
coronavirus ,rhinitis:2
disease ,allergic:4
disease ,rhinitis:2
asthma ,allergic:2
asthma ,rhinitis:2
asthma ,molecular:2
asthma ,mechanisms:2
allergic ,rhinitis:2
allergic ,molecular:2
allergic ,mechanisms:2
rhinitis ,molecular:2
rhinitis ,mechanisms:2
analyzing ,barriers:2
analyzing ,implementation:2
analyzing ,public:2
analyzing ,health:2
analyzing ,social:2
analyzing ,measures:2
barriers ,implementation:2
barriers ,public:2
barriers ,health:2
barriers ,social:2
barriers ,measures:2
implementation ,public:2
implementation ,health:4
implementation ,social:2
health ,team:2
health ,training:2
health ,simulation-based:2
health ,education:4
health ,obstetrics:2
care ,team:2
care ,training:2
care ,simulation-based:2
care ,education:2
care ,obstetrics:2
team ,training:2
team ,simulation-based:2
team ,education:2
team ,obstetrics:2
training ,obstetrics:2
simulation-based ,education:2
simulation-based ,obstetrics:2
education ,obstetrics:2
first ,29:2
first ,covid-19-patients:2
first ,clinic:2
first ,experiences:2
first ,dutch:2
29 ,covid-19-patients:2
29 ,clinic:2
29 ,early:2
29 ,experiences:2
29 ,dutch:2
covid-19-patients ,clinic:2
covid-19-patients ,early:2
covid-19-patients ,experiences:2
covid-19-patients ,dutch:2
clinic ,early:2
clinic ,experiences:2
clinic ,dutch:2
early ,experiences:6
early ,dutch:2
experiences ,dutch:2
sex ,determinant:2
sex ,truth:2
sex ,myth:2
determinant ,infection:2
determinant ,truth:2
determinant ,myth:2
covid-19 ,truth:2
covid-19 ,myth:2
infection ,truth:2
infection ,myth:2
truth ,myth:2
robust ,neutralization:2
robust ,assay:2
robust ,based:2
robust ,s-protein-bearing:2
robust ,vesicular:2
neutralization ,based:2
neutralization ,s-protein-bearing:2
neutralization ,vesicular:2
assay ,s-protein-bearing:2
assay ,vesicular:2
based ,s-protein-bearing:2
based ,vesicular:2
sars-cov-2 ,s-protein-bearing:2
sars-cov-2 ,vesicular:4
s-protein-bearing ,vesicular:2
exploring ,mechanism:2
exploring ,liver:2
exploring ,enzyme:2
exploring ,abnormalities:2
exploring ,patients:2
mechanism ,liver:4
mechanism ,enzyme:2
mechanism ,abnormalities:2
liver ,enzyme:4
liver ,abnormalities:2
enzyme ,abnormalities:2
enzyme ,novel:2
abnormalities ,patients:4
abnormalities ,novel:2
retrospective ,cross-national:2
retrospective ,examination:2
retrospective ,outbreak:2
retrospective ,175:2
retrospective ,countries:2
cross-national ,examination:2
cross-national ,covid-19:2
cross-national ,outbreak:2
cross-national ,175:2
cross-national ,countries:2
examination ,outbreak:2
examination ,175:2
examination ,countries:2
covid-19 ,175:2
outbreak ,175:2
175 ,countries:2
construction ,immunogenic:2
construction ,studies:2
construction ,mfc:2
construction ,fusion:2
construction ,receptor:2
construction ,binding:2
construction ,domain:2
construction ,rbd:2
immunogenic ,studies:2
immunogenic ,mfc:2
immunogenic ,fusion:2
immunogenic ,receptor:2
immunogenic ,binding:2
immunogenic ,domain:2
immunogenic ,rbd:2
studies ,mfc:2
studies ,fusion:2
studies ,receptor:2
studies ,binding:2
studies ,domain:2
studies ,rbd:2
mfc ,fusion:2
mfc ,receptor:2
mfc ,binding:2
mfc ,domain:2
mfc ,rbd:2
fusion ,receptor:2
fusion ,domain:2
fusion ,rbd:2
comparative ,evaluation:4
comparative ,nasopharyngeal:2
comparative ,swab:2
comparative ,saliva:2
comparative ,specimens:2
evaluation ,nasopharyngeal:2
nasopharyngeal ,specimens:4
nasopharyngeal ,molecular:2
swab ,molecular:4
saliva ,molecular:4
passive ,antibody:2
passive ,therapy:2
passive ,covid-19:2
first ,hiv:2
first ,diagnosed:2
case ,diagnosed:4
case ,korea:6
hiv ,diagnosed:2
hiv ,korea:2
patient ,diagnosed:4
patient ,korea:2
diagnosed ,korea:2
abnormal ,patients:6
abnormal ,hospitalized:2
abnormal ,coronavirus:2
abnormal ,disease:2
tests ,hospitalized:2
tests ,coronavirus:2
tests ,disease:2
mouse-adapted ,induces:2
mouse-adapted ,acute:2
mouse-adapted ,lung:2
mouse-adapted ,injury:2
mouse-adapted ,mortality:2
mouse-adapted ,standard:2
induces ,acute:2
induces ,lung:2
induces ,injury:2
induces ,mortality:2
induces ,standard:2
acute ,mortality:2
acute ,standard:2
lung ,mortality:4
lung ,standard:2
injury ,standard:2
mortality ,standard:2
active ,finding:2
active ,management:2
active ,key:2
active ,tackling:2
active ,pandemic:2
case ,finding:2
case ,key:2
case ,tackling:2
finding ,management:2
finding ,key:2
finding ,tackling:2
management ,key:2
management ,tackling:2
key ,tackling:2
key ,pandemic:2
tackling ,covid-19:6
tackling ,pandemic:6
hypertransaminasemia ,course:2
hypertransaminasemia ,infection:2
hypertransaminasemia ,sars-cov-2:2
hypertransaminasemia ,incidence:2
course ,incidence:4
occurrence ,transmission:2
occurrence ,asymptomatic:2
occurrence ,presymptomatic:2
asymptomatic ,presymptomatic:4
meta-analysis ,serology:2
diagnostic ,impact:2
performance ,serology:2
performance ,impact:2
serology ,tests:2
serology ,impact:2
tests ,impact:2
providing ,high-quality:2
providing ,remotely:2
providing ,patients:2
providing ,rare:2
providing ,bone:2
providing ,diseases:2
high-quality ,care:2
high-quality ,remotely:2
high-quality ,patients:2
high-quality ,rare:2
high-quality ,bone:2
high-quality ,diseases:2
care ,remotely:2
care ,rare:2
care ,bone:2
care ,diseases:2
remotely ,patients:2
remotely ,rare:2
remotely ,bone:2
remotely ,diseases:2
patients ,bone:2
rare ,bone:2
rare ,diseases:2
bone ,diseases:2
phenotype ,kinetics:2
phenotype ,sars-cov-2-specific:2
phenotype ,cells:2
phenotype ,covid-19:2
phenotype ,patients:2
kinetics ,sars-cov-2-specific:2
kinetics ,cells:4
sars-cov-2-specific ,patients:4
nosocomial ,infection:2
nosocomial ,haematological:2
nosocomial ,unit:2
nosocomial ,high:2
outbreak ,haematological:2
outbreak ,high:2
sars-cov-2 ,haematological:2
infection ,haematological:2
haematological ,unit:2
haematological ,high:2
unit ,high:4
viral ,determined:2
viral ,culture:2
viral ,tool:4
viral ,discharge:2
rna ,determined:2
rna ,management:2
rna ,tool:2
rna ,discharge:2
load ,determined:2
load ,cell:2
load ,culture:2
load ,management:2
load ,tool:4
load ,discharge:2
determined ,cell:2
determined ,culture:2
determined ,management:2
determined ,tool:2
determined ,discharge:2
cell ,tool:2
cell ,discharge:2
culture ,management:2
culture ,tool:2
culture ,discharge:2
management ,tool:2
management ,discharge:2
tool ,discharge:2
covid-19 ,notch:2
heart ,notch:2
heart ,inflammatory:2
heart ,storm:2
lungs ,notch:2
notch ,inflammatory:2
notch ,storm:2
can ,science:2
can ,well-ordered:2
can ,times:2
can ,crisis:2
can ,learning:4
science ,well-ordered:2
science ,times:6
science ,crisis:2
science ,learning:2
well-ordered ,times:2
well-ordered ,crisis:2
well-ordered ,learning:2
well-ordered ,sars-cov-2:2
times ,crisis:4
times ,learning:2
crisis ,learning:2
asymptomatic ,residents:2
presymptomatic ,infections:4
presymptomatic ,residents:2
presymptomatic ,long-term:2
infections ,residents:2
residents ,long-term:2
robotic ,laparosocpic:2
robotic ,urological:2
robotic ,surgery:4
robotic ,covid-19:4
robotic ,pandemia:2
laparosocpic ,urological:2
laparosocpic ,surgery:2
laparosocpic ,covid-19:2
laparosocpic ,pandemia:2
urological ,surgery:4
urological ,covid-19:6
urological ,pandemia:2
basic ,die:2
reproduction ,sars-cov-2:4
reproduction ,die:2
number ,die:2
sars-cov-2 ,die:2
wuhan ,die:2
novel ,henan:2
coronavirus ,henan:2
pneumonia ,henan:2
serologic ,responses:6
serologic ,among:2
serologic ,hospital:2
serologic ,staff:2
serologic ,mild:2
serologic ,disease:2
responses ,hospital:2
responses ,staff:2
among ,mild:4
hospital ,mild:2
staff ,mild:2
staff ,disease:2
elevation ,liver:4
elevation ,fibrosis:2
elevation ,index:2
elevation ,fib-4:2
elevation ,associated:2
elevation ,poor:2
elevation ,clinical:2
elevation ,outcomes:2
liver ,fibrosis:2
liver ,index:2
liver ,fib-4:2
liver ,poor:2
fibrosis ,index:2
fibrosis ,fib-4:2
fibrosis ,associated:2
fibrosis ,poor:2
fibrosis ,clinical:2
fibrosis ,outcomes:2
index ,fib-4:2
index ,associated:2
index ,poor:2
index ,clinical:2
index ,outcomes:2
fib-4 ,associated:2
fib-4 ,poor:2
fib-4 ,clinical:2
fib-4 ,outcomes:2
poor ,clinical:2
management ,chronic:4
patients ,chronic:14
sars-cov-2 ,chronic:4
infections ,chronic:2
infections ,lung:2
chronic ,lung:2
covid-19 ,reevaluate:2
opportunity ,reevaluate:2
opportunity ,correlation:2
opportunity ,long-term:2
opportunity ,effects:2
reevaluate ,correlation:2
reevaluate ,long-term:2
reevaluate ,effects:2
correlation ,long-term:2
correlation ,effects:2
long-term ,effects:2
ocular ,expression:2
ocular ,receptors:2
surface ,expression:2
surface ,receptors:2
expression ,receptors:6
utility ,native:2
utility ,ms:2
utility ,understanding:2
utility ,mechanism:2
utility ,action:2
utility ,repurposed:2
native ,ms:2
native ,understanding:2
native ,mechanism:2
native ,action:2
native ,repurposed:2
ms ,understanding:2
ms ,mechanism:2
ms ,action:2
ms ,repurposed:2
understanding ,mechanism:2
understanding ,action:2
understanding ,repurposed:2
mechanism ,repurposed:2
clinical ,clustering:2
features ,familial:2
features ,clustering:2
familial ,clustering:2
familial ,patients:2
familial ,infected:2
clustering ,patients:2
clustering ,infected:2
clustering ,novel:2
infected ,novel:6
value ,validity:2
validity ,coronavirus:2
validity ,antibody:2
validity ,testing:2
value ,serology:2
value ,manage:2
value ,infections:2
serology ,manage:2
serology ,infections:2
testing ,infections:2
manage ,sars-cov-2:2
manage ,infections:2
clinical-epidemiological ,relation:2
clinical-epidemiological ,sars-cov-2:2
clinical-epidemiological ,kawasaki:2
clinical-epidemiological ,disease:2
relation ,sars-cov-2:2
relation ,kawasaki:2
relation ,disease:4
thrombotic ,complications:4
thrombotic ,may:2
thrombotic ,reflect:2
thrombotic ,upregulation:2
thrombotic ,endothelial:4
complications ,may:2
complications ,reflect:2
complications ,upregulation:2
complications ,endothelial:2
covid-19 ,reflect:2
covid-19 ,upregulation:2
may ,reflect:2
may ,upregulation:2
may ,endothelial:2
reflect ,upregulation:2
reflect ,endothelial:2
upregulation ,endothelial:2
rna-dependent ,target:4
rna-dependent ,covid-19:2
rna-dependent ,discovery:2
rna ,discovery:2
polymerase ,covid-19:2
polymerase ,discovery:2
target ,discovery:2
public ,management:4
public ,case:2
public ,study:2
health ,study:6
emergency ,crisis:2
emergency ,case:2
emergency ,study:2
emergency ,outbreak:4
crisis ,management:4
crisis ,case:4
crisis ,study:4
expression ,coincident:2
expression ,response:2
expression ,signature:2
expression ,varies:2
sars-cov-2 ,coincident:2
sars-cov-2 ,signature:2
sars-cov-2 ,varies:2
receptor ,coincident:2
receptor ,response:2
receptor ,signature:2
receptor ,varies:2
ace2 ,coincident:2
ace2 ,response:2
ace2 ,signature:2
ace2 ,varies:2
coincident ,host:2
coincident ,response:2
coincident ,signature:2
coincident ,varies:2
host ,signature:2
host ,varies:2
response ,signature:2
response ,varies:2
signature ,varies:2
covid-19 ,cardiologist:2
cardiologist ,basic:2
cardiologist ,virology:2
cardiologist ,epidemiology:2
cardiologist ,cardiac:2
cardiologist ,manifestations:2
basic ,virology:2
basic ,epidemiology:2
basic ,cardiac:2
basic ,manifestations:2
virology ,cardiac:2
virology ,manifestations:2
epidemiology ,cardiac:4
epidemiology ,manifestations:2
cardiac ,manifestations:4
bcg ,epidemiology:2
bcg ,supports:2
bcg ,protection:2
bcg ,word:2
bcg ,caution:2
epidemiology ,supports:2
epidemiology ,protection:2
epidemiology ,word:2
epidemiology ,caution:2
supports ,protection:2
supports ,covid-19:2
supports ,word:2
supports ,caution:2
protection ,word:2
protection ,caution:2
covid-19 ,word:2
word ,caution:2
characteristics ,reproductive:4
characteristics ,age:4
characteristics ,laboratory-confirmed:4
women ,reproductive:4
women ,age:4
women ,laboratory-confirmed:2
reproductive ,age:4
reproductive ,laboratory-confirmed:2
age ,laboratory-confirmed:2
red ,blood:6
red ,cell:4
red ,exchange:2
red ,avoid:2
red ,intubating:2
red ,positive:2
red ,patient:2
red ,sickle:2
blood ,cell:6
blood ,exchange:2
blood ,avoid:2
blood ,intubating:2
blood ,positive:2
blood ,sickle:2
cell ,exchange:2
cell ,avoid:2
cell ,intubating:2
cell ,positive:2
cell ,patient:4
exchange ,avoid:2
exchange ,intubating:2
exchange ,covid-19:4
exchange ,positive:2
exchange ,patient:2
exchange ,sickle:2
avoid ,intubating:2
avoid ,covid-19:2
avoid ,positive:4
avoid ,patient:2
avoid ,sickle:2
intubating ,covid-19:2
intubating ,positive:2
intubating ,patient:2
intubating ,sickle:2
positive ,sickle:2
patient ,sickle:2
safe ,performance:2
safe ,diagnostic:2
safe ,bronchoscopyebus:2
performance ,bronchoscopyebus:2
performance ,pandemic:2
diagnostic ,bronchoscopyebus:2
bronchoscopyebus ,sars-cov-2:2
bronchoscopyebus ,pandemic:2
case ,pcr-positive:2
case ,specimen:2
imported ,diagnosed:2
imported ,pcr-positive:2
imported ,lower:2
imported ,specimen:2
covid-19 ,pcr-positive:2
diagnosed ,pcr-positive:2
diagnosed ,lower:2
diagnosed ,respiratory:2
diagnosed ,specimen:2
pcr-positive ,lower:2
pcr-positive ,respiratory:2
pcr-positive ,specimen:2
lower ,specimen:2
respiratory ,specimen:2
molecular ,dynamics:6
molecular ,fda:2
molecular ,approved:4
molecular ,main:4
docking ,dynamics:4
docking ,simulation:2
docking ,fda:2
docking ,approved:2
docking ,main:2
dynamics ,simulation:2
dynamics ,fda:2
dynamics ,approved:4
dynamics ,drugs:4
dynamics ,main:2
simulation ,fda:2
simulation ,approved:2
simulation ,drugs:2
simulation ,main:2
trained ,induced:2
trained ,live:2
trained ,attenuated:2
trained ,vaccines:2
trained ,protect:2
immunity ,live:2
immunity ,attenuated:2
immunity ,protect:2
induced ,live:2
induced ,attenuated:2
induced ,vaccines:2
induced ,protect:2
live ,attenuated:2
live ,vaccines:2
live ,protect:2
attenuated ,vaccines:2
attenuated ,protect:2
vaccines ,protect:2
coronavirus ,epilepticus:2
disease ,febrile:2
disease ,epilepticus:2
covid-19 ,febrile:4
associated ,febrile:2
associated ,status:2
associated ,epilepticus:2
febrile ,status:2
febrile ,epilepticus:2
end ,social:2
end ,confinement:2
end ,re-emergence:2
end ,risk:2
social ,confinement:2
social ,re-emergence:2
social ,risk:2
confinement ,covid-19:6
confinement ,re-emergence:2
confinement ,risk:2
covid-19 ,re-emergence:4
re-emergence ,risk:2
newly ,emerging:2
newly ,human:2
newly ,coronaviruses:2
newly ,animal:2
newly ,models:2
newly ,vaccine:2
newly ,research:2
newly ,sars:2
emerging ,vaccine:2
emerging ,research:2
human ,vaccine:4
coronaviruses ,vaccine:6
animal ,vaccine:2
models ,vaccine:2
models ,sars:2
research ,sars:2
handling ,emergency:2
handling ,department:2
handling ,field:2
handling ,report:2
covid-19 ,field:2
emergency ,field:2
emergency ,report:4
department ,field:2
field ,report:2
gastrointestinal ,95:2
gastrointestinal ,cases:2
symptoms ,95:2
95 ,cases:2
95 ,sars-cov-2:2
95 ,infection:2
modeling ,stability:2
modeling ,severe:2
modeling ,acute:2
modeling ,respiratory:2
modeling ,syndrome:2
covid-19 ,return:4
covid-19 ,athletic:2
review ,recommendations:6
review ,return:2
review ,athletic:2
review ,play:2
current ,return:2
current ,athletic:2
current ,play:2
recommendations ,return:2
recommendations ,athletic:2
recommendations ,play:2
return ,athletic:2
return ,play:2
athletic ,play:2
snapshot ,department:2
snapshot ,urology:2
snapshot ,bergamo:2
snapshot ,evaluating:2
snapshot ,timeline:2
department ,urology:2
department ,bergamo:2
department ,evaluating:2
department ,timeline:2
urology ,bergamo:2
urology ,evaluating:2
urology ,timeline:2
bergamo ,evaluating:2
bergamo ,timeline:2
evaluating ,timeline:2
comparing ,influenza:2
comparing ,pandemics:2
sars-cov-2 ,pandemics:2
sars-cov ,pandemics:2
influenza ,pandemics:2
platypnea-orthodeoxia ,fibrotic:2
platypnea-orthodeoxia ,evolution:2
platypnea-orthodeoxia ,sars-cov-2:2
platypnea-orthodeoxia ,interstitial:2
platypnea-orthodeoxia ,pneumonia:2
fibrotic ,evolution:2
fibrotic ,sars-cov-2:2
fibrotic ,interstitial:2
fibrotic ,pneumonia:2
evolution ,interstitial:2
routine ,screening:2
routine ,sars:2
routine ,cov-2:2
routine ,unselected:2
routine ,pregnant:2
routine ,women:2
routine ,delivery:2
screening ,unselected:2
sars ,unselected:2
sars ,pregnant:2
sars ,women:2
sars ,delivery:2
cov-2 ,unselected:2
cov-2 ,pregnant:2
cov-2 ,women:2
cov-2 ,delivery:2
unselected ,delivery:2
raloxifene ,bazedoxifene:2
raloxifene ,promising:2
raloxifene ,candidates:2
raloxifene ,preventing:2
bazedoxifene ,promising:2
bazedoxifene ,candidates:2
bazedoxifene ,preventing:2
promising ,candidates:2
promising ,preventing:2
candidates ,preventing:2
nucleotide ,sars-cov:2
analogues ,sars-cov:2
inhibitors ,sars-cov:4
sars-cov ,polymerase:2
hemophagocytic ,core:2
hemophagocytic ,issue:2
hemophagocytic ,severe:2
hemophagocytic ,covid-19:2
hemophagocytic ,cases:2
lymphohistiocytosis ,core:2
lymphohistiocytosis ,issue:2
lymphohistiocytosis ,severe:2
lymphohistiocytosis ,covid-19:2
lymphohistiocytosis ,cases:2
core ,issue:2
core ,severe:2
core ,cases:2
issue ,severe:2
issue ,covid-19:2
issue ,cases:2
effectiveness ,full:2
effectiveness ,partial:2
effectiveness ,travel:2
effectiveness ,bans:2
effectiveness ,spread:2
full ,partial:2
full ,travel:2
full ,bans:2
full ,covid-19:2
full ,spread:2
partial ,travel:2
partial ,bans:2
partial ,covid-19:4
partial ,spread:2
travel ,bans:2
bans ,covid-19:2
bans ,spread:2
guillain-barr ,coronavirus:2
guillain-barr ,disease:2
among ,national:2
among ,system:2
healthcare ,national:2
healthcare ,system:4
workers ,national:2
workers ,system:2
national ,system:2
dietary ,choices:2
dietary ,habits:2
dietary ,lockdown:2
dietary ,experience:2
dietary ,poland:2
choices ,habits:2
choices ,covid-19:2
choices ,lockdown:2
choices ,experience:2
choices ,poland:2
habits ,lockdown:2
habits ,experience:2
habits ,poland:2
covid-19 ,poland:2
lockdown ,experience:4
lockdown ,poland:2
experience ,poland:2
disproportionate ,case:2
disproportionate ,reduction:2
disproportionate ,ban:2
disproportionate ,elective:2
disproportionate ,surgeries:2
case ,reduction:2
case ,ban:2
case ,elective:2
case ,surgeries:2
reduction ,ban:2
reduction ,elective:2
reduction ,surgeries:2
ban ,elective:2
ban ,surgeries:2
angiotensin-receptor ,blockers:2
two ,important:2
two ,controversial:2
two ,risk:2
two ,factors:2
two ,obesity:4
important ,controversial:2
important ,risk:2
important ,factors:2
important ,infection:2
important ,obesity:2
controversial ,risk:2
controversial ,factors:2
controversial ,sars-cov-2:2
controversial ,infection:2
controversial ,obesity:2
factors ,obesity:2
airborne ,lifetime:2
airborne ,small:2
airborne ,speech:2
airborne ,droplets:2
airborne ,importance:2
lifetime ,small:2
lifetime ,speech:2
lifetime ,droplets:2
lifetime ,potential:2
lifetime ,importance:2
small ,speech:2
small ,droplets:2
small ,importance:2
speech ,droplets:2
speech ,potential:2
speech ,importance:2
droplets ,potential:2
droplets ,importance:2
miller ,diagnosis:2
miller ,treatment:2
miller ,patient:2
miller ,sars-cov-2:2
fisher ,diagnosis:2
fisher ,treatment:2
fisher ,patient:2
fisher ,sars-cov-2:2
disease-19 ,heart:2
disease-19 ,failure:2
disease-19 ,current:2
disease-19 ,perspective:4
heart ,current:2
heart ,perspective:4
failure ,current:2
failure ,perspective:2
angioedema ,ace:2
angioedema ,inhibitor:2
angioedema ,covid-19:4
ace ,inhibitor:2
inhibitor ,covid-19:6
routes ,importation:2
routes ,brazil:2
covid-19 ,brazil:10
importation ,brazil:2
lung ,case:2
lung ,series:2
ultrasound ,case:2
ultrasound ,series:2
diagnosis ,series:2
successful ,safe:2
successful ,reinstitution:2
successful ,chemotherapy:2
successful ,pancreatic:2
successful ,cancer:2
safe ,reinstitution:2
safe ,chemotherapy:2
safe ,pancreatic:2
safe ,cancer:2
reinstitution ,chemotherapy:2
reinstitution ,pancreatic:2
reinstitution ,cancer:2
chemotherapy ,pancreatic:2
chemotherapy ,cancer:4
pancreatic ,cancer:2
key ,residues:4
key ,motif:2
residues ,receptor:2
residues ,binding:4
residues ,motif:2
residues ,spike:2
residues ,protein:2
residues ,sars-cov-2:2
receptor ,motif:2
binding ,motif:2
motif ,protein:2
putative ,contributions:2
putative ,circadian:2
putative ,clock:2
putative ,sleep:2
putative ,context:2
contributions ,circadian:2
contributions ,clock:2
contributions ,sleep:2
contributions ,context:2
contributions ,sars-cov-2:2
circadian ,sleep:2
circadian ,context:2
circadian ,sars-cov-2:2
clock ,sleep:2
clock ,context:2
sleep ,context:2
rational ,vaccine:4
rational ,time:2
rational ,covid-19:2
design ,time:2
narrative ,literature:4
narrative ,traditional:2
narrative ,options:2
narrative ,treatment:2
literature ,traditional:2
literature ,medicine:2
literature ,options:2
literature ,treatment:4
review ,traditional:2
traditional ,options:2
medicine ,options:2
implications ,therapies:2
outbreak ,therapies:2
outbreak ,multiple:2
outbreak ,sclerosis:2
immune ,therapies:2
immune ,multiple:4
immune ,sclerosis:4
therapies ,multiple:2
therapies ,sclerosis:2
inpatient ,neurology:2
inpatient ,consultations:2
inpatient ,onset:2
inpatient ,new:2
inpatient ,york:2
inpatient ,city:2
neurology ,consultations:2
neurology ,onset:2
neurology ,sars-cov-2:2
neurology ,new:2
neurology ,york:2
neurology ,city:2
consultations ,onset:2
consultations ,sars-cov-2:2
consultations ,new:2
consultations ,york:2
consultations ,city:2
onset ,york:2
onset ,city:2
health ,issues:2
health ,psychosomatic:2
issues ,among:2
issues ,healthcare:2
issues ,workers:2
issues ,psychosomatic:2
among ,psychosomatic:2
healthcare ,psychosomatic:2
workers ,psychosomatic:2
covid-19 ,psychosomatic:2
pandemic ,psychosomatic:2
extensive ,cerebral:2
extensive ,sinus:2
extensive ,thrombosis:2
extensive ,potential:2
extensive ,complication:2
extensive ,patient:2
cerebral ,sinus:2
cerebral ,potential:2
cerebral ,complication:2
venous ,sinus:2
venous ,complication:2
venous ,patient:2
sinus ,thrombosis:2
sinus ,potential:2
sinus ,complication:2
thrombosis ,potential:6
thrombosis ,complication:2
thrombosis ,patient:4
potential ,patient:2
complication ,patient:2
point-of-care ,findings:2
point-of-care ,novel:2
point-of-care ,coronavirus:2
point-of-care ,disease-19:2
point-of-care ,pnemoniae:2
lung ,disease-19:2
lung ,pnemoniae:2
ultrasound ,novel:2
ultrasound ,coronavirus:2
ultrasound ,disease-19:2
ultrasound ,pnemoniae:2
findings ,novel:6
findings ,disease-19:4
findings ,pnemoniae:2
novel ,disease-19:2
novel ,pnemoniae:2
coronavirus ,pnemoniae:2
disease-19 ,pnemoniae:2
estimating ,physical:2
estimating ,distancing:2
estimating ,measures:2
estimating ,containing:2
impact ,physical:2
impact ,distancing:4
physical ,measures:2
physical ,containing:2
distancing ,containing:2
measures ,containing:2
silico ,structure:2
silico ,modelling:2
silico ,nsp13:2
silico ,helicase:2
silico ,nsp14:2
structure ,modelling:2
structure ,nsp13:2
structure ,helicase:2
structure ,nsp14:2
structure ,repurposing:2
modelling ,nsp13:2
modelling ,helicase:2
modelling ,nsp14:2
modelling ,repurposing:2
sars-cov-2 ,nsp13:4
sars-cov-2 ,helicase:4
sars-cov-2 ,nsp14:2
nsp13 ,helicase:4
nsp13 ,nsp14:2
nsp13 ,repurposing:2
helicase ,nsp14:2
helicase ,repurposing:2
nsp14 ,repurposing:2
sars-cov-2 ,stem:4
infection ,intervention:2
stem ,interaction:2
stem ,intervention:2
cells ,intervention:2
interaction ,intervention:2
reply ,current:2
reply ,smoking:2
reply ,associated:2
testing ,behaviour:2
testing ,time:2
behaviour ,change:4
behaviour ,time:2
behaviour ,children:2
behaviour ,current:2
behaviour ,covid-19:2
change ,current:2
time ,current:2
asthma ,copd:4
asthma ,management:2
copd ,management:2
copd ,covid-19:4
copd ,pandemic:2
potential ,graphene-based:2
potential ,materials:2
graphene-based ,materials:4
graphene-based ,combat:2
graphene-based ,covid-19:2
graphene-based ,properties:2
graphene-based ,perspectives:2
materials ,combat:2
materials ,covid-19:2
materials ,properties:2
materials ,perspectives:2
combat ,properties:2
combat ,perspectives:2
properties ,perspectives:2
imaging ,mechanisms:2
imaging ,study:4
mechanisms ,pneumonia:2
mechanisms ,study:2
novel ,study:6
retrospective ,inflammatory:2
retrospective ,markers:2
retrospective ,patient:2
analysis ,markers:2
analysis ,patient:2
inflammatory ,characteristics:2
markers ,patient:2
markers ,characteristics:2
patient ,characteristics:2
convalescent ,first:2
convalescent ,436:2
plasma ,first:2
plasma ,436:2
treatment ,first:2
treatment ,436:2
sars-cov-2 ,436:2
infection ,436:2
analysis ,436:2
first ,436:2
dedicated ,path:2
dedicated ,emergent:2
dedicated ,thoracic:2
dedicated ,surgery:2
dedicated ,patients:2
dedicated ,italian:2
path ,emergent:2
path ,thoracic:2
path ,patients:2
path ,italian:2
emergent ,thoracic:2
emergent ,surgery:2
emergent ,covid-19:4
emergent ,patients:2
emergent ,italian:2
thoracic ,patients:4
surgery ,italian:2
patients ,italian:4
guide ,forensic:2
guide ,pathology:2
guide ,practice:2
guide ,death:2
guide ,cases:2
guide ,related:2
forensic ,pathology:2
forensic ,death:2
forensic ,cases:2
forensic ,related:2
forensic ,corona:2
forensic ,virus:2
pathology ,practice:2
pathology ,death:2
pathology ,cases:2
pathology ,related:2
pathology ,corona:2
pathology ,virus:2
practice ,death:2
practice ,cases:2
practice ,corona:2
practice ,virus:2
death ,corona:2
death ,virus:2
related ,corona:2
related ,virus:4
epidemiological ,practical:2
epidemiological ,experience:2
analysis ,practical:2
analysis ,experience:2
practical ,experience:2
practical ,china:2
experience ,china:2
potential ,deciphering:2
neuroinvasive ,pathways:2
neuroinvasive ,deciphering:2
neuroinvasive ,spectrum:2
pathways ,deciphering:2
pathways ,spectrum:2
sars-cov-2 ,spectrum:4
deciphering ,spectrum:2
understanding ,sars-cov-2-related:2
understanding ,multisystem:2
understanding ,syndrome:2
sars-cov-2-related ,multisystem:2
sars-cov-2-related ,inflammatory:2
sars-cov-2-related ,syndrome:2
sars-cov-2-related ,children:2
comprehensive ,two:2
comprehensive ,potential:6
comprehensive ,entries:2
comprehensive ,tmprss2:2
analysis ,potential:6
analysis ,entries:2
analysis ,tmprss2:2
two ,potential:4
two ,entries:2
two ,tmprss2:2
potential ,entries:2
novel ,entries:2
novel ,tmprss2:2
sars-cov-2 ,entries:2
entries ,tmprss2:2
use ,weather:2
use ,variables:2
use ,studies:2
weather ,variables:2
weather ,transmission:2
weather ,studies:2
variables ,studies:2
transmission ,studies:2
five ,common:2
five ,skin:2
five ,manifestations:2
five ,identified:2
common ,skin:2
common ,manifestations:2
common ,identified:2
skin ,manifestations:4
skin ,identified:2
manifestations ,identified:2
neurology ,revisited:2
neurology ,proposal:2
neurology ,environmental:2
covid-19 ,proposal:4
revisited ,proposal:2
revisited ,environmental:2
proposal ,environmental:2
cytotoxic ,lesion:2
cytotoxic ,corpus:2
cytotoxic ,callosum:2
cytotoxic ,adolescent:2
cytotoxic ,multisystem:2
lesion ,corpus:2
lesion ,callosum:2
lesion ,adolescent:2
lesion ,multisystem:2
corpus ,callosum:2
corpus ,adolescent:2
corpus ,multisystem:2
callosum ,adolescent:2
callosum ,multisystem:2
adolescent ,multisystem:2
moderate ,severe:2
moderate ,impairment:2
moderate ,pulmonary:2
moderate ,function:2
moderate ,associated:2
moderate ,mortality:2
severe ,impairment:2
severe ,function:2
impairment ,pulmonary:2
impairment ,function:2
impairment ,associated:2
impairment ,mortality:2
pulmonary ,mortality:2
function ,associated:2
function ,mortality:2
silico ,agents:2
silico ,approach:2
studies ,therapeutic:2
studies ,agents:2
studies ,drug:2
studies ,repurposing:2
studies ,approach:2
agents ,drug:2
agents ,approach:2
drug ,approach:4
coronavirus ,monitoring:2
coronavirus ,belgian:2
coronavirus ,twitter:2
coronavirus ,discourse:2
monitoring ,belgian:2
monitoring ,twitter:2
monitoring ,discourse:2
monitoring ,severe:2
monitoring ,acute:2
belgian ,twitter:2
belgian ,discourse:2
belgian ,severe:2
belgian ,acute:2
twitter ,discourse:2
twitter ,severe:2
twitter ,acute:2
discourse ,severe:2
discourse ,acute:2
transmission ,protocols:2
transmission ,dentistry:2
risk ,protocols:2
risk ,dentistry:2
protective ,protocols:2
protective ,dentistry:2
protocols ,dentistry:2
protocols ,systematic:2
dentistry ,systematic:2
detection ,among:2
detection ,residents:2
detection ,staff:2
detection ,members:2
detection ,independent:2
sars-cov-2 ,members:4
sars-cov-2 ,independent:2
among ,members:4
residents ,members:2
staff ,members:2
members ,independent:2
proactive ,infection:2
proactive ,prevention:2
proactive ,measures:2
proactive ,hyperbaric:2
proactive ,oxygen:2
proactive ,therapy:2
infection ,hyperbaric:2
infection ,oxygen:2
prevention ,hyperbaric:2
prevention ,oxygen:2
measures ,hyperbaric:2
measures ,oxygen:2
measures ,therapy:2
potential ,diagnostics:2
rapid ,vaccine:4
rapid ,therapeutics:4
diagnostics ,vaccine:2
vaccine ,therapeutics:2
vitro ,fda:2
vitro ,approved:4
vitro ,chemical:2
vitro ,library:2
vitro ,reveals:2
vitro ,inhibitors:2
screening ,chemical:2
screening ,library:2
fda ,chemical:2
fda ,library:2
fda ,potential:2
fda ,inhibitors:2
approved ,chemical:2
approved ,library:2
approved ,inhibitors:6
chemical ,library:2
chemical ,reveals:2
chemical ,potential:4
chemical ,inhibitors:2
library ,reveals:2
library ,potential:2
library ,inhibitors:6
reveals ,inhibitors:4
comment ,cutaneous:4
comment ,manifestations:4
comment ,covid-19:4
comment ,first:4
comment ,perspective:4
comment ,recalcati:2
cutaneous ,first:4
cutaneous ,perspective:4
cutaneous ,recalcati:2
manifestations ,first:4
manifestations ,perspective:4
manifestations ,recalcati:2
covid-19 ,recalcati:2
first ,perspective:4
first ,recalcati:2
perspective ,recalcati:2
masks ,protect:2
masks ,others:2
masks ,reducing:2
masks ,inoculum:2
protect ,others:2
protect ,reducing:2
protect ,inoculum:2
others ,covid-19:2
others ,reducing:2
others ,inoculum:2
covid-19 ,inoculum:2
reducing ,inoculum:2
neurological ,meta-analysis:2
manifestations ,meta-analysis:2
deaths ,sars-cov-2:2
deaths ,positive:2
deaths ,patients:4
deaths ,influence:2
deaths ,health:2
positive ,italy:2
positive ,influence:2
positive ,underlying:2
patients ,italy:2
patients ,influence:2
patients ,underlying:2
italy ,influence:2
influence ,underlying:2
influence ,health:2
underlying ,health:4
comparative ,lung:2
comparative ,ultrasound:2
comparative ,chest:2
comparative ,computed:2
comparative ,tomography:2
comparative ,scan:2
study ,chest:4
study ,computed:2
study ,tomography:2
study ,scan:2
lung ,scan:2
ultrasound ,chest:4
ultrasound ,computed:2
ultrasound ,tomography:2
ultrasound ,scan:2
chest ,scan:4
computed ,scan:2
tomography ,scan:2
covid-19 ,vaccine-readiness:2
covid-19 ,anti-cd20-depleting:2
covid-19 ,autoimmune:8
vaccine-readiness ,anti-cd20-depleting:2
vaccine-readiness ,therapy:2
vaccine-readiness ,autoimmune:2
vaccine-readiness ,diseases:2
anti-cd20-depleting ,therapy:2
anti-cd20-depleting ,autoimmune:2
anti-cd20-depleting ,diseases:2
coronavirus ,arrhythmia:2
cardiovascular ,myocardial:2
cardiovascular ,injury:2
cardiovascular ,arrhythmia:2
disease ,arrhythmia:2
myocardial ,arrhythmia:2
injury ,arrhythmia:2
clinical ,spinal:2
clinical ,cord:2
features ,prognosis:2
features ,people:2
features ,spinal:2
features ,cord:2
prognosis ,people:2
prognosis ,spinal:2
prognosis ,cord:2
prognosis ,injury:2
covid-19 ,spinal:2
covid-19 ,cord:4
people ,spinal:2
people ,cord:2
people ,injury:2
spinal ,cord:2
spinal ,injury:2
cord ,injury:2
immunobiology ,immunotherapy:2
immunobiology ,covid-19:2
immunobiology ,clinically:2
immunobiology ,updated:2
immunobiology ,overview:2
immunotherapy ,clinically:2
immunotherapy ,updated:2
immunotherapy ,overview:2
clinically ,updated:2
clinically ,overview:2
projected ,effects:2
projected ,nonpharmaceutical:2
projected ,public:2
projected ,health:2
projected ,interventions:2
projected ,prevent:2
effects ,nonpharmaceutical:2
effects ,public:2
effects ,interventions:2
effects ,prevent:2
nonpharmaceutical ,public:4
nonpharmaceutical ,health:2
nonpharmaceutical ,prevent:2
public ,prevent:2
health ,prevent:2
interventions ,prevent:2
covid-19 ,race:6
covid-19 ,middle:2
covid-19 ,devastation:2
vaccines ,race:2
vaccines ,death:2
vaccines ,devastation:2
race ,time:2
race ,middle:2
race ,death:2
race ,devastation:2
time ,middle:2
time ,death:2
time ,devastation:2
middle ,death:2
middle ,devastation:2
death ,devastation:2
pharmacists ,preparedness:2
pharmacists ,patients:2
pharmacists ,education:2
pharmacists ,time:2
pharmacists ,pandemic-a:2
preparedness ,patients:2
preparedness ,education:2
preparedness ,time:2
preparedness ,pandemic-a:2
patients ,education:2
patients ,pandemic-a:2
education ,time:2
education ,pandemic-a:2
time ,pandemic-a:2
management ,childhood-onset:2
management ,autoinflammatory:2
management ,diseases:16
childhood-onset ,autoinflammatory:2
childhood-onset ,diseases:2
childhood-onset ,covid-19:2
autoinflammatory ,diseases:2
autoinflammatory ,covid-19:4
differences ,case:2
differences ,fatality:2
differences ,ratios:2
differences ,children:2
differences ,adults:2
differences ,tell:2
differences ,us:2
case ,ratios:2
case ,adults:2
case ,tell:2
case ,us:2
fatality ,ratios:2
fatality ,children:2
fatality ,adults:2
fatality ,tell:2
ratios ,children:2
ratios ,adults:2
ratios ,tell:2
ratios ,us:2
children ,tell:2
children ,us:2
adults ,tell:2
adults ,us:2
icu ,management:2
delirium ,management:2
preliminary ,evaluation:2
preliminary ,public:2
preliminary ,risk:2
preliminary ,perception:2
preliminary ,related:2
evaluation ,public:2
evaluation ,perception:2
evaluation ,related:2
public ,risk:2
public ,perception:2
public ,related:2
perception ,related:2
immunoinformatic ,identification:4
immunoinformatic ,cell:2
immunoinformatic ,epitopes:2
winter ,coming:2
winter ,southern:2
winter ,hemisphere:2
winter ,perspective:2
winter ,environmental:2
winter ,drivers:2
coming ,southern:2
coming ,hemisphere:2
coming ,perspective:2
coming ,environmental:2
coming ,drivers:2
southern ,hemisphere:2
southern ,perspective:4
southern ,environmental:2
southern ,drivers:2
hemisphere ,perspective:2
hemisphere ,environmental:2
hemisphere ,drivers:2
perspective ,environmental:4
perspective ,drivers:2
environmental ,drivers:2
study ,medicines:2
screening ,traditional:2
screening ,medicines:2
potential ,medicines:4
traditional ,2019-ncov:2
traditional ,based:2
chinese ,based:4
medicines ,2019-ncov:2
medicines ,based:4
remdesivir ,induction:2
remdesivir ,chemotherapy:2
remdesivir ,newly:2
remdesivir ,diagnosed:2
remdesivir ,paediatric:2
remdesivir ,acute:2
induction ,chemotherapy:2
induction ,newly:2
induction ,diagnosed:2
induction ,paediatric:2
induction ,acute:2
chemotherapy ,newly:2
chemotherapy ,diagnosed:2
chemotherapy ,paediatric:2
chemotherapy ,acute:2
newly ,diagnosed:4
newly ,paediatric:2
diagnosed ,paediatric:2
diagnosed ,acute:2
paediatric ,acute:2
therapeutic ,exchange:4
therapeutic ,critically:6
plasma ,management:2
plasma ,strategy:2
exchange ,potential:2
exchange ,management:2
exchange ,strategy:2
exchange ,critically:2
exchange ,ill:2
potential ,critically:2
potential ,ill:2
strategy ,critically:2
strategy ,ill:2
effective ,immune:2
effective ,functions:2
effective ,micronutrients:2
immune ,functions:2
immune ,micronutrients:2
functions ,micronutrients:2
functions ,sars-cov-2:2
micronutrients ,sars-cov-2:2
virological ,serological:2
virological ,discordant:2
virological ,profiles:2
virological ,pneumonia:2
virological ,two:2
virological ,atypical:2
serological ,discordant:2
serological ,profiles:2
serological ,pneumonia:2
serological ,atypical:2
discordant ,profiles:2
discordant ,covid-19:2
discordant ,pneumonia:2
discordant ,two:2
discordant ,atypical:2
profiles ,pneumonia:4
profiles ,atypical:2
pneumonia ,atypical:6
two ,atypical:4
induction ,pro-inflammatory:2
induction ,cytokines:2
induction ,il-1:2
induction ,il-6:2
induction ,lung:2
induction ,inflammation:2
pro-inflammatory ,cytokines:2
pro-inflammatory ,il-1:2
pro-inflammatory ,il-6:2
pro-inflammatory ,lung:2
pro-inflammatory ,inflammation:2
cytokines ,il-1:2
cytokines ,il-6:4
cytokines ,lung:2
cytokines ,inflammation:2
il-1 ,il-6:2
il-1 ,lung:2
il-1 ,inflammation:4
il-6 ,lung:2
il-6 ,inflammation:2
delayed ,cytokine:2
delayed ,storm:2
delayed ,immune:2
delayed ,cell:2
delayed ,infiltration:2
delayed ,sars-cov-2-infected:2
severe ,infiltration:2
severe ,sars-cov-2-infected:2
cytokine ,cell:2
cytokine ,infiltration:2
cytokine ,sars-cov-2-infected:2
storm ,cell:2
storm ,infiltration:2
storm ,sars-cov-2-infected:2
immune ,sars-cov-2-infected:2
infiltration ,sars-cov-2-infected:2
quantitative ,viral:2
quantitative ,load:2
quantitative ,analysis:6
quantitative ,infected:2
detection ,infected:2
load ,analysis:2
load ,infected:4
analysis ,infected:4
inflammatory ,outbreak:2
inflammatory ,ten:2
inflammatory ,dos:2
bowel ,outbreak:2
bowel ,ten:2
bowel ,dos:2
disease ,ten:4
disease ,dos:2
management ,ten:2
management ,dos:2
covid-19 ,dos:2
outbreak ,ten:2
outbreak ,dos:2
ten ,dos:2
coronavirus ,antiphospholipid:2
disease ,antiphospholipid:2
infection ,antiphospholipid:2
covid-19 ,scoped-who:2
covid-19 ,gets:2
covid-19 ,scoped:2
pandemic ,scoped-who:2
pandemic ,gets:2
pandemic ,scoped:2
pandemic ,now:2
ibd ,patients:2
ibd ,need:2
ibd ,scoped-who:2
ibd ,gets:2
ibd ,scoped:2
ibd ,now:2
ibd ,can:2
patients ,scoped-who:2
patients ,gets:2
patients ,scoped:2
patients ,now:2
need ,scoped-who:2
need ,gets:2
need ,scoped:2
need ,now:2
need ,can:4
scoped-who ,gets:2
scoped-who ,scoped:2
scoped-who ,now:2
scoped-who ,can:2
gets ,scoped:2
gets ,now:2
gets ,can:2
scoped ,now:2
scoped ,can:2
now ,can:2
covid-19 ,immune-related:2
pneumonia ,immune-related:2
pneumonia ,issues:2
pneumonia ,differential:2
immune-related ,pneumonitis:2
immune-related ,critical:2
immune-related ,issues:2
immune-related ,differential:2
pneumonitis ,critical:2
pneumonitis ,issues:2
pneumonitis ,differential:2
critical ,differential:2
issues ,differential:2
obesity ,immune:2
obesity ,derangement:2
obesity ,possible:4
covid-19 ,derangement:2
immune ,derangement:2
immune ,link:2
immune ,adverse:2
metabolic ,derangement:2
metabolic ,possible:2
metabolic ,link:2
metabolic ,adverse:2
derangement ,possible:2
derangement ,link:2
derangement ,adverse:2
possible ,adverse:2
link ,adverse:2
lord ,nanorings:2
lord ,cyclodextrins:2
lord ,battle:2
lord ,sars-cov-2:2
nanorings ,cyclodextrins:2
nanorings ,battle:2
nanorings ,sars-cov-2:2
cyclodextrins ,battle:2
cyclodextrins ,sars-cov-2:2
battle ,sars-cov-2:2
updated ,data:2
updated ,relation:2
updated ,cardiovascular:2
updated ,system:2
data ,relation:2
data ,cardiovascular:2
data ,system:6
relation ,cardiovascular:2
relation ,system:2
impact ,people:2
impact ,living:2
impact ,visual:2
impact ,disability:2
covid-19 ,disability:2
pandemic ,people:4
pandemic ,visual:2
pandemic ,disability:2
people ,visual:2
people ,disability:2
living ,visual:2
living ,disability:2
visual ,disability:2
management ,gastrointestinal:2
gastrointestinal ,outbreak:2
hepatic ,diseases:4
hepatic ,outbreak:2
diseases ,outbreak:2
longitudinal ,cell:2
longitudinal ,receptor:2
longitudinal ,repertoire:2
longitudinal ,transcripts:2
longitudinal ,reveal:2
longitudinal ,dynamic:2
analysis ,repertoire:2
analysis ,dynamic:2
cell ,repertoire:2
cell ,transcripts:2
cell ,reveal:2
cell ,dynamic:2
receptor ,repertoire:2
receptor ,transcripts:2
receptor ,reveal:2
receptor ,dynamic:2
repertoire ,transcripts:2
repertoire ,reveal:2
repertoire ,dynamic:2
transcripts ,reveal:2
transcripts ,dynamic:2
reveal ,dynamic:2
evidence ,hemoglobin:2
evidence ,damage:4
hemoglobin ,damage:2
hemoglobin ,sars-cov-2:2
hemoglobin ,infection:2
testing ,accuracy:2
testing ,arima:2
testing ,models:2
testing ,forecasting:2
testing ,spreading:2
accuracy ,arima:2
accuracy ,models:2
accuracy ,forecasting:2
accuracy ,spreading:2
arima ,models:2
arima ,spreading:2
models ,forecasting:2
models ,spreading:2
forecasting ,spreading:2
coronavirus ,gastroenterologists:2
coronavirus ,may:2
disease ,gastroenterologists:2
disease ,may:4
gastroenterologists ,perspective:4
gastroenterologists ,may:2
grp78 ,targeting:2
grp78 ,hitting:2
grp78 ,two:2
grp78 ,birds:2
grp78 ,stone:2
targeting ,hitting:2
targeting ,two:2
targeting ,birds:2
targeting ,stone:2
hitting ,two:2
hitting ,birds:2
hitting ,stone:2
two ,birds:2
two ,stone:2
birds ,stone:2
sars-cov-2 ,laryngectomized:2
upper ,lower:2
upper ,laryngectomized:2
upper ,patient:6
upper ,new:2
lower ,airway:2
lower ,samples:2
lower ,laryngectomized:2
lower ,new:2
airway ,laryngectomized:2
airway ,patient:2
airway ,new:2
samples ,laryngectomized:2
samples ,new:2
laryngectomized ,patient:2
laryngectomized ,new:2
sars-cov-2 ,pre-analytics:2
rna ,issues:2
rna ,pre-analytics:2
identification ,nasopharyngeal:2
identification ,swabs:2
identification ,issues:2
identification ,pre-analytics:2
nasopharyngeal ,issues:2
nasopharyngeal ,pre-analytics:2
swabs ,issues:2
swabs ,pre-analytics:2
issues ,pre-analytics:2
epidemic ,four:2
epidemic ,cities:2
characteristics ,chinese:2
characteristics ,cities:2
four ,chinese:2
four ,cities:2
chinese ,cities:2
pragmatic ,approach:4
pragmatic ,inpatient:2
pragmatic ,diabetes:2
pragmatic ,management:2
pragmatic ,covid-19:6
pragmatic ,pandemic:4
approach ,inpatient:2
approach ,diabetes:2
inpatient ,diabetes:2
inpatient ,management:2
inpatient ,pandemic:2
association ,gynecological:2
association ,endoscopy:2
association ,nigeria:2
association ,ages:2
association ,advisory:2
gynecological ,endoscopy:2
gynecological ,surgeons:2
gynecological ,nigeria:2
gynecological ,ages:2
gynecological ,advisory:2
endoscopy ,surgeons:2
endoscopy ,nigeria:2
endoscopy ,ages:2
endoscopy ,advisory:2
surgeons ,nigeria:2
surgeons ,ages:2
surgeons ,advisory:2
nigeria ,ages:2
nigeria ,advisory:2
ages ,advisory:2
covid-19 ,indigenous:2
brazilian ,indigenous:2
brazilian ,populations:2
indigenous ,populations:2
computed ,brazilian:2
computed ,cohort:2
computed ,48:2
computed ,due:2
tomography ,findings:4
tomography ,brazilian:2
tomography ,cohort:2
tomography ,48:2
tomography ,pneumonia:4
tomography ,due:2
findings ,brazilian:2
findings ,cohort:2
findings ,48:2
findings ,due:2
brazilian ,cohort:2
brazilian ,48:2
brazilian ,patients:2
brazilian ,pneumonia:2
brazilian ,due:2
cohort ,48:2
cohort ,pneumonia:2
cohort ,due:2
48 ,patients:2
48 ,pneumonia:2
48 ,due:2
patients ,due:2
highlights ,fight:2
highlights ,autophagy:2
highlights ,play:2
highlights ,role:2
fight ,autophagy:2
covid-19 ,autophagy:8
autophagy ,play:2
autophagy ,role:4
safety ,return:2
safety ,context:2
safety ,stable:2
considerations ,return:2
considerations ,work:2
considerations ,context:2
considerations ,stable:2
return ,work:2
return ,context:2
return ,stable:2
work ,context:2
work ,stable:2
context ,stable:2
stable ,covid-19:2
cardiovascular ,special:2
considerations ,focus:2
disease ,special:2
disease ,focus:2
qualitative ,review:2
qualitative ,early:2
qualitative ,experiences:2
qualitative ,off-site:2
qualitative ,testing:2
qualitative ,centers:2
review ,experiences:2
review ,off-site:2
review ,centers:2
early ,off-site:2
experiences ,off-site:2
experiences ,testing:2
experiences ,centers:2
off-site ,covid-19:2
off-site ,testing:2
off-site ,centers:2
local ,spikes:2
local ,cases:2
local ,recommendations:2
local ,maintaining:2
local ,otolaryngology:2
spikes ,covid-19:2
spikes ,cases:2
spikes ,recommendations:2
spikes ,maintaining:2
spikes ,otolaryngology:2
cases ,recommendations:2
cases ,maintaining:2
cases ,otolaryngology:2
recommendations ,maintaining:2
recommendations ,otolaryngology:4
maintaining ,otolaryngology:2
special ,assessment:2
special ,catastrophic:2
special ,brain:2
special ,injury:2
considerations ,assessment:2
considerations ,catastrophic:2
considerations ,brain:2
considerations ,injury:2
assessment ,catastrophic:2
assessment ,brain:2
catastrophic ,brain:2
epidemiological ,shenzhen:2
characteristics ,shenzhen:2
shenzhen ,china:4
shenzhen ,comparison:2
china ,comparison:4
translating ,bioactive:2
translating ,peptides:2
translating ,covid-19:2
translating ,therapy:2
bioactive ,peptides:4
bioactive ,therapy:2
peptides ,covid-19:2
peptides ,therapy:2
first ,nosocomial:2
reported ,nosocomial:2
reported ,outbreak:2
reported ,severe:2
reported ,acute:2
reported ,respiratory:2
reported ,syndrome:2
nosocomial ,severe:2
nosocomial ,syndrome:2
anticoagulant ,nafamostat:2
anticoagulant ,potently:2
anticoagulant ,inhibits:2
anticoagulant ,sars-cov-2:2
anticoagulant ,protein-mediated:2
anticoagulant ,fusion:2
nafamostat ,potently:2
nafamostat ,inhibits:2
nafamostat ,sars-cov-2:2
nafamostat ,protein-mediated:2
nafamostat ,fusion:2
potently ,inhibits:2
potently ,protein-mediated:2
potently ,fusion:2
inhibits ,protein-mediated:2
inhibits ,fusion:2
sars-cov-2 ,protein-mediated:6
protein-mediated ,fusion:2
revisiting ,role:2
revisiting ,vitamin:2
revisiting ,levels:2
revisiting ,prevention:2
revisiting ,covid-19:2
revisiting ,infection:2
role ,levels:4
levels ,prevention:2
difference ,incubation:2
difference ,period:2
difference ,novel:2
difference ,coronavirus:2
difference ,sars-cov-2:2
epidemiological ,surveillance:2
epidemiological ,common:2
epidemiological ,respiratory:2
epidemiological ,viruses:2
surveillance ,common:2
surveillance ,viruses:2
surveillance ,patients:2
common ,viruses:2
respiratory ,viruses:4
viruses ,patients:2
severe ,orchitis:2
acute ,orchitis:2
respiratory ,orchitis:2
syndrome ,cause:2
syndrome ,orchitis:2
coronavirus-2 ,cause:2
coronavirus-2 ,orchitis:2
sars-cov-2 ,orchitis:2
cause ,orchitis:2
update ,life:2
update ,cycle:2
update ,immunopathology:2
update ,bcg:2
update ,vaccination:2
covid-19 ,cycle:2
life ,immunopathology:2
cycle ,immunopathology:2
cycle ,bcg:2
cycle ,vaccination:2
immunopathology ,bcg:2
immunopathology ,vaccination:2
covid-19 ,infection-update:2
management ,ulcerative:2
management ,colitis:2
management ,woman:2
acute ,ulcerative:2
acute ,colitis:2
acute ,woman:2
severe ,ulcerative:2
severe ,woman:2
ulcerative ,pregnant:2
ulcerative ,woman:2
colitis ,pregnant:2
colitis ,woman:2
immunosuppressive ,drugs:2
immunosuppressive ,covid-19:4
immunosuppressive ,review:2
silico ,fight:2
silico ,finding:2
silico ,chromone:2
fight ,finding:2
fight ,chromone:2
fight ,derivatives:2
novel ,finding:2
novel ,chromone:2
novel ,derivatives:2
coronavirus ,finding:2
coronavirus ,chromone:2
coronavirus ,derivatives:2
finding ,chromone:2
finding ,derivatives:2
chromone ,derivatives:2
turning ,tide:2
turning ,natural:2
turning ,products:2
turning ,natural-product-inspired:2
turning ,chemicals:2
tide ,natural:2
tide ,products:2
tide ,natural-product-inspired:2
tide ,chemicals:2
natural ,natural-product-inspired:2
natural ,chemicals:2
products ,natural-product-inspired:2
products ,chemicals:2
natural-product-inspired ,chemicals:2
atypical ,novel:2
atypical ,coronavirus:4
atypical ,disease:4
atypical ,peritoneal:2
atypical ,dialysis:2
presentation ,peritoneal:2
presentation ,dialysis:2
novel ,peritoneal:2
novel ,dialysis:2
coronavirus ,peritoneal:2
coronavirus ,dialysis:2
disease ,peritoneal:2
disease ,dialysis:2
peritoneal ,dialysis:4
early ,landscape:2
early ,vaccine:2
early ,development:2
early ,uk:2
landscape ,disease:4
landscape ,vaccine:2
landscape ,development:2
landscape ,uk:2
disease ,uk:2
vaccine ,uk:2
development ,uk:2
sars-cov-2 ,binds:2
sars-cov-2 ,platelet:2
sars-cov-2 ,enhance:2
binds ,platelet:2
binds ,ace2:2
binds ,enhance:2
binds ,thrombosis:2
binds ,covid-19:2
platelet ,ace2:2
platelet ,enhance:2
platelet ,thrombosis:2
ace2 ,thrombosis:2
enhance ,thrombosis:2
enhance ,covid-19:6
mutation ,patterns:2
mutation ,human:2
mutation ,bat:2
mutation ,ratg13:2
mutation ,coronavirus:2
mutation ,genomes:4
patterns ,human:2
patterns ,sars-cov-2:2
patterns ,bat:2
patterns ,ratg13:2
patterns ,genomes:2
human ,bat:4
human ,ratg13:2
human ,genomes:2
sars-cov-2 ,ratg13:2
bat ,ratg13:2
bat ,genomes:2
ratg13 ,coronavirus:2
ratg13 ,genomes:2
review ,currently:2
currently ,potential:2
currently ,therapeutic:2
currently ,options:2
currently ,covid-19:2
available ,therapeutic:4
available ,options:2
first ,meningitisencephalitis:2
first ,sars-coronavirus-2:2
case ,meningitisencephalitis:2
case ,sars-coronavirus-2:2
meningitisencephalitis ,associated:2
meningitisencephalitis ,sars-coronavirus-2:2
associated ,sars-coronavirus-2:2
geroscience ,approach:2
geroscience ,preventing:2
geroscience ,pathologic:2
geroscience ,consequences:2
approach ,pathologic:2
approach ,consequences:2
preventing ,pathologic:2
preventing ,consequences:2
pathologic ,consequences:2
case ,familial:2
case ,prevalence:2
report ,familial:2
report ,prevalence:4
report ,anosmia:2
familial ,high:2
familial ,prevalence:2
familial ,anosmia:2
cluster ,high:2
cluster ,prevalence:2
cluster ,anosmia:2
associated ,prevalence:2
high ,anosmia:2
prevalence ,anosmia:2
italy ,next:2
combined ,tocilizumab:2
combined ,hemoadsorption:2
combined ,patient:2
use ,hemoadsorption:2
tocilizumab ,hemoadsorption:2
tocilizumab ,patient:8
hemoadsorption ,patient:2
ocular ,conjunctival:2
ocular ,inoculation:2
ocular ,cause:2
ocular ,mild:2
ocular ,rhesus:2
conjunctival ,inoculation:2
conjunctival ,can:2
conjunctival ,cause:2
conjunctival ,mild:2
conjunctival ,rhesus:2
inoculation ,sars-cov-2:2
inoculation ,can:2
inoculation ,cause:2
inoculation ,mild:2
inoculation ,covid-19:2
inoculation ,rhesus:2
can ,mild:2
can ,rhesus:2
cause ,rhesus:2
mild ,rhesus:2
covid-19 ,rhesus:2
new ,diagnoses:2
new ,two:2
new ,case:4
new ,reports:2
new ,brief:2
new ,literature:2
hiv ,diagnoses:2
hiv ,patients:2
hiv ,two:2
hiv ,reports:2
hiv ,brief:2
hiv ,literature:2
diagnoses ,two:2
diagnoses ,case:2
diagnoses ,reports:2
diagnoses ,brief:2
diagnoses ,literature:2
patients ,reports:2
patients ,brief:4
patients ,literature:2
two ,brief:2
two ,literature:2
case ,brief:2
reports ,brief:2
reports ,literature:2
brief ,literature:2
importance ,early:2
importance ,precautionary:2
importance ,actions:2
importance ,avoiding:2
importance ,spread:2
importance ,saudi:2
early ,precautionary:2
early ,actions:2
early ,avoiding:2
early ,saudi:2
precautionary ,actions:2
precautionary ,avoiding:2
precautionary ,spread:2
precautionary ,saudi:2
actions ,avoiding:2
actions ,spread:2
actions ,covid-19:4
actions ,saudi:2
avoiding ,spread:2
avoiding ,covid-19:4
avoiding ,saudi:2
high ,anti-ssaro:2
high ,antibodies:2
levels ,anti-ssaro:2
levels ,antibodies:2
levels ,respiratory:2
anti-ssaro ,antibodies:2
anti-ssaro ,covid-19:2
anti-ssaro ,patients:2
anti-ssaro ,severe:2
anti-ssaro ,respiratory:2
serum ,igm:2
serum ,correlates:2
serum ,in-hospital:2
serum ,mortality:2
igm ,correlates:2
igm ,in-hospital:2
igm ,mortality:2
sars-cov-2 ,in-hospital:2
correlates ,in-hospital:2
correlates ,mortality:4
in-hospital ,mortality:6
electroencephalography ,sars-cov-2:2
electroencephalography ,outbreak:2
electroencephalography ,practical:2
electroencephalography ,recommendations:2
outbreak ,practical:2
outbreak ,recommendations:4
smell ,biomarker:2
dysfunction ,biomarker:2
biomarker ,covid-19:2
rationale ,adipose-derived:2
rationale ,mesenchymal:2
rationale ,stem:2
rationale ,cells:2
clinical ,adipose-derived:2
clinical ,mesenchymal:2
clinical ,stem:2
clinical ,cells:2
use ,adipose-derived:2
use ,stem:2
adipose-derived ,mesenchymal:2
adipose-derived ,stem:2
adipose-derived ,cells:2
high ,seroprevalence:2
high ,household:2
high ,members:2
high ,essential:2
seroprevalence ,household:2
seroprevalence ,members:2
seroprevalence ,essential:2
seroprevalence ,workers:4
among ,household:2
among ,essential:2
household ,members:2
household ,essential:2
household ,workers:2
members ,essential:2
essential ,workers:2
clinical ,benefit:2
clinical ,rhesus:2
clinical ,macaques:2
benefit ,remdesivir:2
benefit ,rhesus:2
benefit ,macaques:2
benefit ,infected:2
benefit ,sars-cov-2:2
covid ,diagnostic:2
covid ,multiplicity:2
covid ,role:2
covid ,surveillance:2
covid ,control:2
19 ,diagnostic:2
19 ,multiplicity:2
19 ,role:2
19 ,community:2
19 ,surveillance:2
19 ,control:2
diagnostic ,multiplicity:2
diagnostic ,community:2
diagnostic ,surveillance:2
diagnostic ,control:2
multiplicity ,role:2
multiplicity ,community:2
multiplicity ,surveillance:2
multiplicity ,control:2
role ,surveillance:2
surveillance ,control:2
european ,society:4
european ,trauma:2
european ,emergency:2
european ,surgery:2
european ,estes:2
european ,recommendations:2
society ,trauma:2
society ,emergency:2
society ,surgery:6
society ,estes:2
trauma ,estes:2
emergency ,estes:2
surgery ,estes:2
estes ,recommendations:2
pathophysiology ,mechanism:2
pathophysiology ,molecular:2
pathophysiology ,drug:2
mechanism ,transmission:2
mechanism ,drug:2
transmission ,molecular:2
transmission ,drug:2
possible ,molecular:2
possible ,drug:4
canonical ,noncanonical:2
canonical ,autophagy:2
canonical ,potential:2
canonical ,targets:2
canonical ,covid-19:2
noncanonical ,autophagy:2
noncanonical ,potential:2
noncanonical ,targets:2
noncanonical ,covid-19:2
autophagy ,potential:4
autophagy ,targets:2
potential ,post-entry:2
potential ,stages:2
anti-sars-cov-2 ,therapeutics:2
anti-sars-cov-2 ,target:2
anti-sars-cov-2 ,post-entry:2
anti-sars-cov-2 ,stages:2
therapeutics ,target:2
therapeutics ,post-entry:2
therapeutics ,stages:2
target ,post-entry:2
target ,stages:2
post-entry ,stages:2
importance ,chest:2
importance ,ct:2
importance ,scan:2
scan ,covid-19:2
covid-19 ,replacement:2
undergoing ,chronic:2
undergoing ,kidney:2
undergoing ,replacement:2
undergoing ,therapy:2
chronic ,replacement:2
chronic ,therapy:2
kidney ,replacement:2
correlation ,disease:4
correlation ,clinical:6
correlation ,biochemical:2
analysis ,severity:2
potential ,rare:2
potential ,weaponizing:2
potential ,lipid:2
potential ,dysregulation:2
covid-19 ,weaponizing:2
therapeutics ,rare:2
therapeutics ,disease:2
therapeutics ,weaponizing:2
therapeutics ,lipid:2
therapeutics ,dysregulation:2
rare ,weaponizing:2
rare ,lipid:2
rare ,dysregulation:2
disease ,weaponizing:2
disease ,lipid:2
disease ,dysregulation:2
weaponizing ,lipid:2
weaponizing ,dysregulation:2
lipid ,dysregulation:2
anesthesiologist ,behavior:2
anesthesiologist ,anesthesia:2
anesthesiologist ,machine:2
anesthesiologist ,use:2
anesthesiologist ,operating:2
anesthesiologist ,room:2
behavior ,anesthesia:2
behavior ,machine:2
behavior ,use:2
behavior ,operating:2
behavior ,room:2
anesthesia ,machine:2
anesthesia ,use:4
anesthesia ,operating:2
anesthesia ,room:2
machine ,operating:2
machine ,room:2
use ,operating:2
use ,room:2
may ,target:2
may ,double-membrane:2
may ,vesicles:2
may ,oxysterol-binding:2
may ,protein:2
may ,combat:2
target ,double-membrane:2
target ,vesicles:2
target ,oxysterol-binding:2
target ,combat:6
double-membrane ,vesicles:2
double-membrane ,oxysterol-binding:2
double-membrane ,protein:2
double-membrane ,combat:2
vesicles ,oxysterol-binding:2
vesicles ,protein:2
vesicles ,combat:2
oxysterol-binding ,protein:2
oxysterol-binding ,combat:2
protein ,combat:2
epidemiological ,first:4
epidemiological ,53:2
epidemiological ,laboratory-confirmed:2
characteristics ,first:2
characteristics ,53:2
first ,53:2
first ,laboratory-confirmed:2
53 ,laboratory-confirmed:2
53 ,cases:2
laboratory-confirmed ,cases:2
type ,induction:2
type ,evasion:6
type ,application:2
iii ,induction:2
iii ,signaling:2
iii ,evasion:2
iii ,application:2
interferons ,induction:2
interferons ,signaling:2
interferons ,evasion:2
interferons ,application:2
induction ,signaling:2
induction ,evasion:2
induction ,application:2
signaling ,evasion:2
signaling ,application:2
evasion ,application:2
affine ,analysis:2
affine ,quantitative:2
affine ,pcr:2
affine ,measurements:2
analysis ,pcr:2
analysis ,measurements:2
quantitative ,measurements:2
pcr ,measurements:2
covid-19 ,workshop:2
serology ,studies:2
serology ,workshop:2
serology ,recommendations:2
serology ,challenges:2
studies ,workshop:2
studies ,recommendations:2
studies ,challenges:2
workshop ,recommendations:2
workshop ,challenges:2
recommendations ,challenges:2
cardiovascular ,literature:2
implications ,literature:2
laryngeal ,evaluation:2
laryngeal ,covid-19:2
laryngeal ,pandemic:2
laryngeal ,transcervical:2
evaluation ,pandemic:8
evaluation ,transcervical:2
covid-19 ,transcervical:2
pandemic ,transcervical:2
vaccines ,strains:2
lessons ,strains:2
coronavirus ,strains:2
case ,breakthrough:2
case ,hydroxychloroquine:2
case ,maintenance:2
breakthrough ,covid-19:2
breakthrough ,hydroxychloroquine:2
breakthrough ,maintenance:2
hydroxychloroquine ,maintenance:2
susceptible ,supply:2
susceptible ,limits:2
susceptible ,role:2
susceptible ,climate:2
susceptible ,early:2
susceptible ,pandemic:2
supply ,limits:2
supply ,role:2
supply ,climate:2
supply ,early:2
supply ,pandemic:2
limits ,role:2
limits ,climate:2
limits ,early:2
limits ,pandemic:2
role ,climate:2
climate ,early:2
climate ,pandemic:2
retrospective ,initial:4
retrospective ,chest:2
retrospective ,ct:2
retrospective ,imaging:2
retrospective ,findings:2
retrospective ,50:2
study ,ct:2
study ,50:2
initial ,chest:8
initial ,imaging:4
initial ,findings:6
initial ,50:2
chest ,findings:12
chest ,50:2
ct ,50:2
imaging ,50:2
findings ,50:2
50 ,covid-19:2
neurobiology ,coronaviruses:2
neurobiology ,potential:2
neurobiology ,relevance:2
neurobiology ,covid-19:2
coronaviruses ,relevance:2
potential ,relevance:4
relevance ,covid-19:8
early ,nutritional:2
early ,zinc:2
early ,selenium:2
early ,vitamin:2
early ,raising:2
nutritional ,interventions:2
nutritional ,zinc:2
nutritional ,selenium:2
nutritional ,vitamin:2
nutritional ,raising:2
interventions ,zinc:2
interventions ,selenium:2
interventions ,vitamin:2
interventions ,raising:2
zinc ,selenium:2
zinc ,vitamin:2
zinc ,raising:2
selenium ,vitamin:2
selenium ,raising:2
vitamin ,raising:2
coronavirus ,viremia:2
coronavirus ,serologies:2
disease ,viremia:2
disease ,serologies:2
disease ,series:4
viremia ,serologies:2
viremia ,clinical:2
viremia ,course:2
viremia ,case:2
viremia ,series:2
serologies ,clinical:2
serologies ,course:2
serologies ,case:2
serologies ,series:2
course ,series:2
early ,risk:6
early ,factors:2
early ,duration:2
risk ,duration:2
factors ,acute:4
factors ,respiratory:4
factors ,syndrome:4
supporting ,individuals:2
supporting ,intellectual:2
supporting ,developmental:2
supporting ,disability:2
individuals ,intellectual:2
individuals ,developmental:2
individuals ,disability:2
intellectual ,developmental:2
intellectual ,disability:2
developmental ,disability:2
brain ,death:2
brain ,evaluation:2
brain ,pandemic:6
death ,evaluation:2
death ,pandemic:2
effective ,drug:2
effective ,reality:2
effective ,dream:2
drug ,reality:2
drug ,dream:2
covid-19 ,dream:2
reality ,dream:2
hyperinflammation ,derangement:2
hyperinflammation ,renin-angiotensin-aldosterone:2
derangement ,renin-angiotensin-aldosterone:2
derangement ,system:2
recommendations ,adult:2
recommendations ,rheumatic:4
recommendations ,diseases:4
management ,adult:4
management ,rheumatic:4
adult ,rheumatic:2
adult ,diseases:2
innovative ,risk-scoring:2
innovative ,system:2
innovative ,dental:2
innovative ,procedures:2
innovative ,safety:2
innovative ,protocols:2
risk-scoring ,system:2
risk-scoring ,dental:2
risk-scoring ,procedures:2
risk-scoring ,safety:2
risk-scoring ,protocols:2
system ,dental:2
system ,procedures:2
system ,safety:2
system ,protocols:2
dental ,safety:2
dental ,protocols:2
procedures ,safety:2
procedures ,protocols:2
safety ,protocols:4
special ,prevalence:2
special ,selected:2
special ,underlying:2
special ,health:2
special ,conditions:2
special ,among:4
special ,active:2
report ,selected:2
report ,underlying:2
report ,conditions:2
report ,among:2
report ,active:2
prevalence ,selected:2
prevalence ,underlying:2
prevalence ,conditions:2
selected ,underlying:2
selected ,health:2
selected ,conditions:2
selected ,among:2
selected ,active:2
underlying ,conditions:2
underlying ,among:2
underlying ,active:2
health ,active:2
conditions ,active:2
among ,active:2
clinical ,11:2
course ,11:2
course ,thoracic:2
course ,surgery:2
coronavirus ,11:2
disease ,11:2
11 ,patients:2
11 ,thoracic:2
11 ,surgery:2
coronavirus ,gastroenterology:2
disease ,gastroenterology:2
pediatric ,gastroenterology:2
chlorpromazine ,treatment:2
treatment ,recovery:2
role ,asymptomatic:2
role ,positive:2
computed ,asymptomatic:2
computed ,positive:2
tomography ,asymptomatic:2
tomography ,positive:2
drugs ,aggravate:2
drugs ,course:2
drugs ,really:2
aggravate ,course:2
aggravate ,covid-19:2
aggravate ,really:2
course ,really:2
covid-19 ,really:2
clinical ,benefits:2
clinical ,patent:2
clinical ,medicines:2
clinical ,based:4
benefits ,chinese:2
benefits ,patent:2
benefits ,medicines:2
benefits ,based:2
benefits ,current:4
chinese ,current:4
patent ,medicines:2
patent ,based:2
patent ,current:2
medicines ,covid-19:4
medicines ,current:2
brief ,liver:2
brief ,injury:2
brief ,corona:2
brief ,virus:2
brief ,disease-19:2
brief ,duringthe:2
review ,disease-19:2
review ,duringthe:2
liver ,corona:2
liver ,virus:4
liver ,disease-19:2
liver ,duringthe:2
injury ,corona:2
injury ,disease-19:2
injury ,duringthe:2
patients ,disease-19:2
patients ,duringthe:2
corona ,duringthe:2
virus ,duringthe:2
disease-19 ,duringthe:2
prepared ,pandemic:2
prepared ,response:2
prepared ,case:2
prepared ,ethiopia:2
africa ,response:2
africa ,ethiopia:2
covid-19 ,ethiopia:2
pandemic ,ethiopia:2
response ,ethiopia:2
case ,ethiopia:2
swab ,team:2
swab ,instead:2
swab ,swat:2
swab ,medical:2
swab ,students:2
swab ,frontline:2
swab ,force:2
team ,instead:2
team ,swat:2
team ,medical:2
team ,students:2
team ,frontline:2
team ,force:2
instead ,swat:2
instead ,medical:2
instead ,students:2
instead ,frontline:2
instead ,force:2
swat ,medical:2
swat ,students:2
swat ,frontline:2
swat ,force:2
medical ,frontline:2
medical ,force:2
students ,frontline:2
students ,force:2
frontline ,force:2
development ,duo:2
development ,rt-qpcr:2
development ,combining:2
development ,two:4
evaluation ,duo:2
evaluation ,combining:2
duo ,sars-cov-2:2
duo ,rt-qpcr:2
duo ,assay:2
duo ,combining:2
duo ,two:2
duo ,assays:2
rt-qpcr ,combining:2
rt-qpcr ,two:2
rt-qpcr ,assays:2
assay ,combining:2
assay ,assays:2
combining ,two:2
combining ,assays:2
exclusive ,42:2
exclusive ,amino:2
exclusive ,acid:2
exclusive ,signature:2
exclusive ,pp1ab:2
exclusive ,protein:2
exclusive ,provides:2
exclusive ,insights:2
42 ,amino:2
42 ,acid:2
42 ,signature:2
42 ,pp1ab:2
42 ,protein:2
42 ,provides:2
42 ,insights:2
amino ,signature:2
amino ,pp1ab:2
amino ,provides:2
amino ,insights:2
acid ,signature:2
acid ,pp1ab:2
acid ,provides:2
acid ,insights:2
signature ,pp1ab:2
signature ,protein:2
signature ,provides:2
signature ,insights:2
pp1ab ,protein:2
pp1ab ,provides:2
pp1ab ,insights:2
protein ,provides:2
protein ,insights:4
implications ,life:2
implications ,recommendations:2
sexual ,life:2
sexual ,recommendations:2
life ,recommendations:2
pandemic ,returning:2
pandemic ,normalcy:2
pandemic ,normal:2
returning ,normalcy:2
returning ,new:2
returning ,normal:2
normalcy ,new:2
normalcy ,normal:2
new ,normal:2
pathogenesis ,golden:2
pathogenesis ,hamsters:2
transmission ,golden:2
transmission ,hamsters:2
sars-cov-2 ,golden:2
golden ,hamsters:2
high ,concentrations:2
high ,nitric:2
high ,oxide:2
high ,inhalation:2
high ,pregnant:2
concentrations ,nitric:2
concentrations ,oxide:2
concentrations ,inhalation:2
concentrations ,therapy:2
concentrations ,pregnant:2
nitric ,inhalation:2
nitric ,therapy:2
nitric ,pregnant:2
nitric ,patients:2
oxide ,inhalation:2
oxide ,therapy:2
oxide ,pregnant:2
oxide ,patients:2
inhalation ,therapy:2
inhalation ,pregnant:2
inhalation ,patients:2
therapy ,pregnant:2
two ,positive:2
two ,salivary:2
two ,pharyngeal:2
cases ,salivary:2
cases ,negative:2
cases ,pharyngeal:2
covid-19 ,pharyngeal:4
positive ,salivary:2
positive ,pharyngeal:2
salivary ,negative:2
salivary ,pharyngeal:2
salivary ,respiratory:2
negative ,pharyngeal:2
negative ,respiratory:2
pharyngeal ,respiratory:2
sampling ,manholes:2
sampling ,home:2
sampling ,infections:2
manholes ,home:2
manholes ,sars-cov-2:2
manholes ,infections:2
home ,infections:2
psychological ,support:2
psychological ,times:2
psychological ,essen:2
psychological ,community-based:2
psychological ,cope:2
psychological ,concept:2
support ,essen:2
support ,community-based:2
support ,cope:2
support ,concept:2
times ,essen:2
times ,community-based:2
times ,cope:2
times ,concept:2
covid-19 ,essen:2
covid-19 ,community-based:2
covid-19 ,cope:2
covid-19 ,concept:4
essen ,community-based:2
essen ,cope:2
essen ,concept:2
community-based ,cope:2
community-based ,concept:2
cope ,concept:2
surveying ,chemosensory:2
surveying ,dysfunction:2
surveying ,covid-19:2
chemosensory ,covid-19:6
probability ,covid-19:2
probability ,culprit:2
probability ,neurocognitive:2
probability ,deception:2
probability ,case:2
probability ,series:2
covid-19 ,neurocognitive:2
covid-19 ,deception:2
culprit ,neurocognitive:2
culprit ,deception:2
culprit ,case:2
culprit ,series:2
neurocognitive ,deception:2
neurocognitive ,case:2
neurocognitive ,series:2
deception ,case:2
deception ,series:2
coronaviruses ,symptoms:2
coronaviruses ,liaison:2
gastrointestinal ,old:2
gastrointestinal ,liaison:2
gastrointestinal ,new:4
symptoms ,old:2
symptoms ,liaison:2
symptoms ,new:2
old ,liaison:2
liaison ,new:2
liaison ,sars-cov-2:2
mitochondrial ,bioenergetics:2
mitochondrial ,coenzyme:2
mitochondrial ,q10:2
mitochondrial ,target:2
mitochondrial ,virus:2
mitochondrial ,causing:2
bioenergetics ,coenzyme:2
bioenergetics ,q10:2
bioenergetics ,target:2
bioenergetics ,virus:2
bioenergetics ,causing:2
coenzyme ,q10:2
coenzyme ,target:2
coenzyme ,virus:2
coenzyme ,causing:2
q10 ,target:2
q10 ,virus:2
q10 ,causing:2
target ,causing:2
covid-19 ,ecmo:2
covid-19 ,inflammation-a:2
ecmo ,interplay:2
ecmo ,coagulation:2
ecmo ,inflammation-a:2
ecmo ,narrative:2
interplay ,coagulation:2
interplay ,inflammation-a:2
interplay ,narrative:2
coagulation ,inflammation-a:2
coagulation ,narrative:2
inflammation-a ,narrative:2
development ,implementation:2
development ,operational:2
development ,concept:2
development ,university:2
development ,eye:2
implementation ,operational:2
implementation ,concept:2
implementation ,university:2
implementation ,eye:2
operational ,concept:2
operational ,university:2
operational ,eye:2
concept ,university:2
concept ,eye:2
university ,eye:2
maternal ,deaths:2
maternal ,brazil:2
maternal ,severe:2
maternal ,respiratory:2
maternal ,time:2
deaths ,brazil:2
deaths ,severe:2
deaths ,respiratory:2
deaths ,disease:4
deaths ,time:2
brazil ,severe:2
brazil ,respiratory:2
brazil ,disease:2
brazil ,time:2
drive-through ,unique:2
drive-through ,efficient:4
drive-through ,method:2
drive-through ,collecting:2
drive-through ,large:2
drive-through ,volume:2
testing ,unique:2
testing ,efficient:2
testing ,collecting:2
testing ,volume:2
unique ,efficient:2
unique ,method:2
unique ,collecting:2
unique ,large:2
unique ,volume:2
efficient ,method:2
efficient ,collecting:2
efficient ,large:2
efficient ,volume:2
method ,collecting:2
method ,large:2
method ,volume:2
collecting ,large:2
collecting ,volume:2
large ,volume:2
time ,culture:2
time ,understanding:2
time ,reducing:2
time ,morbidity:2
time ,mortality:2
culture ,change:2
culture ,understanding:2
culture ,reducing:2
culture ,risk:2
culture ,morbidity:2
culture ,mortality:2
change ,understanding:2
change ,reducing:4
change ,risk:4
change ,morbidity:2
change ,mortality:2
understanding ,reducing:2
understanding ,morbidity:2
understanding ,mortality:2
reducing ,risk:2
reducing ,morbidity:2
reducing ,mortality:2
risk ,morbidity:2
suspected ,charcot-marie-tooth:2
suspected ,patient:2
suspected ,undergoing:4
sars-cov-2 ,charcot-marie-tooth:2
infection ,charcot-marie-tooth:2
infection ,undergoing:4
charcot-marie-tooth ,patient:2
charcot-marie-tooth ,undergoing:2
covid-19-associated ,myocarditis:2
covid-19-associated ,adolescent:2
myocarditis ,adolescent:2
micronutrients ,immunomodulatory:2
micronutrients ,tools:2
micronutrients ,covid-19:2
micronutrients ,management:2
immunomodulatory ,tools:2
association ,internet:2
association ,search:2
association ,volumes:2
association ,google:2
covid-19 ,volumes:2
covid-19 ,google:2
pandemic ,internet:2
pandemic ,search:2
pandemic ,volumes:2
pandemic ,google:2
internet ,search:2
internet ,volumes:2
internet ,google:2
search ,volumes:2
search ,google:2
volumes ,google:2
diagnostic ,treatment:2
diagnostic ,strategies:2
space-time ,patterns:2
space-time ,change:2
space-time ,propagation:2
space-time ,covid-19:2
space-time ,risk:2
space-time ,relative:2
patterns ,change:2
patterns ,propagation:2
patterns ,risk:4
patterns ,relative:2
change ,propagation:2
change ,relative:2
propagation ,covid-19:2
propagation ,risk:2
propagation ,relative:2
risk ,relative:2
inhibition ,ace2tmprss2:2
inhibition ,pathway:4
sars-cov-2 ,ace2tmprss2:2
entry ,ace2tmprss2:2
entry ,pathway:2
entry ,promising:2
ace2tmprss2 ,pathway:2
ace2tmprss2 ,promising:2
pathway ,promising:4
estimation ,accuracy:4
estimation ,tests:2
estimation ,scoping:2
estimation ,review:2
diagnostic ,scoping:2
accuracy ,scoping:2
accuracy ,review:2
tests ,scoping:2
neutrophil ,infiltrate:2
neutrophil ,airway:2
neutrophil ,interstitial:2
extracellular ,infiltrate:2
extracellular ,lung:2
extracellular ,airway:2
extracellular ,interstitial:2
traps ,infiltrate:2
traps ,lung:2
traps ,airway:2
traps ,interstitial:2
infiltrate ,lung:2
infiltrate ,airway:2
infiltrate ,interstitial:2
lung ,airway:2
lung ,interstitial:2
airway ,interstitial:2
factors ,related:2
factors ,healthcare:2
factors ,spain:2
related ,healthcare:2
related ,professionals:2
related ,spain:2
infection ,professionals:2
healthcare ,spain:2
professionals ,spain:2
cluster ,tertiary:2
cluster ,transmissions:2
tertiary ,transmissions:2
tertiary ,novel:4
tertiary ,coronavirus:4
transmissions ,sars-cov-2:2
covid-19 ,dual:2
high-risk ,dual:2
high-risk ,heart:2
high-risk ,kidney:2
high-risk ,transplant:2
high-risk ,recipient:2
dual ,heart:2
dual ,kidney:2
dual ,transplant:2
dual ,recipient:2
heart ,recipient:2
possible ,path:2
possible ,towards:2
possible ,rapid:2
possible ,live-attenuated:2
possible ,vaccines:2
path ,towards:2
path ,rapid:2
path ,development:2
path ,live-attenuated:2
path ,sars-cov-2:4
path ,vaccines:2
towards ,rapid:2
towards ,live-attenuated:2
towards ,vaccines:4
rapid ,live-attenuated:2
rapid ,vaccines:2
development ,live-attenuated:2
live-attenuated ,sars-cov-2:2
live-attenuated ,vaccines:2
multisystem ,pandemic:2
inflammatory ,pandemic:2
call ,action:2
call ,becomes:2
call ,practice:2
call ,cardiac:2
call ,vascular:2
call ,surgery:2
call ,covid-19:2
action ,becomes:2
action ,practice:2
action ,cardiac:2
action ,vascular:2
action ,surgery:2
becomes ,practice:2
becomes ,cardiac:2
becomes ,vascular:2
becomes ,surgery:2
becomes ,covid-19:2
practice ,cardiac:2
practice ,vascular:2
cardiac ,vascular:2
vascular ,surgery:4
potential ,curcumin:2
effects ,curcumin:2
curcumin ,treatment:2
curcumin ,infection:2
evidence-based ,theory:2
evidence-based ,change:2
evidence-based ,reducing:2
evidence-based ,transmission:2
evidence-based ,reopened:2
theory ,change:2
theory ,reducing:2
theory ,sars-cov-2:2
theory ,transmission:2
theory ,reopened:2
change ,reopened:2
reducing ,transmission:4
reducing ,reopened:2
sars-cov-2 ,reopened:2
transmission ,reopened:2
pulmonary ,extra-pulmonary:2
pulmonary ,clinical:2
pulmonary ,manifestations:2
extra-pulmonary ,covid-19:2
severe ,sars-cov-2-induced:2
acute ,cardiovascular:2
respiratory ,sars-cov-2-induced:2
respiratory ,cardiovascular:2
coronavirus ,sars-cov-2-induced:2
sars-cov-2-induced ,cardiovascular:2
prognostic ,factors:2
prognostic ,diabetes:2
prognostic ,hospitalized:2
prognostic ,findings:2
factors ,findings:2
diabetes ,hospitalized:2
vaccines ,primer:2
vaccines ,clinicians:2
primer ,clinicians:2
managing ,hyperlipidaemia:2
hyperlipidaemia ,patients:2
hyperlipidaemia ,covid-19:2
hyperlipidaemia ,pandemic:2
genetic ,reflects:2
genetic ,clonal:2
genetic ,superspreading:2
genetic ,multiple:2
structure ,reflects:2
structure ,clonal:2
structure ,superspreading:2
structure ,multiple:2
sars-cov-2 ,reflects:2
sars-cov-2 ,superspreading:6
reflects ,clonal:2
reflects ,superspreading:2
reflects ,multiple:2
clonal ,superspreading:2
clonal ,multiple:2
superspreading ,multiple:2
autoimmunity ,comet:2
autoimmunity ,tail:2
autoimmunity ,covid-19:2
autoimmunity ,pandemic:2
comet ,tail:2
comet ,covid-19:2
comet ,pandemic:2
tail ,covid-19:2
tail ,pandemic:2
oral ,ulceration:2
oral ,blistering:2
ulceration ,blistering:2
ulceration ,patients:2
ulceration ,covid-19:2
blistering ,patients:2
blistering ,covid-19:2
social ,low:2
social ,resource:2
social ,setting:2
social ,sierra:2
social ,leone:2
social ,west:2
consequences ,low:2
consequences ,resource:2
consequences ,setting:2
consequences ,sierra:2
consequences ,leone:2
consequences ,west:2
covid-19 ,sierra:2
covid-19 ,leone:2
low ,setting:2
low ,sierra:2
low ,leone:2
low ,west:2
resource ,setting:2
resource ,sierra:2
resource ,leone:2
resource ,west:2
setting ,sierra:2
setting ,leone:2
setting ,west:2
sierra ,leone:2
sierra ,west:2
leone ,west:2
antimalarial ,inhibit:2
antimalarial ,replication:2
antimalarial ,sars-cov-2:2
antimalarial ,vitro:2
antimalarial ,evaluation:2
drugs ,replication:4
drugs ,vitro:6
drugs ,evaluation:6
inhibit ,replication:4
inhibit ,vitro:2
inhibit ,evaluation:2
replication ,evaluation:2
times ,epidemiology:2
times ,unifying:2
covid-19 ,unifying:2
epidemiology ,unifying:2
epidemiology ,science:2
unifying ,science:2
ethical ,challenges:2
ethical ,global:2
ethical ,south:2
challenges ,south:4
pandemic ,south:2
global ,south:2
computational ,guided:2
computational ,2-o-ribose:2
computational ,methyltransferase:2
guided ,drug:2
guided ,repurposing:2
guided ,targeting:2
guided ,2-o-ribose:2
guided ,methyltransferase:2
drug ,2-o-ribose:2
drug ,methyltransferase:2
repurposing ,2-o-ribose:2
repurposing ,methyltransferase:2
targeting ,2-o-ribose:2
targeting ,methyltransferase:2
2-o-ribose ,methyltransferase:2
telemedicine ,ophthalmology:2
telemedicine ,view:2
telemedicine ,emerging:2
telemedicine ,covid-19:4
telemedicine ,outbreak:2
ophthalmology ,view:2
ophthalmology ,emerging:2
view ,emerging:2
view ,outbreak:2
effect ,xuebijing:2
effect ,injection:4
effect ,inflammatory:2
effect ,markers:2
effect ,outcome:2
xuebijing ,injection:2
xuebijing ,inflammatory:2
xuebijing ,markers:2
xuebijing ,disease:2
xuebijing ,outcome:2
injection ,inflammatory:2
injection ,markers:2
injection ,disease:2
injection ,outcome:2
inflammatory ,outcome:2
markers ,outcome:2
candidate ,multi-epitope:4
candidate ,vaccine:16
learn ,previous:2
learn ,coronavirus:2
learn ,better:2
previous ,coronavirus:2
previous ,epidemics:2
previous ,can:2
previous ,better:2
coronavirus ,epidemics:2
coronavirus ,better:2
epidemics ,can:2
epidemics ,better:2
irans ,approach:2
irans ,covid-19:2
irans ,evolving:2
irans ,treatment:2
irans ,protocols:2
irans ,ongoing:2
irans ,clinical:2
approach ,evolving:2
approach ,protocols:2
approach ,ongoing:2
evolving ,protocols:2
evolving ,ongoing:2
evolving ,clinical:2
protocols ,ongoing:2
people ,panthera:2
people ,natural:2
people ,tigers:2
people ,lions:2
panthera ,natural:2
panthera ,sars-cov-2:2
panthera ,infection:2
panthera ,tigers:2
panthera ,lions:2
natural ,infection:2
natural ,tigers:2
natural ,lions:2
sars-cov-2 ,tigers:2
sars-cov-2 ,lions:2
infection ,tigers:2
infection ,lions:2
panel ,human:2
panel ,neutralizing:2
panel ,mabs:2
panel ,targeting:2
panel ,spike:2
panel ,epitopes:2
human ,mabs:2
human ,targeting:2
human ,multiple:2
neutralizing ,mabs:2
neutralizing ,targeting:2
neutralizing ,spike:6
neutralizing ,multiple:2
neutralizing ,epitopes:2
mabs ,targeting:2
mabs ,sars-cov-2:2
mabs ,spike:2
mabs ,multiple:2
mabs ,epitopes:2
targeting ,multiple:2
targeting ,epitopes:2
spike ,multiple:2
multiple ,epitopes:2
achieving ,covid-19:2
achieving ,free:2
achieving ,country:2
achieving ,citizens:2
achieving ,preventive:2
achieving ,measures:2
achieving ,communication:2
covid-19 ,communication:4
free ,country:2
free ,citizens:2
free ,preventive:2
free ,measures:2
free ,communication:2
country ,citizens:2
country ,preventive:2
country ,measures:2
country ,communication:2
citizens ,preventive:2
citizens ,measures:2
citizens ,communication:2
preventive ,communication:2
measures ,communication:2
specific ,metabolome:2
specific ,profiling:4
specific ,infected:2
specific ,supports:2
metabolome ,profiling:2
metabolome ,patients:2
metabolome ,infected:2
metabolome ,sars-cov-2:2
metabolome ,supports:2
profiling ,patients:4
profiling ,infected:2
profiling ,sars-cov-2:6
profiling ,supports:2
patients ,supports:2
infected ,supports:2
sars-cov-2 ,supports:2
factors ,preventing:2
factors ,materno-fetal:2
preventing ,materno-fetal:2
materno-fetal ,transmission:2
materno-fetal ,sars-cov-2:2
lymphocytic ,myocarditis:2
lymphocytic ,patients:2
lymphocytic ,autopsy:2
lymphocytic ,cases:2
myocarditis ,patients:2
myocarditis ,autopsy:2
myocarditis ,cases:2
patients ,autopsy:4
clinical ,dispersion:2
clinical ,pattern:2
laboratory ,dispersion:2
laboratory ,pattern:2
laboratory ,family:2
laboratory ,cluster:2
dispersion ,pattern:2
dispersion ,covid-19:6
dispersion ,family:2
dispersion ,cluster:2
pattern ,family:2
pattern ,cluster:2
diagnostic ,sudden:2
diagnostic ,smell:2
diagnostic ,loss:2
diagnostic ,among:2
diagnostic ,asymptomatic:2
value ,smell:2
value ,among:2
detecting ,sudden:2
detecting ,smell:2
detecting ,loss:2
detecting ,among:2
detecting ,asymptomatic:2
sudden ,among:2
sudden ,asymptomatic:2
smell ,asymptomatic:2
loss ,among:2
loss ,asymptomatic:2
cardiovascular ,manifestations:6
cardiovascular ,therapeutics:2
system ,therapeutics:2
manifestations ,therapeutics:2
ethical ,principles:2
ethical ,compromised:2
principles ,compromised:2
principles ,pandemic:2
compromised ,pandemic:2
pandemic ,consideration:2
consideration ,brain:2
consideration ,infection:2
initial ,experience:4
initial ,attention:2
initial ,private:2
experience ,attention:2
experience ,private:4
attention ,patients:2
attention ,covid-19:2
attention ,private:2
patients ,private:2
covid-19 ,private:4
testing ,masks:2
testing ,respirators:2
testing ,cotton:2
testing ,mask:2
testing ,insert:2
testing ,materials:2
testing ,using:6
commercial ,masks:2
commercial ,respirators:2
commercial ,cotton:2
commercial ,mask:2
commercial ,insert:2
commercial ,materials:2
masks ,cotton:2
masks ,mask:2
masks ,insert:2
masks ,materials:2
masks ,using:2
respirators ,cotton:2
respirators ,mask:2
respirators ,insert:2
respirators ,materials:2
respirators ,using:2
cotton ,mask:2
cotton ,insert:2
cotton ,materials:2
cotton ,using:2
mask ,insert:2
mask ,using:2
insert ,materials:2
insert ,using:2
materials ,using:2
physics ,virus:2
physics ,transmission:2
physics ,speaking:2
physics ,droplets:2
virus ,speaking:2
transmission ,speaking:2
speaking ,droplets:2
zinc ,iodide:2
zinc ,combination:2
zinc ,dimethyl:2
zinc ,sulfoxide:2
iodide ,combination:2
iodide ,dimethyl:2
iodide ,sulfoxide:2
iodide ,treatment:2
iodide ,sars-cov-2:2
combination ,dimethyl:2
combination ,sulfoxide:2
dimethyl ,sulfoxide:2
dimethyl ,treatment:2
dimethyl ,sars-cov-2:2
sulfoxide ,treatment:2
sulfoxide ,sars-cov-2:2
use ,healthcare:4
personal ,coronavirus:2
personal ,disease:2
protective ,disease:2
equipment ,coronavirus:2
equipment ,disease:2
utilizing ,integrating:2
utilizing ,network:2
utilizing ,pharmacological:2
utilizing ,approaches:2
utilizing ,investigate:2
integrating ,network:2
integrating ,pharmacological:2
integrating ,approaches:2
integrating ,investigate:2
network ,pharmacological:2
network ,approaches:2
network ,investigate:2
pharmacological ,investigate:2
approaches ,investigate:2
rapid ,genomic:2
rapid ,characterization:2
rapid ,viruses:2
genomic ,viruses:2
genomic ,specimens:2
genomic ,using:2
characterization ,viruses:2
characterization ,specimens:2
characterization ,using:2
viruses ,clinical:4
viruses ,specimens:2
viruses ,using:2
specimens ,using:2
transition ,online:2
transition ,possible:2
transition ,solution:2
transition ,simulation-based:2
transition ,teaching:2
online ,possible:2
online ,solution:2
online ,simulation-based:2
online ,teaching:2
possible ,solution:2
possible ,simulation-based:2
possible ,teaching:2
solution ,simulation-based:2
solution ,teaching:2
simulation-based ,teaching:2
early ,clearance:2
early ,delayed:2
early ,antibody:2
early ,response:2
virus ,clearance:2
virus ,delayed:2
virus ,response:2
clearance ,delayed:2
clearance ,antibody:2
clearance ,case:2
clearance ,coronavirus:4
clearance ,disease:4
targeting ,endolysosomal:2
targeting ,host-sars-cov-2:2
targeting ,clinically:2
targeting ,licensed:2
endolysosomal ,host-sars-cov-2:2
endolysosomal ,interface:2
endolysosomal ,clinically:2
endolysosomal ,licensed:2
host-sars-cov-2 ,interface:2
host-sars-cov-2 ,clinically:2
host-sars-cov-2 ,licensed:2
interface ,clinically:2
interface ,licensed:2
clinically ,licensed:2
widespread ,severe:2
widespread ,acute:2
widespread ,respiratory:2
widespread ,coronavirus:2
widespread ,virus:2
widespread ,sars-cov-2:2
widespread ,laboratory:2
acute ,laboratory:4
respiratory ,laboratory:4
pregnancy ,neonatal:4
cardiovascular ,viral:2
complications ,consequences:2
complications ,viral:2
patients ,consequences:2
consequences ,viral:2
breastfeeding ,pragmatic:2
breastfeeding ,approach:2
multisystem ,related:4
multisystem ,previously:2
multisystem ,healthy:2
inflammatory ,related:6
inflammatory ,previously:2
inflammatory ,healthy:2
syndrome ,previously:2
syndrome ,healthy:2
related ,previously:2
related ,healthy:2
related ,children:4
covid-19 ,previously:2
previously ,children:2
healthy ,children:2
association ,mode:2
association ,delivery:2
association ,pregnant:2
association ,women:2
association ,maternal:2
mode ,delivery:4
mode ,among:2
mode ,pregnant:2
mode ,women:2
mode ,covid-19:4
mode ,maternal:2
delivery ,maternal:2
among ,maternal:2
pregnant ,maternal:2
women ,maternal:2
clinical ,14:2
clinical ,compared:2
course ,findings:2
course ,14:2
course ,compared:2
findings ,14:2
findings ,compared:2
14 ,patients:2
14 ,compared:2
patients ,compared:2
first ,comes:2
first ,learned:2
comes ,learned:2
comes ,outbreak:2
determining ,relationship:2
determining ,infection:2
determining ,dopamine:2
relationship ,infection:2
relationship ,dopamine:2
sars-cov-2 ,dopamine:2
infection ,dopamine:2
dopamine ,covid-19:2
coronaviruses ,sialic:2
coronaviruses ,acid:2
coronaviruses ,gate:2
coronaviruses ,eye:2
coronaviruses ,cytokine:2
coronaviruses ,storm:2
coronaviruses ,entry:4
sialic ,gate:2
sialic ,eye:2
sialic ,cytokine:2
sialic ,storm:2
sialic ,entry:2
acid ,gate:2
acid ,eye:2
acid ,cytokine:2
acid ,storm:2
acid ,entry:2
gate ,eye:2
gate ,cytokine:2
gate ,storm:2
gate ,entry:2
eye ,entry:2
cytokine ,entry:2
storm ,entry:2
perioperative ,considerations:2
perioperative ,tracheostomies:2
perioperative ,era:2
perioperative ,covid-19:6
considerations ,tracheostomies:2
tracheostomies ,era:2
tracheostomies ,covid-19:2
report ,tocilizumab:2
tocilizumab ,treatment:6
tocilizumab ,infection:2
suspected ,turned:2
suspected ,report:2
case ,turned:2
turned ,confirmed:2
turned ,report:2
unclear ,present:2
unclear ,danger:2
unclear ,asymptomatic:2
unclear ,sars-cov-2:2
unclear ,carrier:2
present ,danger:2
present ,asymptomatic:2
present ,carrier:2
danger ,asymptomatic:2
danger ,sars-cov-2:2
danger ,carrier:2
sars-cov-2 ,carrier:2
efficacy ,povidone-iodine:2
efficacy ,nasal:2
efficacy ,antiseptic:2
efficacy ,preparations:2
povidone-iodine ,nasal:4
povidone-iodine ,antiseptic:2
povidone-iodine ,preparations:2
povidone-iodine ,severe:2
nasal ,oral:2
nasal ,antiseptic:2
nasal ,preparations:2
oral ,antiseptic:2
oral ,preparations:2
antiseptic ,preparations:2
antiseptic ,severe:2
preparations ,severe:2
recommendations ,infection:6
recommendations ,new:6
management ,new:4
viral ,replication:2
viral ,self-limitative:2
replication ,self-limitative:2
sars-cov-2 ,self-limitative:2
self-limitative ,role:2
codon ,phenotypic:2
codon ,divergences:2
codon ,genes:2
usage ,phenotypic:2
usage ,divergences:2
phenotypic ,divergences:2
phenotypic ,genes:2
divergences ,sars-cov-2:2
divergences ,genes:2
survey ,preparedness:2
survey ,hospitals:2
survey ,idaho:2
covid-19 ,hospitals:4
covid-19 ,idaho:2
preparedness ,among:2
preparedness ,hospitals:2
preparedness ,idaho:2
among ,idaho:2
hospitals ,idaho:2
impact ,italian:2
impact ,carbon:2
impact ,footprint:2
covid-19 ,carbon:2
covid-19 ,footprint:2
outbreak ,carbon:2
outbreak ,footprint:2
measures ,italian:2
measures ,carbon:2
measures ,footprint:2
lockdown ,italian:2
lockdown ,carbon:2
lockdown ,footprint:2
italian ,carbon:2
italian ,footprint:2
carbon ,footprint:2
acute ,arterial:2
acute ,mild:4
upper ,ischemia:4
upper ,due:2
upper ,arterial:2
upper ,thrombosis:2
limb ,due:2
limb ,arterial:2
limb ,thrombosis:2
limb ,mild:2
ischemia ,due:2
ischemia ,arterial:2
ischemia ,mild:2
due ,arterial:2
due ,mild:2
due ,patient:2
arterial ,thrombosis:6
arterial ,mild:2
arterial ,patient:2
thrombosis ,mild:2
neurological ,reasons:2
neurological ,consultation:2
neurological ,hospitalization:2
reasons ,consultation:2
reasons ,hospitalization:2
reasons ,covid-19:2
consultation ,hospitalization:2
consultation ,covid-19:2
covid-19 ,generate:2
covid-19 ,apply:2
covid-19 ,modelled:2
generate ,apply:2
generate ,local:2
generate ,modelled:2
generate ,transmission:2
generate ,morbidity:2
generate ,effects:2
apply ,local:2
apply ,modelled:2
apply ,transmission:2
apply ,morbidity:2
apply ,effects:2
local ,modelled:2
local ,transmission:2
local ,morbidity:2
local ,effects:2
modelled ,transmission:2
modelled ,morbidity:2
modelled ,effects:2
transmission ,morbidity:2
morbidity ,effects:2
rapid ,system:2
isothermal ,portable:2
isothermal ,system:2
amplification ,portable:2
amplification ,system:2
portable ,system:2
review ,histotechnology:2
review ,practices:2
review ,pathology:2
review ,investigations:2
histotechnology ,practices:2
histotechnology ,covid-19:2
histotechnology ,pathology:2
histotechnology ,investigations:2
practices ,pathology:2
practices ,investigations:2
covid-19 ,investigations:4
pathology ,investigations:2
roadmap ,safe:2
roadmap ,practice:2
roadmap ,forensic:2
roadmap ,medicine:2
roadmap ,covid-19:2
roadmap ,pandemic:2
safe ,practice:2
safe ,forensic:2
safe ,medicine:2
practice ,medicine:4
forensic ,medicine:2
forensic ,covid-19:2
case ,acquired:2
coronavirus ,acquired:2
coronavirus ,immunodeficiency:2
disease ,acquired:2
disease ,immunodeficiency:2
acquired ,immunodeficiency:2
acquired ,syndrome:2
acquired ,patient:2
immunodeficiency ,syndrome:2
immunodeficiency ,patient:2
practical ,performing:2
practical ,neurodiagnostic:2
practical ,studies:2
considerations ,performing:2
considerations ,neurodiagnostic:2
considerations ,studies:2
performing ,neurodiagnostic:2
performing ,studies:2
performing ,patients:2
neurodiagnostic ,studies:2
neurodiagnostic ,patients:2
air ,syndrome:2
air ,two:2
air ,preterm:2
air ,infants:2
air ,born:2
air ,mothers:2
air ,coronavirus:4
leak ,syndrome:2
leak ,two:2
leak ,preterm:2
leak ,infants:2
leak ,born:2
leak ,mothers:2
leak ,coronavirus:2
syndrome ,two:2
syndrome ,infants:2
syndrome ,born:2
syndrome ,mothers:2
two ,preterm:2
preterm ,infants:2
preterm ,born:2
preterm ,mothers:2
latent ,covid-19:4
latent ,clusters:4
latent ,patients:2
latent ,chronic:2
latent ,respiratory:2
latent ,conditions:2
clusters ,patients:2
clusters ,chronic:2
clusters ,respiratory:2
clusters ,conditions:2
antioxidant ,enzyme:2
antioxidant ,therapeutic:2
enzyme ,therapeutic:2
crushing ,curve:2
crushing ,role:2
crushing ,national:2
crushing ,international:2
crushing ,institutions:2
crushing ,policy:2
curve ,role:2
curve ,national:2
curve ,international:2
curve ,institutions:2
curve ,policy:2
role ,national:2
role ,international:2
role ,institutions:2
role ,policy:2
national ,international:2
national ,institutions:2
national ,policy:2
international ,institutions:2
international ,policy:2
institutions ,policy:2
enhanced ,elicitation:2
enhanced ,potent:2
enhanced ,neutralizing:2
enhanced ,antibodies:2
elicitation ,potent:2
elicitation ,neutralizing:2
elicitation ,antibodies:2
elicitation ,sars-cov-2:2
elicitation ,spike:2
potent ,neutralizing:2
performance ,transcription-mediated:2
characteristics ,automated:2
characteristics ,transcription-mediated:2
high-throughput ,automated:2
automated ,transcription-mediated:2
clinical ,31:2
analysis ,31:2
31 ,cases:2
31 ,novel:2
31 ,coronavirus:2
31 ,infection:2
31 ,children:2
relation ,chest:2
relation ,ct:2
relation ,findings:2
relation ,clinical:4
relation ,conditions:2
chest ,conditions:2
ct ,conditions:2
findings ,conditions:2
clinical ,conditions:2
highly ,specific:4
highly ,diagnosis:4
highly ,19:2
sensitive ,specific:4
sensitive ,diagnosis:4
sensitive ,coronavirus:2
sensitive ,disease:2
sensitive ,19:2
specific ,diagnosis:4
specific ,coronavirus:2
specific ,disease:2
specific ,19:2
diagnosis ,19:2
incidence ,clinical:2
incidence ,rheumatologic:2
incidence ,diseases:2
clinical ,rheumatologic:2
clinical ,diseases:2
course ,rheumatologic:2
course ,diseases:2
covid-19 ,rheumatologic:2
patients ,rheumatologic:2
rheumatologic ,diseases:2
can ,wearing:2
can ,face:2
can ,masks:2
can ,route:2
can ,load:2
wearing ,public:2
wearing ,affect:2
wearing ,route:2
wearing ,viral:2
wearing ,load:2
face ,affect:2
face ,route:2
face ,viral:2
face ,load:2
masks ,public:2
masks ,affect:2
masks ,route:2
masks ,viral:2
masks ,load:2
public ,affect:2
public ,route:2
public ,viral:2
public ,load:2
affect ,transmission:2
affect ,route:2
affect ,viral:6
affect ,load:2
transmission ,load:2
route ,viral:2
route ,load:2
heat ,different:2
heat ,types:2
heat ,protocols:4
inactivation ,types:2
inactivation ,protocols:2
different ,protocols:2
types ,samples:2
types ,protocols:2
sequence ,reveals:2
sequence ,features:2
sequence ,important:2
sequence ,vaccine:2
analysis ,important:2
genome ,reveals:2
genome ,important:2
genome ,vaccine:2
reveals ,features:2
reveals ,important:2
reveals ,vaccine:4
features ,important:2
features ,vaccine:2
important ,vaccine:2
initial ,public:2
initial ,health:2
initial ,response:2
initial ,interim:2
initial ,guidance:2
public ,interim:2
public ,clinical:2
public ,guidance:2
health ,interim:2
health ,clinical:2
response ,interim:2
response ,guidance:2
interim ,clinical:2
interim ,guidance:4
guidance ,novel:2
conformational ,transition:2
conformational ,sars-cov-2:2
conformational ,spike:2
conformational ,glycoprotein:2
conformational ,closed:2
transition ,sars-cov-2:2
transition ,spike:2
transition ,glycoprotein:2
transition ,closed:2
sars-cov-2 ,closed:2
spike ,closed:2
glycoprotein ,closed:2
interfaces ,silver:2
interfaces ,bullets:2
interfaces ,technologies:2
interfaces ,policies:2
silver ,bullets:2
silver ,technologies:2
silver ,policies:2
bullets ,technologies:2
bullets ,policies:2
technologies ,policies:2
review ,contamination:2
contamination ,wastewater:2
contamination ,impact:2
contamination ,treatment:2
wastewater ,virus:4
wastewater ,impact:2
implementation ,pooled:4
implementation ,surveillance:2
implementation ,testing:2
implementation ,program:2
implementation ,asymptomatic:2
pooled ,surveillance:2
pooled ,program:2
pooled ,asymptomatic:2
surveillance ,program:2
surveillance ,asymptomatic:2
program ,asymptomatic:2
case ,multiple:4
case ,sclerosis:2
series ,multiple:2
series ,sclerosis:2
literature ,multiple:2
literature ,sclerosis:2
review ,multiple:2
review ,sclerosis:2
sclerosis ,clinical:2
use ,therapeutic-dose:2
use ,anticoagulation:2
use ,effect:2
use ,mortality:2
therapeutic-dose ,anticoagulation:2
therapeutic-dose ,effect:2
therapeutic-dose ,mortality:2
therapeutic-dose ,patients:2
anticoagulation ,effect:2
anticoagulation ,mortality:4
anticoagulation ,patients:4
pharmacotherapy ,narrative:2
pharmacotherapy ,review:2
pharmacotherapy ,emergency:2
pharmacotherapy ,providers:2
narrative ,emergency:2
narrative ,providers:2
review ,emergency:4
review ,providers:2
emergency ,providers:2
chest ,severity:4
chest ,index:2
chest ,predictor:2
chest ,in-hospital:2
chest ,mortality:2
x-ray ,severity:2
x-ray ,index:2
x-ray ,predictor:2
x-ray ,in-hospital:2
x-ray ,mortality:2
x-ray ,coronavirus:4
severity ,predictor:2
severity ,in-hospital:4
index ,predictor:2
index ,in-hospital:2
index ,mortality:2
index ,coronavirus:2
predictor ,in-hospital:2
predictor ,mortality:2
predictor ,coronavirus:2
in-hospital ,coronavirus:2
atazanavir ,alone:2
atazanavir ,combination:2
atazanavir ,ritonavir:2
atazanavir ,inhibits:2
atazanavir ,sars-cov-2:2
atazanavir ,replication:2
alone ,combination:2
alone ,ritonavir:2
alone ,inhibits:2
alone ,sars-cov-2:2
alone ,replication:2
combination ,ritonavir:2
combination ,inhibits:2
combination ,replication:2
ritonavir ,inhibits:2
ritonavir ,sars-cov-2:2
ritonavir ,replication:2
amantadine ,disrupts:2
amantadine ,lysosomal:2
amantadine ,gene:2
amantadine ,expression:2
amantadine ,hypothesis:2
amantadine ,covid19:2
amantadine ,treatment:2
disrupts ,lysosomal:2
disrupts ,gene:2
disrupts ,expression:2
disrupts ,hypothesis:2
disrupts ,covid19:2
disrupts ,treatment:2
lysosomal ,gene:2
lysosomal ,expression:2
lysosomal ,hypothesis:2
lysosomal ,covid19:2
lysosomal ,treatment:2
gene ,hypothesis:2
gene ,covid19:2
gene ,treatment:2
expression ,hypothesis:2
expression ,covid19:2
expression ,treatment:2
risk ,new:2
risk ,corona:4
risk ,protection:2
assessment ,corona:2
assessment ,virus:2
assessment ,protection:2
aerosol ,new:2
aerosol ,corona:2
aerosol ,virus:2
aerosol ,protection:2
new ,protection:2
corona ,protection:2
virus ,protection:2
transplantation ,nothing:2
transplantation ,noble:2
transplantation ,accomplished:2
transplantation ,without:2
covid-19 ,noble:2
covid-19 ,accomplished:2
pandemic ,nothing:2
pandemic ,noble:2
pandemic ,accomplished:2
pandemic ,without:2
nothing ,noble:2
nothing ,accomplished:2
nothing ,without:2
noble ,accomplished:2
noble ,without:2
accomplished ,without:2
unexpected ,better:2
unexpected ,outcome:2
unexpected ,liver:2
unexpected ,transplant:2
unexpected ,recipient:2
better ,outcome:2
better ,liver:2
better ,transplant:2
better ,recipient:2
outcome ,liver:2
outcome ,transplant:2
outcome ,recipient:2
human ,viruses:2
gene ,sequences:2
gene ,viruses:2
treatment ,algorithm:2
treatment ,point:2
algorithm ,multidisciplinary:2
algorithm ,point:2
algorithm ,view:2
multidisciplinary ,point:2
multidisciplinary ,view:2
virtual ,dynamics:2
screening ,dynamics:2
dynamics ,study:2
dynamics ,inhibitors:2
study ,approved:2
manifestations ,blood:2
manifestations ,coagulation:2
manifestations ,relation:2
manifestations ,outcomes:4
blood ,relation:2
blood ,clinical:6
blood ,outcomes:2
coagulation ,relation:2
coagulation ,clinical:2
coagulation ,outcomes:2
relation ,outcomes:2
relation ,severe:2
anesthesia ,considerations:4
anesthesia ,trauma:2
anesthesia ,acute:2
anesthesia ,cases:2
considerations ,precautions:2
considerations ,trauma:2
considerations ,care:4
infection ,trauma:2
precautions ,trauma:2
precautions ,acute:2
precautions ,cases:2
trauma ,acute:2
trauma ,care:2
trauma ,cases:2
acute ,care:4
care ,cases:2
clinical ,inpatients:4
imaging ,characteristics:4
imaging ,inpatients:2
imaging ,disease-2019:2
characteristics ,inpatients:4
characteristics ,disease-2019:2
inpatients ,coronavirus:2
inpatients ,disease-2019:2
interpret ,evaluation:2
interpret ,commercial:2
interpret ,ausdiagnostics:2
interpret ,versus:2
caution ,evaluation:2
caution ,commercial:2
caution ,ausdiagnostics:2
caution ,versus:2
evaluation ,versus:2
commercial ,ausdiagnostics:2
commercial ,versus:2
ausdiagnostics ,versus:2
distinct ,features:2
distinct ,sars-cov-2-specific:2
distinct ,iga:2
distinct ,response:2
distinct ,patients:2
features ,sars-cov-2-specific:2
features ,iga:2
features ,response:2
sars-cov-2-specific ,iga:2
sars-cov-2-specific ,response:2
iga ,response:2
iga ,covid-19:2
iga ,patients:2
anti ,antibodies:2
anti ,monitoring:2
anti ,group:2
anti ,residents:2
anti ,long:2
anti ,term:2
anti ,care:2
sars-cov-2 ,long:2
sars-cov-2 ,term:4
antibodies ,monitoring:2
antibodies ,residents:2
antibodies ,long:2
antibodies ,term:2
monitoring ,group:2
monitoring ,residents:2
monitoring ,long:2
monitoring ,term:2
monitoring ,care:2
group ,residents:2
group ,long:2
group ,term:2
residents ,long:2
residents ,term:2
residents ,care:2
long ,term:4
long ,care:2
term ,care:2
potential ,component:2
potential ,global:4
vaccine ,component:2
component ,comprehensive:2
component ,review:2
component ,global:2
comprehensive ,global:4
review ,global:6
importance ,vitamin:2
importance ,metabolism:2
importance ,prophylactic:2
importance ,immunoregulatory:2
vitamin ,metabolism:2
vitamin ,potential:4
vitamin ,prophylactic:2
vitamin ,immunoregulatory:2
metabolism ,potential:2
metabolism ,prophylactic:2
metabolism ,immunoregulatory:2
potential ,immunoregulatory:2
prophylactic ,immunoregulatory:2
intensive ,suffering:2
intensive ,neuchtel:2
care ,suffering:2
care ,neuchtel:2
unit ,treatment:2
unit ,patients:10
unit ,suffering:2
unit ,neuchtel:2
treatment ,neuchtel:2
patients ,neuchtel:2
suffering ,neuchtel:2
covid-19 ,neuchtel:2
polycystic ,ovary:2
polycystic ,syndrome:2
polycystic ,pcos:2
polycystic ,covid-19:2
polycystic ,overlooked:2
polycystic ,female:2
polycystic ,patient:2
ovary ,syndrome:2
ovary ,pcos:2
ovary ,covid-19:2
ovary ,overlooked:2
ovary ,female:2
ovary ,patient:2
syndrome ,pcos:2
syndrome ,overlooked:2
syndrome ,female:2
pcos ,covid-19:2
pcos ,overlooked:2
pcos ,female:2
pcos ,patient:2
overlooked ,female:2
overlooked ,patient:2
female ,patient:2
pros ,cons:2
pros ,corticosteroid:2
pros ,therapy:2
pros ,covid-19:2
pros ,patients:2
cons ,corticosteroid:2
cons ,therapy:2
cons ,covid-19:2
cons ,patients:2
corticosteroid ,therapy:4
corticosteroid ,patients:4
suppressed ,anti-inflammatory:2
suppressed ,heat:2
suppressed ,shock:2
suppressed ,response:2
suppressed ,high-risk:2
suppressed ,covid-19:2
suppressed ,patients:2
anti-inflammatory ,heat:2
anti-inflammatory ,shock:2
anti-inflammatory ,response:2
anti-inflammatory ,high-risk:2
anti-inflammatory ,patients:2
heat ,shock:4
heat ,response:2
heat ,high-risk:2
heat ,patients:2
shock ,response:2
shock ,high-risk:2
response ,high-risk:2
infection ,emerging:2
infection ,problem:2
health-care ,emerging:2
health-care ,problem:2
workers ,emerging:2
workers ,problem:2
emerging ,problem:2
special ,dentistry:2
special ,outbreak:2
special ,lesson:2
special ,learn:2
care ,dentistry:2
care ,lesson:2
care ,learn:2
dentistry ,lesson:2
outbreak ,lesson:2
outbreak ,learn:2
lesson ,learn:2
past ,present:2
past ,review:2
present ,future:6
present ,review:2
novel ,computed:4
novel ,tomography:2
coronavirus ,serial:2
pneumonia ,serial:2
serial ,tomography:2
performance ,nucleocapsid:2
performance ,spike-based:2
nucleocapsid ,spike-based:2
nucleocapsid ,serologic:2
nucleocapsid ,assays:2
spike-based ,sars-cov-2:2
spike-based ,serologic:2
spike-based ,assays:2
covid-19 ,regulatory:4
covid-19 ,medicinal:2
regulatory ,landscape:2
regulatory ,medicinal:2
regulatory ,medical:2
regulatory ,device:2
regulatory ,products:2
regulatory ,human:2
landscape ,medicinal:2
landscape ,medical:2
landscape ,device:2
landscape ,products:2
landscape ,human:4
medicinal ,medical:2
medicinal ,device:2
medical ,device:4
medical ,products:2
medical ,human:2
device ,products:2
device ,human:2
products ,human:2
remdesivir ,lopinavir:2
remdesivir ,emetine:2
remdesivir ,homoharringtonine:2
remdesivir ,inhibit:2
remdesivir ,replication:2
lopinavir ,emetine:2
lopinavir ,homoharringtonine:2
lopinavir ,inhibit:2
lopinavir ,sars-cov-2:2
lopinavir ,replication:2
emetine ,homoharringtonine:2
emetine ,inhibit:2
emetine ,sars-cov-2:2
emetine ,replication:2
homoharringtonine ,inhibit:2
homoharringtonine ,sars-cov-2:2
homoharringtonine ,replication:2
use ,powered:2
use ,air-purifying:2
use ,respirator:2
use ,papr:2
use ,preventing:2
powered ,air-purifying:2
powered ,respirator:2
powered ,papr:2
powered ,healthcare:2
powered ,workers:2
powered ,preventing:2
air-purifying ,respirator:2
air-purifying ,papr:2
air-purifying ,healthcare:2
air-purifying ,workers:2
air-purifying ,preventing:2
respirator ,papr:2
respirator ,healthcare:2
respirator ,workers:2
respirator ,preventing:2
papr ,healthcare:2
papr ,workers:2
papr ,preventing:2
healthcare ,preventing:2
workers ,preventing:2
combination ,short-course:2
combination ,systemic:2
combination ,corticosteroid:2
combination ,favipiravir:2
treatment ,short-course:2
treatment ,corticosteroid:2
short-course ,systemic:2
short-course ,corticosteroid:2
short-course ,favipiravir:2
systemic ,favipiravir:2
corticosteroid ,favipiravir:2
tocilizumab ,reduced:2
tocilizumab ,intensive:2
tocilizumab ,care:2
tocilizumab ,unit:2
tocilizumab ,admissions:2
therapy ,reduced:2
therapy ,intensive:2
therapy ,care:2
therapy ,unit:2
therapy ,admissions:2
therapy ,andor:2
therapy ,mortality:2
reduced ,intensive:2
reduced ,care:2
reduced ,unit:2
reduced ,admissions:4
reduced ,andor:2
reduced ,mortality:4
intensive ,andor:2
intensive ,mortality:6
care ,andor:2
care ,mortality:4
unit ,admissions:2
unit ,andor:2
unit ,mortality:2
admissions ,andor:2
admissions ,mortality:2
autopsy ,suspected:2
specific ,non-specific:2
specific ,manifestations:2
specific ,symptoms:2
non-specific ,clinical:2
non-specific ,manifestations:2
non-specific ,symptoms:2
manifestations ,symptoms:2
importance ,intra-:2
importance ,inter-institutional:2
importance ,networks:2
importance ,capacity:2
importance ,building:2
intra- ,inter-institutional:2
intra- ,networks:2
intra- ,capacity:2
intra- ,building:2
inter-institutional ,networks:2
inter-institutional ,capacity:2
inter-institutional ,building:2
networks ,capacity:2
networks ,building:2
capacity ,building:2
clinical ,immunochromatographic:2
clinical ,igmigg:2
evaluation ,igmigg:4
immunochromatographic ,igmigg:2
immunochromatographic ,antibody:2
immunochromatographic ,assay:2
immunochromatographic ,chest:2
igmigg ,antibody:4
igmigg ,assay:2
igmigg ,chest:2
antibody ,chest:2
assay ,chest:2
establishment ,pediatric:2
establishment ,covid-19:4
establishment ,biorepository:4
establishment ,unique:2
establishment ,considerations:2
pediatric ,biorepository:2
pediatric ,unique:2
pediatric ,considerations:4
covid-19 ,biorepository:4
biorepository ,unique:2
biorepository ,considerations:2
unique ,considerations:2
natural ,product-derived:2
natural ,phytochemicals:2
natural ,agents:2
natural ,coronaviruses:4
product-derived ,phytochemicals:2
product-derived ,potential:2
product-derived ,agents:2
product-derived ,coronaviruses:2
phytochemicals ,potential:4
phytochemicals ,agents:4
phytochemicals ,coronaviruses:2
large-scale ,implementation:2
large-scale ,pooled:2
large-scale ,rna:4
large-scale ,extraction:4
large-scale ,rt-pcr:2
implementation ,rna:2
implementation ,extraction:2
implementation ,rt-pcr:2
pooled ,rna:4
pooled ,extraction:2
extraction ,rt-pcr:2
silico ,comparative:2
silico ,characterization:4
studies ,comparative:2
studies ,characterization:2
studies ,interactions:2
comparative ,characterization:2
comparative ,interactions:2
characterization ,interactions:2
sars-cov-2 ,orf8-deletion:2
genomic ,surveillance:2
genomic ,taiwan:2
genomic ,revealed:2
genomic ,orf8-deletion:2
genomic ,mutant:2
surveillance ,taiwan:2
surveillance ,revealed:2
surveillance ,novel:2
surveillance ,orf8-deletion:2
surveillance ,mutant:2
taiwan ,revealed:2
taiwan ,orf8-deletion:2
taiwan ,mutant:2
revealed ,novel:2
revealed ,orf8-deletion:2
revealed ,mutant:2
novel ,orf8-deletion:2
novel ,mutant:2
orf8-deletion ,mutant:2
comparative ,igg:2
comparative ,india:2
evaluation ,india:2
igg ,india:2
assays ,india:2
clinical ,54:2
clinical ,staff:2
characteristics ,54:2
characteristics ,medical:2
characteristics ,staff:2
54 ,medical:2
54 ,staff:2
54 ,covid-19:2
54 ,retrospective:2
54 ,study:2
medical ,study:4
staff ,retrospective:2
staff ,study:2
evidence ,structural:2
evidence ,protein:2
evidence ,membrane:2
evidence ,lipid:2
evidence ,remodeling:2
evidence ,red:2
structural ,damage:2
structural ,lipid:2
structural ,remodeling:2
structural ,red:2
structural ,blood:2
protein ,damage:2
protein ,membrane:4
protein ,lipid:2
protein ,remodeling:2
protein ,red:2
protein ,blood:2
damage ,membrane:2
damage ,lipid:2
damage ,remodeling:2
damage ,red:2
damage ,blood:2
membrane ,lipid:2
membrane ,remodeling:2
membrane ,red:2
membrane ,blood:2
lipid ,remodeling:2
lipid ,red:2
lipid ,blood:2
remodeling ,red:2
remodeling ,blood:2
on-target ,versus:2
on-target ,off-target:2
on-target ,effects:2
on-target ,drugs:2
on-target ,inhibiting:2
on-target ,replication:2
versus ,off-target:2
versus ,effects:2
versus ,drugs:2
versus ,inhibiting:2
versus ,replication:2
off-target ,effects:2
off-target ,drugs:2
off-target ,inhibiting:2
off-target ,replication:2
effects ,drugs:2
effects ,inhibiting:2
effects ,replication:2
drugs ,inhibiting:2
inhibiting ,replication:2
effect ,delay:2
effect ,diagnosis:2
delay ,diagnosis:2
delay ,transmission:2
delay ,covid-19:2
understanding ,renin-angiotensin-aldosterone-sars-cov:2
understanding ,axis:2
renin-angiotensin-aldosterone-sars-cov ,axis:2
renin-angiotensin-aldosterone-sars-cov ,comprehensive:2
axis ,comprehensive:2
evaluation ,iggigm:2
evaluation ,orient:2
evaluation ,gene:2
evaluation ,biotech:2
covid-19 ,iggigm:2
covid-19 ,orient:2
covid-19 ,biotech:2
iggigm ,rapid:4
iggigm ,test:2
iggigm ,orient:2
iggigm ,gene:2
iggigm ,biotech:2
rapid ,orient:2
rapid ,gene:2
rapid ,biotech:2
test ,orient:2
test ,biotech:2
orient ,gene:2
orient ,biotech:2
gene ,biotech:2
emergency ,radiology:2
emergency ,canadian:2
emergency ,association:2
radiology ,pandemic:2
radiology ,canadian:2
radiology ,association:2
covid-19 ,canadian:6
pandemic ,canadian:2
canadian ,association:2
role ,ocular:2
ocular ,tissue:2
tissue ,transmission:2
cardiac ,tamponade:4
cardiac ,secondary:2
cardiac ,tocovid-19:2
tamponade ,secondary:2
tamponade ,tocovid-19:2
secondary ,tocovid-19:2
report ,diagnosis:2
report ,nine:2
clinical ,nine:2
diagnosis ,nine:2
treatment ,nine:2
treatment ,cases:2
nine ,cases:2
nine ,coronavirus:2
nine ,disease:2
infection ,dermatologic:2
infection ,therapeutics:2
risk ,dermatologic:2
risk ,therapeutics:2
dermatologic ,therapeutics:2
therapeutics ,pandemic:2
personalised ,health:2
personalised ,education:2
personalised ,damage:2
personalised ,covid-19:2
personalised ,epidemic:2
health ,damage:2
education ,damage:2
education ,epidemic:2
damage ,epidemic:2
covid-19 ,quest:4
update ,regarding:2
update ,quest:2
update ,finding:2
update ,effective:2
update ,cure:2
regarding ,quest:2
regarding ,finding:2
regarding ,effective:2
regarding ,cure:2
quest ,finding:2
quest ,effective:4
quest ,cure:2
finding ,effective:2
finding ,cure:2
effective ,cure:2
comment ,safety:2
cutaneous ,safety:2
manifestations ,safety:2
first ,safety:4
perspective ,safety:2
anti-sars-cov ,natural:2
anti-sars-cov ,products:2
anti-sars-cov ,potential:2
anti-sars-cov ,inhibit:2
anti-sars-cov ,sars-cov-2:2
anti-sars-cov ,covid-19:2
natural ,inhibit:2
products ,inhibit:2
potential ,inhibit:2
inhibit ,covid-19:2
postmortem ,swabs:2
postmortem ,severe:2
postmortem ,acute:2
postmortem ,respiratory:2
postmortem ,syndrome:2
postmortem ,pandemic:2
swabs ,pandemic:2
association ,influenza:2
association ,vaccination:2
association ,risk:6
influenza ,vaccination:2
influenza ,risk:2
influenza ,infection:2
vaccination ,risk:2
vaccination ,infection:2
rt-lamp ,rapid:2
rt-lamp ,diagnosis:2
rt-lamp ,coronavirus:2
rt-lamp ,sars-cov-2:2
first ,phylogenetic:2
first ,malian:2
first ,provides:2
phylogenetic ,malian:2
phylogenetic ,sequences:2
phylogenetic ,provides:2
analysis ,malian:2
malian ,sars-cov-2:2
malian ,sequences:2
malian ,provides:2
malian ,molecular:2
sequences ,provides:2
sequences ,molecular:2
provides ,molecular:2
discovery ,clioquinol:2
discovery ,analogues:2
discovery ,severe:2
discovery ,acute:2
clioquinol ,analogues:2
clioquinol ,novel:2
clioquinol ,inhibitors:2
clioquinol ,severe:2
clioquinol ,acute:2
analogues ,novel:2
analogues ,severe:2
analogues ,acute:2
detection ,coupled:2
detection ,temperature:2
sars-cov-2 ,coupled:2
raw ,patient:2
raw ,samples:2
raw ,coupled:2
raw ,high:2
raw ,temperature:2
raw ,reverse:2
patient ,coupled:2
patient ,high:2
patient ,temperature:4
patient ,reverse:2
samples ,coupled:2
samples ,high:2
samples ,temperature:2
samples ,reverse:2
coupled ,high:2
coupled ,temperature:2
coupled ,reverse:2
high ,temperature:2
high ,reverse:2
temperature ,reverse:2
guidelines ,practice:2
guidelines ,swallowing:2
guidelines ,disorders:2
clinical ,swallowing:2
clinical ,disorders:4
practice ,swallowing:2
practice ,disorders:2
management ,swallowing:2
management ,disorders:4
swallowing ,disorders:2
postoperative ,myocardial:2
postoperative ,injury:2
postoperative ,patient:4
postoperative ,left:2
postoperative ,ureteric:2
postoperative ,stone:2
myocardial ,patient:4
myocardial ,left:2
myocardial ,ureteric:2
myocardial ,stone:2
injury ,patient:6
injury ,left:2
injury ,ureteric:2
injury ,stone:2
patient ,left:2
patient ,ureteric:2
patient ,stone:2
left ,ureteric:2
left ,stone:2
ureteric ,stone:2
first ,systemic:2
first ,lupus:2
first ,erythematosus:2
first ,sle:2
first ,triggered:2
case ,lupus:2
case ,erythematosus:2
case ,sle:2
case ,triggered:4
systemic ,lupus:4
systemic ,erythematosus:4
systemic ,sle:2
systemic ,triggered:2
lupus ,erythematosus:4
lupus ,sle:2
lupus ,triggered:2
erythematosus ,sle:2
erythematosus ,triggered:2
erythematosus ,covid-19:4
sle ,triggered:2
sle ,covid-19:2
dynamics ,rt-pcr:2
dynamics ,positivity:2
dynamics ,seroprevalence:2
dynamics ,among:2
dynamics ,high-risk:2
rt-pcr ,positivity:2
rt-pcr ,seroprevalence:2
rt-pcr ,among:2
rt-pcr ,high-risk:2
positivity ,seroprevalence:2
positivity ,among:2
positivity ,high-risk:2
seroprevalence ,high-risk:2
among ,high-risk:2
evidence ,central:2
evidence ,nervous:2
evidence ,system:2
evidence ,neuroinvasive:2
evidence ,routes:2
evidence ,well:2
central ,neuroinvasive:2
central ,well:2
nervous ,neuroinvasive:2
nervous ,well:2
system ,neuroinvasive:2
system ,well:2
infection ,neuroinvasive:2
infection ,well:2
neuroinvasive ,routes:2
neuroinvasive ,well:2
routes ,well:2
current ,pregnant:2
current ,women:2
state ,pregnant:2
state ,women:2
knowledge ,pregnant:2
knowledge ,women:2
obesity ,leptin:2
common ,comorbidity:2
common ,leptin:2
common ,link:2
comorbidity ,sars-cov-2:2
comorbidity ,leptin:2
comorbidity ,link:2
sars-cov-2 ,leptin:2
leptin ,link:2
headache ,striking:2
headache ,prodromal:2
headache ,symptom:2
headache ,predictive:2
striking ,prodromal:2
striking ,persistent:2
striking ,symptom:2
striking ,predictive:2
striking ,covid-19:4
prodromal ,persistent:2
prodromal ,symptom:2
prodromal ,predictive:2
prodromal ,covid-19:2
persistent ,symptom:2
persistent ,predictive:2
symptom ,predictive:2
novel ,nervous:4
covid-19 ,veterinary:2
animals ,veterinary:2
animals ,zoonotic:2
animals ,links:2
veterinary ,zoonotic:2
veterinary ,links:2
zoonotic ,links:2
sars-cov-2 ,perioperative:2
sars-cov-2 ,lobectomy:2
infection ,perioperative:4
infection ,lobectomy:2
perioperative ,pulmonary:2
perioperative ,lobectomy:2
perioperative ,case:2
pulmonary ,lobectomy:2
lobectomy ,case:2
high ,screen:2
high ,tmprss2:2
high ,identifies:2
high ,fda-approved:2
throughput ,screen:2
throughput ,tmprss2:2
throughput ,expression:2
throughput ,identifies:2
throughput ,fda-approved:2
screen ,tmprss2:2
screen ,expression:2
screen ,identifies:2
screen ,fda-approved:2
tmprss2 ,identifies:2
tmprss2 ,fda-approved:2
expression ,identifies:2
expression ,fda-approved:2
identifies ,fda-approved:2
fungal ,co-infection:2
fungal ,concerned:2
co-infection ,concerned:2
covid-19 ,concerned:2
patients ,concerned:2
isolated ,sudden:2
isolated ,onset:2
isolated ,anosmia:2
isolated ,covid-19:6
isolated ,infection:2
isolated ,syndrome:2
sudden ,anosmia:2
sudden ,infection:2
sudden ,novel:2
sudden ,syndrome:2
onset ,anosmia:2
anosmia ,novel:2
coronavirus ,etiology:2
disease ,etiology:2
comprehensive ,etiology:2
comprehensive ,pathogenesis:2
review ,etiology:2
etiology ,pathogenesis:2
clinical ,hospitals:2
clinical ,hubei:2
characteristics ,hospitals:2
characteristics ,hubei:2
novel ,hubei:2
coronavirus ,hubei:4
cases ,tertiary:2
cases ,hospitals:2
cases ,hubei:2
tertiary ,hospitals:2
tertiary ,hubei:2
hospitals ,hubei:2
emcam ,multiple:2
emcam ,sclerosis:2
emcam ,autonomous:2
emcam ,community:2
emcam ,madrid:2
emcam ,document:2
multiple ,autonomous:2
multiple ,community:2
multiple ,madrid:2
multiple ,document:2
sclerosis ,autonomous:2
sclerosis ,community:2
sclerosis ,madrid:2
sclerosis ,document:2
autonomous ,community:2
autonomous ,madrid:2
autonomous ,document:2
community ,madrid:2
community ,document:2
madrid ,document:2
case ,successful:4
case ,antiviral:2
case ,therapy:2
case ,77-year-old:2
sars-cov-2 ,77-year-old:2
pneumonia ,antiviral:2
pneumonia ,77-year-old:2
successful ,antiviral:2
successful ,77-year-old:2
antiviral ,77-year-old:2
therapy ,77-year-old:2
simulations ,may:2
simulations ,help:2
simulations ,us:2
simulations ,understand:2
simulations ,dynamics:4
simulations ,spread:2
may ,us:2
may ,understand:2
may ,dynamics:2
help ,us:2
help ,understand:2
help ,dynamics:2
help ,spread:2
us ,understand:2
us ,dynamics:2
us ,spread:2
understand ,dynamics:2
understand ,spread:2
dynamics ,spread:4
duration ,rna:2
duration ,detection:2
duration ,home:2
duration ,isolation:2
rna ,home:2
detection ,home:2
patients ,home:2
home ,isolation:2
evaluation ,nucleocapsid:2
evaluation ,spike:2
evaluation ,protein-based:2
evaluation ,enzyme-linked:2
nucleocapsid ,protein-based:2
nucleocapsid ,enzyme-linked:2
nucleocapsid ,immunosorbent:2
spike ,protein-based:2
spike ,enzyme-linked:2
spike ,immunosorbent:2
protein-based ,enzyme-linked:2
protein-based ,immunosorbent:2
optimising ,triage:2
optimising ,procedures:2
optimising ,patients:2
optimising ,cancer:2
optimising ,needing:2
optimising ,active:2
optimising ,anticancer:2
triage ,procedures:2
triage ,cancer:4
triage ,needing:2
triage ,active:2
triage ,anticancer:2
procedures ,needing:2
procedures ,active:2
procedures ,anticancer:2
patients ,needing:2
patients ,active:6
patients ,anticancer:2
cancer ,needing:2
cancer ,active:4
cancer ,anticancer:2
needing ,active:2
needing ,anticancer:2
active ,anticancer:2
radiographic ,chest:2
radiographic ,ct:2
radiographic ,imaging:2
radiographic ,presentation:2
radiographic ,follow-up:2
chest ,presentation:2
ct ,follow-up:2
imaging ,presentation:2
presentation ,follow-up:2
pivotal ,link:2
pivotal ,ace2:2
pivotal ,deficiency:2
pivotal ,sars-cov-2:2
pivotal ,infection:2
link ,deficiency:2
ace2 ,deficiency:2
wastewater ,population-wide:2
wastewater ,present:2
wastewater ,future:2
surveillance ,population-wide:2
surveillance ,present:2
surveillance ,future:2
population-wide ,covid-19:4
population-wide ,present:2
population-wide ,future:2
fecal-oral ,review:2
fecal-oral ,laboratory-confirmed:2
fecal-oral ,virus:2
transmission ,laboratory-confirmed:2
review ,laboratory-confirmed:2
laboratory-confirmed ,virus:2
modeling ,between-population:2
modeling ,variation:4
modeling ,hubei:2
modeling ,lombardy:2
between-population ,variation:2
between-population ,covid-19:2
between-population ,dynamics:2
between-population ,hubei:2
between-population ,lombardy:2
variation ,dynamics:2
variation ,hubei:2
variation ,lombardy:2
dynamics ,hubei:2
dynamics ,lombardy:2
hubei ,lombardy:2
challenge ,trials:2
challenge ,vaccines:2
challenge ,ethical:2
challenge ,despite:2
challenge ,risk:2
challenge ,severe:2
trials ,vaccines:2
trials ,ethical:2
trials ,despite:2
trials ,risk:2
trials ,severe:2
vaccines ,ethical:2
vaccines ,despite:2
vaccines ,risk:2
ethical ,despite:2
ethical ,risk:2
ethical ,severe:2
despite ,risk:2
despite ,severe:4
facing ,combination:2
facing ,nanomaterials:2
facing ,medicine:2
sars-cov-2 ,nanomaterials:2
covid-19 ,nanomaterials:2
combination ,nanomaterials:2
nanomaterials ,medicine:2
rapidly ,increasing:2
rapidly ,cumulative:2
rapidly ,incidence:2
rapidly ,disease:2
increasing ,cumulative:2
increasing ,incidence:2
increasing ,disease:2
cumulative ,incidence:2
cumulative ,coronavirus:2
cumulative ,disease:2
cumulative ,covid-19:2
incidence ,disease:2
potent ,activities:2
potent ,type:2
potent ,interferons:2
potent ,infection:2
seroprevalence ,frontline:2
seroprevalence ,health:2
seroprevalence ,care:2
seroprevalence ,personnel:2
seroprevalence ,multistate:2
sars-cov-2 ,multistate:2
among ,multistate:2
frontline ,personnel:2
frontline ,multistate:2
health ,multistate:2
care ,multistate:2
personnel ,multistate:2
innate ,signaling:2
innate ,proteolytic:2
innate ,resolution:2
innate ,exacerbation:2
immune ,signaling:2
immune ,proteolytic:2
immune ,resolution:2
immune ,exacerbation:2
signaling ,proteolytic:2
signaling ,resolution:2
signaling ,exacerbation:2
proteolytic ,pathways:2
proteolytic ,resolution:2
proteolytic ,exacerbation:2
pathways ,resolution:2
pathways ,exacerbation:2
resolution ,exacerbation:2
challenges ,dermatology:2
consistent ,localization:2
consistent ,sars-cov-2:2
consistent ,spike:2
consistent ,glycoprotein:2
consistent ,ace2:2
consistent ,tmprss2:2
localization ,sars-cov-2:2
localization ,spike:2
localization ,glycoprotein:2
localization ,ace2:2
localization ,tmprss2:2
spike ,tmprss2:2
glycoprotein ,ace2:2
glycoprotein ,tmprss2:2
fulminant ,encephalitis:2
fulminant ,sole:2
encephalitis ,sole:2
encephalitis ,manifestation:2
encephalitis ,covid-19:2
covan ,new:2
covan ,hivan:2
covan ,re-emergence:2
covan ,collapsing:2
covan ,glomerulopathy:2
covan ,covid-19:2
new ,hivan:2
new ,re-emergence:2
new ,collapsing:2
new ,glomerulopathy:2
hivan ,re-emergence:2
hivan ,collapsing:2
hivan ,glomerulopathy:2
hivan ,covid-19:2
re-emergence ,collapsing:2
re-emergence ,glomerulopathy:2
collapsing ,covid-19:2
glomerulopathy ,covid-19:2
available ,compounds:2
available ,antimicrobial:2
compounds ,antimicrobial:2
therapeutic ,antimicrobial:2
potential ,antimicrobial:4
covid-19 ,antimicrobial:4
polish ,society:2
polish ,gynecologists:2
polish ,obstetricians:2
polish ,statement:2
polish ,surgery:2
society ,gynecologists:2
society ,obstetricians:2
gynecologists ,statement:2
gynecologists ,surgery:2
obstetricians ,statement:2
obstetricians ,surgery:2
statement ,surgery:2
usefulness ,covid-19:4
usefulness ,screen-and-test:2
usefulness ,approach:2
usefulness ,pregnant:2
usefulness ,women:2
usefulness ,experience:2
covid-19 ,screen-and-test:2
screen-and-test ,approach:2
screen-and-test ,pregnant:2
screen-and-test ,women:2
screen-and-test ,experience:2
approach ,pregnant:2
approach ,women:2
approach ,experience:2
sars-cov ,alternative:2
sars-cov ,receptors:2
sars-cov ,pathophysiological:2
possible ,alternative:2
possible ,receptors:2
possible ,pathophysiological:2
alternative ,virus:2
alternative ,receptors:2
alternative ,pathophysiological:2
virus ,receptors:4
virus ,pathophysiological:2
receptors ,pathophysiological:2
covid-19-like ,observed:2
covid-19-like ,chinese:2
covid-19-like ,tree:2
covid-19-like ,shrews:2
covid-19-like ,infected:2
covid-19-like ,sars-cov-2:2
symptoms ,observed:2
symptoms ,chinese:2
symptoms ,tree:2
symptoms ,shrews:2
symptoms ,infected:2
observed ,chinese:2
observed ,tree:2
observed ,shrews:2
observed ,infected:2
chinese ,tree:2
chinese ,shrews:2
tree ,shrews:2
tree ,infected:2
shrews ,infected:2
shrews ,sars-cov-2:2
vitamin ,d3:2
vitamin ,k2:2
vitamin ,contribution:2
vitamin ,reducing:2
d3 ,k2:2
d3 ,potential:2
d3 ,contribution:2
d3 ,reducing:2
d3 ,covid-19:2
k2 ,potential:2
k2 ,contribution:2
k2 ,reducing:2
k2 ,covid-19:2
potential ,reducing:2
contribution ,reducing:2
consensus ,statement:2
consensus ,immune:2
consensus ,modulation:2
consensus ,multiple:2
consensus ,sclerosis:2
consensus ,related:2
consensus ,disorders:2
statement ,immune:2
statement ,modulation:2
statement ,multiple:2
statement ,sclerosis:2
statement ,related:2
statement ,disorders:2
immune ,related:2
immune ,disorders:2
modulation ,multiple:2
modulation ,sclerosis:2
modulation ,related:2
modulation ,disorders:2
multiple ,disorders:2
sclerosis ,related:2
sclerosis ,disorders:2
related ,disorders:2
point-of-care ,serological:2
point-of-care ,assays:2
point-of-care ,delayed:2
point-of-care ,case:2
point-of-care ,identification:2
point-of-care ,among:2
serological ,delayed:2
serological ,identification:4
serological ,among:2
assays ,delayed:2
assays ,case:2
assays ,identification:2
assays ,among:4
delayed ,sars-cov-2:2
delayed ,identification:2
case ,identification:2
case ,among:4
identification ,among:2
inhaled ,modified:2
inhaled ,angiotensin:2
inhaled ,converting:2
inhaled ,enzyme:2
inhaled ,ace2:2
inhaled ,decoy:2
inhaled ,mitigate:2
modified ,angiotensin:2
modified ,converting:2
modified ,enzyme:2
modified ,ace2:2
modified ,decoy:2
modified ,mitigate:2
angiotensin ,decoy:2
angiotensin ,mitigate:2
converting ,decoy:2
converting ,mitigate:2
enzyme ,decoy:2
enzyme ,mitigate:2
ace2 ,decoy:2
ace2 ,mitigate:2
decoy ,mitigate:2
symptom ,illness:2
symptom ,care:2
symptom ,personnel:2
screening ,illness:2
screening ,onset:2
screening ,health:2
screening ,personnel:2
illness ,onset:2
illness ,health:2
illness ,care:2
illness ,personnel:2
onset ,health:2
onset ,care:2
onset ,personnel:2
clinical ,possibility:2
manifestation ,outcomes:2
manifestation ,pregnant:2
manifestation ,women:2
manifestation ,possibility:2
outcomes ,possibility:2
visceral ,fat:2
visceral ,shows:2
visceral ,strongest:2
visceral ,association:2
visceral ,need:2
visceral ,intensive:2
visceral ,care:2
fat ,shows:2
fat ,strongest:2
fat ,association:2
fat ,need:2
fat ,intensive:2
fat ,care:2
shows ,strongest:2
shows ,association:2
shows ,need:2
shows ,intensive:2
shows ,care:2
strongest ,association:2
strongest ,need:2
strongest ,intensive:2
strongest ,care:2
association ,need:2
association ,intensive:2
need ,intensive:4
need ,care:6
vitamin ,association:6
vitamin ,endothelial:2
vitamin ,dysfunction:2
vitamin ,implications:2
deficiency ,association:2
deficiency ,endothelial:2
deficiency ,dysfunction:2
deficiency ,implications:2
association ,endothelial:2
association ,dysfunction:4
association ,implications:2
endothelial ,implications:2
dysfunction ,implications:2
students ,lecturers:2
students ,perspective:2
students ,implementation:2
students ,online:2
students ,learning:2
lecturers ,perspective:2
lecturers ,implementation:2
lecturers ,online:2
lecturers ,learning:2
perspective ,implementation:2
perspective ,online:2
perspective ,learning:2
implementation ,online:2
implementation ,learning:2
severe ,treated:4
severe ,corticosteroids:2
incidence ,outcomes:2
incidence ,severe:4
incidence ,acute:2
incidence ,respiratory:2
incidence ,syndrome:2
ability ,immune:2
ability ,system:2
ability ,fight:2
ability ,viruses:2
ability ,highlighted:2
ability ,cytometry:2
ability ,t-cell:2
immune ,fight:4
immune ,viruses:2
immune ,highlighted:2
immune ,cytometry:2
immune ,t-cell:2
system ,fight:4
system ,viruses:2
system ,highlighted:2
system ,cytometry:2
system ,t-cell:2
fight ,viruses:2
fight ,highlighted:2
fight ,cytometry:2
fight ,t-cell:2
viruses ,highlighted:2
viruses ,cytometry:2
viruses ,t-cell:2
highlighted ,cytometry:2
highlighted ,t-cell:2
cytometry ,t-cell:2
functional ,assessment:2
functional ,cell:2
functional ,entry:4
functional ,usage:2
functional ,lineage:2
assessment ,cell:2
assessment ,entry:2
assessment ,receptor:2
assessment ,usage:2
assessment ,lineage:2
cell ,usage:2
cell ,lineage:2
entry ,usage:2
entry ,lineage:2
receptor ,lineage:2
usage ,lineage:2
special ,analysis:2
special ,expression:2
special ,2019-ncov:2
epidemic ,analysis:6
epidemic ,expression:2
prevention ,analysis:4
prevention ,expression:2
control ,analysis:4
control ,expression:2
control ,2019-ncov:2
clinical ,neurological:4
manifestations ,evidence:2
manifestations ,involvement:2
evidence ,involvement:2
corticosteroid ,pneumonia:2
corticosteroid ,before-after:2
corticosteroid ,study:2
therapy ,before-after:2
patients ,before-after:2
covid-19 ,before-after:2
pneumonia ,before-after:2
before-after ,study:2
personalized ,predictive:2
personalized ,models:2
personalized ,symptomatic:2
personalized ,patients:2
personalized ,using:2
personalized ,basic:2
predictive ,symptomatic:2
predictive ,patients:4
predictive ,basic:2
models ,symptomatic:2
models ,basic:2
symptomatic ,using:2
symptomatic ,basic:2
patients ,basic:2
using ,basic:2
improving ,care:2
improving ,older:2
improving ,patients:4
improving ,covid-19:4
improving ,pandemic:2
care ,older:2
chloroquine ,human:2
chloroquine ,lung:2
chloroquine ,cells:2
inhibit ,infection:2
inhibit ,human:2
inhibit ,lung:2
inhibit ,cells:2
lung ,cells:8
early ,consensus:2
early ,non-icu:2
early ,failure:2
consensus ,non-icu:2
consensus ,acute:4
consensus ,respiratory:2
consensus ,failure:2
consensus ,sars-cov-2:2
management ,non-icu:2
management ,failure:4
non-icu ,acute:2
non-icu ,respiratory:2
non-icu ,failure:2
non-icu ,sars-cov-2:2
impact ,breastfeeding:2
impact ,birth:2
impact ,importance:2
pandemic ,breastfeeding:2
pandemic ,birth:2
pandemic ,importance:2
breastfeeding ,birth:2
breastfeeding ,care:2
breastfeeding ,importance:2
birth ,care:2
birth ,importance:2
care ,importance:2
rapid ,vitro:2
rapid ,neutralizing:2
rapid ,antivirals:2
vitro ,neutralizing:2
vitro ,antibodies:2
vitro ,antivirals:2
assays ,neutralizing:2
assays ,antivirals:2
screening ,antivirals:2
neutralizing ,antivirals:2
antibodies ,antivirals:2
diagnostic ,iggigm:2
diagnostic ,euroimmun:2
performance ,iggigm:2
performance ,euroimmun:2
seven ,iggigm:2
seven ,antibody:2
seven ,tests:2
seven ,euroimmun:2
rapid ,euroimmun:2
iggigm ,antibody:2
iggigm ,tests:2
iggigm ,euroimmun:2
antibody ,euroimmun:2
tests ,euroimmun:2
host ,transcriptome-guided:2
host ,drug:2
host ,repurposing:2
host ,meta-analysis:2
transcriptome-guided ,drug:2
transcriptome-guided ,repurposing:2
transcriptome-guided ,covid-19:2
transcriptome-guided ,treatment:2
transcriptome-guided ,meta-analysis:2
drug ,meta-analysis:2
repurposing ,meta-analysis:2
treatment ,meta-analysis:2
pilot ,preventative:2
pilot ,potential:4
pilot ,alpha-cyclodextrin:2
pilot ,hydroxytyrosol:2
study ,preventative:2
study ,alpha-cyclodextrin:2
study ,hydroxytyrosol:2
preventative ,alpha-cyclodextrin:2
preventative ,hydroxytyrosol:2
potential ,alpha-cyclodextrin:2
potential ,hydroxytyrosol:2
alpha-cyclodextrin ,hydroxytyrosol:2
renal ,changes:4
renal ,kidney:2
renal ,injury:2
changes ,acute:4
changes ,kidney:2
changes ,systematic:4
changes ,review:6
kidney ,systematic:2
kidney ,review:2
injury ,systematic:4
asthma ,among:2
asthma ,hospitalized:2
asthma ,related:2
asthma ,outcomes:4
among ,related:2
hospitalized ,related:2
related ,outcomes:4
effectiveness ,remdesivir:2
effectiveness ,mechanical:2
effectiveness ,ventilation:2
remdesivir ,mechanical:2
remdesivir ,ventilation:2
treat ,brain:2
treat ,tumour:2
treat ,pandemic:2
patients ,brain:2
patients ,tumour:2
brain ,tumour:2
tumour ,covid-19:2
tumour ,pandemic:2
high ,venous:2
high ,thromboembolic:2
high ,anticoagulated:2
incidence ,venous:2
incidence ,thromboembolic:2
incidence ,events:2
incidence ,anticoagulated:2
venous ,thromboembolic:2
venous ,events:2
venous ,anticoagulated:2
venous ,severe:2
thromboembolic ,anticoagulated:2
thromboembolic ,severe:2
events ,anticoagulated:2
events ,severe:2
anticoagulated ,severe:2
anticoagulated ,covid-19:2
tomographic ,novel:2
genetic ,influence:2
genetic ,receptor:2
variants ,influence:2
variants ,receptor:2
variants ,tmprss2:2
variants ,among:2
influence ,receptor:2
influence ,tmprss2:2
influence ,expression:2
influence ,among:2
receptor ,tmprss2:6
receptor ,among:2
tmprss2 ,among:2
monitoring ,antibody:2
monitoring ,response:2
monitoring ,following:2
monitoring ,diagnostic:2
monitoring ,efficiency:2
antibody ,following:2
antibody ,efficiency:2
response ,following:4
response ,efficiency:2
following ,diagnostic:2
following ,efficiency:2
sars-cov-2 ,efficiency:2
diagnostic ,efficiency:2
direct ,specimens:2
rt-qpcr ,nasopharyngeal:4
rt-qpcr ,specimens:2
nasopharyngeal ,without:2
specimens ,without:2
insights ,diagnosis:2
pandemic ,diagnosis:6
virulence ,pathogenesis:2
virulence ,infection:2
virulence ,rhesus:2
virulence ,macaques:2
virulence ,nonhuman:2
pathogenesis ,rhesus:2
pathogenesis ,macaques:2
pathogenesis ,nonhuman:4
sars-cov-2 ,nonhuman:2
infection ,rhesus:2
infection ,macaques:2
infection ,nonhuman:2
rhesus ,nonhuman:2
macaques ,nonhuman:2
considerations ,povidone-iodine:2
considerations ,antisepsis:2
considerations ,nasal:2
considerations ,pharyngeal:2
povidone-iodine ,antisepsis:2
povidone-iodine ,pediatric:2
povidone-iodine ,pharyngeal:2
antisepsis ,pediatric:2
antisepsis ,nasal:2
antisepsis ,pharyngeal:2
pediatric ,nasal:2
pediatric ,pharyngeal:2
nasal ,pharyngeal:2
prevalence ,depression:2
prevalence ,sars:2
prevalence ,mers:2
prevalence ,pandemics:2
prevalence ,protocol:2
depression ,sars:2
depression ,mers:2
depression ,covid-19:2
depression ,pandemics:2
depression ,protocol:2
sars ,pandemics:2
sars ,protocol:2
mers ,pandemics:2
mers ,protocol:2
pandemics ,protocol:2
pandemic ,cardio-oncology:2
impact ,cardio-oncology:2
cardio-oncology ,population:2
landscape ,integrated:2
landscape ,analysis:2
coronavirus ,integrated:2
disease ,integrated:2
covid-19 ,integrated:4
integrated ,analysis:2
rapidly ,organizing:2
rapidly ,pneumonia:2
rapidly ,associated:2
progressive ,organizing:2
progressive ,pneumonia:2
progressive ,associated:2
organizing ,associated:2
multivariate ,analysis:2
multivariate ,black:2
multivariate ,race:2
multivariate ,environmental:2
multivariate ,temperature:2
multivariate ,covid-19:4
analysis ,black:2
analysis ,race:2
analysis ,environmental:2
black ,race:2
black ,environmental:2
black ,temperature:2
black ,covid-19:2
race ,environmental:2
race ,temperature:2
case ,renal:4
case ,infarction:2
case ,ascending:2
case ,aortic:2
report ,infarction:2
report ,ascending:2
report ,aortic:2
covid-19 ,ascending:2
associated ,renal:2
associated ,infarction:2
associated ,ascending:2
associated ,aortic:2
renal ,infarction:2
renal ,ascending:2
renal ,aortic:2
renal ,thrombosis:2
infarction ,ascending:2
infarction ,aortic:2
infarction ,thrombosis:4
ascending ,aortic:2
ascending ,thrombosis:2
validation ,modified:2
validation ,cdc:2
validation ,comparison:2
validation ,neumodx:2
modified ,cdc:2
modified ,assay:2
modified ,performance:2
modified ,comparison:2
modified ,neumodx:2
cdc ,assay:2
cdc ,performance:2
cdc ,comparison:4
cdc ,neumodx:2
assay ,neumodx:2
performance ,neumodx:2
comparison ,neumodx:2
chloroquine ,derivatives:2
chloroquine ,management:4
chloroquine ,scoping:2
derivatives ,management:2
derivatives ,covid-19:2
derivatives ,scoping:2
derivatives ,review:2
management ,scoping:2
infection ,sexual:2
infection ,reproductive:2
infection ,position:6
implications ,reproductive:2
implications ,position:2
sexual ,reproductive:2
sexual ,position:2
reproductive ,position:2
health ,position:2
structural ,role:4
basis ,role:2
potent ,role:2
neutralization ,role:2
persistent ,patients:2
persistent ,healthcare:2
persistent ,workers:2
rna ,healthcare:2
rna ,workers:2
medication ,covid-19-an:2
medication ,overview:2
medication ,approaches:2
medication ,currently:2
covid-19-an ,overview:2
covid-19-an ,approaches:2
covid-19-an ,currently:2
covid-19-an ,study:2
overview ,currently:2
overview ,study:2
approaches ,currently:2
approaches ,study:2
currently ,study:2
estimation ,mortality:2
estimation ,early:2
estimation ,stages:2
estimation ,epidemic:2
mortality ,stages:2
mortality ,epidemic:2
early ,stages:6
stages ,epidemic:2
sars-cov-2-specific ,elisa:2
novel ,community:2
novel ,sample:2
novel ,pooling:2
strategy ,community:2
strategy ,screening:4
strategy ,sample:2
strategy ,pooling:2
community ,sample:2
community ,pooling:2
covid-19 ,sample:2
early ,infectious:2
early ,tropical:2
early ,diseases:2
experience ,infectious:2
experience ,tropical:2
experience ,diseases:2
experience ,unit:6
infectious ,tropical:2
infectious ,unit:2
infectious ,coronavirus:2
tropical ,diseases:6
tropical ,unit:2
tropical ,coronavirus:2
diseases ,unit:2
associated ,geriatric:2
associated ,brief:2
associated ,narrative:2
geriatric ,population:2
geriatric ,brief:2
geriatric ,narrative:2
geriatric ,review:2
population ,brief:2
population ,narrative:2
population ,review:2
brief ,narrative:2
emerging ,neurology:4
quantitative ,proteomic:2
quantitative ,expression:2
quantitative ,receptors:2
quantitative ,gut:2
proteomic ,expression:2
proteomic ,receptors:2
proteomic ,gut:2
analysis ,receptors:2
analysis ,gut:2
expression ,gut:2
receptors ,gut:2
mis-c ,ards:2
mis-c ,associated:2
mis-c ,sars-cov-2:2
ards ,associated:2
thyroid ,disease:2
derivation ,internal:2
derivation ,validation:2
derivation ,model:2
derivation ,predict:2
derivation ,probability:2
derivation ,severe:2
internal ,validation:2
internal ,model:2
internal ,predict:2
internal ,probability:2
internal ,severe:2
validation ,predict:2
validation ,probability:2
validation ,severe:2
model ,probability:2
model ,severe:2
predict ,probability:2
probability ,severe:2
fragile ,endothelium:2
fragile ,brain:2
fragile ,dysregulated:2
fragile ,neurochemical:2
fragile ,activity:2
fragile ,covid-19:2
endothelium ,brain:2
endothelium ,dysregulated:2
endothelium ,neurochemical:2
endothelium ,activity:2
endothelium ,covid-19:2
brain ,dysregulated:2
brain ,neurochemical:2
brain ,activity:2
dysregulated ,neurochemical:2
dysregulated ,activity:2
dysregulated ,covid-19:4
neurochemical ,activity:2
neurochemical ,covid-19:4
alternative ,binding:2
alternative ,mode:2
alternative ,ighv3-53:2
alternative ,antibodies:2
alternative ,receptor:2
binding ,mode:2
binding ,ighv3-53:2
mode ,ighv3-53:2
mode ,antibodies:2
mode ,sars-cov-2:2
mode ,receptor:2
ighv3-53 ,antibodies:2
ighv3-53 ,sars-cov-2:2
ighv3-53 ,receptor:2
seroprevalence ,first:2
seroprevalence ,response:2
seroprevalence ,public:4
seroprevalence ,safety:2
among ,response:2
among ,public:2
among ,safety:2
healthcare ,first:2
healthcare ,response:4
healthcare ,public:4
healthcare ,safety:2
first ,response:4
response ,safety:2
public ,safety:4
long-term ,coexistence:2
long-term ,antibody:2
long-term ,response:2
coexistence ,sars-cov-2:2
coexistence ,antibody:2
coexistence ,response:2
coexistence ,covid-19:2
coexistence ,patients:2
pulse ,immunosuppressive:2
pulse ,therapy:2
pulse ,multiple:2
pulse ,sclerosis:2
pulse ,sars-cov-2:2
immunosuppressive ,multiple:2
immunosuppressive ,sclerosis:2
human ,monoclonal:8
monoclonal ,blocking:2
monoclonal ,sars-cov-2:6
monoclonal ,infection:4
antibody ,blocking:2
social ,participation:2
social ,inclusion:2
social ,well-being:2
social ,following:2
social ,related:2
participation ,inclusion:2
participation ,mental:2
participation ,well-being:2
participation ,following:2
participation ,sars-cov-2:2
participation ,related:2
inclusion ,mental:2
inclusion ,well-being:2
inclusion ,following:2
inclusion ,sars-cov-2:2
inclusion ,related:2
mental ,well-being:2
mental ,following:2
mental ,related:2
well-being ,following:2
well-being ,sars-cov-2:2
well-being ,related:2
following ,related:2
asthma ,risk:2
asthma ,factor:2
asthma ,severe:2
factor ,severe:2
factor ,outcomes:2
association ,severity:6
hypertension ,severity:2
role ,angiotensin-converting:2
role ,pericytes:2
role ,cardiac:4
role ,complications:6
angiotensin-converting ,pericytes:2
angiotensin-converting ,cardiac:2
angiotensin-converting ,complications:2
enzyme ,pericytes:2
enzyme ,cardiac:2
enzyme ,complications:2
pericytes ,cardiac:2
pericytes ,complications:2
diabetes ,evidence:4
diabetes ,status:2
diabetes ,unanswered:2
diabetes ,research:2
diabetes ,questions:2
evidence ,status:4
evidence ,unanswered:2
evidence ,research:2
current ,unanswered:2
current ,questions:4
status ,unanswered:2
status ,research:2
status ,questions:2
unanswered ,research:2
covid-19-associated ,transverse:2
covid-19-associated ,myelitis:2
covid-19-associated ,rare:2
covid-19-associated ,entity:2
acute ,transverse:2
acute ,rare:2
acute ,entity:2
transverse ,myelitis:2
transverse ,rare:2
transverse ,entity:2
myelitis ,rare:2
myelitis ,entity:2
rare ,entity:2
delaying ,covid-19:2
delaying ,epidemic:2
delaying ,australia:2
delaying ,evaluating:2
epidemic ,australia:2
epidemic ,evaluating:2
epidemic ,effectiveness:2
australia ,evaluating:2
australia ,effectiveness:2
panel ,broad-spectrum:2
panel ,antivirals:2
panel ,topical:2
panel ,ophthalmic:2
panel ,medications:2
panel ,drug:2
broad-spectrum ,topical:2
broad-spectrum ,ophthalmic:2
broad-spectrum ,medications:2
broad-spectrum ,drug:2
antivirals ,topical:2
antivirals ,ophthalmic:2
antivirals ,medications:2
topical ,ophthalmic:2
topical ,medications:2
topical ,drug:2
ophthalmic ,medications:2
ophthalmic ,drug:2
medications ,drug:2
quaternary ,workhorse:2
quaternary ,disinfectants:2
quaternary ,effective:2
ammonium ,workhorse:2
ammonium ,disinfectants:2
ammonium ,effective:2
compounds ,workhorse:2
compounds ,disinfectants:2
workhorse ,disinfectants:2
workhorse ,effective:2
disinfectants ,effective:2
exploring ,links:2
exploring ,vitamin:2
exploring ,deficiency:2
links ,vitamin:2
links ,deficiency:2
clinical ,without:2
analysis ,without:2
neonates ,without:2
born ,without:2
mothers ,without:2
recommendations ,eye:2
recommendations ,alarm:2
recommendations ,state:2
recommendations ,disease:2
eye ,alarm:2
eye ,state:2
care ,alarm:2
care ,state:2
alarm ,state:2
alarm ,coronavirus:2
alarm ,disease:2
psycho-neuroendocrine-immune ,interactions:2
psycho-neuroendocrine-immune ,covid-19:2
psycho-neuroendocrine-immune ,potential:2
psycho-neuroendocrine-immune ,impacts:2
psycho-neuroendocrine-immune ,mental:2
interactions ,potential:4
interactions ,impacts:2
interactions ,mental:2
potential ,mental:2
impacts ,mental:2
use ,antiviral:2
use ,filter:2
use ,attached:2
use ,pleural:2
use ,drain:2
use ,bottle:2
use ,prevent:4
use ,aerosol:2
antiviral ,filter:2
antiviral ,attached:2
antiviral ,pleural:2
antiviral ,drain:2
antiviral ,bottle:2
antiviral ,prevent:2
antiviral ,aerosol:2
filter ,attached:2
filter ,pleural:2
filter ,drain:2
filter ,bottle:2
filter ,prevent:2
filter ,aerosol:2
attached ,pleural:2
attached ,drain:2
attached ,bottle:2
attached ,prevent:2
attached ,aerosol:2
pleural ,drain:2
pleural ,bottle:2
pleural ,prevent:2
pleural ,aerosol:2
drain ,bottle:2
drain ,prevent:2
drain ,aerosol:2
bottle ,prevent:2
bottle ,aerosol:2
covid-19 ,epiglottitis:2
infection ,epiglottitis:2
presenting ,epiglottitis:2
acute ,epiglottitis:2
household ,severe:2
household ,acute:2
household ,respiratory:2
household ,syndrome:2
household ,coronavirus:2
current ,direct-acting:2
future ,direct-acting:2
direct-acting ,antivirals:2
direct-acting ,covid-19:2
assessment ,conferred:2
assessment ,coding:2
assessment ,regulatory:2
assessment ,variations:2
assessment ,tmprss2:2
assessment ,cd26:2
risk ,conferred:2
risk ,coding:2
risk ,regulatory:2
risk ,variations:2
risk ,tmprss2:2
risk ,cd26:2
conferred ,coding:2
conferred ,regulatory:2
conferred ,variations:2
conferred ,tmprss2:2
conferred ,cd26:2
coding ,regulatory:2
coding ,variations:2
coding ,tmprss2:2
coding ,cd26:2
regulatory ,variations:2
regulatory ,tmprss2:2
regulatory ,cd26:2
variations ,tmprss2:2
variations ,cd26:2
tmprss2 ,cd26:2
receptor ,result:2
binding ,result:2
domain ,protein:2
domain ,result:2
spike ,result:2
protein ,result:2
case ,2019-infected:2
case ,donor:2
coronavirus ,2019-infected:2
coronavirus ,donor:2
disease ,2019-infected:2
disease ,donor:2
2019-infected ,liver:2
2019-infected ,transplant:2
2019-infected ,donor:2
liver ,donor:2
transplant ,donor:2
common ,cold:2
common ,coronavirus:4
common ,protect:2
common ,sars-cov2:2
common ,disease:2
cold ,coronavirus:2
cold ,infection:2
cold ,protect:2
cold ,severe:2
cold ,sars-cov2:2
cold ,disease:2
coronavirus ,protect:2
coronavirus ,sars-cov2:4
protect ,severe:2
protect ,sars-cov2:2
sars-cov2 ,disease:2
epidemiological ,initial:2
initial ,family:4
initial ,characters:2
initial ,imported:2
initial ,cluster:2
ct ,characters:2
ct ,imported:2
ct ,family:2
ct ,cluster:2
imaging ,characters:2
imaging ,imported:2
imaging ,family:2
imaging ,cluster:2
characters ,imported:2
characters ,family:2
characters ,cluster:2
characters ,covid-19:2
imported ,family:2
imported ,cluster:2
primary ,concentration:2
primary ,critical:2
primary ,step:2
primary ,implementing:2
primary ,wastewater:2
primary ,based:2
concentration ,critical:2
concentration ,step:2
concentration ,implementing:2
concentration ,wastewater:2
concentration ,based:2
critical ,step:2
critical ,implementing:2
critical ,wastewater:4
critical ,based:2
step ,implementing:2
step ,wastewater:2
step ,based:2
implementing ,wastewater:2
implementing ,based:2
wastewater ,based:2
novel ,transplant:2
novel ,recipient:2
recipient ,case:2
acute ,demyelinating:2
acute ,encephalomyelitis:2
acute ,adem:2
demyelinating ,encephalomyelitis:2
demyelinating ,adem:2
demyelinating ,covid-19:2
demyelinating ,infection:2
demyelinating ,case:2
demyelinating ,series:2
encephalomyelitis ,adem:2
encephalomyelitis ,covid-19:2
encephalomyelitis ,infection:2
encephalomyelitis ,case:2
encephalomyelitis ,series:2
adem ,covid-19:2
adem ,infection:2
adem ,case:2
adem ,series:2
endourology ,lithiasis:2
endourology ,management:2
endourology ,surgical:2
endourology ,considerations:2
endourology ,follow-up:2
lithiasis ,management:2
lithiasis ,surgical:2
lithiasis ,considerations:2
lithiasis ,follow-up:2
surgical ,follow-up:2
considerations ,follow-up:2
tracking ,spike:4
tracking ,d614g:2
tracking ,increases:2
tracking ,infectivity:2
changes ,spike:2
changes ,d614g:2
changes ,increases:2
changes ,infectivity:2
spike ,evidence:2
spike ,increases:2
spike ,infectivity:2
evidence ,d614g:2
evidence ,increases:2
evidence ,infectivity:2
d614g ,increases:2
d614g ,infectivity:2
increases ,infectivity:2
can ,artificial:2
can ,intelligence:2
can ,identify:2
can ,effective:2
can ,therapies:2
artificial ,identify:2
artificial ,effective:2
artificial ,therapies:2
intelligence ,identify:2
intelligence ,effective:2
intelligence ,therapies:2
identify ,effective:2
identify ,therapies:2
effective ,therapies:4
rational ,multi-epitope:2
rational ,accounts:2
design ,accounts:2
multi-epitope ,accounts:2
vaccine ,accounts:2
sars-cov-2 ,accounts:2
false-negative ,syndrome:2
false-negative ,coronavirus:2
results ,organization:2
results ,model:2
healthcare ,organization:2
healthcare ,model:2
healthcare ,hemodialysis:2
organization ,model:2
organization ,covid-19:2
organization ,hemodialysis:2
model ,hemodialysis:2
sars-cov-2 ,latinos:2
sars-cov-2 ,baltimore-washington:2
sars-cov-2 ,dc:2
positivity ,latinos:2
positivity ,baltimore-washington:2
positivity ,dc:2
positivity ,region:2
rate ,latinos:2
rate ,baltimore-washington:2
rate ,dc:2
rate ,region:2
latinos ,baltimore-washington:2
latinos ,dc:2
latinos ,region:2
baltimore-washington ,dc:2
baltimore-washington ,region:2
dc ,region:2
neutralizing ,robust:2
antibody ,robust:2
responses ,robust:2
robust ,patients:2
robust ,severe:2
clinical ,hematological:2
clinical ,88:2
hematological ,characteristics:2
hematological ,88:2
characteristics ,88:2
88 ,patients:2
88 ,covid-19:2
optimization ,primer:2
optimization ,sets:2
optimization ,protocols:2
optimization ,coronavirus:2
primer ,sets:2
primer ,detection:2
primer ,protocols:2
sets ,protocols:2
sets ,coronavirus:2
protocols ,coronavirus:2
characterization ,noncovalent:2
characterization ,inhibition:2
characterization ,deubiquitinase:2
characterization ,deisgylase:2
noncovalent ,inhibition:2
noncovalent ,deubiquitinase:2
noncovalent ,deisgylase:2
inhibition ,deubiquitinase:2
inhibition ,deisgylase:2
deubiquitinase ,deisgylase:2
application ,ethics:2
application ,labor:2
application ,unit:2
principles ,biomedical:2
principles ,ethics:2
principles ,labor:2
principles ,delivery:2
principles ,unit:2
biomedical ,ethics:2
biomedical ,labor:2
biomedical ,unit:2
ethics ,labor:2
ethics ,delivery:2
ethics ,unit:2
labor ,delivery:4
labor ,unit:2
delivery ,unit:2
coronavirus ,known:2
coronavirus ,needs:2
disease ,known:2
disease ,needs:2
neonates ,known:2
neonates ,needs:2
known ,needs:2
diagnosis ,facts:2
facts ,challenges:2
repurposing ,cefuroxime:2
repurposing ,scoping:2
cefuroxime ,treatment:2
cefuroxime ,covid-19:2
cefuroxime ,scoping:2
cefuroxime ,review:2
cefuroxime ,silico:2
treatment ,scoping:2
treatment ,silico:2
scoping ,silico:2
review ,silico:2
structural ,insight:4
insight ,role:2
insight ,protein:2
insight ,potential:2
insight ,target:2
world ,clinical:4
world ,trial:2
world ,development:2
world ,post:2
world ,lessons:2
world ,learned:2
world ,global:4
clinical ,post:2
clinical ,learned:2
trial ,development:2
trial ,post:2
trial ,lessons:2
trial ,learned:2
trial ,global:2
development ,post:2
development ,lessons:2
development ,learned:2
post ,lessons:2
post ,learned:2
post ,global:2
lessons ,global:2
learned ,global:2
covid-19 ,single-center:4
solid ,recipients:2
solid ,single-center:2
solid ,case:2
solid ,series:2
organ ,recipients:2
organ ,single-center:2
organ ,case:2
organ ,series:2
transplant ,single-center:2
transplant ,series:2
recipients ,single-center:2
recipients ,case:2
recipients ,series:2
single-center ,case:2
single-center ,series:2
clinical ,fight:2
clinical ,urgently:2
clinical ,needed:2
trials ,use:2
trials ,melatonin:2
trials ,fight:2
trials ,urgently:2
trials ,needed:2
use ,melatonin:2
use ,urgently:2
use ,needed:2
melatonin ,fight:2
melatonin ,urgently:2
melatonin ,needed:2
fight ,urgently:2
fight ,needed:2
covid-19 ,urgently:2
urgently ,needed:2
application ,cells:2
application ,lung:2
application ,injury:2
mesenchymal ,lung:2
mesenchymal ,injury:2
stem ,lung:2
stem ,injury:2
cells ,exosomes:6
cells ,injury:2
exosomes ,lung:2
exosomes ,injury:2
role ,rooms:2
role ,facemasks:2
role ,intensified:2
role ,hand:2
role ,hygiene:2
isolation ,facemasks:2
isolation ,intensified:2
isolation ,hand:2
rooms ,facemasks:2
rooms ,intensified:2
rooms ,hand:2
rooms ,hygiene:2
facemasks ,intensified:2
facemasks ,hand:2
facemasks ,hygiene:2
intensified ,hand:2
intensified ,hygiene:2
demographics ,clinical:2
demographics ,presentation:2
demographics ,patients:2
demographics ,ocular:2
demographics ,disorders:2
presentation ,ocular:2
presentation ,disorders:2
patients ,disorders:8
ocular ,disorders:2
design ,implementation:2
design ,regional:2
design ,inpatient:2
design ,psychiatry:2
design ,unit:2
implementation ,regional:2
implementation ,inpatient:2
implementation ,psychiatry:2
implementation ,unit:2
implementation ,patients:2
regional ,inpatient:2
regional ,psychiatry:2
regional ,unit:2
inpatient ,psychiatry:2
inpatient ,unit:4
psychiatry ,unit:2
psychiatry ,patients:2
pneumothorax ,late:2
pneumothorax ,complication:2
multicentre ,italian:2
multicentre ,infection:2
multicentre ,children:2
multicentre ,adolescents:2
italian ,adolescents:4
study ,adolescents:2
challenges ,around:2
challenges ,tertiary-level:2
challenges ,healthcare:2
challenges ,facility:2
around ,covid-19:2
around ,tertiary-level:2
around ,healthcare:2
around ,facility:2
around ,south:2
around ,africa:2
covid-19 ,tertiary-level:2
tertiary-level ,healthcare:2
tertiary-level ,facility:2
tertiary-level ,south:2
tertiary-level ,africa:2
healthcare ,facility:2
healthcare ,south:2
healthcare ,africa:4
facility ,south:2
facility ,africa:2
south ,africa:2
isolated ,intracranial:2
isolated ,hypertension:2
isolated ,associated:2
intracranial ,hypertension:2
intracranial ,associated:2
intracranial ,covid-19:2
hypertension ,associated:2
will ,environmental:2
will ,changes:2
will ,temperature:2
will ,affect:2
will ,course:2
environmental ,changes:2
environmental ,affect:2
environmental ,course:2
changes ,temperature:2
changes ,affect:2
changes ,course:2
temperature ,affect:2
temperature ,course:2
affect ,course:2
sars-cov-2 ,immunogenetics:2
sars-cov-2 ,arms:2
immunogenetics ,call:2
immunogenetics ,arms:2
call ,arms:2
baricitinib ,drug:2
baricitinib ,potential:2
baricitinib ,effect:2
baricitinib ,prevent:2
baricitinib ,sars-cov-2:2
baricitinib ,entering:2
baricitinib ,target:2
drug ,effect:2
drug ,prevent:2
drug ,entering:2
potential ,entering:2
effect ,prevent:2
effect ,entering:2
effect ,target:2
prevent ,entering:2
prevent ,target:4
sars-cov-2 ,entering:2
entering ,target:2
covid-19 ,rheumatoid:4
covid-19 ,arthritis:6
covid-19 ,faraway:2
infection ,faraway:2
infection ,close:4
rheumatoid ,faraway:2
rheumatoid ,close:2
arthritis ,faraway:2
arthritis ,close:2
faraway ,close:2
factors ,perceived:4
factors ,effectiveness:2
factors ,prevention:2
factors ,measures:2
affecting ,perceived:2
affecting ,effectiveness:2
affecting ,prevention:2
affecting ,measures:2
affecting ,among:2
perceived ,effectiveness:2
perceived ,covid-19:2
perceived ,prevention:2
perceived ,measures:2
perceived ,among:4
effectiveness ,prevention:2
effectiveness ,among:2
prevention ,among:2
measures ,among:2
clinical ,sari:2
epidemiological ,sari:2
epidemiological ,ward:2
features ,sari:2
features ,ward:2
sars-cov-2 ,sari:2
patients ,sari:2
sari ,ward:2
seroprevalence ,adults:2
seroprevalence ,los:2
seroprevalence ,angeles:2
seroprevalence ,county:2
sars-cov-2-specific ,among:2
sars-cov-2-specific ,adults:2
sars-cov-2-specific ,los:2
sars-cov-2-specific ,angeles:2
sars-cov-2-specific ,county:2
antibodies ,adults:2
antibodies ,los:2
antibodies ,angeles:2
antibodies ,county:2
among ,adults:4
among ,los:2
among ,angeles:2
among ,county:2
adults ,los:2
adults ,angeles:2
adults ,county:2
los ,angeles:2
los ,county:2
angeles ,county:2
early ,neonatal:2
early ,manifesting:2
early ,hypoxemia:2
early ,requiring:2
neonatal ,manifesting:2
neonatal ,hypoxemia:2
neonatal ,requiring:2
sars-cov-2 ,manifesting:2
sars-cov-2 ,hypoxemia:2
sars-cov-2 ,requiring:2
infection ,manifesting:2
infection ,hypoxemia:2
infection ,requiring:2
manifesting ,hypoxemia:2
manifesting ,requiring:2
manifesting ,respiratory:2
hypoxemia ,requiring:2
hypoxemia ,respiratory:2
requiring ,respiratory:2
delirium ,epidemiology:2
delirium ,clinical:2
delirium ,correlations:2
delirium ,large:2
delirium ,group:2
covid-19 ,correlations:4
epidemiology ,correlations:2
epidemiology ,large:2
epidemiology ,group:2
clinical ,large:2
clinical ,group:6
correlations ,large:2
correlations ,group:2
large ,group:2
review ,practical:2
review ,otolaryngologists:2
review ,head:2
review ,neck:2
review ,surgeons:2
practical ,otolaryngologists:2
practical ,head:2
practical ,neck:2
practical ,surgeons:2
recommendations ,otolaryngologists:2
recommendations ,head:6
recommendations ,neck:4
otolaryngologists ,head:2
otolaryngologists ,neck:2
otolaryngologists ,surgeons:2
head ,surgeons:2
neck ,surgeons:2
comprehensive ,current:2
comprehensive ,outbreak:2
current ,outbreak:4
use ,copper:2
use ,help:2
use ,sars-coronavirus:2
use ,influenza:2
copper ,help:2
copper ,prevent:2
copper ,transmission:2
copper ,sars-coronavirus:2
copper ,influenza:2
help ,prevent:2
help ,transmission:2
help ,sars-coronavirus:2
help ,influenza:2
prevent ,sars-coronavirus:2
prevent ,influenza:2
transmission ,sars-coronavirus:2
transmission ,influenza:2
sars-coronavirus ,influenza:2
global ,telemedicine:2
global ,implementation:2
global ,integration:2
global ,within:2
global ,systems:2
global ,fight:2
telemedicine ,implementation:2
telemedicine ,integration:2
telemedicine ,within:2
telemedicine ,health:2
telemedicine ,systems:2
telemedicine ,fight:2
implementation ,integration:2
implementation ,within:2
implementation ,systems:2
implementation ,fight:2
integration ,within:2
integration ,health:2
integration ,systems:2
integration ,fight:2
within ,health:4
within ,systems:2
within ,fight:2
systems ,fight:2
occupational ,stress:2
occupational ,mental:2
occupational ,anesthetists:2
stress ,mental:2
stress ,health:2
stress ,anesthetists:2
mental ,anesthetists:2
health ,anesthetists:2
among ,anesthetists:2
anesthetists ,covid-19:2
traveling ,abyss:2
traveling ,risk:2
traveling ,perception:2
traveling ,german:2
traveling ,travelers:2
traveling ,onset:2
abyss ,risk:2
abyss ,perception:2
abyss ,german:2
abyss ,travelers:2
abyss ,onset:2
risk ,german:2
risk ,travelers:2
risk ,onset:2
perception ,german:2
perception ,travelers:2
perception ,onset:2
german ,travelers:2
german ,onset:2
travelers ,onset:2
epidemiological ,parameters:2
epidemiological ,implication:2
epidemiological ,infectivity:2
epidemiological ,among:2
parameters ,implication:2
parameters ,infectivity:2
parameters ,among:2
covid-19 ,infectivity:2
implication ,infectivity:2
implication ,among:2
infectivity ,among:2
children ,hubei:2
sars-cov-2 ,hubei:2
infection ,hubei:2
epidemic ,outside:2
management ,transplant:2
patients ,transplant:2
transplant ,chronic:2
transplant ,diseases:2
chronic ,diseases:2
viral ,cpg:2
viral ,deficiency:2
viral ,provides:2
viral ,dogs:2
viral ,intermediate:2
viral ,hosts:2
cpg ,provides:2
cpg ,evidence:2
cpg ,dogs:2
cpg ,intermediate:2
cpg ,hosts:2
deficiency ,provides:2
deficiency ,evidence:2
deficiency ,dogs:2
deficiency ,intermediate:2
deficiency ,hosts:2
provides ,evidence:2
provides ,dogs:2
provides ,intermediate:2
provides ,hosts:2
evidence ,dogs:2
evidence ,intermediate:2
evidence ,hosts:2
dogs ,intermediate:2
dogs ,hosts:2
evidence ,regarding:2
evidence ,vitamin:4
evidence ,severity:2
regarding ,vitamin:2
regarding ,risk:6
regarding ,severity:2
sars-cov-2 ,in-silico:6
sars-cov-2 ,cloning:2
vaccine ,in-silico:4
vaccine ,cloning:2
vaccine ,validation:4
candidate ,in-silico:4
candidate ,cloning:2
candidate ,validation:4
in-silico ,cloning:2
in-silico ,validation:2
cloning ,validation:2
salivary ,nasal:2
salivary ,virus:2
salivary ,antiviral:2
salivary ,mouthrinses:2
nasal ,virus:2
nasal ,antiviral:2
nasal ,mouthrinses:2
detection ,antiviral:2
detection ,mouthrinses:2
sars-cov-2 ,mouthrinses:2
virus ,antiviral:2
virus ,mouthrinses:2
antiviral ,mouthrinses:2
protein ,printer:2
protein ,exploring:2
protein ,domains:2
surface ,printer:2
surface ,exploring:2
surface ,domains:2
printer ,exploring:2
printer ,domains:2
exploring ,domains:2
designing ,therapeutic:2
designing ,strategies:2
designing ,severe:2
designing ,acute:2
designing ,respiratory:2
designing ,syndrome:2
strategies ,syndrome:2
combat ,syndrome:2
primary ,population:2
care ,population:2
population ,management:2
population ,patients:2
public ,mainland:2
public ,narrative:2
health ,mainland:2
response ,mainland:2
covid-19 ,mainland:2
outbreak ,mainland:2
outbreak ,narrative:2
mainland ,narrative:2
china ,narrative:2
neurologically ,devastating:2
neurologically ,intraparenchymal:2
neurologically ,hemorrhage:2
neurologically ,covid-19:2
neurologically ,patients:2
devastating ,intraparenchymal:2
devastating ,hemorrhage:4
devastating ,patients:2
intraparenchymal ,hemorrhage:2
intraparenchymal ,covid-19:2
intraparenchymal ,patients:2
psychological ,status:4
psychological ,surgical:4
psychological ,staff:2
status ,surgical:2
status ,staff:2
status ,outbreak:2
surgical ,staff:2
multiple ,hypothesis:2
multiple ,treatment:4
therapy ,hypothesis:2
hypothesis ,patients:4
humoral ,infected:2
immune ,infected:2
responses ,infected:2
analysis ,co-inhibitory:2
analysis ,compared:2
co-inhibitory ,receptor:2
co-inhibitory ,expression:2
co-inhibitory ,covid-19:2
co-inhibitory ,infection:2
co-inhibitory ,compared:2
receptor ,compared:2
expression ,compared:2
infection ,compared:2
sars-cov-2 ,aiming:2
aiming ,heart:2
aiming ,multicenter:2
aiming ,italian:2
aiming ,perspective:2
heart ,multicenter:2
heart ,italian:2
multicenter ,italian:2
multicenter ,perspective:2
italian ,perspective:4
scope ,mental:2
scope ,health:2
scope ,research:2
scope ,covid-19:2
scope ,pandemic:2
scope ,aftermath:2
mental ,research:2
mental ,aftermath:2
health ,aftermath:2
research ,aftermath:2
covid-19 ,aftermath:2
pandemic ,aftermath:2
replication-competent ,studies:2
replication-competent ,sars-cov-2:2
vesicular ,studies:2
stomatitis ,studies:2
stomatitis ,sars-cov-2:2
clinical ,116:2
characteristics ,116:2
116 ,hospitalized:2
116 ,patients:2
116 ,covid-19:2
116 ,wuhan:2
116 ,china:2
hospitalized ,wuhan:2
hospitalized ,china:2
sars-cov-2 ,kingdom:2
infection ,united:2
infection ,kingdom:2
clinical ,kingdom:2
features ,united:2
features ,kingdom:2
outcome ,united:2
outcome ,kingdom:2
covid-19 ,kingdom:6
united ,kingdom:4
structural ,remdesivir:2
basis ,remdesivir:2
potential ,binding:2
potential ,remdesivir:2
binding ,remdesivir:2
deleterious ,outcomes:2
deleterious ,long-hauler:2
deleterious ,covid-19:2
deleterious ,effects:2
deleterious ,sars-cov-2:2
deleterious ,cns:2
outcomes ,long-hauler:2
outcomes ,effects:4
outcomes ,cns:2
long-hauler ,covid-19:2
long-hauler ,effects:2
long-hauler ,sars-cov-2:2
long-hauler ,cns:2
effects ,cns:2
advances ,viral:2
advances ,diagnostic:6
advances ,technologies:2
advances ,combating:2
advances ,future:2
viral ,technologies:2
viral ,combating:2
diagnostic ,combating:2
technologies ,combating:2
technologies ,future:2
combating ,future:2
lung ,respiratory:2
lung ,failure:2
lung ,reduces:2
lung ,conventional:2
ultrasound ,acute:4
ultrasound ,respiratory:4
ultrasound ,failure:2
ultrasound ,reduces:2
ultrasound ,conventional:2
patients ,failure:6
patients ,reduces:2
patients ,conventional:2
acute ,reduces:2
acute ,conventional:2
respiratory ,reduces:4
respiratory ,conventional:2
failure ,reduces:2
failure ,conventional:2
reduces ,conventional:2
multi-tiered ,screening:2
multi-tiered ,diagnosis:2
multi-tiered ,strategy:2
multi-tiered ,covid-19:2
multi-tiered ,model:2
multi-tiered ,sustainable:2
screening ,sustainable:2
diagnosis ,strategy:2
diagnosis ,model:2
diagnosis ,sustainable:2
strategy ,model:2
strategy ,sustainable:2
covid-19 ,sustainable:4
model ,sustainable:2
statutory ,obligations:2
statutory ,doctor:2
statutory ,field:2
statutory ,prevention:2
statutory ,control:2
obligations ,doctor:2
obligations ,field:2
obligations ,prevention:2
obligations ,control:2
doctor ,field:2
doctor ,prevention:2
doctor ,control:2
field ,control:2
wellbeing ,work:2
wellbeing ,sars-cov-2:2
wellbeing ,pandemic:2
wellbeing ,brazilian:2
wellbeing ,nationwide:2
work ,pandemic:2
work ,brazilian:2
work ,nationwide:2
sars-cov-2 ,brazilian:2
pandemic ,nationwide:2
brazilian ,nationwide:2
role ,community-wide:2
role ,wearing:2
role ,face:2
role ,mask:2
community-wide ,wearing:2
community-wide ,face:2
community-wide ,mask:2
community-wide ,control:2
community-wide ,coronavirus:2
community-wide ,disease:2
wearing ,control:2
wearing ,disease:2
face ,mask:4
face ,control:2
face ,coronavirus:2
face ,disease:2
mask ,control:2
mask ,disease:2
coinfection ,wuhan:2
coinfection ,china:2
coinfection ,12-person:2
hiv ,wuhan:2
hiv ,china:4
hiv ,12-person:2
hiv ,series:2
sars-cov-2 ,12-person:2
wuhan ,12-person:2
wuhan ,series:2
china ,12-person:2
china ,series:2
12-person ,case:2
12-person ,series:2
sars-cov-2 ,nonsynonymous:2
orf3a ,nonsynonymous:2
orf3a ,mutations:2
orf3a ,functional:2
orf3a ,domains:2
orf3a ,viral:2
nonsynonymous ,mutations:2
nonsynonymous ,functional:2
nonsynonymous ,domains:2
nonsynonymous ,viral:2
mutations ,functional:2
mutations ,domains:2
functional ,domains:2
functional ,viral:2
domains ,viral:2
silico ,based:2
molecular ,coumarin:2
docking ,evaluation:2
docking ,coumarin:2
evaluation ,coumarin:2
evaluation ,derivatives:2
coumarin ,based:2
based ,derivatives:2
disease ,hemodialysis:4
hemodialysis ,case:2
coronavirus ,technologies:2
coronavirus ,country-based:2
disease ,technologies:2
disease ,country-based:2
covid-19 ,country-based:2
diagnostic ,country-based:2
technologies ,country-based:2
behavioral ,manipulation-key:2
behavioral ,successful:2
behavioral ,global:2
behavioral ,spread:2
behavioral ,new:2
behavioral ,coronavirus:4
manipulation-key ,successful:2
manipulation-key ,global:2
manipulation-key ,spread:2
manipulation-key ,new:2
manipulation-key ,coronavirus:2
successful ,global:2
successful ,spread:2
successful ,new:2
global ,new:4
spread ,new:2
integrative ,network:4
integrative ,biology:4
integrative ,framework:4
integrative ,elucidates:4
integrative ,molecular:4
integrative ,mechanisms:4
network ,biology:4
network ,framework:4
network ,elucidates:4
network ,mechanisms:4
biology ,framework:4
biology ,elucidates:4
biology ,mechanisms:4
framework ,elucidates:4
framework ,molecular:4
framework ,mechanisms:4
framework ,sars-cov-2:4
elucidates ,molecular:4
elucidates ,mechanisms:4
elucidates ,sars-cov-2:4
sensitive ,sars-cov-2-specific:2
sensitive ,antibodies:2
sensitive ,dried:2
sensitive ,blood:2
sensitive ,spot:2
sensitive ,samples:2
detection ,dried:2
detection ,spot:2
sars-cov-2-specific ,dried:2
sars-cov-2-specific ,blood:2
sars-cov-2-specific ,spot:2
sars-cov-2-specific ,samples:2
antibodies ,dried:2
antibodies ,spot:2
dried ,blood:2
dried ,spot:2
dried ,samples:2
blood ,spot:2
spot ,samples:2
syrian ,small:2
syrian ,animal:2
syrian ,model:2
syrian ,countermeasure:2
hamsters ,small:2
hamsters ,animal:2
hamsters ,model:2
hamsters ,countermeasure:2
small ,animal:2
small ,countermeasure:2
animal ,model:2
animal ,countermeasure:2
model ,countermeasure:2
sars-cov-2 ,countermeasure:2
infection ,countermeasure:2
temporal ,location:2
temporal ,variations:2
temporal ,link:2
temporal ,categories:2
temporal ,dissemination:2
location ,variations:2
location ,link:2
location ,categories:2
location ,dissemination:2
variations ,link:2
variations ,categories:2
variations ,dissemination:2
link ,categories:2
link ,dissemination:2
categories ,dissemination:2
nervous ,coronaviruses:2
involvement ,coronaviruses:2
impact ,dynamics:2
impact ,domestic:2
international ,dynamics:2
international ,domestic:2
international ,2019-ncov:2
international ,india:2
travel ,dynamics:2
travel ,domestic:2
travel ,2019-ncov:2
travel ,india:2
dynamics ,domestic:2
dynamics ,india:2
domestic ,spread:2
domestic ,2019-ncov:2
domestic ,india:2
2019-ncov ,india:2
development ,parallel:2
development ,reaction:2
development ,monitoring:2
development ,mass:2
development ,spectrometry:2
parallel ,reaction:2
parallel ,monitoring:2
parallel ,mass:2
parallel ,spectrometry:2
parallel ,assay:2
reaction ,monitoring:2
reaction ,mass:2
reaction ,spectrometry:2
reaction ,assay:2
monitoring ,mass:2
monitoring ,spectrometry:2
mass ,assay:2
spectrometry ,assay:2
characteristics ,based:4
outcomes ,based:2
patients ,based:4
2-pyridone ,natural:2
2-pyridone ,products:2
2-pyridone ,inhibitors:2
2-pyridone ,sars-cov-2:2
2-pyridone ,main:2
2-pyridone ,protease:2
mistakes ,hiv:2
mistakes ,pandemic:2
mistakes ,inform:2
mistakes ,covid-19:2
mistakes ,response:2
mistakes ,maternal:2
hiv ,inform:2
hiv ,response:2
hiv ,maternal:2
pandemic ,inform:2
pandemic ,maternal:4
inform ,covid-19:4
inform ,response:2
inform ,maternal:2
sustainable ,practice:2
sustainable ,ophthalmology:2
sustainable ,challenges:2
sustainable ,solutions:4
practice ,challenges:4
practice ,solutions:2
ophthalmology ,challenges:2
ophthalmology ,solutions:2
covid-19 ,solutions:4
coronavirus ,staged:2
disease ,staged:2
pandemic ,staged:2
staged ,management:2
staged ,surgical:2
staged ,services:2
management ,services:2
surgical ,services:4
convalescent ,relay:2
convalescent ,baton:2
convalescent ,race:2
plasma ,relay:2
plasma ,baton:2
plasma ,race:2
relay ,baton:2
relay ,race:2
relay ,coronavirus:2
relay ,disease:2
baton ,race:2
baton ,coronavirus:2
baton ,disease:2
race ,coronavirus:4
race ,disease:2
development ,fluorescence-based:2
development ,high-throughput:2
development ,3clpro:2
development ,reporter:2
fluorescence-based ,high-throughput:2
fluorescence-based ,sars-cov-2:2
fluorescence-based ,3clpro:2
fluorescence-based ,reporter:2
high-throughput ,3clpro:2
high-throughput ,reporter:2
sars-cov-2 ,reporter:2
3clpro ,reporter:2
covid-19-associated ,encephalopathy:2
covid-19-associated ,manifestation:2
covid-19-associated ,covid-19:2
encephalopathy ,manifestation:2
neurological ,manifestation:2
analysis ,rna-dependent:2
analysis ,polymerase:2
analysis ,therapeutic:2
rna-dependent ,therapeutic:4
rna ,therapeutic:4
polymerase ,therapeutic:4
contamination ,inert:2
contamination ,persistence:2
contamination ,stability:2
inert ,surfaces:2
inert ,sars-cov-2:2
inert ,persistence:2
inert ,stability:2
surfaces ,stability:2
persistence ,stability:2
atypical ,general:2
atypical ,practice:2
atypical ,case:2
atypical ,gastrointestinal:2
manifestations ,general:2
manifestations ,practice:2
manifestations ,case:4
general ,practice:2
general ,case:2
general ,gastrointestinal:2
practice ,case:2
practice ,gastrointestinal:2
suggestions ,radiation:2
suggestions ,oncologists:2
suggestions ,pandemic:2
radiation ,oncologists:2
oncologists ,covid-19:2
oncologists ,pandemic:2
nasal ,nitric:2
nasal ,oxide:2
nasal ,help:2
nasal ,mitigate:2
nasal ,severity:2
nitric ,help:2
nitric ,mitigate:2
nitric ,severity:2
nitric ,covid-19:2
oxide ,help:2
oxide ,mitigate:2
oxide ,severity:2
oxide ,covid-19:2
help ,mitigate:2
help ,severity:2
mitigate ,severity:2
case ,febrile:4
case ,infants:2
series ,novel:2
series ,febrile:2
series ,infants:2
series ,new:2
novel ,febrile:2
febrile ,new:2
infants ,new:2
tyrosine ,kinase:2
tyrosine ,inhibitor:2
tyrosine ,nilotinib:2
tyrosine ,inhibits:2
tyrosine ,sars-cov-2:2
tyrosine ,vitro:2
kinase ,nilotinib:2
kinase ,inhibits:2
kinase ,vitro:2
inhibitor ,nilotinib:2
inhibitor ,inhibits:2
inhibitor ,vitro:2
nilotinib ,inhibits:2
nilotinib ,sars-cov-2:2
nilotinib ,vitro:2
rheumatic ,report:2
rheumatic ,cases:2
diseases ,cases:2
biospecimen ,collection:2
biospecimen ,covid-19:2
biospecimen ,pandemic:2
collection ,pandemic:2
adoption ,contact:2
adoption ,tracing:2
adoption ,app:2
adoption ,containing:2
adoption ,covid-19:2
adoption ,health:2
adoption ,belief:2
adoption ,model:2
contact ,app:2
contact ,containing:2
contact ,health:2
contact ,belief:2
contact ,model:2
tracing ,app:2
tracing ,containing:2
tracing ,health:2
tracing ,belief:2
tracing ,model:2
app ,containing:2
app ,covid-19:2
app ,health:2
app ,belief:2
app ,model:2
containing ,belief:2
containing ,model:2
health ,model:4
belief ,model:2
safety ,tolerability:4
safety ,pharmacokinetics:2
safety ,remdesivir:2
tolerability ,pharmacokinetics:2
tolerability ,remdesivir:2
tolerability ,antiviral:2
tolerability ,treatment:2
pharmacokinetics ,remdesivir:2
pharmacokinetics ,antiviral:2
pharmacokinetics ,treatment:2
sars-cov-2 ,parma:2
infection ,parma:4
children ,parma:2
venous ,non-critically:2
venous ,infection:4
thromboembolism ,non-critically:2
thromboembolism ,infection:4
non-critically ,ill:4
non-critically ,patients:4
non-critically ,covid-19:2
non-critically ,infection:2
ill ,infection:4
imaging ,infections:2
imaging ,sars-cov:2
imaging ,mers-cov:2
findings ,sars-cov:2
findings ,mers-cov:2
infections ,sars-cov:6
infections ,mers-cov:4
hospital ,healthcare:4
hospital ,novel:2
covid-19 ,balance:4
pandemic ,maintaining:2
pandemic ,optimal:4
pandemic ,zinc:2
pandemic ,balance:2
pandemic ,enhance:2
pandemic ,host:2
pandemic ,resistance:2
can ,maintaining:2
can ,optimal:2
can ,zinc:2
can ,balance:2
can ,enhance:4
can ,host:2
can ,resistance:2
maintaining ,optimal:2
maintaining ,zinc:2
maintaining ,balance:2
maintaining ,enhance:2
maintaining ,host:2
maintaining ,resistance:2
optimal ,zinc:2
optimal ,balance:2
optimal ,enhance:2
optimal ,host:2
optimal ,resistance:2
zinc ,balance:2
zinc ,host:2
zinc ,resistance:2
balance ,enhance:2
balance ,host:2
balance ,resistance:2
enhance ,host:2
enhance ,resistance:2
host ,resistance:2
first ,cohort:2
first ,vietnam:2
cohort ,vietnam:2
cohort ,national:4
cohort ,response:2
patients ,vietnam:2
patients ,national:4
vietnam ,national:2
vietnam ,response:2
pipeline ,pharmacological:2
pipeline ,therapies:2
pipeline ,clinical:2
pipeline ,trial:2
pipeline ,covid-19:2
pipeline ,pandemic:2
pipeline ,recent:2
pharmacological ,clinical:2
pharmacological ,trial:2
pharmacological ,pandemic:2
pharmacological ,recent:2
therapies ,trial:2
therapies ,pandemic:4
trial ,pandemic:2
trial ,recent:2
covid-19 ,veneto:2
challenge ,proactive:2
challenge ,management:2
challenge ,tertiary:2
challenge ,university:2
challenge ,hospital:2
challenge ,veneto:2
proactive ,management:2
proactive ,tertiary:2
proactive ,university:2
proactive ,hospital:2
proactive ,veneto:2
management ,tertiary:2
management ,veneto:2
tertiary ,university:2
tertiary ,veneto:2
university ,veneto:2
hospital ,veneto:2
bromelain ,review:2
bromelain ,potential:2
bromelain ,therapy:2
bromelain ,management:2
bromelain ,covid-19:2
evolution ,resolution:2
evolution ,brain:2
evolution ,involvement:2
evolution ,associated:2
evolution ,sars-:2
evolution ,cov2:2
resolution ,brain:2
resolution ,involvement:2
resolution ,associated:2
resolution ,sars-:2
resolution ,cov2:2
resolution ,infection:2
brain ,involvement:2
brain ,sars-:2
brain ,cov2:2
involvement ,associated:2
involvement ,sars-:2
involvement ,cov2:2
associated ,sars-:2
associated ,cov2:2
sars- ,infection:2
cov2 ,infection:2
small ,matter:2
small ,perspective:2
small ,nanotechnology-enabled:2
small ,solutions:2
small ,fight:2
matter ,perspective:2
matter ,nanotechnology-enabled:2
matter ,solutions:2
matter ,fight:2
perspective ,nanotechnology-enabled:2
perspective ,solutions:2
nanotechnology-enabled ,solutions:4
nanotechnology-enabled ,fight:2
solutions ,fight:2
evaluation ,response:2
igg ,response:2
igg ,pcr:2
igg ,positive:2
antibody ,pcr:2
response ,pcr:2
response ,positive:2
response ,comparison:2
course ,positive:4
course ,neonates:2
positive ,neonates:2
single-cell ,map:2
single-cell ,human:4
single-cell ,coronavirus:4
single-cell ,entry:2
single-cell ,factors:2
rna ,map:2
rna ,entry:2
expression ,map:2
expression ,factors:2
map ,coronavirus:4
map ,entry:2
map ,factors:2
human ,entry:6
entry ,factors:2
review ,prevent:2
current ,prevent:2
vaccine ,prevent:2
development ,prevent:2
insights ,use:2
insights ,c-reactive:2
insights ,diagnostic:2
insights ,index:2
use ,c-reactive:2
use ,protein:2
use ,diagnostic:2
use ,index:2
c-reactive ,diagnostic:2
c-reactive ,index:2
c-reactive ,disease:2
protein ,diagnostic:2
protein ,index:2
protein ,disease:2
diagnostic ,index:2
index ,disease:2
immune ,health:2
immune ,care:2
immune ,workers:2
health ,following:2
care ,following:2
workers ,following:2
following ,outbreak:2
malaria ,parasitic:2
malaria ,neglected:2
malaria ,tropical:2
malaria ,diseases:2
malaria ,potential:2
malaria ,syndemics:2
parasitic ,neglected:2
parasitic ,tropical:2
parasitic ,diseases:2
parasitic ,potential:2
parasitic ,syndemics:2
neglected ,tropical:4
neglected ,diseases:4
neglected ,potential:2
neglected ,syndemics:2
tropical ,potential:2
tropical ,syndemics:2
diseases ,potential:4
diseases ,syndemics:2
potential ,syndemics:2
best ,practice:4
best ,recommendations:2
best ,pediatric:2
best ,otolaryngology:2
practice ,pediatric:2
practice ,otolaryngology:4
pediatric ,otolaryngology:2
prevalence ,time:2
prevalence ,hospitalized:2
recovery ,time:2
recovery ,dysfunction:2
recovery ,hospitalized:2
time ,gustatory:2
time ,hospitalized:2
olfactory ,hospitalized:2
gustatory ,hospitalized:2
dysfunction ,hospitalized:2
interpretative ,immune:2
interpretative ,targets:2
interpretative ,contemporary:2
interpretative ,position:2
interpretative ,vaccine:2
interpretative ,development:2
immune ,contemporary:2
immune ,position:4
immune ,vaccine:2
targets ,contemporary:2
targets ,position:2
contemporary ,position:2
contemporary ,vaccine:2
contemporary ,development:2
position ,vaccine:2
position ,development:2
identification ,symptoms:2
identification ,biomedical:2
risk ,symptoms:2
risk ,biomedical:2
factors ,symptoms:2
factors ,analysis:6
factors ,biomedical:2
symptoms ,analysis:2
symptoms ,biomedical:2
analysis ,biomedical:2
study ,behavior:2
study ,attitude:2
study ,toward:2
knowledge ,behavior:2
knowledge ,novel:2
behavior ,attitude:2
behavior ,toward:2
attitude ,toward:2
attitude ,novel:2
prolonged ,immunocompetent:2
prolonged ,patient:2
viral ,immunocompetent:2
viral ,patient:4
shedding ,immunocompetent:2
shedding ,patient:4
immunocompetent ,covid-19:2
rapid ,determination:2
rapid ,bedside:2
determination ,antibodies:2
determination ,using:2
determination ,bedside:2
determination ,point-of-care:2
antibodies ,bedside:2
antibodies ,point-of-care:2
using ,bedside:2
bedside ,point-of-care:2
daily ,impact:2
daily ,gastroenterology:2
impact ,gastroenterology:2
comparison ,sars:4
comparison ,mers:4
symptoms ,medications:2
symptoms ,inflammatory:2
symptoms ,bowel:2
symptoms ,hubei:2
medications ,patients:2
medications ,inflammatory:2
medications ,bowel:2
medications ,disease:2
medications ,hubei:2
patients ,hubei:2
inflammatory ,hubei:2
bowel ,hubei:2
disease ,hubei:2
common ,childhood:2
common ,vaccines:2
common ,elicit:2
common ,antibody:2
common ,response:2
childhood ,vaccines:2
childhood ,elicit:2
childhood ,cross-reactive:2
childhood ,antibody:2
childhood ,response:2
vaccines ,elicit:2
vaccines ,cross-reactive:2
vaccines ,antibody:2
elicit ,cross-reactive:2
elicit ,antibody:2
elicit ,response:2
cross-reactive ,antibody:4
cross-reactive ,response:4
covid-19 ,yancheng:2
transmission ,within:2
transmission ,yancheng:2
within ,family:2
within ,cluster:2
within ,yancheng:2
within ,china:2
family ,yancheng:2
cluster ,yancheng:2
yancheng ,china:2
broncho-alveolar ,inflammation:2
broncho-alveolar ,covid-19:2
broncho-alveolar ,patients:2
broncho-alveolar ,correlation:2
broncho-alveolar ,clinical:2
inflammation ,correlation:2
impact ,attendance:2
coronavirus ,attendance:2
disease ,attendance:2
outbreak ,attendance:2
attendance ,patients:2
plasmapheresis ,treatment:2
plasmapheresis ,covid-19-related:2
plasmapheresis ,autoimmune:2
plasmapheresis ,meningoencephalitis:2
plasmapheresis ,case:2
treatment ,meningoencephalitis:2
covid-19-related ,autoimmune:2
covid-19-related ,meningoencephalitis:2
autoimmune ,meningoencephalitis:2
autoimmune ,case:2
meningoencephalitis ,case:2
biomarkers ,progression:2
prevalence ,hypovitaminosis:2
prevalence ,elderly:2
obesity ,hypovitaminosis:2
obesity ,elderly:2
hypovitaminosis ,elderly:2
hypovitaminosis ,severe:2
hypovitaminosis ,acute:2
hypovitaminosis ,respiratory:2
elderly ,severe:2
elderly ,acute:2
elderly ,respiratory:2
bronchoscopy ,help:2
bronchoscopy ,diagnosis:2
bronchoscopy ,infection:2
help ,diagnosis:2
help ,infection:2
tocilizumab ,single:2
tocilizumab ,center:2
tocilizumab ,experience:2
treatment ,single:2
treatment ,experience:2
single ,experience:4
maternal ,neonate:2
maternal ,possible:2
maternal ,routes:2
transmission ,neonate:2
sars-cov-2 ,neonate:2
neonate ,possible:2
neonate ,routes:2
hematology ,time:2
radiological ,manifestations:2
radiological ,key:2
radiological ,points:2
radiological ,physician:2
manifestations ,key:2
manifestations ,points:2
manifestations ,physician:2
key ,points:2
key ,physician:2
points ,physician:2
obesity ,prolongs:2
obesity ,hospital:2
obesity ,stay:2
obesity ,patients:2
obesity ,affected:2
obesity ,may:2
obesity ,impact:2
prolongs ,hospital:2
prolongs ,stay:2
prolongs ,patients:2
prolongs ,affected:2
prolongs ,covid-19:2
prolongs ,may:2
prolongs ,impact:2
hospital ,stay:2
hospital ,affected:2
hospital ,may:2
stay ,patients:2
stay ,affected:2
stay ,may:2
stay ,impact:2
affected ,may:2
affected ,impact:2
disease ,targets:2
virology ,drug:2
virology ,targets:2
covid-19 ,lambda:2
lambda ,interferon:2
lambda ,viral:2
lambda ,load:2
lambda ,hyperinflammation:2
interferon ,viral:2
interferon ,load:2
interferon ,hyperinflammation:2
viral ,hyperinflammation:2
load ,hyperinflammation:2
harnessing ,via:2
harnessing ,fcr:2
harnessing ,function:2
harnessing ,therapy:2
harnessing ,pathway:2
immune ,fcr:2
immune ,function:2
immune ,pathway:2
system ,via:2
system ,fcr:2
system ,function:2
system ,pathway:2
via ,fcr:2
via ,function:2
via ,pathway:2
fcr ,function:2
fcr ,therapy:2
fcr ,pathway:2
function ,pathway:2
therapy ,pathway:2
single-cell ,landscape:2
single-cell ,immunological:2
single-cell ,responses:2
single-cell ,cd4:2
single-cell ,cells:2
single-cell ,hiv:2
single-cell ,versus:2
landscape ,immunological:2
landscape ,responses:2
landscape ,cd4:2
landscape ,cells:2
landscape ,hiv:2
landscape ,versus:2
immunological ,cd4:2
immunological ,cells:2
immunological ,hiv:2
immunological ,versus:2
responses ,cd4:2
responses ,cells:2
responses ,hiv:2
cd4 ,cells:2
cd4 ,hiv:2
cd4 ,versus:2
cells ,hiv:2
cells ,versus:2
hiv ,versus:2
identification ,three:2
identification ,enzymes:2
identification ,sars-cov2:2
potential ,three:2
potential ,key:2
inhibitors ,three:2
inhibitors ,enzymes:2
inhibitors ,sars-cov2:2
three ,key:2
three ,enzymes:2
three ,sars-cov2:2
key ,enzymes:2
key ,sars-cov2:2
key ,using:2
enzymes ,sars-cov2:2
enzymes ,using:2
sars-cov2 ,using:2
acute ,multicenter:2
respiratory ,multicenter:2
syndrome ,multicenter:2
coronavirus ,multicenter:4
children ,multicenter:2
past ,epidemics:2
past ,natural:2
past ,disasters:2
past ,covid19:2
past ,mental:2
past ,health:2
past ,history:2
epidemics ,natural:2
epidemics ,disasters:2
epidemics ,covid19:2
epidemics ,mental:2
epidemics ,health:2
epidemics ,learning:2
epidemics ,history:2
natural ,disasters:2
natural ,covid19:2
natural ,mental:2
natural ,health:2
natural ,learning:2
disasters ,covid19:2
disasters ,mental:2
disasters ,health:2
disasters ,learning:2
disasters ,history:2
covid19 ,mental:2
covid19 ,health:2
covid19 ,learning:2
covid19 ,history:2
mental ,learning:2
mental ,history:2
health ,learning:2
health ,history:2
learning ,history:4
evaluation ,cmia:2
evaluation ,iggiga:2
abbott ,anti-sars-cov-2:2
abbott ,cmia:2
abbott ,euroimmun:2
abbott ,elisa:2
abbott ,iggiga:2
abbott ,assays:2
anti-sars-cov-2 ,cmia:2
anti-sars-cov-2 ,iggiga:2
anti-sars-cov-2 ,assays:2
cmia ,igg:2
cmia ,euroimmun:2
cmia ,elisa:2
cmia ,iggiga:2
cmia ,assays:2
igg ,iggiga:2
euroimmun ,iggiga:2
euroimmun ,assays:2
elisa ,iggiga:2
elisa ,assays:2
iggiga ,assays:2
obesitya ,risk:2
obesitya ,factor:2
obesitya ,increased:2
obesitya ,covid19:2
obesitya ,prevalence:2
obesitya ,severity:2
obesitya ,lethality:2
risk ,covid19:2
risk ,lethality:2
factor ,increased:2
factor ,covid19:2
factor ,prevalence:2
factor ,severity:4
factor ,lethality:2
increased ,covid19:2
increased ,prevalence:2
increased ,severity:4
increased ,lethality:2
covid19 ,prevalence:2
covid19 ,severity:2
covid19 ,lethality:2
prevalence ,lethality:2
severity ,lethality:2
hot ,spot:2
hot ,profiles:2
hot ,human:2
hot ,ace2:2
hot ,receptor:2
hot ,protein:2
hot ,interaction:2
spot ,profiles:2
spot ,sars-cov-2:2
spot ,human:2
spot ,ace2:2
spot ,receptor:2
spot ,protein:2
spot ,interaction:2
profiles ,human:2
profiles ,receptor:2
profiles ,interaction:2
receptor ,interaction:6
testing ,cancer:2
testing ,treated:2
testing ,hospital:2
cancer ,treated:2
treated ,tertiary:2
treated ,care:2
treated ,hospital:2
assessing ,impact:6
assessing ,management:2
assessing ,liver:2
assessing ,diseases:2
pathogenesis ,perspective:2
pathogenesis ,damage-response:2
pathogenesis ,framework:2
covid-19 ,damage-response:2
perspective ,damage-response:2
perspective ,framework:2
damage-response ,framework:2
innovative ,way:2
innovative ,achieve:2
innovative ,safe:2
innovative ,lung:2
innovative ,deflation:2
innovative ,one-lung:2
innovative ,ventilation:2
way ,achieve:2
way ,safe:2
way ,lung:2
way ,deflation:2
way ,one-lung:2
way ,ventilation:2
achieve ,safe:2
achieve ,lung:2
achieve ,deflation:2
achieve ,one-lung:2
achieve ,ventilation:2
safe ,lung:2
safe ,deflation:2
safe ,one-lung:2
safe ,ventilation:2
lung ,deflation:2
lung ,one-lung:2
lung ,ventilation:2
deflation ,one-lung:2
deflation ,ventilation:2
one-lung ,ventilation:2
clinical ,bowel:4
trials ,inflammatory:2
trials ,bowel:2
trials ,global:2
trials ,guidance:2
inflammatory ,global:2
bowel ,global:2
global ,guidance:2
lysine ,164:2
lysine ,critical:2
lysine ,sars-cov-2:2
lysine ,nsp1:2
lysine ,inhibition:2
lysine ,host:2
lysine ,gene:2
lysine ,expression:2
164 ,critical:2
164 ,sars-cov-2:2
164 ,nsp1:2
164 ,inhibition:2
164 ,host:2
164 ,gene:2
164 ,expression:2
critical ,nsp1:2
critical ,inhibition:2
critical ,host:2
critical ,gene:2
critical ,expression:2
nsp1 ,inhibition:2
nsp1 ,host:4
nsp1 ,gene:2
nsp1 ,expression:2
inhibition ,host:2
inhibition ,gene:2
inhibition ,expression:2
host ,gene:2
clinical ,71:4
characteristics ,71:4
71 ,patients:4
71 ,coronavirus:2
71 ,disease:2
optimization ,rules:2
optimization ,mpro:2
optimization ,antivirals:2
optimization ,ensemble:2
optimization ,docking:2
rules ,sars-cov-2:2
rules ,mpro:2
rules ,antivirals:2
rules ,ensemble:2
rules ,docking:2
sars-cov-2 ,ensemble:2
sars-cov-2 ,docking:4
mpro ,antivirals:2
mpro ,ensemble:2
mpro ,docking:2
antivirals ,ensemble:2
antivirals ,docking:2
ensemble ,docking:2
remdesivir ,management:2
remdesivir ,systematic:2
remdesivir ,current:2
management ,systematic:2
covid-19 ,toxicities:2
therapeutics ,toxicities:2
spontaneous ,retroperitoneal:2
spontaneous ,bleed:2
spontaneous ,coincided:2
spontaneous ,massive:2
spontaneous ,acute:2
spontaneous ,deep:2
spontaneous ,vein:2
spontaneous ,thrombosis:2
retroperitoneal ,bleed:2
retroperitoneal ,coincided:2
retroperitoneal ,massive:2
retroperitoneal ,acute:2
retroperitoneal ,deep:2
retroperitoneal ,vein:2
retroperitoneal ,thrombosis:2
bleed ,coincided:2
bleed ,massive:2
bleed ,acute:2
bleed ,deep:2
bleed ,vein:2
bleed ,thrombosis:2
coincided ,massive:2
coincided ,acute:2
coincided ,deep:2
coincided ,vein:2
coincided ,thrombosis:2
massive ,acute:4
massive ,deep:2
massive ,vein:2
massive ,thrombosis:2
acute ,vein:2
patient ,presented:2
patient ,86:2
patient ,later:2
asymptomatic ,presented:2
asymptomatic ,86:2
asymptomatic ,days:2
asymptomatic ,later:2
sars-cov-2 ,86:2
sars-cov-2 ,later:2
infection ,presented:2
infection ,86:2
infection ,days:2
infection ,later:2
presented ,86:2
presented ,days:2
presented ,later:2
86 ,days:2
86 ,later:2
days ,later:2
quantum ,dot-conjugated:2
quantum ,sars-cov-2:2
quantum ,spike:2
quantum ,pseudo-virions:2
quantum ,enable:2
quantum ,tracking:2
dot-conjugated ,sars-cov-2:2
dot-conjugated ,spike:2
dot-conjugated ,pseudo-virions:2
dot-conjugated ,enable:2
dot-conjugated ,tracking:2
sars-cov-2 ,pseudo-virions:2
sars-cov-2 ,enable:2
spike ,pseudo-virions:2
spike ,enable:2
pseudo-virions ,enable:2
pseudo-virions ,tracking:2
enable ,tracking:2
infection ,bat:2
bat ,intestinal:2
bat ,organoids:2
human ,organoids:2
intestinal ,organoids:2
prevalence ,comorbidities:4
prevalence ,effects:2
prevalence ,infected:2
comorbidities ,effects:2
comorbidities ,infected:2
comorbidities ,sars-cov-2:2
effects ,infected:2
laboratory ,preparedness:4
laboratory ,india:2
laboratory ,harnessing:2
laboratory ,network:2
preparedness ,testing:2
preparedness ,india:2
preparedness ,harnessing:2
preparedness ,network:2
sars-cov-2 ,harnessing:2
testing ,india:2
testing ,harnessing:2
testing ,network:2
india ,harnessing:2
india ,network:2
harnessing ,network:2
obesity ,sides:2
obesity ,coin:2
novel ,pressure:2
novel ,device:2
novel ,transmissible:2
negative ,pressure:2
negative ,isolation:2
negative ,device:2
negative ,aerosol:2
negative ,transmissible:2
pressure ,isolation:2
pressure ,device:2
pressure ,aerosol:2
pressure ,transmissible:2
pressure ,covid-19:2
isolation ,device:2
isolation ,transmissible:2
device ,aerosol:2
device ,transmissible:2
aerosol ,transmissible:2
transmissible ,covid-19:2
tracheostomy ,sars-cov-2:2
tracheostomy ,recommendations:2
tracheostomy ,new:2
tracheostomy ,york:2
tracheostomy ,head:2
recommendations ,york:2
new ,head:2
york ,head:2
characteristics ,immune:4
characteristics ,mechanisms:2
immune ,injury:2
immune ,71:2
injury ,71:2
mechanisms ,71:2
71 ,covid-19:2
alterations ,microbiota:2
gut ,patients:2
gut ,time:2
microbiota ,patients:2
microbiota ,covid-19:4
microbiota ,time:2
disease ,chinese:2
disease ,data:2
among ,series:2
pregnant ,chinese:2
pregnant ,series:2
pregnant ,data:2
chinese ,women:2
chinese ,case:2
chinese ,series:2
chinese ,data:2
women ,case:2
women ,series:2
women ,data:2
series ,data:2
hyperpyrexia ,patients:2
hyperpyrexia ,covid-19:2
comprehensive ,investigation:4
comprehensive ,mrna:2
comprehensive ,protein:2
comprehensive ,level:2
comprehensive ,ace2:2
comprehensive ,putative:2
investigation ,mrna:2
investigation ,protein:2
investigation ,level:2
investigation ,putative:2
mrna ,protein:2
mrna ,level:2
mrna ,ace2:2
mrna ,putative:2
protein ,level:2
level ,putative:2
ace2 ,putative:2
prospects ,use:2
prospects ,regulators:2
prospects ,oxidative:2
prospects ,stress:2
prospects ,comprehensive:2
use ,regulators:2
use ,oxidative:2
use ,stress:2
use ,comprehensive:2
regulators ,oxidative:2
regulators ,stress:2
regulators ,comprehensive:2
oxidative ,comprehensive:2
stress ,comprehensive:2
anti-sars-cov-2 ,activities:2
anti-sars-cov-2 ,shuanghuanglian:2
anti-sars-cov-2 ,preparations:2
anti-sars-cov-2 ,bioactive:2
activities ,vitro:2
activities ,shuanghuanglian:2
activities ,preparations:2
activities ,bioactive:2
vitro ,shuanghuanglian:2
vitro ,preparations:2
vitro ,bioactive:2
shuanghuanglian ,preparations:2
shuanghuanglian ,bioactive:2
preparations ,bioactive:2
comparison ,transgenic:2
comparison ,adenovirus:2
comparison ,hace2:2
comparison ,mouse:2
comparison ,models:4
transgenic ,adenovirus:2
transgenic ,mouse:2
transgenic ,infection:4
adenovirus ,hace2:2
adenovirus ,mouse:2
adenovirus ,models:2
adenovirus ,sars-cov-2:2
adenovirus ,infection:2
hace2 ,mouse:2
hace2 ,models:2
mouse ,infection:4
prospective ,detailed:2
prospective ,neurological:2
prospective ,manifestations:2
prospective ,patients:6
clinical ,detailed:2
study ,detailed:2
study ,neurological:4
study ,manifestations:2
detailed ,neurological:2
detailed ,manifestations:2
detailed ,patients:2
pit ,latrines:2
pit ,may:2
pit ,potential:2
pit ,risk:2
pit ,rural:2
pit ,china:2
pit ,low-income:2
pit ,countries:2
latrines ,may:2
latrines ,potential:2
latrines ,risk:2
latrines ,rural:2
latrines ,china:2
latrines ,low-income:2
latrines ,countries:2
may ,rural:2
may ,china:2
may ,low-income:2
may ,countries:2
potential ,rural:2
potential ,low-income:2
potential ,countries:2
risk ,rural:4
risk ,low-income:2
rural ,china:2
rural ,low-income:2
rural ,countries:2
china ,low-income:2
china ,countries:2
low-income ,countries:2
cardiovascular ,narrative:4
system ,narrative:4
co-diagnoses ,acute:2
co-diagnoses ,myeloid:2
co-diagnoses ,leukaemia:2
co-diagnoses ,covid-19:2
co-diagnoses ,presentation:2
co-diagnoses ,management:2
acute ,myeloid:2
acute ,leukaemia:2
myeloid ,leukaemia:2
myeloid ,covid-19:2
myeloid ,presentation:2
myeloid ,management:2
leukaemia ,covid-19:2
leukaemia ,presentation:2
leukaemia ,management:2
massive ,application:2
massive ,diagnostic:2
massive ,test:2
massive ,simulation:2
massive ,effect:2
application ,test:2
application ,simulation:2
sars-cov-2 ,simulation:2
diagnostic ,simulation:2
diagnostic ,effect:2
test ,simulation:2
test ,effect:2
simulation ,effect:2
national ,registry:2
national ,inflammatory:2
national ,rheumatic:2
national ,diseases:2
national ,ird:2
national ,infected:2
registry ,patients:2
registry ,inflammatory:2
registry ,rheumatic:2
registry ,diseases:2
registry ,ird:2
registry ,infected:2
patients ,ird:2
inflammatory ,rheumatic:2
inflammatory ,ird:2
inflammatory ,infected:2
rheumatic ,ird:2
rheumatic ,infected:2
diseases ,ird:2
diseases ,infected:2
ird ,infected:2
differences ,terms:2
differences ,presentation:2
differences ,outcomes:2
differences ,lung:2
differences ,cancer:2
terms ,presentation:2
terms ,outcomes:2
terms ,patients:2
terms ,lung:2
terms ,cancer:2
presentation ,lung:2
presentation ,cancer:2
outcomes ,lung:4
outcomes ,cancer:6
ethical ,conflicts:2
ethical ,times:2
conflicts ,covid-19:2
conflicts ,times:2
covid-19-related ,aortic:2
covid-19-related ,thrombosis:2
covid-19-related ,areport:2
covid-19-related ,four:2
covid-19-related ,cases:2
aortic ,areport:2
aortic ,four:2
thrombosis ,areport:2
thrombosis ,four:2
areport ,four:2
areport ,cases:2
vitamin ,increase:2
deficiency ,increase:2
deficiency ,severity:2
in-silico ,design:2
in-silico ,potential:2
in-silico ,protein:2
design ,inhibitor:2
dysregulation ,aktmtorhif-1:2
dysregulation ,signaling:2
dysregulation ,identified:2
dysregulation ,proteo-transcriptomics:2
aktmtorhif-1 ,signaling:2
aktmtorhif-1 ,identified:2
aktmtorhif-1 ,proteo-transcriptomics:2
signaling ,identified:2
signaling ,proteo-transcriptomics:2
identified ,proteo-transcriptomics:2
impact ,micrornas:2
impact ,mirnas:2
impact ,genotype:2
micrornas ,mirnas:2
micrornas ,genotype:2
micrornas ,coronaviruses:2
mirnas ,genotype:2
mirnas ,coronaviruses:2
genotype ,coronaviruses:2
repurposing ,prediction:2
repurposing ,commercially:2
repurposing ,available:2
therapeutics ,prediction:2
therapeutics ,commercially:2
therapeutics ,available:2
covid-19 ,commercially:2
rapid ,prediction:2
rapid ,commercially:2
rapid ,available:2
prediction ,commercially:2
prediction ,available:2
covid-19 ,vv-ecmo:2
respiratory ,targeting:4
respiratory ,inflammation:2
respiratory ,vv-ecmo:2
failure ,targeting:2
failure ,inflammation:6
failure ,vv-ecmo:2
failure ,support:2
targeting ,vv-ecmo:2
targeting ,support:2
inflammation ,vv-ecmo:2
inflammation ,support:2
vv-ecmo ,support:2
pathological ,features:2
pathological ,infection:2
pathological ,biopsy:2
pathological ,autopsy:2
pathological ,series:2
features ,biopsy:2
features ,autopsy:2
features ,series:2
covid-19 ,biopsy:4
infection ,biopsy:2
biopsy ,autopsy:2
autopsy ,series:2
harnessing ,adenosine:2
harnessing ,a2a:2
harnessing ,receptors:2
harnessing ,strategy:2
harnessing ,suppressing:2
harnessing ,lung:2
adenosine ,a2a:2
adenosine ,receptors:2
adenosine ,strategy:2
adenosine ,suppressing:2
adenosine ,lung:2
a2a ,receptors:2
a2a ,strategy:2
a2a ,suppressing:2
a2a ,lung:2
receptors ,strategy:2
receptors ,suppressing:2
receptors ,lung:2
strategy ,suppressing:2
strategy ,lung:2
suppressing ,lung:2
clinical ,focus:2
radiological ,pediatric:2
radiological ,patients:2
radiological ,focus:2
characteristics ,focus:2
pediatric ,focus:2
patients ,focus:4
pregnant ,pandemic:2
women ,pandemic:2
multiple ,early:2
multiple ,global:2
multiple ,travel:2
multiple ,hub:2
multiple ,middle:2
early ,global:2
early ,travel:2
early ,middle:2
introductions ,global:2
introductions ,travel:2
introductions ,hub:2
introductions ,middle:2
sars-cov-2 ,hub:2
sars-cov-2 ,middle:2
global ,hub:2
global ,middle:2
travel ,hub:2
travel ,middle:2
hub ,middle:2
inhibitory ,activities:2
inhibitory ,marine:2
inhibitory ,sulfated:2
inhibitory ,polysaccharides:2
activities ,marine:2
activities ,sulfated:2
activities ,polysaccharides:2
marine ,sulfated:2
marine ,polysaccharides:2
marine ,sars-cov-2:4
sulfated ,polysaccharides:2
sulfated ,sars-cov-2:2
polysaccharides ,sars-cov-2:2
development ,pseudovirus:2
development ,entry:2
development ,identify:2
development ,viral:2
cell-based ,pseudovirus:2
cell-based ,entry:2
cell-based ,assay:2
cell-based ,identify:2
cell-based ,potential:2
cell-based ,viral:2
pseudovirus ,entry:2
pseudovirus ,identify:2
pseudovirus ,potential:2
pseudovirus ,viral:2
entry ,assay:2
entry ,identify:2
assay ,identify:2
assay ,potential:2
assay ,viral:2
identify ,potential:2
identify ,viral:2
early ,phylogenetic:2
early ,estimate:2
early ,effective:2
early ,reproduction:2
early ,number:2
phylogenetic ,estimate:2
phylogenetic ,effective:2
phylogenetic ,reproduction:2
phylogenetic ,number:2
estimate ,effective:2
estimate ,reproduction:2
estimate ,number:2
estimate ,sars-cov-2:2
anal ,covid-19:2
swab ,findings:2
swab ,infant:2
findings ,infant:2
targeting ,proteases:2
targeting ,treating:2
proteases ,treating:2
early ,antibodies:6
evidence ,syndrome-coronavirus:2
evidence ,semen:2
evidence ,males:2
severe ,semen:2
severe ,males:2
acute ,males:2
respiratory ,semen:2
respiratory ,males:2
syndrome-coronavirus ,semen:2
syndrome-coronavirus ,males:2
semen ,males:2
sars-cov-2 ,brazil:4
sars-cov-2 ,successive:2
antibody ,brazil:2
antibody ,successive:2
antibody ,nationwide:2
prevalence ,brazil:2
prevalence ,successive:2
brazil ,results:2
brazil ,two:2
brazil ,successive:2
brazil ,nationwide:2
results ,successive:2
results ,nationwide:2
two ,successive:2
two ,nationwide:2
successive ,nationwide:2
inhaled ,steroid:2
inhaled ,ciclesonide:2
inhaled ,blocks:2
inhaled ,sars-cov-2:2
inhaled ,rna:2
inhaled ,replication:2
inhaled ,targeting:2
steroid ,ciclesonide:2
steroid ,blocks:2
steroid ,rna:2
steroid ,replication:2
steroid ,targeting:2
ciclesonide ,blocks:2
ciclesonide ,sars-cov-2:2
ciclesonide ,rna:2
ciclesonide ,replication:2
ciclesonide ,targeting:2
blocks ,rna:2
blocks ,replication:2
blocks ,targeting:2
replication ,targeting:2
ethical ,regarding:2
ethical ,heart:2
ethical ,lung:2
ethical ,transplantation:2
ethical ,mechanical:2
considerations ,regarding:2
considerations ,heart:2
considerations ,transplantation:2
considerations ,mechanical:2
regarding ,heart:2
regarding ,lung:2
regarding ,transplantation:2
regarding ,mechanical:2
heart ,lung:6
heart ,mechanical:2
lung ,mechanical:2
transplantation ,mechanical:2
acute ,type:2
acute ,aortic:2
acute ,dissection:2
type ,complicated:2
aortic ,complicated:4
aortic ,infection:2
dissection ,complicated:2
dissection ,covid-19:2
dissection ,infection:2
complicated ,infection:2
longer ,incubation:2
longer ,sars:2
longer ,mers:2
incubation ,sars:2
incubation ,mers:2
period ,sars:2
period ,mers:2
acute ,olfactory:2
acute ,dysfunction-a:2
acute ,primary:2
olfactory ,dysfunction-a:2
olfactory ,primary:2
olfactory ,presentation:2
dysfunction-a ,primary:2
dysfunction-a ,presentation:2
dysfunction-a ,covid-19:2
dysfunction-a ,infection:2
primary ,presentation:2
primary ,infection:4
presentation ,infection:6
italian ,paediatric:2
italian ,raccomandations:2
paediatric ,society:2
paediatric ,raccomandations:2
paediatric ,children:2
paediatric ,adolescents:2
society ,raccomandations:2
society ,adolescents:2
raccomandations ,children:2
raccomandations ,adolescents:2
clinical ,artesunate:2
study ,artesunate:2
artesunate ,coronavirus:2
artesunate ,disease:2
liver ,histopathology:2
liver ,covid:2
liver ,19:2
liver ,suggestive:2
histopathology ,severe:2
histopathology ,covid:2
histopathology ,19:2
histopathology ,respiratory:2
histopathology ,failure:2
histopathology ,suggestive:2
severe ,covid:2
severe ,19:2
severe ,suggestive:2
covid ,respiratory:2
covid ,suggestive:2
19 ,respiratory:2
19 ,suggestive:2
respiratory ,suggestive:2
failure ,suggestive:2
laboratory ,test:2
laboratory ,non:2
laboratory ,interstitial:2
test ,alterations:2
test ,non:2
test ,interstitial:2
alterations ,non:2
alterations ,interstitial:2
patients ,non:2
patients ,interstitial:2
covid-19 ,non:4
covid-19 ,interstitial:2
non ,interstitial:2
clinical ,microbiological:4
microbiological ,features:2
microbiological ,asymptomatic:2
microbiological ,infection:2
microbiological ,mild:2
universal ,term:2
universal ,east:2
screening ,term:2
screening ,east:2
pregnant ,term:2
pregnant ,east:2
women ,term:2
women ,east:2
term ,admitted:2
term ,east:2
admitted ,east:2
harnessing ,potential:2
harnessing ,crispr-based:2
harnessing ,platforms:2
harnessing ,advance:2
harnessing ,field:2
harnessing ,hospital:2
potential ,crispr-based:2
potential ,platforms:2
potential ,advance:2
potential ,field:2
potential ,hospital:2
crispr-based ,platforms:2
crispr-based ,advance:2
crispr-based ,field:2
crispr-based ,hospital:2
platforms ,advance:2
platforms ,field:2
platforms ,hospital:2
advance ,field:2
advance ,hospital:2
field ,hospital:2
detection ,maldi-ms:2
sars-cov-2 ,maldi-ms:2
nasal ,using:2
nasal ,maldi-ms:2
swabs ,maldi-ms:2
using ,maldi-ms:2
cancer ,higher:2
cancer ,regarding:2
cancer ,vice:2
cancer ,versa:2
patients ,regarding:2
patients ,vice:2
patients ,versa:2
higher ,regarding:2
higher ,vice:2
higher ,versa:2
risk ,vice:2
risk ,versa:2
regarding ,vice:2
regarding ,versa:2
covid-19 ,vice:2
covid-19 ,versa:2
vice ,versa:2
heart ,multimodality:2
heart ,imagingincovid-19:2
lung ,multimodality:2
lung ,imagingincovid-19:2
multimodality ,imagingincovid-19:2
intravenous ,collected:2
intravenous ,recovered:2
intravenous ,coronavirus:4
intravenous ,patients:2
immunoglobulin ,collected:2
immunoglobulin ,recovered:2
immunoglobulin ,coronavirus:4
immunoglobulin ,patients:2
collected ,recovered:2
collected ,coronavirus:2
collected ,patients:2
coronavirus ,inform:2
coronavirus ,transmission-reducing:2
disease ,model:2
disease ,inform:2
disease ,transmission-reducing:2
model ,inform:2
model ,transmission-reducing:2
model ,measures:2
model ,system:2
inform ,transmission-reducing:2
inform ,measures:2
inform ,health:2
inform ,system:2
transmission-reducing ,measures:2
transmission-reducing ,health:2
transmission-reducing ,system:2
measures ,system:2
conjunctivitis ,sole:2
conjunctivitis ,symptom:2
conjunctivitis ,case:2
conjunctivitis ,report:2
conjunctivitis ,review:2
conjunctivitis ,literature:2
sole ,symptom:2
sole ,case:2
sole ,report:2
sole ,review:2
sole ,literature:2
symptom ,report:2
symptom ,review:4
symptom ,literature:2
health-care ,three:2
health-care ,hospitals:2
health-care ,south:2
health-care ,netherlands:2
workers ,three:2
workers ,south:2
workers ,netherlands:2
three ,hospitals:2
three ,south:2
three ,netherlands:2
hospitals ,south:2
hospitals ,netherlands:2
south ,netherlands:2
susceptibility ,livestock:2
susceptibility ,companion:2
susceptibility ,animals:6
livestock ,covid-19:2
estimating ,unobserved:2
estimating ,sars-cov-2:4
estimating ,infections:2
estimating ,united:2
estimating ,states:2
unobserved ,sars-cov-2:2
unobserved ,infections:2
unobserved ,united:2
unobserved ,states:2
sars-cov-2 ,states:4
infections ,united:2
infections ,states:2
favipiravir ,treating:2
favipiravir ,novel:2
favipiravir ,protocol:2
treating ,protocol:2
novel ,protocol:2
coronavirus ,protocol:2
high-resolution ,computed:2
high-resolution ,tomography:2
high-resolution ,features:2
high-resolution ,17:2
high-resolution ,cases:2
high-resolution ,coronavirus:2
high-resolution ,disease:2
computed ,17:2
computed ,cases:2
tomography ,17:2
tomography ,cases:2
features ,17:2
17 ,coronavirus:2
17 ,disease:2
pediatric ,family-centered:2
pediatric ,at-home:2
pediatric ,otologic:2
pediatric ,physical:2
pediatric ,examination:2
family-centered ,at-home:2
family-centered ,otologic:2
family-centered ,physical:2
family-centered ,examination:2
family-centered ,covid-19:2
at-home ,otologic:2
at-home ,physical:2
at-home ,examination:2
otologic ,physical:2
otologic ,examination:2
otologic ,covid-19:2
physical ,examination:4
active ,monitoring:4
active ,persons:2
active ,exposed:2
active ,confirmed:2
active ,united:2
monitoring ,persons:2
monitoring ,exposed:2
monitoring ,confirmed:2
monitoring ,united:2
persons ,exposed:2
persons ,confirmed:2
exposed ,patients:2
exposed ,confirmed:2
exposed ,united:2
patients ,united:2
confirmed ,united:2
spatio-temporal ,mutational:2
spatio-temporal ,profile:2
spatio-temporal ,appearances:2
spatio-temporal ,swedish:2
spatio-temporal ,sars-cov-2:2
mutational ,profile:2
mutational ,appearances:2
mutational ,swedish:2
profile ,appearances:2
profile ,swedish:2
appearances ,swedish:2
appearances ,sars-cov-2:2
swedish ,sars-cov-2:2
novel ,biosensor:4
novel ,platforms:2
biosensor ,platforms:2
biosensor ,coronavirus:2
biosensor ,infection:2
biosensor ,severe:4
platforms ,coronavirus:2
platforms ,infection:2
platforms ,severe:2
covid-2019-associated ,overexpressed:2
covid-2019-associated ,prevotella:2
covid-2019-associated ,proteins:2
covid-2019-associated ,mediated:2
covid-2019-associated ,host-pathogen:2
overexpressed ,prevotella:2
overexpressed ,proteins:2
overexpressed ,mediated:2
overexpressed ,host-pathogen:2
prevotella ,proteins:2
prevotella ,mediated:2
prevotella ,host-pathogen:2
proteins ,mediated:2
proteins ,host-pathogen:2
mediated ,host-pathogen:2
covid ,neonates:2
obesity ,mechanisms:4
obesity ,implications:2
risk ,possible:2
risk ,mechanisms:2
factor ,possible:2
factor ,mechanisms:2
factor ,implications:2
mechanisms ,implications:2
endoscopic ,protocol:2
endoscopic ,frontlines:2
endoscopic ,transnasal:2
skull ,protocol:2
skull ,frontlines:2
skull ,transnasal:2
base ,protocol:2
base ,frontlines:2
base ,transnasal:2
surgery ,frontlines:2
surgery ,transnasal:2
protocol ,frontlines:2
protocol ,transnasal:2
frontlines ,transnasal:2
adverse ,skin:2
adverse ,reactions:2
adverse ,health:2
adverse ,care:2
adverse ,workers:2
adverse ,using:2
adverse ,personal:2
adverse ,protective:2
skin ,reactions:2
skin ,health:2
skin ,care:2
skin ,workers:2
skin ,using:2
skin ,personal:2
skin ,protective:2
reactions ,health:2
reactions ,care:2
reactions ,workers:2
reactions ,using:2
reactions ,personal:2
reactions ,protective:2
health ,using:2
health ,personal:2
care ,using:2
care ,personal:2
care ,protective:2
workers ,using:4
using ,personal:2
using ,protective:2
reinfection ,pakistan:2
reinfection ,first:2
pakistan ,first:2
pakistan ,case:2
pakistan ,report:2
outbreak ,estimating:2
diamond ,estimating:2
diamond ,epidemic:2
princess ,estimating:2
princess ,epidemic:2
cruise ,estimating:2
cruise ,epidemic:2
ship ,estimating:2
ship ,epidemic:2
estimating ,epidemic:2
loop ,mediated:2
loop ,isothermal:2
loop ,amplification:2
loop ,lamp:2
loop ,assays:2
loop ,rapid:2
loop ,diagnostic:2
mediated ,isothermal:2
mediated ,amplification:2
mediated ,lamp:2
mediated ,assays:2
mediated ,rapid:2
mediated ,diagnostic:2
isothermal ,lamp:2
isothermal ,diagnostic:2
amplification ,lamp:2
amplification ,diagnostic:2
lamp ,assays:2
lamp ,rapid:2
lamp ,diagnostic:2
otolaryngology ,time:2
otolaryngology ,corona:2
otolaryngology ,assessing:2
otolaryngology ,operative:2
otolaryngology ,impact:4
otolaryngology ,risk:2
time ,assessing:2
time ,operative:2
time ,impact:2
corona ,assessing:2
corona ,operative:2
corona ,impact:2
assessing ,operative:2
assessing ,risk:2
operative ,impact:2
operative ,risk:2
sars-cov-2 ,navy:2
infections ,responses:2
infections ,sample:2
infections ,us:2
infections ,navy:2
infections ,service:2
serologic ,sample:2
serologic ,us:2
serologic ,navy:2
serologic ,service:2
responses ,sample:2
responses ,us:2
responses ,navy:2
responses ,service:2
sample ,us:2
sample ,navy:2
sample ,service:2
us ,navy:2
us ,service:2
navy ,service:2
novel ,one-step:2
novel ,single-tube:4
novel ,nested:4
novel ,highly:6
one-step ,single-tube:2
one-step ,nested:2
one-step ,real-time:2
one-step ,pcr:2
one-step ,highly:2
single-tube ,nested:4
single-tube ,quantitative:2
single-tube ,real-time:2
single-tube ,pcr:2
single-tube ,assay:4
single-tube ,highly:4
nested ,quantitative:2
nested ,real-time:2
nested ,pcr:2
nested ,assay:2
nested ,highly:4
quantitative ,highly:2
real-time ,highly:2
pcr ,highly:2
assay ,highly:2
covid-19 ,repercussions:2
covid-19 ,plastics:2
pandemic ,repercussions:2
pandemic ,plastics:2
repercussions ,use:2
repercussions ,management:2
repercussions ,plastics:2
use ,plastics:2
management ,plastics:2
care ,laryngectomy:2
patients ,laryngectomy:2
laryngectomy ,covid-19:2
laryngectomy ,pandemic:2
exploring ,human-animal:2
exploring ,host:2
exploring ,emergence:2
exploring ,evolutionary:2
human-animal ,host:2
human-animal ,interactions:2
human-animal ,emergence:2
human-animal ,covid-19:2
human-animal ,evolutionary:2
host ,emergence:2
interactions ,emergence:2
interactions ,evolutionary:2
emergence ,evolutionary:2
emergence ,recombination:2
emergence ,strong:2
emergence ,purifying:2
emergence ,selection:2
sars-cov-2 ,recombination:2
sars-cov-2 ,purifying:2
recombination ,strong:2
recombination ,purifying:2
recombination ,selection:2
strong ,purifying:2
strong ,selection:2
purifying ,selection:2
anesthetic ,concerns:2
anesthetic ,pediatric:2
anesthetic ,era:2
concerns ,pediatric:2
concerns ,patients:2
concerns ,era:2
maintaining ,patient:2
maintaining ,safety:2
maintaining ,data:2
maintaining ,integrity:2
maintaining ,nonalcoholic:2
maintaining ,steatohepatitis:2
patient ,data:2
patient ,integrity:2
patient ,nonalcoholic:2
patient ,steatohepatitis:2
safety ,data:2
safety ,integrity:2
safety ,nonalcoholic:2
safety ,steatohepatitis:2
data ,integrity:2
data ,nonalcoholic:2
data ,steatohepatitis:2
integrity ,nonalcoholic:2
integrity ,steatohepatitis:2
nonalcoholic ,steatohepatitis:2
treatment ,comprehensive:4
treatment ,global:2
options ,comprehensive:2
options ,global:2
factors ,diffusion:2
factors ,suggested:2
factors ,strategy:2
factors ,prevent:2
determining ,diffusion:2
determining ,suggested:2
determining ,strategy:4
determining ,prevent:2
diffusion ,suggested:2
diffusion ,strategy:2
diffusion ,prevent:2
suggested ,strategy:2
suggested ,prevent:2
immunity ,online:2
immunity ,experimental:2
immunity ,study:2
passports ,sars-cov-2:2
passports ,online:2
passports ,experimental:2
passports ,study:2
passports ,impact:2
sars-cov-2 ,online:4
online ,experimental:2
online ,study:2
experimental ,impact:2
study ,impact:2
diagnostic ,serological-based:2
characteristics ,serological-based:2
serological-based ,covid-19:2
serological-based ,testing:2
serological-based ,systematic:2
neutrophil ,nets:2
neutrophil ,damage-associated:2
neutrophil ,molecular:2
neutrophil ,patterns:2
extracellular ,nets:2
extracellular ,damage-associated:2
extracellular ,molecular:2
extracellular ,patterns:2
traps ,nets:2
traps ,damage-associated:2
traps ,molecular:2
traps ,patterns:2
nets ,damage-associated:2
nets ,molecular:2
nets ,patterns:2
damage-associated ,molecular:2
damage-associated ,patterns:2
molecular ,patterns:2
comparison ,deep:2
comparison ,learning:2
comparison ,regression:2
comparison ,creating:2
comparison ,predictive:2
deep ,regression:2
deep ,analysis:2
deep ,creating:2
deep ,predictive:2
learning ,regression:2
learning ,creating:2
learning ,predictive:2
regression ,creating:2
regression ,predictive:2
regression ,models:2
analysis ,creating:2
analysis ,predictive:2
analysis ,models:2
creating ,predictive:2
creating ,models:2
coronavirus ,reassembly:2
disease ,reassembly:2
reassembly ,attack:2
ddpcr ,accurate:2
ddpcr ,tool:2
ddpcr ,sars-cov-2:4
ddpcr ,detection:4
ddpcr ,low:2
ddpcr ,viral:2
ddpcr ,load:2
ddpcr ,specimens:2
accurate ,tool:2
accurate ,detection:6
accurate ,low:2
accurate ,viral:4
accurate ,load:2
accurate ,specimens:2
tool ,low:2
tool ,specimens:2
low ,viral:2
low ,load:2
low ,specimens:4
load ,specimens:2
rapid ,molecular-based:2
point-of-care ,antigen:2
point-of-care ,molecular-based:2
point-of-care ,tests:2
antigen ,molecular-based:2
antigen ,tests:2
antigen ,diagnosis:2
molecular-based ,tests:2
molecular-based ,diagnosis:2
molecular-based ,sars-cov-2:2
effect ,serum:2
effect ,total:2
effect ,testosterone:2
effect ,relationship:2
effect ,laboratory:2
serum ,total:2
serum ,testosterone:2
serum ,relationship:2
serum ,laboratory:2
total ,testosterone:2
total ,relationship:2
total ,laboratory:2
testosterone ,relationship:2
testosterone ,laboratory:2
relationship ,laboratory:2
testing ,day:2
testing ,world:2
testing ,turned:2
testing ,attention:2
sars-cov-2 ,day:2
day ,world:2
day ,turned:2
day ,attention:2
day ,clinical:2
world ,turned:2
world ,attention:2
turned ,attention:2
turned ,clinical:2
attention ,clinical:2
covid-19 ,hispanic:2
hispanic ,woman:2
chest ,early:2
chest ,progressive:2
chest ,phase:2
chest ,us:2
ct ,progressive:2
ct ,phase:2
ct ,us:2
findings ,progressive:2
findings ,phase:2
findings ,us:2
early ,progressive:2
early ,us:2
progressive ,phase:2
progressive ,infection:2
progressive ,us:2
phase ,infection:2
phase ,us:2
structure ,antigenicity:2
function ,antigenicity:2
antigenicity ,sars-cov-2:2
antigenicity ,spike:2
antigenicity ,glycoprotein:2
comparison ,realtime:2
comparison ,transcription:2
commercial ,realtime:2
commercial ,reverse:2
commercial ,transcription:2
realtime ,reverse:2
realtime ,transcription:2
realtime ,pcr:2
realtime ,assays:2
realtime ,detection:2
rapid ,white:2
rapid ,blood:2
rapid ,cell:2
rapid ,scattergrams:2
rapid ,study:2
screening ,white:2
screening ,blood:2
screening ,cell:2
screening ,scattergrams:2
covid-19 ,scattergrams:2
patients ,white:2
patients ,scattergrams:2
using ,white:2
using ,scattergrams:2
using ,study:4
white ,blood:2
white ,cell:2
white ,scattergrams:2
white ,study:2
blood ,scattergrams:2
blood ,study:2
cell ,scattergrams:2
cell ,study:2
scattergrams ,study:2
early ,evaluation:4
early ,enhanced:2
early ,surveillance:2
early ,eave:2
early ,ii:2
early ,protocol:2
pandemic ,enhanced:2
pandemic ,eave:2
pandemic ,ii:2
pandemic ,protocol:2
evaluation ,enhanced:2
evaluation ,surveillance:2
evaluation ,eave:2
evaluation ,ii:2
evaluation ,protocol:2
enhanced ,surveillance:2
enhanced ,covid-19:2
enhanced ,eave:2
enhanced ,ii:2
enhanced ,protocol:2
surveillance ,eave:2
surveillance ,ii:2
surveillance ,protocol:2
covid-19 ,eave:2
eave ,ii:2
eave ,protocol:2
ii ,protocol:2
coronavirus ,gender-related:2
coronavirus ,european:2
coronavirus ,countries:2
disease ,gender-related:2
disease ,european:2
disease ,countries:2
gender-related ,mortality:2
gender-related ,european:2
gender-related ,countries:2
mortality ,european:2
european ,countries:2
matrix ,metallopeptidase:2
matrix ,host:2
matrix ,protein:2
matrix ,target:2
matrix ,chloroquine:2
matrix ,melatonin:2
metallopeptidase ,host:2
metallopeptidase ,protein:2
metallopeptidase ,target:2
metallopeptidase ,chloroquine:2
metallopeptidase ,melatonin:2
host ,target:2
host ,chloroquine:2
host ,melatonin:2
protein ,chloroquine:2
protein ,melatonin:2
target ,chloroquine:2
target ,melatonin:2
chloroquine ,melatonin:2
patients ,deliveries:2
patients ,adapting:2
patients ,suite:2
covid-19 ,cesarean:2
covid-19 ,deliveries:2
covid-19 ,adapting:2
covid-19 ,suite:2
undergoing ,cesarean:2
undergoing ,deliveries:2
undergoing ,adapting:2
undergoing ,suite:2
cesarean ,deliveries:2
cesarean ,adapting:2
cesarean ,suite:2
deliveries ,adapting:2
deliveries ,suite:2
adapting ,suite:2
myocardial ,early:2
myocardial ,stage:2
myocardial ,association:2
myocardial ,risk:2
myocardial ,death:2
injury ,early:2
injury ,stage:2
injury ,association:4
injury ,death:2
early ,association:2
early ,death:2
stage ,association:2
stage ,risk:2
stage ,death:2
association ,death:4
coronavirus ,spectrum:6
spectrum ,infections:2
spectrum ,mers:2
spectrum ,sars:2
spectrum ,cancer:2
spectrum ,patients:2
mers ,cancer:2
mers ,patients:2
sars ,cancer:2
emergency ,essential:2
emergency ,surgical:4
emergency ,healthcare:2
emergency ,services:4
emergency ,low-:2
essential ,surgical:2
essential ,healthcare:4
essential ,services:6
essential ,low-:2
surgical ,healthcare:2
surgical ,low-:2
healthcare ,low-:2
services ,low-:2
covid-19 ,low-:2
surge ,delayed:2
surge ,myocardial:2
surge ,infarction:2
surge ,presentations:2
surge ,inadvertent:2
surge ,consequence:2
delayed ,myocardial:2
delayed ,infarction:2
delayed ,presentations:2
delayed ,inadvertent:2
delayed ,consequence:2
myocardial ,infarction:6
myocardial ,presentations:2
myocardial ,inadvertent:2
myocardial ,consequence:2
infarction ,presentations:2
infarction ,inadvertent:2
infarction ,consequence:2
presentations ,inadvertent:2
presentations ,consequence:2
inadvertent ,consequence:2
sars-cov-2 ,really:2
sars-cov-2 ,partners:2
sars-cov-2 ,crime:2
cancer ,really:2
cancer ,partners:2
cancer ,crime:2
really ,partners:2
really ,crime:2
partners ,crime:2
confinement ,staff:2
confinement ,residents:2
confinement ,nursing:2
confinement ,homes:2
confinement ,solution:2
staff ,nursing:2
staff ,solution:2
residents ,nursing:2
residents ,homes:2
residents ,solution:2
nursing ,solution:2
homes ,solution:2
controlled ,study:2
controlled ,vaccines:2
infection ,vaccines:2
study ,vaccines:2
challenge ,oral:2
challenge ,healthcare:2
oral ,healthcare:2
hepatic ,consequences:2
hepatic ,lapping:2
hepatic ,biting:2
consequences ,lapping:2
consequences ,biting:2
covid-19 ,lapping:2
covid-19 ,biting:2
infection ,lapping:2
infection ,biting:2
lapping ,biting:2
discovery ,fda-approved:2
discovery ,drugs:4
discovery ,bexarotene:2
discovery ,cetilistat:2
discovery ,diiodohydroxyquinoline:2
fda-approved ,drugs:6
fda-approved ,bexarotene:2
fda-approved ,cetilistat:2
fda-approved ,diiodohydroxyquinoline:2
drugs ,bexarotene:2
drugs ,cetilistat:2
drugs ,diiodohydroxyquinoline:2
bexarotene ,cetilistat:2
bexarotene ,diiodohydroxyquinoline:2
cetilistat ,diiodohydroxyquinoline:2
review ,ibd:2
article ,prevention:2
article ,ibd:2
article ,patient:2
prevention ,ibd:2
prevention ,patient:2
diagnosis ,ibd:2
management ,ibd:2
sars-cov-2 ,proteome:2
proteome ,microarray:2
proteome ,global:2
proteome ,profiling:2
proteome ,covid-19:2
proteome ,specific:2
proteome ,igg:2
proteome ,igm:2
microarray ,global:2
microarray ,profiling:2
microarray ,specific:2
microarray ,igg:2
microarray ,igm:2
global ,profiling:2
global ,specific:2
global ,igg:2
global ,igm:2
profiling ,igg:2
profiling ,igm:2
dry ,heat:2
dry ,microwave-generated:2
dry ,steam:2
dry ,protocols:2
dry ,rapid:2
dry ,decontamination:2
heat ,microwave-generated:2
heat ,steam:2
heat ,rapid:2
heat ,decontamination:2
microwave-generated ,protocols:2
microwave-generated ,rapid:2
steam ,protocols:2
steam ,rapid:2
protocols ,rapid:2
protocols ,decontamination:2
rapid ,decontamination:2
older ,coronavirus:4
older ,disease:2
alimentary ,system:2
alimentary ,directly:2
alimentary ,attacked:2
alimentary ,sars-cov-2:2
alimentary ,prevents:2
alimentary ,immune:2
system ,attacked:2
system ,prevents:2
directly ,attacked:2
directly ,prevents:2
directly ,immune:2
attacked ,sars-cov-2:2
attacked ,prevents:2
attacked ,immune:2
prevents ,immune:2
personal ,evidence-based:2
personal ,advice:2
personal ,surgical:2
personal ,departments:2
protective ,evidence-based:2
protective ,advice:2
protective ,departments:2
equipment ,evidence-based:2
equipment ,advice:2
equipment ,surgical:2
equipment ,departments:2
evidence-based ,advice:2
evidence-based ,surgical:2
evidence-based ,departments:2
advice ,surgical:2
advice ,departments:2
surgical ,departments:4
potential ,3c-like:2
coronavirus ,3c-like:2
coronavirus ,inhibitors:2
3c-like ,development:2
3c-like ,new:2
protease ,development:2
protease ,new:2
inhibitors ,development:2
review ,environmental:2
review ,challenges:8
review ,crisis:2
environmental ,challenges:2
environmental ,pandemic:2
environmental ,crisis:2
challenges ,crisis:2
systems ,approach:2
systems ,assess:2
systems ,transport:2
systems ,diffusion:2
systems ,hazardous:2
systems ,particles:2
approach ,transport:2
approach ,diffusion:2
approach ,hazardous:2
approach ,airborne:2
approach ,particles:2
assess ,transport:2
assess ,diffusion:2
assess ,hazardous:2
assess ,airborne:2
assess ,particles:2
transport ,diffusion:2
transport ,hazardous:2
transport ,airborne:2
transport ,particles:2
diffusion ,hazardous:2
diffusion ,airborne:2
diffusion ,particles:2
hazardous ,airborne:2
hazardous ,particles:2
airborne ,particles:2
clinical ,98:2
features ,98:2
features ,hospitalized:2
outcomes ,98:2
98 ,patients:2
98 ,hospitalized:2
98 ,sars-cov-2:2
98 ,infection:2
vaginal ,sars-cov-2-infected:2
vaginal ,northern:2
vaginal ,italy:2
delivery ,sars-cov-2-infected:2
delivery ,northern:2
delivery ,italy:2
sars-cov-2-infected ,pregnant:2
sars-cov-2-infected ,northern:2
sars-cov-2-infected ,italy:2
pregnant ,northern:2
pregnant ,italy:2
women ,northern:2
women ,italy:2
prevalence ,previously:2
prevalence ,undiagnosed:2
sars-cov-2 ,undiagnosed:2
infection ,previously:2
infection ,undiagnosed:2
previously ,undiagnosed:2
previously ,health:2
previously ,care:2
previously ,workers:2
undiagnosed ,health:2
undiagnosed ,care:2
undiagnosed ,workers:2
detection ,rnascope:2
detection ,hybridization:2
sars-cov-2 ,rnascope:2
sars-cov-2 ,hybridization:2
rnascope ,situ:2
rnascope ,hybridization:2
situ ,hybridization:4
update ,related:2
related ,current:2
development ,expression:2
development ,subunit:2
development ,viruses:2
development ,plants:2
expression ,subunit:2
expression ,vaccines:2
expression ,viruses:2
expression ,plants:2
subunit ,viruses:2
subunit ,plants:2
vaccines ,viruses:2
vaccines ,plants:2
viruses ,plants:2
high-flow ,cannula:4
high-flow ,therapy:2
high-flow ,treat:2
high-flow ,hypoxemic:2
high-flow ,acute:2
nasal ,treat:2
nasal ,hypoxemic:2
nasal ,acute:2
cannula ,treat:2
cannula ,patients:4
cannula ,hypoxemic:2
cannula ,acute:2
oxygen ,treat:2
oxygen ,hypoxemic:2
oxygen ,acute:2
therapy ,hypoxemic:2
treat ,hypoxemic:2
treat ,acute:2
patients ,hypoxemic:2
hypoxemic ,acute:2
exposome ,immunity:2
exposome ,training:2
exposome ,pathogen:2
exposome ,exposure:2
exposome ,order:2
exposome ,influences:2
exposome ,innate:2
exposome ,immune:2
immunity ,training:2
immunity ,pathogen:2
immunity ,exposure:2
immunity ,order:2
immunity ,influences:2
immunity ,immune:2
training ,pathogen:2
training ,exposure:2
training ,order:2
training ,influences:2
training ,innate:2
training ,immune:2
pathogen ,exposure:2
pathogen ,order:2
pathogen ,influences:2
pathogen ,innate:2
pathogen ,immune:2
exposure ,order:2
exposure ,influences:2
exposure ,innate:2
order ,influences:2
order ,innate:2
order ,immune:2
influences ,innate:2
influences ,immune:2
characteristics ,70:2
characteristics ,diarrhea:2
peripheral ,70:2
peripheral ,hospitalized:2
peripheral ,diarrhea:2
blood ,70:2
blood ,hospitalized:2
blood ,diarrhea:2
70 ,hospitalized:2
70 ,patients:2
70 ,diarrhea:2
hospitalized ,diarrhea:2
patients ,diarrhea:2
analysis ,deposition:2
analysis ,placentas:2
complement ,deposition:2
complement ,viral:2
complement ,rna:2
complement ,placentas:2
complement ,patients:4
deposition ,viral:2
deposition ,rna:2
deposition ,placentas:2
deposition ,covid-19:4
deposition ,patients:2
viral ,placentas:2
rna ,placentas:2
placentas ,covid-19:2
placentas ,patients:2
lopinavir ,ritonavir:2
lopinavir ,effective:2
lopinavir ,newly:2
lopinavir ,emerged:2
lopinavir ,coronavirus:2
ritonavir ,effective:2
ritonavir ,newly:2
ritonavir ,emerged:2
ritonavir ,coronavirus:2
effective ,newly:2
effective ,emerged:2
emerged ,coronavirus:2
decay ,sars-cov-2:2
decay ,surrogate:2
decay ,murine:2
decay ,hepatitis:2
decay ,virus:2
decay ,rna:2
decay ,untreated:2
decay ,wastewater:2
sars-cov-2 ,surrogate:2
sars-cov-2 ,murine:2
sars-cov-2 ,hepatitis:2
surrogate ,murine:2
surrogate ,hepatitis:2
surrogate ,virus:2
surrogate ,rna:2
surrogate ,untreated:2
surrogate ,wastewater:2
murine ,hepatitis:2
murine ,rna:2
murine ,untreated:2
murine ,wastewater:2
hepatitis ,virus:2
hepatitis ,rna:2
hepatitis ,untreated:2
hepatitis ,wastewater:2
virus ,untreated:2
rna ,untreated:2
hemorrhagic ,encephalopathy:2
hemorrhagic ,associated:2
hemorrhagic ,covid-19:6
potential ,predictors:4
potential ,poor:2
potential ,prognosis:2
potential ,among:2
predictors ,poor:2
predictors ,prognosis:2
predictors ,among:2
predictors ,critical:2
poor ,among:2
poor ,critical:2
poor ,pneumonia:2
prognosis ,among:2
prognosis ,critical:2
prognosis ,pneumonia:2
among ,critical:2
lung ,pneumonia:8
lung ,correlations:2
lung ,hospital:2
ultrasound ,pneumonia:4
ultrasound ,correlations:2
ultrasound ,ct:2
ultrasound ,hospital:2
pneumonia ,correlations:2
pneumonia ,hospital:2
correlations ,chest:2
correlations ,ct:2
correlations ,hospital:2
chest ,hospital:2
ct ,hospital:2
strategies ,otolaryngology:2
strategies ,head:2
strategies ,neck:2
practice ,head:2
practice ,neck:2
otolaryngology ,head:2
otolaryngology ,neck:2
elevated ,transaminases:2
elevated ,positive:2
elevated ,patient:2
elevated ,term:2
elevated ,gestation:2
elevated ,case:2
transaminases ,covid-19:2
transaminases ,positive:2
transaminases ,patient:2
transaminases ,term:2
transaminases ,gestation:2
transaminases ,case:2
covid-19 ,gestation:2
positive ,term:2
positive ,gestation:2
patient ,term:2
patient ,gestation:2
term ,gestation:2
term ,case:2
gestation ,case:2
evaluation ,truvian:2
evaluation ,easy:2
evaluation ,check:2
evaluation ,device:2
truvian ,easy:2
truvian ,check:2
truvian ,covid-19:2
truvian ,igmigg:2
truvian ,lateral:2
truvian ,flow:2
truvian ,device:2
truvian ,rapid:2
easy ,check:2
easy ,covid-19:2
easy ,igmigg:2
easy ,lateral:2
easy ,flow:2
easy ,device:2
easy ,rapid:2
check ,covid-19:4
check ,igmigg:2
check ,lateral:2
check ,flow:2
check ,device:2
check ,rapid:2
covid-19 ,igmigg:2
igmigg ,lateral:2
igmigg ,flow:2
igmigg ,device:2
igmigg ,rapid:2
lateral ,device:2
flow ,device:2
device ,rapid:2
epitope ,similarity:2
epitope ,explain:2
epitope ,pre-formed:2
epitope ,cell:2
epitope ,immunity:2
epitope ,structural:2
similarity ,explain:2
similarity ,pre-formed:2
similarity ,cell:2
similarity ,immunity:2
similarity ,towards:2
similarity ,structural:2
explain ,pre-formed:2
explain ,cell:2
explain ,immunity:2
explain ,towards:2
explain ,structural:2
pre-formed ,cell:2
pre-formed ,immunity:2
pre-formed ,towards:2
pre-formed ,structural:2
cell ,towards:2
cell ,structural:2
immunity ,towards:2
immunity ,structural:2
towards ,structural:2
comparing ,binding:2
comparing ,interactions:2
comparing ,receptor:2
comparing ,domains:2
binding ,domains:4
interactions ,domains:2
receptor ,domains:4
comprehensive ,tocilizumab:2
comprehensive ,distress:2
review ,tocilizumab:2
tocilizumab ,acute:6
tocilizumab ,respiratory:6
tocilizumab ,distress:4
enclosure ,augmented:2
enclosure ,airflow:2
enclosure ,decrease:2
enclosure ,risk:2
enclosure ,exposure:2
enclosure ,aerosolized:2
augmented ,airflow:2
augmented ,decrease:2
augmented ,risk:2
augmented ,exposure:2
augmented ,aerosolized:2
airflow ,decrease:2
airflow ,risk:2
airflow ,exposure:2
airflow ,aerosolized:2
decrease ,risk:4
decrease ,exposure:2
decrease ,aerosolized:2
risk ,aerosolized:2
exposure ,aerosolized:2
delivery ,asymptomatic:2
delivery ,familial:2
delivery ,cluster:2
infection ,carriers:2
carriers ,covid-19:2
carriers ,familial:2
carriers ,cluster:2
lung ,lus:2
lung ,usefulness:2
lung ,atypical:2
ultrasound ,lus:2
ultrasound ,two:2
ultrasound ,atypical:2
ultrasound ,cases:2
lus ,covid-19:2
lus ,pneumonia:2
lus ,usefulness:2
lus ,two:2
lus ,atypical:2
lus ,cases:2
pneumonia ,usefulness:2
usefulness ,two:2
usefulness ,atypical:2
usefulness ,cases:2
atypical ,cases:2
lung ,risks:2
cancer ,risks:2
cancer ,mechanisms:2
cancer ,interactions:2
risks ,mechanisms:2
risks ,treatment:2
risks ,interactions:2
mechanisms ,interactions:2
treatment ,interactions:2
coronavirus ,new-onset:2
coronavirus ,fibrillation:2
disease ,new-onset:2
disease ,atrial:2
disease ,fibrillation:2
new-onset ,atrial:2
new-onset ,fibrillation:2
new-onset ,two:2
new-onset ,cases:2
atrial ,two:2
atrial ,cases:2
fibrillation ,two:2
fibrillation ,cases:2
role ,imaging:2
role ,experiences:4
role ,central:2
role ,switzerland:2
imaging ,early:2
imaging ,experiences:2
imaging ,central:2
imaging ,switzerland:2
early ,central:2
early ,switzerland:2
experiences ,central:2
experiences ,switzerland:2
central ,switzerland:2
vitro ,invivo:2
vitro ,identification:2
vitro ,clinically:2
vitro ,modify:2
vitro ,ace2:2
invivo ,identification:2
invivo ,clinically:2
invivo ,approved:2
invivo ,drugs:2
invivo ,modify:2
invivo ,ace2:2
identification ,clinically:2
identification ,approved:2
identification ,modify:2
identification ,ace2:2
clinically ,modify:2
clinically ,ace2:4
approved ,modify:2
approved ,ace2:2
drugs ,modify:2
drugs ,ace2:2
modify ,ace2:2
frequency ,duration:2
frequency ,sars-cov-2:4
frequency ,shedding:2
frequency ,oral:2
frequency ,fluid:2
frequency ,samples:2
frequency ,assessed:2
duration ,oral:2
duration ,fluid:2
duration ,samples:2
duration ,assessed:2
sars-cov-2 ,assessed:4
shedding ,oral:4
shedding ,fluid:2
shedding ,assessed:2
oral ,fluid:2
oral ,samples:2
oral ,assessed:2
fluid ,assessed:2
samples ,assessed:2
implications ,high:2
implications ,burden:2
implications ,hivtb:2
implications ,systematic:2
covid-19 ,hivtb:2
high ,countries:2
high ,hivtb:2
high ,systematic:2
high ,review:2
burden ,countries:2
burden ,hivtb:2
burden ,systematic:2
countries ,hivtb:2
countries ,systematic:2
countries ,review:2
hivtb ,systematic:2
hivtb ,review:2
iron ,innocent:2
iron ,bystander:2
iron ,vicious:2
iron ,culprit:2
iron ,pathogenesis:2
innocent ,bystander:2
innocent ,vicious:2
innocent ,culprit:2
innocent ,covid-19:2
innocent ,pathogenesis:2
bystander ,vicious:2
bystander ,pathogenesis:2
vicious ,culprit:2
vicious ,covid-19:2
vicious ,pathogenesis:2
culprit ,pathogenesis:2
type ,multiple:2
type ,sclerosis:2
type ,therapy:2
interferons ,multiple:2
interferons ,sclerosis:2
interferons ,therapy:2
treatment ,sclerosis:2
multiple ,potential:2
sclerosis ,potential:2
evolutionary ,origins:2
evolutionary ,sarbecovirus:2
evolutionary ,lineage:2
evolutionary ,responsible:2
origins ,sarbecovirus:2
origins ,lineage:2
origins ,responsible:2
sars-cov-2 ,sarbecovirus:2
sars-cov-2 ,lineage:2
sarbecovirus ,lineage:2
sarbecovirus ,responsible:2
lineage ,responsible:2
bioinformatics ,analysis:2
bioinformatics ,epitope-based:2
bioinformatics ,vaccine:2
bioinformatics ,novel:2
analysis ,epitope-based:2
analysis ,design:2
homes ,era:2
homes ,use:2
homes ,values:2
homes ,changing:2
era ,values:2
era ,changing:2
use ,values:2
use ,changing:2
values ,changing:2
covid-19 ,familiar:2
new ,familiar:2
new ,receptor:2
virus ,familiar:2
virus ,receptor:2
virus ,release:2
familiar ,receptor:2
familiar ,cytokine:2
familiar ,release:2
familiar ,syndrome:2
receptor ,cytokine:2
receptor ,release:2
receptor ,syndrome:6
prophylactic ,covid-19:2
prophylactic ,relevance:2
prophylactic ,cardiac:2
hydroxychloroquine ,potential:4
hydroxychloroquine ,relevance:2
hydroxychloroquine ,cardiac:2
potential ,cardiac:2
relevance ,cardiac:2
guidance ,anticoagulation:2
guidance ,venous:2
guidance ,thromboembolism:2
anticoagulation ,management:2
anticoagulation ,venous:2
anticoagulation ,thromboembolism:2
management ,venous:2
management ,thromboembolism:2
shell ,suggests:2
shell ,pangolins:2
shell ,offered:2
shell ,window:2
shell ,silent:2
shell ,spread:2
disorder ,suggests:2
disorder ,pangolins:2
disorder ,offered:2
disorder ,window:2
disorder ,silent:2
disorder ,spread:2
analysis ,suggests:2
analysis ,pangolins:2
analysis ,offered:2
analysis ,window:2
analysis ,silent:2
suggests ,pangolins:2
suggests ,offered:2
suggests ,window:2
suggests ,silent:2
suggests ,spread:2
pangolins ,offered:2
pangolins ,window:2
pangolins ,silent:2
pangolins ,spread:2
offered ,window:2
offered ,silent:2
offered ,spread:2
window ,silent:2
window ,spread:2
silent ,spread:2
promising ,antiviral:2
promising ,candidate:2
promising ,pandemic:2
promising ,mini-review:2
antiviral ,pandemic:4
antiviral ,mini-review:2
candidate ,pandemic:2
candidate ,mini-review:2
drug ,pandemic:4
drug ,mini-review:2
pandemic ,mini-review:2
sars-cov-2 ,invade:2
sars-cov-2 ,translational:2
invade ,brain:2
invade ,translational:2
invade ,lessons:2
invade ,animal:2
invade ,models:2
brain ,translational:2
brain ,lessons:2
brain ,animal:2
brain ,models:2
translational ,lessons:2
translational ,animal:2
lessons ,animal:2
lessons ,models:2
microclots ,pathophysiology:2
microclots ,covid:2
microclots ,19:2
pathophysiology ,covid:2
pathophysiology ,19:2
usefulness ,bronchoalveolar:2
usefulness ,lavage:2
usefulness ,management:2
usefulness ,patients:2
usefulness ,presenting:2
bronchoalveolar ,management:2
bronchoalveolar ,patients:2
bronchoalveolar ,presenting:2
lavage ,management:2
lavage ,patients:2
lavage ,presenting:2
management ,presenting:2
rt-pcr ,coronaviruses:2
rt-pcr ,four:2
rt-pcr ,genera:2
assay ,coronaviruses:2
assay ,four:2
assay ,genera:2
detection ,genera:2
coronaviruses ,four:2
coronaviruses ,genera:2
four ,genera:2
putative ,mpro:2
putative ,inhibitors:4
putative ,in-house:2
putative ,library:4
putative ,natural:4
sars-cov-2 ,library:4
mpro ,in-house:2
mpro ,library:2
mpro ,natural:2
inhibitors ,in-house:2
in-house ,library:2
in-house ,natural:2
library ,natural:6
melatonin ,treatment:2
comparison ,panther:2
comparison ,fusion:2
panther ,fusion:2
panther ,laboratory-developed:2
panther ,test:2
panther ,targeting:2
fusion ,laboratory-developed:2
fusion ,test:2
fusion ,targeting:2
ischemic ,covid-19-positive:2
ischemic ,overview:2
ischemic ,sars-cov-2:2
stroke ,covid-19-positive:2
stroke ,overview:2
covid-19-positive ,patients:2
covid-19-positive ,overview:2
covid-19-positive ,sars-cov-2:2
cancer ,precautionary:2
cancer ,principle:2
cancer ,prioritizing:2
covid-19 ,principle:2
precautionary ,principle:2
precautionary ,prioritizing:2
precautionary ,treatment:2
principle ,prioritizing:2
principle ,treatment:2
prioritizing ,treatment:2
atypical ,manifestation:2
atypical ,covid-19-induced:2
atypical ,myocarditis:2
manifestation ,covid-19-induced:2
manifestation ,myocarditis:2
covid-19-induced ,myocarditis:2
origin ,underlying:2
origin ,driving:2
origin ,forces:2
underlying ,driving:2
underlying ,forces:2
underlying ,outbreak:2
driving ,forces:2
driving ,outbreak:2
forces ,sars-cov-2:2
forces ,outbreak:2
reply ,letter:2
reply ,editor:2
reply ,elevated:2
reply ,liver:2
reply ,biochemistries:2
reply ,hospitalized:2
reply ,chinese:2
letter ,editor:2
letter ,elevated:2
letter ,liver:2
letter ,biochemistries:2
letter ,hospitalized:2
letter ,chinese:2
editor ,elevated:2
editor ,liver:2
editor ,biochemistries:2
editor ,hospitalized:2
editor ,chinese:2
elevated ,liver:2
elevated ,biochemistries:2
elevated ,hospitalized:2
elevated ,chinese:2
liver ,biochemistries:2
liver ,chinese:2
biochemistries ,hospitalized:2
biochemistries ,chinese:2
hospitalized ,chinese:2
collateral ,medical:2
collateral ,care:2
collateral ,avoidance:2
collateral ,behavior:2
collateral ,among:2
collateral ,myocardial:2
damage ,medical:2
damage ,care:2
damage ,avoidance:2
damage ,behavior:2
damage ,among:2
damage ,myocardial:2
medical ,behavior:2
medical ,among:2
medical ,myocardial:2
care ,behavior:2
care ,myocardial:2
avoidance ,behavior:2
avoidance ,among:2
avoidance ,patients:2
avoidance ,myocardial:2
behavior ,among:2
behavior ,myocardial:2
among ,myocardial:2
coronavirus ,population-based:4
coronavirus ,hospitalization:2
disease ,population-based:2
disease ,hospitalization:2
population-based ,prevalence:2
population-based ,factors:2
population-based ,hospitalization:2
prevalence ,factors:2
prevalence ,hospitalization:2
risk ,hospitalization:4
factors ,hospitalization:4
abdominal ,transplant:2
abdominal ,stepwise:2
abdominal ,approach:2
abdominal ,practice:2
abdominal ,pandemic:2
transplant ,stepwise:2
transplant ,approach:2
transplant ,practice:2
stepwise ,approach:2
stepwise ,practice:2
stepwise ,pandemic:2
approach ,practice:2
paromomycin ,potential:2
paromomycin ,dual:2
paromomycin ,targeted:2
paromomycin ,drug:2
paromomycin ,effectively:2
paromomycin ,inhibits:2
paromomycin ,spike:2
paromomycin ,s1:2
potential ,dual:2
potential ,targeted:2
potential ,effectively:2
potential ,inhibits:2
potential ,s1:2
dual ,targeted:2
dual ,drug:2
dual ,effectively:2
dual ,inhibits:2
dual ,spike:2
dual ,s1:2
targeted ,effectively:2
targeted ,inhibits:2
targeted ,spike:2
targeted ,s1:2
drug ,effectively:2
drug ,s1:2
effectively ,inhibits:2
effectively ,spike:2
effectively ,s1:2
inhibits ,spike:2
inhibits ,s1:2
spike ,s1:2
emerging ,mechanisms:2
emerging ,pulmonary:2
emerging ,vasoconstriction:2
emerging ,sars-cov-2-induced:2
emerging ,acute:2
mechanisms ,pulmonary:2
mechanisms ,vasoconstriction:2
mechanisms ,sars-cov-2-induced:2
mechanisms ,acute:2
pulmonary ,vasoconstriction:2
pulmonary ,sars-cov-2-induced:2
vasoconstriction ,sars-cov-2-induced:2
vasoconstriction ,acute:2
analysis ,daily:2
analysis ,programme:2
sars-cov-2 ,programme:2
daily ,screening:2
daily ,programme:2
daily ,healthcare:2
daily ,workers:2
screening ,programme:2
screening ,healthcare:2
screening ,workers:2
programme ,healthcare:2
programme ,workers:2
angiotensin ,interface:2
converting ,interface:2
enzyme ,interface:2
enzyme ,renin-angiotensin:2
enzyme ,system:2
interface ,renin-angiotensin:2
interface ,system:2
qualitative ,study:4
qualitative ,zoonotic:2
qualitative ,risk:2
qualitative ,factors:2
qualitative ,among:2
qualitative ,rural:2
qualitative ,communities:2
qualitative ,southern:2
study ,zoonotic:2
study ,factors:6
study ,communities:2
study ,southern:2
zoonotic ,risk:2
zoonotic ,factors:2
zoonotic ,among:2
zoonotic ,rural:2
zoonotic ,communities:2
zoonotic ,southern:2
risk ,communities:2
risk ,southern:2
factors ,rural:2
factors ,communities:2
factors ,southern:2
among ,rural:2
among ,communities:2
rural ,communities:2
rural ,southern:2
communities ,southern:2
seasonality ,respiratory:2
seasonality ,viral:2
seasonality ,infections:2
seasonality ,will:2
seasonality ,follow:2
seasonality ,suit:2
respiratory ,will:2
respiratory ,follow:2
respiratory ,suit:2
viral ,will:2
viral ,follow:2
viral ,suit:2
infections ,will:2
infections ,follow:2
infections ,suit:2
will ,follow:2
will ,suit:2
covid-19 ,suit:2
follow ,suit:2
acute ,effusive:2
acute ,complication:2
effusive ,pericarditis:2
effusive ,late:2
effusive ,complication:2
effusive ,covid-19:2
pericarditis ,late:2
pericarditis ,complication:2
pericarditis ,covid-19:2
impact ,mental:6
putative ,vitamin:2
putative ,modulating:2
putative ,immune:2
putative ,response:2
putative ,immunopathology:2
roles ,vitamin:2
roles ,modulating:2
roles ,immune:2
roles ,immunopathology:2
vitamin ,modulating:2
vitamin ,immune:2
vitamin ,response:2
vitamin ,immunopathology:2
modulating ,immune:2
modulating ,response:2
modulating ,immunopathology:2
cardiac ,comprehensive:4
comparative ,antiviral:4
comparative ,activity:2
comparative ,remdesivir:2
comparative ,anti-hiv:2
comparative ,nucleoside:2
comparative ,analogs:2
antiviral ,anti-hiv:2
antiviral ,nucleoside:2
antiviral ,analogs:2
activity ,remdesivir:2
activity ,anti-hiv:2
activity ,nucleoside:2
activity ,analogs:2
remdesivir ,anti-hiv:2
remdesivir ,nucleoside:2
remdesivir ,analogs:2
anti-hiv ,nucleoside:2
anti-hiv ,analogs:2
nucleoside ,analogs:2
corona ,pandemic-beyond:2
corona ,omnipresent:2
corona ,prevention:2
pandemic-beyond ,omnipresent:2
pandemic-beyond ,prevention:2
omnipresent ,prevention:2
environmental ,occurrence:2
environmental ,persistence:2
perspective ,occurrence:2
perspective ,persistence:2
occurrence ,surveillance:2
persistence ,surveillance:2
disinfection ,n95:2
disinfection ,masks:2
disinfection ,artificially:2
disinfection ,contaminated:2
disinfection ,eskape:2
n95 ,artificially:2
n95 ,contaminated:2
n95 ,eskape:2
masks ,artificially:2
masks ,contaminated:2
masks ,eskape:2
artificially ,contaminated:2
artificially ,sars-cov-2:2
artificially ,eskape:2
contaminated ,sars-cov-2:2
contaminated ,eskape:2
sars-cov-2 ,eskape:2
genome ,detective:4
genome ,typing:4
genome ,rapid:4
genome ,identification:4
detective ,coronavirus:4
detective ,typing:4
detective ,tool:4
detective ,rapid:4
detective ,identification:4
coronavirus ,typing:4
typing ,tool:4
typing ,rapid:4
typing ,identification:4
unsupervised ,machine:2
unsupervised ,learning:2
unsupervised ,discovery:2
unsupervised ,latent:2
unsupervised ,clusters:2
unsupervised ,covid-19:2
machine ,discovery:2
machine ,latent:2
machine ,clusters:2
learning ,discovery:2
learning ,latent:2
learning ,clusters:2
discovery ,latent:2
discovery ,clusters:2
nitazoxanide ,covid-19:2
nitazoxanide ,three:2
nitazoxanide ,explorative:2
nitazoxanide ,scenarios:2
covid-19 ,explorative:4
three ,explorative:2
three ,scenarios:2
explorative ,scenarios:2
clustered ,cases:2
clustered ,acral:2
clustered ,perniosis:2
clustered ,clinical:2
clustered ,features:2
clustered ,histopathology:2
cases ,acral:2
cases ,perniosis:2
cases ,histopathology:2
acral ,perniosis:2
acral ,clinical:2
acral ,features:2
acral ,histopathology:2
perniosis ,clinical:2
perniosis ,features:2
perniosis ,histopathology:2
clinical ,histopathology:2
features ,histopathology:2
characteristics ,longitudinal:4
characteristics ,chest:6
characteristics ,ct:6
longitudinal ,chest:2
longitudinal ,ct:2
longitudinal ,healthcare:2
longitudinal ,workers:2
chest ,healthcare:2
chest ,workers:2
ct ,healthcare:2
ct ,workers:2
features ,healthcare:2
features ,workers:2
factors ,intubation:2
associated ,intubation:2
intubation ,prolonged:2
intubation ,hospitalized:2
prolonged ,hospitalized:2
cerebrovascular ,patients:2
cerebrovascular ,neuroimaging:2
cerebrovascular ,histological:2
disease ,neuroimaging:4
disease ,histological:2
patients ,neuroimaging:4
patients ,histological:2
covid-19 ,neuroimaging:2
covid-19 ,histological:2
neuroimaging ,histological:2
prevalence ,abnormal:2
prevalence ,liver:2
prevalence ,function:2
prevalence ,tests:2
prevalence ,tertiary:2
abnormal ,tertiary:2
abnormal ,care:2
liver ,tertiary:2
function ,tertiary:2
function ,care:2
tests ,tertiary:2
tests ,care:2
neurological ,mental:4
neurological ,health:2
manifestations ,mental:2
manifestations ,health:2
clinical ,307:2
characteristics ,changes:4
characteristics ,307:2
changes ,307:2
chest ,307:2
ct ,307:2
features ,307:2
307 ,patients:2
predictors ,self-reported:2
predictors ,symptoms:2
predictors ,testing:2
predictors ,canada:2
predictors ,using:2
self-reported ,symptoms:2
self-reported ,testing:2
self-reported ,canada:2
self-reported ,using:2
symptoms ,testing:2
symptoms ,canada:2
testing ,canada:2
canada ,using:2
recommendations ,antithrombotic:2
recommendations ,position:2
antithrombotic ,covid-19:4
antithrombotic ,pandemic:2
antithrombotic ,position:2
influence ,outbreak:2
influence ,people:2
influence ,epilepsy:2
influence ,analysis:2
influence ,spanish:2
covid-19 ,epilepsy:4
outbreak ,people:2
outbreak ,epilepsy:2
people ,epilepsy:2
people ,analysis:2
people ,spanish:2
epilepsy ,analysis:2
epilepsy ,spanish:2
analysis ,spanish:2
covid-19 ,proposed:2
review ,proposed:2
proposed ,pharmacological:2
proposed ,treatments:2
clinical ,viable:2
clinical ,preterm:2
implications ,viable:2
implications ,preterm:2
implications ,period:2
infection ,viable:2
viable ,preterm:2
viable ,period:2
preterm ,period:2
endocrinology ,hyperthyroidism:2
time ,hyperthyroidism:2
covid-19 ,hyperthyroidism:2
management ,hyperthyroidism:2
pediatric ,korea:2
comparison ,hospitalized:4
comparison ,pneumonia:4
comparison ,caused:2
comparison ,influenza:2
hospitalized ,caused:2
hospitalized ,influenza:2
patients ,influenza:2
caused ,influenza:4
management ,non:2
management ,traumatic:2
management ,emergencies:2
management ,pandemia:4
non ,traumatic:2
non ,surgical:2
non ,emergencies:2
non ,pandemia:2
traumatic ,surgical:2
traumatic ,emergencies:2
traumatic ,covid-19:2
traumatic ,pandemia:2
surgical ,emergencies:2
surgical ,pandemia:2
emergencies ,pandemia:2
immunology ,multisystem:2
immunology ,inflammatory:2
immunology ,syndrome:2
immunology ,children:2
immunology ,covid-19:4
estimates ,potential:2
estimates ,impact:2
estimates ,pandemic:2
estimates ,sexual:2
potential ,sexual:2
impact ,sexual:2
mining ,antibody:2
mining ,repertoire:2
mining ,solutions:2
mining ,sars-cov-2:2
antibody ,repertoire:2
antibody ,solutions:2
repertoire ,solutions:2
repertoire ,sars-cov-2:2
vimentin ,target:2
vimentin ,treatment:2
vimentin ,covid-19:2
modelling ,implementation:2
modelling ,population-wide:2
modelling ,interventions:4
epidemic ,implementation:2
epidemic ,population-wide:2
implementation ,population-wide:2
implementation ,interventions:2
population-wide ,interventions:2
recommendations ,german:2
recommendations ,rheumatology:2
german ,management:2
society ,management:2
rheumatology ,management:2
making ,sense:2
making ,mutation:2
making ,d614g:2
making ,means:2
making ,pandemic:2
making ,remains:2
sense ,mutation:2
sense ,d614g:2
sense ,means:2
sense ,pandemic:2
sense ,remains:2
mutation ,means:2
mutation ,covid-19:2
mutation ,pandemic:2
mutation ,remains:2
d614g ,means:2
d614g ,covid-19:2
d614g ,pandemic:2
d614g ,remains:2
means ,covid-19:2
means ,pandemic:2
means ,remains:2
covid-19 ,remains:2
pandemic ,remains:2
reducing ,uk:2
reducing ,behavioural:2
reducing ,science:2
sars-cov-2 ,behavioural:2
transmission ,uk:2
transmission ,behavioural:2
transmission ,science:2
uk ,behavioural:2
uk ,science:2
uk ,approach:2
behavioural ,science:2
behavioural ,approach:2
science ,approach:2
reactive ,psychoses:2
reactive ,context:2
reactive ,covid-19:4
reactive ,pandemic:2
reactive ,clinical:2
reactive ,perspectives:2
psychoses ,context:2
psychoses ,covid-19:2
psychoses ,pandemic:2
psychoses ,clinical:2
psychoses ,perspectives:2
context ,clinical:2
potential ,social:2
potential ,distancing:2
potential ,mitigating:2
role ,mitigating:2
social ,mitigating:2
distancing ,mitigating:2
distancing ,spread:2
mitigating ,spread:2
chest ,radiological:2
chest ,lesions:2
chest ,classical:2
chest ,artificial:2
radiological ,lesions:2
radiological ,classical:2
radiological ,imaging:2
radiological ,artificial:2
lesions ,classical:2
lesions ,imaging:2
lesions ,artificial:2
covid-19 ,classical:2
classical ,imaging:2
classical ,artificial:2
imaging ,artificial:2
early ,test-and-treat:2
early ,strategy:2
test-and-treat ,strategy:2
test-and-treat ,severe:2
test-and-treat ,acute:2
test-and-treat ,respiratory:2
test-and-treat ,syndrome:2
test-and-treat ,coronavirus:2
strategy ,syndrome:2
atypical ,endovascular:2
atypical ,cells:2
atypical ,sars-cov-2:4
endovascular ,cells:2
endovascular ,sars-cov-2:2
endovascular ,pneumonia:2
cells ,pneumonia:2
children ,need:4
children ,longer:2
children ,shed:2
children ,stool:2
need ,longer:2
need ,shed:2
need ,stool:2
need ,adults:2
longer ,time:2
longer ,shed:2
longer ,stool:2
longer ,adults:2
time ,shed:2
time ,stool:2
time ,adults:2
shed ,sars-cov-2:2
shed ,stool:2
shed ,adults:2
stool ,adults:2
clinical ,active:2
clinical ,tuberculosis:2
characteristics ,active:2
characteristics ,tuberculosis:2
characteristics ,co-infection:2
active ,co-infection:2
sars-cov-2cell ,receptor:2
sars-cov-2cell ,gene:2
sars-cov-2cell ,ace2:2
sars-cov-2cell ,-mediated:2
sars-cov-2cell ,immunomodulation:2
sars-cov-2cell ,breast:2
sars-cov-2cell ,cancer:2
receptor ,-mediated:2
receptor ,immunomodulation:2
receptor ,breast:2
receptor ,cancer:2
gene ,-mediated:2
gene ,immunomodulation:2
gene ,breast:2
gene ,cancer:2
ace2 ,-mediated:2
ace2 ,immunomodulation:2
ace2 ,breast:2
ace2 ,cancer:2
-mediated ,immunomodulation:2
-mediated ,breast:2
-mediated ,cancer:2
immunomodulation ,breast:2
immunomodulation ,cancer:2
recruiting ,innate:2
recruiting ,immune:2
recruiting ,system:2
recruiting ,gm-csf:2
recruiting ,fight:2
recruiting ,viral:2
recruiting ,diseases:2
recruiting ,including:2
innate ,system:2
innate ,gm-csf:2
innate ,fight:2
innate ,diseases:2
innate ,including:2
immune ,gm-csf:2
immune ,diseases:2
system ,gm-csf:2
system ,diseases:2
system ,including:4
gm-csf ,fight:2
gm-csf ,viral:2
gm-csf ,diseases:2
gm-csf ,including:2
fight ,viral:2
fight ,diseases:2
fight ,including:2
viral ,including:2
diseases ,including:2
telemedicine ,rhythmology:2
telemedicine ,prepared:2
telemedicine ,pandemics:2
rhythmology ,prepared:2
rhythmology ,pandemics:2
prepared ,pandemics:2
severe ,exhibits:2
severe ,predicted:2
acute ,exhibits:2
acute ,predicted:2
respiratory ,exhibits:2
respiratory ,predicted:2
syndrome ,exhibits:2
syndrome ,predicted:2
coronavirus ,exhibits:2
sars-cov-2 ,predicted:4
exhibits ,high:2
exhibits ,predicted:2
high ,predicted:2
in-silico ,strategies:2
in-silico ,probing:2
in-silico ,chloroquine:2
in-silico ,based:2
in-silico ,inhibitors:2
strategies ,probing:2
strategies ,chloroquine:2
strategies ,based:2
strategies ,inhibitors:2
probing ,chloroquine:2
probing ,based:2
probing ,inhibitors:2
chloroquine ,based:2
chloroquine ,inhibitors:2
based ,inhibitors:4
disease ,assessment:2
assessment ,patients:4
ounce ,prevention:2
ounce ,coronavirus:2
ounce ,covid-19:2
ounce ,mass:2
ounce ,gatherings:2
prevention ,mass:2
prevention ,gatherings:2
coronavirus ,gatherings:2
surgical ,economic:2
surgical ,impacts:2
surgical ,kansas:2
surgical ,community:2
economic ,psychological:2
economic ,impacts:2
economic ,sars-cov-2:2
economic ,kansas:2
economic ,community:2
psychological ,impacts:2
psychological ,sars-cov-2:2
psychological ,kansas:2
psychological ,community:2
impacts ,kansas:2
impacts ,community:2
sars-cov-2 ,kansas:2
kansas ,community:2
neurological ,critical:2
complications ,critical:2
clue ,covid-19:2
clue ,lung:2
clue ,ultrasound:2
clue ,emergency:2
clue ,department:2
lung ,emergency:2
lung ,department:2
ultrasound ,emergency:2
ultrasound ,department:2
aga ,clinical:2
aga ,practice:2
aga ,update:2
aga ,management:2
aga ,inflammatory:2
aga ,bowel:2
aga ,disease:2
practice ,update:2
practice ,inflammatory:2
practice ,bowel:2
update ,inflammatory:4
update ,bowel:2
calm ,storm:2
calm ,re-starting:2
calm ,art:2
calm ,treatments:2
calm ,safely:2
calm ,wake:2
storm ,re-starting:2
storm ,art:2
storm ,treatments:2
storm ,safely:2
storm ,wake:2
re-starting ,art:2
re-starting ,treatments:2
re-starting ,safely:2
re-starting ,wake:2
art ,treatments:2
art ,safely:2
art ,wake:2
treatments ,safely:2
treatments ,wake:2
safely ,wake:2
identification ,rt-pcr-negative:2
identification ,asymptomatic:2
identification ,via:2
rt-pcr-negative ,asymptomatic:2
rt-pcr-negative ,covid-19:2
rt-pcr-negative ,patients:2
rt-pcr-negative ,via:2
rt-pcr-negative ,serological:2
asymptomatic ,via:2
via ,serological:2
diagnosis ,despite:2
diagnosis ,missing:2
diagnosis ,nucleic:4
diagnosis ,acid:2
pneumonia ,missing:2
pneumonia ,nucleic:2
pneumonia ,acid:2
despite ,missing:2
despite ,detection:2
despite ,viral:6
despite ,nucleic:2
despite ,acid:2
missing ,detection:2
missing ,viral:2
missing ,nucleic:2
missing ,acid:2
neurological ,insights:2
power-law ,distribution:2
power-law ,number:2
power-law ,confirmed:2
power-law ,covid-19:2
power-law ,cases:2
distribution ,number:2
distribution ,confirmed:2
distribution ,cases:2
number ,confirmed:4
number ,cases:4
relation ,guillain-barr:2
relation ,syndrome:2
relation ,adults:2
relation ,systematic:2
relation ,review:2
guillain-barr ,adults:2
syndrome ,adults:2
adults ,systematic:2
adults ,review:2
anosmia ,uncommon:2
anosmia ,presentation:2
anosmia ,children:2
ageusia ,uncommon:2
ageusia ,presentation:2
ageusia ,infection:2
ageusia ,children:2
uncommon ,presentation:2
uncommon ,infection:2
uncommon ,children:2
assessing ,ground:2
assessing ,ozone:2
assessing ,o3:2
assessing ,nitrogen:2
relationship ,ground:2
relationship ,ozone:2
relationship ,o3:2
relationship ,nitrogen:2
ground ,levels:2
ground ,ozone:2
ground ,o3:2
ground ,nitrogen:2
levels ,ozone:2
levels ,o3:2
levels ,nitrogen:2
ozone ,o3:2
ozone ,nitrogen:2
o3 ,nitrogen:2
protocol ,randomized:2
protocol ,controlled:2
protocol ,trial:2
protocol ,testing:2
protocol ,inhaled:2
protocol ,nitric:2
protocol ,oxide:2
randomized ,testing:2
randomized ,inhaled:2
randomized ,nitric:2
randomized ,oxide:2
controlled ,testing:2
controlled ,inhaled:2
controlled ,nitric:2
controlled ,oxide:2
trial ,testing:2
trial ,inhaled:2
trial ,nitric:2
trial ,oxide:2
testing ,inhaled:2
testing ,nitric:2
testing ,oxide:2
inhaled ,nitric:2
inhaled ,oxide:2
pooling ,control:2
pooling ,care:2
pooling ,institutions:2
control ,institutions:2
care ,institutions:2
correlation ,stomatognathic:2
correlation ,homeopathic:2
correlation ,proposal:2
covid-19 ,stomatognathic:2
covid-19 ,homeopathic:2
stomatognathic ,system:2
stomatognathic ,homeopathic:2
stomatognathic ,proposal:2
system ,homeopathic:2
system ,proposal:2
homeopathic ,proposal:2
consequences ,continuum:2
consequences ,care:2
consequences ,people:2
covid-19 ,continuum:2
pandemic ,continuum:2
continuum ,care:2
continuum ,cohort:2
continuum ,people:2
care ,cohort:2
care ,people:2
cohort ,people:2
basics ,vaccine:2
basics ,development:2
basics ,canadian:2
basics ,perspective:2
vaccine ,canadian:2
development ,canadian:2
canadian ,perspective:2
potential ,post-exposure:2
potential ,prophylaxis:4
arbidol ,post-exposure:2
arbidol ,prophylaxis:2
arbidol ,transmission:2
post-exposure ,transmission:2
prophylaxis ,transmission:2
analysis ,coagulation:6
analysis ,shanghai:2
coagulation ,parameters:2
coagulation ,shanghai:2
coagulation ,china:2
parameters ,shanghai:2
parameters ,china:2
patients ,shanghai:2
presenting ,persistent:4
presenting ,abdominal:2
presenting ,pain:2
presenting ,causing:2
severe ,abdominal:2
severe ,pain:2
severe ,causing:2
persistent ,abdominal:2
persistent ,pain:2
persistent ,causing:2
persistent ,late:4
abdominal ,pain:2
abdominal ,causing:2
abdominal ,late:2
pain ,causing:2
pain ,late:2
causing ,late:2
epidemiological ,design:2
epidemiological ,infection:2
design ,asymptomatic:2
first ,united:2
first ,states:2
case ,united:2
case ,states:2
urologists ,trouble:2
urologists ,reflections:2
urologists ,recommendations:2
trouble ,sars-cov-2:2
trouble ,reflections:2
trouble ,recommendations:2
sars-cov-2 ,reflections:2
reflections ,recommendations:2
coronavirus ,birth:2
birth ,italy:2
birth ,results:2
birth ,national:2
birth ,population-based:2
birth ,cohort:2
birth ,study:2
italy ,results:2
italy ,national:2
italy ,population-based:2
italy ,cohort:2
results ,population-based:2
results ,study:2
national ,population-based:2
national ,study:2
population-based ,cohort:2
population-based ,study:4
acute ,encephalopathy:2
acute ,elevated:2
acute ,csf:2
acute ,inflammatory:2
acute ,markers:2
encephalopathy ,elevated:2
encephalopathy ,csf:2
encephalopathy ,inflammatory:2
encephalopathy ,markers:2
encephalopathy ,initial:2
elevated ,csf:2
elevated ,inflammatory:2
elevated ,markers:2
csf ,inflammatory:2
csf ,markers:2
csf ,initial:2
inflammatory ,initial:2
markers ,initial:2
spatiotemporal ,distribution:2
spatiotemporal ,trend:2
spatiotemporal ,covid-19:2
spatiotemporal ,yangtze:2
spatiotemporal ,river:2
spatiotemporal ,delta:2
spatiotemporal ,region:2
distribution ,trend:2
distribution ,yangtze:2
distribution ,river:2
distribution ,delta:2
distribution ,region:2
trend ,yangtze:2
trend ,river:2
trend ,delta:2
trend ,region:2
covid-19 ,yangtze:2
covid-19 ,river:2
covid-19 ,delta:2
yangtze ,river:2
yangtze ,delta:2
yangtze ,region:2
river ,delta:2
river ,region:2
delta ,region:2
children ,microbiological:2
children ,immunological:2
microbiological ,immunological:2
microbiological ,insights:2
immunological ,insights:2
preceding ,infection:2
preceding ,risk:2
preceding ,stroke:2
preceding ,old:2
preceding ,concept:2
preceding ,revived:2
preceding ,covid-19:2
infection ,concept:2
infection ,revived:2
risk ,stroke:4
risk ,old:2
risk ,concept:2
risk ,revived:2
stroke ,old:2
stroke ,concept:2
stroke ,revived:2
old ,concept:2
old ,revived:2
concept ,revived:2
revived ,covid-19:2
covid-19 ,zero:2
patient ,zero:2
patient ,netherlands:2
zero ,netherlands:2
endoscopy ,outbreak:2
endoscopy ,experience:2
endoscopy ,recommendations:2
endoscopy ,single:2
outbreak ,single:2
experience ,recommendations:2
recommendations ,single:2
seroprevalence ,anti-sars-cov-2:6
seroprevalence ,rio:2
seroprevalence ,de:2
seroprevalence ,janeiro:2
seroprevalence ,brazil:2
anti-sars-cov-2 ,among:2
anti-sars-cov-2 ,blood:2
anti-sars-cov-2 ,rio:2
anti-sars-cov-2 ,de:2
anti-sars-cov-2 ,janeiro:2
anti-sars-cov-2 ,brazil:2
among ,blood:2
among ,donors:2
among ,rio:2
among ,de:2
among ,janeiro:2
among ,brazil:2
blood ,rio:2
blood ,de:2
blood ,janeiro:2
blood ,brazil:2
donors ,rio:2
donors ,de:2
donors ,janeiro:2
donors ,brazil:2
rio ,de:2
rio ,janeiro:2
rio ,brazil:2
de ,janeiro:2
de ,brazil:2
janeiro ,brazil:2
functional ,prediction:2
functional ,comparative:2
functional ,population:2
functional ,variants:2
functional ,genes:2
prediction ,comparative:2
prediction ,population:2
prediction ,variants:2
prediction ,genes:2
comparative ,population:2
comparative ,variants:2
comparative ,genes:2
population ,analysis:2
population ,variants:2
population ,genes:2
analysis ,genes:2
variants ,genes:2
outbreak ,hide:2
outbreak ,another:2
can ,hide:2
can ,another:2
hide ,another:2
covid-19 ,physicians:2
infection ,physicians:2
implications ,perioperative:2
implications ,critical:2
implications ,physicians:2
perioperative ,critical:2
perioperative ,care:4
perioperative ,physicians:2
critical ,physicians:2
care ,physicians:2
proof ,sars-cov-2:2
proof ,genomes:2
proof ,endomyocardial:2
proof ,biopsy:2
proof ,latency:2
proof ,acute:2
sars-cov-2 ,endomyocardial:2
sars-cov-2 ,biopsy:2
genomes ,endomyocardial:2
genomes ,biopsy:2
genomes ,latency:2
genomes ,acute:2
endomyocardial ,biopsy:2
endomyocardial ,latency:2
endomyocardial ,acute:2
biopsy ,latency:2
biopsy ,acute:2
latency ,acute:2
antiviral ,discovery:2
antiviral ,address:2
drug ,address:2
discovery ,address:2
address ,covid-19:4
address ,pandemic:2
narrative ,cancer:2
narrative ,cytology:2
narrative ,times:2
review ,cytology:2
review ,times:4
lung ,cytology:2
lung ,times:2
cancer ,cytology:2
cancer ,times:2
cytology ,times:2
cytology ,coronavirus:2
times ,coronavirus:2
coronavirus ,vulnerable:2
coronavirus ,spared:2
disease ,vulnerable:2
disease ,spared:2
covid-19 ,spared:4
children ,vulnerable:2
children ,spared:4
vulnerable ,spared:2
vulnerable ,systematic:2
spared ,systematic:2
immunometabolic ,status:2
immunometabolic ,covid-19:2
immunometabolic ,cancer:2
immunometabolic ,patients:2
status ,cancer:2
evidence ,indirect:2
evidence ,reported:2
evidence ,guangzhou:2
evidence ,china:2
indirect ,sars-cov-2:2
indirect ,reported:2
indirect ,guangzhou:2
transmission ,reported:2
transmission ,guangzhou:2
sars-cov-2 ,guangzhou:2
reported ,guangzhou:2
reported ,china:2
genomics ,insights:2
genomics ,covid-19:2
genomics ,target-based:2
genomics ,drug:2
genomics ,discovery:2
insights ,target-based:2
insights ,discovery:2
sars-cov-2 ,target-based:2
covid-19 ,target-based:2
target-based ,discovery:2
estimating ,unreported:2
estimating ,number:2
estimating ,novel:2
estimating ,2019-ncov:2
estimating ,cases:2
unreported ,number:2
unreported ,novel:2
unreported ,coronavirus:2
unreported ,2019-ncov:2
unreported ,cases:2
unreported ,china:2
number ,2019-ncov:2
number ,china:2
determinants ,survival:2
determinants ,severe:2
determinants ,acute:2
determinants ,respiratory:2
determinants ,syndrome:2
determinants ,coronavirus:2
survival ,severe:2
survival ,acute:2
survival ,respiratory:2
survival ,syndrome:2
changes ,virus-specific:2
changes ,igmigg:2
changes ,antibody:4
changes ,asymptomatic:2
changes ,discharged:2
serum ,virus-specific:2
serum ,asymptomatic:2
serum ,discharged:2
virus-specific ,igmigg:2
virus-specific ,antibody:2
virus-specific ,asymptomatic:2
virus-specific ,discharged:2
igmigg ,asymptomatic:2
igmigg ,discharged:2
antibody ,discharged:2
asymptomatic ,discharged:2
th17 ,responses:2
th17 ,cytokine:2
th17 ,storm:2
th17 ,covid-19:2
th17 ,emerging:2
th17 ,target:2
th17 ,jak2:2
th17 ,inhibitor:2
responses ,storm:2
responses ,emerging:2
responses ,target:2
responses ,jak2:2
responses ,inhibitor:2
cytokine ,emerging:2
cytokine ,target:2
cytokine ,jak2:2
cytokine ,inhibitor:2
storm ,emerging:2
storm ,target:2
storm ,jak2:2
storm ,inhibitor:2
covid-19 ,jak2:2
emerging ,target:4
emerging ,jak2:2
emerging ,inhibitor:2
target ,jak2:2
target ,inhibitor:2
jak2 ,inhibitor:2
aerodynamic ,analysis:2
aerodynamic ,sars-cov-2:2
aerodynamic ,two:2
aerodynamic ,wuhan:2
aerodynamic ,hospitals:2
analysis ,hospitals:2
two ,wuhan:2
two ,hospitals:2
wuhan ,hospitals:2
risk ,contacts:2
risk ,individuals:2
among ,contacts:2
among ,individuals:4
contacts ,individuals:2
individuals ,covid-19:8
deciphering ,co-adaptation:2
deciphering ,codon:2
deciphering ,usage:2
deciphering ,respiratory:2
deciphering ,coronaviruses:2
co-adaptation ,codon:2
co-adaptation ,usage:2
co-adaptation ,respiratory:2
co-adaptation ,coronaviruses:2
codon ,coronaviruses:2
usage ,coronaviruses:2
histamine ,receptors:2
histamine ,covid-19:2
receptors ,covid-19:2
animal ,disease:2
animal ,one:2
animal ,approach:2
coronaviruses ,one:2
lesson ,one:2
lesson ,health:2
lesson ,approach:2
one ,approach:4
health ,approach:4
chronic ,concomitant:2
chronic ,covid:4
chronic ,19:2
chronic ,case:2
chronic ,report:2
lymphocytic ,concomitant:2
lymphocytic ,covid:2
lymphocytic ,19:2
lymphocytic ,case:2
lymphocytic ,report:2
leukemia ,concomitant:2
leukemia ,covid:2
leukemia ,19:2
leukemia ,case:2
leukemia ,report:2
concomitant ,covid:2
concomitant ,19:2
covid ,report:2
specific ,considerations:2
specific ,protection:2
specific ,echocardiography:2
specific ,service:2
considerations ,protection:2
considerations ,echocardiography:2
considerations ,service:2
protection ,patients:2
protection ,echocardiography:2
protection ,service:2
patients ,echocardiography:2
patients ,service:2
echocardiography ,service:2
glucocorticoids ,improve:2
glucocorticoids ,activating:2
glucocorticoids ,ace2:2
glucocorticoids ,reducing:2
improve ,critical:2
improve ,activating:2
improve ,ace2:2
improve ,reducing:2
severe ,activating:2
severe ,reducing:2
critical ,activating:2
critical ,ace2:2
critical ,reducing:2
activating ,ace2:2
activating ,reducing:2
ace2 ,reducing:2
orf8 ,orf3b:2
orf8 ,antibodies:2
orf8 ,serological:2
orf8 ,markers:2
orf8 ,early:2
orf8 ,late:2
orf3b ,antibodies:2
orf3b ,accurate:2
orf3b ,serological:2
orf3b ,markers:2
orf3b ,early:2
orf3b ,late:2
antibodies ,accurate:2
antibodies ,markers:2
antibodies ,late:2
accurate ,serological:2
accurate ,markers:2
accurate ,early:2
accurate ,late:2
serological ,markers:2
serological ,late:2
markers ,early:4
markers ,late:2
early ,late:2
successful ,baricitinib:2
recovery ,baricitinib:2
covid-19 ,baricitinib:4
pneumonia ,baricitinib:2
receiving ,baricitinib:2
analysis ,shield:2
analysis ,implications:2
sars-cov-2 ,shield:2
spike ,shield:2
spike ,implications:2
protein ,glycan:2
protein ,shield:2
protein ,implications:2
glycan ,shield:2
glycan ,reveals:2
glycan ,implications:2
shield ,reveals:2
shield ,implications:2
reveals ,implications:2
replication ,transmission:4
replication ,mechanisms:4
replication ,highly:4
replication ,pathogenic:4
transmission ,highly:4
transmission ,pathogenic:4
mechanisms ,highly:4
sars-cov-2 ,emphasis:2
infections ,pediatric:2
emphasis ,pediatric:2
emphasis ,patients:2
emphasis ,narrative:2
emphasis ,review:2
pediatric ,narrative:2
clinical ,deaths:2
clinical ,nepal:2
epidemiological ,deaths:2
epidemiological ,nepal:2
features ,deaths:2
features ,nepal:2
deaths ,nepal:2
coronavirus ,plastic:2
coronavirus ,carrier:2
coronavirus ,refrigeration:2
persistence ,plastic:2
persistence ,carrier:2
persistence ,refrigeration:2
persistence ,conditions:2
plastic ,carrier:2
plastic ,refrigeration:2
plastic ,conditions:2
carrier ,refrigeration:2
carrier ,conditions:2
refrigeration ,conditions:2
review ,-coronavirus:2
review ,food:2
review ,industry:2
novel ,-coronavirus:2
novel ,food:2
novel ,industry:2
human ,-coronavirus:2
human ,food:2
human ,industry:2
-coronavirus ,2019-ncov:2
-coronavirus ,sars-cov-2:2
-coronavirus ,food:2
-coronavirus ,industry:2
2019-ncov ,food:2
2019-ncov ,industry:2
sars-cov-2 ,industry:2
food ,industry:4
integrated ,prevention:2
integrated ,sars-cov-2:2
integrated ,infection:2
integrated ,healthcare:2
strategy ,prevention:2
strategy ,infection:4
strategy ,healthcare:2
recent ,endemic:2
recent ,less:2
endemic ,coronavirus:2
endemic ,infection:2
endemic ,associated:2
endemic ,less:2
endemic ,severe:2
endemic ,covid-19:2
associated ,less:2
less ,severe:2
less ,covid-19:2
clinical ,intrauterine:2
clinical ,vertical:2
characteristics ,intrauterine:2
characteristics ,vertical:2
intrauterine ,potential:2
understanding ,evolution:2
understanding ,genetic:2
evolution ,perspective:2
perspective ,analysis:2
approved ,sars-cov-2:4
approved ,protease:2
mobile ,phones:2
mobile ,represent:2
mobile ,pathway:2
mobile ,microbial:2
mobile ,transmission:2
mobile ,scoping:2
mobile ,review:2
phones ,represent:2
phones ,pathway:2
phones ,microbial:2
phones ,transmission:2
phones ,scoping:2
phones ,review:2
represent ,pathway:2
represent ,microbial:2
represent ,transmission:2
represent ,scoping:2
represent ,review:2
pathway ,microbial:2
pathway ,scoping:2
pathway ,review:2
microbial ,transmission:2
microbial ,scoping:2
microbial ,review:2
transmission ,scoping:2
analysis ,sars-cov-2-positive:2
ace2 ,131:2
ace2 ,italian:2
ace2 ,sars-cov-2-positive:2
genetic ,131:2
genetic ,italian:2
genetic ,sars-cov-2-positive:2
genetic ,patients:2
variants ,131:2
variants ,italian:2
variants ,sars-cov-2-positive:2
variants ,patients:2
131 ,italian:2
131 ,sars-cov-2-positive:2
131 ,patients:2
italian ,sars-cov-2-positive:2
sars-cov-2-positive ,patients:4
autophagy ,lung:2
autophagy ,inflammation:2
risk ,professionals:2
risk ,global:2
dental ,healthcare:2
dental ,professionals:2
dental ,global:2
healthcare ,global:2
professionals ,global:2
comparison ,detecting:2
comparison ,antibodies:2
comparison ,nucleocapsid:2
fully ,tests:2
fully ,detecting:2
fully ,antibodies:2
fully ,nucleocapsid:2
automated ,detecting:2
automated ,antibodies:2
automated ,nucleocapsid:2
tests ,nucleocapsid:2
detecting ,antibodies:2
detecting ,nucleocapsid:2
chemosensory ,integration:2
chemosensory ,genetic:2
chemosensory ,epidemiological:2
dysfunction ,integration:2
dysfunction ,genetic:2
dysfunction ,epidemiological:2
covid-19 ,integration:2
integration ,genetic:2
integration ,epidemiological:2
genetic ,epidemiological:2
silico ,exploration:2
silico ,mechanism:2
silico ,clinically:2
silico ,oriented:2
exploration ,molecular:2
exploration ,mechanism:2
exploration ,clinically:2
exploration ,oriented:2
exploration ,drugs:2
molecular ,clinically:2
molecular ,oriented:2
mechanism ,clinically:2
mechanism ,oriented:2
clinically ,oriented:2
oriented ,drugs:2
research ,methodology:2
research ,journal:2
research ,articles:2
research ,original:2
research ,data:4
methodology ,characteristics:2
methodology ,journal:2
methodology ,articles:2
methodology ,original:2
methodology ,data:2
characteristics ,journal:2
characteristics ,articles:2
characteristics ,original:2
characteristics ,data:2
journal ,articles:2
journal ,original:2
journal ,data:2
articles ,original:2
articles ,data:2
original ,data:2
research ,based:2
progress ,based:2
progress ,bibliometric:2
based ,bibliometric:2
french ,consensus:4
french ,management:2
french ,head:2
french ,neck:2
french ,cancer:2
french ,surgery:2
consensus ,head:2
consensus ,neck:2
consensus ,cancer:2
consensus ,surgery:2
non-optimal ,effectiveness:2
non-optimal ,convalescent:2
non-optimal ,plasma:2
non-optimal ,transfusion:2
non-optimal ,hydroxychloroquine:2
effectiveness ,convalescent:2
effectiveness ,plasma:2
effectiveness ,transfusion:2
effectiveness ,hydroxychloroquine:4
convalescent ,hydroxychloroquine:2
plasma ,hydroxychloroquine:2
transfusion ,hydroxychloroquine:2
neuroplastic ,surgery:2
neuroplastic ,aboard:2
neuroplastic ,usns:2
neuroplastic ,comfort:2
neuroplastic ,covid-19:2
neuroplastic ,pandemic:2
neuroplastic ,new:2
neuroplastic ,york:2
surgery ,aboard:2
surgery ,usns:2
surgery ,comfort:2
surgery ,new:2
surgery ,york:2
aboard ,usns:2
aboard ,comfort:2
aboard ,covid-19:2
aboard ,pandemic:2
aboard ,new:2
aboard ,york:2
usns ,comfort:2
usns ,covid-19:2
usns ,pandemic:2
usns ,new:2
usns ,york:2
comfort ,covid-19:2
comfort ,pandemic:2
comfort ,new:2
comfort ,york:2
familial ,mediterranean:2
familial ,fever:2
familial ,friends:2
familial ,foes:2
mediterranean ,fever:2
mediterranean ,covid-19:4
mediterranean ,friends:2
mediterranean ,foes:2
fever ,friends:2
fever ,foes:2
structure-based ,drug:2
structure-based ,designing:2
structure-based ,naphthalene:2
structure-based ,based:2
structure-based ,sars-cov:2
structure-based ,plpro:2
structure-based ,inhibitors:2
drug ,designing:2
drug ,naphthalene:2
drug ,plpro:2
designing ,naphthalene:2
designing ,based:2
designing ,sars-cov:2
designing ,plpro:2
designing ,inhibitors:2
naphthalene ,based:2
naphthalene ,sars-cov:2
naphthalene ,plpro:2
naphthalene ,inhibitors:2
based ,sars-cov:2
based ,plpro:2
sars-cov ,plpro:2
plpro ,inhibitors:2
air ,operating:2
contamination ,operating:2
contamination ,room:2
sars-cov-2 ,operating:2
social ,metrics:2
social ,estimates:2
distancing ,metrics:2
distancing ,estimates:2
distancing ,sars-cov-2:4
metrics ,estimates:2
metrics ,sars-cov-2:2
metrics ,transmission:2
metrics ,rates:2
estimates ,transmission:2
estimates ,rates:2
extracorporeal ,ecmo:2
extracorporeal ,role:2
extracorporeal ,treatment:2
membrane ,ecmo:2
membrane ,role:2
membrane ,treatment:2
oxygenation ,ecmo:2
oxygenation ,role:2
oxygenation ,treatment:2
ecmo ,role:2
ecmo ,treatment:2
artificial ,ophthalmology:2
artificial ,post:2
intelligence ,ophthalmology:2
intelligence ,post:2
ophthalmology ,post:2
immunopathogenesis ,coronavirus-induced:2
immunopathogenesis ,acute:2
immunopathogenesis ,respiratory:2
immunopathogenesis ,distress:2
immunopathogenesis ,syndrome:2
coronavirus-induced ,acute:2
coronavirus-induced ,respiratory:2
coronavirus-induced ,distress:2
coronavirus-induced ,syndrome:2
covid-19 ,kidneys:2
sars-cov-2-human ,protein-protein:2
sars-cov-2-human ,interaction:2
sars-cov-2-human ,network:2
protein-protein ,interaction:2
protein-protein ,network:2
interaction ,network:2
threshold ,value:2
threshold ,correctly:2
threshold ,reflect:2
threshold ,severity:2
threshold ,novel:2
threshold ,coronavirus:2
cycle ,value:2
cycle ,correctly:2
cycle ,reflect:2
cycle ,severity:2
cycle ,novel:2
cycle ,coronavirus:2
value ,correctly:2
value ,reflect:2
correctly ,reflect:2
correctly ,severity:2
correctly ,novel:2
correctly ,coronavirus:2
reflect ,severity:2
reflect ,novel:2
reflect ,coronavirus:2
severity ,novel:2
clinical ,metastatic:2
clinical ,prostate:2
characteristics ,metastatic:2
characteristics ,prostate:2
metastatic ,prostate:2
metastatic ,cancer:2
metastatic ,patients:4
metastatic ,infected:2
prostate ,infected:2
head ,surgical:2
head ,procedures:2
neck ,surgical:2
neck ,procedures:2
surgical ,procedures:2
covid-19 ,advanced:2
covid-19 ,merkel:2
patient ,merkel:2
advanced ,merkel:2
advanced ,cell:2
advanced ,carcinoma:2
advanced ,receiving:2
advanced ,immunotherapy:2
merkel ,cell:2
merkel ,carcinoma:2
merkel ,receiving:2
merkel ,immunotherapy:2
cell ,carcinoma:2
cell ,receiving:2
cell ,immunotherapy:2
carcinoma ,receiving:2
receiving ,immunotherapy:2
saliva ,promising:2
saliva ,biofluid:2
saliva ,early:2
saliva ,stages:2
promising ,biofluid:2
promising ,detection:4
promising ,early:2
biofluid ,sars-cov-2:2
biofluid ,detection:2
biofluid ,early:2
biofluid ,stages:2
detection ,stages:2
pediatric ,time:2
pediatric ,collaborate:2
inflammatory ,time:2
inflammatory ,collaborate:2
multisystem ,time:2
multisystem ,collaborate:2
syndrome ,collaborate:2
time ,collaborate:2
clinical ,16:2
characteristics ,16:2
characteristics ,fecal:2
16 ,patients:2
16 ,fecal:2
16 ,severe:2
16 ,acute:2
16 ,respiratory:2
16 ,syndrome:2
fecal ,severe:2
fecal ,acute:2
fecal ,respiratory:2
fecal ,syndrome:2
autoimmune ,inflammatory:2
autoimmune ,following:2
inflammatory ,following:2
diseases ,following:2
ear ,nose:4
ear ,throat-related:2
ear ,symptoms:2
ear ,focus:2
ear ,loss:2
ear ,smell:2
ear ,andor:2
ear ,taste:2
nose ,throat-related:2
nose ,symptoms:2
nose ,focus:2
nose ,loss:2
nose ,smell:2
nose ,andor:2
nose ,taste:2
throat-related ,symptoms:2
throat-related ,focus:2
throat-related ,loss:2
throat-related ,smell:2
throat-related ,andor:2
throat-related ,taste:2
symptoms ,focus:2
symptoms ,loss:2
symptoms ,andor:2
focus ,loss:2
focus ,smell:2
focus ,andor:2
focus ,taste:2
loss ,andor:2
smell ,andor:2
andor ,taste:2
viral ,infection-induced:2
viral ,gut:2
viral ,dysbiosis:2
viral ,neuroinflammation:2
viral ,-synuclein:2
infection-induced ,gut:2
infection-induced ,dysbiosis:2
infection-induced ,neuroinflammation:2
infection-induced ,-synuclein:2
gut ,dysbiosis:2
gut ,neuroinflammation:2
gut ,-synuclein:2
dysbiosis ,neuroinflammation:2
dysbiosis ,-synuclein:2
neuroinflammation ,-synuclein:2
novel ,vascular:2
novel ,consequences:2
insights ,pulmonary:2
insights ,vascular:2
insights ,consequences:2
pulmonary ,vascular:2
pulmonary ,consequences:2
vascular ,consequences:2
rna ,predictor:2
serum ,predictor:2
serum ,outcome:4
serum ,retrospective:2
predictor ,severe:2
predictor ,outcome:2
predictor ,retrospective:2
outcome ,retrospective:2
epidemiologic ,features:2
epidemiologic ,course:2
epidemiologic ,infected:2
epidemiologic ,sars-cov-2:2
alpaca ,nanobody:2
alpaca ,neutralizes:2
alpaca ,sars-cov-2:2
alpaca ,blocking:2
alpaca ,receptor:2
alpaca ,interaction:2
nanobody ,neutralizes:2
nanobody ,sars-cov-2:2
nanobody ,blocking:2
nanobody ,receptor:2
nanobody ,interaction:2
neutralizes ,blocking:2
neutralizes ,receptor:2
neutralizes ,interaction:2
blocking ,receptor:2
blocking ,interaction:2
successful ,containment:4
successful ,outbreak:2
successful ,large:2
successful ,maternity:2
successful ,perinatal:2
containment ,maternity:2
containment ,perinatal:2
outbreak ,maternity:2
outbreak ,perinatal:2
large ,maternity:2
large ,perinatal:2
maternity ,perinatal:2
bmi ,future:2
bmi ,risk:2
bmi ,covid-19:2
bmi ,infection:2
bmi ,death:2
bmi ,across:2
bmi ,sex:2
bmi ,age:2
bmi ,ethnicity:2
future ,infection:2
future ,death:2
future ,across:2
future ,sex:2
future ,age:2
future ,ethnicity:2
risk ,sex:2
risk ,ethnicity:2
infection ,ethnicity:2
death ,across:2
death ,sex:2
death ,age:2
death ,ethnicity:2
across ,sex:2
across ,ethnicity:2
sex ,ethnicity:2
age ,ethnicity:2
putative ,main:2
putative ,protease:2
putative ,marine:2
inhibitors ,marine:2
main ,library:2
main ,marine:2
protease ,library:2
protease ,marine:2
library ,marine:2
marine ,natural:2
expression ,determines:2
level ,angiotensin-converting:2
level ,enzyme:2
level ,determines:2
level ,severity:2
angiotensin-converting ,determines:2
angiotensin-converting ,severity:2
enzyme ,determines:2
enzyme ,severity:2
determines ,severity:2
pre-existing ,immunity:2
pre-existing ,knowns:2
pre-existing ,unknowns:2
immunity ,knowns:2
immunity ,unknowns:2
behavioral ,changes:2
behavioral ,confinement:2
behavioral ,france:2
behavioral ,web-based:2
behavioral ,study:2
changes ,confinement:2
changes ,france:2
changes ,web-based:2
changes ,study:4
covid-19 ,web-based:2
confinement ,france:2
confinement ,web-based:2
confinement ,study:2
france ,web-based:2
france ,study:2
web-based ,study:2
coronaviruses ,updated:2
coronaviruses ,replication:6
updated ,replication:2
replication ,pathogenesis:4
identification ,rnase-binding:2
identification ,site:2
identification ,anchor:2
identification ,primer-pcr:2
rnase-binding ,site:2
rnase-binding ,sars-cov-2:2
rnase-binding ,rna:2
rnase-binding ,anchor:2
rnase-binding ,primer-pcr:2
site ,rna:2
site ,anchor:2
site ,primer-pcr:2
sars-cov-2 ,anchor:2
sars-cov-2 ,primer-pcr:2
rna ,anchor:2
rna ,primer-pcr:2
anchor ,primer-pcr:2
mapping ,neutralizing:2
mapping ,immunodominant:2
mapping ,sites:2
neutralizing ,immunodominant:2
neutralizing ,sites:2
immunodominant ,sites:2
immunodominant ,sars-cov-2:2
immunodominant ,spike:2
theoretical ,insights:2
theoretical ,anti-sars-cov-2:2
theoretical ,activity:2
theoretical ,chloroquine:2
insights ,anti-sars-cov-2:2
insights ,activity:2
anti-sars-cov-2 ,chloroquine:2
activity ,chloroquine:2
renin-angiotensin ,important:2
renin-angiotensin ,player:2
system ,important:2
system ,player:2
important ,player:2
important ,pathogenesis:2
important ,acute:2
player ,pathogenesis:2
efficacy ,tocilizumab:4
efficacy ,ards:2
efficacy ,undergoing:2
efficacy ,noninvasive:2
tocilizumab ,ards:2
tocilizumab ,undergoing:2
tocilizumab ,noninvasive:2
patients ,ards:2
patients ,noninvasive:2
covid-19 ,noninvasive:2
ards ,undergoing:2
ards ,noninvasive:2
undergoing ,noninvasive:2
mechanistic ,model:2
mechanistic ,therapeutic:2
mechanistic ,interventions:2
mechanistic ,involving:2
model ,therapeutic:2
model ,interventions:2
model ,involving:2
therapeutic ,involving:2
interventions ,involving:2
cross-reactive ,infections:2
antibody ,infections:2
response ,infections:4
infections ,ace2:2
infections ,outcomes:2
infections ,increased:2
infections ,morbidity:2
ace2 ,clinical:4
ace2 ,linked:2
ace2 ,increased:2
ace2 ,morbidity:2
clinical ,increased:2
clinical ,morbidity:2
outcomes ,linked:2
outcomes ,morbidity:2
linked ,increased:2
linked ,morbidity:2
balancing ,evidence:2
balancing ,frontline:2
balancing ,experience:2
balancing ,early:2
balancing ,phases:2
balancing ,covid-19:2
evidence ,frontline:2
evidence ,experience:2
evidence ,phases:2
frontline ,experience:2
frontline ,early:2
frontline ,phases:2
experience ,phases:2
early ,phases:2
phases ,covid-19:2
imperfect ,cytokine:2
imperfect ,storm:2
imperfect ,severe:2
imperfect ,covid-19:2
imperfect ,ards:2
imperfect ,patient:2
cytokine ,ards:2
cytokine ,patient:2
storm ,ards:2
storm ,patient:2
severe ,ards:2
ards ,patient:2
covid-19 ,crdoba:2
covid-19 ,argentina:2
disease ,confirmed:2
disease ,crdoba:2
disease ,argentina:2
report ,crdoba:2
report ,argentina:2
first ,crdoba:2
first ,argentina:2
confirmed ,crdoba:2
confirmed ,argentina:2
case ,crdoba:2
case ,argentina:2
crdoba ,argentina:2
mitochondria ,microbiota:2
mitochondria ,dysfunction:2
microbiota ,dysfunction:2
microbiota ,pathogenesis:2
ethical ,framework:2
ethical ,nutrition:2
ethical ,support:2
ethical ,resource:2
ethical ,allocation:2
ethical ,shortages:2
framework ,nutrition:2
framework ,support:2
framework ,resource:2
framework ,allocation:2
framework ,shortages:2
nutrition ,resource:2
nutrition ,allocation:2
nutrition ,shortages:2
support ,resource:2
support ,allocation:2
support ,shortages:2
resource ,allocation:2
resource ,shortages:2
allocation ,shortages:2
covid-19 ,malignancy:2
hematological ,malignancy:2
hematological ,protocol:2
hematological ,systematic:2
malignancy ,patients:2
malignancy ,protocol:2
malignancy ,systematic:2
malignancy ,review:2
protocol ,review:2
implementation ,sample:2
implementation ,preparation:2
implementation ,method:2
implementation ,detection:2
rapid ,sample:2
rapid ,preparation:2
rapid ,method:2
sample ,preparation:2
sample ,method:2
sample ,detection:6
preparation ,method:2
preparation ,detection:2
prevalence ,sars-cov-2-positive:2
prevalence ,individuals:4
prevalence ,general:2
asymptomatic ,sars-cov-2-positive:2
asymptomatic ,individuals:6
asymptomatic ,general:2
sars-cov-2-positive ,individuals:2
sars-cov-2-positive ,general:2
sars-cov-2-positive ,population:2
individuals ,general:2
individuals ,population:2
covid-19 ,grade:2
covid-19 ,4-5:2
grade ,4-5:2
grade ,chronic:2
grade ,kidney:2
grade ,disease:2
grade ,patients:2
4-5 ,chronic:2
4-5 ,kidney:2
4-5 ,disease:2
4-5 ,patients:2
bilateral ,central:2
bilateral ,retinal:2
bilateral ,vein:2
bilateral ,occlusion:2
bilateral ,40-year-old:2
bilateral ,man:2
bilateral ,severe:2
central ,40-year-old:2
central ,man:2
retinal ,40-year-old:2
retinal ,man:2
retinal ,severe:2
vein ,40-year-old:2
vein ,man:2
vein ,severe:2
occlusion ,40-year-old:2
occlusion ,man:2
occlusion ,severe:2
40-year-old ,man:2
40-year-old ,severe:2
man ,severe:2
air ,ontario:2
air ,canada:2
air ,state:2
air ,emergency:2
pollution ,ontario:2
pollution ,canada:2
pollution ,state:2
pollution ,emergency:2
ontario ,canada:2
ontario ,covid-19:2
ontario ,state:2
ontario ,emergency:2
canada ,state:2
canada ,emergency:2
state ,emergency:2
central ,review:2
epidemiological ,predictors:2
response ,ophthalmologists:2
ophthalmologists ,israel:2
ophthalmologists ,2019-ncov:2
israel ,novel:2
israel ,coronavirus:2
israel ,2019-ncov:2
rna ,conservation:2
rna ,sars-related:2
genome ,conservation:2
genome ,secondary:2
genome ,sars-related:2
conservation ,secondary:2
conservation ,structure:2
conservation ,sars-related:2
secondary ,sars-related:2
structure ,sars-related:2
sars-cov-2 ,sars-related:2
personal ,availability:2
personal ,usage:2
personal ,amongst:2
protective ,availability:2
protective ,usage:2
protective ,amongst:2
equipment ,availability:2
equipment ,usage:2
equipment ,amongst:2
availability ,usage:2
availability ,amongst:2
availability ,pediatric:2
usage ,amongst:2
usage ,pediatric:2
amongst ,pediatric:2
venous ,complicated:2
venous ,know:2
venous ,far:2
thromboembolism ,complicated:2
thromboembolism ,know:2
thromboembolism ,far:2
complicated ,know:2
complicated ,far:2
immune ,thrombocytopenic:2
immune ,purpura:2
immune ,different:2
immune ,presentations:2
thrombocytopenic ,purpura:2
thrombocytopenic ,different:2
thrombocytopenic ,presentations:2
thrombocytopenic ,two:2
thrombocytopenic ,covid-19:2
thrombocytopenic ,patients:2
purpura ,different:2
purpura ,presentations:2
purpura ,two:2
purpura ,covid-19:2
purpura ,patients:2
different ,presentations:2
presentations ,two:2
updates ,laboratory:2
updates ,investigations:2
laboratory ,investigations:2
investigations ,coronavirus:2
investigations ,disease:2
toll ,noninfected:2
toll ,crs:2
toll ,patients:2
toll ,covid-19:2
toll ,pandemic:2
noninfected ,crs:2
noninfected ,patients:2
noninfected ,covid-19:2
noninfected ,pandemic:2
crs ,patients:2
crs ,covid-19:2
crs ,pandemic:2
laboratory ,syndrome-coronavirus-2:2
testing ,syndrome-coronavirus-2:2
methods ,severe:4
methods ,acute:4
methods ,respiratory:4
methods ,syndrome-coronavirus-2:2
novel ,syndrome-coronavirus-2:2
severe ,syndrome-coronavirus-2:4
acute ,syndrome-coronavirus-2:4
respiratory ,syndrome-coronavirus-2:4
pneumomediastinum ,emphysema:2
pneumomediastinum ,noninvasive:2
pneumomediastinum ,ventilation:2
subcutaneous ,noninvasive:2
subcutaneous ,ventilation:2
emphysema ,noninvasive:2
emphysema ,ventilation:2
noninvasive ,ventilation:2
neurological ,immunotherapy:2
neurological ,era:2
neurological ,looking:2
neurological ,consensus:2
immunotherapy ,looking:2
immunotherapy ,consensus:2
era ,looking:2
era ,consensus:2
covid-19 ,looking:4
looking ,consensus:2
pregnant ,risk:2
pregnant ,adverse:2
pregnant ,maternal-fetal:2
women ,risk:2
women ,adverse:2
women ,maternal-fetal:2
covid-19 ,maternal-fetal:2
risk ,birth:2
risk ,maternal-fetal:2
adverse ,birth:2
adverse ,maternal-fetal:2
birth ,maternal-fetal:2
outcomes ,maternal-fetal:2
evolutionary ,adaptation:2
evolutionary ,toward:2
evolutionary ,entry:2
evolutionary ,recognition:2
evolutionary ,receptor:2
adaptation ,toward:2
adaptation ,host:2
adaptation ,entry:2
adaptation ,recognition:2
adaptation ,receptor:2
toward ,host:2
toward ,entry:2
toward ,recognition:2
toward ,receptor:2
entry ,recognition:2
know ,systematic:2
infectious ,cdna:2
infectious ,clone:2
cdna ,clone:2
cdna ,sars-cov-2:2
clone ,sars-cov-2:2
health ,seeking:2
health ,due:2
health ,related:2
health ,symptoms:4
health ,cancellations:2
care ,seeking:2
care ,symptoms:2
care ,cancellations:2
seeking ,due:2
seeking ,related:2
seeking ,symptoms:2
seeking ,cancellations:2
due ,related:2
due ,cancellations:2
covid-19 ,cancellations:2
related ,symptoms:2
related ,cancellations:2
symptoms ,cancellations:2
importance ,imaging:2
importance ,techniques:2
importance ,covid-19-infected:2
imaging ,techniques:2
imaging ,management:2
imaging ,covid-19-infected:2
techniques ,management:2
techniques ,covid-19-infected:2
management ,covid-19-infected:2
scaffold ,morphing:2
scaffold ,arbidol:2
scaffold ,umifenovir:2
scaffold ,search:2
scaffold ,multi-targeting:2
scaffold ,therapy:2
morphing ,arbidol:2
morphing ,umifenovir:2
morphing ,search:2
morphing ,multi-targeting:2
morphing ,therapy:2
arbidol ,umifenovir:2
arbidol ,search:2
arbidol ,multi-targeting:2
arbidol ,therapy:4
umifenovir ,search:2
umifenovir ,multi-targeting:2
umifenovir ,therapy:2
search ,multi-targeting:2
search ,therapy:2
multi-targeting ,therapy:2
metatryp ,20:2
metatryp ,metaproteomic:2
metatryp ,least:2
metatryp ,common:2
metatryp ,ancestor:2
metatryp ,analysis:2
metatryp ,taxonomic:2
metatryp ,inference:2
20 ,metaproteomic:2
20 ,least:2
20 ,common:2
20 ,ancestor:2
20 ,taxonomic:2
20 ,inference:2
metaproteomic ,least:2
metaproteomic ,common:2
metaproteomic ,ancestor:2
metaproteomic ,analysis:2
metaproteomic ,taxonomic:2
metaproteomic ,inference:2
least ,common:2
least ,ancestor:2
least ,analysis:2
least ,taxonomic:2
least ,inference:2
common ,ancestor:2
common ,analysis:4
common ,taxonomic:2
common ,inference:2
ancestor ,analysis:2
ancestor ,taxonomic:2
ancestor ,inference:2
analysis ,taxonomic:2
analysis ,inference:2
taxonomic ,inference:2
next-generation ,sequencing:2
next-generation ,cell:2
next-generation ,receptor:2
next-generation ,repertoires:2
next-generation ,covid-19:2
sequencing ,cell:2
sequencing ,receptor:2
sequencing ,repertoires:2
sequencing ,covid-19:4
cell ,repertoires:2
receptor ,repertoires:2
repertoires ,covid-19:2
cardiac ,patient:4
cardiac ,infarction:2
cardiac ,electron:2
tamponade ,patient:2
tamponade ,myocardial:2
tamponade ,infarction:2
tamponade ,covid-19:2
tamponade ,electron:2
patient ,infarction:4
patient ,electron:2
myocardial ,electron:2
infarction ,electron:2
covid-19 ,electron:2
facing ,acute:2
facing ,neuromuscular:2
facing ,diseases:2
facing ,focus:2
acute ,neuromuscular:2
acute ,diseases:4
acute ,focus:4
neuromuscular ,focus:2
diseases ,focus:4
remdesivir ,therapy:2
remdesivir ,fourth:2
remdesivir ,chance:2
gs-5734 ,covid-19:2
gs-5734 ,therapy:2
gs-5734 ,fourth:2
gs-5734 ,chance:2
covid-19 ,chance:2
therapy ,fourth:2
therapy ,chance:2
fourth ,chance:2
neonatal ,early-onset:2
neonatal ,33:2
neonatal ,neonates:2
early-onset ,infection:2
early-onset ,sars-cov-2:2
early-onset ,33:2
early-onset ,neonates:2
early-onset ,born:2
early-onset ,mothers:2
infection ,born:2
sars-cov-2 ,33:2
33 ,neonates:2
33 ,born:2
33 ,mothers:2
human ,ipsc-derived:4
human ,cardiomyocytes:4
human ,susceptible:4
ipsc-derived ,cardiomyocytes:4
ipsc-derived ,susceptible:4
ipsc-derived ,sars-cov-2:4
ipsc-derived ,infection:4
cardiomyocytes ,susceptible:4
cardiomyocytes ,sars-cov-2:4
cardiomyocytes ,infection:4
susceptible ,infection:4
can ,summer:2
can ,temperatures:2
summer ,temperatures:2
summer ,reduce:2
summer ,cases:2
temperatures ,reduce:2
temperatures ,covid-19:2
temperatures ,cases:2
reduce ,cases:2
rheumatic ,immunosuppressive:2
rheumatic ,agents:2
disease ,immunosuppressive:4
disease ,agents:2
patients ,immunosuppressive:2
patients ,agents:4
immunosuppressive ,agents:2
efficacy ,face:2
efficacy ,mask:2
efficacy ,virus:2
efficacy ,transmission:2
face ,respiratory:2
face ,virus:2
face ,systematic:2
mask ,preventing:2
mask ,respiratory:2
mask ,virus:2
mask ,systematic:2
preventing ,respiratory:2
preventing ,virus:2
preventing ,systematic:2
lianhuaqingwen ,exerts:2
lianhuaqingwen ,anti-viral:2
lianhuaqingwen ,anti-inflammatory:2
lianhuaqingwen ,activity:2
lianhuaqingwen ,novel:2
exerts ,activity:2
anti-viral ,activity:2
anti-inflammatory ,activity:2
activity ,novel:2
seroprevalence ,estimates:2
estimates ,severe:2
estimates ,acute:2
estimates ,respiratory:2
estimates ,syndrome:2
novel ,romiplostim:2
novel ,thrombocytopenia:2
use ,romiplostim:2
use ,sars-cov-2-induced:2
use ,thrombocytopenia:2
romiplostim ,sars-cov-2-induced:2
romiplostim ,thrombocytopenia:2
sars-cov-2-induced ,thrombocytopenia:2
immunological ,physical:2
immunological ,inactivity:2
immunological ,among:2
immunological ,older:2
immunological ,adults:2
implications ,physical:2
implications ,inactivity:2
implications ,among:2
implications ,older:2
implications ,adults:2
physical ,inactivity:2
physical ,among:2
physical ,older:2
physical ,adults:4
inactivity ,among:2
inactivity ,older:2
inactivity ,adults:2
among ,older:2
clinical ,46:2
clinical ,year:2
clinical ,old:2
epidemiological ,46:2
epidemiological ,year:2
epidemiological ,old:2
features ,46:2
features ,year:2
features ,old:2
46 ,children:2
46 ,year:2
46 ,old:2
46 ,coronavirus:2
children ,year:2
children ,old:2
year ,old:2
year ,coronavirus:2
old ,coronavirus:2
role ,humans:2
host ,infections:4
host ,humans:2
genetics ,viral:2
genetics ,infections:2
genetics ,humans:2
susceptibility ,viral:4
susceptibility ,infections:2
susceptibility ,humans:2
severe ,humans:2
viral ,humans:2
infections ,humans:2
conversations ,medical:2
conversations ,news:2
conversations ,frames:2
conversations ,twitter:2
conversations ,infodemiological:2
conversations ,study:2
conversations ,covid-19:2
medical ,news:2
medical ,frames:2
medical ,twitter:2
medical ,infodemiological:2
news ,frames:2
news ,twitter:2
news ,infodemiological:2
news ,study:2
news ,covid-19:2
frames ,twitter:2
frames ,infodemiological:2
frames ,study:2
frames ,covid-19:2
twitter ,infodemiological:2
infodemiological ,study:2
infodemiological ,covid-19:2
liver ,multicenter:2
enzyme ,elevation:2
enzyme ,disease:2
enzyme ,multicenter:2
enzyme ,retrospective:2
elevation ,multicenter:2
elevation ,retrospective:2
multicenter ,retrospective:2
determining ,optimal:2
determining ,reopening:2
determining ,schools:2
determining ,impact:2
determining ,test:2
determining ,trace:2
optimal ,reopening:2
optimal ,schools:2
optimal ,impact:2
optimal ,test:2
optimal ,trace:2
strategy ,reopening:2
strategy ,schools:2
strategy ,test:2
strategy ,trace:2
reopening ,schools:2
reopening ,impact:2
reopening ,test:2
reopening ,trace:2
schools ,impact:2
schools ,test:2
schools ,trace:2
impact ,test:2
impact ,trace:2
test ,trace:2
kidney ,critically:2
kidney ,ill:2
injury ,critically:2
injury ,ill:2
role ,biological:2
role ,data:2
role ,mining:2
role ,machine:2
role ,learning:2
role ,techniques:2
role ,detecting:2
biological ,data:2
biological ,mining:2
biological ,machine:2
biological ,learning:2
biological ,techniques:2
biological ,detecting:2
data ,mining:4
data ,machine:2
data ,techniques:2
data ,detecting:2
mining ,machine:2
mining ,learning:2
mining ,techniques:2
mining ,detecting:2
machine ,techniques:2
machine ,detecting:2
learning ,techniques:2
learning ,detecting:2
techniques ,detecting:2
covid-19 ,forecasts:2
covid-19 ,cuba:2
covid-19 ,logistic:2
covid-19 ,regression:2
covid-19 ,gompertz:2
covid-19 ,curves:2
forecasts ,cuba:2
forecasts ,using:2
forecasts ,logistic:2
forecasts ,regression:2
forecasts ,gompertz:2
forecasts ,curves:2
cuba ,using:2
cuba ,logistic:2
cuba ,regression:2
cuba ,gompertz:2
cuba ,curves:2
using ,logistic:2
using ,regression:2
using ,gompertz:2
using ,curves:2
logistic ,regression:2
logistic ,gompertz:2
logistic ,curves:2
regression ,gompertz:2
regression ,curves:2
gompertz ,curves:2
proteolytic ,cleavage:2
proteolytic ,spike:2
proteolytic ,protein:2
proteolytic ,role:2
proteolytic ,novel:2
proteolytic ,s1s2:2
cleavage ,sars-cov-2:4
cleavage ,spike:4
cleavage ,protein:4
cleavage ,role:2
cleavage ,novel:2
cleavage ,s1s2:2
sars-cov-2 ,s1s2:2
spike ,s1s2:2
protein ,s1s2:2
role ,s1s2:2
novel ,s1s2:2
measurement ,rna:2
measurement ,wastewater:2
measurement ,tracks:2
measurement ,community:2
measurement ,dynamics:2
rna ,tracks:2
rna ,community:2
rna ,infection:2
rna ,dynamics:2
wastewater ,tracks:2
wastewater ,community:2
wastewater ,infection:2
wastewater ,dynamics:2
tracks ,community:2
tracks ,infection:2
tracks ,dynamics:2
community ,dynamics:2
presymptomatic ,skilled:2
presymptomatic ,nursing:2
presymptomatic ,facility:2
sars-cov-2 ,facility:4
infections ,skilled:2
infections ,nursing:2
infections ,facility:2
transmission ,skilled:2
skilled ,nursing:2
skilled ,facility:2
nursing ,facility:2
successful ,coronary:2
successful ,artery:2
successful ,bypass:2
successful ,operation:2
successful ,infected:2
coronary ,artery:2
coronary ,bypass:2
coronary ,operation:2
coronary ,sars-cov-2:4
coronary ,infected:2
artery ,bypass:2
artery ,operation:2
artery ,sars-cov-2:2
artery ,infected:2
bypass ,operation:2
bypass ,sars-cov-2:2
bypass ,infected:2
bypass ,patient:2
operation ,sars-cov-2:4
operation ,infected:2
operation ,patient:2
anatomy ,sars-cov-2:2
anatomy ,biomedical:2
anatomy ,literature:2
anatomy ,introducing:2
anatomy ,covidx:2
anatomy ,network:2
sars-cov-2 ,biomedical:2
sars-cov-2 ,introducing:2
sars-cov-2 ,covidx:2
biomedical ,literature:2
biomedical ,introducing:2
biomedical ,covidx:2
biomedical ,network:2
literature ,introducing:2
literature ,covidx:2
literature ,network:2
introducing ,covidx:2
introducing ,network:2
covidx ,network:2
case ,sars-cov-2-induced:2
case ,urticaria:2
case ,just:2
case ,concomitance:2
report ,sars-cov-2-induced:2
report ,urticaria:2
report ,just:2
report ,concomitance:2
sars-cov-2-induced ,urticaria:2
sars-cov-2-induced ,just:2
sars-cov-2-induced ,concomitance:2
urticaria ,just:2
urticaria ,concomitance:2
just ,concomitance:2
assumed ,vertical:2
assumed ,transmission:2
assumed ,pregnancy:2
assumed ,case:2
assumed ,report:2
reduction ,severe:2
reduction ,acute:2
reduction ,respiratory:2
reduction ,syndrome:2
reduction ,coronavirus-2:2
reduction ,infectivity:2
coronavirus-2 ,infectivity:2
single-cell ,transcriptome:2
single-cell ,novel:2
single-cell ,associated:2
transcriptome ,novel:2
transcriptome ,coronavirus:2
transcriptome ,associated:2
analysis ,associated:2
estimation ,country-level:2
estimation ,reproductive:2
estimation ,ratios:2
country-level ,basic:2
country-level ,reproductive:2
country-level ,ratios:2
country-level ,novel:2
country-level ,coronavirus:2
basic ,ratios:2
reproductive ,ratios:2
reproductive ,novel:2
reproductive ,coronavirus:2
ratios ,novel:2
ratios ,coronavirus:2
covid-19 ,low-middle:2
infection ,low-middle:2
outbreak ,low-middle:2
among ,perspective:2
among ,low-middle:2
health ,low-middle:2
care ,low-middle:2
workers ,low-middle:2
perspective ,low-middle:2
update ,symptomatic:2
update ,women:2
update ,reproductive:2
update ,age:4
symptomatic ,women:2
symptomatic ,reproductive:2
symptomatic ,age:2
involvement ,patient:2
rapid ,emergence:2
rapid ,greater:2
rapid ,new:2
rapid ,york:2
rapid ,metropolitan:2
rapid ,area:2
emergence ,greater:2
emergence ,new:2
emergence ,york:2
emergence ,metropolitan:2
emergence ,area:2
sars-cov-2 ,metropolitan:2
greater ,new:2
greater ,york:2
greater ,metropolitan:2
greater ,area:2
new ,metropolitan:2
new ,area:2
york ,metropolitan:2
york ,area:2
metropolitan ,area:2
human ,express:2
human ,canonical:2
human ,mediators:2
placenta ,express:2
placenta ,canonical:2
placenta ,cell:4
placenta ,entry:2
placenta ,mediators:2
express ,canonical:2
express ,cell:2
express ,entry:4
express ,mediators:2
express ,sars-cov-2:4
canonical ,cell:2
canonical ,entry:2
canonical ,mediators:2
canonical ,sars-cov-2:2
cell ,mediators:2
entry ,mediators:2
cross-reactive ,memory:2
cross-reactive ,herd:2
memory ,cells:4
memory ,herd:2
memory ,immunity:4
cells ,herd:2
chilblain-like ,prominent:2
chilblain-like ,bullae:2
chilblain-like ,patient:2
lesions ,prominent:2
lesions ,bullae:2
prominent ,bullae:2
prominent ,patient:2
prominent ,covid-19:2
bullae ,patient:2
bullae ,covid-19:2
imiquimod ,toll:2
imiquimod ,like:2
imiquimod ,receptor:2
imiquimod ,agonist:2
imiquimod ,ideal:2
imiquimod ,option:2
imiquimod ,management:2
toll ,like:2
toll ,receptor:2
toll ,agonist:2
toll ,ideal:2
toll ,option:2
toll ,management:2
like ,receptor:2
like ,agonist:2
like ,ideal:2
like ,option:2
like ,management:2
receptor ,agonist:2
receptor ,ideal:2
receptor ,option:2
receptor ,management:2
agonist ,ideal:2
agonist ,option:2
agonist ,management:2
sex-derived ,attributes:2
sex-derived ,contributing:2
sex-derived ,sars-cov-2:2
sex-derived ,mortality:2
attributes ,contributing:2
attributes ,sars-cov-2:2
attributes ,mortality:2
contributing ,sars-cov-2:2
contributing ,mortality:2
design ,multiepitope-based:2
design ,human:2
multiepitope-based ,peptide:2
multiepitope-based ,protein:2
multiepitope-based ,human:2
peptide ,vaccine:2
peptide ,protein:2
peptide ,human:2
medical ,research:2
covid-19 ,german-speaking:2
treatment ,german-speaking:2
treatment ,pediatric:2
treatment ,rheumatologists:2
strategies ,german-speaking:2
strategies ,pediatric:2
strategies ,rheumatologists:2
german-speaking ,pediatric:2
german-speaking ,rheumatologists:2
prevalence ,serum:2
prevalence ,igg:2
prevalence ,staff:2
serum ,clinic:2
serum ,staff:2
igg ,among:4
igg ,clinic:2
igg ,staff:4
antibodies ,clinic:2
antibodies ,staff:4
among ,clinic:2
clinic ,staff:2
fulminant ,acute:2
fulminant ,respiratory:2
fulminant ,distress:2
myopericarditis ,acute:2
myopericarditis ,respiratory:2
myopericarditis ,distress:2
role ,chronic:2
role ,air:6
role ,outbreak:6
role ,risk:2
chronic ,air:2
chronic ,pollution:2
chronic ,levels:2
chronic ,italy:2
air ,levels:2
air ,italy:2
pollution ,levels:2
pollution ,outbreak:2
levels ,outbreak:2
levels ,risk:2
levels ,italy:2
protocol ,prospective:2
protocol ,observational:2
protocol ,hospital-based:2
protocol ,multicentre:2
prospective ,observational:2
prospective ,hospital-based:2
prospective ,multicentre:2
observational ,hospital-based:2
hospital-based ,multicentre:2
hospital-based ,study:2
covid-19 ,rheumatologist:2
primer ,rheumatologist:2
primer ,management:4
primer ,patients:2
primer ,care:2
primer ,settings:2
rheumatologist ,management:2
rheumatologist ,patients:2
rheumatologist ,care:2
rheumatologist ,settings:2
management ,settings:2
patients ,settings:2
features ,manifestations:2
features ,adults:2
neurological ,children:2
neurological ,adults:2
manifestations ,adults:4
brain ,microvascular:2
brain ,occlusive:2
brain ,disorder:2
brain ,case:2
brain ,report:2
microvascular ,occlusive:2
microvascular ,disorder:2
microvascular ,case:2
microvascular ,report:2
occlusive ,disorder:2
occlusive ,covid-19:2
occlusive ,case:2
occlusive ,report:2
disorder ,case:2
disorder ,report:2
clinical ,characteristic:2
clinical ,eight:2
characteristic ,eight:2
characteristic ,covid-19:2
characteristic ,positive:2
characteristic ,rt-pcr:2
characteristic ,test:2
eight ,patients:2
eight ,covid-19:2
eight ,positive:2
eight ,rt-pcr:2
eight ,test:2
learning ,immunological:2
learning ,sars-cov:2
learning ,teach:2
learning ,us:2
immunological ,history:2
immunological ,can:2
immunological ,teach:2
immunological ,us:2
history ,can:2
history ,sars-cov:2
history ,teach:2
history ,us:2
can ,sars-cov:2
can ,teach:4
can ,us:4
sars-cov ,teach:2
sars-cov ,us:2
teach ,us:4
investigation ,three:2
investigation ,singapore:2
investigation ,implications:2
three ,clusters:2
three ,singapore:2
three ,implications:2
clusters ,singapore:2
clusters ,implications:2
singapore ,implications:2
analysis ,pudilan:2
analysis ,pdl:2
molecular ,pudilan:2
molecular ,pdl:2
mechanism ,pudilan:2
mechanism ,pdl:2
pudilan ,pdl:2
pudilan ,treatment:2
pudilan ,covid-19:2
pdl ,treatment:2
pdl ,covid-19:2
two ,pediatric:4
two ,oncohematologic:2
two ,spain:2
cases ,oncohematologic:2
cases ,spain:2
sars-cov-2 ,oncohematologic:2
infection ,pediatric:4
infection ,oncohematologic:2
pediatric ,oncohematologic:2
pediatric ,spain:2
oncohematologic ,patients:2
oncohematologic ,spain:2
patients ,spain:2
respiratory ,severely:2
respiratory ,icu:2
support ,severely:2
support ,critically:2
support ,ill:2
support ,icu:2
severely ,critically:2
severely ,ill:2
severely ,icu:2
severely ,patients:2
critically ,icu:4
ill ,icu:2
icu ,patients:2
methods ,inactivation:4
methods ,downstream:2
methods ,biological:2
methods ,assays:2
inactivation ,downstream:2
inactivation ,biological:2
inactivation ,assays:2
sars-cov-2 ,downstream:2
downstream ,biological:2
downstream ,assays:2
biological ,assays:2
responding ,outbreak:2
responding ,singapore:2
responding ,staff:2
responding ,protection:2
outbreak ,singapore:2
outbreak ,protection:2
singapore ,staff:2
singapore ,protection:2
staff ,protection:2
recommendation ,practical:2
recommendation ,guideline:2
recommendation ,safe:2
recommendation ,tracheostomy:2
practical ,guideline:2
practical ,tracheostomy:2
guideline ,safe:2
guideline ,tracheostomy:2
safe ,tracheostomy:2
mechanical ,thrombectomy:2
mechanical ,positive:2
mechanical ,acute:2
mechanical ,ischemic:2
mechanical ,stroke:2
mechanical ,patient:2
mechanical ,case:2
thrombectomy ,covid-19:2
thrombectomy ,positive:2
thrombectomy ,acute:2
thrombectomy ,ischemic:2
thrombectomy ,stroke:2
thrombectomy ,case:2
positive ,ischemic:2
acute ,ischemic:2
prenatal ,screening:2
prenatal ,diagnosis:2
prenatal ,management:2
prenatal ,era:2
prenatal ,coronavirus:2
prenatal ,sardinian:2
screening ,era:2
screening ,sardinian:2
diagnosis ,sardinian:2
management ,sardinian:2
era ,sardinian:2
coronavirus ,sardinian:2
sars-cov-2 ,congenital:2
infection ,congenital:2
patients ,congenital:6
syndrome ,congenital:2
syndrome ,heart:2
congenital ,heart:4
congenital ,disease:4
effect ,wet:2
effect ,market:2
effect ,dynamics:2
wet ,market:2
wet ,coronavirus:2
wet ,disease:2
wet ,covid-19:2
wet ,transmission:2
wet ,dynamics:2
market ,coronavirus:2
market ,disease:2
market ,covid-19:2
market ,transmission:2
market ,dynamics:2
disease ,dynamics:4
retrospective ,luoyang:2
retrospective ,china:2
study ,luoyang:2
initial ,25:2
initial ,luoyang:2
initial ,china:2
25 ,patients:4
25 ,luoyang:2
25 ,china:2
covid-19 ,luoyang:2
patients ,luoyang:2
luoyang ,china:2
retrospective ,risk:2
retrospective ,factors:2
retrospective ,syndrome:2
main ,target:2
protease ,target:2
immunomodulatory ,therapeutic:2
immunomodulatory ,proteins:2
immunomodulatory ,current:2
immunomodulatory ,clinical:2
immunomodulatory ,development:2
therapeutic ,proteins:2
proteins ,covid-19:4
proteins ,current:2
proteins ,clinical:2
covid-19 ,unholy:2
diabetes ,unholy:2
diabetes ,interaction:2
diabetes ,two:2
diabetes ,pandemics:2
mellitus ,unholy:2
mellitus ,interaction:2
mellitus ,two:2
mellitus ,pandemics:2
unholy ,interaction:2
unholy ,two:2
unholy ,pandemics:2
interaction ,two:2
interaction ,pandemics:2
infection ,active:2
cancer ,undergoing:2
cancer ,analysis:2
undergoing ,active:2
undergoing ,treatment:2
undergoing ,analysis:4
active ,treatment:2
active ,analysis:2
association ,cardiovascular:4
association ,diseases:2
association ,mellitus:4
cardiovascular ,mellitus:2
diseases ,diabetes:2
diseases ,mellitus:2
large ,mortality:2
large ,increase:2
large ,directly:2
large ,indirectly:2
mortality ,directly:2
mortality ,indirectly:2
increase ,directly:2
increase ,indirectly:2
increase ,caused:2
directly ,indirectly:2
directly ,caused:2
directly ,covid-19:2
indirectly ,caused:2
indirectly ,covid-19:2
conjunctivitis ,frequency:2
conjunctivitis ,clinical:2
conjunctivitis ,presentation:2
covid-19 ,frequency:8
patients ,frequency:4
frequency ,clinical:2
frequency ,presentation:2
advances ,virus:2
advances ,pathogenesis:2
advances ,evidence-based:2
advances ,control:2
virus ,evidence-based:2
virus ,control:2
pathogenesis ,evidence-based:2
evidence-based ,control:2
profiling ,analysis:2
profiling ,receptor:2
profiling ,ace2:2
profiling ,expression:4
profiling ,reveals:4
profiling ,potential:2
profiling ,risk:2
receptor ,risk:2
reveals ,risk:2
covid-19 ,pathologists:2
covid-19 ,archive:2
brief ,check:2
brief ,pathologists:2
brief ,eye:2
brief ,autopsy:2
brief ,archive:2
check ,pathologists:2
check ,eye:2
check ,autopsy:2
check ,archive:2
pathologists ,eye:2
pathologists ,autopsy:2
pathologists ,archive:2
eye ,autopsy:2
eye ,archive:2
autopsy ,archive:2
clinical ,serology:2
evaluation ,five:2
evaluation ,serology:2
five ,different:2
five ,automated:2
five ,serology:2
different ,automated:2
automated ,serology:2
covid-19 ,inequity:2
covid-19 ,chicago:2
inequity ,comparative:2
inequity ,spatial:2
inequity ,analysis:2
inequity ,new:2
inequity ,york:2
inequity ,city:2
inequity ,chicago:2
comparative ,spatial:2
comparative ,new:4
comparative ,york:4
comparative ,city:4
comparative ,chicago:2
spatial ,analysis:2
spatial ,new:2
spatial ,york:2
spatial ,city:2
spatial ,chicago:2
analysis ,chicago:2
new ,chicago:2
york ,chicago:2
city ,chicago:2
effect ,virus:4
effect ,reducing:2
effect ,ghg:2
effect ,emission:2
effect ,increasing:2
effect ,energy:2
effect ,generated:2
covid-19 ,ghg:2
covid-19 ,emission:2
covid-19 ,energy:2
covid-19 ,generated:2
virus ,reducing:2
virus ,ghg:2
virus ,emission:2
virus ,increasing:2
virus ,energy:2
virus ,generated:2
reducing ,ghg:2
reducing ,emission:2
reducing ,increasing:2
reducing ,energy:2
reducing ,generated:2
ghg ,emission:2
ghg ,increasing:2
ghg ,energy:2
ghg ,generated:2
emission ,increasing:2
emission ,energy:2
emission ,generated:2
increasing ,energy:2
increasing ,generated:2
energy ,generated:2
emerging ,thrombotic:2
emerging ,syndrome:2
emerging ,implications:2
evidence ,thrombotic:2
thrombotic ,syndrome:2
thrombotic ,treatment:2
thrombotic ,implications:2
syndrome ,implications:4
antiviral ,efficacies:2
antiviral ,ferrets:2
efficacies ,fda-approved:2
efficacies ,drugs:2
efficacies ,sars-cov-2:2
efficacies ,infection:2
efficacies ,ferrets:2
fda-approved ,infection:2
fda-approved ,ferrets:2
drugs ,ferrets:2
deducing ,n-:2
deducing ,o-glycosylation:2
deducing ,profile:2
deducing ,spike:2
deducing ,protein:2
deducing ,novel:2
n- ,o-glycosylation:2
n- ,profile:2
n- ,spike:2
n- ,protein:2
n- ,novel:2
o-glycosylation ,profile:2
o-glycosylation ,spike:2
o-glycosylation ,protein:2
o-glycosylation ,novel:2
profile ,spike:2
profile ,protein:2
profile ,novel:2
comparison ,oro-nasopharyngeal:2
comparison ,sample:2
saliva ,oro-nasopharyngeal:2
oro-nasopharyngeal ,swab:2
oro-nasopharyngeal ,sample:2
oro-nasopharyngeal ,molecular:2
oro-nasopharyngeal ,diagnosis:2
swab ,sample:2
swab ,diagnosis:2
sample ,diagnosis:2
impact ,mexican:2
impact ,sars-cov-2-positive:2
impact ,retrospective:2
comorbidities ,mexican:2
comorbidities ,sars-cov-2-positive:2
comorbidities ,retrospective:2
mexican ,sars-cov-2-positive:2
mexican ,patients:2
mexican ,retrospective:2
ultrasound ,testicular:2
imaging ,acute:2
imaging ,testicular:2
findings ,testicular:2
acute ,testicular:2
testicular ,infection:2
testicular ,patients:2
electrolyte ,imbalances:2
electrolyte ,patients:2
electrolyte ,severe:2
electrolyte ,coronavirus:2
electrolyte ,disease:2
electrolyte ,covid-19:2
imbalances ,patients:2
imbalances ,severe:2
imbalances ,coronavirus:2
imbalances ,disease:2
imbalances ,covid-19:2
air ,measurements:2
air ,inside:2
air ,bus:2
air ,normal:2
air ,operation:2
surface ,measurements:2
surface ,inside:2
surface ,bus:2
surface ,normal:2
surface ,operation:2
measurements ,sars-cov-2:2
measurements ,inside:2
measurements ,bus:2
measurements ,normal:2
measurements ,operation:2
sars-cov-2 ,bus:2
sars-cov-2 ,normal:4
inside ,bus:2
inside ,normal:2
inside ,operation:2
bus ,normal:2
bus ,operation:2
normal ,operation:2
hispidin ,lepidine:2
hispidin ,two:2
hispidin ,natural:2
hispidin ,compounds:2
hispidin ,folic:2
hispidin ,acid:2
hispidin ,potential:2
lepidine ,two:2
lepidine ,natural:2
lepidine ,compounds:2
lepidine ,folic:2
lepidine ,acid:2
lepidine ,potential:2
two ,natural:2
two ,compounds:2
two ,folic:2
natural ,folic:2
natural ,acid:2
compounds ,folic:2
compounds ,acid:2
folic ,acid:2
folic ,potential:2
evidence ,association:2
possible ,association:2
possible ,vitamin:2
possible ,status:2
possible ,cytokine:4
association ,cytokine:4
association ,storm:2
vitamin ,status:2
vitamin ,cytokine:2
vitamin ,storm:2
status ,cytokine:2
status ,storm:2
covid-19 ,keeping:4
covid-19 ,clean:4
covid-19 ,ascertain:2
keeping ,clean:4
keeping ,narrative:2
keeping ,review:2
keeping ,ascertain:2
keeping ,efficacy:2
keeping ,personal:2
clean ,narrative:2
clean ,review:2
clean ,ascertain:2
clean ,efficacy:2
clean ,personal:2
narrative ,ascertain:2
narrative ,efficacy:2
narrative ,personal:2
review ,ascertain:2
ascertain ,efficacy:2
ascertain ,personal:2
efficacy ,personal:2
hydroxychloroquine ,mechanism:2
hydroxychloroquine ,action:2
potential ,action:4
action ,sars-cov-2:2
analytical ,comparisons:2
analytical ,qrt-pcr:2
analytical ,ddpcr:2
analytical ,multiple:2
comparisons ,detection:2
comparisons ,qrt-pcr:2
comparisons ,ddpcr:2
comparisons ,multiple:2
qrt-pcr ,ddpcr:2
qrt-pcr ,multiple:2
ddpcr ,multiple:2
new ,erap2iso3:2
new ,isoform:2
new ,triggered:2
new ,different:2
new ,microbial:2
new ,stimuli:2
erap2iso3 ,isoform:2
erap2iso3 ,expression:2
erap2iso3 ,triggered:2
erap2iso3 ,different:2
erap2iso3 ,microbial:2
erap2iso3 ,stimuli:2
isoform ,expression:2
isoform ,triggered:2
isoform ,different:2
isoform ,microbial:2
isoform ,stimuli:2
expression ,triggered:2
expression ,microbial:2
expression ,stimuli:2
triggered ,different:2
triggered ,microbial:2
triggered ,stimuli:2
different ,microbial:2
different ,stimuli:2
microbial ,stimuli:2
bloodstream ,infections:2
bloodstream ,critically:2
bloodstream ,ill:2
bloodstream ,patients:2
bloodstream ,covid-19:2
frequency ,five:2
frequency ,unusual:2
frequency ,presentations:2
frequency ,results:4
five ,unusual:2
five ,presentations:2
five ,results:2
unusual ,presentations:2
unusual ,patients:2
unusual ,results:2
presentations ,results:2
capacity ,evaluation:2
capacity ,diagnostic:2
capacity ,tests:2
capacity ,using:2
capacity ,multicriteria:2
evaluation ,multicriteria:2
diagnostic ,multicriteria:2
tests ,using:6
tests ,multicriteria:2
covid-19 ,multicriteria:2
using ,multicriteria:2
ongoing ,epidemic:2
ongoing ,minas:2
ongoing ,gerais:2
ongoing ,brazil:2
ongoing ,insights:2
ongoing ,epidemiological:2
covid-19 ,minas:2
covid-19 ,gerais:2
epidemic ,minas:2
epidemic ,gerais:2
epidemic ,brazil:2
epidemic ,epidemiological:4
minas ,gerais:2
minas ,brazil:2
minas ,insights:2
minas ,epidemiological:2
gerais ,brazil:2
gerais ,insights:2
gerais ,epidemiological:2
brazil ,insights:2
brazil ,epidemiological:2
socio-economic ,atmospheric:2
socio-economic ,variables:2
socio-economic ,impact:2
socio-economic ,influenza:2
socio-economic ,outbreaks:2
atmospheric ,variables:2
atmospheric ,impact:2
atmospheric ,influenza:2
atmospheric ,outbreaks:2
variables ,impact:2
variables ,covid-19:2
variables ,influenza:2
variables ,outbreaks:2
impact ,influenza:2
impact ,outbreaks:2
head ,oncology:4
head ,reconsidering:2
head ,traditional:2
neck ,oncology:4
neck ,reconsidering:2
neck ,traditional:2
oncology ,reconsidering:2
oncology ,traditional:2
covid-19 ,reconsidering:2
pandemic ,reconsidering:2
pandemic ,traditional:2
reconsidering ,traditional:2
predictive ,criteria:2
predictive ,severe:2
predictive ,cases:2
predictive ,stage:2
criteria ,severe:2
criteria ,cases:2
criteria ,early:2
criteria ,stage:2
severe ,stage:2
cases ,stage:2
solid ,patients:2
solid ,systematic:2
solid ,review:2
organ ,systematic:2
organ ,review:2
transplantation ,systematic:2
transplantation ,review:2
ohio ,response:2
ohio ,covid-19:2
ohio ,impact:2
ohio ,interventional:2
ohio ,pain:2
ohio ,management:2
response ,impact:4
response ,interventional:2
response ,pain:2
covid-19 ,interventional:2
impact ,interventional:2
impact ,pain:2
interventional ,pain:2
interventional ,management:2
pain ,management:2
emergent ,disease:2
emergent ,aging:2
disease ,aging:2
serological ,review:2
tests ,comparative:2
proposal ,rt-pcr-based:2
proposal ,mass:2
proposal ,population:2
proposal ,screening:2
proposal ,severe:2
proposal ,acute:2
proposal ,respiratory:2
rt-pcr-based ,mass:2
rt-pcr-based ,population:2
rt-pcr-based ,screening:2
rt-pcr-based ,severe:2
rt-pcr-based ,acute:2
rt-pcr-based ,respiratory:2
mass ,population:2
population ,screening:2
population ,severe:2
population ,acute:2
population ,respiratory:2
screening ,severe:2
screening ,acute:4
risk-adapted ,treatment:2
risk-adapted ,strategy:2
risk-adapted ,covid-19:2
risk-adapted ,patients:2
molecular ,pathogen-host:2
molecular ,pathway:2
characterization ,pathogen-host:2
characterization ,interaction:2
characterization ,pathway:2
pathogen-host ,interaction:2
pathogen-host ,pathway:2
pathogen-host ,silico:2
interaction ,pathway:2
pathway ,silico:2
documenting ,covid-19:2
documenting ,screening:2
documenting ,surgery:2
documenting ,lockdown:2
documenting ,covid:2
documenting ,screen:2
covid-19 ,screen:2
screening ,lockdown:2
screening ,screen:2
surgery ,lockdown:2
surgery ,screen:2
lockdown ,covid:2
lockdown ,screen:2
covid ,screen:2
self-amplifying ,rna:2
self-amplifying ,sars-cov-2:2
self-amplifying ,lipid:2
self-amplifying ,nanoparticle:2
self-amplifying ,vaccine:2
self-amplifying ,candidate:2
self-amplifying ,induces:2
self-amplifying ,high:2
rna ,lipid:2
rna ,nanoparticle:2
rna ,vaccine:4
rna ,candidate:2
rna ,induces:4
rna ,high:2
sars-cov-2 ,lipid:2
sars-cov-2 ,nanoparticle:2
lipid ,nanoparticle:2
lipid ,vaccine:2
lipid ,candidate:2
lipid ,induces:2
lipid ,high:2
nanoparticle ,vaccine:2
nanoparticle ,candidate:2
nanoparticle ,induces:2
nanoparticle ,high:2
vaccine ,induces:4
vaccine ,high:2
candidate ,induces:2
candidate ,high:2
induces ,high:2
immune ,distinguish:2
characteristics ,distinguish:2
distinguish ,patients:4
distinguish ,severe:2
distinguish ,disease:2
distinguish ,associated:2
early ,remdesivir:2
experience ,remdesivir:2
experience ,pneumonia:2
remdesivir ,pneumonia:2
clinical ,nationwide:2
characteristics ,nationwide:2
characteristics ,cohort:2
asymptomatic ,nationwide:2
patients ,nationwide:2
nationwide ,cohort:2
early ,postmortem:2
early ,brain:2
early ,mri:2
early ,non-survivors:2
postmortem ,mri:2
postmortem ,non-survivors:2
brain ,mri:2
brain ,findings:2
brain ,non-survivors:2
mri ,findings:2
mri ,covid-19:2
mri ,non-survivors:2
findings ,non-survivors:2
covid-19 ,non-survivors:2
coronavirus ,ongoing:2
disease ,ongoing:2
perspectives ,ongoing:2
guidelines ,surgical:2
guidelines ,departments:2
guidelines ,non-uniform:2
guidelines ,hospitals:2
management ,departments:2
management ,non-uniform:2
management ,hospitals:4
surgical ,non-uniform:2
surgical ,hospitals:2
departments ,non-uniform:2
departments ,hospitals:2
non-uniform ,hospitals:2
herd ,suppression:2
herd ,strategy:2
herd ,combat:2
immunity ,suppression:2
immunity ,strategy:2
immunity ,combat:2
suppression ,strategy:2
suppression ,combat:2
suppression ,covid-19:2
maternity ,protection-also:2
maternity ,corona:2
maternity ,crisis:2
protection-also ,corona:2
protection-also ,crisis:2
corona ,crisis:2
children ,questions:2
current ,key:2
evidence ,key:2
key ,questions:2
potential ,jakstat:2
potential ,inhibition:4
potential ,ruxolitinib:2
jakstat ,pathway:2
jakstat ,inhibition:2
jakstat ,ruxolitinib:2
jakstat ,treatment:2
pathway ,ruxolitinib:2
pathway ,treatment:4
inhibition ,ruxolitinib:2
inhibition ,treatment:2
ruxolitinib ,treatment:2
potential ,elimination:2
potential ,sar-cov-2:2
potential ,vaccination:4
potential ,inspired:2
elimination ,sar-cov-2:2
elimination ,vaccination:2
elimination ,inspired:2
sar-cov-2 ,vaccination:2
sar-cov-2 ,inspired:2
vaccination ,inspired:2
ezh2-mediated ,h3k27me3:2
ezh2-mediated ,inhibits:2
ezh2-mediated ,ace2:2
ezh2-mediated ,expression:2
h3k27me3 ,inhibits:2
h3k27me3 ,ace2:2
h3k27me3 ,expression:2
inhibits ,ace2:2
inhibits ,expression:2
dual ,role:2
dual ,echocardiography:2
dual ,diagnosis:2
dual ,acute:2
dual ,cardiac:2
dual ,complications:2
echocardiography ,diagnosis:2
echocardiography ,acute:2
echocardiography ,cardiac:2
echocardiography ,complications:2
diagnosis ,cardiac:2
acute ,complications:2
embolism ,pneumonia:2
characteristics ,lymphocyte:4
characteristics ,subset:2
characteristics ,alteration:2
peripheral ,subset:2
peripheral ,alteration:2
peripheral ,covid-19:2
peripheral ,pneumonia:2
lymphocyte ,subset:4
lymphocyte ,alteration:4
lymphocyte ,pneumonia:2
subset ,alteration:4
subset ,covid-19:2
subset ,pneumonia:2
alteration ,pneumonia:2
continue ,essential:2
continue ,orthopedic:2
continue ,services:2
continue ,covid-19:2
continue ,crisis:2
essential ,orthopedic:2
essential ,crisis:2
orthopedic ,services:2
orthopedic ,crisis:2
services ,crisis:2
short ,term:2
short ,follow-up:2
short ,patients:2
short ,presenting:2
short ,acute:2
short ,onset:2
short ,diabetes:2
short ,diabetic:2
term ,follow-up:2
term ,patients:2
term ,presenting:2
term ,acute:2
term ,onset:2
term ,diabetes:2
term ,diabetic:2
follow-up ,presenting:2
follow-up ,acute:2
follow-up ,onset:2
follow-up ,diabetes:2
follow-up ,diabetic:2
presenting ,onset:2
presenting ,diabetes:2
presenting ,diabetic:2
acute ,diabetic:2
onset ,diabetes:2
onset ,diabetic:2
diabetes ,diabetic:4
review ,sulfate:2
clinical ,sulfate:2
pharmacology ,hydroxychloroquine:2
pharmacology ,sulfate:2
pharmacology ,treatment:2
sulfate ,treatment:2
mesenchymal ,infusion:2
mesenchymal ,shows:2
mesenchymal ,combating:2
mesenchymal ,covid-19-:2
stem ,infusion:2
stem ,shows:2
stem ,combating:2
stem ,covid-19-:2
cell ,infusion:2
cell ,shows:2
cell ,promise:2
cell ,combating:2
cell ,covid-19-:2
infusion ,shows:2
infusion ,promise:2
infusion ,combating:2
infusion ,coronavirus:2
infusion ,covid-19-:2
shows ,promise:2
shows ,combating:2
shows ,coronavirus:2
shows ,covid-19-:2
promise ,combating:2
promise ,coronavirus:2
promise ,covid-19-:2
combating ,covid-19-:2
coronavirus ,covid-19-:2
based ,principles:2
based ,insights:2
based ,epidemiology:2
based ,genome:2
based ,sequencing:2
principles ,insights:2
principles ,epidemiology:2
principles ,genome:2
principles ,sequencing:2
insights ,epidemiology:2
insights ,sequencing:2
epidemiology ,sequencing:2
assessment ,specificity:2
assessment ,patient-collected:2
assessment ,lower:2
assessment ,nasal:2
assessment ,specimens:2
sensitivity ,patient-collected:2
sensitivity ,lower:2
sensitivity ,nasal:2
sensitivity ,specimens:2
specificity ,patient-collected:2
specificity ,lower:2
specificity ,nasal:2
specificity ,specimens:2
patient-collected ,lower:2
patient-collected ,nasal:2
patient-collected ,specimens:2
lower ,nasal:2
crisis ,within:2
crisis ,situation:2
crisis ,refugees:2
crisis ,world:2
within ,mental:2
within ,situation:2
within ,refugees:2
within ,world:2
mental ,situation:2
mental ,refugees:2
mental ,world:2
health ,situation:2
health ,refugees:2
situation ,refugees:2
situation ,world:2
refugees ,world:2
use ,disinfection:2
use ,tunnels:2
use ,disinfectant:2
use ,spraying:2
use ,humans:2
use ,measure:2
disinfection ,tunnels:2
disinfection ,disinfectant:2
disinfection ,spraying:2
disinfection ,humans:2
tunnels ,disinfectant:2
tunnels ,spraying:2
tunnels ,humans:2
tunnels ,measure:2
disinfectant ,spraying:2
disinfectant ,humans:2
disinfectant ,measure:2
spraying ,humans:2
spraying ,measure:2
humans ,measure:2
progress ,role:2
progress ,cytokine:2
progress ,storm:2
progress ,exacerbation:2
role ,exacerbation:2
cytokine ,exacerbation:2
cytokine ,disease:2
storm ,exacerbation:2
storm ,disease:4
candidates ,rapid:2
meditation ,yoga:2
meditation ,practices:2
meditation ,potential:2
meditation ,adjunctive:2
meditation ,treatment:2
meditation ,sars-cov-2:2
yoga ,practices:2
yoga ,potential:2
yoga ,adjunctive:2
yoga ,treatment:2
yoga ,sars-cov-2:2
practices ,potential:2
practices ,adjunctive:2
practices ,sars-cov-2:2
potential ,adjunctive:2
adjunctive ,treatment:4
unexpected ,detection:2
unexpected ,antibodies:2
unexpected ,prepandemic:2
unexpected ,period:2
unexpected ,italy:2
detection ,prepandemic:2
detection ,period:2
sars-cov-2 ,prepandemic:2
antibodies ,prepandemic:2
antibodies ,period:2
antibodies ,italy:2
prepandemic ,italy:2
period ,italy:2
studying ,neuropsychological:2
studying ,sequelae:2
studying ,sars-cov-2:2
studying ,lessons:2
studying ,learned:2
studying ,35:2
neuropsychological ,sequelae:2
neuropsychological ,sars-cov-2:2
neuropsychological ,lessons:2
neuropsychological ,learned:2
neuropsychological ,35:2
sequelae ,sars-cov-2:2
sequelae ,lessons:2
sequelae ,learned:2
sequelae ,35:2
sars-cov-2 ,35:2
lessons ,35:2
learned ,35:2
baricitinib ,review:2
baricitinib ,pharmacology:2
baricitinib ,safety:2
baricitinib ,emerging:2
baricitinib ,clinical:2
baricitinib ,experience:2
pharmacology ,safety:2
pharmacology ,experience:2
safety ,emerging:2
safety ,experience:2
emerging ,experience:2
keeping ,track:2
keeping ,sars-cov-2:2
keeping ,vaccine:2
keeping ,pipeline:2
track ,vaccine:2
track ,pipeline:2
vaccine ,pipeline:2
sars-cov-2 ,nlrp3:2
sars-cov-2 ,plausible:2
infection ,nlrp3:2
infection ,inflammasome:2
infection ,plausible:2
nlrp3 ,plausible:2
nlrp3 ,target:2
nlrp3 ,prevent:2
inflammasome ,plausible:2
inflammasome ,target:2
inflammasome ,prevent:2
plausible ,target:2
plausible ,prevent:2
need ,strengthen:2
need ,primary:2
need ,brazil:2
need ,context:2
strengthen ,primary:2
strengthen ,health:2
strengthen ,care:2
strengthen ,brazil:2
strengthen ,context:2
primary ,brazil:2
primary ,context:2
health ,brazil:2
care ,brazil:2
care ,context:2
brazil ,context:2
sars-cov-2 ,addis:2
sars-cov-2 ,ababa:2
sars-cov-2 ,ethiopia:2
serosurvey ,addis:2
serosurvey ,ababa:2
serosurvey ,ethiopia:2
addis ,ababa:2
addis ,ethiopia:2
ababa ,ethiopia:2
pediatric ,inflammation:2
case ,shock:2
case ,inflammation:2
severe ,shock:2
severe ,multisystem:2
shock ,multisystem:2
shock ,inflammation:2
multisystem ,inflammation:2
scenario ,safely:2
scenario ,ease:2
scenario ,lockdown:2
scenario ,allowing:2
scenario ,economic:2
scenario ,recovery:2
safely ,ease:2
safely ,covid-19:4
safely ,lockdown:2
safely ,allowing:2
safely ,economic:2
safely ,recovery:2
ease ,covid-19:2
ease ,allowing:2
ease ,economic:2
ease ,recovery:2
covid-19 ,allowing:2
covid-19 ,economic:2
lockdown ,allowing:2
lockdown ,economic:2
lockdown ,recovery:2
allowing ,economic:2
allowing ,recovery:2
economic ,recovery:2
graphene ,graphene-derived:2
graphene ,products:2
graphene ,capable:2
graphene ,preventing:2
graphene ,covid-19:2
graphene ,infection:2
graphene-derived ,products:2
graphene-derived ,capable:2
graphene-derived ,preventing:2
graphene-derived ,covid-19:2
graphene-derived ,infection:2
products ,capable:2
products ,preventing:2
products ,infection:2
capable ,preventing:2
capable ,covid-19:2
capable ,infection:2
mutations ,diagnostic:2
mutations ,targets:2
diagnostic ,targets:2
serologic ,healthy:2
serologic ,adult:2
serologic ,reinfection:2
serologic ,hong:2
serologic ,kong:2
serologic ,august:2
responses ,healthy:2
responses ,adult:2
responses ,reinfection:2
responses ,august:2
healthy ,adult:2
healthy ,reinfection:2
healthy ,hong:2
healthy ,kong:2
healthy ,august:2
adult ,sars-cov-2:6
adult ,reinfection:2
adult ,hong:2
adult ,kong:2
adult ,august:2
sars-cov-2 ,august:2
reinfection ,hong:2
reinfection ,kong:2
reinfection ,august:2
hong ,august:2
kong ,august:2
role ,hospital:2
hospital ,community:2
hospital ,pharmacists:2
community ,pharmacists:2
community ,management:2
pharmacists ,management:2
rapid ,polymerase:4
rapid ,chain:2
serological ,real-time:2
serological ,polymerase:2
serological ,chain:2
serological ,reaction:2
estimated ,demand:2
estimated ,us:2
estimated ,hospital:2
estimated ,inpatient:2
estimated ,unit:2
estimated ,beds:2
estimated ,patients:2
demand ,us:2
demand ,hospital:2
demand ,inpatient:2
demand ,unit:2
demand ,beds:2
us ,hospital:2
us ,inpatient:2
us ,intensive:2
us ,care:2
us ,unit:2
us ,beds:2
us ,patients:4
hospital ,inpatient:2
hospital ,intensive:2
hospital ,unit:2
hospital ,beds:2
inpatient ,intensive:2
inpatient ,beds:2
intensive ,beds:2
care ,beds:2
unit ,beds:2
beds ,patients:2
estimation ,percentages:2
estimation ,undiagnosed:2
estimation ,patients:2
percentages ,undiagnosed:2
percentages ,patients:2
percentages ,novel:2
percentages ,coronavirus:2
undiagnosed ,patients:2
undiagnosed ,novel:2
undiagnosed ,coronavirus:2
diagnostic ,head:2
diagnostic ,neck:2
diagnostic ,oncology:2
tests ,implications:2
tests ,head:2
tests ,neck:2
tests ,oncology:2
implications ,head:2
implications ,neck:2
implications ,oncology:2
quantitative ,determination:2
quantitative ,mechanical:2
quantitative ,stability:2
quantitative ,spike:2
determination ,mechanical:2
determination ,stability:2
determination ,spike:2
mechanical ,stability:2
mechanical ,novel:2
mechanical ,coronavirus:2
mechanical ,spike:2
stability ,novel:2
stability ,spike:2
gender ,susceptibility:2
gender ,outcomes:2
gender ,systematic:2
gender ,review:2
susceptibility ,outcomes:2
susceptibility ,systematic:2
clinical ,groote:2
management ,experiences:2
management ,groote:2
covid-19 ,groote:2
experiences ,epidemic:2
experiences ,groote:2
epidemic ,groote:2
potential ,bacillus:2
potential ,calmette-gurin:2
potential ,bcg:2
role ,bacillus:2
role ,calmette-gurin:2
role ,bcg:2
role ,vaccination:2
bacillus ,calmette-gurin:2
bacillus ,bcg:2
bacillus ,covid-19:2
bacillus ,pandemic:2
calmette-gurin ,bcg:2
calmette-gurin ,vaccination:2
calmette-gurin ,covid-19:2
calmette-gurin ,pandemic:2
bcg ,pandemic:4
vaccination ,pandemic:4
hyperinflammatory ,children:2
hyperinflammatory ,associated:2
hyperinflammatory ,need:2
hyperinflammatory ,awareness:2
syndrome ,need:2
syndrome ,awareness:2
children ,associated:2
children ,awareness:2
associated ,need:4
associated ,awareness:2
need ,awareness:2
guillain-barr ,literature:4
impact ,thiol-disulfide:2
impact ,balance:2
impact ,binding:2
impact ,spike:2
impact ,protein:2
thiol-disulfide ,balance:2
thiol-disulfide ,binding:2
thiol-disulfide ,covid-19:2
thiol-disulfide ,spike:2
thiol-disulfide ,protein:2
balance ,binding:2
balance ,spike:2
balance ,protein:2
binding ,covid-19:2
status ,high:2
status ,factors:2
status ,severe:2
status ,distress:2
status ,migraine:2
high ,factors:2
high ,psychological:2
high ,distress:2
high ,migraine:2
risk ,psychological:2
risk ,distress:2
risk ,migraine:2
factors ,psychological:2
factors ,distress:2
factors ,migraine:2
severe ,psychological:4
severe ,migraine:2
psychological ,distress:2
psychological ,migraine:2
distress ,migraine:2
persistence ,inanimate:2
persistence ,inactivation:2
coronaviruses ,inanimate:2
coronaviruses ,surfaces:4
inanimate ,inactivation:2
surfaces ,inactivation:2
novel ,bat:2
novel ,closely:2
novel ,contains:2
novel ,insertions:2
bat ,closely:2
bat ,contains:2
bat ,natural:2
bat ,insertions:2
coronavirus ,closely:2
coronavirus ,insertions:2
closely ,sars-cov-2:2
closely ,contains:2
closely ,natural:2
closely ,insertions:2
related ,contains:2
related ,natural:2
related ,insertions:2
sars-cov-2 ,contains:2
sars-cov-2 ,insertions:2
contains ,natural:2
contains ,insertions:2
natural ,insertions:2
seizure ,covid-19:4
seizure ,association:2
seizure ,review:2
seizure ,potential:2
seizure ,mechanism:2
association ,review:2
association ,potential:2
association ,mechanism:2
review ,mechanism:2
antimicrobial ,management:2
antimicrobial ,respiratory:2
antimicrobial ,infections:2
antimicrobial ,severe:2
antimicrobial ,acute:2
impact ,thyroid:2
impact ,adjunct:2
thyroid ,surgery:2
thyroid ,adjunct:2
thyroid ,therapy:2
cancer ,adjunct:2
surgery ,adjunct:2
surgery ,therapy:2
adjunct ,therapy:2
optimal ,control:6
optimal ,non-pharmaceutical:2
optimal ,interventions:2
control ,non-pharmaceutical:2
covid-19 ,non-pharmaceutical:2
pandemic ,non-pharmaceutical:2
coagulopathy ,similarities:2
coagulopathy ,differences:2
coagulopathy ,among:2
coagulopathy ,pathogenic:2
thrombosis ,similarities:2
thrombosis ,differences:2
thrombosis ,among:2
thrombosis ,pathogenic:2
similarities ,among:2
similarities ,pathogenic:2
differences ,among:4
differences ,pathogenic:2
among ,pathogenic:2
comprehensive ,sarilumab:2
review ,sarilumab:2
sarilumab ,covid-19:2
overexpression ,severe:2
overexpression ,acute:2
overexpression ,respiratory:2
overexpression ,syndrome:2
overexpression ,coronavirus-2:2
overexpression ,receptor:2
acute ,receptor:4
coronavirus-2 ,receptor:2
bradycardia ,renal:2
bradycardia ,failure:2
bradycardia ,atrioventricular:2
bradycardia ,nodal:2
bradycardia ,blockade:2
bradycardia ,shock:2
bradycardia ,hyperkalemia:2
renal ,atrioventricular:2
renal ,nodal:2
renal ,blockade:2
renal ,shock:2
renal ,hyperkalemia:2
failure ,atrioventricular:2
failure ,nodal:2
failure ,blockade:2
failure ,shock:2
failure ,hyperkalemia:2
atrioventricular ,nodal:2
atrioventricular ,blockade:2
atrioventricular ,shock:2
atrioventricular ,hyperkalemia:2
nodal ,blockade:2
nodal ,shock:2
nodal ,hyperkalemia:2
blockade ,shock:2
blockade ,hyperkalemia:2
shock ,hyperkalemia:2
tumor ,markers:2
tumor ,entry:2
markers ,entry:2
markers ,sars-cov-2:2
markers ,infection:2
entry ,infection:4
structural ,full-length:2
basis ,full-length:2
basis ,human:2
basis ,ace2:2
recognition ,full-length:2
recognition ,human:2
sars-cov-2 ,full-length:2
full-length ,human:2
full-length ,ace2:2
complicating ,coronavirus:2
complicating ,disease:2
neutropenic ,enterocolitis:2
neutropenic ,rapid:2
neutropenic ,spontaneous:2
neutropenic ,resolution:2
neutropenic ,portal:2
neutropenic ,venous:2
neutropenic ,gas:2
enterocolitis ,rapid:2
enterocolitis ,spontaneous:2
enterocolitis ,resolution:2
enterocolitis ,portal:2
enterocolitis ,venous:2
enterocolitis ,gas:2
rapid ,spontaneous:2
rapid ,resolution:2
rapid ,venous:2
rapid ,gas:2
spontaneous ,resolution:2
spontaneous ,portal:2
spontaneous ,venous:2
spontaneous ,gas:2
resolution ,portal:2
resolution ,venous:2
resolution ,gas:2
presence ,infectivity:2
presence ,virus:2
presence ,wastewaters:2
presence ,rivers:2
infectivity ,wastewaters:2
infectivity ,rivers:2
sars-cov-2 ,rivers:2
virus ,wastewaters:2
virus ,rivers:2
wastewaters ,rivers:2
early ,multi-organ:2
early ,point-of-care:2
early ,distress:2
multi-organ ,point-of-care:2
multi-organ ,ultrasound:2
multi-organ ,evaluation:2
multi-organ ,respiratory:2
multi-organ ,distress:2
point-of-care ,respiratory:2
point-of-care ,distress:2
ultrasound ,evaluation:2
ultrasound ,distress:2
evaluation ,distress:2
evaluation ,droplet:2
evaluation ,digital:2
evaluation ,quantification:2
droplet ,virus:2
digital ,virus:2
pcr ,virus:2
modeling ,potential:2
modeling ,autophagy:2
modeling ,pathways:2
modeling ,sarcoidosis:2
potential ,sarcoidosis:2
autophagy ,pathways:2
autophagy ,sarcoidosis:2
pathways ,sarcoidosis:2
diabetes ,increased:2
mellitus ,increased:2
coronavirus-related ,health:2
coronavirus-related ,literacy:2
coronavirus-related ,cross-sectional:2
coronavirus-related ,study:2
coronavirus-related ,adults:2
literacy ,cross-sectional:2
literacy ,study:2
literacy ,adults:2
cross-sectional ,adults:2
study ,adults:2
evidence ,herbal:4
evidence ,medicines:2
evidence ,adjuvant:2
evidence ,symptomatic:2
use ,herbal:2
use ,medicines:2
use ,adjuvant:2
herbal ,adjuvant:2
herbal ,symptomatic:2
medicines ,adjuvant:2
medicines ,symptomatic:2
adjuvant ,symptomatic:2
crucial ,laboratory:2
crucial ,parameters:2
crucial ,covid-19:2
crucial ,diagnosis:2
crucial ,prognosis:2
crucial ,updated:2
laboratory ,parameters:4
laboratory ,updated:2
parameters ,diagnosis:2
parameters ,prognosis:4
parameters ,updated:2
diagnosis ,updated:2
prognosis ,updated:2
analysis ,amid:2
patients ,urological:2
patients ,intervention:2
patients ,amid:2
undergoing ,urological:2
undergoing ,intervention:2
undergoing ,amid:2
urological ,intervention:2
urological ,amid:2
intervention ,amid:2
amid ,covid-19:4
guillain-barr ,triggered:2
syndrome ,triggered:2
triggered ,report:2
triggered ,literature:2
can ,post-exposure:2
can ,response:2
post-exposure ,considered:2
post-exposure ,outbreak:2
post-exposure ,response:2
prophylaxis ,considered:2
prophylaxis ,outbreak:2
prophylaxis ,response:2
covid-19 ,considered:2
considered ,outbreak:2
considered ,response:2
fetal ,diagnosis:2
fetal ,therapy:2
fetal ,pandemic:2
fetal ,guidance:2
fetal ,behalf:2
diagnosis ,guidance:2
diagnosis ,behalf:2
therapy ,behalf:2
covid-19 ,behalf:2
pandemic ,guidance:4
pandemic ,behalf:2
guidance ,behalf:2
caffeine ,caffeine-containing:2
caffeine ,pharmaceuticals:2
caffeine ,promising:2
caffeine ,inhibitors:2
caffeine-containing ,pharmaceuticals:2
caffeine-containing ,promising:2
caffeine-containing ,inhibitors:2
pharmaceuticals ,promising:2
pharmaceuticals ,inhibitors:2
drug ,affinity:2
screening ,affinity:2
screening ,new:2
development ,affinity:2
affinity ,protein:2
affinity ,new:2
affinity ,coronavirus:2
rapid ,perinatal:2
rapid ,biorepository:2
rapid ,lessons:2
establishment ,perinatal:2
establishment ,early:2
establishment ,lessons:2
perinatal ,biorepository:2
perinatal ,early:2
perinatal ,lessons:2
biorepository ,early:2
biorepository ,lessons:2
eco-epidemiological ,assessment:2
eco-epidemiological ,covid-19:2
eco-epidemiological ,epidemic:2
eco-epidemiological ,china:2
eco-epidemiological ,january-february:2
assessment ,epidemic:2
assessment ,china:2
assessment ,january-february:2
covid-19 ,january-february:2
epidemic ,january-february:2
drive-through ,screening:4
drive-through ,center:2
drive-through ,safe:2
drive-through ,system:4
center ,safe:2
center ,system:2
safe ,system:2
efficient ,system:2
inactivation ,hcov-229e:2
inactivation ,vitro:2
inactivation ,coldzyme:2
inactivation ,medical:2
inactivation ,device:2
sars-cov-2 ,hcov-229e:2
sars-cov-2 ,coldzyme:2
sars-cov-2 ,device:2
hcov-229e ,vitro:2
hcov-229e ,coldzyme:2
hcov-229e ,medical:2
hcov-229e ,device:2
vitro ,coldzyme:2
vitro ,medical:2
vitro ,device:2
coldzyme ,medical:2
coldzyme ,device:2
cerebellar ,infarction:2
cerebellar ,requiring:2
cerebellar ,surgical:2
cerebellar ,decompression:2
cerebellar ,patient:4
cerebellar ,covid:2
cerebellar ,19:2
infarction ,requiring:2
infarction ,surgical:2
infarction ,decompression:2
infarction ,covid:2
infarction ,19:2
requiring ,surgical:2
requiring ,decompression:2
requiring ,covid:2
requiring ,19:2
surgical ,decompression:2
surgical ,covid:2
surgical ,19:2
decompression ,patient:2
decompression ,covid:2
decompression ,19:2
patient ,covid:2
patient ,19:2
covid-19 ,advice:2
covid-19 ,gastroenterologists:2
pandemic ,advice:2
pandemic ,gastroenterologists:4
clinical ,advice:2
clinical ,gastroenterologists:2
practice ,advice:2
practice ,gastroenterologists:2
advice ,gastroenterologists:2
contamination-free ,visual:2
contamination-free ,detection:2
contamination-free ,sars-cov-2:2
contamination-free ,crisprcas12a:2
contamination-free ,promising:2
visual ,crisprcas12a:2
visual ,promising:2
detection ,crisprcas12a:2
sars-cov-2 ,crisprcas12a:2
crisprcas12a ,promising:2
covid-19 ,professional:2
covid-19 ,football:2
covid-19 ,teams:2
covid-19 ,referees:2
covid-19 ,training:6
indications ,professional:2
indications ,football:2
indications ,teams:2
indications ,referees:2
indications ,training:2
professional ,football:2
professional ,teams:2
professional ,referees:2
professional ,training:2
football ,teams:2
football ,referees:2
football ,training:2
teams ,referees:2
teams ,training:2
referees ,training:2
long ,culture:2
long ,human:2
long ,kidney:2
long ,proximal:2
long ,tubule:2
long ,epithelial:2
long ,cells:2
long ,maintains:2
long ,lineage:2
term ,culture:2
term ,human:2
term ,kidney:2
term ,proximal:2
term ,tubule:2
term ,epithelial:2
term ,cells:2
term ,maintains:2
term ,lineage:2
culture ,human:2
culture ,kidney:2
culture ,proximal:2
culture ,tubule:2
culture ,epithelial:2
culture ,cells:2
culture ,maintains:2
culture ,lineage:2
human ,kidney:2
human ,proximal:2
human ,tubule:2
human ,maintains:2
human ,lineage:2
kidney ,proximal:2
kidney ,tubule:2
kidney ,epithelial:2
kidney ,cells:2
kidney ,maintains:2
kidney ,lineage:2
proximal ,tubule:2
proximal ,epithelial:2
proximal ,cells:2
proximal ,maintains:2
proximal ,lineage:2
tubule ,epithelial:2
tubule ,cells:2
tubule ,maintains:2
tubule ,lineage:2
epithelial ,maintains:2
epithelial ,lineage:2
cells ,maintains:4
cells ,lineage:2
maintains ,lineage:2
robust ,cell:2
robust ,immunity:2
robust ,convalescent:2
robust ,individuals:2
robust ,asymptomatic:2
robust ,mild:2
cell ,convalescent:4
cell ,individuals:4
cell ,asymptomatic:4
cell ,mild:4
immunity ,individuals:4
immunity ,asymptomatic:4
immunity ,mild:4
convalescent ,asymptomatic:4
convalescent ,mild:4
sars-cov-2 ,depends:2
sars-cov-2 ,blocked:2
sars-cov-2 ,clinically:2
cell ,depends:2
cell ,tmprss2:2
cell ,blocked:2
cell ,clinically:2
entry ,depends:2
entry ,blocked:2
entry ,clinically:2
depends ,ace2:2
depends ,tmprss2:2
depends ,blocked:2
depends ,clinically:2
ace2 ,blocked:2
tmprss2 ,blocked:2
tmprss2 ,clinically:2
blocked ,clinically:2
pooled ,sample:2
pooled ,reverse:2
pooled ,transcriptase:2
pooled ,real:2
pooled ,time:2
pooled ,pcr:2
pooled ,assay:2
pooled ,sars:2
pooled ,cov-2:2
rna ,reverse:2
rna ,transcriptase:2
rna ,real:2
rna ,time:2
rna ,pcr:2
sample ,reverse:2
sample ,transcriptase:2
sample ,real:2
sample ,time:2
sample ,pcr:2
sample ,assay:2
sample ,sars:2
sample ,cov-2:2
reverse ,transcriptase:4
reverse ,real:2
reverse ,time:2
reverse ,sars:2
reverse ,cov-2:2
transcriptase ,real:2
transcriptase ,time:2
transcriptase ,pcr:2
transcriptase ,assay:2
transcriptase ,sars:2
transcriptase ,cov-2:2
real ,assay:2
real ,sars:2
real ,cov-2:2
time ,sars:2
time ,cov-2:2
pcr ,sars:2
pcr ,cov-2:2
assay ,sars:2
assay ,cov-2:2
bioinformatic ,prediction:2
bioinformatic ,potential:2
bioinformatic ,cell:2
bioinformatic ,epitopes:2
miller-fisher ,syndrome:2
miller-fisher ,covid-19:2
miller-fisher ,neurochemical:2
miller-fisher ,markers:2
miller-fisher ,early:2
miller-fisher ,sign:2
syndrome ,neurochemical:2
syndrome ,markers:2
syndrome ,sign:2
neurochemical ,markers:2
neurochemical ,early:2
neurochemical ,sign:2
markers ,sign:2
spike ,protein-mediated:4
spike ,signaling:4
spike ,lung:4
spike ,vascular:4
protein-mediated ,cell:4
protein-mediated ,signaling:4
protein-mediated ,lung:4
protein-mediated ,vascular:4
protein-mediated ,cells:4
cell ,signaling:4
cell ,vascular:4
cell ,cells:4
signaling ,lung:4
signaling ,vascular:4
signaling ,cells:4
lung ,vascular:4
vascular ,cells:4
sars-cov-2 ,phylogeny:2
structural ,diversity:2
structural ,phylogeny:2
structural ,animal:4
structural ,host:6
diversity ,phylogeny:2
diversity ,potential:2
diversity ,animal:2
diversity ,host:4
phylogeny ,potential:2
phylogeny ,animal:2
phylogeny ,host:2
variation ,false-negative:2
variation ,rate:2
variation ,reverse:2
variation ,transcriptase:2
variation ,polymerase:2
variation ,chain:2
false-negative ,rate:2
false-negative ,reverse:2
false-negative ,transcriptase:2
rate ,reverse:2
rate ,transcriptase:2
rate ,polymerase:2
rate ,chain:2
reverse ,polymerase:4
reverse ,chain:6
transcriptase ,polymerase:2
transcriptase ,chain:2
investigation ,beta-lactoglobulin:2
investigation ,derived:2
investigation ,bioactive:2
investigation ,peptides:2
beta-lactoglobulin ,derived:2
beta-lactoglobulin ,bioactive:2
beta-lactoglobulin ,peptides:2
beta-lactoglobulin ,sars-cov-2:2
derived ,bioactive:2
derived ,peptides:2
bioactive ,sars-cov-2:2
thoracic ,experience:2
quality ,cochlear:2
quality ,implant:2
quality ,rehabilitation:2
quality ,conditions:2
quality ,german:2
cochlear ,implant:2
cochlear ,rehabilitation:2
cochlear ,covid-19:2
cochlear ,conditions:2
cochlear ,german:2
implant ,rehabilitation:2
implant ,covid-19:2
implant ,conditions:2
implant ,german:2
rehabilitation ,conditions:2
rehabilitation ,german:2
covid-19 ,german:2
conditions ,german:2
comparison ,venues:2
comparison ,case:2
comparison ,clusters:2
comparison ,northeast:2
infection ,venues:2
infection ,clusters:2
venues ,covid-19:2
venues ,case:2
venues ,clusters:2
venues ,northeast:2
venues ,china:2
covid-19 ,northeast:4
case ,clusters:2
case ,northeast:2
clusters ,northeast:2
northeast ,china:2
outbreak ,gynecological:2
management ,gynecological:2
patients ,gynecological:2
viewpoint ,angiotensin-converting:2
viewpoint ,enzyme:2
viewpoint ,anti-hypertensives:2
viewpoint ,coronavirus:2
angiotensin-converting ,anti-hypertensives:2
enzyme ,anti-hypertensives:2
anti-hypertensives ,coronavirus:2
characterization ,100:2
characterization ,sequential:2
characterization ,convalescent:2
characterization ,plasma:2
characterization ,donations:2
100 ,sequential:2
100 ,sars-cov-2:2
100 ,convalescent:2
100 ,plasma:2
100 ,donations:2
sequential ,sars-cov-2:2
sequential ,convalescent:2
sequential ,plasma:2
sequential ,donations:2
sars-cov-2 ,donations:2
convalescent ,donations:2
plasma ,donations:2
guiding ,opinion:2
guiding ,infection:2
guiding ,protection:2
guiding ,ear:2
guiding ,nose:2
guiding ,throat:2
guiding ,department:2
opinion ,infection:2
opinion ,protection:2
opinion ,ear:2
opinion ,nose:2
opinion ,throat:2
opinion ,department:2
infection ,ear:2
infection ,nose:2
infection ,throat:2
protection ,ear:2
protection ,nose:2
protection ,throat:2
protection ,department:4
ear ,throat:2
ear ,department:2
nose ,throat:2
nose ,department:2
throat ,department:2
laboratory-proven ,asymptomatic:2
laboratory-proven ,sars-cov-2:2
laboratory-proven ,covid-19:2
laboratory-proven ,infection:2
laboratory-proven ,18f-fdg:2
laboratory-proven ,petct:2
sars-cov-2 ,18f-fdg:2
infection ,18f-fdg:2
infection ,petct:2
epilepsy ,patient:2
epilepsy ,management:2
epilepsy ,optimization:2
epilepsy ,antiepileptic:2
epilepsy ,therapy:2
covid-19 ,antiepileptic:2
patient ,optimization:2
patient ,antiepileptic:2
patient ,therapy:6
management ,optimization:2
management ,antiepileptic:2
optimization ,antiepileptic:2
antiepileptic ,therapy:2
experience ,severe:2
management ,intensive:4
management ,unit:2
severe ,unit:2
hybridization ,chain:2
hybridization ,reactions:2
hybridization ,targeting:2
hybridization ,severe:2
hybridization ,acute:2
hybridization ,respiratory:2
hybridization ,syndrome:2
chain ,reactions:2
chain ,targeting:2
chain ,severe:4
chain ,acute:4
chain ,respiratory:2
chain ,syndrome:2
reactions ,targeting:2
reactions ,severe:2
reactions ,acute:2
reactions ,respiratory:2
reactions ,syndrome:2
targeting ,syndrome:2
sars-cov-2 ,settling:2
sars-cov-2 ,arb:2
sars-cov-2 ,acei:2
ace2 ,biology:2
ace2 ,settling:2
ace2 ,arb:2
ace2 ,acei:2
biology ,clinical:2
biology ,data:2
biology ,settling:2
biology ,arb:2
biology ,acei:2
clinical ,settling:2
clinical ,arb:2
clinical ,acei:2
data ,settling:2
data ,arb:2
data ,acei:2
settling ,arb:2
settling ,acei:2
arb ,acei:2
antigen-specific ,adaptive:2
antigen-specific ,immunity:2
antigen-specific ,sars-cov-2:2
antigen-specific ,acute:2
antigen-specific ,covid-19:2
antigen-specific ,associations:2
adaptive ,associations:2
immunity ,associations:2
acute ,associations:2
covid-19 ,associations:6
modelling ,predicting:2
modelling ,spatio-temporal:2
modelling ,spread:4
modelling ,italy:2
predicting ,spatio-temporal:2
predicting ,spread:2
predicting ,italy:2
spatio-temporal ,spread:2
spatio-temporal ,italy:2
cross-neutralization ,human:2
cross-neutralization ,monoclonal:2
cross-neutralization ,sars-cov:2
cross-neutralization ,antibody:2
silico ,azithromycin:2
silico ,chloroquine:2
silico ,hydroxychloroquine:2
study ,azithromycin:2
study ,chloroquine:2
study ,hydroxychloroquine:2
azithromycin ,chloroquine:4
test ,importance:2
test ,specificity:2
covid-19 ,sensitivity:4
covid-19 ,specificity:4
antibodies ,importance:2
antibodies ,specificity:2
importance ,sensitivity:2
importance ,specificity:2
epidemiological ,approximation:2
epidemiological ,enteric:2
epidemiological ,manifestation:2
epidemiological ,possible:2
epidemiological ,fecal-oral:2
approximation ,enteric:2
approximation ,manifestation:2
approximation ,possible:2
approximation ,fecal-oral:2
enteric ,manifestation:2
enteric ,possible:2
manifestation ,possible:2
manifestation ,fecal-oral:2
possible ,fecal-oral:2
dysregulation ,immune:2
dysregulation ,system:2
dysregulation ,driver:2
dysregulation ,critical:2
dysregulation ,course:2
dysregulation ,novel:2
immune ,driver:2
system ,driver:2
system ,course:2
driver ,critical:2
driver ,course:2
driver ,novel:2
critical ,course:2
critical ,novel:2
course ,novel:2
anxiety ,public:2
anxiety ,responses:2
anxiety ,covid-19:4
anxiety ,early:2
anxiety ,data:2
anxiety ,thailand:2
public ,data:2
public ,thailand:2
responses ,data:2
responses ,thailand:2
covid-19 ,thailand:2
early ,data:2
early ,thailand:2
data ,thailand:2
factors ,stability:2
factors ,infectivity:2
affecting ,stability:2
affecting ,infectivity:2
stability ,infectivity:2
crisis ,strategies:2
crisis ,hospitals:2
management ,strategies:4
strategies ,hospitals:2
hospitals ,pandemic:2
similarity ,mutation:2
similarity ,spectra:2
similarity ,hypermutated:2
similarity ,genomes:2
similarity ,rubella:2
similarity ,virus:2
mutation ,spectra:2
mutation ,hypermutated:2
mutation ,rubella:2
spectra ,hypermutated:2
spectra ,genomes:2
spectra ,rubella:2
spectra ,virus:2
hypermutated ,genomes:2
hypermutated ,rubella:2
hypermutated ,virus:2
genomes ,rubella:2
rubella ,virus:2
collapsing ,affecting:2
collapsing ,native:2
collapsing ,kidneys:2
collapsing ,individuals:2
glomerulopathy ,affecting:2
glomerulopathy ,native:2
glomerulopathy ,kidneys:2
glomerulopathy ,individuals:2
affecting ,native:2
affecting ,transplant:2
affecting ,kidneys:2
affecting ,individuals:2
native ,transplant:2
native ,kidneys:2
native ,individuals:2
transplant ,kidneys:2
transplant ,individuals:2
kidneys ,individuals:2
risks ,features:2
risks ,secondary:2
risks ,infections:2
risks ,severe:2
risks ,critical:2
risks ,ill:2
features ,secondary:2
features ,infections:2
features ,ill:2
secondary ,critical:2
infections ,critical:2
critical ,ill:2
chest ,preschool:2
chest ,children:4
ct ,preschool:2
imaging ,preschool:2
imaging ,children:2
characteristics ,preschool:2
covid-19 ,preschool:2
pneumonia ,preschool:2
preschool ,children:2
immune ,friend:2
immune ,foe:2
system ,friend:4
system ,foe:4
africa ,care:2
africa ,protection:2
africa ,frontline:2
africa ,workers:2
care ,healthcare:2
protection ,frontline:2
frontline ,healthcare:2
risks ,aerosol:2
risks ,contamination:2
risks ,dental:2
risks ,procedures:2
risks ,second:2
risks ,wave:2
aerosol ,dental:2
aerosol ,second:2
aerosol ,wave:2
contamination ,dental:2
contamination ,procedures:2
contamination ,second:2
contamination ,wave:2
dental ,second:2
dental ,wave:2
procedures ,second:2
procedures ,wave:2
efficacy ,same-day:2
efficacy ,ring:2
efficacy ,adult:2
efficacy ,individuals:2
efficacy ,exposed:2
pragmatic ,same-day:2
pragmatic ,ring:2
pragmatic ,prophylaxis:2
pragmatic ,adult:2
pragmatic ,individuals:2
pragmatic ,exposed:2
same-day ,ring:2
same-day ,prophylaxis:2
same-day ,adult:2
same-day ,individuals:2
same-day ,exposed:2
ring ,prophylaxis:2
ring ,adult:2
ring ,individuals:2
ring ,exposed:2
prophylaxis ,adult:2
prophylaxis ,individuals:2
prophylaxis ,exposed:2
adult ,individuals:2
adult ,exposed:2
individuals ,exposed:2
treat ,covid:2
treat ,19-positive:2
treat ,forget:2
treat ,negative:2
treat ,chronic:2
covid ,19-positive:2
covid ,negative:2
19-positive ,patients:2
19-positive ,forget:2
19-positive ,negative:2
19-positive ,chronic:2
patients ,forget:2
forget ,negative:2
forget ,chronic:2
negative ,chronic:2
bariatric ,metabolic:2
bariatric ,surgery:4
bariatric ,covid-19:2
bariatric ,outbreak:2
bariatric ,phase:2
bariatric ,italy:2
metabolic ,surgery:2
metabolic ,outbreak:2
metabolic ,phase:2
metabolic ,italy:2
surgery ,outbreak:2
surgery ,phase:2
phase ,italy:4
covid-19 ,avenues:2
molecular ,avenues:2
targets ,avenues:2
targets ,discovery:2
drug ,avenues:2
repurposing ,avenues:2
new ,avenues:2
avenues ,discovery:2
online ,antenatal:2
online ,care:2
online ,pandemic:4
online ,opportunities:2
online ,challenges:2
antenatal ,covid-19:2
antenatal ,pandemic:2
antenatal ,opportunities:2
antenatal ,challenges:2
care ,opportunities:2
care ,challenges:6
pandemic ,opportunities:2
perspective ,oncology:2
perspective ,patients:2
perspective ,prospective:2
oncology ,prospective:2
pandemic ,prospective:2
using ,video:2
using ,presentation:2
using ,recruit:2
video ,presentation:2
video ,recruit:2
video ,healthcare:2
video ,workers:2
video ,covid-19:2
video ,pandemic:2
presentation ,recruit:2
presentation ,pandemic:2
recruit ,healthcare:2
recruit ,workers:2
recruit ,covid-19:2
recruit ,pandemic:2
medical ,protection:2
medical ,healthcare:2
masks ,healthcare:2
masks ,workers:2
respirators ,protection:2
respirators ,healthcare:2
respirators ,workers:2
management ,ward:2
management ,designated:2
management ,wuhan:4
suspected ,ward:2
suspected ,designated:2
suspected ,hospital:2
suspected ,wuhan:2
ward ,designated:2
ward ,wuhan:2
designated ,wuhan:2
safety ,tocilizumab:2
safety ,severe:2
safety ,acute:2
safety ,respiratory:2
tocilizumab ,severe:4
treatment ,respiratory:2
ace-inhibitors ,angiotensin:2
ace-inhibitors ,receptor:2
ace-inhibitors ,blockers:2
ace-inhibitors ,severe:2
ace-inhibitors ,acute:2
ace-inhibitors ,respiratory:2
ace-inhibitors ,syndrome:2
angiotensin ,severe:2
angiotensin ,acute:2
angiotensin ,respiratory:2
angiotensin ,syndrome:2
blockers ,severe:2
blockers ,acute:2
blockers ,respiratory:2
blockers ,syndrome:2
expression ,proteins:2
entry ,proteins:2
entry ,cells:2
proteins ,tmprss2:2
proteins ,cells:2
tmprss2 ,cells:4
sars-cov-2 ,infertility:2
sars-cov-2 ,multifaceted:2
male ,infertility:2
male ,possible:2
male ,multifaceted:2
male ,pathology:2
infertility ,possible:2
infertility ,multifaceted:2
infertility ,pathology:2
possible ,multifaceted:2
possible ,pathology:2
multifaceted ,pathology:2
involvement ,comprehensive:2
outbreak ,malaysia:2
amiloride ,promising:2
amiloride ,cardiovascular:2
amiloride ,medication:2
amiloride ,persist:2
amiloride ,covid-19:2
promising ,cardiovascular:2
promising ,medication:2
promising ,persist:2
cardiovascular ,medication:2
cardiovascular ,persist:2
medication ,persist:2
persist ,covid-19:2
association ,mobile:2
association ,phone:2
association ,location:2
association ,data:2
association ,indications:2
association ,travel:2
association ,stay-at-home:2
mobile ,phone:2
mobile ,location:2
mobile ,data:2
mobile ,indications:2
mobile ,travel:2
mobile ,stay-at-home:2
phone ,location:2
phone ,data:2
phone ,indications:2
phone ,travel:2
phone ,stay-at-home:2
location ,data:2
location ,indications:2
location ,travel:2
location ,stay-at-home:2
data ,indications:2
data ,travel:2
data ,stay-at-home:2
indications ,travel:2
indications ,stay-at-home:2
travel ,stay-at-home:2
upper ,gene:2
upper ,reveals:2
upper ,suppressed:2
upper ,immune:2
upper ,responses:2
airway ,gene:2
airway ,reveals:2
airway ,suppressed:2
airway ,immune:2
airway ,responses:2
gene ,reveals:2
gene ,suppressed:2
gene ,immune:2
gene ,responses:2
expression ,suppressed:2
expression ,immune:2
expression ,responses:2
reveals ,suppressed:2
reveals ,immune:2
reveals ,responses:2
suppressed ,immune:2
suppressed ,responses:2
suppressed ,sars-cov-2:2
coast-to-coast ,spread:2
coast-to-coast ,sars-cov-2:2
coast-to-coast ,early:2
coast-to-coast ,epidemic:2
coast-to-coast ,united:2
coast-to-coast ,states:2
spread ,epidemic:2
spread ,united:4
spread ,states:4
early ,states:4
recombinant ,lactobacillus:2
recombinant ,plantarum:2
recombinant ,strain:2
recombinant ,expressing:2
lactobacillus ,plantarum:2
lactobacillus ,strain:2
lactobacillus ,expressing:2
lactobacillus ,spike:2
lactobacillus ,protein:2
plantarum ,strain:2
plantarum ,expressing:2
plantarum ,spike:2
plantarum ,protein:2
strain ,expressing:2
strain ,spike:2
strain ,protein:2
expressing ,spike:2
expressing ,protein:2
right ,clot:2
right ,transit:2
right ,implications:2
right ,pulmonary:2
ventricular ,clot:2
ventricular ,transit:2
ventricular ,implications:2
ventricular ,pulmonary:2
clot ,transit:2
clot ,implications:2
clot ,pulmonary:2
transit ,covid-19:2
transit ,implications:2
transit ,pulmonary:2
implications ,pulmonary:2
hivsars-cov-2 ,coinfection:2
hivsars-cov-2 ,global:2
hivsars-cov-2 ,perspective:2
coinfection ,global:2
coinfection ,perspective:2
pooled ,diagnosis:2
pooled ,real-time:2
pooled ,multi-site:2
pooled ,comparative:2
testing ,real-time:4
testing ,multi-site:2
testing ,comparative:2
covid-19 ,multi-site:2
diagnosis ,real-time:2
diagnosis ,multi-site:2
diagnosis ,comparative:2
real-time ,multi-site:2
real-time ,comparative:2
rt-pcr ,multi-site:2
rt-pcr ,comparative:2
multi-site ,comparative:2
multibasic ,cleavage:2
multibasic ,site:2
multibasic ,spike:2
multibasic ,protein:2
multibasic ,sars-cov-2:2
multibasic ,essential:2
cleavage ,site:2
cleavage ,essential:2
site ,essential:2
spike ,essential:2
protein ,essential:2
chinese ,evidence:2
chinese ,systematic:2
herbal ,current:2
herbal ,systematic:2
medicine ,current:2
medicine ,evidence:2
medicine ,systematic:2
evidence ,systematic:4
evidence ,limited:2
evidence ,spread:2
evidence ,within:2
evidence ,united:2
evidence ,states:2
limited ,early:2
limited ,spread:2
limited ,within:2
limited ,united:2
limited ,states:2
early ,within:2
spread ,within:2
within ,united:2
within ,states:2
peptide ,peptide-based:2
peptide-based ,inhibitors:2
peptide-based ,entry:2
structure ,membrane:2
structure ,resembles:2
structure ,sugar:2
structure ,transporter:2
membrane ,resembles:2
membrane ,sugar:2
membrane ,transporter:2
protein ,resembles:2
protein ,sugar:2
protein ,transporter:2
sars-cov-2 ,sugar:2
sars-cov-2 ,transporter:2
resembles ,sugar:2
resembles ,transporter:2
sugar ,transporter:2
histopathologic ,findings:2
histopathologic ,coronavirus:2
histopathologic ,lung:2
histopathologic ,mini-review:2
findings ,mini-review:2
coronavirus ,mini-review:2
lung ,mini-review:2
cytokine ,aged:2
cytokine ,people:2
cytokine ,cov-2:2
cytokine ,vitamins:2
storm ,aged:2
storm ,people:2
storm ,cov-2:2
storm ,vitamins:2
aged ,people:2
aged ,cov-2:2
aged ,possible:2
aged ,role:2
aged ,vitamins:2
aged ,therapy:2
people ,cov-2:2
people ,possible:2
people ,role:2
people ,vitamins:2
people ,therapy:2
cov-2 ,possible:2
cov-2 ,role:2
cov-2 ,vitamins:2
cov-2 ,therapy:2
possible ,vitamins:2
role ,vitamins:2
vitamins ,therapy:2
atypical ,presentations:2
atypical ,patient:2
presentations ,coronavirus:2
presentations ,disease:2
presentations ,patient:2
presentations ,acute:2
optimizing ,use:4
optimizing ,theranostic:2
optimizing ,nanoparticles:2
optimizing ,life-saving:2
optimizing ,strategy:2
optimizing ,treating:2
use ,theranostic:2
use ,nanoparticles:2
use ,life-saving:2
use ,treating:4
theranostic ,nanoparticles:2
theranostic ,life-saving:2
theranostic ,strategy:2
theranostic ,treating:2
nanoparticles ,life-saving:2
nanoparticles ,strategy:2
nanoparticles ,treating:2
life-saving ,strategy:2
life-saving ,treating:2
strategy ,treating:2
coronavirus ,guidelines:2
coronavirus ,resuming:2
disease ,guidelines:2
disease ,resuming:2
pandemic ,resuming:4
review ,guidelines:2
review ,resuming:2
guidelines ,resuming:4
recommendations ,intensive:6
recommendations ,medicine:2
repositioning ,parp:2
repositioning ,inhibitors:2
repositioning ,sars-cov-2:2
repositioning ,infectioncovid-19:2
repositioning ,new:2
parp ,inhibitors:2
parp ,sars-cov-2:2
parp ,infectioncovid-19:2
parp ,new:2
inhibitors ,infectioncovid-19:2
infectioncovid-19 ,new:2
reorganization ,istituti:2
reorganization ,fisioterapici:2
reorganization ,ospitalieri:2
reorganization ,oncological:2
istituti ,fisioterapici:2
istituti ,ospitalieri:2
istituti ,oncological:2
fisioterapici ,ospitalieri:2
fisioterapici ,oncological:2
ospitalieri ,oncological:2
hospital-acquired ,sars-cov-2:2
hospital-acquired ,pneumonia:2
hospital-acquired ,person:2
hospital-acquired ,living:2
hospital-acquired ,hiv:2
pneumonia ,person:2
pneumonia ,living:2
pneumonia ,hiv:2
person ,living:2
person ,hiv:2
il-6 ,relevance:2
il-6 ,immunopathology:2
il-6 ,sars-cov-2:2
relevance ,immunopathology:2
covid-19 ,prevents:2
covid-19 ,biologics:2
covid-19 ,discontinuation:2
knowledge ,prevents:2
knowledge ,biologics:2
knowledge ,discontinuation:2
knowledge ,data:2
knowledge ,italian:2
prevents ,biologics:2
prevents ,discontinuation:2
prevents ,data:2
prevents ,italian:2
biologics ,discontinuation:2
biologics ,data:2
biologics ,italian:2
discontinuation ,data:2
discontinuation ,italian:2
data ,italian:2
covid-19-associated ,multisystem:2
covid-19-associated ,inflammatory:4
covid-19-associated ,children:4
covid-19-associated ,presenting:2
multisystem ,presenting:2
inflammatory ,presenting:2
children ,presenting:2
bioactive ,natural:2
bioactive ,compounds:2
bioactive ,human:2
bioactive ,coronaviruses:2
bioactive ,review:2
bioactive ,perspective:2
natural ,perspective:2
compounds ,human:2
compounds ,coronaviruses:2
compounds ,review:2
compounds ,perspective:2
covid-19 ,intermediately:2
endoscopy ,services:2
endoscopy ,intermediately:2
endoscopy ,affected:2
endoscopy ,countries:2
services ,intermediately:2
services ,affected:2
services ,countries:2
services ,position:2
intermediately ,affected:2
intermediately ,countries:2
intermediately ,position:2
affected ,countries:2
affected ,position:2
countries ,position:2
lessons ,performing:2
lessons ,neurosurgical:2
lessons ,procedures:2
china ,performing:2
china ,neurosurgical:2
china ,procedures:2
performing ,neurosurgical:2
performing ,procedures:2
neurosurgical ,procedures:2
procedures ,coronavirus:4
covid-19 ,immunotherapy-induced:2
pneumonia ,immunotherapy-induced:2
pneumonia ,18f-fdg:2
mimicking ,immunotherapy-induced:2
mimicking ,18f-fdg:2
mimicking ,petct:2
immunotherapy-induced ,pneumonitis:2
immunotherapy-induced ,18f-fdg:2
immunotherapy-induced ,petct:2
pneumonitis ,18f-fdg:2
pneumonitis ,petct:2
cardiorenal ,tissues:2
cardiorenal ,express:2
cardiorenal ,sars-cov-2:2
cardiorenal ,entry:2
cardiorenal ,genes:2
cardiorenal ,basigin:2
cardiorenal ,bsgcd147:2
cardiorenal ,increases:2
tissues ,express:2
tissues ,entry:2
tissues ,genes:2
tissues ,basigin:2
tissues ,bsgcd147:2
tissues ,increases:2
express ,genes:2
express ,basigin:2
express ,bsgcd147:2
express ,increases:2
sars-cov-2 ,basigin:2
sars-cov-2 ,bsgcd147:2
entry ,basigin:2
entry ,bsgcd147:2
entry ,increases:2
genes ,basigin:2
genes ,bsgcd147:2
genes ,increases:2
basigin ,bsgcd147:2
basigin ,increases:2
bsgcd147 ,increases:2
sars-cov-2 ,likely:2
sars-cov-2 ,match:2
vaccine ,likely:2
vaccine ,match:2
vaccine ,currently:2
vaccine ,circulating:2
candidate ,likely:2
candidate ,match:2
candidate ,currently:2
candidate ,circulating:2
likely ,match:2
likely ,currently:2
likely ,circulating:2
match ,currently:2
match ,circulating:2
currently ,circulating:2
expansion ,plasmablasts:2
expansion ,loss:2
expansion ,memory:2
expansion ,peripheral:2
expansion ,blood:2
plasmablasts ,loss:2
plasmablasts ,memory:2
plasmablasts ,cells:2
plasmablasts ,peripheral:2
plasmablasts ,blood:2
loss ,memory:2
loss ,cells:2
loss ,peripheral:2
loss ,blood:2
memory ,peripheral:2
memory ,blood:2
cells ,peripheral:2
cells ,blood:2
clinical ,imported:4
clinical ,non-imported:2
features ,load:2
features ,imported:2
features ,non-imported:2
dynamics ,load:6
dynamics ,imported:2
dynamics ,non-imported:2
viral ,imported:2
viral ,non-imported:2
load ,imported:2
load ,non-imported:2
imported ,non-imported:2
imported ,patients:2
non-imported ,patients:2
covid-19 ,re-opening:2
covid-19 ,makers:2
re-opening ,schools:2
re-opening ,policy:2
re-opening ,makers:2
re-opening ,dilemma:2
schools ,policy:2
schools ,makers:2
schools ,dilemma:2
policy ,makers:2
policy ,dilemma:2
makers ,dilemma:2
observations ,symptomatic:2
observations ,asymptomatic:2
observations ,infections:2
observations ,494:2
observations ,patients:2
symptomatic ,infections:2
symptomatic ,494:2
asymptomatic ,494:2
infections ,494:2
494 ,patients:2
hand ,care:2
hand ,pandemic:2
hand ,challenges:2
hygiene ,care:2
hygiene ,workers:2
hygiene ,pandemic:2
hygiene ,challenges:2
among ,challenges:2
workers ,challenges:2
potential ,structure:2
chemical ,structure:2
chemical ,anti-sars-cov-2:2
chemical ,rna-dependent:2
chemical ,rna:2
chemical ,polymerase:2
structure ,anti-sars-cov-2:2
structure ,rna-dependent:2
structure ,polymerase:4
anti-sars-cov-2 ,rna-dependent:2
anti-sars-cov-2 ,rna:2
anti-sars-cov-2 ,polymerase:2
overview ,gut:2
overview ,side:2
gut ,side:2
side ,sars-cov-2:2
side ,infection:2
preparing ,coming:2
preparing ,transnational:2
preparing ,cancer:2
preparing ,crisis:2
preparing ,amid:2
preparing ,covid-19:2
preparing ,pandemic:2
coming ,transnational:2
coming ,cancer:2
coming ,crisis:2
coming ,amid:2
coming ,covid-19:4
coming ,pandemic:2
transnational ,cancer:2
transnational ,crisis:2
transnational ,amid:2
transnational ,covid-19:2
transnational ,pandemic:2
cancer ,amid:2
crisis ,amid:2
amid ,pandemic:2
incidence ,nosocomial:2
incidence ,hospitalized:2
incidence ,large:2
incidence ,us:2
incidence ,academic:2
nosocomial ,patients:2
nosocomial ,hospitalized:2
nosocomial ,us:2
nosocomial ,academic:2
patients ,large:2
patients ,academic:2
hospitalized ,large:2
hospitalized ,us:2
hospitalized ,academic:2
large ,us:2
us ,academic:2
recommendations ,gastroenterology:2
recommendations ,peru:2
recommendations ,avoid:2
recommendations ,spread:2
society ,gastroenterology:2
society ,peru:2
society ,avoid:2
society ,spread:2
gastroenterology ,peru:2
gastroenterology ,avoid:2
gastroenterology ,spread:2
peru ,avoid:2
peru ,spread:2
severe ,induced:2
severe ,focal:2
severe ,segmental:2
acute ,induced:2
acute ,focal:2
respiratory ,induced:2
respiratory ,focal:2
respiratory ,segmental:2
syndrome ,induced:4
syndrome ,focal:2
syndrome ,segmental:2
coronavirus ,focal:2
coronavirus ,segmental:2
induced ,focal:2
induced ,segmental:2
focal ,segmental:2
disease ,deceased:2
progression ,patterns:2
progression ,mortality:2
progression ,deceased:2
patterns ,factors:2
patterns ,associated:2
patterns ,mortality:2
patterns ,deceased:2
risk ,deceased:2
factors ,mortality:4
factors ,deceased:2
associated ,deceased:2
mortality ,deceased:2
tobacco ,use:2
tobacco ,cessation:2
tobacco ,three:2
tobacco ,patients:2
tobacco ,suffering:2
tobacco ,psychotic:2
tobacco ,disorders:2
use ,cessation:2
use ,three:2
use ,suffering:2
use ,psychotic:2
use ,disorders:2
cessation ,three:2
cessation ,suffering:2
cessation ,psychotic:2
cessation ,disorders:2
three ,suffering:2
three ,psychotic:2
three ,disorders:2
suffering ,psychotic:2
suffering ,disorders:2
psychotic ,disorders:2
terminal ,complement:2
terminal ,inhibition:2
terminal ,dampens:2
terminal ,inflammation:2
complement ,inhibition:2
complement ,dampens:2
complement ,inflammation:2
inhibition ,dampens:2
inhibition ,inflammation:2
dampens ,inflammation:2
dampens ,covid-19:2
strategy ,vaccines:2
perspective ,proteomics:2
perspective ,virus:4
perspective ,detection:2
perspective ,samples:2
proteomics ,virus:2
proteomics ,detection:2
proteomics ,clinical:2
proteomics ,samples:2
virus ,samples:2
covid-19 ,84-year-old:2
covid-19 ,exacerbation:4
case ,84-year-old:2
case ,exacerbation:2
case ,comorbidities:2
report ,84-year-old:2
report ,man:2
report ,exacerbation:2
report ,multiple:2
report ,comorbidities:2
84-year-old ,man:2
84-year-old ,exacerbation:2
84-year-old ,multiple:2
84-year-old ,comorbidities:2
man ,exacerbation:2
man ,comorbidities:2
exacerbation ,multiple:2
exacerbation ,comorbidities:2
multiple ,comorbidities:2
effectiveness ,efficacy:2
effectiveness ,rpe:2
efficacy ,protective:2
efficacy ,equipment:2
efficacy ,rpe:2
respiratory ,rpe:2
protective ,rpe:2
equipment ,rpe:2
angiotensin-converting ,regulator:2
enzyme ,regulator:2
sars-cov-2 ,regulator:2
receptor ,regulator:2
flattening ,risk:2
flattening ,pre-exposure:2
flattening ,prophylaxis:2
flattening ,covid-19:4
risk ,pre-exposure:2
risk ,prophylaxis:2
pre-exposure ,covid-19:2
exploring ,growth:2
exploring ,cases:2
exploring ,using:2
exploring ,exponential:2
exploring ,modelling:2
exploring ,across:2
exploring ,42:2
growth ,using:2
growth ,exponential:2
growth ,modelling:2
growth ,across:2
growth ,42:2
covid-19 ,exponential:4
covid-19 ,42:2
cases ,exponential:2
cases ,modelling:2
cases ,across:2
cases ,42:2
using ,exponential:2
using ,modelling:2
using ,across:2
using ,42:2
exponential ,modelling:2
exponential ,across:2
exponential ,42:2
modelling ,across:2
modelling ,42:2
across ,42:2
spectrum ,covid-19-associated:2
spectrum ,dermatologic:2
spectrum ,international:2
covid-19-associated ,dermatologic:2
covid-19-associated ,manifestations:2
covid-19-associated ,international:2
dermatologic ,international:2
manifestations ,international:2
neurological ,narrative:2
involvement ,narrative:2
functional ,characteristics:4
functional ,pneumonia:2
functional ,30days:2
characteristics ,30days:2
patients ,30days:2
sars-cov-2 ,30days:2
pneumonia ,30days:2
comprehensive ,drugs:2
comprehensive ,treat:2
comprehensive ,sarscov2:2
comprehensive ,mechanistic:2
comprehensive ,insights:2
analysis ,drugs:2
analysis ,treat:2
analysis ,sarscov2:2
analysis ,mechanistic:2
drugs ,sarscov2:2
drugs ,mechanistic:2
treat ,sarscov2:2
treat ,infection:2
treat ,mechanistic:2
treat ,insights:2
sarscov2 ,mechanistic:2
sarscov2 ,insights:2
infection ,mechanistic:2
virus ,understanding:2
infections ,understanding:2
case ,undifferentiated:2
case ,illness-a:2
report ,undifferentiated:2
report ,febrile:2
report ,illness-a:2
covid-19 ,undifferentiated:2
covid-19 ,illness-a:2
presenting ,undifferentiated:2
presenting ,febrile:2
presenting ,illness-a:2
acute ,undifferentiated:2
acute ,illness-a:2
undifferentiated ,febrile:2
undifferentiated ,illness-a:2
febrile ,illness-a:2
immunologic ,characterization:2
immunologic ,immunosuppressed:2
immunologic ,multiple:2
immunologic ,sclerosis:2
immunologic ,patient:2
characterization ,immunosuppressed:2
characterization ,multiple:2
characterization ,sclerosis:2
immunosuppressed ,multiple:2
immunosuppressed ,sclerosis:2
analysis ,clinic:2
analysis ,including:2
analysis ,drive-through:2
sars-cov-2 ,drive-through:2
screening ,clinic:2
screening ,including:2
screening ,data:2
clinic ,including:2
clinic ,drive-through:2
clinic ,system:2
clinic ,data:2
including ,drive-through:2
including ,data:2
drive-through ,data:2
cardiovascular ,cvds:2
diseases ,cvds:2
cvds ,covid-19:2
cvds ,pandemic:2
cvds ,era:2
covid-19 ,zealand:2
new ,national:2
new ,response:2
new ,descriptive:2
zealand ,impact:2
zealand ,national:2
zealand ,response:2
zealand ,descriptive:2
impact ,national:4
impact ,descriptive:2
national ,descriptive:2
response ,descriptive:2
effectiveness ,airport:2
effectiveness ,screening:2
effectiveness ,detecting:2
effectiveness ,infected:2
airport ,screening:2
airport ,detecting:2
airport ,travellers:2
airport ,infected:2
airport ,novel:2
screening ,detecting:2
screening ,travellers:2
screening ,infected:2
detecting ,travellers:2
detecting ,infected:2
travellers ,infected:2
epidemiology ,epidemic:2
treatment ,epidemic:4
prolonged ,case:2
prolonged ,rheumatoid:2
prolonged ,arthritis:2
prolonged ,taking:2
presence ,case:2
presence ,rheumatoid:2
presence ,arthritis:2
presence ,taking:2
case ,rheumatoid:2
case ,arthritis:2
case ,taking:2
rheumatoid ,taking:2
arthritis ,taking:2
best ,guidance:2
best ,adult:2
best ,infusion:2
best ,centres:2
best ,pandemic:2
practice ,guidance:2
practice ,adult:2
practice ,infusion:2
practice ,centres:2
guidance ,infusion:2
guidance ,centres:2
adult ,infusion:2
adult ,centres:2
adult ,pandemic:2
infusion ,centres:2
infusion ,covid-19:2
infusion ,pandemic:2
centres ,covid-19:2
centres ,pandemic:2
first ,adsorptive:2
first ,hemofilter:2
first ,critically:2
reported ,use:2
reported ,highly:2
reported ,adsorptive:2
reported ,hemofilter:2
reported ,critically:2
reported ,ill:2
use ,adsorptive:2
use ,hemofilter:2
highly ,adsorptive:2
highly ,hemofilter:2
highly ,critically:2
highly ,ill:2
adsorptive ,hemofilter:2
adsorptive ,critically:2
adsorptive ,ill:2
adsorptive ,covid-19:2
hemofilter ,critically:2
hemofilter ,ill:2
hemofilter ,covid-19:2
prone ,pregnant:2
prone ,women:2
prone ,hypoxemia:2
prone ,due:2
prone ,coronavirus:2
prone ,disease:2
positioning ,pregnant:2
positioning ,women:2
positioning ,hypoxemia:2
positioning ,due:2
positioning ,coronavirus:2
positioning ,disease:2
pregnant ,hypoxemia:2
pregnant ,due:2
women ,hypoxemia:2
women ,due:2
hypoxemia ,due:2
hypoxemia ,coronavirus:2
hypoxemia ,disease:2
evolving ,oxygenation:2
evolving ,management:2
evolving ,reasoning:2
oxygenation ,management:2
oxygenation ,reasoning:2
management ,reasoning:2
reasoning ,covid-19:2
unexpected ,ground-glass:2
unexpected ,opacities:2
unexpected ,abdominopelvic:2
unexpected ,ct:2
unexpected ,negative:2
ground-glass ,opacities:2
ground-glass ,abdominopelvic:2
ground-glass ,patient:2
ground-glass ,negative:2
opacities ,abdominopelvic:2
opacities ,ct:2
opacities ,patient:2
opacities ,negative:2
abdominopelvic ,ct:4
abdominopelvic ,patient:2
abdominopelvic ,negative:2
pushing ,past:2
pushing ,tipping:2
pushing ,points:2
pushing ,containment:2
pushing ,trajectories:2
pushing ,severe:2
pushing ,acute:2
past ,tipping:2
past ,points:2
past ,containment:2
past ,trajectories:2
past ,acute:2
tipping ,points:2
tipping ,containment:2
tipping ,trajectories:2
tipping ,severe:2
tipping ,acute:2
points ,containment:2
points ,trajectories:2
points ,severe:2
points ,acute:2
containment ,trajectories:2
containment ,severe:2
containment ,acute:2
trajectories ,severe:2
trajectories ,acute:2
neonates ,infants:2
neonates ,progression:2
neonates ,recovery:2
infants ,progression:2
infants ,recovery:2
progression ,recovery:2
facial ,trauma:2
facial ,management:2
facial ,covid-19:2
facial ,era:2
facial ,primer:2
facial ,surgeons:2
trauma ,management:2
trauma ,era:2
trauma ,primer:2
trauma ,surgeons:2
management ,surgeons:2
era ,surgeons:2
primer ,surgeons:2
effects ,pneumonia:2
control ,pneumonia:2
measures ,pneumonia:2
pneumonia ,prevention:2
renin-angiotensin-aldosterone ,blockers:2
renin-angiotensin-aldosterone ,covic-19:2
renin-angiotensin-aldosterone ,infection:2
renin-angiotensin-aldosterone ,friends:2
blockers ,covic-19:2
blockers ,infection:2
blockers ,friends:2
covic-19 ,infection:2
covic-19 ,friends:2
infection ,friends:2
case ,daegu:2
delivery ,daegu:2
delivery ,korea:2
pregnant ,daegu:2
pregnant ,korea:2
woman ,daegu:2
woman ,korea:2
covid-19 ,daegu:2
infection ,daegu:2
daegu ,korea:2
thoughts ,chemists:2
thoughts ,can:2
thoughts ,contribute:2
thoughts ,fighting:2
thoughts ,sars-cov-2:2
thoughts ,short:2
thoughts ,note:2
chemists ,can:2
chemists ,contribute:2
chemists ,fighting:2
chemists ,sars-cov-2:2
chemists ,short:2
chemists ,note:2
can ,fighting:2
can ,short:2
can ,note:2
contribute ,fighting:2
contribute ,short:2
contribute ,note:2
fighting ,short:2
fighting ,note:2
sars-cov-2 ,note:2
short ,note:2
flattening ,curve:2
flattening ,affect:2
flattening ,critical:2
flattening ,care:2
flattening ,services:2
flattening ,delivery:2
curve ,affect:2
curve ,critical:2
curve ,care:2
curve ,services:2
curve ,delivery:2
curve ,covid-19:2
affect ,critical:2
affect ,care:2
affect ,services:2
affect ,delivery:2
critical ,services:2
critical ,delivery:2
care ,delivery:2
services ,delivery:2
covid-19 ,simulation:2
covid-19 ,covidsim:2
pandemic ,simulation:2
pandemic ,covidsim:2
preparedness ,simulation:2
preparedness ,covidsim:2
simulation ,tool:2
simulation ,covidsim:2
tool ,covidsim:2
myocardial ,microvascular:2
myocardial ,due:2
microvascular ,injury:2
microvascular ,due:2
microvascular ,coronavirus:2
injury ,due:2
viral ,upper:2
viral ,airway:2
viral ,primer:2
infections ,upper:2
infections ,airway:2
infections ,setting:2
infections ,primer:2
upper ,setting:2
upper ,primer:2
airway ,setting:2
airway ,primer:2
setting ,primer:2
sars-cov-2 ,dynamicome:2
covid-19 ,dynamicome:2
structural ,dynamicome:2
evolutionary ,dynamicome:2
evolutionary ,insights:2
dynamicome ,insights:2
low ,transmission:2
low ,asymptomatic:2
low ,carriers:2
low ,tested:2
low ,positive:2
transmission ,carriers:2
transmission ,tested:2
transmission ,positive:2
risk ,carriers:2
risk ,tested:2
risk ,positive:4
asymptomatic ,tested:2
carriers ,tested:2
carriers ,positive:2
tested ,positive:2
human-igg-neutralizing ,monoclonal:2
human-igg-neutralizing ,antibodies:2
human-igg-neutralizing ,block:2
human-igg-neutralizing ,sars-cov-2:2
human-igg-neutralizing ,infection:2
monoclonal ,block:2
antibodies ,block:2
antibodies ,infection:6
block ,infection:2
case ,neurodegenerative:2
case ,dementia:2
fatality ,neurodegenerative:2
fatality ,dementia:2
patients ,neurodegenerative:2
patients ,dementia:2
neurodegenerative ,dementia:2
diabetes ,pathophysiology:2
diabetes ,prognosis:6
diabetes ,practical:2
prevalence ,pathophysiology:2
prevalence ,prognosis:2
prevalence ,practical:2
pathophysiology ,prognosis:2
pathophysiology ,practical:2
prognosis ,practical:2
point-of-care ,diagnostics:2
point-of-care ,current:2
point-of-care ,work:2
point-of-care ,future:2
point-of-care ,perspectives:2
diagnostics ,work:2
diagnostics ,future:2
diagnostics ,perspectives:4
current ,work:2
work ,future:2
work ,perspectives:2
covid-19 ,food:4
covid-19 ,vectors:2
hong ,public:2
hong ,health:2
hong ,food:2
hong ,safety:2
hong ,animal:2
hong ,vectors:2
hong ,perspectives:2
kong ,public:2
kong ,health:2
kong ,food:2
kong ,safety:2
kong ,animal:2
kong ,vectors:2
kong ,perspectives:2
public ,food:2
public ,animal:2
public ,vectors:2
public ,perspectives:2
health ,food:2
health ,vectors:2
health ,perspectives:2
food ,animal:2
food ,vectors:2
food ,perspectives:2
safety ,animal:2
safety ,vectors:2
safety ,perspectives:2
animal ,vectors:2
animal ,perspectives:2
vectors ,perspectives:2
serum ,proteomics:2
serum ,patients:6
serum ,altered:2
serum ,coagulation:2
serum ,complement:2
serum ,status:2
proteomics ,patients:2
proteomics ,altered:2
proteomics ,coagulation:2
proteomics ,complement:2
proteomics ,status:2
covid-19 ,altered:2
altered ,coagulation:2
altered ,complement:2
altered ,status:4
complement ,status:2
organizing ,orthopaedic:2
organizing ,department:2
organizing ,pandemic:2
organizing ,mitigate:2
orthopaedic ,department:2
orthopaedic ,mitigate:2
department ,mitigate:2
pandemic ,mitigate:2
host ,update:2
host ,natural:2
host ,experimental:2
diversity ,update:2
diversity ,natural:2
diversity ,infections:2
diversity ,experimental:2
update ,natural:2
update ,infections:2
update ,experimental:2
natural ,experimental:2
infections ,experimental:2
surface ,patients:2
occurrence ,fate:2
occurrence ,current:2
occurrence ,knowledge:2
fate ,removal:2
fate ,sars-cov-2:2
fate ,wastewater:2
fate ,current:2
fate ,knowledge:2
removal ,sars-cov-2:2
removal ,wastewater:2
removal ,current:2
removal ,knowledge:2
wastewater ,current:2
venous ,position:2
thromboembolism ,sars-cov-2:2
thromboembolism ,position:2
assessing ,pandemic:2
assessing ,spain:2
assessing ,large-scale:2
impact ,spain:2
impact ,large-scale:2
pandemic ,large-scale:2
spain ,large-scale:2
spain ,online:2
large-scale ,online:2
issues ,acute:2
issues ,geriatric:2
issues ,care:2
issues ,lessons:2
issues ,learned:2
challenges ,related:2
challenges ,acute:2
challenges ,geriatric:2
challenges ,learned:2
related ,geriatric:2
related ,lessons:2
related ,learned:2
acute ,geriatric:2
acute ,lessons:2
acute ,learned:2
geriatric ,care:2
geriatric ,lessons:2
geriatric ,learned:2
care ,lessons:2
care ,learned:2
sinonasal ,pathophysiology:2
sinonasal ,systematic:2
pathophysiology ,systematic:2
pathophysiology ,review:4
pandemic ,stand:2
cardiovascular ,stand:2
disease ,stand:2
molecular ,formalin:2
molecular ,fixed:2
molecular ,paraffin:2
molecular ,embedded:2
detection ,formalin:2
detection ,fixed:2
detection ,paraffin:2
detection ,embedded:2
sars-cov-2 ,formalin:2
sars-cov-2 ,fixed:2
sars-cov-2 ,paraffin:2
sars-cov-2 ,embedded:2
formalin ,fixed:2
formalin ,paraffin:2
formalin ,embedded:2
formalin ,specimens:2
fixed ,paraffin:2
fixed ,embedded:2
fixed ,specimens:2
paraffin ,embedded:2
paraffin ,specimens:2
embedded ,specimens:2
hypertension ,lower:2
hypertension ,respiratory:4
hypertension ,tract:2
renin-angiotensin ,risk:4
renin-angiotensin ,lower:2
renin-angiotensin ,tract:2
system ,lower:2
system ,tract:2
risk ,tract:2
angiotensin-converting ,ras:2
angiotensin-converting ,modulator:2
enzyme ,ras:2
enzyme ,modulator:2
ace2 ,modulator:2
sars-cov-2 ,ras:2
sars-cov-2 ,modulator:2
receptor ,ras:2
receptor ,modulator:2
ras ,modulator:2
venous ,andreview:2
venous ,literature:2
thromboembolism ,case:2
thromboembolism ,report:2
thromboembolism ,andreview:2
thromboembolism ,literature:2
covid-19 ,andreview:2
case ,andreview:2
report ,andreview:2
andreview ,literature:2
preparedness ,administrative:2
preparedness ,challenges:2
preparedness ,establishing:2
preparedness ,services:2
administrative ,challenges:2
administrative ,establishing:2
administrative ,obstetric:2
administrative ,services:2
challenges ,establishing:2
challenges ,obstetric:2
challenges ,services:2
establishing ,obstetric:2
establishing ,services:2
obstetric ,services:2
novel ,central:2
novel ,complications:2
disease ,nervous:2
autophagy ,emerging:2
autophagy ,target:2
autophagy ,lessons:2
autophagy ,old:2
autophagy ,friend:2
emerging ,old:2
emerging ,friend:2
target ,lessons:2
target ,old:2
target ,friend:2
lessons ,old:2
lessons ,friend:2
type ,ifns:2
type ,blessing:2
type ,disguise:2
type ,partner:2
type ,crime:2
type ,mers-cov-:2
type ,sars-cov-:2
ifns ,blessing:2
ifns ,disguise:2
ifns ,partner:2
ifns ,crime:2
ifns ,mers-cov-:2
ifns ,sars-cov-:2
blessing ,disguise:2
blessing ,partner:2
blessing ,crime:2
blessing ,mers-cov-:2
blessing ,sars-cov-:2
disguise ,partner:2
disguise ,crime:2
disguise ,mers-cov-:2
disguise ,sars-cov-:2
partner ,crime:2
partner ,mers-cov-:2
partner ,sars-cov-:2
crime ,mers-cov-:2
crime ,sars-cov-:2
mers-cov- ,sars-cov-:2
understanding ,alternative:2
understanding ,solutions:2
understanding ,address:2
implementing ,alternative:2
implementing ,solutions:2
implementing ,address:2
implementing ,covid-19:2
alternative ,solutions:2
alternative ,address:2
covid-19 ,vaping:2
vaping ,risk:2
vaping ,increased:2
vaping ,susceptibility:2
vaping ,sars-cov-2:2
vaping ,infection:2
increased ,susceptibility:4
environmental ,side:2
environmental ,effects:4
environmental ,injudicious:2
environmental ,use:2
environmental ,antimicrobials:2
environmental ,era:2
side ,effects:2
side ,injudicious:2
side ,use:2
side ,antimicrobials:2
side ,era:2
effects ,injudicious:2
effects ,use:2
effects ,antimicrobials:2
effects ,era:2
injudicious ,use:2
injudicious ,antimicrobials:2
injudicious ,era:2
use ,antimicrobials:2
antimicrobials ,era:2
basal ,ganglia:2
basal ,involvement:2
basal ,altered:2
basal ,mental:2
basal ,status:2
basal ,unique:2
basal ,neurological:2
ganglia ,involvement:2
ganglia ,altered:2
ganglia ,mental:2
ganglia ,status:2
ganglia ,unique:2
ganglia ,neurological:2
involvement ,altered:2
involvement ,mental:2
involvement ,unique:2
altered ,mental:2
altered ,unique:2
altered ,neurological:2
mental ,status:2
mental ,unique:2
status ,unique:2
status ,neurological:2
unique ,neurological:2
baseline ,chest:2
baseline ,x-ray:2
baseline ,coronavirus:2
baseline ,disease:2
baseline ,19:2
baseline ,patients:2
baseline ,association:2
chest ,19:2
chest ,association:2
x-ray ,disease:2
x-ray ,19:2
x-ray ,patients:4
x-ray ,association:2
19 ,association:2
theoretical ,design:2
theoretical ,functionalized:2
theoretical ,gold:2
theoretical ,nanoparticles:2
theoretical ,antiviral:2
theoretical ,agents:2
design ,functionalized:2
design ,gold:2
design ,nanoparticles:2
design ,agents:4
functionalized ,gold:2
functionalized ,nanoparticles:2
functionalized ,antiviral:2
functionalized ,agents:2
gold ,nanoparticles:2
gold ,antiviral:2
gold ,agents:2
nanoparticles ,agents:2
cutaneous ,update:2
intestinal ,flora:2
intestinal ,potential:2
intestinal ,strategy:2
intestinal ,fight:2
flora ,potential:2
flora ,strategy:2
flora ,fight:2
flora ,sars-cov-2:2
flora ,infection:2
strategy ,fight:2
fight ,infection:2
acalculous ,acute:2
acalculous ,pancreatitis:2
acalculous ,covid-19:2
acalculous ,patient:2
d-dimer ,admission:2
d-dimer ,predict:2
d-dimer ,in-hospital:2
levels ,admission:2
levels ,predict:2
levels ,in-hospital:2
admission ,predict:4
admission ,in-hospital:2
admission ,mortality:2
admission ,patients:2
predict ,in-hospital:2
predict ,mortality:2
predict ,patients:2
in-hospital ,patients:4
use ,non-invasive:2
use ,vagus:2
use ,nerve:2
use ,stimulation:2
use ,symptoms:2
non-invasive ,vagus:2
non-invasive ,nerve:2
non-invasive ,stimulation:2
non-invasive ,treat:2
non-invasive ,respiratory:2
non-invasive ,symptoms:2
vagus ,nerve:2
vagus ,stimulation:2
vagus ,treat:2
vagus ,respiratory:2
vagus ,symptoms:2
nerve ,stimulation:2
nerve ,treat:2
nerve ,respiratory:2
nerve ,symptoms:2
stimulation ,treat:2
stimulation ,respiratory:2
stimulation ,symptoms:2
treat ,respiratory:2
treat ,symptoms:2
mathematical ,investigate:2
mathematical ,transmission:4
mathematical ,kingdom:2
model ,investigate:2
model ,kingdom:2
investigate ,transmission:2
investigate ,covid-19:2
investigate ,kingdom:2
transmission ,kingdom:2
mental ,outcomes:2
respiratory ,complaints:2
complaints ,time:2
complaints ,covid-19:2
challenging ,issues:2
challenging ,management:2
challenging ,cardiovascular:2
challenging ,risk:2
challenging ,factors:2
challenging ,diabetes:2
issues ,factors:2
management ,factors:2
cardiovascular ,factors:2
susceptibility ,ferrets:2
susceptibility ,cats:2
susceptibility ,domesticated:2
ferrets ,cats:2
ferrets ,dogs:2
ferrets ,domesticated:2
ferrets ,animals:2
cats ,domesticated:2
dogs ,domesticated:2
dogs ,animals:2
domesticated ,animals:2
stability ,analysis:2
stability ,covid-19:2
stability ,within-host:2
stability ,model:2
stability ,immune:2
stability ,response:2
analysis ,within-host:2
analysis ,model:2
within-host ,model:2
within-host ,immune:2
within-host ,response:2
maternal ,newborn:2
maternal ,care:2
maternal ,kenya:2
maternal ,re-contextualising:2
newborn ,care:2
newborn ,pandemic:2
newborn ,kenya:2
newborn ,re-contextualising:2
care ,kenya:2
care ,re-contextualising:2
covid-19 ,kenya:2
covid-19 ,re-contextualising:2
pandemic ,kenya:2
pandemic ,re-contextualising:2
kenya ,re-contextualising:2
diagnostic ,severe:2
diagnostic ,acute:2
diagnostic ,syndrome-related:2
testing ,syndrome-related:2
forgotten ,element:2
forgotten ,resumption:2
forgotten ,elective:2
forgotten ,bariatric:2
forgotten ,surgery:2
element ,resumption:2
element ,elective:2
element ,bariatric:2
element ,surgery:2
resumption ,elective:2
resumption ,bariatric:2
resumption ,surgery:2
elective ,bariatric:2
multiple ,fatalities:2
multiple ,family:2
multiple ,cluster:2
multiple ,respiratory:2
multiple ,distress:2
fatalities ,family:2
fatalities ,cluster:2
fatalities ,acute:2
fatalities ,respiratory:2
fatalities ,distress:2
family ,distress:2
cluster ,distress:2
diabetes ,implications:2
diabetes ,treatment:2
endoscopy ,pandemic:4
endoscopy ,overview:2
endoscopy ,infection:4
endoscopy ,control:2
endoscopy ,measures:2
pandemic ,measures:2
overview ,control:2
overview ,measures:2
consideration ,publication-derived:2
consideration ,immune-related:2
consideration ,associations:2
consideration ,coronavirus:2
publication-derived ,immune-related:2
publication-derived ,associations:2
publication-derived ,coronavirus:2
immune-related ,associations:2
immune-related ,coronavirus:2
associations ,coronavirus:2
pregnancy ,overview:2
overview ,maternal:2
overview ,characteristics:2
maternal ,characteristics:2
maternal ,clinical:2
air ,particulate:2
air ,matter:2
air ,spread:4
pollution ,particulate:2
pollution ,matter:2
role ,particulate:2
role ,matter:2
particulate ,spread:2
matter ,spread:2
need ,manage:2
need ,risk:2
need ,thromboembolism:2
manage ,risk:2
manage ,thromboembolism:2
manage ,patients:2
features ,anosmia:2
shotgun ,proteomics:2
shotgun ,analysis:2
shotgun ,sars-cov-2-infected:2
shotgun ,cells:2
shotgun ,can:2
shotgun ,optimize:2
proteomics ,analysis:2
proteomics ,optimize:2
analysis ,optimize:2
sars-cov-2-infected ,optimize:2
cells ,optimize:2
can ,optimize:2
moroccan ,medicinal:2
moroccan ,plants:2
moroccan ,inhibitors:2
moroccan ,sars-cov-2:2
moroccan ,main:2
moroccan ,protease:2
medicinal ,plants:2
medicinal ,inhibitors:2
medicinal ,main:2
medicinal ,protease:2
plants ,inhibitors:2
plants ,sars-cov-2:2
plants ,main:2
plants ,protease:2
relationship ,abo:2
relationship ,blood:2
relationship ,group:2
relationship ,distribution:2
relationship ,clinical:2
relationship ,characteristics:2
abo ,distribution:2
abo ,clinical:2
abo ,characteristics:2
blood ,distribution:2
group ,distribution:2
group ,characteristics:2
distribution ,clinical:2
distribution ,characteristics:2
world ,organization:2
world ,declares:2
world ,emergency:2
world ,review:2
world ,novel:2
health ,organization:2
health ,declares:2
organization ,declares:2
organization ,global:2
organization ,emergency:2
organization ,review:2
organization ,novel:2
declares ,global:2
declares ,emergency:2
declares ,review:2
declares ,novel:2
body ,may:2
body ,contribute:2
body ,human-to-human:2
body ,transmission:2
body ,severe:2
body ,acute:2
fluids ,may:2
fluids ,contribute:2
fluids ,human-to-human:2
fluids ,transmission:2
fluids ,severe:2
fluids ,acute:2
may ,contribute:2
may ,human-to-human:2
may ,acute:2
contribute ,human-to-human:2
contribute ,transmission:2
contribute ,acute:2
human-to-human ,severe:2
human-to-human ,acute:2
correlation ,migration:2
correlation ,scale:2
correlation ,index:2
correlation ,number:2
correlation ,new:2
correlation ,confirmed:2
migration ,scale:2
migration ,index:2
migration ,number:2
migration ,new:2
migration ,confirmed:2
scale ,index:2
scale ,number:2
scale ,new:2
scale ,confirmed:2
index ,number:2
index ,new:2
index ,confirmed:2
number ,new:2
new ,confirmed:2
using ,il-2rlymphocytes:2
using ,progression:2
il-2rlymphocytes ,predicting:2
il-2rlymphocytes ,clinical:2
il-2rlymphocytes ,progression:2
il-2rlymphocytes ,patients:2
predicting ,clinical:2
predicting ,progression:2
predicting ,patients:2
design ,surfaces:2
design ,prospective:2
design ,detection:2
design ,quartz:2
engineered ,surfaces:2
engineered ,prospective:2
engineered ,detection:2
engineered ,quartz:2
surfaces ,prospective:2
surfaces ,using:2
surfaces ,quartz:2
prospective ,detection:2
prospective ,quartz:2
detection ,quartz:2
sars-cov-2 ,quartz:2
using ,quartz:2
emerging ,structure:2
emerging ,replication:2
coronaviruses ,genome:2
coronaviruses ,structure:2
genome ,replication:2
structure ,replication:2
clinical ,semi-quantitative:2
clinical ,sars-cov2:4
performance ,semi-quantitative:2
performance ,sars-cov2:2
semi-quantitative ,assay:2
semi-quantitative ,sars-cov2:2
semi-quantitative ,igg:2
assay ,sars-cov2:2
sars-cov2 ,igg:2
correlation ,coagulation:2
correlation ,dysfunction:2
correlation ,liver:2
correlation ,damage:2
analysis ,dysfunction:2
analysis ,damage:2
coagulation ,damage:2
dysfunction ,damage:2
covid-19 ,vit-d:2
covid-19 ,negatively:2
covid-19 ,sunlight:2
vit-d ,disease:2
vit-d ,mortality:2
vit-d ,negatively:2
vit-d ,correlates:2
vit-d ,sunlight:2
vit-d ,exposure:2
disease ,negatively:2
disease ,correlates:2
disease ,sunlight:2
mortality ,negatively:2
mortality ,sunlight:2
mortality ,exposure:2
negatively ,correlates:2
negatively ,exposure:2
correlates ,sunlight:2
correlates ,exposure:2
sunlight ,exposure:2
temporal ,profiles:2
temporal ,viral:2
temporal ,load:2
temporal ,posterior:2
temporal ,oropharyngeal:2
temporal ,saliva:2
temporal ,samples:2
temporal ,serum:2
profiles ,viral:2
profiles ,load:2
profiles ,posterior:2
profiles ,oropharyngeal:2
profiles ,saliva:2
profiles ,samples:2
profiles ,serum:2
viral ,posterior:2
viral ,oropharyngeal:2
load ,posterior:2
load ,oropharyngeal:2
posterior ,samples:2
posterior ,serum:2
oropharyngeal ,samples:2
oropharyngeal ,serum:2
saliva ,samples:2
saliva ,serum:2
samples ,serum:2
attitudes ,concerns:2
attitudes ,undergraduate:2
attitudes ,university:2
attitudes ,health:2
attitudes ,sciences:2
attitudes ,students:2
concerns ,undergraduate:2
concerns ,university:2
concerns ,health:2
concerns ,sciences:2
concerns ,students:2
undergraduate ,university:2
undergraduate ,health:2
undergraduate ,sciences:2
undergraduate ,students:2
university ,sciences:2
university ,students:2
health ,sciences:4
health ,students:2
sciences ,students:2
clinical ,physiotherapy:2
features ,physiotherapy:2
features ,management:2
physiotherapy ,management:2
physiotherapy ,covid-19:2
physiotherapy ,children:2
population-based ,changes:2
population-based ,food:2
population-based ,choice:2
population-based ,determinants:2
population-based ,secondary:2
study ,food:2
study ,choice:2
study ,determinants:2
changes ,food:2
changes ,choice:2
changes ,determinants:2
changes ,secondary:2
food ,choice:2
food ,determinants:2
food ,secondary:2
choice ,determinants:2
choice ,secondary:2
determinants ,secondary:4
comparative ,genome:2
genome ,different:2
novel ,different:2
competitive ,sars-cov-2:2
competitive ,serology:2
competitive ,reveals:2
competitive ,antibodies:2
competitive ,targeting:2
competitive ,spike:2
serology ,reveals:2
serology ,antibodies:2
serology ,targeting:2
reveals ,antibodies:2
reveals ,targeting:2
antibodies ,targeting:2
alkamides ,piperamides:2
alkamides ,potential:2
alkamides ,antivirals:2
alkamides ,severe:2
alkamides ,acute:2
piperamides ,potential:2
piperamides ,antivirals:2
piperamides ,severe:2
piperamides ,acute:2
antivirals ,severe:2
antivirals ,acute:2
sars-cov-2 ,navarra-isglobal:2
sars-cov-2 ,saint:2
ivermectin ,navarra-isglobal:2
ivermectin ,trial:2
ivermectin ,saint:2
ivermectin ,evaluate:2
navarra-isglobal ,trial:2
navarra-isglobal ,saint:2
navarra-isglobal ,evaluate:2
navarra-isglobal ,potential:2
trial ,saint:2
trial ,evaluate:4
trial ,potential:2
saint ,evaluate:2
saint ,potential:2
confirmed ,negative:2
confirmed ,antibodies:2
confirmed ,results:2
negative ,antibodies:2
antibodies ,results:2
case ,complement:2
case ,activation:2
case ,multiorgan:2
complement ,impact:2
activation ,multiorgan:2
activation ,impact:2
covid-19 ,multiorgan:4
multiorgan ,impact:2
dermatological ,manifestations:4
dermatological ,sars-cov-2:2
dermatological ,systematic:2
dermatological ,review:4
global ,consortium:2
global ,study:2
global ,neurological:2
global ,dysfunction:2
global ,gcs-neurocovid:2
consortium ,study:2
consortium ,neurological:2
consortium ,dysfunction:2
consortium ,covid-19:2
consortium ,gcs-neurocovid:2
study ,dysfunction:2
study ,gcs-neurocovid:2
neurological ,gcs-neurocovid:2
dysfunction ,gcs-neurocovid:2
covid-19 ,gcs-neurocovid:2
inverse ,correlation:2
inverse ,average:2
inverse ,monthly:2
inverse ,high:2
inverse ,temperatures:2
inverse ,covid-19-related:2
correlation ,average:2
correlation ,monthly:2
correlation ,high:2
correlation ,temperatures:2
correlation ,covid-19-related:2
average ,monthly:2
average ,high:2
average ,temperatures:2
average ,covid-19-related:2
monthly ,high:2
monthly ,temperatures:2
monthly ,covid-19-related:2
high ,temperatures:2
high ,covid-19-related:2
temperatures ,covid-19-related:2
role ,angiology:2
role ,vascular:2
role ,surgery:2
angiology ,vascular:2
angiology ,surgery:2
angiology ,covid-19:2
angiology ,pandemic:2
vascular ,pandemic:2
can ,beta-2-adrenergic:2
can ,pathway:2
can ,new:2
can ,target:2
can ,combat:4
can ,hyperinflammatory:2
beta-2-adrenergic ,pathway:2
beta-2-adrenergic ,new:2
beta-2-adrenergic ,target:2
beta-2-adrenergic ,combat:2
beta-2-adrenergic ,sars-cov-2:2
beta-2-adrenergic ,hyperinflammatory:2
pathway ,new:2
pathway ,target:4
pathway ,combat:2
pathway ,hyperinflammatory:2
new ,target:2
new ,combat:2
new ,hyperinflammatory:2
target ,hyperinflammatory:2
combat ,hyperinflammatory:2
sars-cov-2 ,hyperinflammatory:2
role ,aging:2
aging ,respiratory:2
aging ,viral:2
aging ,infections:2
infections ,potential:4
fast ,rt-qpcr:2
fast ,preheated:2
fast ,nasopharyngeal:2
fast ,swab:2
fast ,samples:2
sars-cov-2 ,preheated:2
detection ,preheated:2
rt-qpcr ,preheated:2
rt-qpcr ,swab:2
rt-qpcr ,samples:2
preheated ,nasopharyngeal:2
preheated ,swab:2
preheated ,samples:2
swab ,samples:2
cathepsin ,l-selective:2
cathepsin ,inhibitors:2
cathepsin ,potentially:2
cathepsin ,promising:2
cathepsin ,treatment:2
cathepsin ,covid-19:2
l-selective ,inhibitors:2
l-selective ,potentially:2
l-selective ,promising:2
l-selective ,treatment:2
l-selective ,covid-19:2
inhibitors ,potentially:2
inhibitors ,treatment:6
potentially ,promising:2
potentially ,treatment:2
mouse ,pathogenesis:2
model ,pathogenesis:4
risk ,mastocytosis:2
risk ,mcas:2
management ,mastocytosis:2
management ,mcas:2
patients ,mastocytosis:2
patients ,mcas:2
mastocytosis ,mcas:2
mastocytosis ,sars-cov-2:2
mcas ,sars-cov-2:2
diagnostic ,groups:2
diagnostic ,short-term:2
diagnostic ,outcomes:2
diagnostic ,treated:2
groups ,short-term:2
groups ,outcomes:2
groups ,suspected:2
groups ,covid-19:2
groups ,cases:2
groups ,treated:2
short-term ,outcomes:4
short-term ,suspected:2
short-term ,cases:2
short-term ,treated:2
outcomes ,suspected:2
outcomes ,cases:2
outcomes ,treated:2
suspected ,treated:2
host ,tropism:2
host ,silico:4
host ,analysis:6
host ,main:2
tropism ,silico:2
tropism ,analysis:2
tropism ,main:2
tropism ,cellular:2
tropism ,factors:2
silico ,cellular:2
silico ,factors:2
analysis ,cellular:2
main ,cellular:2
main ,factors:2
cellular ,factors:2
manifestations ,literature:2
complications ,literature:2
real-time ,pcr-based:2
real-time ,canadian:2
real-time ,laboratories:2
pcr-based ,detection:2
pcr-based ,canadian:2
pcr-based ,laboratories:2
sars-cov-2 ,canadian:2
detection ,canadian:2
detection ,laboratories:2
canadian ,laboratories:2
endothelial ,major:2
endothelial ,player:2
cell ,major:2
cell ,player:2
dysfunction ,major:2
dysfunction ,player:2
major ,player:2
player ,infection:2
dynamics ,severity:2
severity ,infected:2
accurate ,screening:2
accurate ,attention-based:2
accurate ,deep:2
accurate ,3d:2
accurate ,multiple:2
accurate ,instance:2
screening ,attention-based:2
screening ,3d:2
screening ,multiple:2
screening ,instance:2
covid-19 ,attention-based:2
covid-19 ,instance:2
using ,attention-based:2
using ,3d:2
using ,multiple:2
using ,instance:2
attention-based ,deep:2
attention-based ,3d:2
attention-based ,multiple:2
attention-based ,instance:2
deep ,3d:2
deep ,multiple:2
deep ,instance:2
3d ,multiple:2
3d ,instance:2
multiple ,instance:2
randomized ,multicenter:4
randomized ,clinical:2
randomized ,evaluate:2
randomized ,melatonin:2
multicenter ,clinical:2
multicenter ,trial:2
multicenter ,evaluate:2
multicenter ,efficacy:2
multicenter ,melatonin:2
evaluate ,efficacy:2
evaluate ,melatonin:2
tribute ,health:2
tribute ,workers:2
tribute ,china:2
tribute ,group:2
tribute ,respectable:2
tribute ,population:2
health ,group:2
health ,respectable:2
workers ,china:2
workers ,group:2
workers ,respectable:2
workers ,population:2
china ,group:2
china ,respectable:2
group ,respectable:2
group ,population:2
respectable ,population:2
guidelines ,frontline:2
guidelines ,staff:2
guidelines ,safety:2
frontline ,staff:2
frontline ,safety:2
health ,staff:2
care ,safety:2
staff ,safety:2
liver ,association:2
liver ,death:2
dysfunction ,risk:2
dysfunction ,death:2
death ,patients:2
56-year-old ,man:2
56-year-old ,rt-pcr:2
56-year-old ,negative:2
56-year-old ,nasopharyngeal:2
56-year-old ,swabs:2
56-year-old ,coronavirus:2
56-year-old ,disease:2
man ,rt-pcr:2
man ,negative:2
man ,nasopharyngeal:2
man ,swabs:2
rt-pcr ,nasopharyngeal:2
rt-pcr ,swabs:2
negative ,disease:2
nasopharyngeal ,disease:2
swabs ,disease:2
role ,treating:2
interferons ,treating:2
interferons ,patients:2
public ,perceptions:4
public ,attitudes:2
public ,toward:2
perceptions ,attitudes:2
perceptions ,toward:2
perceptions ,nonpharmaceutical:2
perceptions ,interventions:2
attitudes ,nonpharmaceutical:2
attitudes ,interventions:2
toward ,nonpharmaceutical:2
toward ,interventions:2
covid-19 ,nonpharmaceutical:2
potential ,benefit:2
potential ,telmisartan:2
potential ,protect:2
potential ,overweight:2
potential ,copd:2
benefit ,telmisartan:2
benefit ,protect:2
benefit ,overweight:2
benefit ,patients:4
benefit ,copd:2
telmisartan ,protect:2
telmisartan ,overweight:2
telmisartan ,patients:2
telmisartan ,copd:2
protect ,overweight:2
protect ,copd:2
overweight ,patients:2
overweight ,copd:2
patients ,copd:4
occult ,sars-cov-2:2
occult ,infection:2
occult ,possible:2
occult ,hypothesis:2
occult ,viral:2
occult ,relapse:2
sars-cov-2 ,relapse:2
infection ,hypothesis:2
infection ,relapse:2
possible ,hypothesis:2
possible ,relapse:2
hypothesis ,relapse:2
viral ,relapse:2
repurposing ,metocurine:2
repurposing ,inhibitor:2
repurposing ,develop:2
repurposing ,therapy:2
metocurine ,main:2
metocurine ,protease:2
metocurine ,inhibitor:2
metocurine ,develop:2
metocurine ,novel:2
metocurine ,antiviral:2
metocurine ,therapy:2
main ,develop:2
main ,antiviral:2
main ,therapy:2
protease ,develop:2
protease ,therapy:2
inhibitor ,develop:2
inhibitor ,novel:2
inhibitor ,antiviral:2
inhibitor ,therapy:2
develop ,novel:2
develop ,antiviral:2
develop ,therapy:2
characteristics ,mechanism:2
characteristics ,liver:2
viruses ,can:2
viruses ,coexist:2
viruses ,humans:2
viruses ,future:2
can ,coexist:2
can ,humans:2
can ,future:2
coexist ,humans:2
coexist ,future:2
coexist ,sars-cov-2:2
humans ,future:2
repurposing ,candidate:2
candidate ,main:2
cluster ,french:2
cluster ,alps:2
cluster ,february:2
coronavirus ,french:2
coronavirus ,alps:2
coronavirus ,february:2
disease ,french:2
disease ,alps:2
disease ,february:2
covid-19 ,alps:2
covid-19 ,february:2
french ,alps:2
french ,february:2
alps ,february:2
potential ,black:2
potential ,seed:2
potential ,principal:2
potential ,constituent:2
potential ,thymoquinone:2
implications ,black:2
implications ,seed:2
implications ,principal:2
implications ,constituent:2
implications ,thymoquinone:2
black ,seed:2
black ,principal:2
black ,constituent:2
black ,thymoquinone:2
seed ,principal:2
seed ,constituent:2
seed ,thymoquinone:2
principal ,constituent:2
principal ,thymoquinone:2
constituent ,thymoquinone:2
analysis ,vertical:2
update ,molecular:2
update ,diagnostics:2
chloroquine ,evidence:2
chloroquine ,effectiveness:2
evidence ,effectiveness:2
endocrine ,surgery:2
endocrine ,pandemic:2
endocrine ,need:2
endocrine ,update:2
endocrine ,indications:2
surgery ,update:2
surgery ,indications:2
need ,update:2
need ,indications:2
update ,indications:2
impact ,climate:2
impact ,ambient:2
impact ,air:2
impact ,pollution:2
impact ,growth:2
climate ,ambient:2
climate ,air:2
climate ,pollution:2
climate ,epidemic:2
climate ,growth:2
ambient ,epidemic:2
ambient ,growth:2
air ,epidemic:2
air ,growth:2
pollution ,epidemic:2
pollution ,growth:2
epidemic ,growth:2
household ,secondary:2
household ,attack:2
household ,rate:2
household ,associated:2
household ,determinants:2
secondary ,attack:2
secondary ,rate:2
attack ,associated:2
attack ,determinants:2
rate ,determinants:2
associated ,determinants:2
global ,psychological:2
global ,implications:2
psychological ,implications:2
psychological ,acute:2
psychological ,respiratory:2
psychological ,syndrome:2
implications ,severe:2
implications ,acute:4
implications ,respiratory:2
direct ,on-the-spot:2
on-the-spot ,detection:2
on-the-spot ,sars-cov-2:2
on-the-spot ,patients:2
disease ,dictates:2
disease ,sars-cov-2-specific:2
disease ,neutralizing:2
severity ,dictates:2
severity ,sars-cov-2-specific:2
severity ,neutralizing:2
dictates ,sars-cov-2-specific:2
dictates ,neutralizing:2
dictates ,antibody:2
dictates ,responses:2
sars-cov-2-specific ,neutralizing:2
successful ,distress:2
successful ,syndrome:2
successful ,newly:2
management ,distress:2
management ,newly:2
distress ,newly:2
disentangling ,primer:2
disentangling ,interactions:2
disentangling ,improves:2
disentangling ,sars-cov-2:2
disentangling ,genome:2
disentangling ,sequencing:2
disentangling ,multiplex:2
primer ,interactions:2
primer ,improves:2
primer ,genome:2
primer ,sequencing:2
primer ,multiplex:2
interactions ,improves:2
interactions ,genome:2
interactions ,sequencing:2
interactions ,multiplex:2
improves ,sars-cov-2:2
improves ,genome:2
improves ,sequencing:2
improves ,multiplex:2
genome ,multiplex:2
sequencing ,multiplex:2
antibody ,identification:2
antibody ,current:2
antibody ,past:2
tests ,current:2
tests ,past:2
identification ,current:2
identification ,past:2
vertical ,asymptomatic:2
vertical ,woman:2
vertical ,india:2
transmission ,woman:2
transmission ,india:4
asymptomatic ,india:2
pregnant ,india:2
woman ,india:2
landscape ,cancer:2
landscape ,proteins:2
landscape ,targeted:2
human ,cancer:2
human ,proteins:2
human ,targeted:2
cancer ,proteins:2
cancer ,targeted:2
proteins ,targeted:2
local ,lockdowns:2
local ,outperform:2
local ,global:2
local ,lockdown:2
local ,far:2
local ,side:2
local ,epidemic:4
lockdowns ,outperform:2
lockdowns ,global:2
lockdowns ,lockdown:2
lockdowns ,far:2
lockdowns ,side:2
lockdowns ,covid-19:4
outperform ,global:2
outperform ,lockdown:2
outperform ,far:2
outperform ,side:2
outperform ,covid-19:2
outperform ,epidemic:2
global ,far:2
global ,side:2
global ,epidemic:2
lockdown ,far:2
lockdown ,side:2
lockdown ,epidemic:2
far ,side:2
far ,epidemic:2
side ,epidemic:2
updated ,understanding:2
updated ,outbreak:2
updated ,2019-ncov:2
understanding ,outbreak:2
understanding ,2019-ncov:2
pandemic ,japan:2
searching ,sars-cov-2:2
searching ,particulate:2
searching ,matter:2
searching ,possible:2
searching ,early:2
searching ,indicator:2
sars-cov-2 ,indicator:4
particulate ,early:2
particulate ,indicator:2
matter ,early:2
matter ,indicator:2
possible ,indicator:2
early ,indicator:2
health ,anxiety:2
health ,cyberchondria:2
health ,coping:2
anxiety ,cyberchondria:2
anxiety ,coping:2
anxiety ,current:2
anxiety ,pandemic:2
cyberchondria ,coping:2
cyberchondria ,current:2
cyberchondria ,covid-19:2
cyberchondria ,pandemic:2
coping ,current:2
coping ,covid-19:2
coping ,pandemic:2
understanding ,air:2
understanding ,water:2
understanding ,borne:2
understanding ,transmission:2
understanding ,survival:2
air ,water:2
air ,borne:2
air ,survival:2
air ,insights:2
water ,borne:2
water ,survival:2
water ,insights:2
borne ,transmission:2
borne ,survival:2
borne ,coronavirus:2
borne ,insights:2
transmission ,survival:2
survival ,insights:2
ent ,management:2
ent ,children:2
ent ,adenotonsillar:2
ent ,disease:2
management ,adenotonsillar:2
children ,adenotonsillar:2
adenotonsillar ,disease:2
adenotonsillar ,covid-19:2
adenotonsillar ,pandemic:2
associated ,aspergillosis:2
associated ,literature:2
pulmonary ,aspergillosis:2
pulmonary ,literature:2
pulmonary ,review:2
aspergillosis ,literature:2
aspergillosis ,review:2
coagulation ,abnormalities:2
coagulation ,thrombosis:2
coagulation ,infected:2
abnormalities ,thrombosis:2
abnormalities ,infected:2
abnormalities ,sars-cov-2:2
thrombosis ,infected:2
forty ,years:2
forty ,coronaviruses:2
years ,coronaviruses:2
cancer ,effects:2
patients ,patient:2
novel ,hemodialysis:2
hemodialysis ,two:2
combination ,thrombolytic:2
combination ,immunosuppressive:2
thrombolytic ,immunosuppressive:2
thrombolytic ,therapy:2
thrombolytic ,coronavirus:2
thrombolytic ,disease:2
immunosuppressive ,coronavirus:2
parallel-group ,multicenter:2
parallel-group ,randomized:2
parallel-group ,double-blinded:2
parallel-group ,placebo-controlled:2
parallel-group ,phase:2
multicenter ,double-blinded:2
multicenter ,placebo-controlled:2
multicenter ,phase:2
randomized ,double-blinded:2
randomized ,placebo-controlled:2
randomized ,phase:2
double-blinded ,placebo-controlled:2
double-blinded ,phase:2
placebo-controlled ,phase:2
practical ,treatment:2
practical ,dental:2
practical ,congenital:2
practical ,bleeding:2
recommendations ,dental:2
recommendations ,congenital:2
recommendations ,bleeding:2
treatment ,dental:2
treatment ,congenital:2
treatment ,bleeding:2
dental ,patients:2
dental ,congenital:2
dental ,bleeding:2
congenital ,bleeding:2
possible ,environmental:2
possible ,china:2
environmental ,spread:2
environmental ,china:2
effects ,spread:2
knowledge ,symptoms:2
knowledge ,gender:2
knowledge ,differences:2
knowledge ,communication:2
assessment ,symptoms:2
assessment ,gender:2
assessment ,differences:2
assessment ,communication:2
symptoms ,gender:2
symptoms ,differences:2
symptoms ,communication:2
gender ,differences:2
gender ,communication:2
differences ,communication:2
covid ,challenges:2
covid ,virologists:2
covid ,food:2
covid ,industry:2
19 ,challenges:2
19 ,virologists:2
19 ,food:2
19 ,industry:2
challenges ,virologists:2
challenges ,food:2
challenges ,industry:2
virologists ,food:2
virologists ,industry:2
ace2 ,ace:2
ace2 ,structure-based:2
ace ,structure-based:2
ace ,insights:2
ace ,mechanism:2
ace ,regulation:2
ace ,receptor:2
structure-based ,insights:2
structure-based ,mechanism:2
structure-based ,regulation:2
structure-based ,receptor:2
insights ,mechanism:2
insights ,regulation:2
mechanism ,regulation:2
mechanism ,receptor:2
heart ,update:2
heart ,clinicians:2
update ,clinicians:2
aspects ,mechanisms:2
aspects ,manifestations:2
systematic ,associated:2
meta-analysis ,associated:2
meta-analysis ,injury:2
preferential ,use:2
preferential ,total:2
preferential ,intravenous:2
preferential ,anesthesia:2
preferential ,ambulatory:2
preferential ,otolaryngology:2
use ,total:2
use ,intravenous:4
use ,ambulatory:2
use ,otolaryngology:2
total ,intravenous:2
total ,anesthesia:2
total ,ambulatory:2
total ,otolaryngology:2
intravenous ,anesthesia:2
intravenous ,ambulatory:2
intravenous ,otolaryngology:2
anesthesia ,ambulatory:2
anesthesia ,otolaryngology:2
ambulatory ,otolaryngology:2
respiratory ,rehabilitation:2
respiratory ,post-covid19:2
respiratory ,spa:2
respiratory ,centers:2
respiratory ,steps:2
rehabilitation ,post-covid19:2
rehabilitation ,spa:2
rehabilitation ,centers:2
rehabilitation ,first:2
rehabilitation ,steps:2
post-covid19 ,patients:2
post-covid19 ,spa:2
post-covid19 ,centers:2
post-covid19 ,first:2
post-covid19 ,steps:2
patients ,spa:2
patients ,centers:2
patients ,steps:2
spa ,centers:2
spa ,first:2
spa ,steps:2
centers ,first:2
centers ,steps:2
first ,steps:2
nutrition ,management:4
nutrition ,critically:2
nutrition ,acutely:2
nutrition ,unwell:2
nutrition ,hospitalised:2
nutrition ,patients:2
management ,acutely:2
management ,unwell:2
management ,hospitalised:2
critically ,acutely:2
critically ,unwell:2
critically ,hospitalised:2
acutely ,unwell:2
acutely ,hospitalised:2
acutely ,patients:2
unwell ,hospitalised:2
unwell ,patients:2
hospitalised ,patients:6
atypical ,incidentally:2
atypical ,detected:2
atypical ,18f-fdg:2
atypical ,petct:2
presentation ,incidentally:2
presentation ,detected:2
presentation ,18f-fdg:2
presentation ,petct:2
covid-19 ,incidentally:2
incidentally ,detected:2
incidentally ,18f-fdg:2
incidentally ,petct:2
detected ,18f-fdg:2
implications ,sars-cov-2-associated:2
implications ,myocarditis:2
implications ,medical:2
implications ,evaluation:2
sars-cov-2-associated ,myocarditis:2
sars-cov-2-associated ,medical:2
sars-cov-2-associated ,evaluation:2
myocarditis ,medical:2
myocarditis ,evaluation:2
medical ,evaluation:2
antibody-dependent ,vaccines:2
antibody-dependent ,therapies:2
enhancement ,vaccines:2
enhancement ,therapies:2
potential ,platelets:2
role ,platelets:2
platelets ,implications:2
platelets ,thrombosis:2
implications ,thrombosis:2
covid-19 ,peptidase:2
comorbidities ,dipeptidyl:2
comorbidities ,peptidase:2
comorbidities ,dpp4:2
comorbidities ,disease:2
role ,peptidase:2
role ,dpp4:2
dipeptidyl ,peptidase:2
dipeptidyl ,disease:2
peptidase ,dpp4:2
peptidase ,disease:2
dpp4 ,disease:2
considerations ,coronary:2
considerations ,syndromes:2
management ,coronary:2
management ,syndromes:2
acute ,syndromes:4
coronary ,syndromes:4
optimizing ,medication:2
optimizing ,treatment:2
optimizing ,opioid:2
optimizing ,disorder:2
medication ,opioid:2
medication ,use:2
medication ,disorder:2
medication ,sars-cov-2:2
treatment ,opioid:2
treatment ,disorder:2
opioid ,use:2
opioid ,disorder:2
opioid ,covid-19:2
opioid ,sars-cov-2:2
use ,disorder:2
characteristics ,predictors:2
predictors ,symptomatic:2
predictors ,coronavirus:2
predictors ,disease:2
placental ,mild:2
placental ,disease:2
pregnant ,mild:2
woman ,mild:2
woman ,disease:2
impaired ,natural:2
impaired ,killer:2
impaired ,counts:2
impaired ,cytolytic:2
impaired ,activity:2
impaired ,severe:2
natural ,counts:2
natural ,cytolytic:2
natural ,patients:2
natural ,severe:4
killer ,counts:2
killer ,cytolytic:2
killer ,activity:2
killer ,patients:2
killer ,severe:2
cell ,cytolytic:2
cell ,activity:2
counts ,cytolytic:2
counts ,activity:2
counts ,severe:2
cytolytic ,activity:2
cytolytic ,patients:2
cytolytic ,severe:2
activity ,patients:2
cause ,neurological:2
cause ,complications:2
chronic ,neurological:2
plasma ,ip-10:2
plasma ,mcp-3:2
plasma ,highly:2
plasma ,associated:2
plasma ,severity:2
ip-10 ,mcp-3:2
ip-10 ,levels:2
ip-10 ,highly:2
ip-10 ,associated:2
ip-10 ,disease:2
ip-10 ,severity:2
mcp-3 ,levels:2
mcp-3 ,highly:2
mcp-3 ,associated:2
mcp-3 ,disease:2
mcp-3 ,severity:2
levels ,highly:2
levels ,disease:2
levels ,severity:2
highly ,associated:2
highly ,severity:2
use ,immunoglobulin:2
use ,gamma:2
intravenous ,gamma:2
immunoglobulin ,gamma:2
immunoglobulin ,severe:4
gamma ,treatment:2
gamma ,severe:2
gamma ,coronavirus:2
potential ,zoonotic:4
potential ,origins:2
zoonotic ,insights:2
zoonotic ,preventing:2
zoonotic ,future:2
origins ,insights:2
origins ,preventing:2
origins ,future:2
insights ,preventing:2
insights ,future:2
preventing ,future:2
infection ,origin:2
origin ,human:2
characteristics ,human:4
sars-cov-2 ,oxidative:2
sars-cov-2 ,stress:2
infection ,oxidative:2
infection ,stress:2
pathogenesis ,related:2
pathogenesis ,oxidative:2
pathogenesis ,stress:2
related ,oxidative:2
related ,stress:2
related ,response:4
oxidative ,response:2
stress ,response:2
legal ,implications:2
legal ,personal:2
legal ,protective:2
legal ,equipment:2
legal ,use:2
legal ,treating:2
legal ,patients:2
implications ,protective:2
implications ,equipment:2
implications ,use:2
implications ,treating:2
personal ,treating:2
personal ,patients:2
protective ,treating:2
equipment ,treating:2
equipment ,patients:2
pulmonary ,cardiac:2
pulmonary ,african:2
pulmonary ,american:2
cardiac ,pathology:2
cardiac ,african:2
cardiac ,american:2
pathology ,african:2
pathology ,american:2
african ,american:2
african ,patients:2
american ,patients:2
american ,covid-19:4
humor ,age:2
humor ,covid-19:2
humor ,lockdown:2
humor ,explorative:2
humor ,qualitative:2
humor ,study:2
age ,lockdown:2
age ,explorative:2
age ,qualitative:2
age ,study:2
lockdown ,explorative:2
lockdown ,qualitative:2
lockdown ,study:2
explorative ,qualitative:2
explorative ,study:2
status ,laboratory:2
laboratory ,narrative:2
diagnosis ,narrative:2
prognostic ,modeling:2
prognostic ,using:2
prognostic ,artificial:2
prognostic ,intelligence:2
prognostic ,united:2
prognostic ,kingdom:2
modeling ,artificial:2
modeling ,intelligence:2
modeling ,united:2
modeling ,kingdom:2
using ,intelligence:2
using ,united:2
using ,kingdom:2
artificial ,united:2
artificial ,kingdom:2
intelligence ,united:2
intelligence ,kingdom:2
pneumonia ,transplant:4
pneumonia ,recipients:2
lung ,transplant:2
lung ,recipients:2
lung ,report:2
transplant ,cases:2
recipients ,report:2
recipients ,cases:2
antibody ,lets:2
antibody ,stick:2
antibody ,known:2
antibody ,knowns:2
responses ,lets:2
responses ,stick:2
responses ,known:2
responses ,knowns:2
sars-cov-2 ,lets:2
sars-cov-2 ,stick:2
lets ,stick:2
lets ,known:2
lets ,knowns:2
stick ,known:2
stick ,knowns:2
known ,knowns:2
disease ,temporal:2
spectrum ,ct:4
spectrum ,findings:4
spectrum ,temporal:2
spectrum ,progression:2
ct ,progression:2
findings ,temporal:2
temporal ,progression:2
glycogen ,synthase:2
glycogen ,kinase-3:2
glycogen ,putative:2
glycogen ,target:2
glycogen ,combat:2
glycogen ,severe:2
glycogen ,acute:2
glycogen ,respiratory:2
synthase ,kinase-3:2
synthase ,putative:2
synthase ,target:2
synthase ,combat:2
synthase ,severe:2
synthase ,acute:2
synthase ,respiratory:2
kinase-3 ,putative:2
kinase-3 ,target:2
kinase-3 ,combat:2
kinase-3 ,severe:2
kinase-3 ,acute:2
kinase-3 ,respiratory:2
putative ,target:2
putative ,combat:2
putative ,severe:2
putative ,acute:2
putative ,respiratory:2
target ,acute:2
target ,respiratory:2
impact ,tuberculosis:2
impact ,outcome:2
impact ,northern:2
epidemic ,tuberculosis:2
tuberculosis ,treatment:2
tuberculosis ,outcome:2
tuberculosis ,northern:2
treatment ,northern:2
outcome ,northern:2
rationale ,targeting:2
rationale ,complement:2
debate ,together:2
debate ,despite:2
debate ,distance:2
together ,despite:2
together ,distance:2
despite ,distance:2
cyclooxgenase-2 ,induced:2
cyclooxgenase-2 ,sars-cov-2:2
cyclooxgenase-2 ,infection:2
cyclooxgenase-2 ,affect:2
cyclooxgenase-2 ,viral:2
cyclooxgenase-2 ,entry:2
induced ,infection:2
induced ,affect:2
induced ,viral:2
induced ,entry:2
infection ,affect:2
affect ,entry:2
medical ,bedside:2
medical ,motivations:2
students ,bedside:2
students ,covid-19:2
students ,patients:2
students ,motivations:2
students ,challenges:2
bedside ,motivations:2
bedside ,challenges:2
covid-19 ,motivations:2
patients ,motivations:2
motivations ,challenges:2
neutralizing ,antibody-conjugated:2
neutralizing ,photothermal:2
neutralizing ,nanoparticle:2
neutralizing ,captures:2
antibody-conjugated ,photothermal:2
antibody-conjugated ,nanoparticle:2
antibody-conjugated ,captures:2
photothermal ,nanoparticle:2
photothermal ,captures:2
nanoparticle ,captures:2
persistent ,despite:2
persistent ,seroconversion:2
persistent ,kidney:2
persistent ,transplant:2
persistent ,recipient:2
viral ,seroconversion:2
viral ,kidney:4
viral ,transplant:4
viral ,recipient:2
shedding ,despite:2
shedding ,seroconversion:4
shedding ,kidney:4
shedding ,transplant:4
shedding ,recipient:2
despite ,seroconversion:2
despite ,kidney:2
despite ,transplant:2
despite ,recipient:2
seroconversion ,kidney:4
seroconversion ,transplant:2
seroconversion ,recipient:2
brief ,chloroquine:2
brief ,hydroxychloroquine:2
brief ,toxicity:2
brief ,management:2
review ,toxicity:2
chloroquine ,toxicity:2
hydroxychloroquine ,toxicity:2
hydroxychloroquine ,management:2
toxicity ,management:2
comparative ,diseases:2
comparative ,caused:2
review ,diseases:2
diseases ,caused:2
diseases ,influenza:2
caused ,coronaviruses:2
ultra-sensitive ,high-throughput:2
ultra-sensitive ,crispr-p:2
ultra-sensitive ,owered:2
ultra-sensitive ,covid-19:2
ultra-sensitive ,diagnosis:2
high-throughput ,crispr-p:2
high-throughput ,owered:2
high-throughput ,covid-19:2
high-throughput ,diagnosis:2
crispr-p ,owered:2
crispr-p ,covid-19:2
crispr-p ,diagnosis:2
owered ,covid-19:2
owered ,diagnosis:2
current ,vertical:2
current ,integrative:2
evidence ,integrative:2
vertical ,integrative:2
transmission ,integrative:2
integrative ,review:2
anesthetic ,undergoing:2
anesthetic ,aortic:2
anesthetic ,dissection:2
anesthetic ,repair:2
anesthetic ,suspected:2
management ,undergoing:2
management ,repair:2
patients ,dissection:2
patients ,repair:2
undergoing ,aortic:2
undergoing ,dissection:2
undergoing ,repair:2
aortic ,repair:2
aortic ,suspected:2
dissection ,repair:2
dissection ,suspected:2
repair ,suspected:2
ssrna ,virus:2
ssrna ,host:2
ssrna ,lipid:2
ssrna ,rearrangements:2
ssrna ,role:2
ssrna ,droplets:2
virus ,rearrangements:2
host ,lipid:2
host ,rearrangements:2
host ,droplets:2
lipid ,rearrangements:2
lipid ,droplets:2
rearrangements ,role:2
rearrangements ,droplets:2
role ,droplets:2
technical ,tips:2
technical ,keeping:2
technical ,clean:2
technical ,covid-19:2
tips ,keeping:2
tips ,clean:2
tips ,covid-19:2
coronaviruses ,sugar:2
coronaviruses ,shields:2
coronaviruses ,candidates:2
sugar ,shields:2
sugar ,vaccine:2
sugar ,candidates:2
shields ,vaccine:2
shields ,candidates:2
enhanced ,isolation:2
enhanced ,tmprss2-expressing:2
enhanced ,cells:2
isolation ,tmprss2-expressing:2
isolation ,cells:2
sars-cov-2 ,tmprss2-expressing:2
tmprss2-expressing ,cells:2
pulmonary ,contusion:2
pulmonary ,pandemic:2
pulmonary ,challenges:2
contusion ,covid-19:2
contusion ,pandemic:2
contusion ,challenges:2
contusion ,diagnosis:2
janus ,sword:2
janus ,actions:2
janus ,chloroquine:2
janus ,hydroxychloroquine:2
janus ,covid-19:2
sword ,actions:2
sword ,chloroquine:2
sword ,hydroxychloroquine:2
sword ,covid-19:2
actions ,chloroquine:2
actions ,hydroxychloroquine:2
autopsy ,venous:2
autopsy ,thromboembolism:2
autopsy ,prospective:2
findings ,venous:2
findings ,thromboembolism:2
findings ,prospective:2
update ,efficacy:2
update ,safety:2
therapeutic ,adults:2
plasma ,adults:2
exchange ,adults:2
exchange ,severe:2
exchange ,infection:2
adults ,severe:2
adults ,infection:2
prosthetic ,aortic:2
prosthetic ,valve:2
prosthetic ,endocarditis:2
prosthetic ,complicated:2
prosthetic ,covid-19:2
prosthetic ,hemorrhage:2
aortic ,valve:2
aortic ,endocarditis:2
aortic ,hemorrhage:2
valve ,endocarditis:2
valve ,complicated:2
valve ,covid-19:2
valve ,hemorrhage:2
endocarditis ,complicated:2
endocarditis ,hemorrhage:2
complicated ,hemorrhage:2
single ,dose:2
single ,adenovirus-vectored:2
single ,vaccine:2
single ,provides:2
single ,protection:2
dose ,adenovirus-vectored:2
dose ,vaccine:2
dose ,provides:2
dose ,protection:2
adenovirus-vectored ,vaccine:2
adenovirus-vectored ,provides:2
adenovirus-vectored ,protection:2
vaccine ,provides:2
vaccine ,protection:4
provides ,protection:2
saliva-friend ,foe:2
saliva-friend ,covid-19:2
saliva-friend ,outbreak:2
foe ,outbreak:2
transmission ,coronaviruses:2
mechanisms ,coronaviruses:2
sars-cov-2 ,mimicry:2
sars-cov-2 ,shock:4
guillain-barr ,molecular:2
guillain-barr ,mimicry:2
guillain-barr ,human:2
guillain-barr ,heat:2
guillain-barr ,shock:2
syndrome ,mimicry:2
syndrome ,heat:2
molecular ,mimicry:4
molecular ,heat:2
molecular ,shock:2
mimicry ,human:2
mimicry ,heat:2
mimicry ,shock:2
human ,heat:2
human ,shock:2
sars-cov-2 ,endurance:2
sars-cov-2 ,influenced:2
infection ,environmental:2
infection ,endurance:2
infection ,influenced:2
environmental ,endurance:2
environmental ,virus:2
environmental ,influenced:2
endurance ,virus:2
endurance ,can:2
endurance ,influenced:2
virus ,influenced:2
can ,influenced:2
intestinal ,barrier:2
intestinal ,function:2
intestinal ,health:2
intestinal ,disease-any:2
intestinal ,role:2
barrier ,function:2
barrier ,health:2
barrier ,disease-any:2
barrier ,role:2
function ,health:2
function ,disease-any:2
health ,disease-any:2
health ,role:2
disease-any ,role:2
disease-any ,sars-cov-2:2
coronavirus ,driving:2
disease ,modeling:2
disease ,driving:2
disease ,variation:2
covid-19 ,driving:2
modeling ,factors:2
modeling ,driving:2
study ,driving:2
study ,variation:2
factors ,driving:2
factors ,variation:2
driving ,variation:2
pulmonary ,arterial:2
pulmonary ,thrombosis:2
pulmonary ,fatal:2
pulmonary ,outcome:2
pulmonary ,results:2
arterial ,fatal:2
arterial ,outcome:2
arterial ,results:2
thrombosis ,fatal:2
thrombosis ,outcome:2
thrombosis ,results:2
fatal ,results:2
outcome ,results:2
national ,library:2
national ,medicine:2
national ,global:4
national ,events:2
national ,web:2
national ,archive:2
library ,medicine:2
library ,global:2
library ,health:2
library ,events:2
library ,web:2
library ,archive:2
library ,coronavirus:2
medicine ,global:2
medicine ,health:2
medicine ,events:2
medicine ,web:2
medicine ,archive:2
global ,web:2
global ,archive:2
health ,events:2
health ,web:2
health ,archive:2
events ,web:2
events ,archive:2
events ,coronavirus:2
web ,archive:2
web ,coronavirus:2
archive ,coronavirus:2
precautions ,operating:2
precautions ,room:2
precautions ,team:2
precautions ,members:2
operating ,team:2
operating ,members:2
room ,team:2
room ,members:2
team ,members:2
team ,covid-19:2
team ,pandemic:2
members ,pandemic:2
dynamic ,early:2
dynamic ,stage:2
changes ,early:2
changes ,stage:2
antibodies ,stage:2
imex ,coronavirus:2
imex ,interactome:2
imex ,evolving:2
imex ,map:2
imex ,coronaviridae-host:2
imex ,molecular:2
coronavirus ,interactome:2
coronavirus ,evolving:2
coronavirus ,coronaviridae-host:2
interactome ,evolving:2
interactome ,map:2
interactome ,coronaviridae-host:2
interactome ,molecular:2
evolving ,map:2
evolving ,coronaviridae-host:2
evolving ,molecular:2
map ,coronaviridae-host:2
map ,molecular:2
coronaviridae-host ,molecular:2
natural ,rich:2
natural ,source:2
natural ,drug:6
natural ,lead:2
natural ,candidates:2
natural ,management:2
products ,rich:2
products ,source:2
products ,antiviral:2
products ,drug:4
products ,lead:2
products ,candidates:2
products ,management:2
rich ,source:2
rich ,antiviral:2
rich ,drug:2
rich ,lead:2
rich ,candidates:2
rich ,management:2
source ,drug:2
source ,lead:2
source ,candidates:2
source ,management:2
antiviral ,management:2
drug ,lead:2
lead ,candidates:2
lead ,management:2
candidates ,management:2
heart ,exacerbation:2
heart ,presenting:2
heart ,sign:2
failure ,exacerbation:2
failure ,sign:2
exacerbation ,presenting:2
exacerbation ,sign:2
presenting ,sign:2
review ,antibody:2
antibody ,therapies:2
dilemma ,prioritising:2
dilemma ,health:2
dilemma ,economy:2
dilemma ,pandemic:2
prioritising ,health:2
prioritising ,economy:2
prioritising ,covid-19:2
prioritising ,pandemic:2
health ,economy:2
economy ,covid-19:2
economy ,pandemic:2
current ,opinion:2
status ,opinion:2
covid-19 ,opinion:2
treatment ,opinion:2
opinion ,review:2
covid-19 ,ovarian:2
covid-19 ,alternatives:2
ovarian ,cancer:2
ovarian ,exploring:2
ovarian ,alternatives:2
ovarian ,intravenous:2
ovarian ,iv:2
ovarian ,therapies:2
cancer ,exploring:2
cancer ,alternatives:2
cancer ,intravenous:2
cancer ,iv:2
exploring ,alternatives:2
exploring ,intravenous:2
exploring ,iv:2
exploring ,therapies:2
alternatives ,intravenous:2
alternatives ,iv:2
alternatives ,therapies:2
intravenous ,iv:2
intravenous ,therapies:2
iv ,therapies:2
increasing ,maternal:2
increasing ,mortality:2
increasing ,associated:2
increasing ,shortage:2
increasing ,intensive:2
maternal ,associated:2
maternal ,shortage:2
maternal ,intensive:2
mortality ,shortage:2
associated ,shortage:2
associated ,intensive:4
shortage ,intensive:2
tetralogy ,palliation:2
tetralogy ,covid-19:2
tetralogy ,positive:2
tetralogy ,neonate:2
fallot ,palliation:2
fallot ,covid-19:2
fallot ,positive:2
fallot ,neonate:2
palliation ,covid-19:2
palliation ,positive:2
palliation ,neonate:2
positive ,neonate:2
heart ,inflammation:4
heart ,angiotensin:2
heart ,ii:2
failure ,infection:2
failure ,angiotensin:2
failure ,ii:2
infection ,inflammation:2
infection ,angiotensin:2
infection ,ii:2
inflammation ,angiotensin:2
inflammation ,ii:2
effects ,angiotensin:2
effects ,converting:2
effects ,enzyme:2
effects ,inhibitorangiotensin:2
effects ,blocker:2
angiotensin ,inhibitorangiotensin:2
angiotensin ,blocker:2
converting ,inhibitorangiotensin:2
converting ,receptor:2
converting ,blocker:2
enzyme ,inhibitorangiotensin:2
enzyme ,blocker:2
inhibitorangiotensin ,receptor:2
inhibitorangiotensin ,blocker:2
receptor ,blocker:2
differences ,receptor-binding:2
similarities ,sars-cov:2
similarities ,spike:2
similarities ,receptor-binding:2
sars-cov ,spike:2
hemorrhagic ,presentations:2
hemorrhagic ,risk:2
hemorrhagic ,factors:2
hemorrhagic ,mortality:2
presentations ,risk:2
presentations ,factors:2
presentations ,mortality:2
18f-fdg ,findings:2
18f-fdg ,series:2
18f-fdg ,four:2
18f-fdg ,highly:2
18f-fdg ,suspected:2
18f-fdg ,cases:2
petct ,findings:4
petct ,series:2
petct ,four:2
petct ,highly:2
petct ,suspected:2
petct ,cases:2
findings ,four:2
findings ,suspected:2
findings ,cases:2
series ,cases:2
four ,highly:2
four ,suspected:2
highly ,suspected:2
highly ,cases:2
molecular ,methods:2
agreed ,experts:2
agreed ,position:2
agreed ,eurasian:2
agreed ,association:2
agreed ,therapists:2
agreed ,new:2
experts ,position:2
experts ,eurasian:2
experts ,association:2
experts ,therapists:2
experts ,new:2
position ,eurasian:2
position ,association:2
position ,therapists:2
position ,new:2
eurasian ,association:2
eurasian ,therapists:2
eurasian ,new:2
association ,therapists:2
association ,new:2
therapists ,new:2
structure ,receptor-binding:2
structure ,domain:2
structure ,bound:2
structure ,ace2:4
receptor-binding ,bound:2
domain ,bound:2
bound ,ace2:2
perioperative ,newborns:2
perioperative ,chds:2
perioperative ,time:2
care ,newborns:2
care ,chds:2
newborns ,chds:2
newborns ,time:2
chds ,time:2
chds ,covid-19:2
risk ,rna:6
hidden ,role:2
hidden ,nlrp3:2
hidden ,inflammasome:2
hidden ,obesity-related:2
hidden ,covid-19:4
hidden ,exacerbations:2
role ,obesity-related:2
role ,exacerbations:2
nlrp3 ,obesity-related:2
nlrp3 ,exacerbations:2
inflammasome ,obesity-related:2
inflammasome ,exacerbations:2
obesity-related ,exacerbations:2
covid-19 ,exacerbations:2
pandemics ,glossary:2
pandemics ,abc:2
pandemics ,coronavirus:2
pandemics ,concepts:2
glossary ,abc:2
glossary ,coronavirus:2
glossary ,concepts:2
abc ,coronavirus:2
abc ,concepts:2
coronavirus ,concepts:2
12 ,lessons:2
12 ,learned:2
12 ,management:2
12 ,coronavirus:2
12 ,pandemic:2
learned ,management:2
learned ,pandemic:4
clinical ,hospitalised:2
clinical ,indonesias:2
profile ,elderly:2
profile ,hospitalised:2
profile ,indonesias:2
elderly ,hospitalised:2
elderly ,indonesias:2
patients ,indonesias:2
covid-19 ,indonesias:2
hospitalised ,indonesias:2
current ,hypercoagulability:2
overview ,hypercoagulability:2
hypercoagulability ,covid-19:2
population-based ,seroprevalence:2
population-based ,surveys:2
population-based ,anti-sars-cov-2:2
population-based ,antibody:2
population-based ,up-to-date:2
seroprevalence ,surveys:2
seroprevalence ,antibody:2
seroprevalence ,up-to-date:2
surveys ,anti-sars-cov-2:2
surveys ,antibody:2
surveys ,up-to-date:2
anti-sars-cov-2 ,up-to-date:2
antibody ,up-to-date:2
impact ,commentary:2
impact ,task:2
covid-19 ,task:2
otolaryngology ,commentary:2
otolaryngology ,task:2
italy ,commentary:2
italy ,task:2
commentary ,task:2
multi-stage ,group:2
multi-stage ,testing:2
multi-stage ,improves:2
multi-stage ,efficiency:2
multi-stage ,large-scale:2
multi-stage ,covid-19:2
multi-stage ,screening:4
group ,improves:2
group ,efficiency:2
group ,large-scale:2
group ,screening:2
testing ,improves:2
testing ,efficiency:2
improves ,efficiency:2
improves ,large-scale:2
improves ,covid-19:2
improves ,screening:2
efficiency ,large-scale:2
efficiency ,covid-19:4
efficiency ,screening:2
large-scale ,screening:2
neurological ,acute:2
neurological ,respiratory:4
neurological ,2-a:2
manifestations ,acute:2
manifestations ,respiratory:2
manifestations ,syndrome:2
manifestations ,2-a:2
severe ,2-a:2
acute ,2-a:2
respiratory ,2-a:2
syndrome ,2-a:2
coronavirus ,2-a:2
wastewater ,african:2
wastewater ,perspective:2
surveillance ,african:2
profile ,immunoglobulin:2
profile ,igm:2
profile ,severe:2
profile ,acute:2
profile ,respiratory:2
immunoglobulin ,igm:2
immunoglobulin ,acute:2
immunoglobulin ,respiratory:2
igm ,antibodies:2
igm ,acute:2
igm ,respiratory:2
aspiration ,periodontopathic:2
aspiration ,bacteria:2
aspiration ,due:2
aspiration ,poor:2
aspiration ,oral:2
aspiration ,hygiene:2
aspiration ,potentially:2
periodontopathic ,bacteria:2
periodontopathic ,due:2
periodontopathic ,poor:2
periodontopathic ,oral:2
periodontopathic ,hygiene:2
periodontopathic ,potentially:2
bacteria ,due:2
bacteria ,poor:2
bacteria ,oral:2
bacteria ,hygiene:2
bacteria ,potentially:2
due ,poor:2
due ,oral:2
due ,hygiene:2
due ,potentially:2
poor ,oral:2
poor ,hygiene:2
poor ,potentially:2
oral ,potentially:2
hygiene ,potentially:2
disparities ,positivity:2
disparities ,rates:2
disparities ,associations:2
disparities ,race:2
disparities ,ethnicity:2
sars-cov-2 ,ethnicity:2
positivity ,associations:2
positivity ,race:2
positivity ,ethnicity:2
rates ,associations:2
rates ,race:2
rates ,ethnicity:2
associations ,race:2
associations ,ethnicity:2
effectiveness ,corticoid:2
effectiveness ,pulses:2
effectiveness ,cytokine:2
effectiveness ,storm:2
effectiveness ,syndrome:2
effectiveness ,induced:2
corticoid ,pulses:2
corticoid ,patients:2
corticoid ,cytokine:2
corticoid ,storm:2
corticoid ,syndrome:2
corticoid ,induced:2
pulses ,patients:2
pulses ,cytokine:2
pulses ,storm:2
pulses ,syndrome:2
pulses ,induced:2
patients ,induced:2
intranasal ,antiviral:2
intranasal ,drug:2
intranasal ,delivery:2
intranasal ,coronavirus:2
intranasal ,disease:2
intranasal ,covid-19:2
intranasal ,state:2
antiviral ,state:2
drug ,state:2
delivery ,disease:2
delivery ,state:2
differences ,performance:2
differences ,characteristics:2
differences ,four:2
differences ,high-throughput:2
differences ,assays:2
performance ,among:2
characteristics ,assays:2
among ,four:2
among ,high-throughput:2
lopinavirritonavir ,use:2
lopinavirritonavir ,infection:2
lopinavirritonavir ,completely:2
lopinavirritonavir ,non-beneficial:2
use ,completely:2
use ,non-beneficial:2
covid-19 ,completely:2
covid-19 ,non-beneficial:2
infection ,non-beneficial:2
completely ,non-beneficial:2
coming ,together:2
coming ,region:2
coming ,tackle:2
together ,region:2
together ,tackle:2
together ,covid-19:2
region ,tackle:2
controlling ,spread:2
controlling ,optimal:2
controlling ,control:2
controlling ,analysis:2
spread ,optimal:2
optimal ,analysis:2
static ,all-atom:2
static ,energetic:2
static ,mappings:2
static ,sars-cov-2:2
static ,spike:2
static ,protein:2
static ,dynamic:2
all-atom ,energetic:2
all-atom ,mappings:2
all-atom ,sars-cov-2:4
all-atom ,spike:2
all-atom ,protein:2
all-atom ,dynamic:2
energetic ,mappings:2
energetic ,sars-cov-2:2
energetic ,spike:2
energetic ,protein:2
energetic ,dynamic:2
mappings ,sars-cov-2:2
mappings ,spike:2
mappings ,protein:2
mappings ,dynamic:2
protein ,dynamic:2
nanopore ,targeted:2
nanopore ,sequencing:2
nanopore ,accurate:2
nanopore ,comprehensive:2
nanopore ,detection:2
targeted ,sequencing:2
targeted ,accurate:2
targeted ,comprehensive:2
sequencing ,accurate:2
sequencing ,comprehensive:2
sequencing ,detection:2
accurate ,comprehensive:2
clinical ,undergoing:2
clinical ,pneumonectomy:2
course ,undergoing:2
course ,pneumonectomy:2
covid-19 ,pneumonectomy:2
pneumonia ,undergoing:2
pneumonia ,pneumonectomy:2
patient ,pneumonectomy:2
undergoing ,pneumonectomy:2
persistence ,positive:2
persistence ,coronavirus-2:2
persistence ,reverse:2
positive ,coronavirus-2:2
positive ,reverse:2
respiratory ,reverse:2
syndrome ,reverse:2
coronavirus-2 ,reverse:2
clinical ,74:2
characteristics ,74:2
characteristics ,critical:2
outcomes ,74:2
outcomes ,critical:2
74 ,patients:2
74 ,severe:2
74 ,critical:2
type ,inflammation:2
type ,modulates:2
type ,tmprss2:2
type ,epithelial:2
type ,cells:2
inflammation ,modulates:2
inflammation ,ace2:4
inflammation ,tmprss2:2
inflammation ,airway:2
inflammation ,epithelial:2
inflammation ,cells:2
modulates ,ace2:2
modulates ,tmprss2:2
modulates ,airway:2
modulates ,epithelial:2
modulates ,cells:2
tmprss2 ,airway:2
tmprss2 ,epithelial:2
airway ,epithelial:2
airway ,cells:2
complete ,heart:2
complete ,block:2
complete ,severeventriculardysfunction:2
complete ,myocardial:2
complete ,inflammation:2
heart ,block:2
heart ,severeventriculardysfunction:2
heart ,myocardial:2
block ,severeventriculardysfunction:2
block ,myocardial:2
block ,inflammation:2
severeventriculardysfunction ,myocardial:2
severeventriculardysfunction ,inflammation:2
related ,coagulopathy:2
related ,known:2
related ,now:2
coagulopathy ,known:2
coagulopathy ,now:2
known ,now:2
high-flow ,low:2
high-flow ,risk:2
high-flow ,bio-aerosol:2
high-flow ,dispersion:2
nasal ,low:2
nasal ,risk:2
nasal ,bio-aerosol:2
nasal ,dispersion:2
cannula ,covid-19:2
cannula ,low:2
cannula ,risk:2
cannula ,bio-aerosol:2
cannula ,dispersion:2
covid-19 ,bio-aerosol:2
patients ,low:4
patients ,bio-aerosol:2
patients ,dispersion:2
low ,bio-aerosol:2
low ,dispersion:2
risk ,bio-aerosol:2
risk ,dispersion:2
bio-aerosol ,dispersion:2
recent ,plasmonic:2
recent ,biosensing:2
recent ,schemes:2
recent ,virus:2
recent ,detection:2
progress ,plasmonic:2
progress ,biosensing:2
progress ,schemes:2
progress ,virus:2
plasmonic ,biosensing:2
plasmonic ,schemes:2
plasmonic ,virus:2
plasmonic ,detection:2
biosensing ,schemes:2
biosensing ,virus:2
biosensing ,detection:2
schemes ,virus:2
schemes ,detection:2
covid19 ,systematic:2
covid19 ,approach:2
covid19 ,early:2
covid19 ,identification:2
covid19 ,healthcare:4
covid19 ,worker:2
systematic ,approach:2
systematic ,early:2
systematic ,identification:2
systematic ,worker:2
approach ,early:2
approach ,identification:2
approach ,healthcare:2
approach ,worker:2
early ,healthcare:2
early ,worker:2
identification ,healthcare:2
identification ,worker:2
healthcare ,worker:4
ruptured ,popliteal:2
ruptured ,artery:2
ruptured ,aneurysm:2
ruptured ,complicated:2
ruptured ,acute:2
ruptured ,respiratory:2
ruptured ,distress:2
popliteal ,artery:2
popliteal ,aneurysm:2
popliteal ,complicated:2
popliteal ,acute:2
popliteal ,respiratory:2
popliteal ,distress:2
artery ,aneurysm:2
artery ,complicated:2
artery ,respiratory:4
artery ,distress:2
aneurysm ,complicated:2
aneurysm ,acute:2
aneurysm ,respiratory:2
aneurysm ,distress:2
complicated ,respiratory:2
complicated ,distress:2
recent ,influenza:2
recent ,vaccines:4
advances ,influenza:2
influenza ,vaccines:2
cloth ,under-resourced:2
cloth ,healthcare:2
cloth ,settings:2
cloth ,covid19:2
cloth ,pandemic:2
mask ,under-resourced:2
mask ,healthcare:2
mask ,settings:2
mask ,covid19:2
mask ,pandemic:4
under-resourced ,healthcare:2
under-resourced ,settings:2
under-resourced ,covid19:2
under-resourced ,pandemic:2
healthcare ,settings:2
settings ,covid19:2
settings ,pandemic:2
covid19 ,pandemic:2
coronavirus ,smart:2
covid-19 ,smart:2
outbreak ,smart:2
outbreak ,network:2
outbreak ,universal:2
smart ,city:2
smart ,network:2
smart ,universal:2
smart ,data:2
city ,network:2
city ,universal:2
network ,universal:2
universal ,data:2
nigella ,supplementation:2
nigella ,treat:2
nigella ,symptomatic:2
nigella ,mild:2
nigella ,covid-19:2
nigella ,structured:2
sativa ,supplementation:2
sativa ,treat:2
sativa ,symptomatic:2
sativa ,mild:2
sativa ,covid-19:2
sativa ,structured:2
supplementation ,treat:2
supplementation ,symptomatic:2
supplementation ,mild:2
supplementation ,structured:2
treat ,symptomatic:2
treat ,mild:2
treat ,structured:2
symptomatic ,structured:2
mild ,structured:2
covid-19 ,structured:2
front-line ,dentist:2
front-line ,literature:2
front-line ,review:2
dentist ,covid-19:2
dentist ,pandemic:2
dentist ,literature:2
dentist ,review:2
covid-19 ,pocus:2
covid-19 ,sparing:2
covid-19 ,stethoscope:2
lung ,pocus:2
lung ,sparing:2
lung ,stethoscope:2
lung ,x-ray:2
pocus ,sparing:2
pocus ,use:2
pocus ,stethoscope:2
pocus ,chest:2
pocus ,x-ray:2
sparing ,use:2
sparing ,stethoscope:2
sparing ,chest:2
sparing ,x-ray:2
use ,stethoscope:2
use ,chest:2
use ,x-ray:2
stethoscope ,chest:2
stethoscope ,x-ray:2
conspiracy ,beliefs:4
conspiracy ,associated:2
conspiracy ,lower:2
conspiracy ,knowledge:2
conspiracy ,higher:2
conspiracy ,anxiety:2
conspiracy ,levels:2
beliefs ,associated:2
beliefs ,lower:2
beliefs ,knowledge:2
beliefs ,higher:2
beliefs ,anxiety:2
beliefs ,levels:2
associated ,anxiety:2
lower ,knowledge:2
lower ,higher:2
lower ,anxiety:2
knowledge ,higher:2
knowledge ,anxiety:2
knowledge ,levels:2
higher ,anxiety:2
higher ,levels:2
anxiety ,levels:2
recommendations ,triage:2
recommendations ,prioritization:2
recommendations ,breast:2
triage ,prioritization:2
triage ,treatment:2
triage ,breast:2
prioritization ,treatment:2
prioritization ,breast:2
prioritization ,cancer:2
treatment ,breast:2
newly-diagnosed ,diabetes:2
newly-diagnosed ,admission:2
newly-diagnosed ,hyperglycemia:2
newly-diagnosed ,predict:2
newly-diagnosed ,covid-19:2
newly-diagnosed ,severity:2
diabetes ,admission:2
diabetes ,predict:2
admission ,hyperglycemia:2
admission ,severity:2
hyperglycemia ,predict:2
hyperglycemia ,severity:2
strategies ,perspectives:2
strategies ,develop:2
strategies ,detection:4
strategies ,methods:2
strategies ,diagnostics:2
perspectives ,develop:2
perspectives ,methods:2
develop ,sars-cov-2:2
develop ,detection:2
develop ,methods:2
develop ,diagnostics:2
methods ,diagnostics:2
aquaporin ,modulators:2
aquaporin ,employed:2
aquaporin ,prospective:2
aquaporin ,drugs:2
aquaporin ,covid-19:2
aquaporin ,related:2
modulators ,employed:2
modulators ,prospective:2
modulators ,drugs:2
modulators ,covid-19:4
modulators ,related:2
employed ,prospective:2
employed ,drugs:2
employed ,covid-19:2
employed ,related:2
prospective ,drugs:2
prospective ,related:2
drugs ,related:2
emergency ,inter-hospital:2
emergency ,transfer:2
emergency ,newborns:2
plan ,inter-hospital:2
plan ,transfer:2
plan ,newborns:2
plan ,infection:2
inter-hospital ,transfer:2
inter-hospital ,newborns:2
inter-hospital ,sars-cov-2:2
inter-hospital ,infection:2
transfer ,newborns:2
transfer ,sars-cov-2:2
resuming ,elective:2
resuming ,orthopaedic:2
elective ,orthopaedic:4
elective ,guidelines:2
anticoagulate ,acute:2
anticoagulate ,stroke:2
anticoagulate ,covid-19:2
anticoagulate ,patient:2
anticoagulate ,gastrointestinal:2
stroke ,gastrointestinal:2
patient ,gastrointestinal:2
liver ,comprehensive:2
comprehensive ,systematic:2
possible ,pregnant:2
possible ,female:2
early ,vertical:2
early ,infected:2
early ,female:2
vertical ,female:2
transmission ,female:2
infected ,female:2
pregnant ,female:2
variable ,performance:2
variable ,commercial:2
variable ,assays:2
variable ,may:2
variable ,affect:2
performance ,may:2
performance ,affect:2
commercial ,may:2
commercial ,affect:2
antibody ,may:2
antibody ,affect:2
assays ,may:2
assays ,affect:2
compassionate ,communication:2
compassionate ,end-of-life:2
compassionate ,care:2
compassionate ,critically:2
compassionate ,ill:2
compassionate ,patients:2
communication ,end-of-life:2
communication ,care:2
communication ,critically:2
communication ,ill:2
communication ,patients:2
end-of-life ,care:2
end-of-life ,critically:2
end-of-life ,ill:2
end-of-life ,patients:2
care ,critically:2
care ,ill:2
applications ,artificial:2
applications ,intelligence:2
applications ,battling:2
applications ,covid-19:2
applications ,literature:2
artificial ,battling:2
artificial ,literature:2
intelligence ,battling:2
intelligence ,literature:2
battling ,literature:2
effects ,type:2
effects ,diabetes:2
effects ,mellitus:2
effects ,metabolism:2
effects ,immune:2
type ,organ:2
type ,metabolism:2
type ,system:2
diabetes ,organ:2
diabetes ,metabolism:2
diabetes ,immune:2
diabetes ,system:2
mellitus ,organ:2
mellitus ,metabolism:2
mellitus ,immune:2
mellitus ,system:2
organ ,metabolism:2
organ ,immune:2
organ ,system:2
metabolism ,immune:2
structural ,hotspot:2
structural ,residues:2
simulation ,analysis:4
simulation ,hotspot:2
simulation ,residues:2
simulation ,interactions:2
simulation ,sars-cov:2
analysis ,hotspot:2
analysis ,residues:2
analysis ,sars-cov:2
hotspot ,residues:2
hotspot ,interactions:2
hotspot ,sars-cov:2
residues ,interactions:2
residues ,sars-cov:2
covid-19 ,stop:2
covid-19 ,birthing:2
stop ,obstetrics:2
stop ,need:2
stop ,change:2
stop ,go:2
stop ,safely:2
stop ,birthing:2
obstetrics ,need:2
obstetrics ,change:2
obstetrics ,go:2
obstetrics ,safely:2
obstetrics ,birthing:2
need ,change:2
need ,go:2
need ,safely:2
need ,birthing:2
change ,go:2
change ,safely:2
change ,birthing:2
go ,safely:2
go ,birthing:2
safely ,birthing:2
sars-cov-2rna ,found:2
sars-cov-2rna ,particulate:2
sars-cov-2rna ,matter:2
sars-cov-2rna ,bergamo:2
sars-cov-2rna ,northern:2
sars-cov-2rna ,italy:2
sars-cov-2rna ,first:2
found ,particulate:2
found ,matter:2
found ,bergamo:2
found ,northern:2
found ,italy:2
found ,first:2
particulate ,bergamo:2
particulate ,northern:2
particulate ,italy:2
particulate ,first:2
matter ,bergamo:2
matter ,northern:2
matter ,italy:2
matter ,first:2
bergamo ,northern:2
bergamo ,italy:2
bergamo ,first:2
northern ,first:2
associations ,blood:2
associations ,type:2
associations ,infection:2
associations ,intubation:2
associations ,death:2
blood ,type:2
blood ,intubation:2
blood ,death:2
type ,intubation:2
type ,death:2
covid-19 ,intubation:2
infection ,intubation:2
intubation ,death:2
covid-19 ,unraveling:2
diabetes ,unraveling:2
diabetes ,hypotheses:2
diabetes ,worsen:2
mellitus ,unraveling:2
mellitus ,hypotheses:2
mellitus ,worsen:2
mellitus ,prognosis:4
unraveling ,hypotheses:2
unraveling ,worsen:2
unraveling ,prognosis:2
hypotheses ,worsen:2
hypotheses ,prognosis:2
worsen ,prognosis:2
blood ,banking:2
blood ,medicine:2
blood ,challenges:2
blood ,pandemic:2
banking ,transfusion:2
banking ,medicine:2
banking ,challenges:2
banking ,covid-19:2
banking ,pandemic:2
transfusion ,challenges:2
transfusion ,pandemic:2
meningococcal ,meningitis:2
meningococcal ,covid-19:2
meningococcal ,co-infection:2
meningitis ,covid-19:2
meningitis ,co-infection:2
lower-extremity ,arterial:2
lower-extremity ,thrombosis:2
lower-extremity ,associated:2
lower-extremity ,covid-19:2
lower-extremity ,characterized:2
arterial ,associated:2
arterial ,characterized:2
thrombosis ,characterized:2
associated ,characterized:2
covid-19 ,characterized:2
treatment ,guidance:2
guidance ,lung:2
guidance ,cancer:2
covid-19 ,sciences:2
pandemic ,beyond:2
pandemic ,sciences:2
pandemic ,reflections:2
beyond ,health:2
beyond ,sciences:2
beyond ,reflections:2
beyond ,social:2
health ,reflections:2
sciences ,reflections:2
sciences ,social:2
reflections ,social:2
epidemiology ,successful:2
epidemiology ,containment:2
epidemiology ,strategy:2
epidemiology ,hong:2
cases ,successful:2
cases ,containment:2
cases ,strategy:2
cases ,hong:2
successful ,strategy:2
successful ,hong:2
containment ,strategy:2
containment ,hong:2
strategy ,hong:2
consequences ,covid-19sars-cov-2:2
consequences ,gastroenterology:2
consequences ,germany:2
covid-19sars-cov-2 ,gastroenterology:2
covid-19sars-cov-2 ,germany:2
pandemic ,germany:2
gastroenterology ,germany:2
recent ,modalities:2
recent ,counter:2
advances ,modalities:2
advances ,counter:2
therapeutic ,modalities:2
therapeutic ,counter:2
modalities ,vaccines:2
modalities ,counter:2
vaccines ,counter:2
human ,elicited:2
neutralizing ,elicited:2
neutralizing ,infection:4
antibodies ,elicited:2
elicited ,sars-cov-2:2
elicited ,infection:2
severe ,influenza:4
bcg ,causally:2
bcg ,related:2
bcg ,reduced:2
vaccination ,causally:2
vaccination ,related:2
vaccination ,reduced:2
causally ,related:2
causally ,reduced:2
causally ,covid-19:2
causally ,mortality:2
related ,reduced:2
vitamin ,coronavirus:2
vitamin ,disease:4
expression ,cd147:2
expression ,protease:4
sars-cov-2 ,cd147:2
receptor ,cd147:2
receptor ,protease:4
ace2 ,cd147:2
ace2 ,protease:4
cd147 ,protease:2
cd147 ,tmprss2:2
cd147 ,human:2
protease ,tmprss2:4
protease ,human:2
tmprss2 ,human:2
symptomatology ,head:2
symptomatology ,neck:2
symptomatology ,district:2
symptomatology ,coronavirus:2
symptomatology ,disease:2
head ,district:2
head ,coronavirus:2
head ,disease:2
neck ,district:2
neck ,coronavirus:2
neck ,disease:2
chemotherapy ,reactivate:2
chemotherapy ,sars-cov-2:2
chemotherapy ,patients:2
chemotherapy ,recovered:2
chemotherapy ,prior:2
reactivate ,sars-cov-2:2
reactivate ,cancer:2
reactivate ,patients:2
reactivate ,recovered:2
reactivate ,prior:2
cancer ,recovered:2
cancer ,prior:2
patients ,prior:2
recovered ,prior:2
sars-cov-2 ,conventional:2
sars-cov-2 ,biomimetic:2
vaccine ,conventional:2
vaccine ,biomimetic:2
research ,development:2
research ,conventional:2
research ,biomimetic:2
development ,conventional:2
development ,biomimetic:2
conventional ,vaccines:2
conventional ,biomimetic:2
vaccines ,biomimetic:2
age ,driving:2
age ,variable:2
age ,epidemic:2
age ,trajectories:2
age ,worldwide:2
driving ,variable:2
driving ,epidemic:2
driving ,trajectories:2
driving ,worldwide:2
variable ,epidemic:2
variable ,trajectories:2
variable ,worldwide:2
sars-cov-2 ,trajectories:2
epidemic ,trajectories:2
trajectories ,worldwide:2
autoantibody-negative ,insulin-dependent:2
autoantibody-negative ,diabetes:2
autoantibody-negative ,mellitus:2
autoantibody-negative ,sars-cov-2:2
insulin-dependent ,diabetes:2
insulin-dependent ,mellitus:2
insulin-dependent ,sars-cov-2:2
emerging ,spectrum:2
emerging ,radiological:2
spectrum ,neurology:2
spectrum ,radiological:2
spectrum ,laboratory:2
neurology ,clinical:2
neurology ,radiological:2
neurology ,laboratory:2
radiological ,laboratory:2
development ,taqman:2
development ,transcription-pcr:2
two ,taqman:2
taqman ,real-time:2
taqman ,reverse:2
taqman ,transcription-pcr:2
taqman ,assays:2
real-time ,transcription-pcr:2
transcription-pcr ,assays:2
hiv ,brain:2
hiv ,can:2
hiv ,teach:2
hiv ,us:2
hiv ,neurological:2
hiv ,complications:2
brain ,teach:2
brain ,us:2
brain ,complications:2
can ,neurological:2
can ,complications:2
teach ,sars-cov-2:2
teach ,neurological:2
teach ,complications:2
us ,neurological:2
us ,complications:2
decreased ,mortality:2
decreased ,patients:2
decreased ,severe:2
decreased ,bronchospasm:2
decreased ,associated:2
decreased ,sars-cov-2:2
mortality ,bronchospasm:2
patients ,bronchospasm:2
severe ,bronchospasm:2
bronchospasm ,associated:2
bronchospasm ,sars-cov-2:2
challenges ,shared:2
challenges ,decision:2
challenges ,highlighted:2
opportunities ,shared:2
opportunities ,decision:2
opportunities ,making:2
opportunities ,highlighted:2
shared ,decision:2
shared ,making:2
shared ,highlighted:2
decision ,highlighted:2
making ,highlighted:2
highlighted ,covid-19:2
structural ,nsp12-nsp7-nsp8:2
structural ,core:2
biochemical ,characterization:2
biochemical ,nsp12-nsp7-nsp8:2
biochemical ,core:2
biochemical ,polymerase:2
characterization ,nsp12-nsp7-nsp8:2
characterization ,core:2
characterization ,polymerase:2
nsp12-nsp7-nsp8 ,core:2
nsp12-nsp7-nsp8 ,polymerase:2
core ,polymerase:2
modeling ,epidemiological:2
modeling ,trend:2
modeling ,behavior:2
epidemiological ,trend:2
epidemiological ,italy:2
trend ,behavior:2
trend ,italy:2
behavior ,italy:2
overview ,effect:2
overview ,bioaerosol:2
overview ,size:2
effect ,bioaerosol:2
effect ,size:2
bioaerosol ,size:2
bioaerosol ,coronavirus:2
bioaerosol ,disease:2
size ,coronavirus:2
size ,disease:2
role ,profile:2
role ,lymphocyte:2
role ,subsets:2
cytokine ,lymphocyte:4
cytokine ,subsets:2
lymphocyte ,severity:2
subsets ,severity:2
subsets ,coronavirus:2
overview ,macau:2
overview ,sar:2
epidemiology ,macau:2
epidemiology ,sar:2
covid-19 ,sar:2
macau ,sar:2
focus ,mental:2
focus ,health:4
focus ,applying:2
mental ,coronavirus:2
mental ,applying:2
health ,applying:2
coronavirus ,applying:2
covid-19 ,applying:2
pandemic ,applying:2
coronavirus ,116:2
disease ,116:2
pregnant ,based:2
pregnant ,116:2
pregnant ,cases:2
women ,based:2
women ,116:2
women ,cases:2
report ,based:2
report ,116:2
based ,116:2
based ,cases:2
116 ,cases:2
spontaneous ,emphysema:2
spontaneous ,patient:2
pneumothorax ,emphysema:2
pneumothorax ,patient:2
pneumothorax ,case:8
subcutaneous ,patient:2
subcutaneous ,case:2
emphysema ,covid-19:2
emphysema ,patient:2
emphysema ,case:2
viral ,level:2
rna ,antibody:4
rna ,responses:2
rna ,transmission:2
level ,serum:2
level ,antibody:2
level ,responses:2
level ,transmission:2
level ,risk:4
level ,recovered:2
serum ,responses:2
serum ,risk:2
serum ,recovered:2
antibody ,transmission:2
antibody ,risk:2
antibody ,recovered:2
responses ,transmission:2
responses ,risk:2
responses ,recovered:2
transmission ,recovered:2
viability ,faecal:2
viability ,bio-aerosols:2
sars-cov-2 ,faecal:2
sars-cov-2 ,bio-aerosols:2
faecal ,bio-aerosols:2
discovery ,nsp13:2
discovery ,helicase:2
covid-19 ,nsp13:2
covid-19 ,helicase:2
inhibitors ,nsp13:2
inhibitors ,helicase:2
targeting ,nsp13:2
targeting ,helicase:2
montelukast ,drug:2
montelukast ,may:2
montelukast ,improve:2
montelukast ,covid-19:2
montelukast ,prognosis:2
montelukast ,review:2
montelukast ,evidence:2
drug ,may:2
drug ,improve:2
drug ,prognosis:2
drug ,evidence:2
may ,improve:2
may ,prognosis:2
may ,evidence:2
improve ,prognosis:2
improve ,review:2
improve ,evidence:2
prognosis ,evidence:2
anosmia ,missing:2
anosmia ,link:2
anosmia ,neuroimmunology:2
anosmia ,coronavirus:2
anosmia ,disease:2
missing ,neuroimmunology:2
missing ,coronavirus:2
missing ,disease:2
link ,neuroimmunology:2
neuroimmunology ,coronavirus:2
neuroimmunology ,disease:2
clinical ,second-generation:2
characteristics ,imported:2
characteristics ,second-generation:2
imported ,second-generation:2
imported ,coronavirus:2
imported ,disease:2
second-generation ,coronavirus:2
second-generation ,disease:2
first ,art:2
first ,pregnancies:2
first ,context:2
follow-up ,art:2
follow-up ,pregnancies:2
follow-up ,context:2
follow-up ,outbreak:2
art ,pregnancies:2
art ,context:2
art ,outbreak:2
pregnancies ,context:2
pregnancies ,outbreak:2
context ,outbreak:2
barrier ,device:2
barrier ,prototype:2
barrier ,open:2
barrier ,tracheotomy:2
barrier ,pandemic:2
device ,prototype:2
device ,open:2
device ,tracheotomy:2
device ,pandemic:2
prototype ,open:2
prototype ,tracheotomy:2
prototype ,covid-19:2
prototype ,pandemic:2
open ,tracheotomy:2
open ,pandemic:2
complement ,system:2
complement ,friend:2
complement ,foe:2
covid-19 ,non-alcoholic:2
covid-19 ,fatty:2
covid-19 ,intersecting:2
non-alcoholic ,fatty:2
non-alcoholic ,liver:2
non-alcoholic ,disease:2
non-alcoholic ,two:2
non-alcoholic ,intersecting:2
non-alcoholic ,pandemics:2
fatty ,two:2
fatty ,intersecting:2
fatty ,pandemics:2
liver ,two:2
liver ,intersecting:2
liver ,pandemics:2
disease ,intersecting:2
disease ,pandemics:2
two ,intersecting:2
intersecting ,pandemics:2
potent ,3c-like:2
potent ,protease:6
potent ,derived:2
potent ,n-substituted:2
potent ,isatin:2
inhibitors ,derived:2
inhibitors ,n-substituted:2
inhibitors ,isatin:2
sars-cov-2 ,n-substituted:2
sars-cov-2 ,isatin:2
3c-like ,derived:2
3c-like ,n-substituted:2
3c-like ,isatin:2
protease ,derived:2
protease ,n-substituted:2
protease ,isatin:2
derived ,n-substituted:2
derived ,isatin:2
n-substituted ,isatin:2
covid-19 ,directions:2
pandemic ,directions:2
lessons ,directions:2
learned ,directions:2
presentation ,experience:2
presentation ,brazil:2
pulmonary ,initial:2
pulmonary ,brazil:2
infection ,initial:2
infection ,brazil:2
ct ,experience:2
ct ,brazil:2
initial ,brazil:2
experience ,brazil:2
influence ,different:2
influence ,inactivation:2
influence ,methods:2
influence ,severe:2
influence ,acute:2
influence ,respiratory:2
influence ,syndrome:2
different ,methods:2
different ,syndrome:2
methods ,syndrome:2
defines ,efficacious:2
defines ,covid-19:2
defines ,vaccine:2
defines ,review:2
defines ,challenges:2
defines ,assessing:2
efficacious ,covid-19:2
efficacious ,vaccine:2
efficacious ,review:2
efficacious ,challenges:2
efficacious ,assessing:2
vaccine ,assessing:2
review ,assessing:2
challenges ,assessing:2
pediatric ,inpatients:2
inpatients ,sars-cov-2:2
inpatients ,infection:2
guidelines ,pregnancy:2
guidelines ,public:2
pregnancy ,public:2
pregnancy ,health:2
adverse ,sar-cov-2:2
adverse ,sars:2
adverse ,virus:2
adverse ,related:2
adverse ,pregnancies:2
outcomes ,sar-cov-2:2
outcomes ,sars:2
outcomes ,virus:2
outcomes ,pregnancies:2
sar-cov-2 ,covid-19:2
sar-cov-2 ,sars:2
sar-cov-2 ,virus:2
sar-cov-2 ,related:2
sar-cov-2 ,pregnancies:2
sars ,virus:2
sars ,pregnancies:2
virus ,pregnancies:2
related ,pregnancies:2
evaluation ,outbreak:2
evaluation ,caused:2
evaluation ,temporal:2
evaluation ,contact-increase:2
covid-19 ,contact-increase:2
epidemic ,caused:2
epidemic ,temporal:2
epidemic ,contact-increase:2
outbreak ,temporal:2
outbreak ,contact-increase:2
caused ,temporal:2
caused ,contact-increase:2
temporal ,contact-increase:2
missed ,takes:2
missed ,towards:2
missed ,pandemic:2
missed ,covid-19:2
missed ,systematic:2
missed ,literature:2
missed ,review:2
takes ,towards:2
takes ,pandemic:2
takes ,covid-19:2
takes ,systematic:2
takes ,literature:2
takes ,review:2
towards ,pandemic:2
towards ,systematic:2
towards ,literature:2
towards ,review:4
assessment ,serum:2
assessment ,levels:2
assessment ,tweak:2
assessment ,prostaglandin:2
assessment ,f2:2
assessment ,covid:2
assessment ,19:2
serum ,levels:2
serum ,tweak:2
serum ,prostaglandin:2
serum ,f2:2
serum ,covid:2
serum ,19:2
levels ,tweak:2
levels ,prostaglandin:2
levels ,f2:2
levels ,covid:2
levels ,19:2
tweak ,prostaglandin:2
tweak ,f2:2
tweak ,covid:2
tweak ,19:2
prostaglandin ,f2:2
prostaglandin ,covid:2
prostaglandin ,19:2
f2 ,covid:2
f2 ,19:2
protection ,large:2
protection ,teaching:2
healthcare ,teaching:2
workers ,teaching:2
covid-19 ,teaching:2
large ,teaching:2
teaching ,hospital:2
ferritin ,marker:2
ferritin ,severity:2
ferritin ,covid-19:2
ferritin ,patients:2
ferritin ,fatal:2
ferritin ,correlation:2
marker ,severity:2
marker ,fatal:2
marker ,correlation:2
severity ,fatal:2
patients ,fatal:2
fatal ,correlation:2
emergency ,policies:2
emergency ,one:2
emergency ,institutions:2
emergency ,experience:4
department ,covid:2
department ,management:6
department ,policies:2
department ,one:2
department ,institutions:2
covid ,policies:2
covid ,one:2
covid ,institutions:2
covid ,experience:2
management ,policies:2
management ,one:2
management ,institutions:2
policies ,one:2
policies ,institutions:2
policies ,experience:2
one ,institutions:2
one ,experience:2
institutions ,experience:2
early ,postpartum:2
early ,discharge:2
postpartum ,discharge:2
postpartum ,pandemic:2
discharge ,pandemic:2
impact ,us:2
impact ,canadian:2
impact ,neurologists:2
impact ,approach:2
us ,canadian:2
us ,neurologists:2
us ,therapeutic:2
us ,approach:2
canadian ,neurologists:2
canadian ,therapeutic:2
canadian ,approach:2
neurologists ,therapeutic:2
neurologists ,approach:2
high-resolution ,structure:2
high-resolution ,biophysical:2
high-resolution ,characterization:2
high-resolution ,nucleocapsid:2
structure ,biophysical:2
structure ,characterization:2
structure ,nucleocapsid:2
biophysical ,characterization:2
biophysical ,nucleocapsid:2
characterization ,nucleocapsid:2
pediatric ,central:2
pediatric ,nervous:2
pediatric ,system:2
pediatric ,involvement:2
inflammatory ,central:2
inflammatory ,nervous:2
inflammatory ,involvement:2
multisystem ,central:2
multisystem ,nervous:2
multisystem ,system:2
multisystem ,involvement:2
review ,virology:2
review ,anti-viral:2
sars-cov-2 ,anti-viral:2
virology ,pathophysiology:2
virology ,animal:2
virology ,models:2
virology ,anti-viral:2
pathophysiology ,animal:2
pathophysiology ,models:2
pathophysiology ,anti-viral:2
animal ,anti-viral:2
models ,anti-viral:2
prevalence ,brazilians:2
prevalence ,aged:2
prevalence ,50:2
prevalence ,received:2
characteristics ,brazilians:2
characteristics ,50:2
characteristics ,received:2
brazilians ,aged:2
brazilians ,50:2
brazilians ,received:2
aged ,50:2
aged ,received:2
50 ,received:2
assessment ,prevalence:2
assessment ,homeless:2
assessment ,shelters:2
assessment ,four:2
assessment ,us:2
sars-cov-2 ,shelters:2
infection ,shelters:2
prevalence ,shelters:2
prevalence ,four:2
homeless ,shelters:2
homeless ,four:2
homeless ,us:2
shelters ,four:2
shelters ,us:2
four ,us:2
baricitinib ,rescue:2
baricitinib ,therapy:2
baricitinib ,patient:2
baricitinib ,complete:2
baricitinib ,response:2
rescue ,therapy:2
rescue ,patient:2
rescue ,complete:2
rescue ,response:2
therapy ,complete:2
therapy ,response:4
patient ,complete:2
complete ,response:2
towards ,reduction:2
towards ,bias:2
towards ,epidemic:2
towards ,curves:2
towards ,due:2
towards ,outcome:2
towards ,misclassification:2
reduction ,bias:2
reduction ,epidemic:2
reduction ,curves:2
reduction ,due:2
reduction ,outcome:2
reduction ,misclassification:2
bias ,epidemic:2
bias ,curves:2
bias ,due:2
bias ,outcome:2
bias ,misclassification:2
epidemic ,curves:2
epidemic ,due:2
epidemic ,misclassification:2
curves ,due:2
curves ,outcome:2
curves ,misclassification:2
due ,outcome:2
due ,misclassification:2
outcome ,misclassification:2
high-throughput ,screening:2
high-throughput ,inhibitors:2
high-throughput ,protease:2
high-throughput ,using:2
fdg-petct ,imaging:2
fdg-petct ,emergency:2
fdg-petct ,southern:2
fdg-petct ,perspective:2
imaging ,emergency:2
imaging ,southern:2
imaging ,italian:2
imaging ,perspective:2
covid-19 ,southern:2
emergency ,southern:2
emergency ,italian:2
emergency ,perspective:2
southern ,italian:2
multivariate ,analyses:4
multivariate ,codon:2
multivariate ,usage:2
multivariate ,sars-cov-2:2
multivariate ,betacoronaviruses:2
analyses ,codon:2
analyses ,usage:2
analyses ,betacoronaviruses:2
codon ,betacoronaviruses:2
usage ,betacoronaviruses:2
sars-cov-2 ,betacoronaviruses:2
sars-cov-2 ,triggers:2
sars-cov-2 ,caspase-8:2
triggers ,inflammatory:2
triggers ,responses:2
triggers ,cell:2
triggers ,death:2
triggers ,caspase-8:2
inflammatory ,death:2
inflammatory ,caspase-8:2
responses ,death:2
responses ,caspase-8:2
cell ,death:2
cell ,caspase-8:2
death ,caspase-8:2
prevention ,nursing:2
prevention ,homes:2
prevention ,orphanages:2
prevention ,prisons:2
control ,nursing:2
control ,homes:2
control ,orphanages:2
control ,prisons:2
covid-19 ,orphanages:2
covid-19 ,prisons:2
nursing ,orphanages:2
nursing ,prisons:2
homes ,orphanages:2
homes ,prisons:2
orphanages ,prisons:2
strategies ,recommendations:2
strategies ,urolithiasis:2
strategies ,follow-up:2
recommendations ,urolithiasis:2
recommendations ,follow-up:2
urolithiasis ,treatment:2
urolithiasis ,follow-up:2
urolithiasis ,covid-19:2
treatment ,follow-up:2
progress ,pitfalls:2
progress ,quest:2
progress ,effective:2
pitfalls ,quest:2
pitfalls ,effective:2
pitfalls ,sars-cov-2:2
pitfalls ,vaccines:2
quest ,sars-cov-2:2
quest ,vaccines:2
effective ,vaccines:4
lactate ,dehydrogenase:2
lactate ,susceptibility:2
lactate ,deterioration:2
lactate ,mild:2
lactate ,covid-19:2
lactate ,patients:2
dehydrogenase ,susceptibility:2
dehydrogenase ,deterioration:2
dehydrogenase ,mild:2
dehydrogenase ,covid-19:2
dehydrogenase ,patients:2
susceptibility ,deterioration:2
susceptibility ,mild:2
susceptibility ,patients:2
deterioration ,mild:2
prophylactic ,intranasal:2
prophylactic ,administration:2
prophylactic ,tlr26:2
prophylactic ,agonist:2
prophylactic ,reduces:2
prophylactic ,upper:2
prophylactic ,respiratory:2
intranasal ,administration:2
intranasal ,tlr26:2
intranasal ,agonist:2
intranasal ,reduces:2
intranasal ,upper:2
intranasal ,respiratory:2
administration ,tlr26:2
administration ,agonist:2
administration ,reduces:2
administration ,upper:2
administration ,respiratory:2
tlr26 ,agonist:2
tlr26 ,reduces:2
tlr26 ,upper:2
tlr26 ,respiratory:2
agonist ,reduces:2
agonist ,upper:2
agonist ,respiratory:2
reduces ,upper:2
viral ,fragment:2
viral ,theory:2
protein ,fragment:2
protein ,theory:2
protein ,pathogenesis:2
fragment ,theory:2
fragment ,covid-19:2
fragment ,pathogenesis:2
theory ,pathogenesis:2
considerations ,recommendations:2
considerations ,obstetric:2
recommendations ,anesthesia:2
detection ,fragments:2
detection ,ipsc-cardiomyocytes:2
detection ,following:2
viral ,fragments:2
viral ,ipsc-cardiomyocytes:2
viral ,following:2
rna ,fragments:2
rna ,ipsc-cardiomyocytes:2
rna ,following:2
rna ,treatment:2
fragments ,human:2
fragments ,ipsc-cardiomyocytes:2
fragments ,following:2
fragments ,treatment:2
human ,ipsc-cardiomyocytes:2
human ,following:2
human ,treatment:2
ipsc-cardiomyocytes ,following:2
ipsc-cardiomyocytes ,treatment:2
correlation ,healthcare:2
correlation ,response:4
correlation ,prevention:2
response ,prevention:2
serum ,albumin-mediated:2
serum ,strategy:2
serum ,targeting:2
albumin-mediated ,strategy:2
albumin-mediated ,effective:2
albumin-mediated ,targeting:2
albumin-mediated ,sars-cov-2:2
strategy ,effective:2
strategy ,targeting:2
effective ,targeting:2
established ,infection:2
established ,prevention:2
established ,control:2
established ,measures:2
established ,prevent:2
established ,spread:2
prevention ,prevent:2
measures ,prevent:2
short-term ,exposure:2
short-term ,air:2
short-term ,quality:2
short-term ,polluted:2
short-term ,indian:2
short-term ,cities:2
short-term ,due:2
exposure ,ambient:2
exposure ,quality:2
exposure ,polluted:2
exposure ,indian:2
exposure ,cities:2
exposure ,due:2
ambient ,quality:2
ambient ,polluted:2
ambient ,indian:2
ambient ,cities:2
ambient ,due:2
air ,polluted:2
air ,indian:2
air ,cities:2
quality ,polluted:2
quality ,indian:2
quality ,cities:2
polluted ,indian:2
polluted ,cities:2
polluted ,due:2
indian ,cities:2
indian ,due:2
cities ,due:2
biopsy ,patients:2
docking ,qsar:2
docking ,aminothioureas:2
docking ,s-protein-human:2
docking ,ace2:2
docking ,receptor:2
qsar ,aminothioureas:2
qsar ,sars-cov-2:2
qsar ,s-protein-human:2
qsar ,ace2:2
qsar ,receptor:2
aminothioureas ,sars-cov-2:2
aminothioureas ,s-protein-human:2
aminothioureas ,ace2:2
aminothioureas ,receptor:2
sars-cov-2 ,s-protein-human:2
s-protein-human ,ace2:2
s-protein-human ,receptor:2
fibrinogen ,d-dimer:2
fibrinogen ,variances:2
fibrinogen ,anticoagulation:2
fibrinogen ,recommendations:2
fibrinogen ,covid-19:2
d-dimer ,variances:2
d-dimer ,anticoagulation:2
d-dimer ,recommendations:2
variances ,anticoagulation:2
variances ,recommendations:2
variances ,covid-19:2
anticoagulation ,recommendations:2
turnaround ,times:2
turnaround ,achilles:2
turnaround ,heel:2
turnaround ,community:2
turnaround ,screening:2
turnaround ,testing:2
turnaround ,cape:2
times ,achilles:2
times ,heel:2
times ,community:2
times ,screening:2
times ,testing:2
times ,cape:2
achilles ,heel:2
achilles ,community:2
achilles ,screening:2
achilles ,testing:2
achilles ,cape:2
heel ,community:2
heel ,screening:2
heel ,testing:2
heel ,cape:2
community ,cape:2
screening ,cape:2
testing ,cape:2
upper ,sampling:2
tract ,sampling:2
sampling ,covid-19:4
abdominopelvic ,findings:2
abdominopelvic ,patients:2
abdominopelvic ,novel:2
abdominopelvic ,coronavirus:2
abdominopelvic ,disease:2
clinical ,time:2
trials ,time:2
pangolins ,intermediate:2
pangolins ,host:2
pangolins ,novel:2
pangolins ,sars-cov-2:2
intermediate ,novel:2
intermediate ,coronavirus:2
host ,novel:2
testing ,repatriated:2
testing ,sars-cov2:2
testing ,laboratory-based:2
testing ,quarantine:2
testing ,replace:2
repatriated ,sars-cov2:2
repatriated ,laboratory-based:2
repatriated ,quarantine:2
repatriated ,replace:2
sars-cov2 ,laboratory-based:2
sars-cov2 ,quarantine:2
sars-cov2 ,replace:2
laboratory-based ,quarantine:2
laboratory-based ,replace:2
quarantine ,replace:2
herbal ,plants:2
herbal ,coordinate:2
herbal ,multiple:2
herbal ,dimensions:2
herbal ,insight:2
herbal ,analysis:2
plants ,coordinate:2
plants ,covid-19:2
plants ,multiple:2
plants ,dimensions:2
plants ,insight:2
plants ,analysis:2
coordinate ,covid-19:2
coordinate ,multiple:2
coordinate ,dimensions:2
coordinate ,insight:2
coordinate ,analysis:2
covid-19 ,dimensions:2
multiple ,dimensions:2
multiple ,insight:2
dimensions ,insight:2
dimensions ,analysis:2
insight ,analysis:2
smell ,associated:2
smell ,younger:2
smell ,age:2
smell ,ambulatory:2
taste ,associated:2
taste ,younger:2
taste ,age:2
taste ,ambulatory:2
dysfunction ,associated:2
dysfunction ,younger:2
dysfunction ,age:2
dysfunction ,ambulatory:2
covid-19 ,younger:4
associated ,younger:2
associated ,age:2
associated ,ambulatory:2
younger ,age:2
younger ,ambulatory:2
age ,ambulatory:2
unleashing ,immune:2
unleashing ,system:2
unleashing ,covid-19:2
unleashing ,sepsis:2
unleashing ,calm:2
immune ,calm:2
system ,sepsis:2
system ,calm:2
covid-19 ,calm:2
sepsis ,calm:2
sars-cov-2 ,abnormal:2
infection ,normal:2
infection ,abnormal:2
patients ,normal:2
normal ,abnormal:2
normal ,liver:2
hypolipidemia ,associated:2
hypolipidemia ,severity:2
hypolipidemia ,covid-19:2
cholesterol ,25-hydroxylase:2
cholesterol ,coronaviruses:2
cholesterol ,depleting:2
25-hydroxylase ,inhibits:2
25-hydroxylase ,sars-cov-2:2
25-hydroxylase ,coronaviruses:2
25-hydroxylase ,depleting:2
inhibits ,coronaviruses:2
inhibits ,depleting:2
sars-cov-2 ,depleting:2
coronaviruses ,depleting:2
loss ,marker:2
loss ,tracking:2
loss ,reduced:2
smell ,marker:2
smell ,tracking:2
smell ,reduced:2
taste ,marker:2
taste ,tracking:2
taste ,reduced:2
new ,marker:2
new ,reduced:2
new ,sense:2
marker ,tracking:2
marker ,reduced:2
marker ,sense:2
tracking ,reduced:2
tracking ,sense:2
reduced ,sense:2
case ,45-day-old:2
case ,fecal:2
covid-19 ,45-day-old:2
45-day-old ,infant:2
45-day-old ,persistent:2
45-day-old ,fecal:2
45-day-old ,virus:2
45-day-old ,shedding:2
infant ,persistent:2
infant ,fecal:2
infant ,shedding:2
persistent ,fecal:2
persistent ,virus:2
fecal ,virus:2
spectrum ,neonatal:2
spectrum ,iran:2
spectrum ,19:2
spectrum ,infants:2
spectrum ,perinatal:2
neonatal ,iran:2
neonatal ,19:2
iran ,19:2
iran ,infants:2
iran ,perinatal:2
19 ,infants:2
19 ,perinatal:2
infants ,perinatal:2
expression ,airways:2
expression ,implication:2
expression ,management:2
ace2 ,airways:2
ace2 ,implication:2
ace2 ,management:2
airways ,implication:2
airways ,risk:2
airways ,disease:2
airways ,management:2
implication ,risk:2
implication ,disease:2
implication ,management:2
clinical ,112:2
characteristics ,112:2
characteristics ,cardiovascular:2
outcomes ,112:2
outcomes ,cardiovascular:2
112 ,cardiovascular:2
112 ,disease:2
112 ,patients:2
ethical ,aspects:2
ethical ,deal:2
ethical ,overwhelming:2
ethical ,shortage:2
aspects ,crisis:2
aspects ,deal:2
aspects ,overwhelming:2
aspects ,shortage:2
covid-19 ,overwhelming:2
crisis ,deal:2
crisis ,overwhelming:2
crisis ,shortage:2
deal ,overwhelming:2
deal ,shortage:2
overwhelming ,shortage:2
essential ,face:2
essential ,prevention:2
essential ,experiences:2
healthcare ,face:2
healthcare ,experiences:2
services ,face:2
services ,prevention:2
face ,prevention:2
face ,experiences:2
profiling ,serum:2
profiling ,cytokines:2
profiling ,il-6:2
profiling ,il-10:2
profiling ,disease:2
serum ,reveals:2
serum ,il-6:2
serum ,il-10:2
cytokines ,patients:2
cytokines ,reveals:2
cytokines ,il-10:2
covid-19 ,il-6:2
covid-19 ,il-10:2
patients ,reveals:2
patients ,il-6:2
patients ,il-10:2
reveals ,il-6:2
reveals ,il-10:2
reveals ,disease:2
il-6 ,il-10:2
il-6 ,disease:2
il-10 ,disease:2
comparison ,fecalperianal:2
clinical ,fecalperianal:2
characteristics ,fecalperianal:2
fecalperianal ,swab:2
fecalperianal ,nucleic:2
swab ,nucleic:2
diabetic ,disease:2
diabetic ,mellitus:2
ketoacidosis ,coronavirus:2
ketoacidosis ,disease:2
ketoacidosis ,type:4
ketoacidosis ,diabetes:2
ketoacidosis ,mellitus:2
evaluation ,health-related:2
evaluation ,quality:2
evaluation ,life:2
evaluation ,eq-5d:2
evaluation ,china:2
health-related ,quality:2
health-related ,life:2
health-related ,using:2
health-related ,eq-5d:2
health-related ,china:2
quality ,life:2
quality ,using:2
quality ,eq-5d:2
quality ,china:2
life ,using:2
life ,eq-5d:2
life ,china:2
using ,eq-5d:2
using ,china:2
eq-5d ,china:2
clinical ,impact:8
clinical ,supplemental:2
clinical ,nutrients:2
clinical ,adjuncts:2
impact ,supplemental:2
impact ,nutrients:2
impact ,adjuncts:2
potential ,supplemental:2
potential ,nutrients:2
supplemental ,nutrients:2
supplemental ,adjuncts:2
supplemental ,therapy:2
nutrients ,adjuncts:2
nutrients ,therapy:2
adjuncts ,therapy:2
sublingual ,microcirculation:2
sublingual ,patients:2
sublingual ,sars-cov-2:2
sublingual ,undergoing:2
sublingual ,veno-venous:2
microcirculation ,patients:2
microcirculation ,sars-cov-2:2
microcirculation ,undergoing:2
microcirculation ,veno-venous:2
patients ,veno-venous:2
sars-cov-2 ,veno-venous:2
undergoing ,veno-venous:2
impacts ,disease:2
impacts ,healthcare:2
impacts ,workers:2
evidence ,reinfection:2
acute ,reinfection:2
respiratory ,reinfection:2
syndrome ,reinfection:2
coronavirus ,reinfection:2
novel ,scaffolds:2
novel ,candidates:2
small-molecule ,scaffolds:2
small-molecule ,candidates:2
small-molecule ,sars:2
small-molecule ,main:2
scaffolds ,candidates:2
scaffolds ,sars:2
scaffolds ,coronavirus:2
scaffolds ,main:2
candidates ,main:2
coronavirus ,main:4
transmission ,brief:2
transmission ,preventive:2
dental ,brief:2
dental ,review:4
dental ,preventive:2
practice ,brief:2
practice ,preventive:2
practice ,measures:2
brief ,preventive:2
brief ,measures:2
covid-19 ,distant:2
covid-19 ,sequence:2
covid-19 ,similarity:2
covid-19 ,hepcidin:2
iron ,dysregulation:2
iron ,distant:2
iron ,sequence:2
iron ,similarity:2
iron ,hepcidin:2
dysregulation ,distant:2
dysregulation ,sequence:2
dysregulation ,similarity:2
dysregulation ,hepcidin:2
distant ,sequence:2
distant ,similarity:2
distant ,hepcidin:2
sequence ,similarity:2
sequence ,hepcidin:2
similarity ,hepcidin:2
end ,endothelial:2
end ,disease:2
endothelial ,disease:2
ace2 ,allergic:2
ace2 ,decrease:2
ace2 ,severity:2
expression ,allergic:2
expression ,decrease:2
allergic ,airway:2
allergic ,may:2
allergic ,decrease:2
allergic ,risk:2
airway ,disease:2
airway ,may:2
airway ,decrease:2
airway ,risk:2
airway ,severity:2
disease ,decrease:2
may ,decrease:2
may ,severity:2
decrease ,severity:2
scalable ,topical:2
scalable ,vectored:2
scalable ,vaccine:2
scalable ,candidate:2
scalable ,sars-cov-2:2
topical ,vectored:2
topical ,vaccine:2
topical ,candidate:2
vectored ,vaccine:2
vectored ,candidate:2
vectored ,sars-cov-2:2
preparation ,next:2
preparation ,covid-19:2
preparation ,wave:2
preparation ,european:2
preparation ,hip:2
preparation ,society:2
preparation ,knee:2
next ,wave:2
next ,european:2
next ,hip:2
next ,society:2
next ,knee:2
wave ,european:2
wave ,hip:2
wave ,society:2
wave ,knee:2
european ,hip:2
european ,knee:2
hip ,society:2
society ,knee:2
highly ,thrusting:2
highly ,vaccine:2
highly ,spotlight:2
pathogenic ,thrusting:2
pathogenic ,vaccine:2
pathogenic ,development:2
pathogenic ,spotlight:2
coronaviruses ,thrusting:2
coronaviruses ,spotlight:2
thrusting ,vaccine:2
thrusting ,development:2
thrusting ,spotlight:2
vaccine ,spotlight:2
development ,spotlight:2
partnerships ,avenue:2
partnerships ,translate:2
partnerships ,emerging:2
partnerships ,disease:2
partnerships ,ecology:2
partnerships ,sars-cov-2:2
avenue ,translate:2
avenue ,emerging:2
avenue ,disease:2
avenue ,ecology:2
avenue ,sars-cov-2:2
translate ,emerging:2
translate ,disease:2
translate ,ecology:2
translate ,sars-cov-2:2
emerging ,ecology:2
disease ,ecology:2
diagnosis ,asymptomatic:2
diagnosis ,oncological:2
covid-19 ,oncological:2
pneumonia ,oncological:2
asymptomatic ,oncological:2
hiv ,care:4
hiv ,disease-2019:2
hiv ,shenzhen:2
care ,disease-2019:2
care ,shenzhen:2
care ,china:2
disease-2019 ,pandemic:2
disease-2019 ,shenzhen:2
disease-2019 ,china:2
pandemic ,shenzhen:2
vitamin ,survival:4
vitamin ,quasi-experimental:2
vitamin ,study:2
survival ,covid-19:2
survival ,quasi-experimental:2
survival ,study:2
covid-19 ,quasi-experimental:2
patients ,quasi-experimental:2
quasi-experimental ,study:2
intention ,participate:2
intention ,covid-19:2
intention ,vaccine:2
intention ,clinical:2
intention ,trial:2
intention ,get:2
intention ,vaccinated:2
participate ,covid-19:2
participate ,vaccine:2
participate ,clinical:2
participate ,trial:2
participate ,get:2
participate ,vaccinated:2
covid-19 ,vaccinated:2
vaccine ,clinical:2
vaccine ,trial:2
vaccine ,get:2
vaccine ,vaccinated:2
clinical ,get:2
clinical ,vaccinated:2
trial ,get:2
trial ,vaccinated:2
get ,vaccinated:2
severe ,dysregulated:2
nlrp3 ,dysregulated:2
inflammasome ,dysregulated:2
development ,single-tube:2
development ,nested:2
evaluation ,highly:2
evaluation ,sensitive:2
evaluation ,single-tube:4
evaluation ,nested:2
novel ,sensitive:4
sensitive ,single-tube:2
sensitive ,nested:2
transplantation ,cells:2
transplantation ,adjuvant:2
transplantation ,therapy:2
mesenchymal ,adjuvant:2
stem ,adjuvant:2
cells ,adjuvant:2
initial ,correlation:2
initial ,features:2
findings ,correlation:2
correlation ,features:2
effect ,smoking:2
effect ,symptom:2
effect ,severity:2
effect ,systematic:2
smoking ,symptom:2
smoking ,severity:2
smoking ,systematic:2
symptom ,systematic:2
severity ,systematic:2
severity ,review:2
unique ,transcriptional:2
unique ,changes:2
unique ,coagulation:2
unique ,cascade:2
unique ,genes:2
unique ,sars-cov-2-infected:2
transcriptional ,changes:2
transcriptional ,coagulation:2
transcriptional ,cascade:2
transcriptional ,genes:2
transcriptional ,sars-cov-2-infected:2
changes ,cascade:2
changes ,genes:2
changes ,sars-cov-2-infected:2
coagulation ,cascade:2
coagulation ,genes:2
coagulation ,sars-cov-2-infected:2
cascade ,genes:2
cascade ,sars-cov-2-infected:2
genes ,sars-cov-2-infected:2
in-hospital ,pathway:2
in-hospital ,acute:2
in-hospital ,coronary:2
in-hospital ,syndrome:2
in-hospital ,covid-19:4
pathway ,acute:2
pathway ,coronary:2
pathway ,syndrome:2
pathway ,covid-19:4
coronary ,syndrome:2
coronary ,patients:2
sars-cov-2 ,vertically:2
vertically ,transmitted:2
molecular ,sulawesi:2
molecular ,propolis:2
molecular ,compounds:2
interaction ,analysis:2
interaction ,sulawesi:2
interaction ,propolis:2
interaction ,compounds:2
analysis ,sulawesi:2
analysis ,propolis:2
analysis ,compounds:2
sulawesi ,propolis:2
sulawesi ,compounds:2
sulawesi ,sars-cov-2:2
sulawesi ,main:2
propolis ,compounds:2
propolis ,main:2
compounds ,main:2
societal ,impact:2
societal ,vaccination:2
societal ,beyond:2
societal ,individual:2
societal ,protection:2
societal ,renewed:2
societal ,interest:2
impact ,beyond:2
impact ,individual:2
impact ,protection:2
impact ,renewed:2
impact ,interest:2
vaccination ,beyond:2
vaccination ,individual:2
vaccination ,protection:2
vaccination ,renewed:2
vaccination ,interest:2
beyond ,individual:2
beyond ,protection:2
beyond ,renewed:2
beyond ,interest:2
individual ,protection:2
individual ,renewed:2
individual ,interest:2
protection ,renewed:2
protection ,interest:2
renewed ,interest:2
covid-19 ,plastic:2
pandemia ,consequences:2
pandemia ,plastic:2
pandemia ,hand:2
consequences ,plastic:2
consequences ,surgery:2
consequences ,hand:2
plastic ,hand:2
surgery ,hand:2
type ,pathogenesis:2
case ,21:2
spontaneous ,21:2
spontaneous ,days:2
spontaneous ,diagnosis:2
spontaneous ,disease:2
pneumothorax ,21:2
pneumothorax ,days:2
pneumothorax ,diagnosis:2
pneumothorax ,disease:2
21 ,days:2
21 ,diagnosis:2
21 ,coronavirus:2
21 ,disease:2
days ,diagnosis:2
business ,intelligence:2
business ,applied:2
business ,emergency:2
business ,medical:2
business ,services:2
business ,lombardy:2
business ,region:2
intelligence ,applied:2
intelligence ,emergency:2
intelligence ,medical:2
intelligence ,services:2
intelligence ,lombardy:2
intelligence ,region:2
applied ,emergency:2
applied ,medical:2
applied ,services:2
applied ,lombardy:2
applied ,region:2
emergency ,lombardy:2
emergency ,region:2
medical ,services:2
medical ,lombardy:2
medical ,region:2
services ,lombardy:2
services ,region:2
lombardy ,region:2
effect ,emergency:2
effect ,accesses:2
effect ,experience:2
lockdown ,surgical:2
lockdown ,emergency:2
lockdown ,accesses:2
surgical ,accesses:2
surgical ,experience:2
emergency ,accesses:2
accesses ,experience:2
accesses ,covid-19:2
alternative ,multidisciplinary:2
alternative ,management:2
alternative ,options:2
alternative ,locally:2
alternative ,advanced:2
alternative ,nsclc:2
multidisciplinary ,options:2
multidisciplinary ,locally:2
multidisciplinary ,advanced:2
multidisciplinary ,nsclc:2
management ,options:2
management ,locally:2
management ,advanced:2
management ,nsclc:2
options ,locally:2
options ,advanced:2
options ,nsclc:2
locally ,advanced:2
locally ,nsclc:2
advanced ,nsclc:2
safety ,crisis:2
safety ,rapid:2
safety ,on-site:2
safety ,evaluation:4
crisis ,rapid:2
crisis ,on-site:2
crisis ,evaluation:2
crisis ,time:2
rapid ,on-site:2
rapid ,time:2
on-site ,evaluation:2
on-site ,time:2
on-site ,covid-19:2
on-site ,pandemic:2
evaluation ,time:2
first-time ,diabetic:2
first-time ,ketoacidosis:2
first-time ,type:2
first-time ,diabetics:2
first-time ,covid-19:2
first-time ,infection:2
diabetic ,diabetics:2
ketoacidosis ,diabetics:2
ketoacidosis ,covid-19:2
ketoacidosis ,infection:2
type ,diabetics:2
diabetics ,covid-19:2
diabetics ,infection:2
searching ,therapeutic:2
searching ,strategy:2
searching ,new:2
searching ,pneumonia:2
therapeutic ,pneumonia:4
strategy ,new:2
strategy ,pneumonia:2
evasion ,interferon:4
advanced ,bioinformatics:2
advanced ,rapidly:2
advanced ,identifies:2
advanced ,existing:2
advanced ,therapeutics:2
advanced ,patients:2
bioinformatics ,rapidly:2
bioinformatics ,identifies:2
bioinformatics ,existing:2
bioinformatics ,therapeutics:2
bioinformatics ,patients:2
rapidly ,identifies:2
rapidly ,existing:2
rapidly ,therapeutics:2
rapidly ,patients:2
identifies ,therapeutics:2
identifies ,patients:2
existing ,therapeutics:2
existing ,patients:2
estrogen ,shields:2
estrogen ,women:2
estrogen ,covid-19:2
estrogen ,complications:2
estrogen ,reducing:2
estrogen ,er:2
estrogen ,stress:2
shields ,women:2
shields ,complications:2
shields ,reducing:2
shields ,er:2
shields ,stress:2
women ,complications:2
women ,reducing:2
women ,er:2
women ,stress:2
covid-19 ,er:2
complications ,er:2
complications ,stress:2
reducing ,er:2
reducing ,stress:2
er ,stress:2
effects ,online:2
effects ,survey:2
quarantine ,sleep:2
quarantine ,online:2
quarantine ,survey:2
sleep ,online:2
sleep ,survey:2
online ,survey:2
individual ,variation:2
individual ,receptor:2
individual ,ace2:2
individual ,gene:2
individual ,expression:2
individual ,regulation:2
variation ,receptor:2
variation ,gene:2
variation ,expression:2
variation ,regulation:2
management ,haemophilia:2
haemophilia ,patients:2
haemophilia ,covid-19:2
haemophilia ,pandemic:2
haemophilia ,experience:2
haemophilia ,wuhan:2
systemic ,mucosal:2
systemic ,antibody:2
systemic ,specific:2
systemic ,mild:2
systemic ,versus:2
mucosal ,antibody:2
mucosal ,responses:2
mucosal ,specific:2
mucosal ,mild:2
mucosal ,versus:2
antibody ,versus:2
specific ,mild:2
specific ,versus:2
rapid ,incorporation:2
rapid ,favipiravir:2
rapid ,fast:2
rapid ,permissive:2
incorporation ,favipiravir:2
incorporation ,fast:2
incorporation ,permissive:2
incorporation ,viral:2
incorporation ,rna:2
incorporation ,polymerase:2
favipiravir ,fast:2
favipiravir ,permissive:2
favipiravir ,viral:2
favipiravir ,rna:2
favipiravir ,polymerase:2
fast ,permissive:2
fast ,viral:2
fast ,rna:2
fast ,polymerase:2
permissive ,viral:2
permissive ,rna:2
permissive ,polymerase:2
viral ,polymerase:2
multivariate ,mortality:2
multivariate ,comparing:2
multivariate ,patients:2
multivariate ,cancer:2
mortality ,analyses:2
mortality ,comparing:2
analyses ,covid-19:2
analyses ,comparing:2
analyses ,patients:2
analyses ,cancer:2
comparing ,patients:2
comparing ,cancer:2
theoretical ,mortality:2
theoretical ,risk:2
theoretical ,asymptomatic:2
theoretical ,patient:2
theoretical ,negative:2
theoretical ,sars-cov-2:2
mortality ,asymptomatic:2
mortality ,patient:2
mortality ,negative:2
risk ,patient:2
risk ,negative:2
asymptomatic ,negative:2
evidence-based ,cancer:2
evidence-based ,patients:2
cancer ,guideline:2
patients ,guideline:2
mechanisms ,diseaseis:2
mechanisms ,sepsis:2
mechanisms ,exosome:2
covid-19-induced ,cardiovascular:2
covid-19-induced ,diseaseis:2
covid-19-induced ,sepsis:2
covid-19-induced ,exosome:2
cardiovascular ,diseaseis:2
cardiovascular ,sepsis:2
cardiovascular ,exosome:2
diseaseis ,sepsis:2
diseaseis ,exosome:2
sepsis ,exosome:2
computational ,sars-cov-2covid-19:2
computational ,surveillance:2
computational ,wastewater-based:2
analysis ,sars-cov-2covid-19:2
analysis ,surveillance:2
analysis ,wastewater-based:2
sars-cov-2covid-19 ,surveillance:2
sars-cov-2covid-19 ,wastewater-based:2
covid-19-associated ,retinopathy:2
retinopathy ,case:2
retinopathy ,report:2
detection ,sections:2
sars-cov-2 ,sections:2
formalin-fixed ,sections:2
formalin-fixed ,using:2
paraffin-embedded ,sections:2
paraffin-embedded ,using:2
tissue ,sections:2
tissue ,using:2
sections ,using:2
antibody-like ,proteins:2
antibody-like ,capture:2
antibody-like ,neutralize:2
antibody-like ,sars-cov-2:2
proteins ,capture:2
proteins ,neutralize:2
capture ,neutralize:2
capture ,sars-cov-2:2
environmental ,decontamination:2
environmental ,issues:2
environmental ,coronaviruses:2
environmental ,potential:2
decontamination ,issues:2
decontamination ,human:2
decontamination ,coronaviruses:2
decontamination ,potential:2
issues ,human:2
issues ,coronaviruses:2
role ,passive:2
role ,immunization:2
role ,age:2
role ,update:2
passive ,age:2
passive ,update:2
immunization ,age:2
immunization ,update:2
sars-cov-2 ,industrialized:2
sars-cov-2 ,gujarat:2
pandemic ,lockdown:6
pandemic ,quality:4
pandemic ,industrialized:2
pandemic ,gujarat:2
lockdown ,air:6
lockdown ,quality:6
lockdown ,industrialized:2
lockdown ,gujarat:2
effects ,air:4
effects ,industrialized:2
effects ,gujarat:2
air ,industrialized:2
air ,gujarat:2
quality ,industrialized:2
quality ,gujarat:2
industrialized ,gujarat:2
clinical ,ethics:2
clinical ,allocation:2
clinical ,treatments:2
ethics ,recommendations:2
ethics ,allocation:2
ethics ,intensive:2
ethics ,care:2
ethics ,treatments:2
recommendations ,allocation:2
recommendations ,treatments:2
allocation ,intensive:2
allocation ,care:2
allocation ,treatments:2
intensive ,treatments:2
care ,treatments:2
sars-cov-2 ,epilepsy:2
sars-cov-2 ,attendances:2
pandemic ,epilepsy:2
pandemic ,attendances:2
epilepsy ,impact:2
epilepsy ,emergency:2
epilepsy ,department:2
epilepsy ,attendances:2
impact ,attendances:2
emergency ,attendances:2
department ,attendances:2
covid-19 ,immunohistochemical:2
covid-19 ,demonstration:2
chilblain-like ,lesion:2
chilblain-like ,immunohistochemical:2
chilblain-like ,demonstration:2
chilblain-like ,sars-cov-2:2
lesion ,immunohistochemical:2
lesion ,demonstration:2
lesion ,sars-cov-2:2
immunohistochemical ,demonstration:2
immunohistochemical ,sars-cov-2:2
demonstration ,sars-cov-2:2
renin-angiotensin ,narrative:2
consensus ,chinese:2
consensus ,experts:2
consensus ,diagnosis:2
consensus ,treatment:2
consensus ,processes:2
chinese ,experts:2
chinese ,diagnosis:2
chinese ,processes:2
chinese ,acute:2
experts ,diagnosis:2
experts ,treatment:2
experts ,processes:2
experts ,acute:2
diagnosis ,processes:2
treatment ,processes:2
processes ,acute:2
curb-65 ,may:2
curb-65 ,serve:2
curb-65 ,useful:2
curb-65 ,prognostic:2
curb-65 ,marker:2
curb-65 ,covid-19:2
curb-65 ,patients:2
curb-65 ,within:2
curb-65 ,wuhan:2
may ,serve:2
may ,useful:2
may ,prognostic:2
may ,marker:2
may ,within:2
may ,wuhan:2
serve ,useful:2
serve ,prognostic:2
serve ,marker:2
serve ,covid-19:2
serve ,patients:2
serve ,within:2
serve ,wuhan:2
useful ,prognostic:2
useful ,marker:2
useful ,within:2
useful ,wuhan:2
prognostic ,marker:2
prognostic ,within:2
prognostic ,wuhan:2
marker ,within:2
marker ,wuhan:2
within ,wuhan:2
headache ,frequency:2
headache ,characteristics:2
headache ,association:2
associated ,frequency:2
associated ,association:2
frequency ,characteristics:2
frequency ,association:4
recommendations ,bladder:2
recommendations ,lessons:2
bladder ,management:2
bladder ,covid-19:2
bladder ,pandemia:2
bladder ,lessons:2
cancer ,lessons:2
pandemia ,lessons:2
structural ,entry:2
functional ,modelling:2
functional ,animal:2
functional ,models:2
modelling ,entry:2
modelling ,animal:2
modelling ,models:2
entry ,animal:2
entry ,models:2
discharged ,rna:2
discharged ,minireview:2
covid-19 ,minireview:2
patients ,minireview:2
testing ,minireview:2
positive ,minireview:2
rna ,minireview:2
neurological ,associations:2
mitigating ,impact:2
mitigating ,oncology:2
mitigating ,clinical:2
mitigating ,operational:2
mitigating ,lessons:2
impact ,operational:2
impact ,lessons:2
oncology ,clinical:2
oncology ,operational:2
oncology ,lessons:2
clinical ,operational:2
operational ,lessons:2
sars ,brief:2
sars ,summary:2
mers ,brief:2
mers ,summary:2
mers ,severe:2
mers ,acute:2
covid-19 ,summary:2
brief ,comparison:2
brief ,severe:2
brief ,acute:2
summary ,comparison:2
summary ,acute:2
prognosis ,changes:2
systematic ,investigation:2
systematic ,semen:2
review ,investigation:2
review ,semen:2
severe ,animal:2
severe ,reservoirs:2
acute ,natural:2
acute ,animal:2
acute ,reservoirs:2
respiratory ,natural:2
respiratory ,animal:2
respiratory ,reservoirs:2
syndrome ,natural:2
syndrome ,animal:2
syndrome ,reservoirs:2
coronavirus-2 ,animal:2
coronavirus-2 ,reservoirs:2
natural ,animal:2
natural ,reservoirs:2
animal ,reservoirs:2
lymphocyte ,monocyte:2
lymphocyte ,expression:2
lymphocyte ,reduction:2
subset ,monocyte:2
subset ,cd4:2
subset ,expression:2
subset ,reduction:2
subset ,patients:2
alteration ,monocyte:2
alteration ,cd4:2
alteration ,expression:4
monocyte ,cd4:2
monocyte ,expression:2
monocyte ,reduction:2
cd4 ,expression:2
cd4 ,reduction:2
cd4 ,patients:2
expression ,reduction:2
fight ,rapidly:2
fight ,evolving:2
fight ,review:2
fight ,indias:2
rapidly ,pandemic:2
rapidly ,review:2
rapidly ,indias:2
evolving ,pandemic:2
evolving ,review:2
evolving ,indias:2
covid-19 ,indias:2
review ,indias:2
drape ,prevent:2
drape ,disease:2
drape ,transmission:2
drape ,endotracheal:2
drape ,intubation:2
prevent ,endotracheal:2
prevent ,intubation:2
disease ,endotracheal:2
disease ,intubation:2
transmission ,endotracheal:2
transmission ,intubation:2
endotracheal ,intubation:2
isolation ,reported:2
isolation ,brazil:2
isolation ,establishment:2
first ,brazil:2
first ,establishment:2
reported ,patients:2
reported ,brazil:2
reported ,establishment:2
patients ,brazil:2
patients ,establishment:2
brazil ,establishment:2
neutralizing ,soluble:2
neutralizing ,ace2:2
neutralizing ,inhibition:2
neutralizing ,replication-competent:2
antibody ,soluble:2
antibody ,inhibition:2
antibody ,replication-competent:2
soluble ,ace2:2
soluble ,inhibition:2
soluble ,replication-competent:2
ace2 ,inhibition:4
ace2 ,replication-competent:2
inhibition ,replication-competent:2
public ,might:2
public ,endangered:2
public ,possible:2
public ,prolonged:2
public ,discharge:2
health ,might:2
health ,endangered:2
health ,possible:2
health ,prolonged:2
health ,discharge:2
might ,endangered:2
might ,possible:2
might ,prolonged:2
might ,discharge:2
endangered ,possible:2
endangered ,prolonged:2
endangered ,discharge:2
endangered ,sars-cov-2:2
possible ,prolonged:2
possible ,discharge:2
prolonged ,discharge:2
discharge ,sars-cov-2:2
post-lockdown ,period:2
post-lockdown ,used:2
post-lockdown ,acquire:2
post-lockdown ,effective:2
post-lockdown ,therapies:2
post-lockdown ,future:2
period ,used:2
period ,acquire:2
period ,effective:2
period ,therapies:2
period ,future:2
used ,acquire:2
used ,effective:2
used ,therapies:2
used ,future:2
acquire ,effective:2
acquire ,therapies:2
acquire ,future:2
effective ,future:2
advances ,western:2
treatment ,western:2
novel ,western:2
coronavirus ,western:2
disease ,western:2
kidney ,covid-19and:2
kidney ,treatments:2
involvement ,covid-19and:2
involvement ,treatments:2
covid-19and ,treatments:2
design ,evaluation:2
design ,anti-sars-coronavirus:2
design ,based:2
evaluation ,anti-sars-coronavirus:2
evaluation ,agents:2
anti-sars-coronavirus ,agents:2
anti-sars-coronavirus ,based:2
anti-sars-coronavirus ,molecular:2
agents ,based:2
agents ,molecular:2
high ,neutralizing:2
high ,titer:2
high ,intensive:2
neutralizing ,titer:2
neutralizing ,intensive:2
neutralizing ,care:2
neutralizing ,unit:2
antibody ,titer:2
antibody ,intensive:2
antibody ,care:4
antibody ,unit:2
titer ,intensive:2
titer ,care:2
titer ,unit:2
titer ,patients:2
titer ,covid-19:2
tocilizumab ,remdesivir:2
tocilizumab ,pregnant:2
tocilizumab ,coronavirus:2
tocilizumab ,disease:2
remdesivir ,pregnant:2
remdesivir ,coronavirus:2
remdesivir ,disease:4
trained ,tool:2
trained ,reducing:2
trained ,susceptibility:2
trained ,severity:2
immunity ,tool:2
immunity ,reducing:2
immunity ,susceptibility:2
tool ,reducing:2
tool ,susceptibility:2
tool ,severity:2
reducing ,susceptibility:2
reducing ,severity:2
psychiatric ,face:2
elective ,mechanical:2
elective ,ventilation:2
elective ,affected:2
tracheostomy ,affected:2
mechanical ,affected:2
ventilation ,affected:2
covid-19 ,underwent:2
covid-19 ,endonasal:2
covid-19 ,endoscopic:2
covid-19 ,adenoma:2
patient ,underwent:2
patient ,endonasal:2
patient ,endoscopic:2
patient ,adenoma:2
underwent ,endonasal:2
underwent ,endoscopic:2
underwent ,pituitary:2
underwent ,adenoma:2
underwent ,resection:2
endonasal ,endoscopic:4
endonasal ,pituitary:2
endonasal ,adenoma:2
endonasal ,resection:2
endoscopic ,pituitary:2
endoscopic ,adenoma:2
endoscopic ,resection:2
pituitary ,adenoma:2
adenoma ,resection:2
prior ,novel:2
prior ,coronavirus:2
prior ,disease:2
prior ,covid-19:2
prior ,human:2
role ,pm:2
role ,no2:2
role ,lethality:2
air ,pm:2
air ,no2:2
air ,lethality:2
pollution ,pm:2
pollution ,no2:2
pollution ,lethality:2
pm ,no2:2
pm ,covid-19:2
pm ,spread:2
pm ,lethality:2
no2 ,covid-19:2
no2 ,spread:2
no2 ,lethality:2
spread ,lethality:2
fda ,efficiency:2
fda ,approval:2
fda ,process:2
fda ,therapeutics:2
efficiency ,approval:2
efficiency ,process:2
efficiency ,therapeutics:2
approval ,process:2
approval ,covid-19:2
approval ,therapeutics:2
process ,therapeutics:2
coronavirus ,breastfeeding:2
coronavirus ,exploratory:2
infection ,exploratory:2
breastfeeding ,exploratory:2
breastfeeding ,review:2
exploratory ,review:2
multicenter ,clinicopathologic:2
multicenter ,correlation:2
multicenter ,kidney:2
multicenter ,biopsies:2
multicenter ,performed:2
clinicopathologic ,correlation:2
clinicopathologic ,kidney:2
clinicopathologic ,biopsies:2
clinicopathologic ,performed:2
clinicopathologic ,covid-19:2
correlation ,kidney:2
correlation ,biopsies:2
correlation ,performed:2
kidney ,biopsies:2
kidney ,performed:2
biopsies ,performed:2
performed ,covid-19:2
potential ,hemorrhagic:2
potential ,stroke:2
mechanisms ,hemorrhagic:2
mechanisms ,stroke:2
mechanisms ,elderly:2
hemorrhagic ,stroke:2
hemorrhagic ,elderly:2
hemorrhagic ,patients:2
stroke ,elderly:2
using ,based:2
using ,routine:2
using ,distinguish:2
diagnostic ,model:2
diagnostic ,routine:2
diagnostic ,distinguish:2
model ,routine:2
model ,tests:2
model ,distinguish:2
based ,routine:2
based ,tests:2
based ,distinguish:2
routine ,laboratory:2
routine ,tests:2
routine ,distinguish:2
routine ,patients:4
laboratory ,distinguish:2
tests ,distinguish:2
roborovski ,dwarf:2
roborovski ,hamster:2
roborovski ,highly:2
roborovski ,susceptible:2
roborovski ,model:2
roborovski ,rapid:2
roborovski ,fatal:2
dwarf ,hamster:2
dwarf ,highly:2
dwarf ,susceptible:2
dwarf ,model:2
dwarf ,rapid:2
dwarf ,fatal:2
hamster ,highly:2
hamster ,susceptible:2
hamster ,model:2
hamster ,rapid:2
hamster ,fatal:2
highly ,susceptible:2
highly ,model:2
highly ,rapid:2
highly ,fatal:2
susceptible ,model:2
susceptible ,rapid:2
susceptible ,fatal:2
model ,fatal:2
rapid ,fatal:2
potential ,cd8:2
potential ,cross-reactivity:2
potential ,conferred:2
cd8 ,cross-reactivity:2
cd8 ,sars-cov-2:2
cd8 ,conferred:2
cell ,cross-reactivity:2
cell ,conferred:2
cross-reactivity ,sars-cov-2:2
cross-reactivity ,conferred:2
sars-cov-2 ,conferred:2
covid-19 ,bilateral:2
pneumonia ,complicated:2
pneumonia ,bilateral:2
complicated ,bilateral:2
complicated ,pneumothorax:2
bilateral ,pneumothorax:2
pneumothorax ,report:2
epidemiology ,future:2
epidemiology ,concerning:2
diagnosis ,future:2
diagnosis ,perspectives:2
diagnosis ,concerning:2
treatment ,future:2
treatment ,perspectives:2
future ,concerning:2
perspectives ,concerning:2
concerning ,sars-cov-2:2
ly6e ,restricts:2
ly6e ,entry:2
ly6e ,human:2
ly6e ,coronaviruses:2
ly6e ,including:2
ly6e ,currently:2
ly6e ,pandemic:2
restricts ,entry:2
restricts ,human:2
restricts ,coronaviruses:2
restricts ,including:2
restricts ,currently:2
restricts ,pandemic:2
entry ,including:2
entry ,currently:2
entry ,pandemic:2
human ,currently:2
coronaviruses ,currently:2
including ,currently:2
including ,pandemic:2
currently ,pandemic:2
exosomes ,derived:2
exosomes ,bone:2
exosomes ,marrow:2
exosomes ,treatment:2
exosomes ,severe:4
derived ,bone:2
derived ,marrow:2
derived ,mesenchymal:2
derived ,stem:2
derived ,treatment:2
derived ,severe:2
bone ,mesenchymal:2
bone ,stem:2
bone ,cells:2
bone ,treatment:2
bone ,severe:2
marrow ,mesenchymal:2
marrow ,stem:2
marrow ,cells:2
marrow ,treatment:2
marrow ,severe:2
mesenchymal ,severe:6
stem ,severe:4
lung ,associated:2
lung ,need:2
ultrasound ,associated:2
ultrasound ,mortality:2
ultrasound ,need:2
findings ,need:2
findings ,intensive:2
findings ,care:2
mortality ,need:2
sars-cov-2 ,done:2
disease ,connection:2
disease ,done:2
severity ,connection:2
severity ,done:2
diabetes ,connection:2
diabetes ,done:2
connection ,done:2
three ,long-term:2
three ,shedding:2
three ,tunisia:2
cases ,long-term:2
cases ,tunisia:2
long-term ,shedding:2
long-term ,period:2
long-term ,tunisia:2
viral ,tunisia:2
shedding ,period:2
shedding ,tunisia:2
period ,tunisia:2
virus ,strain:2
virus ,mild:2
virus ,hangzhou:2
virus ,represents:2
virus ,trend:2
strain ,mild:2
strain ,covid-19:2
strain ,patient:2
strain ,hangzhou:2
strain ,represents:2
strain ,new:2
strain ,trend:2
mild ,hangzhou:2
mild ,represents:2
mild ,new:2
mild ,trend:2
covid-19 ,hangzhou:2
covid-19 ,represents:2
patient ,hangzhou:2
patient ,represents:2
patient ,trend:2
hangzhou ,represents:2
hangzhou ,new:2
hangzhou ,trend:2
represents ,new:2
represents ,trend:2
new ,trend:2
neutralizing ,binding:2
neutralizing ,activities:2
neutralizing ,sars-cov-12:2
neutralizing ,mers-cov:2
binding ,activities:2
binding ,sars-cov-12:2
binding ,mers-cov:2
binding ,human:4
activities ,sars-cov-12:2
activities ,mers-cov:2
activities ,human:2
sars-cov-12 ,mers-cov:2
sars-cov-12 ,human:2
potential ,sources:2
zoonotic ,sources:2
zoonotic ,infections:2
sources ,infections:2
contraception ,reproductive:2
contraception ,planning:2
contraception ,covid-19:2
contraception ,pandemic:2
reproductive ,planning:2
reproductive ,pandemic:2
cytokine ,intervention:2
cytokine ,early:2
cytokine ,stages:2
cytokine ,pneumonia:4
storm ,intervention:2
storm ,early:2
storm ,stages:2
storm ,pneumonia:2
intervention ,early:2
intervention ,stages:2
intervention ,pneumonia:2
stages ,pneumonia:2
serology ,apprehensions:2
serology ,opportunities:2
serology ,path:2
serology ,forward:2
sars-cov-2 ,apprehensions:2
sars-cov-2 ,forward:2
apprehensions ,opportunities:2
apprehensions ,path:2
apprehensions ,forward:2
opportunities ,path:2
opportunities ,forward:2
path ,forward:2
characteristics ,related:2
disease ,related:2
related ,therapeutic:2
related ,options:2
potential ,ebselen:2
therapeutic ,ebselen:2
use ,ebselen:2
ebselen ,covid-19:2
ebselen ,respiratory:2
ebselen ,viral:2
triazavirin ,potential:2
triazavirin ,inhibitor:2
triazavirin ,2019-ncov:2
triazavirin ,coronavirus:2
triazavirin ,protease:2
triazavirin ,dft:2
triazavirin ,study:2
potential ,dft:4
inhibitor ,2019-ncov:4
inhibitor ,coronavirus:4
inhibitor ,dft:4
inhibitor ,study:4
2019-ncov ,dft:4
coronavirus ,dft:4
protease ,dft:2
protease ,study:2
dft ,study:2
features ,pathogenic:2
features ,gastrointestinal:2
pathogenic ,gastrointestinal:4
mechanisms ,gastrointestinal:2
evidence ,autopsies:2
evidence ,positive:2
evidence ,deceased:2
evidence ,report:2
systematic ,autopsies:2
systematic ,positive:2
systematic ,deceased:2
systematic ,case:2
systematic ,report:2
autopsies ,positive:2
autopsies ,case:2
positive ,deceased:2
deceased ,case:2
deceased ,report:2
anthocyanin ,derivatives:2
anthocyanin ,potent:2
anthocyanin ,inhibitors:2
anthocyanin ,sars-cov-2:2
anthocyanin ,main:2
anthocyanin ,protease:2
derivatives ,potent:2
derivatives ,sars-cov-2:2
derivatives ,protease:2
potent ,main:4
investigation ,compatibility:2
investigation ,syndrome:2
investigation ,coronavirus:4
compatibility ,severe:2
compatibility ,acute:2
compatibility ,respiratory:2
compatibility ,syndrome:2
compatibility ,coronavirus:2
test-negative ,design:2
test-negative ,additional:2
test-negative ,population:2
test-negative ,controls:2
test-negative ,can:2
test-negative ,used:2
test-negative ,rapidly:2
design ,additional:2
design ,population:2
design ,controls:2
design ,can:2
design ,used:2
design ,rapidly:2
additional ,population:2
additional ,controls:2
additional ,can:2
additional ,used:2
additional ,rapidly:2
population ,controls:2
population ,can:2
population ,used:2
population ,rapidly:2
controls ,can:2
controls ,used:2
controls ,rapidly:2
can ,rapidly:2
used ,rapidly:2
detection ,material:2
coronavirus ,material:2
disease ,material:2
disease ,environmental:2
disease ,surfaces:2
viral ,material:2
viral ,surfaces:2
material ,environmental:2
material ,surfaces:2
erythropoietin ,candidate:2
erythropoietin ,supportive:2
erythropoietin ,treatment:2
erythropoietin ,severe:2
erythropoietin ,covid-19:2
candidate ,supportive:2
supportive ,treatment:2
supportive ,severe:2
supportive ,covid-19:2
diabetes ,greater:2
diabetes ,in-hospital:2
diabetes ,death:2
risk ,in-hospital:2
factor ,greater:2
factor ,in-hospital:2
factor ,death:2
greater ,severity:2
greater ,in-hospital:2
greater ,death:2
severity ,death:2
in-hospital ,death:2
clinical ,orthodontic:2
orthodontic ,management:2
orthodontic ,covid-19:4
orthodontic ,pandemic:2
recommended ,shielding:2
recommended ,covid-19:4
recommended ,impacts:2
recommended ,physical:2
recommended ,activity:2
recommended ,levels:2
recommended ,adults:2
shielding ,covid-19:2
shielding ,impacts:2
shielding ,physical:2
shielding ,activity:2
shielding ,levels:2
shielding ,adults:2
impacts ,physical:2
impacts ,activity:2
impacts ,levels:2
impacts ,adults:2
physical ,activity:4
physical ,levels:2
activity ,levels:2
activity ,adults:2
levels ,adults:2
part ,ii:2
part ,high-dose:2
part ,methotrexate:2
part ,leucovorin:2
part ,rescue:2
ii ,high-dose:2
ii ,methotrexate:2
ii ,leucovorin:2
ii ,rescue:2
ii ,severe:2
high-dose ,methotrexate:2
high-dose ,leucovorin:2
high-dose ,rescue:2
methotrexate ,leucovorin:2
methotrexate ,rescue:2
methotrexate ,severe:2
methotrexate ,covid-19:2
leucovorin ,rescue:2
leucovorin ,severe:2
leucovorin ,covid-19:2
rescue ,severe:2
rna-gps ,predicts:2
rna-gps ,sars-cov-2:2
rna-gps ,rna:2
rna-gps ,residency:2
rna-gps ,host:2
rna-gps ,mitochondria:2
rna-gps ,nucleolus:2
predicts ,rna:2
predicts ,residency:2
predicts ,mitochondria:2
predicts ,nucleolus:2
sars-cov-2 ,nucleolus:2
rna ,residency:2
rna ,mitochondria:2
rna ,nucleolus:2
residency ,host:2
residency ,mitochondria:2
residency ,nucleolus:2
host ,nucleolus:2
mitochondria ,nucleolus:2
point-of-use ,rapid:2
point-of-use ,detection:2
point-of-use ,sars-cov-2:2
point-of-use ,nanotechnology-enabled:2
point-of-use ,solutions:2
rapid ,nanotechnology-enabled:2
rapid ,solutions:2
detection ,nanotechnology-enabled:2
sars-cov-2 ,nanotechnology-enabled:2
late ,embolism:2
late ,mild:2
pulmonary ,mild:2
embolism ,mild:2
embolism ,case:2
diagnostic ,automated:2
diagnostic ,chemiluminescent:2
diagnostic ,immunoassay:2
diagnostic ,anti-sars-cov-2:2
accuracy ,automated:2
accuracy ,chemiluminescent:2
accuracy ,immunoassay:2
accuracy ,anti-sars-cov-2:2
automated ,chemiluminescent:2
automated ,immunoassay:2
chemiluminescent ,immunoassay:2
chemiluminescent ,anti-sars-cov-2:2
multiple-centre ,clinical:2
multiple-centre ,evaluation:2
multiple-centre ,ultrafast:2
multiple-centre ,single-tube:2
multiple-centre ,assay:2
multiple-centre ,sars-cov-2:2
clinical ,ultrafast:2
clinical ,single-tube:2
evaluation ,ultrafast:2
ultrafast ,single-tube:2
ultrafast ,assay:2
ultrafast ,sars-cov-2:2
single-tube ,sars-cov-2:2
double-edged ,sword-cardiovascular:2
double-edged ,concerns:2
double-edged ,potential:2
double-edged ,anti-covid-19:2
double-edged ,drugs:2
sword-cardiovascular ,concerns:2
sword-cardiovascular ,potential:2
sword-cardiovascular ,anti-covid-19:2
sword-cardiovascular ,drugs:2
concerns ,potential:2
concerns ,anti-covid-19:2
concerns ,drugs:2
anti-covid-19 ,drugs:2
clinical ,82:2
clinical ,death:2
characteristics ,82:2
characteristics ,death:2
82 ,cases:2
82 ,death:2
82 ,covid-19:2
surveillance ,system:2
surveillance ,maternal:2
surveillance ,child:2
surveillance ,mch:2
surveillance ,population:2
system ,maternal:2
system ,child:2
system ,mch:2
system ,population:2
maternal ,child:2
maternal ,health:2
maternal ,mch:2
maternal ,population:2
child ,health:2
child ,mch:2
child ,population:2
health ,mch:2
mch ,population:2
eculizumab ,treatment:2
eculizumab ,patients:2
eculizumab ,covid-19:2
eculizumab ,preliminary:2
eculizumab ,results:2
eculizumab ,real:2
eculizumab ,life:2
treatment ,preliminary:2
treatment ,real:2
treatment ,life:2
patients ,real:2
patients ,life:2
preliminary ,real:2
preliminary ,life:2
results ,real:2
results ,life:2
cardiovascular ,changes:2
cardiovascular ,wuhan:2
changes ,wuhan:2
changes ,china:2
reactive ,arthritis:2
reactive ,infection:2
combating ,trials:2
combating ,therapies:2
combating ,perspectives:2
trials ,therapies:2
trials ,perspectives:2
therapies ,perspectives:2
incidental ,f18-fdg:2
incidental ,petct:2
findings ,f18-fdg:2
covid-19 ,f18-fdg:2
f18-fdg ,petct:2
f18-fdg ,asymptomatic:2
f18-fdg ,patients:2
recommendations ,systemic:2
systemic ,rheumatic:2
current ,whats:2
current ,next:2
pharmacological ,whats:2
pharmacological ,next:2
treatments ,whats:2
treatments ,next:2
whats ,next:2
clinical ,immunologic:2
clinical ,covid-19-affected:2
clinical ,mother-infant:2
clinical ,pairs:2
immunologic ,among:2
immunologic ,covid-19-affected:2
immunologic ,mother-infant:2
immunologic ,pairs:2
features ,among:2
features ,covid-19-affected:2
features ,mother-infant:2
features ,pairs:2
among ,covid-19-affected:2
among ,mother-infant:2
among ,pairs:2
covid-19-affected ,mother-infant:2
covid-19-affected ,pairs:2
mother-infant ,pairs:2
clinical ,short-term:2
clinical ,102:2
features ,short-term:2
features ,102:2
short-term ,102:2
short-term ,coronavirus:2
short-term ,disease:2
outcomes ,102:2
102 ,patients:2
102 ,coronavirus:2
102 ,disease:2
ultra-sensitive ,viral:2
ultra-sensitive ,glycoprotein:2
ultra-sensitive ,detection:2
ultra-sensitive ,nanosystem:2
ultra-sensitive ,toward:2
ultra-sensitive ,accurate:2
ultra-sensitive ,tracing:2
viral ,glycoprotein:2
viral ,nanosystem:2
viral ,toward:2
viral ,tracing:2
glycoprotein ,detection:2
glycoprotein ,nanosystem:2
glycoprotein ,toward:2
glycoprotein ,accurate:2
glycoprotein ,tracing:2
detection ,nanosystem:2
detection ,tracing:2
nanosystem ,toward:2
nanosystem ,accurate:2
nanosystem ,tracing:2
toward ,accurate:2
toward ,tracing:2
accurate ,tracing:2
chest ,reverse:2
computed ,children:2
computed ,reverse:2
tomography ,children:2
tomography ,reverse:2
ct ,reverse:2
features ,reverse:2
children ,reverse:2
decline ,antibodies:2
decline ,mild:2
decline ,infection:2
decline ,among:2
decline ,frontline:2
decline ,health:2
decline ,care:2
antibodies ,mild:2
antibodies ,frontline:2
mild ,frontline:2
mild ,health:2
mild ,care:4
pi3k ,inhibition:2
pi3k ,potential:2
pi3k ,therapeutic:2
pi3k ,target:2
pi3k ,covid-19:2
inhibition ,target:2
fragment ,library:2
fragment ,natural:2
fragment ,products:2
fragment ,compound:2
fragment ,databases:2
fragment ,drug:2
fragment ,discovery:2
library ,products:2
library ,compound:2
library ,databases:2
library ,drug:2
library ,discovery:2
natural ,compound:2
natural ,databases:2
natural ,discovery:4
products ,compound:2
products ,databases:2
products ,discovery:2
compound ,databases:2
compound ,drug:2
compound ,discovery:2
databases ,drug:2
databases ,discovery:2
bibliometric ,evaluation:2
bibliometric ,latin:2
bibliometric ,american:2
bibliometric ,contributions:2
evaluation ,latin:2
evaluation ,american:2
evaluation ,contributions:2
latin ,contributions:2
latin ,covid-19:2
american ,contributions:2
single-cell ,identifies:2
single-cell ,cell:2
single-cell ,subsets:2
single-cell ,placenta:2
single-cell ,highly:2
single-cell ,expresses:2
rna-seq ,identifies:2
rna-seq ,cell:2
rna-seq ,subsets:2
rna-seq ,human:2
rna-seq ,placenta:2
rna-seq ,highly:2
rna-seq ,expresses:2
identifies ,cell:2
identifies ,subsets:2
identifies ,placenta:2
identifies ,highly:2
identifies ,expresses:2
cell ,subsets:2
cell ,highly:2
cell ,expresses:2
subsets ,human:2
subsets ,placenta:2
subsets ,highly:2
subsets ,expresses:2
human ,expresses:2
placenta ,highly:2
placenta ,expresses:2
highly ,expresses:2
mast ,alveolar:2
mast ,septa:2
mast ,patients:2
mast ,pathogenic:2
mast ,pathway:2
mast ,may:2
cells ,alveolar:2
cells ,septa:2
cells ,pathogenic:2
cells ,pathway:2
alveolar ,septa:2
alveolar ,patients:2
alveolar ,pathogenic:2
alveolar ,pathway:2
alveolar ,may:2
septa ,covid-19:2
septa ,patients:2
septa ,pathogenic:2
septa ,pathway:2
septa ,may:2
pathogenic ,pathway:2
pathogenic ,may:2
pathway ,may:2
association ,levels:2
using ,telemedicine:2
telemedicine ,pandemic:2
low ,utility:2
low ,real-time:2
low ,pcr:2
low ,clinical:2
utility ,repeat:2
utility ,real-time:2
utility ,testing:2
utility ,specimens:2
repeat ,real-time:2
repeat ,pcr:2
repeat ,clinical:2
repeat ,specimens:2
real-time ,specimens:2
pcr ,specimens:2
kawasaki ,features:2
kawasaki ,myocarditis:2
kawasaki ,patient:2
disease ,myocarditis:2
features ,myocarditis:2
myocarditis ,patient:2
coronavirus ,masquerade:2
coronavirus ,postoperative:2
disease ,masquerade:2
disease ,postoperative:2
covid-19 ,masquerade:2
can ,masquerade:2
can ,acute:2
can ,postoperative:2
masquerade ,acute:2
masquerade ,postoperative:2
acute ,postoperative:2
study ,amniotic:2
study ,fluid:2
study ,pregnant:2
study ,women:2
study ,infected:4
amniotic ,fluid:2
amniotic ,pregnant:2
amniotic ,women:2
amniotic ,infected:2
amniotic ,sars-cov-2:2
amniotic ,first:2
fluid ,pregnant:2
fluid ,infected:2
pregnant ,first:2
women ,first:2
infected ,first:2
changing ,paradigms:2
changing ,sinus:2
changing ,skull:2
changing ,base:2
changing ,evolves:2
paradigms ,sinus:2
paradigms ,skull:2
paradigms ,base:2
paradigms ,surgery:2
paradigms ,covid-19:2
paradigms ,pandemic:2
paradigms ,evolves:2
sinus ,skull:2
sinus ,base:2
sinus ,surgery:2
sinus ,pandemic:2
sinus ,evolves:2
skull ,covid-19:2
skull ,pandemic:2
skull ,evolves:2
base ,pandemic:2
base ,evolves:2
surgery ,evolves:2
covid-19 ,evolves:2
pandemic ,evolves:2
arterial ,thrombotic:2
arterial ,complications:2
thrombotic ,patients:2
st-elevation ,myocardial:2
st-elevation ,infarction:2
st-elevation ,27-year-old:2
st-elevation ,male:2
st-elevation ,covid-19:2
myocardial ,27-year-old:2
myocardial ,male:2
infarction ,27-year-old:2
infarction ,male:2
27-year-old ,male:2
27-year-old ,covid-19:2
practical ,perioperative:2
practical ,patient:2
recommendations ,perioperative:2
recommendations ,patient:4
perioperative ,management:2
perioperative ,patient:2
cutaneous ,systematic:2
covid-19 ,valuable:2
antibody ,valuable:2
antibody ,public:2
antibody ,health:4
antibody ,tool:2
antibody ,relevance:2
tests ,valuable:2
tests ,public:2
tests ,health:2
tests ,tool:2
tests ,relevance:2
valuable ,public:2
valuable ,health:2
valuable ,tool:2
valuable ,limited:2
valuable ,relevance:2
public ,tool:2
public ,limited:2
public ,relevance:2
health ,tool:2
health ,limited:2
health ,relevance:2
tool ,limited:2
tool ,relevance:2
limited ,relevance:2
remain ,hopeful:2
remain ,key:2
remain ,8weeks:2
remain ,spatiotemporal:2
remain ,epidemic:2
remain ,characteristics:2
hopeful ,key:2
hopeful ,8weeks:2
hopeful ,spatiotemporal:2
hopeful ,epidemic:2
hopeful ,characteristics:2
key ,8weeks:2
key ,spatiotemporal:2
key ,epidemic:2
key ,characteristics:2
8weeks ,spatiotemporal:2
8weeks ,epidemic:2
8weeks ,characteristics:2
spatiotemporal ,epidemic:2
spatiotemporal ,characteristics:2
crystal ,structure:4
crystal ,nsp15:2
crystal ,endoribonuclease:2
crystal ,nendou:2
crystal ,sars-cov-2:2
structure ,nsp15:2
structure ,endoribonuclease:2
structure ,nendou:2
nsp15 ,endoribonuclease:2
nsp15 ,nendou:2
nsp15 ,sars-cov-2:2
endoribonuclease ,nendou:2
endoribonuclease ,sars-cov-2:2
nendou ,sars-cov-2:2
retestpositive ,sars-cov-2:2
retestpositive ,rna:2
retestpositive ,recovered:2
retestpositive ,patients:2
retestpositive ,covid-19:2
relationship ,hypertension:2
relationship ,cardiovascular:2
relationship ,disease:2
hypertension ,cardiovascular:2
obesity ,paradox:2
obesity ,analysis:2
obesity ,smatteo:2
obesity ,registry:2
obesity ,smacore:2
obesity ,cohort:2
paradox ,analysis:2
paradox ,smatteo:2
paradox ,registry:2
paradox ,smacore:2
paradox ,cohort:2
analysis ,smatteo:2
analysis ,registry:2
analysis ,smacore:2
analysis ,cohort:2
smatteo ,covid-19:2
smatteo ,registry:2
smatteo ,smacore:2
smatteo ,cohort:2
covid-19 ,smacore:2
registry ,smacore:2
registry ,cohort:2
smacore ,cohort:2
urology ,comprehensive:2
urology ,review:2
urology ,literature:2
analytical ,viasure:2
analytical ,certest:2
analytical ,biotec:2
analytical ,2019-ncov:2
analytical ,cdc:2
clinical ,viasure:2
clinical ,certest:2
clinical ,biotec:2
clinical ,cdc:2
comparison ,viasure:2
comparison ,certest:2
comparison ,biotec:2
comparison ,2019-ncov:2
viasure ,certest:2
viasure ,biotec:2
viasure ,2019-ncov:2
viasure ,cdc:2
certest ,biotec:2
certest ,2019-ncov:2
certest ,cdc:2
biotec ,2019-ncov:2
biotec ,cdc:2
2019-ncov ,cdc:2
cutaneous ,coronavirus:4
cutaneous ,disease:2
clinical ,recurrence:2
course ,recurrence:2
course ,rna:2
factors ,recurrence:2
tracking ,via:2
covid-19 ,sewage:2
via ,sewage:2
laboratory ,within:2
laboratory ,modular:2
laboratory ,hospital:2
laboratory ,time:2
diagnostics ,within:2
diagnostics ,modular:2
diagnostics ,hospital:2
diagnostics ,time:2
within ,modular:2
within ,hospital:2
within ,time:2
within ,coronavirus:4
within ,disease:4
modular ,hospital:2
modular ,time:2
modular ,coronavirus:2
modular ,disease:2
hospital ,time:2
safety ,harmful:2
safety ,pharmacological:2
safety ,interactions:2
safety ,nutritional:2
safety ,supplements:2
issues ,harmful:2
issues ,pharmacological:2
issues ,interactions:2
issues ,nutritional:2
issues ,supplements:2
harmful ,pharmacological:2
harmful ,interactions:2
harmful ,nutritional:2
harmful ,supplements:2
pharmacological ,interactions:2
pharmacological ,nutritional:2
pharmacological ,supplements:2
interactions ,nutritional:2
interactions ,supplements:2
nutritional ,supplements:4
characterizing ,superspreading:2
characterizing ,events:2
characterizing ,age-specific:2
characterizing ,infectiousness:2
characterizing ,sars-cov-2:2
superspreading ,age-specific:2
superspreading ,infectiousness:2
events ,age-specific:2
events ,infectiousness:2
age-specific ,infectiousness:2
infectiousness ,sars-cov-2:2
expression ,suggests:2
receptor ,suggests:2
ace2 ,suggests:2
protease ,suggests:2
tmprss2 ,suggests:2
transplacental ,transmission:2
transplacental ,infection:2
delirium ,case:2
delirium ,series:2
delirium ,exploration:2
delirium ,potential:2
delirium ,mechanisms:2
case ,exploration:2
case ,potential:4
case ,mechanisms:2
series ,exploration:2
series ,potential:2
series ,mechanisms:2
exploration ,potential:2
review ,december:2
review ,april:2
mode ,december:2
mode ,april:2
delivery ,december:2
delivery ,april:2
covid-19 ,december:2
december ,april:2
impact ,worker:2
impact ,wellness:2
impact ,scoping:2
covid-19 ,wellness:2
healthcare ,wellness:2
healthcare ,scoping:2
worker ,wellness:2
worker ,scoping:2
wellness ,scoping:2
wellness ,review:2
covid ,laparoscopic:2
covid ,surgeons:2
covid ,indian:2
covid ,scenario:2
covid ,perspective:2
19 ,laparoscopic:2
19 ,surgeons:2
19 ,indian:2
19 ,scenario:2
19 ,perspective:2
laparoscopic ,surgeons:2
laparoscopic ,indian:2
laparoscopic ,scenario:2
laparoscopic ,perspective:2
surgeons ,indian:2
surgeons ,scenario:2
surgeons ,perspective:2
indian ,scenario:2
indian ,perspective:2
follow-up ,patient:2
follow-up ,received:2
follow-up ,tocilizumab:2
follow-up ,severe:2
follow-up ,case:2
patient ,received:2
received ,tocilizumab:2
received ,severe:2
received ,covid-19:2
received ,case:2
recommendations ,performing:2
recommendations ,bronchoscopy:2
recommendations ,times:2
performing ,bronchoscopy:2
performing ,times:2
performing ,covid-19:2
performing ,pandemic:2
bronchoscopy ,times:2
predisposition ,protection:2
predisposition ,covid-19:2
predisposition ,patient:2
predisposition ,lvad:2
predisposition ,support:2
predisposition ,hivaids:2
protection ,patient:4
protection ,lvad:2
protection ,support:2
protection ,hivaids:2
covid-19 ,lvad:2
covid-19 ,hivaids:2
patient ,lvad:2
patient ,support:2
patient ,hivaids:2
lvad ,support:2
lvad ,hivaids:2
support ,hivaids:2
management ,pneumonia:2
covid-19 ,cariovascular:2
pandemia ,impact:2
pandemia ,cariovascular:2
pandemia ,system:2
pandemia ,data:2
pandemia ,1st:2
pandemia ,april:2
impact ,cariovascular:2
impact ,1st:2
impact ,april:2
cariovascular ,system:2
cariovascular ,data:2
cariovascular ,1st:2
cariovascular ,april:2
system ,1st:2
system ,april:2
data ,1st:2
data ,april:2
1st ,april:2
value ,chest:2
value ,imaging:2
value ,newborn:2
value ,suspected:2
chest ,newborn:2
imaging ,newborn:2
imaging ,suspected:2
newborn ,suspected:2
clinical ,chemiluminescence:2
clinical ,microparticle:2
clinical ,immunoassay:2
application ,chemiluminescence:2
application ,microparticle:2
application ,immunoassay:2
chemiluminescence ,microparticle:2
microparticle ,immunoassay:2
microparticle ,sars-cov-2:2
update ,ocular:2
update ,adults:2
recommendations ,adults:2
ocular ,adults:2
virus-receptor ,interactions:2
virus-receptor ,glycosylated:2
virus-receptor ,sars-cov-2:2
virus-receptor ,spike:2
virus-receptor ,human:2
virus-receptor ,ace2:2
interactions ,glycosylated:2
interactions ,human:4
glycosylated ,sars-cov-2:2
glycosylated ,spike:2
glycosylated ,human:2
glycosylated ,ace2:2
electric ,fans:2
electric ,potential:2
electric ,stay-at-home:2
electric ,cooling:2
electric ,strategy:2
electric ,covid-19:2
fans ,potential:2
fans ,stay-at-home:2
fans ,cooling:2
fans ,strategy:2
fans ,covid-19:2
potential ,stay-at-home:2
potential ,cooling:2
stay-at-home ,cooling:2
stay-at-home ,strategy:2
stay-at-home ,covid-19:2
cooling ,strategy:2
cooling ,covid-19:2
asthma-associated ,risk:2
asthma-associated ,covid-19:2
asthma-associated ,development:2
snapshot ,pcr:2
snapshot ,surveillance:2
snapshot ,hospital:2
snapshot ,staff:2
snapshot ,england:2
pcr ,surveillance:2
pcr ,hospital:2
pcr ,staff:2
pcr ,england:2
surveillance ,hospital:2
surveillance ,staff:2
surveillance ,england:2
hospital ,england:2
staff ,england:2
gastrointestinal ,renal:2
gastrointestinal ,complications:2
gastrointestinal ,sars-cov-2-infected:2
gastrointestinal ,role:2
renal ,complications:2
renal ,sars-cov-2-infected:2
renal ,role:4
complications ,sars-cov-2-infected:2
sars-cov-2-infected ,role:2
surfaces ,equal:2
surfaces ,contact:2
surfaces ,transmission:2
equal ,contact:2
equal ,transmission:2
equal ,sars-cov-2:2
war ,coronavirus:2
war ,disease:2
war ,covid-2019:2
war ,keys:2
war ,successfully:2
coronavirus ,covid-2019:2
coronavirus ,keys:2
coronavirus ,successfully:2
disease ,successfully:2
covid-2019 ,keys:2
covid-2019 ,successfully:2
keys ,successfully:2
management ,inflows:2
management ,chu:2
emergency ,inflows:2
emergency ,chu:2
department ,inflows:2
department ,chu:2
inflows ,covid-19:2
inflows ,outbreak:2
inflows ,chu:2
covid-19 ,chu:2
outbreak ,chu:2
novel ,optical:2
novel ,sepsis:2
optical ,biosensor:2
optical ,early:2
optical ,diagnosis:2
optical ,sepsis:2
optical ,severe:2
optical ,covid-19:2
biosensor ,early:2
biosensor ,diagnosis:2
biosensor ,sepsis:2
biosensor ,covid-19:2
early ,sepsis:2
diagnosis ,sepsis:2
sepsis ,severe:2
update ,diagnosis:2
update ,treatment:2
neurological ,comparative:2
complications ,comparative:2
super-factors ,associated:2
super-factors ,transmission:2
super-factors ,occupational:2
super-factors ,covid-19:2
super-factors ,infection:2
super-factors ,among:2
associated ,occupational:2
transmission ,occupational:2
mesenchymal ,msc:2
mesenchymal ,secretome:2
mesenchymal ,possible:2
stem ,msc:2
stem ,secretome:2
stem ,possible:2
cell ,msc:2
cell ,secretome:2
cell ,possible:2
cell ,strategy:2
msc ,secretome:2
msc ,possible:2
msc ,therapeutic:2
msc ,strategy:2
secretome ,possible:2
secretome ,therapeutic:2
secretome ,strategy:2
lack ,standard:2
lack ,doses:2
lack ,ivermectin:2
lack ,covid-19:2
lack ,patients:2
efficacy ,standard:2
efficacy ,doses:2
efficacy ,ivermectin:2
standard ,doses:2
standard ,ivermectin:2
standard ,severe:2
doses ,ivermectin:2
doses ,severe:2
doses ,covid-19:2
doses ,patients:2
ivermectin ,severe:2
ivermectin ,patients:2
case ,polycythaemia:2
case ,massive:2
covid-19 ,polycythaemia:2
infection ,polycythaemia:2
polycythaemia ,presenting:2
polycythaemia ,massive:2
polycythaemia ,acute:2
polycythaemia ,pulmonary:2
presenting ,massive:2
presenting ,pulmonary:2
massive ,pulmonary:2
smoking ,ace-2:2
smoking ,ongoing:2
smoking ,controversies:2
ace-2 ,covid-19:2
ace-2 ,ongoing:2
ace-2 ,controversies:2
ongoing ,controversies:2
substantial ,undocumented:2
substantial ,infection:2
substantial ,facilitates:2
substantial ,rapid:2
substantial ,dissemination:2
substantial ,novel:2
undocumented ,infection:2
undocumented ,facilitates:2
undocumented ,rapid:2
undocumented ,dissemination:2
undocumented ,novel:2
infection ,facilitates:2
infection ,dissemination:2
facilitates ,rapid:2
facilitates ,dissemination:2
facilitates ,novel:2
rapid ,dissemination:2
dissemination ,novel:2
iranian ,sulfur:2
iranian ,mustard:2
iranian ,gas-exposed:2
iranian ,survivors:2
iranian ,vulnerable:2
iranian ,sars-cov-2:2
sulfur ,mustard:2
sulfur ,gas-exposed:2
sulfur ,survivors:2
sulfur ,vulnerable:2
sulfur ,sars-cov-2:2
mustard ,gas-exposed:2
mustard ,survivors:2
mustard ,vulnerable:2
mustard ,sars-cov-2:2
gas-exposed ,survivors:2
gas-exposed ,vulnerable:2
gas-exposed ,sars-cov-2:2
survivors ,vulnerable:2
survivors ,sars-cov-2:2
electroencephalogram ,eeg:2
electroencephalogram ,covid-19:2
electroencephalogram ,systematic:2
electroencephalogram ,retrospective:2
electroencephalogram ,study:2
eeg ,covid-19:2
eeg ,systematic:2
eeg ,retrospective:2
eeg ,study:2
systematic ,retrospective:2
asymptotic ,estimates:2
asymptotic ,sars-cov-2:2
asymptotic ,infection:2
asymptotic ,counts:2
asymptotic ,sensitivity:2
estimates ,infection:2
estimates ,counts:2
estimates ,sensitivity:2
infection ,counts:2
infection ,sensitivity:2
counts ,sensitivity:2
towards ,contactless:2
towards ,positioning:2
contactless ,patient:2
contactless ,positioning:2
coronavirus ,necrotising:2
coronavirus ,pancreatitis:2
disease-19 ,associated:2
disease-19 ,acute:2
disease-19 ,necrotising:2
disease-19 ,pancreatitis:2
covid-19 ,necrotising:2
associated ,necrotising:2
associated ,pancreatitis:2
acute ,necrotising:2
necrotising ,pancreatitis:2
pediatric ,covid-19-associated:4
pediatric ,rhabdomyolysis:2
covid-19-associated ,rhabdomyolysis:2
post-traumatic ,stress:2
post-traumatic ,disorder:2
post-traumatic ,differential:2
post-traumatic ,diagnostic:2
post-traumatic ,consideration:2
post-traumatic ,covid-19:2
stress ,disorder:2
stress ,differential:2
stress ,diagnostic:2
stress ,consideration:2
disorder ,differential:2
disorder ,consideration:2
differential ,diagnostic:2
differential ,consideration:2
dermatological ,coronavirus:2
dermatological ,disease:2
self-reported ,olfactory:2
self-reported ,loss:2
self-reported ,associates:2
self-reported ,outpatient:2
self-reported ,clinical:2
self-reported ,course:2
olfactory ,associates:2
olfactory ,outpatient:2
olfactory ,clinical:2
olfactory ,course:2
loss ,associates:2
loss ,outpatient:2
loss ,clinical:2
loss ,course:2
associates ,outpatient:2
associates ,clinical:2
associates ,course:2
associates ,covid-19:2
outpatient ,course:2
ocular ,hospitalized:2
ocular ,northeast:2
ocular ,iran:2
manifestations ,hospitalized:2
manifestations ,northeast:2
manifestations ,iran:2
hospitalized ,northeast:2
hospitalized ,iran:2
patients ,iran:2
northeast ,iran:2
otolaryngologists ,anesthesiologists:2
otolaryngologists ,collaborative:2
otolaryngologists ,role:2
otolaryngologists ,pandemic:2
anesthesiologists ,collaborative:2
anesthesiologists ,role:2
anesthesiologists ,pandemic:2
collaborative ,role:2
collaborative ,pandemic:2
dupilumab ,covid-19:2
dupilumab ,expect:2
sars-cov-2 ,orthopaedic:2
sars-cov-2 ,post-pandemic:2
impact ,orthopaedic:2
impact ,post-pandemic:2
elective ,implications:2
elective ,post-pandemic:2
orthopaedic ,implications:2
orthopaedic ,post-pandemic:2
surgery ,implications:2
surgery ,post-pandemic:2
implications ,post-pandemic:2
applying ,principles:2
applying ,behaviour:2
applying ,change:2
applying ,reduce:2
applying ,transmission:2
principles ,behaviour:2
principles ,change:2
principles ,reduce:2
principles ,transmission:2
behaviour ,reduce:2
behaviour ,sars-cov-2:2
behaviour ,transmission:2
change ,reduce:2
seizure ,presenting:2
seizure ,symptom:2
seizure ,retrospective:2
seizure ,case:2
seizure ,series:2
presenting ,retrospective:2
presenting ,series:2
symptom ,retrospective:2
symptom ,series:2
peripartum ,cardiomyopathy:2
peripartum ,covid-19-infected:2
peripartum ,woman:2
peripartum ,differential:2
peripartum ,diagnosis:2
cardiomyopathy ,covid-19-infected:2
cardiomyopathy ,woman:2
cardiomyopathy ,differential:2
cardiomyopathy ,diagnosis:2
covid-19-infected ,woman:2
covid-19-infected ,differential:2
covid-19-infected ,diagnosis:2
woman ,differential:2
woman ,diagnosis:2
corona-steps ,tracheotomy:2
corona-steps ,covid-19:2
corona-steps ,patients:2
corona-steps ,staff-safe:2
corona-steps ,method:2
corona-steps ,airway:2
tracheotomy ,staff-safe:2
tracheotomy ,method:2
tracheotomy ,airway:2
covid-19 ,staff-safe:2
covid-19 ,method:2
patients ,staff-safe:2
patients ,method:2
patients ,airway:2
staff-safe ,method:2
staff-safe ,airway:2
method ,airway:2
school ,closure:2
school ,covid-19:4
school ,lunch:2
school ,programme:2
school ,unprecedented:2
school ,undernutrition:2
school ,crisis:2
closure ,covid-19:2
closure ,lunch:2
closure ,programme:2
closure ,unprecedented:2
closure ,undernutrition:2
closure ,crisis:2
covid-19 ,lunch:2
covid-19 ,programme:2
covid-19 ,undernutrition:2
lunch ,programme:2
lunch ,unprecedented:2
lunch ,undernutrition:2
lunch ,crisis:2
programme ,unprecedented:2
programme ,undernutrition:2
programme ,crisis:2
unprecedented ,undernutrition:2
unprecedented ,crisis:2
undernutrition ,crisis:2
genomic ,open:2
genomic ,reading:2
genomic ,frames:2
genomic ,orfs:2
genomic ,protein:2
variance ,open:2
variance ,reading:2
variance ,frames:2
variance ,orfs:2
variance ,spike:2
variance ,protein:2
variance ,severe:2
variance ,acute:2
open ,orfs:2
open ,spike:2
open ,protein:2
open ,severe:2
open ,acute:2
reading ,orfs:2
reading ,spike:2
reading ,protein:2
reading ,severe:2
reading ,acute:2
frames ,orfs:2
frames ,spike:2
frames ,protein:2
frames ,severe:2
frames ,acute:2
orfs ,spike:2
orfs ,protein:2
orfs ,severe:2
orfs ,acute:2
assessing ,application:2
assessing ,pseudovirus:2
assessing ,system:2
assessing ,emerging:2
application ,pseudovirus:2
application ,system:2
application ,emerging:2
pseudovirus ,system:2
pseudovirus ,emerging:2
sars-coronavirus-2 ,replication:2
sars-coronavirus-2 ,vero:2
sars-coronavirus-2 ,e6:2
sars-coronavirus-2 ,cells:2
sars-coronavirus-2 ,kinetics:2
replication ,vero:2
replication ,e6:2
replication ,cells:2
replication ,rapid:2
vero ,e6:4
vero ,kinetics:2
vero ,rapid:2
e6 ,cells:4
e6 ,kinetics:2
e6 ,rapid:2
cells ,rapid:2
kinetics ,rapid:2
survey ,perceived:2
survey ,work:2
survey ,stress:2
survey ,influencing:2
survey ,factors:2
perceived ,work:2
perceived ,stress:2
perceived ,influencing:2
perceived ,hospital:2
perceived ,staff:2
work ,stress:2
work ,influencing:2
work ,factors:2
work ,among:2
work ,hospital:2
work ,staff:2
stress ,influencing:2
stress ,factors:2
influencing ,among:2
influencing ,hospital:2
influencing ,staff:2
factors ,hospital:2
hybrid ,multi-scale:2
hybrid ,model:2
hybrid ,covid-19:2
hybrid ,transmission:2
hybrid ,dynamics:2
hybrid ,assess:2
hybrid ,potential:2
multi-scale ,model:2
multi-scale ,covid-19:2
multi-scale ,transmission:2
multi-scale ,dynamics:2
multi-scale ,assess:2
multi-scale ,potential:2
model ,assess:2
covid-19 ,assess:2
transmission ,assess:2
dynamics ,assess:2
dynamics ,potential:2
assess ,potential:2
performance ,acute:2
amplification ,severe:2
amplification ,acute:2
tests ,severe:2
tests ,acute:2
computational ,rna:2
computational ,dependent:2
approach ,dependent:2
drug ,dependent:2
repurposing ,dependent:2
sars-cov-2 ,dependent:2
rna ,dependent:2
computational ,main:2
computational ,protease:2
coronavirus ,obesity:2
coronavirus ,icu:2
risk ,critically:2
risk ,illness:4
risk ,icu:4
obesity ,critically:2
obesity ,illness:2
obesity ,icu:2
critically ,illness:2
illness ,icu:2
validation ,single-step:2
validation ,single-tube:2
validation ,loop-mediated:2
single-step ,single-tube:2
single-step ,reverse:2
single-step ,transcription:2
single-step ,loop-mediated:2
single-tube ,reverse:2
single-tube ,transcription:2
single-tube ,loop-mediated:2
diseases ,biological:2
diseases ,situation:2
diseases ,therapeutic:2
current ,biological:2
biological ,situation:2
biological ,potential:2
biological ,therapeutic:2
situation ,potential:2
situation ,therapeutic:2
ageing ,sex:2
ageing ,obesity:2
ageing ,smoking:2
ageing ,covid-19:2
ageing ,truths:2
ageing ,myths:2
ageing ,speculations:2
sex ,smoking:2
sex ,truths:2
sex ,myths:2
sex ,speculations:2
obesity ,smoking:2
obesity ,truths:2
obesity ,myths:2
obesity ,speculations:2
smoking ,truths:2
smoking ,myths:2
smoking ,speculations:2
covid-19 ,truths:2
covid-19 ,myths:2
truths ,myths:2
truths ,speculations:2
myths ,speculations:2
potential ,literature:2
inflammation ,triggered:2
inflammation ,augment:2
inflammation ,drives:2
inflammation ,multiple:2
inflammation ,organ:2
triggered ,ace2:2
triggered ,augment:2
triggered ,drives:2
triggered ,multiple:2
triggered ,organ:2
triggered ,failure:2
sars-cov-2 ,augment:2
ace2 ,augment:2
ace2 ,drives:2
augment ,drives:2
augment ,multiple:2
augment ,organ:2
augment ,failure:2
drives ,multiple:2
drives ,organ:2
drives ,failure:2
detection ,recovered:2
rt-pcr ,anal:2
anal ,recovered:2
immunomodulatory ,therapy:2
immunomodulatory ,severe:4
immunomodulatory ,beyond:2
therapy ,beyond:2
management ,beyond:2
severe ,beyond:2
key ,influencing:2
key ,affinities:2
key ,2019-ncov:2
key ,different:2
residues ,influencing:2
residues ,affinities:2
residues ,2019-ncov:2
residues ,ace2:2
residues ,different:2
influencing ,binding:2
influencing ,affinities:2
influencing ,2019-ncov:2
influencing ,ace2:2
influencing ,different:2
binding ,affinities:2
binding ,different:2
affinities ,2019-ncov:2
affinities ,ace2:2
affinities ,different:2
laboratory ,systematic:2
laboratory ,meta-analysis:2
findings ,meta-analysis:2
clinical ,childbearing-age:2
characteristics ,childbearing-age:2
outcomes ,childbearing-age:2
childbearing-age ,women:2
childbearing-age ,covid-19:2
spread ,wuhan:2
spread ,rural:2
spread ,villages:2
spread ,hubei:2
spread ,province:2
coronavirus ,rural:2
coronavirus ,villages:2
wuhan ,rural:2
wuhan ,villages:2
rural ,hubei:2
rural ,province:2
villages ,hubei:2
villages ,province:2
quarantine ,changes:2
quarantine ,diet:2
quarantine ,physical:2
quarantine ,activity:2
quarantine ,increase:2
covid-19 ,diet:2
outbreak ,changes:2
outbreak ,diet:2
outbreak ,physical:2
outbreak ,increase:2
changes ,diet:2
changes ,physical:4
changes ,activity:2
changes ,increase:2
diet ,physical:2
diet ,activity:2
diet ,increase:2
physical ,increase:2
activity ,increase:2
sars-cov-2 ,invasively:2
sars-cov-2 ,ventilated:2
detection ,lower:2
detection ,tract:2
detection ,invasively:2
detection ,ventilated:2
detection ,ards:2
lower ,invasively:2
lower ,ventilated:2
lower ,ards:2
respiratory ,invasively:2
respiratory ,ventilated:2
respiratory ,ards:2
tract ,invasively:2
tract ,ventilated:2
tract ,ards:2
invasively ,ventilated:2
invasively ,ards:2
ventilated ,ards:2
sars-cov-2 ,primate:2
sars-cov-2 ,breeding:2
surveillance ,non-human:2
surveillance ,primate:2
surveillance ,breeding:2
surveillance ,research:2
surveillance ,facility:2
non-human ,primate:2
non-human ,breeding:2
non-human ,research:2
non-human ,facility:2
primate ,breeding:2
primate ,research:2
primate ,facility:2
breeding ,research:2
breeding ,facility:2
research ,facility:2
clinical ,feature:2
clinical ,condition:2
feature ,changes:2
feature ,covid-19:2
feature ,patient:2
feature ,mild:2
feature ,critical:2
feature ,condition:2
changes ,critical:2
changes ,condition:2
covid-19 ,condition:2
patient ,critical:2
patient ,condition:2
mild ,critical:2
mild ,condition:2
critical ,condition:2
therapeutic ,ciclesonide:2
therapeutic ,inahalation:2
therapeutic ,report:2
potential ,ciclesonide:2
potential ,inahalation:2
potential ,report:2
ciclesonide ,inahalation:2
ciclesonide ,covid-19:2
ciclesonide ,pneumonia:2
ciclesonide ,report:2
inahalation ,covid-19:2
inahalation ,pneumonia:2
inahalation ,report:2
association ,hospitalized:2
race ,mortality:2
race ,hospitalized:2
review ,treating:4
action ,chinese:2
action ,medicines:2
action ,treating:2
medicines ,treating:2
sars-cov-2 ,demonstrates:2
infection ,demonstrates:2
model ,demonstrates:2
model ,protection:2
model ,neutralizing:2
mice ,demonstrates:2
mice ,protection:2
mice ,neutralizing:2
demonstrates ,protection:2
demonstrates ,neutralizing:2
unspecific ,post-mortem:2
unspecific ,findings:2
unspecific ,despite:2
unspecific ,multiorgan:2
unspecific ,viral:2
unspecific ,spread:2
unspecific ,covid-19:2
post-mortem ,findings:2
post-mortem ,despite:2
post-mortem ,multiorgan:2
post-mortem ,viral:2
post-mortem ,spread:2
findings ,despite:2
findings ,multiorgan:2
findings ,viral:2
findings ,spread:2
despite ,multiorgan:2
despite ,spread:2
multiorgan ,viral:2
multiorgan ,spread:2
early ,emerging:2
early ,options:2
emerging ,options:2
population ,risk:2
population ,factors:2
population ,deaths:2
population ,nigeria:2
population ,sub-national:2
population ,level:2
risk ,deaths:2
risk ,nigeria:2
risk ,sub-national:2
factors ,deaths:2
factors ,nigeria:2
factors ,sub-national:2
factors ,level:2
covid-19 ,sub-national:2
deaths ,nigeria:2
deaths ,sub-national:2
deaths ,level:2
nigeria ,sub-national:2
nigeria ,level:2
sub-national ,level:2
silico ,major:2
silico ,metabolites:2
silico ,spices:2
drug ,major:2
drug ,metabolites:2
discovery ,major:2
discovery ,metabolites:2
discovery ,spices:2
discovery ,main:4
major ,metabolites:2
major ,spices:2
major ,main:2
metabolites ,spices:2
metabolites ,sars-cov-2:2
metabolites ,main:2
spices ,sars-cov-2:2
spices ,main:2
pharmacologic ,management:2
pharmacologic ,patients:2
pharmacologic ,hepatic:2
pharmacologic ,pancreatic:2
pharmacologic ,diseases:2
management ,pancreatic:2
patients ,hepatic:2
hepatic ,pancreatic:2
pancreatic ,diseases:2
current ,landscape:2
current ,coronavirus-host:2
current ,protein-protein:2
current ,interactions:2
landscape ,coronavirus-host:2
landscape ,protein-protein:2
landscape ,interactions:2
coronavirus-host ,protein-protein:2
coronavirus-host ,interactions:2
protein-protein ,interactions:2
protective ,factors:2
sars-cov-2 ,saudi:2
sars-cov-2 ,arabia:2
pandemic ,dynamic:2
course ,saudi:2
course ,arabia:2
course ,dynamic:2
course ,epidemiological:2
course ,model:2
saudi ,dynamic:2
saudi ,epidemiological:2
saudi ,model:2
arabia ,dynamic:2
arabia ,epidemiological:2
arabia ,model:2
dynamic ,epidemiological:2
dynamic ,model:2
epidemiological ,model:2
pediatric ,infectious:2
pediatric ,diseases:2
infectious ,perspective:2
infectious ,acute:2
infectious ,respiratory:2
infectious ,syndrome:2
diseases ,perspective:2
diseases ,syndrome:2
perspective ,severe:2
perspective ,respiratory:2
perspective ,syndrome:2
receptor-binding ,domain-specific:2
receptor-binding ,human:2
receptor-binding ,neutralizing:2
receptor-binding ,monoclonal:2
receptor-binding ,antibodies:2
domain-specific ,human:2
domain-specific ,neutralizing:2
domain-specific ,monoclonal:2
domain-specific ,antibodies:2
neutralizing ,monoclonal:2
clinical ,concerns:2
challenges ,wuhan:2
challenges ,concerns:2
outbreak ,concerns:2
wuhan ,concerns:2
china ,concerns:2
potential ,compound:2
potential ,rhizoma:2
potential ,polygonati:2
compound ,herbal:2
compound ,food:2
compound ,rhizoma:2
compound ,polygonati:2
compound ,treatment:2
compound ,covid-19:2
herbal ,food:2
herbal ,rhizoma:2
herbal ,polygonati:2
herbal ,treatment:2
food ,rhizoma:2
food ,polygonati:2
food ,treatment:2
rhizoma ,polygonati:2
rhizoma ,treatment:2
rhizoma ,covid-19:2
polygonati ,treatment:2
polygonati ,covid-19:2
clinical ,narrative:2
clinical ,synthesis:2
practice ,narrative:2
practice ,synthesis:2
narrative ,synthesis:2
patient ,volume:2
patient ,mechanisms:2
patient ,alevel:2
patient ,trauma:2
patient ,center:2
volume ,diagnosis:2
volume ,injury:2
volume ,mechanisms:2
volume ,alevel:2
volume ,trauma:2
volume ,center:2
diagnosis ,injury:2
diagnosis ,mechanisms:2
diagnosis ,alevel:2
diagnosis ,trauma:2
diagnosis ,center:2
injury ,alevel:2
injury ,trauma:2
injury ,center:2
mechanisms ,alevel:2
mechanisms ,trauma:2
mechanisms ,center:2
alevel ,trauma:2
alevel ,center:2
trauma ,center:2
prevalence ,rapid:2
comorbidities ,individuals:2
comorbidities ,rapid:2
among ,rapid:2
among ,review:2
individuals ,rapid:2
individuals ,review:2
multicenter ,comparison:2
multicenter ,cobas:2
multicenter ,6800:2
multicenter ,system:2
multicenter ,realstar:2
multicenter ,rt-pcr:2
multicenter ,kit:2
comparison ,6800:2
comparison ,system:2
comparison ,realstar:2
comparison ,kit:2
cobas ,6800:2
cobas ,system:2
cobas ,realstar:2
cobas ,rt-pcr:2
cobas ,kit:2
6800 ,system:2
6800 ,realstar:2
6800 ,rt-pcr:2
6800 ,kit:2
system ,realstar:2
system ,kit:2
epidemiological ,convalescence:2
characteristics ,convalescence:2
covid-19 ,convalescence:2
patients ,convalescence:2
patients ,period:2
convalescence ,period:2
development ,patient-derived:2
development ,human:2
development ,nucleocapsid:2
patient-derived ,human:2
patient-derived ,monoclonal:2
patient-derived ,antibodies:2
patient-derived ,nucleocapsid:2
human ,nucleocapsid:2
monoclonal ,nucleocapsid:2
harnessing ,power:2
harnessing ,hospitalists:2
harnessing ,operational:2
harnessing ,disaster:2
harnessing ,planning:2
harnessing ,covid-19:2
power ,hospitalists:2
power ,operational:2
power ,disaster:2
power ,planning:2
power ,covid-19:2
hospitalists ,operational:2
hospitalists ,disaster:2
hospitalists ,planning:2
operational ,disaster:2
operational ,planning:2
disaster ,planning:2
disaster ,covid-19:2
precautions ,recommendations:2
precautions ,orthodontic:2
precautions ,settings:2
recommendations ,orthodontic:2
recommendations ,settings:2
orthodontic ,settings:2
broad ,host:2
broad ,sars-cov-2:2
broad ,predicted:2
broad ,comparative:2
broad ,structural:2
broad ,analysis:2
host ,predicted:2
host ,comparative:2
range ,sars-cov-2:2
range ,predicted:2
range ,comparative:2
range ,structural:2
range ,analysis:2
predicted ,comparative:2
predicted ,structural:2
predicted ,analysis:2
assessment ,seroconversion:2
assessment ,pediatric:2
assessment ,kidney:2
seroconversion ,cohort:2
cohort ,pediatric:2
cohort ,kidney:2
pediatric ,kidney:4
water ,wastewater:2
water ,critical:2
water ,review:2
critical ,presence:2
development ,hnc-ll:2
development ,score:2
development ,predicting:2
development ,severity:2
validation ,hnc-ll:2
validation ,score:2
validation ,predicting:2
validation ,severity:2
hnc-ll ,score:2
hnc-ll ,predicting:2
hnc-ll ,severity:2
predicting ,severity:2
silico ,marine:2
silico ,fish:2
silico ,nutritional:2
silico ,supplements:2
evaluation ,marine:2
evaluation ,fish:2
evaluation ,proteins:2
evaluation ,nutritional:2
evaluation ,supplements:2
marine ,fish:2
marine ,proteins:2
marine ,nutritional:2
marine ,supplements:2
fish ,proteins:2
fish ,nutritional:2
fish ,supplements:2
fish ,covid-19:2
proteins ,nutritional:2
proteins ,supplements:2
supplements ,covid-19:2
high ,30-day:2
high ,cirrhosis:2
rates ,30-day:2
rates ,cirrhosis:2
30-day ,mortality:2
30-day ,patients:2
30-day ,cirrhosis:2
30-day ,covid-19:2
mortality ,cirrhosis:2
patients ,cirrhosis:2
cirrhosis ,covid-19:2
dried ,sars-cov-2:2
dried ,virus:2
dried ,maintains:2
dried ,infectivity:2
dried ,vero:2
dried ,e6:2
dried ,cells:2
dried ,48:2
sars-cov-2 ,maintains:2
sars-cov-2 ,vero:2
sars-cov-2 ,e6:2
sars-cov-2 ,48:2
virus ,maintains:2
virus ,vero:2
virus ,e6:2
virus ,cells:2
virus ,48:2
maintains ,infectivity:2
maintains ,vero:2
maintains ,e6:2
maintains ,48:2
infectivity ,vero:2
infectivity ,e6:2
infectivity ,cells:2
infectivity ,48:2
vero ,48:2
e6 ,48:2
cells ,48:2
radical ,change:2
radical ,osteosarcoma:2
radical ,surgical:2
radical ,plan:2
radical ,due:2
radical ,pandemic:2
change ,osteosarcoma:2
change ,surgical:2
change ,plan:2
change ,due:2
osteosarcoma ,surgical:2
osteosarcoma ,plan:2
osteosarcoma ,due:2
osteosarcoma ,covid-19:2
osteosarcoma ,pandemic:2
surgical ,plan:2
surgical ,due:2
plan ,due:2
evaluation ,mechanisms:2
evaluation ,action:2
evaluation ,re-purposed:2
mechanisms ,re-purposed:2
action ,re-purposed:2
action ,treatment:2
multi-organ ,failure:2
multi-organ ,acute:2
multi-organ ,kidney:2
multi-organ ,injury:2
multi-organ ,patient:2
multi-organ ,hiv:2
multi-organ ,covid-19:2
failure ,kidney:2
failure ,injury:2
failure ,patient:2
failure ,hiv:2
acute ,hiv:2
kidney ,hiv:2
injury ,hiv:2
atypical ,deep:2
atypical ,cerebral:2
atypical ,vein:2
atypical ,thrombosis:2
atypical ,hemorrhagic:2
atypical ,venous:2
atypical ,infarction:2
deep ,hemorrhagic:2
deep ,infarction:2
cerebral ,vein:2
cerebral ,hemorrhagic:2
cerebral ,infarction:2
vein ,hemorrhagic:2
vein ,venous:2
vein ,infarction:2
thrombosis ,hemorrhagic:2
hemorrhagic ,venous:2
hemorrhagic ,infarction:2
venous ,infarction:2
coronavirus ,adolescents:2
disease ,adolescents:2
adolescents ,update:4
adolescents ,current:2
adolescents ,clinical:2
comparative ,nonhuman:2
comparative ,primate:2
pathogenesis ,mers:2
pathogenesis ,primate:2
covid-19 ,nonhuman:4
covid-19 ,primate:2
mers ,nonhuman:2
mers ,primate:2
mers ,model:2
sars ,nonhuman:2
sars ,primate:2
sars ,model:2
nonhuman ,primate:2
nonhuman ,model:4
primate ,model:2
sars-cov-2 ,looking:2
modeling ,present:2
modeling ,looking:2
modeling ,future:2
present ,looking:2
looking ,future:2
can ,pioglitazone:2
can ,potentially:2
can ,therapeutically:2
can ,treating:2
pioglitazone ,potentially:2
pioglitazone ,useful:2
pioglitazone ,therapeutically:2
pioglitazone ,treating:2
pioglitazone ,patients:2
potentially ,useful:2
potentially ,therapeutically:2
potentially ,treating:2
potentially ,patients:2
useful ,therapeutically:2
therapeutically ,treating:2
therapeutically ,patients:2
estimation ,blood:2
estimation ,donors:2
estimation ,incubation:2
estimation ,period:2
number ,blood:2
number ,donors:2
number ,incubation:2
number ,period:2
blood ,incubation:2
blood ,period:2
donors ,incubation:2
donors ,period:2
hereditary ,angioedema:2
hereditary ,make:2
hereditary ,covid-19:2
hereditary ,worse:2
angioedema ,make:2
angioedema ,worse:2
make ,worse:2
pandemic ,perceptions:4
knowledge ,perceptions:2
knowledge ,public:2
perceptions ,healthcare:2
boosting ,test-efficiency:2
boosting ,pooled:2
boosting ,testing:2
boosting ,sars-cov-2-formula:2
boosting ,optimal:2
boosting ,pool:2
test-efficiency ,pooled:2
test-efficiency ,testing:2
test-efficiency ,sars-cov-2-formula:2
test-efficiency ,optimal:2
test-efficiency ,pool:2
pooled ,sars-cov-2-formula:2
pooled ,optimal:2
pooled ,pool:2
testing ,sars-cov-2-formula:2
sars-cov-2-formula ,optimal:2
sars-cov-2-formula ,pool:2
sars-cov-2 ,25:2
sars-cov-2 ,pseudo-chilblains:2
antibody ,25:2
antibody ,pseudo-chilblains:2
response ,25:2
response ,pseudo-chilblains:2
25 ,pseudo-chilblains:2
patients ,pseudo-chilblains:2
adenovirus ,novel:2
adenovirus ,coronavirus:2
adenovirus ,sars-cov2:2
adenovirus ,coinfection:2
adenovirus ,case:2
adenovirus ,report:2
novel ,sars-cov2:2
sars-cov2 ,coinfection:2
sars-cov2 ,case:2
sars-cov2 ,report:2
impact ,urgent:2
impact ,endoscopy:4
impact ,nation-wide:2
covid-19 ,nation-wide:2
pandemic ,nation-wide:2
urgent ,endoscopy:2
urgent ,italy:2
urgent ,nation-wide:2
endoscopy ,italy:2
endoscopy ,nation-wide:2
italy ,nation-wide:2
absence ,severe:2
absence ,acute:2
absence ,syndrome-coronavirus-2:2
absence ,rna:2
absence ,ocular:2
absence ,tissues:2
severe ,tissues:2
acute ,tissues:2
respiratory ,tissues:2
syndrome-coronavirus-2 ,rna:2
syndrome-coronavirus-2 ,ocular:2
syndrome-coronavirus-2 ,tissues:2
rna ,ocular:2
rna ,tissues:2
analysis ,34:2
analysis ,pneumonia:6
clinical ,34:2
characteristics ,34:2
34 ,novel:2
34 ,coronavirus:2
34 ,pneumonia:2
34 ,cases:2
association ,incidence:2
association ,distance:2
association ,virus:2
incidence ,distance:2
distance ,virus:2
comparison ,nonhuman:2
comparison ,primates:2
comparison ,identified:2
comparison ,model:2
nonhuman ,primates:2
nonhuman ,identified:2
nonhuman ,suitable:2
primates ,identified:2
primates ,suitable:2
primates ,model:2
primates ,covid-19:2
identified ,suitable:2
identified ,model:2
suitable ,model:2
suitable ,covid-19:2
individual ,quarantine:2
individual ,versus:2
individual ,active:2
individual ,monitoring:2
individual ,contacts:2
individual ,mitigation:2
quarantine ,versus:2
quarantine ,active:2
quarantine ,contacts:2
quarantine ,mitigation:2
versus ,active:2
versus ,monitoring:2
versus ,contacts:2
versus ,mitigation:2
active ,contacts:2
active ,mitigation:2
monitoring ,contacts:2
monitoring ,mitigation:2
contacts ,mitigation:2
attitudes ,collateral:2
attitudes ,psychological:2
attitudes ,effects:2
attitudes ,pregnant:2
attitudes ,women:2
collateral ,psychological:2
collateral ,effects:2
collateral ,pregnant:2
collateral ,women:2
psychological ,pregnant:2
psychological ,women:2
effects ,women:2
infectivity ,coronaviruses:2
infectivity ,dry:2
infectivity ,surfaces:2
sars-cov-2 ,dry:2
coronaviruses ,dry:2
dry ,surfaces:2
dry ,potential:2
highly ,cryptic:2
highly ,epitope:2
highly ,domains:2
conserved ,cryptic:2
conserved ,epitope:2
conserved ,domains:2
cryptic ,epitope:2
cryptic ,receptor:2
cryptic ,binding:2
cryptic ,domains:2
cryptic ,sars-cov-2:2
epitope ,receptor:2
epitope ,binding:2
epitope ,domains:2
bats ,humans:2
case ,disseminated:2
case ,strongyloidiasis:2
report ,disseminated:2
report ,strongyloidiasis:2
disseminated ,strongyloidiasis:2
disseminated ,patient:2
strongyloidiasis ,patient:2
strongyloidiasis ,covid-19:2
role ,happenings:2
role ,africa:2
testing ,fight:2
testing ,happenings:2
testing ,africa:2
fight ,happenings:2
fight ,africa:2
covid-19 ,happenings:2
current ,happenings:2
happenings ,africa:2
electronic ,record:2
electronic ,analysis:2
electronic ,identifies:2
electronic ,kidney:2
electronic ,disease:2
electronic ,leading:2
electronic ,risk:2
health ,record:2
health ,identifies:2
health ,kidney:2
health ,leading:2
record ,analysis:2
record ,identifies:2
record ,kidney:2
record ,disease:2
record ,leading:2
record ,risk:2
analysis ,identifies:2
analysis ,leading:2
identifies ,kidney:2
identifies ,disease:2
identifies ,leading:2
identifies ,risk:2
kidney ,leading:2
kidney ,risk:2
leading ,risk:2
evaluation ,features:4
evaluation ,patient:2
evaluation ,macao:2
chest ,macao:2
ct ,macao:2
clinical ,macao:2
features ,macao:2
covid-19 ,macao:2
patient ,macao:2
lipid ,treatment:2
lipid ,period:2
treatment ,period:2
public ,aspects:2
public ,infection:2
public ,focus:2
public ,cardiovascular:2
public ,diseases:2
health ,diseases:2
aspects ,focus:2
aspects ,cardiovascular:2
aspects ,diseases:2
infection ,focus:4
modeling ,reading:2
modeling ,ability:2
modeling ,gain:2
modeling ,kindergarten:2
modeling ,children:2
modeling ,school:2
reading ,ability:2
reading ,gain:2
reading ,kindergarten:2
reading ,children:2
reading ,covid-19:2
reading ,school:2
ability ,gain:2
ability ,kindergarten:2
ability ,children:2
ability ,school:2
gain ,kindergarten:2
gain ,children:2
gain ,covid-19:2
gain ,school:2
kindergarten ,children:2
kindergarten ,covid-19:2
kindergarten ,school:2
children ,school:2
prevention ,aedes:2
prevention ,transmitted:2
prevention ,post-pandemic:2
prevention ,scenario:2
control ,aedes:2
control ,transmitted:2
control ,infections:2
control ,post-pandemic:2
control ,scenario:2
aedes ,transmitted:2
aedes ,infections:2
aedes ,post-pandemic:2
aedes ,scenario:2
transmitted ,infections:2
transmitted ,post-pandemic:2
transmitted ,scenario:2
infections ,post-pandemic:2
infections ,scenario:2
post-pandemic ,scenario:2
available ,evidence:2
available ,ongoing:2
available ,clinical:2
available ,trials:2
available ,remdesivir:2
evidence ,trials:2
ongoing ,remdesivir:2
trials ,remdesivir:2
characteristics ,prognosis:2
characteristics ,single:2
prognosis ,cancer:2
prognosis ,single:2
cancer ,single:4
patients ,single:4
global ,gastrointestinal:2
global ,endoscopy:2
global ,units:2
impact ,units:2
gastrointestinal ,endoscopy:4
gastrointestinal ,units:2
gastrointestinal ,international:2
endoscopy ,units:2
units ,international:2
clinical ,radiographic:2
characteristics ,radiographic:2
characteristics ,signs:2
laboratory ,radiographic:2
laboratory ,outcomes:2
findings ,radiographic:2
findings ,outcomes:2
radiographic ,signs:2
radiographic ,outcomes:2
signs ,outcomes:2
sars-cov-2 ,disbalance:2
sars-cov-2 ,suspect:2
factor ,disbalance:2
factor ,renin-angiotensin:2
factor ,suspect:2
disbalance ,renin-angiotensin:2
disbalance ,system:2
disbalance ,suspect:2
renin-angiotensin ,suspect:2
system ,suspect:2
acute ,coagulopathy:2
coagulopathy ,pregnancy:2
delayed-phase ,thrombocytopenia:2
delayed-phase ,patients:2
delayed-phase ,coronavirus:2
delayed-phase ,disease:2
delayed-phase ,covid-19:2
thrombocytopenia ,coronavirus:2
thrombocytopenia ,disease:2
repositioning ,chloroquine:2
repositioning ,antiviral:2
repositioning ,prophylaxis:2
chloroquine ,prophylaxis:2
hydroxychloroquine ,hospitalised:2
hydroxychloroquine ,observational:2
use ,hospitalised:2
use ,observational:2
hospitalised ,observational:2
patients ,observational:2
recovery ,distress:2
recovery ,syndrome:2
recovery ,tocilizumab:2
nurses ,know:2
nurses ,covid-19:2
computational ,evaluation:2
computational ,inhibition:2
computational ,efficacies:2
computational ,hiv:2
computational ,antivirals:2
evaluation ,inhibition:2
evaluation ,efficacies:2
evaluation ,hiv:2
evaluation ,antivirals:2
inhibition ,efficacies:2
inhibition ,hiv:2
inhibition ,antivirals:2
efficacies ,hiv:2
efficacies ,antivirals:2
hiv ,antivirals:2
covid-19 ,reportscase:2
skin ,overview:2
skin ,reportscase:2
skin ,series:2
manifestations ,reportscase:2
manifestations ,series:2
overview ,case:2
overview ,reportscase:2
overview ,series:2
case ,reportscase:2
reportscase ,series:2
selenium ,viral:2
selenium ,infection:2
selenium ,lessons:2
selenium ,covid-19:4
decoy ,nanoparticles:2
decoy ,protect:2
decoy ,covid-19:2
decoy ,concurrently:2
decoy ,adsorbing:2
decoy ,viruses:2
nanoparticles ,protect:2
nanoparticles ,covid-19:2
nanoparticles ,concurrently:2
nanoparticles ,adsorbing:2
nanoparticles ,viruses:2
protect ,concurrently:2
protect ,adsorbing:2
protect ,viruses:2
covid-19 ,concurrently:2
covid-19 ,adsorbing:2
concurrently ,adsorbing:2
concurrently ,viruses:2
adsorbing ,viruses:2
molecular ,effects:2
molecular ,retinopathy:2
molecular ,hydroxychloroquine:2
effects ,retinopathy:2
effects ,hydroxychloroquine:2
retinopathy ,induced:2
retinopathy ,hydroxychloroquine:2
retinopathy ,sars-cov-2:2
induced ,hydroxychloroquine:2
race ,arsenal:2
race ,therapeutics:2
race ,current:2
race ,alarming:2
race ,status:2
race ,future:2
arsenal ,covid-19:2
arsenal ,therapeutics:2
arsenal ,current:2
arsenal ,alarming:2
arsenal ,status:2
arsenal ,future:2
covid-19 ,alarming:2
therapeutics ,alarming:2
therapeutics ,future:2
current ,alarming:2
alarming ,status:2
alarming ,future:2
current ,sudan:2
situation ,sudan:2
covid-19 ,sudan:2
autonomic ,dysfunction:2
autonomic ,heralding:2
autonomic ,acute:2
autonomic ,motor:2
autonomic ,axonal:2
autonomic ,neuropathy:2
dysfunction ,heralding:2
dysfunction ,acute:2
dysfunction ,motor:2
dysfunction ,axonal:2
dysfunction ,neuropathy:2
heralding ,acute:2
heralding ,motor:2
heralding ,axonal:2
heralding ,neuropathy:2
heralding ,covid-19:2
acute ,motor:2
acute ,axonal:2
motor ,axonal:2
motor ,neuropathy:2
motor ,covid-19:2
axonal ,neuropathy:2
axonal ,covid-19:2
neuropathy ,covid-19:2
lifting ,lockdown:2
lifting ,policies:2
lifting ,critical:2
lifting ,moment:2
lifting ,stigma:2
lockdown ,policies:2
lockdown ,critical:2
lockdown ,moment:2
lockdown ,stigma:2
policies ,critical:2
policies ,moment:2
policies ,stigma:2
critical ,moment:2
critical ,stigma:2
moment ,covid-19:2
moment ,stigma:2
covid-19 ,stigma:2
coinfection ,hku1-the:2
coinfection ,critical:2
coinfection ,need:2
coinfection ,repeat:2
coinfection ,testing:2
covid-19 ,hku1-the:2
covid-19 ,repeat:4
coronavirus ,hku1-the:2
coronavirus ,repeat:2
hku1-the ,critical:2
hku1-the ,need:2
hku1-the ,repeat:2
hku1-the ,testing:2
critical ,need:2
critical ,repeat:2
critical ,testing:2
need ,repeat:2
clinical ,hematologic:2
clinical ,setting:2
impact ,hematologic:2
impact ,setting:2
covid-19 ,hematologic:2
epidemic ,hematologic:2
epidemic ,setting:2
hematologic ,setting:2
kinetic ,changes:2
kinetic ,virology:2
kinetic ,specific:2
kinetic ,antibody:2
kinetic ,response:2
kinetic ,imaging:2
changes ,virology:2
changes ,specific:2
changes ,response:2
changes ,imaging:2
virology ,specific:2
virology ,antibody:2
virology ,response:2
virology ,imaging:2
specific ,imaging:2
antibody ,imaging:2
response ,imaging:2
decoding ,proteome:2
decoding ,severe:2
decoding ,acute:2
decoding ,respiratory:2
decoding ,syndrome:2
proteome ,severe:2
proteome ,acute:2
proteome ,respiratory:2
proteome ,syndrome:2
proteome ,coronavirus:2
cardiovascular ,treating:2
treating ,disease:2
naltrexone ,potential:2
naltrexone ,therapeutic:2
naltrexone ,candidate:2
naltrexone ,covid-19:2
covid-19 ,allergy:2
allergy ,take:2
allergy ,care:2
allergy ,allergic:2
allergy ,patients:2
allergy ,pandemic:2
take ,care:2
take ,allergic:2
take ,patients:2
take ,pandemic:2
care ,allergic:2
allergic ,patients:2
allergic ,pandemic:2
sars-cov-2 ,intravascular:2
sars-cov-2 ,volume:2
intravascular ,volume:2
intravascular ,management:2
intravascular ,strategies:2
volume ,management:2
volume ,strategies:2
pathological ,postmortem:2
pathological ,biopsies:2
pathological ,lung:2
pathological ,heart:2
pathological ,liver:2
findings ,biopsies:2
findings ,heart:2
findings ,liver:2
postmortem ,biopsies:2
postmortem ,heart:2
postmortem ,liver:2
biopsies ,lung:2
biopsies ,heart:2
biopsies ,liver:2
lung ,liver:2
heart ,liver:2
risk ,prediction:2
risk ,older:2
assessment ,prediction:2
assessment ,severe:2
assessment ,illness:2
assessment ,older:2
prediction ,critical:2
prediction ,illness:2
prediction ,older:2
severe ,older:2
air ,temperature:2
air ,increased:2
air ,incidence:2
pollution ,temperature:2
pollution ,increased:2
pollution ,incidence:2
temperature ,associated:2
temperature ,increased:2
treatment ,success:2
treatment ,repeat:2
treatment ,three:2
success ,repeat:2
success ,courses:2
success ,azithromycin:2
success ,report:2
success ,three:2
repeat ,courses:2
repeat ,azithromycin:2
repeat ,report:2
repeat ,three:2
courses ,azithromycin:2
courses ,report:2
courses ,three:2
azithromycin ,report:2
azithromycin ,three:2
community-onset ,severe:2
community-onset ,acute:2
community-onset ,respiratory:2
community-onset ,syndrome:2
community-onset ,coronavirus:2
community-onset ,infection:2
community-onset ,young:2
respiratory ,young:2
syndrome ,young:2
potential ,benefits:2
potential ,omega-3:2
potential ,fatty:2
potential ,acids:2
benefits ,risks:2
benefits ,omega-3:2
benefits ,fatty:2
benefits ,acids:2
benefits ,supplementation:2
benefits ,patients:2
risks ,omega-3:2
risks ,fatty:2
risks ,acids:2
risks ,supplementation:2
omega-3 ,fatty:2
omega-3 ,acids:2
omega-3 ,supplementation:2
omega-3 ,patients:2
fatty ,acids:2
fatty ,supplementation:2
fatty ,patients:2
acids ,supplementation:2
acids ,patients:2
supplementation ,patients:2
molecular ,knowledge:2
biology ,coronaviruses:2
biology ,current:2
biology ,knowledge:2
coronaviruses ,current:2
coronaviruses ,knowledge:2
sars-cov-2 ,rhinovirusenterovirus:2
rhinovirusenterovirus ,co-infection:2
rhinovirusenterovirus ,critically:2
rhinovirusenterovirus ,ill:2
rhinovirusenterovirus ,young:2
rhinovirusenterovirus ,adult:2
co-infection ,critically:2
co-infection ,ill:2
co-infection ,young:2
co-infection ,adult:2
critically ,young:2
critically ,adult:2
ill ,young:2
ill ,adult:2
persistence ,viral:4
persistence ,pneumocyte:2
persistence ,syncytia:2
persistence ,thrombosis:2
persistence ,hallmarks:2
viral ,pneumocyte:2
viral ,syncytia:2
viral ,thrombosis:2
viral ,hallmarks:2
rna ,pneumocyte:2
rna ,syncytia:2
rna ,thrombosis:2
rna ,hallmarks:2
pneumocyte ,syncytia:2
pneumocyte ,thrombosis:2
pneumocyte ,hallmarks:2
syncytia ,thrombosis:2
syncytia ,hallmarks:2
thrombosis ,hallmarks:2
reconsidering ,assumptions:2
reconsidering ,adolescent:2
reconsidering ,young:2
reconsidering ,adult:2
reconsidering ,sars-cov-2:2
reconsidering ,transmission:2
assumptions ,adolescent:2
assumptions ,young:2
assumptions ,adult:2
assumptions ,sars-cov-2:2
assumptions ,transmission:2
adolescent ,young:2
adolescent ,adult:2
adolescent ,sars-cov-2:2
adolescent ,transmission:2
young ,transmission:2
adult ,transmission:2
identification ,conjunctival:2
identification ,swab:2
identification ,italian:2
identification ,pediatric:2
rna ,italian:2
rna ,pediatric:2
conjunctival ,italian:2
conjunctival ,pediatric:2
swab ,italian:2
swab ,pediatric:2
perspective ,antibodies:2
perspective ,combat:2
role ,antibodies:2
role ,drugs:2
antibodies ,drugs:2
antibodies ,combat:2
drugs ,combat:2
acute ,increase:2
acute ,deaths:2
acute ,congenital:2
acute ,heart:2
increase ,deaths:2
increase ,adult:2
increase ,congenital:2
increase ,heart:2
increase ,disease:2
deaths ,among:2
deaths ,adult:2
deaths ,congenital:2
deaths ,heart:2
among ,adult:2
among ,congenital:2
among ,heart:2
adult ,congenital:2
adult ,heart:2
adult ,disease:2
dft ,investigation:2
dft ,atazanavir:2
investigation ,atazanavir:2
investigation ,inhibitor:2
atazanavir ,potential:2
atazanavir ,inhibitor:2
atazanavir ,2019-ncov:2
atazanavir ,coronavirus:2
enhancing ,colorimetric:2
enhancing ,loop-mediated:2
enhancing ,isothermal:2
enhancing ,amplification:2
enhancing ,speed:2
enhancing ,sensitivity:2
colorimetric ,loop-mediated:2
colorimetric ,isothermal:2
colorimetric ,amplification:2
colorimetric ,speed:2
colorimetric ,sensitivity:2
loop-mediated ,speed:2
loop-mediated ,sensitivity:2
isothermal ,speed:2
isothermal ,sensitivity:2
amplification ,speed:2
amplification ,sensitivity:2
speed ,sensitivity:2
ischemic ,among:2
ischemic ,symptoms:2
ischemic ,caused:2
ischemic ,infection:2
stroke ,among:2
stroke ,symptoms:2
stroke ,caused:2
among ,caused:2
symptoms ,caused:2
cardiovascular ,experimental:2
cardiovascular ,hydroxychloroquine:2
cardiovascular ,therapy:2
considerations ,experimental:2
considerations ,hydroxychloroquine:2
considerations ,therapy:2
experimental ,hydroxychloroquine:2
experimental ,patients:2
estimating ,binding:2
estimating ,peptides:2
estimating ,hla:2
estimating ,class:2
estimating ,human:2
estimating ,subpopulations:2
binding ,class:2
binding ,subpopulations:2
sars-cov-2 ,subpopulations:2
peptides ,class:2
peptides ,human:2
peptides ,subpopulations:2
hla ,class:2
hla ,human:2
hla ,subpopulations:2
class ,human:4
class ,subpopulations:2
human ,subpopulations:2
volatile ,molecules:2
volatile ,covid-19:2
volatile ,possible:2
volatile ,pharmacological:2
volatile ,strategy:2
molecules ,possible:2
molecules ,pharmacological:2
molecules ,strategy:2
possible ,pharmacological:2
pharmacological ,strategy:2
twenty-first ,century:2
twenty-first ,viral:2
twenty-first ,pandemics:2
twenty-first ,literature:2
twenty-first ,review:2
twenty-first ,sexual:2
twenty-first ,transmission:2
century ,viral:2
century ,pandemics:2
century ,literature:2
century ,review:2
century ,sexual:2
century ,transmission:2
viral ,pandemics:2
viral ,literature:2
viral ,sexual:2
pandemics ,literature:2
pandemics ,review:2
pandemics ,sexual:2
pandemics ,transmission:2
literature ,sexual:2
review ,sexual:2
sexual ,transmission:2
decoding ,transmission:2
decoding ,ramifications:2
sars-cov-2 ,ramifications:2
transmission ,ramifications:2
evolution ,ramifications:2
ramifications ,covid-19:2
vitamin ,supplementation:2
vitamin ,better:2
vitamin ,hospitalized:2
vitamin ,frail:2
supplementation ,associated:2
supplementation ,better:2
supplementation ,survival:2
supplementation ,hospitalized:2
supplementation ,frail:2
associated ,better:2
associated ,survival:2
associated ,frail:2
better ,survival:2
better ,hospitalized:2
better ,frail:2
survival ,hospitalized:2
survival ,frail:2
hospitalized ,frail:2
essential ,functional:2
essential ,molecules:2
essential ,associated:2
functional ,molecules:2
functional ,associated:2
functional ,infection:2
molecules ,associated:2
molecules ,infection:2
molecules ,potential:2
emergency ,pandemia:2
animals ,species:2
animals ,viral:2
animals ,transmission:2
species ,susceptibility:2
species ,viral:2
species ,transmission:2
susceptibility ,transmission:4
impact ,professionals:2
mental ,healthcare:4
detection ,influenza:2
severe ,viruses:2
acute ,viruses:2
syndrome ,viruses:2
influenza ,viruses:2
takotsubo ,cardiomyopathy:2
takotsubo ,triggered:2
takotsubo ,infection:2
takotsubo ,critically:2
takotsubo ,ill:2
cardiomyopathy ,triggered:2
cardiomyopathy ,sars-cov-2:2
cardiomyopathy ,infection:2
cardiomyopathy ,critically:2
cardiomyopathy ,ill:2
triggered ,infection:2
triggered ,critically:2
triggered ,ill:2
infection ,critically:2
role ,ofthe:2
role ,radiologist:2
role ,indiagnosing:2
role ,parma:2
ofthe ,radiologist:2
ofthe ,indiagnosing:2
ofthe ,covid-19:2
ofthe ,infection:2
ofthe ,parma:2
ofthe ,experiences:2
radiologist ,indiagnosing:2
radiologist ,infection:2
radiologist ,parma:2
radiologist ,experiences:2
indiagnosing ,covid-19:2
indiagnosing ,infection:2
indiagnosing ,parma:2
indiagnosing ,experiences:2
covid-19 ,parma:2
infection ,experiences:2
parma ,experiences:2
obesity ,oro-naso-sensory:2
obesity ,perception:2
covid-19 ,oro-naso-sensory:2
oro-naso-sensory ,perception:2
impact ,alzheimers:2
impact ,viewpoint:2
impact ,action:2
alzheimers ,risk:2
alzheimers ,viewpoint:2
alzheimers ,research:2
alzheimers ,action:2
disease ,viewpoint:2
risk ,viewpoint:2
risk ,research:2
risk ,action:2
viewpoint ,research:2
viewpoint ,action:2
research ,action:2
short-term ,inhibition:2
short-term ,hydrogen:2
short-term ,peroxide:2
short-term ,persistent:2
inhibition ,hydrogen:2
inhibition ,peroxide:2
inhibition ,persistent:2
sars-cov-2 ,hydrogen:4
sars-cov-2 ,peroxide:2
hydrogen ,persistent:2
peroxide ,persistent:2
radiological ,non-sars-cov-2:2
radiological ,viruses:2
radiological ,era:2
diagnosis ,non-sars-cov-2:2
diagnosis ,viruses:2
non-sars-cov-2 ,viruses:2
non-sars-cov-2 ,era:2
viruses ,era:2
delayed ,acute:2
delayed ,generalized:2
delayed ,exanthematous:2
delayed ,pustulosis:2
delayed ,following:2
presentation ,generalized:2
presentation ,exanthematous:2
presentation ,pustulosis:2
presentation ,following:2
acute ,generalized:2
acute ,exanthematous:2
acute ,pustulosis:2
generalized ,exanthematous:2
generalized ,pustulosis:2
generalized ,following:2
exanthematous ,pustulosis:2
exanthematous ,following:2
pustulosis ,following:2
analysis ,role:2
analysis ,local:2
analysis ,interventional:2
sars-cov-2 ,interventional:2
epidemic ,role:2
epidemic ,interventional:2
italy ,local:2
italy ,interventional:2
role ,local:2
role ,interventional:2
local ,interventional:2
clinical ,arbidol:2
clinical ,220:2
clinical ,nonemergency:2
features ,efficacy:2
features ,antiviral:2
features ,drug:2
features ,arbidol:2
features ,220:2
features ,nonemergency:2
efficacy ,antiviral:2
efficacy ,arbidol:2
efficacy ,220:2
efficacy ,nonemergency:2
antiviral ,220:2
antiviral ,nonemergency:2
drug ,220:2
drug ,nonemergency:2
arbidol ,220:2
arbidol ,nonemergency:2
220 ,nonemergency:2
sars-cov-2 ,know-focus:2
sars-cov-2 ,lipids:2
known ,know-focus:2
known ,coagulation:2
known ,lipids:2
know-focus ,coagulation:2
know-focus ,lipids:2
coagulation ,lipids:2
interventions ,singapore:2
mitigate ,singapore:2
mitigate ,modelling:2
early ,singapore:2
early ,modelling:4
spread ,singapore:2
singapore ,modelling:2
severe ,penetrating:2
severe ,dementia:2
severe ,research:2
acute ,penetrating:2
acute ,dementia:2
acute ,research:2
respiratory ,penetrating:2
respiratory ,dementia:2
respiratory ,research:2
syndrome ,penetrating:2
syndrome ,dementia:2
syndrome ,research:2
coronavirus ,penetrating:2
coronavirus ,dementia:2
penetrating ,dementia:2
penetrating ,research:2
dementia ,research:2
current ,target-specific:2
current ,discovery:2
current ,compounds:2
approaches ,target-specific:2
approaches ,natural:2
approaches ,compounds:2
target-specific ,drug:2
target-specific ,discovery:2
target-specific ,using:2
target-specific ,natural:2
target-specific ,compounds:2
discovery ,compounds:2
using ,natural:2
using ,compounds:2
retrospective ,post-mortem:2
retrospective ,rt-pcr:2
retrospective ,autopsies:2
retrospective ,covid-19-suggestive:2
post-mortem ,sars-cov-2:2
post-mortem ,rt-pcr:2
post-mortem ,autopsies:2
post-mortem ,covid-19-suggestive:2
sars-cov-2 ,autopsies:2
sars-cov-2 ,covid-19-suggestive:2
rt-pcr ,autopsies:2
rt-pcr ,covid-19-suggestive:2
autopsies ,covid-19-suggestive:2
aerosol ,tract:2
aerosol ,various:2
aerosol ,modes:2
aerosol ,oxygen:2
aerosol ,delivery:2
generation ,respiratory:2
generation ,tract:2
generation ,various:2
generation ,modes:2
generation ,oxygen:2
generation ,delivery:2
respiratory ,various:2
respiratory ,modes:2
respiratory ,delivery:2
tract ,various:2
tract ,modes:2
tract ,oxygen:2
tract ,delivery:2
various ,modes:2
various ,oxygen:2
various ,delivery:2
modes ,oxygen:2
oxygen ,delivery:2
management ,heart:2
management ,joint:2
management ,paper:2
heart ,joint:2
heart ,position:2
heart ,paper:2
failure ,joint:2
failure ,paper:2
patients ,joint:2
patients ,paper:2
joint ,position:2
joint ,paper:2
can ,epigenetic:2
can ,modifiers:2
vitamins ,epigenetic:2
vitamins ,modifiers:2
vitamins ,enhance:2
vitamins ,immunity:2
vitamins ,patients:2
epigenetic ,modifiers:2
epigenetic ,enhance:2
epigenetic ,immunity:2
epigenetic ,covid-19:2
epigenetic ,patients:2
modifiers ,enhance:2
modifiers ,immunity:2
modifiers ,patients:2
enhance ,immunity:2
enhance ,patients:2
clinical ,co-infections:2
clinical ,354:2
characteristics ,co-infections:2
characteristics ,354:2
co-infections ,354:2
co-infections ,hospitalized:2
354 ,hospitalized:2
354 ,patients:2
hiv-infected ,patient:2
hiv-infected ,favourable:2
hiv-infected ,prognosis:2
patient ,favourable:2
patient ,prognosis:2
coronavirus ,favourable:2
coronavirus ,prognosis:2
disease ,favourable:2
disease ,prognosis:4
favourable ,prognosis:2
dynamic ,panel:2
dynamic ,transmission:2
dynamic ,united:2
dynamic ,states:2
dynamic ,inform:2
panel ,surveillance:2
panel ,covid-19:2
panel ,transmission:2
panel ,united:2
panel ,states:2
panel ,inform:2
surveillance ,united:2
surveillance ,states:2
surveillance ,inform:2
transmission ,united:2
transmission ,states:2
transmission ,inform:2
united ,inform:2
states ,inform:2
toward ,preparing:2
toward ,base:2
toward ,explore:2
toward ,potential:2
toward ,drugs:2
toward ,biomedical:2
toward ,entities:2
preparing ,knowledge:2
preparing ,base:2
preparing ,explore:2
preparing ,potential:2
preparing ,drugs:2
preparing ,biomedical:2
preparing ,entities:2
knowledge ,base:2
knowledge ,explore:2
knowledge ,potential:2
knowledge ,drugs:2
knowledge ,entities:2
base ,explore:2
base ,potential:2
base ,drugs:2
base ,biomedical:2
base ,entities:2
explore ,potential:2
explore ,drugs:2
explore ,biomedical:2
explore ,entities:2
potential ,biomedical:2
potential ,entities:2
drugs ,biomedical:2
biomedical ,entities:2
diagnostic ,solid:2
diagnostic ,organ:2
diagnostic ,transplantation:2
testing ,solid:2
testing ,organ:2
testing ,transplantation:2
solid ,current:2
solid ,clinical:2
organ ,current:2
organ ,clinical:2
transplantation ,current:2
transplantation ,clinical:2
combinations ,pcr:2
combinations ,isothermal:2
combinations ,amplification:2
combinations ,techniques:2
combinations ,suitable:2
combinations ,fast:2
pcr ,isothermal:2
pcr ,amplification:2
pcr ,techniques:2
pcr ,suitable:2
pcr ,fast:2
isothermal ,techniques:2
isothermal ,suitable:2
isothermal ,fast:2
amplification ,techniques:2
amplification ,suitable:2
amplification ,fast:2
techniques ,suitable:2
techniques ,fast:2
suitable ,fast:2
obesity ,comorbidities:2
obesity ,underlying:2
diabetes ,underlying:2
diabetes ,mechanisms:2
comorbidities ,underlying:2
comorbidities ,mechanisms:2
frequency ,serological:2
frequency ,non-responders:2
frequency ,false-negative:2
frequency ,rt-pcr:2
serological ,non-responders:2
serological ,false-negative:2
non-responders ,false-negative:2
non-responders ,rt-pcr:2
non-responders ,results:2
false-negative ,rt-pcr:2
smoking ,know:2
smoking ,far:2
acute ,cerebrovascular:2
acute ,single:2
acute ,center:2
cerebrovascular ,following:2
cerebrovascular ,single:2
cerebrovascular ,center:2
cerebrovascular ,retrospective:2
disease ,following:2
disease ,single:2
following ,single:2
following ,center:2
following ,retrospective:2
single ,retrospective:2
center ,retrospective:2
characteristics ,5630:2
characteristics ,subjects:2
characteristics ,receiving:2
diagnosis ,rate:2
diagnosis ,5630:2
diagnosis ,subjects:2
diagnosis ,receiving:2
rate ,5630:2
rate ,subjects:2
rate ,receiving:2
rate ,nucleic:2
5630 ,subjects:2
5630 ,receiving:2
5630 ,sars-cov-2:2
5630 ,nucleic:2
subjects ,receiving:2
subjects ,nucleic:2
receiving ,sars-cov-2:2
receiving ,nucleic:2
discovery ,potential:2
discovery ,multi-target-directed:2
discovery ,ligands:2
discovery ,host-specific:2
potential ,multi-target-directed:2
potential ,ligands:2
potential ,host-specific:2
multi-target-directed ,ligands:2
multi-target-directed ,targeting:2
multi-target-directed ,host-specific:2
ligands ,targeting:2
ligands ,host-specific:2
targeting ,host-specific:2
targeting ,pneumonia:2
targeting ,lessons:2
coagulation ,activation:2
coagulation ,pneumonia:2
coagulation ,lessons:2
activation ,pneumonia:2
activation ,lessons:2
severe ,lessons:2
pneumonia ,lessons:2
sars-cov-2 ,dialyzed:2
sars-cov-2 ,transplanted:2
recommendations ,nursing:2
recommendations ,dialyzed:2
recommendations ,transplanted:2
nursing ,dialyzed:2
nursing ,transplanted:2
care ,dialyzed:2
care ,transplanted:2
dialyzed ,transplanted:2
dialyzed ,patient:2
transplanted ,patient:2
covid-19 ,eastern:4
eastern ,mediterranean:2
eastern ,region:2
eastern ,saudi:2
eastern ,arabia:2
eastern ,prevention:2
mediterranean ,region:2
mediterranean ,saudi:2
mediterranean ,arabia:2
mediterranean ,prevention:2
region ,saudi:2
region ,arabia:2
region ,prevention:2
saudi ,prevention:2
arabia ,prevention:2
sars-cov-2 ,magnetic:2
sars-cov-2 ,beads:2
rna ,magnetic:2
rna ,beads:2
extraction ,magnetic:2
extraction ,beads:2
extraction ,testing:2
using ,magnetic:2
using ,beads:2
using ,large-scale:2
magnetic ,rapid:2
magnetic ,large-scale:2
magnetic ,testing:2
beads ,rapid:2
beads ,large-scale:2
beads ,testing:2
successful ,critical:2
successful ,extracorporeal:2
successful ,membrane:2
recovery ,critical:2
recovery ,extracorporeal:2
recovery ,membrane:2
critical ,extracorporeal:2
critical ,membrane:2
pneumonia ,extracorporeal:2
pneumonia ,membrane:2
willingness ,use:2
willingness ,home:2
willingness ,collection:2
willingness ,methods:2
willingness ,provide:2
willingness ,specimens:2
use ,home:2
use ,collection:2
use ,methods:2
use ,provide:2
use ,specimens:2
home ,provide:2
home ,specimens:2
collection ,provide:2
collection ,specimens:2
methods ,provide:2
methods ,specimens:2
provide ,specimens:2
european ,us:2
european ,lockdowns:2
european ,second:2
european ,waves:2
european ,pandemic:2
us ,lockdowns:2
us ,second:2
us ,waves:2
us ,pandemic:2
lockdowns ,second:2
lockdowns ,waves:2
lockdowns ,pandemic:2
second ,waves:2
second ,pandemic:2
waves ,pandemic:2
first ,documentation:2
first ,persistent:2
first ,late:2
documentation ,persistent:2
documentation ,sars-cov-2:2
documentation ,infection:2
documentation ,presenting:2
documentation ,late:2
documentation ,acute:2
potential ,covalent:4
potential ,priming:2
potential ,proteases:2
clinical ,drugs:2
clinical ,covalent:2
clinical ,inhibitors:2
clinical ,priming:2
clinical ,proteases:2
drugs ,covalent:4
drugs ,priming:2
drugs ,proteases:2
covalent ,priming:2
covalent ,proteases:2
inhibitors ,priming:2
inhibitors ,proteases:2
priming ,proteases:2
exploiting ,early:2
exploiting ,warning:2
exploiting ,nomogram:2
exploiting ,predicting:2
exploiting ,risk:2
exploiting ,icu:2
exploiting ,admission:2
early ,nomogram:2
early ,predicting:2
early ,icu:2
early ,admission:2
warning ,nomogram:2
warning ,predicting:2
warning ,risk:2
warning ,icu:2
warning ,admission:2
nomogram ,predicting:2
nomogram ,risk:2
nomogram ,icu:2
nomogram ,admission:2
predicting ,risk:2
predicting ,icu:2
predicting ,admission:2
risk ,admission:2
icu ,admission:2
covid-19 ,usurps:2
usurps ,host:2
usurps ,regulatory:2
usurps ,networks:2
host ,regulatory:2
host ,networks:2
regulatory ,networks:2
correspondence ,structure:2
correspondence ,terrestrial:2
correspondence ,mobility:2
correspondence ,network:2
structure ,terrestrial:2
structure ,mobility:2
terrestrial ,mobility:2
terrestrial ,network:2
mobility ,network:2
genetic ,alteration:2
genetic ,rna:2
genetic ,dna:2
genetic ,methylation:2
genetic ,profiling:2
alteration ,rna:2
alteration ,dna:2
alteration ,methylation:2
alteration ,profiling:2
alteration ,coronavirus:2
rna ,dna:2
rna ,methylation:2
rna ,profiling:2
expression ,dna:2
expression ,methylation:2
dna ,methylation:2
dna ,profiling:2
dna ,coronavirus:2
methylation ,profiling:2
methylation ,coronavirus:2
profiling ,coronavirus:2
isolated ,severe:2
isolated ,thrombocytopenia:2
isolated ,patient:2
isolated ,case:2
isolated ,report:2
thrombocytopenia ,report:2
screening ,hospital:2
screening ,problems:2
covid-19 ,problems:2
children ,problems:2
admitted ,acute:2
admitted ,problems:2
hospital ,acute:2
hospital ,problems:2
acute ,problems:2
systematic ,recovery:2
systematic ,physical:2
systematic ,function:2
systematic ,fitness:2
review ,recovery:2
review ,physical:2
review ,function:2
review ,fitness:2
changes ,recovery:2
changes ,function:2
changes ,fitness:2
recovery ,physical:2
recovery ,function:2
recovery ,fitness:2
physical ,function:2
physical ,fitness:2
function ,fitness:2
vaccination ,global:4
vaccination ,disruption:2
global ,disruption:2
excess ,cases:2
excess ,influenza-like:2
excess ,illnesses:2
excess ,synchronous:2
excess ,coronavirus:2
excess ,disease:2
cases ,influenza-like:2
cases ,illnesses:2
cases ,synchronous:2
influenza-like ,illnesses:2
influenza-like ,synchronous:2
influenza-like ,coronavirus:2
influenza-like ,disease:2
illnesses ,synchronous:2
illnesses ,coronavirus:2
illnesses ,disease:2
synchronous ,coronavirus:2
synchronous ,disease:2
course ,outcomes:2
course ,kidney:2
course ,transplant:2
imaging ,outcomes:2
imaging ,kidney:2
imaging ,transplant:2
features ,kidney:2
features ,transplant:2
outcomes ,kidney:2
outcomes ,transplant:2
activation ,interferon:2
activation ,responses:2
evasion ,responses:2
ethnic ,differences:2
ethnic ,prospective:2
ethnic ,cohort:2
socioeconomic ,differences:2
socioeconomic ,prospective:2
socioeconomic ,cohort:2
differences ,infection:2
differences ,prospective:2
differences ,cohort:2
infection ,prospective:2
infection ,cohort:2
changes ,reverse:2
changes ,transcription:2
changes ,polymerase:2
changes ,chain:2
changes ,reaction-positive:2
reverse ,reaction-positive:2
transcription ,polymerase:2
transcription ,chain:2
transcription ,reaction-positive:2
polymerase ,reaction-positive:2
polymerase ,severe:2
polymerase ,acute:2
chain ,reaction-positive:2
reaction-positive ,severe:2
reaction-positive ,acute:2
fast ,identification:2
fast ,possible:2
fast ,drug:2
fast ,treatment:2
fast ,coronavirus:2
fast ,disease-19:2
identification ,possible:2
identification ,treatment:2
identification ,disease-19:2
possible ,disease-19:2
drug ,disease-19:2
treatment ,disease-19:2
can ,opportunities:2
can ,urgent:2
nanotechnology ,combat:2
nanotechnology ,opportunities:2
nanotechnology ,urgent:2
nanotechnology ,need:2
help ,combat:2
help ,opportunities:2
help ,urgent:2
help ,need:2
combat ,opportunities:2
combat ,urgent:2
combat ,need:2
opportunities ,urgent:2
opportunities ,need:2
improved ,molecular:2
improved ,diagnosis:2
improved ,covid-19:4
improved ,novel:2
improved ,highly:2
improved ,sensitive:2
improved ,specific:2
molecular ,specific:2
novel ,specific:2
bind ,human:2
bind ,strongly:2
bind ,sars-cov:2
human ,strongly:2
ace2 ,strongly:2
ace2 ,sars-cov:2
strongly ,sars-cov:2
anti-sars-cov-2 ,testing:2
anti-sars-cov-2 ,ibd:2
anti-sars-cov-2 ,healthcare:2
anti-sars-cov-2 ,professionals:2
anti-sars-cov-2 ,currently:2
antibody ,ibd:2
antibody ,professionals:2
antibody ,currently:2
testing ,ibd:2
testing ,professionals:2
testing ,currently:2
ibd ,healthcare:2
ibd ,professionals:2
ibd ,currently:2
healthcare ,currently:2
professionals ,currently:2
management ,reconfiguration:2
management ,radiology:2
management ,threat:2
reconfiguration ,radiology:2
reconfiguration ,department:2
reconfiguration ,threat:2
radiology ,department:2
radiology ,threat:2
department ,threat:2
azithromycin ,ambroxol:2
azithromycin ,potential:2
azithromycin ,pharmacotherapy:2
ambroxol ,potential:2
ambroxol ,pharmacotherapy:2
ambroxol ,sars-cov-2:2
potential ,pharmacotherapy:2
pharmacotherapy ,sars-cov-2:2
rhabdomyolysis ,initial:2
rhabdomyolysis ,presentation:2
rhabdomyolysis ,diagnosed:2
initial ,patient:2
initial ,diagnosed:2
presentation ,diagnosed:2
severe ,initially:2
severe ,mesenteric:2
severe ,adenopathy:2
covid-19 ,initially:2
covid-19 ,adenopathy:2
initially ,presenting:2
initially ,mesenteric:2
initially ,adenopathy:2
presenting ,mesenteric:2
presenting ,adenopathy:2
mesenteric ,adenopathy:2
emerging ,prevention:2
emerging ,control:2
analysis ,austrian:2
analysis ,age:2
analysis ,sex:2
austrian ,covid-19:2
austrian ,deaths:2
austrian ,age:2
austrian ,sex:2
deaths ,age:2
deaths ,sex:2
convalescent ,memory:2
memory ,individuals:2
memory ,mild:2
memory ,asymptomatic:2
autoinflammatory ,autoimmune:2
autoinflammatory ,conditions:2
autoinflammatory ,crossroad:2
autoimmune ,conditions:2
autoimmune ,crossroad:2
conditions ,crossroad:2
crossroad ,covid-19:2
acute ,direct:2
kidney ,direct:2
kidney ,effect:2
injury ,direct:2
injury ,effect:2
direct ,effect:2
direct ,virus:2
sars-cov-2 ,nonprimate:2
sars-cov-2 ,mammalian:2
sars-cov-2 ,probably:2
replicating ,nonprimate:2
replicating ,mammalian:2
replicating ,cells:2
replicating ,probably:2
replicating ,critical:2
nonprimate ,mammalian:2
nonprimate ,cells:2
nonprimate ,probably:2
nonprimate ,critical:2
mammalian ,cells:2
mammalian ,probably:2
mammalian ,critical:2
cells ,probably:2
probably ,critical:2
microvascular ,changes:2
improved ,early:2
improved ,recognition:2
improved ,coronavirus:2
improved ,disease-2019:2
improved ,single-center:2
early ,recognition:2
early ,disease-2019:2
early ,single-center:2
recognition ,disease-2019:2
recognition ,single-center:2
coronavirus ,single-center:2
disease-2019 ,single-center:2
true ,number:2
true ,covid-19:2
true ,infections:2
true ,effect:2
true ,sensitivity:2
true ,specificity:2
number ,infections:2
number ,effect:2
number ,sensitivity:2
number ,specificity:2
infections ,effect:2
infections ,sensitivity:2
infections ,specificity:2
effect ,sensitivity:2
effect ,specificity:2
comparison ,whole:2
comparison ,genome:2
comparison ,sequencing:2
comparison ,using:2
comparison ,amplicon-based:2
whole ,amplicon-based:2
genome ,amplicon-based:2
sequencing ,amplicon-based:2
sars-cov-2 ,amplicon-based:2
using ,amplicon-based:2
comparison ,expert:2
comparison ,recommendations:2
comparison ,nutrition:2
expert ,recommendations:2
expert ,clinical:2
expert ,nutrition:2
expert ,hospitalized:2
recommendations ,nutrition:2
recommendations ,hospitalized:2
clinical ,nutrition:2
nutrition ,hospitalized:2
stepping ,infection:2
stepping ,control:2
stepping ,measures:2
stepping ,ophthalmology:2
stepping ,novel:2
stepping ,coronavirus:2
advanced ,analysis:2
advanced ,biosensor:2
advanced ,data:2
advanced ,rbd:2
advanced ,ace2:2
advanced ,interactions:2
analysis ,biosensor:2
analysis ,rbd:2
biosensor ,data:2
biosensor ,rbd:2
biosensor ,ace2:2
biosensor ,interactions:2
data ,rbd:2
data ,interactions:2
rbd ,interactions:2
superspreading ,event:2
superspreading ,infection:2
superspreading ,bar:2
superspreading ,ho:2
superspreading ,chi:2
superspreading ,minh:2
superspreading ,city:2
superspreading ,vietnam:2
event ,sars-cov-2:2
event ,infection:2
event ,bar:2
event ,ho:2
event ,chi:2
event ,minh:2
event ,city:2
event ,vietnam:2
sars-cov-2 ,bar:2
sars-cov-2 ,ho:2
sars-cov-2 ,chi:2
sars-cov-2 ,minh:2
sars-cov-2 ,vietnam:2
infection ,bar:2
infection ,ho:2
infection ,chi:2
infection ,minh:2
infection ,vietnam:2
bar ,ho:2
bar ,chi:2
bar ,minh:2
bar ,city:2
bar ,vietnam:2
ho ,chi:2
ho ,minh:2
ho ,city:2
ho ,vietnam:2
chi ,minh:2
chi ,city:2
chi ,vietnam:2
minh ,city:2
minh ,vietnam:2
city ,vietnam:2
seroconversion ,newly:2
seroconversion ,diagnosed:2
seroconversion ,cases:2
seroconversion ,coronavirus:2
seroconversion ,disease:2
newly ,cases:2
diagnosed ,cases:2
recent ,nucleic:2
recent ,acid-based:2
recent ,diagnostic:4
recent ,tool:2
advances ,nucleic:2
advances ,acid-based:2
advances ,tool:2
nucleic ,acid-based:2
nucleic ,tool:2
acid-based ,diagnostic:2
acid-based ,tool:2
acid-based ,coronavirus:2
diagnostic ,tool:2
characteristics ,asthmatic:2
outcomes ,asthmatic:2
outcomes ,pneumonia:2
asthmatic ,covid-19:2
iscan ,rt-lamp-coupled:2
iscan ,crispr-cas12:2
iscan ,module:2
iscan ,rapid:2
iscan ,sensitive:2
iscan ,detection:2
rt-lamp-coupled ,crispr-cas12:2
rt-lamp-coupled ,module:2
rt-lamp-coupled ,rapid:2
rt-lamp-coupled ,sensitive:2
rt-lamp-coupled ,detection:2
crispr-cas12 ,module:2
crispr-cas12 ,rapid:2
crispr-cas12 ,sensitive:2
crispr-cas12 ,detection:2
module ,rapid:2
module ,sensitive:2
module ,detection:2
application ,artificial:2
application ,intelligence:2
application ,repurposing:2
artificial ,drug:2
intelligence ,drug:2
covid-19 ,ample:2
children ,ample:2
ample ,review:2
corona ,gastroenterologists:2
corona ,perspective:2
virus ,gastroenterologists:2
disease-19 ,pandemic:2
disease-19 ,gastroenterologists:2
smell ,spanish:2
smell ,mild:2
taste ,spanish:2
taste ,mild:2
disorders ,spanish:2
disorders ,mild:2
spanish ,patients:2
spanish ,mild:2
genomic ,sequencing:2
genomic ,eight:2
genomic ,camel-derived:2
genomic ,middle:2
genomic ,east:2
sequencing ,analysis:2
sequencing ,eight:2
sequencing ,camel-derived:2
sequencing ,middle:2
sequencing ,east:2
analysis ,eight:2
analysis ,camel-derived:2
analysis ,middle:2
analysis ,east:2
eight ,camel-derived:2
eight ,middle:2
eight ,east:2
eight ,respiratory:2
camel-derived ,middle:2
camel-derived ,east:2
camel-derived ,respiratory:2
risk ,mechanical:2
risk ,ventilation:2
risk ,10131:2
factors ,mechanical:2
factors ,death:2
factors ,10131:2
factors ,us:2
hospitalization ,mechanical:2
hospitalization ,ventilation:2
hospitalization ,death:2
hospitalization ,among:2
hospitalization ,10131:2
hospitalization ,us:2
mechanical ,death:2
mechanical ,among:2
mechanical ,10131:2
mechanical ,us:2
ventilation ,death:2
ventilation ,among:2
ventilation ,10131:2
ventilation ,us:2
death ,10131:2
death ,us:2
among ,10131:2
10131 ,us:2
holding ,back:2
holding ,development:2
holding ,antiviral:2
holding ,metallodrugs:2
holding ,literature:2
back ,development:2
back ,antiviral:2
back ,metallodrugs:2
back ,literature:2
development ,metallodrugs:2
development ,literature:2
antiviral ,metallodrugs:2
antiviral ,literature:2
metallodrugs ,literature:2
antibody ,hype:2
antibody ,immunological:2
antibody ,reality:2
testing ,hype:2
testing ,immunological:2
testing ,reality:2
hype ,immunological:2
hype ,reality:2
immunological ,reality:2
repurposing ,3cl-protease:2
approved ,3cl-protease:2
drugs ,3cl-protease:2
potential ,3cl-protease:2
inhibitors ,3cl-protease:2
3cl-protease ,sars-cov-2:2
attenuated ,influenza:2
attenuated ,virions:2
attenuated ,expressing:2
attenuated ,sars-cov-2:2
attenuated ,receptor-binding:2
attenuated ,domain:2
influenza ,virions:2
influenza ,expressing:2
influenza ,receptor-binding:2
influenza ,domain:2
virions ,expressing:2
virions ,sars-cov-2:2
virions ,receptor-binding:2
virions ,domain:2
expressing ,receptor-binding:2
expressing ,domain:2
gynecologic ,oncology:2
gynecologic ,time:2
gynecologic ,covid-19:2
gynecologic ,outbreak:2
oncology ,time:2
oncology ,outbreak:2
heme ,oxygenase-1:2
heme ,modulation:2
heme ,potential:2
heme ,therapeutic:2
heme ,target:2
heme ,covid-19:2
oxygenase-1 ,modulation:2
oxygenase-1 ,potential:2
oxygenase-1 ,therapeutic:2
oxygenase-1 ,target:2
oxygenase-1 ,covid-19:2
modulation ,potential:2
modulation ,target:2
thrombosis ,nutrition:2
pneumothorax ,series:2
panic ,narrative:2
panic ,risks:2
pandemic ,risks:2
narrative ,links:2
literature ,risks:2
links ,risks:2
molecular ,inhibition:2
molecular ,ace2:2
molecular ,receptor:2
interaction ,binding:2
inhibition ,binding:2
truncated ,inception:2
truncated ,net:2
truncated ,covid-19:2
truncated ,outbreak:2
truncated ,screening:2
truncated ,using:2
truncated ,chest:2
truncated ,x-rays:2
inception ,net:2
inception ,covid-19:2
inception ,outbreak:2
inception ,screening:2
inception ,using:2
inception ,chest:2
inception ,x-rays:2
net ,covid-19:2
net ,outbreak:2
net ,screening:2
net ,using:2
net ,chest:2
net ,x-rays:2
outbreak ,screening:2
outbreak ,using:2
outbreak ,x-rays:2
screening ,x-rays:2
using ,x-rays:2
saliva ,implications:2
saliva ,transport:2
saliva ,storage:2
implications ,transport:2
implications ,storage:2
specimen ,storage:2
transport ,storage:2
clinical ,major:2
characteristics ,major:2
characteristics ,outbreaks:2
diagnosis ,major:2
diagnosis ,outbreaks:2
treatment ,major:2
treatment ,outbreaks:2
major ,coronavirus:2
major ,outbreaks:2
coronavirus ,outbreaks:2
managing ,close:2
managing ,contacts:2
managing ,confirmed:2
managing ,cases:2
managing ,metropolitan:2
managing ,areas:2
managing ,china:2
close ,confirmed:2
close ,cases:2
close ,metropolitan:2
close ,areas:2
close ,china:2
contacts ,cases:2
contacts ,metropolitan:2
contacts ,areas:2
contacts ,china:2
covid-19 ,metropolitan:2
confirmed ,metropolitan:2
confirmed ,areas:2
cases ,metropolitan:2
cases ,areas:2
metropolitan ,areas:2
metropolitan ,china:2
areas ,china:2
comparative ,effectiveness:2
comparative ,safety:2
comparative ,agents:2
comparative ,patients:4
effectiveness ,safety:2
effectiveness ,antiviral:2
effectiveness ,agents:2
safety ,agents:2
real-time ,transmission:2
real-time ,potential:2
real-time ,singapore:2
real-time ,march:2
monitoring ,transmission:2
monitoring ,potential:2
monitoring ,singapore:2
monitoring ,march:2
potential ,singapore:2
potential ,march:2
singapore ,march:2
french ,regarding:2
french ,precautions:2
french ,tracheostomy:2
french ,post-tracheostomy:2
consensus ,regarding:2
consensus ,precautions:2
consensus ,tracheostomy:2
consensus ,post-tracheostomy:2
regarding ,precautions:2
regarding ,tracheostomy:2
regarding ,post-tracheostomy:2
precautions ,tracheostomy:2
precautions ,post-tracheostomy:2
tracheostomy ,post-tracheostomy:2
developing ,risk:2
developing ,assessment:2
developing ,score:2
developing ,patients:2
developing ,cancer:2
developing ,coronavirus:2
assessment ,score:2
assessment ,cancer:2
score ,cancer:2
score ,coronavirus:2
closing ,serological:2
closing ,diagnostic:2
closing ,testing:2
closing ,value:2
serological ,gap:2
serological ,value:2
gap ,diagnostic:2
gap ,testing:2
gap ,value:2
impact ,unlocking:2
impact ,apex:2
impact ,tertiary:2
covid-19 ,unlocking:2
covid-19 ,apex:2
pandemic ,unlocking:2
pandemic ,apex:2
national ,lockdown:4
national ,unlocking:2
national ,apex:2
national ,tertiary:2
lockdown ,unlocking:2
lockdown ,apex:2
lockdown ,tertiary:2
unlocking ,apex:2
unlocking ,tertiary:2
apex ,tertiary:2
spectrum ,chest:2
spectrum ,computed:2
spectrum ,tomographic:2
spectrum ,disease-19:2
chest ,tomographic:2
chest ,disease-19:2
computed ,disease-19:2
tomographic ,ct:2
tomographic ,disease-19:2
ct ,disease-19:2
smell ,recovery:2
smell ,60-day:2
smell ,objective:2
taste ,recovery:2
taste ,60-day:2
taste ,objective:2
recovery ,60-day:2
recovery ,objective:2
coronavirus ,60-day:2
coronavirus ,objective:2
disease ,60-day:2
disease ,objective:2
patients ,60-day:2
patients ,objective:2
60-day ,objective:2
management ,lymphatic:2
management ,lipoedema:2
patients ,lymphatic:2
patients ,lipoedema:2
lymphatic ,diseases:2
lymphatic ,lipoedema:2
lymphatic ,covid-19:2
diseases ,lipoedema:2
lipoedema ,covid-19:2
potential ,biomarkers:2
potential ,mortality:2
potential ,emergency:2
biomarkers ,predictors:2
biomarkers ,patients:2
biomarkers ,emergency:2
predictors ,emergency:2
mortality ,emergency:2
concerns ,low-resource:2
concerns ,countries:2
concerns ,under-prepared:2
concerns ,intensive:2
concerns ,care:2
concerns ,units:2
low-resource ,countries:2
low-resource ,under-prepared:2
low-resource ,intensive:2
low-resource ,care:2
low-resource ,units:2
countries ,under-prepared:2
countries ,intensive:2
countries ,care:2
countries ,units:2
under-prepared ,intensive:2
under-prepared ,care:2
under-prepared ,units:2
development ,inactivated:2
development ,candidate:2
development ,bbibp-corv:2
development ,protection:2
inactivated ,vaccine:2
inactivated ,candidate:2
inactivated ,bbibp-corv:2
inactivated ,potent:2
inactivated ,protection:2
vaccine ,bbibp-corv:2
vaccine ,potent:2
candidate ,bbibp-corv:2
candidate ,potent:2
candidate ,protection:2
bbibp-corv ,potent:2
bbibp-corv ,protection:2
potent ,protection:2
sars-cov-2-reactive ,interferon--producing:2
sars-cov-2-reactive ,cd8:2
sars-cov-2-reactive ,hospitalized:2
interferon--producing ,cd8:2
interferon--producing ,cells:2
interferon--producing ,patients:2
interferon--producing ,hospitalized:2
cd8 ,hospitalized:2
cells ,hospitalized:2
reverse-transcription ,detection:2
recombinase-aided ,detection:2
acetylcysteine ,treatment:2
acetylcysteine ,suspected:2
acetylcysteine ,remdesivir-associated:2
acetylcysteine ,acute:2
acetylcysteine ,liver:2
treatment ,suspected:2
treatment ,remdesivir-associated:2
suspected ,remdesivir-associated:2
suspected ,liver:2
remdesivir-associated ,acute:2
remdesivir-associated ,liver:2
neuronophagia ,microglial:2
neuronophagia ,nodules:2
neuronophagia ,sars-cov-2:2
neuronophagia ,patient:2
neuronophagia ,cerebellar:2
microglial ,nodules:2
microglial ,sars-cov-2:2
microglial ,patient:2
microglial ,cerebellar:2
nodules ,sars-cov-2:2
nodules ,patient:2
nodules ,cerebellar:2
sars-cov-2 ,cerebellar:2
neurocovid ,pharmacological:2
neurocovid ,recommendations:2
neurocovid ,delirium:2
neurocovid ,associated:2
neurocovid ,covid-19:2
pharmacological ,recommendations:2
pharmacological ,delirium:2
recommendations ,delirium:2
recommendations ,associated:2
delirium ,associated:2
dying ,due:2
dying ,covid-19:2
dying ,cause:2
dying ,death:2
dying ,analysis:2
dying ,hospitalised:2
due ,cause:2
due ,hospitalised:2
cause ,death:2
cause ,hospitalised:2
death ,hospitalised:2
analysis ,hospitalised:2
retrospective ,61:2
retrospective ,children:2
retrospective ,died:2
retrospective ,viral:2
retrospective ,pneumonia:2
analysis ,61:2
analysis ,died:2
61 ,cases:2
61 ,children:2
61 ,died:2
61 ,viral:2
61 ,pneumonia:2
cases ,died:2
children ,died:2
died ,viral:2
died ,pneumonia:2
insights ,fatal:2
insights ,histopathology:2
pathogenesis ,pneumonia:2
pathogenesis ,histopathology:2
fatal ,pneumonia:2
pneumonia ,histopathology:2
standard ,headache:2
standard ,neuralgia:2
standard ,treatments:2
standard ,opinion:2
standard ,spanish:2
headache ,neuralgia:2
headache ,treatments:2
headache ,opinion:2
headache ,spanish:2
neuralgia ,treatments:2
neuralgia ,sars-cov-2:2
neuralgia ,opinion:2
neuralgia ,spanish:2
treatments ,opinion:2
treatments ,spanish:2
opinion ,spanish:2
empiric ,therapeutic:2
empiric ,anticoagulation:2
empiric ,mortality:2
empiric ,critically:2
empiric ,ill:2
empiric ,patients:2
therapeutic ,anticoagulation:2
therapeutic ,mortality:2
anticoagulation ,critically:2
anticoagulation ,ill:2
mortality ,critically:2
mortality ,ill:2
high ,neutrophil-to-lymphocyte:2
high ,ratio:2
high ,progression:2
high ,critical:2
high ,illness:2
neutrophil-to-lymphocyte ,associated:2
neutrophil-to-lymphocyte ,progression:2
ratio ,progression:2
associated ,critical:2
progression ,critical:2
progression ,illness:2
role ,initial:2
role ,x-ray:2
role ,triaging:2
initial ,x-ray:2
initial ,triaging:2
initial ,suspected:2
chest ,triaging:2
x-ray ,triaging:2
x-ray ,suspected:2
triaging ,patients:2
triaging ,suspected:2
triaging ,covid-19:2
psychological ,ophthalmologists-in-training:2
psychological ,practising:2
impact ,ophthalmologists-in-training:2
impact ,practising:2
covid-19 ,ophthalmologists-in-training:2
covid-19 ,practising:2
ophthalmologists-in-training ,practising:2
recommendations ,future:2
recommendations ,university:2
recommendations ,responses:2
recommendations ,first:2
future ,university:2
future ,first:2
university ,responses:2
responses ,first:2
immunoinformatic ,nucleocapsid:2
nucleocapsid ,identification:2
prospects ,mucosal:2
prospects ,vaccine:2
prospects ,shutting:2
prospects ,door:2
mucosal ,vaccine:2
mucosal ,shutting:2
mucosal ,door:2
vaccine ,shutting:2
vaccine ,door:2
shutting ,door:2
shutting ,sars-cov-2:2
immersive ,journey:2
immersive ,molecular:2
immersive ,structure:2
immersive ,sars-cov-2:2
immersive ,virtual:2
immersive ,reality:2
journey ,molecular:2
journey ,structure:2
journey ,virtual:2
journey ,reality:2
molecular ,structure:2
molecular ,reality:2
structure ,virtual:2
structure ,reality:2
virtual ,reality:2
holistic ,way:2
holistic ,tackling:2
holistic ,pandemic:2
holistic ,one:2
holistic ,health:2
holistic ,approach:2
way ,tackling:2
way ,one:2
way ,health:2
way ,approach:2
tackling ,one:2
tackling ,health:2
tackling ,approach:2
pandemic ,one:2
case ,false-negative:2
case ,pharyngeal:2
case ,swab:2
covid-19 ,false-negative:2
patient ,false-negative:2
patient ,pharyngeal:2
patient ,swab:2
false-negative ,sars-cov-2:2
false-negative ,pharyngeal:2
false-negative ,swab:2
sars-cov-2 ,pharyngeal:2
pharyngeal ,swab:2
cardiovascular ,evidence-based:2
manifestations ,evidence-based:2
manifestations ,narrative:2
evidence-based ,narrative:2
evidence-based ,review:2
patient ,referral:2
patient ,typical:2
covid-19 ,referral:2
covid-19 ,typical:2
disease ,referral:2
disease ,typical:2
referral ,hospital:2
referral ,iran:2
referral ,typical:2
referral ,case:2
hospital ,iran:2
hospital ,typical:2
hospital ,case:2
iran ,typical:2
iran ,case:2
typical ,case:2
veno-venous ,covid-19-associated:2
veno-venous ,pediatric:2
extracorporeal ,covid-19-associated:2
extracorporeal ,pediatric:2
membrane ,covid-19-associated:2
membrane ,pediatric:2
oxygenation ,covid-19-associated:2
oxygenation ,pediatric:2
interpretation ,laboratory:2
interpretation ,tests:2
interpretation ,sars-cov-2:2
interpretation ,transmission:2
laboratory ,prevention:2
tests ,prevention:2
tests ,transmission:2
anti-sars-cov-2 ,immune:2
anti-sars-cov-2 ,responses:2
anti-sars-cov-2 ,covid-19:2
anti-sars-cov-2 ,via:2
anti-sars-cov-2 ,molecular:2
anti-sars-cov-2 ,mimicry:2
immune ,mimicry:2
responses ,via:2
responses ,molecular:2
responses ,mimicry:2
covid-19 ,mimicry:2
via ,mimicry:2
alphavirus-derived ,replicon:2
alphavirus-derived ,rna:2
alphavirus-derived ,vaccine:2
alphavirus-derived ,induces:2
alphavirus-derived ,sars-cov-2:2
alphavirus-derived ,neutralizing:2
alphavirus-derived ,antibody:2
replicon ,rna:2
replicon ,vaccine:2
replicon ,induces:2
replicon ,sars-cov-2:2
replicon ,neutralizing:2
replicon ,antibody:2
rna ,neutralizing:2
vaccine ,neutralizing:2
vaccine ,antibody:2
induces ,neutralizing:2
induces ,antibody:2
euglycemic ,diabetic:2
euglycemic ,ketoacidosis:2
euglycemic ,associated:2
euglycemic ,empagliflozin:2
euglycemic ,use:2
euglycemic ,course:2
diabetic ,associated:2
diabetic ,empagliflozin:2
diabetic ,use:2
diabetic ,course:2
ketoacidosis ,associated:2
ketoacidosis ,empagliflozin:2
ketoacidosis ,use:2
ketoacidosis ,course:2
associated ,empagliflozin:2
empagliflozin ,use:2
empagliflozin ,course:2
use ,course:2
towards ,effective:2
towards ,covid19:2
towards ,updates:2
towards ,perspectives:2
towards ,challenges:2
effective ,covid19:2
effective ,updates:2
effective ,perspectives:2
effective ,challenges:2
effective ,review:2
covid19 ,vaccines:2
covid19 ,updates:2
covid19 ,perspectives:2
covid19 ,challenges:2
covid19 ,review:4
vaccines ,updates:2
updates ,perspectives:2
updates ,challenges:2
updates ,review:2
taste ,chemosensory:2
taste ,dysfunctions:2
smell ,chemosensory:2
smell ,dysfunctions:2
chemosensory ,dysfunctions:2
chemosensory ,infection:2
dysfunctions ,infection:2
correlation ,self-reported:2
correlation ,depression:2
immune ,self-reported:2
immune ,depression:2
response ,self-reported:2
response ,depression:2
self-reported ,depression:2
hydroxychloroquine ,current:2
hydroxychloroquine ,state:2
hydroxychloroquine ,knowledge:2
case ,collaborative:2
case ,allied:2
case ,nursing:2
study ,collaborative:2
study ,allied:2
study ,nursing:2
collaborative ,allied:2
collaborative ,health:2
collaborative ,nursing:2
collaborative ,crisis:2
collaborative ,response:2
allied ,health:2
allied ,nursing:2
allied ,crisis:2
allied ,response:2
health ,nursing:2
nursing ,crisis:2
nursing ,response:2
crisis ,response:2
clinical ,indicator:2
clinical ,67:2
characteristics ,indicator:2
characteristics ,67:2
laboratory ,indicator:2
laboratory ,67:2
indicator ,analysis:2
indicator ,67:2
indicator ,covid-19:2
indicator ,pneumonia:2
analysis ,67:2
67 ,covid-19:2
67 ,pneumonia:2
age ,location:2
age ,pathology:2
age ,lactoferrin:2
age ,pneumococcal:2
location ,severity:2
location ,covid-19:2
location ,pathology:2
location ,lactoferrin:2
location ,pneumococcal:2
severity ,pathology:2
severity ,lactoferrin:2
severity ,pneumococcal:2
covid-19 ,pneumococcal:2
pathology ,lactoferrin:2
pathology ,pneumococcal:2
lactoferrin ,pneumococcal:2
ace2 ,enables:2
ace2 ,biochemistry:2
receptor ,enables:2
receptor ,biochemistry:2
enables ,infection:2
enables ,sars-cov-2:2
enables ,biochemistry:2
enables ,structure:2
infection ,biochemistry:2
infection ,structure:2
sars-cov-2 ,biochemistry:2
biochemistry ,structure:2
role ,rates:2
environmental ,rates:2
factors ,rates:2
rates ,outbreak:2
sars-cov-2 ,gingival:2
sars-cov-2 ,crevicular:2
detection ,gingival:2
detection ,crevicular:2
detection ,fluid:4
gingival ,crevicular:2
gingival ,fluid:2
crevicular ,fluid:2
cardiac ,imaging:4
cardiac ,procedures:2
imaging ,procedures:2
imaging ,pandemic:2
imaging ,recommendations:2
type ,astrocytes:2
type ,microglia:2
type ,induce:2
type ,cytokine:2
type ,encephalitic:2
type ,murine:2
astrocytes ,microglia:2
astrocytes ,induce:2
astrocytes ,cytokine:2
astrocytes ,response:2
astrocytes ,encephalitic:2
astrocytes ,murine:2
microglia ,induce:2
microglia ,cytokine:2
microglia ,response:2
microglia ,encephalitic:2
microglia ,murine:2
induce ,cytokine:2
induce ,response:2
induce ,encephalitic:2
induce ,murine:2
cytokine ,encephalitic:2
cytokine ,murine:2
response ,encephalitic:2
response ,murine:2
encephalitic ,murine:2
phosphodiesterase ,inhibitors:2
phosphodiesterase ,beneficial:2
phosphodiesterase ,treatment:2
inhibitors ,beneficial:2
beneficial ,treatment:2
dermatological ,therapies:2
dermatological ,relevance:2
therapies ,relevance:2
face ,technical:2
face ,technological:2
face ,functional:2
face ,characteristics:2
masks ,technical:2
masks ,technological:2
masks ,functional:2
masks ,characteristics:2
technical ,technological:2
technical ,functional:2
technical ,characteristics:2
technological ,functional:2
technological ,characteristics:2
environmental ,isolation:2
environmental ,rooms:2
contamination ,rooms:2
rooms ,covid-19:2
rooms ,patients:2
rooms ,severe:2
silent ,hypoxia:2
silent ,patients:2
silent ,sars:2
silent ,cov-2:2
silent ,infection:2
silent ,hospital:2
silent ,discharge:2
hypoxia ,patients:2
hypoxia ,sars:2
hypoxia ,cov-2:2
hypoxia ,infection:2
hypoxia ,hospital:2
hypoxia ,discharge:2
sars ,hospital:2
sars ,discharge:2
cov-2 ,hospital:2
cov-2 ,discharge:2
hospital ,discharge:2
biochemical ,common:2
biochemical ,type:2
biochemical ,critical:2
analysis ,critical:2
common ,type:2
common ,critical:2
common ,clinical:2
type ,clinical:2
tracheostomy ,guidelines:2
tracheostomy ,developed:2
tracheostomy ,large:2
tracheostomy ,academic:2
tracheostomy ,medical:2
tracheostomy ,center:2
guidelines ,developed:2
guidelines ,large:2
guidelines ,academic:2
guidelines ,medical:2
guidelines ,center:2
developed ,large:2
developed ,academic:2
developed ,medical:2
developed ,center:2
large ,medical:2
large ,center:2
academic ,medical:4
academic ,center:4
remote ,oxygen:2
remote ,saturation:2
remote ,individuals:2
remote ,pneumonia:2
monitoring ,oxygen:2
monitoring ,saturation:2
monitoring ,individuals:2
monitoring ,pneumonia:2
oxygen ,individuals:2
oxygen ,pneumonia:2
saturation ,individuals:2
saturation ,pneumonia:2
individuals ,pneumonia:2
clotting ,severe:2
clotting ,acute:2
clotting ,syndrome:2
clotting ,coronavirus:2
disorder ,severe:2
disorder ,acute:2
disorder ,syndrome:2
disorder ,coronavirus:2
covid ,19-:2
covid ,clinical:2
covid ,profile:2
covid ,radiological:2
covid ,presentation:2
covid ,prognostic:2
covid ,predictors:2
19- ,clinical:2
19- ,profile:2
19- ,radiological:2
19- ,presentation:2
19- ,prognostic:2
19- ,predictors:2
clinical ,prognostic:2
profile ,radiological:2
profile ,presentation:2
profile ,prognostic:2
profile ,predictors:2
radiological ,presentation:2
radiological ,prognostic:2
radiological ,predictors:2
presentation ,prognostic:2
presentation ,predictors:2
prognostic ,predictors:2
immune ,cancer:2
system ,insight:2
insight ,cancer:2
insight ,patients:2
encephalitis ,virus:2
encephalitis ,case:2
encephalitis ,report:2
early ,dynamics:2
early ,control:2
dynamics ,control:2
dynamics ,mathematical:2
dynamics ,modelling:2
transmission ,modelling:2
control ,mathematical:2
control ,modelling:2
association ,modulation:2
vitamin ,modulation:2
modulation ,severity:2
considerations ,otolaryngologist:2
considerations ,review:2
otolaryngologist ,era:2
era ,review:2
case ,devastating:2
case ,intracranial:2
case ,hemorrhage:2
case ,venovenous:2
series ,devastating:2
series ,intracranial:2
series ,hemorrhage:2
series ,venovenous:2
devastating ,intracranial:2
devastating ,venovenous:2
intracranial ,hemorrhage:2
intracranial ,venovenous:2
hemorrhage ,venovenous:2
pathological ,spleen:2
pathological ,ten:2
changes ,spleen:2
changes ,ten:2
spleen ,ten:2
spleen ,patients:2
spleen ,coronavirus:2
spleen ,disease:2
ten ,patients:2
ten ,coronavirus:2
four ,paediatric:2
four ,malaysia:2
paediatric ,cases:2
paediatric ,malaysia:2
cases ,malaysia:2
ct ,2019-ncov:2
imaging ,2019-ncov:2
il-1 ,induces:2
il-1 ,throboxane-a2:2
il-1 ,txa2:2
il-1 ,covid-19:2
il-1 ,causing:2
induces ,throboxane-a2:2
induces ,txa2:2
induces ,causing:2
induces ,inflammation:2
throboxane-a2 ,txa2:2
throboxane-a2 ,covid-19:2
throboxane-a2 ,causing:2
throboxane-a2 ,inflammation:2
txa2 ,covid-19:2
txa2 ,causing:2
txa2 ,inflammation:2
causing ,inflammation:2
supporting ,pandemic:2
supporting ,response:2
supporting ,genomics:2
supporting ,bioinformatics:2
supporting ,case:2
supporting ,study:2
pandemic ,genomics:2
pandemic ,bioinformatics:2
response ,using:2
response ,genomics:2
response ,bioinformatics:2
using ,genomics:2
using ,bioinformatics:2
genomics ,bioinformatics:2
genomics ,case:2
genomics ,study:2
bioinformatics ,case:2
bioinformatics ,study:2
lockdown ,unity:2
lockdown ,solidarity:2
lockdown ,simplified:2
lockdown ,arithmetic:2
lockdown ,tools:2
national ,unity:2
national ,solidarity:2
national ,simplified:2
national ,arithmetic:2
national ,tools:2
unity ,global:2
unity ,solidarity:2
unity ,simplified:2
unity ,arithmetic:2
unity ,tools:2
global ,solidarity:2
global ,simplified:2
global ,arithmetic:2
global ,tools:2
solidarity ,simplified:2
solidarity ,arithmetic:2
solidarity ,tools:2
simplified ,arithmetic:2
simplified ,tools:2
arithmetic ,tools:2
ct ,score:2
ct ,severity:2
score ,correlation:2
score ,disease:2
kawasaki ,influence:2
kawasaki ,infections:2
kawasaki-like ,influence:2
kawasaki-like ,infections:2
influence ,infections:2
deep ,alternative:2
deep ,diagnostic:2
deep ,specimen:2
deep ,type:2
throat ,alternative:2
throat ,diagnostic:2
throat ,specimen:2
throat ,type:2
saliva ,type:2
alternative ,diagnostic:2
alternative ,specimen:2
alternative ,type:2
diagnostic ,type:2
specimen ,type:2
type ,detection:2
haemoptysis ,treated:2
haemoptysis ,bronchial:2
haemoptysis ,artery:2
haemoptysis ,embolisation:2
haemoptysis ,severe:2
haemoptysis ,acute:2
haemoptysis ,respiratory:2
treated ,bronchial:2
treated ,artery:2
treated ,embolisation:2
treated ,respiratory:2
bronchial ,embolisation:2
bronchial ,severe:2
bronchial ,acute:2
bronchial ,respiratory:2
artery ,embolisation:2
artery ,severe:2
embolisation ,severe:2
embolisation ,acute:2
embolisation ,respiratory:2
impact ,related:6
impact ,ophthalmology:4
impact ,training:4
impact ,programs:4
covid-19 ,programs:4
related ,ophthalmology:4
related ,training:4
related ,programs:4
related ,india:4
lockdown ,ophthalmology:4
lockdown ,training:4
lockdown ,programs:4
ophthalmology ,training:4
ophthalmology ,programs:4
ophthalmology ,india:4
training ,programs:4
training ,india:4
programs ,india:4
covid-19 ,10-day:2
covid-19 ,motorcycle:2
covid-19 ,rally:2
covid-19 ,neighboring:2
outbreak ,10-day:2
outbreak ,motorcycle:2
outbreak ,rally:2
outbreak ,neighboring:2
outbreak ,state:4
associated ,10-day:2
associated ,motorcycle:2
associated ,rally:2
associated ,neighboring:2
associated ,state:2
10-day ,motorcycle:2
10-day ,rally:2
10-day ,neighboring:2
10-day ,state:2
motorcycle ,rally:2
motorcycle ,neighboring:2
motorcycle ,state:2
rally ,neighboring:2
rally ,state:2
neighboring ,state:2
cytokine ,come:2
cytokine ,wont:2
storm ,come:2
storm ,wont:2
covid-19 ,come:2
covid-19 ,wont:2
come ,wont:2
management ,low:2
management ,prevalence:2
management ,region:2
suspected ,low:2
suspected ,prevalence:2
suspected ,region:2
patients ,region:2
low ,region:2
prevalence ,region:2
interim ,preparticipation:2
interim ,physical:2
interim ,examination:2
interim ,athletes:2
guidance ,preparticipation:2
guidance ,physical:2
guidance ,examination:2
guidance ,athletes:2
preparticipation ,physical:2
preparticipation ,examination:2
preparticipation ,athletes:2
physical ,athletes:2
examination ,athletes:2
antithrombotic ,therapies:2
antithrombotic ,disease:2
antithrombotic ,systematic:2
antithrombotic ,review:2
multi-stage ,virtual:2
multi-stage ,fda-approved:2
multi-stage ,drugs:2
multi-stage ,reveals:2
multi-stage ,potential:2
multi-stage ,inhibitors:2
virtual ,fda-approved:2
screening ,fda-approved:2
fda-approved ,reveals:2
fda-approved ,potential:2
fda-approved ,inhibitors:2
position ,preparation:2
position ,plasma:2
position ,used:2
paper ,preparation:2
paper ,immune:2
paper ,plasma:2
paper ,used:2
preparation ,immune:2
preparation ,plasma:2
preparation ,used:2
preparation ,treatment:2
immune ,plasma:2
immune ,treatment:4
plasma ,used:2
differentiation ,pneumonitis:2
differentiation ,ici:2
differentiation ,induced:2
covid-19 ,ici:2
pneumonitis ,ici:2
pneumonitis ,induced:2
ici ,induced:2
global ,incidence:2
global ,mortality:2
global ,rate:2
global ,special:2
global ,focus:2
global ,iran:2
global ,italy:2
incidence ,rate:2
incidence ,special:2
incidence ,focus:2
incidence ,iran:2
mortality ,special:2
mortality ,focus:2
mortality ,iran:2
rate ,special:2
rate ,focus:2
rate ,iran:2
rate ,italy:2
special ,iran:2
special ,italy:2
focus ,iran:2
focus ,italy:2
iran ,italy:2
genetic ,real-time:2
genetic ,reverse:2
analysis ,real-time:2
analysis ,reverse:2
pandemic ,real-time:2
pandemic ,reverse:2
hydroxychloroquine ,non-human:2
hydroxychloroquine ,primates:2
use ,non-human:2
use ,primates:2
sars-cov-2 ,primates:2
infection ,non-human:2
infection ,primates:2
non-human ,primates:2
virus ,expression:2
virus ,mechanisms:2
liver ,expression:2
liver ,host:2
liver ,receptors:2
liver ,putative:2
liver ,mechanisms:2
expression ,putative:2
expression ,mechanisms:2
host ,putative:2
host ,mechanisms:2
receptors ,putative:2
receptors ,mechanisms:2
putative ,mechanisms:2
icmr ,bulletin:2
icmr ,targeted:2
icmr ,hydroxychloroquine:2
icmr ,prophylaxis:2
icmr ,covid-19:2
icmr ,need:2
bulletin ,targeted:2
bulletin ,hydroxychloroquine:2
bulletin ,prophylaxis:2
bulletin ,covid-19:2
bulletin ,need:2
targeted ,hydroxychloroquine:2
targeted ,prophylaxis:2
targeted ,need:2
hydroxychloroquine ,need:2
prophylaxis ,need:2
pregnant ,susceptible:2
pregnant ,immunological:2
pregnant ,viewpoint:2
women ,susceptible:2
women ,immunological:2
women ,viewpoint:2
susceptible ,covid-19:2
susceptible ,immunological:2
susceptible ,viewpoint:2
immunological ,viewpoint:2
saliva ,pooling:2
pooling ,detection:4
comparison ,microbiological:2
comparison ,diagnoses:2
comparison ,older:2
comparison ,adults:2
clinical ,diagnoses:2
microbiological ,diagnoses:2
microbiological ,older:2
microbiological ,adults:2
diagnoses ,older:2
diagnoses ,adults:2
cadaveric ,simulation:2
cadaveric ,endoscopic:2
cadaveric ,endonasal:2
cadaveric ,procedures:2
cadaveric ,analysis:2
cadaveric ,droplet:2
simulation ,endoscopic:2
simulation ,endonasal:2
simulation ,procedures:2
simulation ,droplet:2
endoscopic ,procedures:2
endoscopic ,droplet:2
endonasal ,procedures:2
endonasal ,analysis:2
endonasal ,droplet:2
procedures ,analysis:2
procedures ,droplet:2
analysis ,droplet:2
vitamin ,prophylaxis:2
vitamin ,adjunctive:2
vitamin ,medical:2
prophylaxis ,adjunctive:2
prophylaxis ,medical:2
adjunctive ,medical:2
estimation ,real-time:2
estimation ,reverse:2
estimation ,transcription:2
diagnostic ,real-time:2
diagnostic ,reverse:2
diagnostic ,transcription:2
accuracy ,real-time:2
accuracy ,reverse:2
accuracy ,transcription:2
gordian ,knot:2
gordian ,gastrointestinal:2
gordian ,lesions:2
gordian ,caused:2
gordian ,three:2
gordian ,highly:2
gordian ,pathogenic:2
knot ,gastrointestinal:2
knot ,lesions:2
knot ,caused:2
knot ,three:2
knot ,highly:2
knot ,pathogenic:2
gastrointestinal ,lesions:2
gastrointestinal ,caused:2
gastrointestinal ,three:2
gastrointestinal ,highly:2
lesions ,caused:2
lesions ,three:2
lesions ,highly:2
lesions ,pathogenic:2
caused ,three:2
caused ,pathogenic:2
three ,highly:2
three ,pathogenic:2
immunomodulation ,severe:2
immunomodulation ,covid-19:2
immunomodulation ,pneumonia:2
immunomodulation ,state:2
immunomodulation ,art:2
severe ,art:2
pneumonia ,art:2
assessing ,spreading:2
assessing ,potential:2
assessing ,undetected:2
assessing ,orthopaedic:2
spreading ,undetected:2
spreading ,case:2
spreading ,orthopaedic:2
potential ,undetected:2
potential ,orthopaedic:2
undetected ,case:2
undetected ,covid-19:2
undetected ,orthopaedic:2
case ,orthopaedic:2
health ,models:2
policy ,leadership:2
policy ,models:2
policy ,pandemic:2
policy ,review:2
leadership ,models:2
leadership ,review:2
delivering ,urgent:2
delivering ,urological:2
delivering ,surgery:2
delivering ,covid-19:2
delivering ,pandemic:2
delivering ,uk:2
urgent ,urological:2
urgent ,surgery:2
urgent ,uk:2
urological ,pandemic:2
urological ,uk:2
surgery ,uk:2
covid-19 ,uk:2
pandemic ,uk:2
self-removing ,passive:2
self-removing ,drain:2
self-removing ,facilitate:2
self-removing ,postoperative:2
self-removing ,care:2
self-removing ,via:2
self-removing ,telehealth:2
passive ,drain:2
passive ,facilitate:2
passive ,postoperative:2
passive ,care:2
passive ,via:2
passive ,telehealth:2
drain ,facilitate:2
drain ,postoperative:2
drain ,care:2
drain ,via:2
drain ,telehealth:2
facilitate ,postoperative:2
facilitate ,care:2
facilitate ,via:2
facilitate ,telehealth:2
postoperative ,care:2
postoperative ,via:2
postoperative ,telehealth:2
care ,via:2
care ,telehealth:2
via ,telehealth:2
successful ,first:2
successful ,reported:2
successful ,austria:2
successful ,ards:2
management ,reported:2
management ,austria:2
management ,ards:2
first ,austria:2
first ,ards:2
reported ,austria:2
reported ,ards:2
case ,austria:2
austria ,ards:2
longitudinal ,lymphocyte:2
longitudinal ,cytokine:2
longitudinal ,profiles:2
characteristics ,cytokine:2
characteristics ,profiles:2
lymphocyte ,responses:2
lymphocyte ,profiles:2
responses ,profiles:2
cytokine ,profiles:4
sars-cov-2 ,s1:2
sars-cov-2 ,n-based:2
s1 ,n-based:2
s1 ,serological:2
s1 ,assays:2
s1 ,reveal:2
s1 ,rapid:2
s1 ,seroconversion:2
n-based ,serological:2
n-based ,assays:2
n-based ,reveal:2
n-based ,rapid:2
n-based ,seroconversion:2
serological ,reveal:2
assays ,reveal:2
reveal ,rapid:2
reveal ,seroconversion:2
rapid ,seroconversion:2
dynamic ,treatment:4
first ,defense:2
first ,masks:2
line ,defense:2
line ,masks:2
line ,clinical:2
line ,practice:2
defense ,masks:2
defense ,clinical:2
defense ,practice:2
masks ,clinical:2
masks ,practice:2
novel ,in-cell:2
novel ,elisa:2
novel ,allows:2
novel ,automated:2
novel ,quantification:2
in-cell ,elisa:2
in-cell ,assay:2
in-cell ,allows:2
in-cell ,rapid:2
in-cell ,automated:2
in-cell ,quantification:2
in-cell ,sars-cov-2:2
elisa ,allows:2
elisa ,rapid:2
elisa ,quantification:2
assay ,allows:2
allows ,rapid:2
allows ,automated:2
allows ,quantification:2
allows ,sars-cov-2:2
automated ,quantification:2
renal ,critically:2
renal ,ill:2
renal ,focus:2
failure ,critically:2
failure ,ill:2
failure ,focus:2
critically ,focus:2
critically ,role:2
ill ,focus:2
ill ,role:2
implementation ,science:2
implementation ,times:2
sars-cov-2 ,suppresses:2
sars-cov-2 ,translation:2
sars-cov-2 ,bipartite:2
nsp1 ,suppresses:2
nsp1 ,translation:2
nsp1 ,bipartite:2
suppresses ,host:2
suppresses ,viral:2
suppresses ,translation:2
suppresses ,bipartite:2
host ,translation:2
host ,bipartite:2
viral ,translation:2
viral ,bipartite:2
translation ,bipartite:2
convergence ,global:2
convergence ,bcg:2
convergence ,vaccination:2
convergence ,covid-19:2
convergence ,pandemic:2
global ,bcg:2
inflammatory ,endotypes:2
inflammatory ,crswnp:2
endotypes ,crswnp:2
endotypes ,responses:2
endotypes ,covid-19:2
crswnp ,responses:2
crswnp ,covid-19:2
molecular ,reactivity:2
docking ,simulations:2
docking ,reactivity:2
dynamics ,reactivity:2
dynamics ,studies:2
simulations ,reactivity:2
simulations ,studies:2
reactivity ,studies:2
autoimmune ,musculoskeletal:2
autoimmune ,consequence:2
rheumatic ,musculoskeletal:2
rheumatic ,consequence:2
musculoskeletal ,diseases:2
musculoskeletal ,consequence:2
musculoskeletal ,sars-cov-2:2
diseases ,consequence:2
consequence ,sars-cov-2:2
challenges ,sexual:2
challenges ,time:2
challenges ,united:2
practice ,sexual:2
practice ,time:2
practice ,united:2
sexual ,medicine:2
sexual ,time:2
sexual ,united:2
medicine ,time:2
medicine ,united:2
multidisciplinary ,three-dimensional:2
multidisciplinary ,individualized:2
multidisciplinary ,comprehensive:2
three-dimensional ,individualized:2
three-dimensional ,comprehensive:2
three-dimensional ,treatment:2
individualized ,comprehensive:2
individualized ,treatment:2
coronavirus ,cardiologists-:2
disease ,cardiologists-:2
covid-19 ,cardiologists-:2
information ,cardiologists-:2
information ,systematic:2
cardiologists- ,systematic:2
hospital ,biosecurity:2
hospital ,capacitation:2
hospital ,recommendations:2
hospital ,prevention:2
biosecurity ,capacitation:2
biosecurity ,analysis:2
biosecurity ,recommendations:2
biosecurity ,prevention:2
capacitation ,analysis:2
capacitation ,recommendations:2
capacitation ,prevention:2
reporting ,d-dimer:2
reporting ,data:2
reporting ,confusion:2
reporting ,potential:2
d-dimer ,data:2
d-dimer ,confusion:2
d-dimer ,potential:2
data ,confusion:2
data ,potential:2
covid-19 ,confusion:2
confusion ,potential:2
long-term ,neurological:2
long-term ,sequelae:2
respiratory ,sequelae:2
neurological ,sequelae:2
remdesivir ,beacon:2
remdesivir ,virus:2
beacon ,hope:2
beacon ,ebola:2
beacon ,virus:2
beacon ,disease:2
beacon ,covid-19:2
hope ,ebola:2
hope ,virus:2
hope ,disease:2
ebola ,virus:2
ebola ,disease:2
sars-cov-2-related ,can:2
sars-cov-2-related ,successfully:2
sars-cov-2-related ,managed:2
sars-cov-2-related ,patients:2
sars-cov-2-related ,metastatic:2
pneumonia ,can:2
pneumonia ,successfully:2
pneumonia ,managed:2
pneumonia ,metastatic:2
can ,managed:2
can ,metastatic:2
successfully ,managed:2
successfully ,patients:2
successfully ,metastatic:2
managed ,patients:2
managed ,metastatic:2
cardiac ,workup:2
cardiac ,monitoring:2
cardiac ,hospitalised:2
cardiac ,covid-:2
cardiac ,19:2
workup ,monitoring:2
workup ,hospitalised:2
workup ,children:2
workup ,covid-:2
workup ,19:2
monitoring ,hospitalised:2
monitoring ,children:2
monitoring ,covid-:2
monitoring ,19:2
hospitalised ,children:2
hospitalised ,covid-:2
hospitalised ,19:2
children ,covid-:2
three ,presenting:2
three ,erythema:2
cases ,presenting:2
cases ,erythema:2
patients ,erythema:2
presenting ,erythema:2
packed ,red:2
packed ,blood:2
packed ,cell:2
packed ,transfusion:2
packed ,potential:2
packed ,treatment:2
packed ,option:2
packed ,covid-19:2
red ,transfusion:2
red ,potential:2
red ,treatment:2
red ,option:2
blood ,treatment:2
blood ,option:2
cell ,transfusion:2
cell ,option:2
transfusion ,potential:2
transfusion ,option:2
treatment ,option:2
response ,preventive:2
response ,iraqi:2
response ,kurdistan:2
public ,preventive:2
public ,iraqi:2
public ,kurdistan:2
preventive ,iraqi:2
preventive ,kurdistan:2
measures ,iraqi:2
measures ,kurdistan:2
covid-19 ,iraqi:2
covid-19 ,kurdistan:2
iraqi ,kurdistan:2
viral ,korean:2
load ,korean:2
kinetics ,saliva:2
kinetics ,korean:2
sars-cov-2 ,korean:2
infection ,saliva:2
infection ,korean:2
saliva ,korean:2
korean ,patients:2
characterization ,neutralizing:2
characterization ,prophylactic:2
characterization ,efficacy:2
neutralizing ,prophylactic:2
neutralizing ,efficacy:2
antibody ,prophylactic:2
antibody ,efficacy:2
prophylactic ,efficacy:2
covid-19 ,great:2
covid-19 ,mime:2
covid-19 ,trigger:2
covid-19 ,event:2
great ,mime:2
great ,trigger:2
great ,event:2
great ,autoimmune:2
great ,manifestations:2
mime ,trigger:2
mime ,event:2
mime ,autoimmune:2
mime ,manifestations:2
trigger ,event:2
trigger ,autoimmune:2
trigger ,manifestations:2
event ,autoimmune:2
event ,manifestations:2
autoimmune ,manifestations:2
evolutionary ,portrait:2
evolutionary ,progenitor:2
evolutionary ,dominant:2
evolutionary ,offshoots:2
portrait ,progenitor:2
portrait ,sars-cov-2:2
portrait ,dominant:2
portrait ,offshoots:2
progenitor ,sars-cov-2:2
progenitor ,dominant:2
progenitor ,offshoots:2
sars-cov-2 ,dominant:2
sars-cov-2 ,offshoots:2
dominant ,offshoots:2
discovery ,development:2
diagnostics ,drug:2
epidemiologic ,10:2
epidemiologic ,disease:2
clinical ,10:2
characteristics ,10:2
10 ,children:2
10 ,coronavirus:2
10 ,disease:2
coronavirus ,attending:2
coronavirus ,antenatal:2
testing ,attending:2
testing ,antenatal:2
women ,attending:2
attending ,antenatal:2
attending ,care:2
docked ,severe:2
docked ,acute:2
docked ,respiratory:2
docked ,syndrome:2
docked ,coronavirus:2
docked ,proteins:2
docked ,within:2
docked ,cutaneous:2
severe ,within:2
severe ,cutaneous:2
acute ,within:2
acute ,cutaneous:2
respiratory ,within:2
respiratory ,cutaneous:2
syndrome ,within:2
syndrome ,cutaneous:2
proteins ,within:2
proteins ,cutaneous:2
within ,cutaneous:2
infection ,proposal:2
pregnancy ,proposal:2
information ,proposal:2
information ,management:2
proposal ,management:2
proposal ,care:2
continuous ,positive:2
continuous ,airway:2
continuous ,pressure:2
continuous ,avoid:2
continuous ,intubation:2
continuous ,pneumonia:2
positive ,airway:2
positive ,pressure:2
positive ,intubation:2
airway ,pressure:2
airway ,avoid:2
airway ,intubation:2
airway ,pneumonia:2
pressure ,avoid:2
pressure ,intubation:2
pressure ,sars-cov-2:2
pressure ,pneumonia:2
avoid ,intubation:2
avoid ,sars-cov-2:4
avoid ,pneumonia:2
intubation ,sars-cov-2:2
intubation ,pneumonia:2
society ,robotic:2
society ,regarding:2
society ,risk:2
robotic ,review:2
robotic ,recommendations:2
robotic ,regarding:2
robotic ,risk:2
surgery ,review:2
surgery ,regarding:2
surgery ,risk:2
review ,regarding:2
recommendations ,regarding:2
association ,profiles:2
association ,lung:2
association ,pneumonia:4
cytokine ,injury:2
profiles ,lung:2
profiles ,injury:2
injury ,pneumonia:2
transmission ,required:2
transmission ,developments:2
transmission ,research:2
sars-cov-2 ,required:2
sars-cov-2 ,developments:2
required ,developments:2
required ,research:2
required ,associated:2
developments ,research:2
developments ,associated:2
developments ,public:2
research ,associated:2
associated ,public:2
case ,military:2
case ,recruit:2
case ,school:2
series ,military:2
series ,recruit:2
series ,school:2
coronavirus ,military:2
coronavirus ,recruit:2
coronavirus ,school:2
sars-cov-2 ,recruit:2
sars-cov-2 ,school:2
military ,recruit:2
military ,school:2
military ,clinical:2
recruit ,school:2
recruit ,clinical:2
school ,clinical:2
epidemiological ,chronicle:2
epidemiological ,recovered:2
chronicle ,first:2
chronicle ,recovered:2
chronicle ,coronavirus:2
chronicle ,disease:2
chronicle ,patient:2
first ,recovered:2
recovered ,disease:2
persistence ,clearance:2
persistence ,disease:2
clearance ,rna:2
clearance ,novel:2
inactivating ,three:2
inactivating ,interferon:2
inactivating ,antagonists:2
inactivating ,attenuates:2
inactivating ,pathogenesis:2
inactivating ,enteric:2
three ,interferon:2
three ,antagonists:2
three ,attenuates:2
three ,pathogenesis:2
three ,enteric:2
interferon ,antagonists:2
interferon ,attenuates:2
interferon ,pathogenesis:2
interferon ,enteric:2
antagonists ,attenuates:2
antagonists ,pathogenesis:2
antagonists ,enteric:2
attenuates ,pathogenesis:2
attenuates ,enteric:2
pathogenesis ,enteric:2
dynamics ,anti-sars-cov-2:2
dynamics ,antibodies:2
dynamics ,positive:2
viral ,anti-sars-cov-2:2
viral ,antibodies:2
load ,anti-sars-cov-2:2
load ,antibodies:2
load ,positive:2
anti-sars-cov-2 ,positive:2
antibodies ,positive:2
intensive ,palliative:2
intensive ,time:2
care ,palliative:4
palliative ,time:2
palliative ,covid-19:4
investigations ,sars-cov-2:2
approaching ,otolaryngology:2
approaching ,patients:2
approaching ,pandemic:2
involvement ,spike:2
involvement ,protein:2
involvement ,furin:2
involvement ,ace2:4
involvement ,sars-cov-2-related:2
involvement ,cardiovascular:2
spike ,furin:2
spike ,sars-cov-2-related:2
spike ,cardiovascular:2
protein ,furin:2
protein ,sars-cov-2-related:2
protein ,cardiovascular:2
furin ,ace2:2
furin ,sars-cov-2-related:2
furin ,cardiovascular:2
ace2 ,sars-cov-2-related:2
sars-cov-2-related ,cardiovascular:2
insights ,neuroimaging:2
insights ,findings:2
insights ,patients:2
neuroimaging ,findings:2
neuroimaging ,coronavirus:2
covid-19 ,nicotine:2
smoking ,nicotine:2
smoking ,hidden:2
smoking ,link:2
nicotine ,hidden:2
nicotine ,link:2
hidden ,link:2
comparing ,two:2
comparing ,sample:2
comparing ,pooling:2
comparing ,strategies:2
comparing ,rna:2
comparing ,detection:2
comparing ,efficient:2
two ,pooling:2
two ,strategies:2
two ,efficient:2
sample ,strategies:2
sample ,efficient:2
pooling ,strategies:2
pooling ,efficient:2
strategies ,rna:2
strategies ,efficient:2
airborne ,dispersion:2
airborne ,lung:2
airborne ,deposition:2
transmission ,dispersion:2
transmission ,lung:2
transmission ,deposition:2
aerosol ,dispersion:2
aerosol ,lung:2
aerosol ,deposition:2
dispersion ,lung:2
dispersion ,deposition:2
lung ,deposition:2
patients ,sustained:2
patients ,lopinavir-combined:2
patients ,regimen:2
covid-19 ,sustained:2
covid-19 ,lopinavir-combined:2
covid-19 ,regimen:2
may ,benefit:2
may ,sustained:2
may ,lopinavir-combined:2
may ,regimen:2
benefit ,sustained:2
benefit ,lopinavir-combined:2
benefit ,regimen:2
sustained ,lopinavir-combined:2
sustained ,regimen:2
lopinavir-combined ,regimen:2
novel ,symptoms:2
novel ,persistent:2
novel ,hypertension:2
case ,symptoms:2
case ,hypertension:2
severe ,symptoms:2
symptoms ,persistent:2
symptoms ,pulmonary:2
symptoms ,hypertension:2
persistent ,pulmonary:2
persistent ,hypertension:2
pulmonary ,hypertension:2
immunopathological ,similarities:2
immunopathological ,influenza:2
immunopathological ,investigating:2
similarities ,influenza:2
similarities ,investigating:2
covid-19 ,investigating:2
influenza ,investigating:2
sars-cov-2 ,skin:4
skin ,immunology:2
skin ,know:2
skin ,far:2
immunology ,know:2
immunology ,far:2
elective ,sars-cov-2covid-19:2
elective ,safety:2
elective ,protocols:2
surgery ,sars-cov-2covid-19:2
surgery ,safety:2
surgery ,protocols:2
sars-cov-2covid-19 ,pandemic:2
sars-cov-2covid-19 ,safety:2
sars-cov-2covid-19 ,protocols:2
pandemic ,protocols:2
changes ,62:2
changes ,died:2
clinical ,62:2
clinical ,died:2
characteristics ,62:2
characteristics ,died:2
62 ,patients:2
62 ,died:2
62 ,coronavirus:2
patients ,died:2
hesperidin ,sars-cov-2:2
hesperidin ,new:2
hesperidin ,light:2
hesperidin ,healthy:2
hesperidin ,function:2
hesperidin ,citrus:2
hesperidin ,fruits:2
sars-cov-2 ,citrus:2
sars-cov-2 ,fruits:2
new ,light:2
new ,healthy:2
new ,function:2
new ,citrus:2
new ,fruits:2
light ,healthy:2
light ,function:2
light ,citrus:2
light ,fruits:2
healthy ,function:2
healthy ,citrus:2
healthy ,fruits:2
function ,citrus:2
function ,fruits:2
citrus ,fruits:2
vitro ,single:2
vitro ,repurposable:2
evaluation ,antiviral:2
evaluation ,activity:2
evaluation ,single:2
evaluation ,repurposable:2
antiviral ,single:2
antiviral ,combined:2
antiviral ,repurposable:2
activity ,single:2
activity ,combined:2
activity ,repurposable:2
single ,combined:2
single ,repurposable:2
single ,drugs:2
combined ,repurposable:2
combined ,drugs:2
repurposable ,drugs:2
mesenchymal ,immunomodulatory:2
mesenchymal ,players:2
stromal ,potential:2
stromal ,immunomodulatory:2
stromal ,players:2
stromal ,severe:2
stromal ,acute:2
cells ,immunomodulatory:2
cells ,players:2
potential ,players:2
immunomodulatory ,players:2
immunomodulatory ,acute:2
players ,severe:2
players ,acute:2
managing ,clinical:2
managing ,trials:2
managing ,alzheimers:2
managing ,disease:2
managing ,crisis:2
clinical ,alzheimers:2
trials ,alzheimers:2
trials ,crisis:2
alzheimers ,crisis:2
disease ,crisis:2
recurrence ,relapse:2
recurrence ,older:2
recurrence ,description:2
recurrence ,three:2
recurrence ,cases:2
relapse ,older:2
relapse ,patients:2
relapse ,description:2
relapse ,three:2
relapse ,cases:2
older ,description:2
older ,three:2
older ,cases:2
patients ,description:2
description ,three:2
impact ,self-imposed:2
impact ,short-term:2
impact ,government-imposed:2
self-imposed ,prevention:2
self-imposed ,measures:2
self-imposed ,short-term:2
self-imposed ,government-imposed:2
self-imposed ,social:2
prevention ,short-term:2
prevention ,government-imposed:2
prevention ,social:2
measures ,short-term:2
measures ,government-imposed:2
short-term ,government-imposed:2
short-term ,social:2
government-imposed ,social:2
reduced ,rate:2
reduced ,acute:2
reduced ,coronary:2
reduced ,syndromes:2
rate ,admissions:2
rate ,acute:2
rate ,coronary:2
rate ,syndromes:2
admissions ,acute:2
admissions ,coronary:2
admissions ,syndromes:2
progress ,developing:2
progress ,3c-like:2
progress ,protease:2
developing ,inhibitors:2
developing ,3c-like:2
developing ,protease:2
host ,potentially:2
host ,associated:2
host ,multi-population:2
genetic ,potentially:2
genetic ,multi-population:2
variants ,potentially:2
variants ,associated:2
variants ,multi-population:2
potentially ,associated:2
potentially ,multi-population:2
associated ,multi-population:2
sars-cov-2 ,multi-population:2
first ,real-time:2
first ,reverse:2
first ,transcriptase-polymerase:2
first ,chain:2
detection ,transcriptase-polymerase:2
sars-cov-2 ,transcriptase-polymerase:2
real-time ,transcriptase-polymerase:2
reverse ,transcriptase-polymerase:2
transcriptase-polymerase ,chain:2
use ,asthma:2
use ,copd:2
corticosteroids ,copd:2
corticosteroids ,without:2
asthma ,without:2
copd ,without:2
sars-cov-2 ,sperm:2
sars-cov-2 ,cryopreservation:2
infection ,male:2
infection ,fertility:2
infection ,sperm:2
infection ,cryopreservation:2
male ,sperm:2
male ,cryopreservation:2
male ,position:2
fertility ,sperm:2
fertility ,cryopreservation:2
fertility ,position:2
sperm ,cryopreservation:2
sperm ,position:2
cryopreservation ,position:2
sars-cov-2 ,dimension:2
new ,dimension:2
dimension ,understanding:2
dimension ,coronaviruses:2
understanding ,coronaviruses:2
shouldnt ,worry:2
shouldnt ,virus:2
shouldnt ,mutates:2
shouldnt ,disease:2
shouldnt ,outbreaks:2
worry ,virus:2
worry ,mutates:2
worry ,disease:2
worry ,outbreaks:2
virus ,mutates:2
virus ,outbreaks:2
mutates ,disease:2
mutates ,outbreaks:2
structure ,replicating:2
replicating ,polymerase:2
in-silico ,approach:2
in-silico ,develop:2
in-silico ,multi-epitope:2
approach ,develop:2
approach ,multi-epitope:2
develop ,multi-epitope:2
develop ,vaccine:2
develop ,candidate:2
preliminary ,pragmatic:2
preliminary ,lessons:2
preliminary ,pandemic:2
pragmatic ,lessons:2
pragmatic ,france:2
lessons ,france:2
pandemic ,france:2
covid-19-related ,severe:2
covid-19-related ,hypercoagulability:2
covid-19-related ,patients:2
covid-19-related ,admitted:2
covid-19-related ,intensive:2
covid-19-related ,care:2
severe ,hypercoagulability:2
severe ,admitted:2
hypercoagulability ,patients:2
hypercoagulability ,admitted:2
hypercoagulability ,intensive:2
hypercoagulability ,care:2
admitted ,intensive:2
admitted ,care:2
gastrointestinal ,importance:2
gastrointestinal ,reducing:2
endoscopy ,importance:2
endoscopy ,reducing:2
endoscopy ,sars-cov-2:2
importance ,reducing:2
reducing ,infection:2
data ,text:2
data ,identify:2
data ,key:2
data ,proteins:2
data ,involved:2
data ,molecular:2
data ,mechanisms:2
text ,mining:2
text ,help:2
text ,identify:2
text ,key:2
text ,proteins:2
text ,involved:2
text ,molecular:2
text ,mechanisms:2
mining ,help:2
mining ,identify:2
mining ,key:2
mining ,proteins:2
mining ,involved:2
mining ,molecular:2
mining ,mechanisms:2
help ,key:2
help ,proteins:2
help ,involved:2
help ,molecular:2
help ,mechanisms:2
identify ,proteins:2
identify ,involved:2
identify ,molecular:2
identify ,mechanisms:2
key ,involved:2
key ,molecular:2
key ,mechanisms:2
proteins ,involved:2
proteins ,mechanisms:2
involved ,molecular:2
multisystem ,new:2
multisystem ,york:2
multisystem ,city:2
inflammatory ,new:2
inflammatory ,york:2
inflammatory ,city:2
syndrome ,york:2
syndrome ,city:2
children ,york:2
children ,city:2
related ,new:2
related ,york:2
related ,city:2
effects ,storage:2
effects ,mediabuffer:2
effects ,nucleic:2
effects ,acid:2
storage ,temperature:2
storage ,mediabuffer:2
temperature ,mediabuffer:2
temperature ,nucleic:2
temperature ,acid:2
mediabuffer ,sars-cov-2:2
mediabuffer ,nucleic:2
mediabuffer ,acid:2
immune ,checkpoint:2
immune ,inhibitors:2
immune ,physiology-driven:2
checkpoint ,inhibitors:2
checkpoint ,physiology-driven:2
checkpoint ,approach:2
checkpoint ,treatment:2
inhibitors ,physiology-driven:2
physiology-driven ,approach:2
physiology-driven ,treatment:2
potential ,receptors:2
potential ,skin:2
interactions ,cell:2
interactions ,receptors:2
interactions ,skin:2
human ,receptors:2
human ,skin:2
cell ,receptors:2
cell ,skin:2
receptors ,skin:2
epidemiology ,reverse:2
reverse ,transmission:2
reverse ,gansu:2
reverse ,province:2
reverse ,china:2
transmission ,gansu:2
covid-19 ,gansu:2
analysis ,older:2
epidemiological ,older:2
features ,older:2
manifestations ,perinatal:2
manifestations ,pregnant:2
manifestations ,women:2
perinatal ,pregnant:2
perinatal ,women:2
epidemiological ,diagnostic:2
recent ,findings:2
recent ,immunopathogenesis:2
findings ,immunopathogenesis:2
coronavirus ,immunopathogenesis:2
disease ,immunopathogenesis:2
development ,interpretable:2
development ,easily:2
development ,transferable:2
development ,qsar:2
development ,quick:2
simple ,interpretable:2
simple ,easily:2
simple ,transferable:2
simple ,qsar:2
simple ,quick:2
interpretable ,easily:2
interpretable ,transferable:2
interpretable ,qsar:2
interpretable ,model:2
interpretable ,quick:2
easily ,transferable:2
easily ,qsar:2
easily ,model:2
easily ,quick:2
transferable ,qsar:2
transferable ,model:2
transferable ,quick:2
qsar ,model:2
qsar ,quick:2
model ,quick:2
update ,covid-19-associated:2
update ,syndrome:2
update ,children:2
covid-19-associated ,adolescents:2
inflammatory ,adolescents:2
syndrome ,adolescents:2
hypoxia ,response:2
hypoxia ,acute:2
hypoxia ,lung:2
hypoxia ,kidney:2
hypoxia ,injury:2
hypoxia ,possible:2
hypoxia ,implications:2
hypoxia ,therapy:2
response ,lung:2
response ,kidney:2
response ,injury:2
lung ,kidney:2
lung ,implications:2
kidney ,possible:2
injury ,implications:2
injury ,therapy:2
biomimetic ,virus-like:2
biomimetic ,particles:2
biomimetic ,severe:2
biomimetic ,acute:2
biomimetic ,respiratory:2
biomimetic ,syndrome:2
biomimetic ,coronavirus:2
virus-like ,particles:2
virus-like ,severe:2
virus-like ,acute:2
virus-like ,syndrome:2
virus-like ,coronavirus:2
particles ,severe:2
particles ,acute:2
particles ,syndrome:2
particles ,coronavirus:2
combination ,arbidol:2
combination ,interferon-1b:2
antiviral ,interferon-1b:2
therapy ,interferon-1b:2
lopinavirritonavir ,interferon-1b:2
arbidol ,interferon-1b:2
performance ,electrophysiology:2
performance ,procedures:2
performance ,academic:2
performance ,medical:2
performance ,center:2
performance ,amidst:2
electrophysiology ,procedures:2
electrophysiology ,academic:2
electrophysiology ,medical:2
electrophysiology ,center:2
electrophysiology ,amidst:2
procedures ,academic:2
procedures ,medical:2
procedures ,center:2
procedures ,amidst:2
academic ,amidst:2
medical ,amidst:2
center ,amidst:2
risk ,hospitalized:2
risk ,multinational:2
stroke ,hospitalized:2
stroke ,infected:2
stroke ,multinational:2
stroke ,study:2
hospitalized ,infected:2
hospitalized ,multinational:2
hospitalized ,study:2
infected ,multinational:2
patients ,multinational:2
multinational ,study:2
botulinum ,therapy:2
botulinum ,sars-cov-2:2
botulinum ,pandemic:2
botulinum ,patient:2
botulinum ,perceptions:2
toxin ,therapy:2
toxin ,sars-cov-2:2
toxin ,pandemic:2
toxin ,patient:2
toxin ,perceptions:2
therapy ,perceptions:2
sars-cov-2 ,perceptions:2
patient ,perceptions:2
mini-review ,effects:2
mini-review ,younger:2
mini-review ,individuals:2
effects ,younger:2
effects ,individuals:2
younger ,individuals:2
remote ,psychophysical:2
remote ,evaluation:2
remote ,olfactory:2
remote ,gustatory:2
remote ,functions:2
remote ,early-stage:2
psychophysical ,evaluation:2
psychophysical ,olfactory:2
psychophysical ,gustatory:2
psychophysical ,functions:2
psychophysical ,early-stage:2
evaluation ,olfactory:2
evaluation ,gustatory:2
evaluation ,functions:2
evaluation ,early-stage:2
olfactory ,functions:2
olfactory ,early-stage:2
gustatory ,functions:2
gustatory ,early-stage:2
functions ,early-stage:2
silico ,candidate:2
discovery ,candidate:2
cardiac ,arrest:2
cardiac ,drug-related:2
cardiac ,toxicity:2
cardiac ,era:2
arrest ,drug-related:2
arrest ,toxicity:2
arrest ,covid-19:2
arrest ,era:2
arrest ,epidemiology:2
drug-related ,toxicity:2
drug-related ,covid-19:2
drug-related ,era:2
drug-related ,epidemiology:2
toxicity ,covid-19:2
toxicity ,era:2
toxicity ,epidemiology:2
era ,epidemiology:2
screening ,therapeutic:2
screening ,agents:2
screening ,machine:2
screening ,ensemble:2
therapeutic ,using:2
therapeutic ,machine:2
therapeutic ,learning:2
therapeutic ,ensemble:2
agents ,using:2
agents ,machine:2
agents ,learning:2
agents ,ensemble:2
covid-19 ,ensemble:2
using ,ensemble:2
machine ,ensemble:2
learning ,ensemble:2
data ,reagents:2
data ,assays:2
data ,merits:2
data ,testing:2
reagents ,assays:2
reagents ,merits:2
reagents ,proteomics:2
reagents ,sars-cov-2:2
reagents ,research:2
reagents ,testing:2
assays ,merits:2
assays ,proteomics:2
assays ,research:2
merits ,proteomics:2
merits ,sars-cov-2:2
merits ,research:2
merits ,testing:2
proteomics ,testing:2
efficacy ,current:2
efficacy ,options:2
efficacy ,lessons:2
safety ,current:2
safety ,options:2
safety ,lessons:2
current ,lessons:2
therapeutic ,lessons:2
options ,lessons:2
samples ,review:2
samples ,early:2
samples ,literature:2
early ,literature:2
using ,all-atom:2
using ,potentials:2
using ,refine:2
using ,structure:2
using ,stem:2
all-atom ,potentials:2
all-atom ,refine:2
all-atom ,rna:2
all-atom ,structure:2
all-atom ,predictions:2
all-atom ,stem:2
potentials ,refine:2
potentials ,rna:2
potentials ,structure:2
potentials ,predictions:2
potentials ,sars-cov-2:2
potentials ,stem:2
refine ,rna:2
refine ,structure:2
refine ,predictions:2
refine ,sars-cov-2:2
refine ,stem:2
rna ,predictions:2
rna ,stem:2
structure ,predictions:2
structure ,stem:2
predictions ,sars-cov-2:2
predictions ,stem:2
effect ,outbreak:2
effect ,treatment:2
effect ,time:2
effect ,st-segment:2
covid-19 ,st-segment:2
outbreak ,treatment:2
outbreak ,st-segment:2
treatment ,time:2
treatment ,st-segment:2
time ,st-segment:2
patients ,st-segment:2
acute ,st-segment:2
raas ,riddle:2
raas ,solve:2
sars-cov-2 ,riddle:2
sars-cov-2 ,solve:2
riddle ,solve:2
predictors ,severe:2
vitro ,covid-19:2
vitro ,recent:2
vitro ,advances:2
vitro ,emerging:2
vitro ,trends:2
diagnostic ,emerging:2
diagnostic ,trends:2
assays ,recent:2
assays ,advances:2
assays ,emerging:2
assays ,trends:2
recent ,emerging:2
advances ,emerging:2
advances ,trends:2
emerging ,trends:2
reorganization ,haemodialysis:2
reorganization ,report:2
reorganization ,dialysis:2
haemodialysis ,emergency:2
haemodialysis ,dialysis:2
emergency ,dialysis:2
report ,dialysis:2
direct ,oral:2
direct ,anticoagulant:2
direct ,plasma:2
direct ,levels:2
direct ,striking:2
direct ,severe:2
oral ,anticoagulant:2
oral ,plasma:2
oral ,levels:2
oral ,striking:2
oral ,increase:2
anticoagulant ,plasma:2
anticoagulant ,levels:2
anticoagulant ,striking:2
anticoagulant ,increase:2
anticoagulant ,severe:2
plasma ,striking:2
plasma ,increase:2
levels ,striking:2
levels ,increase:2
striking ,increase:2
striking ,severe:2
increase ,severe:2
clinical ,ii:2
update ,ii:2
sars-cov-2 ,advocacy:2
infection ,advocacy:2
infection ,training:2
infection ,social:2
infection ,distancing:2
advocacy ,training:2
advocacy ,social:2
advocacy ,distancing:2
advocacy ,healthcare:2
training ,social:2
training ,distancing:2
training ,healthcare:2
social ,healthcare:4
distancing ,healthcare:4
importance ,flu:2
importance ,vaccination:2
importance ,covid:2
importance ,time:2
flu ,vaccination:2
flu ,covid:2
flu ,time:2
vaccination ,covid:2
vaccination ,time:2
detection ,routine:2
detection ,exams:2
detection ,machine:2
covid-19 ,exams:2
infection ,exams:2
routine ,blood:4
routine ,exams:2
routine ,machine:2
routine ,learning:2
blood ,exams:2
blood ,machine:2
blood ,learning:2
exams ,machine:2
exams ,learning:2
recommendations ,resource:2
recommendations ,units:2
resource ,management:2
resource ,intensive:2
resource ,care:2
resource ,units:2
impact ,available:2
cardiovascular ,available:2
cardiovascular ,reports:2
system ,available:2
system ,reports:2
available ,reports:2
clinical ,non-critically:2
characteristics ,non-critically:2
non-critically ,novel:2
non-critically ,coronavirus:2
ill ,novel:2
clinical ,living:2
clinical ,human:2
clinical ,immunodeficiency:2
characteristics ,living:2
characteristics ,immunodeficiency:2
outcomes ,people:2
outcomes ,living:2
outcomes ,human:2
outcomes ,immunodeficiency:2
covid-19-related ,mental:2
covid-19-related ,health:2
covid-19-related ,effects:2
covid-19-related ,workplace:2
covid-19-related ,narrative:2
covid-19-related ,review:2
mental ,narrative:2
effects ,workplace:2
effects ,narrative:2
workplace ,narrative:2
workplace ,review:2
epidemic ,india:4
epidemic ,features:2
epidemic ,silico:2
india ,epidemiological:2
india ,features:2
india ,silico:2
epidemiological ,silico:2
features ,silico:2
umbilical ,cord:2
umbilical ,blood:2
umbilical ,therapy:2
umbilical ,prevent:2
umbilical ,progression:2
umbilical ,covid-19:2
umbilical ,related:2
umbilical ,pneumonia:2
cord ,blood:2
cord ,therapy:2
cord ,prevent:2
cord ,progression:2
cord ,related:2
cord ,pneumonia:2
blood ,therapy:2
blood ,prevent:2
blood ,progression:2
blood ,related:2
blood ,pneumonia:2
therapy ,progression:2
therapy ,related:2
prevent ,progression:2
prevent ,related:2
prevent ,pneumonia:2
progression ,related:2
progression ,pneumonia:2
exponential ,phase:2
exponential ,pandemic:2
exponential ,central:2
exponential ,italy:2
exponential ,integrated:2
exponential ,care:2
phase ,central:2
phase ,integrated:2
phase ,care:2
pandemic ,central:2
pandemic ,integrated:2
central ,italy:2
central ,integrated:2
central ,care:4
italy ,integrated:2
italy ,care:2
integrated ,care:2
reappearance ,effector:2
reappearance ,cells:2
reappearance ,associated:2
reappearance ,recovery:2
reappearance ,covid-19:2
effector ,cells:2
effector ,associated:2
effector ,recovery:2
effector ,covid-19:2
cells ,associated:2
cells ,recovery:2
associated ,recovery:2
youtube ,rheumatic:2
youtube ,link:2
source ,rheumatic:2
source ,link:2
information ,rheumatic:2
information ,link:2
rheumatic ,link:2
potential ,noncoding:2
potential ,rnas:2
potential ,innovative:2
use ,noncoding:2
use ,rnas:2
use ,innovative:2
use ,strategies:2
use ,target:2
noncoding ,innovative:2
noncoding ,therapeutic:2
noncoding ,strategies:2
noncoding ,target:2
rnas ,innovative:2
rnas ,therapeutic:2
rnas ,strategies:2
rnas ,target:2
innovative ,therapeutic:2
innovative ,strategies:2
innovative ,target:2
strategies ,target:2
bromelain ,inhibits:2
bromelain ,sars-cov-2:2
bromelain ,infection:2
bromelain ,veroe6:2
bromelain ,cells:2
inhibits ,veroe6:2
inhibits ,cells:2
sars-cov-2 ,veroe6:2
infection ,veroe6:2
veroe6 ,cells:2
covid-19 ,in-depth:2
coagulopathy ,in-depth:2
coagulopathy ,analysis:2
coagulopathy ,coagulation:2
coagulopathy ,system:2
in-depth ,analysis:2
in-depth ,coagulation:2
in-depth ,system:2
coagulation ,system:2
concomitant ,new:2
concomitant ,diagnosis:2
concomitant ,systemic:2
concomitant ,lupus:2
concomitant ,erythematosus:2
concomitant ,possible:2
new ,diagnosis:4
new ,systemic:2
new ,lupus:2
new ,erythematosus:2
diagnosis ,systemic:2
diagnosis ,lupus:2
diagnosis ,erythematosus:2
diagnosis ,possible:2
systemic ,possible:2
lupus ,possible:2
erythematosus ,possible:2
quantifying ,reporting:2
quantifying ,cardiac:2
quantifying ,findings:2
quantifying ,imaging:2
quantifying ,patients:2
reporting ,cardiac:2
reporting ,findings:2
reporting ,imaging:2
reporting ,patients:2
cardiac ,findings:2
ocular ,systematic:2
surface ,disease:2
surface ,systematic:2
hypernatremia-a ,manifestation:2
hypernatremia-a ,covid-19:2
hypernatremia-a ,case:2
hypernatremia-a ,series:2
clinical ,human-to-human:2
clinical ,transmitted:2
clinical ,coronaviruses:2
characteristics ,two:2
characteristics ,human-to-human:2
characteristics ,transmitted:2
characteristics ,coronaviruses:2
two ,human-to-human:2
two ,corona:2
human-to-human ,transmitted:2
human-to-human ,coronaviruses:2
human-to-human ,corona:2
transmitted ,corona:2
coronaviruses ,corona:2
treating ,drug:2
treating ,hypersensitivity:2
treating ,reactions:2
review ,hypersensitivity:2
review ,reactions:2
drug ,hypersensitivity:2
drug ,reactions:2
hypersensitivity ,reactions:2
role ,serological:2
serological ,outbreak:2
testing ,outbreak:2
early ,18:2
early ,f-fdg:2
early ,petct:2
18 ,f-fdg:2
18 ,petct:2
f-fdg ,petct:2
f-fdg ,covid-19:2
protective ,antibody:2
protective ,responses:2
antibody ,pandemic:2
blood ,mild:2
blood ,common:2
routine ,test:2
routine ,mild:2
routine ,common:2
routine ,coronavirus:2
test ,mild:2
test ,common:2
mild ,common:2
epidemiological ,nantong:2
clinical ,nantong:2
characteristics ,nantong:2
covid-19 ,nantong:2
patients ,nantong:2
nantong ,china:2
tissue ,distributions:2
tissue ,antiviral:2
tissue ,drugs:2
tissue ,affect:2
tissue ,capabilities:2
tissue ,reducing:2
tissue ,viral:2
distributions ,antiviral:2
distributions ,drugs:2
distributions ,affect:2
distributions ,capabilities:2
distributions ,reducing:2
distributions ,viral:2
antiviral ,affect:2
antiviral ,capabilities:2
antiviral ,reducing:2
antiviral ,viral:2
drugs ,affect:2
drugs ,capabilities:2
drugs ,reducing:2
drugs ,viral:2
affect ,capabilities:2
affect ,reducing:2
capabilities ,reducing:2
capabilities ,viral:2
reducing ,viral:2
transmission ,contacts:2
transmission ,index:2
children ,contacts:2
children ,index:2
study ,contacts:2
study ,index:2
contacts ,index:2
agents ,renin-angiotensin:2
agents ,system:2
agents ,severe:2
acting ,renin-angiotensin:2
acting ,system:2
acting ,risk:2
acting ,severe:2
acting ,acute:2
prominent ,disorder:2
prominent ,closely:2
prominent ,related:2
prominent ,inflammatory:2
prominent ,response:2
coagulation ,disorder:2
coagulation ,closely:2
coagulation ,related:2
coagulation ,inflammatory:2
coagulation ,response:2
disorder ,closely:2
disorder ,related:2
disorder ,inflammatory:2
disorder ,response:2
closely ,inflammatory:2
closely ,response:2
synergistic ,role:2
synergistic ,convalescent:2
synergistic ,plasma:2
synergistic ,mesenchymal:2
synergistic ,stem:2
synergistic ,cells:2
role ,convalescent:2
role ,plasma:2
role ,mesenchymal:2
role ,stem:2
convalescent ,mesenchymal:2
convalescent ,stem:2
convalescent ,cells:2
plasma ,mesenchymal:2
plasma ,stem:2
plasma ,cells:2
impact ,dental:2
impact ,italy-outcomes:2
covid-19 ,italy-outcomes:2
related ,dental:2
related ,central:2
related ,italy-outcomes:2
lockdown ,dental:2
lockdown ,central:2
lockdown ,italy-outcomes:2
dental ,central:2
dental ,italy-outcomes:2
practice ,central:2
practice ,italy-outcomes:2
central ,italy-outcomes:2
experience ,implement:2
experience ,preanalytical:2
experience ,poct:2
experience ,madrids:2
experience ,ifema:2
experience ,field:2
implement ,preanalytical:2
implement ,poct:2
implement ,unit:2
implement ,madrids:2
implement ,ifema:2
implement ,field:2
preanalytical ,poct:2
preanalytical ,unit:2
preanalytical ,madrids:2
preanalytical ,ifema:2
preanalytical ,field:2
poct ,unit:2
poct ,madrids:2
poct ,ifema:2
poct ,field:2
unit ,madrids:2
unit ,ifema:2
unit ,field:2
madrids ,ifema:2
madrids ,field:2
ifema ,field:2
extremely ,severe:2
extremely ,pneumonia:2
extremely ,recovered:2
extremely ,despite:2
extremely ,bad:2
extremely ,prognostic:2
severe ,bad:2
case ,despite:2
case ,bad:2
case ,prognostic:2
pneumonia ,bad:2
pneumonia ,prognostic:2
recovered ,despite:2
recovered ,bad:2
recovered ,prognostic:2
despite ,bad:2
despite ,prognostic:2
bad ,prognostic:2
identification ,phytochemicals:2
identification ,therapeutic:2
identification ,agents:2
identification ,binds:2
identification ,nsp15:2
phytochemicals ,therapeutic:2
phytochemicals ,binds:2
phytochemicals ,nsp15:2
potential ,binds:2
potential ,nsp15:2
therapeutic ,binds:2
therapeutic ,nsp15:2
agents ,binds:2
agents ,nsp15:2
binds ,nsp15:2
comprehensive ,in-hospital:2
comprehensive ,cluster:2
comprehensive ,symptomatic:2
investigation ,in-hospital:2
investigation ,transmission:2
investigation ,cluster:2
investigation ,symptomatic:2
in-hospital ,transmission:2
in-hospital ,cluster:2
in-hospital ,symptomatic:2
transmission ,symptomatic:2
aesthetic ,dermatology:2
aesthetic ,procedures:2
aesthetic ,coronavirus:2
aesthetic ,days:2
dermatology ,procedures:2
dermatology ,coronavirus:2
dermatology ,days:2
procedures ,days:2
sars-cov ,pregnancy:2
sars-cov ,fetal:2
sars-cov ,development:2
mers-cov ,pregnancy:2
mers-cov ,fetal:2
mers-cov ,development:2
sars-cov-2 ,fetal:2
infections ,fetal:2
infections ,development:2
pregnancy ,development:2
fetal ,development:2
follow-up ,study:2
follow-up ,long-time:2
follow-up ,positive:2
follow-up ,rt-pcr:2
follow-up ,stool:2
follow-up ,specimens:2
follow-up ,asymptomatic:2
study ,long-time:2
study ,stool:2
study ,specimens:2
long-time ,positive:2
long-time ,rt-pcr:2
long-time ,stool:2
long-time ,specimens:2
long-time ,asymptomatic:2
positive ,stool:2
positive ,specimens:2
rt-pcr ,specimens:2
stool ,specimens:2
specimens ,asymptomatic:2
gastrointestinal ,focus:2
gastrointestinal ,diagnosis:2
new ,focus:2
diabetes ,enough:2
higher ,males:2
higher ,sex:2
higher ,differences:2
higher ,immune:2
higher ,response:2
mortality ,males:2
mortality ,sex:2
mortality ,differences:2
mortality ,immune:2
males ,sex:2
males ,differences:2
males ,immune:2
males ,response:2
sex ,immune:2
differences ,immune:2
differences ,response:2
improving ,early:2
improving ,diagnosis:2
improving ,suspected:2
improving ,retrospective:2
early ,suspected:2
early ,retrospective:2
diagnosis ,retrospective:2
suspected ,retrospective:2
seroprevalence ,staff:2
seroprevalence ,school:2
anti-sars-cov-2 ,staff:2
anti-sars-cov-2 ,public:4
anti-sars-cov-2 ,school:2
igg ,public:2
igg ,school:2
antibodies ,public:4
antibodies ,school:2
staff ,public:2
staff ,school:2
public ,school:2
predicting ,impact:2
predicting ,public:2
predicting ,health:2
epidemic ,trend:2
epidemic ,transmission:2
epidemic ,lockdown-1:2
trend ,india:2
trend ,lockdown-1:2
trend ,phase:2
covid-19 ,lockdown-1:2
transmission ,lockdown-1:2
transmission ,phase:2
india ,lockdown-1:2
india ,phase:2
lockdown-1 ,phase:2
tmprss2 ,involvement:2
involvement ,genetic:2
involvement ,susceptibility:2
practical ,ambulatory:2
indications ,prevention:2
indications ,management:2
indications ,ambulatory:2
prevention ,ambulatory:2
optimal ,management:2
optimal ,acute:2
optimal ,lymphoblastic:2
optimal ,leukemia:2
optimal ,adult:2
optimal ,patients:2
management ,lymphoblastic:2
management ,leukemia:2
acute ,lymphoblastic:2
lymphoblastic ,leukemia:2
lymphoblastic ,adult:2
lymphoblastic ,patients:2
leukemia ,adult:2
leukemia ,patients:2
promising ,effects:2
promising ,tocilizumab:2
promising ,non-controlled:2
promising ,prospective:2
promising ,clinical:2
effects ,tocilizumab:2
effects ,non-controlled:2
tocilizumab ,non-controlled:2
tocilizumab ,prospective:2
tocilizumab ,clinical:2
covid-19 ,non-controlled:2
non-controlled ,prospective:2
non-controlled ,clinical:2
coronavirus ,food:2
coronavirus ,processing:2
coronavirus ,manufacturing:2
disease ,food:2
disease ,processing:2
disease ,manufacturing:2
among ,food:2
among ,processing:2
among ,manufacturing:2
workers ,food:2
workers ,processing:2
workers ,manufacturing:2
food ,processing:2
food ,manufacturing:2
processing ,manufacturing:2
coronavirus ,portrait:2
coronavirus ,perfect:2
disease ,portrait:2
disease ,perfect:2
covid-19 ,portrait:2
covid-19 ,perfect:2
portrait ,perfect:2
portrait ,storm:2
effect ,chloroquine:2
effect ,corrected:2
effect ,qt:2
chloroquine ,corrected:2
chloroquine ,qt:2
hydroxychloroquine ,corrected:2
hydroxychloroquine ,qt:2
azithromycin ,corrected:2
azithromycin ,qt:2
corrected ,qt:2
modeling ,state:2
modeling ,estimation:2
modeling ,optimal:2
modeling ,control:2
modeling ,us:2
state ,estimation:2
state ,optimal:2
state ,control:2
state ,us:2
estimation ,optimal:2
estimation ,control:2
estimation ,us:2
optimal ,us:2
optimal ,outbreak:2
us ,outbreak:2
clinical ,surgically:2
courses ,outcomes:2
courses ,five:2
courses ,patients:2
courses ,primary:2
courses ,cancer:2
courses ,surgically:2
outcomes ,five:2
outcomes ,surgically:2
five ,primary:2
five ,lung:2
five ,cancer:2
five ,surgically:2
patients ,surgically:2
primary ,lung:2
primary ,cancer:2
primary ,surgically:2
lung ,surgically:2
cancer ,surgically:2
human ,model:2
human ,learning:2
human ,experience:2
viral ,challenge:2
viral ,model:2
viral ,learning:2
viral ,experience:2
challenge ,model:2
challenge ,learning:2
challenge ,experience:2
model ,learning:2
model ,experience:2
learning ,experience:2
viral ,prolongation:2
shedding ,prolongation:2
shedding ,pneumonia:2
prolongation ,kidney:2
prolongation ,transplant:2
prolongation ,patient:2
prolongation ,covid-19:2
prolongation ,pneumonia:2
kidney ,pneumonia:2
mesenchymal ,novel:2
exosomes ,novel:2
three ,pediatric:2
three ,multisystem:2
three ,inflammatory:2
three ,syndrome:2
three ,associated:2
cases ,multisystem:2
cases ,inflammatory:2
covid-19 ,dataset:2
covid-19 ,civil:2
italy ,dataset:2
italy ,civil:2
italy ,protection:2
italy ,department:2
dataset ,italian:2
dataset ,civil:2
dataset ,protection:2
dataset ,department:2
italian ,civil:2
italian ,protection:2
italian ,department:2
civil ,protection:2
civil ,department:2
structural ,variant:2
functional ,d614g:2
functional ,variant:2
analysis ,d614g:2
d614g ,variant:2
spike ,variant:2
protein ,variant:2
recent ,repurposing:2
recent ,drugsmolecules:2
recent ,management:2
progress ,repurposing:2
progress ,drugsmolecules:2
progress ,management:2
repurposing ,drugsmolecules:2
drugsmolecules ,management:2
effects ,neonatal:2
effects ,prognosis:2
pregnancy ,prognosis:2
neonatal ,prognosis:2
high ,affinity:2
high ,host:2
high ,micrornas:2
high ,genome:2
high ,silico:2
affinity ,host:2
affinity ,human:2
affinity ,micrornas:2
affinity ,sars-cov-2:2
affinity ,genome:2
affinity ,silico:2
affinity ,analysis:2
host ,micrornas:2
host ,genome:2
human ,micrornas:2
human ,silico:2
micrornas ,sars-cov-2:2
micrornas ,genome:2
micrornas ,silico:2
micrornas ,analysis:2
dentistry ,prevention:2
dentistry ,dental:2
dentistry ,practice:2
dentistry ,literature:2
dentistry ,review:2
prevention ,practice:2
prevention ,literature:2
dental ,literature:2
practice ,literature:2
avoiding ,ibuprofen:2
avoiding ,good:2
avoiding ,evidence:2
ibuprofen ,good:2
good ,evidence:2
update ,teleconference:2
update ,paediatric:2
update ,virology:2
update ,study:2
update ,group:2
covid-19 ,teleconference:2
teleconference ,paediatric:2
teleconference ,virology:2
teleconference ,study:2
teleconference ,group:2
paediatric ,virology:2
paediatric ,study:2
virology ,study:2
virology ,group:2
prospective ,sero-epidemiological:2
prospective ,evaluation:2
prospective ,among:2
prospective ,health:2
prospective ,care:2
prospective ,workers:2
sero-epidemiological ,evaluation:2
sero-epidemiological ,sars-cov-2:2
sero-epidemiological ,among:2
sero-epidemiological ,health:2
sero-epidemiological ,care:2
sero-epidemiological ,workers:2
evaluation ,care:2
evaluation ,workers:2
effect ,healthcare:2
effect ,workers:2
effect ,mental:2
effect ,health:2
workers ,mental:2
e-health ,tools:2
e-health ,overcome:2
e-health ,gap:2
e-health ,epilepsy:2
e-health ,care:2
tools ,overcome:2
tools ,gap:2
tools ,epilepsy:2
overcome ,gap:2
overcome ,epilepsy:2
overcome ,care:2
gap ,epilepsy:2
gap ,care:2
epilepsy ,care:2
benign ,immunocompromised:2
benign ,cancer:2
benign ,case:2
benign ,married:2
covid-19 ,married:2
immunocompromised ,cancer:2
immunocompromised ,case:2
immunocompromised ,married:2
cancer ,case:2
cancer ,married:2
patient ,married:2
case ,married:2
effectiveness ,steroid:2
effectiveness ,treatment:2
effectiveness ,pneumonia:2
effectiveness ,cop-like:2
effectiveness ,reaction:2
steroid ,treatment:2
steroid ,pneumonia:2
steroid ,cop-like:2
steroid ,reaction:2
treatment ,cop-like:2
treatment ,reaction:2
sars-cov-2 ,cop-like:2
pneumonia ,cop-like:2
pneumonia ,reaction:2
cop-like ,reaction:2
effects ,pollutants:2
effects ,viral:4
air ,pollutants:2
air ,respiratory:2
air ,viral:2
pollutants ,transmission:2
pollutants ,severity:2
pollutants ,respiratory:2
pollutants ,viral:2
transmission ,severity:2
severity ,respiratory:2
crosstalk ,platelets:2
crosstalk ,microbial:2
crosstalk ,pathogens:2
platelets ,microbial:2
platelets ,pathogens:2
microbial ,pathogens:2
covid-19 ,beliefs:2
covid-19 ,behaviors:2
conspiracy ,behaviors:2
conspiracy ,policy:2
conspiracy ,support:2
beliefs ,health:2
beliefs ,behaviors:2
beliefs ,policy:2
beliefs ,support:2
health ,behaviors:2
behaviors ,policy:2
behaviors ,support:2
policy ,support:2
curative ,effect:2
curative ,reduning:2
curative ,injection:2
curative ,combined:2
curative ,xuanfeibaidu:2
curative ,formula:2
effect ,reduning:2
effect ,combined:2
effect ,xuanfeibaidu:2
effect ,formula:2
reduning ,injection:2
reduning ,combined:2
reduning ,xuanfeibaidu:2
reduning ,formula:2
injection ,combined:2
injection ,xuanfeibaidu:2
injection ,formula:2
combined ,xuanfeibaidu:2
xuanfeibaidu ,formula:2
review ,preclinical:2
preclinical ,clinical:2
preclinical ,efficacy:2
preclinical ,remdesivir:2
preclinical ,hydroxychloroquine:2
efficacy ,remdesivir:2
remdesivir ,hydroxychloroquine:2
genomic ,early:2
genomic ,variants:2
genomic ,introduced:2
genomic ,mexico:2
analysis ,introduced:2
analysis ,mexico:2
early ,variants:2
early ,introduced:2
early ,mexico:2
sars-cov-2 ,introduced:2
sars-cov-2 ,mexico:2
variants ,introduced:2
variants ,mexico:2
introduced ,mexico:2
cytokine ,parthenolide:2
cytokine ,preclinical:2
storm ,parthenolide:2
storm ,preclinical:2
covid-19 ,parthenolide:2
parthenolide ,preclinical:2
parthenolide ,evidence:2
preclinical ,evidence:2
hypoxemia ,patients:2
covalent ,targeting:2
covalent ,main:2
covalent ,protease:2
potential ,resistance:2
long-term ,antimicrobial:2
long-term ,resistance:2
impact ,antimicrobial:2
impact ,resistance:2
antimicrobial ,resistance:2
covid-19-associated ,immune:2
covid-19-associated ,thrombocytopenia:2
effects ,blood:2
effects ,group:2
effects ,types:2
effects ,risk:2
blood ,types:2
blood ,risk:2
group ,types:2
group ,risk:2
types ,risk:2
types ,infection:2
primary ,workers:2
primary ,assessed:2
primary ,antibody:2
care ,assessed:2
health ,assessed:2
workers ,assessed:2
assessed ,antibody:2
improving ,protection:2
improving ,bioaerosol:2
improving ,exposure:2
improving ,postoperative:2
protection ,bioaerosol:2
protection ,exposure:2
protection ,postoperative:2
bioaerosol ,exposure:2
bioaerosol ,postoperative:2
bioaerosol ,patient:2
exposure ,postoperative:2
host-membrane ,interacting:2
host-membrane ,interface:2
host-membrane ,sars:2
host-membrane ,coronavirus:2
host-membrane ,envelope:2
host-membrane ,protein:2
interacting ,interface:2
interacting ,sars:2
interacting ,coronavirus:2
interacting ,envelope:2
interacting ,protein:2
interface ,sars:2
interface ,coronavirus:2
interface ,envelope:2
sars ,envelope:2
coronavirus ,envelope:2
gastrointestinal ,digestive:2
gastrointestinal ,comorbidities:2
gastrointestinal ,italian:2
gastrointestinal ,cohort:2
symptoms ,digestive:2
symptoms ,italian:2
symptoms ,cohort:2
digestive ,comorbidities:2
digestive ,italian:2
digestive ,cohort:2
comorbidities ,italian:2
comorbidities ,cohort:2
italian ,cohort:2
absence ,infection:2
absence ,cats:2
absence ,dogs:2
absence ,close:2
absence ,contact:2
absence ,cluster:2
infection ,contact:2
cats ,contact:2
cats ,cluster:2
dogs ,close:2
dogs ,contact:2
dogs ,cluster:2
close ,cluster:2
coronavirus ,conundrum:2
coronavirus ,ras:2
coronavirus ,blockade:2
coronavirus ,geriatric-associated:2
disease-2019 ,conundrum:2
disease-2019 ,ras:2
disease-2019 ,blockade:2
disease-2019 ,geriatric-associated:2
conundrum ,ras:2
conundrum ,blockade:2
conundrum ,geriatric-associated:2
ras ,blockade:2
ras ,geriatric-associated:2
blockade ,geriatric-associated:2
serum ,hydrogen:2
serum ,sulfide:2
serum ,pneumonia:2
hydrogen ,outcome:2
hydrogen ,association:2
hydrogen ,pneumonia:2
sulfide ,outcome:2
sulfide ,association:2
sulfide ,pneumonia:2
sulfide ,sars-cov-2:2
outcome ,association:2
genetic ,collected:2
genetic ,bangladesh:2
analysis ,bangladesh:2
sars-cov-2 ,bangladesh:2
isolates ,collected:2
isolates ,bangladesh:2
isolates ,insights:2
collected ,bangladesh:2
collected ,insights:2
bangladesh ,insights:2
structural ,s-adenosyl-l-homocysteine:2
structural ,sinefungin:2
insight ,recognition:2
insight ,s-adenosyl-l-homocysteine:2
insight ,sinefungin:2
recognition ,s-adenosyl-l-homocysteine:2
recognition ,sinefungin:2
s-adenosyl-l-homocysteine ,sinefungin:2
detection ,pleural:2
severe ,pleural:2
acute ,pleural:2
acute ,fluid:2
respiratory ,pleural:2
respiratory ,fluid:2
syndrome ,pleural:2
syndrome ,fluid:2
coronavirus ,pleural:2
pleural ,fluid:2
massive ,rapid:2
massive ,testing:2
massive ,feasible:2
massive ,extraction-free:2
massive ,rt-pcr:2
rapid ,feasible:2
covid-19 ,feasible:2
covid-19 ,extraction-free:2
testing ,feasible:2
testing ,extraction-free:2
feasible ,extraction-free:2
feasible ,rt-pcr:2
extraction-free ,rt-pcr:2
dental ,infection-control:2
care ,infection-control:2
infection-control ,procedures:2
infection-control ,covid-19:2
infection-control ,pandemic:2
systemic ,immunobiological:2
systemic ,immunosuppressant:2
systemic ,oncologic:2
systemic ,agents:2
immunobiological ,immunosuppressant:2
immunobiological ,oncologic:2
immunobiological ,agents:2
immunobiological ,treatment:2
immunosuppressant ,oncologic:2
immunosuppressant ,agents:2
immunosuppressant ,treatment:2
oncologic ,agents:2
oncologic ,treatment:2
agents ,treatment:2
understanding ,age:2
understanding ,divide:2
understanding ,overwhelmingly:2
understanding ,spared:2
age ,divide:2
age ,children:2
age ,overwhelmingly:2
age ,spared:2
divide ,covid-19:2
divide ,children:2
divide ,overwhelmingly:2
divide ,spared:2
covid-19 ,overwhelmingly:2
children ,overwhelmingly:2
overwhelmingly ,spared:2
hmox1 ,pathway:2
hmox1 ,promising:2
hmox1 ,target:2
hmox1 ,treatment:2
hmox1 ,prevention:2
pathway ,prevention:2
promising ,target:2
promising ,prevention:2
target ,prevention:2
crystal ,non-structural:2
crystal ,protein:2
crystal ,10:2
crystal ,severe:2
crystal ,acute:2
crystal ,respiratory:2
structure ,non-structural:2
structure ,10:2
non-structural ,10:2
non-structural ,severe:2
non-structural ,acute:2
non-structural ,respiratory:2
protein ,10:2
10 ,severe:2
10 ,acute:2
10 ,respiratory:2
factors ,asymptomatic:2
factors ,health-care:2
associated ,asymptomatic:2
associated ,health-care:2
associated ,workers:2
asymptomatic ,health-care:2
health-care ,severe:2
covid-19 ,trajectory:2
pandemic ,environment:2
pandemic ,trajectory:2
early ,trajectory:2
life ,environment:2
life ,trajectory:2
environment ,trajectory:2
kidney ,epidemiology:2
kidney ,practice:2
epidemiology ,practice:2
new ,paths:2
new ,sustainable:2
new ,tackle:2
new ,infectious:2
paths ,sustainable:2
paths ,solutions:2
paths ,tackle:2
paths ,global:2
paths ,emerging:2
paths ,infectious:2
sustainable ,tackle:2
sustainable ,global:2
sustainable ,emerging:2
sustainable ,infectious:2
solutions ,tackle:2
solutions ,global:2
solutions ,emerging:2
solutions ,infectious:2
tackle ,global:2
tackle ,emerging:2
tackle ,infectious:2
global ,infectious:2
emerging ,infectious:2
sars-cov-2 ,sweden:2
exposure ,symptoms:2
exposure ,seroprevalence:2
exposure ,sweden:2
symptoms ,seroprevalence:2
symptoms ,sweden:2
seroprevalence ,sweden:2
healthcare ,sweden:2
workers ,sweden:2
safety ,outcomes:2
safety ,hospitalized:2
tolerability ,clinical:2
tolerability ,outcomes:2
tolerability ,hydroxychloroquine:2
tolerability ,hospitalized:2
outcomes ,hydroxychloroquine:2
hydroxychloroquine ,hospitalized:2
hydroxychloroquine ,protection:2
hydroxychloroquine ,versus:2
hydroxychloroquine ,proarrhythmia:2
covid-19 ,proarrhythmia:2
therapy ,versus:2
therapy ,proarrhythmia:2
protection ,versus:2
protection ,proarrhythmia:2
versus ,proarrhythmia:2
outcome ,children:2
hematological ,covid19:2
changes ,covid19:2
structural ,variations:2
structural ,expression:2
structural ,profiles:2
structural ,invasion:2
structural ,genes:2
variations ,expression:2
variations ,invasion:2
expression ,invasion:2
profiles ,host:2
profiles ,invasion:2
profiles ,genes:2
host ,invasion:2
host ,genes:2
invasion ,genes:2
human ,graphene-based:2
human ,materials:2
virus ,graphene-based:2
virus ,materials:2
detection ,graphene-based:2
detection ,materials:2
management ,radiotherapy:2
management ,center:2
management ,covid-19outbreak:2
radiotherapy ,center:2
radiotherapy ,covid-19outbreak:2
radiotherapy ,experience:2
center ,covid-19outbreak:2
covid-19outbreak ,experience:2
platelet ,activation:2
platelet ,platelet-monocyte:2
platelet ,aggregate:2
platelet ,formation:2
platelet ,trigger:2
platelet ,tissue:2
platelet ,factor:2
activation ,platelet-monocyte:2
activation ,aggregate:2
activation ,formation:2
activation ,tissue:2
activation ,factor:2
platelet-monocyte ,aggregate:2
platelet-monocyte ,formation:2
platelet-monocyte ,trigger:2
platelet-monocyte ,tissue:2
platelet-monocyte ,factor:2
aggregate ,formation:2
aggregate ,trigger:2
aggregate ,tissue:2
aggregate ,factor:2
formation ,trigger:2
formation ,tissue:2
formation ,factor:2
trigger ,tissue:2
trigger ,factor:2
dental ,services:2
dental ,norway:2
health ,services:2
health ,norway:2
services ,response:2
services ,norway:2
response ,norway:2
covid-19 ,norway:2
neglected ,non-endemic:2
neglected ,countries:2
neglected ,era:2
neglected ,covid-19:2
tropical ,non-endemic:2
tropical ,countries:2
tropical ,era:2
diseases ,non-endemic:2
diseases ,countries:2
non-endemic ,countries:2
non-endemic ,era:2
non-endemic ,covid-19:2
countries ,era:2
stability ,coronaviruses:2
stability ,environment:2
stability ,common:2
coronaviruses ,environment:2
environment ,common:2
chinese ,fighting:2
chinese ,small-molecule:2
therapeutic ,fighting:2
therapeutic ,small-molecule:2
strategy ,fighting:2
strategy ,small-molecule:2
fighting ,potential:2
fighting ,small-molecule:2
covid-19 ,small-molecule:2
covid-19 ,repeated:2
repeated ,positive:2
repeated ,test:2
repeated ,results:2
repeated ,pcr:2
repeated ,negative:2
test ,negative:2
management ,hidradenitis:2
management ,suppurativa:2
patients ,hidradenitis:2
patients ,suppurativa:2
hidradenitis ,suppurativa:2
hidradenitis ,covid-19:2
hidradenitis ,pandemic:2
suppurativa ,covid-19:2
suppurativa ,pandemic:2
frequency ,igg:2
frequency ,antibodies:2
frequency ,among:2
frequency ,special:2
frequency ,police:2
frequency ,squad:2
frequency ,lahore:2
frequency ,pakistan:2
covid-19 ,police:2
covid-19 ,squad:2
covid-19 ,lahore:2
igg ,special:2
igg ,police:2
igg ,squad:2
igg ,lahore:2
igg ,pakistan:2
antibodies ,special:2
antibodies ,police:2
antibodies ,squad:2
antibodies ,lahore:2
antibodies ,pakistan:2
among ,police:2
among ,squad:2
among ,lahore:2
among ,pakistan:2
special ,police:2
special ,squad:2
special ,lahore:2
special ,pakistan:2
police ,squad:2
police ,lahore:2
police ,pakistan:2
squad ,lahore:2
squad ,pakistan:2
lahore ,pakistan:2
covid-19 ,smokeless:2
covid-19 ,habitus:2
smokeless ,tobacco:2
smokeless ,habitus:2
smokeless ,increased:2
smokeless ,susceptibility:2
smokeless ,transmission:2
tobacco ,habitus:2
tobacco ,increased:2
tobacco ,susceptibility:2
tobacco ,transmission:2
habitus ,increased:2
habitus ,susceptibility:2
habitus ,transmission:2
increased ,transmission:2
changes ,air:2
changes ,quality:2
changes ,lockdown:4
changes ,barcelona:2
changes ,spain:2
changes ,one:2
changes ,month:2
air ,barcelona:2
air ,spain:2
air ,one:2
air ,month:2
quality ,barcelona:2
quality ,spain:2
quality ,one:2
quality ,month:2
lockdown ,barcelona:2
lockdown ,spain:2
lockdown ,one:2
lockdown ,month:2
barcelona ,one:2
barcelona ,month:2
spain ,month:2
one ,month:2
continuing ,care:2
continuing ,patients:2
continuing ,affected:2
continuing ,urologic:2
continuing ,chronic:2
continuing ,pelvic:2
continuing ,pain:2
continuing ,era:2
care ,affected:2
care ,urologic:2
care ,pelvic:2
care ,pain:2
patients ,pelvic:2
patients ,pain:2
affected ,urologic:2
affected ,chronic:2
affected ,pelvic:2
affected ,pain:2
affected ,era:2
urologic ,chronic:2
urologic ,pelvic:2
urologic ,pain:2
urologic ,era:2
chronic ,pelvic:2
chronic ,pain:2
chronic ,era:2
pelvic ,pain:2
pelvic ,era:2
pain ,era:2
lung ,recommendations:2
lung ,brazilian:2
lung ,thoracic:2
cancer ,brazilian:2
cancer ,thoracic:2
pandemic ,thoracic:2
recommendations ,brazilian:2
recommendations ,thoracic:2
brazilian ,thoracic:2
adolescents ,health:2
adolescents ,times:2
adolescents ,scoping:2
adolescents ,review:2
health ,scoping:2
times ,scoping:2
repurposing ,pandemic:2
sars-cov-2 ,infects:2
sars-cov-2 ,choroid:2
sars-cov-2 ,plexus:2
sars-cov-2 ,blood-csf:2
infects ,brain:2
infects ,choroid:2
infects ,plexus:2
infects ,disrupts:2
infects ,blood-csf:2
infects ,barrier:2
brain ,choroid:2
brain ,plexus:2
brain ,disrupts:2
brain ,blood-csf:2
brain ,barrier:2
choroid ,plexus:2
choroid ,disrupts:2
choroid ,blood-csf:2
choroid ,barrier:2
plexus ,disrupts:2
plexus ,blood-csf:2
plexus ,barrier:2
disrupts ,blood-csf:2
disrupts ,barrier:2
blood-csf ,barrier:2
children ,heterogeneity:2
children ,within:2
children ,hypothetical:2
heterogeneity ,within:2
heterogeneity ,disease:2
heterogeneity ,hypothetical:2
within ,hypothetical:2
disease ,hypothetical:2
chest ,physiotherapy:2
chest ,important:2
chest ,adjuvant:2
chest ,critically:2
chest ,ill:2
chest ,mechanically:2
chest ,ventilated:2
physiotherapy ,important:2
physiotherapy ,adjuvant:2
physiotherapy ,critically:2
physiotherapy ,ill:2
physiotherapy ,mechanically:2
physiotherapy ,ventilated:2
important ,adjuvant:2
important ,critically:2
important ,ill:2
important ,mechanically:2
important ,ventilated:2
adjuvant ,critically:2
adjuvant ,ill:2
adjuvant ,mechanically:2
adjuvant ,ventilated:2
critically ,mechanically:2
critically ,ventilated:2
ill ,mechanically:2
ill ,ventilated:2
unaddressed ,behavioral:2
unaddressed ,health:2
unaddressed ,aspect:2
unaddressed ,coronavirus:2
unaddressed ,pandemic:2
behavioral ,aspect:2
health ,aspect:2
aspect ,coronavirus:2
aspect ,pandemic:2
origin ,interaction:2
genomic ,interaction:2
characteristics ,interaction:2
nanoluciferase ,sars-cov-2:2
nanoluciferase ,rapid:2
nanoluciferase ,neutralization:2
nanoluciferase ,testing:2
nanoluciferase ,screening:2
rapid ,neutralization:2
neutralization ,testing:2
neutralization ,screening:2
covid-19 ,sites:2
recommended ,sampling:2
recommended ,sites:2
recommended ,different:2
recommended ,stages:2
recommended ,disease:2
sampling ,sites:2
sampling ,different:2
sampling ,stages:2
sampling ,disease:2
sites ,stages:2
sites ,disease:2
different ,stages:2
stages ,disease:2
rapid ,trials:2
rapid ,utilizing:2
rapid ,chloroquine:2
systematic ,utilizing:2
review ,utilizing:2
clinical ,utilizing:2
clinical ,chloroquine:2
trials ,utilizing:2
trials ,chloroquine:2
utilizing ,chloroquine:2
sars-cov-2 ,testing-questions:2
sars-cov-2 ,asked:2
antibody ,testing-questions:2
antibody ,asked:2
testing-questions ,asked:2
convalescent ,b-cell-depleted:2
convalescent ,protracted:2
plasma ,b-cell-depleted:2
plasma ,protracted:2
therapy ,b-cell-depleted:2
therapy ,protracted:2
b-cell-depleted ,patients:2
b-cell-depleted ,protracted:2
patients ,protracted:2
protracted ,covid-19:2
three ,systematic:2
three ,review:2
three ,meta-analysis:2
months ,systematic:2
months ,review:2
months ,meta-analysis:2
selenium ,supplementation:2
selenium ,prevention:2
selenium ,coronavirus:2
selenium ,infections:2
supplementation ,prevention:2
supplementation ,coronavirus:2
supplementation ,infections:2
high ,frequency:2
high ,rnaemia:2
frequency ,rnaemia:2
frequency ,severe:2
frequency ,disease:2
sars-cov-2 ,rnaemia:2
rnaemia ,association:2
rnaemia ,severe:2
association ,severe:2
additive ,manufacturing:2
additive ,technologies:2
additive ,enabling:2
additive ,rapid:2
additive ,interventional:2
additive ,production:2
manufacturing ,technologies:2
manufacturing ,enabling:2
manufacturing ,rapid:2
manufacturing ,interventional:2
manufacturing ,production:2
technologies ,enabling:2
technologies ,rapid:2
technologies ,interventional:2
technologies ,production:2
enabling ,rapid:2
enabling ,interventional:2
enabling ,production:2
rapid ,interventional:2
interventional ,production:2
nasopharyngeal ,carriage:2
nasopharyngeal ,among:2
nasopharyngeal ,health:2
nasopharyngeal ,personnel:2
nasopharyngeal ,symptoms:2
carriage ,among:2
carriage ,health:2
carriage ,personnel:2
personnel ,symptoms:2
targeting ,pivotal:2
targeting ,inflammatory:2
targeting ,mechanistic:2
targeting ,review:2
pivotal ,inflammatory:2
pivotal ,pathways:2
pivotal ,covid-19:2
pivotal ,mechanistic:2
pivotal ,review:2
inflammatory ,pathways:2
inflammatory ,mechanistic:2
pathways ,mechanistic:2
pathways ,review:2
mechanistic ,review:2
potential ,modal:2
potential ,dynamic:2
treatment ,modal:2
covid-19 ,modal:2
based ,modal:2
based ,dynamic:2
modal ,characteristics:2
modal ,dynamic:2
sexx ,covid-19:2
sexx ,tussle:2
sexx ,two:2
covid-19 ,tussle:2
tussle ,two:2
ultra-sensitive ,serial:2
ultra-sensitive ,profiling:2
ultra-sensitive ,sars-cov-2:2
ultra-sensitive ,antigens:2
ultra-sensitive ,antibodies:2
ultra-sensitive ,plasma:2
serial ,profiling:2
serial ,antigens:2
serial ,antibodies:2
serial ,plasma:2
profiling ,antigens:2
profiling ,antibodies:2
profiling ,plasma:2
antigens ,antibodies:2
antigens ,plasma:2
antibodies ,plasma:2
adjusting ,rt-qpcr:2
adjusting ,conditions:2
adjusting ,avoid:2
adjusting ,unspecific:2
adjusting ,amplification:2
adjusting ,sars-cov-2:2
rt-qpcr ,conditions:2
rt-qpcr ,avoid:2
rt-qpcr ,unspecific:2
rt-qpcr ,amplification:2
conditions ,avoid:2
conditions ,unspecific:2
conditions ,amplification:2
avoid ,unspecific:2
avoid ,amplification:2
unspecific ,amplification:2
unspecific ,sars-cov-2:2
biological ,epidemiological:2
biological ,features:2
biological ,sars:2
biological ,mers:2
clinical ,mers:2
epidemiological ,sars:2
epidemiological ,mers:2
features ,mers:2
covid-19 ,institution:2
covid-19 ,buenos:2
covid-19 ,aires:2
covid-19 ,month:2
experience ,institution:2
experience ,buenos:2
experience ,aires:2
experience ,first:2
experience ,month:2
private ,institution:2
private ,buenos:2
private ,aires:2
private ,first:2
private ,month:2
institution ,buenos:2
institution ,aires:2
institution ,first:2
institution ,month:2
buenos ,aires:2
buenos ,first:2
buenos ,month:2
aires ,first:2
aires ,month:2
first ,month:2
discovery ,potent:2
discovery ,sars-cov-2s:2
discovery ,protease:2
potent ,sars-cov-2s:2
inhibitors ,sars-cov-2s:2
sars-cov-2s ,main:2
sars-cov-2s ,protease:2
vascular ,manifestations:2
vascular ,thromboembolism:2
vascular ,microvascular:2
manifestations ,thromboembolism:2
manifestations ,dysfunction:2
thromboembolism ,microvascular:2
thromboembolism ,dysfunction:2
microvascular ,dysfunction:2
lockdown ,relative:2
lockdown ,age-specific:2
lockdown ,incidence:2
measures ,relative:2
measures ,age-specific:2
relative ,changes:2
relative ,age-specific:2
relative ,incidence:2
relative ,sars-cov-2:2
changes ,age-specific:2
age-specific ,incidence:2
considerations ,home:2
considerations ,parenteral:2
considerations ,nutrition:2
management ,home:2
management ,parenteral:2
home ,parenteral:2
parenteral ,nutrition:2
analysis ,gender-dependent:2
analysis ,personal:2
analysis ,protective:2
analysis ,behaviors:2
analysis ,sample:2
gender-dependent ,personal:2
gender-dependent ,protective:2
gender-dependent ,behaviors:2
gender-dependent ,national:2
gender-dependent ,sample:2
personal ,behaviors:2
personal ,national:2
personal ,sample:2
protective ,behaviors:2
protective ,national:2
protective ,sample:2
behaviors ,national:2
behaviors ,sample:2
national ,sample:2
pandemic ,partial:2
impacts ,air:2
impacts ,quality:2
impacts ,partial:2
impacts ,lockdown:2
air ,partial:2
quality ,partial:2
partial ,lockdown:2
impact ,labor:2
impact ,newborn:2
impact ,nursery:2
covid-19 ,nursery:2
infection ,labor:2
infection ,newborn:2
infection ,nursery:2
labor ,newborn:2
labor ,nursery:2
delivery ,newborn:2
delivery ,nursery:2
newborn ,nursery:2
seroprevalence ,southern:2
seroprevalence ,us:2
seroprevalence ,population:2
seroprevalence ,indicates:2
seroprevalence ,limited:2
among ,indicates:2
among ,limited:2
southern ,us:2
southern ,population:2
southern ,indicates:2
southern ,limited:2
us ,population:2
us ,indicates:2
us ,limited:2
population ,indicates:2
population ,limited:2
indicates ,limited:2
containment ,healthcare-associated:2
containment ,university:2
containment ,hospital:2
healthcare-associated ,covid-19:2
healthcare-associated ,outbreak:2
healthcare-associated ,university:2
healthcare-associated ,hospital:2
outbreak ,university:2
effects ,oral:2
effects ,care:2
effects ,prolonged:2
effects ,shedding:2
oral ,prolonged:2
oral ,viral:2
care ,prolonged:2
care ,viral:2
care ,shedding:2
free ,fatty:2
free ,acid:2
free ,pocket:2
free ,locked:2
free ,structure:2
free ,protein:2
fatty ,binding:2
fatty ,pocket:2
fatty ,locked:2
fatty ,structure:2
fatty ,sars-cov-2:2
fatty ,spike:2
fatty ,protein:2
acid ,binding:2
acid ,pocket:2
acid ,locked:2
acid ,structure:2
acid ,spike:2
binding ,pocket:2
binding ,locked:2
pocket ,locked:2
pocket ,structure:2
pocket ,protein:2
locked ,structure:2
locked ,sars-cov-2:2
locked ,spike:2
locked ,protein:2
covid-19 ,immunonutrition:2
covid-19 ,obese:2
role ,immunonutrition:2
role ,obese:2
role ,patient:2
immunonutrition ,obese:2
immunonutrition ,patient:2
obese ,patient:2
spontaneous ,pneumomediastinumpneumothorax:2
spontaneous ,patients:2
pneumomediastinumpneumothorax ,patients:2
pneumomediastinumpneumothorax ,covid-19:2
renin-angiotensin ,modulators:2
renin-angiotensin ,know:2
renin-angiotensin ,far:2
system ,modulators:2
system ,know:2
system ,far:2
modulators ,know:2
modulators ,far:2
rapid ,asymptomatic:2
rapid ,incubation:2
rapid ,period:2
asymptomatic ,incubation:2
asymptomatic ,period:2
host ,polymorphisms:2
host ,infectivity:2
polymorphisms ,may:2
polymorphisms ,impact:2
polymorphisms ,sars-cov-2:2
polymorphisms ,infectivity:2
may ,infectivity:2
impact ,infectivity:2
airborne ,meters6:2
airborne ,feet:2
airborne ,inter-personal:2
transmission ,meters6:2
transmission ,feet:2
transmission ,inter-personal:2
route ,covid-19:2
route ,meters6:2
route ,feet:2
route ,inter-personal:2
covid-19 ,meters6:2
covid-19 ,feet:2
covid-19 ,inter-personal:2
meters6 ,feet:2
meters6 ,inter-personal:2
feet ,inter-personal:2
incidence ,arrhythmias:2
incidence ,electrocardiographic:2
incidence ,abnormalities:2
incidence ,symptomatic:2
arrhythmias ,electrocardiographic:2
arrhythmias ,abnormalities:2
arrhythmias ,symptomatic:2
electrocardiographic ,abnormalities:2
electrocardiographic ,symptomatic:2
abnormalities ,symptomatic:2
genomics ,approaches:2
genomics ,synthesis:2
genomics ,plant-based:2
genomics ,biomolecules:2
approaches ,synthesis:2
approaches ,plant-based:2
approaches ,biomolecules:2
synthesis ,plant-based:2
synthesis ,biomolecules:2
synthesis ,therapeutic:2
plant-based ,biomolecules:2
plant-based ,therapeutic:2
biomolecules ,therapeutic:2
management ,agitation:2
agitation ,covid-19:2
agitation ,pandemic:2
covid-19 ,revive:2
covid-19 ,cyclophilin:2
covid-19 ,alisporivir:2
pandemic ,revive:2
pandemic ,cyclophilin:2
pandemic ,inhibitor:2
pandemic ,alisporivir:2
time ,revive:2
time ,cyclophilin:2
time ,inhibitor:2
time ,alisporivir:2
revive ,cyclophilin:2
revive ,inhibitor:2
revive ,alisporivir:2
cancer ,new:2
cancer ,york:2
cancer ,city:2
cancer ,comparative:2
cancer ,center:2
patients ,york:2
patients ,city:2
new ,single:2
york ,single:2
city ,single:2
comparative ,single:2
comparative ,center:2
clinical ,pre-admission:2
clinical ,antithrombotic:2
impact ,pre-admission:2
impact ,antithrombotic:2
impact ,hospitalized:2
pre-admission ,antithrombotic:2
pre-admission ,therapy:2
pre-admission ,hospitalized:2
pre-admission ,patients:2
antithrombotic ,therapy:2
antithrombotic ,hospitalized:2
therapy ,hospitalized:2
sars-cov-2-related ,rapid:2
sars-cov-2-related ,reorganization:2
sars-cov-2-related ,epilepsy:2
sars-cov-2-related ,outpatient:2
sars-cov-2-related ,clinic:2
rapid ,reorganization:2
rapid ,epilepsy:2
rapid ,outpatient:2
rapid ,clinic:2
reorganization ,epilepsy:2
reorganization ,outpatient:2
reorganization ,clinic:2
epilepsy ,outpatient:2
epilepsy ,clinic:2
outpatient ,clinic:2
renin-angiotensin ,patients:2
inhibition ,patients:2
covid-19 ,worried:2
children ,worried:2
clinical ,phenotypes:2
clinical ,clinicians:2
clinical ,researchers:2
phenotypes ,sars-cov-2:2
phenotypes ,implications:2
phenotypes ,clinicians:2
phenotypes ,researchers:2
sars-cov-2 ,researchers:2
implications ,clinicians:2
implications ,researchers:2
clinicians ,researchers:2
systematic ,analyses:2
systematic ,anti-inflammatory:2
systematic ,mechanisms:2
analyses ,immune:2
analyses ,anti-inflammatory:2
analyses ,mechanisms:2
potential ,anti-inflammatory:2
immune ,anti-inflammatory:2
anti-inflammatory ,mechanisms:2
navigating ,impact:2
navigating ,palliative:2
navigating ,care:2
navigating ,head:2
navigating ,neck:2
navigating ,cancer:2
impact ,palliative:2
palliative ,head:2
palliative ,neck:2
palliative ,cancer:2
covid-19 ,olfactorylossandincreased:2
covid-19 ,resting:2
variable ,symptoms:2
variable ,mild:2
variable ,course:2
variable ,olfactorylossandincreased:2
variable ,resting:2
symptoms ,course:2
symptoms ,olfactorylossandincreased:2
symptoms ,resting:2
mild ,olfactorylossandincreased:2
mild ,resting:2
course ,olfactorylossandincreased:2
course ,resting:2
olfactorylossandincreased ,resting:2
norwegian ,coronavirus:2
norwegian ,disease:2
norwegian ,covid-19:2
norwegian ,pragmatic:2
norwegian ,open:2
norwegian ,label:2
norwegian ,study:2
coronavirus ,pragmatic:2
coronavirus ,open:2
coronavirus ,label:2
disease ,pragmatic:2
disease ,open:2
disease ,label:2
covid-19 ,label:2
pragmatic ,open:2
pragmatic ,label:2
pragmatic ,study:2
open ,label:2
open ,study:2
label ,study:2
covid19 ,antibody:2
covid19 ,detection:2
covid19 ,using:2
covid19 ,lateral:2
covid19 ,flow:2
covid19 ,tests:2
covid19 ,cohort:2
antibody ,cohort:2
detection ,cohort:2
using ,cohort:2
lateral ,cohort:2
flow ,cohort:2
assay ,tests:2
assay ,cohort:2
tests ,cohort:2
analysis ,49:2
clinical ,49:2
characteristics ,49:2
49 ,cases:2
49 ,covid-19:2
cardiogenic ,caused:2
cardiogenic ,sars-cov-2:2
cardiogenic ,patient:2
cardiogenic ,serial:2
cardiogenic ,negative:2
cardiogenic ,nucleic:2
shock ,caused:2
shock ,patient:2
shock ,serial:2
shock ,negative:2
shock ,nucleic:2
caused ,patient:2
caused ,serial:2
caused ,negative:2
caused ,nucleic:2
patient ,serial:2
patient ,nucleic:2
serial ,negative:2
serial ,nucleic:2
sars-cov-2 ,passengers:2
shedding ,among:2
shedding ,passengers:2
shedding ,quarantined:2
seroconversion ,among:2
seroconversion ,passengers:2
seroconversion ,quarantined:2
among ,quarantined:2
passengers ,quarantined:2
impact ,weather:2
impact ,conditions:2
impact ,incidence:2
weather ,incidence:2
weather ,mortality:2
weather ,pandemic:2
conditions ,incidence:2
conditions ,mortality:2
incidence ,pandemic:2
mortality ,pandemic:2
insights ,action:2
insights ,perspectives:2
insights ,implications:2
insights ,malaria:2
chloroquine ,action:2
chloroquine ,perspectives:2
chloroquine ,malaria:2
action ,perspectives:2
action ,implications:2
action ,malaria:2
perspectives ,implications:2
perspectives ,malaria:2
implications ,malaria:2
eculizumab ,sars-cov-2:2
eculizumab ,atypical:2
eculizumab ,hemolytic:2
eculizumab ,uremic:2
eculizumab ,syndrome:2
sars-cov-2 ,hemolytic:2
sars-cov-2 ,uremic:2
atypical ,hemolytic:2
atypical ,uremic:2
hemolytic ,uremic:2
hemolytic ,syndrome:2
uremic ,syndrome:2
sars ,genome:2
sars ,infectome:2
coronavirus ,infectome:2
genome ,infectome:2
multistage ,ct:2
multistage ,features:2
multistage ,coronavirus:2
multistage ,disease:2
comparison ,situ:2
comparison ,hybridization:2
comparison ,immunohistochemistry:2
comparison ,techniques:2
rna ,situ:2
rna ,hybridization:2
rna ,immunohistochemistry:2
rna ,techniques:2
situ ,immunohistochemistry:2
situ ,techniques:2
hybridization ,immunohistochemistry:2
hybridization ,techniques:2
immunohistochemistry ,techniques:2
multisystem ,distinct:2
inflammatory ,distinct:2
syndrome ,distinct:2
children ,distinct:2
impact ,demand:2
social ,demand:2
distancing ,demand:2
measures ,demand:2
coronavirus ,demand:2
disease ,demand:2
healthcare ,demand:2
structural ,3clpro:2
structural ,anti-covid-19:2
structural ,discovery:2
basis ,3clpro:2
basis ,anti-covid-19:2
basis ,discovery:2
sars-cov-2 ,anti-covid-19:2
3clpro ,anti-covid-19:2
3clpro ,drug:2
3clpro ,discovery:2
anti-covid-19 ,drug:2
anti-covid-19 ,discovery:2
evaluation ,exposure:2
evaluation ,hospital:2
evaluation ,environment:2
exposure ,different:2
risk ,hospital:2
different ,hospital:2
different ,environment:2
hospital ,environment:2
investigation ,effective:2
investigation ,climatology:2
investigation ,parameters:2
investigation ,iran:2
effective ,climatology:2
effective ,parameters:2
effective ,outbreak:2
effective ,iran:2
climatology ,parameters:2
climatology ,covid-19:2
climatology ,outbreak:2
climatology ,iran:2
parameters ,outbreak:2
parameters ,iran:2
statins ,sars-cov-2:2
statins ,disease:2
statins ,current:2
statins ,concepts:2
statins ,possible:2
statins ,benefits:2
sars-cov-2 ,concepts:2
sars-cov-2 ,benefits:2
disease ,concepts:2
disease ,benefits:2
current ,concepts:2
concepts ,possible:2
concepts ,benefits:2
possible ,benefits:2
prognostic ,thrombocytopenia:2
prognostic ,systematic:2
value ,thrombocytopenia:2
value ,systematic:2
thrombocytopenia ,systematic:2
thrombocytopenia ,review:2
development ,sers-based:2
sers-based ,lateral:2
sers-based ,flow:2
sers-based ,immunoassay:2
sers-based ,rapid:2
sers-based ,ultra-sensitive:2
lateral ,ultra-sensitive:2
flow ,ultra-sensitive:2
immunoassay ,ultra-sensitive:2
rapid ,ultra-sensitive:2
enacting ,national:2
enacting ,social:2
enacting ,distancing:2
enacting ,policies:2
enacting ,corresponds:2
enacting ,dramatic:2
enacting ,reduction:2
national ,distancing:2
national ,policies:2
national ,corresponds:2
national ,dramatic:2
national ,reduction:2
social ,policies:2
social ,corresponds:2
social ,dramatic:2
social ,reduction:2
distancing ,policies:2
distancing ,corresponds:2
distancing ,dramatic:2
distancing ,reduction:2
policies ,corresponds:2
policies ,dramatic:2
policies ,reduction:2
corresponds ,dramatic:2
corresponds ,reduction:2
dramatic ,reduction:2
monoclonal ,anti-covid-19:2
antibody ,anti-covid-19:2
neutralization ,destruction:2
neutralization ,prefusion:2
sars-cov-2 ,destruction:2
destruction ,prefusion:2
destruction ,spike:2
therapeutic ,temperature:2
therapeutic ,patient:2
temperature ,modulation:2
temperature ,critically:2
temperature ,ill:2
modulation ,critically:2
modulation ,ill:2
modulation ,patient:2
serum ,interleukin-6:2
serum ,indicator:2
serum ,901:2
interleukin-6 ,indicator:2
interleukin-6 ,901:2
interleukin-6 ,patients:4
indicator ,severity:2
indicator ,901:2
indicator ,patients:2
severity ,901:2
901 ,patients:2
901 ,sars-cov-2:2
identification ,validation:2
identification ,174:2
identification ,reveals:2
identification ,low:2
validation ,174:2
validation ,covid-19:2
validation ,epitopes:2
validation ,reveals:2
validation ,low:2
174 ,covid-19:2
174 ,vaccine:2
174 ,candidate:2
174 ,epitopes:2
174 ,reveals:2
174 ,low:2
vaccine ,epitopes:2
vaccine ,low:2
candidate ,reveals:2
candidate ,low:2
epitopes ,reveals:2
epitopes ,low:2
reveals ,low:2
phylogenetic ,relationship:2
phylogenetic ,within:2
phylogenetic ,sars-cov-2s:2
phylogenetic ,expanding:2
phylogenetic ,basal:2
phylogenetic ,clade:2
relationship ,within:2
relationship ,sars-cov-2s:2
relationship ,expanding:2
relationship ,basal:2
relationship ,clade:2
within ,sars-cov-2s:2
within ,expanding:2
within ,basal:2
within ,clade:2
sars-cov-2s ,expanding:2
sars-cov-2s ,basal:2
sars-cov-2s ,clade:2
expanding ,basal:2
expanding ,clade:2
basal ,clade:2
lungs ,human:2
lungs ,transgenic:2
lungs ,mice:2
lungs ,causes:2
lungs ,severe:2
human ,causes:2
ace2 ,transgenic:2
ace2 ,mice:2
ace2 ,causes:2
transgenic ,causes:2
transgenic ,severe:2
mice ,causes:2
mice ,severe:2
causes ,severe:2
nasal ,gene:2
nasal ,expression:2
nasal ,angiotensin-converting:2
nasal ,enzyme:2
nasal ,adults:2
gene ,children:2
gene ,adults:2
expression ,children:2
expression ,adults:2
angiotensin-converting ,children:2
angiotensin-converting ,adults:2
enzyme ,children:2
enzyme ,adults:2
systemic ,medications:2
systemic ,dermatological:2
systemic ,importance:2
medications ,dermatological:2
medications ,importance:2
dermatological ,importance:2
anti-covid ,vaccines:2
anti-covid ,look:2
anti-covid ,collective:2
anti-covid ,health:2
vaccines ,look:2
vaccines ,collective:2
vaccines ,health:2
look ,collective:2
look ,health:2
collective ,health:2
covid-19 ,tasks:2
infection ,preparedness:2
infection ,tasks:2
data ,gaps:2
data ,diagnostic:2
data ,laboratory:2
data ,preparedness:2
data ,tasks:2
gaps ,diagnostic:2
gaps ,laboratory:2
gaps ,preparedness:2
gaps ,tasks:2
diagnostic ,tasks:2
laboratory ,tasks:2
preparedness ,tasks:2
mining ,characteristics:2
mining ,covid-19:2
mining ,patients:2
mining ,china:2
mining ,analysis:2
mining ,social:2
mining ,media:2
characteristics ,media:2
covid-19 ,media:2
patients ,media:2
china ,media:2
laboratory ,practices:2
laboratory ,mitigate:2
laboratory ,biohazard:2
laboratory ,risks:2
laboratory ,outbreak:2
practices ,mitigate:2
practices ,biohazard:2
practices ,risks:2
practices ,outbreak:2
mitigate ,biohazard:2
mitigate ,risks:2
mitigate ,outbreak:2
biohazard ,risks:2
biohazard ,covid-19:2
biohazard ,outbreak:2
risks ,outbreak:2
analysis ,readmission:2
risk ,readmission:2
risk ,cases:2
risk ,republic:2
risk ,korea:2
factors ,readmission:2
factors ,cases:2
factors ,republic:2
factors ,korea:2
readmission ,cases:2
readmission ,covid-19:2
readmission ,republic:2
readmission ,korea:2
covid-19 ,republic:2
comprehensive ,mask:2
comprehensive ,utility:2
comprehensive ,challenges:2
comprehensive ,pandemic:2
review ,mask:2
review ,utility:2
mask ,utility:2
mask ,challenges:2
utility ,challenges:2
utility ,pandemic:2
clinical ,huangshi:2
characteristics ,re-positive:2
characteristics ,huangshi:2
re-positive ,huangshi:2
re-positive ,china:2
covid-19 ,huangshi:2
patients ,huangshi:2
huangshi ,china:2
sars-cov-2 ,attachment:2
sars-cov-2 ,rgd-integrin:2
attachment ,host:2
attachment ,cells:2
attachment ,possibly:2
attachment ,mediated:2
attachment ,via:2
attachment ,rgd-integrin:2
host ,possibly:2
host ,mediated:2
host ,rgd-integrin:2
cells ,possibly:2
cells ,mediated:2
cells ,via:2
cells ,rgd-integrin:2
possibly ,mediated:2
possibly ,via:2
possibly ,rgd-integrin:2
mediated ,via:2
mediated ,rgd-integrin:2
via ,rgd-integrin:2
novel ,treatments:2
case ,treatments:2
report ,treatments:2
clinical ,fingolimod:2
clinical ,withdrawal:2
exacerbation ,sars-cov2:2
exacerbation ,infection:2
exacerbation ,fingolimod:2
exacerbation ,withdrawal:2
sars-cov2 ,fingolimod:2
sars-cov2 ,withdrawal:2
infection ,fingolimod:2
infection ,withdrawal:2
fingolimod ,withdrawal:2
hiv ,times:2
hiv ,crisis:2
hiv ,now:2
hiv ,central:2
hiv ,eastern:2
care ,now:2
care ,eastern:2
times ,now:2
times ,central:2
times ,eastern:2
crisis ,now:2
crisis ,central:2
crisis ,eastern:2
now ,central:2
now ,eastern:2
central ,eastern:2
human ,ii:2
human ,immunopeptidome:2
leukocyte ,class:2
leukocyte ,ii:2
leukocyte ,immunopeptidome:2
leukocyte ,spike:2
antigen ,class:2
antigen ,ii:2
antigen ,immunopeptidome:2
antigen ,spike:2
class ,immunopeptidome:2
class ,spike:2
ii ,immunopeptidome:2
ii ,spike:2
immunopeptidome ,sars-cov-2:2
immunopeptidome ,spike:2
coagulopathy ,endothelial:2
coagulopathy ,dysfunction:2
coagulopathy ,microangiopathy:2
coagulopathy ,complement:2
endothelial ,microangiopathy:2
endothelial ,complement:2
dysfunction ,thrombotic:2
dysfunction ,microangiopathy:2
dysfunction ,complement:2
thrombotic ,complement:2
microangiopathy ,complement:2
inter ,nation:2
inter ,social:2
inter ,lockdown:2
inter ,versus:2
inter ,medical:2
inter ,care:2
inter ,covid-19:2
inter ,mild:2
nation ,social:2
nation ,lockdown:2
nation ,versus:2
nation ,medical:2
nation ,care:2
nation ,mild:2
social ,versus:2
social ,mild:2
lockdown ,versus:2
lockdown ,medical:2
lockdown ,mild:2
medical ,mild:2
combination ,early:2
combination ,stage:2
combination ,novel:2
combination ,infection:2
therapy ,stage:2
stage ,novel:2
stage ,coronavirus:2
stage ,infection:2
management ,hemoglobin:2
hemoglobin ,disorders:2
hemoglobin ,covid-19:2
hemoglobin ,pandemic:2
disorders ,pandemic:2
taste ,interleukin-6:2
smell ,interleukin-6:2
disorders ,interleukin-6:2
prevalence ,anti-sars-cov-2:2
prevalence ,outpatients:2
prevalence ,public:2
prevalence ,university:2
anti-sars-cov-2 ,outpatients:2
anti-sars-cov-2 ,large:2
anti-sars-cov-2 ,university:2
antibodies ,outpatients:2
antibodies ,large:2
antibodies ,university:2
outpatients ,large:2
outpatients ,public:2
outpatients ,university:2
large ,public:2
large ,university:2
public ,university:2
mental ,whose:2
mental ,rights:2
mental ,taken:2
mental ,away:2
mental ,essay:2
health ,whose:2
health ,rights:2
health ,taken:2
health ,away:2
health ,essay:2
whose ,rights:2
whose ,taken:2
whose ,away:2
whose ,essay:2
rights ,taken:2
rights ,away:2
rights ,essay:2
taken ,away:2
taken ,essay:2
away ,essay:2
preliminary ,invitro:2
preliminary ,invivo:2
preliminary ,effectiveness:2
preliminary ,dornase:2
preliminary ,alfa:2
report ,invitro:2
report ,invivo:2
report ,effectiveness:2
report ,dornase:2
report ,alfa:2
invitro ,invivo:2
invitro ,effectiveness:2
invitro ,dornase:2
invitro ,alfa:2
invivo ,effectiveness:2
invivo ,dornase:2
invivo ,alfa:2
effectiveness ,dornase:2
effectiveness ,alfa:2
dornase ,alfa:2
extending ,identification:2
extending ,structural:2
extending ,features:2
extending ,responsible:2
extending ,anti-sars-cov:2
identification ,structural:2
identification ,features:2
identification ,anti-sars-cov:2
structural ,responsible:2
structural ,anti-sars-cov:2
features ,responsible:2
features ,anti-sars-cov:2
responsible ,anti-sars-cov:2
potential ,interventions:2
interventions ,novel:2
interventions ,coronavirus:2
interventions ,china:2
interventions ,systematic:2
china ,systematic:2
pilot ,evaluation:2
pilot ,safety:2
pilot ,profile:2
pilot ,inhibitor:2
study ,safety:2
study ,profile:2
evaluation ,profile:2
evaluation ,potential:2
evaluation ,inhibitor:2
safety ,profile:2
safety ,potential:2
safety ,inhibitor:2
profile ,potential:2
profile ,inhibitor:2
absence ,effluent:2
absence ,peritoneal:2
absence ,dialysis:2
absence ,patients:2
sars-cov-2 ,peritoneal:2
effluent ,peritoneal:2
effluent ,dialysis:2
effluent ,patients:2
peritoneal ,patients:2
dialysis ,patients:2
